TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72146755
TI  - Hydrogen peroxide release is increased in umbilical venous endothelial cells obtained from premature infants who die or develop bronchopulmonary dysplasia
AU  - Kandasamy J.
AU  - Ambalavanan N.
Y1  - 2015//
KW  - *endothelium cell
KW  - *prematurity
KW  - *infant
KW  - *human
KW  - *lung dysplasia
KW  - *society
KW  - risk
KW  - fluorescence
KW  - female
KW  - petri dish
KW  - pregnancy
KW  - in vitro study
KW  - death
KW  - diseases
KW  - adult
KW  - oxidative stress
KW  - hypothesis
KW  - excitation
KW  - model
KW  - *hydrogen peroxide
KW  - *free radical
KW  - mitochondrial DNA
KW  - resorufin
KW  - phosphate
KW  - superoxide
KW  - horseradish peroxidase
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 87
IS  - SUPPL. 1
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - J. Kandasamy, University of Alabama, Birmingham, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2015.10.353
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72146755
AB  - Purpose of Study: Human umbilical venous endothelial cells (HUVECs) have been used as model systems to study oxidative stress and associated inflammatory pathways in several adult onset diseases. Our primary aim in this study was to investigate if differences in free radical generation in HUVECs obtained from extremely preterm infants could be associated with varying risk for death or bronchopulmonary dysplasia (BPD) Methods Used: In vitro cultures of HUVECs isolated from cord segments of 32 infants between 23-32 weeks gestation were grown to confluence in P100 petri dishes and incubated with Krebs's ringer phosphate Solution containing Amplex Red reagent and horseradish peroxidase for 30 min at 37degreeC. Extracellular hydrogen peroxide (H2O2) released by these cells was quantified using resorufin arbitrary fluorescence units measured in their supernatants at excitation and emission wavelengths of 530 and 590 nm respectively. Summary of Results: HUVECs of infants who developed BPD or died released higher concentrations of H2O2 into their supernatants compared to HUVECs obtained from infants who survived without BPD (resorufin arbitrary fluorescence units/30000 cells; Median [25-75th centiles]: 2529.4 [1388.9-4481.3] vs. 402.6 [356.5-650.6], p<0.001 (Figure 1). HbFe3+ Increased production of free radicals such as H2O2 from vascular endothelial cells of infants at risk for BPD could lead to mtDNA damage and reduced mitochondrial function. Measurements of generation of other free radicals such as the superoxide anion and mtDNA damage in these HUVECs are ongoing, and will be useful to further investigate these hypotheses.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72146749
TI  - Protective effects of aurothioglucose on hyperoxia-dependent cellular toxicity in murine airway clara cells
AU  - Wall S.B.
AU  - Locy M.L.
AU  - Moore M.
AU  - Hill C.L.
AU  - Ricart K.C.
AU  - Li Q.
AU  - Tipple T.E.
Y1  - 2015//
KW  - *hyperoxia
KW  - *toxicity
KW  - *airway
KW  - *Clara cell
KW  - *society
KW  - cell count
KW  - lung injury
KW  - lung
KW  - exposure
KW  - mouse
KW  - lung development
KW  - mouse model
KW  - lung dysplasia
KW  - newborn
KW  - human
KW  - epithelium cell
KW  - intraperitoneal drug administration
KW  - ambient air
KW  - infant
KW  - prematurity
KW  - cell viability
KW  - density
KW  - morbidity
KW  - hypothesis
KW  - *free radical
KW  - *aurothioglucose
KW  - thioredoxin reductase 1
KW  - transcription factor
KW  - nuclear factor
KW  - selenocysteine
KW  - sodium selenite
KW  - oxygen
KW  - trypan blue
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 87
IS  - SUPPL. 1
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - S.B. Wall, University of Alabama, Birmingham, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2015.10.366
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72146749
AB  - Bronchopulmonary dysplasia (BPD), characterized by disrupted lung development, is the most common respiratory morbidity in premature infants. Previous in vivo data from our lab indicated that a single intraperitoneal injection of the thioredoxin reductase-1 (TrxR1) inhibitor, aurothioglucose (ATG), attenuates lung injury in a newborn mouse model of BPD, likely by mechanisms mediated by activation of the transcription factor nuclear factor E2-related factor 2 (Nrf2). The present study examined cellular responses to ATG using murine airway Club cells (mtCCs). We tested the hypothesis that ATG would attenuate the effect of hyperoxia on viable cell numbers of mtCCs. Cells were seeded at equal densities in media supplemented with 25 nM sodium selenite to optimize selenocysteine incorporation and TrxR1 activity, as previously described and were exposed to hyperoxia (85% oxygen) or room air (RA) in the presence or absence of 5 muM ATG for 24 h. Viable cell numbers were determined using trypan blue exclusion. ATG inhibited TrxR1 activity and induced Nrf2 nuclear accumulation in mtCCs. Hyperoxia exposure decreased viable cell numbers by 54% compared to RA controls (n = 6, P = 0.0001). Importantly, ATG-treated hyperoxia exposed cells showed an increase of 23% when compared to control hyperoxia exposed cells (n = 6, p = 0.001). In RA-exposed cells, ATG treatment also significantly increased viable cell numbers by 24% from control (n = 6, p = 0.01). The present study demonstrates that ATG treatment enhances cell viability upon exposure to hyperoxia in airway epithelial cells. The fact that ATG enhanced viable cell numbers in RA suggests that ATG may stimulate proliferation. Collectively, these data provide insight into the potential mechanisms by which ATG attenuates lung injury in the neonatal lung in vivo. Our data provide compelling rationale for the potential clinical efficacy of the TrxR1 inhibitor ATG to protect against hyperoxic lung injury in the newborn lung.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72146743
TI  - Dose dependent effects of aurothioglucose in Murine Derived Type II lung epithelial cells
AU  - Moore M.
AU  - Wall S.B.
AU  - Locy M.L.
AU  - Hill C.L.
AU  - Ricart K.C.
AU  - Li Q.
AU  - Tipple T.E.
Y1  - 2015//
KW  - *lung
KW  - *epithelium cell
KW  - *society
KW  - mouse
KW  - injury
KW  - lung dysplasia
KW  - human
KW  - morbidity
KW  - prematurity
KW  - lung development
KW  - lung injury
KW  - mouse model
KW  - time-dependent inhibition
KW  - attenuation
KW  - antioxidant responsive element
KW  - lung alveolus epithelium cell
KW  - cell viability
KW  - intraperitoneal drug administration
KW  - assay
KW  - cell count
KW  - cell culture
KW  - exposure
KW  - infant
KW  - lung parenchyma
KW  - hyperoxia
KW  - safety
KW  - newborn
KW  - *free radical
KW  - *aurothioglucose
KW  - insulin
KW  - transcription factor
KW  - nuclear factor
KW  - thioredoxin reductase 1
KW  - trypan blue
KW  - disulfide
KW  - oxidoreductase
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 87
IS  - SUPPL. 1
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - M. Moore, University of Alabama, Birmingham, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2015.10.360
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72146743
AB  - Bronchopulmonary dysplasia (BPD), characterized by disrupted lung development, is the most common respiratory morbidity in premature infants. Previous in vivo data from our lab indicated that a single intraperitoneal injection of the thioredoxin reductase-1 (TrxR1) inhibitor, aurothioglucose (ATG), attenuates lung injury in a newborn mouse model of BPD. Mechanisms of injury attenuation are likely mediated by activation of the transcription factor nuclear factor E2-related factor 2 (Nrf2) as ATG activates the antioxidant response element (ARE) via activation of Nrf2. We hypothesized that ATG would inhibit TrxR1 in cultured lung epithelial cells in a concentration and time-dependent manner. Murine alveolar epithelial cells (MLE-12) were cultured in the presence or absence of ATG (0.1 to 10 muM) and cell viability (trypan blue exclusion), TrxR1 activity (insulin disulfide reductase assay), and ARE activation (Nrf2 nuclear accumulation). Our data indicated that viable cell number in MLE-12 cells cultured in ATG concentrations of up to 10 muM were not different than control-treated cells. Concentrations of >=1 muM ATG inhibited TrxR significantly at 1 h post-treatment when compared to control; while increasing the exposure time to 24 h resulted in significant inhibition at 0.5 muM ATG. These data reflect a time-dependent inhibition of TrxR1 in MLE-12 cells which is similar to inhibition of TrxR1 and Nrf2 activation observed in neonatal lung tissues from 1 d and 3 d old neonatal mice treated with ATG. Future studies in MLE-12 cells will assess direct ARE activation and Nrf2 accumulation and will provide additional insights into the mechanisms by which ATG attenuates hyperoxia-induced lung developmental deficits in vivo. Moreover, these studies will provide rational for the clinical efficacy and safety of the TrxR1 inhibitor, ATG, to protect against hyperoxic injury in the newborn lung.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72114188
TI  - Physiotherapy treatment in the prevention of bronchopulmonary dysplasia and reduction of perinatal risk in preterm infants
AU  - Gomez-Conesa A.
AU  - Fernandez-Rego F.J.
AU  - Perez-Lopez J.
AU  - Aguera-Arenas J.A.
Y1  - 2015//
KW  - *physiotherapy
KW  - *lung dysplasia
KW  - *prematurity
KW  - *infant
KW  - *human
KW  - *risk
KW  - *prevention
KW  - air conditioning
KW  - hospitalization
KW  - risk factor
KW  - disability
KW  - respiratory distress syndrome
KW  - child
KW  - gestational age
KW  - male
KW  - health
KW  - effect size
KW  - newborn care
KW  - Student t test
KW  - birth weight
KW  - morbidity
KW  - survival
KW  - intensive care unit
KW  - newborn intensive care
KW  - low birth weight
KW  - control group
KW  - respiratory tract disease
KW  - neonatology
KW  - pathology
KW  - child development
T2  - Physiotherapy (United Kingdom)
LA  - English
VL  - 101
IS  - SUPPL. 1
PB  - Elsevier Ltd
SN  - 0031-9406
AD  - A. Gomez-Conesa, Murcia University, Physiotherapy, Murcia, Spain
DO  - https://dx.doi.org/10.1016/j.physio.2015.03.3249
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72114188
AB  - Background: Advances in intensive neonatal care mean that preterm infants with low birth weights have a greater chance of survival than ever before, what has been accompanied by an increase in the morbidity associated with prematurity. Recent studies relate the presence of perinatal risk factors with the future development of disabilities. Bronchopulmonary Dysplasia (BPD), a consequence of perinatal Respiratory Distress Syndrome (RDS) and ventilation extended beyond 28 days, is a frequent pathology in preterm infants and a risk factor affecting the child's development. One of the objectives of physiotherapy in neonatology is to prevent respiratory disorders from developing in preterm infants and to reduce risk factors concerning the development of disabilities. Purpose(s): To ascertain whether physiotherapy, following the Vojta method applied in the Neonatal Intensive Care Unit (NICU), can reduce both the number of days that preterm infants with RDS need ventilation and hospitalization and the neonatal risk of future abnormalities. Method(s): 45 children with a gestational age of<=32 weeks diagnosed with RDS were randomly allocated to two groups: (i) the experimental group (EG), which, besides the normal standard care provided by the NICU, also received physiotherapy for 30 days in two daily 10-minute sessions, and (ii) a control group (CG) that only received standard NICU care. Both groups were homogeneous regarding size (EG: 25 and CG: 20), sex (EG: 13 males and CG: 8 males), gestational age (EG: 199.32 days and CG: 200.70 days), and birth weight (EG: 1132.92 g and CG: 1139.00 g). The number of days that the members of each group needed ventilation support and remained in the NICU was recorded and also the preterm infants were assessed using the Perinatal Risk Inventory (PERI) at discharge. Result(s): Differences among means were assessed with a Student t test for independent samples and Cohen's d statistic was also calculated to determine the effect size. The results identified significant differences in favor of the experimental group in the number of days that preterm infants needed hospitalization (EG: Mean 71.32, SD 28.49; CG: Mean 120.70, SD 64.56; p = 0.004) and ventilation (EG: Mean 38.72; SD 34.31; CG: Mean 83.50, SD 67.10; p = 0.011), and also had lower risk scores upon discharge (EG: Mean 8.44, SD 3.20; CG: Mean 11.40, SD 3.40; p = 0.005). For all three variables the physiotherapy treatment had a high clinical relevance: ventilation: d = 0.81; hospitalization: d = 0.95 and perinatal risk: d = 0.89. Conclusion(s): Votja-based physiotherapy treatment was effective in reducing the need for ventilation and hospitalization, and also perinatal risk factors upon discharge from the NICU in preterm infants suffering RDS and BPD. Implications: Physiotherapy treatment in the NICU was effective in improving BPD in prematurely born children with RDS, reducing the number of days that ventilation and hospitalization were needed, while favouring the prevention of future disabilities. This will contribute to reducing future health costs, and the short, medium and long term educational and social costs that these childrenwould otherwise generate.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72107952
TI  - Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats
AU  - Chen X.
AU  - Walther F.
AU  - Van Boxtel R.
AU  - Laghmani E.H.
AU  - Sengers R.
AU  - Folkerts G.
AU  - Cuppen E.
AU  - Wagenaar G.
Y1  - 2015//
KW  - *hyperoxia
KW  - *lung injury
KW  - *rat
KW  - *European
KW  - *society
KW  - pneumonia
KW  - rat mutant
KW  - mortality
KW  - thickness
KW  - neutrophil
KW  - fibrosis
KW  - lung
KW  - adverse drug reaction
KW  - heart right ventricle hypertrophy
KW  - fibrin deposition
KW  - survival
KW  - lung dysplasia
KW  - heart
KW  - parameters
KW  - Wistar rat
KW  - macrophage
KW  - pulmonary hypertension
KW  - pathogenesis
KW  - gene
KW  - arteriole
KW  - histopathology
KW  - *lysophosphatidic acid receptor
KW  - collagen
KW  - messenger RNA
KW  - fibrin
KW  - ligand
KW  - collagen type 3
T2  - European Respiratory Journal
LA  - English
VL  - 46
IS  - SUPPL. 59
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - X. Chen
UR  - http://erj.ersjournals.com/content/46/suppl_59/PA1866
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72107952
DO  - https://dx.doi.org/10.1183/13993003.congress2015.PA1866
AB  - Blocking of lysophosphatidic acid (LPA) receptor (LPAR) 1 may be a novel therapeutic option for bronchopulmonary dysplasia (BPD) by preventing the LPAR1 mediated adverse effects of its ligand (LPA), consisting of pulmonary inflammation, pulmonary arterial hypertension (PAH) and fibrosis. In neonatal Wistar rats with hyperoxia-induced experimental BPD we determined the beneficial effects of LPAR1 deficiency and of LPAR1 and -3 blocking with Ki16425. Parameters investigated included survival, lung and heart histopathology, fibrin and collagen deposition, vascular leakage, and differential mRNA expression in the lungs of key genes involved in LPA signalling and BPD pathogenesis. LPAR1 mutant rats were protected against experimental BPD and mortality with reduced alveolar septal thickness, lung inflammation (reduced influx of macrophages and neutrophils, and CINC1 expression), and collagen III deposition. However, LPAR1 mutant rats were not protected against alveolar enlargement, increased medial wall thickness of small arterioles, fibrin deposition, and vascular alveolar leakage. Treatment of experimental BPD with Ki16425 confirmed the data observed in LPAR1 mutant rats, but did not reduce the pulmonary influx of neutrophils, CINC1 expression, and mortality in rats with experimental BPD. In addition, Ki16425 treatment protected against PAH and right ventricular hypertrophy. In conclusion, LPAR1 deficiency attenuates pulmonary injury by reducing pulmonary inflammation and fibrosis, thereby reducing mortality, but does not affect alveolar and vascular development and, unlike Ki16425 treatment, does not prevent PAH in neonatal rats with experimental BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72107771
TI  - Polymorphisms of ADRB2 gene and airway resistance in children with bronchopulmonary dysplasia
AU  - Zhdanovich E.
AU  - Furman E.
AU  - Ponomareva M.
AU  - Koryukina I.
Y1  - 2015//
KW  - *airway resistance
KW  - *child
KW  - *human
KW  - *lung dysplasia
KW  - *European
KW  - *society
KW  - *gene
KW  - DNA polymorphism
KW  - incidence
KW  - patient
KW  - air conditioning
KW  - bronchus
KW  - adrenergic receptor stimulating agent
KW  - bronchodilating agent
T2  - European Respiratory Journal
LA  - English
VL  - 46
IS  - SUPPL. 59
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - E. Zhdanovich
UR  - http://erj.ersjournals.com/content/46/suppl_59/PA4158
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72107771
DO  - https://dx.doi.org/10.1183/13993003.congress2015.PA4158
AB  - Actuality: Polymorphisms in the ADRB2 gene among children with bronchopulmonary dysplasia (BPD) can be associated with decreased reactivity of bronchi. Objective(s): To study the incidence rate of two ADRB2 gene polymorphisms and ventilation status in BPD. Method(s): Polymorphism variants in the ADRB2 gene were determined in 20 BPD children aged 8-23 months (the age at birth was 24-25 to 34 weeks) and healthy children. The patients with BPD were divided into 2 groups: group I (n=10) - with heterozygous polymorphism variant (Arg16Gly and Gln27Glu) in the ADRB2 gene or variants of their norm; group II (n=10) - with homozygous variant of one (Arg16Gly) or both polymorphisms (Arg16Gly and Gln27Glu) in the ADRB2 gene. Airway resistance was investigated with the interrupt technique (Rint) with broncholytic test. Result(s): In BPD, homozygous variant of one or both polymorphisms in the ADRB2 gene was revealed in 50% of children (n=10) and in 28% of healthy children, respectively. In both groups, increased Rint index was registered in 37,5% of children and was 1,3+/-0,13 kPa/l/s (145,1+/-9,8% of the standard) in group I, and 1,7+/-0,47 kPa/l/s (185,8+/-49,8%) in group II. After bronchial spasmolytic test, the mean value of Rint index in group I was 0,83+/-0,43 kPa/l/s (92,22+/-45,87%), and in group II 1,0+/-0,65 kPa/l/s (110,2+/-68,11%). Conclusion(s): There was a tendency to higher rate of homozygous variant of one or both polymorphisms in the ADRB2 gene in BPD - 50% compared to healthy 28%, respectively. There was a tendency to higher Rint index in group II (BPD with homozygous variant of one or both polymorphisms in the ADRB2 gene) compared to group I with decreased reactivity to sadrenergic agonist in group II.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72053402
TI  - Interstitial lung disease, bronchiectasis, and asthma in a patient with filamin a, alpha (FLNA) mutation
AU  - Bickel S.
AU  - Siefman M.
AU  - Eid N.S.
Y1  - 2015//
KW  - *bronchiectasis
KW  - *asthma
KW  - *patient
KW  - *human
KW  - *mutation
KW  - *American
KW  - *society
KW  - *interstitial lung disease
KW  - lung disease
KW  - phenotype
KW  - diagnosis
KW  - periventricular heterotopia
KW  - thorax
KW  - heart ventricle septum defect
KW  - neurologic disease
KW  - failure to thrive
KW  - medical history
KW  - open lung biopsy
KW  - acute disease
KW  - infant
KW  - visual hallucination
KW  - brain
KW  - hospital
KW  - cytoskeleton
KW  - girl
KW  - follow up
KW  - female
KW  - atelectasis
KW  - lung dysplasia
KW  - hyperinflation
KW  - lung
KW  - bronchoscopy
KW  - pneumothorax
KW  - pulmonology
KW  - seizure
KW  - esophagography
KW  - eye movement disorder
KW  - dysplasia
KW  - gliosis
KW  - corpus callosum
KW  - airway obstruction
KW  - sweat
KW  - lung function
KW  - etiology
KW  - heart injury
KW  - computer assisted tomography
KW  - lung diffusion capacity
KW  - intestine pseudoobstruction
KW  - case report
KW  - pulmonary valve stenosis
KW  - emphysema
KW  - bronchomalacia
KW  - nuclear magnetic resonance imaging
KW  - *filamin A
KW  - actin
KW  - glass
KW  - corticosteroid
KW  - chloride
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Bickel, University of Louisville, Louisville, KY, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A5487
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72053402
AB  - INTRODUCTION: Filamin A, Alpha (FLNA) assists in the formation of cellular cytoskeleton and actin linking throughout the body. Mutations have been reported as a cause of musculoskeletal, cardiovascular, and neurologic disorders. There is scarce literature regarding associations with pulmonary disease. We report on a pediatric patient with diffuse lung disease and a later diagnosis of FLNA mutation. CASE PRESENTATION: A 9 year old girl presented for routine follow-up to the pulmonology clinic. She had a complex past medical history including interstitial lung disease (ILD) and failure to thrive as an infant. She was born at term with a ventricular septal defect, pulmonary stenosis, and developed respiratory symptoms considered to be out of proportion to her cardiac lesions. Sweat chloride testing, upper GI series, and modified barium swallow were negative. High resolution chest CT showed ground glass opacification with areas of atelectasis and hyperinflation, resulting in diagnosis of ILD. A bronchoscopy and open lung biopsy were not performed due to parental preference, and later improvement on systemic corticosteroids. At 19 months of age, she experienced a moderate sized pneumothorax associated with an acute illness. She was later diagnosed with asthma which was well controlled. At age eight, she developed seizures described as visual hallucinations and abnormal eye movements. A CT and MRI of the brain showed magna cisterna, nonspecific gliosis in the corpus callosum, and periventricular heterotopia. Genetic workup resulted in the diagnosis of FLNA mutation (c.988-1 G>C). A chest CT scan was performed which showed new bronchiectasis without clear etiology. Complete pulmonary function testing demonstrated airflow obstruction (FEV1 75%, FEV1/FVC 0.71) with significant air trapping (RV/TLC 0.41) and diminished diffusion capacity (DLCO 52%). DISCUSSION: FLNA mutation causes a wide array of phenotypes including otopalatodigital syndromes, frontometaphyseal dysplasia, intestinal pseudo-obstruction and periventricular heterotopia. Rare case reports have described lung disease similar to bronchopulmonary dysplasia, congenital lobar emphysema, and bronchomalacia. Our case builds upon these prior reports as our patient presented with lung disease very early in life which evolved with time and later presented with a more well-recognized FLNA mutation phenotype. CONCLUSION(S): These findings highlight the importance of considering genetic abnormalities in young patients with otherwise unexplained diffuse lung disease, especially in those with co-existing musculoskeletal, cardiac, or neurologic abnormalities. Our case also demonstrates that FLNA mutation lung phenotypes may evolve with age.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2023 to 2024>
TI  - MALAT1 binds to miR-188-3p to regulate ALOX5 activity in the lung inflammatory response of neonatal bronchopulmonary dysplasia.
DO  - https://dx.doi.org/10.1016/j.molimm.2023.06.008
AU  - Feng, Dan-Dan
AU  - Chen, Jia-He
AU  - Chen, Yu-Fei
AU  - Cao, Qian
AU  - Li, Bing-Jie
AU  - Chen, Xiao-Qing
AU  - Jin, Rui
AU  - Zhou, Guo-Ping
Y1  - 2023//
Y2  - 20230627//
KW  - Animals
KW  - Rats
KW  - Arachidonate 5-Lipoxygenase
KW  - Bronchopulmonary Dysplasia/ge [Genetics]
KW  - *Bronchopulmonary Dysplasia
KW  - Cell Line, Tumor
KW  - *Hyperoxia
KW  - Leukocytes, Mononuclear/me [Metabolism]
KW  - Lung/me [Metabolism]
KW  - MicroRNAs/ge [Genetics]
KW  - MicroRNAs/me [Metabolism]
KW  - *MicroRNAs
KW  - RNA, Long Noncoding/ge [Genetics]
KW  - RNA, Long Noncoding/me [Metabolism]
KW  - *RNA, Long Noncoding
T2  - Molecular immunology
VL  - 160
SN  - 0161-5890
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med24&NEWS=N&AN=37385102
AD  - England
AB  - Bronchopulmonary dysplasia (BPD) causes high morbidity and mortality in infants, but no effective preventive or therapeutic agents have been developed to combat BPD. In this study, we assessed the expression of MALAT1 and ALOX5 in peripheral blood mononuclear cells from BPD neonates, hyperoxia-induced rat models and lung epithelial cell lines. Interestingly, we found upregulated expression of MALAT1 and ALOX5 in the experimental groups, along with upregulated expression of proinflammatory cytokines. According to bioinformatics prediction, MALAT1 and ALOX5 simultaneously bind to miR-188-3p, which was downregulated in the experimental groups above. Silencing MALAT1 or ALOX5 and overexpressing miR-188-3p inhibited apoptosis and promoted the proliferation of hyperoxia-treated A549 cells. Suppressing MALAT1 or overexpressing miR-188-3p increased the expression levels of miR-188-3p but decreased the expression levels of ALOX5. Moreover, RNA immunoprecipitation (RIP) and luciferase assays showed that MALAT1 directly targeted miR-188-3p to regulate ALOX5 expression in BPD neonates. Collectively, our study demonstrates that MALAT1 regulates ALOX5 expression by binding to miR-188-3p, providing novel insights into potential therapeutics for BPD treatment. Copyright Â© 2023 Elsevier Ltd. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2016>
TI  - Association of C609T-Inborn Polymorphism of NAD(P)H: Quinone Oxidoreductase 1 with the Risk of Bronchopulmonary Dysplasia in Preterm Neonates.
DO  - https://dx.doi.org/10.1055/s-0035-1569991
AU  - Gavrili, Stavroula
AU  - Zachaki, Sophia
AU  - Daraki, Aggeliki
AU  - Polycarpou, Elena
AU  - Manola, Kalliopi
AU  - Stavropoulou, Chryssa
AU  - Sambani, Constantina
AU  - Baroutis, George
Y1  - 2016//
Y2  - 20151218//
KW  - Alleles
KW  - *Bronchopulmonary Dysplasia/ge [Genetics]
KW  - Case-Control Studies
KW  - Female
KW  - Gene Frequency
KW  - Genetic Predisposition to Disease
KW  - Greece
KW  - Humans
KW  - Infant, Newborn
KW  - *Infant, Premature
KW  - Logistic Models
KW  - Male
KW  - *NAD(P)H Dehydrogenase (Quinone)/ge [Genetics]
KW  - Polymerase Chain Reaction
KW  - *Polymorphism, Single Nucleotide
T2  - American journal of perinatology
VL  - 33
IS  - 6
SN  - 0735-1631
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=26683602
AD  - United States
AB  - UNLABELLED: Objectives In bronchopulmonary dysplasia (BPD), direct exposure to oxygen therapy can damage the pulmonary epithelium via oxidative stress. The, NAD(P)H: quinone oxidoreductase 1 (NQO1) enzyme detoxifies genotoxic products of oxidative stress. The corresponding gene is subject to an inactivating single-nucleotide polymorphism (C(609)T), which reduces detoxifying ability. The aim of this study was to investigate whether the C(609)T NQO1 inborn gene polymorphism is associated with an increased risk of BPD. Study Design Peripheral blood samples from 119 premature neonates <= 32 weeks of gestational age (42 BPD and 77 non-BPD) were used for DNA extraction. NQO1 genotyping was performed using the polymerase chain reaction-restriction fragment length polymorphism method. Results A significantly higher frequency of the NQO1 polymorphism was observed in BPD neonates compared with neonates without BPD. All neonates with <= 1,000 g birth weight who carried the mutant allele in heterozygous or homozygous state developed BPD. None of the BPD nonaffected group neonates with <= 1,000 g birth weight carried the NQO1 polymorphism. Conclusion The higher incidence of NQO1 mutants among BPD neonates as well as the presence of the mutant allele in all neonates with <= 1,000 g who developed BPD provided the first evidence for a possible pathogenetic role of the C(609)T polymorphism in BPD susceptibility due to the reduction or loss of NQO1 enzymatic activity. Copyright Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72053392
TI  - RAC1 plays an important role in lung morphogenesis through regulation of canonical WNT signaling
AU  - Danopoulos S.
AU  - Krainock M.
AU  - Warburton D.
AU  - Al Alam D.
Y1  - 2015//
KW  - *morphogenesis
KW  - *American
KW  - *society
KW  - *lung
KW  - explant
KW  - branching morphogenesis
KW  - lung hypoplasia
KW  - cell proliferation
KW  - congenital malformation
KW  - epithelium cell
KW  - prematurity
KW  - lung dysplasia
KW  - lung development
KW  - cell polarity
KW  - cell differentiation
KW  - polarization
KW  - organogenesis
KW  - mouse
KW  - mesenchyme cell
KW  - cell death
KW  - gene
KW  - angiogenesis
KW  - Wnt signaling pathway
KW  - Rho guanine nucleotide binding protein
KW  - ligand
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Danopoulos, Children's Hospital Los Angeles, Los Angeles, CA, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A5477
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72053392
AB  - Lung branching morphogenesis relies on a number of factors, including proper epithelial cell polarity and migration; however, little is understood about how these factors support epithelial branching. For this reason treatments for congenital malformations such as pulmonary hypoplasia or prematurity related bronchopulmonary dysplasia are limited and insufficient. Rac1 is a small Rho GTPase that orchestrates a number of diverse cellular responses including cell proliferation and differentiation, cell alignment, polarization, and cytoskeletal rearrangements, all of which are primary events for lung branching. Furthermore, Rac1 has been shown to play a role in both non-canonical and canonical Wnt signaling, both of which are necessary in lung organogenesis. Using a Rac1 inhibitor (NSC23766) on embryonic mouse lung explants (E12.5), we now can report that Rac1/canonical Wnt signaling is critical in lung development. Rac1 inhibition resulted in impaired branching following 48 hours in culture. Branching defects were accompanied with impaired vascular development seen in Flk1-LacZ reporter explants and increased mesenchymal cell death. A decrease in the expression of key genes in lung branching such as Fgf10, Fgfr2b, Sprouty2 and Vegfa was also observed. In order to determine whether this inhibitory effect of Rac1 is mediated through canonical Wnt signaling, we then used the Axin2-LacZ reporter line, and demonstrated a strong inhibition in canonical Wnt signaling in the explants treated with the Rac1 inhibitor. Moreover, we observed a strong increase in the Wnt inhibitory factor 1 (Wif-1). Canonical Wnt ligands (Wnt3a and Wnt7b) in presence of the Rac1 inhibitor were able to rescue the branching defects. In conclusion, we provide functional evidence that Rac1 regulates lung branching morphogenesis and vasculogenesis likely through the canonical Wnt signaling pathway.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72053389
TI  - Cytokine airway responses to acute rhinovirus infection and respiratory morbidity in severe premature children
AU  - Perez G.F.
AU  - Pancham K.
AU  - Huseni S.
AU  - Jain A.
AU  - Rodriguez-Martinez C.E.
AU  - Preciado D.
AU  - Rose M.
AU  - Nino G.
Y1  - 2015//
KW  - *human
KW  - *airway
KW  - *morbidity
KW  - *prematurity
KW  - *child
KW  - *Rhinovirus infection
KW  - *American
KW  - *society
KW  - infection
KW  - secretion (process)
KW  - asthma
KW  - electronic medical record
KW  - immunoassay
KW  - pathogenesis
KW  - Rhinovirus
KW  - infant
KW  - hospitalization
KW  - pregnancy
KW  - virus
KW  - lung dysplasia
KW  - cytokine response
KW  - intensive care unit
KW  - risk factor
KW  - medical record review
KW  - *cytokine
KW  - interleukin 4
KW  - protein
KW  - thymic stromal lymphopoietin
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - G.F. Perez, Children's National Health System, Washington, DC, United States. E-mail: gperez@childrensnational.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A5474
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72053389
AB  - Background Rhinovirus (RV) has been strongly linked to the pathogenesis of asthma in children. Prematurity is a risk factor for severe RV infection in early life, but is unknown if RV elicits pro-asthmatic airway cytokine responses in premature infants. This study investigated if young children born severely premature (<32 weeks gestation) exhibit airway secretion of Th2/Th17 cytokines during natural RV infections and if RV-induced Th2/Th17 responses are linked to more respiratory morbidity in premature children during the first two years of life. Methods We measured Th2/Th17 nasal airway cytokines in a retrospective cohort of young children aged 0-2 years with PCR-confirmed RV infection or non-detectable virus. Protein levels of IL-4, IL- 13, TSLP and IL-17 were determined with multiplex magnetic bead immunoassays. Demographic and clinical variables were obtained by electronic medical record (EMR) review. Results The study comprised 214 children born full term (n=108), pre-term (n=44) or severely premature (n=62). Natural RV infection in severely premature children was associated with elevated airway secretion of Th2 (IL-4 and IL-13) and Th17 (IL-17) cytokines, particularly in subjects with history of bronchopulmonary dysplasia. Severely premature children with high RV-induced airway IL-4 had recurrent respiratory hospitalizations (median 3.65 hosp/year; IQR 2.8-4.8) and were more likely to have at least one pediatric intensive care unit admission during the first two years of life (OR 8.72; 95% CI 1.3-58.7; p=0.02). Conclusions Severely premature children have increased airway secretion of Th2/Th17 cytokines during RV infections, which is associated with more respiratory morbidity in the first two years of life.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72053387
TI  - The role of miR-135b in late lung development
AU  - Nardiello C.
AU  - Ruiz-Camp J.
AU  - Seeger W.
AU  - Morty R.E.
Y1  - 2015//
KW  - *American
KW  - *society
KW  - *lung development
KW  - mouse
KW  - lung
KW  - hyperoxia
KW  - thickness
KW  - epithelium cell
KW  - exposure
KW  - macrophage
KW  - chronic lung disease
KW  - species
KW  - lung fibroblast
KW  - human
KW  - lung dysplasia
KW  - computer model
KW  - mouse model
KW  - animal model
KW  - infant
KW  - experimental animal
KW  - plasticity
KW  - tissue differentiation
KW  - prematurity
KW  - cells by body anatomy
KW  - organogenesis
KW  - smooth muscle fiber
KW  - antagomir
KW  - microRNA
KW  - bone morphogenetic protein
KW  - transforming growth factor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C. Nardiello, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany. E-mail: claudio.nardiello@mpi-bn.mpg.de
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A5472
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72053387
AB  - Bronchopulmonary dysplasia (BPD) is a chronic lung disease of premature infants, characterized by arrested alveolar septation, leading to impaired development of the immature lung. The pathomechanisms at play that underlie this arrested lung development are largely unknown. In the present study, a potential role for microRNA (miR) species - which are emerging as key regulators or organogenesis and tissue differentiation - in arrested alveolarization in an experimental animal model of BPD was assessed. A microarray screen identified miR-135b as being highly upregulated (2-fold, 2-fold, 4-fold, 8-fold, at 2, 3, 5, and 14 days post-natal, respectively) by exposure of newborn mouse lungs to hyperoxic (85% O2) conditions, in a well-characterized mouse model of BPD. A comparison of primary mouse lung fibroblasts, macrophages, and epithelial (alveolar type II) and smooth muscle cells revealed miR-135b to be expressed primarily in lung epithelial cells, placing miR-135b in an ideal cell-type to influence epithelial cell plasticity and septal development. Application of antagomiR-135b consistently suppressed lung miR-135b expression, as well as that of miR-135a, which together constitute the miR-135 family of microRNA. This suppression was seen under normoxic and hyperoxic conditions. The total septal volume in lungs from 14-day old mice was reduced from 0.11 cm3 (normoxia, scrambled antagomiRs) to 0.06 cm3 (hyperoxia, scrambled antagomiRs). Application of antagomiR-135b largely restored lung septal volume, to 0.10 cm3 (hyperoxia, antagomirs-135b), as assessed by state-of-the-art stereomorphological analysis. The miR-135 family was also demonstrated to play a role in the regulation of septal wall thickness, where the septal thickness in lungs from 14-day old mice was increased from 10.2 mum (normoxia, scrambled antagomiRs) to 15.7 mum (hyperoxia, scrambled antagomiRs). Application of antagomiR-135b tended to further increase septal wall thickness in hyperoxia-exposed mouse pups, to 18.4 mum (hyperoxia, antagomirs-135b). In silico analysis identified Smad5 as a candidate miR-135b target, which is a key signalling molecule in the developmentally important transforming growth factor-beta and bone morphogenetic protein signalling systems. Consistent with this idea, Smad5 levels in the lungs of hyperoxia-exposed newborn mouse pups were reduced compared with normoxia-exposed mouse pups. Furthermore, application of antagomir-135b to hyperoxia-exposed mouse largely restored normal Smad5 expression. These data suggest that the impact of miR-135b - levels of which are elevated during perturbed late lung development associated with hyperoxia exposure - on Smad5 expression may play a role in aberrant alveolarization of the developing mouse lung.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72053386
TI  - Antagonizing lysyl oxidase activity in experimental bronchopulmonary dysplasia
AU  - Mizikova I.
AU  - Ruiz-Camp J.
AU  - Brinckmann J.
AU  - Seeger W.
AU  - Morty R.E.
Y1  - 2015//
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - mouse
KW  - lung
KW  - hyperoxia
KW  - model
KW  - exposure
KW  - lung structure
KW  - architecture
KW  - lung development
KW  - thickness
KW  - turnover time
KW  - mouse model
KW  - cross linking
KW  - in vitro study
KW  - extracellular matrix
KW  - processing
KW  - ultrastructure
KW  - fiber
KW  - lung homogenate
KW  - pathology
KW  - premature labor
KW  - assay
KW  - intraperitoneal drug administration
KW  - *protein lysine 6 oxidase
KW  - 3 aminopropionitrile
KW  - collagen
KW  - pyridinoline
KW  - elastin
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - I. Mizikova, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany. E-mail: Ivana.Mizikova@mpi-bn.mpg.de
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A5471
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72053386
AB  - Bronchopulmonary dysplasia (BPD) is a key complication of preterm birth characterised by arrested alveolarization during late lung development. Perturbations to the production and processing of the extracellular matrix (ECM) are believed to play a pivotal role in this aberrant lung development. The expression of lysyl oxidases, which include five family members, is known to be upregulated in both clinical and experimental BPD. The aim of the current study was to assess a causal role for lysyl oxidases in a mouse model of BPD. In this study, the lysyl oxidase inhibitor beta-aminopropionitrile (BAPN; 15 mg/kg/day) was applied (intraperitoneal) to newborn mouse pups, exposed to 85% O2, in a well-characterised BPD model. Hyperoxic exposure led to an increase in lysyl oxidase activity from 152 AFU.min-1 (under normoxic conditions) to 356 AFU.min-1 (under hyperoxic conditions), which was reduced to 53 AFU.min-1 (under hyperoxic conditions with BAPN application) in lung homogenates, assessed in vitro in an Amplex Red-based assay. Additionally, application of BAPN led to a reduction in lysyl oxidase activity on endogenous collagen substrates in vivo, evident from a decrease in hydroxylysylpyridinoline collagen cross-links, and also led to a decrease in total collagen abundance in the lung, normalizing lung total collagen levels, possibly reflecting increased collagen turnover. These data indicated that BAPN administration did antagonize lysyl oxidase activity in vivo, in the BPD model. However, antagonism of lysyl oxidase activity did not lead to normalised lung structure. Exposure of newborn mouse pups to hyperoxia for 20 days decreased the total alveoli number from 7.05 million (under normoxic conditions) to 2.33 million (under hyperoxic conditions). Concomitant administration of BAPN had no impact on alveoli number. Similarly, exposure of newborn mouse pups to hyperoxia for 20 days increased septal wall thickness from 8.8 mum (under normoxic conditions) to 13.2 mum (under hyperoxic conditions). Septal thickness was further increased to 15.2 mum under hyperoxic conditions with concomitant BAPN administration, thus worsening lung architecture. Thus, BAPN administration, although successful in antagonizing lysyl oxidase activity, could not improve lung architecture in the mouse BPD model. Noteworthy, however, was an apparent improvement in the septal elastin fiber ultrastructure upon BAPN administration, perhaps indicating that BAPN administration could partially reverse lung pathology, but antagonisms of lysyl oxidase activity alone was not sufficient to restore proper lung structure to the hyperoxia-exposed developing mouse lung.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72053379
TI  - Serum neurotrophin levels may help predict bronchopulmonary dysplasia diagnosis in premature neonates
AU  - Schneeberger D.
AU  - Grayson S.
AU  - Worley S.
AU  - Tang A.
AU  - Piedimonte G.
Y1  - 2015//
KW  - *serum
KW  - *lung dysplasia
KW  - *diagnosis
KW  - *prematurity
KW  - *newborn
KW  - *human
KW  - *American
KW  - *society
KW  - receiver operating characteristic
KW  - patient
KW  - baby
KW  - airway
KW  - birth weight
KW  - mother
KW  - innervation
KW  - physician
KW  - gestational age
KW  - clinical study
KW  - female
KW  - infant
KW  - mortality
KW  - immunoassay
KW  - morbidity
KW  - prospective study
KW  - hospital
KW  - school
KW  - university
KW  - United States
KW  - prediction
KW  - pathology
KW  - inflammation
KW  - age
KW  - risk
KW  - area under the curve
KW  - oxygen consumption
KW  - *neurotrophin
KW  - brain derived neurotrophic factor
KW  - antibiotic agent
KW  - protein
KW  - nerve growth factor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - D. Schneeberger, Cleveland Clinic Children's, Cleveland, OH, United States. E-mail: brownp4@ccf.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A5464
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72053379
AB  - Rationale: Bronchopulmonary dysplasia (BPD), defined as oxygen requirement at 28 days chronological age, is a common cause of morbidity and mortality in premature infants. While the development of BPD is strongly related to gestational age (GA), this factor alone does not allow physicians to predict which babies will develop BPD. Because of their role in airway innervation and inflammation, two processes that define BPD pathology, we hypothesized that serum neurotrophin levels at birth may help predict which premature babies will develop BPD. Method(s): Premature neonates (GA < 37 weeks) admitted to the NICU at West Virginia University School of Medicine and Cleveland Clinic were enrolled as part of an ongoing prospective study of serum neurotrophin levels and BPD. Serum samples were collected within 48 hours of birth, and a highly sensitive immunoassay was used to measure nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) protein concentrations. Subjects were followed until discharge, and both maternal and patient clinical data were collected. Receiver operating characteristic (ROC) analysis was used to compare subject characteristics on prediction of BPD as measured by the area under the ROC curve (AUC). Result(s): Of the 57 subjects who had both NGF and BDNF concentrations measured, 23 (40%) developed BPD. These subjects had significantly younger mothers, lower rates of antenatal antibiotic administration, and had significantly lower GA (median 27 vs. 34 weeks), birthweight (median 965 vs. 2,270 grams), and serum NGF concentrations (median 2,052 vs. 5,835 pg/mL) compared to subjects without BPD (p<0.05). Additionally, BDNF concentrations were lower in subjects with BPD compared to subjects without BPD (p=0.13). ROC analysis showed that GA is the best predictor of BPD in our cohort (AUC = 0.91, 95% CI 0.83-1.00). Serum NGF and BDNF levels on their own were not able to predict BPD diagnosis as well as GA (NGF AUC = 0.69; BDNF AUC = 0.62), but the addition of serum neurotrophins to GA improves the ability to predict BPD diagnosis by a small amount (GA + NGF + BDNF AUC = 0.94, 95% CI 0.87-1.00; p=0.25 versus GA alone). Conclusion(s): In this interim analysis, serum neurotrophin levels at birth were associated with the development of BPD in preterm neonates and may increase the ability to predict a baby's risk of developing BPD at 28 days of life. Further analysis and adjustment for other patient characteristics is needed as more data is collected.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72053002
TI  - Omeprazole potentiates hyperoxia-induced developmental lung injury in newborn mice via aryl hydrocarbon receptor dependent mechanism(S)
AU  - Shivanna B.
AU  - Zhang S.
AU  - Patel A.
AU  - Zhang W.
AU  - Wang L.
AU  - Moorthy B.
Y1  - 2015//
KW  - *hyperoxia
KW  - *lung injury
KW  - *mouse
KW  - *American
KW  - *society
KW  - oxidative stress
KW  - pneumonia
KW  - exposure
KW  - newborn
KW  - hypothesis
KW  - wild type
KW  - therapy
KW  - lung
KW  - inflammation
KW  - lung dysplasia
KW  - neutrophil
KW  - membrane
KW  - lung alveolus macrophage
KW  - adult
KW  - human
KW  - oxygen toxicity
KW  - angiogenesis
KW  - model
KW  - infant
KW  - lung lavage
KW  - prematurity
KW  - dose response
KW  - lung blood vessel
KW  - *omeprazole
KW  - *aromatic hydrocarbon receptor
KW  - 3 nitrotyrosine
KW  - malonaldehyde
KW  - macrogol
KW  - hyalin
KW  - enzyme
KW  - protein
KW  - antioxidant
KW  - vasculotropin
KW  - protein A
KW  - receptor
KW  - marker
KW  - quinone derivative
KW  - oxidoreductase
KW  - nicotinamide adenine dinucleotide phosphate
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - B. Shivanna, Baylor College of Medicine, Houston, TX, United States. E-mail: shivanna@bcm.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A5132
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72053002
AB  - RATIONALE: Hyperoxia contributes to bronchopulmonary dysplasia (BPD) in preterm infants. We showed that omeprazole (OM) protects adult mice against hyperoxic lung injury via aryl hydrocarbon receptor (AhR)-dependent mechanisms. Additionally, we observed that newborn AhR dysfunctional mice are more susceptible to hyperoxia-induced lung inflammation and alveolar simplification than wild type controls. Whether OM protects newborn mice against hyperoxia-induced developmental lung injury is unknown. Therefore, we tested the hypothesis that omeprazole will decrease hyperoxia-induced lung inflammation, oxidative stress, and alveolar simplification in newborn mice via AhR activation. METHOD(S): One day-old wild type C57BL/6J (WT) pups while exposed to either air (normoxia) or 85 % O2 (hyperoxia) for 14 d, were administered 10 or 25 mg/kg of OM or an equivalent volume of the vehicle, polyethylene glycol (PEG), i.p. once daily from birth for 14 d. The dosing regimen was based on our dose-response studies that suggested at least 25 mg/kg/d of i.p. OM for 3-6 d is required to activate the AhR. Additionally, we used OM at a dose of 10 mg/kg/d to determine its AhR independent effects. Following experiments, the lungs and bronchoalveolar lavage fluid (BALF) of the mice were harvested to determine AhR activation, inflammation, oxidative stress, angiogenesis, and alveolarization. RESULT(S): OM treatment (10 to 25 mg/kg) increased oxygen toxicity in a dose-dependent manner. OM treated mice were significantly growth restricted upon exposure to hyperoxia. Furthermore, OM increased hyperoxia induced lung macrophage influx. Interestingly, mice treated with the 25 mg/kg dose of OM had persistent acute lung inflammation upon exposure to hyperoxia as evident by the presence of hyaline membranes, neutrophil infiltrates, and proteinaceous debris in the alveolar space. Additionally, higher dose OM: i. Increased BALF protein concentration, lung malondialdehyde and nitrotyrosine levels, and alveolar simplification; and ii. Decreased the expression of vascular endothelial growth factor and its receptor, and vonWillibrand factor positive lung blood vessels, compared to the vehicle-treated mice exposed to hyperoxia. Surprisingly, CYP1A1 protein, a marker of AhR-activation, was degraded with prolonged treatment (14 d) with OM. Furthermore, OM decreased the expression of NADP(H) quinone oxidoreductase, an antioxidant enzyme, which is also regulated by the AhR. CONCLUSION(S): Contrary to our hypothesis, prolonged OM therapy decreases functional AhR activation and potentiates inflammation, oxidative stress, and alveolar simplification in a model of hyperoxia-induced lung injury in newborn mouse. These findings suggest the need to be cautious before instituting OM therapy in neonates.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72052998
TI  - Lung epithelial cell-specific knockout of GRP78 perturbs the unfolded protein response and affects lung maturation
AU  - Flodby P.
AU  - Li C.
AU  - Liu Y.
AU  - Wang H.
AU  - Marconett C.N.
AU  - Lee A.S.
AU  - Minoo P.
AU  - Crandall E.D.
AU  - Borok Z.
AU  - Zhou B.
Y1  - 2015//
KW  - *epithelium cell
KW  - *unfolded protein response
KW  - *fetus lung maturation
KW  - *American
KW  - *society
KW  - *lung
KW  - mouse
KW  - apoptosis
KW  - endoplasmic reticulum stress
KW  - lung development
KW  - immunohistochemistry
KW  - gene
KW  - TUNEL assay
KW  - pathogenesis
KW  - fetus lung
KW  - cell differentiation
KW  - lung alveolus cell
KW  - oxidative stress
KW  - airway
KW  - respiratory distress
KW  - cell cycle arrest
KW  - lethality
KW  - lung alveolus epithelium
KW  - morphogenesis
KW  - electron microscopy
KW  - lung dysplasia
KW  - microarray analysis
KW  - protection
KW  - cell population
KW  - knockout mouse
KW  - chronic lung disease
KW  - messenger RNA
KW  - marker
KW  - reactive oxygen metabolite
KW  - antioxidant
KW  - caspase 3
KW  - protein disulfide isomerase
KW  - protein
KW  - initiation factor 2
KW  - heat shock protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - P. Flodby, Will Rogers Institute Pulmonary Research Center, Department of Medicine, University of Southern California, Los Angeles, CA, United States. E-mail: flodby@usc.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A5128
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72052998
AB  - Multiple signaling pathways are involved in morphogenesis and cell differentiation during lung development. Signaling associated with endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR) is implicated in pathogenesis of the neonatal chronic lung disease bronchopulmonary dysplasia (BPD). However, little is known about the effects of ER stress on lung maturation, especially alveolar epithelial development/differentiation. In this study, we generated mice with lung epithelial cell-specific knockout of Grp78, a master regulator of ER stress responses/homeostasis by crossing floxed Grp78 mice to Sftpc-cre mice. Loss of Grp78 in lung epithelium caused early perinatal lethality. The proportion of knockouts was 17.2% at embryonic day 18 (E18), lower than the expected 25%. At postnatal day 1 (PN1) the proportion of knockouts decreased to 5.6% and all knockout pups died within a few hours from respiratory distress. Histological analysis of embryonic lungs revealed dilated airways at E14 and enlarged, irregular airspaces filled with cellular debris at E18. At PN1, lungs appeared severely dilated or simplified with thin alveolar septae compared to control animals. Western analysis and immunostaining of lung sections showed that expression of markers for both alveolar epithelial type I (AT1) and type II (AT2) cells was significantly decreased in E18 knockouts. Analysis of UPR signaling/ER stress protein markers showed increased levels of GRP94, p-eIF-2alpha, C/EBP homologous protein (CHOP) and protein disulphide isomerase (PDI) in E18 knockout lungs. Microarray analysis revealed that UPR signaling was the most affected pathway in E18 knockout lungs and qRT-PCR confirmed increased mRNA expression of GRP94, CHOP and PDI and several other major UPR components. Electron microscopy revealed abnormal ER expansion in AT2 cells, which were more loosely arranged and appeared to be detaching from the epithelial sheet. TUNEL assays and immunohistochemistry for cleaved caspase-3 demonstrated increased levels of apoptosis in knockouts at E18. While mRNA expression of antioxidant genes (e.g. Nrf2) was reduced, expression of genes involved in generation of reactive oxygen species was elevated. Additionally, increased levels of p21, a key downstream target of TGF-beta signaling involved in cell cycle arrest and apoptosis, and p-Smad3 were detected. Collectively, these results suggest that GRP78 plays a key role in protection of AT2 cells, a major stem/progenitor lung cell population, from apoptosis via regulation of UPR signaling during lung development, and implicate oxidative stress and TGF-beta/Smad signaling as mediators of AT2 cell apoptosis in Grp78 knockout mice.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72052823
TI  - In vivo hyperoxia alters the repair potential and gene expression profile of a CD146+ endogenous lung mesenchymal stromal cells
AU  - Collins J.J.P.
AU  - Lithopoulos M.A.
AU  - Dos Santos C.C.
AU  - Mobius M.A.
AU  - Vadivel A.
AU  - Zhong S.
AU  - Thebaud B.
Y1  - 2015//
KW  - *hyperoxia
KW  - *gene expression
KW  - *lung
KW  - *mesenchymal stroma cell
KW  - *American
KW  - *society
KW  - exposure
KW  - gene
KW  - rat
KW  - lung injury
KW  - angiogenesis
KW  - assay
KW  - adverse outcome
KW  - digestion
KW  - lung dysplasia
KW  - endothelium cell
KW  - rat model
KW  - wound healing
KW  - purification
KW  - colony forming unit
KW  - computer program
KW  - animal model
KW  - microarray analysis
KW  - premature labor
KW  - cell therapy
KW  - lung development
KW  - transducer
KW  - growth, development and aging
KW  - mesenchyme
KW  - immunoregulation
KW  - therapy
KW  - oxygen
KW  - fibroblast growth factor
KW  - ficoll
KW  - marker
KW  - plastic
KW  - Janus kinase
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J.J.P. Collins, Ottawa Hospital Research Institute, Ottawa, ON, Canada. E-mail: jecollins@ohri.ca
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4951
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72052823
AB  - Rationale: Bronchopulmonary dysplasia (BPD), one of the most common adverse outcomes of extreme preterm birth, can be caused by oxygen-related lung injury and is characterized by an arrest in alveolar development. Mesenchymal stromal cells (MSCs) prevent and rescue lung injury when administered exogenously in animal models of BPD. Given the regenerative potential of MSCs, it is unclear why resident lung MSCs (L-MSCs) do not support lung repair and growth in BPD. We hypothesized that in vivo hyperoxia exposure perturbs the repair potential and gene expression in CD146+ endogenous lung MSCs in an oxygen-induced rat model of BPD. Method(s): Rat pups were exposed to 21% or 95% oxygen from postnatal day 0 to 10 and sacrificed on day 12. L-MSCs were isolated by enzymatic digestion, Ficoll-purification and plastic adherence. CD146+ L-MSCs were isolated through magnetic bead selection and characterized according to the International Society for Cellular Therapy criteria. Epithelial repair potential was tested by scratch assay, angiogenesis potential by network formation assay. Microarray analysis was performed using the Affymetrix Rat Gene 2.1 ST array, significance analysis of microarrays (SAM) and gene set enrichment analysis (GSEA) software. Result(s): Hyperoxia exposure decreased CD73 expression in CD146+ L-MSCs 2-fold, but not colony forming capacity and other surface marker expression. CD146+ L-MSCs promoted epithelial wound healing over baseline by 25% over 24 hours, regardless of in vivo hyperoxia exposure. Network formation was decreased by ~25% in endothelial cells exposed to conditioned media from hyperoxia CD146+ L-MSCs. GSEA analysis revealed that gene expression of the axonal guidance cue and CDC42 pathways were most strongly increased after in vivo hyperoxia. Among the decreased gene sets, most notably fibroblast growth factor (FGF) signaling and the janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway were decreased. Conclusion(s): Exposure to hyperoxia in vivo lowered CD73 and JAK/STAT expression, indicating decreased immune-regulatory function and repair capacity. Increased axonal guidance cue signaling and decreased FGF signaling would indicate a halt in alveolar growth and development signaling from the mesenchyme. This is further supported by a decrease in angiogenesis potential. These changes in endogenous L-MSCs likely reflect both their role in normal lung development, immune regulation and repair, and possibly their dysfunction in BPD. A better understanding of endogenous MSCs may lead to improved effectiveness of exogenous MSC therapy.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72052770
TI  - Bronchopulmonary anastomotic pathways (BAP): Possible etiology of isolated idiopathic hypoxemia (IIH) in 11 year old girl
AU  - Galambos C.
AU  - Dishop M.K.
AU  - Sims-Lucas S.
AU  - Ivy D.
AU  - Deterding R.R.
Y1  - 2015//
KW  - *hypoxemia
KW  - *girl
KW  - *female
KW  - *human
KW  - *American
KW  - *society
KW  - *etiology
KW  - exercise
KW  - vein
KW  - microcirculation
KW  - blood
KW  - lung biopsy
KW  - capillary
KW  - pulmonary vein
KW  - vein blood flow
KW  - lung capillary
KW  - newborn
KW  - heart right left shunt
KW  - computer assisted tomography
KW  - congenital diaphragm hernia
KW  - liver
KW  - heart catheterization
KW  - hemodynamics
KW  - lung dysplasia
KW  - environmental exposure
KW  - noise
KW  - histology
KW  - physical examination
KW  - ambient air
KW  - lung
KW  - examination
KW  - thorax
KW  - genetic screening
KW  - lung perfusion
KW  - air conditioning
KW  - hemoglobinopathy
KW  - obstruction
KW  - lip
KW  - lung function
KW  - lung volume
KW  - spirometry
KW  - cyanosis
KW  - fatty acid desaturation
KW  - Rendu Osler Weber disease
KW  - gene
KW  - pathology
KW  - dysplasia
KW  - tissue section
KW  - accuracy
KW  - image reconstruction
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C. Galambos, Children's Hospital Colorado, Aurora, CO, United States. E-mail: csaba.galambos@childrenscolorado.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4898
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72052770
AB  - INTRODUCTION We have recently identified striking intrapulmonary BAP as a source of right-to-left-shunt in neonates who died of alveolar capillary dysplasia, bronchopulmonary dysplasia and congenital diaphragmatic hernia. Blood via BAP bypass the pulmonary capillary bed that contributes to lethal hypoxemia. One of the major histologic features of BAP is the presence of dilated and congested bronchial veins that drain massive amount of shunted blood from the bronchial microcirculation to the pulmonary veins. We describe a case of IIH with BAP and propose that BAP contribute to the underlying pathology. CASE SUMMARY An 11 year old previously healthy female presented with signs of cyanosis (blue lips) with activity documented by formal exercise evaluation in the absence of pulmonary symptoms that had been ongoing for an unknown period of time. She had a negative history for noise bleeds, environmental exposures or other chronic issues. Her physical examination was only remarkable for a room air saturation at 1600 meters of 92-91% with clear lung fields, normal cardiac examination and no clubbing. She underwent the following evaluation which was unremarkable: Bubble ECHO, Chest CT scan high resolution and with contrast, CT liver, Lung perfusion and ventilation scan, ABG, Hemoglobin abnormalities, and cardiac catheterization that demonstrated normal hemodynamics and no notable obstruction to pulmonary venous flow. Pulmonary function testing showed normal spirometry, lung volumes and DLCO. The only evaluation abnormality was a 6 minute walk that documented desaturation to 86% in 2 minutes and then rebounding back to mid-90 % post exercise. Genetic testing for Hereditary Hemorrhagic Telangiectasia (HHT) noted one variant of uncertain significance in the RASA1 gene. A lung biopsy was completed to evaluate subtle findings to explain her hypoxemia. Histologic sections showed unremarkable pulmonary histology except for the presence of large, dilated and congested thin walled veins that bridged the systemic microcirculation with pulmonary veins. High precision 3-dimensional image reconstruction studies confirmed that these vessels were pathologically dilated bronchial veins. DISCUSSION IIH with and without exercise may be associated with BAP that require lung biopsy and special histologic evaluation to identify. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72052641
TI  - Bronchopulmonary dysplasia is associated with lower serum neurotrophin levels in neonates
AU  - Schneeberger D.
AU  - Worley S.
AU  - Tang A.
AU  - Piedimonte G.
Y1  - 2015//
KW  - *lung dysplasia
KW  - *serum
KW  - *newborn
KW  - *American
KW  - *society
KW  - prematurity
KW  - human
KW  - infant
KW  - morbidity
KW  - age
KW  - adulthood
KW  - prospective study
KW  - Kruskal Wallis test
KW  - etiology
KW  - artificial ventilation
KW  - intensive care unit
KW  - newborn intensive care
KW  - adolescence
KW  - blood level
KW  - blood
KW  - lung
KW  - mortality
KW  - hospital
KW  - risk
KW  - immunoassay
KW  - gestational age
KW  - procedures
KW  - exposure
KW  - oxygen consumption
KW  - *neurotrophin
KW  - brain derived neurotrophic factor
KW  - protein
KW  - biological marker
KW  - nerve growth factor
KW  - cytokine
KW  - steel
KW  - oxygen
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - D. Schneeberger, Cleveland Clinic Children's, Cleveland, OH, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4768
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72052641
AB  - Rationale: Bronchopulmonary dysplasia (BPD), defined as an oxygen requirement at 28 days chronological age, is a common cause of morbidity and mortality in premature infants. Many infants continue to experience BPD sequelae well into adolescence and adulthood, however there are no biomarkers available to diagnose BPD prior to 28 days of life. Studies indicate a multi-factorial etiology including prematurity, mechanical ventilation, oxygen exposure, and cytokine imbalance. Previous studies from our group have shown increased levels of neurotrophins (NT) in the lungs of premature babies with BPD, however neurotrophin expression in the blood has not been explored. We hypothesized that serum levels of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) may also be associated with BPD in premature babies. Method(s): Newborns admitted to the neonatal intensive care unit (NICU) at Cleveland Clinic were enrolled as part of an ongoing prospective study of serum NT levels and BPD. Serum samples were collected within 48 hours of birth, and a highly sensitive immunoassay was used to measure NGF and BDNF protein concentrations. Subjects were classified as term, preterm without BPD, and preterm with BPD; groups were compared on serum NT concentrations using Kruskal-Wallis tests with Steel-Dwass multiple comparison procedure. Result(s): Nine term, 24 preterm without BPD, and 16 preterm with BPD subjects have been enrolled. Median gestational ages in weeks were 39 in the term group (range 37-41), 34 in the preterm without BPD group (range 29-36), and 26 in the preterm group (range 22-36). Groups differ significantly on serum NGF (overall p=0.035) and serum BDNF (overall p=0.008). Preterm subjects with BPD have significantly lower NGF than preterm subjects without BPD (p=0.030). Both groups of preterm subjects (with and without BPD) have significantly lower BDNF than term subjects (p=0.029 for both). Conclusion(s): We conclude that protein levels of both NGF and BDNF are markedly decreased in the serum of premature infants and may be associated with an increased risk in the development of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2016>
TI  - A three-dimensional study of alveologenesis in mouse lung.
DO  - https://dx.doi.org/10.1016/j.ydbio.2015.11.017
AU  - Branchfield, Kelsey
AU  - Li, Rongbo
AU  - Lungova, Vlasta
AU  - Verheyden, Jamie M
AU  - McCulley, David
AU  - Sun, Xin
Y1  - 2016//
Y2  - 20151126//
KW  - Actins/me [Metabolism]
KW  - Animals
KW  - Artifacts
KW  - Elastin/me [Metabolism]
KW  - Green Fluorescent Proteins/me [Metabolism]
KW  - *Imaging, Three-Dimensional
KW  - Lipids/ch [Chemistry]
KW  - Mice
KW  - Models, Animal
KW  - Models, Biological
KW  - Myofibroblasts/cy [Cytology]
KW  - Myofibroblasts/me [Metabolism]
KW  - Pericytes/me [Metabolism]
KW  - Pulmonary Alveoli/cy [Cytology]
KW  - *Pulmonary Alveoli/gd [Growth & Development]
KW  - Receptor, Platelet-Derived Growth Factor alpha/me [Metabolism]
KW  - Stress, Physiological
T2  - Developmental biology
VL  - 409
IS  - 2
SN  - 0012-1606
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=26632490
AD  - United States
AB  - Alveologenesis is the final step of lung maturation, which subdivides the alveolar region of the lung into smaller units called alveoli. Each of the nascent dividers serves as a new gas-exchange surface, and collectively they drastically increase the surface area for breathing. Disruption of alveologenesis results in simplification of alveoli, as is seen in premature infants diagnosed with bronchopulmonary dysplasia (BPD), a prevalent lung disease that is often associated with lifelong breathing deficiencies. To date, a majority of studies of alveologenesis rely on two-dimensional (2D) analysis of tissue sections. Given that an overarching theme of alveologenesis is thinning and extension of the epithelium and mesenchyme to facilitate gas exchange, often only a small portion of a cell or a cellular structure is represented in a single 2D plane. Here, we use a three-dimensional (3D) approach to examine the structural architecture and cellular composition of myofibroblasts, alveolar type 2 cells, elastin and lipid droplets in normal as well as BPD-like mouse lung. We found that 2D finger-like septal crests, commonly used to depict growing alveolar septae, are often artifacts of sectioning through fully established alveolar walls. Instead, a more accurate representation of growing septae are 3D ridges that are lined by platelet-derived growth factor receptor alpha (PDGFRA) and alpha smooth muscle actin (alpha-SMA)-expressing myofibroblasts, as well as the elastin fibers that they produce. Accordingly in 3D, both alpha-SMA and elastin were each found in connected networks underlying the 3D septal ridges rather than as isolated dots at the tip of 2D septal crests. Analysis through representative stages of alveologenesis revealed unappreciated dynamic changes in these patterns. PDGFRA-expressing cells are only alpha-SMA-positive during the first phase of alveologenesis, but not in the second phase, suggesting that the two phases of septae formation may be driven by distinct mechanisms. Thin elastin fibers are already present in the alveolar region prior to alveologenesis, suggesting that during alveologenesis, there is not only new elastin deposition, but also extensive remodeling to transform thin and uniformly distributed fibers into thick cables that rim the nascent septae. Analysis of several genetic as well as hyperoxia-induced models of BPD revealed that the myofibroblast organization is perturbed in all, regardless of whether the origin of defect is epithelial, mesenchymal, endothelial or environmental. Finally, analysis of relative position of PDGFRA-positive cells and alveolar type 2 cells reveal that during alveologenesis, these two cell types are not always adjacent to one another. This result suggests that the niche and progenitor relationship afforded by their close juxtaposition in the adult lung may be a later acquired property. These insights revealed by 3D reconstruction of the septae set the foundation for future investigations of the mechanisms driving normal alveologenesis, as well as causes of alveolar simplification in BPD. Copyright Â© 2015 Elsevier Inc. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72052621
TI  - Role of inflammatory biomarkers in the development of pulmonary hypertension in extremely low birth weight premature infants
AU  - Siddaiah R.
AU  - Graff G.
AU  - Stanley B.
AU  - Silveyra P.
Y1  - 2015//
KW  - *pulmonary hypertension
KW  - *extremely low birth weight
KW  - *prematurity
KW  - *infant
KW  - *human
KW  - *American
KW  - *society
KW  - pH
KW  - tracheal aspiration procedure
KW  - computer program
KW  - immunocompetent cell
KW  - physical disease by body function
KW  - cell migration
KW  - population
KW  - pathogenesis
KW  - diagnosis
KW  - mortality
KW  - newborn care
KW  - lung dysplasia
KW  - algorithm
KW  - mass spectrometry
KW  - very low birth weight
KW  - brain
KW  - blood level
KW  - echocardiography
KW  - gold standard
KW  - protein analysis
KW  - pipeline
KW  - heart catheterization
KW  - survival
KW  - cardiovascular system
KW  - data analysis
KW  - upregulation
KW  - morbidity
KW  - *biological marker
KW  - protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - R. Siddaiah, Penn State Milton S Hershey Medical Center, Hershey, PA, United States. E-mail: roopasiddaiah@gmail.com
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4748
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72052621
AB  - Introduction: With recent advances of neonatal care, there is improved survival of extremely premature babies with very low birth weight, but no significant reduction in the complications of bronchopulmonary dysplasia (BPD). Each year over 10,000 premature infants in the US develop BPD. Pulmonary hypertension (PH) occurs in roughly one-third (17%- 43%) of preterm infants with BPD and results in significant mortality and morbidity. The diagnosis of PH in BPD is challenging with overlapping signs and symptoms with the BPD related respiratory problems. Cardiac catheterization is the gold standard for diagnosis; however, because of its invasive nature and complications, echocardiogram and serum levels of brain natriuretic protein (BNP) are frequently used with questionable accuracy. We hypothesize that by analyzing the proteomic profile of tracheal-aspirate protein samples we will identify noninvasive biomarkers that will differ in those with BPD with and without PH. Method(s): With IRB approval we obtained tracheal-aspirate samples from 3 preterm babies with BPD and PH and 3 preterm babies with BPD but with no signs and symptoms of PH. These samples were digested, iTRAQ labeled and analyzed via mass spectrometry using the ABSciex 5600 TripleTOF. Protein identification was accomplished using the Paragon Algorithm as implemented in ProteinPilotTM 4.5beta software (ABSciex) and the results were filtered through stringent Local FDR estimation calculated fromProteomics System Performance Evaluation Pipeline (PSPEP). A comprehensive biological network analysis was evaluated with the Ingenuity Pathway Analysis (IPA) software. Result(s): We Identified 285 proteins with unused score of > 1.3 (95% of confidence) and 14 proteins were significantly unregulated or down regulated in the two groups (p<0.05). On analyzing these proteins via the IPA software we found significant correlation of these proteins with the cardiovascular, hematological system development and function along with immune cell trafficking all of which have been implicated to be affected in the pathogenesis of development of PH in BPD. Of these 14 proteins, 3 proteins namely BPIFB1, IGLL1/IGLL5 and MUC5B showed highly significant different expression in the two study population (FDR q=<0.05). Conclusion(s): Preliminary study showed significant up regulation of at-least 3 proteins: BPIFB1, IGLL1/IGLL5, MUC5B in the tracheal aspirate of preterm babies with BPD+PH when compared to those with BPD. The IPA data analysis has demonstrated these proteins to be closely associated with the cardiovascular-systems development and function and immune cell trafficking which has been implicated in the pathogenesis of PH in BPD. We aim to pursue a larger study with powered population to demonstrate if these results are reproducible and aid in developing putative biomarkers. (Table Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72052620
TI  - Hyperoxic injury disrupts redox-dependent thioredoxin-1 signaling in lung epithelial cells
AU  - Booze M.
AU  - Guevara W.
AU  - Vitiello P.
Y1  - 2015//
KW  - *lung
KW  - *epithelium cell
KW  - *American
KW  - *society
KW  - *injury
KW  - hyperoxia
KW  - oxidation
KW  - human
KW  - cell death
KW  - infection
KW  - artificial ventilation
KW  - lung dysplasia
KW  - lung alveolus epithelium cell
KW  - ambient air
KW  - Retroviridae
KW  - in vitro study
KW  - cell proliferation
KW  - homeostasis
KW  - protein expression
KW  - microvasculature
KW  - cell culture
KW  - infant
KW  - mouse
KW  - exposure
KW  - transgene
KW  - prematurity
KW  - lung alveolus epithelium
KW  - *thioredoxin 1
KW  - oxidoreductase
KW  - antioxidant
KW  - thiol
KW  - protein
KW  - auranofin
KW  - thioredoxin
KW  - cysteine
KW  - oxygen
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - P. Vitiello, Sanford Research, Sioux Falls, SD, United States. E-mail: peter.vitiello@sanfordhealth.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4747
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72052620
AB  - Pulmonary complications from bronchopulmonary dysplasia (BPD) are attributed to alveolar simplification and impaired microvasculature growth resulting from oxidative injuries associated with hyperoxia, mechanical ventilation, and infection; which is often experienced by the premature infant. Developmental programs are further aggravated by concurrent immature antioxidant systems in these individuals. Thioredoxins, part of a major antioxidant system, regulate the reduction-oxidation (redox) state of protein thiols through oxidoreductase activities of a highly conserved catalytic site capable of undergoing reversible oxidation. Redox regulation of dithiol/disulfide status is critical for numerous signaling processes as an endogenous thiol oxidoreductase, thioredoxin-1 (Trx1) is necessary for normal cell proliferation, redox homeostasis, and antioxidant induction. Little is known about its signaling role in distal lung epithelium during hyperoxic exposure and how deficiencies in this redox node may lead to BPD. Mouse lung epithelial (MLE-12) cells cultured in 95% oxygen for up to three days had significantly reduced oxidoreductase activity of Trx1 and its corresponding reductase, TrxR1. Reduction of these activities did not correlate with changes in protein expression and we speculate this is due to oxidation of cysteines in the catalytic sites of these two molecules. Inhibition of TrxR with auranofin, thereby impairing Trx1 activity, augmented hyperoxic cell death. MLE-12 cells transduced with retrovirus expressing the BioID transgene fused to the carboxy-terminus of redox-active (hTrx1-BirA-HA) and -inactive (hTrx1C32/35S-BirA-HA) human Trx1 were cultured in room air or hyperoxia for subsequent proteomic analysis. This proximity-based labeling method, BioID, was used to identify protein substrates targeted by Trx1 and pinpoint molecular events, regulated via dithiol/disulfide interactions, underlying hyperoxia-induced injury. Ongoing studies are focused on prioritizing novel Trx1 substrates identified via BioID based on pathway analysis, known functional relevance within alveolar type II cells, and secondary validation through in vitro and in vivo approaches. Taken together, these studies demonstrate that maintenance of Trx1 activity attenuates hyperoxia-mediated cell death of alveolar epithelial cells and novel redox-sensitive Trx1 substrates were identified that may serve as molecular targets in BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72052608
TI  - Role of NF-E2 related factor (NRF2) and nadph quinone reductase (NQO1) in oxygen mediated lung injury and implications for bronchopulmonary dysplasia(BPD)
AU  - Kalikkot-Thekkeveedu R.
AU  - Chu C.
AU  - Basu S.
AU  - Moorthy B.
Y1  - 2015//
KW  - *lung injury
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - hyperoxia
KW  - human
KW  - gene
KW  - protein expression
KW  - ambient air
KW  - promoter region
KW  - adult respiratory distress syndrome
KW  - air quality control
KW  - protection
KW  - luciferase assay
KW  - Western blotting
KW  - acute lung injury
KW  - oxygen toxicity
KW  - transcription initiation
KW  - reporter gene
KW  - single nucleotide polymorphism
KW  - wild type
KW  - plasmid
KW  - genetic variability
KW  - lung alveolus cell
KW  - exposure
KW  - hypothesis
KW  - *oxygen
KW  - *reduced nicotinamide adenine dinucleotide (phosphate) dehydrogenase (quinone)
KW  - transcription factor Nrf2
KW  - oxidizing agent
KW  - reactive oxygen metabolite
KW  - antioxidant
KW  - Renilla luciferin 2 monooxygenase
KW  - firefly luciferase
KW  - luciferase
KW  - reduced nicotinamide adenine dinucleotide phosphate
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - R. Kalikkot-Thekkeveedu, Baylor College of Medicine, Houston, TX, United States. E-mail: rkalikkot@gmail.com
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4735
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72052608
AB  - Background Hyperoxia contributes to the development of bronchopulmonary dysplasia. Reactive oxygen species (ROS) play an important role in the molecular mechanism of oxygen mediated lung injury. Innate anti-oxidant mechanisms in the cells play an important role in the protection against oxygen toxicity and recent studies have suggested that genetic variants (e.g. single nucleotide polymorphism (SNP) of antioxidant genes such as NADPH quinone reductase (NQO1) and NF-E2 related factor (Nrf2)contribute to the development of acute lung injury and acute respiratory distress syndrome in humans. Objective(s): Our objective was to test the hypothesis that hyperoxia will augment the transcriptional activity of NrF2 and NQO1 genes in human pulmonary cells. Design/Methods: Plasmids containing the whole wild type human Nrf2/NQO1 promoter, the firefly luciferase reporter genes (pGL4- NQO1, PGL4-Nrf2) with internal control renilla luciferase reporter (pGL4-Rluc) were transiently transfected into human H441 cells, were grown in room air or hyperoxia (85% O2), 5% CO2 for 0-48 hours to study transcriptional activation of NQO1 and NrF2 genes by hyperoxia. Activation of NQO1 and NrF2 protein expression by hyperoxia(70% O2, 5%CO2 at 24 and 48 hours was measured by Western Blot analysis. Dual luciferase assay indicated NQO 1/Nrf2 promoter induction in the pGL4-luciferase constructs. Result(s): Hyperoxia transcriptionally activated NQO1 gene (~2.4 fold at 48 hours) and Nrf2 gene (~1.7 fold at 48 hrs) in H441 cells, compared to room air controls. While the NrF2 protein expression was enhanced by hyperoxia at 48 hours, there was no significant alteration in NQO1 protein expression at 48 hours on exposure to hyperoxia. Conclusion(s): Our experiments indicate that NQO1 and NrF2 genes are activated by hyperoxia. Further studies may help to develop innovative strategies against hyperoxic lung injury. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72051986
TI  - Disruption of TrkB-BDNF signaling improves airway function in newborn mice exposed to hyperoxia
AU  - Stewart A.L.
AU  - Britt R.D.
AU  - Thompson M.A.
AU  - Freeman M.R.
AU  - Pabelick C.M.
AU  - Martin R.J.
AU  - Prakash Y.S.
Y1  - 2015//
KW  - *hyperoxia
KW  - *airway
KW  - *mouse
KW  - *American
KW  - *society
KW  - ambient air
KW  - exposure
KW  - supplementation
KW  - airway resistance
KW  - lung dysplasia
KW  - infant
KW  - prematurity
KW  - postnatal development
KW  - air quality control
KW  - rat
KW  - diseases
KW  - lung
KW  - lung disease
KW  - hypothesis
KW  - respiratory tract allergy
KW  - risk
KW  - mare
KW  - asthma
KW  - nursing
KW  - lung function
KW  - model
KW  - human
KW  - *brain derived neurotrophic factor
KW  - methacholine
KW  - brain derived neurotrophic factor receptor
KW  - drinking water
KW  - protein tyrosine kinase
KW  - dimethyl sulfoxide
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - A.L. Stewart, Mayo Clinic, Rochester, MN, United States. E-mail: stewart.alecia@mayo.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4111
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72051986
AB  - Introduction: Preterm infants are at risk of developing lung diseases such as bronchopulmonary dysplasia and asthma. Hyperoxia contributes to airway hyperresponsiveness associated with these diseases, however, the mechanisms by which hyperoxia induces these changes are still being explored. In previous studies, expression of brain derived neurotrophic factor (BDNF) and its receptor, TrkB, was found to be increased in rat lungs following exposure to hyperoxia. In neonatal mice, we tested the hypothesis that BDNF/TrkB signaling is important to mediating hyperoxia effects, and that inhibition of TrkB activation blunts the effects of hyperoxia on airway function. Methods and Results: Mice expressing a mutated TrkB receptor with inhibitable tyrosine kinase activity via a cell permeable and reversible compound (1NMPP1; knockin model) were used. Subsequent to birth, the drinking water of nursing dams was supplemented with vehicle (0.003% DMSO) or 25 muM 1NMPP1, during exposure to room air (21% O2) or hyperoxia (40-50% O2) for 7 days. Pups were then placed back in room air with continued 1NMPP1 supplementation until day 21, when lung function and methacholine challenge (0 - 50 mg/ml in PBS) was performed using a SciReq flexivent system. Compared to room air controls, hyperoxia-exposed pups showed increased airway resistance and higher responses to methacholine, while 1NMPP1 supplementation substantially blunted the effects of hyperoxia on airway resistance and responses to methacholine. Structural changes to the airways such as remodeling, matched these functional changes. Conclusion(s): These novel data highlight the importance of BDNF-TrkB signaling in hyperoxia-induced airway dysfunction during early postnatal development. Sustained effects at 21 days in spite of only 7 days hyperoxia suggest ongoing airway changes that also involve BDNF-TrkB signaling. Overall, these data point to a novel mechanism that is potentially targetable.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72051962
TI  - Hyperoxic exposure of neonatal mice is associated with dendritic cell activation and increased expression of damp receptors
AU  - Popova A.P.
AU  - Cui T.X.
AU  - Maheshwer B.
AU  - Bentley J.K.
Y1  - 2015//
KW  - *mouse
KW  - *dendritic cell
KW  - *cell activation
KW  - *American
KW  - *society
KW  - *exposure
KW  - lung
KW  - hyperoxia
KW  - human
KW  - plasma
KW  - gene expression
KW  - infant
KW  - respiratory tract inflammation
KW  - prematurity
KW  - model
KW  - viral respiratory tract infection
KW  - chronic lung disease
KW  - innate immunity
KW  - hospitalization
KW  - lung dysplasia
KW  - risk
KW  - child
KW  - lung lavage
KW  - myofibroblast
KW  - mass spectrometry
KW  - respiratory tract allergy
KW  - flow cytometry
KW  - Rhinovirus
KW  - infection
KW  - *receptor
KW  - adenosine
KW  - adenosine phosphate
KW  - adenosine triphosphate
KW  - oxygen
KW  - adenosine diphosphate
KW  - ligand
KW  - messenger RNA
KW  - ecto 5' nucleotidase
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - A.P. Popova, University of Michigan, Ann Arbor, MI, United States. E-mail: antoniap@med.umich.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4087
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72051962
AB  - RATIONALE: Bronchopulmonary dysplasia (BPD), a chronic pulmonary disease of premature infants, is characterized by airway hyperresponsiveness, hypoalveolarization, interstitial thickening with myofibroblasts and a requirement for supplemental oxygen for months or years. Infants and children with BPD have an increased incidence and higher risk for hospitalization with respiratory viral infections. We previously showed that hyperoxic exposure of neonatal mice (a model of BPD) leads to increased airway inflammation and responsiveness following treatment with polyI:C or infection with rhinovirus (RV) (Am J Respir Crit Care Med 189: A2317, 2014). Hyperoxic exposure also increased the number and activation of CD103+ lung dendritic cells (DCs). Objective(s): We hypothesize that hyperoxic exposure of neonatal mice induces activation of lung dendritic cells via increased extracellular release of danger signaling molecules, as evidenced by increased expression of damage-associated molecular pattern (DAMP) receptors. Method(s): Two or three day-old mice were exposed to air or 75% oxygen for up to 14 days. Mice were harvested on day 3, 7 and 14 of exposure. Whole lung gene expression was analyzed by qPCR. Subsets of lung DCs were sorted by flow cytometry and DC gene expression was analyzed by qPCR. Mass spectroscopy was used to measure plasma and bronchoalveolar lavage fluid (BALF) adenosine, AMP, ADP and ATP levels. Result(s): Compared to lungs from air-exposed neonatal mice, lungs of hyperoxia-exposed neonatal mice show increased expression of CD73 (ecto-5'-nucleotidase, which converts AMP to adenosine) and Adora1 (adenosine A1 receptor) at 7 and 14 days after exposure, consistent with conversion of AMP to adenosine and engagement of Adora1. Hyperoxic exposure had no effect on mRNA expression of CD39 (ectonucleoside triphosphate diphosphohydrolase 1), which hydrolyzes ATP and ADP to AMP). Expression of the DC DAMP receptor Clec9a was also increased after 7 and 14 days of hyperoxia. Analysis of the sorted lung DCs showed that Clec9a expression was specific for CD103+ lung DCs. Finally, we found significantly elevated AMP levels and increased AMP:ATP and ADP:ATP ratios in plasma after 14 days of hyperoxic exposure, and these measures tended to be elevated in BALF as well. Conclusion(s): Our findings demonstrate that neonatal hyperoxia exposure is associated with increased expression of different DAMP receptors and their ligands. We hypothesize that these danger signals induce DC activation and promote pro-inflammatory alterations in the innate immune response.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72051957
TI  - Moderate prenatal cigarette smoke increases the risk for ventilation induced injury in the developing lung
AU  - Kamgari N.
AU  - Oak P.S.
AU  - Gimm T.
AU  - John-Schuster G.
AU  - Yildirim A.O.
AU  - Hilgendorff A.
Y1  - 2015//
KW  - *risk
KW  - *air conditioning
KW  - *injury
KW  - *lung
KW  - *American
KW  - *society
KW  - female
KW  - pregnancy
KW  - mouse
KW  - human
KW  - lung development
KW  - smoke
KW  - patient
KW  - density
KW  - low birth weight
KW  - lung dysplasia
KW  - prematurity
KW  - vascularization
KW  - extracellular matrix
KW  - gas
KW  - artificial ventilation
KW  - chronic lung disease
KW  - clinical study
KW  - fetus growth
KW  - filter
KW  - ambient air
KW  - control group
KW  - elastic fiber
KW  - lung alveolus wall
KW  - tracheal aspiration procedure
KW  - newborn
KW  - wild type mouse
KW  - *cigarette smoke
KW  - elastin
KW  - growth factor
KW  - oxygen
KW  - protein
KW  - messenger RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - P.S. Oak, Helmholtz Zentrum Munchen, Munich, Germany. E-mail: prajakta.oak@helmholtz-muenchen.de
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4082
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72051957
AB  - Introduction: Clinical studies showed that prenatal cigarette smoke (PCS) is associated with premature birth and low birth weight. This patient cohort is known for its increased probability to develop neonatal chronic lung disease (nCLD), i.e. bronchopulmonary dysplasia. CLD in this patient cohort is characterized by impaired lung growth exemplified by perturbed alveolarization and vascularization as well as extracellular matrix (ECM) remodeling and dysregulation of growth factor signaling. Whether the impact of CS in doses, which do not induce fetal growth restriction during pregnancy, affects pulmonary development is largely unknown. We therefore studied the role of prenatal smoke on pulmonary development in newborn mice with and without the additional impact of postnatal mechanical ventilation with oxygen-rich gas (MV-O2). Method(s): Pregnant C57BL/6 wild type (WT) mice were exposed to moderate PCS (500 mg/m3- 50min/day) or filter air (FA) from day 7 to 18 of pregnancy. Following delivery, 5-7 days old pups from both groups were either assigned to receive MV-O2 (MV with 40% O2) or breathe room air (control groups) for eight hours. Lungs were collected for histological (alveolar area, radial alveolar count (RAC), septal density) analysis, assessment of ECM structure and micro-vessel number. Frozen specimen served for protein and mRNA analysis. Result(s): Unventilated neonatal mice exposed to PCS exhibited no significant differences with respect to alveolar area, RAC and septal density when compared to pups exposed to FA during pregnancy. MV-O2 led to the development of larger and fewer alveoli in the lungs from pups of both groups (PCS, FA). The underlying structure of the ECM showed a similar abundance of elastin in the lungs obtained from unventilated mice following PCS and FA. However, the lungs from pups exposed to PCS were characterized by the pathologic distribution of elastic fibers in the alveolar walls in contrast to pups following FA, similar to the changes observed with MV-O2. With respect to micro-vessels, MV-O2 led to a significant decrease (2,3 -fold) in vessel number (20-100 mum) in the lungs from pups after PCS when compared to pups exposed FA during pregnancy. Conclusion(s): Moderate PCS leads to decreased micro-vessel formation and altered elastin deposition in the developing lung, which is aggravated upon MV-O2. These findings provide an insight into the role of PCS and MV-O2 on lung development and nCLD. Further studies in tracheal aspirates from neonates after moderate prenatal smoke will translate these findings further into the clinical setting.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72051956
TI  - Copy number variation associated with bronchopulmonary dysplasia
AU  - Ahmad A.
AU  - Bhattacharya S.
AU  - Lopez A.M.
AU  - Sridhar A.
AU  - Pryhuber G.S.
AU  - Iqbal A.M.
AU  - Mariani T.J.
Y1  - 2015//
KW  - *copy number variation
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - gene
KW  - prematurity
KW  - DNA microarray
KW  - infant
KW  - control group
KW  - human
KW  - heredity
KW  - lung parenchyma
KW  - genome
KW  - technology
KW  - computer program
KW  - risk factor
KW  - extraction
KW  - gestational age
KW  - lung
KW  - pathogenesis
KW  - genetic susceptibility
KW  - chronic lung disease
KW  - risk
KW  - DNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - A. Ahmad, University of Rochester Medical Center, Rochester, NY, United States. E-mail: ausaf_ahmad@urmc.rochester.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4081
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72051956
AB  - RATIONALE: Bronchopulmonary Dysplasia (BPD) is common in premature babies born before 29 weeks of gestational age and weighing less than 2.2 lb. Variability in the incidence and severity of BPD among premature infants with similar risk factors suggests that genetic susceptibility plays a significant role in its pathogenesis. The goal of this study is to leverage existing clinical DNA microarray data repositories to identify CNVs that are either predictive of, or associated with, BPD. METHOD(S): We conducted a retrospective analysis of clinical DNA microarray data (n=2800) from our institution. We identified 19 subjects diagnosed with BPD, and two controls groups with no lung-related disease; full term (n=43) and pre-term (n=23). DNA microarray experiments were previously performed on the high resolution 4 x44K Agilent platform, and data were re-analyzed using Feature Extraction v10.10 and Genomic Workbench v7.0 software (Agilent Technologies, USA). To test for disease-associated changes in expression for genes residing in the CNV regions, we used a previously published dataset describing genome-wide expression in lung tissue from subjects with BPD. For those genes within recurrent CNV regions, and demonstrating evidence for differential expression in existing datasets, we attempted expression validation by qPCR. RESULT(S): Mean CNV burden in BPD subject was 2-fold higher than either control group (p=0.056). We identified six recurrent CNV loci in BPD subjects. The frequency of two of these recurrent loci (chr2q31.1 and chr10q11.22) were significantly higher (p<0.05) in BPD subjects as compared with at least one control group. Using our previously published data sets, we interrogated 32 genes within the recurrent CNVs regions for differential expression. Five genes within recurrent CNV loci (15.6%) demonstrated significant changes (p<0.05) in expression in BPD. Differential expression was confirmed for two of these genes (ANXA8 and GPRIN2) by qPCR. CONCLUSION(S): Our data should be useful to aid in the identification of genetic factors associated with increased risk for chronic lung disease in preterm infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72051955
TI  - Lymphocyte-specific biomarkers associated with bronchopulmonary dysplasia
AU  - Bhattacharya S.
AU  - Misra R.
AU  - Mereness J.
AU  - Hyuck H.
AU  - Slaunwhite C.
AU  - Chu C.-Y.
AU  - Lunger V.
AU  - Lopez A.
AU  - Baran A.
AU  - Peterson D.
AU  - Reynolds A.M.
AU  - Ryan R.M.
AU  - Pryhuber G.S.
AU  - Mariani T.J.
Y1  - 2015//
KW  - *lymphocyte
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - gene
KW  - gene expression
KW  - human
KW  - prematurity
KW  - infant
KW  - blood
KW  - gestational age
KW  - diagnosis
KW  - gender
KW  - university
KW  - pregnancy
KW  - blood sampling
KW  - peripheral lymphocyte
KW  - lymphocyte proliferation
KW  - hospital discharge
KW  - maturation
KW  - workshop
KW  - risk
KW  - flow cytometry
KW  - computer program
KW  - buffalo
KW  - analysis of variance
KW  - *biological marker
KW  - CD8 antigen
KW  - calpain
KW  - oncostatin M
KW  - RNA
KW  - molecular marker
KW  - transcriptome
KW  - ciliary neurotrophic factor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Bhattacharya, University of Rochester, Rochester, NY, United States. E-mail: soumyaroop_bhattacharya@urmc.rochester.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4080
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72051955
AB  - Rationale: Bronchopulmonary Dysplasia (BPD) is a major complication in premature infants, particularly those born at less than 29 weeks of gestation. Comprehensive transcriptomic analysis of fractionated peripheral lymphocytes obtained from preterm infants could identify predictors of BPD, both in terms of biomarkers and pathways, and also uncover disease-related mechanisms. Method(s): Sorted CD8+ lymphocytes were isolated from peripheral blood samples collected at the time of hospital discharge from 143 preterm infants enrolled with consent in the NHLBI Prematurity and Respiratory Outcomes Program (PROP) at the University of Rochester and the University at Buffalo. RNA isolated from sorted lymphocytes was interrogated by RNA-Seq analysis. We identified age-, gender- and outcome-related gene expression patterns following standard methods (SAM-Seq, ANOVA, etc.). Ingenuity Pathway Analysis software was used for gene set interpretation. Cell purity and gene expression estimates were validated by quantitative RT-PCR. Result(s): Infant peripheral blood CD8+ lymphocytes were consistently isolated at discharge from preterm infants, ranging from 23-37 weeks gestational age at birth, with a high degree of purity as defined by flow cytometry and qPCR-based gene expression analysis. RNA-Seq analysis was completed for CD8+ cells from 79 subjects, generating an average of 9+4 million reads/sample with detection of 64+5% of the transcriptome. Gene expression patterns significantly associated with gestational age at birth, and days of life at sample collection, were identified. Gene expression was only modestly associated (6 genes) with being born at a gestational age with high risk for BPD (<29 weeks). Similarly, few genes were significantly associated with race (7 genes) or gender (14 genes). Consistent gene expression patterns associated with a diagnosis of BPD were identified. However, the magnitude of gene expression differences were highly dependent upon the criteria used to define BPD; 190 genes identified by Shennan definition, 64 genes identified by clinical diagnosis, 7 genes identified by NIH workshop definition. Regardless of BPD definition, dysregulation of Calpain-, Oncostatin M-, and CNTF-associated pathways were implicated. Summary: We have generated transcriptomic data from sort-purified peripheral blood CD8+ lymphocytes from 143 preterm infants. Our analyses have identified sets of molecular markers putatively associated with age-related lymphocyte maturation and with BPD outcome. The implication of Calpain- and Oncostatin M-related pathways with BPD suggests disease-associated differences in lymphocyte proliferation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72051953
TI  - Balancing anti-inflammatory and anti-oxidant responses in murine bone marrow derived macrophages
AU  - Nitkin C.R.
AU  - Bonfield T.L.
Y1  - 2015//
KW  - *bone marrow derived macrophage
KW  - *American
KW  - *society
KW  - inflammation
KW  - oxidative stress
KW  - macrophage
KW  - lung injury
KW  - lung dysplasia
KW  - human
KW  - oxygen therapy
KW  - pathogenesis
KW  - stimulus
KW  - chorioamnionitis
KW  - newborn sepsis
KW  - hyperoxia
KW  - Student t test
KW  - newborn
KW  - prism
KW  - morbidity
KW  - oxygen concentration
KW  - therapy
KW  - mouse
KW  - *oxidizing agent
KW  - oxygen
KW  - lipopolysaccharide
KW  - peroxisome proliferator activated receptor
KW  - complementary DNA
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C.R. Nitkin, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH, United States. E-mail: christopher.nitkin@uhhospitals.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4078
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72051953
AB  - RATIONALE: Bronchopulmonary dysplasia (BPD) is the major pulmonary morbidity experienced by premature human neonates. Lung injury results from a combination of inflammation and oxidative stress, the cellular responses to which are orchestrated by PPARgamma and Nrf2, respectively. Macrophages produce many signaling molecules implicated in BPD pathogenesis and lie at the intersection of inflammation and oxidative stress. This study sought to determine the combined effect of a pro-inflammatory stimulus and oxidative stress on PPARgamma and Nrf2 in murine macrophages. METHOD(S): Primary bone marrow-derived macrophages from C57BL/6J mice were exposed to two oxygen concentrations (21% or 95%), with or without lipopolysaccharide (LPS) (1mug/mL), for 24 hours, after which RNA was isolated and cDNA generated, followed by PCR analysis using primers against PPARgamma, TNFalpha, and Nrf2. Data represents fold-change in expression from four independent experiments and was analyzed with Prism using two-sided t tests for significance. RESULT(S): At 21% oxygen, LPS decreased anti-inflammatory PPARgamma (0.07+/-0.02, p<.0001), increased pro-inflammatory TNFalpha (18.60+/-7.94, p=.0686), and decreased anti-oxidant Nrf2 (0.32+/-0.11, p=.0008) expression compared to unstimulated cells. Similarly, at 95% oxygen, LPS decreased PPARgamma (0.16+/-0.07, p<.0001), increased TNFalpha (12.06+/-2.72, p=.0066), and decreased Nrf2 (0.25+/-0.08, p=.0001) expression compared to unstimulated cells. In the absence of LPS, 95% oxygen alone did not significantly affect PPARgamma (0.92+/-0.21, p=.7176), TNFalpha (1.53+/-0.36, p=.1880), or Nrf2 (1.16+/-0.23, p=.5103) expression, compared to 21% oxygen. However, in the presence of LPS, 95% oxygen did not significantly affect PPARgamma (2.4+/-0.94, p=.1787) or TNFalpha (1.03+/-0.39, p=.9494), but did significantly increase Nrf2 (1.39+/-0.11, p=.0139) expression, compared to 21% oxygen. CONCLUSION(S): This study re-demonstrates the pro-inflammatory effect of LPS on PPARgamma and TNFalpha, but is the first to demonstrate LPS-induced suppression of the anti-oxidant response, as suggested by decreased Nrf2 expression. Although 95% hyperoxia alone did not impact expression of PPARgamma, TNFalpha, or Nrf2, combination treatment with LPS resulted in increased Nrf2 expression. Clinically, lung injury from inflammation due to neonatal sepsis or antenatal maternal chorioamnionitis may be exacerbated by postnatal oxygen therapy. Therapies that decrease the pro-inflammatory response or augment the anti-oxidant response may represent beneficial interventions for BPD. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72051949
TI  - Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats
AU  - Wagenaar G.T.M.
AU  - Chen X.
AU  - Van Boxtel R.
AU  - Laghmani E.
AU  - Sengers R.
AU  - Folkerts G.
AU  - Cuppen E.
AU  - Walther F.
Y1  - 2015//
KW  - *hyperoxia
KW  - *lung injury
KW  - *rat
KW  - *American
KW  - *society
KW  - rat mutant
KW  - mortality
KW  - pneumonia
KW  - lung
KW  - fibrosis
KW  - thickness
KW  - phenotype
KW  - neutrophil
KW  - lung dysplasia
KW  - model
KW  - cell proliferation
KW  - exposure
KW  - mutant
KW  - phosphorylation
KW  - Wistar rat
KW  - risk
KW  - human
KW  - pulmonary hypertension
KW  - pathogenesis
KW  - gene
KW  - infant
KW  - macrophage
KW  - prematurity
KW  - fibroblast
KW  - histopathology
KW  - heart
KW  - craniofacial malformation
KW  - survival
KW  - adverse drug reaction
KW  - mouse
KW  - knockout mouse
KW  - parameters
KW  - mutation
KW  - wild type
KW  - drug therapy
KW  - arteriole
KW  - fibrin deposition
KW  - heart right ventricle hypertrophy
KW  - *lysophosphatidic acid receptor
KW  - mitogen activated protein kinase
KW  - collagen
KW  - receptor
KW  - arginine
KW  - methionine
KW  - messenger RNA
KW  - fibrin
KW  - ligand
KW  - collagen type 3
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - G.T.M. Wagenaar, Leiden University Medical Center, Leiden, Netherlands. E-mail: g.t.m.wagenaar@lumc.nl
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4074
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72051949
AB  - RATIONALE. Blocking of lysophosphatidic acid (LPA) receptor (LPAR) 1 may be a novel therapeutic option for premature infants at risk of bronchopulmonary dysplasia (BPD) by preventing the LPAR1 mediated adverse effects of its ligand LPA, consisting of pulmonary inflammation, pulmonary arterial hypertension (PAH) and fibrosis. METHODS. To advance our knowledge on LPAR1 signaling in neonatal cardiopulmonary disease in vivo, we studied the beneficial effects of LPAR1 blocking in neonatal Wistar rats with experimental BPD, induced by exposure to hyperoxia for 10 days, using two different models: (I) LPAR1 mutant rats with a loss of function phenotype, and (II) pharmacological treatment with the LPAR1 and -3 inhibitor Ki16425 (5 mg/kg/day). Parameters investigated included survival, lung and heart histopathology, fibrin and collagen deposition, vascular leakage, and differential mRNA expression in the lungs of key genes involved in LPA signaling and BPD pathogenesis. LPAR1 mutant rats have a substitution of methionine 318 by arginine in helix 8 of the receptor. To test the effect of LPAR1M318R on the LPA-induced MAP kinase-signaling cascade, which is the main mediator of the stimulatory effect of LPA on cell proliferation, we isolated primary rat embryonic fibroblasts (REFs) that endogenously express LPAR1 and tested activation of the MAP kinase-signaling cascade in these cells. RESULTS. Homozygous LPAR1M318R mutant REFs showed a strongly reduced LPA-induced ERK1/2 phosphorylation response compared to wild type REFs, demonstrating that the M318R mutation in LPAR1 diminishes LPA signaling in primary REFs. The lack of function phenotype that was predicted by computational analyses is further supported by a similar craniofacial malformation in mutant rats as observed in LPAR1 knockout mice. LPAR1 mutant rats were protected against experimental BPD and mortality with reduced alveolar septal thickness, lung inflammation (a reduced influx of macrophages and neutrophils), and hyperoxia-induced collagen III deposition. However, LPAR1 mutant rats were not protected against alveolar enlargement, increased medial wall thickness of small arterioles, fibrin deposition, and vascular alveolar leakage. Treatment of experimental BPD with Ki16425 confirmed the data observed in LPAR1 mutant rats, but did not reduce the influx of neutrophils to the lung and mortality in rats with experimental BPD. In addition, Ki16425 treatment protected against hyperoxia-induced PAH and right ventricular hypertrophy (RVH). CONCLUSION. LPAR1 deficiency attenuates pulmonary injury by reducing pulmonary inflammation and fibrosis, thereby reducing mortality, but does not affect alveolar and vascular development and, unlike Ki16425 treatment, does not prevent PAH-induced RVH in neonatal rats with experimental BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2016>
TI  - Age, Sexual Dimorphism, and Disease Associations in the Developing Human Fetal Lung Transcriptome.
DO  - https://dx.doi.org/10.1165/rcmb.2015-0326OC
AU  - Kho, Alvin T
AU  - Chhabra, Divya
AU  - Sharma, Sunita
AU  - Qiu, Weiliang
AU  - Carey, Vincent J
AU  - Gaedigk, Roger
AU  - Vyhlidal, Carrie A
AU  - Leeder, J Steven
AU  - Tantisira, Kelan G
AU  - Weiss, Scott T
Y1  - 2016//
KW  - Age Factors
KW  - Databases, Genetic
KW  - Female
KW  - *Fetus/me [Metabolism]
KW  - Gene Expression Profiling
KW  - Gene Expression Regulation, Developmental
KW  - Humans
KW  - *Lung/em [Embryology]
KW  - *Lung/pa [Pathology]
KW  - *Lung Diseases/ge [Genetics]
KW  - Male
KW  - Principal Component Analysis
KW  - *Sex Characteristics
KW  - Statistics as Topic
KW  - *Transcriptome/ge [Genetics]
T2  - American journal of respiratory cell and molecular biology
VL  - 54
IS  - 6
SN  - 1044-1549
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=26584061
AD  - United States
AB  - The fetal origins of disease hypothesis suggests that variations in the course of prenatal lung development may affect life-long pulmonary function growth, decline, and pathobiology. Many studies support the existence of differences in the developing lung trajectory in males and females, and sex-specific differences in the prevalence of chronic lung diseases, such as asthma and bronchopulmonary dysplasia. The objectives of this study were to investigate the early developing fetal lung for transcriptomic correlates of postconception age (maturity) and sex, and their associations with chronic lung diseases. We analyzed whole-lung transcriptome profiles of 61 females and 78 males at 54-127 days postconception (dpc) from nonsmoking mothers using unsupervised principal component analysis and supervised linear regression models. We identified dominant transcriptomic correlates for postconception age and sex with corresponding gene sets that were enriched for developing lung structural and functional ontologies. We observed that the transcriptomic sex difference was not a uniform global time shift/lag, rather, lungs of males appear to be more mature than those of females before 96 dpc, and females appear to be more mature than males after 96 dpc. The age correlate gene set was consistently enriched for asthma and bronchopulmonary dysplasia genes, but the sex correlate gene sets were not. Despite sex differences in the developing fetal lung transcriptome, postconception age appears to be more dominant than sex in the effect of early fetal lung developments on disease risk during this early pseudoglandular phase of development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72051948
TI  - microRNA 219-5p (miR219) in bronchopulmonary dysplasia
AU  - Lal C.V.
AU  - Olave N.
AU  - Ambalavanan N.
Y1  - 2015//
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - human
KW  - hyperoxia
KW  - mouse
KW  - infant
KW  - lung
KW  - in vitro study
KW  - prematurity
KW  - lung alveolus cell
KW  - mouse model
KW  - diseases
KW  - exposure
KW  - Student t test
KW  - gene
KW  - autopsy
KW  - lung fibrosis
KW  - genomics
KW  - macrophage
KW  - fibroblast
KW  - lung development
KW  - epithelium cell
KW  - cell line
KW  - pathogenesis
KW  - *microRNA
KW  - oxygen
KW  - platelet derived growth factor alpha receptor
KW  - messenger RNA
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C.V. Lal, University of Alabama, Birmingham, AL, United States. E-mail: clal@peds.uab.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4073
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72051948
AB  - Rationale - MicroRNAs have been found to be dysregulated in multiple disorders and could either directly or inversely correlate with their predicted mRNA targets. A recent large multicenter integrated genomics analysis comprising of 751 preterm infants identified Micro RNA 219-5p (Mir219) as one of the most critical molecules in Bronchopulmonary Dysplasia (BPD). Prominent targets of Mir219 are platelet derived growth factor receptor-alpha (PDGFRalpha), which is a regulator of alveolar septation and ELMO domain containing 2 (ELMOD2), which is genetically implicated in pulmonary fibrosis. We hypothesized that the dysregulation of Mir219 and its target genes ELMOD 2 and PDGFRalpha contribute to hyperoxia-induced alveolar simplification in mouse models and human BPD. Methods -1) In vivo: C57BL/6 normoxic mice were evaluated at postnatal day 1(P1), P14, and P42 for Mir219 expression. In addition newborn mice were exposed to normoxia (21% oxygen) or hyperoxia (85% oxygen) from P4 to P14. 2) In vitro: Different mouse lung cell lines including mouse lung epithelial cell (MLE), primary mice fibroblast (FB) and macrophage (RAW 264.7) were exposed to either 21% or 85% oxygen for 24 hours. 3) Human: Autopsy lung samples from human preterm infants, term stillborn infants, and preterm infants who died of BPD at term corrected age were evaluated for Mir219 expression. Results - 1a) Under normal conditions, the expression of Mir219 decreased during lung development from P1 to P14. 1b) Compared to animals in normoxia, pups exposed to hyperoxia developed alveolar simplification consistent with BPD (RAC: p<0.001, t test) and had significantly increased expression of Mir219 at P14. 2) In in vitro experiments, Mir219 expression was significantly increased in hyperoxia exposed MLE, FB, and RAW 264.7 cells. A corresponding decrease in PDGFRalpha expression was seen in hyperoxic MLE cells. An increase in ELMOD2 expression was seen in hyperoxic MLE, FB, and RAW cells. 3) Mir219 expression was significantly increased in lung samples of human infants who died of BPD compared to preterm or term stillbith controls. Conclusion - The expression of Mir219 decreases on completion of normal alveolar septation (PN14) but is significantly increased by hyperoxia exposure both in vivo and in vitro experiments and in human BPD lungs. We speculate that Mir219 and its targets are critical to the pathogenesis of hyperoxia induced alveolar simplification and BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72051307
TI  - Expression profiling of miRNAs in pediatric bronchopulmonary dysplasia
AU  - Howrylak J.A.
AU  - Pham M.
AU  - Oji-Mmuo C.
AU  - DiAngelo S.
AU  - Spear D.
AU  - Group K.
AU  - Siddaiah R.
AU  - Thomas N.
AU  - Silveyra P.
Y1  - 2015//
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - human
KW  - infant
KW  - lung
KW  - artificial ventilation
KW  - prematurity
KW  - pathogenesis
KW  - tracheal aspiration procedure
KW  - child
KW  - early diagnosis
KW  - morbidity
KW  - mortality
KW  - ventilator
KW  - United States
KW  - newborn
KW  - gene
KW  - statistical model
KW  - synthetic bone graft
KW  - newborn care
KW  - RNA purification
KW  - oxygen therapy
KW  - lung development
KW  - gene expression
KW  - respiratory tract disease
KW  - health
KW  - comprehension
KW  - chronic lung disease
KW  - pediatric hospital
KW  - *microRNA
KW  - biological marker
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J.A. Howrylak, Penn State, Milton S. Hershey Medical Center, Hershey, PA, United States. E-mail: pzs13@psu.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A3480
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72051307
AB  - Background: Bronchopulmonary dysplasia (BPD) is a chronic lung disease of preterm infants, affecting 10,000-15,000 children per year in the United States with significant mortality. Oxygen therapy and mechanical ventilation in neonatal care are necessary to assist infants with inadequately-developed lungs but also contribute to the development of BPD. Despite improvements of clinical treatments and new ventilator strategies, BPD has remained the most serious pulmonary morbidity in preterm newborns over the past decade. Therefore, it is essential to identify novel non-invasive biomarkers for early diagnosis of BPD to prevent its progression and later implications of impaired lifelong lung health. In this project, we aimed to identify changes of lung miRNAs involved in the pathogenesis of BPD, as miRNAs- regulators of gene expression- have been shown to control essential mechanisms of lung development. Method(s): Following IRB approval, we collected tracheal aspirates (n=20) from infants diagnosed with mild and severe BPD receiving mechanical ventilation at the Penn State Hershey Children's Hospital NICU and PICU, and controls (Table 1). We purified miRNAs using the miRNA circulating RNA purification mini kit (Norgen Biotek). We reverse transcribed these with the the miScript II RT kit (Qiagen) for subsequent quantitation of 1,066 human miRNAs utilizing the human miRNome miScript miRNA PCR array v.16 (Qiagen). We used the limma package in Bioconductor to develop linear models to detect miRNAs differentially expressed between BPD and control infants. Result(s): Preliminary results demonstrated statistically significant (p<0.05) differential expression of 16 miRNAs among infants with BPD compared to control infants (with no signs of respiratory disease). These included 13 miRNAs up-regulated and 5 miRNAs down-regulated in infants with BPD vs. control. The most significantly differentially expressed miRNAs were miR-628-5p (p=0.0001), miR-541 (p=0.002), and miR-497 (p=0.01). Conclusion(s): This is the first study to identify miRNAs associated with BPD in pediatric tracheal aspirates. The miRNA biomarkers identified may reveal specific candidate gene networks that are affected in BPD, contributing towards the comprehension of BPD pathogenesis and potential preventive and therapeutic strategies. (Table Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72050160
TI  - Molecular regulation of cytochrome P450 1A1 induction by hyperoxia: Implications in hyperoxic lung injury
AU  - Basu S.K.
AU  - Chu C.
AU  - Maturu P.
AU  - Kalikkot Thekkevedu R.
AU  - Jiang W.
AU  - Couroucli X.I.
AU  - Moorthy B.
Y1  - 2015//
KW  - *hyperoxia
KW  - *lung injury
KW  - *American
KW  - *society
KW  - promoter region
KW  - statistical significance
KW  - human
KW  - assay
KW  - ambient air
KW  - gel mobility shift assay
KW  - lung dysplasia
KW  - chromatin immunoprecipitation
KW  - infant
KW  - prematurity
KW  - air quality control
KW  - mouse
KW  - model
KW  - acute lung injury
KW  - reporter gene
KW  - adult
KW  - morbidity
KW  - Western blotting
KW  - site directed mutagenesis
KW  - wild type
KW  - mortality
KW  - luciferase assay
KW  - exposure
KW  - oxygen toxicity
KW  - hypothesis
KW  - protein interaction
KW  - *cytochrome
KW  - *cytochrome P450
KW  - luciferase
KW  - oxygen radical
KW  - apoprotein
KW  - aromatic hydrocarbon
KW  - firefly luciferase
KW  - Renilla luciferin 2 monooxygenase
KW  - ethoxyresorufin deethylase
KW  - messenger RNA
KW  - receptor
KW  - DNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S.K. Basu, Baylor College of Medicine, Houston, TX, United States. E-mail: sudeeptb@bcm.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A2384
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72050160
AB  - Background and Hypothesis Oxygen toxicity contributes to acute lung injury(ALI) and bronchopulmonary dysplasia (BPD) which is a major cause of mortality and morbidity in adults as well as premature infants. Cytochrome P450 1A1 (CYP1A1) metabolizes oxygen radicals and attenuates lung injury in mice models and is a potential endogenous protective pathway against hyperoxic lung injury. Hyperoxia induces CYP1A1 by arylhydrocarbon receptor (AhR) pathway. We hypothesize that AhR interacts with hyperoxia responsive element (HRE) in the promoter region to induce CYP1A1 on exposure to hyperoxia. Our study aims to identify this HRE location and understand the molecular regulation of CYP1A1 by hyperoxia. Methods Transformed human bronchoalveolar cells (H441) were grown in room air or hyperoxia (95% O2, 5% CO2 for 0-72 hrs) to study CYP1A1 induction by hyperoxia and the known inducer 3-methylchloranthrene (MC). Endogenous CYP1A1 induction was measured by ethoxyresorufin o-deethylase (EROD) assay, Western Blot and RT-PCR. CYP1A1 promoter was mutated by site-directed mutagenesis at proposed sites of HRE (for e.g. -974, -1373). Wild type (WT) or mutated CYP1A1 promoter was inserted in pGL4 vector with firefly luciferase reporter gene (pGL4-WT, pGL4-DELTA974, pGL4-DELTA1373) and co-transfected with internal control renilla luciferase reporter (pGL4-Rluc) in the H441 cells. Dual luciferase assay indicated CYP1A1 promoter induction in the respective pGL4-luciferase (WT or deletion constructs of CYP1A1). Binding of AHR to the CYP1A1 promoter was demonstrated by electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (CHIP) assay. Results Hyperoxia induced endogenous CYP1A1 in H441 cells, as evidenced by increased expression of EROD activities, apoprotein, and mRNA levels. Hyperoxia induced pGL4-WT luciferase, compared to room air controls (0.33 vs 0.5, p value 0.03) (Fig 1). Induction of luciferase by hyperoxia was decreased by the mutated pGL4-DELTA974 CYP1A1 promoter (0.19 vs 0.22, p value 0.25) (Fig 1). The pGL4-DELTA974 also diminished luciferase induction by MC (fold of increase 7.7 vs 2.8, p value <0.01). EMSA and CHIP assay demonstrated diminished AhR/HRE band with DELTA974 which indicated altered DNA-AhR protein interaction at the mutated -974 promoter region. Conclusion We conclude that CYP1A1 induction in response to hyperoxia is mediated by the AHR pathway and the -974 region of CYP1A1 promoter is the proposed HRE regulation site. Further studies targeting CYP1A1 regulation may lead to innovative strategies for hyperoxia mediated ALI and BPD. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72050138
TI  - PDGFRalpha is required for mesenchymal cell differentiation and expansion of secondary crest myofibroblast progenitors
AU  - Yang C.-Y.
AU  - Li C.
AU  - Li S.
AU  - Li A.
AU  - Borok Z.
AU  - Minoo P.
Y1  - 2015//
KW  - *mesenchyme cell
KW  - *cell differentiation
KW  - *myofibroblast
KW  - *American
KW  - *society
KW  - lung
KW  - cells by body anatomy
KW  - mutant
KW  - lung development
KW  - cell proliferation
KW  - lung dysplasia
KW  - newborn death
KW  - mesodermal cell
KW  - chronic lung disease
KW  - cell fate
KW  - biological model
KW  - fetus lung maturation
KW  - mesoderm
KW  - endothelium cell
KW  - mouse
KW  - apoptosis
KW  - model
KW  - clobetasol propionate
KW  - platelet derived growth factor receptor
KW  - marker
KW  - tamoxifen
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C.-Y. Yang, Division of Neonatology, Department of Pediatrics, University of Southern California, Los Angeles, CA, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A2362
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72050138
AB  - Alveologenesis is the major step in lung maturation and the least understood phase of lung development. Disruption of alveologenesis is associated with the neonatal chronic lung disease, bronchopulmonary dysplasia (BPD). Platelet-derived growth factor receptor-a (PDGFRalpha) is expressed throughout lung development, with dynamic changes in expression pattern and cell type specificity. Recent studies indicate that PDGFRalpha is required for alveologenesis. However little is known about the precise role, timing and cell-type specificity of PDGFRalpha in alveogenesis. To address these questions we used Pdgfralpha floxed mice in two genetic models to target Pdgfralpha in lung mesodermal cells at different stages of lung development. Targeted inactivation of Pdgfralpha in early embryonic mesoderm via Dermo1-cre resulted in neonatal death coinciding in time with the onset of alveologenesis. PdgfralphaDermo lungs showed severely dilated distal airspaces, disrupted septation, decreased cell proliferation and increased apoptosis. Realtime PCR analyses revealed that Dermo1cre-mediated Pdgfralpha inactivation altered expression of multiple cell-type specific markers including those for interstitial myofibroblasts (ATCA2), lipofibroblasts (ADRP, WISP2, and FABP4), endothelial cells (Flk-1) and alveolar type 1 (AQP5) cells. Therefore Pdgfralpha appears essential for differentiation of, or interaction amongst multiple mesenchymal cell progenitors. To understand a cell type-specific functional role of PDGFRalpha in alveologenesis, we targeted Pdgfralpha specifically in myofibroblast progenitors by using a regulable cre model, Gli1creER, which can be activated by time-specific administration of Tamoxifen. Our previous study demonstrated that Gli1creER targets the differentiating myofibroblast progenitors in neonatal lungs. We found that deletion of Pdgfralpha in Gli1creER targeted cells during early neonatal stages lead to disruption of alveologenesis. The mutant lungs show dilated alveoli with a reduced number of secondary crests at postnatal day 11. Importantly, lack of PDGFRalpha on secondary crest myofibroblasts reduced their number (identified by ACTA2positive) in the mutant lungs. To determine whether the reduction of ACTA2 positive cells was caused by alteration of cell fate or cell proliferation, we used GFP to label and trace the Gli1creER targeted cells in both PDGFRalpha deficient and control lungs and found that the number of GFP positive cells was reduced in the mutant lungs. These results indicate that PDGFRalpha is required specifically for the expansion of secondary crest myofibroblast progenitors during alveologenesis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72049698
TI  - Serum neurotrophin levels are associated with clinical outcomes in premature neonates
AU  - Worley S.
AU  - Schneeberger D.
AU  - Tang A.
AU  - Piedimonte G.
Y1  - 2015//
KW  - *serum
KW  - *prematurity
KW  - *newborn
KW  - *human
KW  - *American
KW  - *society
KW  - ventilator
KW  - gestational age
KW  - newborn intensive care
KW  - blood level
KW  - blood
KW  - hazard
KW  - lung dysplasia
KW  - logistic regression analysis
KW  - lung
KW  - immunoassay
KW  - prospective study
KW  - hospital
KW  - risk
KW  - length of stay
KW  - survival
KW  - patient
KW  - intensive care unit
KW  - infant
KW  - *neurotrophin
KW  - surfactant
KW  - oxygen
KW  - brain derived neurotrophic factor
KW  - nerve growth factor
KW  - protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Worley, Cleveland Clinic Children's, Cleveland, OH, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A1911
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72049698
AB  - Rationale: Premature infants may require intensive and lengthy treatment in neonatal intensive care units (NICUs), but few factors known at birth besides gestational age and size are known to be associated with need for treatment and length of stay. Previous studies from our group have shown increased levels of neurotrophins (NT) measured within 48 hours of birth in the lungs of premature babies who go on to develop bronchopulmonary dysplasia; however, NT expression in the blood or its association with other outcomes has not been explored. We hypothesized that serum levels of the NTs nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), or the ratio of these, may be associated with short-term outcomes and length of NICU stay (LOS) in premature babies. Method(s): Premature neonates (gestational age < 37 weeks) admitted to the NICU at Cleveland Clinic were enrolled as part of an ongoing prospective study of serum neurotrophin levels and postnatal outcomes. Serum samples were collected within 48 hours of birth and a highly sensitive immunoassay was used to measure NGF and BDNF protein concentrations. The associations between log-scale NT levels and the ratio of serum NGF to BDNF, and the outcomes treatment with surfactant, use of ventilator, use of supplementary oxygen, and LOS were assessed using logistic regression and competing risks proportional hazards survival analysis. Result(s): Of the 40 enrolled subjects, 18 (45%) had at least one dose of surfactant, 16 (40%) required use of ventilator, and 27 (68%) had supplementary oxygen. Median LOS was 13 days (range 2-133 days). Lower serum NGF was significantly associated with greater use of ventilator (P=0.032) and longer LOS (P=0.013), but not with treatment with surfactant or use of supplementary oxygen. Lower serum BDNF was significantly associated with great likelihood of treatment with surfactant (P=0.018), use of ventilator (P=0.027) and supplementary oxygen (P=0.042), and longer LOS (P=0.028). NGF to BDNF ratio was not significantly associated with surfactant, ventilator, or oxygen use or LOS. Conclusion(s): In this interim analysis, serum NT levels within 48 hours of birth were associated with need for treatment with surfactant, use of ventilator and supplementary oxygen, and longer LOS. Further analysis and adjustment for other patient characteristics is needed as more data is collected.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72049697
TI  - Clinical characteristics of children with tracheotomy who failed decannulation: A retrospective single center study
AU  - Bandyopadhyay A.
AU  - Cristea I.
AU  - Jalou H.E.
AU  - Slaven J.E.
AU  - Givan D.
AU  - Ackerman V.L.
AU  - Daftary A.
Y1  - 2015//
KW  - *human
KW  - *tracheotomy
KW  - *American
KW  - *society
KW  - *child
KW  - patient
KW  - tracheostomy tube
KW  - tracheostomy
KW  - airway
KW  - comorbidity
KW  - feeding
KW  - risk
KW  - diagnosis
KW  - injury
KW  - mortality
KW  - plastic surgery
KW  - morbidity
KW  - tertiary care center
KW  - medical record review
KW  - algorithm
KW  - airway obstruction
KW  - pulmonary hypertension
KW  - lung dysplasia
KW  - retrospective study
KW  - etiology
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 191
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - A. Bandyopadhyay, Indiana University, School of Medicine, Indianapolis, IN, United States. E-mail: anubandy@iupui.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A1910
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=72049697
AB  - RATIONALE: Decannulation is the process of elective removal of a tracheostomy tube when it is no longer needed. Decannulation failure places the patient at significant risk of morbidity and mortality. A recent retrospective analysis noted a shorter time to decannulation in children with laryngotracheal/maxillofacial trauma compared to children who received tracheotomy for cardiopulmonary or neurological reasons. This implies that decannulation outcome may be related to underlying etiologic factors. This retrospective study sought to identify the clinical characteristics of patients who failed decannulation, so as to develop an appropriate diagnostic algorithm for successful decannulation. AIM: Determine the demographics, indication for tracheotomy and comorbidities most associated with patients who had decannulation failure. METHOD(S): After IRB approval, a retrospective chart review was performed on all patients with failed decannulation from June 2006 to October 2013 in a tertiary care center. Failed decannulation was defined as reinsertion of tracheostomy tube within six months. Clinical characteristics on each patient who failed decannulation were collected. RESULT(S): 189 patients had attempted decannulation. At first attempt, 40 (21%) failed decannulation. The median age at initiation tracheotomy was 3 months (IQR 1.25-6) and at attempted decannulation was 3 years (IQR 2-4) , with median duration of tracheostomy use being 29 months (IQR 15.5-40). 35 (87.5%) patients failed immediately. 21 patients had a second decannulation attempt of which 10 were successful (48%), mostly after airway corrective surgeries. Dynamic airway collapse was the most frequent primary diagnosis leading to tracheotomy (50%) in subjects who failed decannulation. Feeding dysfunction was the most frequently associated comorbidity occurring in 37 patients (92.5%) followed by neurological abnormalities in 21 patients (52.5%), genetic abnormalities in 19 patients (47.5%), bronchopulmonary dysplasia in 15 patients (37.5%), cardiac defects in 9 patients (23.1%) and pulmonary hypertension in 6 patients (15.4%).11 (28%) patients had 2 comorbidities while 18 (45%) had 3 comorbidities. CONCLUSION(S): Patients who had dynamic airway obstruction at the time of initiation tracheotomy were most prone to decannulation failure. Feeding dysfunction was the most common comorbidity and the presence of underlying neurologic abnormality and/or genetic abnormality was associated with a higher risk of decannulation failure. A more detailed evaluation of these patients may be required when considering tracheostomy decannulation. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71947684
TI  - The risk of necrotizing enterocolitis (NEC) and other complications associated with red blood cells and platelet transfusions in sick neonates
AU  - Dame C.
Y1  - 2015//
KW  - *blood transfusion
KW  - *society
KW  - *necrotizing enterocolitis
KW  - *erythrocyte
KW  - *thrombocyte transfusion
KW  - *newborn
KW  - *risk
KW  - transfusion
KW  - thrombocyte
KW  - meta analysis
KW  - anemia
KW  - hematocrit
KW  - transfusion related acute lung injury
KW  - very low birth weight
KW  - lung dysplasia
KW  - brain hemorrhage
KW  - patent ductus arteriosus
KW  - baby
KW  - cohort analysis
KW  - diseases
KW  - retinopathy
KW  - consensus
KW  - morbidity
KW  - thrombocytopenia
KW  - death
KW  - prematurity
KW  - adult
KW  - liver dysfunction
KW  - controlled clinical trial (topic)
KW  - disease transmission
KW  - clinical practice
KW  - von Willebrand factor
KW  - hemoglobin
KW  - adrenalin
KW  - polymer
T2  - Vox Sanguinis
LA  - English
VL  - 109
IS  - SUPPL. 1
PB  - Blackwell Publishing Ltd
SN  - 0042-9007
AD  - C. Dame, Department of Neonatology, Charite - Universitatsmedizin, Berlin, Germany
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71947684
AB  - Introduction: Thresholds for transfusions of red blood cells (RBC) and platelets (PLT) in sick neonates are controversially discussed. Specific considerations are required for preterm vs term neonates and should attend to the underlying cause of anaemia or thrombocytopenia. Objective(s): To evaluate the risk of transfusion-associated necrotizing enterocolitis (TANEC), retinopathy (ROP), and other disorders causing long-term sequelae in preterm and term neonates. Result(s): The current meta-analysis on liberal vs restrictive haemoglobin thresholds for RBC transfusions in very low birth weight (VLBW) infants exhibiting anaemia of prematurity does not indicate significant differences in the combined outcomes of death or serious morbidity at 18-21 months corrected age. Any trial eligible for this meta-analysis did not support an association between RBC transfusion strategies and NEC [RR 1.62 (0.083, 3.13), Cochrane 2011]. However, in almost all retrospective case-control or cohort studies a recent transfusion (>48 h) is significantly associated with NEC. The risk for TANEC increases as younger and lighter the neonate is, and if the baby is ventilated or exhibiting patent ductus arteriosus (PDA). The risk of TANEC seems to be inversely related to pre-transfusion haematocrit levels. The risk for severe ROP (33degree) is as higher as earlier RBC are transfused. It also increases with the total number and cumulative volume of RBC transfusions. There is no evidence that RBC transfusion affect the incidence of intraventricular haemorrhage (IVH). Single studies link the risk of bronchopulmonary dysplasia (BPD) to the volume and frequency of RBC transfusion, while others do not show this association. Uncertainty exists regarding the incidence of RBC transfusion-related acute lung injury (TRALI) in neonates, and whether it putatively contributes to severe BPD. Besides the general risks for transmission of infectious diseases and errors in administration as in RBC transfusions, PLT transfusions to sick neonates could be associated with other specific complications such as microembolisms, which are repetitively considered causing TANEC, IVH or TRALI. However, such associations have not been proven in randomised controlled clinical trials (RCTs) yet. Noteably, repeated PLT transfusions seem to be associated with hepatic dysfunction following NEC. Likely, the experimental observation is very important that transfusion of adult platelets results in a dysbalance of the neonatal haemostatic system with shortened epinephrine closure times, eventually explaining a specific risk for microembolisms. Normally, hyporeactivity of neonatal platelets is part of a delicately balanced haemostatic system, which is counteracted by high haematocrit levels, higher von Willebrand factor (vWF) concentrations, and predominance of longer vWF polymers. Conclusion(s): Currently, no international consensus exists on transfusion guidelines for RBC or PLT to preterm and term neonates. However, transfusion-associated complications, such as TANEC, ROP among others per se affecting long-term outcomes of sick neonates, deserve more attention in clinical practice and justify careful evaluation of RBC and PLT transfusion thresholds by performing RCTs.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71930473
TI  - Individualised care rooms: The future of neonatal care
AU  - Liew E.
AU  - Cane C.
Y1  - 2015//
KW  - *newborn care
KW  - *college
KW  - *pediatrics
KW  - *child health
KW  - parent
KW  - human
KW  - baby
KW  - education
KW  - health practitioner
KW  - satisfaction
KW  - nurse
KW  - model
KW  - prematurity
KW  - gestational age
KW  - physician
KW  - monitoring
KW  - kangaroo care
KW  - feedback system
KW  - bay
KW  - incubator
KW  - birth weight
KW  - weight
KW  - health care quality
KW  - environment
KW  - newborn intensive care
KW  - bath
KW  - television
KW  - general hospital
KW  - child
KW  - air conditioning
KW  - illumination
KW  - adult
KW  - brain function
KW  - lung dysplasia
KW  - nursing station
KW  - privacy
KW  - policy
KW  - study design
KW  - planning
KW  - length of stay
KW  - hope
KW  - community
KW  - pulse oximetry
KW  - consultation
T2  - Archives of Disease in Childhood
LA  - English
VL  - 100
IS  - SUPPL. 3
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - E. Liew, Starlight Neonatal Unit, Barnet Hospital, Royal Free London NHS Foundation Trust, London, United Kingdom
UR  - http://adc.bmj.com/content/100/Suppl_3/A259.full.pdf+html?sid=d99e06f8-085d-4e80-ac37-599c3073805c
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71930473
DO  - https://dx.doi.org/10.1136/archdischild-2015-308599.521
AB  - Context Individualised care rooms (ICR) were established in District General Hospital with a Level 2 Neonatal Unit. This was a result of consultation between the medical health professionals, members of the allied health professionals and parent groups. Problem In a traditional Neonatal Intensive Care (NICU) setting, the majority of care is undertaken by neonatal nurses and incubators are set out in an 'open bay' layout. Assessment of problem and analysis of its causes As a result of this traditional setting, parents often report feeling disempowered. The lack of privacy also limits opportunities for kangaroo care and this can affect parent-child bonding. In the Individualised Care Rooms (ICR) model, parents are encouraged to be resident alongside their premature baby from an early stage and become integral to their daily care in a developmental care environment. They are supported by doctors and nurses, and the babies are monitored by cardiac monitoring and pulse oximetry. Research has shown that there is greater parents' satisfaction with the ICR model and premature babies benefit from a shorter length of stay and lower incidence of bronchopulmonary dysplasia. Evidence also supports the provision of regular kangaroo care to improve cerebral function. Intervention There are three broad phases: First phase: Design and building of the ICR. We converted an area within our neonatal unit that was not in clinical use into 10 fully equipped individual rooms. Each room is designed specifically to allow adequate natural lighting, ventilation and space for an adult bed and an incubator. The rooms are also equipped with monitoring equipment and amenities including washbasin and television. Parents share bathrooms and dayroom facilities. A nursing station with central monitor is manned by trained neontal nurses to support parents and babies. Second phase: Education and training. We formulated an admission policy and expected standard of care for the ICR. We set off to promote the ICR in a launch event. There is an ongoing programme of education and training sessions for health professionals and parent groups. Third phase: Admission of babies to the ICR since December 2013. Study design We are in the process of designing a pilot cohort analytical study comparing outcomes of premature babies in the ICR with matched controls of babies nursed in the open bay in our neonatal unit. Our primary outcome targets will include duration of stay, gestational age at discharge and weight at discharge. The secondary outcome target will be a formal neurodevelopmental assessment at various corrected gestation age timepoints. Strategy for change The implementation of the ICR was carried out in a phased manner. This allows adequate time for specific consideration in the design and build of the rooms, education and training sessions, troubleshooting and lastly, implementation. Measurement of improvement Alongside with the planned pilot cohot analytical study, we also plan to conduct a parent satisfaction survey to obtain formal feedback about the ICR. Effects of changes Observation from health professionals are that babies are being discharged at a younger gestational age and lower birth weight with no significant unintended consequence in the community. Verbal feedback from the parent groups regarding ICR has been overwhelmingly positive so far. However we hope to produce a more formal and measurable outcome with the planned study and parents' satisfaction survey. Lessons learnt With the change of junior doctors every six months, education and training sessions need to be ongoing to promote awareness of the purpose and benefits of ICR. Ongoing troubleshooting sessions also help fine tune the running of ICR. Message for others Based on current evidence, we believe that the ICR model should be taken into consideration in the future design and planning of any neonatal unit.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71915067
TI  - The study of oxidative stress in preterm neonates: Lipid and protein peroxidation
AU  - Matyas M.
AU  - Blaga L.D.
AU  - Hasmasanu M.
AU  - Zaharie G.
Y1  - 2015//
KW  - *oxidative stress
KW  - *prematurity
KW  - *newborn
KW  - *human
KW  - *peroxidation
KW  - *European
KW  - *society
KW  - asphyxia
KW  - brain hemorrhage
KW  - respiratory distress
KW  - pathology
KW  - lung dysplasia
KW  - necrotizing enterocolitis
KW  - cell membrane
KW  - retrolental fibroplasia
KW  - statistical analysis
KW  - patient
KW  - control group
KW  - leukomalacia
KW  - data analysis software
KW  - *lipid
KW  - *protein
KW  - free radical
KW  - antioxidant
KW  - polyunsaturated fatty acid
KW  - nucleic acid
T2  - European Journal of Clinical Investigation
LA  - English
VL  - 45
IS  - SUPPL. 2
PB  - Blackwell Publishing Ltd
SN  - 0014-2972
AD  - M. Matyas, Neonatology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania
DO  - https://dx.doi.org/10.1111/eci.12436
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71915067
AB  - Background: The oxidative stress is produced by the harmful effects of free radicals. Several neonatal conditions are correlated with oxidative stress : bronchopulmonary dysplasia, periventricular leucomalacia, retinopathy of prematurity, intraventricular haemorrhage, necrotizing enterocolitis. The harmful effect of free radicals are linked to their capacity to react with polyunsaturated fatty acids of cell membranes, proteins and nucleic acids. Material(s) and Method(s): We conducted a prospective, non-randomized study. In the study group were included 14 preterm neonates with different pathologies: respiratory distress, asphyxia, cerebral hemorrhage. The control group consist in 13 healthy, late preterm neonates. For all patients family's consent was obtained. For the study of the oxidative stress we measured the malonildyaldehide (MDA) by Satoh's method and the protein peroxidation was determined spectrophotometrically as described by Reznick and Packer . For neonates from the study group we performed two determination on the first and third day of life. For control we performed one measurement on first day of life. The statistical analysis was done with SPSS program . Result(s): Five neonates of the study group presented sever asphyxia and ten neonates respiratory distress. The median value of MDA in the study group was higher on the third day of life than on the first day (5.12 vs. 4.87 nmol mL-1). The protein peroxidation process presented the same behaviour (5.57 vs. 4.91 nmol mL-1). The protein peroxidation was significantly higher in the study group than at the control ( P < 0.05). Conclusion(s): The oxidative stress at preterm neonates is more severe when different pathologies are associated which are leading to overproduction of free radicals than in healthy condition. The knowledge of oxidative stress could be useful to implement antioxidant defenses strategies for preterm neonates.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71874055
TI  - Investigating the early mechanisms leading from ventilation-induced lung injury to bronchopulmonary dysplasia using in vitro lung cell over-distension
AU  - Li A.
AU  - McDougall A.R.A.
AU  - Zahra V.A.
AU  - Chandrasena J.
AU  - Hooper S.B.
AU  - Wallace M.J.
Y1  - 2015//
KW  - *ventilator induced lung injury
KW  - *lung dysplasia
KW  - *in vitro study
KW  - *lung alveolus cell
KW  - *society
KW  - *Australia and New Zealand
KW  - lung injury
KW  - apoptosis
KW  - lung fibroblast
KW  - lung
KW  - fibroblast
KW  - cells by body anatomy
KW  - injury
KW  - model
KW  - human
KW  - infant
KW  - rat
KW  - imaging software
KW  - cell proliferation
KW  - prematurity
KW  - fetus lung
KW  - lung development
KW  - assisted ventilation
KW  - caspase 3
KW  - marker
KW  - protein
KW  - messenger RNA
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 51
IS  - SUPPL. 1
PB  - Blackwell Publishing
SN  - 1034-4810
AD  - A. Li, Ritchie Centre, MIMR-PHI Institute of Medical Research, Melbourne, VIC, Australia. E-mail: anqi.li@mimr-phi.org
DO  - https://dx.doi.org/10.1111/jpc.12884-6
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71874055
AB  - Background: Preterm infants often require respiratory support, which can injure their lungs and lead to abnormal lung development called bronchopulmonary dysplasia (BPD). The initial lung cell types affected by injury and the molecular mechanisms leading from lung injury to BPD are not fully understood. Therefore our aim is to mimic ventilation-induced lung injury (VILI) in vitro to investigate the cell types and mechanisms leading to BPD. Method(s): Fetal rat lung fibroblasts were isolated at embryonic day (E)19 and exposed to 0 or 20% phasic over-distension. Cells were collected after 15 minutes, 1, 3, 6 or 24 hours to measure cell proliferation (ki67), apoptosis (caspase-3) and early lung injury markers (CTGF, CYR61 and EGR1). Result(s): Fibroblasts exposed to 20% over-distension had a 3-fold increase in EGR1 mRNA and protein levels within 1 hour of over-distension (p < 0.05). There was a 2-3 fold increase in caspase-3 positive cells after 6 hours of over-distension (p < 0.05). At 24 hours, very few over-distended cells were caspase-3 positive, yet there was a 6% increase in the proportion of cells proliferating (p < 0.05). Conclusion(s): This in vitro model of over-distension injury successfully replicates many of the features associated with VILI including increased fibroblast apoptosis, proliferation and markers of lung injury, suggesting that fetal lung fibroblasts are involved in the initial response to VILI. This in vitro model of VILI will allow future studies to identify the early cellular mechanisms that mediate the response of the lung to VILI and that may initiate the cascade of events leading to BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2016>
TI  - Protective effect of chorioamnionitis on the development of bronchopulmonary dysplasia triggered by postnatal systemic inflammation in neonatal rats.
DO  - https://dx.doi.org/10.1038/pr.2015.224
AU  - Choi, Chang Won
AU  - Lee, Juyoung
AU  - Oh, Joo Youn
AU  - Lee, Seung Hyun
AU  - Lee, Hyun Ju
AU  - Kim, Beyong Il
Y1  - 2016//
Y2  - 20151109//
KW  - Angiogenic Proteins/ge [Genetics]
KW  - Angiogenic Proteins/me [Metabolism]
KW  - Animals
KW  - Animals, Newborn
KW  - Bronchoalveolar Lavage Fluid
KW  - Bronchopulmonary Dysplasia/ge [Genetics]
KW  - Bronchopulmonary Dysplasia/im [Immunology]
KW  - Bronchopulmonary Dysplasia/me [Metabolism]
KW  - *Bronchopulmonary Dysplasia/pc [Prevention & Control]
KW  - *Chorioamnionitis/ci [Chemically Induced]
KW  - Chorioamnionitis/ge [Genetics]
KW  - Chorioamnionitis/im [Immunology]
KW  - Chorioamnionitis/me [Metabolism]
KW  - Cytokines/ge [Genetics]
KW  - Cytokines/me [Metabolism]
KW  - Disease Models, Animal
KW  - Female
KW  - Gene Expression Regulation
KW  - Gestational Age
KW  - Inflammation Mediators/me [Metabolism]
KW  - Leukocyte Count
KW  - *Lipopolysaccharides
KW  - Lung/bs [Blood Supply]
KW  - Lung/gd [Growth & Development]
KW  - *Lung/im [Immunology]
KW  - Lung/me [Metabolism]
KW  - Neovascularization, Physiologic
KW  - Neutrophil Infiltration
KW  - Pregnancy
KW  - Protective Factors
KW  - Rats, Sprague-Dawley
KW  - *Systemic Inflammatory Response Syndrome/co [Complications]
KW  - Systemic Inflammatory Response Syndrome/ge [Genetics]
KW  - Systemic Inflammatory Response Syndrome/im [Immunology]
KW  - Systemic Inflammatory Response Syndrome/me [Metabolism]
KW  - Time Factors
T2  - Pediatric research
VL  - 79
IS  - 2
SN  - 0031-3998
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=26551413
AD  - United States
AB  - BACKGROUND: Prenatal or postnatal systemic inflammation can contribute to the development of bronchopulmonary dysplasia (BPD). We investigated whether prenatal intra-amniotic (i.a.) inflammation or early postnatal systemic inflammation can induce BPD in a rat model., METHODS: One microgram of lipopolysaccharide (LPS) or vehicle was injected into the amniotic sacs 2 d before delivery (E20). After birth, 0.25 mg/kg of LPS or vehicle was injected into the peritoneum of pups on postnatal day (P)1, P3, and P5. On P7 and P14, peripheral blood (PB), bronchoalveolar lavage fluid (BALF), and lung tissue were obtained and analyzed., RESULTS: Postnatal i.p. injections of LPS significantly increased neutrophil counts in PB and BALF on P7 and P14. Similarly, proinflammatory cytokine and angiogenic factor transcript levels were increased in the lung by i.p. LPS on P7. Alveolar and pulmonary vascular development was markedly disrupted by i.p. LPS on P14. However, pretreatment with i.a. LPS significantly negated the detrimental effects of postnatal i.p. LPS on PB and BALF neutrophil counts and on lung proinflammatory cytokine expression and histopathological changes., CONCLUSION: Exposure to early postnatal systemic LPS induces BPD, an arrest in alveolarization, in neonatal rats. Preceding exposure to i.a. LPS protects the lungs against BPD triggered by postnatal systemic inflammation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71873978
TI  - General movement trajectories from birth to term equivalent age in infants born <30 weeks' gestation
AU  - Olsen J.
AU  - Doyle L.W.
AU  - Brown N.C.
AU  - Eeles A.
AU  - Cheong J.
AU  - Spittle A.J.
Y1  - 2015//
KW  - *pregnancy
KW  - *society
KW  - *Australia and New Zealand
KW  - *infant
KW  - human
KW  - infection
KW  - prematurity
KW  - nerve cell differentiation
KW  - gestational age
KW  - hospital
KW  - lung dysplasia
KW  - risk factor
KW  - female
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 51
IS  - SUPPL. 1
PB  - Blackwell Publishing
SN  - 1034-4810
AD  - J. Olsen, Murdoch Childrens Research Institute, Parkville, Australia. E-mail: joy.olsen@thewomens.org.au
DO  - https://dx.doi.org/10.1111/jpc.12884-5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71873978
AB  - Background: Little is known about neurodevelopment prior to term, particularly for very preterm infants who are often difficult to assess due to medical instability. This study used an observational assessment, General Movements (GMs), to describe the early neurodevelopment of infants born <30 weeks' gestation from birth to term equivalent age. The relationships of GMs with known perinatal risk factors were also examined. Method(s): 150 very preterm infants (<30 weeks' gestation) were recruited from the Royal Women's Hospital. Serial GMs were documented weekly from birth to 32 weeks' postmenstrual age, fortnightly until term equivalent age and classified as 'normal' or 'abnormal'. Detailed perinatal data were also collected. Result(s): Overall, 669 GMs were assessed, with 118 GMs assessed at term. The majority of GMs were abnormal. Prior to term, 15% (n = 82) of GMs were normal and 85% (n = 469) were abnormal. The proportion of abnormal GMs decreased with increasing postmenstrual age (p < 0.001), and by term equivalent age 30% (n = 35) of GMs were normal. Lower gestational age (p < 0.001), postnatal infections (p < 0.001) and bronchopulmonary dysplasia (p = 0.002) were associated with abnormal GMs. Postnatal infections were the only perinatal association with abnormal GMs on multivariable analysis (p = 0.001). All infants with grade III/IV IVH had abnormal GMs. Conclusion(s): GMs were predominantly abnormal in very preterm infants, with a higher proportion of normal GMs observed at term equivalent age than prior to term. Abnormal GMs were independently associated with postnatal infections.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71873820
TI  - Measuring biomarkers of lung injury in preterm infants at birth-a feasibility study
AU  - Sloss S.
AU  - Dawson J.A.
AU  - Zahra V.A.
AU  - Hooper S.B.
AU  - Davis P.G.
AU  - Cole T.J.
AU  - White L.
AU  - Wallace M.J.
Y1  - 2015//
KW  - *lung injury
KW  - *prematurity
KW  - *infant
KW  - *human
KW  - *feasibility study
KW  - *society
KW  - *Australia and New Zealand
KW  - blood
KW  - pregnancy
KW  - assisted ventilation
KW  - lung dysplasia
KW  - risk
KW  - chorioamnionitis
KW  - lung
KW  - flow cytometry
KW  - umbilical cord
KW  - lung parenchyma
KW  - baby
KW  - delivery room
KW  - enzyme linked immunosorbent assay
KW  - *biological marker
KW  - cytokine
KW  - protein
KW  - connective tissue growth factor
KW  - cysteine
KW  - interleukin 1
KW  - tumor necrosis factor
KW  - interleukin 10
KW  - interleukin 8
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 51
IS  - SUPPL. 1
PB  - Blackwell Publishing
SN  - 1034-4810
AD  - S. Sloss, University of Melbourne, Australia
DO  - https://dx.doi.org/10.1111/jpc.12884-2
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71873820
AB  - Background: Preterm infants may require respiratory support in the delivery room (DR). However, this support can injure the lung predisposing infants to the development of bronchopulmonary dysplasia (BPD). There are no very early biomarkers of lung injury that are routinely used in preterm infants. Our aim was to see if biomarkers of lung injury known to be increased in injured lung tissue could be identified <=24 hours after birth in the blood of infants <30 weeks gestation. Method(s): Blood was collected from the umbilical cord and at 1-2 hours and ~24 hours after birth, in 14 preterm infants. We measured connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61) protein levels by ELISA and the cytokines interleukin (IL) IL-1s, IL-8, IL-10 and tumour necrosis factor, by flow cytometry. Result(s): CTGF, CYR61 and cytokines were present in detectable levels in the blood of most preterm infants. Levels did not differ over time and did not correlate with the level of respiratory support in the DR in the small number of babies tested. There was considerable variation between infants. Cytokine levels were highest in infants exposed to chorioamnionitis. Conclusion(s): It is feasible to measure biomarkers associated with lung injury in the blood of infants <30 weeks gestation. Further investigation is required in a larger cohort of infants to determine if these proteins are clinically useful as early biomarkers of lung injury and increased risk of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71873766
TI  - Protein c and interleukin 1 receptor antagonist prevent murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia
AU  - Rudloff I.
AU  - Mangan N.E.
AU  - Cho S.X.
AU  - Samarasinghe T.
AU  - Pedersen J.
AU  - Veldman A.
AU  - Berger P.J.
AU  - Nold M.F.
AU  - Nold-Petry C.A.
Y1  - 2015//
KW  - *lung dysplasia
KW  - *inflammation
KW  - *hyperoxia
KW  - *society
KW  - *Australia and New Zealand
KW  - human
KW  - immunocompetent cell
KW  - injection
KW  - mare
KW  - mortality
KW  - chronic lung disease
KW  - patient
KW  - rearing
KW  - histology
KW  - prognosis
KW  - mouse
KW  - cell population
KW  - cell activation
KW  - lung
KW  - immune response
KW  - lung disease
KW  - infection
KW  - flow cytometry
KW  - nerve cell differentiation
KW  - infant
KW  - prematurity
KW  - clinical trial
KW  - enzyme linked immunosorbent assay
KW  - *protein C
KW  - *interleukin 1 receptor blocking agent
KW  - interleukin 1beta
KW  - interleukin 1alpha
KW  - lipopolysaccharide
KW  - protein
KW  - cytokine
KW  - macrophage inflammatory protein 1alpha
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 51
IS  - SUPPL. 1
PB  - Blackwell Publishing
SN  - 1034-4810
AD  - I. Rudloff, Ritchie Centre, MIMR-PHI Institute of Medical Research, Melbourne, Australia. E-mail: ina.rudloff@monash.edu
DO  - https://dx.doi.org/10.1111/jpc.12884
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71873766
AB  - Background: Bronchopulmonary dysplasia (BPD) is a severe chronic lung disease of premature infants with devastating consequences, e.g. impaired neurodevelopment, increased susceptibility to infections and higher mortality. We investigated whether protein C (PC) and interleukin 1 receptor antagonist (IL-1Ra) prevent murine BPD. Method(s): We induced BPD by perinatal inflammation (lipopolysaccharide injection to pregnant dams) and rearing pups in hyperoxia (65% O2). Pups received daily injections of PC, IL-1Ra or vehicle. After 3 or 28 days, lung histology was assessed and pulmonary cytokines and immune cells analyzed by ELISA, protein profiler and flow cytometry. Result(s): Control animals developed a severe BPD-like lung disease, with a 44% decrease in alveolar number and surface area, and a 2.3-fold increase in alveolar size. PC and IL-1Ra almost completely prevented this structural disintegration. At day 3, a distinct pulmonary immune response revealed pivotal roles for IL-1alpha, IL-1beta, MIP-1alpha and TREM-1 in murine BPD. PC and IL-1Ra reduced the levels of these and other proinflammatory mediators by 73% and 94%. At day 28, hyperoxia depleted the pulmonary immune cells by 67%; however, the remaining cells were hyperactivated. Unlike PC, which did not affect the loss of cells or cell activation, IL-1Ra partially rescued the immune cell population and reduced the percentage of activated cells by 63%. Conclusion(s): Because they shield newborn mice from BPD, PC and IL-1Ra emerge as promising treatments for a currently irremediable disease and may potentially brighten the prognosis of preterm patients. A clinical trial for treatment of BPD with IL-1Ra is being planned.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71871126
TI  - A retrospective review of pulmonary hemorrhage in neonatal respiratory distress syndrome-imaging, course, complications, and long term outcomes
AU  - Yu A.
AU  - Shailam R.
AU  - Sagar P.
Y1  - 2015//
KW  - *lung hemorrhage
KW  - *neonatal respiratory distress syndrome
KW  - *imaging
KW  - *society
KW  - *radiology
KW  - pH
KW  - human
KW  - follow up
KW  - newborn
KW  - mortality
KW  - patient
KW  - prematurity
KW  - respiratory distress syndrome
KW  - lung
KW  - survivor
KW  - ambient air
KW  - extremely low birth weight
KW  - lung dysplasia
KW  - radiography
KW  - thorax radiography
KW  - emphysema
KW  - barotrauma
KW  - death
KW  - risk factor
KW  - tracheostomy
KW  - steroid therapy
KW  - patent ductus arteriosus
KW  - hemispheric dominance
KW  - case report
KW  - birth weight
KW  - pneumothorax
KW  - gestational age
KW  - surfactant
KW  - oxygen
T2  - Pediatric Radiology
LA  - English
VL  - 45
IS  - SUPPL. 1
PB  - Springer Verlag
SN  - 0301-0449
AD  - A. Yu, Radiology, Massachusetts General Hospital, Boston, MA, United States. E-mail: alvinyu@post.harvard.edu
DO  - https://dx.doi.org/10.1007/s00247-015-3297-9
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71871126
AB  - Purpose or Case Report: Pulmonary hemorrhage (PH) is a known complication after surfactant treatment for respiratory distress syndrome (RDS) in premature neonates. Patent ductus arteriosus (PDA) is a known risk factor. In the modern era, many neonates are surviving PH and RDS and receive frequent chest radiography (CXR), enabling close radiography- clinical correlation during PH and at long-term follow-up. Methods & Materials: Premature neonates with RDS and PH were included. Clinical notes were reviewed for gestational age (GA), birth weight (BW), surfactant dose, PD duration, PDA, oxygen use at discharge, comorbidities, and mortality. CXRs were interpreted for laterality of new alveolar opacities before, during, and after the episode of PH, within 1 week of discharge, and at furthest follow-up. Result(s): Sixteen premature neonates born between 2005 and 2014 were included with mean GA 26.3 weeks and mean BW 838 g. 75% had antenatal steroid therapy. PH onset was 1.75 days of life and lasted 1.53 days. 88% had PDA and 56% developed ICH. All 3/16 (19%) who died from overwhelming PH had ICH and were born before 2010. At discharge, 50% required oxygen and 17% had tracheostomies. All were on room air at mean furthest follow-up of 18.4 months. One patient is still hospitalized. Immediately before PH, CXR showed findings of RDS in all 16 patients. At time of PH, CXR showed bilateral opacification in 44%, left lung opacities in 31%, right lung opacities in 13%, and no significant change in 13%. All three mortalities showed bilateral opacification at time of PH persisting until death. All survivors reverted to an RDS pattern after PH resolution, out of which 31% developed barotrauma (pulmonary interstitial emphysema or pneumothorax). Follow-up CXR showed fine diffuse hazy and reticular opacities suggesting CLD in 92% of patients, air-trapping in 43%, and normal CXR in 9%. No classic pattern of bronchopulmonary dysplasia was seen. Conclusion(s): PH is predominantly seen in extremely low birth weight premature neonates with a mortality of 19%. During PH, CXR shows bilateral opacification (44%) and left predominant unilateral opacification (31%), which generally resolves within 2 days. Interestingly, all mortalities had ICH and were born before 2010. Patients born after 2010 had no ICH, which may reflect changes in RDS management. All survivors were on room air with CXR showing CLD (92%) and air trapping (43%) at 18.4 months follow-up. None developed traditional patterns of cystic changes with architectural distortion as in BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71867659
TI  - Mice deficient in the SRC family tyrosine kinase yes are protected from hyperoxia-induced lung injury
AU  - Nelin L.
AU  - Jin Y.
AU  - Liu Y.
AU  - Chicoine L.
AU  - Chen B.
Y1  - 2015//
KW  - *hyperoxia
KW  - *lung injury
KW  - *mouse
KW  - lung
KW  - apoptosis
KW  - endothelium cell
KW  - pneumonia
KW  - dry weight
KW  - lung parenchyma
KW  - ambient air
KW  - hypothesis
KW  - mouse model
KW  - wild type
KW  - cell culture
KW  - adult respiratory distress syndrome
KW  - lung dysplasia
KW  - body weight
KW  - Western blotting
KW  - exposure
KW  - *protein kinase Yes
KW  - caspase 3
KW  - arginase
KW  - protein p21
KW  - cyclooxygenase 2
KW  - inducible nitric oxide synthase
KW  - amino acid transporter
KW  - protein
KW  - messenger RNA
T2  - FASEB Journal
LA  - English
VL  - 29
IS  - Meeting Abstracts
SP  -
PB  - FASEB
SN  - 0892-6638
AD  - L. Nelin
UR  - http://www.fasebj.org/content/29/1_Supplement/1017.3.abstract?sid=b46849be-d136-4b7f-ad33-a7c13be3385f
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71867659
AB  - Endothelial cell apoptosis is an early event in the development of inflammatory lung diseases such as acute respiratory distress syndrome (ARDS) and bronchopulmonary dysplasia (BPD). In pulmonary endothelial cell culture studies we found that the Src family tyrosine kinase (STK) yes activated caspase 3, while the STK fyn inhibited caspase 3 activation. Therefore, we tested the hypothesis that mice deficient in yes will be protected from hyperoxia-induced lung injury. Wild-type (WT), yes-/- and fyn-/- mice were exposed to >95% O2 or room air for 48 hours. The animals were weighed and lung tissue harvested. The left lungs were used for determination of wet-to-dry weight ratios (W/D) and the right lungs for western blotting for p21 and cleaved caspase-3, as well as qPCR for cationic amino acid transporter (CAT)-1, CAT-2, arginase1, arginase2, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX2). In the mice exposed to hyperoxia, yes-/- mice lost less body weight than did the WT or fyn-/- mice. Furthermore, yes-/-mice also had significantly lower lung W/D than did the WT or fyn-/- mice. Cleaved caspase-3 protein levels were lower in the yes-/-mice than in WT and fyn-/- mice, while fyn-/- mice showed higher p21 protein levels than did WT and yes-/-mice. Following hyperoxia exposure the mRNA levels for CAT-1, arginase 2, and iNOS were lower in the yes-/-mice than in WT and fyn-/- mice. Our results demonstrate that yes is an important positive regulator of hyperoxiainduced iNOS expression and apoptosis in a mouse model of inflammatory lung disease.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71867657
TI  - Bronchopulmonary dysplasia-associated pulmonary hypertension and mutations in the DDAH1 gene
AU  - Trittmann J.
AU  - Gastier-Foster J.
AU  - Vieland V.
AU  - Klebanoff M.
AU  - Chicoine L.
AU  - Nelin L.
Y1  - 2015//
KW  - *lung dysplasia
KW  - *pulmonary hypertension
KW  - *mutation
KW  - *gene
KW  - pH
KW  - human
KW  - patient
KW  - risk
KW  - statistical significance
KW  - endothelium cell
KW  - birth weight
KW  - gender
KW  - ethnicity
KW  - hypothesis
KW  - model
KW  - single nucleotide polymorphism
KW  - newborn
KW  - gestational age
KW  - comorbidity
KW  - logistic regression analysis
KW  - recessive inheritance
KW  - gene frequency
KW  - pediatric hospital
KW  - n(g),n(g) dimethylarginine
KW  - nitric oxide
KW  - dimethylargininase
KW  - enzyme
KW  - synthetase
KW  - vasodilator agent
KW  - biological marker
KW  - DNA
T2  - FASEB Journal
LA  - English
VL  - 29
IS  - Meeting Abstracts
SP  -
PB  - FASEB
SN  - 0892-6638
AD  - J. Trittmann
UR  - http://www.fasebj.org/content/29/1_Supplement/1017.1.abstract?sid=93ac006c-1528-4f16-b576-c2505d880a49
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71867657
AB  - Pulmonary hypertension (PH) is the most common comorbidity in bronchopulmonary dysplasia (BPD). Nitric oxide (NO) is produced by endothelial NO synthase (eNOS) in pulmonary endothelial cells and is a potent vasodilator. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of eNOS. Our group has recently published that ADMA levels are elevated in patients with BPD-associated PH. ADMA is degraded by the enzyme NG, NG- dimethylarginine dimethylaminohydrolase (DDAH). We tested the hypothesis that there are single nucleotide polymorphisms (SNPs) in DDAH1 associated with PH in BPD. Neonates diagnosed with BPD were enrolled at Nationwide Children's Hospital. DNA was assayed for 34 SNPs in DDAH1. Calculated minor allele frequency (MAF) for cases and controls were compared using chi-square. Assuming recessive inheritance, logistic regression was used to estimate the odds ratio. Among 157 patients with BPD, 53 (34%) also had echocardiographic evidence of PH. Gestational age, birth weight, gender, and ethnicity were not different between groups. DDAH1 rs11161637 SNP had a significantly (p=0.04) lower MAF in cases than in controls (0.25 vs. 0.34). DDAH1 rs11161637 was associated with a decreased risk (OR=0.27) of PH in this BPD cohort, although this did not reach statistical significance (p-value=0.06). These results indicate that rs11161637 SNP of DDAH1 may be protective against the development of PH in patients with BPD. We speculate that the DDAH1 SNP may be a useful biomarker in developing predictive models for PH in patients with BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71866742
TI  - Calcium signaling in the bronchopulmonary dysplasia rat heart
AU  - Haraldsdottir K.
AU  - Farrell E.
AU  - Sobotik A.
AU  - Eldridge M.
Y1  - 2015//
KW  - *lung dysplasia
KW  - *rat
KW  - *heart
KW  - *calcium signaling
KW  - protein expression
KW  - pH
KW  - mortality
KW  - perinatal morbidity
KW  - pathophysiology
KW  - infancy
KW  - prematurity
KW  - heart right ventricle hypertrophy
KW  - Western blotting
KW  - adulthood
KW  - heart failure
KW  - heart muscle
KW  - pulmonary hypertension
KW  - rat model
KW  - chronic lung disease
KW  - homogenate
KW  - protein
KW  - calcium channel L type
KW  - ryanodine receptor
KW  - cyclic AMP dependent protein kinase
KW  - sodium calcium exchange protein
KW  - phospholamban
KW  - antibody
T2  - FASEB Journal
LA  - English
VL  - 29
IS  - Meeting Abstracts
SP  -
PB  - FASEB
SN  - 0892-6638
AD  - K. Haraldsdottir
UR  - http://www.fasebj.org/content/29/1_Supplement/946.12.abstract?sid=6512d383-0a00-45d8-88f8-adaa15c09dbf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71866742
AB  - Bronchopulmonary dysplasia (BPD) is a chronic lung disease associated with premature birth. It is a significant contributor to perinatal morbidity and mortality. The disease results in disrupted alveolar and pulmonary vascular growth, and may lead to pulmonary hypertension (PH) and right ventricular hypertrophy (RVH) during infancy. Although recent studies have shed light on the pathophysiology of BPD, much remains unknown about the long-lasting effects of the disease into adulthood. Previous studies on heart failure, PH and RVH have shown that there are alterations in Ca2+ signaling proteins in the right heart myocardium. The objective of this study is to identify whether there are alterations in Ca2+ signaling protein expression in right ventricular (RV) myocytes in rats with BPD. We hypothesize that there is decreased expression of Ryanodine Receptor (RyR2), SERCA2A and L-type Calcium Channel (LTCC), and an increased expression of protein kinase A (PKA), Na-Ca exchanger (NCX) and phospholamban (PLN). A previously established rat model of BPD was used, where BPD rats were exposed to 85% O2 for 14 days and controls were exposed to 21% O2 for 14 days. 78 rat hearts in total were harvested during the study at p0, p7, p14, p21, p28, p56, p90, p180. Relative protein expression differences were determined using Western Blots with antibodies against key Ca2+ signaling proteins in control and BPD RV homogenate.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71857685
TI  - Trisomy 18. New case of a survival child: Cytogenetical and phenotype data
AU  - Rumiantsava N.
AU  - Artushevskaja M.
AU  - Zobikova O.
AU  - Naumchik I.
Y1  - 2015//
KW  - *survival
KW  - *child
KW  - *human
KW  - *phenotype
KW  - *trisomy 18
KW  - female
KW  - patient
KW  - mosaicism
KW  - pregnancy
KW  - follow up
KW  - male
KW  - fetus
KW  - screening
KW  - pulmonary hypertension
KW  - genetic counseling
KW  - cytogenetics
KW  - boy
KW  - neurologic disease
KW  - heart ventricle septum defect
KW  - heart foramen ovale
KW  - weight
KW  - hypoplasia
KW  - invasive procedure
KW  - mortality
KW  - newborn
KW  - heart
KW  - intrauterine growth retardation
KW  - congenital malformation
KW  - prenatal screening
KW  - cesarean section
KW  - pregnant woman
KW  - risk
KW  - karyotype
KW  - examination
KW  - diagnosis
KW  - genetic risk
KW  - pulmonary vein
KW  - vein dilatation
KW  - Belarus
KW  - feeding difficulty
KW  - lung dysplasia
KW  - anemia
KW  - mental deficiency
KW  - infant
KW  - brain
KW  - palliative therapy
KW  - heart surgery
KW  - nutrition
KW  - mental development
KW  - case report
KW  - prevention
KW  - chromosome disorder
KW  - lifespan
KW  - disease management
KW  - medical care
KW  - nuclear magnetic resonance imaging
KW  - patient care
KW  - biochemical marker
T2  - Medizinische Genetik
LA  - English
VL  - 27
IS  - 1
PB  - Springer Verlag
SN  - 0936-5931
AD  - N. Rumiantsava, Republican Scientific and Practice Centre Mother and Child, Minsk, Belarus
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71857685
AB  - Trisomy 18 (T18) is characterized by multiply malformations, high frequency of heart defects (HD), severe retardation, high incidence of mortality (from published data 5-10 % patients survival up age 1-year). Patients with mosaic forms displayed significant variability of phenotype's expression, longer survival and need for medical management. In Belarus 98 % of pregnant women undergoing to conventional screening 1-2-st trimesters. T18 was detected in 159 fetuses during 2009-2014, 95 % pregnancies were terminated. Eight children with T18 were born because the pregnant refused from invasive procedure or decided to continue the pregnancy with affected fetus. We presented the 1,5 years old boy with mosaic T18: phenotype, cytogenetics, genetic counseling, management. Case report. 41 years old pregnant, counseled due to age-related genetic risk, refused from invasive diagnostics. Results of combined screening (US and biochemical markers) were normal (risk < 1:360). Pregnancy complicated by intrauterine growth retardation; labor was at 33 weeks by cesarean section. Newborn male underwent for genetic examinations due to prenatal hypoplasia (weight 915 g, length 37 cm, OFC 26 cm), dysmorphisms, neurological disturbances, HD (perimembranouse ventricular septal defect, trikuspid valve's insufficiency, foramen ovale, pulmonary vein dilatation, pulmonary hypertension). Renal, brain abnormalities were not found by US, MRI studies. The infant suffered from bronchopulmonary dysplasia, pulmonary hypertension, feeding difficulties, anemia. Severe growth, motor, mental retardation was detected by follow-up. Karyotype: 47,XY, + 18[9]/46,XY[10]. Patient's management: symptomatic treatment; cardiac surgery at 10 months old, regular cardiovascular evaluations; nutrition; growth, mental development follow-up. Conclusion. Prenatal screening plays the main role for prevention outcome with chromosomal disorders. But, children with mosaic 18T may present a longer lifespan and need for complex medical care. So, information collection concerning phenotype of survival patients may be important for management strategies improving at each life stage.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71820567
TI  - Cytokine airway responses to acute rhinovirus infection and respiratory morbidity in severe premature children
AU  - Perez G.F.
AU  - Nino G.
AU  - Pancham K.
AU  - Huseni S.
AU  - Jain A.
AU  - Rodriguez-Martinez C.
AU  - Preciado D.
AU  - Rose M.
Y1  - 2015//
KW  - *human
KW  - *airway
KW  - *morbidity
KW  - *prematurity
KW  - *child
KW  - *Rhinovirus infection
KW  - *American
KW  - *medical research
KW  - infection
KW  - secretion (process)
KW  - asthma
KW  - electronic medical record
KW  - immunoassay
KW  - pathogenesis
KW  - Rhinovirus
KW  - pregnancy
KW  - intensive care unit
KW  - hospitalization
KW  - virus
KW  - lung dysplasia
KW  - infant
KW  - cytokine response
KW  - risk factor
KW  - medical record review
KW  - *cytokine
KW  - interleukin 4
KW  - protein
KW  - thymic stromal lymphopoietin
T2  - Journal of Investigative Medicine
LA  - English
VL  - 63
IS  - 3
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - G.F. Perez, Pulmonary and Sleep Medicine, Children's National Medical Health Systems, Washington, DC, United States
DO  - https://dx.doi.org/10.1097/JIM.0000000000000173
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71820567
AB  - Purpose of Study: Rhinovirus (RV) has been strongly linked to the pathogenesis of asthma in children. Prematurity is a risk factor for severe RVinfection in early life, but is unknown if RV elicits pro-asthmatic airway cytokine responses in premature infants. This study investigated if young children born severely premature (<32 weeks gestation) exhibit airway secretion of Th2/Th17 cytokines during natural RV infections and if RV-induced Th2/Th17 responses are linked to more respiratory morbidity in premature children during the first two years of life. Methods Used: We measured Th2/Th17 nasal airway cytokines in a retrospective cohort of young children aged 0-2 years with PCR-confirmed RV infection or non-detectable virus. Protein levels of IL-4, IL- 13, TSLP and IL-17 were determined with multiplex magnetic bead immunoassays. Demographic and clinical variables were obtained by electronic medical record (EMR) review. Summary of Results: The study comprised 214 children born full term (n=108), pre-term (n=44) or severely premature (n=62). Natural RV infection in severely premature children was associated with elevated airway secretion of Th2 (IL-4 and IL-13) and Th17 (IL-17) cytokines, particularly in subjects with history of bronchopulmonary dysplasia. Severely premature children with high RV-induced airway IL-4 had recurrent respiratory hospitalizations (median 3.65 hosp/year; IQR 2.8-4.8) and were more likely to have at least one pediatric intensive care unit admission during the first two years of life (OR 8.72; 95% CI 1.3-58.7; p=0.02). Conclusion(s): Severely premature children have increased airway secretion of Th2/Th17 cytokines during RV infections, which is associated with more respiratory morbidity in the first two years of life.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71798342
TI  - Forced deflation PFT: A novel method to evaluate lung function in infants and young children
AU  - Goyal R.K.
AU  - Ibrahimova A.
AU  - Escolar M.L.
AU  - Szabolcs P.
AU  - Lugt M.V.
AU  - Windreich R.M.
AU  - Weiner D.J.
Y1  - 2015//
KW  - *infant
KW  - *child
KW  - *human
KW  - *lung function
KW  - transplantation
KW  - patient
KW  - anesthesia (sensory dysfunction)
KW  - procedures
KW  - anesthesia
KW  - respiratory failure
KW  - immune deficiency
KW  - pneumotachograph
KW  - total lung capacity
KW  - diseases
KW  - breathing circuit
KW  - adult
KW  - lung function test
KW  - endotracheal tube
KW  - mortality
KW  - bronchitis
KW  - forced vital capacity
KW  - forced expiratory flow
KW  - lung
KW  - respiratory system
KW  - follow up
KW  - residual volume
KW  - pneumonia
KW  - lung disease
KW  - devices
KW  - lung dysplasia
KW  - general anesthesia
KW  - risk
KW  - prevalence
KW  - pilot study
KW  - graft recipient
KW  - bone marrow depression
KW  - toddler
KW  - metabolic disorder
KW  - adult respiratory distress syndrome
T2  - Biology of Blood and Marrow Transplantation
LA  - English
VL  - 21
IS  - 2 SUPPL. 1
PB  - Elsevier Inc.
SN  - 1083-8791
AD  - R.K. Goyal, Division of Blood and Marrow Transplantation and Cellular Therapies, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, United States
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71798342
AB  - Pretransplant pulmonary function test (PFT) abnormalities are correlated with risk of early respiratory failure and mortality in adults and older children. While there is an increasing use of allogeneic BMT in infants and young children with metabolic and immune deficiency disorders, lung function has not been systematically studied in this age group.We describe use of forced deflation PFT (dPFT), a novel technique for assessment of lung function in a series of infants and young children and those unable to perform cooperative testing. Forced dPFT studies were coordinated with other procedures requiring general anesthesia and performed according to previously published techniques1. Briefly, a specially constructed forced deflation device was inserted between the endotracheal tube and anesthesia breathing circuit via a 3- way slide valve (Figure). The lungs were inflated three times to 40 cm H2O (total lung capacity) and then rapidly deflated to -40 cmH2O via a pneumotachograph (to residual volume). Raw flow or volume measurements were normalized and converted to %predicted and standard deviation scores using data obtained in healthy children. Between October 2008 and April 2014, 52 dPFT studies were performed in 26 transplant recipients. Indications for BMT were inherited metabolic disease (42%), malignancy (31%), primary immune deficiency (15%) and bone marrow failure (12%). Median age of 21 patients who had pretransplant studies was 0.9+/-1.3 y (0.1 - 4.9 y); nine of them (43%) had one or more prior lung diseases (respiratory failure [n=7]; pneumonia [n=7]; ARDS [n=3]; bronchopulmonary dysplasia [n=1]; and bronchitis [n=1]). Forced vital capacity (FVC) and forced expiratory flow (FEF75) were normal in all but respiratory system compliance (Crs) was reduced in 5/21 cases. Six out of nine (66.7%) patients with clinical resp. issues pre-BMT also had respiratory complications post-BMT compared with 3/12 (25%) that had no pre-transplant respiratory issues. There were no significant differences in pretransplant FVC, FEF75 and Crs between those patients who did and who did not have post-transplant pulmonary complications with median follow-up of 1.7+/-1.5 y (p=0.435, p=0.305, and p=0.301 respectively). There were no complications during the procedures and dPFT studies could be safely done in coordination with other procedures requiring anesthesia. In this pilot study, pre-transplant PFTs were not predictive of post-transplant pulmonary complications, and most patients had normal volume and flows. A larger study would be required to determine prevalence and significance of lung function abnormalities in infants and toddlers undergoing transplantation. (Figure presented) .
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2016>
TI  - The Haplotype TGGAG in the ABCA3 Gene Increases the Risk of Respiratory Distress Syndrome in Preterm Infants in Southern China.
DO  - https://dx.doi.org/10.1016/j.pedneo.2015.09.002
AU  - Tian, Wenjun
AU  - Chen, Xiuqi
AU  - Qin, Huijuan
AU  - Wei, Qiufen
AU  - Zhang, Shuying
AU  - Tang, Shangying
AU  - Liao, Liangrong
AU  - Zhang, Yanming
AU  - Chen, Yujun
Y1  - 2016//
Y2  - 20151027//
KW  - *ATP-Binding Cassette Transporters/ge [Genetics]
KW  - Asian People
KW  - China
KW  - Female
KW  - Gene Frequency
KW  - Genotype
KW  - *Haplotypes
KW  - Humans
KW  - Infant, Newborn
KW  - *Infant, Premature
KW  - Male
KW  - Mutation
KW  - Polymorphism, Single Nucleotide
KW  - Real-Time Polymerase Chain Reaction
KW  - *Respiratory Distress Syndrome, Newborn/ge [Genetics]
T2  - Pediatrics and neonatology
VL  - 57
IS  - 3
SN  - 1875-9572
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=26522252
AD  - Singapore
AB  - BACKGROUND: Rare mutations in the ATP-binding cassette (ABC) transporter A3 (ABCA3) gene are associated with neonatal respiratory distress syndrome (RDS). The contribution of common single nucleotide polymorphisms (SNPs) to preterm RDS differs between ethnicities and remains unclear in Chinese infants. This study evaluated whether common SNPs and consequent haplotypes increase susceptibility to RDS in a population of preterm infants from the Guangxi Zhuang Autonomous Region of China., METHODS: Using a tagging SNP (tSNP) strategy and real-time polymerase chain reaction, we genotyped four tSNPs (i.e., rs150929, rs4787273, rs11867129, and rs17135889) and one coding SNP (p.F353F) of the ABCA3 gene in preterm infants with RDS (n = 83) and without RDS (n = 83). We predicted the haplotypes. Minor allele frequencies (MAFs) and haplotype distributions were compared between the two groups. We analyzed correlations between the clinical data and the genotypes., RESULTS: Seven haplotypes existed at a frequency of 0.01 or greater. The haplotype TGGAG was significantly more frequent in RDS infants than in non-RDS infants (p = 0.026; odds ratio 3.41; 95% confidence interval 1.088-10.685). The MAF of rs17135889 SNP, a crucial SNP of the haplotype TGGAG located in the transcription factor binding site of ABCA3, was significantly higher in RDS infants (p < 0.05); however, the Bonferroni correction test showed no significant difference (p > 0.05). No significant correlation existed between the rs17135889 genotypes (AG/GG) and any clinical characteristic (e.g., oxygen supplementation duration and hospitalization, requirement for ventilation, bronchopulmonary dysplasia complications, and mortality rate)., CONCLUSION: The TGGAG haplotype may be a risk factor for RDS in preterm infants in this Chinese population. Further study is needed with a larger sample size to verify the association between the rs17135889 SNP and increased risk of RDS in preterm infants, and to determine whether rs17135889 can be a reference in further population-based studies of ABCA3. Copyright Â© 2015. Published by Elsevier B.V.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71770482
TI  - Brain vascular growth factor protein abundance is differently affected by ventilation mode in preterm lambs
AU  - Clayton A.
AU  - Havlicak A.
AU  - Alvord J.
AU  - Dong L.
AU  - Wang Z.M.
AU  - Dahl M.J.
AU  - Null D.M.
AU  - Yoder B.A.
AU  - Albertine K.
Y1  - 2015//
KW  - *air conditioning
KW  - *lamb
KW  - *American
KW  - *medical research
KW  - *brain
KW  - gray matter
KW  - prematurity
KW  - female
KW  - human
KW  - lung injury
KW  - capillary
KW  - artificial ventilation
KW  - apoptosis
KW  - white matter
KW  - lung dysplasia
KW  - immunoblotting
KW  - temporal lobe
KW  - pregnancy
KW  - newborn
KW  - respiratory failure
KW  - *growth factor
KW  - *protein
KW  - vasculotropin
KW  - caffeine citrate
KW  - surfactant
KW  - steroid
KW  - vasculotropin receptor 2
T2  - Journal of Investigative Medicine
LA  - English
VL  - 63
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - A. Clayton, University of Utah, Salt Lake City, UT, United States
DO  - https://dx.doi.org/10.1097/JIM.0000000000000133
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71770482
AB  - Purpose of Study: Respiratory failure and mechanical ventilation (RFMV) predisposes preterm babies towards lung injury (bronchopulmonary dysplasia or BPD). MV is necessary to keep many preterm babies with RF alive. Therefore, MV is life-saving. But MV has collateral consequences. An important collateral consequence is neurodevelopmental impairment that often is life-long. The mechanisms by which impairment occurs are not known. We recently showed that MV of preterm lambs is associated with shifts in apoptosis and proliferation in the brain. Another possible mechanism may be disrupted formation of capillaries in the brain. We hypothesized that MV disrupts abundance of vascular growth factor proteins in the brain of preterm lambs. Methods Used: Preterm (PT) lambs, treated with antenatal steroids and postnatal surfactant and caffeine citrate, were managed by invasive MV or non-invasive HFNV for 3d or 21d. Other PT lambs were managed by MV for 3d and recovered from ventilation support (former preterm lambs). Former preterm term lambs lived to 11 wk or 20 wk corrected postnatal age (equivalent to ~2 yr and ~6 yr, respectively, corrected postnatal age in humans). Reference groups were gestation and postnatal age-matched lambs that were not ventilated. Brain white and gray matter in the temporal lobe was isolated and analyzed by immunoblot. Summary of Results: Vascular endothelial growth factor (VEGF) protein abundance was significantly lower in gray matter of preterm lambs managed for 3d by MV, and in white matter at 21d of MVas well as at 11 wk in former preterm lambs, compared to HFNV. VEGF receptor 2 also was consistently significantly lower in gray matter in all of the preterm and former preterm groups compared to preterm HFNV and term postnatal age-matched lambs. Conclusion(s): We conclude that invasive MV decreases VEGF and VEGFR2 in the brain, especially in gray matter, compared to non-invasive HFNV. We speculate that reduced abundance of vascular growth factors in the brain during invasive MV may disrupt subsequent, appropriate development of the immature brain of preterm neonates.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71770266
TI  - Transfusion of washed packed red blood cells and necrotizing enterocolitis in extremely preterm infants
AU  - Joshi A.
AU  - Ramanathan R.
AU  - Cayabyab R.
Y1  - 2015//
KW  - *erythrocyte
KW  - *necrotizing enterocolitis
KW  - *prematurity
KW  - *infant
KW  - *human
KW  - *American
KW  - *medical research
KW  - *transfusion
KW  - newborn morbidity
KW  - donor
KW  - gestational age
KW  - birth weight
KW  - inflammation
KW  - pathogenesis
KW  - newborn
KW  - lung dysplasia
KW  - brain hemorrhage
KW  - death
KW  - data base
KW  - injury
KW  - intestine
KW  - clinical study
KW  - hospital
KW  - intensive care unit
KW  - newborn intensive care
KW  - cohort analysis
KW  - adverse outcome
KW  - retrolental fibroplasia
KW  - plasma
KW  - air conditioning
KW  - mortality
KW  - length of stay
KW  - patient
KW  - noninvasive ventilation
KW  - adverse drug reaction
KW  - risk
KW  - antibody
KW  - potassium
KW  - plasma protein
KW  - oxygen
T2  - Journal of Investigative Medicine
LA  - English
VL  - 63
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - A. Joshi, LAC-USC Medical Center, Los Angeles, CA, United States
DO  - https://dx.doi.org/10.1097/JIM.0000000000000133
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71770266
AB  - Purpose of Study: Washing packed red blood cells (pRBC) decreases the risk of adverse effects from constituents of plasma (plasma proteins, donor antibodies, potassium). Transfusion-related acute gut injury in the form of necrotizing enterocolitis (NEC) has been reported in premature neonates within 48 hours after a pRBC transfusion. The pathogenesis may be secondary to an inflammatory reaction to donor antibodies. The objective of this study is to examine the differences in neonatal morbidities of extremely preterm infants who received washed pRBCs compared to unwashed pRBCs. Methods Used: This is a retrospective, cohort study examining infants less than 28 weeks gestational age admitted to the neonatal intensive care unit at Good Samaritan Hospital who received pRBC transfusion with washed pRBCs during January 2005 to September 2009 and unwashed pRBCs during December 2009 to March 2014. Neonatal demographics and clinical data were extracted from the neonatal database and paper charts. Neonatal morbidities evaluated were NEC, death, intraventricular hemorrhage (IVH), retinopathy of prematurity (ROP), and bronchopulmonary dysplasia (BPD). Summary of Results: One hundred sixteen infants were studied. There were no significant differences in birth weight and gestational age between the two groups. In addition, no patient developed NEC and there was no significant difference in the rate of severe IVH, ROP, length of stay and mortality. However, there was a trend towards lower incidence of BPD, significantly shorter duration of invasive ventilation, and lower use of home oxygen in the unwashed group compared to the washed group. Conclusion(s): Use of unwashed pRBCs was not associated with NEC or any other adverse outcomes. The trend towards a lower incidence of BPD in preterm infants exposed to unwashed pRBC may be secondary to use of more non-invasive ventilation during the latter period. (Table Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71770175
TI  - Serotonin signaling is increased in a model of bronchopulmonary dysplasia and pulmonary arterial hypertension
AU  - Delaney C.A.
AU  - Woods C.
AU  - Kailey J.
AU  - Grayck E.
Y1  - 2015//
KW  - *model
KW  - *lung dysplasia
KW  - *pulmonary hypertension
KW  - *American
KW  - *medical research
KW  - lung
KW  - mouse
KW  - pulmonary vascular disease
KW  - wild type mouse
KW  - murine model
KW  - density
KW  - prism
KW  - Western blotting
KW  - surgical technique
KW  - post hoc analysis
KW  - injection
KW  - Student t test
KW  - intraperitoneal drug administration
KW  - protein expression
KW  - rodent model
KW  - analysis of variance
KW  - *serotonin
KW  - bleomycin
KW  - serotonin transporter
KW  - nonoxinol 9
KW  - blood clotting factor 8
KW  - protein
T2  - Journal of Investigative Medicine
LA  - English
VL  - 63
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - C.A. Delaney, University of Colorado, Denver, CO, United States
DO  - https://dx.doi.org/10.1097/JIM.0000000000000133
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71770175
AB  - Purpose of Study: Determine whether 5-HT signaling is increased in a novel murine model of BPD and PAH. Methods Used: Wild-type mice were injected with intraperitoneal bleomycin (IP) (2u/kg) dissolved inPBS or PBS alone 3 times/wkbeginning on day 2 of life for 3wks (total 9 injections, 10Kl).Micewere euthanized for tissue harvesting at 3 or 4 wks of age. To evaluate alveolar development, inflation fixed lungs were analyzed for radial alveolar counts (RAC), and mean linear intercept (MLI). To identify total and muscularized small vessels (<30 microns), lung sections were immunostained with Factor VIII or alpha-SMA. Total or % muscularized vessels were expressed per high-powered field under 20x magnification. Lung protein from 3 week old mice was analyzed by Western blot for Tph1, 5-HT2A and 5- HT2B R and the serotonin transporter (SERT). Datawere analyzed by unpaired t-test or 2-way ANOVA with Bonferroni post-hoc analysis using Prism. Significance defined as p<0.05. Summary of Results: Treatment of neonatal mice with bleomycin disrupted alveolar development, shown by a decrease in RAC (17+/-0.6 - 11.72+/-0.63, p <0.0001) and increased MLI (45.36+/-1.86 - 58+/-2.8, pG 0.0013). Bleomycin also decreased vessel density (7.3+/-0.35 - 4.6 +/-0.62, P<0.0056) and increased the ratio of muscularized vessels/total number of vessels (0.19+/-0.03 - 0.62+/-0.03, P<0.0001). Bleomycin also increased the protein expression of lung TPH-1 (0.39 +/-0.03 - 0.94 +/-0.12, P<0.0023), 5-HT2A R (1.01+/- 0.14 - 1.98 +/- 0.27, PG 0.01) and 5-HT2BR, (0.87 +/-0.04 - 1.21 +/- 0.12, PG 0.02). Bleomycin did not cause a change in expression of the serotonin transporter. Conclusion(s): We conclude that TPH-1 and 5HT 2A and 2B R expression are increased in a novel rodent model of bleomycin induced BPD and PAH. These findings suggest that 5-HT contributes to alveolar simplification and pulmonary vascular disease.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71769940
TI  - Omeprazole potentiates hyperoxia-induced developmental lung injury in newborn mice
AU  - Shivanna B.
AU  - Zhang S.
AU  - Patel A.
AU  - Moorthy B.
Y1  - 2015//
KW  - *hyperoxia
KW  - *lung injury
KW  - *mouse
KW  - *American
KW  - *medical research
KW  - inflammation
KW  - exposure
KW  - angiogenesis
KW  - lung
KW  - drug megadose
KW  - neutrophil
KW  - hypothesis
KW  - newborn
KW  - pneumonia
KW  - therapy
KW  - prematurity
KW  - lung alveolus macrophage
KW  - lung dysplasia
KW  - oxygen toxicity
KW  - morphometrics
KW  - wild type
KW  - macrophage
KW  - immunohistochemistry
KW  - human
KW  - lung lavage
KW  - infant
KW  - membrane
KW  - model
KW  - *omeprazole
KW  - protein
KW  - macrogol
KW  - aromatic hydrocarbon receptor
KW  - hyalin
T2  - Journal of Investigative Medicine
LA  - English
VL  - 63
IS  - 2
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - B. Shivanna, Baylor College of Medicine, Houston, TX, United States
DO  - https://dx.doi.org/10.1097/JIM.0000000000000146
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed16&NEWS=N&AN=71769940
AB  - Purpose of Study: Hyperoxia contributes to bronchopulmonary dysplasia (BPD) in preterm infants. We showed that omeprazole (OM) protects adultmice against hyperoxic lung injury via aryl hydrocarbon receptor (AhR)-dependent mechanisms. Whether OM protects newborn mice against hyperoxia-induced developmental lung injury is unknown. Therefore, we tested the hypothesis that omeprazole-treated newborn mice will have decreased inflammation and alveolar simplification upon exposure to hyperoxia. Methods Used: Within 12 h of birth, wild type C57BL/6J (WT) pups were immediately exposed to either air (normoxia) or 85 % O2 (hyperoxia) for 14 d. WT newborn pups while exposed to either air or hyperoxia, were administered 10 or 25 mg/kg of OM or an equivalent volume of the vehicle, polyethylene glycol (PEG), i.p. once daily from birth for 14 d. The dosing regimen was based on our finding that at least 25 mg/kg/d of i.p. OM is required to activate the AhR. Additionally, we used OM at a dose of 10 mg/kg/d to determine its AhR independent effects. Following exposure, the lungs and bronchoalveolar lavage fluid (BALF) of the mice were harvested to determine inflammation, angiogenesis, and alveolarization. Lung inflammation was determined by immunohistochemistry (neutrophils and macrophages) and BALF protein concentration, alveolarization was determined by lung morphometry (radial alveolar counts), and angiogenesis was determined by vonWillibrand factor immunostaing. Summary of Results: OM treatment (10 to 25 mg/kg) increased oxygen toxicity in a dose-depenedent manner. OM-treated mice were significantly growth restricted upon exposure to hyperoxia. Furthermore, OM increased hyperoxia-induced lung macrophage influx. Interestingly, mice treated with high-dose OM had persistent acute lung inflammation as evident by the presence of hyaline membranes, neutrophil infiltrates, and proteinaceous debris in the alveolar space. Additionally, high-dose OM increased alveolar simplification (radial alveolar counts) and BALF protein concentration. However, OM at either dose did not decrease lung angiogenesis. Conclusion(s): Contrary to our hypothesis, OM potentiates alveolar simplification and inflammation in a model of hyperoxia-induced lung injury in newborn mouse. These findings suggest the need to be cautious before instituting OM therapy in neonates.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 613748470
TI  - B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: A marker of severity?
AU  - Kalra V.K.
AU  - Aggarwal S.
AU  - Arora P.
AU  - Natarajan G.
Y1  - 2014//
KW  - case control study
KW  - *chronic lung disease
KW  - controlled study
KW  - *disease course
KW  - *gene expression
KW  - human
KW  - human tissue
KW  - infant
KW  - *lung dysplasia
KW  - major clinical study
KW  - molecularly targeted therapy
KW  - plasma
KW  - *prematurity
KW  - receiver operating characteristic
KW  - stratification
KW  - *brain natriuretic peptide
KW  - endogenous compound
T2  - Pediatric Pulmonology
LA  - English
VL  - 49
IS  - 11
PB  - John Wiley and Sons Inc. (P.O.Box 18667, Newark NJ 07191-8667, United States)
SN  - 1099-0496
AD  - V.K. Kalra, Division of Neonatology, The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Children's Hospital of Michigan and Hutzel Women's Hospital, Detroit, MI, United States. E-mail: kalravaneet@yahoo.com
UR  - http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-0496
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=613748470
DO  - https://dx.doi.org/10.1002/ppul.22942
AB  - Rationale for the Study: B type natriuretic peptide (BNP) is a hormone released in response to stretching of the ventricular wall. The role of BNP as a biomarker of bronchopulmonary dysplasia (BPD) has not been clarified. Objective(s): To determine if plasma BNP concentrations correlate with the severity of BPD. Method(s): This prospective observational case control study included 60 preterm infants (<=32 weeks); 27 infants had no/mild BPD, 19 had moderate and 14 had severe BPD. BNP levels were measured at 36 +/- 2 weeks PMA or within a week of discharge home. Groups were compared using Mann-Whitney's U-test, Kruskal-Wallis, and bivariate regression. Result(s): Median (IQR) plasma levels of BNP in infants with moderate/severe BPD infants (n = 33) were higher as compared to those with no/mild BPD (n = 27); 27.1 (12.1-43.5) pg/ml versus 9.3 (6-18.5) pg/ml; P < 0.05 (Mann Whitney U). Median (IQR) BNP levels in infants with severe BPD (n = 14), 43.5 (28.4-189) pg/ml differed significantly from levels in those with moderate (n = 19), 22.8 (10.3-27.7) pg/ml; mild (n = 16), 11.5 (6.6-44.5 pg/ml); or no (n = 11), 8.1 (5-12.6 pg/ml) BPD (P < 0.001 Kruskal-Wallis). Based on receiver operating characteristic curves, BNP > 24.4 pg/ml at 36 +/- 2 weeks PMA or discharge home was 85.7% sensitive and 76.1% specific for severe BPD. Conclusion(s): An elevation in plasma BNP was significantly associated with severe BPD. We speculate that plasma BNP measurement in infants with BPD may aid in risk-stratification and further targeted therapies. Pediatr Pulmonol. 2014; 49:1106-1111. Â© 2013 Wiley Periodicals, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 610388214
TI  - Surfactant protein B expression in bronchoalveolar lavage fluid of full-term neonates with respiratory distress syndrome
AU  - Yin X.
AU  - Xie L.
AU  - Chai Y.
AU  - Fan H.
AU  - Han X.
AU  - Feng Z.
Y1  - 2014//
KW  - article
KW  - artificial ventilation
KW  - *bronchoalveolar lavage fluid
KW  - controlled study
KW  - disease classification
KW  - enzyme linked immunosorbent assay
KW  - female
KW  - human
KW  - major clinical study
KW  - male
KW  - *neonatal respiratory distress syndrome
KW  - newborn
KW  - prospective study
KW  - protein blood level
KW  - *protein expression
KW  - thorax radiography
KW  - *surfactant protein B/ec [Endogenous Compound]
T2  - Acta Clinica Croatica
LA  - English
VL  - 53
IS  - 2
PB  - Klinicka Bolnica Sestre Milosrdnice
SN  - 1333-9451
AD  - Z. Feng, Affiliated Bayi Children's Hospital, Beijing Military Region General Hospital, No. 5, Nan Mencang, Dongcheng District, Beijing 100700, China. E-mail: drfengzc@fmmu.edu.cn
UR  - http://hrcak.srce.hr/index.php?show=clanak&id_clanak_jezik=188425
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=610388214
AB  - The aim was to investigate the surfactant protein B (SP-B) expression in the bron-choalveolar lavage fluid (BALF) of full-term neonates with respiratory distress syndrome (RDS). The enzyme-linked immunosorbent assay was performed to assess SP-B expression in BALF of 60 full-term neonates with RDS and 23 healthy neonates and correlation of SP-B level with RDS classification according to chest x-ray findings and PaO2/FiO2 before mechanical ventilation in neonates with RDS. The SP-B level was significantly lower in the RDS group (17.63+/-6.80 ng/mL) than in healthy neonates (103.95+/-6.38 ng/mL) (P<0.001). The SP-B level correlated positively with PaO2/FiO2 before mechanical ventilation (r=0.838, P<0.001). Moreover, the lower the SP-B level, the more severe was the RDS as determined by chest x-ray (P<0.001). In conclusion, full-term neonates with RDS had reduced SP-B in BALF, which was related to the severity of RDS, suggesting that SP-B supplement may be an effective strategy in the treatment of RDS in full-term neonates.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 53080877
TI  - Prophylactic erythropoietin exacerbates ventilation-induced lung inflammation and injury in preterm lambs
AU  - Polglase G.R.
AU  - Barton S.K.
AU  - Melville J.M.
AU  - Zahra V.
AU  - Wallace M.J.
AU  - Siew M.L.
AU  - Tolcos M.
AU  - Moss T.J.M.
Y1  - 2014//
KW  - airway resistance
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - arterial carbon dioxide tension
KW  - arterial oxygen saturation
KW  - article
KW  - *artificial ventilation
KW  - bleeding
KW  - controlled study
KW  - disease exacerbation
KW  - disease severity
KW  - drug efficacy
KW  - drug megadose
KW  - female
KW  - histology
KW  - incidence
KW  - inflammation
KW  - *lamb
KW  - liver
KW  - lung
KW  - lung compliance
KW  - male
KW  - newborn
KW  - nonhuman
KW  - oxygenation
KW  - *pneumonia/dt [Drug Therapy]
KW  - *pneumonia/pc [Prevention]
KW  - pneumonia/dt [Drug Therapy]
KW  - *prematurity
KW  - priority journal
KW  - tidal volume
KW  - *ventilator induced lung injury/dt [Drug Therapy]
KW  - *ventilator induced lung injury/pc [Prevention]
KW  - ventilator induced lung injury/dt [Drug Therapy]
KW  - C reactive protein/ec [Endogenous Compound]
KW  - *erythropoietin/dt [Drug Therapy]
KW  - *erythropoietin/to [Drug Toxicity]
KW  - *erythropoietin/iv [Intravenous Drug Administration]
KW  - hepcidin/ec [Endogenous Compound]
KW  - interleukin 1beta/ec [Endogenous Compound]
KW  - interleukin 6/ec [Endogenous Compound]
KW  - interleukin 8/ec [Endogenous Compound]
KW  - phosphate buffered saline
KW  - recombinant erythropoietin
KW  - airway wall thickness
KW  - epithelial sloughing
T2  - Journal of Physiology
LA  - English
VL  - 592
IS  - 9
PB  - Blackwell Publishing Ltd (E-mail: customerservices@oxonblackwellpublishing.com)
SN  - 1469-7793
AD  - G.R. Polglase, Ritchie Centre, Monash Institute of Medical Research, PO Box 5418, Clayton, VIC, 3168, Australia. E-mail: graeme.polglase@monash.edu
C3  - eprex: Janssen [Australia]
C4  - Janssen [Australia]
DO  - https://dx.doi.org/10.1113/jphysiol.2013.270348
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=53080877
AB  - Ventilation-induced lung injury (VILI) of preterm neonates probably contributes to the pathogenesis of bronchopulmonary dysplasia (BPD). Erythropoietin (EPO) has been suggested as a therapy for BPD. The aim of this study was to determine whether prophylactic administration of EPO reduces VILI in preterm newborn lambs. Lambs at 126 days of gestation (term is 147 days) were delivered and ventilated with a high tidal volume strategy for 15 min to cause lung injury, then received gentle ventilation until 2 h of age. Lambs were randomized to receive intravenous EPO (5000 IU kg-1: Vent+EPO; n = 6) or phosphate-buffered saline (Vent; n = 7) soon after birth: unventilated controls (UVC; n = 8) did not receive ventilation or any treatment. Physiological parameters were recorded throughout the experimental procedure. Samples of lung were collected for histological and molecular assessment of inflammation and injury. Samples of liver were collected to assess the systemic acute phase response. Vent+EPO lambs received higher F IO 2, P aO 2 and oxygenation during the first 10 min than Vent lambs. There were no differences in physiological indices beyond this time. Total lung injury score, airway wall thickness, inflammation and haemorrhage were higher in Vent+EPO lambs than in Vent lambs. Lung inflammation and early markers of lung and systemic injury were elevated in ventilated lambs relative to unventilated lambs; EPO administration further increased lung inflammation and markers of lung and systemic injury. Prophylactic EPO exacerbates VILI, which may increase the incidence and severity of long-term respiratory disease. More studies are required before EPO can be used for lung protection in preterm infants. Â© 2014 The Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 53047100
TI  - The effects of resveratrol on hyperoxia-induced lung injury in neonatal rats
AU  - Ozdemir O.M.A.
AU  - Gozkeser E.
AU  - Bir F.
AU  - Yenisey C.
Y1  - 2014//
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - *antiinflammatory activity
KW  - *antioxidant activity
KW  - article
KW  - biochemistry
KW  - body weight
KW  - controlled study
KW  - enzyme activity
KW  - histopathology
KW  - *hyperoxia
KW  - immunohistochemistry
KW  - lung fibrosis
KW  - *lung injury/dt [Drug Therapy]
KW  - *lung injury/et [Etiology]
KW  - lung injury/dt [Drug Therapy]
KW  - lung parenchyma
KW  - newborn
KW  - nonhuman
KW  - oxidative stress
KW  - pathogenesis
KW  - rat
KW  - glutathione/ec [Endogenous Compound]
KW  - immunoglobulin enhancer binding protein/ec [Endogenous Compound]
KW  - nitric oxide/ec [Endogenous Compound]
KW  - *resveratrol/dt [Drug Therapy]
KW  - *resveratrol/ip [Intraperitoneal Drug Administration]
KW  - *resveratrol/pd [Pharmacology]
KW  - smooth muscle actin/ec [Endogenous Compound]
KW  - superoxide dismutase/ec [Endogenous Compound]
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
T2  - Pediatrics and Neonatology
LA  - English
VL  - 55
IS  - 5
PB  - Elsevier (Singapore) Pte Ltd (3 Killiney Road, 08-01, Winsland House I, Singapore 239519, Singapore)
SN  - 1875-9572
AD  - E. Gozkeser, Department of Pediatrics, Faculty of Medicine, Pamukkale University, Kat 2, Denizli, Kinikli 20070, Turkey
C4  - Sigma Aldrich [United States]
UR  - http://ajws.elsevier.com/pedn
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=53047100
DO  - https://dx.doi.org/10.1016/j.pedneo.2013.11.004
AB  - Background: Bronchopulmonary dysplasia (BPD) is a chronic lung disease that causes significant morbidity and mortality in premature infants. Inflammation and oxidative injury play an important role in the pathogenesis of BPD. Resveratrol is an antioxidant and anti-inflammatory agent. In this study, the histopathological and biochemical effects of resveratrol on a hyperoxia-induced lung injury model in newborn rats were investigated., Methods: The experiment was performed on newborn rat pups from the 3rd to 13th postnatal day and they were randomly divided into four groups: Group 1 (air-exposed + saline, n Z 10), Group 2 (air-exposed + resveratrol, n Z 11), Group 3 (hyperoxia-exposed + saline, n Z 6) and Group 4 (hyperoxia-exposed + resveratrol, n Z 7). Resveratrol was administered (30 mg/kg/day) intraperitoneally. The histopathological effects of resveratrol on lung tissue were assessed by alveolar surface area, fibrosis, and smooth muscle actin (SMA) score, and the biochemical effects on lung tissue were assessed by glutathione (GSH), superoxide dismutase (SOD), nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), and nuclear factor kappa B (NF-kappaB) levels., Results: The alveolar surface area, fibrosis, SMA score, and NO levels were found to be significantly higher in Group 3 compared with Group 1 (p < 0.05). In addition, it was found that resveratrol treatment significantly reduced the SMA score and the NO and TNF-alpha levels, and increased the GSH and SOD levels in the hyperoxia group (p < 0.05)., Conclusion: This experimental study showed that oxidative stress and NO contributed to the pathogenesis of hyperoxia-induced lung injury, and that resveratrol had a preventive effect on hyperoxic lung injury through its anti-inflammatory and antioxidant properties.Copyright Â© 2014, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 373447388
TI  - Combined oral sildenafil and bosentan in an ex preterm infant with bronchopulmonary dysplasia, sepsis and severe pulmonary arterial hypertension refractory to inhaled nitric oxide
AU  - Marseglia L.
AU  - Pellegrino S.
AU  - Calabro M.P.
AU  - D'Angelo G.
AU  - Manti S.
AU  - Gitto E.
Y1  - 2014//
KW  - adult respiratory distress syndrome
KW  - antibiotic therapy
KW  - article
KW  - artificial ventilation
KW  - blood culture
KW  - case report
KW  - clinical laboratory
KW  - deterioration
KW  - disease severity
KW  - drug dose increase
KW  - drug efficacy
KW  - drug safety
KW  - female
KW  - fever
KW  - gestational age
KW  - heart muscle contractility
KW  - hemodynamic parameters
KW  - human
KW  - infant
KW  - intensive care unit
KW  - leukocyte count
KW  - leukocytosis
KW  - *lung dysplasia
KW  - neutrophilia
KW  - oxygen consumption
KW  - pneumonia
KW  - prematurity
KW  - *pulmonary hypertension/dt [Drug Therapy]
KW  - pulmonary hypertension/dt [Drug Therapy]
KW  - *sepsis/dt [Drug Therapy]
KW  - sepsis/dt [Drug Therapy]
KW  - Stenotrophomonas maltophilia
KW  - systolic blood pressure
KW  - thorax radiography
KW  - tracheal aspiration procedure
KW  - transthoracic echocardiography
KW  - treatment response
KW  - *bosentan/cb [Drug Combination]
KW  - *bosentan/dt [Drug Therapy]
KW  - *bosentan/po [Oral Drug Administration]
KW  - C reactive protein/ec [Endogenous Compound]
KW  - ceftazidime/iv [Intravenous Drug Administration]
KW  - dobutamine
KW  - dopamine
KW  - lung surfactant
KW  - *nitric oxide/ih [Inhalational Drug Administration]
KW  - noradrenalin
KW  - *sildenafil/cb [Drug Combination]
KW  - *sildenafil/dt [Drug Therapy]
KW  - *sildenafil/po [Oral Drug Administration]
KW  - sultamicillin/dt [Drug Therapy]
T2  - Experimental and Clinical Cardiology
LA  - English
VL  - 20
IS  - 6
PB  - Cardiology Academic Press
SN  - 1205-6626
UR  - http://cardiologyacademicpress.com/soap/pdf/delme_759_53958178baace1.72164800.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=373447388
AD  - Canada
AB  - Objective: To describe the combined use of novel vasodilatator agents (i.e., Sildenafil and Bosentan) to increase the overall efficacy of therapeutic interventions for pulmonary arterial hypertension. Method(s): We report a case of a 5-month-old preterm infant with bronchopulmonary dysplasia, who developed ARDS related to sepsis and pneumonia from Stenotrophomonas Maltophilia and severe pulmonary arterial hypertension refractory to inhaled nitric oxide and maximal ventilatory support. She was treated with either antibiotic, hemodinamic support and a combination of oral Sildenafil and Bosentan therapy. Result(s): Forty-eight hours after starting Sildenafil plus Bosentan, there was an improvement in her clinical condition, with a reduction in the oxygen requirement and a significant improvement of the laboratory tests. An echocardiogram showed a substantial reduction in pulmonary hypertension. No complications or adverse effects related to long term Sildenafil or Bosentan therapy were noted. Conclusion(s): This case illustrates the safety and efficacy of a combination treatment with oral Sildenafil and Bosentan in a infants with bronchopulmonary dysplasia and severe pulmonary hypertension secondary to ARDS refractory to inhaled nitric oxide.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 372067343
TI  - Rho-Kinase inhibitor prevents bleomycin-induced injury in neonatal rats independent of effects on lung inflammation
AU  - Lee A.H.
AU  - Dhaliwal R.
AU  - Kantores C.
AU  - Ivanovska J.
AU  - Gosal K.
AU  - McNamara P.J.
AU  - Letarte M.
AU  - Jankov R.P.
Y1  - 2014//
KW  - angiogenesis
KW  - animal cell
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - bleomycin-induced lung injury/dt [Drug Therapy]
KW  - body weight
KW  - controlled study
KW  - down regulation
KW  - drug effect
KW  - drug mechanism
KW  - endothelium cell
KW  - *experimental disease/dt [Drug Therapy]
KW  - *experimental disease/pc [Prevention]
KW  - experimental disease/dt [Drug Therapy]
KW  - heart right ventricle hypertrophy
KW  - histopathology
KW  - in vitro study
KW  - inflammatory cell
KW  - lung alveolus
KW  - lung artery
KW  - lung capillary
KW  - lung dysplasia/et [Etiology]
KW  - lung dysplasia/pc [Prevention]
KW  - *lung injury/dt [Drug Therapy]
KW  - *lung injury/pc [Prevention]
KW  - lung injury/dt [Drug Therapy]
KW  - lung resistance
KW  - lung vascular resistance
KW  - lung weight
KW  - macrophage
KW  - neutrophil chemotaxis
KW  - newborn
KW  - nonhuman
KW  - perinatal period
KW  - pneumonia
KW  - protein phosphorylation
KW  - protein synthesis
KW  - pulmonary artery
KW  - pulmonary hypertension/dt [Drug Therapy]
KW  - rat
KW  - *4 (1 aminoethyl) n (4 pyridyl)cyclohexanecarboxamide/dt [Drug Therapy]
KW  - *4 (1 aminoethyl) n (4 pyridyl)cyclohexanecarboxamide/ip [Intraperitoneal Drug Administration]
KW  - *4 (1 aminoethyl) n (4 pyridyl)cyclohexanecarboxamide/pd [Pharmacology]
KW  - bleomycin/to [Drug Toxicity]
KW  - *chemokine receptor CXCR2 antagonist/dt [Drug Therapy]
KW  - *chemokine receptor CXCR2 antagonist/pd [Pharmacology]
KW  - etanercept/to [Drug Toxicity]
KW  - etanercept/ip [Intraperitoneal Drug Administration]
KW  - etanercept/pd [Pharmacology]
KW  - Smad2 protein/ec [Endogenous Compound]
KW  - thrombospondin 1/ec [Endogenous Compound]
KW  - unclassified drug
KW  - *bleomycin-induced lung injury/dt [Drug Therapy]
KW  - *bleomycin-induced lung injury/et [Etiology]
KW  - *bleomycin-induced lung injury/pc [Prevention]
KW  - *sb 265610/dt [Drug Therapy]
KW  - *sb 265610/pd [Pharmacology]
T2  - American Journal of Respiratory Cell and Molecular Biology
LA  - English
VL  - 50
IS  - 1
PB  - American Thoracic Society (61 Broadway 4th Floor, New York NY 10006 - 2755, United States)
SN  - 1535-4989
AD  - R.P. Jankov, Physiology and Experimental Medicine, Hospital for Sick Children Research Institute, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. E-mail: robert.jankov@sickkids.ca
C3  - sb 265610, y 27632
UR  - http://www.atsjournals.org/doi/pdf/10.1165/rcmb.2013-0131OC
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=372067343
DO  - https://dx.doi.org/10.1165/rcmb.2013-0131OC
AB  - Bleomycin-induced lung injury is characterized in the neonatal rat by inflammation dominated by neutrophils and macrophages, inhibited distal airway and vascular development, and pulmonary hypertension. Similar to human infants with severe bronchopulmonary dysplasia. Rho-kinase (ROCK) is known to mediate lung injury in adult animals via stimulatory effects on inflammation. We therefore hypothesized that inhibition of ROCK may ameliorate bleomycin-induced lung injury in the neonatal rat. Pups received daily intraperitoneal bleomycin or saline from Postnatal Days 1 through 14 with or without Y-27632, a ROCK inhibitor. Treatment with Y-27632 prevented bleomycin-induced pulmonary hypertension, as evidenced by normalized pulmonary vascular resistance, decreased right-ventricular hypertrophy, and attenuated remodeling of pulmonary resistance arteries. Bleomycininduced changes in distal lung architecture, including septal thinning, inhibited alveolarization, and decreased numbers of peripheral arteries and capillaries, were partially or completely normalized by Y-27632. Treatment with Y-27632 or a CXCR2 antagonist, SB265610, also abrogated tissue neutrophil influx, while having no effect on macrophages. However, treatment with SB265610 did not prevent bleomycin-induced lung injury. Lung content of angiostatic thrombospondin-1 (TSP1) was increased significantly in the lungs of bleomycin-exposed animals, and was completely attenuated by treatment with Y-27632. Thrombinstimulated TSP1 production by primary cultured rat pulmonary artery endothelial cells was also attenuated by Y-27632. Taken together, our findings suggest a preventive effect of Y-27632 on bleomycin-mediated injury by a mechanism unrelated to inflammatory cells. Our data suggest that improvements in lung morphology may have been related to indirect stimulatory effects on angiogenesis via down-regulation of TSP1. Copyright Â© 2014 by the American Thoracic Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2016>
TI  - Does Haptoglobin Phenotype Influence Postnatal Morbidity in Preterm Neonates?.
DO  - https://dx.doi.org/10.1055/s-0035-1560042
AU  - Kessel, Irena
AU  - Leib, Maayan
AU  - Levy, Andrew
AU  - Miller-Lotan, Rachel
AU  - Waisman, Dan
AU  - Jacobson, Eyal
AU  - Rotschild, Avi
AU  - Blum, Shany
Y1  - 2016//
Y2  - 20150907//
KW  - *Bronchopulmonary Dysplasia/ep [Epidemiology]
KW  - Bronchopulmonary Dysplasia/ge [Genetics]
KW  - Bronchopulmonary Dysplasia/me [Metabolism]
KW  - *Cerebral Hemorrhage/ep [Epidemiology]
KW  - Cerebral Hemorrhage/ge [Genetics]
KW  - Cerebral Hemorrhage/me [Metabolism]
KW  - Cohort Studies
KW  - Electrophoresis, Polyacrylamide Gel
KW  - *Enterocolitis, Necrotizing/ep [Epidemiology]
KW  - Enterocolitis, Necrotizing/ge [Genetics]
KW  - Enterocolitis, Necrotizing/me [Metabolism]
KW  - Female
KW  - Haptoglobins/ge [Genetics]
KW  - *Haptoglobins/me [Metabolism]
KW  - Humans
KW  - Infant, Newborn
KW  - Infant, Premature
KW  - Infant, Premature, Diseases/ep [Epidemiology]
KW  - Infant, Premature, Diseases/ge [Genetics]
KW  - Infant, Premature, Diseases/me [Metabolism]
KW  - Israel/ep [Epidemiology]
KW  - Male
KW  - Phenotype
KW  - Polymerase Chain Reaction
KW  - Prospective Studies
KW  - Protective Factors
KW  - *Retinopathy of Prematurity/ep [Epidemiology]
KW  - Retinopathy of Prematurity/ge [Genetics]
KW  - Retinopathy of Prematurity/me [Metabolism]
KW  - Risk Factors
KW  - *Sepsis/ep [Epidemiology]
KW  - Sepsis/ge [Genetics]
KW  - Sepsis/me [Metabolism]
T2  - American journal of perinatology
VL  - 33
IS  - 2
SN  - 0735-1631
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=26344008
AD  - United States
AB  - BACKGROUND: Haptoglobin (Hp) is an acute phase protein with antioxidant, bacteriostatic, and anti-inflammatory activities. Hp proteins associated with the three major phenotypes differ in their proinflammatory and anti-inflammatory action. Inflammation and oxidative stress are both involved in most pathophysiological processes in premature infants. The objective of this study was to determine whether Hp phenotype influences clinical manifestations and sepsis incidence in the premature infants., OBJECTIVE: Infants born before 35 weeks gestational age were prospectively evaluated for Hp phenotype and clinical events, including sepsis, necrotizing enterocolitis, bronchopulmonary dysplasia, intraventricular hemorrhage, and retinopathy of prematurity. The participants were observed until discharge., METHODS: A total of 122 preterm infants were enrolled in the study. Clinical events were not affected by the Hp phenotype. The expression of Hp protein was extremely low in the study population. More septic episodes were found in infants with a birth weight greater than 1,500 g, although, the difference was not statistically significant., RESULTS: Extremely low expression of Hp may explain the lack of a correlation between Hp phenotype and sepsis in preterm infants. Further research involving a larger neonatal population is required to better understand the role of the Hp phenotype in morbidity of premature infants. Copyright Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52473152
TI  - Mycobacterium abscessus complex lung infection in a toddler with a Tracheostomy
AU  - Iwanaga K.
AU  - Carter E.R.
Y1  - 2014//
KW  - acid fast bacterium
KW  - article
KW  - artificial ventilation
KW  - bacterium culture
KW  - case report
KW  - child
KW  - computer assisted tomography
KW  - consultation
KW  - cystic fibrosis
KW  - disease severity
KW  - drug substitution
KW  - drug withdrawal
KW  - female
KW  - fever/dt [Drug Therapy]
KW  - flow rate
KW  - follow up
KW  - hospitalization
KW  - human
KW  - larynx stenosis/su [Surgery]
KW  - leukocyte
KW  - leukocyte count
KW  - lower respiratory tract infection/dt [Drug Therapy]
KW  - lung dysplasia/su [Surgery]
KW  - lung infection/dt [Drug Therapy]
KW  - *lung infection/co [Complication]
KW  - *lung infection/di [Diagnosis]
KW  - *lung infection/dt [Drug Therapy]
KW  - lung lavage
KW  - mechanical ventilator
KW  - methicillin susceptible Staphylococcus aureus
KW  - *Mycobacterium abscessus
KW  - mycobacterium abscessus complex lung infection/dt [Drug Therapy]
KW  - oxygen consumption
KW  - preschool child
KW  - priority journal
KW  - Pseudomonas aeruginosa
KW  - respiratory distress
KW  - stoma
KW  - thorax radiography
KW  - toddler
KW  - tracheal aspiration procedure
KW  - tracheitis/dt [Drug Therapy]
KW  - *tracheostomy
KW  - treatment duration
KW  - amikacin/dt [Drug Therapy]
KW  - amikacin/ih [Inhalational Drug Administration]
KW  - amoxicillin/dt [Drug Therapy]
KW  - C reactive protein/ec [Endogenous Compound]
KW  - ceftazidime/iv [Intravenous Drug Administration]
KW  - cefuroxime/dt [Drug Therapy]
KW  - ciprofloxacin/dt [Drug Therapy]
KW  - clarithromycin/dt [Drug Therapy]
KW  - clarithromycin/po [Oral Drug Administration]
KW  - clavulanic acid/dt [Drug Therapy]
KW  - gentamicin/iv [Intravenous Drug Administration]
KW  - linezolid/dt [Drug Therapy]
KW  - linezolid/po [Oral Drug Administration]
KW  - oxygen
KW  - oxyhemoglobin/ec [Endogenous Compound]
KW  - tigecycline/dt [Drug Therapy]
KW  - tigecycline/iv [Intravenous Drug Administration]
KW  - tobramycin/dt [Drug Therapy]
KW  - tobramycin/ih [Inhalational Drug Administration]
KW  - *mycobacterium abscessus complex lung infection/co [Complication]
KW  - *mycobacterium abscessus complex lung infection/di [Diagnosis]
KW  - *mycobacterium abscessus complex lung infection/dt [Drug Therapy]
T2  - Pediatric Pulmonology
LA  - English
VL  - 49
IS  - 3
PB  - Wiley-Liss Inc. (111 River Street, Hoboken NJ 07030-5774, United States)
SN  - 1099-0496
AD  - K. Iwanaga, Seattle Children's Hospital, Mailstop OC.7.720, 4800 Sand Point Way NE, Seattle, WA 98105, United States. E-mail: kensho.iwanaga@seattlechildrens.org
DO  - https://dx.doi.org/10.1002/ppul.22789
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=52473152
AB  - Mycobacterium abscessus complex and other non-tuberculous mycobacteria are infrequently encountered respiratory pathogens in patients with tracheostomies. We report a 4-year-old girl with a tracheostomy, placed during infancy for management of severe bronchopulmonary dysplasia and laryngeal stenosis, who developed a M. abscessus complex lung infection. There was clear evidence of parenchymal involvement and true infection beyond colonization. She demonstrated dramatic clinical, laboratory, and radiographic improvement after prolonged anti-mycobacterial therapy. Â© 2013 Wiley Periodicals, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 372751493
TI  - B-type natriuretic peptide and mortality in extremely low birth weight infants with pulmonary hypertension: A retrospective cohort analysis
AU  - Cuna A.
AU  - Kandasamy J.
AU  - Sims B.
Y1  - 2014//
KW  - article
KW  - assisted ventilation
KW  - birth weight
KW  - brain hemorrhage
KW  - clinical article
KW  - cohort analysis
KW  - correlation analysis
KW  - disease severity
KW  - *extremely low birth weight
KW  - female
KW  - gestational age
KW  - human
KW  - infant
KW  - *infant mortality
KW  - lung dysplasia
KW  - male
KW  - necrotizing enterocolitis
KW  - protein blood level
KW  - *pulmonary hypertension
KW  - receiver operating characteristic
KW  - retrospective study
KW  - sensitivity and specificity
KW  - survival
KW  - *brain natriuretic peptide/ec [Endogenous Compound]
T2  - BMC Pediatrics
LA  - English
VL  - 14
IS  - 1
PB  - BioMed Central Ltd. (34 - 42 Cleveland Street, London W1T 4LB, United Kingdom)
SN  - 1471-2431
AD  - B. Sims, Department of Pediatrics, Division of Neonatology, University of Alabama at Birmingham, 619 S 19th St, Birmingham AL, 35249, United States. E-mail: bsims@peds.uab.edu
UR  - http://www.biomedcentral.com/1471-2431/14/68
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=372751493
DO  - https://dx.doi.org/10.1186/1471-2431-14-68
AB  - Background:B-type natriuretic peptide (BNP) is a strong predictor of mortality in adult patients with various forms of pulmonary hypertension (PH) and may be a strong prognostic marker in extremely low birth weight (ELBW) infants with bronchopulmonary dysplasia (BPD) associated PH as well. We sought to assess the relationship between BNP levels and all-cause mortality in a cohort of ELBW infants with BPD and PH. Method(s):We retrospectively identified ELBW infants with BPD and PH who had serum BNP levels measured as part of routine clinical care in the neonatal intensive care unit. Peak serum BNP levels were correlated with survival to discharge or death. Result(s):Thirty-six ELBW infants (mean gestational age 26.0 +/- 1.9 weeks and mean birth weight 740 +/- 290 grams) with BPD and PH had available survival data and had serum BNP levels measured. Peak BNP level was significantly lower among infants who survived than among those who died (128 pg/ml, [IQR 23 to 463] vs. 997 pg/ml, [IQR 278 to 1770], P < 0.004). On multivariate Cox proportional hazard analysis, BNP predicted survival independent of age, gender, and BPD severity. Area under receiver operator characteristic analysis identified a BNP value of 220 pg/ml to have 90% sensitivity and 65% specificity in predicting mortality. Conclusion(s):BNP estimation may be useful as a prognostic marker of all-cause mortality in ELBW infants with BPD associated PH. Â© 2014 Cuna et al.; licensee BioMed Central Ltd.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 53005638
TI  - Anti-inflammatory actions of endogenous and exogenous interleukin-10 versus glucocorticoids on macrophage functions of the newly born
AU  - Kasat K.
AU  - Patel H.
AU  - Predtechenska O.
AU  - Vancurova I.
AU  - Davidson D.
Y1  - 2014//
KW  - *antiinflammatory activity
KW  - article
KW  - cell differentiation
KW  - controlled study
KW  - cytokine release
KW  - *cytokine response
KW  - human
KW  - human cell
KW  - in vitro study
KW  - lung dysplasia
KW  - *macrophage function
KW  - monocyte
KW  - *newborn
KW  - phagocytosis
KW  - protein synthesis inhibition
KW  - respiratory burst
KW  - umbilical cord blood
KW  - *betamethasone/cm [Drug Comparison]
KW  - *betamethasone/pd [Pharmacology]
KW  - *dexamethasone/cm [Drug Comparison]
KW  - *dexamethasone/pd [Pharmacology]
KW  - *interleukin 10/cm [Drug Comparison]
KW  - *interleukin 10/ec [Endogenous Compound]
KW  - *interleukin 10/pd [Pharmacology]
KW  - interleukin 6/ec [Endogenous Compound]
KW  - interleukin 8/ec [Endogenous Compound]
KW  - monoclonal antibody/ec [Endogenous Compound]
KW  - tumor necrosis factor/ec [Endogenous Compound]
T2  - Journal of Perinatology
LA  - English
VL  - 34
IS  - 5
PB  - Nature Publishing Group (Houndmills, Basingstoke, Hampshire RG21 6XS, United Kingdom)
SN  - 1476-5543
AD  - D. Davidson, Division of Neonatal-Perinatal Medicine, Stony Brook Long Island Children's Hospital, HSC 11-060, Stony Brook, NY 11794, United States. E-mail: Dennis.davidson@stonybrookmedicine.edu
UR  - http://www.nature.com/jp/index.html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=53005638
DO  - https://dx.doi.org/10.1038/jp.2014.16
AB  - Objective:To determine whether specific macrophage immune functions of the newly born are insensitive to the actions of therapeutic levels of dexamethasone (DEX), previously measured in infants with bronchopulmonary dysplasia (BPD), compared with betamethasone (BETA) and exogenous or endogenous interleukin-10 (IL-10).Study design:Macrophages were differentiated from cord blood monocytes (N=18). A serial dose-response (around 10-8 M), in vitro study was used to examine the effect of DEX, BETA and IL-10, on proinflammatory (PI) cytokine release, phagocytosis and respiratory burst. Result(s):Exogenous IL-10 (10-8 M) significantly (P<0.05) inhibited the endotoxin-stimulated release of IL-6, IL-8 and tumor necrosis factor by 63 to 82% with no significant effect by DEX and BETA. There was no inhibition by these three agents at 10-8 M on phagocytosis and respiratory burst. Inhibition of endogenous IL-10 with a monoclonal antibody significantly increased endotoxin-stimulated cytokine release by at least fourfold. Conclusion(s):Macrophages were relatively insensitive to therapeutic levels of DEX and BETA with regard to PI cytokine release. This study provides rationale for translational and preclinical research using airway instillation of IL-10 for the treatment of BPD. Â© 2014 Nature America, Inc. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 372537567
TI  - Preclinical screening for retinopathy of prematurity risk using IGF1 levels at 3 weeks post-partum
AU  - Perez-Munuzuri A.
AU  - Couce-Pico Ma.L.
AU  - Bana-Souto A.
AU  - Lopez-Suarez O.
AU  - Iglesias-Deus A.
AU  - Blanco-Teijeiro J.
AU  - Fernandez-Lorenzo J.R.
AU  - Fraga-Bermudez J.M.
Y1  - 2014//
KW  - article
KW  - artificial ventilation
KW  - birth weight
KW  - brain hemorrhage
KW  - controlled study
KW  - disease association
KW  - disease course
KW  - disease predisposition
KW  - erythrocyte transfusion
KW  - female
KW  - gestational age
KW  - high risk infant
KW  - human
KW  - lung dysplasia
KW  - major clinical study
KW  - male
KW  - newborn
KW  - *newborn screening
KW  - oxygen therapy
KW  - predictive value
KW  - prematurity
KW  - prospective study
KW  - protein blood level
KW  - puerperium
KW  - *retrolental fibroplasia
KW  - *risk assessment
KW  - sepsis
KW  - erythropoietin
KW  - *somatomedin C/ec [Endogenous Compound]
T2  - PLoS ONE
LA  - English
VL  - 9
IS  - 2
PB  - Public Library of Science (185 Berry Street, Suite 1300, San Francisco CA 94107, United States)
SN  - 1932-6203
AD  - Neonatology Service, Department of Paediatrics, Clinical Hospital of the University of Santiago de Compostela, Santiago de Compostela, Spain
UR  - http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0088781&representation=PDF
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=372537567
DO  - https://dx.doi.org/10.1371/journal.pone.0088781
AB  - Following current recommendations for preventing retinopathy of prematurity (ROP) involves screening a large number of patients. We performed a prospective study to establish a useful screening system for ROP prediction and we have determined that measuring serum levels of IGF1 at week three and the presence of sepsis have a high predictive value for the subsequent development of ROP. A total of 145 premature newborn, with birthweight <1500 g and/or <32 weeks gestational age, were enrolled. 26.9% of them showed some form of retinopathy. A significant association was found between the development of retinopathy and each of the following variables: early gestational age, low birthweight, requiring mechanical ventilation, oxygen treatment, intracranial haemorrhage, sepsis during the first three weeks, bronchopulmonary dysplasia, the need for erythrocyte transfusion, erythropoietin treatment, and low levels of serum IGF1 in the third week. A multiple logistic regression analysis was used to obtain curves for the probability of developing ROP, based on the main factors linked with ROP, namely serum levels of IGF1 and presence of sepsis. Such preclinical screening has the ability to identify patients with high-risk of developing retinopathy and should lead to better prediction for ROP, while at the same time optimising the use of clinical resources, both human and material. Â© 2014 Perez-Munuzuri et al.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 53238582
TI  - Anti-inflammatory effect of caffeine is associated with improved lung function after lipopolysaccharide-induced amnionitis
AU  - Korotlu O.A.
AU  - MacFarlane P.M.
AU  - Balan K.V.
AU  - Zenebe W.J.
AU  - Martin A.J.R.J.
AU  - Prabha Kc.
Y1  - 2014//
KW  - *amnionitis
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - *antiinflammatory activity
KW  - article
KW  - cell count
KW  - controlled study
KW  - drug blood level
KW  - lung alveolus cell
KW  - lung compliance
KW  - lung dysplasia
KW  - *lung function
KW  - lung homogenate
KW  - lung parenchyma
KW  - lung resistance
KW  - lung volume
KW  - newborn
KW  - nonhuman
KW  - postnatal care
KW  - prenatal exposure
KW  - protein expression
KW  - rat
KW  - survival rate
KW  - tidal volume
KW  - *antiinflammatory agent/cr [Drug Concentration]
KW  - *antiinflammatory agent/po [Oral Drug Administration]
KW  - *antiinflammatory agent/pd [Pharmacology]
KW  - *caffeine/cr [Drug Concentration]
KW  - *caffeine/po [Oral Drug Administration]
KW  - *caffeine/pd [Pharmacology]
KW  - CD68 antigen/ec [Endogenous Compound]
KW  - interleukin 1beta/ec [Endogenous Compound]
KW  - interleukin 6/ec [Endogenous Compound]
KW  - lipopolysaccharide/to [Drug Toxicity]
KW  - sodium chloride
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
T2  - Neonatology
LA  - English
VL  - 106
IS  - 3
PB  - S. Karger AG
SN  - 1661-7819
AD  - A.J.R.J. Martin, Department of Pediatrics, Case Western Reserve University, Rainbow Babies and Children's Hospital, 11100 Euclid Avenue, Cleveland, OH 44106-6010, United States
UR  - http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=232056
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=53238582
DO  - https://dx.doi.org/10.1159/000363217
AB  - Background: Although caffeine enhances respiratory control and decreases the need for mechanical ventilation and resultant bronchopulmonary dysplasia, it may also have anti- inflammatory properties in protecting lung function., Objective: We hypothesized that caffeine improves respiratory function via an anti-inflammatory effect in lungs of a lipopolysaccharide (LPS)-induced pro-inflammatory amnionitis rat pup model., Methods: Caffeine was given orally (10 mg/ kg/day) from postnatal day (p)1 to p14 to pups exposed to intra-amniotic LPS or normal saline. Expression of IL-1beta was assessed in lung homogenates at p8 and p14, and respiratory system resistance (Rrs ) and compliance (Crs ) as well as CD68 cell counts and radial alveolar counts were assessed at p8., Results: In LPS-exposed rats, IL-1beta and CD68 cell counts both increased at p8 compared to normal saline controls. These increases in pro-inflammatory markers were no longer present in caffeine-treated LPS-exposed pups. R rs was higher in LPS-exposed pups (4.7 +/- 0.9 cm H2O/ml . s) at p8 versus controls (1.6 +/- 0.3 cm H2O/ml . s, p < 0.01). LPS-exposed pups no longer exhibited a significant increase in Rrs (2.8 +/- 0.5 cm H2O/ml . s) after caffeine. Crs did not differ significantly between groups, although radial alveolar counts were lower in both groups of LPS-exposed pups., Conclusions: Caffeine promotes anti-inflammatory effects in the immature lung of prenatal LPS-exposed rat pups associated with improvement of Rrs , suggesting a protective effect of caffeine on respiratory function via an anti-inflammatory mechanism.Copyright Â© 2014 S. Karger AG, Basel.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 53033725
TI  - Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia
AU  - Bhandari V.
Y1  - 2014//
KW  - article
KW  - baboon
KW  - cytokine release
KW  - developmental stage
KW  - disease predisposition
KW  - genetic predisposition
KW  - Gram negative sepsis
KW  - human
KW  - hyperoxia
KW  - *inflammation
KW  - inflammatory cell
KW  - lamb
KW  - lung alveolus macrophage
KW  - lung development
KW  - *lung dysplasia/et [Etiology]
KW  - lung lavage
KW  - mononuclear cell
KW  - mouse model
KW  - neutrophil
KW  - nonhuman
KW  - noninvasive ventilation
KW  - ovine model
KW  - *pathogenesis
KW  - *perinatal period
KW  - pneumonia
KW  - positive end expiratory pressure
KW  - prematurity
KW  - priority journal
KW  - rat model
KW  - sepsis
KW  - tidal volume
KW  - virus infection
KW  - apelin
KW  - azithromycin
KW  - bombesin/ec [Endogenous Compound]
KW  - caffeine
KW  - citrulline
KW  - colchicine
KW  - connective tissue growth factor/ec [Endogenous Compound]
KW  - curcumin
KW  - CXCL1 chemokine/ec [Endogenous Compound]
KW  - CXCL2 chemokine/ec [Endogenous Compound]
KW  - cytokine induced neutrophil chemoattractant/ec [Endogenous Compound]
KW  - elastin/ec [Endogenous Compound]
KW  - gastrin releasing peptide/ec [Endogenous Compound]
KW  - gelatinase B/ec [Endogenous Compound]
KW  - immunoglobulin enhancer binding protein/ec [Endogenous Compound]
KW  - interleukin 10/ec [Endogenous Compound]
KW  - interleukin 1beta/ec [Endogenous Compound]
KW  - interleukin 6/ec [Endogenous Compound]
KW  - interleukin 8/ec [Endogenous Compound]
KW  - matrix protein/ec [Endogenous Compound]
KW  - monocyte chemotactic protein 1/ec [Endogenous Compound]
KW  - monocyte chemotactic protein 2/ec [Endogenous Compound]
KW  - Nigella sativa extract
KW  - pentoxifylline
KW  - peroxisome proliferator activated receptor gamma/ec [Endogenous Compound]
KW  - sildenafil
KW  - transforming growth factor beta/ec [Endogenous Compound]
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
KW  - vasculotropin/ec [Endogenous Compound]
KW  - vasculotropin receptor 2/ec [Endogenous Compound]
T2  - Birth Defects Research Part A - Clinical and Molecular Teratology
LA  - English
VL  - 100
IS  - 3
PB  - John Wiley and Sons Inc. (P.O.Box 18667, Newark NJ 07191-8667, United States)
SN  - 1542-0760
AD  - V. Bhandari, Yale University School of Medicine, Yale Child Health Research Center, P.O. Box 208081, 464 Congress Avenue, New Haven, CT 06520, United States. E-mail: vineet.bhandari@yale.edu
UR  - http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1542-0760
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=53033725
DO  - https://dx.doi.org/10.1002/bdra.23220
AB  - Exposure to hyperoxia, invasive mechanical ventilation, and systemic/local sepsis are important antecedents of postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia (BPD). This review will summarize information obtained from animal (baboon, lamb/sheep, rat and mouse) models that pertain to the specific inflammatory agents and signaling molecules that predispose a premature infant to BPD. Â© 2014 Wiley Periodicals, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 372921803
TI  - Bronchopulmonary dysplasia: NHLBI Workshop on the primary prevention of chronic lung diseases
AU  - McEvoy C.T.
AU  - Jain L.
AU  - Schmidt B.
AU  - Abman S.
AU  - Bancalari E.
AU  - Aschner J.L.
Y1  - 2014//
KW  - *chronic lung disease/pc [Prevention]
KW  - clinical research
KW  - clinical trial (topic)
KW  - conference paper
KW  - endothelial dysfunction
KW  - endothelium injury
KW  - environmental factor
KW  - epigenetics
KW  - genetics
KW  - human
KW  - immune response
KW  - infant nutrition
KW  - inflammation
KW  - lung development
KW  - *lung dysplasia/et [Etiology]
KW  - *lung dysplasia/pc [Prevention]
KW  - maternal nutrition
KW  - medical research
KW  - obstetric procedure
KW  - oxidation reduction reaction
KW  - oxidative stress
KW  - pathogenesis
KW  - perinatal period
KW  - prematurity
KW  - *primary prevention
KW  - stem cell
KW  - translational research
KW  - workshop
KW  - biological marker/ec [Endogenous Compound]
T2  - Annals of the American Thoracic Society
LA  - English
VL  - 11
IS  - SUPPL. 3
PB  - American Thoracic Society
SN  - 2325-6621
AD  - J.L. Aschner, Montefiore Medical Center, Department of Pediatrics, Rosenthal Pavilion, 111 East 210th Street, Bronx, NY 10467, United States. E-mail: judy.aschner@einstein.yu.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1513/AnnalsATS.201312-424LD
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=372921803
DO  - https://dx.doi.org/10.1513/AnnalsATS.201312-424LD
AB  - Bronchopulmonary dysplasia (BPD) is the most common complication of extreme preterm birth. Infants who develop BPD manifest aberrant or arrested pulmonary development and can experience lifelong alterations in cardiopulmonary function. Despite decades of promising research, primary prevention of BPD has proven elusive. This workshop report identifies current barriers to the conduct of primary prevention studies for BPD and causal pathways implicated in BPD pathogenesis. Throughout, we highlight promising areas for research to improve understanding of normal and aberrant lung development, distinguish BPD endotypes, and ascertain biomarkers for more targeted therapeutic approaches to prevention. We conclude with research recommendations and priorities to accelerate discovery and promote lung health in infants born preterm. Copyright Â© 2014 by the American Thoracic Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 372410169
TI  - Extremely hypotrophic newborn of mother with systemic lupus erythematosus and antiphospholipid syndrome
AU  - Mockova A.
AU  - Dortova E.
AU  - Dort J.
AU  - Nahlovsky J.
AU  - Korecko V.
AU  - Ulcova-Gallova Z.
Y1  - 2014//
KW  - adult
KW  - alopecia
KW  - amniocentesis
KW  - antibiotic therapy
KW  - antibody titer
KW  - anticonvulsant therapy
KW  - *antiphospholipid syndrome/dt [Drug Therapy]
KW  - antiphospholipid syndrome/dt [Drug Therapy]
KW  - Apgar score
KW  - article
KW  - artificial ventilation
KW  - assisted ventilation
KW  - Bayley Scales of Infant Development
KW  - birth weight
KW  - blood cell count
KW  - body mass
KW  - brain vasculitis
KW  - case report
KW  - central nervous system disease
KW  - chemoprophylaxis
KW  - disease activity
KW  - disease severity
KW  - dizziness
KW  - drug substitution
KW  - drug withdrawal
KW  - faintness
KW  - fatigue
KW  - female
KW  - fetus death
KW  - fetus echography
KW  - generalized epilepsy
KW  - gestational age
KW  - hair loss
KW  - head circumference
KW  - headache
KW  - histopathology
KW  - hospitalization
KW  - human
KW  - hydrocortisone blood level
KW  - hyperactivity
KW  - hypothyroidism
KW  - *hypotrophy
KW  - immunosuppressive treatment
KW  - intrauterine growth retardation
KW  - leukopenia/si [Side Effect]
KW  - livedo reticularis
KW  - long term care
KW  - lung diffusion capacity
KW  - lung dysplasia/di [Diagnosis]
KW  - lung function test
KW  - lupus erythematosus nephritis
KW  - male
KW  - medical history
KW  - micturition cystourethrography
KW  - necrotizing enterocolitis/co [Complication]
KW  - neuromuscular function
KW  - newborn
KW  - *newborn disease
KW  - nuclear magnetic resonance
KW  - pathologic fracture/co [Complication]
KW  - photosensitivity
KW  - positive end expiratory pressure
KW  - priority journal
KW  - protein blood level
KW  - proteinuria
KW  - psychomotor development
KW  - Raynaud phenomenon
KW  - seizure/dt [Drug Therapy]
KW  - smoking
KW  - speech delay
KW  - spontaneous abortion
KW  - systemic lupus erythematosus/dt [Drug Therapy]
KW  - *systemic lupus erythematosus/dt [Drug Therapy]
KW  - thorax radiography
KW  - thrombocytopenia/si [Side Effect]
KW  - thyrotropin blood level
KW  - total parenteral nutrition
KW  - vesicoureteral reflux
KW  - acetylsalicylic acid
KW  - ampicillin/cb [Drug Combination]
KW  - antinuclear antibody/ec [Endogenous Compound]
KW  - azathioprine/dt [Drug Therapy]
KW  - C reactive protein
KW  - calcium
KW  - carbon monoxide
KW  - cardiolipin antibody
KW  - complement component C3/ec [Endogenous Compound]
KW  - corticosteroid
KW  - cyclophosphamide/ae [Adverse Drug Reaction]
KW  - cyclophosphamide/dt [Drug Therapy]
KW  - double stranded DNA antibody/ec [Endogenous Compound]
KW  - gentamicin/cb [Drug Combination]
KW  - hydrocortisone
KW  - hydroxychloroquine/dt [Drug Therapy]
KW  - immunoglobulin G antibody
KW  - La antibody/ec [Endogenous Compound]
KW  - low molecular weight heparin/sc [Subcutaneous Drug Administration]
KW  - nitrofurantoin
KW  - phospholipid antibody
KW  - phosphorus
KW  - Ro antibody/ec [Endogenous Compound]
KW  - surfactant
KW  - thyroid hormone
KW  - thyrotropin/ec [Endogenous Compound]
KW  - valproic acid/dt [Drug Therapy]
KW  - vitamin D
T2  - Lupus
LA  - English
VL  - 23
IS  - 3
PB  - SAGE Publications Ltd (55 City Road, London EC1Y 1SP, United Kingdom)
SN  - 1477-0962
AD  - A. Mockova, Faculty Hospital Pilsen, Alej Svobody 80, Pilsen, 32600, Czechia. E-mail: amnicu@gmail.com
C3  - aspirin
DO  - https://dx.doi.org/10.1177/0961203313517406
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=372410169
AB  - The case presented describes a high-risk pregnancy of a woman with systemic lupus erythematosus (SLE) with multiple lesions of central nervous system (CNS), vasculitis, secondary epilepsy and antiphospholipid syndrome (APS). At gestational age 28 weeks and 3 days the pregnancy was urgently terminated via caesarean section and an extremely hypotrophic immature newborn with a birth weight of 580 g was born. The high disease activity in the mother at the time of conception and the histologically proven chronic placental insufficiency due to APS are presumably the causes for the extensive hypotrophy of the neonate. The significant comorbidity of the newborn, including respiratory distress syndrome, bronchopulmonary dysplasia, necrotizing enterocolitis, osteopathy of prematurity, transient hypothyroidism and hypocortisolism, vesicoureteral reflux, and hypertonic-hyperexcitation syndrome complicated his three-month stay in NICU. A positive titre of transplacentally transferred anticardiolipin and anti-beta2 glycoprotein antibody was detected in the child and persisted through the following 30 months. During the three-year follow-up, significantly delayed neuropsychological development with microcephaly (-4 SD) and short stature of the child was observed. Finally, the authors discuss possible causes of neuropsychological consequences in children of mothers with SLE and APS and emphasize the need for long-term monitoring and specialized care to improve development of these children. Â© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 373796017
TI  - Expression of TGF-beta1 and PAI-1 in premature infants with bronchopulmonary dysplasia
AU  - Zhang J.-F.
AU  - Hunag R.-Z.
AU  - Huang G.-F.
AU  - Ou W.-M.
AU  - Li J.-F.
AU  - Chen J.-J.
Y1  - 2014//
KW  - article
KW  - birth
KW  - clinical study
KW  - controlled study
KW  - enzyme linked immunosorbent assay
KW  - gestational age
KW  - human
KW  - infant
KW  - *lung dysplasia/et [Etiology]
KW  - major clinical study
KW  - newborn intensive care
KW  - predictive value
KW  - *prematurity
KW  - protein expression
KW  - retrospective study
KW  - very low birth weight
KW  - *plasminogen activator inhibitor 1
KW  - *transforming growth factor beta1
T2  - Chinese Journal of Contemporary Pediatrics
LA  - Chinese
VL  - 16
IS  - 8
PB  - Xiangya Hospital of CSU (141 Xiangya Road, Changsha Hunan 410008, China)
SN  - 1008-8830
UR  - http://www.cjcp.org/EN/article/downloadArticleFile.do?attachType=PDF&id=13432
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=373796017
DO  - https://dx.doi.org/10.7499/j.issn.1008-8830.2014.08.008
AD  - China
AB  - Objective: To study the expression of transforming growth factor-beta1 (TGF-beta1) and plasminogen activator inhibitor-1 (PAI-1) and its significance in premature infants with bronchopulmonary dysplasia (BPD). Method(s): A retrospective analysis was performed on the clinical data of 96 very low birth weight infants (gestational age of <=32 weeks) who survived for more than 28 days and were admitted to the Neonatal Intensive Care Unit between January 2010 and December 2012. These subjects were divided into BPD group (n=21) and non-BPD group (n=75). The expression of TGF-beta1 and PAI-1 in blood was measured by ELISA. Result(s): The levels of TGF-beta1 and PAI-1 in the BPD group increased gradually from the 7th day to the 14th day and then to the 21st day after birth, and were significantly higher than in the non-BPD group at all time points (P<0.01). The TGF-beta1 and PAI-1 levels in the non-BPD group on the 7th, 14th, and 21st days after birth were not significantly different from each other (P>0.05). Conclusion(s): The expression of TGF-beta1 and PAI-1 in blood is elevated in premature infants with BPD, which may be associated with the development of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 373678362
TI  - Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats
AU  - Wagenaar G.T.M.
AU  - Sengers R.M.A.
AU  - Laghmani E.H.
AU  - Chen X.
AU  - Lindeboom M.P.H.A.
AU  - Roks A.J.M.
AU  - Folkerts G.
AU  - Walther F.J.
Y1  - 2014//
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - arterial wall thickness
KW  - article
KW  - body weight
KW  - controlled study
KW  - fibrin deposition
KW  - gene expression
KW  - *heart right ventricle hypertrophy/dt [Drug Therapy]
KW  - *heart right ventricle hypertrophy/pc [Prevention]
KW  - heart right ventricle hypertrophy/dt [Drug Therapy]
KW  - histopathology
KW  - *hyperoxia
KW  - inflammatory cell
KW  - low drug dose
KW  - lung blood vessel
KW  - *lung dysplasia/dt [Drug Therapy]
KW  - *lung dysplasia/pc [Prevention]
KW  - lung dysplasia/dt [Drug Therapy]
KW  - lung fibrosis
KW  - macrophage
KW  - neutrophil
KW  - newborn
KW  - nonhuman
KW  - pneumonia
KW  - priority journal
KW  - protein expression
KW  - pulmonary hypertension
KW  - rat
KW  - respiratory tract parameters
KW  - tissue distribution
KW  - *1 (4 dimethylamino 3 methylbenzyl) 5 diphenylacetyl 4,5,6,7 tetrahydro 1h imidazo[4,5 c]pyridine 6 carboxylic acid/dt [Drug Therapy]
KW  - *1 (4 dimethylamino 3 methylbenzyl) 5 diphenylacetyl 4,5,6,7 tetrahydro 1h imidazo[4,5 c]pyridine 6 carboxylic acid/pd [Pharmacology]
KW  - angiotensin 1A receptor/ec [Endogenous Compound]
KW  - angiotensin 2 receptor/pd [Pharmacology]
KW  - collagen type 3/ec [Endogenous Compound]
KW  - monocyte chemotactic protein 1/ec [Endogenous Compound]
KW  - oxygen
KW  - plasminogen activator inhibitor 1/ec [Endogenous Compound]
KW  - protein/ec [Endogenous Compound]
KW  - unclassified drug
KW  - pulmonary vessel density
KW  - lp2 3/pd [Pharmacology]
KW  - neutrophilic chemoattractant 1/ec [Endogenous Compound]
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 307
IS  - 3
PB  - American Physiological Society (E-mail: subscrip@the-aps.org)
SN  - 1522-1504
AD  - G. T. M. Wagenaar, Division of Neonatology, Dept. of Pediatrics, Leiden Univ. Medical Center, P3-P30, P.O. Box 9600, 2300 RC Leiden, Netherlands. E-mail: g.t.m.wagenaar@lumc.nl
C3  - pd 123319
UR  - http://ajplung.physiology.org/content/307/3/L261.full.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=373678362
DO  - https://dx.doi.org/10.1152/ajplung.00345.2013
AB  - Intervening in angiotensin (Ang)-II type 2 receptor (AT2) signaling may have therapeutic potential for bronchopulmonary dysplasia (BPD) by attenuating lung inflammation and preventing arterial hypertension (PAH)-induced right ventricular hypertrophy (RVH). We first investigated the role of AT2 inhibition with PD123319 (0.5 and 2 mg.kg-1.day-1) on the beneficial effect of AT2 agonist LP2-3 (5 mug/kg twice a day) on RVH in newborn rats with hyperoxia-induced BPD. Next we determined the cardiopulmonary effects of PD123319 (0.1 mg.kg-1.day-1) in two models: early treatment during continuous exposure to hyperoxia for 10 days and late treatment starting on day 6 in rat pups exposed postnatally to hyperoxia for 9 days, followed by a 9-day recovery period in room air. Parameters investigated included lung and heart histopathology, fibrin deposition, vascular leakage, and differential mRNA expression. Ten days of coadministration of LP2-3 and PD123319 abolished the beneficial effects of LP2-3 on RVH in experimental BPD. In the early treatment model PD123319 attenuated cardiopulmonary injury by reducing alveolar septal thickness, pulmonary influx of inflammatory cells, including macrophages and neutrophils, medial wall thickness of small arterioles, and extravascular collagen III deposition, and by preventing RVH. In the late treatment model PD123319 diminished PAH and RVH, demonstrating that PAH is reversible in the neonatal period. At high concentrations PD123319 blocks the beneficial effects of the AT2-agonist LP2-3 on RVH. At low concentrations PD123319 attenuates cardiopulmonary injury by reducing pulmonary inflammation and fibrosis and preventing PAH-induced RVH but does not affect alveolar and vascular development in newborn rats with experimental BPD. Â© 2014 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2016>
TI  - Neonatal Biomarkers of Inflammation: Correlates of Early Neurodevelopment and Gait in Very-Low-Birth-Weight Preterm Children.
DO  - https://dx.doi.org/10.1055/s-0035-1557106
AU  - Rose, Jessica
AU  - Vassar, Rachel
AU  - Cahill-Rowley, Katelyn
AU  - Hintz, Susan R
AU  - Stevenson, David K
Y1  - 2016//
Y2  - 20150724//
KW  - *Biomarkers/bl [Blood]
KW  - Birth Weight
KW  - Bronchopulmonary Dysplasia/ep [Epidemiology]
KW  - C-Reactive Protein/an [Analysis]
KW  - Child Development
KW  - Cognition
KW  - Enterocolitis, Necrotizing/ep [Epidemiology]
KW  - Female
KW  - *Gait
KW  - Gestational Age
KW  - Humans
KW  - Infant
KW  - Infant, Newborn
KW  - *Infant, Premature/gd [Growth & Development]
KW  - *Infant, Very Low Birth Weight/gd [Growth & Development]
KW  - Inflammation/bl [Blood]
KW  - *Inflammation/di [Diagnosis]
KW  - Intensive Care Units, Neonatal
KW  - Linear Models
KW  - Male
KW  - Motor Activity
KW  - Multivariate Analysis
KW  - Psychiatric Status Rating Scales
KW  - Risk Factors
KW  - Sepsis/ep [Epidemiology]
KW  - Speech
T2  - American journal of perinatology
VL  - 33
IS  - 1
SN  - 0735-1631
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=26212060
AD  - United States
AB  - OBJECTIVE: Neonatal biomarkers of inflammation were examined in relation to early neurodevelopment and gait in very-low-birth-weight (VLBW) preterm children. We hypothesized that preterm infants exposed to higher levels of neonatal inflammation would demonstrate lower scores on Bayley Scales of Infant Toddler Development, 3rd ed. (BSID-III) and slower gait velocity at 18 to 22 months adjusted age., STUDY DESIGN: A total of 102 VLBW preterm infants (birthweight [BW] <= 1,500 g, gestational age [GA] <= 32 weeks) admitted to neonatal intensive care unit [NICU] were recruited. Neonatal risk factors examined were GA at birth, BW, bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of prematurity, sepsis, and serum C-reactive protein (CRP), albumin, and total bilirubin over first 2 postnatal weeks. At 18 to 22 months, neurodevelopment was assessed with BSID-III and gait was assessed with an instrumented mat., RESULTS: Children with neonatal CRP >= 0.20 mg/dL (n = 52) versus < 0.20 mg/dL (n = 37) had significantly lower BSID-III composite cognitive (92.0 +/- 13.1 vs. 100.1 +/- 9.6, p = 0.002), language (83.9 +/- 16.0 vs. 95.8 +/- 14.2, p < 0.001), and motor scores (90.0 +/- 13.2 vs. 98.8 +/- 10.1, p = 0.002), and slower gait velocity (84.9 +/- 19.0 vs. 98.0 +/- 22.4 cm/s, p = 0.004). Higher neonatal CRP correlated with lower cognitive (rho = - 0.327, p = 0.002), language (rho = - 0.285, p = 0.007), and motor scores (rho = - 0.257, p = 0.015), and slower gait (rho = - 0.298, p = 0.008). Multivariate analysis demonstrated neonatal CRP >= 0.20 mg/dL significantly predicted BSID-III cognitive (adjusted R(2) = 0.104, p = 0.008), language (adjusted R(2) = 0.124, p = 0.001), and motor scores (adjusted R(2) = 0.122, p = 0.004)., CONCLUSIONS: Associations between low-level neonatal inflammation and neurodevelopment suggest early biomarkers that may inform neuroprotective treatment for preterm children. Copyright Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 373833821
TI  - Fresh from the designation pipeline: Orphan drugs recently designated in the EU (March-April 2014)
AU  - Antoniu S.
Y1  - 2014//
KW  - article
KW  - autotransplantation
KW  - cells
KW  - charcot marie tooth disease type 1A/dt [Drug Therapy]
KW  - comparative effectiveness
KW  - drug efficacy
KW  - drug indication
KW  - drug industry
KW  - drug marketing
KW  - European Medicines Agency
KW  - evidence based practice
KW  - gene
KW  - genetic transduction
KW  - hereditary motor sensory neuropathy/dt [Drug Therapy]
KW  - human
KW  - Leber congenital amaurosis/dt [Drug Therapy]
KW  - lung dysplasia/dt [Drug Therapy]
KW  - priority journal
KW  - severe combined immunodeficiency/dt [Drug Therapy]
KW  - viral gene delivery system
KW  - baclofen/cb [Drug Combination]
KW  - baclofen/dt [Drug Therapy]
KW  - caffeine citrate/dt [Drug Therapy]
KW  - lentivirus vector
KW  - naltrexone/cb [Drug Combination]
KW  - naltrexone/dt [Drug Therapy]
KW  - *orphan drug/dt [Drug Therapy]
KW  - parvovirus vector
KW  - sorbitol/cb [Drug Combination]
KW  - sorbitol/dt [Drug Therapy]
KW  - unclassified drug
KW  - CD34 + cell
KW  - charcot marie tooth disease type 1A/dt [Drug Therapy]
KW  - GUCY2D gene
KW  - RAG1 gene
KW  - human recombinant surfactant protein d/dt [Drug Therapy]
T2  - Expert Opinion on Orphan Drugs
LA  - English
VL  - 2
IS  - 9
PB  - Informa Healthcare (E-mail: healthcare.enquiries@informa.com)
SN  - 2167-8707
AD  - S. Antoniu, University of Medicine and Pharmacy, Faculty of Medicine-Interdisciplinary Medicine, 16 Universitatii Str, Iasi 700115, Romania. E-mail: sabina.antoniu@umfiasi.ro
UR  - https://informahealthcare.com/journal/eod
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=373833821
DO  - https://dx.doi.org/10.1517/21678707.2014.953482
AB  - Introduction: Many rare diseases could benefit from a therapeutic point of view; examples include targeted gene therapies or 'borrowing' therapies from other diseases based on their mechanism of action, which is similar to that of the rare disease in question.Areas covered: This paper discusses five of the most recent orphan drug designations in the EU. Their corresponding compounds are to treat severe combined immune deficiency, Leber's congenital amaurosis, Charcot-Marie-Tooth 1A disease or bronchopulmonary dysplasia.Expert opinion: Most of the therapies discussed are currently still at an experimental stage and the demonstration of a comparable efficacy in clinical stages of development will be essential for market access. Â© 2014 Informa UK, Ltd.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 372785919
TI  - Neonatal hyperoxia stimulates the expansion of alveolar epithelial type II cells
AU  - Yee M.
AU  - Buczynski B.W.
AU  - O'Reilly M.A.
Y1  - 2014//
KW  - adult
KW  - ambient air
KW  - animal cell
KW  - animal tissue
KW  - article
KW  - BrdU assay
KW  - *cell expansion
KW  - cell fate
KW  - cell labeling
KW  - cell population
KW  - cell proliferation
KW  - cell stimulation
KW  - controlled study
KW  - endothelium cell
KW  - *hyperoxia
KW  - *lung alveolus epithelium
KW  - mouse
KW  - newborn
KW  - nonhuman
KW  - nucleotide sequence
KW  - promoter region
KW  - protein expression
KW  - aquaporin 5/ec [Endogenous Compound]
KW  - CD31 antigen/ec [Endogenous Compound]
KW  - green fluorescent protein
KW  - messenger RNA/ec [Endogenous Compound]
T2  - American Journal of Respiratory Cell and Molecular Biology
LA  - English
VL  - 50
IS  - 4
PB  - American Thoracic Society
SN  - 1535-4989
AD  - M.A. O'Reilly, Department of Pediatrics, University of Rochester, School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, United States. E-mail: michael_oreilly@urmc.rochester.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1165/rcmb.2013-0207OC
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=372785919
DO  - https://dx.doi.org/10.1165/rcmb.2013-0207OC
AB  - Supplemental oxygen used to treat infants born prematurely disrupts angiogenesis and is a risk factor for persistent pulmonary disease later in life. Although it is unclear how neonatal oxygen affects development of the respiratory epithelium, alveolar simplification and depletion of type II cells has been observed in adult mice exposed to hyperoxia between postnatal Days 0 and 4. Because hyperoxia inhibits cell proliferation, we hypothesized that it depleted the adult lung of type II cells by inhibiting their proliferation at birth. Newborn mice were exposed to room air (RA) or hyperoxia, and the oxygen-exposed mice were recovered in RA. Hyperoxia stimulated mRNA expressed by type II (Sftpc, Abca3) and type I (T1alpha, Aquaporin 5) cells and inhibited Pecam expressed by endothelial cells. 5-Bromo-2'-deoxyuridine labeling and fate mapping with enhanced green fluorescence protein controlled statically by the Sftpc promoter or conditionally by the Scgb1a1 promoter revealed increased Sftpc and Abca3 mRNAseen on Day 4 reflected an increase in expansion of type II cells shortly after birth. When mice were returned to RA, this expanded population of type II cells was slowly depleted until few were detected by 8 weeks. These findings reveal that hyperoxia stimulates alveolar epithelial cell expansion when it disrupts angiogenesis. The loss of type II cells during recovery in RA may contribute to persistent pulmonary diseases such as those reported in children born preterm who were exposed to supplemental oxygen. Copyright Â© 2014 by the American Thoracic Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 373318795
TI  - Biological markers in cord blood for prediction of bronchopulmonary dysplasia in premature infants
AU  - Tian X.Y.
AU  - Zhang X.D.
AU  - Li Q.L.
AU  - Shen Y.
AU  - Zheng J.
Y1  - 2014//
KW  - article
KW  - controlled study
KW  - diagnostic test accuracy study
KW  - diagnostic value
KW  - disease association
KW  - enzyme linked immunosorbent assay
KW  - female
KW  - gestational age
KW  - human
KW  - human cell
KW  - human tissue
KW  - *lung dysplasia/di [Diagnosis]
KW  - major clinical study
KW  - male
KW  - neutrophil
KW  - placenta
KW  - predictive value
KW  - *prematurity
KW  - sensitivity and specificity
KW  - *umbilical cord blood
KW  - very low birth weight
KW  - *biological marker/ec [Endogenous Compound]
KW  - *gelatinase B/ec [Endogenous Compound]
KW  - *interleukin 6/ec [Endogenous Compound]
KW  - *interleukin 6 receptor/ec [Endogenous Compound]
KW  - unclassified drug
KW  - *Sgp130 protein/ec [Endogenous Compound]
T2  - Clinical and Experimental Obstetrics and Gynecology
LA  - English
VL  - 41
IS  - 3
PB  - S.O.G. CANADA Inc.
SN  - 0390-6663
AD  - J. Zheng, Neonatal Department, Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin 300100, China. E-mail: junzheng268@163.com
UR  - http://www.irog.net/archives
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=373318795
DO  - https://dx.doi.org/10.12891/ceog16292014
AB  - Objective: The current study aims to determine the contents of biological markers in cord blood and to investigate their feasibility as the predictive indices of bronchopulmonary dysplasia (BPD) in premature infants. Material(s) and Method(s): Cord blood was collected from 134 premature infants that had birth weight <= 1500 g and gestational age (GA) <= 32 weeks at the time of birth. The contents of IL-6, IL-6R, Sgp130, and MMP-9 were determined. Infants' clinical data, as well as their mothers' placental pathological data were also collected. Infants with BPD constituted the BPD group, whereas those without BPD comprised the non-BPD (NBPD) group. Differences in the contents of the biological markers between the groups were analyzed to investigate the correlations of these markers with BPD, and then biological markers that can serve as the predictive factors of BPD were defined. Result(s): GA was negatively correlated with BPD. IL-6, IL-6R, and Sgp130 in the BPD group was higher than those in the NBPD group, whereas MMP-9 in the BPD group was lower than that in the NBPD group. IL-6 was positively correlated with BPD and therefore had a predictive effect on BPD. Sgp130 had a collinear correlation with IL-6, which had a predictive effect on BPD as well. When GA was < 30 weeks and IL-6 was > 46.125 pg/ml, the sensitivity, specificity, and area under curve were 1, 0.59, and 0.849, respectively, indicating a good predictive effect on BPD. Conclusion(s): IL-6 and Sgp130 can serve as the independent predictive cytokines of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 611887799
TI  - BK channel differences in ovine near-term fetus and adult small pulmonary arteries
AU  - Hessinger D.
AU  - Thorington G.
AU  - Sokolova I.
AU  - Longo L.
Y1  - 2014//
KW  - adult
KW  - alpha chain
KW  - animal cell
KW  - animal experiment
KW  - cell surface
KW  - conductance
KW  - current density
KW  - DNA transcription
KW  - fetus
KW  - fetus cell
KW  - flow cytometry
KW  - gene expression regulation
KW  - immunoblotting
KW  - lung
KW  - membrane steady potential
KW  - nonhuman
KW  - polymerase chain reaction
KW  - *pulmonary artery smooth muscle cell
KW  - resistance blood vessel
KW  - *sheep
KW  - stoichiometry
KW  - vasodilatation
KW  - whole cell
KW  - calcium
KW  - *large conductance calcium activated potassium channel
KW  - large conductance calcium activated potassium channel beta subunit
T2  - Journal of Vascular Research
LA  - English
VL  - 51
IS  - Supplement 2
PB  - S. Karger AG
SN  - 1423-0135
AD  - D. Hessinger, Loma Linda University, United States
DO  - https://dx.doi.org/10.1159/000369652
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=611887799
AB  - Pulmonary vasodilatation at birth underlies fetal transition to lung breathing. Failure to vasodilate causes persistent pulmonary hypertension of the newborn, persistent patency of the ductus arteriosus and foramen ovale, and bronchopulmonary dysplasia-related hypoxia, often with dire consequences. The mechanism of pulmonary vasodilatation at birth is poorly understood. Pulmonary artery smooth muscle cells (PASMCs) isolated from 4th and 5th order resistance vessels of ovine near-term fetus exhibited resting membrane potentials 8 mV more depolarized than adult (P<0.05). Although whole-cell Kv current densities for voltage-clamped fetal and adult PASMCs were similar, large-conductance, calcium-activated K+ (BK) current densities for fetal cells were significantly lower than adult at moderate potentials (i.e. +20 to +60 mV), but equaled those of adult at higher potentials. Fetal PASMCs expressed twice the pore-forming BKalpha subunit protein as adult, but only half as much accessary BKbeta-1 subunit on Western immunoblots. Cell surface beta-l expression was also significantly lower in fetal PASMCs by flow cytometry. Since optimal BK channel activity occurs at 1:1 beta-to-alpha stoichiometry, our results suggested the near-term fetus expressed BK beta:alpha ratios about 1/4 that of adult. In contrast to measured current densities and protein levels, both BKalpha and BKbeta-1 RNA transcripts were two-fold higher in near-term fetus than adult by qRT-PCR. These findings suggest that near-term fetal PASMCs are more depolarized and exhibit lower BK activity due to lower BKbeta-1 subunit expression, but may be poised to express higher levels of BKbeta-1 to enhance BK activity and promote pulmonary vasodilatation at birth.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72047750
TI  - Bone morphogenetic protein receptor II (BMPRII) expression is decreased in human pulmonary arterial endothelial cells (HPAECS) exposed to hyperoxia
AU  - Arawiran J.
AU  - Olson S.
AU  - Calo J.M.
AU  - Parton L.
Y1  - 2014//
KW  - *human
KW  - *hyperoxia
KW  - *endothelium cell
KW  - *American
KW  - *society
KW  - pulmonary hypertension
KW  - incubator
KW  - exposure
KW  - lung development
KW  - lung dysplasia
KW  - apoptosis
KW  - gas
KW  - cells by body anatomy
KW  - signal transduction
KW  - statistical significance
KW  - cell culture
KW  - culture medium
KW  - primary culture
KW  - nutrition
KW  - ambient air
KW  - morbidity
KW  - Western blotting
KW  - assay
KW  - protein expression
KW  - patient
KW  - *bone morphogenetic protein receptor 2
KW  - receptor
KW  - bone morphogenetic protein
KW  - antibody
KW  - cytokine
KW  - trypsin
KW  - transforming growth factor beta
KW  - trypan blue
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J. Arawiran, Maria Fareri Children's Hospital, Westchester Medical Center, New York Medical College, Valhalla, NY, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A5765
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72047750
AB  - Background: Bone morphogenetic proteins (BMP), which belong to the Transforming Growth Factor Beta (TGFbeta) superfamily, are currently considered to be pleiotropic cytokines that influence proliferation, growth, differentiation, and apoptosis of many different cell types. Dysregulated BMP signal transduction may influence pathological processes such as bronchopulmonary dysplasia (BPD). BPD remains to be a common morbidity in the NICU despite advances in gentle ventilatory strategies, limitation of hyperoxia exposure, and nutrition. The aim of this study was to assess the temporal expression of BMP and its receptor, BMPRII, in human pulmonary endothelial cells (HPAEcs) exposed to hyperoxia. We also seek to determine if hyperoxia affects viablity of HPAECs. Method(s): HPAECs were cultured in endothelial cell culture medium and maintained in a sterile humidified cell culture incubator at 37C with 5% CO2. Cells were passaged at 70-80% confluence with trypsin. Primary cultures of passage 5 were used in the experiments. HPAECs were plated in 30mm well plates and exposed to hyperoxic gas with 95% O2 and 5% CO2 for up to 72 hours and cell lysates were collected at 24, 48 and 72h. For control studies, HPAEC at passage 5 were placed at room air in an incubator and harvested at 0h, 24h, 48h and 72h. Antibodies to BMP4 and BMPRII were used in Western blot assays to determine protein expression. Cells were counted using the Neubauer hemocytometer stained with trypan blue. Results Results showed that BMPRII expression is decreased in HPAECs exposed to hyperoxia, however this did not reach statistical significance. Expression of BMP4 did not change with hyperoxia exposure. Cells exposed to hyperoxia showed a decrease in number as the duration of hyperoxia increased compared to the control wherein the cells proliferated. Discussion(s): BMPs are significant for lung development. With this preliminary results, we have shown that hyperoxia may disrupt lung development by downregulation of the receptor BMPRII. In idiopathic pulmonary hypertension, this is also the defective receptor. Probably with the downregulation of the receptor, the BMP signaling pathway is interrupted resulting in hypoalveolarization and pulmonary hypertension. Conclusion(s): Hyperoxia may decrease the BMPRII expression in HPAECs. Though these are very preliminary data, this is a possible explanation for pulmonary hypertension seen in patients with BPD. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72047223
TI  - Genome-wide expression profiling of peripheral blood from bronchopulmonary dysplasia subjects
AU  - Bhattacharya S.
AU  - Mereness J.
AU  - Pryhuber G.S.
AU  - Baran A.
AU  - Peterson D.R.
AU  - Mariani T.J.
Y1  - 2014//
KW  - *blood
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - *genome
KW  - gene
KW  - gene expression
KW  - infant
KW  - diagnosis
KW  - peripheral blood mononuclear cell
KW  - human
KW  - prematurity
KW  - classifier
KW  - lung parenchyma
KW  - logistic regression analysis
KW  - risk factor
KW  - risk
KW  - newborn
KW  - blood sampling
KW  - pregnancy
KW  - model
KW  - urea cycle
KW  - biosynthesis
KW  - metabolism
KW  - minimally invasive procedure
KW  - biological marker
KW  - arginine
KW  - melatonin
KW  - myeloperoxidase
KW  - arginase 1
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Bhattacharya, University of Rochester Medical Center, Rochester, NY, United States. E-mail: soumyaroop_bhattacharya@urmc.rochester.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A5283
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72047223
AB  - Rationale: Bronchopulmonary Dysplasia (BPD) is a major complication in premature infants, particularly those born at less than 32 weeks of gestation or weighing less than 1500 g. Due to the complexity of risk factors and limited availability of clinical samples, an understanding of this disease, its potential biomarkers and causal mechanisms are limited. The application of discovery approaches to samples derived from minimally-invasive procedures may provide biomarkers for diagnosis and therapeutic management of BPD. Method(s): We analyzed a dataset (GSE32472) describing gene expression in peripheral blood mononuclear cells (PBMC), obtained near the time of birth (5+/-2 days of life) or near the time of diagnosis (25+/-3 days of life), from premature infants at risk for BPD. The dataset consists of 298 Affymetrix HuGene ST 1.0 arrays from 111 subjects. Raw data files were normalized by PLIER or RMA. Multiple statistical tests were used to identify gene expression changes that discriminate between BPD cases and controls. Expression validation was performed using RNA from BPD or control lung tissue. LASSO-penalized logistic regression was applied to form a classifier of BPD using 9-fold cross-validation. Result(s): Near birth, 15 genes were consistently identified as differentially expressed in PBMC from subjects with BPD. Near diagnosis, 19 genes were identified as differentially expressed in PBMC from subjects with BPD. Three genes were consistently different at both time-points: Arginase-1 (ARG1), Myeloperoxidase (MPO), and Olfactomedin-4 (OLFM4). Members of the CEACAM family, whose expression has been previously associated with BPD in lung tissue, were also identified as differentially expressed in PBMC. We validated significant changes in expression for three genes; ARG1, CEACAM1 and CEACAM6. Pathway analysis of BPD-associated genes implicated melatonin and arginine metabolism, citruline biosynthesis and the urea cycle. Importantly, we developed a classifier model from PBMC gene expression near birth, consisting of 16 genes, which predicted a future diagnosis of BPD with 76% accuracy. Summary: These results contribute to our understanding of gene expression changes in the peripheral blood of infants with BPD, and may provide insight into disease mechanism. These data also suggest that gene expression from blood samples of newborn premature infants, collected just following birth, may provide potential to predict those infants who may develop BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72047067
TI  - Thioredoxin reductase inhibition attenuates hyperoxia-induced lung developmental deficits in newborn mice
AU  - Tipple T.E.
AU  - Hill C.L.
AU  - Pierce D.L.
AU  - Velten M.
AU  - Rogers L.K.
Y1  - 2014//
KW  - *hyperoxia
KW  - *lung
KW  - *mouse
KW  - *American
KW  - *society
KW  - lung development
KW  - body weight
KW  - hypothesis
KW  - human
KW  - gene
KW  - lung injury
KW  - prematurity
KW  - newborn
KW  - infant
KW  - protection
KW  - oxygen toxicity
KW  - fetus lung maturation
KW  - lung dysplasia
KW  - adult
KW  - toxicity
KW  - endothelium cell
KW  - in vitro study
KW  - injection
KW  - attenuation
KW  - model
KW  - safety
KW  - morbidity
KW  - ambient air
KW  - murine model
KW  - *thioredoxin reductase
KW  - sodium chloride
KW  - antioxidant
KW  - mitogenic agent
KW  - vasculotropin
KW  - nuclear factor
KW  - auranofin
KW  - aurothioglucose
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - T.E. Tipple, Research Institute at Nationwide Children's Hospital, Columbus, OH, United States. E-mail: trent.tipple@nationwidechildrens.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A5120
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72047067
AB  - Oxygen toxicity and antioxidant deficiencies contribute to the development of bronchopulmonary dysplasia (BPD) in premature infants. Aurothioglucose (ATG) and auranofin (AFN) potently inhibit thioredoxin (Trx) reductase (TrxR), while TrxR inhibition activates nuclear factor E2-related factor 2 (Nrf2). We have previously shown that ATG safely and effectively prevents hyperoxic lung injury in adult mice, likely via Nrf2-dependent mechanisms. In newborn mice, Nrf2 regulates lung maturation and protection from O2 toxicity suggesting that TrxR inhibition might prevent BPD. The present studies tested the hypothesis that ATG would attenuate hyperoxia-induced lung developmental deficits in a newborn murine model of BPD. To test this hypothesis, newborn C3H/HeN mice were treated with a single i.p. dose of 25 mg/kg ATG or saline within 12 h of birth and were exposed in either room air (RA) or 85% hyperoxia (O2) for 14 d. Morphometric analyses revealed arrested lung development in hyperoxia-exposed mice. ATG treatment significantly attenuated O2 -induced increases in alveolar area and decreases in alveolar number. Lung development was not different between ATG-treated and saline-treated mice raised in RA. Body weights in saline-treated O2-exposed mice were significantly lower at 7 d and 14 d than in RA controls. ATG treatment significantly attenuated O2-induced decreases in body weight. To determine the impact of TrxR inhibition on Nrf2 activation in vitro, murine alveolar epithelial (MLE-12) cells were treated with 1 muM AFN for 1 h. AFN treatment decreased TrxR1 activities by 90% compared to saline-treated controls. qRT-PCR analyses of AFN-treated cells revealed that transcription of Nrf2-driven genes GCLM, HO-1, NQ01, and TrxR1 was significantly increased as was transcription of vascular endothelial growth factor (VEGF), an endothelial cell mitogen that is significantly decreased in BPD. Our novel data indicate that a single ATG injection at birth attenuates O2-induced alterations in alveolar development in newborn mice. Furthermore, ATG treatment appears to be well tolerated as evidenced by normal lung growth in RA-exposed controls and attenuation of O2-induced decreases body weight in saline-treated mice. Induction of Nrf2 target genes by AFN treatment in MLE-12 cells supports a working model in which the protective effects of TrxR inhibition are Nrf2-dependent. Future studies will determine the safety and efficacy of TrxR inhibition as a novel approach to attenuate O2-mediated neonatal lung injury and arrested lung development, a significant and costly cause of morbidity in preterm infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72047066
TI  - MTORC1 inhibition prevents hyperoxia-induced injury and attenuates bronchopulmonary dysplasia by enhancing autophagy in mice lungs
AU  - Angara S.
AU  - Bhandari V.
Y1  - 2014//
KW  - *hyperoxia
KW  - *injury
KW  - *lung dysplasia
KW  - *autophagy
KW  - *mouse
KW  - *lung
KW  - *American
KW  - *society
KW  - model
KW  - cell death
KW  - protein expression
KW  - mouse model
KW  - intranasal drug administration
KW  - lung alveolus cell
KW  - newborn
KW  - architecture
KW  - mortality
KW  - respiratory failure
KW  - lung injury
KW  - raptor
KW  - exposure
KW  - Western blotting
KW  - lung alveolus epithelium cell
KW  - acute lung injury
KW  - morphometrics
KW  - diseases
KW  - long term exposure
KW  - wild type mouse
KW  - marker
KW  - caspase 3
KW  - small interfering RNA
KW  - protein p53
KW  - mammalian target of rapamycin inhibitor
KW  - chloroquine
KW  - mammalian target of rapamycin complex 1
KW  - beclin 1
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Angara, Yale University, School of Medicine, New Haven, CT, United States. E-mail: sureshbabu.angara@yale.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A5119
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72047066
AB  - Introduction: Administering high-concentrations of O2 remains a life-sustaining intervention for neonates with respiratory failure. However, prolonged exposure to hyperoxia could result in developmental diseases embodied as hyperoxia-induced acute lung injury (HALI) and bronchopulmonary dysplasia (BPD). Rationale: The role of autophagy in development is clearly important; however, its role in relation to HALI and BPD is currently unknown. So, we sought to investigate the role of autophagy in hyperoxia-induced alveolar cell death in developing lungs of mice models. Method(s): Mammalian Target of Rapamycin Complex 1 (mTORC1) is a negative regulator of autophagy. Raptor (RPTOR) is a major subunit, found in mTORC1 but not in mTORC2. So, using RPTOR+/- mice, RPTOR siRNA intranasal delivery and wild-type (WT) mice treated with Torin2 (mTOR inhibitor), we evaluated the apoptotic cell death markers and lung morphometry in HALI and BPD mice models. Result(s): We noted significantly increased protein expression of autophagy markers: Atg5, Beclin-1, P62, LC3-II in concomitant with increased protein expression of acetyl p53 (K382), phospho p53 (S392), phospho mTOR (S2448), phospho S6K1 (S424) and phospho S6 (S235/236) in a model of HALI (100% O2 exposed WT postnatal (PN) day 7 mice lungs). We demonstrated increased co-localization of LC3 with SP-C in Type II alveolar epithelial cells of hyperoxia-exposed WT PN7 mice lungs. We confirmed increased LC3 II in hyperoxia-exposed freshly isolated Type II alveolar cells from E19 - PN2 mice lungs using western blotting. Torin2 treatment showed decreased Bax, cleaved caspase 3 and increased Bcl2 expression, among apoptotic markers. This was accompanied by improved alveolar size as measured by chord length in hyperoxia-exposed WT PN7 mice lungs. Conversely, Chloroquine (an autophagy inhibitor) treatment showed increased Bax and cleaved caspase 3 expression and increased chord length in hyperoxia-exposed WT PN7 mice lungs. Exposure of hyperoxia to RPTOR+/- mice till PN7 resulted in increased LC3 II, but decreased cleaved caspase 3, cleaved PARP and chord length in lungs. Furthermore, temporal inhibition of mTORC1 using intranasal delivery of RPTOR siRNA demonstrated improved chord length in a hyperoxia-induced BPD mouse model. Conclusion(s): We have demonstrated a novel autophagy signaling pathway in developing lungs using a HALI mouse model. Taken together, our data suggest that decreasing mTORC1 increases hyperoxia-induced autophagy, limits lung injury by decreasing apoptotic cell death markers, reduces mortality in HALI and improves lung architecture in BPD mice models.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72046876
TI  - The role of hydrogen sulfide in normal and aberrant late lung development
AU  - Madurga Hernandez A.
AU  - Mizikova I.
AU  - Ruiz Camp J.
AU  - Fehrenbach H.
AU  - Seeger W.
AU  - Morty R.E.
Y1  - 2014//
KW  - *lung development
KW  - *American
KW  - *society
KW  - hyperoxia
KW  - mouse
KW  - control group
KW  - therapy
KW  - in vitro study
KW  - lung dysplasia
KW  - human
KW  - newborn
KW  - prematurity
KW  - leukocyte count
KW  - wound healing
KW  - gas
KW  - donor
KW  - gene
KW  - model
KW  - lung structure
KW  - thickness
KW  - chronic lung disease
KW  - lung lavage
KW  - lung
KW  - transgenic mouse
KW  - biological activity
KW  - experimental model
KW  - stereology
KW  - *hydrogen sulfide
KW  - cystathionine
KW  - enzyme
KW  - sulfurtransferase
KW  - lyase
KW  - synthetase
KW  - gasotransmitter
KW  - interleukin 1
KW  - messenger RNA
KW  - nonoxinol 9
KW  - antioxidant
KW  - interleukin 6
KW  - adenosine triphosphate
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - A. Madurga Hernandez, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany. E-mail: Alicia.MadurgaHernandez@mpi-bn.mpg.de
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A4929
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72046876
AB  - Bronchopulmonary dysplasia (BPD) is a chronic lung disease of the premature newborn, characterized by arrested alveolar development. Little is known about the mechanisms of BPD, and no specific treatment for this disease exists. Hydrogen sulfide (H2S), belongs to a class of endogenously synthesized gaseous molecules referred to as gasotransmitters. Recent evidence suggests that endogenous H2S exerts beneficial biological effects, including cytoprotective, anti-inflammatory and antioxidant properties. Three enzymes are known to synthetize H2S, cystathionine-beta synthase (Cbs), cystathionine-gamma lyase (Cth) and mercaptopyruvate sulfur transferase (Mpst). H2S may play a role in the development of the alveolar airspaces during normal late lung development, and if used as a therapy could be beneficial for BPD. To assess the potential therapeutic benefit of H2S, the slow-releasing gas donor GYY4137 (morpholin-4-ium-4-methoxyphenyl(morpholino) phosphinodithioate) was tested in the mouse BPD model at a dose of 50 mg/kg/day intraperitoneally. Neonatal mouse pups were randomly exposed from birth to either: Normoxia (21% O22), normoxia + GYY4137, to hyperoxia (85% O22) and hyperoxia+ GYY4137. H2S preserved alveolar growth in hyperoxic mice as assessed by lung stereology. The treatment under hyperoxia conditions resulted in a decrease in mean linear intercept from 83.3 to 65.7 cm, a decrease in septal wall thickness from 0.11 to 0.08 mum and an increase in alveolar number, from 5.5 to 8.5x105/cm3 compared to the hyperoxia control group. The improvement in the pulmonary structure could be partially explained by the anti-inflammatory role of H2S. In hyperoxia conditions, the mRNA expression (DELTACt) of IL-1beta decreased from -0.03 to -0.4, for IL-6 from -0.8 to -1.4 and for TNF-alpha from -10.6 to -11.1 in the therapy group, compared to control group. Under hyperoxic conditions, the bronchoalveolar lavage leukocyte count decreased from 56,2 (untreated) to 25,5x105 (H2S-treated) cells/ml. H2S activated cytoprotective Akt in vitro, and the action prevailed in vivo under hyperoxia conditions. We could also demonstrate in vitro, that H2S promoted wound healing in primary alveolar type two cells through K+ATP channels. Two transgenic mice, where the genes encoding Cth and Cbs have been deleted respectively, were tested to study the course of normal late lung development. The Cbs knockout exhibited air space enlargement. H2S helped to prevent arrested alveolar development in the experimental model of BPD. H2S thus plays a role normal late lung development mostly through the generating H2S enzyme, Cbs.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72044762
TI  - Improved early nutrition increases lung function in infants with bronchopulmonary dysplasia
AU  - Filbrun A.G.
AU  - Vasileff A.S.
AU  - Huang S.
AU  - Wang W.
AU  - Varela V.
AU  - McIntosh N.
AU  - Peterson K.E.
AU  - Song P.X.
AU  - Hershenson M.B.
Y1  - 2014//
KW  - *lung function
KW  - *infant
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - *nutrition
KW  - lung function test
KW  - gestational age
KW  - weight
KW  - human
KW  - prematurity
KW  - newborn
KW  - statistical model
KW  - feeding
KW  - caloric intake
KW  - dietary intake
KW  - lung
KW  - risk
KW  - forced expiratory volume
KW  - bronchodilating agent
KW  - protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.B. Hershenson, University of Michigan, Ann Arbor, MI, United States. E-mail: mhershen@med.umich.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2331
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72044762
AB  - Rationale: Optimizing early nutrition is considered essential in premature neonates at risk for bronchopulmonary dysplasia (BPD). We hypothesized that improved early nutrition increases lung function in BPD. Method(s): Infants with a history of BPD were retrospectively studied. Cohort 1 included 18 infants who underwent two lung function tests from 2003-7. Cohort 2 included 29 infants who underwent one or two tests from 2009-11. Institutional increases in early nutritional intake were instituted beginning 2007. We examined whether adjusted subject-specific weight and length growth trajectories before the first lung function test correlated with lung function at the time of the first lung function test or changes in lung function between the two tests. Result(s): Protein and caloric intake during the first week of life were significantly increased in cohort 2 compared to cohort 1. When we compared the growth trajectories of infants born at <= 27 weeks gestational age, infants from cohort 2 had a significantly higher length growth trajectory than infants from cohort 1, demonstrating that the new feeding regimen successfully enhanced length growth in infants born at <= 27 weeks gestational age. There were no differences in lung function at the time of the first test, or change in lung function between the first and second tests, between cohort 1 and cohort 2. However, for infants <= 27 weeks gestational age at birth, changes in percent predicted post-bronchodilator FEV0.5, percent predicted FEF75 and standardized FEF75 were greater in cohort 2 than cohort 1. When we treated individual trajectory deviations as predictors for change in lung function using a linear model for longitudinal analysis, length trajectory before the first lung function test was positively associated with changes in percent predicted post-bronchodilator FEV 0.5, FEF25-75 and FEF75 between the first and second tests. When we considered cohort 1 separately, weight and length trajectories before the first lung test were positively associated with four measures of lung function change between the first and second tests. When we considered cohort 2 separately, weight and length trajectories were positively correlated with 15 measures of lung function change. Conclusion(s): Changes in early nutritional practice resulted in improved length growth trajectory and pulmonary function in neonates born <= 27 weeks gestational age. We conclude that early aggressive nutritional management promotes lung function in premature infants with BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2016>
TI  - CD11b(+) Mononuclear Cells Mitigate Hyperoxia-Induced Lung Injury in Neonatal Mice.
DO  - https://dx.doi.org/10.1165/rcmb.2014-0395OC
AU  - Eldredge, Laurie C
AU  - Treuting, Piper M
AU  - Manicone, Anne M
AU  - Ziegler, Steven F
AU  - Parks, William C
AU  - McGuire, John K
Y1  - 2016//
KW  - Animals
KW  - Animals, Newborn
KW  - Bronchopulmonary Dysplasia/et [Etiology]
KW  - Bronchopulmonary Dysplasia/im [Immunology]
KW  - Bronchopulmonary Dysplasia/me [Metabolism]
KW  - Bronchopulmonary Dysplasia/pa [Pathology]
KW  - *Bronchopulmonary Dysplasia/pc [Prevention & Control]
KW  - CD11b Antigen/ge [Genetics]
KW  - *CD11b Antigen/me [Metabolism]
KW  - Disease Models, Animal
KW  - Heparin-binding EGF-like Growth Factor/ge [Genetics]
KW  - Heparin-binding EGF-like Growth Factor/me [Metabolism]
KW  - *Hyperoxia/co [Complications]
KW  - Inflammation Mediators/me [Metabolism]
KW  - Lung/im [Immunology]
KW  - *Lung/me [Metabolism]
KW  - Lung/pa [Pathology]
KW  - Lung Injury/et [Etiology]
KW  - Lung Injury/im [Immunology]
KW  - Lung Injury/me [Metabolism]
KW  - Lung Injury/pa [Pathology]
KW  - *Lung Injury/pc [Prevention & Control]
KW  - Macrophage Activation
KW  - Macrophages/im [Immunology]
KW  - *Macrophages/me [Metabolism]
KW  - Mice, Inbred C57BL
KW  - Mice, Transgenic
KW  - Phenotype
KW  - Pulmonary Edema/et [Etiology]
KW  - Pulmonary Edema/im [Immunology]
KW  - Pulmonary Edema/me [Metabolism]
KW  - Pulmonary Edema/pc [Prevention & Control]
KW  - Severity of Illness Index
KW  - Time Factors
T2  - American journal of respiratory cell and molecular biology
VL  - 54
IS  - 2
SN  - 1044-1549
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med13&NEWS=N&AN=26192732
AD  - United States
AB  - Bronchopulmonary dysplasia (BPD) is a common consequence of life-saving interventions for infants born with immature lungs. Resident tissue myeloid cells regulate lung pathology, but their role in BPD is poorly understood. To determine the role of lung interstitial myeloid cells in neonatal responses to lung injury, we exposed newborn mice to hyperoxia, a neonatal mouse lung injury model with features of human BPD. In newborn mice raised in normoxia, we identified a CD45(+) F4/80(+) CD11b(+), Ly6G(lo-int) CD71(+) population of cells in lungs of neonatal mice present in significantly greater percentages than in adult mice. In response to hyperoxia, surface marker and gene expression in whole lung macrophages/monocytes was biased to an alternatively activated phenotype. Partial depletion of these CD11b(+) mononuclear cells using CD11b-diphtheria toxin (DT) receptor transgenic mice resulted in 60% mortality by 40 hours of hyperoxia exposure with more severe lung injury, perivascular edema, and alveolar hemorrhage compared with DT-treated CD11b-DT receptor-negative controls, which displayed no mortality. These results identify an antiinflammatory population of CD11b(+) mononuclear cells that are protective in hyperoxia-induced neonatal lung injury in mice, and suggest that enhancing their beneficial functions may be a treatment strategy in infants at risk for BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72044759
TI  - Intracellular granzyme b and peforin are increased in tracheal aspirate lymphocytes of babies who go on to develop bronchopulmonary dysplasia (BPD)
AU  - Ryan R.M.
AU  - Micallef M.A.
AU  - Yawn J.R.
AU  - Koch F.R.
AU  - Baatz J.E.
AU  - Mulligan J.K.
Y1  - 2014//
KW  - *tracheal aspiration procedure
KW  - *lymphocyte
KW  - *baby
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - infant
KW  - ventilator
KW  - prematurity
KW  - human
KW  - assisted ventilation
KW  - T lymphocyte
KW  - immunocompetent cell
KW  - endotracheal tube
KW  - hypothesis
KW  - natural killer cell
KW  - newborn
KW  - lymphocyte subpopulation
KW  - rank sum test
KW  - chronic lung disease
KW  - hospitalization
KW  - death
KW  - morbidity
KW  - lung disease
KW  - parameters
KW  - consensus
KW  - gestational age
KW  - supernatant
KW  - immunohistochemistry
KW  - phenotype
KW  - lung parenchyma
KW  - positive end expiratory pressure
KW  - *granzyme B
KW  - perforin
KW  - CD8 antigen
KW  - cytokine
KW  - CD3 antigen
KW  - nitrogen 13
KW  - chemokine receptor
KW  - interleukin 2
KW  - cytotoxic factor
KW  - surfactant
KW  - protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - R.M. Ryan, Medical University of South Carolina, Charleston, SC, United States. E-mail: ryanr@musc.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2328
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72044759
AB  - Background Bronchopulmonary dysplasia (BPD) is a chronic lung disease of premature infants that leads to significant long-term morbidity. Little attention has been given to lymphocytes and the chronic inflammatory phase of BPD. Ryan et al (AJRCCM 2009:179:A5976) using IHC analysis reported that CD3+ and CD8+ T-lymphocytes were found more frequently in the lung parenchyma of infants who died with BPD compared to those of similar corrected gestational age without lung disease. The aim of our study was to evaluate lymphocyte subpopulations, chemokine receptors CXCR3 and CCR4, and various cytotoxic Th1 and Th2 cytokines in tracheal aspirates (TA) of mechanically ventilated preterm neonates to test our hypothesis that clinical outcomes are correlated to the levels of these inflammatory mediators. Methods Preterm infants <34wks who remained mechanically ventilated at 7-14 days after birth were enrolled (n=13, mean GA 26wks). TAs were collected from routine suctioning of the endotracheal tube. Immune cell phenotyping was conducted by immunostaining with flow cytometric analysis with exclusion of dead cells. Supernatant cytokine levels were determined by cytometric bead array (CBA) and corrected for total protein by BCA. Clinical parameters examined included surfactant doses, ventilator days, respiratory support days (vent or CPAP), BPD as defined by the NIH Consensus Conference, death, and length of hospitalization. Results Higher numbers of CD8+ cells and CXCR3+ cells in TA collected between 7-14d of age were associated with a higher number of ventilator days. Tracheal cell intracellular levels of the cytotoxic factors granzyme B (GrB) and perforin correlated with the number of days of respiratory support (data shown for GrB in Figure), and ventilator days (p=0.0007, r=0.87 for GrB, p=0.0173 and r=0.6390 for perforin). Both CD8+ and natural killer cells stained positive for GrB and perforin. Infants at 7-14d of age who later develop severe BPD had a significantly higher percentage of TA lymphocytes with intracellular GrB and perforin compared with infants who developed mild-moderate BPD (p=0.0286 for both GrB and perforin). Mann-Whitney U test with data sorted by median days on the ventilator revealed a trend towards reduced levels of anti-inflammatory factors (IL10) and increase in pro-inflammatory factors (IL-2 and IFN-g). (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72044758
TI  - Adenosine levels in a hyperoxia model of bronchopulmonary dysplasia
AU  - Davies J.
AU  - Karmouty-Quintana H.
AU  - Le T.T.
AU  - Chen N.-Y.
AU  - Weng T.
AU  - Molina J.
AU  - Blackburn M.R.
Y1  - 2014//
KW  - *hyperoxia
KW  - *model
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - mouse
KW  - exposure
KW  - survival
KW  - lung
KW  - inflammation
KW  - newborn
KW  - acute lung injury
KW  - morbidity
KW  - injury
KW  - therapy
KW  - genetically engineered mouse strain
KW  - lung injury
KW  - cell damage
KW  - examination
KW  - human
KW  - lung lavage
KW  - ambient air
KW  - histopathology
KW  - prematurity
KW  - intracellular transport
KW  - cell count
KW  - hypothesis
KW  - tissues
KW  - mortality
KW  - otorhinolaryngology
KW  - *adenosine
KW  - oxygen
KW  - equilibrative nucleoside transporter
KW  - adenosine receptor
KW  - protein
KW  - marker
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J. Davies, Baylor College of Medicine, Houston, TX, United States. E-mail: jd4@bcm.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2327
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72044758
AB  - Rationale: Bronchopulmonary dysplasia (BPD) remains a significant cause for morbidity and mortality in premature neonates. BPD is caused by multiple factors including supplemental oxygen that cause cellular injury, inflammation and disrupted alveolar development. There are no effective treatments to prevent BPD, and understanding of the pathways leading to BPD are needed to develop novel pharmacologic therapies. Adenosine is a signaling molecule that is generated extra-cellularly by CD39 and CD73 in response to injury. Extracellular adenosine levels are modulated by equilibrative nucleoside transporters (ENTs) that transport adenosine into the cell. Elevated adenosine levels have been found to be protective in acute lung injury, but sustained elevations have been shown to mediate pro-inflammatory pathways and lead to tissue destruction and abnormal alveolar development. The role of adenosine signaling in the development of BPD has not been evaluated. Our hypotheses are: Exposure to hyperoxia in newborn mice leads to increased extracellular adenosine. Altering the generation or intracellular transport of extracellular adenosine will impact survival and histopathology of newborn mice exposed to hyperoxia. Method(s): Newborn C57Bl6 mice, CD73 -/-, and ENT2 -/- mice were exposed to 95% oxygen or room air starting between 12 and 48 hours after birth. After 14 days exposure, surviving mice were sacrificed for collection of bronchoalveolar lavage fluid (BALF) and lungs for biochemical and histologic analysis. BALF was analyzed for adenosine concentrations and markers of inflammation. Lung sections were processed for histologic examination. Result(s): Exposure of C57Bl6 mice to hyperoxia increased BALF cell counts and protein concentrations, disrupted alveolar development and increased BALF adenosine concentrations. C57Bl6 mice had 56% survival in hyperoxia at 14 days. CD73 -/- mice in hyperoxia all died by day 11. ENT -/- mice in hyperoxia all died by day 6. Conclusion(s): Hyperoxia exposure causes lung injury and disrupted alveolar development in newborn mice that is associated with increased extracellular adenosine concentrations. Loss of CD73, which will decrease extracellular adenosine production, leads to decreased survival of newborn mice in hyperoxia. Loss of ENT, which will increase extracellular adenosine levels, also leads to decreased survival of newborn mice in hyperoxia. These results suggest that adenosine plays an important and regulated role in newborn mice exposed to hyperoxia. Additional work using agents that alter adenosine levels and interact with specific adenosine receptors in combination with genetically modified mice will help delineate the role of adenosine in oxygen exposure in newborn mice and the development of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72044751
TI  - Neonatal monocyte/macrophage depletion accelerates hyperoxia-induced lung injury
AU  - Eldredge L.C.
AU  - Treuting P.M.
AU  - Manicone A.M.
AU  - Duffield J.S.
AU  - Parks W.C.
AU  - McGuire J.K.
Y1  - 2014//
KW  - *hyperoxia
KW  - *lung injury
KW  - *American
KW  - *society
KW  - mouse
KW  - macrophage
KW  - lung
KW  - monocyte
KW  - neutrophil
KW  - flow cytometry
KW  - population
KW  - pathogenesis
KW  - infant
KW  - human
KW  - inflammation
KW  - pathologist
KW  - innate immunity
KW  - lung dysplasia
KW  - genetic model
KW  - FVB/N mouse
KW  - adult
KW  - stimulus
KW  - prematurity
KW  - pneumonia
KW  - wild type
KW  - phagocyte
KW  - blood vessel injury
KW  - model
KW  - lung edema
KW  - Leydig cell
KW  - edema
KW  - mononuclear phagocyte
KW  - transgenic mouse
KW  - atelectasis
KW  - fibrin deposition
KW  - lung hemorrhage
KW  - apoptosis
KW  - dying
KW  - exposure
KW  - mortality
KW  - pulmonary vein
KW  - respiratory epithelium
KW  - eukaryotic flagellum
KW  - paraffin
KW  - cell surface marker
KW  - receptor
KW  - toxin
KW  - diphtheria toxin
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - L.C. Eldredge, University of Washington, Seattle, WA, United States. E-mail: lauriech@uw.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2320
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72044751
AB  - Rationale: Bronchopulmonary dysplasia (BPD) is a common consequence of life-saving interventions for infants born prematurely with immature lungs. BPD pathogenesis is multifactorial, including pro-inflammatory stimuli such as hyperoxia. The role of the innate immune system in this process is not well understood. We previously identified a population of M2-like anti-inflammatory macrophages present in lungs of neonatal mice and largely absent in adult mice. We hypothesize that this macrophage population is protective in acute inflammatory lung injury in the developing lung. Method(s): We used a genetic model for conditional depletion of macrophages and monocytes. Administration of diphtheria toxin to CD11b-Diptheria Toxin Receptor (DTR) transgenic mice results in selective in vivo depletion of CD11b-positive mononuclear phagocytes. CD11b-positive neutrophils are preserved in this model. Postnatal (PN) day 0 wild type FVB/N or CD11bDTR mice were injected intraperitoneally with 500ng of DT then placed in 95% FiO2. Pulmonary macrophages were analyzed via flow cytometry utilizing validated cell surface markers. Whole mouse pups from parallel experiments were embedded in paraffin and analyzed by a certified veterinary pathologist. Result(s): DT treated CD11bDTR-negative controls were clinically well but had the expected histologic evidence of hyperoxia-induced lung injury including inflammation, perivascular edema, and loss of cilia on respiratory epithelia. DT treatment resulted in the ablation of approximately 50% CD11b-positive macrophages and monocytes in CD11bDTR-positive mice and led to 60% mortality by 40 hours of hyperoxia exposure; the surviving DTR-positive mice were profoundly moribund. Flow cytometry studies demonstrated a significant increase in the number of pulmonary neutrophils with a more than 60% increase above control mice (p < 0.05). Histologic analysis of lungs from DT treated CD11bDTR-positive mice revealed more severe, diffuse inflammatory lung injury than DTR-negative controls with fulminant pulmonary hemorrhage, intraalveolar fibrin deposition, focal areas of atelectasis, abundant apoptosis of interstitial cells, and pulmonary edema. In addition, cardiomyocytes within medium to large pulmonary veins of DT treated CD11bDTR mice were hypertrophied, suggesting associated pulmonary vascular injury. Conclusion(s): Depletion of CD11b-positive monocytes and macrophages results in severe pulmonary injury when newborn mice are exposed to hyperoxia. These features resemble aspects of inflammatory lung disease observed in premature infants. We conclude that CD11b-positive macrophages and monocytes play a protective role in the setting of hyperoxia-induced neonatal lung injury. This may confirm a profound role for interstitial myeloid-derived phagocytic cells in the pathogenesis of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72044750
TI  - Dysfunctional NRF2 signaling in myeloid cells causes heightened levels of lung inflammation and bronchopulmonary dysplasia (BPD) in newborn mice exposed to hyperoxia
AU  - Tamatam C.
AU  - Reddy N.M.
AU  - Syed M.
AU  - Harijith A.
AU  - Natarajan V.
AU  - Raj J.U.
AU  - Pothireddy S.
Y1  - 2014//
KW  - *bone marrow cell
KW  - *pneumonia
KW  - *lung dysplasia
KW  - *mouse
KW  - *hyperoxia
KW  - *American
KW  - *society
KW  - lung
KW  - mortality
KW  - cell stress
KW  - inflammation
KW  - lung injury
KW  - immune response
KW  - injury
KW  - lung development
KW  - histopathology
KW  - liquid
KW  - leukocyte differential count
KW  - morbidity
KW  - hypothesis
KW  - lung disease
KW  - leukocyte
KW  - risk
KW  - ambient air
KW  - permeability
KW  - oxygen therapy
KW  - gene
KW  - newborn
KW  - prematurity
KW  - transcription factor
KW  - antioxidant
KW  - oxygen
KW  - protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C. Tamatam, Univeristy of Illinois at Chicago, Chicago, IL, United States. E-mail: tamatam@uic.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2319
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72044750
AB  - Rationale: Preterm babies subjected to supplemental oxygen therapy (hyperoxia) are at high risk for BPD, a clinical lung disorder with significant morbidity and mortality. An antioxidant/oxidant imbalance can lead to lung injury, inflammation and immune responses in experimental BPD. The Nrf2 transcription factor, by inducing several antioxidant and cytoprotective genes, mitigates cellular stress caused by hyperoxia. We found significant mortality and over-simplification of alveoli in Nrf2-/- compared to Nrf2+/+ mice during recovery from hyperoxic insult; however, the contribution of cellular stress produced by the resident versus recruited lung leukocytes to BPD is largely undefined. We tested the hypothesis that dysfunctional myeloid-specific Nrf2 signaling contributes to heightened inflammation and alveolar simplification in immature lungs during recovery from hyperoxia. Method(s): We generated mice lacking Nrf2 specifically in myeloid cells (Nrf2-/-DELTAmc) by crossing Nrf2 floxed (Nrf2f/f) mice with LyzM-Cre mice. 1-day-old pups were exposed to 95% oxygen for 72 h and then allowed to recover in room air for 3 weeks, and lung injury and alveolar simplification was evaluated. Result(s): Nrf2 deficiency in myeloid cells resulted in increased neutrophilic infiltration and alveolar permeability as indicated by differential cell counts and total protein levels in the BAL fluid, respectively. Histopathology revealed greater alveolar simplification in lungs of Nrf2-/- DELTAmc compared to Nrf2f/f mice after 3 weeks of recovery from hyperoxia. Conclusion(s): Nrf2 signaling in myeloid cells is critical for dampening of lung inflammation and for promotion of lung development in neonates during recovery from hyperoxic injury.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72044748
TI  - The TLR3 agonist poly(I:C) induces sustained type 1 inflammatory responses in a mouse model of bronchopulmonary dysplasia
AU  - Popova A.P.
AU  - Cui T.X.
AU  - Richardson M.N.
AU  - Bentley J.K.
AU  - Goldsmith A.M.
AU  - Hershenson M.B.
Y1  - 2014//
KW  - *inflammation
KW  - *mouse
KW  - *mouse model
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - *agonist
KW  - hyperoxia
KW  - lung
KW  - human
KW  - viral respiratory tract infection
KW  - infant
KW  - Influenza A virus (H1N1)
KW  - Influenza A virus (H7N7)
KW  - Influenza A virus (H9N2)
KW  - Influenza A virus (H10N8)
KW  - Influenza A virus (H7N3)
KW  - Influenza A virus (H3N2)
KW  - Influenza A virus (H1N2)
KW  - Influenza A virus (H7N2)
KW  - Influenza A virus (H10N7)
KW  - Influenza A virus (H7N1)
KW  - Influenza A virus (H5N2)
KW  - Influenza A virus (H3N8)
KW  - Influenza A virus (H2N2)
KW  - Influenza A virus (H5N1)
KW  - Influenza A virus (H5N3)
KW  - gene expression
KW  - exposure
KW  - adult
KW  - gene
KW  - hospital readmission
KW  - prematurity
KW  - risk
KW  - lung disease
KW  - myofibroblast
KW  - child
KW  - virus infection
KW  - intranasal drug administration
KW  - cytokine production
KW  - disease course
KW  - immunocompetent cell
KW  - airway
KW  - assay
KW  - Influenza A virus
KW  - messenger RNA
KW  - interferon
KW  - polyinosinic polycytidylic acid
KW  - oxygen
KW  - double stranded RNA
KW  - cytokine
KW  - protein
KW  - interleukin 25
KW  - interleukin 4
KW  - interleukin 10
KW  - interleukin 12
KW  - toll like receptor 3
KW  - thymic stromal lymphopoietin
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.B. Hershenson, University of Michigan, Ann Arbor, MI, United States. E-mail: mhershen@umich.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2317
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72044748
AB  - Rationale: Bronchopulmonary dysplasia (BPD) is a chronic fibrotic pulmonary disease of premature infants that is characterized by hypoalveolarization, interstitial thickening with myofibroblasts and a requirement for supplemental oxygen for months or years. Infants who develop BPD often have elevated levels of inflammatory mediators in their airway both at birth and during the later stages of disease progression. Children born prematurely have an increased incidence of respiratory viral infection and risk of rehospitalization in the first year of life. Neonatal hyperoxia has been shown to enhance the inflammatory response in adult mice infected with Influenza A virus. Polyinosinic-polycytidylic acid (poly(I:C)) is a synthetic analog of double-stranded RNA (dsRNA), a molecular pattern associated with respiratory viral infection. Poly(I:C) is recognized by Toll-Like receptor (TLR)-3, engagement of which leads to the expression of cytokines, interferons and interferon-stimulated genes. We hypothesized that poly(I:C) treatment, mimicking a viral infection, would induce sustained proinflammatory responses in hyperoxia-exposed neonatal mice. Method(s): Two to three day-old mice were exposed to air or 75% oxygen for 14 days, as a mouse model of BPD. On day 14, hyperoxic exposure was discontinued and the mice were treated with intranasal poly(I:C) or PBS. The mice were harvested 5 days after poly(I:C) treatment to assess their subacute response. Whole lung gene expression was analyzed by qPCR and multiplex assay. Result(s): Compared to poly(I:C)-treated, normoxia-exposed mice, poly(I:C) treatment of hyperoxia-exposed neonatal mice increased lung mRNA expression of IFNgamma, TNFalpha, MCP-1, IL-12, KC, MIP-1alpha, MIP-1beta and IL-10. No difference in lung mRNA expression of IL-4, IL-13, IL-25 or TSLP was observed. There were no significant differences in the mRNA expression in PBS-treated mice. Whole lung TNFalpha, MCP-1, KC, MIP-1alpha, MIP-1beta protein levels were also increased by poly(I:C) treatment in hyperoxia- but not normoxia-exposed neonatal mice. Conclusion(s): Our findings demonstrate that compared to normoxia-exposed neonatal mice, neonatal mice exposed to prolonged moderate hyperoxia and subsequently treated with poly(I:C) show sustained type 1 inflammatory responses. Future studies will examine the innate immune cells responsible for type 1 cytokine production.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72044746
TI  - Angiotensin II type 2 receptor antagonist PD123319 attenuates hyperoxia-induced lung and heart injury at low doses in Newborn rats
AU  - Wagenaar G.T.M.
AU  - Sengers R.M.A.
AU  - Laghmani E.
AU  - Lindeboom M.H.A.
AU  - Walther F.J.
Y1  - 2014//
KW  - *hyperoxia
KW  - *lung
KW  - *heart injury
KW  - *low drug dose
KW  - *newborn
KW  - *rat
KW  - *American
KW  - *society
KW  - model
KW  - human
KW  - prematurity
KW  - infant
KW  - thickness
KW  - pneumonia
KW  - fibrin deposition
KW  - agonist
KW  - injury
KW  - macrophage
KW  - inflammatory cell
KW  - lung alveolus wall
KW  - inflammation
KW  - gene
KW  - chronic lung disease
KW  - lung dysplasia
KW  - heart
KW  - exposure
KW  - rat model
KW  - ambient air
KW  - parameters
KW  - histopathology
KW  - renin angiotensin aldosterone system
KW  - adult
KW  - morbidity
KW  - heart right ventricle hypertrophy
KW  - mortality
KW  - respiratory failure
KW  - hypertension
KW  - newborn period
KW  - arteriole
KW  - neutrophil
KW  - *angiotensin 2 receptor antagonist
KW  - *1 (4 dimethylamino 3 methylbenzyl) 5 diphenylacetyl 4,5,6,7 tetrahydro 1h imidazo[4,5 c]pyridine 6 carboxylic acid
KW  - angiotensin 2 receptor
KW  - messenger RNA
KW  - oxygen
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - G.T.M. Wagenaar, Leiden University Medical Center, Leiden, Netherlands. E-mail: g.t.m.wagenaar@lumc.nl
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2315
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72044746
AB  - RATIONALE. Intervening in angiotensin (Ang) II type 2 receptor (AT2) signaling may have therapeutic potential for bronchopulmonary dysplasia (BPD), a chronic lung disease in preterm infants, by attenuating lung inflammation and preventing arterial hypertension (PAH)-induced right ventricular hypertrophy (RVH). The newborn rat is an excellent model to study AT2-dependent signaling in cardiopulmonary disease because of the 100-fold higher level of expression of AT2 in neonatal lung compared to adults. METHODS. To advance our knowledge on AT2 receptor signaling in neonatal cardiopulmonary disease, we first investigated the effect of AT2 inhibition with PD123319 (0.5 and 2 mg/kg/day) on the beneficial effect of the AT2 agonist LP2-3 (5 mug/kg twice a day) on RVH in newborn rats exposed to 100% oxygen during the first 10 days after birth. Next, we determined the cardiopulmonary effects of daily treatment with the AT2 antagonist PD123319 (0.1 mg/kg/day) in 2 newborn rat models: early treatment during continuous exposure to hyperoxia for 10 days and late treatment starting on day 6 in rat pups exposed postnatally to hyperoxia for 9 days, followed by a 9 day recovery period in room air. Parameters investigated included lung and heart histopathology, fibrin deposition, vascular leakage and differential mRNA expression in the lungs of key genes involved in the renin-angiotensin system, inflammation, coagulation and alveolar development. RESULTS. Ten days of co-administration of LP2-3 and PD123319 (0.5 and 2 mg/kg/day) abolished the beneficial effects of LP2-3 on RVH in experimental BPD. Treatment with a low dose of PD123319 (0.1 mg/kg/day) in the early treatment model attenuated cardiopulmonary injury by reducing alveolar septum thickness, pulmonary influx of inflammatory cells, including macrophages and neutrophils, medial wall thickness of small arterioles, and preventing RVH. In the late treatment model PD123319 diminished PAH and RVH, demonstrating that RVH is reversible in the neonatal period. PD123319 did not reduce alveolar enlargement, fibrin deposition and vascular alveolar leakage. CONCLUSION. High concentrations of the AT2 antagonist PD123319 block the beneficial effects of the AT2-agonist LP2-3 on RVH. Low concentrations of PD123319 attenuate cardiopulmonary injury by reducing pulmonary inflammation and preventing PAH-induced RVH, but do not affect alveolar and vascular development in newborn rats with experimental BPD. Extrapolation of these findings to preterm infants with respiratory failure, suggests a potential beneficial effect of LP2-3 and PD123319 on PAH and RVH, which are the major causes of mortality and severe morbidity in preterm infants with severe BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72044745
TI  - Single nucleotide polymorphisms of matrix metalloproteinase proteinase-9 gene are associated with bronchopulmonary dysplasia in extremely low birth weight infants
AU  - Paudel U.
AU  - Telliard J.
AU  - Patel N.
AU  - Parton L.A.
AU  - Chhabra D.
AU  - Calo J.M.
Y1  - 2014//
KW  - *single nucleotide polymorphism
KW  - *gene
KW  - *lung dysplasia
KW  - *extremely low birth weight
KW  - *American
KW  - *society
KW  - human
KW  - genotype
KW  - infant
KW  - gestational age
KW  - birth weight
KW  - prematurity
KW  - tracheal aspiration procedure
KW  - chronic obstructive lung disease
KW  - child
KW  - asthma
KW  - pilot study
KW  - allele
KW  - statistical significance
KW  - Student t test
KW  - adult
KW  - connective tissue
KW  - chi square test
KW  - protein degradation
KW  - real time polymerase chain reaction
KW  - chromosome aberration
KW  - extracellular matrix
KW  - cohort analysis
KW  - maturation
KW  - lung development
KW  - newborn
KW  - risk
KW  - lung parenchyma
KW  - hypothesis
KW  - analysis of variance
KW  - enzyme linked immunosorbent assay
KW  - *matrix metalloproteinase
KW  - *proteinase
KW  - gelatinase B
KW  - DNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - U. Paudel, Westchester Medical Center, Valhalla, NY, United States. E-mail: upaudel@yahoo.com
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2314
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72044745
AB  - Background: BPD appears to result from arrested lung development and is characterized by abnormal alveolar septation and abnormal microvascular maturation. Alveolarization requires coordinated extracellular matrix remodeling, a process in which matrix metalloproteinases (MMPs) play an important role. Matrix metalloproteinase 9 (MMP-9) has proteolytic activity against connective tissue and its polymorphism (C-1562T, Q279R) play an important role in the development of chronic obstructive pulmonary disease (COPD) in adults and asthma in children. We therefore considered the polymorphisms of MMP-9 rs3918242 and rs17576 as the candidate genes in the susceptibility to BPD. Objective(s): We tested the hypothesis that rs3918242 and rs17576 are associated with susceptibility to BPD in ELBW infants. Method(s): This is an ongoing cohort study that enrolls infants weighing <1 kg at birth, without congenital or chromosomal anomalies. BPD is defined as need for O2 at 36 weeks post-menstrual age. DNA was isolated from buccal mucosal swabs (N=110) and subjected to allelic discrimination using Taqman probes for MMP 9 SNP C-1562T (rs3918242) and Q279R (rs17576) during real-time PCR. Tracheal aspirates were collected (N=21) and MMP 9 levels measured by ELISA. ANOVA, Chi square analyses and t-test for independent samples were performed with P<0.05 denoting statistical significance. Results Birth weights and gestational ages were significantly smaller in the BPD group. Association analysis carried out using PLINK showed that SNPs were associated with BPD after adjusting for gestational age (p=0.006) and birth weight (p=0.007). Genotype distributions for both MMP 9 SNPs tested were significantly high for BPD (P=0.04). MMP-9 expression in tracheal aspirate (in figures) was significantly higher among tt genotype and rr genotypes. Conclusion(s): In this pilot study, ELBW preterm infants who progressed to BPD were more likely to contain the minor allele for the MMP-9 rs3918242 and rs17475. We speculate that the increased expression of MMP-9 proteolytic enzyme in lung parenchyma increases the risk of BPD in preterm neonates. (Table Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72044464
TI  - Late gestational lung 1(LGL1/CRISPLD2) modulates proliferation, apoptosis and migration of human fetal lung fibroblasts
AU  - Zhang H.
AU  - Sweezey N.B.
AU  - Kaplan F.
Y1  - 2014//
KW  - *human
KW  - *apoptosis
KW  - *American
KW  - *fetus lung
KW  - *lung fibroblast
KW  - *society
KW  - *lung
KW  - cell proliferation
KW  - rat
KW  - mouse
KW  - lung development
KW  - gene
KW  - lung parenchyma
KW  - tissue section
KW  - lung dysplasia
KW  - mucus
KW  - staining
KW  - knockout mouse
KW  - lung alveolus epithelium cell
KW  - wound healing impairment
KW  - cell hyperplasia
KW  - patient
KW  - rat model
KW  - wound healing
KW  - cell migration
KW  - oxygen toxicity
KW  - immunofluorescence
KW  - epithelium cell
KW  - infant
KW  - prematurity
KW  - adult
KW  - fibroblast
KW  - lung alveolus cell
KW  - model
KW  - phosphorylation
KW  - lung disease
KW  - therapy
KW  - gas exchange
KW  - elastin
KW  - lipocortin 5
KW  - protein
KW  - doxycycline
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - H. Zhang, Research Institute, McGill University, Health Centre, Montreal, QC, Canada. E-mail: hui.zhang3@mail.mcgill.ca
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2032
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72044464
AB  - RATIONALE: Rapid growth and formation of new gas exchange units (alveogenesis) are hallmarks of the perinatal lung. Bronchopulmonary dysplasia (BPD), common in very premature infants, is characterized by premature arrest of alveogenesis. Increasing evidence has suggested that disrupted temporal or spatial levels of the mesenchymal protein late gestational lung 1 (LGL1/CRISPLD2) impairs alveogenesis. Dramatically reduced Lgl1 levels in oxygen toxicity rat models of BPD normalized with recovery. Absence of Lgl1 in knockout mice was embryonic lethal. Heterozygous Lgl1+/- mice exhibited features resembling human BPD, including distal airspace enlargement, disruption of elastin, and mucus cell hyperplasia. Secreted Lgl1 concentrated at the tips of budding alveoli. Yet, the mechanism of LGL1 action in lung development and neonatal lung disease remain incompletely understood. METHOD(S): To elucidate the mechanism of LGL1 function we developed a doxycycline (DOX) inducible RNA-mediated LGL1 knockdown model in human fetal lung fibroblasts (MRC5LGL1KD). We used over and under expression of LGL1 in both human fetal lung fibroblasts and adult lung epithelial cells to evaluate the role of LGL1 in cell proliferation, apoptosis, cell migration and wound healing. We used immunofluorescence to investigate LGL1 expression in lung tissue sections from human BPD patients and control. RESULT(S): DOX induction of MRC5LGL1KD suppressed cell proliferation and increased apoptosis of annexin V+ staining cells and caspase3/7 activity. Secreted LGL1 increased migration of post-natal rat primary lung cells and human alveolar epithelial cells. Impaired wound healing of MRC5LGL1KD cells was attenuated by addition of LGL1-enriched medium. Suppression of LGL1 was associated with dysregulation of ECM genes (upregulated TGFbeta, downregulated MMP1, ColXValpha1, ELASTIN) and proapoptosis genes (upregulated BAD, BAK, CASP2, TNFRSF1B and inhibition of 44/42MAPK phosphorylation). Lung tissue sections from human BPD had reduced LGL1 levels. CONCLUSION(S): Our findings define a role for LGL1 in fibroblast expansion and migration, epithelial migration and mesenchymal-epithelial signaling, key processes in fetal lung development. Our combined results point to the potential of LGL1 as a mediator of BPD therapy.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72043327
TI  - Genetic determinants of oxidant-induced nuclear and mitochondrial DNA lesions in a neonatal inbred mouse model of acute lung injury
AU  - Verhein K.C.
AU  - Nichols J.L.
AU  - Panduri V.
AU  - Gladwell W.
AU  - Marzec J.
AU  - McCaw Z.
AU  - Reeves N.
AU  - Malphurs J.
AU  - Solomon G.
AU  - Wiltshire T.
AU  - Burkholder A.
AU  - Fargo D.
AU  - Bell D.
AU  - Van Houten B.
AU  - Kleeberger S.R.
Y1  - 2014//
KW  - *mouse
KW  - *mouse model
KW  - *inbred mouse strain
KW  - *acute lung injury
KW  - *American
KW  - *society
KW  - gene
KW  - hyperoxia
KW  - DNA damage
KW  - ambient air
KW  - exposure
KW  - phenotype
KW  - lung
KW  - lung injury
KW  - infant
KW  - chromosome
KW  - lung development
KW  - lung dysplasia
KW  - oxidative stress
KW  - adverse drug reaction
KW  - blood vessel injury
KW  - lung disease
KW  - inflammatory cell
KW  - assisted ventilation
KW  - pathogenesis
KW  - human
KW  - genome
KW  - prematurity
KW  - inbred strain
KW  - injury
KW  - genetics
KW  - histopathology
KW  - lung homogenate
KW  - genetic polymorphism
KW  - mitochondrion
KW  - DNA replication
KW  - haplotype
KW  - *oxidizing agent
KW  - *mitochondrial DNA
KW  - *DNA
KW  - oxygen
KW  - cell nucleus DNA
KW  - reactive oxygen metabolite
KW  - ribosome protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - K.C. Verhein, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States. E-mail: verheinkc@niehs.nih.gov
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3816
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72043327
AB  - Background: Reactive oxygen species contribute to the pathogenesis of many acute and chronic pulmonary disorders, including bronchopulmonary dysplasia (BPD), a respiratory condition affecting preterm infants. In BPD, treatment often involves respiratory support with high oxygen, and oxidative stress is an adverse effect that is associated with vascular damage and impaired lung development and function in a subset of infants. Genetic polymorphisms in a few candidate genes have been associated with BPD susceptibility, however the genetic basis of differential susceptibility remains poorly understood. Understanding the role of genetics is critical to improving treatment strategies and reducing oxidant injury in developing lungs. The objective of this investigation was to utilize genome-wide association (GWA) mapping of quantitative phenotypes to identify genes important to susceptibility to neonatal hyperoxic lung injury. Method(s): One day after birth, neonatal mice from 29 inbred strains were exposed for 72 hr to room air (20% oxygen) or >95% clinical grade oxygen (hyperoxia). Hyperoxia induced phenotypes (including inflammatory cells and histopathology) that are similar to BPD when compared to normal postnatal lung development in ambient air. We also measured hyperoxia-induced lesions in nuclear and mitochondrial DNA, and mitochondrial copy number from lung homogenates. Results/Conclusions: Significant inter-strain variation was found for all three DNA damage phenotypes after room air and hyperoxia exposure. GWA mapping identified significant QTLs on chromosomes 6, 8, 12, and 18 for DNA lesions and mitochondrial copy number after room air exposure. QTLs on chromosomes 1, 2, 8, 18, and X were found for DNA lesions induced by hyperoxia. Gene candidates include genes involved in DNA replication and repair or mitochondria function: polymerase (DNA directed), beta and iota (Polb, Poli), mitochondrial ribosomal protein S31 (Mrps31). Ingenuity pathway analyses of gene candidates identified gene networks and gene candidates for mitochondrial and nuclear DNA damage. We have also performed ultra-deep sequencing of lung mitochondrial DNA from these mice to provide additional genetic insight to susceptibility to oxidant-induced DNA lesions, and to generate a SNP map for haplotype association mapping. We conclude that exposure to low (20%) and high (>95%) concentrations of oxygen early in life cause lesions in mouse lung mitochondrial and nuclear DNA that are strain dependent. Through these combined approaches, we have identified novel candidate susceptibility genes that may improve our understanding of neonatal lung injury and development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72042925
TI  - Effect of altered TNF-a signaling on early pulmonary changes in newborn mice undergoing mechanical ventilation
AU  - Gimm T.
AU  - Kossert M.
AU  - Alvira C.M.
AU  - Koschlig M.
AU  - Hilgendorff A.
AU  - Ehrhardt H.
Y1  - 2014//
KW  - *artificial ventilation
KW  - *American
KW  - *society
KW  - *mouse
KW  - lung
KW  - apoptosis
KW  - pneumonia
KW  - in vitro study
KW  - wild type mouse
KW  - inflammation
KW  - lung dysplasia
KW  - infant
KW  - prematurity
KW  - chronic lung disease
KW  - lung lavage
KW  - monocyte
KW  - air conditioning
KW  - gas
KW  - myofibroblast
KW  - protein analysis
KW  - wild type
KW  - mouse model
KW  - newborn
KW  - human
KW  - exposure
KW  - cytokine
KW  - chemokine
KW  - tumor necrosis factor
KW  - interleukin 1
KW  - oxygen
KW  - messenger RNA
KW  - monocyte chemotactic protein 1
KW  - caspase 3
KW  - factor A
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - T. Gimm, Comprehensive Pneumology Center (CPC), Munich, Germany
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3407
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72042925
AB  - Rationale: Chronic lung disease in the premature infant, also known as bronchopulmonary dysplasia (BPD), is characterized by impaired alveolar and vascular development preceded by an increase in lung inflammation and apoptosis. The disease mainly occurs after mechanical ventilation with oxygen rich gas (MV-O2). Here, the pro-inflammatory mediator tumor necrosis factor (TNF)-a has been found to be increased in the lung lavage from preterms that later develope BPD. We thus hypothesized, that the absence of TNF-a would significantly reduce the pulmonary inflammatory response following MV-O2 and thus ameliorate apoptosis and histologic changes induced by ventilation in the developing lung in a mouse model of the disease. Objective and Methods: 5-6 days old TNF-a knock-out (TNF-a-/-) and wild type (WT, TNF-a+/+) mice received MV with 40%O2 at 180 breaths/min; controls spontaneously breathed 40%O2. After 8h, lungs (n=10-12/group) were harvested for histologic, mRNA and protein analysis. To further confirm obtained effects in vitro, primary pulmonary myofibroblasts (MFB), critically involved in alveolar septation, were isolated from unventilated newborn TNF-a-/- and WT mice and subjected to mechanical stretch (Flexcell) as well as cytokine exposure. Result(s): Contrary to our expectations, pulmonary chemokine (MCP-1, CXCL-1) and cytokine (IL-1b) expression was significantly elevated in ventilated TNF-a-/- as compared to WT mice accompanied by an increased influx of monocytes into the ventilated lung. Furthermore, apoptosis (TUNEL, caspase 3, 8 and 9) was significantly increased in the lungs of mechanically ventilated TNF-a-/- mice. These differences potentially resulted from a significant increase in pulmonary TGF-b signaling in TNF-a-/- mice following MV-O2 . These results were confirmed in vitro by an elevated apoptotic response to TGF-beta in pulmonary MFB from TNF-a-/- mice in contrast to WT pups. Histological changes were similar in both groups. Conclusion(s): These results point towards a critical balance of pulmonary TNF-a and TGF-b signaling and underline the importance of both pathways in the induction of early changes in the developing lung undergoing MV-O2, i.e. pulmonary inflammation and consecutive apoptosis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Effects of intermittent hypoxia and hyperoxia on angiogenesis and lung development in newborn mice.
DO  - https://dx.doi.org/10.3233/NPM-15814134
AU  - Elberson, V D
AU  - Nielsen, L C
AU  - Wang, H
AU  - Kumar, H S V
Y1  - 2015//
KW  - Angiopoietin-1/ge [Genetics]
KW  - Animals
KW  - Aryl Hydrocarbon Receptor Nuclear Translocator/ge [Genetics]
KW  - Basic Helix-Loop-Helix Transcription Factors/ge [Genetics]
KW  - Cell Proliferation
KW  - Down-Regulation
KW  - *Gene Expression
KW  - Hyperoxia/co [Complications]
KW  - *Hyperoxia/pp [Physiopathology]
KW  - Hypoxia/co [Complications]
KW  - *Hypoxia/pp [Physiopathology]
KW  - Hypoxia-Inducible Factor 1, alpha Subunit/an [Analysis]
KW  - Hypoxia-Inducible Factor 1, alpha Subunit/ge [Genetics]
KW  - Hypoxia-Inducible Factor-Proline Dioxygenases/an [Analysis]
KW  - Hypoxia-Inducible Factor-Proline Dioxygenases/ge [Genetics]
KW  - Ki-67 Antigen/an [Analysis]
KW  - Lung/ch [Chemistry]
KW  - *Lung/gd [Growth & Development]
KW  - Lung/pa [Pathology]
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - *Neovascularization, Physiologic/ge [Genetics]
KW  - *RNA, Messenger/an [Analysis]
KW  - Random Allocation
KW  - Receptor, TIE-2/ge [Genetics]
KW  - Vascular Endothelial Growth Factor A/an [Analysis]
KW  - Vascular Endothelial Growth Factor A/ge [Genetics]
KW  - Vascular Endothelial Growth Factor Receptor-1/ge [Genetics]
KW  - Vascular Endothelial Growth Factor Receptor-2/ge [Genetics]
T2  - Journal of neonatal-perinatal medicine
VL  - 8
IS  - 4
SN  - 1878-4429
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26836820
AD  - Netherlands
AB  - BACKGROUND: Premature birth disrupts hypoxia driven microvascular development that directs alveolar and lung growth. Changes in oxygen exposure after birth can perturb the regulation of angiogenesis leading to bronchopulmonary dysplasia (BPD). We studied the effects of intermittent hypoxia or hyperoxia on HIF and angiogenic gene expression and lung development in newborn mice., METHODS: Newborn litters were randomized within 12 h of birth to 12% O2 (4 h), 50% O2 (4 h) or 12% O2 (2 h)/50% O2 (2 h) followed by room air (RA) recovery for 20 h. Mice in RA were the control group. The mice were exposed to 6 such cycles (D1-D6) and sacrifice on D7. Whole lung mRNA was isolated and gene expression performed by qRT-PCR (HIF1alpha/2alpha/1beta; PHD2, Ang1, Tie2, Vegf, VegfR1 & VegfR2) and analyzed by PCR array data analysis web portal. HIF-1alpha, prolyl hydroxylase-2 and VEGF protein were analyzed in whole lung by ELISA. Lung morphology was assessed by H&E sections and radial alveolar counts; cell proliferation by Ki67 immunostaining., RESULTS: HIF-1alpha mRNA and VEGF protein were significantly downregulated in the 50% O2 group; VEGF mRNA and protein were significantly downregulated in the 12% O2-50% O2 group; Ang-1 and its receptor mRNA expression were downregulated in 12% O2 and 12% O2-50% O2 groups. 50% O2 (hyperoxia) and 12% O2-50% O2 (hypoxia-hyperoxia) groups demonstrated alveolar simplification by RAC and the same groups had decreased cell proliferation by Ki67 staining compared to RA and hypoxia (12% O2) groups., CONCLUSIONS: Downregulation of HIF and angiogenic gene expression with associated changes in lung histology following intermittent hypoxia-hyperoxia is likely an important contributing factor in the development of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72042196
TI  - Evaluation of lysyl oxidases as therapeutic targets in an experimental model of bronchopulmonary dysplasia
AU  - Mizikova I.
AU  - Madurga Hernandez A.
AU  - Seeger W.
AU  - Morty R.E.
Y1  - 2014//
KW  - *experimental model
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - mouse
KW  - protein expression
KW  - surface area
KW  - density
KW  - gene
KW  - human
KW  - upregulation
KW  - phenotype
KW  - lung structure
KW  - thickness
KW  - lung
KW  - survival
KW  - mortality
KW  - patient
KW  - total lung capacity
KW  - infant
KW  - drug megadose
KW  - prematurity
KW  - cross linking
KW  - artificial ventilation
KW  - computer program
KW  - mouse model
KW  - connective tissue
KW  - locomotion
KW  - newborn
KW  - diseases
KW  - metabolism
KW  - hyperoxia
KW  - lung development
KW  - extracellular matrix
KW  - *protein lysine 6 oxidase
KW  - 3 aminopropionitrile
KW  - messenger RNA
KW  - collagen
KW  - elastin
KW  - nonoxinol 9
KW  - enzyme
KW  - copper
KW  - oxygen
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 189
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - I. Mizikova, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany. E-mail: Ivana.Mizikova@mpi-bn.mpg.de
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A2668
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=72042196
AB  - INTRODUCTION: Bronchopulmonary dysplasia (BPD) is a consequence of prolonged mechanical ventilation of premature infants with supplemental oxygen. Evidence suggests that an impaired extracellular matrix (ECM) metabolism contributes to this disorder. Lysyl oxidases are copper-dependent enzymes catalizing the formation of covalent cross-linkages in elastin and collagen molecules. Activity of lysyl oxidases is dysregulated in BPD patients. beta-Aminopropionitrile (BAPN) is a specific inhibitor of lysyl oxidases. OBJECTIVE(S): To evaluate the changes in gene and protein expression and overall improvement of lung structure of hyperoxia-exposed animals upon BAPN treatment. METHOD(S): The newborn mouse model of BPD was used in this study. Newborn mice were exposed to normoxic (21% O2; NOX) or hyperoxic (85% O2; HXY) conditions and treated (1x daily; iintraperitoneal) with PBS or BAPN. Animals were sacrificed on day 9.5 after birth. Gene and protein expression levels, as well as the lung structure were investigated. Surface density, surface area, mean linear intercept (MLI) and total alveolar numbers were assessed by stereological evaluation using newCast visiopharm software. RESULT(S): 15 animals per group were investigated. High doses (150 mg/kg) of BAPN caused severe damage to connective tissues, locomotion problems and increased mortality (56% in NOX, resp. 61.2% in HYX) of newborn pups, demonstrating an importance of lysyl oxidase family in early development. A lower dose (15 mg/kg) was well tolerated and did not affect survival. No change in total lung volume was observed upon BAPN treatment in the HXY group (0.13 cm3 vs. 0.125 cm3). Gene and protein expression, and activity of members of lysyl oxidase family were dysregulated in injured developing mouse lungs [LOX: significant upregulation in mRNA expression (DELTACt) -0.80 vs. 0.58; p=0.002, LOXL4: significant upregulation -2.08 vs. -2.33; p=0.0008], contributing to a BPD-like phenotype. Surface density (60.78 mm-1 vs. 47.24 mm-11 ; p=0.0002), as well as surface area (86.39 cm2 vs. 53.03 cm2; p=0.033) were significantly decreased in the HYX group, while increases in MLI, septal thickness, as well as total airspace volume was observed. Surface density (47.24 mm-1 vs. 38.33 mm-1), surface area (53.03 cm2 vs. 53.71 cm2) and septal thickness were partially restored upon treatment (11.37 mum vs. 10.59 mum), while no marked changes were observed in MLI, total airspace volume or total alveolar number. CONCLUSION(S): Optimal regulation of lysyl oxidases is crutial during the period of late lung development. BAPN treatment has a potential to partially improve disease phenotype.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71881994
TI  - Biomarkers in the arginine metabolome predict pulmonary hypertension in patients with bronchopulmonary dysplasia
AU  - Trittmann J.K.
AU  - Zmuda E.J.
AU  - Gastier-Foster J.M.
AU  - Vieland V.J.
AU  - Klebanoff M.A.
AU  - Rogers L.K.
AU  - Vaynshtok P.M.
AU  - Peterson E.E.
AU  - Nelin L.D.
Y1  - 2014//
KW  - *metabolome
KW  - *pulmonary hypertension
KW  - *patient
KW  - *human
KW  - *lung dysplasia
KW  - *society
KW  - pH
KW  - blood level
KW  - gene
KW  - population
KW  - allele
KW  - single nucleotide polymorphism
KW  - data base
KW  - leukocyte
KW  - mortality
KW  - blood
KW  - morbidity
KW  - pediatrics
KW  - chronic lung disease
KW  - metabolite
KW  - prematurity
KW  - plasma
KW  - newborn
KW  - high performance liquid chromatography
KW  - pediatric hospital
KW  - *arginine
KW  - *nitric oxide
KW  - *biological marker
KW  - n(g),n(g) dimethylarginine
KW  - citrulline
KW  - ornithine
KW  - proline
KW  - urea
KW  - arginase
KW  - nitric oxide synthase
KW  - ornithine carbamoyltransferase
KW  - carbamoyl phosphate synthase
KW  - argininosuccinate synthase
KW  - DNA
T2  - Nitric Oxide - Biology and Chemistry
LA  - English
VL  - 42
PB  - Academic Press Inc.
SN  - 1089-8603
AD  - J.K. Trittmann, Pulmonary Hypertension Group, Center for Perinatal Research, Nationwide Children's Hospital, United States
DO  - https://dx.doi.org/10.1016/j.niox.2014.09.014
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71881994
AB  - Background: Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in pediatrics. Pulmonary hypertension (PH), a common complication of BPD is associated with significantly more morbidity and mortality. Currently, there are no tests for predicting which BPD patients will develop PH. Objective(s): To identify potential biomarkers for the development of PH in patients with BPD by examining single nucleotide polymorphisms (SNPs) in genes of the urea cycle/NOS as well as plasma levels of metabolites of the L-arginine/NO pathway and the endogenous inhibitor of NOS, asymmetric dimethylarginine (ADMA). Design/methods: Neonatal patients with BPD admitted to Nationwide Children's Hospital after September 1, 2009 were enrolled. DNA from140 patients was isolated from whole blood leukocytes and assayed for 17 SNPs in genes of the L-arginine/ NO pathway by Sequenom Mass ARRAY. Genes included carbamoyl-phosphate synthetase (CPS1), ornithine transcarbamylase (OTC), argininosuccinate synthase (ASS1), nitric oxide synthase (NOS2), and arginase (ARG1 and ARG2). SNPs were selected from the NCBI/SNP database for their putative functionality. Plasma levels of citrulline, arginine, ornithine, and proline, as well as ADMA were analyzed by HPLC in 118 patients. Result(s): Of the 140 patients with BPD, 35 (26%) had echocardiographic evidence of PH. Of the 17 SNPs examined, rs2781666 in ARG1 was less common in cases (MAF = 0.23) than controls (MAF = 0.37, p = 0.04). The odds of PH were decreased by 43% (p = 0.047) for each copy of the ARG1 SNP minor allele in patients with BPD. We found no difference in plasma levels of citrulline, arginine, ornithine, or proline between cases and controls. Cases of BPD and PH had higher levels of ADMA (5.0 +/- 4.0 vs. 2.2 +/- 2.8, p = 0.04) and a lower arginine-to-ADMA ratio (131 +/- 152 vs. 330 +/- 562, p = 0.03) than did controls with BPD alone. Conclusion(s): In this neonatal population with BPD, we found that the ARG1 SNP rs2781666 may be protective against the development of PH in preterm neonates with BPD and that plasma ADMA levels are elevated in patients with BPD and PH. These findings suggest that the arginine metabolome may be an important therapeutic target in preventing the development of PH in patients with BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71851177
TI  - A novel association between YKL-40, a marker for structural lung disease, and short telomere length in 10-year old children with BPD
AU  - Henckel E.
AU  - James A.
AU  - Konradsson J.
AU  - Nordlund B.
AU  - Ebersjo C.
AU  - Brostrom E.B.
AU  - Hedlin G.
AU  - Bohlin K.
Y1  - 2014//
KW  - *lung disease
KW  - *telomere
KW  - *child
KW  - *human
KW  - *European
KW  - *society
KW  - lung function
KW  - spirometry
KW  - oxidative stress
KW  - serum
KW  - lung dysplasia
KW  - cohort analysis
KW  - school
KW  - vascular smooth muscle
KW  - gestational age
KW  - airway remodeling
KW  - blood
KW  - morbidity
KW  - asthma
KW  - real time polymerase chain reaction
KW  - blood level
KW  - fibrosis
KW  - lung
KW  - enzyme linked immunosorbent assay
KW  - *marker
KW  - biological marker
KW  - protein
KW  - chitinase
T2  - European Respiratory Journal
LA  - English
VL  - 44
IS  - SUPPL. 58
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - E. Henckel, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
UR  - http://erj.ersjournals.com/content/44/Suppl_58/P3304.abstract?sid=8f566382-4ea2-4684-bb67-a053541d349b
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71851177
AB  - Background There is a lack of reliable biomarkers to predict future lung morbidity following bronchopulmonary dysplasia (BPD). Relative telomere length (RTL) is a biomarker for oxidative stress and the chitinase-like protein YKL-40 is a novel biomarker associated with airway remodeling and vascular smooth muscle proliferation, all of which may contribute to impaired lung function following BPD Aim To investigate the relationship between RTL, YKL-40 and lung function in school age children with a history of BPD Methods A cohort study of 10 year old children born preterm with BPD (n=29, mean gestational age 27 weeks) and control children (CON) born at term (n=28) with a history of asthma. All children performed lung function testing (dynamic and static spirometry). RTL was determined in whole blood by real-time PCR. Serum levels of YKL-40 was analyzed by ELISA Results Serum YKL-40 was higher in BPD compared to CON, p=0.002. RTL was similar between groups, but in children with BPD there was a correlation between shorter RTL and higher levels of serum YKL-40 (r=0,47, p=0,01). Dynamic spirometry showed significantly lower values in BPD children, but lung function did not correlate to YKL-40 or RTL Conclusions Short telomeres correlated to higher levels of YKL-40 suggesting a more severe structural lung disease may be associated with genetic alterations in children growing up with BPD. High levels of YKL-40 suggests an involvement of fibrosis in BPD and the correlation to RTL indicate that oxidative stress may play a part. This study indicate that YKL-40 and telomere length could be future biomarkers to predict the long-term consequences of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71809584
TI  - Genetic risk factors for oxidative stress-associated complications in preterm infants
AU  - Giusti B.
AU  - Poggi C.
AU  - Sereni A.
AU  - Romagnuolo I.
AU  - Kura A.
AU  - Gozzini E.
AU  - Pasquini E.
AU  - Abbate R.
AU  - Dani C.
Y1  - 2014//
KW  - *genetic risk
KW  - *risk factor
KW  - *oxidative stress
KW  - *prematurity
KW  - *infant
KW  - *human
KW  - *society
KW  - *hemostasis
KW  - *thrombosis
KW  - haplotype
KW  - respiratory distress syndrome
KW  - population
KW  - risk
KW  - retrolental fibroplasia
KW  - brain hemorrhage
KW  - lung dysplasia
KW  - gestational age
KW  - newborn
KW  - premature labor
KW  - gene frequency
KW  - DNA polymorphism
KW  - retrospective study
KW  - genotype
KW  - renin angiotensin aldosterone system
KW  - marker
KW  - heme oxygenase 1
T2  - Thrombosis Research
LA  - English
VL  - 134
IS  - SUPPL. 2
PB  - Elsevier Ltd
SN  - 0049-3848
AD  - B. Giusti, Dept. of Experimental and Clinical Medicine, University of Firenze, Atherothrombotic Diseases Centre, AOU-Careggi, Firenze, Italy
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71809584
AB  - There is increasing evidence that some gene polymorphisms are implicated in the development of severe complications of preterm birth, including respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and retinopathy of prematurity (ROP). In this study, we aimed to identify whether specific polymorphisms in VEGFA, eNOS, renin-angiotensin system (AGT, AGTR1, ACE), and heme oxygenase-1 (HMOX1) were associated with the development of RDS, BPD, IVH, and ROP in 342 preterm infants. We carried out a retrospective study to evaluate allele frequency and genotype distribution of VEGFA, eNOS, AGT, AGTR1, ACE, and HMOX1 polymorphisms in a population of preterm neonates with a gestational age <=28 weeks according to the presence or absence of RDS, BPD, IVH, and ROP. Moreover, we evaluated through the haplotype reconstruction analysis whether combinations of the selected polymorphisms are related to RDS, BPD, IVH and ROP. We found that TC+CC rs2070744 eNOS (41.7 vs. 25.4%, p=0.01) and GT+TT rs1799983 eNOS (51.8 vs. 35.2%, p=0.01) polymorphisms are independent risk factor for BPD. Haplotypes reconstruction showed that haplotypes in VEGFA and eNOS are significantly associated with different effect on RDS, BPD, IVH, and ROP in our population. In conclusion, we found that TC+CC rs2070744 eNOS and GT+TT rs1799983 eNOS polymorphisms are per se independent predictors of an increased risk of developing BPD. Haplotypes of VEGFA and eNOS may be independent protecting or risk markers for prematurity complications.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71746405
TI  - Neonatal physiological correlates of early brain development on MRI and DTI in very-low-birthweight preterm infants
AU  - Rose J.
AU  - Vassar R.
AU  - Cahill-Rowley K.
AU  - Stecher Guzman X.
AU  - Hintz S.
AU  - Stevenson D.K.
AU  - Barnea-Goraly N.
Y1  - 2014//
KW  - *very low birth weight
KW  - *prematurity
KW  - *brain development
KW  - *infant
KW  - *human
KW  - *American
KW  - *cerebral palsy
KW  - *nuclear magnetic resonance imaging
KW  - brain
KW  - risk factor
KW  - thalamus
KW  - serum
KW  - child
KW  - male
KW  - white matter
KW  - hospitalization
KW  - female
KW  - nerve cell differentiation
KW  - necrotizing enterocolitis
KW  - cohort analysis
KW  - lung dysplasia
KW  - sepsis
KW  - fractional anisotropy
KW  - glucose blood level
KW  - diffusion tensor imaging
KW  - globus pallidus
KW  - capsula interna
KW  - etiology
KW  - brain region
KW  - limb
KW  - phototherapy
KW  - newborn
KW  - corpus callosum
KW  - health care quality
KW  - pediatric hospital
KW  - bilirubin
KW  - C reactive protein
KW  - albumin
KW  - thyrotropin
KW  - serum albumin
T2  - Developmental Medicine and Child Neurology
LA  - English
VL  - 56
IS  - SUPPL. 5
PB  - Blackwell Publishing Ltd
SN  - 0012-1622
AD  - J. Rose, Department of Orthopedic Surgery, Stanford University, School of Medicine, Stanford, CA, United States
DO  - https://dx.doi.org/10.1111/dmcn.12540
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71746405
AB  - Background/Objectives: Structural brain abnormalities at nearterm age have been recognized as potential predictors of neurodevelopment in children born preterm. The aim of this study was to examine the relationship between early brain development and physiological risk factors in very-low-birthweight (VLBW) preterm infants at near-term age, based on structural brain MRI and semi-automated, atlas-based diffusion tensor imaging (DTI) analysis. Design(s): This ongoing prospective cohort study examines relations between neonatal physiological risk factors and white matter (WM) microstructure on DTI at near-term age. Participants and Setting: A cross-sectional sample of 102 VLBW preterm infants (BW<=1500g, GA<=32wks) were admitted to the Lucile Packard Children's Hospital NICU and recruited to participate prior to standard-of-care MRI conducted at 36.6 (1.8) weeks postmenstrual age from 2010 to 2011; 66/102 also received DTI. Method(s): Brain abnormalities were assessed on structural MRI, and WM microstructure was analyzed in six subcortical regions defined by DiffeoMap neonatal brain atlas. Regions of interest included the genu and splenium of the corpus callosum, anterior and posterior limbs of the internal capsule, the thalamus, and the globus pallidus, using a threshold value of fractional anisotropy (FA)>0.15 to select WM. Regional FA and mean diffusivity (MD) were calculated and examined in relation to early physiological risk factors including: bronchopulmonary dysplasia (BPD), sepsis, necrotizing enterocolitis (NEC) and level of thyroid stimulating hormone (TSH) during the hospital stay, as well as serum glucose, albumin, total bilirubin, and C-reactive protein (CRP) levels during the first two weeks of life. Result(s): Of 38/102 infants had brain abnormalities observed on MRI. These infants had significantly higher mean serum CRP levels (0.64 vs 0.34 mg/dl, p=0.008) and peak CRP levels (1.57 vs 0.67mg/dl, p=0.006) compared to those with no observed brain abnormalities. Number of signal abnormalities observed on MRI correlated to serum CRP levels (r=0.302, p=0.003). Mean genu MD was higher in males than females (p=0.004). Higher thalamus MD on the left and right, respectively, was associated with lower GA-at-birth (r=-0.322, p=0.009; r=-0.381, p=0.002), lower BW (r=-0.287, p=0.021; r=-281, p=0.024). Higher thalamus MD on the left and right was also associated with lower mean serum albumin (r=-0.276 p=0.029; r=--0.385, p=0.002) and with lower total bilirubin (r=-0.293, p=0.020; r=-0.337 p=0.007). Conclusion(s): At near-term age, the thalamus WM microstructure may be particularly vulnerable to neonatal risk factors. Interactions between albumin, bilirubin, phototherapy, and brain development warrant further investigation. Identification of physiological risk factors associated with selective vulnerability of certain brain regions at near-term age may clarify the etiology of neurodevelopmental impairment and inform neuroprotective treatment for neonates.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71745953
TI  - Early losartan treatment prevents the developmental programming of cardiac dysfunction caused by neonatal high oxygen exposure in rats
AU  - Bertagnolli M.
AU  - Beland-Bonenfant S.
AU  - Dios A.
AU  - Dartora D.R.
AU  - Lukaszewski M.-A.
AU  - Cloutier A.
AU  - Sutherland M.
AU  - DeBlois D.
AU  - Paradis P.
AU  - Schiffrin E.L.
AU  - Nuyt A.M.
Y1  - 2014//
KW  - *exposure
KW  - *rat
KW  - *medical society
KW  - *hypertension
KW  - human
KW  - oxidative stress
KW  - implantable cardiac monitor
KW  - newborn
KW  - short course therapy
KW  - prematurity
KW  - hypertrophy
KW  - adult
KW  - renin angiotensin aldosterone system
KW  - male
KW  - weight
KW  - female
KW  - heart ventricle hypertrophy
KW  - infant
KW  - lung dysplasia
KW  - echocardiography
KW  - feeding
KW  - ambient air
KW  - mother
KW  - model
KW  - retinopathy
KW  - heart
KW  - oncogene ras
KW  - *losartan
KW  - *oxygen
KW  - receptor
KW  - water
T2  - Hypertension
LA  - English
VL  - 64
IS  - SUPPL. 1
SP  -
PB  - Lippincott Williams and Wilkins
SN  - 0194-911X
AD  - M. Bertagnolli, CHU Sainte-Justine, Montreal, Canada
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71745953
AB  - Neonatal oxidative stress is a major postnatal deleterious factor predisposing preterm born infants to classical complications of prematurity (retinopathy, bronchopulmonary dysplasia) which are characterized by impaired vascular development. Our group has previously shown that rats transiently exposed to high O2 as newborns (mimicking human preterms oxidative stress conditions) develop high blood pressure (BP), cardiac remodeling and dysfunction later in life, in part mediated by the renin angiotensin system (RAS). Cardiac RAS activation is characterized by AT1/AT2 receptors imbalance, with increased AT1R at adult age. In order to study the role of RAS at early stages of the developmental programming of cardiac dysfunction caused by high O2 exposure, we assessed whether an early and short-term treatment with AT1R blocker Losartan, prevents cardiac alterations at young male 4 wks-old rats (prior to the elevation of BP in this model). Sprague-Dawley newborns rats were kept with their mother in 80% O2 (O2 group, n=9) or room air (Ctrl, n=9) from days 3-10 of life (P3-P10). Losartan (LOS, n=10, 20 mg/Kg) or water was administered by gavage in O2 rats from P8-P10 (last 2 days of O2 to avoid impact on nephrogenesis). At 4 wks, echocardiography reveals that O2 rats have decreased fraction of shortening compared to Ctrl (FS: 37+/-2 vs 42+/-2 %), suggesting impaired systolic function in O2. Cardiac hypertrophy evaluated by heart/body weight and cardiomyocyte surface area (CSA) is also increased in O2 vs Ctrl (141+/-13 vs 118+/-4 [mu]m2). LOS treatment prevented the impairment of systolic function in O2 by ameliorating FS (43+/-2 %) and reducing CSA (121+/-11 [mu]m2). LOS treatment also modulated RAS genes expression (RT-PCR): LOS restored AT1/AT2 balance in O2 hearts by decreasing AT1b subunit (0.8+/-0.2 O2 vs 1.3+/-0.3 O2+LOS vs 0.9+/-0.2 Ctrl) as well as increasing ACE2 (1.5+/-0.4 O2 vs 0.8+/-0.1 O2+LOS vs 1.1+/-0.4 Ctrl) expressions. In conclusion, a short-term treatment with LOS during neonatal O2 exposure prevents the impairment of cardiac systolic function and hypertrophy at young age. This data reinforces the key role of RAS in the developmental programming of cardiac dysfunction and reveals LOS as an effective strategy to prevent early cardiac alterations caused by neonatal high O2 exposure.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71713250
TI  - Protein kinase g mediates hyperoxia-induced vascular changes in bronchopulmonary dysplasia-associated pulmonary hypertension
AU  - Lee K.J.
AU  - Kim G.A.
AU  - Taylor J.M.
AU  - Hofmann F.
AU  - Farrow K.N.
Y1  - 2014//
KW  - *hyperoxia
KW  - *lung dysplasia
KW  - *pulmonary hypertension
KW  - *medical society
KW  - *resuscitation
KW  - mouse
KW  - pH
KW  - vascularization
KW  - heart right ventricle hypertrophy
KW  - oxidative stress
KW  - pulmonary artery
KW  - lung injury
KW  - knockout mouse
KW  - blood vessel tone
KW  - blood vessel injury
KW  - wild type
KW  - mouse strain
KW  - smooth muscle fiber
KW  - artery muscle
KW  - staining
KW  - prematurity
KW  - thickness
KW  - lung
KW  - ambient air
KW  - mouse model
KW  - hypothesis
KW  - modulation
KW  - *cyclic GMP dependent protein kinase
KW  - cyclic GMP
KW  - von Willebrand factor
KW  - cyclic AMP dependent protein kinase
KW  - formaldehyde
T2  - Circulation
LA  - English
VL  - 130
IS  - SUPPL. 2
SP  -
PB  - Lippincott Williams and Wilkins
SN  - 0009-7322
AD  - K.J. Lee, Pediatrics, Northwestern Univ, Chicago, IL, United States
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71713250
AB  - Introduction: Bronchopulmonary dysplasia (BPD) is a complication of prematurity and is often associated with pulmonary hypertension (PH). Protein Kinase G (PKG) is a kinase that phosphorylates multiple cellular targets leading to alterations in the perinatal vascular tone. Little is known about the role of PKG in BPD-associated PH. Hypothesis: To elucidate the role of PKG in the context of BPD-associated PH Methods: PKG has two possible modes of activation - cGMP or oxidative stress. We utilized global PKG knockout mice (PKG KO) and redox-dead PKG mice (C42S) which cannot be activated by oxidative stress, but maintain cGMP activation. For our hyperoxia-induced lung injury mouse model, age-matched litters of PKG KO or C42S mice were placed in room air (control) or 75% O2 (chronic hyperoxia, CH) within 24h of birth. After 14d, right ventricular hypertrophy (RVH) was measured by Fulton's index (right ventricle/left ventricle+septum). Lungs were inflation fixed with 4% formalin and stained to measure alveolar area, pulmonary artery medial wall thickness (MWT) and vascularization by von Willebrand factor staining. Additionally, primary pulmonary artery smooth muscle cells (PASMC) were isolated from both mouse strains, placed in 21% or 95% O2 for 24h, and analyzed for phosphodiesterase5 (PDE5) activity. Result(s): Isogenic wild-type (WT) control mice developed significant RVH in CH, whereas CH PKG KO and C42S mice did not develop RVH. Isogenic WT mice developed significantly increased MWT and decreased vascularization, but PKG KO and C42S mice were protected from vascular injury. However, all CH mice had significantly increased alveolar area. Isogenic WT PASMC had significantly increased PDE5 activity after 24h of 95% O2, but PKG KO and C42S PASMC did not. Conclusion(s): Global loss of PKG and loss of redox-activated PKG protected from hyperoxia-induced right ventricular hypertrophy, vascular remodeling and decreased vascularization that were observed with CH WT mice as well as hyperoxia-induced PDE5 activity in PASMC. However, PKG does not appear to play a role in hyperoxia-induced alveolar simplification. Thus, modulation of redox-activated PKG activity may represent a novel new therapeutic target for BPD-associated PH.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71689685
TI  - Improving the in vivo glutathione level prevents toxic effects of ascorbylperoxide on lung development
AU  - Lavoie J.-C.
AU  - Elremaly W.
AU  - Mohamed I.
AU  - Rouleau T.
Y1  - 2014//
KW  - *toxicity
KW  - *lung development
KW  - *society
KW  - oxidation reduction potential
KW  - infant
KW  - parenteral nutrition
KW  - protection
KW  - catheter
KW  - apoptosis
KW  - human
KW  - lung dysplasia
KW  - jugular vein
KW  - newborn
KW  - plasma
KW  - animal experiment
KW  - guinea pig
KW  - Western blotting
KW  - capillary electrophoresis
KW  - pregnancy
KW  - lung
KW  - continuous infusion
KW  - prematurity
KW  - analysis of variance
KW  - *free radical
KW  - *glutathione
KW  - glucose
KW  - glutathione peroxidase
KW  - nonoxinol 9
KW  - caspase 3
KW  - vitamin
KW  - lipid
KW  - amino acid
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 76
IS  - SUPPL. 1
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - J.-C. Lavoie, Universite de Montreal, Canada
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2014.10.048
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71689685
AB  - Introduction: Hypoalveolarization is a main characteristic of bronchopulmonary dysplasia (BPD) that affects 50% of infants born < 28 weeks of gestation. Animal studies report that ascorbylperoxide (AscOOH) generated in parenteral nutrition (PN) devoid of light protection induces oxidized redox potential and loss of alveoli following an exaggerated apoptosis. Because AscOOH is a substrate of glutathione peroxidase, we hypothesized that improving of the in vivo glutathione level can limit BPD development. The aim was to assess in newborn animals that addition of glutathione in PN prevents the deleterious effects of AscOOH. Method(s): Guinea pigs (n = 40) aged of 3 days were divided in 6 groups to receive the following intravenous solutions through a catheter in jugular vein. Sham: animals fed regular chow, catheter was closed; PN(-L): animals fed exclusively with parenteral nutrition (dextrose, amino acids, lipids, vitamins), PN was light-protected by opaque materials; PN(+L): PN without photo-protection (containing about 35 muM ascorbylperoxyde); PN(+L)+GSSG: + 10 muM GSSG; AscOOH: dextrose + 180 muM ascorbylperoxyde; AscOOH+GSSG: + 10 muM GSSG. after 4 days of continuous infusion, lungs were collected and prepared for determinations of redox potential (mV) calculated from GSH and GSSG concentrations (capillary electrophoresis), activated caspase-3 (apoptosis) (Western blot) and alveolarization (average number of intercepts between a 1 mm line and histological structures from 4 fields / animal). ANOVA, p<0.05. Result(s): Plasma glutathione in PN(+L)+GSSG was higher than in PN(+L) group (0.5+/-0.2 vs. 14.2+/-0.4 muM, p<0.01). Results from PN(-L) were not different than those from Sham. The presence of GSSG has corrected (p<0.05) the modifications induced by PN(+L) or AscOOH (see Table). (Table presented) Conclusion(s): Addition of GSSG in PN could prevent deleterious effect of ascorbylperoxide on lung development of preterm infants by correcting their well-known low glutathione level.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71689626
TI  - Genetic determinants of oxidant-induced nuclear and mitochondrial DNA lesions in a neonatal inbred mouse model of acute lung injury
AU  - Verhein K.C.
AU  - Nichols J.L.
AU  - Panduri V.
AU  - Gladwell W.
AU  - Marzec J.
AU  - McCaw Z.
AU  - Reeves N.
AU  - Malphurs J.
AU  - Solomon G.
AU  - Wiltshire T.
AU  - Burkholder A.
AU  - Fargo D.
AU  - Bell D.
AU  - Van Houten B.
AU  - Kleeberger S.R.
Y1  - 2014//
KW  - *mouse
KW  - *mouse model
KW  - *inbred mouse strain
KW  - *acute lung injury
KW  - *society
KW  - hyperoxia
KW  - lung
KW  - gene
KW  - phenotype
KW  - infant
KW  - lung injury
KW  - inbred strain
KW  - DNA damage
KW  - lung development
KW  - lung dysplasia
KW  - lung disease
KW  - exposure
KW  - lung homogenate
KW  - oxidative stress
KW  - adverse drug reaction
KW  - blood vessel injury
KW  - assisted ventilation
KW  - pathogenesis
KW  - prematurity
KW  - human
KW  - genome
KW  - injury
KW  - genetics
KW  - genetic polymorphism
KW  - mitochondrial genome
KW  - *oxidizing agent
KW  - *mitochondrial DNA
KW  - *free radical
KW  - *DNA
KW  - oxygen
KW  - reactive oxygen metabolite
KW  - cell nucleus DNA
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 76
IS  - SUPPL. 1
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - K.C. Verhein, National Institute of Environmental Health Sciences, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2014.10.058
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71689626
AB  - Reactive oxygen species contribute to the pathogenesis of many acute and chronic pulmonary disorders, including bronchopulmonary dysplasia (BPD), a respiratory condition affecting preterm infants. BPD treatment often involves respiratory support with high oxygen, and oxidative stress is an adverse effect associated with vascular damage and impaired lung development and function in a subset of infants. Genetic polymorphisms in a few candidate genes have been associated with BPD susceptibility, however the genetic basis of differential susceptibility remains poorly understood. Understanding the role of genetics is critical to improving treatment strategies and reducing oxidant injury in developing lungs. The objective of this study was to utilize genome-wide association (GWA) mapping of quantitative phenotypes to identify susceptibility genes for neonatal hyperoxic lung injury. One day after birth, neonatal mice from 29 inbred strains were exposed for 72 hr to normoxia (20% oxygen) or hyperoxia (>95% oxygen). Hyperoxia induced phenotypes (inflammatory cells/histopathology) that are similar to BPD when compared to postnatal lung development in normoxia. We also found significant inter-strain variation in hyperoxia-induced nuclear and mitochondrial DNA lesions and mitochondrial copy number from lung homogenates after normoxia and hyperoxia. GWA mapping identified significant QTLs for normoxia-induced DNA lesions and mitochondrial copy number and for hyperoxia-induced DNA lesions. We also ultra-deep sequenced lung mitochondrial DNA from these mice and found strain-dependent sequence variations. We found 385 variants in the wild-derived inbred strain PWD/PhJ compared to C57BL/6J mice, including 1 found only with hyperoxia. We found higher variation frequency (1/32 bases) in the D-loop region compared to the rest of the mitochondrial genome (1/42 bases). We conclude that exposures to normoxia and hyperoxia early in life cause lesions in mouse lung mitochondrial and nuclear DNA that are strain dependent. through these combined approaches, we have identified novel candidate susceptibility genes that improve our understanding of neonatal lung injury and development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71677068
TI  - Association between cumulative iron exposure and bronchopulmonary dysplasia in very low birth weight infants
AU  - Patel R.M.
AU  - Knezevic A.
AU  - Hinkes M.T.
AU  - Roback J.D.
AU  - Easley K.A.
AU  - Josephson C.
Y1  - 2014//
KW  - *exposure
KW  - *lung dysplasia
KW  - *very low birth weight
KW  - supplementation
KW  - infant
KW  - transfusion
KW  - risk
KW  - erythrocyte
KW  - birth weight
KW  - consensus
KW  - cohort analysis
KW  - statistical model
KW  - gestational age
KW  - therapy
KW  - air conditioning
KW  - disease severity
KW  - hypothesis
KW  - oxidative stress
KW  - enteric feeding
KW  - risk factor
KW  - iron overload
KW  - erythrocyte transfusion
KW  - *iron
KW  - caffeine
T2  - Transfusion
LA  - English
VL  - 54
IS  - SUPPL. 2
PB  - Blackwell Publishing Inc.
SN  - 0041-1132
AD  - R.M. Patel, Pediatrics, Emory University, School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States
DO  - https://dx.doi.org/10.1111/trf.12845
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71677068
AB  - Background/Case Studies: Very low birth weight (VLBW) infants are at risk of iron overload from packed red blood cell (RBC) transfusions and enteral iron supplementation. Unbound iron may lead to oxidative stress and contribute to the development of bronchopulmonary dysplasia (BPD). The risk to BPD from greater amounts of cumulative supplemental iron exposure is unknown. The objective of this study was to test the hypothesis that VLBW infants exposed to a greater quantity of iron in the form of RBC transfusions and enteral supplementation will have a higher risk of BPD. Study Design/ Methods: A secondary, multicenter, observational cohort study used prospectively collected data from VLBW infants (<1500 g at birth). Elemental iron exposure was estimated based on total volume of RBCs transfused, assuming 1 mg of elemental iron per ml of RBC transfused, and from cumulative doses of enteral iron supplementation. BPD was defined according to the NIH consensus definition. Generalized linear models were used to evaluate the association between iron exposure and BPD, after adjustment for potential confounding from type of enteral feeding, birth weight, illness severity, ventilation on the day of birth, caffeine therapy, days to regain birth weight, and medical center. Results/Findings: A total of 589 VLBW infants were evaluated. The median gestational age and birth weight of the cohort was 28 wk (interquartile range [IQR] 26-30 wk) and 1020 g (IQR 787- 1230 g), respectively. Eighty-four percent (492/589) of infants received enteral iron supplementation, and 55.3% (326/589) received at least one RBC transfusion. Cumulative iron exposure per infant was a median of 243 mg (IQR 99-477 mg), with 171 mg (IQR 43-452 mg) from enteral supplementation and 18 mg (IQR 0-57 mg) from RBC transfusion. The overall incidence of BPD was 40.1% (236/589). In multivariable analysis, the risk of BPD increased by 6% for every 100-mg increase in total iron exposure from enteral supplementation (adjusted relative risk [RR] 1.06; 95% CI 1.02-1.10; P = 0.003) and by 7% for every 20-mg increase in total iron exposure from RBC transfusion (RR 1.07; 95% CI 1.04-1.09; P < 0.0001). Conclusion(s): In this study, higher amounts of iron exposure from enteral supplementation and RBC transfusion were both independently associated with an increased risk of BPD in VLBW infants. Further studies are needed to evaluate whether limiting the dose of enteral iron supplementation, particularly among infants with high RBC transfusion burden, may lower the risk of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Trajectories of general movements from birth to term-equivalent age in infants born <30 weeks' gestation.
DO  - https://dx.doi.org/10.1016/j.earlhumdev.2015.09.009
AU  - Olsen, Joy E
AU  - Brown, Nisha C
AU  - Eeles, Abbey L
AU  - Lee, Katherine J
AU  - Anderson, Peter J
AU  - Cheong, Jeanie L Y
AU  - Doyle, Lex W
AU  - Spittle, Alicia J
Y1  - 2015//
Y2  - 20151027//
KW  - *Bronchopulmonary Dysplasia/di [Diagnosis]
KW  - Bronchopulmonary Dysplasia/pp [Physiopathology]
KW  - Female
KW  - Gestational Age
KW  - Humans
KW  - Infant
KW  - Infant, Newborn
KW  - Infant, Premature
KW  - *Intracranial Hemorrhages/di [Diagnosis]
KW  - Intracranial Hemorrhages/pp [Physiopathology]
KW  - Male
KW  - *Movement/ph [Physiology]
KW  - Pregnancy
KW  - Prospective Studies
T2  - Early human development
VL  - 91
IS  - 12
SN  - 0378-3782
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26513629
AD  - Ireland
AB  - BACKGROUND: General movements (GMs) is an assessment with good predictive validity for neurodevelopmental outcomes in preterm infants. However, there is limited information describing the early GMs of very preterm infants, particularly prior to term., AIMS: To describe the early GMs trajectory of very preterm infants (born <30weeks' gestation) from birth to term-equivalent age, and to assess the influence of known perinatal risk factors on GMs., STUDY DESIGN: Prospective cohort study., SUBJECTS: 149 very preterm infants born <30weeks' gestation., OUTCOME MEASURES: GMs were recorded weekly from birth until 32weeks' postmenstrual age, and then fortnightly until 38weeks' postmenstrual age. GMs were also assessed at term-equivalent age. Detailed perinatal data were collected., RESULTS: Of 669 GMs assessed, 551 were preterm and 118 were at term-equivalent age. Prior to term, 15% (n=82) of GMs were normal and 85% (n=469) were abnormal, with the proportion of abnormal GMs decreasing with increasing postmenstrual age (p for trend <0.001). By term-equivalent 30% (n=35) of GMs were normal. On univariable analysis, lower gestational age (p<0.001), postnatal infection (p<0.001) and bronchopulmonary dysplasia (p=0.001) were associated with abnormal GMs. Postnatal infection was the only independent perinatal association with abnormal GMs on multivariable analysis. All four infants with grade III/IV intraventricular haemorrhage (IVH) had persistently abnormal GMs., CONCLUSIONS: GMs were predominantly abnormal in very preterm infants, with a higher proportion of normal GMs at term-equivalent age than prior to term. Abnormal GMs were associated with postnatal infection and IVH. Copyright Â© 2015 Elsevier Ireland Ltd. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71667644
TI  - The prevalence and outcome of babies with bronchopulmonary dysplasia in a UK tertiary neonatal unit
AU  - Abraham D.
AU  - Singh A.
AU  - Rasiah S.V.
Y1  - 2014//
KW  - *prevalence
KW  - *baby
KW  - *lung dysplasia
KW  - *United Kingdom
KW  - *organization
KW  - prematurity
KW  - data base
KW  - badger
KW  - health care cost
KW  - climate
KW  - infancy
KW  - health care
KW  - implantable cardioverter defibrillator
KW  - morbidity
KW  - classification
KW  - gestational age
KW  - survival
KW  - social welfare
KW  - chronic lung disease
KW  - oxygen
T2  - Archives of Disease in Childhood
LA  - English
VL  - 99
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - D. Abraham, Neonatology, Birmingham Women's Hospital, Birmingham, United Kingdom
UR  - http://adc.bmj.com/content/99/Suppl_2/A505.1.abstract?sid=fa8b37b4-4f3e-47a7-b9fc-6a1c225ba4b3
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71667644
DO  - https://dx.doi.org/10.1136/archdischild-2014-307384.1402
AB  - Background Bronchopulmonary dysplasia (BPD) is one of the most important adverse sequelae of premature birth and the most common form of chronic lung disease of infancy. It is relevant in the current health care climate due to the health care costs it may generate owing to the long-term respiratory and neurodevelopmental complications. Aims To understand the prevalence, characteristics and outcomes of BPD cases in a UK tertiary neonatal unit. Methods The Badger neonatal database was analysed for BPD and cases included if they required oxygen at corrected gestational age of 36 weeks. Their outcome and impact on neonatal services were studied over the past 4 years, after categorisation into inborn and outborn babies. Results In the last 4 years we had 5342 admissions to our neonatal unit, 159 of who had BPD. The results are as below: (Table Presented) Conclusion BPD is a major morbidity among preterm babies. The cases are increasing in number due to increasing survival of extremely preterm babies. The increasing demand for home oxygen and associated comorbidities in these babies have implications for paediatric community service teams.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71667625
TI  - Genome-wide association study of bronchopulmonary dysplasia
AU  - Karjalainen M.K.
AU  - Mahlman M.
AU  - Huusko J.M.
AU  - Andersson S.
AU  - Kari A.
AU  - Lehtonen L.
AU  - Sankilampi U.
AU  - Tammela O.
AU  - Marttila R.
AU  - Ramet M.
AU  - Hallman M.
Y1  - 2014//
KW  - *genetic association
KW  - *lung dysplasia
KW  - *organization
KW  - gene
KW  - population
KW  - infant
KW  - university hospital
KW  - genome
KW  - single nucleotide polymorphism
KW  - hypothesis
KW  - gestational age
KW  - heredity
KW  - prematurity
KW  - premature labor
KW  - human
KW  - chronic disease
KW  - quality control
KW  - C reactive protein
KW  - protein tyrosine phosphatase SHP 1
KW  - DNA
T2  - Archives of Disease in Childhood
LA  - English
VL  - 99
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - M.K. Karjalainen, Department of Pediatrics, University of Oulu, Oulu University Hospital, Oulu, Finland
UR  - http://adc.bmj.com/content/99/Suppl_2/A498.3.abstract?sid=fa8b37b4-4f3e-47a7-b9fc-6a1c225ba4b3
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71667625
DO  - https://dx.doi.org/10.1136/archdischild-2014-307384.1383
AB  - Background and aims Bronchopulmonary dysplasia (BPD) is the most common chronic disease associated with very preterm birth. BPD has a significant genetic background but the predisposing genes are insufficiently known. The aim is to find genetic factors that predispose to moderate-severe BPD using a hypothesis-free, genome-wide approach. Methods The study populations included preterm infants (gestational age <31 weeks) born during 1997-2013 in Oulu University Hospital and during 2010-2013 in other Finnish University Hospitals (Helsinki, K uopio, Tampere, Turku). DNA samples were genotyped using the Illumina HumanCoreExome BeadChip consisting of approximately 550,000 single-nucleotide polymorphisms (SNPs); after quality control, 60 cases (moderate-severe BPD) and 114 controls (no or mild BPD) remained for a genome-wide association study (GWAS). In the next step, approximately 200 SNPs showing suggestive signals are genotyped in additional infants (n = 116/232) to determine which associations are replicated. Results In GWAS, we detected suggestive association signals (p < 1-4) for several SNPs; many of these SNPs were located within or near genes that can be considered as plausible candidate genes for BPD (e.g. the CRP and PTPN6 genes encoding C-reactive protein and protein-tyrosine phosphatase SHP-1, respectively). Some of the SNPs showing suggestive associations in two previous GWASs of BPD showed weak associations (e.g. those within the PALM2 and CTNNA3 genes). Conclusions In genome-wide association study of BPD, we detected several suggestive associations. These initial results require verification in subsequent studies, including replication in additional populations and functional studies of the arising candidate genes.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71667530
TI  - To determine the incidence, risk factors and need for surgery for retinopathy of prematurity(ROP) among Very-Low-Birth-Weight(VLBW) infants weighing <1500gms
AU  - Shah V.
AU  - Chiang J.
AU  - Chung S.
AU  - Ling Y.
Y1  - 2014//
KW  - *surgery
KW  - *risk factor
KW  - *retrolental fibroplasia
KW  - *very low birth weight
KW  - *organization
KW  - infant
KW  - bleeding
KW  - multivariate analysis
KW  - patent ductus arteriosus
KW  - prematurity
KW  - human
KW  - hypoglycemia
KW  - tocolysis
KW  - chronic lung disease
KW  - risk
KW  - hypothermia
KW  - infection
KW  - sepsis
KW  - hypotension
KW  - Apgar score
KW  - gestational age
KW  - multivariate logistic regression analysis
KW  - assisted ventilation
KW  - vaginal delivery
KW  - fever
KW  - membrane
KW  - rupture
KW  - univariate analysis
KW  - positive end expiratory pressure
KW  - Singapore
KW  - hyaline membrane disease
KW  - ventilator
KW  - artificial ventilation
KW  - fetus distress
KW  - birth weight
KW  - mother
KW  - female
KW  - prevention
KW  - titrimetry
KW  - oxygen therapy
KW  - general hospital
KW  - extremely low birth weight
KW  - oxygen
KW  - surfactant
T2  - Archives of Disease in Childhood
LA  - English
VL  - 99
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - V. Shah, Neonatal and Dev Medicine, Singapore General Hospital, Singapore, Singapore
UR  - http://adc.bmj.com/content/99/Suppl_2/A465.3.abstract?sid=856812a5-4d19-4180-97f3-5206f1a49f52
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71667530
DO  - https://dx.doi.org/10.1136/archdischild-2014-307384.1288
AB  - Materials and methods Retrospective analysis of 12 years data, of all VLBW screened for ROP, managed by Singapore General Hospital, for maternal, neonatal risk factors using univariate and multiple logistic regressions. Results Incidence of ROP was 24.8% among all screened VLBW. By univariate analysis, maternal risk factors for severe ROP were prolonged rupture of membrane (PROM), pyrexia, multiple births, tocolysis, fetal disress and vaginal delivery. Neonatal risk factors for ROP were, infant with lower gestational age than 25+/- 2 weeks (mean + SD), birth weight lesser than 689 +/- 147 gm (mean + SD), low Apgar scores, hyaline membrane disease (HMD) requiring surfactant, hypothermia, sepsis, hypotension, patent ductus arteriosus (PDA), air-leak, hypoglycaemia, intraventricular haemorrhage (IVH) increased days on assisted ventilation, CPAP, Oxygen and high mean FiO2 and Chronic lung disease (CLD), are significant risk factors for ROP (p < 0.05). By multivariate analysis, lower GA (OR = 0.728, 95% CI = 0.609-0.870), lower BW (OR = 0.996, 95% CI = 0.994-0.997) and increased days on oxygen (OR = 1.015,95% CI = 1.006-1.025) were independent risk factor for ROP. Conclusion High risk factors for severe ROP are extreme preterm infants born vaginally to mother with infection and PROM, multiple birth, used tocolysis, fetal distress with lower GA than 25+2 weeks (mean+SD), with BW lesser than 689+147 gm mean+SD), having low 1,5 min Apgar score, HMD requiring surfactant, hypothermia, sepsis, hypotension, patent ductus arteriosus (PDA), chronic lung disease (CLD), air-leak, hypoglycaemia, intraventricular haemorrhage (IVH). Longer duration of mechanical ventilation, CPAP and oxygen with increased FIO2 due to CLD, are also higher risk of ROP. By multivariate analysis lower GA, BW and increased days on oxygen were found to be high risk factors for ROP. Prevention of extreme prematurity, maternal infection, PROM, optimal ventilator care, with careful titration of oxygen therapy which can decrease CLD may reduce the incidence and severity of ROP in these high-risk ELBW infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71667369
TI  - Revised nichd definition for Bronchopulmonary Dysplasia (BPD) predicts neurodevelopmental impairment (NDI) at 2 years corrected age in Singapore
AU  - Poon W.
AU  - Yang J.
Y1  - 2014//
KW  - *lung dysplasia
KW  - *Singapore
KW  - *organization
KW  - human
KW  - child
KW  - multivariate logistic regression analysis
KW  - birth weight
KW  - air conditioning
KW  - female
KW  - infant
KW  - general hospital
KW  - cohort analysis
KW  - parameters
KW  - language
KW  - pneumonia
KW  - prematurity
KW  - pneumothorax
KW  - multiple pregnancy
KW  - sepsis
KW  - Bayley Scales of Infant Development
KW  - survivor
KW  - teaching hospital
KW  - population
KW  - Asian
KW  - oxygen
T2  - Archives of Disease in Childhood
LA  - English
VL  - 99
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - W. Poon, Neonatal and Developmental Medicine, Singapore General Hospital, Singapore, Singapore
UR  - http://adc.bmj.com/content/99/Suppl_2/A405.2.abstract?sid=b018ba86-cc44-4342-aa3d-71fce089872a
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71667369
DO  - https://dx.doi.org/10.1136/archdischild-2014-307384.1126
AB  - Aim To determine how well the revised NICHD criteria for bronchopulmonary dysplasia (BPD) predicts neurodevelopmental impairment (NDI) and growth impairment at 2 years corrected age (CA) in the contemporary era in a multi-ethnic Asian population. Methods Longitudinal cohort study. Setting Singapore General Hospital, a regional tertiary teaching hospital. Participants Preterm infants with birthweight < 1250 grammes, admitted from Jan 1 2009 to Dec 31 2010 with BPD compared to no BPD. Outcome measures Neurodevelopmental and growth outcomes. Further multiple logistic regression were performed on factors, particularly modifiable factors, associated with BPD, which may be associated with NDI. Results Out of 72 infants who satisfied the inclusion, 60 survived the primary hospitalisation. 46 children (77% of survivors) returned for Bayley III at 2 years, and 44 completed the assessment. BPD children had significantly lower birthweight and were more likely to be from a multiple pregnancy, to require high frequency oscillatory ventilation, to have pneumothorax, hemodynamically significant PDA (HSPDA), nosocomial sepsis and pneumonia, longer duration of ventilation and oxygen. They were also more likely to have ROP and NEC, but not IVH. BPD children were more likely to have NDI (defined by cognitive, language or motor scores < 70) OR 6.3 (95% CI 1.1-36.7). No significant differences were found for growth parameters at 2 years CA. Multiple logistic regression revealed independent association of HSPDA with NDI. Conclusion NICHD definition of BPD significantly predicts NDI at 2 years CA. HSPDA was independently associated with NDI.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71666751
TI  - Genetic predisposition to the development of bronchopulmonary dysplasia in infants born prematurely
AU  - May C.A.
AU  - Best S.
AU  - Peacock J.
AU  - Thein S.L.
AU  - Greenough A.
Y1  - 2014//
KW  - *genetic predisposition
KW  - *lung dysplasia
KW  - *infant
KW  - *organization
KW  - genotype
KW  - gene
KW  - gene product
KW  - heredity
KW  - population
KW  - blood
KW  - prematurity
KW  - DNA polymorphism
KW  - birth weight
KW  - data base
KW  - model
KW  - receiver operating characteristic
KW  - environmental factor
KW  - single nucleotide polymorphism
KW  - gestational age
KW  - human genome
KW  - human
KW  - statistical analysis
KW  - statistical model
KW  - surfactant
KW  - dipeptidyl carboxypeptidase
KW  - protein
KW  - DNA
T2  - Archives of Disease in Childhood
LA  - English
VL  - 99
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - C.A. May, Royal London Neonatal Unit, Barts Health NHS Trust, London, United Kingdom
UR  - http://adc.bmj.com/content/99/Suppl_2/A187.3.abstract?sid=335fbf7b-5293-4c59-a6b3-84789d548a49
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71666751
DO  - https://dx.doi.org/10.1136/archdischild-2014-307384.506
AB  - Background and aims Bronchopulmonary dysplasia (BPD) is an unfortunately common outcome following premature birth. Genetic factors influence BPD development but their role is part of a complex interaction with environmental factors. We postulated that alterations in the gene as well as imbalances in gene products may affect BPD development. Methods The NIH human genome database was interrogated for previously identified gene polymorphisms that have been associated with neonatal respiratory conditions. Angiotensin converting enzyme (ACE) and surfactant proteins A-D gene candidates were selected based upon clinical plausibility for the study population. DNA was extracted from whole blood and Guthrie card specimens. Surfactant single nucleotide polymorphism (SNP) genotyping was arranged using the Taqman technique. ACE gene primers were obtained for the previously known insertion/deletion polymorphism and PCR analysis was performed. Results 236 infants born prematurely survived to 28 days postnatal age and contributed to genotype analysis. 106 infants did not develop BPD and 130 infants did develop BPD (54 mild, 29 moderate, 47 severe). Both gestational age and birth weight were significantly different between those infants who did and did not develop BPD and predicted BPD development with an area under the ROC of 0.88 and 0.82 respectively. We demonstrated using multifactorial statistical analysis that the inclusion of the ACE genotype to a predictive statistical model of BPD development improves the predictive potential of the model (area under ROC curve 0.88). Conclusion The presence of the ACE DD genotype is associated with a higher likelihood of developing BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71666529
TI  - Association of e-NOS gene polymorphism in development of bronchopulmonary dysplasia
AU  - Cetinkaya M.
AU  - Varturk I.
AU  - Korachi M.
AU  - Guven S.
AU  - Akin I.M.
AU  - Erener-Ercan T.
AU  - Buyukkale G.
Y1  - 2014//
KW  - *DNA polymorphism
KW  - *lung dysplasia
KW  - *organization
KW  - genotype
KW  - infant
KW  - allele
KW  - gene
KW  - airway
KW  - human
KW  - prematurity
KW  - control group
KW  - DNA isolation
KW  - blood sampling
KW  - physiology
KW  - epithelium cell
KW  - baby
KW  - risk factor
KW  - gene frequency
KW  - confidence interval
KW  - oxidation
KW  - risk
KW  - real time polymerase chain reaction
KW  - etiology
KW  - Fisher exact test
KW  - DNA
KW  - nitric oxide
KW  - arginine
KW  - citrulline
KW  - genomic DNA
KW  - free radical
T2  - Archives of Disease in Childhood
LA  - English
VL  - 99
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - M. Cetinkaya, Neonatology, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey
UR  - http://adc.bmj.com/content/99/Suppl_2/A105.4.abstract?sid=520042fa-797b-4646-b80c-b06332cf9393
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71666529
DO  - https://dx.doi.org/10.1136/archdischild-2014-307384.283
AB  - Background and aims Bronchopulmonary dysplasia (BPD) is an importantmorbidity in premature infants with an multifactorial aetiology. In recent years, both genetic and epigenetic mechanisms were suggested to play an important role in BPD development. NO (Nitric Oxide) which is produced along with L-Citrulline by the oxidation of L-Arginine and catalysed by three different isoforms of NOS (NOSynthase), is a short-lived free radical involved indiverse physiological and pathological processes. It consists of 3 types such as neuronal NOS, endothelial NOS and inducible NOS. All the NOS genes are expressed in airway epithelial cells and they are important for physiological functions in the airways. The aim of this study was to investigate possible association between eNOS gene polymorphism and development of BPD in preterm infants. Methods One hundred and twenty two blood samples DNA isolation was carried out using the PureLinkTM Genomic DNA Mini Kit and the concentration of the DNA samples was measured by nanophotometerImplen P 300. For the SNP analysis of eNOS (rs1799983) optimised primers were used. Real Time Polymerase Chain Reaction (QRT-PCR) was carried out in a CFX96 thermocycler. Chi-square chi2 test, Fisher's exact test, the odds ratio and confidence intervals were calculated for the comparisons of allelic and genotype frequencies. Results Comparison of the allele frequency distribution revealed the presence of G allele as a highly significant risk factor for development of BPD (p = 0.000*; OR 4.07, 95% CI 2.066-8.009) compared to the T allele. The distribution of the T allele in eNOS was found to be similarly distributed amongst BPD (51.9%) and healthy control groups (48.1%). This study demonstrated that the frequency of the GG genotype (25.37%) of the eNOSgene was higher in babies with BPD rather than TT (53.6%) and TG (59.4)genotype, when these genotypes were compared with the healthy control groups. No healthy infants were seen to carry the GG genotype (p = 0.000*; OR 1.89, 95% CI 1.514-2.148). The TT genotype (p = 0.019*, OR 0.39, 95% CI 0.180-0.870) also displayed a susceptibility fordeveloping BPD. Heterozygous TG genotype (p = 0.631; OR 0.63, 95% CI 0.527-2.873) was not associated with the development of BPD. Conclusion To our best of knowledge, noinvestigation of the eNOS gene polymorphism has previously been documented in BPD. Thefindings of this study demonstrated that the GG genotype in eNOS gene was highly significant for BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71666438
TI  - Mesenchymal stem-or stromal cells from the developing human lung are perturbed by hyperoxia
AU  - Mobius M.A.
AU  - Kos S.
AU  - Ohls R.K.
AU  - Rudiger M.
AU  - Thebaud B.
Y1  - 2014//
KW  - *human
KW  - *hyperoxia
KW  - *lung
KW  - *organization
KW  - *stroma cell
KW  - female
KW  - lung development
KW  - umbilical cord
KW  - atmosphere
KW  - fetus lung
KW  - lung dysplasia
KW  - stroma
KW  - pregnancy
KW  - risk factor
KW  - physiology
KW  - ambient air
KW  - extracellular matrix
KW  - mesenchyme
KW  - prematurity
KW  - oxygen concentration
KW  - stem cell
KW  - infant
KW  - colony forming unit
KW  - cytokine release
KW  - phenotype
KW  - exposure
KW  - oxygen
KW  - protein
KW  - hypocalcin
KW  - prostaglandin E2
KW  - gadolinium
T2  - Archives of Disease in Childhood
LA  - English
VL  - 99
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - M.A. Mobius, Sprott Centre for Stem Cell Research Ottawa/Ontario/Canada, Universitatsklinikum Carl Gustav Carus, Dresden, Germany
UR  - http://adc.bmj.com/content/99/Suppl_2/A73.1.abstract?sid=b2e839b7-2889-46c7-890f-936a0d0147af
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71666438
DO  - https://dx.doi.org/10.1136/archdischild-2014-307384.192
AB  - Exposure of the immature lung to oxygen concentrations higher that the ones in utero - relative (room air) or absolute hyperoxia - represents a major risk factor for the development of bronchopulmonary dysplasia (BPD) in preterm infants. Here, we isolated resident CD146pos./GD-2neg. mesenchymal stem- or stromal cells (MSCs) from human fetal lungs at the canalicular stage of development (16th-18th week of gestation) to obtain new insights into their behaviour in conditions reflecting normal (5% O2) and oxygen disrupted (21% and 60% O2) lung development. We compared them to potentially therapeutic MSCs isolated from the umbilical cord stroma. First, we were able to show that the mesenchyme of the fetal lung is abundant in MSCs, suggesting an important role of these cells in lung development. Single-cell plating of lung MSCs in physiological hypoxic and ambient oxygen atmospheres revealed profound reductions of colony-forming ability and colony size in normoxic conditions. Furthermore, when exposed to absolute hyperoxic (60% O2) atmospheres, MSCs lost ability to form colonies, reduced expression of stem cell-restricted proteins like Oct-4 and Sox2, proliferated and switched cytokine secretion profiles towards a pro-fibrotic, pro-inflammatory phenotype. Alterations in the composition of the extracellular matrix were observed. Conversely, MSCs from the umbilical cord secreted high amounts of anti-fibrotic and lung-protecting proteins like PGE2 and stanniocalcin-1. We conclude that the physiological function of resident lung MSCs is affected by relative and absolute hyperoxia, suggesting a key role of these cells in the immature lung responding to extrauterine oxygen conditions.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71666322
TI  - Longitudinal developmental effects of the infant behavioural assessment and intervention program in very low birth weight infants
AU  - Van Hus J.
AU  - Jeukens-Visser M.
AU  - Koldewijn K.
AU  - Holman R.
AU  - Kok J.H.
AU  - Nollet F.
AU  - Van Wassenaer-Leemhuis A.
Y1  - 2014//
KW  - *very low birth weight
KW  - *organization
KW  - *infant
KW  - human
KW  - motor development
KW  - cognitive development
KW  - child
KW  - risk
KW  - lung dysplasia
KW  - Bayley Scales of Infant Development
KW  - follow up
KW  - model
KW  - Movement Assessment Battery for Children
KW  - Wechsler intelligence scale
KW  - education
KW  - child development
T2  - Archives of Disease in Childhood
LA  - English
VL  - 99
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - J. Van Hus, Rehabilitation, Academic Medical Center, Amsterdam, Netherlands
UR  - http://adc.bmj.com/content/99/Suppl_2/A24.1.abstract?sid=4b8d9a70-e1d9-4ae3-9733-33a1ed51de1d
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71666322
DO  - https://dx.doi.org/10.1136/archdischild-2014-307384.76
AB  - Background Cross-sectional analyses at 6, 12, 24 months and 5.5 years, revealed positive intervention effects on child development in VLBW infants who were supported by the Infant Behavioural Assessment and Intervention ProgramÂ© (IBAIP) as comparing to standard follow-up care. Longitudinal effects were not analysed yet. AIM To investigate the longitudinal effects of the IBAIP in VLBW infants on cognitive and motor development. Methods In a RCT, 86 VLBW infants received the IBAIP until 6 months CA, 90 VLBW infants received standard care. At 6, 12, and 24 months CA, cognitive and motor development were assessed with the Bayley Scales of Infant Development. At 5.5 years CA the Wechsler Preschool and Primary Scale of Intelligence and the Movement Assessment Battery for Children were used. Longitudinal data were analysed with linear mixed models in total group and three subgroups, using Z-scores generated from raw cognitive and motor scores. Results A significant intervention effect (0.4SD) on motor development was found (p = 0.006). On cognitive development, a non-significant intervention effect over time was found (p = 0.063). In children with bronchopulmonary dysplasia (BPD) significant intervention effects were found for both cognitive (effect=0.7SD; p = 0.019) and motor (effect=0.9SD; p = 0.026) outcome. Maternal education hardly influenced intervention effects over time, but in children with combined biological and social risks a longitudinal intervention effect of 0.8SD was found on cognitive development (p = 0.044). Conclusion The IBAIP leads to improved motor development in VLBW infants, and in infants with BPD also to improved cognitive development, over a five years period after the intervention.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71666276
TI  - Drug additives-more dangerous in the critically ill neonate?
AU  - Allegaert K.
Y1  - 2014//
KW  - *critically ill patient
KW  - *human
KW  - *newborn
KW  - *organization
KW  - drug formulation
KW  - safety
KW  - hyaline membrane disease
KW  - palatability
KW  - exposure
KW  - absorption
KW  - shelf life
KW  - solubility
KW  - material coating
KW  - toxicity
KW  - clinical pharmacology
KW  - *drug additive
KW  - excipient
KW  - solvent
KW  - preservative
KW  - sweetening agent
KW  - lung surfactant
KW  - surfactant
KW  - propylene glycol
T2  - Archives of Disease in Childhood
LA  - English
VL  - 99
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - K. Allegaert, Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium
UR  - http://adc.bmj.com/content/99/Suppl_2/A10.4.abstract?sid=8dca4dbb-01b2-4915-8f28-a8272109d24c
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71666276
DO  - https://dx.doi.org/10.1136/archdischild-2014-307384.30
AB  - Medicines given to neonates need to be adapted for this agegroup. This includes both dosage and pharmaceutical form. Dosage, because clearance is lower in neonates, but also because there is extensive between-individual variability in clearance in the first months of life. Pharmaceutical forms, because formulations need to account for dosage variability, but also to the clinical characteristics of neonates. The need for an appropriate balance between dose, volume, drug manipulations and dose flexibility in neonates calls for dedicated, tailored formulations. Besides the active compound (s), drug formulations contain solvents and additives, usually referred as 'excipients', needed as co-solvents, surfactants (general term for compounds that improve absorption, unrelated to the lung surfactant administered for hyaline membrane disease), preservatives, colourants and/or sweeteners. These excipients are added e.g. to ensure stability over a given shelf life, to improve palatability or to facilitate solubility or to bulk up formulations that otherwise contain highly potent active ingredients and are referred to as preservatives, sweeteners, fillers and solvents, coating materials or colouring agents. Consequently, during the development of these formulations, there is a need to quantify and limit excipient exposure based on the currently available knowledge on their safety or toxicity. Furthermore, focused studies on the clinical pharmacology of excipients in neonates should be conducted, and its feasibility will be illustrated by the propylene glycol research project. Finally, until tailored vials and formulations become available, compounding practices for drug formulations in neonates should be evaluated to guarantee the correct dosing, product stability and safety.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71666264
TI  - New therapies for pulmonary hypertension and BPD-from bench to bedside
AU  - Kourembanas S.
AU  - Sdrimas K.
AU  - Lee C.J.
AU  - Hansmann G.
AU  - Fernandez-Gonzalez A.
AU  - Mitsialis S.A.
Y1  - 2014//
KW  - *pulmonary hypertension
KW  - *organization
KW  - *therapy
KW  - exosome
KW  - pH
KW  - model
KW  - mesenchymal stem cell
KW  - murine model
KW  - hyperoxia
KW  - lung dysplasia
KW  - survival
KW  - inflammation
KW  - injury
KW  - hypoxia
KW  - membrane component
KW  - macrophage
KW  - diseases
KW  - lung
KW  - nucleic acid
KW  - protein
T2  - Archives of Disease in Childhood
LA  - English
VL  - 99
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - S. Kourembanas, Division of Newborn Medicine, Boston Children's Hospital, Boston, United States
UR  - http://adc.bmj.com/content/99/Suppl_2/A6.3.abstract?sid=ef6a62b6-bf34-4958-9603-63c44c552317
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71666264
DO  - https://dx.doi.org/10.1136/archdischild-2014-307384.18
AB  - We have used mesenchymal stem cells in preclinical models of pulmonary hypertension (PH) and in the hyperoxia-induced neonatal murine model of bronchopulmonary dysplasia (BPD) to suppress inflammation and improve survival while attenuating alveolar injury and PH. The protective effect was predominantly mediated by paracrine mechanisms, since, cell-free MSC-conditioned media were even more efficacious than MSCs in preventing or reversing established disease. The active moieties that confer the therapeutic efficacy of MSCs remain elusive but likely include secreted proteins, nucleic acids, and membrane components, all potentially packaged in MSC-released microvesicles. We have shown that such particles, a class of which is represented by exosomes, convey the therapeutic efficacy of MSCs in the murine hypoxic model of PH. Exosome treatment was also able to abrogate early hypoxic macrophage influx and downregulate hypoxia-activated inflammatory pathways, thus recapitulating the well-characterised, anti-inflammatory properties of MSCs. The clinical use of MSCs in several on-going trials or the MSC secretome (e.g. exosomes) is a budding new field that represents an exciting and promising approach to therapeutic interventions for diseases of the lung.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2023 to 2024>
TI  - Development of a blood proteins-based model for bronchopulmonary dysplasia prediction in premature infants.
DO  - https://dx.doi.org/10.1186/s12887-023-04065-3
AU  - Ou, Wanting
AU  - Lei, KeJing
AU  - Wang, Huanhuan
AU  - Ma, Hongmei
AU  - Deng, Xiaojuan
AU  - He, Pengcheng
AU  - Zhao, Liping
AU  - Lv, Youdao
AU  - Tang, Guohong
AU  - Zhang, Benjin
AU  - Li, Jie
Y1  - 2023//
Y2  - 20230617//
KW  - Infant, Newborn
KW  - Infant
KW  - Humans
KW  - Bronchopulmonary Dysplasia/di [Diagnosis]
KW  - Bronchopulmonary Dysplasia/ge [Genetics]
KW  - *Bronchopulmonary Dysplasia
KW  - Gestational Age
KW  - Infant, Premature
KW  - Blood Proteins/ge [Genetics]
KW  - ROC Curve
T2  - BMC pediatrics
VL  - 23
IS  - 1
SN  - 1471-2431
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med24&NEWS=N&AN=37330491
AD  - England
AB  - BACKGROUND: Bronchopulmonary dysplasia (BPD) is the most common chronic pulmonary disease in premature infants. Blood proteins may be early predictors of the development of this disease., METHODS: In this study, protein expression profiles (blood samples during their first week of life) and clinical data of the GSE121097 was downloaded from the Gene Expression Omnibus. Weighted gene co-expression network analysis (WGCNA) and differential protein analysis were carried out for variable dimensionality reduction and feature selection. Least absolute shrinkage and selection operator (LASSO) were conducted for BPD prediction model development. The performance of the model was evaluated by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve., RESULTS: The results showed that black module, magenta module and turquoise module, which included 270 proteins, were significantly correlated with the occurrence of BPD. 59 proteins overlapped between differential analysis results and above three modules. These proteins were significantly enriched in 253 GO terms and 11 KEGG signaling pathways. Then, 59 proteins were reduced to 8 proteins by LASSO analysis in the training cohort. The proteins model showed good BPD predictive performance, with an AUC of 1.00 (95% CI 0.99-1.00) and 0.96 (95% CI 0.90-1.00) in training cohort and test cohort, respectively., CONCLUSION: Our study established a reliable blood-protein based model for early prediction of BPD in premature infants. This may help elucidate pathways to target in lessening the burden or severity of BPD. Copyright Â© 2023. The Author(s).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Oxygen and parenteral nutrition two main oxidants for extremely preterm infants: 'It all adds up'.
DO  - https://dx.doi.org/10.3233/NPM-15814091
AU  - Mohamed, I
AU  - Elremaly, W
AU  - Rouleau, T
AU  - Lavoie, J-C
Y1  - 2015//
KW  - Analysis of Variance
KW  - *Bronchopulmonary Dysplasia/th [Therapy]
KW  - Female
KW  - Humans
KW  - *Infant, Extremely Low Birth Weight
KW  - Infant, Newborn
KW  - *Oxygen/tu [Therapeutic Use]
KW  - *Oxygen Inhalation Therapy/sn [Statistics & Numerical Data]
KW  - *Parenteral Nutrition/sn [Statistics & Numerical Data]
KW  - Prospective Studies
T2  - Journal of neonatal-perinatal medicine
VL  - 8
IS  - 3
SN  - 1878-4429
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26485550
AD  - Netherlands
AB  - OBJECTIVES: To assess the effect of early exposure to O2 and parenteral nutrition (PN) on oxidative stress at 36 weeks post-menstrual age (PMA) and on bronchopulmonary dysplasia (BPD) in extremely preterm infants., STUDY DESIGN: A prospective observational study including 116 infants <29 weeks of gestation. Baseline clinical characteristics, FiO2 on day 7, duration of PN and clinical outcomes data were collected. In 39 infants, whole blood glutathione (GSH) and oxidized glutathione (GSSG) at 36 weeks PMA were measured and the redox potential was calculated using Nernst equation. Student's t-test, Chi-square, Spearman correlation, ANOVA, and logistic regression analyses were used as appropriate. P < 0.05 was considered significant., RESULTS: FiO2 >=25% was associated with higher level of GSSG (0.29 +/- 0.04 versus 0.18 +/- 0.02 nmol/mg of protein), a more oxidized redox potential (-191 +/- 2 versus -198 +/- 2 mV) and more BPD (90% versus 45%). PN duration >14 days was also associated with higher level of GSSG (0.26 +/- 0.03 versus 0.13 +/- 0.02 nmol/mg of protein), a more oxidized redox potential (-193 +/- 5 versus -203 +/- 2 mV) and more BPD (89% versus 24%). In logistic regression model, each 1% increase in FiO2 and each day increase in PN duration resulted in an increase in the OR for BPD by 1.57 (1.09 -2.28) and 1.17 (1.03 -1.33) respectively., CONCLUSION: Early O2 supplement and PN have additive effects that were associated with prolonged oxidative stress and increased risk of BPD. Strategies targeting judicious use of O2 and decreasing the duration or developing a safer formulation of PN can be targeted to decrease BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71626310
TI  - Hydrogen protects type? Alveolar epithelial cells from hyperoxia-induced oxidative damage: Promising results from a rat model
AU  - Xu F.
Y1  - 2014//
KW  - *lung alveolus epithelium
KW  - *hyperoxia
KW  - *rat
KW  - *rat model
KW  - *intensive care
KW  - apoptosis
KW  - Western blotting
KW  - lung dysplasia
KW  - in vitro study
KW  - lung disease
KW  - oxidative stress
KW  - lung injury
KW  - prognosis
KW  - assay
KW  - exposure
KW  - flow cytometry
KW  - molecular probe
KW  - *hydrogen
KW  - catenin
KW  - oxygen
KW  - antioxidant
KW  - superoxide
KW  - 3 (4,5 dimethyl 2 thiazolyl) 2,5 diphenyltetrazolium bromide
KW  - reactive oxygen metabolite
KW  - fluorescein diacetate
KW  - hydroethidine
KW  - malonaldehyde
KW  - superoxide dismutase
T2  - Pediatric Critical Care Medicine
LA  - English
VL  - 15
IS  - 4 SUPPL. 1
PB  - Lippincott Williams and Wilkins
SN  - 1529-7535
AD  - F. Xu, PICU, Children's Hospital of Chongqing, Chongqing, China
DO  - https://dx.doi.org/10.1097/01.pcc.0000449218.51960.4d
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71626310
AB  - Background and aims: Hyperoxia-induced oxidative stress plays an important role in many pulmonary diseases including bronchopulmonary dysplasia (BPD). The status of type? alveolar epithelial cells (AECIIs) decide the prognosis of lung injury. Aim(s): In the study, we investigated in vitro the effect of hydrogen, which is considered as a new antioxidant recently,on primary AEC?s upon the exposure of hyperoxia. Method(s): AECIIs were isolated and purified from 19d premature rats and exposed to air (21% oxygen), hyperoxia (95% oxygen), air+hydrogen and hyperoxia+hydrogen, respectively. The apoptosis and proliferation of AECIIs were assessed by flow cytometry (FCM), MTT (3- (4,5- dimethylthiazol- 2- yl) -2,5-diphenyltetrazolium bromide) and western blot assay.The production of intracellular reactive oxygen species (ROS) and superoxide anion(O2 -) were determined by 2',7'- dichlorodihydrotestosterone fluorescein diacetate (DCFH-DA) and dihydroethidium (DHE) molecular probe. The concentration of cellular malonaldehyde (MDA), superoxide dismutase (SOD) were also measured. The activation of Foxkhead box class O 3a (FoxO3a) and beta-catenin was detected by western blot assay. Result(s): Compared with hyperoxia group, cells proliferation significantly increased and apoptosis decreased with hydrogen treatment. In addition, the generation of ROS, O2 - and MDA in the AECIIs were inhibited by hydrogen under hyperoxic conditions. In contrast, the level of SOD was higher with hydrogen treatment compared to hyperoxia group. We also demonstrated that hydrogen inhibited the excessive activation of FoxO3a, and improved the beta-catenin expression which was suppressed by hyperoxia. Conclusion(s): Hydrogen protected the AECIIs from hyperoxia-induced damage and proliferation inhibition, which probably attributed to its reduction of ROS generation,elevation of SOD and the regulation FoxO3a and beta-catenin activity.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71626308
TI  - Dynamic expressions and significance of SMO and Gli1 proteins in lung tissue of hyperoxia-exposed neonatal rat
AU  - Xu F.
Y1  - 2014//
KW  - *lung parenchyma
KW  - *hyperoxia
KW  - *rat
KW  - *intensive care
KW  - lung injury
KW  - lung
KW  - Western blotting
KW  - immunohistochemistry
KW  - lung dysplasia
KW  - staining
KW  - exposure
KW  - lung alveolus epithelium
KW  - epithelium cell
KW  - pathogenesis
KW  - acute lung injury
KW  - ambient air
KW  - lung interstitium
KW  - tissues
KW  - endothelium cell
KW  - vascular endothelium
KW  - lung development
KW  - newborn
KW  - *transcription factor Gli1
KW  - oxygen
KW  - eosin
KW  - hematoxylin
KW  - sonic hedgehog protein
T2  - Pediatric Critical Care Medicine
LA  - English
VL  - 15
IS  - 4 SUPPL. 1
PB  - Lippincott Williams and Wilkins
SN  - 1529-7535
AD  - F. Xu, PICU, Children's Hospital of Chongqing, Chongqing, China
DO  - https://dx.doi.org/10.1097/01.pcc.0000449216.06219.21
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71626308
AB  - Background and aims: Long-term oxygen exposure can result in actue lung injury and bronchopulmonary dysplasia. Aim(s): To investigate the expressions of Smo and Gli1 signaling molecule in lungs of newborn rats exposed to prolonged hyperoxia and explore the role of Sonic hedgehog (SHH) signaling pathway in hyperoxia-induced lung injury. Method(s): Neonatal rat PUPs were placed in chambers containing room air or oxygen about 95% for 14 days after birth. The rats were sacrificed at 3, 7 or 14 days and their lungs removed and subjected to hematoxylin and eosin (HE) staining. Smo and Gli11 were observed by immunohistochemistry, and western blotting was utilized to assess the dynamic expressions of Smo and Gli1 protein. Result(s): Significant histo-morphologic changes were showed in the hyperoxia-exposed lungs at 3, 7 and 14 days of age by HE staining. Smo and Gli1 proteins were observed in bronchial epithelial cells, alveolar epithelial cells, and vascular endothelium cells, and partly showed on the fibrotic tissue in lung interstitium. The results of immunohistochemistry and western blot showed that the expression of Smo was significantly higher in the hyperoxia-exposed lungs at 7 and 14 days, and Gli1 was significantly elevated at 14 days. But low Smo and Gli1 were detected in normal air group. Conclusion(s): Exposure of neonatal rat to prolonged hyperoxia results in acute lung injury and arrested lung development. Smo and Gli1 are up-regulated at time points preceding the lung injury, and SHH signal pathway seems to be involved in the pathogenesis of hyperoxia-induced lung injury and bronchopulmonary dysplasia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71621155
TI  - Early postnatal exposure to oxidants induces prolonged oxidative stress and increases the incidence of oxidative stress related diseases in preterm infants les less than 29 weeks gestational age
AU  - Mohamed I.
AU  - Rouleau T.
AU  - Elremaly W.
AU  - Lavoie J.
Y1  - 2014//
KW  - *oxidative stress
KW  - *diseases
KW  - *gestational age
KW  - *infant
KW  - *prematurity
KW  - *human
KW  - *society
KW  - *exposure
KW  - oxidation reduction potential
KW  - lung dysplasia
KW  - risk
KW  - parenteral nutrition
KW  - laser
KW  - supplementation
KW  - Student t test
KW  - blood sampling
KW  - observational study
KW  - necrotizing enterocolitis
KW  - congenital malformation
KW  - capillary electrophoresis
KW  - retrolental fibroplasia
KW  - intensive care
KW  - scanning electron microscopy
KW  - *oxidizing agent
KW  - oxygen
KW  - peroxide
KW  - antioxidant
KW  - protein
KW  - marker
KW  - vasculotropin
KW  - glutathione
T2  - Paediatrics and Child Health (Canada)
LA  - English
VL  - 19
IS  - 6
PB  - Pulsus Group Inc.
SN  - 1205-7088
AD  - I. Mohamed, Pediatrics/Neonatology, University of Montreal, CHU Sainte-Justine, Montreal, QC, Canada
UR  - http://www.pulsus.com/journals/pdf_frameset.jsp?jnlKy=5&atlKy=12913&isArt=t&jnlAdvert=Paeds&adverifHCTp=&sTitle=Canadian%20Paediatric%20Society%2091st%20Annual%20Conference%3A%20Abstracts%2C%20Pulsus%20Group%20Inc&HCtype=
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71621155
AB  - Background: In preterm infants, the antioxidant defenses are still poorly developed. The two major sources of oxidants during intensive care stay are oxygen and parenteral nutrition (PN) which is contaminated with peroxides. We hypothesize that early O2 supplementation and longer PN duration increase the risk for oxidative stress associated diseases such as bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP) and necrotizing enterocolitis (NEC). Objective(s): To assess the effect of early oxygen (on day 7 and 28) and the PN duration on oxidative stress markers at 36 weeks corrected age and on oxidative stress related diseases. Design/Methods: A prospective observational study including all infants <29 weeks GA without major congenital anomalies admitted to our NICU during one year period (116 infants). During the first week of life, in fifty-one out of 116 infants, consent for blood sample at 36 corrected age (CA) was obtained. GSH and GSSG (nmol/mg protein) were measured by capillary electrophoresis and were used for redox potential (mV) calculation using Nernst equation -expressed as mean (sem). BPD was defined as the need of O2 supplement at 36 weeks CA. Significant ROP was defined as any ROP stage 3 or higher or that required laser or anti-VEGF treatment. Cases of NEC grade 2 or higher according to Bell's criteria were included. Student's t test or chi2 were used, as appropriate, *=P<0.05, * *=P<0.01. Result(s): Basline chracteristics was similar in the consent group and the whole cohort. FiO2 >=25 on day 7 and 28 of life and PN duration >14 days resulted in higher GSSG concentration and more oxidized redox potential at 36 weeks CA indicating prolonged oxidative stress. FiO2 >=25 early on life and PN duration >14 days increased the incidence of BPD, significant ROP and NEC (Table 1). Conclusion(s): Early life exposure to oxidants is associated with prolonged oxidative stress and higher incidence of oxidative stress-related diseases. These results suggest that strategies targeting judicious O2 use and either decreasing the duration or using safer formulation PN will help decreasing the incidence of BPD, ROP and NEC. (Table presented) .
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71555579
TI  - Identification of genetic variants underlying bronchopulmonary dysplasia in preterm newborns using exome sequencing
AU  - Carrera P.
AU  - Di Resta C.
AU  - Somaschini M.
AU  - Castiglioni E.
AU  - Volonteri C.
AU  - Bonfiglio S.
AU  - Lazarevic D.
AU  - Cittaro D.
AU  - Stupka E.
AU  - Ferrari M.
Y1  - 2014//
KW  - *genetic variability
KW  - *lung dysplasia
KW  - *newborn
KW  - *human
KW  - *prematurity
KW  - *exome
KW  - *clinical chemistry
KW  - *laboratory
KW  - *clinical laboratory
KW  - *society
KW  - gene
KW  - pilot study
KW  - prediction
KW  - newborn intensive care
KW  - heredity
KW  - very low birth weight
KW  - etiology
KW  - algorithm
KW  - filtration
KW  - child
KW  - pipeline
KW  - infancy
KW  - bioinformatics
KW  - chronic lung disease
KW  - diseases
KW  - genome
T2  - Clinical Chemistry and Laboratory Medicine
LA  - English
VL  - 52
IS  - SUPPL. 1
PB  - Walter de Gruyter GmbH and Co. KG
SN  - 1434-6621
AD  - P. Carrera, Genomic Unit for the Diagnosis of Human Pathologies, Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, Milan, Italy
DO  - https://dx.doi.org/10.1515/cclm-2014-4004
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71555579
AB  - BACKGROUND: Recent development of next generation sequencing represents a great opportunity to analyse individual genomes in a short time, even if it is still challenging in multifactorial disorders. We recently approached exome sequencing for identification of genetic variants predisposing to bronchopulmonary dysplasia (BPD). BPD is the most common chronic lung disease in infancy affecting preterm children with a very low birth weight. BPD has a multifactorial aetiology and until now the genetic bases are mostly unknown. Several association studies were previously performed but they had a limited statistical power and few of these data have been replicated. In this study we planned a pilot exome sequencing analysis aimed to the identification of genetic factors underlying BPD in Italian preterm newborns, collected with the collaborative efforts of 12 Italian centres of Neonatal Intensive Care. METHOD(S): As a pilot study, we performed the exome analysis of 26 severely-affected BPD cases and of 5 individuals, previously analysed for certain genes in our lab using Sanger sequencing. The sequencing was performed on Illumina Hi-Seq2000. To manage the sequencing data, we used an automated bioinformatics pipeline, mapping reads versus the hg19 reference and filtering them on Broad Institute's latest algorithms. Polyphen 2 and Sift were used for the pathogenic prediction analysis and the prioritization study was performed with ToppGene Suite. RESULT(S): At first, data obtained using NGS have been validated with a quality analysis and with a comparison to known Sanger results. Only samples with a mean coverage15X were taken into account. We identified 3369 novel variants, with a median of 400 variations per sample, and 1524 were predicted probably damaging using the two principal pathogenic prediction tools. Moreover, looking for potentially candidate genes, we highlighted especially APOE and NOS2 using ToppGene for pathway analysis. These variants are being confirmed with Sanger sequencing. CONCLUSION(S): Today a further validation of these data is needed, with functional studies and with study segregation in families. Moreover, since the good results obtained from this pilot study, we are encourage to go on with the exome sequencing of all severe BPD cases collected.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71531055
TI  - Next generation sequence analysis of the transcriptional response to neonatal hyperoxia
AU  - Bhattacharya S.
AU  - Zhou Z.
AU  - Yee M.
AU  - Lopez A.
AU  - Lunger V.
AU  - Buczynski B.
AU  - Pryhuber G.
AU  - Mariani T.
AU  - OReilly M.
Y1  - 2014//
KW  - *human genetics
KW  - *human
KW  - *hyperoxia
KW  - *Indian
KW  - *society
KW  - *sequence analysis
KW  - gene
KW  - mouse
KW  - lung
KW  - lung parenchyma
KW  - exposure
KW  - pathology
KW  - algorithm
KW  - lung development
KW  - rodent model
KW  - lung dysplasia
KW  - extracellular matrix
KW  - implantable cardioverter defibrillator
KW  - inflammation
KW  - newborn
KW  - morbidity
KW  - liver fibrosis
KW  - oxidative stress
KW  - polymerase chain reaction
KW  - oxygen concentration
KW  - premature labor
KW  - shrimp
KW  - ambient air
KW  - transcriptome
KW  - oxygen
KW  - sildenafil
KW  - protein p53
KW  - RNA
T2  - Molecular Cytogenetics
LA  - English
VL  - 7
IS  - SUPPL. 1
SP  -
PB  - BioMed Central Ltd.
SN  - 1755-8166
AD  - S. Bhattacharya, Division of Neonatology, Department of Pediatrics, University of Rochester Medical Center, Rochester, NY, United States. E-mail: soumyaroop_bhattacharya@urmc.rochester.edu
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71531055
AB  - Background: Bronchopulmonary Dysplasia (BPD) is a major complication of preterm birth associated with significant morbidity. BPD is a debilitating condition characterized by inflammation, enlarged airspaces, vascular dysmorphia and aberrant extracellular matrix accumulation that is typically described as arrested lung development. Rodent models involving neonatal exposure to excessive oxygen concentrations (hyperoxia) have been used to study the mechanisms contributing to BPD pathology. Transcriptomic assessment of the effects of hyperoxia in neonatal mouse lungs using RNASeq will help to identify genes and pathways associated with BPD. Material(s) and Method(s): Whole lung tissue from newborn C57BL/6 mice exposed to 100% oxygen for 10 days (n=8) and room air-exposed age matched controls (n=6) were compared. Total RNA was isolated from individual whole lung tissues (n=14) and pooled in duplicates to perform transcriptome Sequencing (RNA-seq). Alignments were generated using multiple algorithms (CASAVA; TopHat; and SHRiMP). Raw counts obtained from each alignment algorithm (using HT-Seq) were further and filtered to remove undetected genes. Differentially expressed genes were detected using Significance Analysis of Microarrays (SAM) and CuffDiff2, on each version of mapped and normalized data. Ingenuity Pathway Analysis (IPA) was used for pathway and network analyses. Expression patterns for selected genes were examined by quantitative polymerase chain reaction (qPCR). Result(s): 248 genes were identified as differentially expressed between hyperoxia and control samples by both SAM (median FDR = 0) and CuffDiff2 (p<0.05) and had a fold-change <= 2. We successfully validated 17 of 24 genes by qPCR. Canonical pathways significantly dysregulated in hyperoxia lungs included Nrf2-mediated oxidative stress signaling, p53 signaling, hepatic fibrosis and sildenafil pathways. Interestingly most genes significantly affected following hyperoxia exposure (~70%) showed a pattern of expression consistent with an arrest in lung development. A subset of the genes dysregulated in hyperoxic neonatal mouse lungs, were also differentially expressed in human BPD lung tissue. Conclusion(s): We have identified genes dysregulated in mouse of BPD-like pathology. Further analysis of these data will enhance our current knowledge of BPD, and may be useful for developing novel therapeutic strategies.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71527995
TI  - The state of non-specific resistance factors in small airways diseases of bronchial tubes in children
AU  - Mustafayev I.
Y1  - 2014//
KW  - *R factor
KW  - *airway
KW  - *diseases
KW  - *bronchial tube
KW  - *child
KW  - *human
KW  - *pulmonology
KW  - phagocytosis
KW  - neutrophil
KW  - granulocyte
KW  - remission
KW  - patient
KW  - lung dysplasia
KW  - bronchiolitis obliterans
KW  - intoxication
KW  - asthma
KW  - nitroblue tetrazolium test
KW  - virus infection
T2  - Pediatric Pulmonology
LA  - English
VL  - 49
IS  - SUPPL. 37
PB  - Wiley-Liss Inc.
SN  - 8755-6863
AD  - I. Mustafayev, Pulmonology, Research Institute of Lung Diseases, Baku, Azerbaijan
DO  - https://dx.doi.org/10.1002/ppul.23068
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71527995
AB  - Objective: To study the dependence of the state of phagocytic activity of granulocytes on the stage of the pathological process in asthma (BA), chronic bronchiolitis obliterans(BO) and bronchopulmonary dysplasia (BPD). Material(s) and Method(s): 112 children with BA and 139 patients with BO and 103 with BPD were observed in age from 1 year to 15 years. Studies were conducted in the period of exacerbation and remission. In all patients the study was carried out phagocytic activity of neutrophils through the spontaneous and stimulated nitroblue tetrazolium reduction test (NBT) Results of the study: In all cases aggravation observed increase of phagocytic activity of neutrophils in the spontaneous (BA-10, 1+/-0,37, BO- 8, 04+/-0,26, BPD-10.0+/-1,12) and a stimulated (BA-31, 6+/-0,57; BO-30, 3+/-1,0; BPD -30,9+/-0,43) test. In the case of BO phagocytic activity of neutrophils was slightly reduced in comparison with BA and BPD. In remission indicators of these continue to grow (BA-11, 26+/-1,3, BO- 9.97+/-0,25; BPD-10.1+/-1,1) and (BA-37, 5+/-1,5; BO-39+/-0,9, BPD-40, 0+/-0,5) in all groups Conclusion. Thus, the phagocytic activity of granulocytes not suffer in BA, BO and BPD. However, indicators of NST are on the lower limit of normal at BO. Probably slight inhibition of phagocytosis associated with the presence of viral infection in the presence of infectious factors in the genesis of disease and, consequently, the growing process of endogenous intoxication.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71527958
TI  - BPD-what do we know about the long-term outcome?
AU  - Vrijlandt E.
Y1  - 2014//
KW  - *pulmonology
KW  - human
KW  - child
KW  - pulmonary hypertension
KW  - airway
KW  - adult
KW  - survivor
KW  - asthma
KW  - childhood
KW  - infant
KW  - school
KW  - lung function
KW  - mortality
KW  - patient
KW  - attention deficit disorder
KW  - morbidity
KW  - computer assisted tomography
KW  - prematurity
KW  - prevalence
KW  - exercise
KW  - lung
KW  - thorax
KW  - motor performance
KW  - adolescent
KW  - intelligence quotient
KW  - low birth weight
KW  - air conditioning
KW  - coughing
KW  - heart left ventricle hypertrophy
KW  - young adult
KW  - gestational age
KW  - wheezing
KW  - cor pulmonale
KW  - exercise tolerance
KW  - respiratory tract allergy
KW  - register
KW  - heart right ventricle hypertrophy
KW  - vascular resistance
KW  - cardiovascular disease
KW  - perfusion
KW  - nerve cell differentiation
KW  - survival
KW  - chronic lung disease
KW  - lung dysplasia
KW  - adolescence
KW  - diseases
KW  - pathophysiology
KW  - atopy
KW  - inflammation
KW  - newborn care
KW  - eosinophil
KW  - health
KW  - diagnosis
KW  - mosaicism
KW  - systematic review
KW  - emphysema
KW  - lung blood vessel
KW  - hypertension
KW  - population
KW  - heart right ventricle failure
KW  - hypoplasia
KW  - risk factor
KW  - implantable cardioverter defibrillator
KW  - lung diffusion capacity
KW  - risk
KW  - follow up
KW  - study design
KW  - nutrition
KW  - hyperinflation
KW  - feeding
KW  - airway obstruction
KW  - lung development
KW  - newborn disease
KW  - social status
KW  - bronchodilating agent
KW  - surfactant
KW  - steroid
KW  - corticosteroid
KW  - marker
KW  - nitric oxide
T2  - Pediatric Pulmonology
LA  - English
VL  - 49
IS  - SUPPL. 37
PB  - Wiley-Liss Inc.
SN  - 8755-6863
AD  - E. Vrijlandt, UMCG/Beatrix Children's Hospital CA 43, Department of Pediatric Pulmonology and Pediatric Allergology, Groningen NL 9700 RB, Netherlands. E-mail: e.j.l.e.vrijlandt@umcg.nl
DO  - https://dx.doi.org/10.1002/ppul.23066
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71527958
AB  - Bronchopulmonary dysplasia (BPD) is a chronic lung disease that affects the mortality and morbidity of children born preterm. The original cases, now termed "old" BPD, were the results of aggressive ventilation strategies in relatively large, premature infants. Over the years, the quality of ventilatory treatment in neonatal care has improved (due to e.g. introduction of antenatal steroids and surfactant replacement). Clinically, however, only the incidence of severe BPD has decreased while the overall incidence of BPD has remained constant. [1] The increasing rates of survival among the smallest of premature infants, contribute to an increase in the incidence of the so-called "new" BPD. New BPD is closely associated with low gestational age and low birth weight. The most prominent features of new BPD are disruption of lung development, with decreased septation and alveolar hypoplasia leading to fewer and larger alveoli and dysmorphic pulmonary vasculature. A recent systematic review of the published literature of general and respiratory health outcomes in adult survivors of BPD showed that survivors of BPD experience more problems during childhood, adolescence and adult age when compared to children born preterm without BPD as well as when compared to healthy controls. [2] These problems emerge in different areas of functioning. We will successively describe pulmonary outcome, neurodevelopment outcome and growth and nutritional problems at school age and beyond. Pulmonary Outcome at school age and beyond Chest symptoms and pulmonary function abnormalities have been found in children as well as in adolescents and young adults with a history of "old" and "new" BPD. The symptoms are often described as recurrent episodes of wheezing, cough and reduced exercise tolerance (compared to peers). [2,3] Additionally, children with BPD describe symptoms due to airway hyperresponsiveness to exercise, that improve after bronchodilator administration. The pulmonary function abnormalities consist of airway obstruction, airway hyper reactivity and hyperinflation as well as an exercise restriction. [2] Some children with BPD have a lower diffusion capacity. [2] The prevalence of airway hyperreactivity is not different from that of children born prematurely without BPD. Children with BPD who have demonstrable airway hyperreactivity do not have elevated levels of exhaled nitric oxide (a marker for eosinophil-driven inflammation) or an increased incidence of atopy. [4] Therefore, although children with BPD and children with asthma have similar symptoms, the underlying pathophysiology of these two diseases seems to be different. The lungs recovered from older childhood and adult survivors of BPD demonstrate airway wall thickening similar to individuals with asthma. In addition there aremorphologic changes noted on CT scans of the chest, which are compatible with a diagnosis of fixed peripheral airway narrowing (see below).[2,5] Children with asthmalike symptoms due to BPD may respond to inhaled corticosteroids, but the effect is less consistent than in children with asthma [6]. The majority of children with BPD show abnormalities on the CT-scan, including linear and triangular opacities, mosaic perfusion, air-trapping and/ or multifocal emphysema, and bronchial wall thickening both in the first year of life and at older age [2,5]. Cardiovascular complications Because of increased vascular resistance in the lungs, children with BPD may develop right ventricular hypertrophy. Left ventricular hypertrophy is also seen, possibly associated with systemic hypertension which is commonly found in children with BPD. [7] A rare but serious complication is the development of pulmonary artery hypertension and the resultant right heart failure (cor pulmonale).[7] The incidence and prevalence of pulmonary hypertension in these infants, its risk factors and the outcome of BPD-associated pulmonary hypertension are insufficiently known. Little is known about the characteristics and outcomes of BPD-associated pulmonary artery hypertension in the current era. Severe BPD complicated by severe pulmonary hypertension is associated with an increased early mortality rate. In survivors, a recent global pediatric Pulmonary Hypertension Registry suggests that BPD-associated pulmonary hypertension is still present several years after birth and is associated with significant morbidity [8]. Neurodevelopmental Children with BPD (compared with those without BPD) are at increased risk for neurodevelopmental impairment. Underdeveloped motor skills, both gross and fine, occur more often in patients with BPD Some studies show that more than one-half of the (severe) BPD group have abnormalities of gross and/or fine motor skills at 10 years of age. More attention deficit problems are seen and children with BPD are more often diagnosed with attention deficit hyperactivity disorder (ADHD). [9] Children with BPD have a lower intelligence quotient (IQ) and usually have more problems with progression at school. Feeding and growth Problems with growth and nutrition are common directly after birth, but are also seen later in childhood. Some studies found that growth remains delayed at older age, but more recent studies have found no difference in growth when correcting for confounders. [10] Various study designs have been used to study specific effects of BPD in children, adolescents and adults. It is currently unclear whether these provide a complete survey of relevant problems. This makes it difficult to ensure that long term follow up, which is of special importance in neonatal disorders, captures all aspects of medical, psychological and social importance to these patients. In general, an important finding from review of the adult literature is the relative absence of studies to determine nonpulmonary outcomes and consequently there is a need for a multidisciplinary research in this population.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71527957
TI  - Optimal management of neonatal lung diseases using current technologies
AU  - Kugelman A.
Y1  - 2014//
KW  - *implantable cardioverter defibrillator
KW  - *technology
KW  - *pulmonology
KW  - *lung disease
KW  - infant
KW  - air conditioning
KW  - intubation
KW  - extubation
KW  - human
KW  - respiratory distress syndrome
KW  - newborn apnea
KW  - artificial ventilation
KW  - prematurity
KW  - extremely low birth weight
KW  - positive end expiratory pressure
KW  - pregnancy
KW  - meta analysis
KW  - ventilator
KW  - risk
KW  - endotracheal intubation
KW  - baby
KW  - breathing
KW  - newborn intensive care
KW  - intensive care unit
KW  - assisted ventilation
KW  - lung function test
KW  - intermittent positive pressure ventilation
KW  - death
KW  - gas
KW  - delivery room
KW  - lung dysplasia
KW  - resuscitation
KW  - noninvasive ventilation
KW  - health care quality
KW  - apnea
KW  - risk reduction
KW  - risk factor
KW  - lung insufficiency
KW  - heart rate
KW  - lung mechanics
KW  - respiratory drive
KW  - nasal prong
KW  - wrist
KW  - pulse oximetry
KW  - neonatal respiratory distress syndrome
KW  - devices
KW  - cesarean section
KW  - pH
KW  - hypercapnia
KW  - endotracheal tube
KW  - oxygenation
KW  - learning curve
KW  - morbidity
KW  - upper respiratory tract
KW  - thorax wall
KW  - cerebral palsy
KW  - premature labor
KW  - maturation
KW  - lung
KW  - follow up
KW  - corticosteroid therapy
KW  - randomized controlled trial (topic)
KW  - liquid
KW  - gestational age
KW  - trachea
KW  - catheter
KW  - adverse drug reaction
KW  - high frequency ventilation
KW  - prospective study
KW  - safety
KW  - conditioning
KW  - energy cost
KW  - survival
KW  - lung dead space
KW  - nutrition
KW  - nasal cannula
KW  - general condition
KW  - personnel
KW  - surfactant
KW  - steroid
KW  - oxygen
KW  - caffeine
KW  - carbon dioxide
T2  - Pediatric Pulmonology
LA  - English
VL  - 49
IS  - SUPPL. 37
PB  - Wiley-Liss Inc.
SN  - 8755-6863
AD  - A. Kugelman, Department of Neonatology and Pediatric Pulmonary Unit, Bnai Zion Medical Center, BandR Rappaport Faculty of Medicine, Technion, Haifa, Israel
DO  - https://dx.doi.org/10.1002/ppul.23066
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71527957
AB  - Neonatal respiratory distress syndrome (RDS) is a condition of pulmonary insufficiency that in its natural course commences at or shortly after birth and increases in severity over the first 2 days of life. The EuroNeoNet figures for 2010 showan incidence of 92% at 24-25 weeks' gestation, 88% at 26-27 weeks, 76% at 28-29 weeks and 57% at 30-31 weeks.1 The aim of management of RDS is to provide interventions that will maximize survival whilst minimizing potential adverse effects.1 Prenatal corticosteroid therapy is recommended in all pregnancies with threatened preterm labor below 34 weeks' gestation. In pregnancies delivering between 34 and 36 weeks prenatal steroids do not appear to improve outcome, although when given before elective caesarean section at term they reduce the risk of admission to the neonatal intensive care unit, albeit with a high number needed to treat.1 At delivery, the term stabilization is preferred to resuscitation for the vast majority of very preterm infants. Only a minority of babies should require delivery room intubation. If intubation is required, the correct placement of the endotracheal tube can be quickly verified using a colorimetric CO2 detection device before administering surfactant and starting mechanical ventilation. A concentration of 21-30% oxygen is appropriate to start stabilization and adjustments up or down should be guided by applying pulse oximetry to the right wrist from birth to give information on heart rate and saturation. Neopuff can be helpful in the delivery room and the transport to the Neonatal Intensive Care Unit (NICU), and enables the administration of continuous positive airway pressure (CPAP) and intermittent positive pressure ventilation under controlled condition. Recent large trials that reflect current practice (including greater utilization of maternal steroids and routine post delivery stabilization on NCPAP) demonstrate less risk of bronchopulmonary dysplasia (BPD) or death when using early stabilization on NCPAP with selective surfactant administration to infants requiring intubation. The comprehensive strategy to prevent BPD in the NICU is based on ventilatory and non-ventilatory measures.2 The ventilatory route allows an individualized endotracheal intubation approach. Recent studies concluded that early nasal CPAP (NCPAP) is a safe alternative to immediate intubation in extremely low birth weight (ELBW) infants.3,4 Endotracheal intubation and ventilation can result in significant damage to premature lungs and are independently associated with cerebral palsy. Furthermore, despite new modes of ventilation and surfactant, BPD remains a significant morbidity and its incidence was correlated with the use and length of endotracheal mechanical ventilation. BPD in itself is associated with adverse neurodevelopmental outcome. Thus, we need to avoid endotracheal ventilation, if possible. The use of NCPAP requires experience, and learning curves show improved outcomes in rates of BPD. When the infant requires nasal respiratory support (NRS), we should aim for adequate oxygenation (SpO2 of 90-95%),1 permissive hypercapnia (PaCO2 of 45-55mm Hg, pH >7.22) and gentle ventilation, similarly as on endotracheal ventilation.1,2 NCPAP is recommended as the early primary treatment of active respiratory distress syndrome (RDS) (to avoid intubation or as part of the INSURE [INtubation SURfactant Extubation] approach), or later, post extubation at RDS resolution, in order to allow shortening of the duration of endotracheal ventilation and to treat apnea of prematurity.1 New studies3,4 report comparable rates of BPD in ELBW infants treated initially with NCPAP as compared to endotracheal ventilation with surfactant administration. Can we enhance NCPAP and get better outcome for NRS by using nasal intermittent positive pressure ventilation (NIPPV)? NIPPV was defined as a method of augmenting NCPAP by delivering ventilator breaths via nasal prongs. The rationale behind the use of NIPPV is the administration of "sigh" to the infant, thus opening microatelectasis and recruiting more ventilation units. It was shown that synchronized NIPPV (SNIPPV) compared with NCPAP may improve the patency of the upper airway, could activate the respiratory drive, improves thoraco-abdominal synchrony, stabilizes the chest wall, improves lung mechanics and decreases the work of breathing in premature infants. When NIPPV was compared to NCPAP for the different indications of NRS, it was shown to enhance the potential of NRS. A recent meta-analysis demonstrated a relative risk reduction for intubation in the first 72 hours in the NIPPV group compared with NCPAP (RR 0.60, 95% CI 0.43, 0.83).5 The NIPPV trial6 was a large international multicenter randomized trial powered to study the important outcome of BPD, recruiting 1,009 extremely low birth weight babies, and it showed no difference between babies randomized to NIPPV compared with CPAP. Yet, the results of this study should be considered with caution because of several limitations. For example: There was no uniform experience and equipment used for NIPPV among participating centers; approximately 50% of the infants were supported with biphasic CPAP that is a limited form of NIPPV (maximal peak inspiratory pressure of 9-10 cm H2O in that study). SNIPPV vs. NCPAP for later use, post extubation at RDS resolution, as a "bridge" to spontaneous unsupported breathing was shown to be more effective than NCPAP. A pooled meta-analysis showed that SNIPPV was more effective than NCPAP in preventing failure of extubation [RR 0.21 (0.10, 0.45)] and the number needed to treat was only 3 infants to prevent one extubation failure.7 SNIPPV vs. NCPAP, post extubation, also tended to decrease the rate of BPD. SNIPPV may be more effective than NCPAP also for apnea of prematurity.2 A meta-analysis, regarding apnea of prematurity, suggests that SNIPPV is more efficacious with apnea that is frequent or severe. However, the studies performed addressed short-term outcomes and as such could not address properly the incidence of requirement for reintubation. Thus, more studies are needed before recommending SNIPPV as standard of care for apnea of prematurity. While non-invasive ventilation is probably safe, its success depends on gestational age. The data indicate that surfactant may still have a significant role in the treatment of RDS, especially in ELBWinfants. Recently, Morley et al3 and the SUPPORT study4 reported on an intubation rate of ~ 50% in their NCPAP group in ELBW infants. This leads us to the INSURE approach. This approach may allow the infant to benefit from both, surfactant and NRS. A Cochrane review,8 concluded that the INSURE approach with NCPAP compared with later selective surfactant administration, continued mechanical ventilation, and extubation from low respiratory support was associated with less need for mechanical ventilation, lower incidence of BPD and fewer air leak syndromes. Another option for surfactant application to the trachea without endotracheal intubation was described by using a thin catheter in spontaneously breathing preterm infants receiving NCPAP. This technique was reported to reduce the need for mechanical ventilation.9 There are ongoing trials with inhaled surfactant. To summarize, the available evidence supports the preference of early or later use of NIPPV/SNIPPV compared to NCPAP because of minimizing the use and the length of endotracheal ventilation.2 There are data to suggest that this approach may also reduce the rate of BPD, however this was not shown yet.2 The results of a large international RCT comparing both primary, and post-extubation use of NIPPV with NCPAP, with a composite primary outcome of death or BPD at 36 weeks' corrected age indicate no additional benefit, or risk, conferred by NIPPV in comparison to NCPAP.6 Whether NIPPV/SNIPPV is more beneficial than NCPAP within the INSURE approach needs to be shown. Recently, heated, humidified high-flow nasal cannula (HHHFNC) is frequently used as a mode of NRS. High flows result in washout of anatomical and physiological dead space and contribute to improved fractions of alveolar gases with respect to carbon dioxide as well as oxygen and decrease the work of breathing and the energy cost of gas conditioning. HHHFNC probably creates positive end expiratory pressure (PEEP) that may contribute to its beneficial effect. However, the PEEP that is not monitored, had raised concerns regarding the safety of HHHFNCin terms of air leak. Recent prospective studies support the notion that HHHFNC is as effective as NCPAP for early stages of RDS, post extubation10 and for apnea of prematurity. Yet, more studies, especially in the initial treatment of RDS and in ELBW infants, are needed before adopting HHHFNC as an alternative mode of NRS in these conditions. New modes of NRS such as neurally adjusted ventilator assist (NAVA), and nasal high frequency ventilation, need to be further studied before concluding on benefits for the short and long term outcomes in premature infants. Non-ventilatory measures in the treatment of RDS, such as caffeine, nutrition, fluid and PDA management and postnatal steroids in certain conditions should be included in the care of premature infants with RDS in order to minimize the rate of BPD.1,2 The noninvasive ventilator strategy needs to be confirmed by large prospective randomized controlled trials (with long-term follow up) in order to assure it is applicable to most ELBW infants. Furthermore, the strategy needs to be tailored to individualized infants according to the infant's maturation; antenatal steroid treatment and severity of RDS; general condition; and to certain practical NICU conditions such as experience, personnel and timing during the day.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71505250
TI  - Neonatal physiological correlates of neurodevelopment at 18-22 months in very-low-birthweight preterm children
AU  - Rose J.
AU  - Cahill-Rowley K.
AU  - Vassar R.
AU  - Tamaresis J.
AU  - Hintz S.R.
AU  - Stevenson D.K.
Y1  - 2014//
KW  - *nerve cell differentiation
KW  - *prematurity
KW  - *human
KW  - *lung dysplasia
KW  - *risk factor
KW  - *very low birth weight
KW  - *child
KW  - *perinatal care
KW  - *infant
KW  - gait
KW  - newborn
KW  - velocity
KW  - gestational age
KW  - quality of life
KW  - bilirubin blood level
KW  - serum
KW  - limb
KW  - toddler
KW  - Bayley Scales of Infant Development
KW  - birth weight
KW  - blood level
KW  - sepsis
KW  - retrolental fibroplasia
KW  - necrotizing enterocolitis
KW  - C reactive protein
KW  - albumin
KW  - bilirubin
KW  - serum albumin
KW  - biological marker
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 27
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - J. Rose, Department of Orthopaedic Surgery, Stanford University, School of Medicine, Stanford, CA, United States
DO  - https://dx.doi.org/10.3109/14767058.2014.924236
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71505250
AB  - Brief Introduction: This study examined neonatal physiological risk factors in relation to neurodevelopment at 18-22 months in verylow- birth-weight (VLBW) preterm children. We hypothesized that preterm infants exposed to neonatal inflammatory risk factors would demonstrate lower neurodevelopment based on BSID-III and gait scores at 18-22 months. Material(s) and Method(s): 102 VLBW preterm neonates (BW<=1500g, gestational age (GA) <=32wks) admitted to the NICU were recruited to participate from 2010-2011. Neonatal physiological risk factors examined included GA at birth, bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP), and sepsis, as well as serum levels of C-reactive protein (CRP), albumin, and total bilirubin during the first two weeks of life. Neurodevelopment was assessed at 18-22 months adjusted age with the Bayley Scales of Infant-Toddler Development, 3rd edition (BSIDIII). Gait velocity and% single limb support (SLS) were assessed using a GAIT Rite mat. Collinearity was estimated by calculating variance inflation factors (VIF). Two-tailed significance was defined as p<0.05. Clinical Cases or Summary Results: Among the 102 neonates, BW was 1087 +/- 279g, GA-at-birth was 28.7 +/- 2.4 wks. The mean GA of children was lower in those with<80 BSID-III cognitive (p = 0.029) and motor (p = 0.034) composite scores. Mean BSID-III cognitive composite scores were lower in children with neonatal BPD (91.7 +/- 11.6 versus 97.6 +/- 12.6, p = 0.013). Lower BSID-III cognitive composite scores correlated with higher neonatal mean and peak serum CRP (Rho =-0.298, p = 0.008; Rho =-0.325, p = 0.002), respectively. Lower BSID-III motor composite and fine-motor scores correlated with higher mean CRP (Rho =-0.264, p = 0.013; Rho =-0.292, p = 0.008) and peak CRP (Rho =-0.275, p = 0.009; Rho =-0.262, p = 0.013), respectively. Slower gait velocity correlated with higher mean and peak CRP (Rho =-0.298, p = 0.008; Rho =-0.279, p = 0.013). Higher mean and peak CRP correlated with lower serum albumin (Rho =-0.338, p = 0.001; Rho =-0.398, p = 0.000). Lower BSID-III motor composite score correlated with lower neonatal mean serum albumin (Rho = 0.262, p = 0.013) and to higher serum bilirubin (Rho = 0.230, p = 0.029). Risk factors analyzed were found to be noncollinear (VIF<10). Conclusion(s): Low to moderate associations found between neonatal inflammatory risk factors in relation to neurodevelopment and gait at 18-22 months of age suggest associations between early neurodevelopmental outcomes and biomarkers including neonatal BPD, CRP, albumin, and bilirubin warrant further investigation. Preliminary analysis of this ongoing research may offer neonatal clues that may ultimately inform neuroprotective treatment to improve neurodevelopment and quality of life for preterm children.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71505199
TI  - Importance of vitamin a for lung maturation and function
AU  - Biesalski H.K.
Y1  - 2014//
KW  - *fetus lung maturation
KW  - *perinatal care
KW  - *supplementation
KW  - female
KW  - human
KW  - pregnancy
KW  - lung
KW  - maternal plasma
KW  - umbilical cord blood
KW  - maturation
KW  - animal experiment
KW  - retinol deficiency
KW  - diabetes mellitus
KW  - protein synthesis
KW  - chronic disease
KW  - lung development
KW  - vaginal delivery
KW  - child
KW  - newborn
KW  - pilot study
KW  - prematurity
KW  - blood
KW  - infant
KW  - colostrum
KW  - lung dysplasia
KW  - consensus
KW  - population
KW  - smoking
KW  - gestation period
KW  - metabolite
KW  - premature labor
KW  - fetus lung
KW  - gene expression
KW  - risk
KW  - inhalation
KW  - Germany
KW  - World Health Organization
KW  - *retinol
KW  - carotene
KW  - retinoic acid
KW  - vitamin
KW  - surfactant
KW  - protein
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 27
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - H.K. Biesalski, Food Security Center and Dept. Biological Chemistry and Nutrition, University Stuttgart-Hohenheim, Garbenstrass 30n D 70593, Stuttgart, Germany
DO  - https://dx.doi.org/10.3109/14767058.2014.924236
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71505199
AB  - Brief Introduction: During pregnancy and the breastfeeding period the need for vitamin A and beta-carotene is increased. On average, intake should be one third higher during pregnancy and during the breastfeeding period it should be 0.7 mg/day higher than for nonpregnant or non-breastfeeding women. Based on studies in Germany and the US inadequate vitamin A supply (30% below recommendation) is evident in females in 45-65%. Due to the importance of the (Figure presented) vitamin for lung development and maturation, sufficient intake should be especially ensured during the second and third pregnancy trimesters.In different studies it was shown that the risk of Bronchopulmonary Dysplasia in preterm infants showing insufficient vitamin A supply is significantly increased. Material(s) and Method(s): The study was conducted as a cross sectional pilot study. 23 women with single conception pregnancy within short birthrates defined as second delivery within 24 months were recruited consecutively at the Universitatsfrauenklinik Ulm between September 03 and August 04. Additionaly 6 women with gemini birth were enrolled to the study. Participants were healthy with absence of chronic disease during pregnancy (gestational diabetics), aged between 20 and 40, normal delivery, full term gestational period (>36 + 0) and smoking less than 5 cigarettes/day. Women were eligible to be enrolled to the study if prenatal no supplementation with>2000 IE/day vitamin A nor with beta-carotene>2 mg/day occurred. Clinical Cases or Summary Results: The frequency distribution of maternal plasma retinol showed that 27.5% of the study population had levels below 1.4 mumol/L which can be taken as a boarderline deficiency near to the deficiency range (<1.05 mumol/L) according to WHO (REF). In one case the retinol level was in a clear vitamin A deficiency range (0.66 mumol/L).It becomes evident, that in cases of multiparous birth mean values of retinol and beta-carotene were significantly lower in samples of maternal plasma (p<0.05) and colostrum (p<0.0001) for retinol. Mean cord blood concentration was 0.51 umol which was significantly lower than the borderline to inadequacy of 0.7umol. There is no clear consensus on the "cut-off" concentration for vitamin A deficiency in cord blood. Levels below 0.35 and 0.7mumol/L are discussed. Taking 0.35 mumol/L as cut off levels, 31% of newborn showed levels below. Conclusion(s): Despite a good scioeconomic status vitamin A supply in pregenant females was below the recommended intake and with consequences for the supply of the developing child. There is clear evidence from human and animal studies that the lung needs vitamin A during the last 3-4 weeks prior delivery for adequate maturation (e.g. surfactant protein synthesis). The active metabolite of vitamin A, retinoic acid, which controls gene expression of a couple of important proteins in the lung, is delivered from specific vitamin A stores in the lung. If vitamin A stores in the embryonic lungs are not formed at the beginning of the last trimester the formation of retinoic acid in the lung might be inadequate. This raises the question how vitamin A status might be improved in particular in cases of preterm birth. In animal experiments we tested different supply routes (parenteral, inhalation) to elucidate how we can increase the vitamin A concentration in the lung. Whether this might be an approach for humans needs to be discussed.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasia.
DO  - https://dx.doi.org/10.3892/ijmm.2015.2347
AU  - Xing, Yujiao
AU  - Fu, Jianhua
AU  - Yang, Haiping
AU  - Yao, Li
AU  - Qiao, Lin
AU  - Du, Yanna
AU  - Xue, Xindong
Y1  - 2015//
Y2  - 20150917//
KW  - Animals
KW  - *Animals, Newborn/ge [Genetics]
KW  - *Bronchopulmonary Dysplasia/ge [Genetics]
KW  - *Bronchopulmonary Dysplasia/pa [Pathology]
KW  - Disease Models, Animal
KW  - Hyperoxia/ge [Genetics]
KW  - Hyperoxia/pa [Pathology]
KW  - *Lung/pa [Pathology]
KW  - *MicroRNAs/ge [Genetics]
KW  - Platelet Endothelial Cell Adhesion Molecule-1/ge [Genetics]
KW  - Proliferating Cell Nuclear Antigen/ge [Genetics]
KW  - RNA, Messenger/ge [Genetics]
KW  - Rats
KW  - Rats, Wistar
T2  - International journal of molecular medicine
VL  - 36
IS  - 5
SN  - 1107-3756
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26398774
AD  - Greece
AB  - In this study, we investigated the mechanisms through which microRNAs (miRNAs or miRs) regulate lung development after birth, as well as the role of miRNAs in the development of bronchopulmonary dysplasia (BPD). For this purpose, a total of 90 neonatal Wistar rats were randomly and equally assigned to either a model group or a control group. On postnatal days 3, 7 and 14, the lung tissues were collected for histological analysis to determine morphological changes. The expression levels of proliferating cell nuclear antigen (PCNA) and platelet endothelial cell adhesion molecule-1 (PECAM-1, also known as CD31) were measured by RT-qPCR and western blot analysis. A miRCURY TM LNA array was employed to screen for differentially expressed miRNAs, and the possible target genes of those miRNAs were predicted. Our results revealed that, compared with the control group, the following changes induced by hyperoxia were observed in the model group over time: a decrease in the number, but an increase in the size of the alveoli, and a decrease in the number of secondary septa formed. In the model group, from postnatal days 3-14, the mRNA and protein expression levels of PCNA and CD31 were significantly lower than those in the control group. The differentially expressed miRNAs between the 2 groups were identified on days 3, 7 and 14 after birth. Possible target genes were identified for 32 differentially expressed miRNAs. Taken together, these findings suggest that during the development of BPD, an alveolarization disorder with microvascular dysplasia co-exists with the differential expression of certain miRNAs during the different stages of alveolar development in a neonatal rat model of hyperoxia-induced BPD. This indicates that miRNAs may participate in the occurrence and development of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71504983
TI  - Evaluation of association between adam33 gene polymorphism and suspectibility to bronchopulmonary dysplasia in preterm infants
AU  - Cetinkaya M.
AU  - Varturk I.
AU  - Korachi M.A.
AU  - Akin I.M.
AU  - Guven S.
AU  - Buyukkale G.
AU  - Erener-Ercan T.
AU  - Ozumut S.
Y1  - 2014//
KW  - *lung dysplasia
KW  - *DNA polymorphism
KW  - *perinatal care
KW  - *prematurity
KW  - *human
KW  - *infant
KW  - genotype
KW  - gestational age
KW  - lung function
KW  - female
KW  - diseases
KW  - wheezing
KW  - asthma
KW  - hospital
KW  - Apgar score
KW  - artificial ventilation
KW  - morbidity
KW  - blood sampling
KW  - gene
KW  - airway remodeling
KW  - pregnancy
KW  - birth weight
KW  - embryo
KW  - prospective study
KW  - intensive care unit
KW  - newborn intensive care
KW  - lung development
KW  - extracellular matrix
KW  - national health organization
KW  - oxygen therapy
KW  - risk
KW  - risk factor
KW  - gene frequency
KW  - child
KW  - allele
KW  - control group
KW  - patient
KW  - airway resistance
KW  - pathogenesis
KW  - disintegrin
KW  - glycoprotein
KW  - surfactant
KW  - metalloproteinase
KW  - genomic DNA
KW  - DNA
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 27
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - M. Cetinkaya, Neonatology Dept., Kanuni Sultan Suleyman Training ad Research Hospital, Istanbul, Turkey
DO  - https://dx.doi.org/10.3109/14767058.2014.924236
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71504983
AB  - Brief Introduction: ADAM 33 is a disintegrin and metalloproteinase glycoprotein that is involved in intercellular and cell-matrix interactions. It was suggested to be important for normal lung development in the embryo as the expression of ADAM 33 can be observed as early as 8-12 weeks after gestation. Although several studies have demonstrated an association between ADAM33 and asthma, bronchial hyperresponsiveness, progression of wheezing illness, airway remodelling, lower lung functions, accelerated lung function decline and higher specific airway resistance in children, no study evaluated the role of ADAM33 in bronchopulmonary dysplasia (BPD). The aim of this study was to investigate the possible association between ADAM33 gene polymorphism and susceptibility to BPD development. Material(s) and Method(s): A total of 120 preterm infants born at gestational age <= 32 weeks and admitted to the Neonatal Intensive Care Unit (NICU) were enrolled to this prospective study. BPD was defined according to the National Institute of Child Health and Human Development. Detailed perinatal history (birth weight, gestational age, Apgar score at 1, and 5 min after birth) and history of treatment in the hospital (duration of mechanical ventilation and total oxygen therapy, need of surfactant treatment, other morbidities) were recorded during the study period. Blood samples were stored at <= 20 degreeC. Genomic DNA was extracted from these samples. ADAM33 gene at rs 2280090 was analyzed. Allelic frequencies and genotype frequencies were determined from BPD patients and healthy controls. Clinical Cases or Summary Results: A total of 120 preterm infants were enrolled. The frequency of AA genotype and GG genotype were significantly higher than those of GA genotype in infants with BPD compared with the infants without BPD. Comparison of the frequency distribution of ADAM 33 in BPD and healthy control groups revealed the presence of A allele was a risk factor for BPD infants. The homozygos AA and GG genotypes were found to be associated with BPD development. Conclusion(s): To our best of knowledge, this is the first study that suggested a possible association between ADAM33 gene polymorphism and increased frequency of BPD in preterm infants. Future studies are needed to assess the contribution of ADAM 33 to the pathogenesis of BPD and to determine if ADAM 33 gene polymorphisms may be helpful to identify infants at high risk for BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71504967
TI  - CYP2B6 genetic polymorphism and the risk of bronchopulmonary dysplasia in preterm neonates
AU  - Daraki A.
AU  - Gavrili S.
AU  - Zachaki S.
AU  - Boudouvi E.
AU  - Baroutis D.
AU  - Polycarpou E.
AU  - Manola K.N.
AU  - Baroutis G.
Y1  - 2014//
KW  - *lung dysplasia
KW  - *genetic polymorphism
KW  - *genetic susceptibility
KW  - *DNA polymorphism
KW  - *prematurity
KW  - *human
KW  - *risk
KW  - *newborn
KW  - *perinatal care
KW  - genotype
KW  - control group
KW  - birth weight
KW  - gestational age
KW  - allele
KW  - mutant
KW  - statistical analysis
KW  - gene
KW  - oxidative stress
KW  - lung alveolus epithelium
KW  - exposure
KW  - therapy
KW  - Greece
KW  - case control study
KW  - amino acid sequence
KW  - environmental factor
KW  - blood
KW  - blood sampling
KW  - single nucleotide polymorphism
KW  - mutation
KW  - baby
KW  - dental floss
KW  - statistical significance
KW  - oxygen
KW  - digestant
KW  - reactive oxygen metabolite
KW  - genomic DNA
KW  - DNA
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 27
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - A. Daraki, Laboratory of Health Physics, Radiobiology and Cytogenetics, NCSR Demokritos, Athens, Greece
DO  - https://dx.doi.org/10.3109/14767058.2014.924236
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71504967
AB  - Brief Introduction: The development of bronchopulmonary dysplasia (BPD) involves genetic and environmental factors. Although supplemental oxygen is the most commonly used therapy, direct exposure to oxygen can damage the pulmonary epithelium through the generation of reactive oxygen species (ROS). CYP2B6, a phase I metabolic enzyme, encoded from the corresponding CYP2B6 gene, inactivates ROS protecting cells from oxidative stress. CYP2B6 G516T single-nucleotide-polymorphism changes the amino-acid sequence (Gln172His), resulting in enzymatic inactivation. Homozygous and heterozygous for the mutant T allele neonates present reduced capacity to counteract products of ROS and thus may be at increased risk of BPD. Material(s) and Method(s): The aim of this study was to investigate the potential role of CYP2B6 germline polymorphism in BPD susceptibility. This case-control study enrolled 82 Greek premature neonates with gestational age <=32 weeks. Among these, 33 developed BPD (case group) and 49 did not develop BPD (control group). Genomic DNA was extracted from peripheral blood samples of all neonates. The CYP2B6 genotype was performed by PCR-RFLPs. Clinical Cases or Summary Results: No significant difference was found between the BPD and control groups concerning sex and mode of delivery. However, mean birth weight and gestational age of BPD cases were significantly lower than controls' (953 +/- 196g vs 1325 +/- 266g and 27.8 +/- 1.6 vs 30.2 +/- 1.7, respectively) (p1200g). The statistical analysis revealed a higher incidence of the variant genotypes in BPD neonates of <=1200g than in no BPD neonates of the same birth weight cohort (46.6% vs 35.7%, respectively), but this difference did not reach statistical significance. Interestingly, all babies carrying the homozygous CYP2B6 mutant genotype developed BPD, while none of the control group carried the mutation in homozygous status. In conclusion, a higher frequency of heterozygous (G/T) and homozygous (T/T) neonates for the CYP2B6 polymorphism was observed among neonates who developed BPD compared to controls. Conclusion(s): Our study comprises the first investigation of the G516T CYP2B6 inactivating gene polymorphism in BPD development. Further studies including a larger number of BPD and no BPD preterm neonates are required to elucidate whether the nonfunctional CYP2B6 T allele is implicated in the BPD susceptibility.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71504962
TI  - Heated humidified high-flow nasal cannula versus nasal continuous positive airway pressure for postextubation ventilatory support in neonates: A meta-analysis
AU  - Daish H.
AU  - Badurdeen S.
Y1  - 2014//
KW  - *newborn
KW  - *positive end expiratory pressure
KW  - *perinatal care
KW  - *meta analysis
KW  - *nasal cannula
KW  - *extubation
KW  - human
KW  - gestational age
KW  - risk
KW  - therapy
KW  - nose injury
KW  - Mantel Haenszel test
KW  - Embase
KW  - lung dysplasia
KW  - baby
KW  - nursing
KW  - Medline
KW  - confidence interval
KW  - devices
KW  - comfort
KW  - intubation
KW  - treatment failure
KW  - randomized controlled trial
KW  - model
KW  - prematurity
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 27
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - H. Daish, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom
DO  - https://dx.doi.org/10.3109/14767058.2014.924236
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71504962
AB  - Brief Introduction: There has been remarkable interest in recent years in the use of heated humidified high-flow nasal cannula (HHHFNC) as a means of providing post-extubation ventilatory support in preterm neonates. Whilst the perceived advantages of reduced nasal trauma and ease-of-use make this an attractive therapy, there is ongoing debate as to its relative efficacy for providing non-invasive ventilatory support when compared to nasal continuous positive airway pressure (nCPAP). Recent trials have attempted to address this important question; however an upto date meta-analysis to provide a bestevidence answer is lacking, and is urgently needed. The objective of this meta-analysis was to assess the efficacy of HHHFNC versus nCPAP in avoiding extubation failure in neonates. Material(s) and Method(s): For studies prior to June 2010, we searched through the list of included and excluded studies generated in the systematic search of a recent Cochrane review (Wilkinson et al. 2011). We updated the search in PubMed, Embase and clinicaltrials. gov for randomised trials assessing the use of high-flow nasal therapy in neonates, published since 2010. The reference lists of articles reviewed in full-text were also screened for relevant studies. Randomised trials examining extubation failure rates in neonates extubated to HHHFNC compared to nCPAP were included. Data were extracted and risk of bias for each study assessed. Meta-analysis was performed with the Mantel-Haenszel method using a random-effects model. Clinical Cases or Summary Results: Three Randomised Controlled Trials (RCTs) with data for 726 neonates were identified for inclusion. Two RCTs (435 neonates) studied neonates born at less than 32 weeks gestational age with the outcome as treatment failure within 7 days of extubation. One RCT (291 neonates) studied neonates born between 28 and 42 weeks gestational age with re-intubation within 72 hours as the outcome. Vapotherm, Optiflow or Comfort Flo devices were used as HHHFNC. None of the studies reported a significant difference in extubation failure rates between HHHFNC and nCPAP groups. The average effect across all studies in the pooled analysis also showed no significant difference between HHHFNC versus nCPAP with respect to extubation failure rate (risk ratio 1.15, 95% confidence interval 0.67-1.97), with a high degree of heterogeneity between studies (I2 66%). Conclusion(s): There is no significant difference in the rate of extubation failure in neonates extubated to HHHFNC compared with those extubated to nCPAP. Given the advantages of HHHFNC with regard to nasal trauma and easier nursing, it may be attractive alternative to nCPAP following extubation. There is limited data for babies less than 26 weeks gestational age, and longer term outcomes, such as rates of bronchopulmonary dysplasia should be evaluated.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71504959
TI  - Caffeine, a potent modulator of lung surfactant homeostasis and airway remodeling
AU  - Fehrholz M.
AU  - Kunzmann S.
AU  - Speer C.P.
Y1  - 2014//
KW  - *airway remodeling
KW  - *homeostasis
KW  - *perinatal care
KW  - human
KW  - parameters
KW  - epithelium cell
KW  - cell line
KW  - airway
KW  - host resistance
KW  - lung function
KW  - lung dysplasia
KW  - defense mechanism
KW  - newborn
KW  - prematurity
KW  - lung
KW  - erythroleukemia
KW  - newborn period
KW  - protein expression
KW  - virus oncogene
KW  - immunoblotting
KW  - limit of detection
KW  - stimulation
KW  - pathogenesis
KW  - *caffeine
KW  - *lung surfactant
KW  - *surfactant
KW  - messenger RNA
KW  - transgelin
KW  - protein
KW  - connective tissue growth factor
KW  - dexamethasone
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 27
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - M. Fehrholz, University Children's Hospital, University of Wuerzburg, Germany
DO  - https://dx.doi.org/10.3109/14767058.2014.924236
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71504959
AB  - Brief Introduction: Administration of caffeine is a common therapeutic intervention in the neonatal period. However, caffeine mediated effects on lung epithelial cells are still poorly defined. The aim of the present study was to assess the impact of caffeine on expression of surfactant proteins (SPs) as key parameters of surfactant homeostasis as well as on selected members of airway remodeling processes, like connective tissue growth factor (CTGF) and transgelin, implicated in the pathogenesis of bronchopulmonary dysplasia (BPD). Material(s) and Method(s): The human airway epithelial cell lines A549 and H441 were treated with different doses of caffeine in combination with dexamethasone (DEX) or TGF-beta1, respectively. After 24 h mRNA and/or protein expression of surfactant proteins A, B, C, and D, the SPB transcription cofactor erythroblastic leukemia viral oncogene homolog 4 (ErbB4), as well as CTGF and transgelin were determined by quantitative PCR and immunoblotting. Clinical Cases or Summary Results: While caffeine was able to modulate SP-B mRNA levels after induction with DEX in H441 (206 +/- 59.7-fold, p<0.001) and A549 cells (31.4 +/- 11.1-fold, p<0.05), respectively, SP-D mRNA levels in H441 cells were also affected, but to a lesser extend (4.8 +/- 1.0-fold, p<0.05). Levels of mature SP-B were also elevated by caffeine for high (p<0.05) as well as low (p<0.05) concentrations in combination with DEX. Caffeine was also able to induce higher expression of ErbB4 mRNA in H441 cells alone (5.1 +/- 1.9-fold, p<0.05) as well as in combination with DEX (7.0 +/- 2.4-fold, p<0.05). SP-A1 mRNA levels were not influenced by caffeine and SP-C mRNA levels were below the detection limit in both cell lines. After stimulation with TGF-beta1, caffeine diminished the induction of CTGF mRNA (0.5 +/- 0.1- fold, p<0.05) as well as transgelin mRNA (0.6 +/- 0.1-fold, p<0.05) in A549 cells, which could also be confirmed on the protein level. Conclusion(s): Given the observed effects, it is most likely that caffeine is able to influence diverse key parameters of surfactant homeostasis and airway remodeling processes. These results may help to understand how caffeine is able to improve lung function and innate host defense mechanisms of premature neonates.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71504564
TI  - Overview of attempts to prevent bronchopulmonary dysplasia (BPD)
AU  - Shinwell E.S.
Y1  - 2014//
KW  - *lung dysplasia
KW  - *perinatal care
KW  - prematurity
KW  - morbidity
KW  - genetic predisposition
KW  - infection
KW  - artificial ventilation
KW  - patent ductus arteriosus
KW  - nutrition
KW  - male
KW  - ventilator
KW  - therapy
KW  - lung
KW  - healing
KW  - oxygen
KW  - vitamin
KW  - caffeine
KW  - steroid
KW  - nitric oxide
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 27
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - E.S. Shinwell, Department of Neonatology, Ziv Medical Center, Tsfat, Bar-Ilan University, Israel
DO  - https://dx.doi.org/10.3109/14767058.2014.924236
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71504564
AB  - The continuing prominence of BPD as a major morbidity of prematurity reflects the difficulties inherent in trying to prevent a complex condition of multifactorial origin. Contributing factors include prematurity itself, together with mechanical ventilation, oxygen, patent ductus arteriosus (PDA), infections, genetic predisposition, male sex and postnatal nutritional failure. This session will review recent advances, both pharmacologic and non-pharmacologic interventions that aim to prevent BPD. Three talks will describe new ventilator approaches and this specific talk will focus on other interventions. Interventions that will be discussed will include therapies such as caffeine, steroids (systemic or inhaled), nitric oxide and vitamin A. The controversial role of pharmacologic or surgical closure of the hemodynamically-significant PDA will be reviewed. Early aggressive nutrition for promotion of lung healing will also be discussed. Experimental approaches that have not yet reached the clinical arena will also be addressed.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71504559
TI  - Inhaled steroids for prevention of bronchopulmonary dysplasia (BPD): What is the evidence?
AU  - Poets C.F.
AU  - Bassler D.
AU  - Carnielli V.
AU  - Halliday H.
AU  - Hallman M.
AU  - Jarreau P.H.
AU  - Plavka R.
AU  - Schwab M.
AU  - Shinwell E.
AU  - Van Den Anker J.
Y1  - 2014//
KW  - *prevention
KW  - *lung dysplasia
KW  - *perinatal care
KW  - infant
KW  - human
KW  - inhalation
KW  - survival
KW  - prematurity
KW  - mortality
KW  - patient
KW  - topical drug administration
KW  - adverse drug reaction
KW  - extremely low birth weight
KW  - pharmacogenetics
KW  - pharmacokinetics
KW  - assisted ventilation
KW  - nerve cell differentiation
KW  - survivor
KW  - death
KW  - risk
KW  - gestational age
KW  - population
KW  - data base
KW  - metered dose inhaler
KW  - multicenter study
KW  - genetic susceptibility
KW  - Netherlands
KW  - Israel
KW  - neurosis
KW  - European Union
KW  - Germany
KW  - France
KW  - Estonia
KW  - financial management
KW  - Italy
KW  - Czech Republic
KW  - Belgium
KW  - controlled study
KW  - therapy
KW  - health care
KW  - *steroid
KW  - budesonide
KW  - oxygen
KW  - dexamethasone
KW  - corticosteroid
KW  - placebo
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 27
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - C.F. Poets, Dept. of Neonatology, University Hospital, Tuebingen, Germany
DO  - https://dx.doi.org/10.3109/14767058.2014.924236
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71504559
AB  - Survival of Extremely Low Birth Weight (ELBW) infants has improved in recent decades but BPD remains a major health care problem, contributing not only to the mortality of preterm infants but being also associated with impaired neurosensory development in survivors. For many years, dexamethasone was the main drug used to prevent BPD. Reports on adverse effects of dexamethasone on growth and neurodevelopmental outcomes, however, turned the enthusiastic use of systemic postnatal steroids into almost complete avoidance, with a subsequent increase in the incidence of BPD. An alternative would be topical application, i.e. via inhalation, but despite a widespread use of this therapy, its effectiveness has never been convincingly shown. With financial support from the 7th Framework Programme of the European Union, we thus launched NEuroSIS, a European multicentre study to investigate whether early prophylactic inhalation of Budesonide (Budiair, Chiesis) reduces the absolute risk of BPD or death in preterm infants born <28 weeks gestational age (GA) by 10%. Our primary objective was to determine whether inhalation of Budesonide within 12 hours of life improves survival without BPD at 36 weeks GA in infants born between 23 and 27 weeks GA. Secondary objectives were whether prophylactic inhalation of Budesonide affects neurodevelopment at a corrected age of 18-22 months, to determine whether inhalation of corticosteroids is associated with adverse treatment effects, alters mortality or BPD incidence at 36 weeks GA, and the duration of positive pressure respiratory support or supplemental oxygen. Data on the pharmacokinetics and pharmacogenetics of inhaled corticosteroids were also collected and a substudy on the genetic susceptibility to BPD performed. The study was designed as a randomised placebo-controlled trial, enrolling a total of 850 infants of 23-27 weeks GA in 40 centres across 8 countries (Belgium, Czech Republic, Estonia, France, Germany, Israel, Italy, The Netherlands). Infants were randomised during the first 12 hours of life to Budesonide or placebo to prevent BPD. Study drugs was administered via a metered dose inhaler (MDI; Aerochamber Mini) and continued until infants were either off supplementary oxygen and positive pressure support or had reached a GA of 32 0/7 weeks regardless of ventilatory status. The primary outcome of survival without BPD was determined at 36 weeks GA and BPD defined according to the physiological definition. Study patients were followed and neurodevelopmental outcomes assessed at a corrected age of 18-22 months. Recruitment was closed in July 2013 and the database in March 2014, but results will only become available in October 2014. It is hoped that results of this trial will ultimately provide guidance to clinicians whether inhaled steroids are an effective measure to reduce BPD in this vulnerable patient population.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71504540
TI  - NCPAP vs. NIPPV vs. heated humidified high-flow nasal cannula (HHHFNC) for the treatment of premature infants with RDS
AU  - Kugelman A.
Y1  - 2014//
KW  - *infant
KW  - *human
KW  - *nasal cannula
KW  - *prematurity
KW  - *perinatal care
KW  - *respiratory distress syndrome
KW  - extubation
KW  - air conditioning
KW  - intubation
KW  - newborn apnea
KW  - extremely low birth weight
KW  - meta analysis
KW  - positive end expiratory pressure
KW  - baby
KW  - ventilator
KW  - breathing
KW  - risk
KW  - gas
KW  - endotracheal intubation
KW  - lung function test
KW  - death
KW  - nasal prong
KW  - lung dysplasia
KW  - implantable cardioverter defibrillator
KW  - intermittent positive pressure ventilation
KW  - personnel
KW  - general condition
KW  - maturation
KW  - follow up
KW  - artificial ventilation
KW  - prospective study
KW  - morbidity
KW  - adverse drug reaction
KW  - cerebral palsy
KW  - energy cost
KW  - lung
KW  - delivery room
KW  - lung dead space
KW  - health care quality
KW  - apnea
KW  - resuscitation
KW  - risk reduction
KW  - risk factor
KW  - conditioning
KW  - lung mechanics
KW  - thorax wall
KW  - respiratory drive
KW  - safety
KW  - upper respiratory tract
KW  - randomized controlled trial (topic)
KW  - survival
KW  - surfactant
KW  - steroid
KW  - oxygen
KW  - carbon dioxide
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 27
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - A. Kugelman, Department of Neonatology and Pediatric Pulmonary Unit, Bnai Zion Medical Center, B and R Rappaport Faculty of Medicine, Technion, Haifa, Israel
DO  - https://dx.doi.org/10.3109/14767058.2014.924236
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71504540
AB  - The aim of the management of premature infants with respiratory distress syndrome (RDS) is to provide interventions that will maximize survival whilst minimizing potential adverse effects,1 mainly bronchopulmonary dysplasia (BPD). At delivery, the term stabilization is preferred to resuscitation for the vast majority of very preterm infants. Only a minority of babies should require delivery room intubation. Recent large trials that reflect current practice (including greater utilization of maternal steroids and routine post delivery stabilization on NCPAP) demonstrate less risk of BPD or death when using early stabilization on NCPAP with selective surfactant administration to infants requiring intubation.2 The comprehensive strategy to prevent BPD in the NICU is based on ventilatory and non-ventilatory measures.3 The ventilatory route allows an individualized endotracheal intubation approach. Recent studies concluded that early nasal CPAP (NCPAP) is a safe alternative to immediate intubation in extremely low birth weight (ELBW) infants.4,5 Endotracheal intubation and ventilation can result in significant damage to premature lungs and are independently associated with cerebral palsy. Furthermore, despite new modes of ventilation and surfactant, BPD remains a significant morbidity and its incidence was correlated with the use and length of endotracheal mechanical ventilation. BPD in itself is associated with adverse neurodevelopmental outcome. Thus, we need to avoid endotracheal ventilation, if possible. NCPAP is recommended as the early primary treatment of active RDS (to avoid intubation or as part of the INSURE [INtubation SURfactant Extubation] approach), or later, post extubation at RDS resolution, in order to allow shortening of the duration of endotracheal ventilation and to treat apnea of prematurity.1 New studies4,5 report comparable rates of BPD in ELBW infants treated initially with NCPAP as compared to endotracheal ventilation with surfactant administration. Can we enhance NCPAP and get better outcome for NRS by using nasal intermittent positive pressure ventilation (NIPPV)? NIPPV was defined as a method of augmenting NCPAP by delivering ventilator breaths via nasal prongs. The rationale behind the use of NIPPV is the administration of "sigh" to the infant, thus opening microatelectasis and recruiting more ventilation units. It was shown that synchronized NIPPV (SNIPPV) compared with NCPAP may improve the patency of the upper airway, could activate the respiratory drive, improves thoraco-abdominal synchrony, stabilizes the chest wall, improves lung mechanics and decreases the work of breathing in premature infants. When NIPPV was compared to NCPAP for the different indications of NRS, it was shown to enhance the potential of NRS.3 A recent meta-analysis demonstrated a relative risk reduction for intubation in the first 72 hours in the NIPPV group compared with NCPAP (RR 0.60, 95% CI 0.43, 0.83).6 The NIPPV trial7 was a large international multicenter randomized trial powered to study the important outcome of BPD, recruiting 1009 extremely low birth weight babies, and it showed no difference between babies randomized to NIPPV compared with CPAP. Yet, the results of this study should be considered with caution because of several limitations. For example: There was no uniform experience and equipment used for NIPPV among participating centers; approximately 50% of the infants were supported with biphasic CPAP that is a limited form of NIPPV (maximal peak inspiratory pressure of 9-10 cm H2O in that study). SNIPPV vs. NCPAP for later use, post extubation at RDS resolution, as a "bridge" to spontaneous unsupported breathing was shown to be more effective than NCPAP. A pooled meta-analysis showed that SNIPPV was more effective than NCPAP in preventing failure of extubation [RR 0.21 (0.10, 0.45)] and the number needed to treat was only 3 infants to prevent one extubation failure.8 SNIPPV vs. NCPAP, post extubation, also tended to decrease the rate of BPD.3 SNIPPV may be more effective than NCPAP also for apnea of prematurity.3 A meta-analysis, regarding apnea of prematurity, suggests that SNIPPV is more efficacious with apnea that is frequent or severe. However, the studies performed addressed short-term outcomes and as such could not address properly the incidence of requirement for reintubation. Thus, more studies are needed before recommending SNIPPV as standard of care for apnea of prematurity. To summarize, the available evidence supports the preference of early or later use of NIPPV/SNIPPV compared to NCPAP because of minimizing the use and the length of endotracheal ventilation.3 There are data to suggest that this approach may also reduce the rate of BPD, however this was not shown yet.3 The results of a large international RCT comparing both primary, and post-extubation use of NIPPV with NCPAP, with a composite primary outcome of death or BPD at 36 weeks' corrected age indicate no additional benefit, or risk, conferred by NIPPV in comparison to NCPAP.7 Whether NIPPV/SNIPPV is more beneficial than NCPAP within the INSURE approach needs to be shown. Recently, heated, humidified high-flow nasal cannula (HHHFNC) is frequently used as a mode of NRS. High flows result in washout of anatomical and physiological dead space and contribute to improved fractions of alveolar gases with respect to carbon dioxide as well as oxygen and decrease the work of breathing and the energy cost of gas conditioning. HHHFNC probably creates positive end expiratory pressure (PEEP) that may contribute to its beneficial effect. However, the PEEP that is not monitored, had raised concerns regarding the safety of HHHFNC in terms of air leak. Recent prospective studies support the notion that HHHFNC is as effective as NCPAP for early stages of RDS,9 post extubation,10,11 and for apnea of prematurity.12 There is one study that found HHHFNC to be as effective as NIPPV for the initial treatments of RDS in infants >1000 g.13 Yet, more studies, especially in the initial treatment of RDS and in ELBW infants, are needed before adopting HHHFNC as an alternative mode of NRS in these conditions. The noninvasive ventilator strategy needs to be confirmed by large prospective randomized controlled trials (with long-term follow up) in order to assure it is applicable to most ELBW infants. Furthermore, the strategy needs to be tailored to individualized infants according to the infant's maturation; antenatal steroid treatment and severity of RDS; general condition; and to certain practical NICU conditions such as experience, personnel and timing during the day.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71501544
TI  - Suspected fatal transfusion-related acute lung injury (trali) in a neonate following red cell transfusion: A case report
AU  - Naim N.
AU  - Kambali M.M.
AU  - Cheah I.
AU  - Mohammad Ismail H.I.
AU  - Hassan R.
Y1  - 2014//
KW  - *transfusion related acute lung injury
KW  - *newborn
KW  - *erythrocyte
KW  - *transfusion
KW  - *human
KW  - *case report
KW  - *society
KW  - *blood transfusion
KW  - *hematology
KW  - *organization
KW  - female
KW  - patient
KW  - donor
KW  - cause of death
KW  - thorax radiography
KW  - adverse drug reaction
KW  - blood component
KW  - sepsis
KW  - Pseudomonas
KW  - heart atrium septum defect
KW  - mechanical ventilator
KW  - respiratory distress syndrome
KW  - oxygen saturation
KW  - intensive care unit
KW  - newborn intensive care
KW  - diagnosis
KW  - feeding
KW  - child
KW  - ambient air
KW  - erythrocyte concentrate
KW  - lung infiltrate
KW  - hyaline membrane disease
KW  - weight gain
KW  - pregnancy
KW  - pH
KW  - metabolic acidosis
KW  - respiratory acidosis
KW  - ward
KW  - arterial gas
KW  - newborn jaundice
KW  - respiratory failure
KW  - recipient
KW  - hypotension
KW  - hospital infection
KW  - bacterium contamination
KW  - patent
KW  - twins
KW  - antibody
KW  - antibiotic agent
KW  - antihypertensive agent
KW  - diuretic agent
KW  - hemoglobin
T2  - Vox Sanguinis
LA  - English
VL  - 107
IS  - SUPPL. 1
PB  - Blackwell Publishing Ltd
SN  - 0042-9007
AD  - N. Naim, National Blood Centre, Kuala Lumpur, Malaysia
DO  - https://dx.doi.org/10.1111/vox.12155
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71501544
AB  - Background: Transfusion-Related Acute Lung Injury (TRALI) is a potentially fatal complication of blood transfusion. Despite increased awareness and better understanding of the condition, diagnosing TRALI may not be as straight forward, particularly when it involved children and neonates. Aim(s): To discuss the possibility of TRALI as the cause of death of a neonate following red cell transfusion. Case Report: This case involved a female neonate, second of a twin born prematurely at 30th week of gestation. She was initially managed in the Neonatal Intensive Care Unit (NICU) with respiratory distress syndrome, atrial septal defect, patent ductus ateriosus and neonatal jaundice. As her condition improved, she was transferred out to the general ward while awaiting weight gain and discharge. One morning patient was noted to be anaemic with haemoglobin of 7.7 g/dl. Decision was made to transfuse her 30 ml of packed red cell with diuretic cover. Transfusion was completed within 4 h without incident. Two hours post transfusion she was noted to be lethargic with poor feeding. Working diagnosis of presumed sepsis was made, septic work-up performed and intravenous antibiotics started. At 4 h post transfusion her oxygen saturation (SpO2) level dropped to below 88% under room air. Four hours later she became hypotensive, tachycardic and apnoeic, requiring mechanical ventilator support. Chest radiographs taken showed bilateral pulmonary infiltrates. Despite continuous intensive intervention, patient condition worsened with intractable hypotension, respiratory failure and renal shut down. She passed away less than 48 h after the transfusion. Results/Discussion: Arterial blood gas taken 6 h post-transfusion showed respiratory acidosis with metabolic acidosis (pH = 7.045, SpO2 = 81.2%, PaO2 = 50.4 mmHg, PaCO2 = 60.5 mmHg, HCO3- = 12.5 mM). Series of chest radiographs showed background of resolving Hyaline Membrane Disease (HMD) but persistent perihilar infiltrates. These findings were consistent with the patient's clinical presentation. The donor of the red cell unit was a regular female donor who was nulliparous with no history of transfusion. Other blood components prepared from this donation and that of her previous donations were safely transfused without causing any adverse reactions to the recipients. The donor was also tested negative for anti-HLA class I and II antibodies. Anti-HNA antibody however was not tested. The septic work-up performed on the patient was positive for Pseudomonas spp. confirming her underlying nosocomial infection. However, with patient remained afebrile throughout and tests on the remains of the transfused red cell unit and other blood components prepared from the same donation were negative for any bacterial contamination, septic transfusion was ruled out as the cause of the adverse reaction she had. Conclusion(s): From the clinical presentation and the investigations performed on both patient and donor, it was difficult to conclude that TRALI was the cause of death. Despite septic work-up was positive for Pseudomonas spp., septic transfusion was ruled out. Thus it was decided that the patient's cause of death was 'Nosocomial sepsis with TRALI cannot be excluded'.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71425624
TI  - Induction of ectopic inflammasome function in fetal lung mesenchyme
AU  - McCoy A.
AU  - Greer R.
AU  - Prince L.
Y1  - 2014//
KW  - *fetus lung
KW  - *mesenchyme
KW  - mesenchyme cell
KW  - lung
KW  - prematurity
KW  - immunocompetent cell
KW  - hypothesis
KW  - human
KW  - lung dysplasia
KW  - infant
KW  - airway
KW  - pathogenesis
KW  - mouse
KW  - inflammation
KW  - *inflammasome
KW  - interleukin 1beta
KW  - lipopolysaccharide
KW  - messenger RNA
KW  - interleukin 1beta converting enzyme
KW  - peptide
KW  - adenosine triphosphate
KW  - cytokine
KW  - interleukin 1
KW  - endotoxin
T2  - FASEB Journal
LA  - English
VL  - 28
IS  - 1 SUPPL. 1
SP  -
PB  - FASEB
SN  - 1530-6860
AD  - A. McCoy, Neuroscience and Pharmacology, Meharry Medical College, Nashville, TN, United States
UR  - http://www.fasebj.org/content/28/1_Supplement/715.4.abstract?sid=35555b08-3981-43ef-8ca6-9c5cde68cb4f
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71425624
AB  - Bronchopulmonary Dysplasia (BPD) commonly affects preterm infants. Inflammation and the soluble inflammatory mediator interleukin-1 beta (IL-1beta) play major roles in BPD pathogenesis and inhibit normal lung airway formation. IL-1beta release requires both NF-kappaB dependent mRNA expression and post-translational cleavage by caspase-1 containing inflammasomes. Best characterized in immune cells, the inflammasome has not been investigated in the developing lung. Here we test the hypothesis that the endotoxin lipopolysaccharide (LPS) can induce ectopic inflammasome expression in fetal lung mesenchyme, leading to IL-1beta release. In primary fetal mouse lung mesenchymal cells, LPS rapidly induced IL-1beta mRNA expression, but neither LPS nor the inflammasome activator ATP stimulated the release of IL-1beta peptide. However, treating mesenchymal cells with LPS for at least 6h and then stimulating with ATP did release IL-1b peptide, suggesting LPS-dependent priming. These results were consistent with immunoblots showing caspase-1 cleavage when mesenchymal cells were primed with LPS and then activated with ATP. LPS priming also increased caspase-1 mRNA expression. Mesenchymal cells expressing a constitutively active IKKbeta contained higher levels of IL-1beta and inflammasome component mRNA, but did not release IL-1beta peptide unless first primed with LPS and then activated with ATP. These data suggested that IKKbeta activity might not be sufficient to assemble a fully functional inflammasome. These data show that LPS can generate functional inflammasome expression and function in lung mesenchymal cells, potentially propagating the release of inflammatory cytokines within the lung.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71425623
TI  - NF-kappaB activation in the fetal lung promotes macrophage maturation
AU  - Stouch A.
AU  - Zaynagetdinov R.
AU  - Barham W.
AU  - Stinnett A.
AU  - Yull F.
AU  - Hoffman H.
AU  - Blackwell T.
AU  - Prince L.
Y1  - 2014//
KW  - *fetus lung
KW  - *macrophage
KW  - *maturation
KW  - lung alveolus macrophage
KW  - adult
KW  - lung
KW  - lung disease
KW  - phenotype
KW  - risk
KW  - inflammation
KW  - transgenic organism
KW  - exposure
KW  - infant
KW  - gene expression
KW  - pneumonia
KW  - prematurity
KW  - mouse
KW  - newborn
KW  - lung dysplasia
KW  - flow cytometry
KW  - agonist
KW  - macrophage activation
KW  - human
KW  - interleukin 4
KW  - marker
KW  - dioxygenase
KW  - indoleamine
KW  - protein
KW  - cytokine
KW  - fibrinogen
T2  - FASEB Journal
LA  - English
VL  - 28
IS  - 1 SUPPL. 1
SP  -
PB  - FASEB
SN  - 1530-6860
AD  - A. Stouch, Vanderbilt University, School of Medicine, Nashville, TN, United States
UR  - http://www.fasebj.org/content/28/1_Supplement/715.3.abstract?sid=35555b08-3981-43ef-8ca6-9c5cde68cb4f
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71425623
AB  - In preterm infants, exposure to inflammation increases the risk of chronic, developmental lung disease bronchopulmonary dysplasia. While macrophages are the key cells that initiate lung inflammation, little is known about lung macrophage phenotype and maturation. We hypothesized that fetal lung macrophages mature into distinct subpopulations during mouse development, and that activation could influence macrophage maturation. Expression of the fetal macrophage markers CD68, CD86, CD206, Ym1, fibrinogen-like protein 2 (FGL2), and indolamine-2, 3-dioxygenase (Ido1) was developmentally regulated. Flow cytometry analysis measured a narrow spectrum of CD11bexpression in fetal lungmacrophages, with separation into CD11bloF4/80hi and CD11bhiF4/80lo subpopulations in newborn and adult lung. Similar to adult alveolar macrophages, fetal lung macrophages responded to the TLR4 agonist LPS and the alternative activation cytokines IL-4 and IL-13. Using a macrophage-specific constitutively active IKKbetaeta transgenic model (IKFM), we demonstrated that macrophage activation increased proinflammatory gene expression and reduced the response of fetal lung macrophages to IL-4 and IL-13. Fetal IKFM lungs contained increased percentages of more mature, CD11bloF4/80hi cells that also expressed higher levels of the alternative activation markers CD204 and CD206. The maturational programming of fetal lung macrophages into mature alveolar macrophages therefore did not follow traditional proinflammatory and alternative activation paradigms.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Gene expression profile in newborn rat lungs after two days of recovery of mechanical ventilation.
DO  - https://dx.doi.org/10.1038/pr.2015.155
AU  - Denervaud, Valerie
AU  - Gremlich, Sandrine
AU  - Trummer-Menzi, Eliane
AU  - Schittny, Johannes C
AU  - Roth-Kleiner, Matthias
Y1  - 2015//
Y2  - 20150909//
KW  - Animals
KW  - Animals, Newborn
KW  - *Bronchopulmonary Dysplasia/ge [Genetics]
KW  - Disease Models, Animal
KW  - Gene Expression Profiling/mt [Methods]
KW  - *Gene Expression Profiling
KW  - Gene Expression Regulation
KW  - Lipopolysaccharides
KW  - *Lung/me [Metabolism]
KW  - Lung/pa [Pathology]
KW  - Lung/pp [Physiopathology]
KW  - Lung Diseases/ci [Chemically Induced]
KW  - Lung Diseases/pa [Pathology]
KW  - Lung Diseases/pp [Physiopathology]
KW  - *Lung Diseases/th [Therapy]
KW  - Male
KW  - Oligonucleotide Array Sequence Analysis
KW  - Rats, Wistar
KW  - *Respiration, Artificial/ae [Adverse Effects]
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Time Factors
T2  - Pediatric research
VL  - 78
IS  - 6
SN  - 0031-3998
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26353077
AD  - United States
AB  - BACKGROUND: Preterm infants having immature lungs often require respiratory support, potentially leading to bronchopulmonary dysplasia (BPD). Conventional BPD rodent models based on mechanical ventilation (MV) present outcome measured at the end of the ventilation period. A reversible intubation and ventilation model in newborn rats recently allowed discovering that different sets of genes modified their expression related to time after MV. In a newborn rat model, the expression profile 48 h after MV was analyzed with gene arrays to detect potentially interesting candidates with an impact on BPD development., METHODS: Rat pups were injected P4-5 with 2 mg/kg lipopolysaccharide (LPS). One day later, MV with 21 or 60% oxygen was applied during 6 h. Animals were sacrified 48 h after end of ventilation. Affymetrix gene arrays assessed the total gene expression profile in lung tissue., RESULTS: In fully treated animals (LPS + MV + 60% O(2)) vs. controls, 271 genes changed expression significantly. All modified genes could be classified in six pathways: tissue remodeling/wound repair, immune system and inflammatory response, hematopoiesis, vasodilatation, and oxidative stress. Major alterations were found in the MMP and complement system., CONCLUSION: MMPs and complement factors play a central role in several of the pathways identified and may represent interesting targets for BPD treatment/prevention.Bronchopulmonary dysplasia (BPD) is a chronic lung disease occurring in ~30% of preterm infants born less than 30 wk of gestation (1). Its main risk factors include lung immaturity due to preterm delivery, mechanical ventilation (MV), oxygen toxicity, chorioamnionitis, and sepsis. The main feature is an arrest of alveolar and capillary formation (2). Models trying to decipher genes involved in the pathophysiology of BPD are mainly based on MV and oxygen application to young mammals with immature lungs of different species (3). In newborn rodent models, analyses of lung structure and gene and protein expression are performed for practical reasons directly at the end of MV (4,5,6). However, later appearing changes of gene expression might also have an impact on lung development and the evolution towards BPD and cannot be discovered by such models. Recently, we developed a newborn rat model of MV using an atraumatic (orotracheal) intubation technique that allows the weaning of the newborn animal off anesthesia and MV, the extubation to spontaneous breathing, and therefore allows the evaluation of effects of MV after a ventilation-free period of recovery (7). Indeed, applying this concept of atraumatic intubation by direct laryngoscopy, we recently were able to show significant differences between gene expression changes appearing directly after MV compared to those measured after a ventilation-free interval of 48 h. Immediately after MV, inflammation-related genes showed a transitory modified expression, while another set of more structurally related genes changed their expression only after a delay of 2 d (7). Lung structure, analyzed by conventional 2D histology and also by 3D reconstruction using synchrotron x-ray tomographic microscopy revealed, 48 h after end of MV, a reduced complexity of lung architecture compared to the nonventilated rat lungs, similar to the typical findings in BPD. To extend these observations about late gene expression modifications, we performed with a similar model a full gene expression profile of lung tissue 48 h after the end of MV with either room air or 60% oxygen. Essentially, we measured changes in the expression of genes related to the MMPs and complement system which played a role in many of the six identified mostly affected pathways.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71425486
TI  - The preterm pig as a model for acute lung disease after preterm birth
AU  - Van Der Merwe M.
AU  - Ewing H.
AU  - Caminita F.
AU  - Buddington R.
Y1  - 2014//
KW  - *model
KW  - *lung disease
KW  - *premature labor
KW  - *swine
KW  - secretion (process)
KW  - animal model
KW  - lung dysplasia
KW  - fetus (anatomy)
KW  - morbidity
KW  - mortality
KW  - human
KW  - nutritional support
KW  - cesarean section
KW  - pregnancy
KW  - fetus
KW  - survival
KW  - intensive care
KW  - newborn
KW  - newborn intensive care
KW  - artificial ventilation
KW  - disability
KW  - procedures
KW  - lung function
KW  - lung parenchyma
KW  - dying
KW  - gestational age
KW  - piglet
KW  - lung
KW  - histology
KW  - pathology
KW  - baboon
KW  - injury
KW  - gadolinium
KW  - surfactant
KW  - oxygen
KW  - surfactant protein B
KW  - surfactant associated protein
T2  - FASEB Journal
LA  - English
VL  - 28
IS  - 1 SUPPL. 1
SP  -
PB  - FASEB
SN  - 1530-6860
AD  - M. Van Der Merwe, Health and Sport Sciences, University of Memphis, Memphis, TN, United States
UR  - http://www.fasebj.org/content/28/1_Supplement/668.3.abstract?sid=5bde222c-d80b-4722-bc41-451dab475b6f
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71425486
AB  - Respiratory distresssyndrome and the more severe sequel bronchopulmonary dysplasia remain the leading causes of morbidity, mortality, and lifelong disability after preterm birth, with inadequate surfactant secretion a key contributor. We present the preterm pig as a translational model for lung disease after preterm birth. Preterm pigs were delivered by caesarian section at gestation days (GD) 98, 100, 102,and 104 (comparable to human fetuses delivered at 25, 28, 30, and 32 wks) and were provided intensive care following newborn neonatal intensive care procedures, including mechanical ventilation (MV) or supplemental oxygen and nutritional support. Expression of Surfactant Protein B (SP-B),a surfactant-associated protein absolutely required for postnatal lung function, was determined by western analysis using lung tissue harvested 24 h after delivery or earlier for pigs that became moribund. Pigs delivered at GD 98 and 100, had low SP-B and MV is required for survival. SP-B increases with gestational age. Moreover, provision of MV to preterm piglets delivered at GD 102 causes a dramatic increase in SP-B expression and suggests MV can induce SP-B secretion and reduce dependency on surfactant administration.Based on SP-B expression, lung histology and pathology, and the responses to MV, the preterm pig is a translational large animal model for studying acute lung disease after preterm birth and for preclinical trials to evaluate interventions and improve MV protocols. The large litters of pigs reduce the numbers of pregnant animals needed, the attributes of the preterm pig allow investigators to refine experimental approaches, and the preterm pig replaces the baboon as a large animal model to study acute lung disease and injury after preterm birth.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71425242
TI  - Identification of redox- and glucose-sensitive Txnip interacting proteins using BioID
AU  - Forred B.
AU  - Neuharth S.
AU  - Kim D.
AU  - Roux K.
AU  - Vitiello P.
Y1  - 2014//
KW  - pathology
KW  - hyperglycemia
KW  - model
KW  - oxidation
KW  - lung dysplasia
KW  - cell death
KW  - heart ventricle hypertrophy
KW  - mutation
KW  - enzyme activity
KW  - *glucose
KW  - *protein
KW  - cysteine
KW  - thioredoxin
KW  - disulfide
KW  - ubiquitin protein ligase
KW  - antioxidant
KW  - biotin
T2  - FASEB Journal
LA  - English
VL  - 28
IS  - 1 SUPPL. 1
SP  -
PB  - FASEB
SN  - 1530-6860
AD  - B. Forred, Children's Health Research Center Sanford Research Sioux, Falls, SD, United States
UR  - http://www.fasebj.org/content/28/1_Supplement/1153.14.abstract?sid=d767ea2e-1125-4104-af73-b3a57499b691
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71425242
AB  - Many cell signaling processes are dependent on redox-dependent interactions through the thioredoxin (Trx) family. Thioredoxins regulate the reduction-oxidation state of protein substrates through antioxidant enzymatic activities. Thioredoxins have a conserved catalytic site that undergoes reversible oxidation to cysteine disulfide through the transfer of reducing equivalents from the catalytic site cysteine residues to a disulfide substrate. While Txnip has been identified as a critical modulator of several disease pathologies, including beta-cell death during hyperglycemia, cardiac hypertrophy, and bronchopulmonary dysplasia, the molecular mechanisms underlying these processes are relatively unknown. The objective of these studies was to establish a cell model to identify Txnip interacting proteins in an effort to understand molecular events underlying the aforementioned disease pathologies. A proximity-based biotin-dependent labeling system (called BioID) was fused to Txnip and stably-transfected into HEK293 cells to identify novel interacting proteins. Proteomic analysis of BioID lysates identified 50 interacting proteins and mutation of a redox-senstive cysteine (C247S) in Txnip disrupted several interactions. Furthermore, we demonstrate that this cell model can identify dynamic Txnip interactions through treatment with endogenous Txnip regulators such as hyperglycemia. HEK293 cells treated with increasing glucose concentration upregulated Txnip expression in a dose-dependent manner. Comparative BioID analysis revealed several glucose-dependent Txnip interacting proteins such as its E3 ubiquitin ligase, ITCH. Continued studies will focus on understanding the biological relevance of the identified interactions to better understand cellular alterations resulting in disease pathologies.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71424965
TI  - Chronic placental ischemia alters expression of placental and fetal insulin-like growth factor proteins in the rat
AU  - Beasley K.
AU  - Needham K.
AU  - Regal J.
AU  - Lovering A.
AU  - Gilbert J.
Y1  - 2014//
KW  - *ischemia
KW  - *rat
KW  - premature labor
KW  - low birth weight
KW  - model
KW  - oxygen therapy
KW  - preeclampsia
KW  - fetus (anatomy)
KW  - lung disease
KW  - lung dysplasia
KW  - kidney
KW  - lung
KW  - chronic disease
KW  - amnion fluid
KW  - risk
KW  - fetus growth
KW  - progeny
KW  - perfusion pressure
KW  - uterus
KW  - newborn
KW  - hyperoxia
KW  - tissues
KW  - pregnancy
KW  - fetus lung
KW  - *somatomedin
KW  - *protein
KW  - growth factor
T2  - FASEB Journal
LA  - English
VL  - 28
IS  - 1 SUPPL. 1
SP  -
PB  - FASEB
SN  - 1530-6860
AD  - K. Beasley, Human Physiology, University or Oregon, Eugene, OR, United States
UR  - http://www.fasebj.org/content/28/1_Supplement/1085.12.abstract?sid=9efc9fe8-6d95-4dd9-bf64-3f55333cad39
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71424965
AB  - Preeclampsia is often characterized by placental ischemia and dysregulation of angiogenic growth factors such as IGF and is a major cause of low birth weight and preterm deliveries. These offspring are at increased risk for chronic diseases such as bronchopulmonary dysplasia (BPD), a hypoplastic lung disease defined by preterm birth and neonatal O2 therapy. While O2 therapy and preterm birth clinically define BPD, current models of BPD employ hyperoxia in normally grown term neonates without considering the role of low birth weight and altered fetal endocrine milieu. To that end, we hypothesized chronic placental ischemia would decrease expression of insulin like growth factors (IGF) I and II and related proteins in placental and fetal tissues. Chronic placental ischemia was achieved using the reduced uterine perfusion pressure (RUPP; n -7) model of preeclampsia and fetal growth restriction. Normal pregnant (NP; n -8) rats served as controls and tissues were collected on day 19 of gestation. Placental IGF-I was decreased in RUPP compared to NP (89.8 +/- 10.9 vs. 133.0 +/- 13.1ng/ml, p<0.05). Conversely, amniotic fluid IGF-I (0.25 +/- 0.04 vs. 0.16 +/- 0.02pg/ml, p<0.05) and IGF-II (62.7 +/- 8.2 vs. 42.0 +/- 5.5 pg/ml, p<0.05) were increased in RUPP vs. NP. Fetal hepatic IGF-2 was increased in RUPP (155.6 +/- 12.6 vs. 117.0 +/- 6.3pg/ml, p<0.05). Finally, fetal lung IGF-IRalpha was not different between the groups. These data indicate chronic placental ischemia alters expression of IGF proteins in placental and fetal tissues and could alter the developmental trajectory of programming susceptible organs such as the lung and kidney.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71424962
TI  - Reduced uterine perfusion pressure alters angiogenic balance in the amniotic fluid and fetal lung of the rat
AU  - Rear A.
AU  - Needham K.
AU  - Lovering A.
AU  - Regal J.
AU  - Gilbert J.
Y1  - 2014//
KW  - *perfusion pressure
KW  - *amnion fluid
KW  - *fetus lung
KW  - *rat
KW  - *uterus
KW  - ischemia
KW  - very low birth weight
KW  - lung parenchyma
KW  - fetus
KW  - preeclampsia
KW  - pregnancy
KW  - lung dysplasia
KW  - angiogenesis
KW  - premature labor
KW  - hypothesis
KW  - fetus (anatomy)
KW  - lung disease
KW  - risk
KW  - vasculotropin
KW  - gadolinium
KW  - angiogenic protein
KW  - vasculotropin receptor 2
KW  - protein tyrosine kinase
T2  - FASEB Journal
LA  - English
VL  - 28
IS  - 1 SUPPL. 1
SP  -
PB  - FASEB
SN  - 1530-6860
AD  - A. Rear, Human Physiology, University of Oregon, Eugene, OR, United States
UR  - http://www.fasebj.org/content/28/1_Supplement/1085.9.abstract?sid=9efc9fe8-6d95-4dd9-bf64-3f55333cad39
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71424962
AB  - Placental ischemia, angiogenic imbalance in the maternal circulation, preterm birth and very low birth weight are characteristic features of preeclampsia. Although recent studies suggest preeclampsia increases risk of the hypoplastic lung disease bronchopulmonary dysplasia (BPD), whether or not chronic placental ischemia results in fetal angiogenic imbalance remains unclear. We hypothesized chronic RUPP would result in decreased expression of angiogenic proteins in the amniotic fluid and fetal lung consistent with the development of BPD. RUPP was induced on gestation day (GD) 14 and fetal lung tissue and amniotic fluid were collected on GD 19 from RUPP and normal pregnant (NP) rats. Fetuses were smaller (1.8 +/- 0.19 vs. 2.3 +/- 0.08 g; P<0.05) and amniotic fluid free vascular endothelial growth factor (VEGF; 12.6+/-0.82 vs. 9.19+/-1.29 pg/ug; P<0.05) decreased in RUPP compared to NP. Soluble fms-like tyrosine kinase (sFlt-1) to VEGF ratio was elevated (12.6+/-0.82 vs. 9.19+/-1.29; P<0.05) in RUPP versus NP amniotic fluid. VEGF receptor-2 was decreased (48%; P< 0.05) in lung tissue from RUPP compared to NP fetuses. These data show that chronic placental ischemia results in angiogenic imbalance in fetal tissues similar to that previously observed in the maternal circulation by our group and others. Furthermore, these findings are consistent with the hypothesis that angiogenic imbalance in utero plays an important role in the abnormal vasculogenesis and alveologenesis associated with very low birth weight infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71392091
TI  - Role of endothelial monocyte activating polypeptide II (EMAP II) in bronchopulmonary dysplasia (BPD)
AU  - Lal C.V.
AU  - Awasthi N.
AU  - Xu H.
AU  - Schwarz A.
AU  - Schwarz R.
AU  - Savani R.
AU  - Schwarz M.
Y1  - 2014//
KW  - *lung dysplasia
KW  - *medical research
KW  - mouse
KW  - hyperoxia
KW  - apoptosis
KW  - lung
KW  - lung function
KW  - cell proliferation
KW  - dysplasia
KW  - lung alveolus cell
KW  - nick end labeling
KW  - fetus lung
KW  - angiogenesis
KW  - rabbit
KW  - rodent
KW  - architecture
KW  - real time polymerase chain reaction
KW  - immunofluorescence
KW  - emphysema
KW  - lung development
KW  - ventilator
KW  - Student t test
KW  - analysis of variance
KW  - *endothelial monocyte activating polypeptide II
KW  - protein
KW  - blocking antibody
KW  - oxygen
KW  - marker
KW  - immunoglobulin G
KW  - nonoxinol 9
T2  - Journal of Investigative Medicine
LA  - English
VL  - 62
IS  - 2
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - C.V. Lal, University of Texas Southwestern, Dallas, TX, United States
DO  - https://dx.doi.org/10.231/JIM.0000000000000055
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71392091
AB  - Purpose of Study: The expression of EMAP II- a potent antiangiogenic and proinflammatory factor, decreases during periods of vasculogenesis in fetal lung development and increases in emphysema and BPD. We hypothesized that exogenous EMAP II administration would cause BPD-like changes in uninjured-normoxic mice, and that the administration of EMAP II blocking antibody (EMAP II Ab) would rescue alveolar growth in mice exposed to hyperoxia. Methods Used: 1) From postnatal days (PN) 3-15, EMAP II protein or vehicle was administered to mice in 21% oxygen (normoxia) 2) PN 3-15, mice were exposed to either 85% oxygen (hyperoxia) or normoxia and treated with either EMAP II Ab or non specific rabbit IgG control (NsIgG). Lungs were harvested on PN 15. Alveolar architecture was demonstrated by mean linear intercept (MLI), cellular proliferation by Ki67 immunofluorescence, and apoptosis by TUNEL assay. Vascular and epithelial lung markers were analysed by real time PCR. Pulmonary function testing (PFT) was performed at 6 weeks using Scireq Flexivent FX rodent ventilator. Summary of Results: 1)Compared to vehicle-treated pups, normoxia pups treated with EMAP II protein developed alveolar simplification consistent with BPD (MLI: p<0.0001, t test), reduction in epithelial and vascular lung markers and worsening lung functions. 2)Compared to normoxia controls, mice exposed to hyperoxia between PN 3-15 demonstrated distal alveolar dysplasia (MLI p<0.001 ANOVA), increased proliferation (p<0.01) and apoptosis (p<0.01). Compared to NsIgG-treated hyperoxia controls, hyperoxia pups treated with EMAP II Ab had a marked reduction in MLI (p<0.01), alveolar cell proliferation (p<0.01), apoptosis (p<0.01) and had improved compliance. EMAP II Ab had no difference in MLI and alveolar cell proliferation in normoxia pups as compared to NsIgG-treated normoxic controls. Conclusion(s): In neonatal mice exogenous delivery of EMAP II protein induces distal alveolar dysplasia consistent with BPD, while delivery of an EMAP II function-blocking antibody rescues hyperoxia induced alveolar dysplasia, reduces cellular hyperproliferation, apoptosis and improves pulmonary functions. This suggests that EMAP II blockade may be a potential target for therapeutic intervention in BPD development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71391555
TI  - Respiratory involvement in costello syndrome: A report of two cases and review of the literature
AU  - Gomez-Ospina N.
AU  - Myers A.
AU  - Brennan M.
AU  - Bernstein J.A.
AU  - Hudgins L.
Y1  - 2014//
KW  - *Costello syndrome
KW  - *medical research
KW  - human
KW  - patient
KW  - newborn period
KW  - respiratory failure
KW  - sleep disordered breathing
KW  - respiratory distress
KW  - follow up
KW  - mutation
KW  - case report
KW  - intellectual impairment
KW  - failure to thrive
KW  - morbidity
KW  - gene
KW  - counseling
KW  - dysplasia
KW  - proto oncogene
KW  - trachea reconstruction
KW  - lung dysplasia
KW  - excision
KW  - facies
KW  - histopathology
KW  - intubation
KW  - upper respiratory tract obstruction
KW  - lung hypoplasia
KW  - lung
KW  - elastic fiber
KW  - phenotype
KW  - hypoventilation
KW  - lower respiratory tract
KW  - disease course
KW  - solid tumor
KW  - diseases
KW  - positive end expiratory pressure
T2  - Journal of Investigative Medicine
LA  - English
VL  - 62
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - N. Gomez-Ospina, Stanford Hospital, Stanford, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0000000000000033
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71391555
AB  - Case Report: Costello Syndrome (CS) is a multisystem disorder caused by a heterozygous germline mutation in the HRAS proto-oncogene. It is characterized by coarse facial features, intellectual disability, postnatal failure to thrive and increased incidence of malignant solid tumors. Integumentary, musculoskeletal and cardiac involvement is also prevalent. Respiratory difficulties have also been reported in CS, however, there has been limited description of their origins. Here we present the clinical course of two patients diagnosed with CS in the neonatal period who presented with respiratory failure soon after birth. Patient 1 presented with respiratory distress requiring temporary intubation. Laringoscopy identified lanringomalacia. The symptoms improved after excision of ariepiglottic folds, lanringoplasty and tracheal reconstruction but on follow up had persistent obstructive sleep apnea. Patient 2 presented with respiratory distress due to hypoventilation and presumptive pulmonary hypoplasia. At follow up the patient was still CPAP dependent. Reviewof the literature revealed additional reports documenting respiratory symptoms in patients with CS including respiratory insufficiency, laryngo/ tracheo/bronchomalacia, hydro/chylothorax, upper airway obstruction, obstructive sleep apnea and small lungs. Postmortem and histopathological studies have shown evidence of lymphagiectasia, atypical elastic fibers in brochi and alveoli, as well as alveolar and bronchopulmonary dysplasia. Review of the literature also revealed a correlation between the presence of severe respiratory phenotype and uncommon mutations in the HRAS gene. Our cases and review of the literature suggest respiratory insufficiency is a source of significant morbidity for patients with CS in the neonatal period. Reported mechanisms to explain the upper and lower respiratory tract involvement include impaired elastogenesis, lymphagiectasia and pulmonary dysplasia. The possibility of respiratory compromise in the neonatal period should prompt adequate counseling and plan for delivery in cases of prenatally diagnosed Costello syndrome.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71351399
TI  - Human rhinovirus bronchiolitis predominant in very low birthweight infants in Argentina
AU  - Linder-Jackson J.E.
AU  - Plachco T.E.
AU  - Bossi L.
AU  - Bauer G.
AU  - Polack F.P.
AU  - Libster R.P.
AU  - Kathryn Miller E.K.
Y1  - 2014//
KW  - *bronchiolitis
KW  - *very low birth weight
KW  - *infant
KW  - *Argentina
KW  - *allergic asthma
KW  - *immunology
KW  - *Human rhinovirus
KW  - human
KW  - hospitalization
KW  - asthma
KW  - prematurity
KW  - species
KW  - infection
KW  - cohort analysis
KW  - population
KW  - nose smear
KW  - lung dysplasia
KW  - smoking
KW  - risk
KW  - mother
KW  - female
KW  - outpatient
KW  - Metapneumovirus
KW  - pregnancy
KW  - Respiratory syncytial pneumovirus
KW  - wheezing
KW  - respiratory virus
KW  - reverse transcription polymerase chain reaction
KW  - Rhinovirus
KW  - respiratory tract infection
KW  - aspiration
KW  - risk factor
KW  - Rhinovirus infection
T2  - Journal of Allergy and Clinical Immunology
LA  - English
VL  - 133
IS  - 2 SUPPL. 1
PB  - Mosby Inc.
SN  - 0091-6749
AD  - J.E. Linder-Jackson, VanderbiltTNUnited States
DO  - https://dx.doi.org/10.1016/j.jaci.2013.12.686
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=71351399
AB  - RATIONALE: Human rhinovirus (HRV) infections early in life may lead to asthma, especially when accompanied by recurrent wheezing. Premature infants are at increased risk for asthma, and the role of HRV in this group is largely unexplored. METHOD(S): In this prospective cohort study, premature infants weighing <1500gm were enrolled in the NICU from June 2011 through October 2012. Infantswere followed for the first year of life, nasal swabs collected at monthly well visits, and nasal aspirates taken during all acute respiratory infections (ARIs). Real time rt-pcr for respiratory viruses was conducted on specimens. HRV-positive specimens were cloned and sequenced to determine species. RESULT(S): of 139 ARI samples, 66% were positive for HRV, and 53% of infants with HRV had bronchiolitis. There were 26 (32%) hospitalizations: 50% positive for HRV, 15% respiratory syncytial virus (RSV), and 15% metapneumovirus (MPV). MPV was more likely to be associated with hospitalizations than outpatient visits forARIs (p=0.002).OfHRV-associated ARIs, 70% were species HRVA, 7%HRVB, and 23%HRVC. Twenty-seven percent of mothers smoked during pregnancy and 55% had smokers in the home; 41% of infants had bronchopulmonary dysplasia (BPD). CONCLUSION(S): Rhinovirus is the predominant infection associated with ARI in VLBW infants in Argentina. HRV, RSV, and MPV are all associated with infant hospitalizations. Bronchiolitis and BPD were common in this population, suggesting that many risk factors for the development of asthma later in life are affecting these premature infants and they should be targeted for preventive measures.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 612646947
TI  - Variability in thy mic size in critically ILL neonates: Ultrasound imaging, clinical and immunological parallels
AU  - Pankratyeva L.L.
AU  - Mukhin V.E.
AU  - Chernova N.V.
AU  - Soldatova I.G.
AU  - Roumiantsev S.A.
AU  - Volodin N.N.
AU  - Roumiantsev A.G.
Y1  - 2014//
KW  - abnormal laboratory result
KW  - adaptive immunity
KW  - anthropometry
KW  - article
KW  - CD4+ CD25+ T lymphocyte
KW  - correlational study
KW  - critically ill patient
KW  - disease association
KW  - disease course
KW  - disease severity
KW  - *echography
KW  - flow cytometry
KW  - gestational age
KW  - hospital admission
KW  - human
KW  - incidence
KW  - intestine perforation
KW  - lung dysplasia
KW  - *lymphatic parameters
KW  - lymphocyte count
KW  - lymphocytopenia
KW  - major clinical study
KW  - necrotizing enterocolitis
KW  - neonatal intensive care unit
KW  - newborn
KW  - normal value
KW  - perinatal period
KW  - peripheral lymphocyte
KW  - phenotypic variation
KW  - *prematurity
KW  - regulatory T lymphocyte
KW  - thymus
KW  - umbilical cord blood
KW  - *weight, mass and size
KW  - transcription factor FOXP3/ec [Endogenous Compound]
KW  - thymic index
KW  - *thymic size
T2  - Immunologiya
LA  - Russian
VL  - 35
IS  - 1
PB  - Meditsina Publishers (E-mail: meditsina@mtu-net.ru)
SN  - 0206-4952
UR  - http://www.medlit.ru/journal/386
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=612646947
AD  - Russian Federation
AB  - The thymus is of extreme importance during the first months of life as it provides the environment for the T-lymphocyte differentiation and maturation. Aim. To assess the variation in size of the thymus in preterm neonates and to identify relations between thymic size, phenotypic characteristics of peripheral blood T-lymphocytes and severity of complications during the first month of life. Patients and methods. We observed 76 preterm neonates (25-34 weeks' gestation) admitted to neonatal intensive care unit. The thymic size was assessed by sonography as a volume estimate, thymic index (Ti), at 36 weeks of postconceptional age. T cells were analyzed on day 1 (cord blood), 7-8, 14-16, 30 by multicolor flow cytometry. Results. A correlation between thymic size and anthropometric measurements and gestational age was not demonstrated. Infants with low Ti values had a significantly higher incidence of progression to severe necrotizing enterocolitis with intestinal perforation and severe bronchopulmonary dysplasia than infants with median and high Ti values (p<0.05). Analyzing abnormal laboratorydata, an association between Ti values and incidence of lymphopenia during the first month of life was not revealed. Ti was positively correlated with CD4+CD25highFoxp3+ T-regulatory cell percentage and absolute counts on days 7-8 of postnatal life (Rs=0.56, p=0.001 and Rs=0.49, p=0.005 respectively). Conclusion. Further elucidation of adaptive immune system in preterm neonates will help to establish new strategies for the treatment and prevention of severe diseases of prematurity.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 370076809
TI  - Cord blood interleukin-8 levels correlate with airway flow limitation at eight years of age in ex-very low birth weight infants
AU  - Stucin Gantar I.
AU  - Praprotnik M.
AU  - Babnik J.
AU  - Wraber B.
AU  - Kornhauser Cerar L.
Y1  - 2013//
KW  - article
KW  - controlled study
KW  - female
KW  - forced expiratory flow
KW  - forced expiratory volume
KW  - forced vital capacity
KW  - gastric suction
KW  - gestational age
KW  - human
KW  - infant
KW  - lung dysplasia
KW  - lung function
KW  - lung function test
KW  - lung ventilation
KW  - major clinical study
KW  - male
KW  - prematurity
KW  - protein blood level
KW  - *respiratory airflow
KW  - umbilical cord blood
KW  - *very low birth weight
KW  - *interleukin 6/ec [Endogenous Compound]
KW  - *interleukin 8/ec [Endogenous Compound]
T2  - Signa Vitae
LA  - English
VL  - 8
IS  - 2
PB  - Pharmamed Mado Ltd
SN  - 1845-206X
AD  - I. Stucin Gantar, Division of Perinatology, Department of Obstetrics and Gynecology, University Medical Center Ljubljana, Zaloska 11, 1000 Ljubljana, Slovenia. E-mail: irena@gantar.com
UR  - http://www.signavitae.com/attachments/SIGNA%20VITAE%202013%208(2)%2030%20-%2036.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=370076809
DO  - https://dx.doi.org/10.22514/sv82.102013.5
AB  - Background. Exposure to prenatal inflammation increases the risk for development of bronchopulmonary dysplasia. Aim. To evaluate the correlation between cord blood and gastric aspirate levels of interleukine-6 (IL-6) and interleukine-8 (IL-8) in preterm infants, and lung function at the age of 8 years. Methods. Between 2000-2002 we recruited 129 infants of gestational age < 30 wks. The concentration of IL-6 and IL-8 were measured in gastric aspirate and cord blood. At the age of 8 years, 30 ex-preterm infants, with mean gestational age of 27 wks and mean birth weight of 955 g, returned for pulmonary function measurement. To exclude major bias, a comparison between the study group and non-responder group was done and showed no statistically significant difference with respect to perinatal characteristics, ventilation days, bronchopulmonary dysplasia and cytokine concentration. Results. Pulmonary function test measurments in children born preterm were lower than in their term pairs. However, only the difference in forced mid-expiratory flow (FEF25-75%) was statisticaly significant. The concentration of IL-6 and IL-8 in cord blood and in gastric aspirate inversely correlated to all parameters of lung fuction at the age of 8 years, however only correlations between the concentration of IL-8 in cord blood and forced expired volume in one second/forced vital capacity (FEV1/FVC) (r = -0.38, p = 0.04) and FEF 25%-75% (r = -0.44, p = 0.02) were statistically significant. Conclusion. These results show a negative correlation between the concentration of IL-8 in cord blood and FEF25%-75% and FEV1/FVC, which suggests the important role of IL-8 in early airway remodeling.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 373911999
TI  - Evaluation of pneumothorax risk factors in mechanically ventilated neonates admitted to neonatal intensive care unit
AU  - Mansouri M.
AU  - Ghotbi N.
AU  - Amozadeh M.H.
AU  - Ghaderi E.
AU  - Hemmatpour S.
Y1  - 2013//
KW  - article
KW  - human
KW  - newborn
KW  - *newborn intensive care
KW  - *pneumothorax
KW  - risk factor
KW  - *ventilated patient
T2  - Scientific Journal of Kurdistan University of Medical Sciences
LA  - Persian
VL  - 18
IS  - 4
PB  - Kurdistan University of Medical Sciences
SN  - 1560-652X
UR  - http://sjku.muk.ac.ir/browse.php?a_id=1186&slc_lang=en&sid=1&ftxt=1
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=373911999
AD  - Iran, Islamic Republic of
AB  - Background and Aim: Pneumothorax is the most common pulmonary air leak syndrome which occurs more frequently in the neonatal period than any other time of life. Mechanical ventilation with positive pressure is one of the most common causes of this condition. The aim of this study was to evaluate pneumothorax risk factors in mechanically ventilated neonates admitted to neonatal intensive care unit (NICU) of Besat Hospital in Sanandaj. Material(s) and Method(s): This was a nested case-control study. Case group were neonates under ventilation with pneumothorax admitted to NICU between April 2012 and March 2013. Control group included neonates under ventilation without pneumothorax whose admission times followed in the immediate chronology to the case group. 31 cases and 62 controls were selected. Data collection was performed by use of medical records and ventilator memory in the last 24 hours. The data were introduced into SPSS software. Analysis of qualitative variables was performed by chi-squared and Fisher test. We used Mann Whitney U test for analysis of quantitative variables and logistic regression in order to control confounders. Result(s): 61.3% of newborns with pneumothorax were male and 38.7% female. 61.3% of these neonates were born by Cesarean section and 38.7% by vaginal delivery. Their mean gestational age was 32 weeks and the mean birth weight was 1819 g. 74% of cases had pneumothorax in the right side, 13% left side and 13% bilaterally. Hyaline membrane disease (HMD) was the most common underlying disease (74.2%) in the newborns with pneumothorax. 38% of neonates under pressure controlled ventilation developed pneumothorax compared to 7.1% of neonates under synchronized intermittent mandatory ventilation (SIMV), which showed a significant difference (p=0.03). Ventilator parameters associated with higher risk of pneumothorax were more episodes of ventilator adjustments (P<0.001), high peak inspiratory pressure (p<0.001), high positive end expiratory pressure (p=0.029) and high mean airway pressure (p<0.001). Conclusion(s): In general pneumothorax risk factors in mechanically ventilated neonates in our investigation were similar to those of other studies. Our findings indicated that pressure controlled ventilation more episodes of ventilator adjustments, increased peak inspiratory pressure, positive end expiratory pressure and mean airway pressure are major pneumothorax risk factors in the mechanically ventilated newborns. To prevent pneumothorax, it is necessary to avoid frequent changes of ventilator adjustments and decrease in the above mentioned parameters to the levels enough to supply lung oxygenation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.
DO  - https://dx.doi.org/10.1038/pr.2015.166
AU  - Delaney, Cassidy
AU  - Wright, Rachel H
AU  - Tang, Jen-Ruey
AU  - Woods, Crystal
AU  - Villegas, Leah
AU  - Sherlock, Laurie
AU  - Savani, Rashmin C
AU  - Abman, Steven H
AU  - Nozik-Grayck, Eva
Y1  - 2015//
Y2  - 20150831//
KW  - Animals
KW  - Animals, Newborn
KW  - *Bleomycin
KW  - Bronchopulmonary Dysplasia/ci [Chemically Induced]
KW  - *Bronchopulmonary Dysplasia/en [Enzymology]
KW  - Bronchopulmonary Dysplasia/ge [Genetics]
KW  - Bronchopulmonary Dysplasia/pa [Pathology]
KW  - Bronchopulmonary Dysplasia/pp [Physiopathology]
KW  - *Endothelial Cells/en [Enzymology]
KW  - Endothelial Cells/pa [Pathology]
KW  - Genetic Predisposition to Disease
KW  - Hypertension, Pulmonary/ci [Chemically Induced]
KW  - *Hypertension, Pulmonary/en [Enzymology]
KW  - Hypertension, Pulmonary/ge [Genetics]
KW  - Hypertension, Pulmonary/pa [Pathology]
KW  - Hypertension, Pulmonary/pp [Physiopathology]
KW  - Hypertrophy, Right Ventricular/ci [Chemically Induced]
KW  - Hypertrophy, Right Ventricular/en [Enzymology]
KW  - Hypertrophy, Right Ventricular/ge [Genetics]
KW  - Hypertrophy, Right Ventricular/pp [Physiopathology]
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - Nitric Oxide/me [Metabolism]
KW  - Nitric Oxide Synthase Type III/me [Metabolism]
KW  - Oxidative Stress
KW  - Phenotype
KW  - Phosphorylation
KW  - *Pulmonary Alveoli/bs [Blood Supply]
KW  - *Pulmonary Alveoli/en [Enzymology]
KW  - Pulmonary Alveoli/pa [Pathology]
KW  - *Pulmonary Artery/en [Enzymology]
KW  - Pulmonary Artery/pa [Pathology]
KW  - Pulmonary Artery/pp [Physiopathology]
KW  - Signal Transduction
KW  - *Superoxide Dismutase/df [Deficiency]
KW  - Superoxide Dismutase/ge [Genetics]
KW  - Vascular Endothelial Growth Factor A/me [Metabolism]
KW  - Vascular Endothelial Growth Factor Receptor-2/me [Metabolism]
KW  - *Vascular Remodeling
KW  - Ventricular Dysfunction, Right/ci [Chemically Induced]
KW  - Ventricular Dysfunction, Right/en [Enzymology]
KW  - Ventricular Dysfunction, Right/ge [Genetics]
KW  - Ventricular Dysfunction, Right/pp [Physiopathology]
KW  - Ventricular Function, Right
KW  - Ventricular Pressure
T2  - Pediatric research
VL  - 78
IS  - 6
SN  - 0031-3998
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26322414
AD  - United States
AB  - BACKGROUND: Pulmonary hypertension (PH) worsens clinical outcomes in former preterm infants with bronchopulmonary dysplasia (BPD). Oxidant stress disrupts alveolar and vascular development in models of BPD. Bleomycin causes oxidative stress and induces BPD and PAH in neonatal rats. Disruption in the vascular endothelial growth factor (VEGF) and nitric oxide signaling pathways contributes to BPD. We hypothesized that loss of EC-SOD would worsen PAH associated with BPD in a neonatal mouse model of bleomycin-induced BPD by disrupting the VEGF/NO signaling pathway., METHODS: Neonatal wild-type mice (WT), and mice lacking EC-SOD (EC-SOD KO) received intraperitoneal bleomycin (2 units/kg) or phosphate-buffered saline (PBS) three times weekly and were evaluated at weeks 3 or 4., RESULTS: Lack of EC-SOD impaired alveolar development and resulted in PH (elevated right ventricular systolic pressures, right ventricular hypertrophy (RVH)), decreased vessel density, and increased small vessel muscularization. Exposure to bleomycin further impaired alveolar development, worsened RVH and vascular remodeling. Lack of EC-SOD and bleomycin treatment decreased lung total and phosphorylated VEGFR2 and eNOS protein expression., CONCLUSION: EC-SOD is critical in preserving normal lung development and loss of EC-SOD results in disrupted alveolar development, PAH and vascular remodeling at baseline, which is further worsened with bleomycin and associated with decreased activation of VEGFR2.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52404425
TI  - Vitamin a supplementation in extremely low-birth-weight infants: Subgroup analysis in small-for-gestational-age infants
AU  - Londhe V.A.
AU  - Nolen T.L.
AU  - Das A.
AU  - Higgins R.D.
AU  - Tyson J.E.
AU  - Oh W.
AU  - Devaskar S.U.
Y1  - 2013//
KW  - article
KW  - assisted ventilation
KW  - birth weight
KW  - brain hemorrhage
KW  - cause of death
KW  - comparative study
KW  - controlled study
KW  - *extremely low birth weight
KW  - gestational age
KW  - human
KW  - infant
KW  - length of stay
KW  - leukomalacia
KW  - lung dysplasia
KW  - major clinical study
KW  - necrotizing enterocolitis
KW  - patent ductus arteriosus
KW  - prematurity
KW  - priority journal
KW  - retrospective study
KW  - risk reduction
KW  - secondary analysis
KW  - sepsis
KW  - *small for date infant
KW  - vitamin blood level
KW  - *vitamin supplementation
KW  - glucocorticoid
KW  - *retinol
KW  - retinol binding protein/ec [Endogenous Compound]
KW  - retinol ester/ec [Endogenous Compound]
T2  - American Journal of Perinatology
LA  - English
VL  - 30
IS  - 9
PB  - Thieme Medical Publishers, Inc. (333 7th Avenue, New York NY 10001-5004, United States)
SN  - 1098-8785
AD  - V.A. Londhe, Division of Neonatology and Developmental, Biology Department of Pediatrics, B2-375 MDCC, 10833 Le Conte Ave., Los Angeles, CA 90095, United States. E-mail: vlondhe@mednet.ucla.edu
DO  - https://dx.doi.org/10.1055/s-0032-1333410
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=52404425
AB  - Objective Preterm infants with intrauterine growth restriction are at increased risk of respiratory distress syndrome and bronchopulmonary dysplasia (BPD). A randomized clinical trial by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Neonatal Research Network demonstrated that vitamin A supplementation in extremely low-birth-weight (ELBW) preterm infants requiring early respiratory support decreased the risk of developing BPD. Study Design A subgroup analysis of small-for-gestational-age (SGA) infants from the original NICHD trial was performed to test the hypothesis that in infants requiring early respiratory support, vitamin A supplementation decreases the relative risk of BPD or death in premature SGA infants to a greater extent than in gestational age-equivalent vitamin A-treated appropriate-for-gestational-age (AGA) infants. Results Although vitamin A supplementation significantly increased serum retinol concentrations in AGA ELBW infants (median [5th percentile, 95th percentile]: 16.3 [-7.0, 68.8] versus 2.4 [-13.9, 55.1]; p < 0.001), no increases were noted in SGA ELBW infants. Conclusions Given the limited power of this analysis due to a low number of SGA infants, these data did not provide evidence to support the hypothesis that vitamin A supplementation in preterm SGA infants requiring early respiratory support decreases the relative risk of BPD or death as compared with preterm AGA infants. Â© 2013 by Thieme Medical Publishers, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 369245355
TI  - Periostin downregulation is an early marker of inhibited neonatal murine lung alveolar septation
AU  - Ahlfeld S.K.
AU  - Gao Y.
AU  - Wang J.
AU  - Horgusluoglu E.
AU  - Bolanis E.
AU  - Clapp D.W.
AU  - Conway S.J.
Y1  - 2013//
KW  - ambient air
KW  - animal cell
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - cell differentiation
KW  - cell proliferation
KW  - controlled study
KW  - down regulation
KW  - histopathology
KW  - hyperoxia
KW  - *lung alveolus
KW  - *lung development
KW  - *lung dysplasia
KW  - morphogenesis
KW  - mouse
KW  - *myofibroblast
KW  - newborn
KW  - nonhuman
KW  - perinatal period
KW  - priority journal
KW  - protein expression
KW  - upregulation
KW  - Western blotting
KW  - alpha smooth muscle actin/ec [Endogenous Compound]
KW  - *transcription factor RUNX2/ec [Endogenous Compound]
T2  - Birth Defects Research Part A - Clinical and Molecular Teratology
LA  - English
VL  - 97
IS  - 6
PB  - Wiley-Liss Inc. (111 River Street, Hoboken NJ 07030-5774, United States)
SN  - 1542-0760
AD  - S.J. Conway, Developmental Biology and Neonatal Medicine Program, HB Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, United States. E-mail: siconway@iupui.edu
DO  - https://dx.doi.org/10.1002/bdra.23149
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=369245355
AB  - BACKGROUND: Extreme preterm birth exposes the saccular lung to multiple teratogens, which ultimately retard alveolar development. Specifically, therapeutic high level oxygen supplementation adversely affects the premature lungs and results in blunted alveolarization. Prolonged hyperoxic lung injury has previously been shown to upregulate the matricellular protein Periostin (Postn) and stimulate ectopic accumulation of alpha smooth muscle actin (alphaSMA) myofibroblasts. Therapies that promote lung septation are lacking largely due to a lack of reliable early biomarkers of injury. Thus, we determined if Postn expression correlated with the initial appearance of myofibroblasts in the saccular lung and was required for early alveolar development. METHOD(S): Lung development in C57BL/6J mice following room-air (RA, 21%-O2) or continuous hyperoxia (85%-O2) from birth (P0) through postnatal day P14 was correlated with Postn and alphaSMA expression. Alveolarization in Postn knockout mice exposed to room-air, 60%-, and 85%-O2 was also examined. RESULT(S): Postn was widely expressed in distal lung septa through P2 to P4 and peak expression coincided with accumulation of saccular myofibroblasts. Initially, 85%-O2 prematurely downregulated Postn and alphaSMA expression and suppressed proliferation before the first evidence of distal lung simplification at P4. By P14, chronic 85%-O2 resulted in secondary upregulation of Postn and alphaSMA in blunted septa. Myofibroblast differentiation and alveolar development was unaffected in Postn null mice and acute 85%-O2 exposure equally inhibited septal formation in Postn null and wild-type littermates. CONCLUSION(S): Postn expression is tightly correlated with the presence of alphaSMA-myofibroblasts and is a novel early biomarker of acutely inhibited alveolar septation during a crucial window of lung development. Â© 2013 Wiley Periodicals, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 370488303
TI  - Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia
AU  - Madurga A.
AU  - Mizikova I.
AU  - Ruiz-Camp J.
AU  - Morty R.E.
Y1  - 2013//
KW  - angiogenesis
KW  - apoptosis
KW  - article
KW  - artificial ventilation
KW  - chorioamnionitis
KW  - environmental impact
KW  - gene control
KW  - human
KW  - hyperoxia
KW  - intrauterine infection
KW  - lung alveolus epithelium
KW  - *lung development
KW  - *lung dysplasia/et [Etiology]
KW  - lung gas exchange
KW  - mesenchymal stroma cell
KW  - nonhuman
KW  - oxidative stress
KW  - oxygen toxicity
KW  - pathogenesis
KW  - persistent pulmonary hypertension/co [Complication]
KW  - priority journal
KW  - respiratory function
KW  - stem cell
KW  - beta catenin/ec [Endogenous Compound]
KW  - betamethasone
KW  - CCAAT enhancer binding protein/ec [Endogenous Compound]
KW  - connective tissue growth factor/ec [Endogenous Compound]
KW  - dexamethasone
KW  - epidermal growth factor/ec [Endogenous Compound]
KW  - fibroblast growth factor/ec [Endogenous Compound]
KW  - heme oxygenase 1/ec [Endogenous Compound]
KW  - hypoxia inducible factor 1alpha/ec [Endogenous Compound]
KW  - imatinib
KW  - integrin linked kinase/ec [Endogenous Compound]
KW  - isobutylmethylxanthine
KW  - lung surfactant/ec [Endogenous Compound]
KW  - microRNA/ec [Endogenous Compound]
KW  - nitrofen/ec [Endogenous Compound]
KW  - platelet derived growth factor/ec [Endogenous Compound]
KW  - reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound]
KW  - succinate dehydrogenase (ubiquinone)/ec [Endogenous Compound]
KW  - transcription factor RUNX1/ec [Endogenous Compound]
KW  - transcription factor Sox5/ec [Endogenous Compound]
KW  - vasculotropin/ec [Endogenous Compound]
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 305
IS  - 12
PB  - American Physiological Society (9650 Rockville Pike, Bethesda MD 20814-3991, United States)
SN  - 1522-1504
AD  - R. E. Morty, Dept. of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Parkstrasse 1, D-61231 Bad Nauheim, Germany. E-mail: rory.morty@mpi-bn.mpg.de
UR  - http://ajplung.physiology.org/content/ajplung/305/12/L893.full.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=370488303
DO  - https://dx.doi.org/10.1152/ajplung.00267.2013
AB  - In contrast to early lung development, a process exemplified by the branching of the developing airways, the later development of the immature lung remains very poorly understood. A key event in late lung development is secondary septation, in which secondary septa arise from primary septa, creating a greater number of alveoli of a smaller size, which dramatically expands the surface area over which gas exchange can take place. Secondary septation, together with architectural changes to the vascular structure of the lung that minimize the distance between the inspired air and the blood, are the objectives of late lung development. The process of late lung development is disturbed in bronchopulmonary dysplasia (BPD), a disease of prematurely born infants in which the structural development of the alveoli is blunted as a consequence of inflammation, volutrauma, and oxygen toxicity. This review aims to highlight notable recent developments in our understanding of late lung development and the pathogenesis of BPD. Â© 2013 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 369525526
TI  - Morbidity and mortality in premature newborns in the Irapuato General Hospital
AU  - Zamudio R.P.
AU  - Terrones C.R.L.
AU  - Barboza A.R.
Y1  - 2013//
KW  - article
KW  - asphyxia
KW  - cause of death
KW  - congenital heart disease
KW  - death
KW  - human
KW  - hyaline membrane disease
KW  - incidence
KW  - major clinical study
KW  - *morbidity
KW  - *mortality
KW  - newborn
KW  - *prematurity
KW  - respiratory distress syndrome
KW  - retrospective study
KW  - risk factor
KW  - sepsis
KW  - septicemia
T2  - Boletin Medico del Hospital Infantil de Mexico
LA  - English, Spanish
VL  - 70
IS  - 4
PB  - Hospital Infantil de Mexico Federico Gomez (Mexico)
SN  - 1665-1146
AD  - R. P. Zamudio, Unidad de Cuidados Intensivos Neonatales, Hospital General de Irapuato, Irapuato, Guanajuato, Mexico. E-mail: rosy_rpz@hotmail.com
UR  - http://www.medigraphic.com/pdfs/bmhim/hi-2013/hi134e.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=369525526
AB  - Background. Preterm birth is currently the leading obstetric problem, affecting between 5 and 12% of all births. The aim of this study was to determine the incidence of prematurity and major causes of morbidity and mortality in preterm infants in the Irapuato General Hospital. Methods. Retrospective study analyzing the clinical records of preterm infants from 2011-2012. Results. There were 10,532 births registered; 736 (6.9%) were premature and of these 472 were admitted to the Neonatal Intensive Care Unit, corresponding to 64% of premature births and 4.4% of all births. An increase was shown in cases of prematurity during the year 2011 (n =206) compared to the year 2012 (n =266). The main causes of admission were hyaline membrane disease, 248 cases (52.5%); septicemia, 12 cases (12.7%) and asphyxia, 43 cases (9.1%). The main causes of neonatal death were sepsis (n =12, 32.4%), respiratory distress syndrome (n =8, 21.6%) and congenital heart disease (n =4, 10.8%). Neonatal mortality rate was 3.5. Conclusions. The incidence of prematurity increased from 6.5% in 2011 to 7.4% in 2012. We must identify the risk factors in order to establish preventive measures.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52743282
TI  - Perinatal risk factors for adverse long-term pulmonary outcome in premature infants: Comparison of different definitions of bronchopulmonary dysplasia/chronic lung disease
AU  - Shima Y.
AU  - Kumasaka S.
AU  - Migita M.
Y1  - 2013//
KW  - article
KW  - assisted ventilation
KW  - breathing
KW  - chorioamnionitis
KW  - *chronic lung disease
KW  - corticosteroid therapy
KW  - disease course
KW  - echocardiography
KW  - endotracheal intubation
KW  - gestational age
KW  - human
KW  - incidence
KW  - *long term care
KW  - *lung dysplasia
KW  - *lung function
KW  - major clinical study
KW  - maternal hypertension
KW  - newborn
KW  - newborn infection
KW  - newborn period
KW  - oxygen saturation
KW  - oxygen therapy
KW  - patent ductus arteriosus
KW  - perinatal care
KW  - positive end expiratory pressure
KW  - premature fetus membrane rupture
KW  - *prematurity
KW  - priority journal
KW  - pulmonary hypertension
KW  - retrolental fibroplasia
KW  - retrospective study
KW  - risk factor
KW  - small for date infant
KW  - C reactive protein/ec [Endogenous Compound]
KW  - glucocorticoid
T2  - Pediatrics International
LA  - English
VL  - 55
IS  - 5
PB  - Blackwell Publishing (550 Swanston Street, Carlton South VIC 3053, Australia)
SN  - 1442-200X
AD  - Y. Shima, Department of Pediatrics, Nippon Medical School, Japanese Red Cross Maternity Hospital, 5-11-12 Tateishi, Katsushika-ku, Tokyo 124-0012, Japan. E-mail: shima-p@nms.ac.jp
DO  - https://dx.doi.org/10.1111/ped.12151
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=52743282
AB  - Background: The aim of the study was to determine factors that affect adverse long-term pulmonary outcome in premature infants. Method(s): This retrospective analysis was done using 306 clinical records of preterm singleton neonates at <32 weeks of gestation. Two definitions of adverse pulmonary outcome were used: chronic lung disease (CLD), defined as a need for supplemental oxygen for at least 28 days after birth; and bronchopulmonary dysplasia (BPD), defined as oxygen dependency for at least 28 days after birth plus at 36 weeks postmenstrual age and/or a need for positive-pressure ventilatory support. Selected perinatal variables were compared between these definitions, and factors related to disease development were identified on multivariate analysis. Result(s): The incidence of CLD and of BPD were 42% and 17%, respectively. Regardless of the definitions, the incidence of patent ductus arteriosus and of neonatal infection were significantly higher in the patients who met the disease criteria, but that of chorioamnionitis and of small for gestational age (SGA) were significantly higher in the patients only when the BPD definition was applied. Multivariate analysis identified SGA as an independent risk factor for the development of BPD after controlling for gestational age. Conclusion(s): Among selected perinatal variables, prenatal risk factors, particularly SGA, contributed to prolonged dependency on oxygen and/or positive-pressure ventilatory support, in combination with neonatal risk factors. Â© 2013 Japan Pediatric Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 368565612
TI  - Fetal to neonatal transition-what can go wrong?
AU  - Reynolds P.
Y1  - 2013//
KW  - anxiety
KW  - article
KW  - conservative treatment
KW  - extracorporeal membrane oxygenation device
KW  - *failure to thrive
KW  - fetus hypoxia
KW  - genetic disorder
KW  - human
KW  - hyperinsulinemia/dt [Drug Therapy]
KW  - hypoglycemia
KW  - maladjustment
KW  - newborn jaundice
KW  - patent ductus arteriosus
KW  - perinatal period
KW  - persistent pulmonary hypertension/dt [Drug Therapy]
KW  - physiology
KW  - priority journal
KW  - respiratory distress syndrome
KW  - respiratory tract disease
KW  - tachypnea
KW  - transient hyperinsulinemia/dt [Drug Therapy]
KW  - unspecified side effect/si [Side Effect]
KW  - adenosine/dt [Drug Therapy]
KW  - bilirubin/ec [Endogenous Compound]
KW  - dobutamine/dt [Drug Therapy]
KW  - dopamine/dt [Drug Therapy]
KW  - glucose/dt [Drug Therapy]
KW  - glucose/iv [Intravenous Drug Administration]
KW  - magnesium sulfate/dt [Drug Therapy]
KW  - milrinone/dt [Drug Therapy]
KW  - nitric oxide/dt [Drug Therapy]
KW  - nitric oxide/ih [Inhalational Drug Administration]
KW  - nitroprusside sodium/ae [Adverse Drug Reaction]
KW  - nitroprusside sodium/dt [Drug Therapy]
KW  - prostacyclin/ae [Adverse Drug Reaction]
KW  - prostacyclin/dt [Drug Therapy]
KW  - sildenafil/dt [Drug Therapy]
KW  - sildenafil/iv [Intravenous Drug Administration]
KW  - sildenafil/po [Oral Drug Administration]
KW  - tolazoline/ae [Adverse Drug Reaction]
KW  - tolazoline/dt [Drug Therapy]
KW  - parental anxiety
KW  - surfactant deficiency hyaline membrane disease
KW  - transient hyperinsulinemia/dt [Drug Therapy]
KW  - transient tachypnea
T2  - Surgery (United Kingdom)
LA  - English
VL  - 31
IS  - 3
PB  - Elsevier Ltd (Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom)
SN  - 1878-1764
AD  - P. Reynolds, St Peter's Hospital, Chertsey, Surrey, United Kingdom
DO  - https://dx.doi.org/10.1016/j.mpsur.2013.01.005
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=368565612
AB  - Failure of the fetus to make a successful transition from the intrauterine environment can be life threatening. Prompt recognition of problems can enable critical, life-saving interventions to be applied. Whilst there are numerous adaptations of the newborn at birth, this article focuses on those which are the most common and/or clinically urgent, and describes not only the conventional treatments but also emerging therapies. The article therefore covers maladaptive processes in the normal newborn, not those with genetic or other congenital problems which cause maladaptation due to the underlying disease. Likewise, it is outside the scope of this article to discuss neonatal jaundice, as it is arguably not a maladaptation, and may also not be the 'design flaw' that it has previously been considered to be, as bilirubin may have a physiological role as the main antioxidant in the newborn in the first week of postnatal life. I have described five neonatal conditions: transient tachypnoea of the newborn, respiratory distress syndrome, persistent pulmonary hypertension, which can all cause significant hypoxaemia, patent ductus arteriosus which is usually not clinically significant but is common and often causes considerable parental anxiety, and transient hyperinsulinaemia which can cause profound hypoglycaemia. It is recommended that the reader has an understanding of the normal physiological adaptive processes which are described in greater detail in the accompanying article. Â© 2013 Elsevier Ltd. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52509368
TI  - Ex vivo expanded human cord blood-derived hematopoietic progenitor cells induce lung growth and alveolarization in injured newborn lungs
AU  - Mao Q.
AU  - Chu S.
AU  - Ghanta S.
AU  - Padbury J.F.
AU  - De Paepe M.E.
Y1  - 2013//
KW  - animal cell
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - CD34 selection
KW  - cell differentiation
KW  - controlled study
KW  - engraftment
KW  - epithelium cell
KW  - ex vivo study
KW  - *hematopoietic stem cell
KW  - immunoreactivity
KW  - *lung development
KW  - *lung injury
KW  - mononuclear cell
KW  - mouse
KW  - newborn
KW  - nonhuman
KW  - protein expression
KW  - *umbilical cord blood
KW  - cytokine/ec [Endogenous Compound]
KW  - dexamethasone/ec [Endogenous Compound]
KW  - growth factor/ec [Endogenous Compound]
KW  - messenger RNA/ec [Endogenous Compound]
KW  - *alveolarization
T2  - Respiratory Research
LA  - English
VL  - 14
IS  - 1
PB  - BioMed Central Ltd. (Floor 6, 236 Gray's Inn Road, London WC1X 8HB, United Kingdom)
SN  - 1465-993X
AD  - M.E. De Paepe, Department of Pathology, Women and Infants Hospital, Providence, RI, United States. E-mail: mdepaepe@wihri.org
UR  - http://respiratory-research.com/content/14/1/37
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=52509368
DO  - https://dx.doi.org/10.1186/1465-9921-14-37
AB  - Background: We investigated the capacity of expanded cord blood-derived CD34+ hematopoietic progenitor cells to undergo respiratory epithelial differentiation ex vivo, and to engraft and attenuate alveolar disruption in injured newborn murine lungs in vivo. Method(s): Respiratory epithelial differentiation was studied in CD34+ cells expanded in the presence of growth factors and cytokines (" basic" medium), in one group supplemented with dexamethasone (" DEX" ). Expanded or freshly isolated CD34+ cells were inoculated intranasally in newborn mice with apoptosis-induced lung injury. Pulmonary engraftment, lung growth and alveolarization were studied at 8 weeks post-inoculation. Result(s): SP-C mRNA expression was seen in 2/7 CD34+ cell isolates expanded in basic media and in 6/7 isolates expanded in DEX, associated with cytoplasmic SP-C immunoreactivity and ultrastructural features suggestive of type II cell-like differentiation. Administration of expanding CD34+ cells was associated with increased lung growth and, in animals treated with DEX-exposed cells, enhanced alveolar septation. Freshly isolated CD34+ cells had no effect of lung growth or remodeling. Lungs of animals treated with expanded CD34+ cells contained intraalveolar aggregates of replicating alu-FISH-positive mononuclear cells, whereas epithelial engraftment was extremely rare. Conclusion(s): Expanded cord blood CD34+ cells can induce lung growth and alveolarization in injured newborn lungs. These growth-promoting effects may be linked to paracrine or immunomodulatory effects of persistent cord blood-derived mononuclear cells, as expanded cells showed limited respiratory epithelial transdifferentiation. Â© 2013 Mao et al.; licensee BioMed Central Ltd.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52171243
TI  - Chorioamnionitis as a risk factor for necrotizing enterocolitis: A systematic review and meta-analysis
AU  - Been J.V.
AU  - Lievense S.
AU  - Zimmermann L.J.I.
AU  - Kramer B.W.
AU  - Wolfs T.G.A.M.
Y1  - 2013//
KW  - article
KW  - *chorioamnionitis
KW  - human
KW  - inflammation
KW  - meta analysis (topic)
KW  - *necrotizing enterocolitis
KW  - priority journal
KW  - risk factor
KW  - systematic review (topic)
KW  - histological chorioamnionitis
T2  - Journal of Pediatrics
LA  - English
VL  - 162
IS  - 2
PB  - Mosby Inc. (11830 Westline Industrial Drive, St. Louis MO 63146, United States)
SN  - 1097-6833
AD  - J.V. Been, Department of Pediatrics, Maastricht University Medical Center, Maastricht, Netherlands
DO  - https://dx.doi.org/10.1016/j.jpeds.2012.07.012
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=52171243
AB  - Objective: To accumulate available evidence regarding the association between antenatal inflammation and necrotizing enterocolitis (NEC). Study design: A systematic literature search was performed using Medline, Embase, Cochrane Library, ISI Web of Knowledge, and reference hand searches. Human studies published in English that reported associations between chorioamnionitis or other indicators of antenatal inflammation and NEC were eligible. Relevant associations were extracted and reported. Studies reporting associations between histological chorioamnionitis (HC) and NEC, HC with fetal involvement and NEC, and clinical chorioamnionitis and NEC were pooled in separate meta-analyses. Result(s): A total of 33 relevant studies were identified. Clinical chorioamnionitis was significantly associated with NEC (12 studies; n = 22 601; OR, 1.24; 95% CI, 1.01-1.52; P =.04; I2 = 12%), but the association between HC and NEC was not statistically significant (13 studies; n = 5889; OR, 1.39; 95% CI, 0.95-2.04; P =.09; I2 = 49%). However, HC with fetal involvement was highly associated with NEC (3 studies; n = 1640; OR, 3.29; 95% CI, 1.87-5.78; P <=.0001; I2 = 10%). Selection based on study quality did not affect the results. No indications of publication bias were apparent. Multivariate analyses in single studies generally attenuated the reported associations. Several associations between other markers of antenatal inflammation and NEC are reported. Conclusion(s): Currently available evidence supports a role for antenatal inflammation in NEC pathophysiology. This finding emphasizes the need to further study the underlying mechanisms and evaluate potential interventions to improve postnatal intestinal outcomes. Copyright Â© 2013 Mosby Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 369732373
TI  - Theophylline improves intra-amniotic LPS-induced alveolar arrest through inflammatory regulation in neonatal rats
AU  - He H.
AU  - Chen F.
AU  - Li H.-P.
AU  - Ni W.-S.
AU  - Li J.-H.
AU  - Zhang Y.-J.
Y1  - 2013//
KW  - animal experiment
KW  - animal model
KW  - article
KW  - chorioamnionitis
KW  - controlled study
KW  - histopathology
KW  - *lung dysplasia
KW  - lung parenchyma
KW  - newborn
KW  - nonhuman
KW  - protein expression
KW  - rat
KW  - chemokine receptor CXCR4/ec [Endogenous Compound]
KW  - interleukin 1alpha/ec [Endogenous Compound]
KW  - interleukin 6/ec [Endogenous Compound]
KW  - lipopolysaccharide
KW  - macrophage inflammatory protein 1alpha/ec [Endogenous Compound]
KW  - macrophage inflammatory protein 2/ec [Endogenous Compound]
KW  - *theophylline
KW  - transforming growth factor beta/ec [Endogenous Compound]
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
T2  - Journal of Shanghai Jiaotong University (Medical Science)
LA  - Chinese
VL  - 33
IS  - 7
PB  - Shanghai Jiaotong Daxue (Shanghai Jiaotong University) (1954 Huasha Lu, Shanghai 200030, China)
SN  - 1674-8115
AD  - Y.-J. Zhang, Department of Neonatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China. E-mail: shanghaiyjzhang@yahoo.com.cn
DO  - https://dx.doi.org/10.3969/j.issn.1674-8115.2013.07.001
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=369732373
AB  - Objective: To investigate the role of theophylline on amelioration of chorioamnionitis-induced alveolar arrest, and explore the potential mechanism. Method(s): Chorioamnionitis was induced by intra-amniotic injection of lipopolysaccharides (LPS) in SD rats (E16.5), and the same amount of normal saline was intra-amniotically injected in control SD pregnant mice (E16.5). Pups of same litter with intra-amniotic injection of LPS were randomly divided into LPS+theo group and LPS+saline group. In LPS+theo group, pups were injected subcutaneously in the neck with theophylline once a day until the seventh day, and the same amount of normal saline instead in LPS+saline group. Pups with intra-amniotic injection of normal saline obtained identical postnatal treatment as LPS+saline group, which was defined as control group. Seven days after treatment, the lungs of neonatal rats were harvested, sections with HE staining and cytokine antibody arrays were prepared, the pathological changes of lung tissues were observed, and the expression of inflammatory cytokines was determined. Result(s): Histopathological examination revealed that the alveolar counts and secondary septa counts in LPS+saline group were significantly smaller than those in control group (P<0.05), and the alveolar counts and secondary septa counts in LPS +theo group were significantly larger than those in LPS+saline group (P<0.05). The detection of antibody arrays indicated that the expression of inflammatory cytokines such as interferon gamma (IFN-gamma), interleukin (IL)-alpha, IL-6 and chemokine receptor type 4 (CXCR4) in lung tissues of neonatal rats in LPS+saline group was higher than that in control group, the expression of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), macrophage inflammatory protein (MIP)-1alpha and MIP-2 in LPS+theo group was significantly lower than that in LPS+saline group (decreased by 37.4 times, 12.5 times and 8.6 times respectively), and the expression of anti-inflammatory cytokines such as transforming growth factor (TGF)-beta1, TGF-beta2 and TGF-beta3 in LPS+theo group was significantly higher than that in LPS+saline group (increased by 2.4 times, 56.9 times and 17.8 times respectively). Conclusion(s): Theophylline can inhibit the expression of pro-inflammatory cytokines, increase the expression of anti-inflammatory cytokines, and relieve alveolar arrest through regulating the balance between pro-and anti-inflammatory cytokines. Theophylline may play a role in the amelioration of chorioamnionitis-induced bronchopulmonary dysplasia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 368351762
TI  - Toll-like receptor levels and caffeine responsiveness in rat pups during perinatal period
AU  - Tunc T.
AU  - Aydemir G.
AU  - Karaoglu A.
AU  - Cekmez F.
AU  - Kul M.
AU  - Aydinoz S.
AU  - Babacan O.
AU  - Yaman H.
AU  - Sarici S.U.
Y1  - 2013//
KW  - animal cell
KW  - antiinflammatory activity
KW  - article
KW  - controlled study
KW  - enzyme linked immunosorbent assay
KW  - lung
KW  - newborn
KW  - newborn apnea
KW  - nonhuman
KW  - *perinatal period
KW  - priority journal
KW  - protein expression
KW  - rat
KW  - very low birth weight
KW  - *caffeine
KW  - *toll like receptor/ec [Endogenous Compound]
KW  - toll like receptor 2/ec [Endogenous Compound]
KW  - toll like receptor 4/ec [Endogenous Compound]
KW  - toll like receptor 9/ec [Endogenous Compound]
T2  - Regulatory Peptides
LA  - English
VL  - 182
IS  - 1
PB  - Elsevier (P.O. Box 211, Amsterdam 1000 AE, Netherlands)
SN  - 1873-1686
AD  - F. Cekmez, Gulhane Military Medical Faculty, Department of Neonatology, Ankara 06018, Turkey. E-mail: ferhat_cocuk@hotmail.com
DO  - https://dx.doi.org/10.1016/j.regpep.2012.12.016
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=368351762
AB  - Infants born prematurely are prone to bronchopulmonary dysplasia which is a devastating form of chronic lung disease that develops in very low birth weight infants. Toll-like receptors (TLRs) are pattern recognition receptors that initiate innate immune responses. We tested TLR2, 4, and 9 levels in the lungs of rat pups given caffeine at the first days of postnatal life. Twenty-four rat pups equally divided into three groups. The study group received caffeine immediately after birth for ten days. The levels of TLR9 were found significantly higher in study group than control groups. We conclude that the beneficial and anti-inflammatory effects of caffeine in the lungs of newborn rats may be due to increased TLR9 levels. Â© 2013 Elsevier B.V.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Carboxyhemoglobin Formation in Preterm Infants Is Related to the Subsequent Development of Bronchopulmonary Dysplasia.
DO  - https://dx.doi.org/10.1155/2015/620921
AU  - Tokuriki, Shuko
AU  - Okuno, Takashi
AU  - Ohta, Genrei
AU  - Ohshima, Yusei
Y1  - 2015//
Y2  - 20150729//
KW  - 8-Hydroxy-2'-Deoxyguanosine
KW  - Advanced Oxidation Protein Products/ur [Urine]
KW  - Biomarkers/bl [Blood]
KW  - Biomarkers/ur [Urine]
KW  - *Bronchopulmonary Dysplasia/bl [Blood]
KW  - Bronchopulmonary Dysplasia/ur [Urine]
KW  - *Carboxyhemoglobin/me [Metabolism]
KW  - Case-Control Studies
KW  - Deoxyguanosine/aa [Analogs & Derivatives]
KW  - Deoxyguanosine/ur [Urine]
KW  - Female
KW  - Humans
KW  - Infant, Newborn
KW  - *Infant, Premature/bl [Blood]
KW  - Infant, Premature/ur [Urine]
KW  - Lysine/ur [Urine]
KW  - Male
T2  - Disease markers
VL  - 2015
SN  - 0278-0240
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26294808
AD  - United States
AB  - OBJECTIVE: To evaluate the usefulness of carboxyhemoglobin (CO-Hb) levels as a biomarker to predict the development and severity of bronchopulmonary dysplasia (BPD)., METHODS: Twenty-five infants born at <33 wk of gestational age or with a birth weight of <1,500 g were enrolled. CO-Hb levels were measured between postnatal days 5 and 8, 12 and 15, 19 and 22, and 26 and 29. Urinary levels of 8-hydroxydeoxyguanosine (8-OHdG), advanced oxidation protein products, and Nepsilon-(hexanoyl) lysine were measured between postnatal days 5 and 8 and 26 and 29. Receiver operating characteristic (ROC) analysis was used to compare the biomarkers' predictive values., RESULTS: Compared with infants in the no-or-mild BPD group, infants with moderate-to-severe BPD exhibited higher CO-Hb levels during the early postnatal period and higher 8-OHdG levels between postnatal days 5 and 8. Using ROC analysis to predict the development of moderate-to-severe BPD, the area under the curve (AUC) for CO-Hb levels between postnatal days 5 and 8 was higher than AUCs for the urinary markers., CONCLUSIONS: CO-Hb levels during the early postnatal period may serve as a practical marker for evaluating oxidative stress and the severity of subsequently developing BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 370367841
TI  - The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates
AU  - Hofer N.
AU  - Kothari R.
AU  - Morris N.
AU  - Muller W.
AU  - Resch B.
Y1  - 2013//
KW  - article
KW  - artificial ventilation
KW  - asphyxia
KW  - blood culture
KW  - blood sampling
KW  - brain hemorrhage
KW  - disease association
KW  - female
KW  - *fetus disease
KW  - gestational age
KW  - human
KW  - leukomalacia
KW  - lung dysplasia
KW  - major clinical study
KW  - male
KW  - multiple organ failure
KW  - newborn
KW  - newborn intensive care
KW  - *newborn morbidity
KW  - newborn mortality
KW  - observational study
KW  - outcome assessment
KW  - positive end expiratory pressure
KW  - *prematurity
KW  - priority journal
KW  - protein blood level
KW  - respiratory distress syndrome
KW  - risk factor
KW  - sepsis
KW  - umbilical cord blood
KW  - interleukin 6/ec [Endogenous Compound]
KW  - *fetal inflammatory response syndrome
T2  - American Journal of Obstetrics and Gynecology
LA  - English
VL  - 209
IS  - 6
PB  - Mosby Inc. (11830 Westline Industrial Drive, St. Louis MO 63146, United States)
SN  - 1097-6868
AD  - Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria
DO  - https://dx.doi.org/10.1016/j.ajog.2013.08.030
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=370367841
AB  - Objective The aim of this study was to show and discuss an association between fetal inflammatory response syndrome (FIRS) and an adverse neonatal outcome defined as combined severe neonatal morbidity and mortality in preterm neonates hospitalized in our neonatal intensive care unit. Study Design This was an observational study including all preterm neonates hospitalized in our neonatal intensive care unit over a 21 month period. FIRS was defined as cord blood interleukin (IL)-6 greater than 11 pg/mL. Main outcome parameter was an adverse neonatal outcome defined as hospital mortality and/or the presence of any of 5 prespecified morbidities (bronchopulmonary dysplasia, periventricular leukomalacia, intraventricular hemorrhage, and early- or late-onset sepsis). Results Fifty-seven of 176 preterm infants hospitalized during the study period (32%) had an adverse neonatal outcome and 62 of these 176 infants (35%) had FIRS with median IL-6 values of 51.8 pg/mL (range, 11.2 to >1000 pg/mL). In a regression analysis, FIRS was significantly associated with adverse neonatal outcome (P <.001) and with the single outcome parameters, intraventricular hemorrhage and early-onset sepsis (P =.006 and P =.018, respectively). In the bivariate analysis, FIRS was associated with death and bronchopulmonary dysplasia (P =.004 and P <.001, respectively). IL-6 correlated with adverse neonatal outcome (r = 0.411, P <.001). When comparing the correlation in neonates less than 32 weeks' gestational age (r = 0.481, P <.001) with neonates 32 weeks or longer (r = 0.233, P =.019), the difference was nearly significant (P =.065). Conclusion FIRS is a risk factor for adverse neonatal outcome in preterm infants. In particular, the combination of IL-6 greater than 11 pg/mL and low gestational age increased the risk for severe neonatal morbidity or death. Â© 2013 Mosby, Inc. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 368368544
TI  - Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injury
AU  - Wagenaar G.T.M.
AU  - Laghmani E.H.
AU  - de Visser Y.P.
AU  - Sengers R.M.A.
AU  - Steendijk P.
AU  - Baelde H.J.
AU  - Walther F.J.
Y1  - 2013//
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - arterial wall thickness
KW  - article
KW  - controlled study
KW  - drug efficacy
KW  - heart
KW  - heart right ventricle pressure
KW  - histopathology
KW  - *hyperoxia
KW  - lung
KW  - lung injury/dt [Drug Therapy]
KW  - *lung injury/dt [Drug Therapy]
KW  - macrophage
KW  - neutrophil
KW  - newborn
KW  - nonhuman
KW  - priority journal
KW  - protein expression
KW  - *pulmonary hypertension/dt [Drug Therapy]
KW  - pulmonary hypertension/dt [Drug Therapy]
KW  - rat
KW  - survival
KW  - vascularization
KW  - *ambrisentan/dt [Drug Therapy]
KW  - *ambrisentan/pd [Pharmacology]
KW  - collagen type 3/ec [Endogenous Compound]
KW  - elastin/ec [Endogenous Compound]
KW  - fibrin/ec [Endogenous Compound]
KW  - messenger RNA/ec [Endogenous Compound]
KW  - n(g) nitroarginine methyl ester
KW  - nitric oxide synthase/ec [Endogenous Compound]
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 304
IS  - 4
PB  - American Physiological Society (9650 Rockville Pike, Bethesda MD 20814-3991, United States)
SN  - 1522-1504
AD  - G. T. M. Wagenaar, Div. of Neonatology, Dept. of Pediatrics, Leiden Univ. Medical Center, PO Box 9600, 2300 RC Leiden, Netherlands. E-mail: g.t.m.wagenaar@lumc.nl
UR  - http://ajplung.physiology.org/content/304/4/L264.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=368368544
DO  - https://dx.doi.org/10.1152/ajplung.00073.2012
AB  - Ambrisentan, an endothelin receptor type A antagonist, may be a novel therapeutic agent in neonatal chronic lung disease (CLD) by blocking the adverse effects of the vasoconstrictor endothelin-1, especially pulmonary arterial hypertension (PAH)-induced right ventricular hypertrophy (RVH). We determined the cardiopulmonary effects of ambrisentan treatment (1-20 mg.kg-1.day-1) in neonatal rats with CLD in 2 models: early treatment during continuous exposure to hyperoxia for 10 days and late treatment starting on day 6 in rat pups exposed postnatally to hyperoxia for 9 days, followed by a 9-day recovery period in room air. Parameters investigated included survival, lung and heart histopathology, right ventricular function, fibrin deposition, and differential mRNA expression in the lungs. In the early treatment model, we investigated the role of nitric oxide synthase (NOS) inhibition with Nomega-nitro-L-arginine methyl ester (L-NAME; 25 mg.kg-1.day-1) during ambrisentan treatment. In the early treatment model, ambrisentan improved survival with reduced lung fibrin and collagen III deposition, arterial medial wall thickness, and RVH. These changes were not affected by L-NAME administration. Ambrisentan did not reduce the influx of macrophages and neutrophils or prevent reduced irregular elastin expression. In the late treatment model, ambrisentan diminished PAH, RVH, and right ventricular peak pressure, demonstrating that RVH is reversible in the neonatal period. Alveolarization and vascularization were not affected by ambrisentan. In conclusion, ambrisentan prolongs survival and reduces lung injury, PAH, and RVH via a NOS-independent mechanism but does not affect inflammation and alveolar and vascular development in neonatal rats with CLD. Â© 2013 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 368358824
TI  - Long-term outcome of human cord blood-derived hematopoietic progenitor cells in murine lungs
AU  - De Paepe M.E.
AU  - Mao Q.
AU  - Chu S.
AU  - Padbury J.F.
Y1  - 2013//
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - cell transdifferentiation
KW  - controlled study
KW  - fluorescence in situ hybridization
KW  - *hematopoietic stem cell
KW  - *hematopoietic stem cell transplantation
KW  - human
KW  - human cell
KW  - immunofluorescence
KW  - inoculation
KW  - lung adenocarcinoma
KW  - lung alveolus cell type 2
KW  - lung alveolus macrophage
KW  - lung development
KW  - *lung dysplasia/th [Therapy]
KW  - lung parenchyma
KW  - morphometrics
KW  - mouse
KW  - newborn
KW  - nonhuman
KW  - outcome assessment
KW  - perinatal period
KW  - priority journal
KW  - protein expression
KW  - respiratory epithelium
KW  - sham procedure
KW  - stereometry
KW  - total lung capacity
KW  - transgenic mouse
KW  - *umbilical cord blood
KW  - volumetry
KW  - *CD34 antigen
KW  - Fas ligand/ec [Endogenous Compound]
KW  - phosphate buffered saline
T2  - Experimental Lung Research
LA  - English
VL  - 39
IS  - 2
PB  - Informa Healthcare (52 Vanderbilt Ave., New York 10017, United States)
SN  - 1521-0499
AD  - M.E. De Paepe, Department of Pathology, Women and Infants Hospital, 101 Dudley Street, Providence, RI 02905, United States. E-mail: mdepaepe@wihri.org
DO  - https://dx.doi.org/10.3109/01902148.2012.752548
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=368358824
AB  - Intranasally delivered human cord blood-derived CD34+ hematopoietic progenitor cells have the capacity to engraft and undergo transdifferentiation to surfactant-containing alveolar epithelial type II cell-like cells in lungs of newborn mice. The aim of this study was to determine the long-term fate of such transplanted cells as well as their effects on alveolar development in neonatally injured lungs. Double transgenic CCSP+/FasL+ mice with inducible lung-specific FasL expression, targeted to induce respiratory epithelial apoptosis in the perinatal period, served as model of neonatal lung injury. Non-injured single transgenic CCSP+/FasL-littermates served as controls. Freshly isolated umbilical cord blood CD34+ cells (0.5 to 1.0 x 106) were administered at postnatal day 5 by intranasal inoculation; sham controls received equal volume PBS. Engraftment, alveolar epithelial differentiation, lung growth, and alveolarization were evaluated one year after transplantation. Engrafted cord blood-derived cells, detected by human-specific FISH (fluorescent in situ hybridization) analysis, and cord blood-derived alveolar type II-like cells, detected by double immunofluorescence analysis, while sparse, were seen in all conditions and more frequent in double than single transgenic recipients. The total lung volume and volume of air-exchanging parenchyma, assessed by stereological volumetry, were significantly greater in CD34-treated double transgenic animals than in PBS-treated double transgenic controls. Alveolarization, assessed by histomorphometry, was equivalent in these groups. These results suggest that transdifferentiated alveolar epithelial cells, derived from cord blood CD34+ cells, can persist up to one year after intrapulmonary delivery. Cord blood-CD34+ cell administration appears to have growth-promoting effects in injured newborn lungs, without affecting alveolar development in this model. Â© 2013 Informa Healthcare USA, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 372197129
TI  - Circulating endothelial progenitor cells decrease in infants with bronchopulmonary dysplasia and increase after inhaled nitric oxide
AU  - Qi Y.
AU  - Jiang Q.
AU  - Chen C.
AU  - Cao Y.
AU  - Qian L.
Y1  - 2013//
KW  - article
KW  - cell count
KW  - clinical article
KW  - comparative study
KW  - controlled study
KW  - *endothelial progenitor cell
KW  - female
KW  - flow cytometry
KW  - gestational age
KW  - human
KW  - immunochemistry
KW  - infant
KW  - low birth weight
KW  - *lung dysplasia/dt [Drug Therapy]
KW  - *lung dysplasia/pc [Prevention]
KW  - *lung dysplasia/th [Therapy]
KW  - lung dysplasia/dt [Drug Therapy]
KW  - male
KW  - molecular dynamics
KW  - newborn
KW  - outcome assessment
KW  - patent ductus arteriosus
KW  - positive end expiratory pressure
KW  - prematurity
KW  - protein blood level
KW  - retrolental fibroplasia
KW  - treatment duration
KW  - CD133 antigen/ec [Endogenous Compound]
KW  - CD34 antigen/ec [Endogenous Compound]
KW  - granulocyte macrophage colony stimulating factor/ec [Endogenous Compound]
KW  - *nitric oxide/dt [Drug Therapy]
KW  - *nitric oxide/ih [Inhalational Drug Administration]
KW  - stromal cell derived factor 1/ec [Endogenous Compound]
KW  - vasculotropin/ec [Endogenous Compound]
KW  - vasculotropin receptor 2/ec [Endogenous Compound]
T2  - PLoS ONE
LA  - English
VL  - 8
IS  - 11
PB  - Public Library of Science (185 Berry Street, Suite 1300, San Francisco CA 94107, United States)
SN  - 1932-6203
AD  - Departments of Pediatrics, Children's Hospital of Fudan University, Shanghai, China
UR  - http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0079060&representation=PDF
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=372197129
DO  - https://dx.doi.org/10.1371/journal.pone.0079060
AB  - Background: Impairment of endothelial progenitor cells (EPCs) has been shown to contribute to the development of bronchopulmonary dysplasia (BPD). In the current study, the relationship between EPC changes of after birth and the development of BPD was investigated, and the effects of inhaled nitric oxide (iNO) on EPCs were evaluated. Method(s): Sixty infants with a gestational age of less than 32 weeks and a birth weight of less than 1500 g were studied. NO was administered to infants who were receiving mechanical ventilation or CPAP for at least 2 days between the ages of 7 and 21 days. EPC level was determined by flow cytometry at birth, 7, 21 and 28 days of age and 36 weeks' postmenstrual age (PMA), before and after the iNO treatment. Plasma concentrations of vascular endothelial growth factor (VEGF), stromal cell-derived factor-1 and granulocyte-macrophage colony-stimulating factor were determined via immunochemical assay. Result(s): Twenty-five neonates developed BPD, 35 neonates survived and did not develop BPD. EPC level was decreased on day 7 and 21 in infants who later developed BPD compared with infants that did not develop BPD. From birth to 21 days of age, BPD infants had a persistently lower VEGF concentration compared with non-BPD infants. No difference was found between the two groups at day 28 or 36 weeks PMA. In infants that later developed BPD, iNO raised the KDR+CD133+ and CD34+KDR +CD133+ EPC numbers along with increasing the level of plasma VEGF. Conclusion(s): EPC level was reduced at 7 days of age in infants with BPD, and iNO increased the EPC number along with increasing the level of VEGF. Further studies are needed to elucidate the mechanism leading to the decrease of EPCs in infants with BPD and to investigate the role of iNO treatment in the prevention of BPD. Â© 2013 Qi et al.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52538843
TI  - Major enzymes controlling the androgenic pressure in the developing lung
AU  - Tremblay Y.
AU  - Provost P.R.
Y1  - 2013//
KW  - article
KW  - fetus lung maturation
KW  - gene inactivation
KW  - human
KW  - lipogenesis
KW  - lung alveolus cell
KW  - *lung development
KW  - *lung pressure
KW  - male
KW  - nonhuman
KW  - protein expression
KW  - respiratory distress syndrome
KW  - steroidogenesis
KW  - testosterone synthesis
KW  - lung surfactant
KW  - messenger RNA/ec [Endogenous Compound]
KW  - protein/ec [Endogenous Compound]
KW  - *steroid 5alpha reductase 1/ec [Endogenous Compound]
KW  - *testosterone/ec [Endogenous Compound]
KW  - *testosterone 17beta dehydrogenase/ec [Endogenous Compound]
KW  - unclassified drug
KW  - akr1c14 protein/ec [Endogenous Compound]
KW  - AKR1C3 protein/ec [Endogenous Compound]
KW  - akr1c6 protein/ec [Endogenous Compound]
T2  - Journal of Steroid Biochemistry and Molecular Biology
LA  - English
VL  - 137
PB  - Elsevier Ltd (Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom)
SN  - 1879-1220
AD  - Y. Tremblay, Dept. Ob/Gyn and Reproduction, Reproduction Axis, Perinatal and Child Health, CHUQ Research Center, 2705 Laurier Boulevard, Quebec, QC G1V 4G2, Canada. E-mail: yves.tremblay@crchul.ulaval.ca
DO  - https://dx.doi.org/10.1016/j.jsbmb.2013.03.006
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=52538843
AB  - A sex difference is observed in the incidence and morbidity of respiratory distress syndrome (RDS) of the neonate and in bronchopulmonary dysplasia (BPD). The involvement of androgens is well evidenced in RDS and it is suspected in BPD. Interestingly, the developing lung is not an inert tissue just exposed to circulating androgens, but is rather an active androgen metabolizing tissue, expressing enzymes involved in both androgen synthesis and inactivation. The present review focuses on the major enzymes involved in androgen metabolism within the developing lung. Testosterone synthesis and inactivation by AKR1C3/Akr1c6 (human/mouse 17beta-hydroxysteroid dehydrogenases (HSDs) type 5) and HSD17B2 (17beta-HSD type 2), respectively, play an important role in the developing lung. Akr1c14 (3alpha-HSD) shows a strong increase in expression according to developmental time. The canalicular stage of lung development corresponding to the surge of surfactant lipid synthesis, which is linked to RDS, as well as saccularization/alveolarization, which are linked to BPD, are covered by this review for the mouse and human species. The androgen metabolizing enzymes expressed within the developing lung can become potential pharmaceutical targets in the objective of accelerating lung maturation by specific treatments. The classic deleterious effects of androgens on lung maturation and the surge of surfactant synthesis in males are well known. Conversely, androgens also have positive impacts on the development of both male and female lungs. Steroidogenic enzymes are key regulators of these positive effects. This article is part of a Special Issue entitled 'CSR 2013'. Crown Copyright Â© 2013 Published by Elsevier Ltd. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 372822400
TI  - Corrected VEGF levels based on platelet count should be calculated: Concerning the article by B.M. Levesque et al.: Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity [neonatology 2013;104:56-64]
AU  - Aksoy H.T.
AU  - Eras Z.
AU  - Canpolat F.E.
AU  - Uras N.
AU  - Oguz S.S.
AU  - Dilmen U.
Y1  - 2013//
KW  - artificial ventilation
KW  - human
KW  - immunocompetent cell
KW  - letter
KW  - lung dysplasia/th [Therapy]
KW  - macrophage
KW  - megakaryopoiesis
KW  - priority journal
KW  - protein blood level
KW  - retrolental fibroplasia
KW  - thrombocyte activation
KW  - *thrombocyte count
KW  - thrombocytopenia
KW  - thrombocytopoiesis
KW  - urine level
KW  - thrombopoietin/ec [Endogenous Compound]
KW  - *vasculotropin/ec [Endogenous Compound]
T2  - Neonatology
LA  - English
VL  - 105
IS  - 1
PB  - S. Karger AG
SN  - 1661-7819
UR  - http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=232056
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=372822400
DO  - https://dx.doi.org/10.1159/000355352
AD  - Switzerland
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 628682618
TI  - Risk factors for retinopathy of prematurity (ROP): Insights from "outlier" infants with low or high birth weights
AU  - Port A.
AU  - Paul Chan R.V.
AU  - Ostmo S.
AU  - Chiang M.
Y1  - 2013//
KW  - artificial ventilation
KW  - brain hemorrhage
KW  - Caucasian
KW  - cohort analysis
KW  - female
KW  - genetic susceptibility
KW  - gestational age
KW  - *high birth weight
KW  - human
KW  - infant
KW  - low birth weight
KW  - low level laser therapy
KW  - lung dysplasia
KW  - major clinical study
KW  - necrotizing enterocolitis
KW  - newborn sepsis
KW  - *retrolental fibroplasia
KW  - *risk factor
KW  - statistical significance
KW  - statistics
KW  - student
KW  - *vitreoretinopathy
KW  - conference abstract
T2  - Investigative Ophthalmology and Visual Science
LA  - English
VL  - 54
IS  - 15
SP  -
PB  - Association for Research in Vision and Ophthalmology Inc.
SN  - 1552-5783
AD  - A. Port, Weill Cornell Medical College, New York, NY, United States
UR  - https://iovs.arvojournals.org/article.aspx?articleid=2150422
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=628682618
AB  - Purpose: Many risk factors for ROP, such as low birth weight (BW), systemic illness and supplemental oxygen, are known. However, clinicians are often unable to explain "outliers": large infants with low apparent risk that develop ROP, and small infants with high apparent risk that never develop disease. This project aims to define features of "outlier" infants, with the goal of gaining insight about protective or predisposing factors. Method(s): We reviewed infants screened at WCMC and CUMC from 2002-2010. ROP exam results were recorded, along with clinical factors including sex, BW, gestational age, multiple gestation, maternal race, IVF status, mechanical ventilation, bronchopulmonary dysplasia, neonatal sepsis, intraventricular hemorrhage, and necrotizing enterocolitis. The cohort was stratified by weight, highest ROP stage, and need for ROP treatment. Descriptive and correlational statistics were performed. Result(s): During the study period, 1377 infants were screened for ROP. For the overall cohort (n=1377), all clinical factors above and Caucasian race were significantly associated with ROP stage and need for laser treatment (p<0.05). Among 258 infants with BW <750g, 78/258 (30%) were "outliers" who developed no ROP. Among 469 infants with BW >1250g, 66/469 (14%) were "outliers" who developed ROP. For "outliers" with BW <750g or >1250g, the only statistically-significant differences between infants with vs. without ROP were in multiple gestation and neonatal sepsis. Among infants with BW < 500g, there were no statistically-significant differences in any clinical risk factors between the 4 (23%) "extreme outliers" without ROP and the 13 (77%) with ROP (Table1). For the 168 with BW >1500g, there were no significant differences in any clinical risk factors between 16 (9%) "extreme outliers" with ROP vs. the 152 (91%) without ROP. Conclusion(s): In this large cohort, known clinical risk factors were predictive of ROP stage and need for laser treatment. However, these risk factors were not significantly associated with ROP at extremes of birth weight. This suggests that other clinical, maternal, or genetic factors may protect from or predispose to ROP pathogenesis. Comparison of ROP risk factors in infants with BW <500g and >1500g. Numbers shown are mean values or proportion of infants with risk factor, P-values are for difference between means calculated by two-tailed student's t-test.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 628679707
TI  - Risk Factors for treatment-requiring retinopathy of prematurity and implications for screening guidelines
AU  - Jordan S.
AU  - Lopez J.L.
AU  - Rychwalski P.
AU  - Abdala C.
Y1  - 2013//
KW  - birth weight
KW  - brain hemorrhage
KW  - Colombia
KW  - controlled study
KW  - *economics
KW  - female
KW  - gestational age
KW  - *health care delivery
KW  - human
KW  - hyaline membrane disease
KW  - infant
KW  - major clinical study
KW  - male
KW  - oxygen therapy
KW  - physician
KW  - *practice guideline
KW  - predictive value
KW  - receiver operating characteristic
KW  - *retrolental fibroplasia
KW  - retrospective study
KW  - *risk factor
KW  - sepsis
KW  - *workforce
KW  - oxygen
KW  - conference abstract
T2  - Investigative Ophthalmology and Visual Science
LA  - English
VL  - 54
IS  - 15
SP  -
PB  - Association for Research in Vision and Ophthalmology Inc.
SN  - 1552-5783
AD  - S. Jordan, Ophthalmology, Cleveland Clinic Lerner, College of Medicine, Cleveland, OH, United States
UR  - https://iovs.arvojournals.org/article.aspx?articleid=2151159
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=628679707
AB  - Purpose: Develop novel screening criteria through evaluation of potential risk factors for treatment-requiring retinopathy of prematurity (ROP), including threshold or type 1, in infants who were screened in 11 Neonatal Intensive Care Units in Colombia, South America between January 2008 and June 2012. Method(s): Retrospective study of 380 infants with a birth weight (BW) of <= 1750 g and/or a gestational age (GA) of <= 32 weeks that were screened by one physician. Univariate and multivariate logistic regression models were fit to determine the odds ratio (OR) and 95% confidence intervals (CI) for treatment-requiring ROP, in association with putative risk factors (year of exam, gestational age, birth weight, sepsis, oxygen, hyaline membrane disease (HMD), transfusion and intraventricular hemorrhage). Result(s): The mean GA and BW for the 92 cases (24%) of treatment-requiring ROP were 28.2+/-2.00 weeks and 1049+/-281 grams respectively, compared to 30.6+/-2.01 weeks and 1394+/-320 grams in controls. Statistically significant risk factors in multivariate analysis included birth weight (OR=0.998, CI=0.996-0.999, p<0.001), gestational age (OR=0.69, CI=0.56-0.83, p<0.001), sepsis (OR=2.2, CI=1.11-4.51, p=0.0228), and year of exam (OR=5.10, CI=2.34-11.41, p<0.0001). HMD was not statistically significant, but was perhaps clinically significant (OR=2.05, CI=0.97-4.54, p=0.0609). History of oxygen administration, transfusion, perinatal surgeries and intraventricular hemorrhage were not independent predictors of high risk ROP. Conclusion(s): Our results indicate that sepsis and possibly HMD are of particular importance in ROP screening in developing nations such as Colombia. It also emphasizes the individual predictive value of both gestational age and birth weight. This information will help to ensure identification of all patients at risk of developing ROP that could benefit from treatment, while decreasing the time and resources required of overextended physicians and the exposure to exams in premature infants. Specifically, utilizing this data to generate a predictive score would decrease the number of patients requiring screening by 26% while still retaining 99% sensitivity (area under ROC curve = 0.86).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 613016373
TI  - Non invasive ventilation strategy in newborns
AU  - Kugelman A.
Y1  - 2013//
KW  - apnea monitoring
KW  - arterial carbon dioxide tension
KW  - catheter
KW  - cerebral palsy
KW  - clinical effectiveness
KW  - controlled study
KW  - death
KW  - endotracheal intubation
KW  - extremely low birth weight
KW  - extubation
KW  - follow up
KW  - general condition
KW  - gestational age
KW  - high frequency ventilation
KW  - human
KW  - hypercapnia
KW  - infant
KW  - intermittent mandatory ventilation
KW  - intermittent positive pressure ventilation
KW  - learning curve
KW  - lung dysplasia
KW  - lung mechanics
KW  - maturation
KW  - meta analysis
KW  - morbidity
KW  - nasal prong
KW  - nervous system malformation
KW  - newborn
KW  - newborn apnea
KW  - *noninvasive ventilation
KW  - oxygenation
KW  - prematurity
KW  - prevention
KW  - respiratory distress syndrome
KW  - respiratory drive
KW  - retrospective study
KW  - risk factor
KW  - thorax wall
KW  - upper respiratory tract
KW  - ventilator
KW  - work of breathing
KW  - steroid
KW  - surfactant
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 14
IS  - Supplement 2
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - A. Kugelman, Department of Neonatology and Pediatric Pulmonary Unit, Bnai Zion Medical Center, B and R Rappaport Faculty of Medicine, Technion, Haifa, Israel
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=613016373
AB  - The comprehensive strategy to prevent bronchopulmonary dysplasia (BPD) is based on ventilatory and non-ventilatory measures [1]. The ventilatory route allows an individualized endotracheal intubation approach. Recent studies concluded that early nasal continuous positive airway pressure (NCPAP) is a safe alternative to immediate intubation in extremely low birth weight (ELBW) infants [2,3]. Endotracheal intubation and ventilation can result in significant damage to premature lungs [4] and are independently associated with cerebral palsy [5]. Furthermore, despite new modes of ventilation and surfactant, BPD remains a significant morbidity and its incidence was correlated with the use and length of endotracheal mechanical ventilation [6]. BPD in itself is associated with adverse neurodevelopmental outcome [7]. Thus, we need to avoid endotracheal ventilation, if possible. Recent trends show an increased use of NCPAP and decreased use of endotracheal ventilation even in ELBW infants [8]. The use of NCPAP requires experience, and learning curves show improved outcomes in rates of BPD [9]. When the infant requires nasal respiratory support (NRS), we should aim for adequate oxygenation (SpO2 of 88-92%), permissive hypercapnia (PaCO2 of 45-55mmHg, pH> 7.2) and gentle ventilation, similarly as on endotracheal ventilation [1]. NCPAP can be used as the early primary treatment of active respiratory distress syndrome (RDS) (to avoid intubation or as part of the INSURE [INtubation SURfactant Extubation] approach), or later, post extubation at RDS resolution, in order to allow shortening of the duration of endotracheal ventilation and to treat apnea of prematurity. However, the common use of NCPAP raises several questions. Does it really prevent BPD? Can we enhance NCPAP? What is the role of surfactant in the era of NRS? While previous studies have shown that the lowest incidence of BPD [10,11] or pulmonary morbidity in ELBW infants [12] occurred in NICUs practicing early NCPAP instead of initial mechanical ventilation, new studies [2,3] do not support that conclusion, and report comparable rates of BPD in ELBW infants treated initially with NCPAP as compared to endotracheal ventilation with surfactant administration. Can we enhance NCPAP and get better outcome for NRS by using nasal intermittent positive pressure ventilation (NIPPV)? NIPPV was defined as a method of augmenting NCPAP by delivering ventilator breaths via nasal prongs [13]. The rationale behind the use of NIPPV is the administration of "sigh" to the infant, thus opening microatelectasis and recruiting more ventilation units. It was shown that synchronized NIPPV (SNIPPV) compared with NCPAP may improve the patency of the upper airway, could activate the respiratory drive, improves thoraco-abdominal synchrony, stabilizes the chest wall, improves lung mechanics and decreases the work of breathing in premature infants. When NIPPV was compared to NCPAP for the different indications of NRS, it was shown to enhance the potential of NRS. NIPPV for the initial treatment of RDS was shown to significantly decrease the rate of endotracheal ventilation and subsequently the rate of BPD when compared to NCPAP [14]. The results of this study in regards to BPD needs to be taken with caution as the number of ELBW infants in this study was relatively small. Two additional studies [15,16] reported shorter duration of respiratory support [15] and reduced need for endotracheal ventilation with NIPPV [16] compared to NCPAP but no difference in the rate of BPD. A recent study [17] reported no significant difference in rates of endotracheal intubation at 72 hours or in rates of BPD. However, in posthoc analysis, from 24 to 72 hours of life, significantly more infants in the NIPPV group remained extubated compared with those in the NCPAP group. The authors concluded that their results suggest that early use of NIPPV is feasible and safe and may have beneficial effects when compared with NCPAP, especially for infants with a birth weight >1000 g. A recent meta-analysis demonstrated a relative risk reduction for intubation in the first 72 hours in the NIPPV group compared with NCPAP (RR 0.60, 95% CI 0.43, 0.83) [18]. SNIPPV vs. NCPAP for later use, post extubation at RDS resolution, as a "bridge" to spontaneous unsupported breathing was shown to be more effective than NCPAP [19,20]. A pooled meta-analysis showed that SNIPPV was more effective than NCPAP in preventing failure of extubation [RR 0.21 (0.10, 0.45)] and the number needed to treat was only 3 infants to prevent one extubation failure [19,20]. SNIPPV vs. NCPAP, post extubation, also tended to decrease the rate of BPD [19,20]. Two retrospective studies [21,22] showed a significantly decreased rate of BPD with NIPPV compared to NCPAP. The larger one showed that early or later use of SNIPPV vs. NCPAP, in infants at greatest risk of BPD or death (500-750 g) was associated with decreased rate of BPD and/or death and decreased rate of neurodevelopmental impairment and/or death [22]. SNIPPV may be more effective than NCPAP also for apnea of prematurity [23]. A meta-analysis, regarding apnea of prematurity, suggests that SNIPPV is more efficacious with apnea that is frequent or severe. However, the studies performed addressed short-term outcomes and as such could not address properly the incidence of requirement for reintubation. Thus, more studies are needed before recommending SNIPPV as standard of care for apnea of prematurity [23]. While non-invasive ventilation is probably safe, its success depends on gestational age [2,3,8]. The data indicate that surfactant may still have a significant role in the treatment of RDS, especially in ELBW infants. Recently, Morley et al. [2] and the SUPPORT study [3] reported on an intubation rate of ~50% in their NCPAP group in ELBW infants. This leads us to the INSURE approach. This approach may allow the infant to benefit from both, surfactant and NRS. A Cochrane review [24] concluded that the INSURE approach with NCPAP compared with later selective surfactant administration, continued mechanical ventilation, and extubation from low respiratory support was associated with less need for mechanical ventilation, lower incidence of BPD and fewer air leak syndromes. Bhandari et al. [25] showed that the INSURE approach with SNIPPV had a significantly lower incidence of BPD/death compared with continued mechanical ventilation. Ramanathan et al. [26] also reported a significant reduction in "physiologic" and clinical BPD in the NIPPV group after the INSURE approach compared to synchronized intermittent mandatory ventilation and early extubation to NCPAP. Results of these studies suggest that NCPAP and NIPPV seem to be feasible and effective and result in a lower incidence of BPD when compared with endotracheal ventilation. Another option for surfactant application to the trachea without endotracheal intubation was described by using a thin catheter in spontaneously breathing preterm infants receiving NCPAP. This technique was reported to reduce the need for mechanical ventilation [27]. To summarize, the available evidence supports the preference of early or later use of NIPPV/SNIPPV compared to NCPAP because of minimizing the use and the length of endotracheal ventilation [28]. There are data to suggest that this approach may also reduce the rate of BPD, however this was not shown yet [28]. The preliminary results of a large international RCT comparing both primary, and post-extubation use of NIPPV with NCPAP, with a composite primary outcome of death or BPD at 36 weeks' corrected age indicate no additional benefit, or risk, conferred by NIPPV in comparison to NCPAP [29]. Whether NIPPV/SNIPPV is more beneficial than NCPAP within the INSURE approach needs to be shown. New modes of NRS such as neurally adjusted ventilator assist (NAVA) [30], and nasal high frequency ventilation [31,32], need to be further studied before concluding on benefits for the short and long term outcomes of premature infants. This non invasive ventilator strategy needs to be confirmed by large prospective randomized controlled trials (with long-term follow up) in order to assure it is applicable to most ELBWinfants. Furthermore, the strategy needs to be tailored to individualized infants according to the infant's maturation; antenatal steroid treatment and severity of RDS; general condition; and to certain practical NICU conditions such as experience, personnel and timing during the day.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 613016328
TI  - Prevention of ventilator-associated pneumonia in neonatal intensive care units
AU  - Manzoni P.
AU  - Mostert M.
AU  - De Luca D.
Y1  - 2013//
KW  - adult
KW  - *adverse device effect
KW  - *artificial ventilation
KW  - awareness
KW  - bacterium contamination
KW  - birth weight
KW  - blood culture
KW  - bronchoalveolar lavage fluid
KW  - case report
KW  - child
KW  - chronic lung disease
KW  - clinical outcome
KW  - clinical trial
KW  - colony forming unit
KW  - complication
KW  - control group
KW  - controlled clinical trial
KW  - controlled study
KW  - cost benefit analysis
KW  - coughing
KW  - critically ill patient
KW  - death
KW  - developing country
KW  - diagnosis
KW  - diagnostic test accuracy study
KW  - endotracheal tube
KW  - Europe
KW  - extubation
KW  - gas exchange
KW  - general condition
KW  - gravity
KW  - hand washing
KW  - heating
KW  - hospital infection
KW  - host resistance
KW  - human
KW  - immune deficiency
KW  - infant
KW  - infection control
KW  - leukocyte
KW  - *lung dysplasia
KW  - nasotracheal intubation
KW  - *neonatal intensive care unit
KW  - neonatal ventilator
KW  - newborn
KW  - North America
KW  - nurse patient ratio
KW  - nursing
KW  - parenteral nutrition
KW  - pediatric intensive care unit
KW  - population based case control study
KW  - pregnancy
KW  - *prematurity
KW  - prevention
KW  - prophylaxis
KW  - randomized controlled trial
KW  - remission
KW  - respiratory distress syndrome
KW  - risk factor
KW  - sepsis
KW  - stress ulcer
KW  - supine position
KW  - thorax radiography
KW  - tracheobronchial toilet
KW  - ultrasound
KW  - ultraviolet radiation
KW  - uncertainty
KW  - *ventilator associated pneumonia
KW  - antibiotic agent
KW  - neuromuscular blocking agent
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 14
IS  - Supplement 2
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - P. Manzoni, Neonatology and NICU, S. Anna Hospital, Turin, Italy. E-mail: paolomanzoni@hotmail.com
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=613016328
AB  - Abbreviations: VLBW= very low birth weight (below 1500 g.) NICU= neonatal intensive care unit VAP = ventilator-associated pneumonia BPD= bronchopulmonary dysplasia Background: Ventilator-associated pneumonia (VAP) is a wellknown problem in adult critical care. VAP represents a particular challenge because it affects patients who need mechanical ventilation for their respiratory failure, thus those who are most critically ill. VAP insurgence is driven by two factors. First, the presence of the endotracheal tube that by-passes natural host defences to the lower respiratory tree and, second, the compromised general conditions of this particular patient population [1]. Clearly, these two conditions also apply to critically ill neonates and to premies in particular, since the latter have even more reduced host defences. Despite this background, research on VAP has been much more limited in neonatal than in adult critical care. However, awareness is raising, since VAP could have relevant clinical consequences in terms of death, length of intensive care unit stay and pulmonary outcomes [2]. Few data are available and several questions need to be addressed. In this paper we will review the topic gathering the knowledge from adult and neonatal research in order to describe the best current evidence to prevent neonatal VAP. Definition and diagnosis of neonatal VAP: VAP requires intubation to occur, but no specific diagnostic test is available. In adults, the diagnosis is attributed gathering together microbiological, clinical and ventilatory data, although microbiological tests have been recently recognised to have little value for the diagnostic process (see below) [3]. This procedure may also be applied to neonates but one more problem is the lack of a specific VAP definition in this population. The US Center for Disease Control and Prevention proposed a VAP definition based on clinical and radiographic criteria for infants aged <=12 months [4,5] and this is currently considered the best option to define neonatal VAP for research and epidemiological purposes. VAP is defined by a worsening of gas exchange together with at least 3 clinical criteria plus radiographic criteria. Table 1 shows a modified CDC definition for VAP where some clinical signs have been adapted to the neonatal clinical reality (for instance, the original definition included cough that is rarely seen in neonates). Some peculiarities of the neonatal population are not included in this definition [6]. For instance, chest x-ray appearance is far less specific in newborn infants (especially in premies) than in older children. No mention is made of lung ultrasound that is becoming commonly used, previous antibiotic courses are common and may mask clinical signs and finally there is uncertainty about microbiological investigations to ascertain VAP etiology. The latter is not included in the definition, since lower respiratory airways are colonized a few minutes after intubation [2,3]. Thus, cultures may be useful only to guide therapy and accuracy of broncho-alveolar lavage fluid (BALF) culture is acceptable but far from optimal. BALF in neonates is often obtained by non-bronchoscopic technique and, fortunately, recovery and accuracy of this technique seems comparable to fiberbronchoscopic lavage [7,8]. The lavage technique itself is not standardised but some advice has been issued by the European Respiratory Society Task Force on pediatric bronchoalveolar lavage [9]. However, no thresholds of colony forming units or leukocytes are available for the clinical interpretation of these tests. Conversely, blood culture is not accurate enough to have any clinical usefulness [10]. Moreover, endotracheal tube culture or any test performed on the fluid that has been simply aspirated (with no broncho-alveolar lavage) should be avoided as they have very little value. Risk factors for neonatal VAP: Some peculiar characteristics of newborn infants may represent risk factors for VAP insurgence such as the relative immunosuppression (especially of preterm infants), the shorter airways and the possible presence of congenital malformations or immunodeficiencies [11]. Beyond these general traits, identifying specific risk factors would be ideal to protect babies more at risk and prevent VAP, albeit few researches have been conducted with this purpose. However, the available data are quite reliable and consistent. A previous episode of sepsis is a significant risk factor for VAP occurrence in preterm babies [12]. The risk for VAP is significantly higher below 28 weeks' gestation [12] and smaller babies are more at risk for concurrent complications. Two elegant Chinese casecontrol studies [13,14] showed birth weight, parenteral nutrition, reintubation, duration of mechanical ventilation, use of opiates, presence of an orogastric tube, frequent endotracheal suctioning and the diagnosis of respiratory distress syndrome (RDS) as significant risk factors associated with VAP. Interestingly, some of these data are consistent with risk factors for VAP identified in pediatric intensive care units or in adults (i.e.: reintubation, duration of ventilation, oral bacterial contamination) [15,16]. The diagnosis of RDS as risk factors deals with prematurity and is linked with the duration of mechanical ventilation that is indeed the main target to be reduced, since the majority of VAP seems to occur after 5.4+/-3.2 days of mechanical ventilation [13]. There are differences concerning VAP distribution. VAP is among the commonest nosocomial pediatric infections in Europe and North- America [17,18], but the International Nosocomial Infection Control Consortium (INICC) showed a higher incidence in developing countries, thus this may also be considered a risk factor [19]. Interestingly, there are strong data suggesting that VAP is responsible for a vicious cycle since it leads to a longer duration of ventilation, being the additional days of ventilation inversely related to the birth weight [20,21], to a longer intensive care unit stay [19] and this may obviously affect the insurgence of BDP and secondary sepsis. It is not surprising that duration of mechanical ventilation and VAP represent a significant risk factor for death in preterm babies (OR: 3.4; 95% CI: 1-2-12.3) [20,21,22]. Preventive measures: Again few researches have been conducted as concerns neonatal VAP prevention. There are some preventive measures that have been widely accepted in adults and that should be considered with no modifications for neonatal critical care, given their simplicity or the positive cost-benefit ratio [1,2]. These include: hand washing and general prevention policy, changing ventilator circuits every 3-4 days, reducing the need for reintubation. Some other measures should also be applied, like preferring orotracheal over nasotracheal intubation and reducing opiates and neuromuscular blocking agents. These measures should be carefully decided for each single patient according to the clinical conditions and to different clinical settings, since an adequate nurse/patient ratio and optimal nursing are obviously needed to achieve the best assistance. What is surely useless is the use of cuffed tubes and repeated endotracheal suctions, while other measures investigated in adults (selective digestive contaminations or stress ulcer prophylaxis) need specific neonatal research and may be even harmful in these little patients. Neonatal research shows that the most important preventive measure is early extubation (<48 h) and the switch to non-invasive respiratory support which reduces the risk of VAP [16]. The choice of which ventilator strategy to adopt is beyond the scope of this study but it is the cornerstone for prevention of VAP and other negative outcomes. The reduction of transfers of babies outside the intensive care unit is also important although no data are available concerning the impact of this specific measure. This goal should not be too difficult to achieve [23]. Recently, an Egyptian study reported an interesting effect of gravitational forces that can reduce respiratory colonization in neonates [24]. It showed that after 5 days of mechanical ventilation, tracheal cultures were positive for 87% of infants randomised to remain in supine position during ventilation and in 30% of infants randomised to the lateral position. Also chest-X rays, inflitration and reintubation rate were significantly higher in the supine position group. These are interesting findings although colonization was studied only on aspirated fluid and not on BALF. Moreover, there are no data on major clinical outcomes and the study enrolled late preterm babies ventilated for up to 5 days. New trials should be conducted to see if there is an effect on main clinical outcomes and also in smaller babies and for reduced ventilation times. Even more recently, two intriguing new approaches have been proposed for preventing VAP in neonatal intensive care units. Ryan et al. used ultraviolet germicidal irradiation in the heating ventilation and air conditioning system of their ward and found a reduction in both tracheal colonization and VAP incidence (from 74% to 39%; relative risk: 1.89; number needed to treat 2.85) [25]. Christensen et al. proposed the use of a low sodium saline solution for airway care and broncho-alveolar lavage in neonates. This strategy was designed to lower the incidence of VAP by reducing the damage to the innate antimicrobial system of airways subjected to serial lavages (as may occur in long term ventilated neonates). In their trial, these authors observed a significant reduction of VAP incidence (from 4.2 episodes over 1.000 ventilator days in the control group, to 1.6 in the treatment group) and a significantly lower incidence of chronic lung disease, as well [26].
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Attenuation of miR-17~92 Cluster in Bronchopulmonary Dysplasia.
DO  - https://dx.doi.org/10.1513/AnnalsATS.201501-058OC
AU  - Rogers, Lynette K
AU  - Robbins, Mary
AU  - Dakhlallah, Duaa
AU  - Yang, Zhaogang
AU  - Lee, L James
AU  - Mikhail, Madison
AU  - Nuovo, Gerard
AU  - Pryhuber, Gloria S
AU  - McGwin, Gerald
AU  - Marsh, Clay B
AU  - Tipple, Trent E
Y1  - 2015//
KW  - Autopsy
KW  - *Bronchopulmonary Dysplasia/ge [Genetics]
KW  - *Bronchopulmonary Dysplasia/pa [Pathology]
KW  - *DNA Methylation
KW  - DNA Modification Methylases/me [Metabolism]
KW  - Humans
KW  - Infant
KW  - Infant, Newborn
KW  - *Infant, Premature
KW  - *Lung/pa [Pathology]
KW  - *MicroRNAs/ge [Genetics]
KW  - Promoter Regions, Genetic
KW  - RNA, Long Noncoding
T2  - Annals of the American Thoracic Society
VL  - 12
IS  - 10
SN  - 2325-6621
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26291337
AD  - United States
AB  - RATIONALE: Bronchopulmonary dysplasia remains a significant cause of neonatal morbidity; however, the identification of novel targets to predict or prevent the development of bronchopulmonary dysplasia remains elusive. Proper microRNA (miR)-17~92 cluster is necessary for normal lung development, and alterations in expression are reported in other pulmonary diseases. The overall hypothesis for our work is that altered miR-17~92 cluster expression contributes to the molecular pathogenesis of bronchopulmonary dysplasia., OBJECTIVES: The current studies tested the hypothesis that alterations in miR-17~92 cluster and DNA methyltransferase expression are present in bronchopulmonary dysplasia., METHODS: miR-17~92 cluster expression, promoter methylation, and DNA methyltransferase expression were determined in autopsy lung samples obtained from premature infants who died with bronchopulmonary dysplasia, or from term/near-term infants who died from nonrespiratory causes. Expression of miR-17~92 cluster members miR-17 and -19b was measured in plasma samples collected in the first week of life from a separate cohort of preterm infants at a second institution in whom bronchopulmonary dysplasia was diagnosed subsequently., MEASUREMENTS AND MAIN RESULTS: Autopsy tissue data indicated that miR-17~92 expression is significantly lower in bronchopulmonary dysplasia lungs and is inversely correlated with promoter methylation and DNA methyltransferase expression when compared with that of control subjects without bronchopulmonary dysplasia. Plasma sample analyses indicated that miR-17 and -19b expression was decreased in infants who subsequently developed bronchopulmonary dysplasia., CONCLUSIONS: Our data are the first to demonstrate altered expression of the miR-17~92 cluster in bronchopulmonary dysplasia. The consistency between our autopsy and plasma findings further support our working hypothesis that the miR-17~92 cluster contributes to the molecular pathogenesis of bronchopulmonary dysplasia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 613016427
TI  - Target oxygen levels in preterm neonates
AU  - Vento M.
AU  - Cernada M.
AU  - Cubells E.
AU  - Torres-Cuevas I.
AU  - Kuligowski I.
AU  - Escobar J.
AU  - Aguar M.
AU  - Escrig R.
AU  - Nunez A.
Y1  - 2013//
KW  - achievement
KW  - arterial gas
KW  - arterial oxygen saturation
KW  - artificial ventilation
KW  - assisted ventilation
KW  - bradycardia
KW  - brain hemorrhage
KW  - confidence interval
KW  - consensus development
KW  - controlled study
KW  - death
KW  - delivery room
KW  - face mask
KW  - female
KW  - fetus
KW  - functional residual capacity
KW  - gender
KW  - gestational age
KW  - hand
KW  - human
KW  - hypoxia
KW  - infant
KW  - liquid
KW  - lower respiratory tract
KW  - lung dysplasia
KW  - lung vascular resistance
KW  - lung vasoconstriction
KW  - male
KW  - maturation
KW  - meta analysis
KW  - monitoring
KW  - mortality
KW  - nasal prong
KW  - newborn
KW  - newborn period
KW  - nitrosative stress
KW  - nomogram
KW  - *oxidative stress
KW  - oxygen concentration
KW  - pulmonary hypertension
KW  - pulse oximeter
KW  - *pulse oximetry
KW  - reoxygenation
KW  - respiratory burst
KW  - *resuscitation
KW  - *retrolental fibroplasia
KW  - sensor
KW  - systematic review
KW  - thorax
KW  - tidal volume
KW  - uncertainty
KW  - wrist
KW  - antioxidant
KW  - carbon dioxide
KW  - nitric oxide
KW  - *oxygen
KW  - reactive oxygen metabolite
KW  - steroid
KW  - surfactant
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 14
IS  - Supplement 2
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - M. Vento, Division of Neonatology, University and Polytechnic Hospital La Fe, Valencia, Spain. E-mail: maximo.vento@uv.es
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=613016427
AB  - To achieve postnatal adaptation newly born infant need to aerate the lungs, reduce pulmonary vascular resistance, and initiate oxygen and carbon dioxide exchange. The cornerstone of newborn resuscitation resides therefore in the establishment of a functional residual capacity and an adequate oxygenation. Recent guidelines have established guidelines concerning oxygen supplementation in preterm infants in the delivery room (DR); however, they are vague and unspecific. Herewith, we will address available information regarding the use of oxygen supplementation in the DR in preterm infants to satisfactorily overcome postnatal adaptation. Introduction: Resuscitation of the newborn is considered the most frequent and one of the most stressful interventions in the neonatal period. In order to successfully resuscitate depressed newborn infants birth attendants have to be adequately trained and the equipment employed has to meet specific standards of quality [1]. In 2010 the International Liaison Committee on Resuscitation (ILCOR) released new recommendations for the use of oxygen supplementation during resuscitation [2]. However, the precise management of oxygen in the DR especially in preterm infants still poses a great deal of uncertainty to care givers. Physiologic changes in oxygenation in the fetal to neonatal transition: Fetal to neonatal transition causes cardio-respiratory changes that lead to an abrupt rise in paO2 from 3.1 kPa to 9.3 kPa; however, as a consequence a burst of reactive oxygen species (ROS) will be generated. Conspicuously, ROS under physiologic circumstances act as signaling molecules modulating maturation of specific metabolic pathways. On the contrary under hypoxic ischemic conditions an excess of oxygen upon re-oxygenation will cause oxidative damage and increased mortality [3]. Conspicuously, the expression of antioxidant enzymes only takes place in the last weeks of gestation paralleling surfactant production. Therefore, babies born prematurely are at high risk of developing oxidative stress associated conditions [3]. Moreover, ROS in the presence of nitric oxide will cause nitrosative stress predisposing preterm infants to pulmonary vasoconstriction and pulmonary hypertension [4]. Prematurity also predisposes to chronic conditions such as bronchopulmonary dysplasia (BPD), retinopathy of prematurity (ROP) or intra-periventricular hemorrhage (IVP) [3]. Interestingly, maturation is gender related and the use of antenatal steroids enhances antioxidant enzymes' activation thus increasing postnatal adaptability of preterm infants [5]. Oxygen supplementation in the delivery room: What is the normal range of oxygen saturation in the first minutes of life? Preductal pulse oximetry provides reliable values of pre-ductal arterial oxygen saturation (SpO2) in 60-90 seconds after birth. In term infants preductal SpO2 rises from ~50% to >90% in the first 5 min after birth. In preterm infants time to achieving SpO2 plateau ~90% takes almost 10-15 min [6] as reflected in Dawson's nomogram [6] (see Figure 1). Measuring saturation in the delivery room: SpO2 is at present the most recommended means of monitoring arterial oxygen saturation and heart rate during resuscitation in the delivery room. Achievement of reliable measurements can be obtained in 60-90 seconds in the right hand or wrist with an adequate training. Of interest is the fact that variability below 70% SpO2 may depend on the type of monitor, gestational age, type of sensor and adjustments of frequency of signaling and sensitivity. Therefore, persistent low values should be always confirmed with arterial blood gas analysis. Furthermore, SpO2 values above 93-95% may correspond to hyperoxic paO2 values [7]. At present preterm babies are frequently supported in the DR with a face mask or nasal prongs. The use of these devices will slightly modify achievement of targeted saturations in the first minutes after birth. In a very recent study it has been shown that preterm babies and especially females receiving positive pressure and air attain higher saturations earlier as those spontaneously breathing [8]. Oxygen supplementation in preterm infants: Preterm infants and especially <32 weeks gestation often need respiratory support and oxygen supplementation immediately after birth to adequately perform postnatal adaption. ILCOR recommends using blended air and oxygen according to the infant's needs guided by pulse oximetry trying to avoid hyper-and/or-hypoxia [2]. Interestingly, most preterm infants are not born severely asphyxiated and will just need a mild positive pressure support to stabilize thoracic cage, favor fluid resorption in the lower airways and expand sacculae [7]. The targeted range of SpO2 in the DR should be in the range of 60% in the first minutes, reach around 80% at five minutes and should not be reaching values around 90% until 10-15 minutes after birth have elapsed [6] thus aiming to avoid the risk of causing increased oxidative stress and damage in babies with lower antioxidant capacity. In a recent systematic review and meta-analysis of randomized controlled trials it was found a statistically significant reduction in the risk of death pooled risk ratio 0.65 (95% confidence interval 0.43, 0.98) for preterm babies who were ventilated with an initial FiO2 < 50%. However, this effect disappeared when only the four trials with adequate allocation concealment were included [pooled risk ratio 1.0 (95% confidence interval 0.45, 2.24)]. It was concluded that with the available data there is not sufficient evidence to affirm that the use of lower or higher initial FiO2 in the delivery room for preterm babies confers important benefits or harms [9]. However, after this study was published new information has been substantiated that has not been yet analyzed but that may permit reaching sufficient evidence to establish new guidelines for the use of oxygen in the delivery room [10]. In a recent commentary by experts it was recommended to use of an initial FiO2 between 21% and 30% in all preterm infants under preductal pulse oximeter control. Thereafter, FiO2 should be titrated according to the SpO2 readings with changes performed ever 30 seconds to allow babies cardio-respiratory response. Heart rate is extremely sensitive to hypoxia, and bradycardia is the most reliable parameter of an adequate response to resuscitation maneuvers. If the baby is not adequately ventilated because of mask leakage, insufficient tidal volume, or flow volume increasing oxygen concentration will be unsuccessful. However, if the baby is adequately ventilated FiO2 should be titrated according to the readings of the pulse oximeter and kept within the recommended range of Dawson's nomogram [6,7].
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 613016892
TI  - Nutritional interventions to prevent or treat bronchopulmonary dysplasia
AU  - Manzoni P.
AU  - Mostert M.
AU  - Franco C.
AU  - Luparia M.
AU  - Tavella E.
AU  - Stronati M.
AU  - Farina D.
Y1  - 2013//
KW  - acceleration
KW  - adverse drug reaction
KW  - animal model
KW  - arm muscle
KW  - artificial ventilation
KW  - asthma
KW  - bovine
KW  - brain hemorrhage
KW  - breast feeding
KW  - breast milk
KW  - *caloric intake
KW  - catch up growth
KW  - chemical binding
KW  - child
KW  - chronic lung disease
KW  - clinical trial
KW  - colostrum
KW  - controlled study
KW  - death
KW  - diet restriction
KW  - differentiation
KW  - disease model
KW  - drug combination
KW  - drug megadose
KW  - enteric feeding
KW  - epithelium
KW  - exposure
KW  - fat intake
KW  - feeding difficulty
KW  - female
KW  - gastrointestinal tract
KW  - growth rate
KW  - guinea pig
KW  - hemolytic anemia
KW  - human
KW  - immune system
KW  - infancy
KW  - infant
KW  - internalization
KW  - intrauterine growth retardation
KW  - Lactobacillus
KW  - lower respiratory tract infection
KW  - lung development
KW  - *lung dysplasia
KW  - lung function
KW  - lung weight
KW  - major clinical study
KW  - male
KW  - maturation
KW  - metabolic rate
KW  - neonatal intensive care unit
KW  - newborn
KW  - newborn morbidity
KW  - newborn period
KW  - nomenclature
KW  - nonhuman
KW  - normal human
KW  - nutrient supply
KW  - nutritional status
KW  - oral drug administration
KW  - oxidation
KW  - oxidative stress
KW  - perinatal period
KW  - postnatal growth
KW  - precursor
KW  - prevention
KW  - protein intake
KW  - protein synthesis
KW  - *retrolental fibroplasia
KW  - school child
KW  - sepsis
KW  - side effect
KW  - stomach
KW  - toxicity
KW  - very low birth weight
KW  - weight gain
KW  - wellbeing
KW  - wheezing
KW  - alpha tocopherol
KW  - antifungal agent
KW  - antioxidant
KW  - endogenous compound
KW  - glucocorticoid
KW  - inositol
KW  - iron
KW  - *lactoferrin
KW  - lung surfactant
KW  - oxygen
KW  - phospholipid
KW  - placebo
KW  - proteinase
KW  - reactive oxygen metabolite
KW  - retinol
KW  - selenium
KW  - surfactant
KW  - trace element
KW  - *vitamin D
KW  - *xanthophyll
KW  - zeaxanthin
KW  - zinc
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 14
IS  - Supplement 2
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - P. Manzoni, Neonatology and NICU, A.O. Regina Margherita-S. Anna. S. Anna Hospital, Torino, Italy. E-mail: paolomanzoni@hotmail.com
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=613016892
AB  - Abbreviations: VLBW = very low birth weight (below 1500 g.) NICU = neonatal intensive care unit NEC = necrotizing enterocholitis ROP = retinopathy of prematurity BPD = bronchopulmonary dysplasia Abstract: Nutrients in the prenatal and perinatal period play a major role in the development of the immune system as well as in the ability to contrast infections. A remarkable body of evidence supports the hypothesis that availability of specific, essential nutrients in these periods is critical for the development and appropriate maturation of the respiratory tract. The lungs have been shown to be the target of the actions of a large number of nutrients which condition, directly or not, the onset of chronic lung disease and/or BPD in preterm infants. Decreased intakes of some of these nutrients have been associated with increased odds of developing BPD in preterm infants. Some of these nutrients play a preventative role thus contrasting respiratory infections and morbidity also during the first months of life. The present review aims at updating the current knowledge about the role of nutrition and specific nutrients in the prevention and management of BPD and - more generally - of respiratory morbidity in neonates and young infants. Introduction - nutritional needs of infants at risk of BPD: It is a common finding that preterm infants with ongoing BPD grow poorly in the NICU. Consistent evidence shows that VLBW preterm neonates with major morbidity including BPD have worse growth than VLBW without, and that the impaired growth sometimes extends over the first few years of life [1]. The question is: why do infants with BPD grow slowly? A number of reasons may account for this. Increased work required to breath, early use of corticosteroids, pre-existing intrauterine growth retardation, early postnatal growth retardation, or feeding problems related to inadequate intake or high metabolic rate [2,3]. In the latter case, decreased and inadequate nutritional intakes could be the key factor giving rise to decreased ability of the lungs to grow and differentiate, thus closing a vicious circle that is difficult to overcome. Historical studies on animal models (guinea pigs) give evidence that adequate nutrient supply plays an important role in growth and repair of the immature lung. In these experiments, guinea pigs exposed to food restriction displayed significantly reduced body and lung weight compared with fed controls [4]. The rate of pulmonary protein synthesis determined in vivo was reduced by 33%, thus impairing not only growth, but also repair ability of the immature lungs. Adequate nutrient supply is even more critical when considering that energy needs of infants with BPD is 15% to 25% above healthy controls [5], thus an energy intake of 140 to 150 kcal/kg/d may be necessary during periods of active disease. In line with this, both ESPGHAN statements and Cochrane reviews acknowledge that a higher caloric intake is beneficial for infants with BPD [6,7], thus prompting clinicians to face the difficulties to increase the feeds to an infant who is - per se - poorly responsive to such strategies since he is often mechanically ventilated and/or fed via orogastric tube. In addition, when infants with BPD achieve full enteral feedings and have similar protein-energy intakes to control infants, they often demonstrate similar rates of growth and arm muscle and fat accretion, but do not demonstrate catch-up growth. These observations support the speculation that early reductions in growth velocity contribute to the long-term growth failure in infants with BPD. According to this, currently it appears appropriate to assume that the protein needs of preterm infants with BPD are at least comparable to the protein needs of those without the disease, and therefore, protein intakes of 3.5 to 4 g protein/kg should be provided to meet needs for growth and anabolism. The role of lipid intake in infants with BPD also needs further investigation, in view of a possible correlation between early trophic feeding and BPD and between early versus delayed initiation of progressive enteral feedings for parenterally fed low birth weight infants and BPD. The role of specific nutrients: The neonatal period: Several studies have examined and demonstrated the properties of human milk in preventing many diseases of newborns and preterms infants, including infection, NEC, ROP, CLD / BPD. The mechanism that seems to be at the basis of this protective role is the presence in breast milk of numerous anti-oxidant agents (Vitamins E, A, D, inositol, lactoferrin, especially carotenoids like lutein and zeaxanthin, long chain polyunsaturated fatty acids, enzymes and anti-oxidants), which contrast oxidative stress, in turn implicated in the pathogenesis of the above listed diseases. The beneficial effect of human milk has been found to depend on the amounts ingested by the infant. A study exploring neonatal morbidities found out that the proportion of VLBWinfants featuring chronic lung disease dropped dramatically by 50% (from 37% to 19%) by increasing the average quantity of maternal milk ingestion to at least 50 ml/kg/day over the stay in NICU [8]. Vitamin A is essential for development and growth of the lung, as well as for integrity and healing of the epithelium lining the respiratory tract. Vitamin A also upregulates genes involved in alveolarization and surfactant production [9]. Preterm infants at birth have low levels of vitamin A and this has been associated with an increased risk of developing respiratory disease. Supplementation with vitamin A in these children has multiple beneficial effects, including reducing death or oxygen requirement at one month of age (typical RR 0.93, RD -0.05, NNT 20), reducing oxygen requirement at 36 weeks postmenstrual age (typical RR 0.87, RD -0.08, NNT 13) and reducing death or oxygen requirement at 36 weeks postmenstrual age (typical RR 0.91) [10]. According to this, administration of vitamin A is currently recommended in all VLBW infants. Inositol is an essential precursor of phospholipids, promoting maturation of several components of surfactant, and potentiating the glucocorticoid induced acceleration of differentiation of lung surfactant. Adequate nutritional intakes of inositol can prevent or decrease drastically the incidence of some negative outcomes of prematurity, including BPD. In line with this, inositol supplementation results in statistically significant and clinically important reductions in important short-term adverse neonatal outcomes, including BPD [11]. Vitamin E is an important anti-oxidant agent and its administration in VLBW infants has been proposed for the prevention of ROP, hemolytic anemia, intracranial hemorrhage, and also chronic lung disease. BPD has been assessed in six studies of vitamin E supplementation, involving 558 treated patients and 569 controls. From these studies, vitamin E supplementation did not significantly affect the risk of BPD (typical estimate RR 0.91, RD -0.02). Toxicity and side effects related to high doses of vitamin E have been described [12]. The postnatal, early infancy period: During early infancy, the available evidence in literature shows that duration of breastfeeding and the general nutritional status, rather than specific nutrients, impact on airway infections and respiratory morbidity. Nonetheless, recent studies have highlighted the importance of some specific nutrients, such as, zinc and other micronutrients, lactoferrin, vitamin D, lutein and carotenoids. A recent study evaluated the pulmonary function of 12 year old children born from mothers with asthma, comparing those who were breastfed with those who were not. Lung function was significantly better in children previously breastfed, even though their mothers had asthma, than in children not breastfed. This improvement was even more pronounced if breastfeeding was extended beyond 4 months of age [13]. Several nutritional interventions have been evaluated over the years with the aim of reducing the risk of lower respiratory tract infections in early childhood. Most results are inconclusive. Only supplementation with zinc, as well as use of milk fortified with micronutrients (iron, zinc, selenium, copper, vitamins A, E and C) have proved to be effective in meeting endpoints [14]. A strong association exists between respiratory infections and inadequate growth, suggesting the need for interventions to decrease the incidence of underweight children and LBW (low birth weight). The balance between weight gain and respiratory well being, however, is very delicate, and perhaps still not entirely clear, as underlined by recent evidence indicating that the presence of asthma symptoms in preschool age may be associated with increased weight (children with excessive weight gain may be more frequently affected by episodes of recurrent wheezing) [15]. Lactoferrin is the most important protein in breast milk. Its concentration is much higher in colostrum than in mature milk and has a homology of 77% with lactoferrin present in bovine milk (in fact they have the same action and the same internalization by gut). Both have a very high survival during passage through the stomach after oral administration. The biological functions of lactoferrin are numerous, and among them anti-inflammatory, immune-modulating, anti-fungal, antibacterial actions, and inhibition of proteases. Lactoferrin can inhibit the formation of ROS (reactive oxygen species), by binding to iron thus attenuating oxidation [16]. One RCT, involving VLBW infants from 11 different Italian NICU, assessed the effects of administration of 100 mg/day of bovine lactoferrin alone or together with Lactobacillus CG compared with placebo, in preventing sepsis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 613015235
TI  - Lung function in infants
AU  - Sanchez-Solis M.
AU  - Garcia Marcos L.
Y1  - 2013//
KW  - airway obstruction
KW  - asthma
KW  - atopic dermatitis
KW  - atopy
KW  - biopsy
KW  - body height
KW  - breathing rate
KW  - bronchus hyperreactivity
KW  - child
KW  - cohort analysis
KW  - compression
KW  - conductance
KW  - controlled study
KW  - eosinophil
KW  - exposure
KW  - female
KW  - first trimester pregnancy
KW  - forced expiratory flow
KW  - forced expiratory volume
KW  - forced vital capacity
KW  - functional residual capacity
KW  - gene frequency
KW  - gene mutation
KW  - genetic susceptibility
KW  - haplotype
KW  - high risk infant
KW  - human
KW  - human tissue
KW  - infancy
KW  - infant
KW  - *lung function test
KW  - maternal smoking
KW  - meta analysis
KW  - newborn
KW  - normal human
KW  - phenotype
KW  - preschool child
KW  - prospective study
KW  - respiratory tract infection
KW  - risk factor
KW  - school child
KW  - single nucleotide polymorphism
KW  - smoking
KW  - statistical significance
KW  - wheezing
KW  - beta 2 adrenergic receptor
KW  - endogenous compound
KW  - glutathione transferase
KW  - glutathione transferase P1
KW  - glutathione transferase T1
KW  - histone deacetylase 4
KW  - natural cytotoxicity triggering receptor 3
KW  - nitric oxide
KW  - retinoic acid receptor
KW  - sonic hedgehog protein
KW  - tobacco smoke
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 14
IS  - Supplement 2
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - M. Sanchez-Solis, University of Murcia, Spain
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=613015235
AB  - From the 1980's the development of new devices has allowed us to learn about the role of infant lung function in respiratory diseases. The knowledge of lung function in newborn and infants, should help us to understand the physiology of the illness in wheezing infants, evolution of lung disease from prematurity and bronchopulmonary dysplasia, and in cystic fibrosis which are the most frequent chronic respiratory diseases in the first two years of life. Wheeze infants: In infants with recurrent wheeze it has been shown a worse lung function compared with healthy matched infant; by mean of the rapid compression technique, it has been possible to show that the maximal flow at functional residual capacity (V'maxFRC) is already diminished in wheeze infants in the first year of life [1,2], suggesting airway obstruction in those infants. Recently, by mean of raised-volume rapid thoraco-abdominal compression technique (RVRTC), after adjustment for sex, age, body length at test and maternal smoking, significant reductions in z-scores for forced expiratory flow at 0.5 seconds (FEV0.5), in forced expiratory flow at 75% of forced vital capacity (FEF75) and in forced expiratory flow at 25 to 75% of forced vital capacity (FEF25-75) were observed in infants with recurrent wheeze when compared with controls, but not in forced vital capacity (FVC) showing an obvious obstructive airway pattern in recurrent wheeze infants [3]. So the conclusion is that, with different methods of assessment, lung function is reduced in patients suffered recurrent lower respiratory illness (LRI), compared with healthy infants. The first study designed to determine whether early childhood respiratory illness led to decreases in lung function or a low lung function previous to the first airway infection led to an increased risk for wheezing, was the Tucson Children's Respiratory Study. In this prospective study of 124 infants enrolled as newborns, was shown that the risk of having a wheezing illness was 3.7 times higher (95% CI, 0.9-15.5; p = 0.06) among infants whose values for total respiratory conductance (the reciprocal of the resistance to air flow of the entire respiratory system) were in the lowest third, as compared with infants with values in the upper two thirds of the range of values for the group [4]. Seven more cohort studies [5-12], by means of different methods of assessment of lung function, demonstrated consistently a premorbid lower lung function in wheeze infants compared with healthy ones. Majority of these studies were developed assessing lung function with V'maxFRC, however the recent data published from the Southamptom cohort (ALSPAC study) [12] shown that reduction in forced expiratory volume at 0.4 seg (FEV0.4), measured before the 14 weeks of age, is a risk factor to wheeze. This study, for the first time, demostrated too that lower lung function in early infancy is a risk factor for non-atopic wheeze rather than atopic wheeze. The conclusion can only be that some children were born with an obstructive airway pattern and they are in risk to suffer LRI. The Tucson Children's Respiratory Study concludes that diminished initial airway function may be a predisposing factor, not only for the first episode of wheezing, but also for recurrent wheezing respiratory illnesses starting in the first year of life [5]. As it is known, they described three phenotypes based in having recurrent wheezing during first three years of life, evaluated at 6 years of age; transient wheeze (these patients had had at least one wheeze lower respiratory illness during the first 3 years of life but had no wheezing at 6 years), persistent wheeze (they had wheezing both before 3 years of age and at 6 years) and late wheeze (had no wheezing in the first 3 years but had wheezing at 6 years of age), and the most important difference between transient and persistent wheeze infants was that the transient wheeze group had diminished lung function, evaluated by mean of V'maxFRC, both in infancy (previously to the first episode) and at 6 years of age when compared to children who never wheezed. But the persistent wheeze group had V'maxFRC values in infancy that were no different from those of the children who never wheezed and by age 6 years, however, had the lowest lung function with a significant reduction in V'maxFRC [13]. In contrast with the Tucson's study, the cohort of Perth [14] demostrated a relationship between reduction in V'maxFRC at 1 month of age and persistence of wheeze at 4-6 years and even at 11 years of age. Those children with no wheeze from 3 years of age (transient wheeze) have normal V'maxFRC when neonate. As in Tucson's study, a lower infant lung function (V'maxFRC) was seen in transient group from the cohort of Southampton (ALSPAC). But furthermore, in the ALSPAC study, V'maxFRC was reduced in persistent wheeze group. Although there is a clear tendency in a reduction of FEV0.4 in persistent wheeze group, no association was seen between infant FEV0.4 and any phenotype, probably because the limited number of lung function test performed in infant of this group [12]. Recently has been published the results of the Copenhagen Prospective Study on Asthma in Childhood (COPSAC) [15], a cohort of 411 high risk infants whose mothers were asthmatic. In this study the authors found that children who developed asthma by age 7 had reduced airflow when neonate: forced expiratory flow at 50% of vital capacity (FEF50) (p = 0.03) and FEV0.5 very close of the statistical significance (p = 0.07). An increased bronchial responsiveness as neonates is related with asthma at 7 years of age, too. This airflow deficit progressed in the first 7 years of life suggesting that disease mechanisms are operating before and after birth. Some risk factors have been described to explain this, very early in life, worse lung function: * Prenatal tobacco exposure. A very recent and large pooled analysis of eight birth cohorts with data on more than 21,000 children showed that maternal smoking during pregnancy is associated with wheeze and asthma in preschool children. The likelihood to develop wheeze and asthma increased statistically significantly in a linear dose-dependent manner in relation to maternal daily cigarette consumption during the first trimester of pregnancy [16]. There is accumulating evidence that exposure to parental smoking is associated with impaired lung function during infancy, which is likely to persist. Maternal smoking during pregnancy and in the early months of life remains the most significant source of such exposure. The most consistent finding, from all studies of infant lung function, is of reduced flows at low lung volumes, which may reflect more extensive underlying pathological and functional alterations in the distal airways [17]. Most of the studies, describes a lose in expiratory flows (V'maxFRC [18-24], FEV0.5 [26], FEF50 and FEF25-75 [27]); but at least, a study described a reduction in FRCHe [19] too. * Gene polymorphisms. Recently, from the Southampton Women's Survey Study [23] has been published that five single nucleotide polymorphisms (SNPs), relating to four genes, showed significant associations with infant lung function: Hedgehog interacting protein (HHIP) was associated with compliance; Retinoic acid receptor b (RARB) was associated with V'maxFRC; the Natural cytotoxicity triggering receptor 3 (NCR3) respiratory rate and the histone deacetylase 4 (HDAC4) was associated with both compliance and V'maxFRC. On the other hand, different SNPs in Glutathione S-Transferase gens (GSTT1, GSTP1) both in mothers and in infants were associated with a diminished V'maxFRC and bronchial hyperreactivity in infant exposed to tobacco smoke in utero [25]. Neonatal V'maxFRC was reduced in those possessing Gln27 or Arg16 alleles, however there was no effect of beta-2 adrenoceptor gen polymorphisms on FEV1 at 10 years [26]. Conversely, the study from Zhang et al. [27] found no association of haplotypes of beta2-adrenoceptor polymorphisms with infant lung function (V'maxFRC), although they found that some SNPs are associated with lung function and bronchial hyperreactivity later in life (6 and 11 years of age). * Atopy and inflammation. Atopy has been studied as another risk factor for diminishing lung function in the first years of life. The article published by Haland et al. [11] shows that children (less than 2 years of age) with both recurrent LRI and atopic eczema had significantly lower tPTEF/tE at 2 yr and at birth, compared with children with no recurrent LRI or atopic eczema. The study conducted by Debley et al. [28] found no correlation between enrollment single breath exhaled nitric oxide and enrollment lung function, but was associated with a decline in FEV0.5, FEF25-75 and FEF75 over 6 months; a 10 ppb increase in single breath exhaled nitric oxide was associated with a 0.4 z-score decline in FEV0.5, a 0.4 z-score decline in FEF25-75, and a 0.42 z-score decline in FEF75, suggesting a loss of expiratory flows as a consequence of eosinophilic inflammation. In a study from Malmstrom et al. [29], lung function and endobronchial biopsy were obtained; the study failed to show relationship between lung function and histological findings, perhaps because of the small sample.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985436
TI  - Longitudinal differences in the airway microbiome in premature infants: Changes that predict the development of bpd
AU  - Lohmann P.
AU  - Welty S.
AU  - Luna R.A.
AU  - Hollister E.B.
AU  - Runge J.K.
AU  - Shang Y.
AU  - Versalovic J.
Y1  - 2013//
KW  - *microbiome
KW  - *prematurity
KW  - *infant
KW  - *human
KW  - *American
KW  - *society
KW  - *airway
KW  - genus
KW  - chorioamnionitis
KW  - female
KW  - Klebsiella
KW  - Staphylococcus
KW  - Acinetobacter
KW  - phylum
KW  - tracheal aspiration procedure
KW  - microbial community
KW  - chronic lung disease
KW  - intubation
KW  - pregnancy
KW  - lung dysplasia
KW  - extubation
KW  - Proteobacteria
KW  - Firmicutes
KW  - diagnosis
KW  - mother
KW  - patient
KW  - microflora
KW  - oxygen consumption
KW  - examination
KW  - community
KW  - library
KW  - hypothesis
KW  - bacterial DNA
KW  - RNA 16S
KW  - DNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - P. Lohmann, Texas Children's Hospital, Houston, TX, United States. E-mail: pxlohman@texaschildrens.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5901
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71985436
AB  - Background: Bronchopulmonary dysplasia (BPD) is a devastating form of chronic lung disease that occurs in some preterm infants. The relationship between microbial communities in tracheal aspirates and BPD is unknown. Hypothesis: Patterns of respiratory microbiota will differ among ventilated preterm infants born to mothers with and without chorioamnionitis and infants developing BPD. Method(s): 25 subjects, born <=32 weeks of gestation and intubated in the first 24 hr of life were enrolled. Tracheal aspirates were obtained at time of intubation, day of life (dol) 3, 7 and 28 or at time of extubation. Bacterial DNA was extracted from specimens and sequence libraries were constructed by amplification of the V1V3 and V3V5 regions of 16S rRNA using universal bar-coded primers. Utilizing 454 sequencing, an average of 3,000 reads per region was obtained with an average read length over 500 bases. Resulting sequences were analyzed using the Genboree Microbiome Workbench. Chorioamnionitis was determined by histological examination. BPD was defined as oxygen requirement at 36 weeks post menstrual age. Results A total of 8 phyla and 53 genera were detected. In the patients in whom more than 1 sample was obtained, decreasing bacterial diversity was noted, accompanied by decreasing Acinetobacter, increasing Staphylococcus and Klebsiella. Decreased diversity was noted when comparing the initial specimens in the chorioamnionitis (30 genera) group to the non affected subjects (43 genera), but it was not significant. Significant differences were noted in the bacterial community when comparing infants with and without a diagnosis of BPD. The phylum-level analysis showed, as a function of time, increasing Firmicutes and decreasing Proteobacteria in the BPD group compared to a relatively stable community in the subjects that did not develop BPD. This trend was also present in the genus-level characterization with 36 genera identified in the BPD group and 49 genera in the non-BPD group. Acinetobacter was the predominant genus across all groups, but Staphylococcus and Klebsiella were in greater abundance in the BPD group than in the non-BPD group. As a function of time, the BPD group exhibited steadily decreasing Acinetobacter paired with steadily increasing Staphylococcus and Klebsiella.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985269
TI  - Hyperoxia-induced changes in estradiol metabolism in neonatal lung
AU  - Martin Y.N.
AU  - Dong J.
AU  - Pabelick C.M.
AU  - Wigle D.
AU  - Prakash Y.S.
Y1  - 2013//
KW  - *hyperoxia
KW  - *metabolism
KW  - *lung
KW  - *American
KW  - *society
KW  - mouse
KW  - human
KW  - lung dysplasia
KW  - cell proliferation
KW  - exposure
KW  - oxygen therapy
KW  - upregulation
KW  - hypothesis
KW  - newborn
KW  - estrogen metabolism
KW  - asthma
KW  - airway smooth muscle cell
KW  - prematurity
KW  - in vitro study
KW  - microarray analysis
KW  - estrogen synthesis
KW  - hypoxia
KW  - gene
KW  - genome
KW  - ambient air
KW  - lung parenchyma
KW  - newborn disease
KW  - *estradiol
KW  - estrogen receptor
KW  - sex hormone
KW  - oxygen
KW  - enzyme
KW  - 2 methoxyestradiol
KW  - estrogen
KW  - protein
KW  - messenger RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J. Dong, Mayo Clinic, Rochester, MN, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5734
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71985269
AB  - Rationale: Supplemental oxygen is commonly used to treat hypoxia in premature neonates. Considerable evidence links oxygen exposure to development of neonatal diseases such as bronchopulmonary dysplasia and asthma. There is a known sex preference for bronchopulmonary dysplasia, but the role of sex steroids (maternal or fetal) is not clear. Understanding the role of local lung metabolism of sex steroids in hyperoxia effects on the immature lung may help to further elucidate mechanisms of bronchopulmonary dysplasia. In this study, we tested the hypothesis that altered local generation of estradiol or estrogen receptor expression with hyperoxia contributes to pathophysiologic changes observed with oxygen treatment in the fetal or neonatal lung. Methods and Results: mRNA expression in postnatal mouse lung was obtained from four groups of mice: room air vs. 80% hyperoxia for 14 vs. 29 days (n=2-3/group) using an Affymetrix GeneChip Mouse Genome 430 2.0 Array. Twelve genes related to estrogen receptors, estrogen synthesis and metabolism were expressed in mouse lung. Microarray analysis showed CYP1a1 - an enzyme responsible estradiol metabolism - with the most significant change in expression after 14 days hyperoxia. Therefore, in vitro studies were performed in human fetal airway smooth muscle cells (fASM) exposed to normoxia or hyperoxia and probed for expression of proteins involved in estrogen metabolism. Proliferation studies were performed in in the presence of estradiol. In fASM cells, CYP1a1 expression was altered with hyperoxia exposure while the enhanced cell proliferation observed in hyperoxia was blunted with estradiol. Pharmacologic inhibition studies indicate that this could be attributed to upregulation of CYP1a1 enzyme and subsequent increased metabolism of estradiol to a downstream intermediate 2-methoxyestradiol. Conclusion(s): The goal of this study was to characterize the expression pattern of pathways involved in estrogen signaling and metabolism in the presence of hyperoxia. These results are the first to specifically study estradiol metabolism in fetal and early postnatal lung tissue and its relationship to hyperoxia. The alterations in CYP1a1 expression and changes in cell proliferation with estradiol (and reversal with inhibition of CYP1a1) all suggest CYP1a1 as a potential mechanism for the protective effect of estradiol in the hyperoxia exposed immature lung.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985268
TI  - The effects of hyperoxia on bone morphogenetic pathway in human pulmonary arterial endothelial cells
AU  - Arawiran J.
AU  - Calo J.M.
AU  - Parton L.
AU  - Olson S.
Y1  - 2013//
KW  - *human
KW  - *bone
KW  - *society
KW  - *endothelium cell
KW  - *American
KW  - *hyperoxia
KW  - phosphorylation
KW  - exposure
KW  - lung dysplasia
KW  - cells by body anatomy
KW  - apoptosis
KW  - assay
KW  - upregulation
KW  - morbidity
KW  - primary culture
KW  - incubator
KW  - cell culture
KW  - gas
KW  - Western blotting
KW  - culture medium
KW  - protein expression
KW  - nutrition
KW  - pathogenesis
KW  - prevention
KW  - oxygen
KW  - transforming growth factor beta
KW  - receptor
KW  - bone morphogenetic protein
KW  - endothelial nitric oxide synthase
KW  - cytokine
KW  - trypsin
KW  - antibody
KW  - protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J. Arawiran, Maria Fareri Children's Hospital, Westchester Medical Center, New York Medical College, Valhalla, NY, United States. E-mail: jendaarawiran@gmail.com
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5733
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71985268
AB  - Background: Bone morphogenetic proteins (BMP), which belong to the Transforming Growth Factor Beta (TGFbeta) superfamily, are currently considered to be pleiotropic cytokines that influence proliferation, growth, differentiation, and apoptosis of many different cell types. Expression of BMP as well as their receptor, BMPRII, and downstream targets such as endothelial nitric oxide synthase (eNOS), may influence pathological processes such as bronchopulmonary dysplasia (BPD). BPD remains to be a common morbidity in the NICU despite advances in gentle ventilatory strategies, limitation of hyperoxia exposure, and nutrition. The aim of this study was to determine the effect of hyperoxia on BMP4, phosphorylated eNOS, total eNOS and BMPRII expression in human pulmonary arterial endothelial cells (HPAECs). Method(s): HPAECs were cultured in endothelial cell culture medium and maintained in a sterile humidified cell culture incubator at 37oC with 5% CO2. Cells were passaged at 70-80% confluence with trypsin. Primary cultures of passage 5-6 were used in the experiments. HPAECs were plated in 6 well plates and exposed to hyperoxic gas with 95% O2 and 5% CO2 for up to 72 hours and cell lysates were collected at 24, 48 and 72h. Antibodies to BMP4, eNOS, phosphorylated eNOS and BMPRII were used in Western blot assays to determine protein expression. Result(s): (Figure presented) Discussion/Conclusion: Preliminary results show that BMP4 expression is decreased in HPAECs exposed to hyperoxia for 72h (Fig 1). Published reports as well as work done in our lab show that BMP influences phosphorylation of eNOS. As such, the effect of hyperoxia on eNOS phosphorylation and eNOS protein expressed was assessed. eNOS phosphorylation was decreased with exposure to high oxygen for 72h (Fig2). Initial upregulation of eNOS expression was seen at 24h but returned to basal levels by 72h (Fig 2). In addition, BMPRII appears to be decreasing with increasing duration of oxygen exposure (Fig 3). Overall, preliminary results demonstrate that hyperoxia decreased BMP4 expression and eNOS phosphorylation at 72h. Information from our studies may provide insight into a novel mechanism in the pathogenesis of BPD and ultimately may provide new pharmacological targets for its prevention and treatment.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985265
TI  - T-cells are preferentially expressed following neonatal hyperoxia in adult mice
AU  - Kumar V.H.S.
AU  - Wang H.
AU  - Nielsen L.
Y1  - 2013//
KW  - *T lymphocyte
KW  - *hyperoxia
KW  - *adult
KW  - *mouse
KW  - *American
KW  - *society
KW  - gene
KW  - infant
KW  - cell proliferation
KW  - lung
KW  - human
KW  - gene expression
KW  - infection
KW  - immunoregulation
KW  - adaptive immunity
KW  - newborn
KW  - oxidative stress
KW  - B lymphocyte
KW  - hypothesis
KW  - lung dysplasia
KW  - T lymphocyte activation
KW  - respiratory system
KW  - cell activation
KW  - data analysis
KW  - lymphocytic infiltration
KW  - cytokine response
KW  - B lymphocyte activation
KW  - lung compliance
KW  - gene expression profiling
KW  - exposure
KW  - ambient air
KW  - immune response gene
KW  - childhood
KW  - cell cycle
KW  - prematurity
KW  - newborn period
KW  - stimulation
KW  - long term exposure
KW  - messenger RNA
KW  - oxygen
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - V.H.S. Kumar, Women and Children's Hospital of Buffalo, Buffalo, NY, United States. E-mail: vkumar@upa.chob.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5730
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71985265
AB  - Background: Prolonged exposure of newborn mice to O2 leads to changes similar to bronchopulmonary dysplasia (BPD) in infants. We have previously shown that neonatal hyperoxia alters lung compliance, cytokine response & induces lymphocyte infiltration of the lung in adult mice. Infants who survive BPD are susceptible to infections particularly of the respiratory tract. We plan to test the hypotheses that oxidative stress from neonatal hyperoxia may disrupt immunoregulation and produce changes in adaptive immune responses in adult mice. Objective(s): To determine the adaptive immune response gene expression following neonatal hyperoxia in adult mice. Method(s): Newborn litters were randomized at 3d to 85% O2 or room air (RA) for 12d. On d15 following exposure, half were sacrificed & the rest were recovered in RA until 3 months. Whole lung mRNA was isolated in all the groups (N=4 in each group; RA & O2 at 12d & 3 months). Gene expression profiling by RT-qPCR was performed on a focused panel of genes representing T-cell / B-cell activation (84 genes) (SA Biosciences, MD). Data was analyzed by PCR array data analysis web portal. A fold change of > 4 & p < 0.05 was considered significant. Results - 12d hyperoxia increased p21 expression and decreased expression of 23 genes representing T/B activation > 4 fold; three of them significantly (cd1d1, Il4 & rag1) compared to the RA group (Table 1). However, no differences were noted between the RA & O2 groups at 3 months. Adult mice at 3 months decreased expression of p21 and increased expression of 11 genes, 6 of them significantly (cd28, cd40Ig, cd3d, cd3e, Il27) (Table 1). (Table presented) Conclusions - Hyperoxia decreased gene expression involved in T-cell/B-cell activation along with cell proliferation, as suggested by increased expression of p21, an inhibitor of cell proliferation. However, adult mice exposed to neonatal hyperoxia, preferentially increased expression of genes involved in T-cell activation, differentiation & proliferation. This selective T-cell response & proliferation was accompanied by a decreased expression of p21. This suggests that p21, a cell cycle regulator, may be involved in immune regulation, particularly T-cell proliferation. P21 may confer proliferation advantages to T-cells over B-cells in adult mice following prolonged stimulation by oxygen in the newborn period. This has implications following BPD in premature newborns. Altered T-cell responses might explain the potential for higher infections in childhood in these infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985261
TI  - Hyperoxia activates WNT/beta-catenin signaling in neonatal rat lungs
AU  - Demirel N.
AU  - Chen S.
AU  - Rong M.
AU  - Wu S.
Y1  - 2013//
KW  - *hyperoxia
KW  - *rat
KW  - *lung
KW  - *American
KW  - *society
KW  - immunohistochemistry
KW  - immunofluorescence
KW  - Western blotting
KW  - ambient air
KW  - pathogenesis
KW  - lung alveolus wall
KW  - lung injury
KW  - staining
KW  - premature labor
KW  - lung dysplasia
KW  - university
KW  - pediatrics
KW  - cell membrane
KW  - cytoplasm
KW  - newborn
KW  - protein expression
KW  - gene expression
KW  - exposure
KW  - gene
KW  - lung development
KW  - therapy
KW  - extracellular matrix
KW  - United States
KW  - school
KW  - *catenin
KW  - connective tissue growth factor
KW  - synapsin I
KW  - protein
KW  - ligand
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - N. Demirel, University of Miami, Miller School of Medicine, Miami, FL, United States. E-mail: NDemirel@med.miami.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5726
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71985261
AB  - ABSTRACT Hyperoxia Activates Wnt/b-catenin Signaling in Neonatal Rat Lungs Nadir Demirel1, Shaoyi Chen2, Min Rong2, Shu Wu2 Divisions of Pulmonology1 and Neonology2, Department of Pediatrics, University of Miami Miller School of Medicine, Miami, Florida Background: Bronchopulmonary dysplasia (BPD) continues to be one of the most common long-term pulmonary complications associated with preterm birth. BPD is increasingly recognized as the results of deranged development and disregulated extracellular matrix remodeling in the immature lung. Wnt/beta-catenin signaling plays an important role in lung development and remodeling. However, the role of Wnt/beta-catenin signaling in BPD pathogenesis is poorly understood. Objective(s): To determine the temporal-spatial expression of Wnt signaling molecules in hyperoxia-induced lung injury in neonatal rats, an experimental BPD. Method(s): Newborn rat pups were randomized within 24 h after birth to receive room air (21% O2) or hyperoxia (90% O2) for 15 days. Lungs were collected on postnatal day (P) 2, 4, 8 and 15 for assessing expression of Wnt7b, beta-catenin, connective tissue growth factor (CTGF) and Wnt-inducible signaling protein 1 (WISP1) by immunohistochemistry, immunofluorescence staining, Western Blot and quantitative Real-Time RT-PCR. Data are expressed as mean +/- SD with n = 5/group. Result(s): Hyperoxia exposure increased gene expression of Wnt7b by 2.5 fold (P<0.01) at P2, CTGF by 3 fold (P<0.01) at P4, and WISP1 by 1.5 fold (P<0.05) at P8. Western blot analysis demonstrated a 2 fold increase (P<0.05) in WISP1 protein expression in hyperoxic lungs at P8. Immunostaining demonstrated a diffused and increased WISP1 expression in the thickened alveolar septa in hyperoxia-exposed lungs at P8 and P15. Immunofluorescence staining demonstrated that in hyperoxia-exposed lungs b-catenin is localized in the nuclei in thickened alveolar septa from P4 to P15 as compared to room air lungs where it is localized in cytoplasm and cell membrane. Conclusion(s): Hyperoxia-induced neonatal lung injury is associated with activation of Wnt/b-catenin signaling as demonstrated by increased expression of Wnt7b (Wnt ligand), and CTGF and WISP1 (Wnt target genes), and nuclear translocation of b-catenin (Wnt signaling protein). Further studies are needed to better understand the role of WISP1 in the pathogenesis of BPD and design novel therapies targeting WISP1 in preventing and treating this disease.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71984904
TI  - Pulmonary hypertensive responses to chronic hypoxia are amplified in mice recovering from previous hyperoxia-induced bronchopulmonary dysplasia (BPD) in a ros-dependent manner
AU  - Berkelhamer S.K.
AU  - Ball M.K.
AU  - Kim G.
AU  - Schumacker P.T.
Y1  - 2013//
KW  - *hypertension
KW  - *hypoxia
KW  - *mouse
KW  - *hyperoxia
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - pH
KW  - oxidative stress
KW  - lung development
KW  - exposure
KW  - pulmonary hypertension
KW  - mare
KW  - newborn
KW  - protein expression
KW  - vascular remodeling
KW  - hypoxia-induced pulmonary hypertension
KW  - therapy
KW  - heart
KW  - heart right ventricle hypertrophy
KW  - echocardiography
KW  - systolic blood pressure
KW  - acceleration
KW  - lung
KW  - risk
KW  - heart catheterization
KW  - infant
KW  - lung injury
KW  - newborn period
KW  - messenger RNA
KW  - acetylcysteine
KW  - antioxidant
KW  - protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S.K. Berkelhamer, Northwestern University, Chicago, IL, United States. E-mail: s-berkelhamer@northwestern.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5364
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71984904
AB  - Rationale: Pulmonary hypertension (PH) commonly coexists with severe BPD. The long-term consequences of BPD-associated PH are unknown, and the possibility that it renders infants more vulnerable to PH later in life has not been explored. We hypothesize that mice with altered lung development associated with experimental BPD are at greater risk of developing PH in response to later pulmonary challenges. We assessed response to chronic hypoxia as a second hit to determine if prior existence of BPD enhances hypoxia-induced PH. Mice were treated with N-Acetylcysteine (NAC) to determine the role of oxidant stress in that response. Method(s): Newborn C57Bl/6 mice were maintained in 21%O2 (control) or 75%O2 (BPD) for 2w with daily rotation of dams. Control and BPD mice were subsequently recovered in 21%O2 for 2w prior to exposure to 4w of 21%O2 (normoxia) or 10%O2 (chronic hypoxia). Some mice were treated with NAC (1 gm/kg PO daily) during the 28d exposure. All outcomes were determined at 8w. Hearts were analyzed for right ventricular hypertrophy (RVH). Right heart catheterization was performed to determine right ventricular systolic pressure (RVSP) and echocardiography was used to quantify pulmonary acceleration time/ejection time (PAT/ET). Lungs were inflation fixed for morphometric analysis or perfused and harvested for protein and mRNA analysis. Result(s): BPD and control mice demonstrated comparable RVH. RVSP and PAT/ET at 8w (0.26 +/- 0.01 versus 0.25 +/- 0.01; 25.4 +/- 0.4 versus 24.2 +/- 1.2; and 48.4 +/- 0.8 versus 49.4 +/- 0.4) indicating that the BPD-associated PH is reversible. Chronic hypoxia (CH) induced RVH and PH in both BPD and controls, however BPD mice evidenced greater disease by RVH, RVSP and PAT/ET (0.39 +/- 0.01 versus 0.36 +/- 0.01; 31.1 +/- 2.5 versus 26.6 +/- 2.2; and 36.8 +/- 0.8 versus 39.9 +/- 0.9 for BPD+CH versus control+CH). While NAC did not affect hypoxia-induced RVH or PH in control mice, it attenuated hypoxia induced increases in RVH and RVSP in BPD mice (0.39 +/- 0.01 versus 0.34 +/- 0.01 and 31.1 +/- 2.5 versus 25.0 +/- 1.3 in untreated versus NAC treated BPD+CH mice). The greater degree of hypoxia-induced PH in BPD mice did not correlate with morphological evidence of exaggerated vascular remodeling. Increased NOX4 mRNA and protein expression was present in hypoxia-exposed BPD but not hypoxia-exposed control mice. Conclusion(s): Altered lung development in BPD enhances susceptibility to later hypoxia-induced pulmonary hypertension, indicating that effects of neonatal lung injury persist beyond resolution of the initial response. Oxidant stress signaling may underlie this response, suggesting that antioxidant therapies may be effective in limiting pulmonary hypertensive response after the neonatal period.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71984901
TI  - Retinoids attenuate oxidative stress and impaired alveolar develpment in the newborn mouse lung
AU  - James M.L.
AU  - Ross A.C.
AU  - Nicola T.
AU  - Zhang W.
AU  - Ambalavanan N.
Y1  - 2013//
KW  - *oxidative stress
KW  - *mouse
KW  - *lung
KW  - *American
KW  - *society
KW  - hyperoxia
KW  - lung development
KW  - exposure
KW  - human
KW  - lung function
KW  - lung dysplasia
KW  - infant
KW  - prematurity
KW  - supplementation
KW  - mouse model
KW  - death
KW  - randomized controlled trial (topic)
KW  - attenuation
KW  - oxidation
KW  - lung homogenate
KW  - Western blotting
KW  - tissues
KW  - density
KW  - plasma
KW  - newborn
KW  - ambient air
KW  - enzyme linked immunosorbent assay
KW  - high performance liquid chromatography
KW  - *retinoid
KW  - retinol
KW  - protein
KW  - retinoic acid
KW  - 3 nitrotyrosine
KW  - retinol ester
KW  - platelet derived growth factor
KW  - DNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.L. James, University of Alabama at Birmingham, Birmingham, AL, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5361
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71984901
AB  - Rationale: Bronchopulmonary dysplasia (BPD) in preterm infants is characterized by an inhibition of lung alveolar development associated with low plasma and tissue concentrations of vitamin A (VA). Randomized controlled trials indicate VA supplementation decreases BPD and/or death. Vitamin A is metabolized into retinoic acid (RA), and we have previously demonstrated that a 10:1 molar combination of VA and RA (VARA) synergistically increases lung retinol content in newborn mice. Objective(s): To determine whether the biochemical synergistic effect of VARA translates into functional benefits in the attenuation of hyperoxia-induced inhibition of alveolar development. Method(s): Newborn C57BL/6 mice were exposed to hyperoxia (85% O2) or room air for 7 or 14 days and given vehicle or VARA every other day. Lung retinol content was measured by HPLC, lung function was assessed by flexiVent, and lung development was evaluated by radial alveolar counts and secondary septal crest density. Additionally, mediators of alveolar development and hyperoxia-induced inhibition of alveolar development were evaluated by qPCR, ELISA, and by western blot in lung homogenates. Result(s): VARA attenuated the hyperoxia-induced inhibition of alveolar development(Figure 1) and improved lung function, with higher compliance and lower resistance (Figure 1), associated with increased lung retinyl ester stores. We also found that VARA attenuated the hyperoxia-induced increases in DNA and protein oxidation associated with activation of Nrf2 but with no changes in MDA-adduct or nitrotyrosine concentrations or MPO activity (Figure 2). In addition, VARA attenuated hyperoxia-induced decreases in PDGF-A protein amounts. Conclusion(s): The VARA combination improves lung development and function, and reduces mediators of oxidative stress in the newborn mouse model of hyperoxia exposure. Further studies are in progress to define more precisely the mechanisms by which retinoids benefit lung development during hyperoxia exposure. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Serum eotaxin-1 is increased in extremely-low-birth-weight infants with bronchopulmonary dysplasia or death.
DO  - https://dx.doi.org/10.1038/pr.2015.152
AU  - Kandasamy, Jegen
AU  - Roane, Claire
AU  - Szalai, Alexander
AU  - Ambalavanan, Namasivayam
Y1  - 2015//
Y2  - 20150813//
KW  - Age Factors
KW  - *Biomarkers/bl [Blood]
KW  - Birth Weight
KW  - *Bronchopulmonary Dysplasia/bl [Blood]
KW  - Bronchopulmonary Dysplasia/di [Diagnosis]
KW  - Bronchopulmonary Dysplasia/mo [Mortality]
KW  - C-Reactive Protein/an [Analysis]
KW  - *Chemokine CCL11/bl [Blood]
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Female
KW  - Hospital Mortality
KW  - Humans
KW  - Infant
KW  - Infant Mortality
KW  - *Infant, Extremely Low Birth Weight/bl [Blood]
KW  - Infant, Newborn
KW  - Male
KW  - Neonatal Screening/mt [Methods]
KW  - Regression Analysis
KW  - Risk Assessment
KW  - Risk Factors
KW  - Time Factors
KW  - Up-Regulation
T2  - Pediatric research
VL  - 78
IS  - 5
SN  - 0031-3998
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26270578
AD  - United States
AB  - BACKGROUND: Early systemic inflammation in extremely-low-birth-weight (ELBW) infants is associated with an increased risk of bronchopulmonary dysplasia (BPD). Our objective was to identify circulating biomarkers and develop prediction models for BPD/death soon after birth., METHODS: Blood samples from postnatal day 1 were analyzed for C-reactive protein (CRP) by enzyme-linked immunosorbent assay and for 39 cytokines/chemokines by a multiplex assay in 152 ELBW infants. The primary outcome was physiologic BPD or death by 36 wk. CRP, cytokines, and clinical variables available at <=24 h were used for forward stepwise regression and Classification and Regression Tree (CART) analysis to identify predictors of BPD/death., RESULTS: Overall, 24% developed BPD and 35% died or developed BPD. Regression analysis identified birth weight and eotaxin (CCL11) as the two most significant variables. CART identified FiO2 at 24 h (11% BPD/death if FiO2 <=28%, 49% if >28%) and eotaxin in infants with FiO2 > 28% (29% BPD/death if eotaxin was <=84 pg/ml; 65% if >84) as variables most associated with outcome., CONCLUSION: Eotaxin measured on the day of birth is useful for identifying ELBW infants at risk of BPD/death. Further investigation is required to determine if eotaxin is involved in lung injury and pathogenesis of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71984899
TI  - A role for the lung-specific tight junction protein claudin-18 in lung injury and alveolarization
AU  - LaFemina M.J.
AU  - Bentley T.
AU  - Sutherland K.
AU  - Gonzales L.W.
AU  - Allen L.
AU  - Rokkam D.
AU  - Ballard P.L.
AU  - Frank J.A.
Y1  - 2013//
KW  - *lung injury
KW  - *American
KW  - *society
KW  - *lung
KW  - human
KW  - mouse
KW  - female
KW  - knockout mouse
KW  - lavage
KW  - lung dysplasia
KW  - liquid
KW  - infant
KW  - gestational age
KW  - transmission electron microscopy
KW  - intraperitoneal drug administration
KW  - agonist
KW  - pregnancy
KW  - lung alveolus cell
KW  - fetus lung maturation
KW  - tight junction
KW  - gene
KW  - real time polymerase chain reaction
KW  - microarray analysis
KW  - surface area
KW  - lung alveolus epithelium cell
KW  - lung development
KW  - angiogenesis
KW  - genotype
KW  - histology
KW  - cell junction
KW  - injury
KW  - biochemical analysis
KW  - chronic lung disease
KW  - genome
KW  - risk
KW  - wild type mouse
KW  - *tight junction protein
KW  - *claudin 18
KW  - claudin
KW  - membrane protein
KW  - albumin
KW  - marker
KW  - nonoxinol 9
KW  - messenger RNA
KW  - fluorescein isothiocyanate
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.J. LaFemina, University of California,San Francisco, San Francisco, CA, United States. E-mail: michael.lafemina@ucsf.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5359
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71984899
AB  - Rationale: The incidence of bronchopulmonary dysplasia is rising despite medical advances. Claudins are a family of transmembrane proteins that are required for tight junction formation. The lung-specific tight junction protein claudin-18.1 is the most abundant claudin in type 1 (AT1) pneumocytes and is specifically regulated in human alveolar epithelial cells by lung maturation agonists and inflammatory mediators. This study was undertaken to investigate a potential role for claudin-18 in alveolar barrier function and postnatal alveolarization. Method(s): Lungs from a novel claudin-18 knockout (KO) mouse were compared with wildtype (WT) mouse lungs using whole genome microarray, in addition to histological and biochemical analyses of injury. Alveolar epithelial barrier structure and function were investigated in vivo, including ultrastructural evaluation. Claudin-18 levels were measured in preterm human lungs. Result(s): Histological analysis demonstrated similar histology between genotypes at postnatal day 3 but markedly decreased alveolarization in KO mice by 4 weeks of age (Figure 1). Mean linear intercept (inversely proportional to lung surface area) was significantly increased at 4 weeks in KO mice (WT 29.3 +/- 4.2 vs. KO 50.5 +/- 1.3 mum; P<0.05) but not at postnatal day 3 (WT 48.5 +/- 0.9 vs. KO 51.1 +/- 0.7 mum; P=NS). Microarray analysis followed by quantitative real time PCR revealed differential expression of critical genes involved in lung development and angiogenesis in KO mouse lungs by 4 weeks of age. KO mice had evidence of alveolar epithelial barrier disruption by 4 weeks, as measured by: 1) the accumulation of the AT1 specific marker T1-alpha in broncholalveolar lavage fluid (2.7-fold increase over WT, P<0.001); 2) increased accumulation of FITC-albumin in lavage fluid 4 hours after intraperitoneal instillation (WT 58 +/- 28 mug/ml vs. KO 148 +/- 28 mug/ml, P <0.001); and 3) ultrastructural distortion of AT1-AT1 cell junctions in transmission electron microscopy images of KO mouse lungs (Figure 2). Preterm human infants born 24-28 weeks of gestation are at the highest risk of developing bronchopulmonary dysplasia, a disease characterized by impaired alveolar development. Preterm human lungs (gestational ages 24-32 weeks, n=4) demonstrated decreased mRNA expression of claudin-18 at 24 to 27 weeks gestational age relative to 32 weeks. Conclusion(s): Claudin-18 deficiency in mice results in alveolar epithelial barrier dysfunction and delayed alveolarization. Data suggest that extremely preterm human lungs are relatively claudin-18 deficient. Therefore, claudin-18 deficiency or dysfunction may contribute to infant chronic lung disease. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71984898
TI  - MiR-17~92 cluster expression is decreased in bronchopulmonary dysplasia
AU  - Tipple T.E.
AU  - Robbins M.
AU  - Dakhlallah D.
AU  - Rogers L.K.
AU  - Piper M.G.
Y1  - 2013//
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - human
KW  - promoter region
KW  - patient
KW  - lung
KW  - methylation
KW  - infant
KW  - fibrosing alveolitis
KW  - newborn disease
KW  - morbidity
KW  - hypothesis
KW  - lung function
KW  - mortality
KW  - DNA methylation
KW  - university
KW  - autopsy
KW  - assay
KW  - adult
KW  - therapy
KW  - gene expression
KW  - DNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - T.E. Tipple, Research Institute, Nationwide Children's Hospital, Columbus, OH, United States. E-mail: trent.tipple@nationwidechildrens.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5358
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71984898
AB  - RATIONALE: Bronchopulmonary Dysplasia (BPD) causes significant morbidity and mortality in prematurely born infants. Specific pro-fibrotic pathways have been implicated in the development of BPD in infants and idiopathic pulmonary fibrosis (IPF) in adults. miR-17~92 cluster is predicted to suppress activation of these pro-fibrotic pathways. Reductions in miR-17~92 cluster expression in IPF patients directly correlates with diminished pulmonary function and appears to be mediated via promoter hypermethylation. The present studies tested the hypothesis that miR~17-92 expression is decreased and promoter methylation increased in lungs from human patients that died with BPD when compared to lungs from patients that died from without BPD. METHOD(S): Lung samples (BioRepository for Investigation of Neonatal Diseases of the Lung, Dr. Gloria Pryhuber, University of Rochester) obtained at autopsy from patients who died with BPD (n=10) or without BPD (n=7) were analyzed for individual miR~17-92 cluster expression by qRT-PCR. miR-17~92 promoter methylation was determined in lung samples using Methyl-Profiler Assay. RESULT(S): Expression of individual members of the miR-17~92 cluster was decreased by 40-80% in samples from patients with BPD when compared to non-BPD controls. In promoter methylation analyses, miR-17~92 promoter was 50% methylated and 50% unmethylated in non-BPD control samples. In contrast, miR~17-92 promoter was 98% methylated and 2% unmethylated in lung samples from patients with BPD. CONCLUSION(S): Our novel data indicate that miR-17~92 cluster expression is significantly decreased and promoter methylation significantly increased in lungs from patients who died with BPD compared to non-BPD controls. We speculate that promoter methylation decreases miR-17~92 cluster expression in BPD, thus contributing to previously reported elevations in pro-fibrotic gene expression in these patients. Therapies directed at restoring miR-17~92 cluster expression by attenuating DNA methylation could be therapeutically beneficial in prematurely born infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71984897
TI  - Agonists of mas oncogene and angiotensin-type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury
AU  - Wagenaar G.T.M.
AU  - Laghmani E.
AU  - Fidder M.
AU  - Sengers R.M.A.
AU  - De Visser Y.P.
AU  - De Vries L.
AU  - Rink R.
AU  - Folkerts G.
AU  - Walther F.J.
Y1  - 2013//
KW  - *oncogene
KW  - *rat
KW  - *hyperoxia
KW  - *lung injury
KW  - *American
KW  - *society
KW  - *agonist
KW  - human
KW  - prematurity
KW  - pneumonia
KW  - stimulation
KW  - fibrin deposition
KW  - lung
KW  - infant
KW  - injury
KW  - thickness
KW  - tissues
KW  - adult
KW  - prophylaxis
KW  - arteriole
KW  - inflammatory cell
KW  - rat model
KW  - lung development
KW  - heart right ventricle hypertrophy
KW  - gene
KW  - hypertension
KW  - histopathology
KW  - lung dysplasia
KW  - renin angiotensin aldosterone system
KW  - inflammation
KW  - precursor
KW  - heart
KW  - parameters
KW  - mortality
KW  - respiratory failure
KW  - macrophage
KW  - exposure
KW  - neutrophil
KW  - fetus
KW  - morbidity
KW  - adverse drug reaction
KW  - chronic lung disease
KW  - *angiotensin
KW  - *receptor
KW  - ligand
KW  - marker
KW  - angiotensinogen
KW  - messenger RNA
KW  - dipeptidyl carboxypeptidase
KW  - angiotensin II
KW  - oxygen
KW  - vasoconstrictor agent
KW  - angiotensin receptor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - G.T.M. Wagenaar, Leiden University Medical Center, Leiden, Netherlands. E-mail: g.t.m.wagenaar@lumc.nl
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A5357
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71984897
AB  - Rationale. Stimulation of MAS oncogene receptor (MAS) or angiotensin (Ang) receptor type 2 (AT2) may be novel therapeutic options for neonatal chronic lung disease (CLD) by counterbalancing the adverse effects of the potent vasoconstrictor angiotensin II after binding to AT1, consisting of arterial hypertension (PAH)-induced right ventricular hypertrophy (RVH) and pulmonary inflammation. Studies to confirm a beneficial effect of AT2 signaling in cardiopulmonary disease have long been hampered by low expression of the receptor in normal adult tissues and lack of a highly specific agonist for AT2. In this study we have overcome both pitfalls by using a recently developed highly specific agonist in a neonatal rat model for cardiopulmonary disease, in which AT2 expression is expected to be high, due to its high expression in the fetal period. Methods. We determined the cardiopulmonary effects in neonatal rats with CLD of daily treatment during continuous exposure to 100% oxygen for 10 days with specific ligands for MAS (cyclic Ang-(1-7); 10-50 mug/kg/day) and AT2 (LP2-3: dKcAng-(1-7); 5-20 mug/kg/day). Both ligands are highly specific agonist, are resistant against degradation and do not bind to AT1. Parameters investigated included lung and heart histopathology, fibrin deposition, vascular leakage and differential mRNA expression in the lungs of key genes involved in the renin-angiotensin system, inflammation, coagulation and alveolar development. Results. The receptors AT1, AT2 and MAS, the precursor of their ligands angiotensinogen and the converting enzymes ACE1 and ACE2 are differentially expressed during lung development and/or in CLD. Prophylactic treatment with agonists for MAS or AT2 (5 mug/kg twice a day) for 10 days diminished cardiopulmonary injury by reducing alveolar septal thickness and medial wall thickness of small arterioles as a marker for PAH, and preventing RVH. Both agonists attenuated the pulmonary influx of inflammatory cells, including macrophages (via AT2) and neutrophils (via MAS), but did not reduce alveolar enlargement and vascular alveolar leakage. The AT2 agonist attenuated fibrin deposition. Conclusion. Stimulation of AT2 or MAS attenuates cardiopulmonary injury by reducing pulmonary inflammation and preventing PAH-induced RVH, but does not affect alveolar and vascular development in neonatal rats with experimental CLD. After extrapolating the beneficial effects of AT2 and MAS agonist treatment in rat pups with experimental CLD to preterm infants with respiratory failure, we might expect a beneficial effect of both agonists on PAH and RVH, which are the major reasons for mortality or severe morbidity in preterm infants with severe CLD or bronchopulmonary dysplasia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71984267
TI  - The p66shc adapter protein regulates mouse lung morphogenesis and epithelial maturation
AU  - Lee M.K.
AU  - Smith S.M.
AU  - Banerjee M.M.
AU  - Volpe M.V.
AU  - Nielsen H.C.
Y1  - 2013//
KW  - *mouse
KW  - *lung
KW  - *morphogenesis
KW  - *maturation
KW  - *American
KW  - *society
KW  - explant
KW  - lung development
KW  - epithelium cell
KW  - Adenoviridae
KW  - apoptosis
KW  - mitochondrion
KW  - prematurity
KW  - stress
KW  - suspension
KW  - oxidative stress
KW  - lung dysplasia
KW  - chronic lung disease
KW  - phenotype
KW  - gene
KW  - LoxP site
KW  - organ culture
KW  - serum
KW  - trachea
KW  - airway
KW  - Clara cell
KW  - infant
KW  - digestion
KW  - adhesion
KW  - fetus lung
KW  - *protein
KW  - small interfering RNA
KW  - growth factor
KW  - cycline
KW  - thyroid transcription factor 1
KW  - smooth muscle actin
KW  - differentiation antigen
KW  - lung surfactant
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.K. Lee, University of Southern California, Los Angeles, CA, United States. E-mail: mattlee@usc.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A4777
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71984267
AB  - Multiple growth factor signaling pathways are mediated by Shc adapter proteins that, in turn, are expressed as three transcriptional and translational variants with distinct and opposing functions. The p66Shc isoform has anti-mitogenic properties, regulates oxidative stress responses, and participates in mitochondria-mediated apoptosis. It is also highly expressed in the canalicular but not the saccular or alveolar stages of mouse lung development, suggesting an important morphogenetic function. Moreover, p66Shc expression persists in the lungs of infants with bronchopulmonary dysplasia, a chronic lung disease that is induced by premature birth. However, constitutive p66Shc deletion yields no morphologic phenotype, and the structure of the Shc gene precludes the incorporation of the LoxP sites necessary for inducible p66Shc deletion. To elucidate its role in lung development, we microinjected Oligofectamine (Invitrogen) suspensions containing 6.6 nM of either isoform-specific p66Shc siRNA or nonsilencing siRNA into the tracheae of E12 mouse lungs. The lung explants were maintained in serum-free organ culture for three days, after which explants were fixed, sectioned, and subjected to morphometric analysis and immunohistochemical assessment of p66Shc; smooth muscle actin (SMA); proliferating cell nuclear antigen (PCNA); the proximal airway differentiation antigens Clara cell 10-kDa protein (CC10) and thyroid transcription factor (TTF)-1; and the alveolar surfactant proteins (SP) -A, B, and C. Confirmatory studies were performed in primary fetal mouse lung epithelial cells that were isolated from E17 mice by tryptic digestion and differential adhesion, transfected with p66Shc siRNA or nonsilencing siRNA, and simultaneously infected with p66Shc adenovirus or GFP adenovirus. After three days, SP-C expression was assessed by Western analysis. Explants injected with nonsilencing siRNA demonstrated specific epithelial uptake and normal morphological development relative to uninjected explants. In contrast, explants injected with p66Shc siRNA had significantly increased lumenal cross-section areas, decreased branching, and increased epithelial proliferation (p<0.05 for all). Relative to controls, the expression of SP-B, SP-C, CC10, and TTF-1 in fetal lung explants was decreased by p66Shc knockdown. Similarly, SP-C expression in primary epithelial cells was reduced by p66Shc silencing and restored by p66Shc rescue expression. SP-A was not expressed in lungs transfected with either p66Shc or control siRNA, and SMA expression was not altered by p66Shc silencing. Taken together, these data suggest that p66Shc promotes distal and proximal epithelial maturation during normal and pathological lung development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71984263
TI  - Asporin expression in mouse lung alveogenesis and after elastase treatment
AU  - Srisuma S.
AU  - Wongkhat L.
AU  - Mariani T.J.
Y1  - 2013//
KW  - *lung
KW  - *American
KW  - *society
KW  - *mouse
KW  - gene expression
KW  - lung development
KW  - statistical significance
KW  - lung dysplasia
KW  - adult
KW  - human
KW  - extracellular matrix
KW  - hypothesis
KW  - architecture
KW  - lung emphysema
KW  - model
KW  - knockout mouse
KW  - animal model
KW  - emphysema
KW  - real time polymerase chain reaction
KW  - newborn
KW  - RNA purification
KW  - lung parenchyma
KW  - *elastase
KW  - nonoxinol 9
KW  - fibroblast growth factor receptor 3
KW  - formaldehyde
KW  - sodium chloride
KW  - protein
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Srisuma, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A4773
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71984263
AB  - Rationale: Bronchopulmonary dysplasia (BPD) is associated with a limitation of lung development and disturbance of alveolar architecture resulting in enlarged airspaces. Several extracellular matrix (ECM) molecules have been reported to regulate airspace development. Asporin is an ECM protein found to be overexpressed in human lung tissue with bronchopulmonary dysplasia (BPD). Asporin is also overexpressed in the lungs of fibroblast growth factor receptor 3 and 4 knockout mice, a model of BPD displaying abnormal airspace enlargement, a feature common to BPD and pulmonary emphysema. The biology of asporin in lung development and disease has not been explored. Hypothesis : Asporin gene expression is important for mouse alveolar formation, and may be involved in alveolar destruction in an animal model of emphysema resulting from elastase instillation. Methods : C57BL/6 mouse lungs at postnatal day (P) 1, 7, 14, 21, 28 and 60 were harvested for RNA purification and quantitative real time - PCR to identify the temporal pattern of asporin expression. We further determined the changes of asporin expression in elastase-induced airspace enlargement. Mice at P60 were treated with normal saline solution or elastase intratracheally. Lungs were isolated at 7 or 21 days after treatment for analysis of asporin gene expression. In addition, lungs were inflated with 10% buffered formalin at 25 cmH2O, and mean liner intercept (MLI) analysis was performed to determine airspace size. Results : Maximal asporin expression in mouse lungs was observed on P14, during the alveolar stage of lung development, when it was ~20-fold greater than in newborn lungs and ~60-fold greater than in adult lungs (P60; P-value < 0.005). In adult lung, 7 days after elastase treatment, asporin expression was significantly increased compared with control (P-value = 0.002). A directly proportional correlation between airspace size and asporin gene expression was observed (R = 0.44, P-value =0.025). Summary : Regulated expression of asporin was observed in the lung during alveogenesis, and during alveolar destruction associated with elastase instillation. These data suggest that this ECM molecule plays a role in alveogenesis and alveolar maintenance.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71983304
TI  - COX-2 regulates alveolar septation and neonatal hyperoxia induced inhibition of lung development
AU  - Olave N.
AU  - Pandit K.
AU  - Kaminski N.
AU  - Halloran B.
AU  - Ambalavanan N.
Y1  - 2013//
KW  - *hyperoxia
KW  - *lung development
KW  - *American
KW  - *society
KW  - mouse
KW  - macrophage
KW  - lung injury
KW  - lung homogenate
KW  - gene
KW  - density
KW  - wild type mouse
KW  - newborn
KW  - gene expression
KW  - lung dysplasia
KW  - antiinflammatory activity
KW  - wild type
KW  - injection
KW  - mare
KW  - hypothesis
KW  - iloprost
KW  - microRNA 214
KW  - messenger RNA
KW  - protein
KW  - interleukin 1beta
KW  - interleukin 6
KW  - microRNA
KW  - tumor necrosis factor alpha
KW  - nonoxinol 9
KW  - prostacyclin
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - N. Ambalavanan, University of Alabama at Birmingham, Birmingham, AL, United States. E-mail: ambal@uab.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3805
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71983304
AB  - RATIONALE: MicroRNAs are small conserved RNA that regulate gene expression. Bioinformatic analysis of microarray data indicated that miR-214 (targets COX-2) is important in mouse lung development. As hyperoxia inhibits normal lung development, our hypothesis was that hyperoxia-induced dysregulation of this miRNA and its target gene COX-2 would contribute to abnormal lung development in hyperoxia. METHOD(S): (1) Lung homogenates from C57BL/6 (Wild-type; WT) mice were evaluated at birth, postnatal day 4 (P4), P7, P14, and P42 for miR-214, Cox-2 mRNA and protein. (2) Newborn WT mice along with their dam were exposed to normoxia (21%) or hyperoxia (95% O2) from 4 to 14 days of age in combination with daily i.p. injections of either Iloprost 200ng/kg/day (a commercially available analog of prostacyclin that is downstream of Cox-2) or vehicle. miR-214, and COX-2 mRNA and protein were estimated in lung homogenates; Alveolar development was estimated by Radial Alveolar Counts, Mean Linear Intercepts, and secondary crest density. (4) The effect of Iloprost on TNF-alpha, Interleukin (IL)-1 beta, and IL-6 production by LPS-stimulated mouse macrophages was determined. RESULT(S): (1) miR-214 decreased over the course of lung development from P4 to P42, with corresponding increases in Cox-2 mRNA and protein (Figure 1). (2) Hyperoxia decreased miR-214, and increased COX-2 mRNA and protein. (3) Iloprost administration attenuated hyperoxia-induced inhibition of lung development in newborn mice as evident by a reduction in MLI and increase in RAC and SCD compared to hyperoxia-exposed mice (Figure 2). (4) Iloprost reduced TNF-alpha, IL-1beta, and IL-6 production by mouse macrophages. CONCLUSION(S): miR-214 and its target gene Cox-2 are regulators of lung development, and mediate abnormal lung development during hyperoxia. Iloprost attenuates hyperoxia-induced lung injury and has anti-inflammatory effects. Augmentation of Cox-2 signaling using Iloprost is a potential therapeutic strategy that may be useful in hyperoxia-induced lung injury, such as in bronchopulmonary dysplasia. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71983300
TI  - Hyperoxia alters macrophage differentiation in a mouse model of bronchopulmonary dysplasia
AU  - Eldredge L.C.
AU  - Manicone A.M.
AU  - Parks W.C.
AU  - McGuire J.K.
Y1  - 2013//
KW  - *hyperoxia
KW  - *macrophage
KW  - *mouse
KW  - *mouse model
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - adult
KW  - lung
KW  - population
KW  - lung injury
KW  - human
KW  - lung alveolus macrophage
KW  - phenotype
KW  - lung development
KW  - immunocompetent cell
KW  - tissues
KW  - gas exchange
KW  - gene expression
KW  - surface area
KW  - flow cytometry
KW  - assisted ventilation
KW  - model
KW  - injury
KW  - newborn care
KW  - gene
KW  - macrophage function
KW  - interleukin 10
KW  - marker
KW  - sialic acid binding immunoglobulin like lectin
KW  - cell surface marker
KW  - messenger RNA
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - L.C. Eldredge, University of Washington, Center for Lung Biology, Seattle, WA, United States. E-mail: lauriech@uw.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3801
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71983300
AB  - Rationale: Despite significant improvements in neonatal care, bronchopulmonary dysplasia (BPD) remains a common consequence of life-saving respiratory support. BPD is an inflammatory lung injury that leads to alveolar simplification and loss of surface area for gas exchange. Macrophages play key roles in lung injury, repair, and tissue remodeling. Yet little is known about the role these innate immune cells play in normal or aberrant lung development. Consequently, we assessed macrophage phenotypes in a mouse hyperoxia model of inflammatory lung injury that mimics aspects of human BPD. Method(s): Postnatal (PN) day 0, day 10, or adult C57BL/6 mice were placed in 95% FiO2 for up to 5 days; control animals were housed in normoxia conditions. Pulmonary macrophages were isolated and analyzed via flow cytometry utilizing validated cell surface markers. Hyperoxia- and normoxia-treated animals were compared at postnatal day 0 (PN0), PN3, PN5, and adult timepoints. In parallel, total RNA was isolated from whole lungs for gene expression analysis of via qRT2-PCR. Result(s): CD45+/CD11b-/Cd11c+/Siglec F+ cells (markers of the mature alveolar macrophage phenotype in adult mice) were identified in the adult mouse and PN5 lung. This population was notably absent at birth (PNO) but was present by 5 days of life (PN5). After treatment with hyperoxia, PN3, PN5, and PN15 mice lack CD45+/CD11b-/CD11c+ cells but gain a CD45+/CD11b+/CD11c+ population. The largest reduction in CD45+/CD11b-/CD11c cells was seen in the youngest mice. Adult mice were seemingly resistant to this change and retained a pulmonary CD45+/CD11b-/CD11c+ population after 3 days of hyperoxia. In addition, hyperoxia suppressed expression of IL10, Nos2, IL-10, and Arg1 mRNA in neonatal mouse lungs. Conclusion(s): Newborn mice lack CD45+/CD11b-/Cd11c+/SiglecF+ cells, raising the possibility that they lack alveolar macrophages at the time of birth. These cells accumulate in the neonatal lung within the first few days of life. Interestingly, these cells are depleted in neonatal, but not adult, mice exposed to hyperoxia. Hyperoxia also suppresses expression of immunomodulatory genes associated with regulation of macrophage function. These data raise the possibility that hyperoxia is deleterious to the developing lung via alteration of pulmonary macrophage differentiation within a critical developmental window, which may make the neonatal lung more susceptible to injury.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71982858
TI  - Expression of CCN5 (cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed protein) in murine alveolar development and response to hyperoxic injury
AU  - Fiaturi N.A.
AU  - Nielsen H.C.
AU  - Castellot J.
Y1  - 2013//
KW  - *injury
KW  - *American
KW  - *society
KW  - lung
KW  - staining
KW  - infant
KW  - pregnancy
KW  - lung alveolus cell
KW  - human
KW  - chronic lung disease
KW  - lung dysplasia
KW  - protein analysis
KW  - stain
KW  - airway
KW  - prematurity
KW  - cell proliferation
KW  - mouse
KW  - mortality
KW  - phenotype
KW  - cell cycle
KW  - smooth muscle fiber
KW  - morbidity
KW  - wild type
KW  - biological functions
KW  - wild type mouse
KW  - ambient air
KW  - lung alveolus epithelium
KW  - angiogenesis
KW  - Western blotting
KW  - lung development
KW  - hyperoxia
KW  - *cysteine
KW  - *connective tissue growth factor
KW  - *nephroblastoma overexpressed protein
KW  - oxygen
KW  - surfactant protein C
KW  - antigen
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - H.C. Nielsen, Floating Hospital for Children at Tufts Medical Center, Boston, United States. E-mail: heber.nielsen@tufts.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3401
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71982858
AB  - RATIONALE: In premature infants, especially those that are born earlier than 28 weeks of gestation, immature lung development and function is the major cause of morbidity and mortality. In particular, these infants are highly likely to develop Bronchopulmonary Dysplasia (BPD), a chronic lung disease with arrested alveolarization and hyperreactive airways. The development of the lung during 23-28 weeks of gestation is a complex process involving cell proliferation, differentiation, and angiogenesis. To understand BPD, new insight is needed into factors which control alveolar development, especially in response to hyperoxic injury. Of novel interest is the factor CCN5 (Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed protein) which we have previously reported is present in developing alveolar epithelium where its function is unknown. The mechanism of action and biological function of CCN5 in smooth muscle cells (SMCs) has received considerable attention. CCN5 in SMCs is a cell cycle regulator that inhibits SMC proliferation and motility while promoting a differentiated phenotype. However, the cell-specific expression and function of CCN5 in alveolar development and injury is unknown. OBJECTIVE(S): To define the role of CCN5 in alveolar epithelial development and in response to hyperoxic injury. METHOD(S): We used neonatal wild-type (WT) C57/B6 mice. Five-day-old neonatal WT mice were exposed to room air (RA) or 90% oxygen (hyperoxia) from days 5 - 13 of life (corresponding to the major period of murine alveolarization). On day 13, pups were sacrificed and used for study. The right lung was fixed, sectioned and used for immunofluoresence staining. The left lung was isolated for protein analysis. RESULT(S): Immunofluoresence co-staining showed that in WT RA pups at day 13 of postnatal life, CCN5 was prominently expressed in type I alveolar cells (identified by stain for T1 antigen). Co-staining for Ki67 showed that CCN5-positive alveolar T1 cells are in active proliferation. Staining for surfactant protein C ( Sftpc) showed type II alveolar cells are not proliferating and do not express CCN5. Western Blot analysis showed that CCN5 expression is greatly reduced in hyperoxic lungs compared to normoxic lungs. CONCLUSION(S): These data indicate CCN5 expression is high in proliferating alveolar type I cells during alveolarization and low or absent in non-proliferating alveolar epitlelium. This is opposite from CCN5 expression in SMCs where CCN5 is expressed in non-proliferating SMCs and absent in proliferating SMCs. We speculate that CCN5 is a functional component controlling alveolar epithelial proliferation during development and the response to injury.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71982820
TI  - Inadequate extracellular superoxide dismutase (SOD3) levels contribute to persistent hyperoxic injury in murine primary alveolar epithelial type II cells
AU  - Poonyagariyagorn H.K.
AU  - Malinina A.
AU  - Lopez-Mercado A.
AU  - Dikeman D.
AU  - Mesarwi O.
AU  - McGrath-Morrow S.A.
AU  - Neptune E.R.
Y1  - 2013//
KW  - *injury
KW  - *American
KW  - *society
KW  - gene
KW  - hyperoxia
KW  - lung
KW  - cell count
KW  - exposure
KW  - pathogenesis
KW  - model
KW  - mouse
KW  - inflammation
KW  - Student t test
KW  - lung dysplasia
KW  - prematurity
KW  - growth inhibition
KW  - whole cell
KW  - chronic respiratory tract disease
KW  - apoptosis
KW  - tumor suppressor gene
KW  - oxidative stress
KW  - cell growth
KW  - statistical significance
KW  - *extracellular superoxide dismutase
KW  - antioxidant
KW  - messenger RNA
KW  - marker
KW  - transcription factor
KW  - glutathione
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - H.K. Poonyagariyagorn, Johns Hopkins University, Baltimore, MD, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3363
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71982820
AB  - Rationale: The pathogenesis of bronchopulmonary dysplasia (BPD), a chronic respiratory disease often seen in prematurity, is believed to be secondary to oxidative damage from hyperoxia (O2) and inflammation that leads to impaired alveolar formation and often chronic lung dysfunction. We have previously shown that O2 exposure leads to a distinct injury profile and induces several antioxidant genes in an alveolar epithelial whole cell model, but information on O2-exposed primary alveolar epithelial type II cells (AECII) remains limited. We hypothesize that extracellular superoxide dismutase (SOD3), an antioxidant produced by AECII, might have a different response (downregulation) and thereby contribute to the persistent airspace injury and inflammation observed in BPD. Method(s): Using 6-8 week old C57Bl/6 mice, AECII were isolated and purified using a modification of published methods. Cells were subjected to either RA/5% CO2 versus 95% O2/5% CO2 for 24h. Each individual experiment was performed using a single isolation, with cells pooled from the lungs of three mice. Measures of alveolar injury were obtained, and RT-PCR measured mRNA expression in cells. Values for measurements were expressed as means+/-SEM, and P-values for significance were designated at <0.05. Student's t-tests were used to determine differences between groups. Result(s): Hyperoxia exposure significantly reduced total cell counts (Figure 1A) and total glutathione (GSH) levels in O2 versus RA groups, indicating increased oxidative stress (Figure 1B). This correlated with increased mRNA expression of Bax (a pro-apoptotic gene) and p21 (a tumor suppressor gene) (Figure 2). Antioxidant genes mediated by Nrf-2, a major antioxidant transcription factor, were significantly increased for Ho-1, Gclc, and Nqo-1 in the O2 versus RA group (Figure 2). However, SOD1 and SOD2 mRNA expression was similar between the RA and O2 groups. Interestingly, SOD3, an Nrf-2-independent antioxidant, was significantly increased in the O2-exposed cells compared to RA (Figure 2). (Figure Presented) Conclusion(s): AECII exposed to O2 demonstrate decreased cell counts, increased oxidative injury, and increased markers of apoptosis and cell growth inhibition. This was associated with increased mRNA SOD3 expression in O2-exposed AECII, suggesting these SOD3 levels are inadequate to protect cells fully from damage caused by O2. Such findings provide insight into a possible mechanism for the pathogenesis of BPD. Future studies are needed to determine if augmented SOD3 levels or a mimetic can attenuate or reverse the damage found in this particular model.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71982720
TI  - Functional polymorphism of matrix metalloproteinase proteinase-9 is associated with high MMP9 expression and bronchopulmonary dysplasia in extremely low birth weight infants
AU  - Paudel U.
AU  - Mercado V.
AU  - Calo J.
AU  - Patel N.
AU  - Parton L.
Y1  - 2013//
KW  - *lung dysplasia
KW  - *extremely low birth weight
KW  - *American
KW  - *society
KW  - infant
KW  - genotype
KW  - tracheal aspiration procedure
KW  - human
KW  - prematurity
KW  - chronic obstructive lung disease
KW  - lung development
KW  - cohort analysis
KW  - gestational age
KW  - birth weight
KW  - hypothesis
KW  - pilot study
KW  - gene
KW  - maturation
KW  - statistical significance
KW  - adult
KW  - Student t test
KW  - chi square test
KW  - connective tissue
KW  - protein degradation
KW  - extracellular matrix
KW  - real time polymerase chain reaction
KW  - chromosome aberration
KW  - allele
KW  - lung parenchyma
KW  - risk
KW  - enzyme linked immunosorbent assay
KW  - analysis of variance
KW  - *proteinase
KW  - *matrix metalloproteinase
KW  - gelatinase B
KW  - protein
KW  - DNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - U. Paudel, Westchester Medical Center, Valhalla, NY, United States. E-mail: upaudel@yahoo.com
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3261
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71982720
AB  - Background BPD appears to result from arrested lung development and is characterized by abnormal alveolar septation and abnormal microvascular maturation. Alveolarization requires coordinated extracellular matrix remodeling, a process in which matrix metalloproteinases (MMPs) play an important role. Matrix metalloproteinase 9 (MMP-9) has proteolytic activity against connective tissue proteins and its functional polymorphism (C-1562T) appears to play an important role in the development of chronic obstructive pulmonary disease (COPD) in adults. We therefore considered the functional polymorphism of MMP-9 (C-1562T) as one of the candidate genes in the susceptibility to BPD. Objective We tested the hypothesis that the MMP 9 rs3918242 SNP is associated with susceptibility to BPD in ELBW infants. Methods This is an ongoing cohort study that enrolls infants weighing <1 kg at birth, without congenital or chromosomal anomalies. BPD is defined as need for O2 at 36 weeks post-menstrual age. DNA was isolated from buccal mucosal swabs (N=110) and subjected to allelic discrimination using specific probes for MMP 9 SNP (C-1562T) during real-time PCR. Tracheal aspirate was collected (N=21) and MMP 9 level measured by ELISA. ANOVA, Chi square analyses and t-test for independent samples were performed with P<0.05 denoting statistical significance. Results As expected, both birth weights and gestational ages were significantly different between the BPD and No-BPD groups. Also, PDA requiring treatment was found significantly higher among infants with BPD. Genotype distributions for this MMP 9 SNP tested was significantly high for BPD (P=0.04). MMP 9 expression in tracheal aspirate was significantly higher among tt genotype as compared to Ct and CC genotype. Conclusions In this pilot study, ELBW preterm infants who progressed to BPD were more likely to contain the minor allele for the MMP-9 (C-1562T). We speculate that the functional increased expression of MMP-9 proteolytic enzyme in lung parenchyma places preterm infants at increased risk for BPD. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - N-BiPAP treatment in infants with respiratory distress syndrome: A population study.
DO  - https://dx.doi.org/10.1016/j.earlhumdev.2015.07.004
AU  - Solevag, Anne Lee
AU  - Kann, Inger Cathrine
Y1  - 2015//
Y2  - 20150725//
KW  - Bronchopulmonary Dysplasia/ep [Epidemiology]
KW  - *Continuous Positive Airway Pressure
KW  - Enterocolitis, Necrotizing/ep [Epidemiology]
KW  - Female
KW  - Hemorrhage/ep [Epidemiology]
KW  - Humans
KW  - Infant
KW  - Infant Mortality
KW  - Infant, Newborn
KW  - Intensive Care Units, Neonatal
KW  - Leukomalacia, Periventricular/ep [Epidemiology]
KW  - Male
KW  - Odds Ratio
KW  - Registries
KW  - *Respiratory Distress Syndrome, Newborn/th [Therapy]
KW  - Retinopathy of Prematurity/ep [Epidemiology]
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Treatment Outcome
T2  - Early human development
VL  - 91
IS  - 10
SN  - 0378-3782
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26217937
AD  - Ireland
AB  - BACKGROUND: Since November 1st 2008, our Norwegian neonatal intensive care unit has used nasal biphasic positive airway pressure (n-BiPAP) instead of invasive mechanical ventilation as first-line treatment after nasal continuous positive airway pressure (n-CPAP) failure in infants with respiratory distress syndrome (RDS)., AIM: To assess utility of a national patient register to compare outcomes of infants in our unit before and after November 1st 2008 as well as to hospitals that did not utilize n-BiPAP during the observation period., STUDY DESIGN: A retrospective study, using a national patient register and a difference-in-difference (DID) statistical approach, adjusting for confounders., SUBJECTS: Infants with RDS admitted to hospital 2002-2010., OUTCOME MEASURES: We compared our unit before and after November 1st 2008 and to other hospitals with regards to morbidity, mortality, and number of hospital days (NHD)., RESULTS: Infants with RDS in our unit had a significantly lower risk of bronchopulmonary dysplasia (BPD) (odds ratio (OR) 0.59, p<0.05), retinopathy of prematurity (ROP) (OR 0.57, p<0.05), and intraventricular hemorrhage (IVH) (OR 0.37, p<0.001); as well as the combined outcome of periventricular leukomalacia (PVL), necrotizing enterocolitis (NEC), ROP, IVH, and/or BPD (OR 0.53, p<0.05) after November 1st 2008 and compared to other hospitals. PVL, NEC, and mortality did not change. NHD was reduced by 8., CONCLUSION: Increasing use of n-BiPAP was associated with reduced morbidity and NHD in infants with RDS. Using a patient register and DID analyses may be a health economic and ethically sound way of generating hypotheses and knowledge about disease and treatment. Copyright Â© 2015 Elsevier Ireland Ltd. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71982716
TI  - Next generation sequence analysis of the transcriptional response to neonatal hyperoxia
AU  - Bhattacharya S.
AU  - Zhou Z.
AU  - Yee M.
AU  - Lopez A.M.
AU  - Lunger V.A.
AU  - Buczynski B.W.
AU  - Pryhuber G.S.
AU  - Mariani T.J.
AU  - O'Reilly M.A.
Y1  - 2013//
KW  - *hyperoxia
KW  - *American
KW  - *society
KW  - *sequence analysis
KW  - gene
KW  - lung parenchyma
KW  - human
KW  - mouse
KW  - lung
KW  - model
KW  - oxidative stress
KW  - gene expression
KW  - pathology
KW  - lung development
KW  - human tissue
KW  - infant
KW  - lung dysplasia
KW  - liver fibrosis
KW  - clinical pathway
KW  - risk factor
KW  - rodent model
KW  - exposure
KW  - oxygen concentration
KW  - morbidity
KW  - ambient air
KW  - algorithm
KW  - computer program
KW  - polymerase chain reaction
KW  - newborn
KW  - organogenesis
KW  - Student t test
KW  - genome
KW  - premature labor
KW  - oxygen
KW  - biological marker
KW  - sildenafil
KW  - protein p53
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Bhattacharya, University of Rochester, Medical Center, Rochester, NY, United States. E-mail: soumyaroop_bhattacharya@urmc.rochester.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3257
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71982716
AB  - Rationale: Bronchopulmonary Dysplasia (BPD) is a major complication of preterm birth associated with significant morbidity. Due to the complexity of risk factors and limited availability of clinical samples, an understanding of this disease, potential biomarkers and causal mechanisms are limited. Prematurely born infants requiring supplemental oxygen often develop BPD, as oxidative stress disrupts critical pathways of lung development. Rodent models involving neonatal exposure to excessive oxygen concentrations (hyperoxia) have been used to study the mechanisms contributing to BPD pathology. Transcriptomic assessment of the effects of hyperoxia in neonatal mouse lungs using RNASeq will identify novel genes and pathways associated with BPD. Method(s): We examined gene expression changes in lung tissue from newborn C57Bl/6 mice exposed to 100% oxygen for 10 days and room air-exposed age matched controls. Total RNA was isolated from individual whole lung tissues (n=14) and pooled in duplicates to perform RNASeq using the Illumina platform. Alignments were generated by ELAND v1.8 algorithm using Illumina CASAVA software. Normalized gene expression data were filtered to remove undetected genes. Significance Analysis of Microarrays (SAM) was used to identify genes with differential expression. Ingenuity Pathway Analysis (IPA) was used for pathway and network analyses. Expression patterns for selected genes were examined by quantitative polymerase chain reaction (qPCR). Result(s): A total of 798 genes were identified as differentially expressed between 3 hyperoxia and 4 control samples by SAM at FDR = 0, and 300 of those had fold change >= 2. We successfully validated 24 of 31 genes by qPCR. There was a clear association between the magnitude change identified by RNASeq and subsequent qPCR validation. Canonical pathways significantly dysregulated in hyperoxia lungs included Nrf2-mediated oxidative stress signaling, p53 signaling, hepatic fibrosis and sildenafil pathways. Interestingly most genes significantly affected in hyperoxic lungs (~70%) showed opposite expression change during organogenesis, consistent with arrested lung development, but some changed in same direction. 13% of the genes demonstrating a significant response to hyperoxia (103 of 798) were also dysregulated (t-test p<0.05) in human BPD lung tissue. Summary: We have generated genome-wide expression data from hyperoxia-exposed neonatal mouse lung tissue using RNA-Seq. We have identified 300 genes dysregulated in this model of BPD-like pathology. This model captures some aspects of BPD, but likely represents a more acute phase than available human tissue. Further analysis of these data would enhance our current knowledge of BPD, and may be used in developing novel therapeutic strategies.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71982715
TI  - Impact of shear stress and transforming growth factor beta on pulmonary (myo)fibroblasts of newborn mice and humans
AU  - Oak P.S.
AU  - Jain N.
AU  - Koschlig M.
AU  - Reicherzer T.
AU  - Ehrhardt H.
AU  - Hilgendorff A.
Y1  - 2013//
KW  - *shear stress
KW  - *fibroblast
KW  - *mouse
KW  - *human
KW  - *American
KW  - *society
KW  - lung
KW  - in vitro study
KW  - prematurity
KW  - infant
KW  - apoptosis
KW  - gas
KW  - artificial ventilation
KW  - lung injury
KW  - fluorescence activated cell sorting
KW  - chronic lung disease
KW  - dispersion
KW  - gestational age
KW  - vascularization
KW  - tracheal aspiration procedure
KW  - primary cell
KW  - immunoblotting
KW  - lung dysplasia
KW  - disease severity
KW  - cells by body anatomy
KW  - *transforming growth factor
KW  - elastin
KW  - growth factor
KW  - platelet derived growth factor
KW  - oxygen
KW  - tropoelastin
KW  - protein
KW  - receptor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - P.S. Oak, Comprehensive Pneumology Center, Helmholtz Zentrum, Munich, Germany. E-mail: prajakta.oak@helmholtz-muenchen.de
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A3256
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71982715
AB  - Introduction Chronic lung disease of the preterm infants, i.e. bronchopulmonary dysplasia (BPD) is characterized by impaired alveolarization and vascularization, dispersion and degradation of matrix elastin and an increase in apoptosis. It results as a consequence of prolonged mechanical ventilation with oxygen rich gas acting on the immature lung. Dysregulation of growth factor signaling such as transforming growth factor (TGF) beta is central in development of the disease. Its impact on the PDGF-Ralpha expressing (myo)fibroblasts (MFB) could significantly affect elastin production and septal formation, driven by this cell type. Here we establish the effect of TGF-beta on mouse lung MFBs with/without the additional application of in vitro stretch concerning their functional properties, elastin production as well as growth factor signaling. Furthermore, findings are translated to primary cells obtained from preterm infants. Materials and Methods MFBs isolated from 5-7 day old newborn mouse (C57B6) lungs and tracheal aspirates obtained during early days of life from preterm infants <=29 weeks gestational age; intubated over 3 days were cultured on 6 well plates with/without TGF-beta treatment. In vitro stretch was applied using the Flexcell Tension system (elongation max 10%; frequency 2Hz; 30 cycles/min). Immunoblot and FACS analysis were performed for cell characterization, indicators of apoptosis, proliferation as well as ECM proteins and growth factor expression. Functional characteristics were assessed using standard assessments for proliferation and migration. Results TGF-beta treatment decreased the proliferation, migration and PDGF-Ralpha expression of pulmonary MFBs from newborn mice with or without additional application of stretch compared to the respective controls; stretch alone did not affect receptor expression. In contrast, TGF-beta treatment altered elastin production in a stretch dependent manner. In human samples, the response to TGF-beta treatment w.r.t proliferation, migration and tropoelastin production was dependent on the underlying BPD grade. PDGF-Ralpha expression decreased in a stretch independent manner following TGF-beta treatment, as seen in mice. Conclusion TGF-beta induces alterations in growth factor signaling, elastin production and functional properties in newborn mouse MBFs; some effects being independent of in vitro stretch. The effect in human MFBs depends on predisposing conditions as disease severity. These findings suggest a central role of TGF-beta in mediating the effect of stretch-dependent lung injury and also point towards the importance of preforming conditions.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71982062
TI  - RHCC10 modulates tlr mediated NF-kB signaling in the premature lung
AU  - Hubert T.L.
AU  - Wu J.
AU  - Kimura K.
AU  - Shaffer T.H.
AU  - Eguchi S.
AU  - Wolfson M.R.
Y1  - 2013//
KW  - *American
KW  - *society
KW  - *lung
KW  - inflammation
KW  - lamb
KW  - respiratory distress syndrome
KW  - lung dysplasia
KW  - antiinflammatory activity
KW  - RNA extraction
KW  - human
KW  - Clara cell
KW  - acute lung injury
KW  - clinical study
KW  - lung parenchyma
KW  - biochemical analysis
KW  - tissues
KW  - Western blotting
KW  - synthesis
KW  - epithelium cell
KW  - cell culture
KW  - airway
KW  - protein
KW  - messenger RNA
KW  - toll like receptor
KW  - beractant
KW  - surfactant
KW  - complementary DNA
KW  - toll like receptor 4
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - T.L. Hubert, Temple University, School of Medicine, Philadelphia, PA, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A2602
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71982062
AB  - Rationale: CC10 is a pleiotrophic protein secreted by airway clara cells, known to have anti-inflammatory effects, but is deficient in the immature lung. Progression from respiratory distress syndrome (RDS) to bronchopulmonary dysplasia (BPD) has been linked to acute, iatrogenic, inflammation. Previous preclinical and clinical studies have demonstrated that rhCC10, when following surfactant treatment, decreases NF-kB mediated inflammation. Additionally, DAMP mediated Toll-Like Receptor (TLR) induced NF-kB activity has been shown to be integral to inflammation in acute lung injury. The effects of rhCC10 on TLR mediated inflammation are unknown. Objective(s): Assess TLR induced NF-kB activity and TLR expression in response to rhCC10 treatment in the preterm lung. Method(s): 24 premature lambs (126 +/- 3 days) were instrumented, delivered, paralyzed, and ventilated. After baseline, animals were randomized to 4 groups (n=6/group): untreated (UNT), SFT (Survanta 100mg/kg; 4ml/kg), or SFT followed by intratracheal rhCC10 (0.5 or 1.5 mg/kg; 2 ml/kg). After 4 hrs, the lambs were anesthetized and lung tissue was harvested and snap frozen for biochemical analysis. Tissue was then homogenized for RNA extraction, followed by cDNA synthesis, and then qPCR of TLR 4, normalized by 18S mRNA expression, was performed. Following qPCR, TLR 4 and pIkB proteins were measured by western blot and then normalized by GAPDH and IkB proteins respectively. Conclusion(s): We demonstrate here that, in the intact preterm animal, rhCC10 increases TLR mRNA expression and protein in a dose dependent manner while also decreasing NF-kB activity. These data demonstrate a disconnect between TLR expression and resulting NF-kB activity that needs further investigation. Further work using lung epithelial cell culture to explore downstream CC10 and Toll-like receptor pathways is ongoing (Table Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71981996
TI  - Serum YKL-40 is increased in children with bronchopulmonary dysplasia compared to children with asthma
AU  - James A.
AU  - Konradsen J.
AU  - Nordlund B.
AU  - Ebersjo C.
AU  - Henckel E.
AU  - Dahlen S.-E.K.
AU  - Bergren Bostrom E.
AU  - Hedlin G.
Y1  - 2013//
KW  - *human
KW  - *child
KW  - *lung dysplasia
KW  - *asthma
KW  - *serum
KW  - *American
KW  - *society
KW  - airway remodeling
KW  - lung function
KW  - fibrosis
KW  - positive end expiratory pressure
KW  - provocation
KW  - spirometry
KW  - questionnaire
KW  - respiratory tract disease
KW  - lung
KW  - smooth muscle
KW  - prematurity
KW  - diseases
KW  - patient
KW  - United Kingdom
KW  - atopy
KW  - blood sampling
KW  - enzyme linked immunosorbent assay
KW  - methacholine
KW  - nitric oxide
KW  - chitinase
KW  - biological marker
KW  - protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - A. James, Karolinska Institutet, Stockholm, Sweden
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A2536
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71981996
AB  - Introduction Bronchopulmonary dysplasia (BPD) is a chronic disorder characterized by underdeveloped and damaged lungs as a result of prematurity. Despite being associated with a greater degree of airway remodeling and fibrosis, the symptoms and treatment of BPD are often similar to those of asthma. A potential novel serum biomarker recently shown to be increased in asthma is the chitinase-like protein YKL-40, however, the biological mechanisms underlying this observation remain elusive. YKL-40 levels correlate with airway remodeling (Chupp et al. NEJM 2007;357:2016) and recently YKL-40 was found to increase smooth muscle proliferation (Bara et al. AJRCCM 2012;185:715). It was therefore of interest to further investigate the role of YKL-40 in airway disease by comparing serum YKL-40 in children with asthma and BPD. Methods Age- and sex-matched children with either diagnosed asthma or BPD were included in the study. The protocol included review of journal charts, questionnaires, spirometry, methacholine provocation, measurement of nitric oxide in exhaled (FENO) and blood sampling for atopy. Serum YKL-40 levels were measured in by ELISA (R&D Systems, Abingdon, UK). All children were examined at 10 years of age and clinical characteristics are shown in table 1. Results Serum YKL-40 was significantly higher in children with BPD compared to asthmatic children, figure 1, and children with BPD had reduced pulmonary function measurement, table 1. When patients were divided into high YKL-40 (upper quartile mean 17.5 ng/ml) vs. low YKL-40 (lower quartile mean 11.5 ng/ml), FEV1 (% predicted) was significantly lower in the high YKL-40 group (73+/-10% vs. 85+/-9%, p<0.007). Furthermore, children with BPD who had received continuous positive airway pressure (CPAP) for more than one month (n=19) had significantly higher levels of YKL-40 compared to BPD children with CPAP treatment for less than one month (19.0+/-5.8 vs. 13.0+/-5.3, p=0.014). Figure 1. Serum YKL-40 in children with asthma and BPD. Conclusion Elevated levels of YKL-40 were found in children with BPD compared to asthma, and the association between high YKL-40 levels, pulmonary function measurements and severity of BPD, suggests that YKL-40 may be involved in the development of airway remodeling and fibrosis in BPD. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71981395
TI  - Protein S-glutathionylation is promoted by ligand/receptor-mediated cell signaling in a specific and selective manner in lung vascular and airway smooth muscle cells
AU  - Suzuki Y.J.
AU  - Das D.
AU  - Wang Y.-H.
AU  - Hsieh C.-Y.
Y1  - 2013//
KW  - *lung
KW  - *airway smooth muscle cell
KW  - *American
KW  - *society
KW  - human
KW  - mass spectrometry
KW  - asthma
KW  - lymphangioleiomyomatosis
KW  - chronic obstructive lung disease
KW  - lung dysplasia
KW  - lung disease
KW  - Western blotting
KW  - second messenger
KW  - smooth muscle fiber
KW  - airway
KW  - cell growth
KW  - protein carbonylation
KW  - pulmonary hypertension
KW  - identity
KW  - multidrug resistance
KW  - molecular weight
KW  - stimulation
KW  - microtubule
KW  - tissues
KW  - pulmonary artery
KW  - *protein S
KW  - protein
KW  - interleukin 22
KW  - reactive oxygen metabolite
KW  - disulfide
KW  - glutathione
KW  - hydrogen peroxide
KW  - growth factor
KW  - platelet derived growth factor
KW  - mercaptoethanol
KW  - ligand
KW  - oxidoreductase
KW  - alpha tubulin
KW  - ribonucleoprotein
KW  - thiol
KW  - nicotinamide adenine dinucleotide
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 187
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - Y.J. Suzuki, Georgetown University, Medical Center, Washington, DC, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A2026
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71981395
AB  - RATIONALE: The growth of smooth muscle cells (SMCs) plays an important role in various lung diseases including asthma, chronic obstructive pulmonary disease, pulmonary hypertension, bronchopulmonary dysplasia, and lymphangioleiomyomatosis. Reactive oxygen species (ROS) have been proposed to serve as second messengers for SMC growth signaling. The mechanism of how ROS target biological molecules to elicit ligand/receptor-mediated cell signaling is, however, largely undefined. ROS can promote disulfide linkage between glutathione and protein thiols, in the process of protein S-glutathionylation. The present study investigated the mechanism and functions of protein S-glutathionylation in cell growth signaling in lung vascular and airway SMCs. METHOD(S): Human pulmonary artery SMCs (HPASMCs) and human bronchial SMCs (HBSMCs) were purchased from ScienCell and cultured. Cells were treated with SMC growth factors such as PDGF and IL-22. Protein S-glutathionylation and protein carbonylation were monitored by Western blotting, and the protein identities were obtained by mass spectrometry. RESULT(S): While multiple proteins are carbonylated, only one protein (~50 kDa) was found to be S-glutathionylated in untreated HPASMCs. Similarly, while a number of proteins are carbonylated, only a few proteins were found to be S-glutathionylated in untreated HBSMCs, but at different molecular weights (>100 kDa and ~40 kDa). S-Glutathionylation was visualized in non-reducing gels, and the addition of beta-mercaptoethanol eliminated glutathionylation signals. Treatment of cells with PDGF or IL-22 increased S-glutathionylation of ~50 kDa protein in HPASMCs and >100 kDa protein in HBSMCs, as early as 10 min and sustained for 30 min after the ligand stimulation. Ligand/receptor-mediated S-glutathionylation is mediated by NAD(P)H oxidase. The bulk addition of high-level hydrogen peroxide did not mimic ligand/receptor-mediated S-glutathionylation. Mass spectrometry identified that ~50 kDa protein in HPASMCs that can be S-glutathionylated is alpha-tubulin (which is essential for the microtubule formation), and >100 kDa protein in HBSMCs is major vault protein/lung resistance-related protein (the major component of vaults, which are ribonucleoprotein particles with a hollow barrel-like structure that may be involved in nucleo-cytoplasmic transport as well as multidrug resistance). CONCLUSION(S): Protein S-glutathionylation represents a specific and selective oxidative modification, which may function to regulate ROS signaling. Further understanding of this mechanism may help developing therapeutic strategies to inhibit SMC growth and migration in a tissue-specific manner.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71844477
TI  - Lung function time change in infants born pretem with and without bronchopulmonary dysplasia
AU  - Pacheco-Gonzalez R.M.
AU  - Sanchez-Solis M.
AU  - Garcia-Marcos L.
AU  - Perez V.
AU  - Quesada J.J.
AU  - Bosch V.
Y1  - 2013//
KW  - *physiology
KW  - *lung function
KW  - *infant
KW  - *lung dysplasia
KW  - *European
KW  - *society
KW  - *lung
KW  - human
KW  - parameters
KW  - respiratory airflow
KW  - compression
KW  - prematurity
KW  - body mass
KW  - gestational age
KW  - patient
KW  - model
KW  - analysis of variance
T2  - European Respiratory Journal
LA  - English
VL  - 42
IS  - SUPPL. 57
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - R.M. Pacheco-Gonzalez, Pediatric Respiratory Unit, Virgen De La Arrixaca University, Children's Hospital. University of Murcia, Murcia 30120, Spain. E-mail: sapachego@hotmail.com
UR  - http://erj.ersjournals.com/content/42/Suppl_57/P4661.full.pdf+html?sid=7a3e88a6-e9e4-4567-8a78-609aa088a899
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71844477
AB  - Introduction: Lung function is lower in preterm infants with bronchopulmonary dysplasia (BPD) as compared with those without BPD. This study compares how lung function changes with time in both groups. Material(s) and Method(s): FVC, FEV0.5, FEF75 and FEF25-75 were measured in 51 infants born preterm (18 with BPD and 33 without BPD) by the rapid thoracic compression with raised volume technique at three time points: initial visit, and 6 and 12 months later. To check for differences troughout the year of study, ANOVA for repeated measurements was performed. In order to analyze the influence of BPD on the change over time of z-scores of those lung function parameters (corrected to the Jaeger equipment) a model was built using the generalized estimated equations method, which was adjusted for gestational age, sex, corrected age, z-score of body mass index. Result(s): At the moment of the first visit non-BPD patients were 4.8 (sd: 0.5) months of age and BPD 5.2 (sd: 0.6) months (p>0.05). (Table presented) Conclusion(s): Except for FVC, lung flows increased during the study year in both BPD and non-BPD groups. However, those flows increased significantly more in non-BPD infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71843148
TI  - Eosinophil-derived neurotoxin in urine may predict the development of bronchopulmonary dysplasia in preterm infants
AU  - Choi S.H.
AU  - Rha Y.H.
AU  - Bae C.W.
AU  - Chang J.Y.
Y1  - 2013//
KW  - *inflammation
KW  - *newborn
KW  - *urine
KW  - *lung dysplasia
KW  - *prematurity
KW  - *infant
KW  - *human
KW  - *European
KW  - *society
KW  - eosinophil
KW  - serum
KW  - female
KW  - respiratory distress syndrome
KW  - patient
KW  - eosinophil count
KW  - blood
KW  - pregnancy
KW  - birth weight
KW  - gestational age
KW  - urinalysis
KW  - lung development
KW  - *eosinophil protein X
KW  - *biological marker
KW  - dexamethasone
KW  - protein
KW  - marker
KW  - eosinophil cationic protein
T2  - European Respiratory Journal
LA  - English
VL  - 42
IS  - SUPPL. 57
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - S.H. Choi, Pediatrics, Kyung Hee University Hospital at Gangdong, Seoul 138-788, South Korea. E-mail: chsh0414@naver.com
UR  - http://erj.ersjournals.com/content/42/Suppl_57/P2060.full.pdf+html?sid=d86ee282-3401-4840-8af6-520f53c2e154
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71843148
AB  - Rationale: Bronchopulmonary dysplasia (BPD) is the consequence of disturbed lung development and inflammation due to perinatal factors related to respiratory distress syndrome (RDS). Eosinophil-derived neurotoxin (EDN) is not the only marker of eosinophil activation, but also acts as an alarm protein. Very few studies have examined the potential role of eosinophil in development of BPD. This study aims to address the roles of eosinophil and EDN in the early phase of BPD development. Method(s): Study patients were preterm neonates with RDS born at 36 weeks of gestation or lesser (RDS group). Control patients were preterm babies with only minor respiratory problems or none at all. Blood and urine samples were collected to measure total eosinophil count in the blood, serum eosinophil cationic protein (ECP), serum EDN and urinary EDN during the first week of life. Comparisons were made between the RDS group and the non-RDS group and between the BPD group and the non-BPD group. Result(s): A total of 43 neonates were recruited and 10 patients were excluded. There were no differences between RDS and non-RDS group in total eosinophil count, serum ECP, serum EDN, or urinary EDN, except when compared by gestational age, birth weight, and prenatal dexamethasone use. Urinary EDN was increased significantly in the BPD group compared to the non-BPD group. Conclusion(s): We demonstrated the roles of eosinophil and EDN in the development of BPD and urinary EDN may be utilized as a non-invasive tool in predicting development of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71840635
TI  - Identification of biomarkers for early diagnosis in BPD
AU  - Gimm T.
AU  - Hoeland A.
AU  - Schwarz M.
AU  - Hossain H.
AU  - Ehrhardt H.
AU  - Gortner L.
AU  - Scholz M.
AU  - Reicherzer T.
AU  - Hauck S.
AU  - Hilgendorff A.
Y1  - 2013//
KW  - *early diagnosis
KW  - *European
KW  - *society
KW  - urine
KW  - fibroblast
KW  - gene expression
KW  - gene
KW  - lung dysplasia
KW  - artificial ventilation
KW  - gestational age
KW  - oxygen toxicity
KW  - human
KW  - umbilical cord blood
KW  - lung function
KW  - infant
KW  - monocyte
KW  - adulthood
KW  - cell differentiation
KW  - prematurity
KW  - embryo development
KW  - homeostasis
KW  - risk
KW  - diagnosis
KW  - infection
KW  - tracheal aspiration procedure
KW  - *biological marker
KW  - cytokine
KW  - proteome
KW  - protein
KW  - ion
KW  - interleukin 8
KW  - growth factor
KW  - transcriptome
T2  - European Respiratory Journal
LA  - English
VL  - 42
IS  - SUPPL. 57
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - T. Gimm, Comprehensive Pneumology Center, Helmholtz Zentrum, Munich, Germany
UR  - http://erj.ersjournals.com/content/42/Suppl_57/PP112.full.pdf+html?sid=3ecece04-b868-4ec9-bd7b-50f1ecd0aea5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71840635
AB  - Rationale: Bronchopulmonary dysplasia (BPD), one of the most common complications in the preterm infant, is characterized by impaired alveolar and vessel development. Mechanical ventilation, oxygen toxicity and infections increase the risk for BPD with impaired pulmonary and neurologic outcome persisting into adulthood. Current definitions rely on late pulmonary function and reliable biomarkers allowing for an early diagnosis are still missing. Objective and Methods: We therefore subjected cord blood (CB) from preterms < 32 weeks gestational age with and without BPD to microarray (Code Link, cohort 1) and cytokine analysis (Luminex, cohort 2) for identification of signaling pathways and potential candidates for biomarker analysis. The results were correlated with data from fibroblasts isolated from tracheal aspirates (TA). First results from proteome analysis in urine and TA (LC-MS/MS) were compared to the results obtained by microarray and cytokine analysis. Result(s): Transcriptome analysis exhibited 102 up- and 134 down-regulated genes in preterms with BPD compared to no-BPD controls. Genes were involved in regulation of gene expression (up), or cell differentiation, embryonic development and ion homeostasis (down). Luminex analyses revealed significant differences in cytokines (sIL-1ra, IL-8, TNF-alpha, MCP-1) and growth factor expression (FGF2, EGF), correlating with functional data in fibroblasts from TA. First proteome data in urine and TA confirmed potential biomarker candidates. Conclusion(s): Gene expression and protein profiling from CB, urine and TA of preterms allows differentiation for later BPD diagnosis with increased monocyte signaling and fibroblast activation playing a central role.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71840634
TI  - Serum YKL-40 is increased in children with bronchopulmonary dysplasia compared to children with asthma
AU  - James A.
AU  - Konradsen J.
AU  - Nordlund B.
AU  - Ebersjo C.
AU  - Bostrom E.B.
AU  - Henckel E.
AU  - Dahlen S.-E.
AU  - Hedlin G.
Y1  - 2013//
KW  - *human
KW  - *child
KW  - *lung dysplasia
KW  - *asthma
KW  - *serum
KW  - *European
KW  - *society
KW  - fibrosis
KW  - airway remodeling
KW  - positive end expiratory pressure
KW  - prematurity
KW  - lung function
KW  - patient
KW  - smooth muscle
KW  - diseases
KW  - enzyme linked immunosorbent assay
KW  - biological marker
KW  - protein
KW  - chitinase
T2  - European Respiratory Journal
LA  - English
VL  - 42
IS  - SUPPL. 57
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - A. James, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
UR  - http://erj.ersjournals.com/content/42/Suppl_57/PP111.full.pdf+html?sid=3ecece04-b868-4ec9-bd7b-50f1ecd0aea5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71840634
AB  - Introduction: Bronchopulmonary dysplasia (BPD) caused by prematurity is associated with more remodeling and fibrosis than asthma, yet symptoms and treatment of these two disorders are similar. The chitinase-like protein YKL-40, is a novel biomarker of asthma although the mechanisms involved are unknown. YKL-40 levels correlate with airway remodeling (Chupp et al. NEJM 2007) and YKL-40 increases smooth muscle proliferation (Bara et al. AJRCCM 2012). We aimed to compare serum YKL-40 in children with asthma and BPD. Method(s): Age- and sex-matched children with diagnosed asthma (n=27) or BPD (n=28) were included in the study at 10 yrs of age. Serum YKL-40 levels were measured by ELISA. Result(s): YKL-40 was higher in children with BPD compared to asthma, fig 1, whereas FEV1 (%pred) was reduced in BPD (77.1 vs 84.1, p=0.03). Patients with high YKL-40 (upper quartile mean 17.5 ng/ml) had a lower FEV1 than those with low YKL-40 (lower quartile mean 11.5 ng/ml), (73% vs 85%, p<0.007). YKL-40 was higher in children who received continuous positive airway pressure (CPAP) for >1 month than those with CPAP treatment for <1 month. Conclusion(s): Serum YKL-40 levels are increased in BPD and relate to lung function and BPD severity suggesting that YKL-40 may be involved in airway remodeling and fibrosis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71785393
TI  - Glucocorticoid receptor gene polymorphisms and neonatal outcome of vlbw preterm infants: Preliminary results from a German multicenter study
AU  - Schreiner F.
AU  - Poralla C.
AU  - Haertel C.
AU  - Heckmann M.
AU  - Woelfle J.
AU  - Bartmann P.
AU  - Herting E.
AU  - Goepel W.
Y1  - 2013//
KW  - *human
KW  - *DNA polymorphism
KW  - *prematurity
KW  - *infant
KW  - *receptor gene
KW  - *German (citizen)
KW  - *multicenter study
KW  - *society
KW  - brain hemorrhage
KW  - necrotizing enterocolitis
KW  - parameters
KW  - gestational age
KW  - allele
KW  - very low birth weight
KW  - mean arterial pressure
KW  - risk factor
KW  - artificial ventilation
KW  - sepsis
KW  - lung dysplasia
KW  - fetus lung maturation
KW  - homozygosity
KW  - newborn sepsis
KW  - risk
KW  - genotype
KW  - hypothesis
KW  - study design
KW  - retinopathy
KW  - incidence
KW  - gene
KW  - *glucocorticoid receptor
KW  - betamethasone
KW  - glucocorticoid
KW  - steroid
KW  - catecholamine
KW  - corticosteroid
T2  - Endocrine Reviews
LA  - English
VL  - 34
IS  - 3 SUPPL. 1
SP  -
PB  - Endocrine Society
SN  - 0163-769X
AD  - F. Schreiner, Children's Hospital, University of Bonn, Bonn, Germany
UR  - http://press.endocrine.org/doi/abs/10.1210/endo-meetings.2013.PE.5.SAT-600
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71785393
AB  - Background: Apart from its beneficial effects on lung maturation, prenatal betamethasone administration has been shown to reduce the incidence of necrotizing enterocolitis, sepsis, and intraventricular hemorrhage in preterm infants. However, little is known about the role of endogenous differences in corticoid sensitivity arising from polymorphisms in the glucocorticoid receptor (GR) gene. Study design: We analyzed GR polymorphisms BclI, N363S and R23K with respect to recorded neonatal outcome parameters in a German Neonatal Network (GNN) multicenter cohort comprising 2.211 very low birth weight preterm (VLBW) infants. Result(s): Birth parameters were not different between genotype groups. Variants BclI and R23K were associated with a significantly higher risk of culture-positive neonatal sepsis (Bcll homozygosity: OR 1.85, p=0.002; R23K-carrier: OR 2.08, p=0.016; adj. for gestational age). In addition, infants carrying BclI alleles were more likely to develop bronchopulmonary dysplasia (OR 1.41 per allele [95% CI 1.14-1.75], p < 0.01 adj. for gestational age and mechanical ventilation). A similar relative risk was seen in the subcohort of infants with antenatal betamethasone treatment (OR 1.44, p < 0.01), whereas no such effect was detectable in the small subgroup without steroid treatment (n=185, OR 1.03, n.s.). N363S-carrier tended to have lower mean arterial blood pressure at the first day of life (total cohort: beta=-0.050, p=0.010; BclI-/R23K-wildtype subcohort: beta-0.055, p=0.074) and were more likely to require catecholamine treatment (p<0.01). However, none of the analyzed GR variants significantly influenced incidence rates of intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), or retinopathy (ROP). Conclusion(s): This study supports the hypothesis that endogenous differences in glucocorticoid sensitivity mediated by GR gene polymorphisms affect the neonatal outcome of VLBW preterm infants. In order to confirm the observed associations, analysis of a replication cohort is ongoing.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Autophagy regulates hyperoxia-induced intracellular accumulation of surfactant protein C in alveolar type II cells.
DO  - https://dx.doi.org/10.1007/s11010-015-2494-z
AU  - Zhang, Liang
AU  - Zhao, Shuang
AU  - Yuan, Li-Jie
AU  - Wu, Hong-Min
AU  - Jiang, Hong
AU  - Zhao, Shi-Meng
AU  - Luo, Gang
AU  - Xue, Xin-Dong
Y1  - 2015//
Y2  - 20150630//
KW  - Animals
KW  - Animals, Newborn
KW  - Autophagy
KW  - Cell Hypoxia
KW  - Cell Line
KW  - *Epithelial Cells/cy [Cytology]
KW  - *MAP Kinase Signaling System
KW  - Mice
KW  - Pulmonary Alveoli/cy [Cytology]
KW  - *Pulmonary Alveoli/me [Metabolism]
KW  - *Pulmonary Surfactant-Associated Protein C/me [Metabolism]
KW  - Rats
KW  - *Ubiquitin-Activating Enzymes/me [Metabolism]
T2  - Molecular and cellular biochemistry
VL  - 408
IS  - 1-2
SN  - 0300-8177
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26122393
AD  - Netherlands
AB  - Surfactant protein C (SP-C) deficiency is a risk factor for hyperoxia-induced bronchopulmonary dysplasia in newborn infants. However, the role of SP-C deficiency in the process is unclear. Here, using neonatal rat BPD model and MLE-12, mouse alveolar epithelial type II cell, we examined the changes of SP-C levels during hyperoxia. Immunohistochemistry, immunofluorescence, and ELISA analysis showed SP-C accumulation in alveolar epithelial type II cells. Electron microscopy further demonstrated the accumulation of lamellar bodies and the co-localization of lamellar bodies with autophagosomes in the cytoplasm of alveolar epithelial type II cells. The inhibition of autophagy with 3-Methyladenine and knockdown of Atg7 abolished hyperoxia-induced SP-C accumulation in the cytoplasm. Furthermore, inhibition of JNK signaling with SP600125 suppressed hyperoxia-induced Atg7 expression and SP-C accumulation. These findings suggest that hyperoxia triggers autophagy via JNK signaling-mediated Atg7 expression, which promotes the accumulation of SP-C within alveolar epithelial type II cells. Our data provide a potential approach for hyperoxic lung injury therapy by targeted pharmacological inhibition of autophagic pathway.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71755831
TI  - A dangerous night at Lauchernalp
AU  - Wuest A.
AU  - Werlen L.
AU  - Casaulta C.
AU  - Pilgrim S.
AU  - Latzin P.
AU  - Ashkenazi M.
AU  - Vuissoz J.-M.
Y1  - 2013//
KW  - *Swiss
KW  - *society
KW  - *pediatrics
KW  - *night
KW  - human
KW  - female
KW  - acute respiratory failure
KW  - capillary
KW  - hyperinflation
KW  - respiratory failure
KW  - skiing
KW  - morbidity
KW  - pregnancy
KW  - childhood
KW  - upper respiratory tract infection
KW  - lung dysplasia
KW  - flying
KW  - thorax radiography
KW  - adolescent
KW  - boy
KW  - male
KW  - airway pressure
KW  - leisure
KW  - respiratory tract infection
KW  - rhinitis
KW  - case report
KW  - sputum
KW  - respiratory distress
KW  - counseling
KW  - travel
KW  - general practitioner
KW  - coughing
KW  - pediatrician
KW  - university hospital
KW  - bronchodilatation
KW  - therapy
KW  - exercise
KW  - patient
KW  - prematurity
KW  - sleep
KW  - capillary leak syndrome
KW  - follow up
KW  - corticosteroid
KW  - diuretic agent
T2  - Swiss Medical Weekly
LA  - English
VL  - 143
IS  - SUPPL. 197
PB  - EMH Swiss Medical Publishers Ltd.
SN  - 1424-7860
AD  - A. Wuest, Department of Pediatrics, University Hospital of Bern, Switzerland
UR  - http://www.smw.ch/fileadmin/smw/pdf/Supplementa_2013/SMW_Suppl-197.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71755831
AB  - Introduction: Bronchopulmonary dysplasia (BPD) is associated with significant morbidity in early life. This is reflected in current recommendations regarding altitude: traveling in altitude or flying on planes is not recommended during the first year. However no clear recommendations exist for later childhood, making it a challenge for the pediatrician to give adequate counseling. We report here an unusual case of a former premature adolescent with acute respiratory failure. Case report: A 13 year-old boy, born at 27 weeks of gestation with a history of BPD, went for holiday to a ski resort at 2000 m. On the previous days he suffered from acute upper respiratory tract infection with rhinitis. During the first night he developed severe cough, but decided to go skiing the day after. In the afternoon he developed a respiratory distress and produced pink, foamy sputum and presented to the general practitioner in respiratory failure. The first chest X-ray showed severe hyperinflation. After transfer to the University hospital he needed aggressive bronchodilatation and therapy with diuretics, corticosteroid, and positive airway pressure. The patient fully recovered within 24 hours. Discussion(s): Multiple elements explain the origin of this acute respiratory insufficiency. Prematurity with BPD leads to epithelial and capillary dysfunction. The respiratory tract infection contributed to further epithelial and capillary dysfunction and hyperinflation. Sleeping in altitude probably induced capillary leakage and exercise in this situation added to final respiration failure. Conclusion(s): Preterms with BPD among others need a regular pulmonary follow-up to correctly advice daily activity on an individual basis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71735295
TI  - Role of sphingolipid signalling in bronchopulmonary dysplasia
AU  - Harijith A.
AU  - Reddy N.
AU  - Bai T.
AU  - Usatyuk P.
AU  - Pendyala S.
AU  - Huang L.
AU  - Berdyshev E.
AU  - Gorshkova I.
AU  - Reddy S.
AU  - Raj U.
AU  - Natarajan V.
Y1  - 2013//
KW  - *lung dysplasia
KW  - hyperoxia
KW  - mouse
KW  - lung injury
KW  - wild type
KW  - lung parenchyma
KW  - newborn
KW  - lung lavage
KW  - histopathology
KW  - chemical analysis
KW  - lung function
KW  - lung
KW  - inflammation
KW  - human
KW  - prematurity
KW  - pathology
KW  - histology
KW  - protection
KW  - Western blotting
KW  - adult
KW  - exposure
KW  - model
KW  - *sphingolipid
KW  - lyase
KW  - sphingosine 1 phosphate
KW  - interleukin 6
KW  - protein
KW  - reduced nicotinamide adenine dinucleotide phosphate oxidase 4
T2  - Clinical and Translational Science
LA  - English
VL  - 6
IS  - 2
PB  - Blackwell Publishing Ltd
SN  - 1752-8054
AD  - A. Harijith, University of Illinois, Chicago, IL, United States
DO  - https://dx.doi.org/10.1111/cts.12047
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71735295
AB  - OBJECTIVES/SPECIFIC AIMS: Bronchopulmonary Dysplasia (BPD) of the premature newborn is characterized by lung injury resulting in alveolar simplification and reduced pulmonary function. We have earlier shown that exposure of adult mice to hyperoxia enhances sphingosine-1-phosphate levels in lung tissues; however, the role of increased S1P generation and signaling in the pathobiology of BPD has not been investigated. We hypothesized that altered S1P signaling axis in BPD, in part, is responsible for neonatal lung injury and inflammation. METHODS/STUDY POPULATION: To test this, newborn (NB) C57BL6/J, SphK1-/-, SphK2-/- and Sgpl1+/- (S1P lyase) mice were exposed to hyperoxia (75%) from postnatal day1 to 7, pups were sacrificed on postnatal day 7, and lungs were perfused and used for histology and biochemical analysis. RESULTS/ANTICIPATED RESULTS: SphK1-/-, but not SphK2-/-, deficiency in mice offered protection against hyperoxia-induced lung injury compared to wild type littermate controls. Histopathology revealed better formed alveoli and comparable levels of proteins in bronchoalveolar lavage (BAL) fluids in SphK1 deficient mice. Further, hyperoxia increased levels of pro-inflammatory IL-6 was decreased in bronchoalveolar lavage fluids in SphK1 deficient mice compared to the wild type. Analysis of total cell lysates by Western blots showed decreased expression of Nox-2 and Nox-4 proteins, in the lung tissue of SphK1-/- mice exposed to hyperoxia compared to its wild type control. DISCUSSION/SIGNIFICANCE OF IMPACT: These results suggest an important role for SphK1 and S1P signaling in the development of hyperoxia-induced lung injury in a murine neonatal model of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71735230
TI  - Down-regulation of the matricellular protein, periostin, is a novel biomarker of acute lung injury
AU  - Ahlfeld S.K.
AU  - Gao Y.
AU  - Conway S.
Y1  - 2013//
KW  - *acute lung injury
KW  - *down regulation
KW  - myofibroblast
KW  - lung injury
KW  - hyperoxia
KW  - lung
KW  - upregulation
KW  - lung development
KW  - lung dysplasia
KW  - pathogenesis
KW  - therapy
KW  - human
KW  - infant
KW  - prematurity
KW  - chronic lung disease
KW  - lung fibrosis
KW  - model
KW  - premature labor
KW  - mouse
KW  - knockout mouse
KW  - *protein
KW  - *transcription factor RUNX2
KW  - *biological marker
KW  - marker
KW  - teratogenic agent
KW  - smooth muscle actin
T2  - Clinical and Translational Science
LA  - English
VL  - 6
IS  - 2
PB  - Blackwell Publishing Ltd
SN  - 1752-8054
AD  - S.K. Ahlfeld, Program in Developmental Biology, Indiana University, School of Medicine, Indianapolis, IN, United States
DO  - https://dx.doi.org/10.1111/cts.12047
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71735230
AB  - OBJECTIVES/SPECIFIC AIMS: Extreme preterm birth exposes the saccular lung to multiple teratogens which retard alveolar lung development resulting in Bronchopulmonary Dysplasia (BPD), a chronic lung disease of preterm infants. Preventative therapies have been hindered by a lack of reliable markers of early disease pathogenesis. Up-regulation of the matricellular protein, Periostin, is a marker of late lung injury, myofibroblast accumulation, and pulmonary fibrosis but it is unknown if Periostin directs normal myofibroblast accumulation during early alveolar septation or if it identifies early lung injury. METHODS/STUDY POPULATION: Using a murine hyperoxia (85%-O2) model of inhibited alveolar septation, we correlated Periostin expression with the appearance of myofibroblasts in the saccular lung, determined if it was required for early alveolar development, and examined its misexpression in early lung injury. RESULTS/ANTICIPATED RESULTS: Periostin was widely expressed in distal lung septa through P2-4 (early alveolar septation) and peak expression coincided with accumulation of alpha -smooth muscle actin ( alpha SMA)+-myofibroblasts. Acutely, hyperoxia blunted normal up-regulation of Periostin and alpha SMA prior to the first evidence of distal lung simplification at P4. Conversely, chronic hyperoxia resulted in abnormal accumulation of Periostin and alpha SMA in blunted septa at P14. Despite its tight association with hyperoxic lung injury, Periostin knockout mice exhibited normal myofibroblast differentiation and alveolar development, and they were equally sensitive to hyperoxia as wildtypes. DISCUSSION/SIGNIFICANCE OF IMPACT: We conclude that Periostin is a novel biomarker of acutely-inhibited alveolar septation during a clinically-relevant window of lung development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71533391
TI  - Lack of worsens lung development and pulmonary hypertension in a neonatal mouse model of BPD
AU  - Grayck E.
AU  - Wright R.
AU  - Tang J.-R.
AU  - Delaney C.
AU  - Woods C.
AU  - Abman S.
Y1  - 2013//
KW  - *intensive care
KW  - *pulmonary hypertension
KW  - *mouse model
KW  - *mouse
KW  - *society
KW  - *lung development
KW  - lung
KW  - knockout mouse
KW  - pH
KW  - human
KW  - infant
KW  - pulmonary vascular disease
KW  - lung dysplasia
KW  - wild type
KW  - intraperitoneal drug administration
KW  - systolic blood pressure
KW  - pathogenesis
KW  - protein content
KW  - immunohistochemistry
KW  - density
KW  - Western blotting
KW  - prematurity
KW  - lung disease
KW  - bleomycin
KW  - serotonin
KW  - tryptophan hydroxylase
KW  - sodium chloride
KW  - antioxidant
KW  - reactive oxygen metabolite
KW  - nonoxinol 9
KW  - serotonin transporter
KW  - serotonin receptor
KW  - vasculotropin
T2  - Critical Care Medicine
LA  - English
VL  - 41
IS  - 12 SUPPL. 1
PB  - Lippincott Williams and Wilkins
SN  - 0090-3493
AD  - E. Grayck, Children's Hospital, University of Colorado, Aurora, CO, United States
DO  - https://dx.doi.org/10.1097/01.ccm.0000439351.21578.8e
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71533391
AB  - Introduction: Bronchopulmonary dysplasia (BPD) complicated by pulmonary hypertension (PH) worsens clinical outcomes in former preterm infants though the factors that predispose to BPD associated with PH are not clear. Studies suggest that excess generation of reactive oxygen species that exceeds the antioxidant capacity is central to the pathogenesis of neonatal alveolar and pulmonary vascular disease. Method(s): Wild-type mice (WT), and mice lacking EC-SOD (KO) received intraperitoneal bleo (2 units per kilogram) or saline three times weekly during weeks 0-3 of life. At week 4, right ventricular systolic pressures (RVSP) were measured and lungs were inflation fixed for morphometric analysis, including radial alveolar counts (RAC), mean linear intercepts (MLI), and nodal point density (NPD), and immunohistochemistry (IHC), or flash frozen for protein content by western blot (WB). Result(s): Lack of EC-SOD impaired alveolar development at week 4, characterized by lower RAC and NPD and increased MLI, and augmented bleo-induced disruption of alveolar development. Bleo also decreased EC-SOD expression in WT mice. Although KO mice had higher RVSP than WT at 4 weeks, bleo treatment did not cause a further increase in RVSP in KO or WT mice. Altered VEGF or serotonin (5-HT) signaling did not account for the impaired lung development in KO mice at baseline or after bleo. No differences were observed between KO and WT mice in VEGF, VEGFR2, or eNOS expression, or in the 5-HT signaling pathway, including 5-HT, tryptophan hydroxylase, 5-HT transporter or 5-HT receptors, 5-HT2a or 5-HT2b. Conclusion(s): We propose that EC-SOD activity preserves normal lung and vascular development, and insufficient EC-SOD activity predisposes to worse outcomes in neonatal lung diseases. Further studies are needed to determine the mechanisms responsible for worsened lung and pulmonary vascular development in the neonatal lung in the setting of insufficient EC-SOD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71527808
TI  - Neonatal cortical auditory evoked potentials are affected by bronchopulmonary dysplasia occurring in early prematurity
AU  - Cainelli E.
AU  - Cappellari A.
AU  - Ermani M.
AU  - Zanardo V.
AU  - Suppiej A.
Y1  - 2013//
KW  - *evoked auditory response
KW  - *lung dysplasia
KW  - *prematurity
KW  - *society
KW  - *electroneurology
KW  - infant
KW  - human
KW  - processing
KW  - inflammation
KW  - encephalomalacia
KW  - genetic disorder
KW  - event related potential
KW  - brain development
KW  - leukemoid reaction
KW  - pure tone audiometry
KW  - brain disease
KW  - bleeding
KW  - stimulus
KW  - brain
KW  - risk factor
KW  - hypothesis
KW  - cytokine
T2  - Clinical Neurophysiology
LA  - English
VL  - 124
IS  - 11
PB  - Elsevier Ireland Ltd
SN  - 1388-2457
AD  - E. Cainelli, PaduaItaly
UR  - http://www.sciencedirect.com/science/article/pii/S1388245713008699/pdfft?md5=d7eef6b982927300b094609c554b3f15&pid=1-s2.0-S1388245713008699-main.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71527808
DO  - https://dx.doi.org/1016/j.clinph.2013.06.145
AB  - Bronchopulmonary dysplasia, the most frequent respiratory sequelae of prematurity, usually occurs as part of the multiorgan foetal inflammatory response syndrome. The underlying mechanism is thought to be the same cytokine mediated leukemoid reaction associated with periventricular leukomalacia of premature infants. Event-related potentials have been shown to serve as early indicators of problems in cortical development. Our aim was to determine the effect of bronchopulmonary dysplasia on neonatal cortical auditory processing. Forty-five premature infants (23-34 weeks) were recorded at 35 post-conceptional weeks. Infants with genetic syndromes, clinical evidence of neonatal encephalopathy, intra-ventricular haemorrhage or periventricular leukomalacia were not recruited. The average of 330 responses to 1000 Hz pure tones (inter-stimulus interval 1250-1850 ms), were recorded at frontal location. Mean amplitudes calculated from the data points of 30 ms centered on P1 and N2 peaks in the waveforms of each subject were measured. The amplitude of P1 component resulted lower in infants with bronchopulmonary dysplasia (p = .004). Results show an association between bronchopulmonary dysplasia and alterations in brain auditory processing, even in absence of major neurological risk factors. This further support the hypothesis of an interference with brain development mediated by the foetal inflammatory response syndrome.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71446272
TI  - Two years outcomes of influenza a (H1N1)-associated acute respiratory distress syndrome survivors treated by extracorporeal membrane oxygenation
AU  - Amsallem M.
AU  - Boucly A.
AU  - Brechot N.
AU  - Trouillet J.-L.
AU  - Nieszkowska A.
AU  - Combes A.
AU  - Chastre J.
AU  - Luyt C.-E.
Y1  - 2013//
KW  - *influenza A
KW  - *adult respiratory distress syndrome
KW  - *survivor
KW  - *extracorporeal oxygenation
KW  - *society
KW  - *intensive care
KW  - human
KW  - patient
KW  - dyspnea
KW  - anxiety
KW  - risk
KW  - posttraumatic stress disorder
KW  - influenza
KW  - quality of life
KW  - population
KW  - smoking
KW  - chronic respiratory failure
KW  - interview
KW  - disability
KW  - lung function
KW  - statistical significance
KW  - health
KW  - walking
KW  - exercise
KW  - female
KW  - sport
KW  - weight
KW  - Simplified Acute Physiology Score
KW  - lung dysplasia
KW  - Impact of Events Scale
KW  - intensive care unit
KW  - asthma
KW  - Hospital Anxiety and Depression Scale
T2  - Intensive Care Medicine
LA  - English
VL  - 39
IS  - SUPPL. 2
PB  - Springer Verlag
SN  - 0342-4642
AD  - M. Amsallem, Groupe Hospitalier Pitie-Salpetriere, APHP, Service de Reanimation Medicale, Paris, France
DO  - https://dx.doi.org/10.1007/s00134-013-3095-5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71446272
AB  - Introduction. Survivors of influenza A (H1N1)-associated acute respiratory distress syndrome (ARDS) treated with extracorporeal membrane oxygenation (ECMO) had psychological impairment and poor health-related quality of life (HR-QoL) 1 year after intensive care unit (ICU) discharge. No data exists on the persistence of these disabilities beyond 2 years. OBJECTIVES. To evaluate quality of life and psychological outcomes of survivors of influenza A (H1N1)-associated ARDS treated by ECMO 2 years after ICU discharge. METHODS. Thirteen survivors of influenza A (H1N1)-associated ARDS having required an ECMO and hospitalized in our ICU from October 2009 to February 2011 were evaluated in February 2013 during a phone-call interview. HR-QoL was evaluated using the SF-36 score, symptoms of posttraumatic stress disorder using the impact of event scale (IES) and anxiety and depression using the Hospital Anxiety and Depression (HAD) scale. HR-QoL was compared to the sex- and age- matched population. Patients were deemed at risk for post traumatic stress disorder (PTSD) if the IES score was above 30, and had signs of anxiety or depression when the corresponding HAD sub scores were above 10. Results are expressed as median [25-75th percentile]. RESULTS. At the time of influenza, patients were 39 years old [28-46], 7 (54 %) were women, 5 (38.5 %) were obese (BMI[30 kg/m2) and 3 (23 %) were pregnant. Two (15 %) had asthma, 3 (23 %) were smokers, and one had chronic respiratory insufficiency secondary to bronchopulmonary dysplasia. At ICU admission, median SAPS II was 59 [54-72] and PaO2/FIO2 ratio was 64 mmHg [52-114]. ECMO and MV duration were 25 days [10-51] and 34 days [15-75], respectively. Patients were evaluated 35 [23.8-40] months after ICU discharge. As compared to their weight after ICU discharge, they gained 8 kg [2.8-19.5 kg]. Only one patient was an actual smoker. Eight out of the 10 patients who previously worked have returned to work, and 7 patients practiced sport at the time of evaluation whereas only 2 did before influenza. Nine (69 %) had no dyspnea or dyspnea on moderate or strenuous exertion, 3 (23 %) had dyspnea when walking, and one (patient with previous chronic respiratory insufficiency) had dyspnea during minimal activity. Their mean SF-36 domains differed significantly from the normative values of the matched population, with lower physical functioning (p = 0.005), general health (p = 0.0003) and vitality scores (p = 0.05) whereas their mean physical and mental composite scores were not different (p values of 0.06 and 0.09, respectively). No patient was at risk of PTSD. Two patients (5 %) showed symptoms of both anxiety and depression, reported by themselves to social concerns. CONCLUSIONS. After 2 years, survivors of influenza A (H1N1)-associated ARDS having required an ECMO have no severe impairment in HR-QoL, and none are at risk of PSTD. However, 31 % have moderate-to-severe dyspnea. Lung function will be assessed more precisely in these patients.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71385578
TI  - 2013 Society for Pediatric Pathology Fall Meeting
AU  - Anonymous.
Y1  - 2013//
KW  - *pathology
KW  - *society
KW  - human
KW  - diagnosis
KW  - lung dysplasia
KW  - seizure
KW  - diagnostic value
KW  - Hirschsprung disease
KW  - gene
KW  - nerve
KW  - rectum biopsy
KW  - patient
KW  - Down syndrome
KW  - gene rearrangement
KW  - spindle cell
KW  - neoplasm
KW  - umbilical artery
KW  - fasciitis
KW  - neuroblastoma
KW  - mitosis
KW  - child
KW  - oncology
KW  - lung
KW  - lung development
KW  - suction
KW  - thyroid gland
KW  - fine needle aspiration biopsy
KW  - urine
KW  - cytomegalovirus infection
KW  - newborn
KW  - infant
KW  - placenta
KW  - Doppler flowmetry
KW  - three-dimensional imaging
KW  - calretinin
KW  - endostatin
T2  - Pediatric and Developmental Pathology
LA  - English
VL  - 16
IS  - 6
SP  -
PB  - Society for Pediatric Pathology
SN  - 1093-5266
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71385578
AB  - The proceedings contain 29 papers. The topics discussed include: histologic evidence of intrapulmonary anastomotic vessels by three-dimensional reconstruction in severe bronchopulmonary dysplasia; diagnostic yield of targeted panels of seizure genes; don't get misled by calretinin-immunoreactive mucosal nerves in suction rectal biopsies from patients with very short-segment hirschsprung disease; USP6 gene rearrangement in spindle cell neoplasms: a diagnostic tool for nodular fasciitis; age-dependent prognostic effect by mitosis-karyorrhexis index in neuroblastoma: a report from the children's oncology group; increased lung endostatin expression impairs perinatal lung development in down syndrome; applying the Bethesda system in pediatric thyroid fine-needle aspiration; evaluation of serial urine viral cultures for the diagnosis of cytomegalovirus infection in neonates and infants; and placenta findings in cases of absent or reversed end diastolic flow abnormality on umbilical artery Doppler ultrasound.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71385555
TI  - Increased lung endostatin expression impairs perinatal lung development in down syndrome
AU  - Galambos C.
AU  - Minic A.D.
AU  - Seedorf G.
AU  - Abman S.H.
Y1  - 2013//
KW  - *lung development
KW  - *Down syndrome
KW  - *society
KW  - *pathology
KW  - *lung
KW  - human
KW  - angiogenesis
KW  - newborn
KW  - lung hypoplasia
KW  - mouse
KW  - patient
KW  - architecture
KW  - infant
KW  - chromosome 21
KW  - gene
KW  - morbidity
KW  - Germany
KW  - pulmonary hypertension
KW  - tissues
KW  - exposure
KW  - pathogenesis
KW  - respiratory tract disease
KW  - lung disease
KW  - risk
KW  - histology
KW  - lung dysplasia
KW  - density
KW  - *endostatin
KW  - messenger RNA
KW  - angiogenic factor
KW  - nonoxinol 9
T2  - Pediatric and Developmental Pathology
LA  - English
VL  - 16
IS  - 6
PB  - Society for Pediatric Pathology
SN  - 1093-5266
AD  - C. Galambos, University of Colorado, School of Medicine, Children's Hospital Colorado, Aurora, CO, United States
UR  - http://www.pedpath.org/doi/pdf/10.2350/13-09-1379-OA.1
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71385555
DO  - https://dx.doi.org/10.2350/13-09-1379-OA.1
AB  - Background: Newborns and infants with Down syndrome (DS) develop lung hypoplasia, which is characterized by abnormal lung architecture with decreased alveoli and vessel density. This impaired lung development frequently leads to respiratory disease, pulmonary hypertension, and significant long-term morbidity in DS. Genes for potent anti-angiogenic factors, including endostatin (ES), are present on the triplicated chromosome 21 and are likely overexpressed in DS patients. We have previously shown that disruption of angiogenesis during critical periods of lung development impairs alveolarization in newborns with bronchopulmonary dysplasia (BPD) and that the histology of BPD and DS lungs shares common features of disrupted lung growth. Whether ES-driven impairment of angiogenesis during early development underlies the high risk for lung disease in DS has not been studied. We hypothesized that chromosome 21-driven lung ES overexpression has a previously unrecognized role in the pathogenesis of lung hypoplasia in newborns and infants with DS. More specifically, we hypothesize that (1) lungs of DS patients overexpress ES and (2) increased ES exposure disrupts normal lung development. Design(s): We used banked tissues of pre-and postnatal human DS lungs and age-matched controls to evaluate mRNA expression of ES, as well as major groups of angiogenic and anti-angiogenic genes (Human Angiogenesis RT2 ProfilerTM PCR Array, Qiagen PAHS-024Z, Hilden, Germany). Newborn mice were injected daily with ES for 7 days, and lung architecture using mean linear intercept (MLI) values were compared with controls. Result(s): We detected marked elevation of lung ES mRNA levels in the group containing both pre-(n 5 11) and postnatal (n 5 11) samples (P 5 0.002), as well as in the prenatal subgroup (P 5 0.0017). Lung sections of ES-treated mice showed fewer and larger and simplified distal alveoli, with an increase in MLI values (P 5 0.0364), indicating impaired alveolar development. Conclusion(s): Endostatin expression is significantly elevated in human prenatal DS lungs. Endostatin treatment significantly impairs normal alveolar growth in newborn mice. These results strongly suggest a key role of antiangiogenic signals, specifically those driven by ES, in the pathomechanism of DS-related lung hypoplasia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71366995
TI  - Indications, feasibility, and outcome of interventional closure of secundum-type atrial septal defect in children with a bodyweight less than 10 kg
AU  - Knirsch W.
AU  - Quandt D.
AU  - Kretschmar O.
Y1  - 2013//
KW  - *heart atrium septum defect
KW  - *child
KW  - *human
KW  - *society
KW  - *pediatric cardiology
KW  - patient
KW  - echocardiography
KW  - pulmonary hypertension
KW  - devices
KW  - failure to thrive
KW  - vein thrombosis
KW  - prematurity
KW  - fluoroscopy
KW  - procedures
KW  - infant
KW  - genetic disorder
KW  - lung dysplasia
KW  - bleeding
KW  - follow up
KW  - male
KW  - sildenafil
T2  - Thoracic and Cardiovascular Surgeon
LA  - English
VL  - 61
IS  - SUPPL. 2
SP  -
PB  - Georg Thieme Verlag
SN  - 0171-6425
AD  - W. Knirsch, Pediatric Cardiology, University Children's Hospital Zurich, Switzerland
DO  - https://dx.doi.org/10.1055/s-0033-1354510
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71366995
AB  - Aim: This study evaluated indications, feasibility, periprocedural complications, and outcome of interventional ASD closures in small children. Method(s): Retrospective analysis (2005 - 2012) of ASD closures in children less than 10 kg bodyweight. Result(s): In 25 children (13 male) 24 successful interventional secundum ASD device closures were performed at a median age of 1.2 years (0.2 - 2.8) and a bodyweight of median 7.5 kg (4.6 - 9.9). RV volume overload was present on echocardiography in 24 patients, resulting in an Qp/Qs of mean 1.7 (+/- 1). Clinically, nine (36%) patients presented with failure to thrive and eight (32%) were past preterm infants with bronchopulmonary dysplasia (BPD). In 12 patients a genetic syndrome (Trisomie 21 in nine patients, 36%) was present. In more than two-third of the patients (n= 18, 72%) pulmonary hypertension was suspected on echocardiography. Hemodynamic evaluation revealed baseline PVR of mean 3.8 WU (+/- 6.7) and mean PAP 25 mm Hg (+/- 10). ASD size was mean 8.1 mm (+/- 2.7) with a ratio of bodyweight/defect size of median 0.87. Mean femoral sheath size used was 7 Fr (+/- 1.5) and ASD closure devices of 10 mm (+/- 3 mm), procedure time 84 minutes (+/- 34), fluoroscopy time 13 minutes (+/- 7). Complications were prolonged femoral bleeding (n= 1) and femoral venous thrombosis (n= 1). Median follow-up was 0.5 years (0.1 - 6) showing complete closure of ASD with no residual shunt in all 24 patients. All patients showed regression of pulmonary hypertension measured by echocardiography, one patient still being treated with sildenafil. Conclusion(s): Interventional ASD closure in small children can be performed safely showing a favorable outcome with a slight device oversizing in defect sizes up to 8 mm and a ratio of bodyweight to defect size of 0.87. Indications for early closure are BPD, failure to thrive or suspected pulmonary hypertension on echocardiography.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71321284
TI  - The role of estrogen in cystic fibrosis
AU  - Zeitlin P.
Y1  - 2013//
KW  - *cystic fibrosis
KW  - female
KW  - human
KW  - asthma
KW  - airway
KW  - lung
KW  - male
KW  - menstrual cycle
KW  - puberty
KW  - gender
KW  - register
KW  - patient
KW  - pregnancy
KW  - menopause
KW  - chloride conductance
KW  - mucociliary clearance
KW  - adolescence
KW  - health
KW  - therapy
KW  - liquid
KW  - fetus
KW  - fluid retention
KW  - childhood
KW  - bacterium
KW  - boy
KW  - metabolite
KW  - follow up
KW  - inflammation
KW  - labor
KW  - lung function
KW  - fetus lung maturation
KW  - non profit organization
KW  - bacterial colonization
KW  - acceleration
KW  - blood
KW  - fetus development
KW  - extracellular fluid
KW  - bloating
KW  - intestine
KW  - survival
KW  - ovulation
KW  - follicular phase
KW  - menstruation
KW  - bronchus
KW  - systemic disease
KW  - gene expression
KW  - aged
KW  - girl
KW  - lifespan
KW  - third trimester pregnancy
KW  - organogenesis
KW  - lung dysplasia
KW  - microbiology
KW  - phenotype
KW  - in vitro study
KW  - uterus
KW  - tissues
KW  - side effect
KW  - United Kingdom
KW  - energy resource
KW  - respiratory distress syndrome
KW  - sex difference
KW  - Pseudomonas aeruginosa
KW  - learning
KW  - adolescent
KW  - modulation
KW  - physiology
KW  - thin layer chromatography
KW  - *estrogen
KW  - oral contraceptive agent
KW  - sex hormone
KW  - progesterone
KW  - estradiol
KW  - calcium
KW  - hormone
KW  - surfactant
KW  - estriol
KW  - corticosteroid
KW  - tamoxifen
KW  - chloride channel
KW  - steroid
KW  - ion
KW  - bicarbonate
KW  - alginic acid
KW  - carbon
KW  - antibiotic agent
KW  - uridine triphosphate
T2  - Pediatric Pulmonology
LA  - English
VL  - 48
IS  - SUPPL. 36
PB  - Wiley-Liss Inc.
SN  - 8755-6863
AD  - P. Zeitlin, Pediatrics, Johns Hopkins Univ., School of Medicine, Baltimore, MD, United States
DO  - https://dx.doi.org/10.1002/ppul.22896
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71321284
AB  - Learning Objectives: 1. Recognize the gender gap in CF: namely that women suffer lower median survival, lower FEV1, and earlier bacterial colonization rates. 2. Review the emerging data linking inflammation and microbiology to 17beta-estradiol (E2). 3. Discuss the implications for therapeutics in CF. Estrogen in Health and Disease: Clinically appreciable female disadvantages in CF appear beginning at puberty when E2 levels in blood begin to rise. Registry data from more than 10 years ago supported the clinical impression that disparities in outcomes could be related to gender and adherence disparities. Recently, epidemiologic data in the US Cystic Fibrosis Foundation Registry linked the rate of pulmonary exacerbations to gender, although FEV1 remained no different, perhaps reflecting the gains made by advances in therapeutic regimens and guidelines (1). Sex hormones influence organ development (structure) and function in health and disease. Inherent gender differences in lung anatomy and physiology have significant impact at specific times in the lifespan such as puberty, pregnancy, menopause, and the elderly. At times, sex hormones can be beneficial to the lungs and at other times, they may be detrimental. Applying this general knowledge to a complex systemic disease like cystic fibrosis is challenging. The lung undergoes the greatest differentiation and development in utero, but continues to modify the alveolar regions for the first few years of life and increase in size and complexity into adolescence (2). Female fetuses have fewer bronchi and earlier appearance of surfactant than male fetuses. Maternal steroids can impact fetal development and it is well recognized that acceleration of lung maturation can be induced during pre-term labor by antenatal maternal corticosteroids (3). Premature male infants are more susceptible to respiratory distress syndrome and bronchopulmonary dysplasia, thought to be related to the decreased surfactant production and larger lung size. These structural differences translate to a lower specific airways resistance and higher FEF in females than males in childhood. During adolescence and puberty, lung growth translates in increases in FVC and TLC for both genders. During the third trimester of pregnancy, the TLC and FRC decrease. Asthma affects more boys than girls in childhood until puberty, when women overtake men (2). The cyclical variation in circulating sex steroid levels influences asthma symptoms and as many as 40% of women with asthma will experience pre-menstrual asthma, typically during the downswing in estrogen levels. Use of oral contraceptives that suppress fluctuations in hormones seems to relieve pre-menstrual asthma. Asthma tends to decrease around the age of menopause. Estrogen and CF: Estrogen has been known to affect the gene expression of multiple ion transporters (4). Importantly the observations have been female-specific. Higher circulating E2 levels adversely affect the calcium-activated chloride conductance pathways in CF and non-CF airways in vivo (5). This might be at least partially offset in F508del CF by the E2 mediated rescue of F508del (6). The target for E2 in the latter paper was Nherf1. During menses E2 levels fall to about 0.1 nM, then increase through the follicular phase and peak several days before ovulation. Coakley, et al demonstrated the target for E2 related to non-CFTR channels to be UTP-stimulated calcium activated chloride conductances which directly impact airway surface liquid depth (5). They predict that airway mucociliary clearance will be compromised for one week out of every four of the menstrual cycle in CF where patients lack functional CFTR chloride channels. Anecdotal complaints of female patients do not exactly coincide with the predicted week of the cycle, likely due to the multiple pathways impacted by E2. Estrogen promotes fluid retention by being pro-absorptive and anti-secretory in the intestines which leads to bloating, particularly when used during assisted reproduction. Extracellular fluid retention is highest mid-menstrual cycle and on oral contraceptives. Progesterone rises as E2 falls during the menstrual cycle. Progesterone did not affect airway surface liquid in the Coakley study (5). However, progesterone can antagonize estrogen-mediated increases in CFTR and the sodium bicarbonate exchanger in vitro in uterine tissues (7). Estrogen-targeted therapy might consist of anti-estrogenic compounds like tamoxifen. However side effects likely outweigh potential benefits. Oral contraceptives are associated with an estrogen state and would be predicted to worsen airway mucociliary clearance. Yet, in a study of 681 women with CF in the UK, use of oral contraceptives was not associated with impairment of lung function or BMI in over 5 years of follow-up (8). CF and Host/Pathogen Interactions: Sex steroids are metabolized or utilized in signaling by some bacteria. Bacteria have developed mechanisms to circumvent the effects of these hormones or to utilize them as carbon and energy sources. Estradiol and its metabolite estriol induce alginate production in a lab strain of Pseudomonas aeruginosa and promote acquisition of the mucoidy phenotype. Using registry data, the authors observed a reduced need for antibiotics if the patient was on oral contraceptives (9). Implications: Early identification of those adolescents and women with CF who experience worsening of symptoms during the menstrual cycle may enable therapeutic modulation of E2 levels.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Hyperoxia-induced methylation decreases RUNX3 in a newborn rat model of bronchopulmonary dysplasia.
DO  - https://dx.doi.org/10.1186/s12931-015-0239-x
AU  - Zhu, Yuting
AU  - Fu, Jianhua
AU  - Yang, Haiping
AU  - Pan, Yuqing
AU  - Yao, Li
AU  - Xue, Xindong
Y1  - 2015//
Y2  - 20150624//
KW  - Animals
KW  - Animals, Newborn
KW  - *Bronchopulmonary Dysplasia/me [Metabolism]
KW  - Bronchopulmonary Dysplasia/pa [Pathology]
KW  - Core Binding Factor Alpha 3 Subunit/ai [Antagonists & Inhibitors]
KW  - *Core Binding Factor Alpha 3 Subunit/bi [Biosynthesis]
KW  - *DNA Methylation/ph [Physiology]
KW  - *Disease Models, Animal
KW  - *Hyperoxia/me [Metabolism]
KW  - Hyperoxia/pa [Pathology]
KW  - Rats
KW  - Rats, Sprague-Dawley
T2  - Respiratory research
VL  - 16
SN  - 1465-9921
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26104385
AD  - England
AB  - BACKGROUND: Bronchopulmonary dysplasia (BPD) in premature infants is a predominantly secondary occurrence to intrauterine inflammation/infection and postpartum mechanical ventilation; in recent years, an association with epigenetics has also been found. DNA methylation, catalyzed by DNA methyl transferases (DNMTs), and tri-methylation of lysine 27 on histone H3 (H3K27me3), mediated by the methyltransferase, Enhancer of Zeste Homolog 2 (EZH2), are some of the most commonly found modifications in epigenetics. Runt-related transcription factor 3 (RUNX3) is associated with pulmonary epithelial and vascular development and regulates expression at the post-transcriptional level by DNA methylation through DNMT1 or DNMT3b. However, the involvements of these epigenetic factors in the occurrence of BPD are, as yet, unclear., METHODS: Newborn rats were randomly assigned to a model, hyperoxia (85 % O2) or control, normoxia group (21 % O2). Lung tissues and alveolar type 2 (AT2) epithelial cells were collected between 1-14 days. The expression of DNMTs, and EZH2 was detected by immunohistochemistry, Western blot and real-time PCR. The percentage of DNA methylation and H3K27me3 levels in the RUNX3 promoter region was measured by bisulfite sequencing PCR and chromatin immunoprecipitation assay. RUNX3 protein and mRNA expression in AT2 cells was also measured after inhibition using the DNA methylation inhibitor, 5-Aza-2'-deoxycytidine, the H3K27me3 inhibitor, JMJD3, and the EZH2 inhibitor, DZNep., RESULTS: Compared with the control group, RUNX3 protein was downregulated and DNMT3b and EZH2 were highly expressed in lung tissues and AT2 cells of the model group (P < 0.05), while high DNA methylation and H3K27me3 modifications were present in the RUNX3 promoter region, in lung tissues of the model group (P < 0.05). Following hyperoxia in the model group, JMJD3 and DZNep significantly reversed the hyperoxia-induced down-regulation of RUNX3 expression in AT2 cells (P < 0.05), more so than 5-Aza-2'-deoxycytidine (P < 0.05)., CONCLUSIONS: 1) DNA methylation and H3K27 trimethylation are present in the BPD model; 2) RUNX3 down-regulation is attributed to both DNMT3b-catalyzed DNA methylation and EZH2-catalyzed histone methylation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71276956
TI  - Identification of txnip interacting proteins using BioID
AU  - Neuharth S.
AU  - Forred B.
AU  - Kim D.
AU  - Roux K.
AU  - Vitiello P.
Y1  - 2013//
KW  - *society
KW  - pathology
KW  - hyperglycemia
KW  - model
KW  - cell death
KW  - oxidation
KW  - heart ventricle hypertrophy
KW  - cell culture
KW  - lung dysplasia
KW  - mutation
KW  - transgene
KW  - diabetes mellitus
KW  - phenotype
KW  - *free radical
KW  - *protein
KW  - thioredoxin
KW  - glucose
KW  - thioredoxin interacting protein
KW  - cysteine
KW  - oxidoreductase
KW  - thiol
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 65
IS  - SUPPL. 2
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - S. Neuharth, Sanford Research, Sioux Falls, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2013.10.784
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71276956
AB  - Thioredoxins regulate the reduction-oxidation (redox) state of protein thiols through oxidoreductase activities of a highly conserved catalytic site capable of undergoing reversible oxidation. Redox regulation of dithiol/disulfide status is critical for numerous cell signaling processes, many of which are dependent on activities of the thioredoxin family. Thioredoxin interacting protein (Txnip) acts as a negative reuglator of thioredoxin function and is a critical modulator of several disease pathologies including beta-cell death during hyperglycemia, cardiac hypertrophy, and bronchopulmonary dysplasia, the molecular mechanisms underlying these processes are relatively unknown. the objective of these studies was to identify Txnip interacting proteins using a novel proximity-based labeling method known as BioID in an effort to understand molecular events underlying the aforementioned disease pathologies. HEK293 cells stably-transfected with the BioID transgene fused to Txnip were used to identify novel interacting proteins. Proteomic analysis of BioID lysates identified 50 interacting proteins and mutation of a redox-senstive cysteine (C247S) in Txnip disrupted several interactions. Furthermore, we demonstrate that this cell model can be used to identify dynamic Txnip interactions due to known environmental regulators such as hyperglycemia. Differential proteomic studies were conducted in cells cultured under low (5.5 mM) and high (25 mM) glucose concentrations to model hyperglycemic pathologies consistent with beta-cell death during diabetic phenotypes. Continued studies will focus on understanding the biological relevance of the identified interactions to better understand cellular alterations resulting in disease pathologies.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71276726
TI  - Aurothioglucose improves alveolarization in a murine model of bronchopulmonary dysplasia
AU  - Tipple T.E.
AU  - Moyer S.
AU  - Pierce D.
AU  - Hill C.L.
AU  - Rogers L.K.
Y1  - 2013//
KW  - *murine model
KW  - *lung dysplasia
KW  - *society
KW  - mouse
KW  - body weight
KW  - lung development
KW  - newborn
KW  - gene
KW  - prematurity
KW  - lung
KW  - hyperoxia
KW  - lung injury
KW  - human
KW  - toxicity
KW  - infant
KW  - hypothesis
KW  - agonist
KW  - morbidity
KW  - protection
KW  - attenuation
KW  - fetus lung maturation
KW  - endothelium cell
KW  - injection
KW  - in vitro study
KW  - model
KW  - safety
KW  - adult
KW  - exposure
KW  - ambient air
KW  - *free radical
KW  - *aurothioglucose
KW  - sodium chloride
KW  - antioxidant
KW  - mitogenic agent
KW  - vasculotropin
KW  - nuclear factor
KW  - auranofin
KW  - thioredoxin reductase 1
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 65
IS  - SUPPL. 2
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - T.E. Tipple, Nationwide Children's Hospital, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2013.10.545
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71276726
AB  - In premature infants, O2 toxicity and antioxidant deficiencies contribute to the development of bronchopulmonary dysplasia (BPD). Aurothioglucose (ATG) and auranofin (AFN) potently inhibit thioredoxin (Trx) reductase-1 (TrxR1). We have previously shown that ATG safely and effectively prevents hyperoxic lung injury in adult mice, likely via nuclear factor E2-related factor 2 (Nrf2) activation. in newborn mice, Nrf2 regulates lung maturation and protection from O2 toxicity suggesting that Nrf2 agonists might prevent BPD. the present studies tested the hypothesis that ATG would attenuate hyperoxia-induced lung developmental deficits in a newborn murine model of BPD. to test our hypothesis, newborn C3H/HeN mice were treated with a single i.p. dose of 25 mg/kg ATG or saline within 12 h of birth and were exposed in either room air (RA) or 85% hyperoxia (O2) for up to 14 d. Morphometric analyses at 14 d revealed that hyperoxic exposure arrested normal lung development. ATG treatment significantly attenuated O2-induced increases in alveolar area and decreases in alveolar number. Lung development was not different between ATG-treated and saline-treated mice raised in RA. Body weights in saline-treated O2-exposed mice were significantly lower at 7 d and 14 d than in RA controls while ATG treatment significantly attenuated O2-induced decreases in body weight. to determine the impact of TrxR1 inhibition on Nrf2 activation in vitro, murine alveolar epithelial (MLE-12) cells were treated with 1 uM AFN for 1 h. AFN treatment decreased TrxR1 activities by 90% compared to saline-treated controls. qRT-PCR analyses of AFN-treated cells revealed that transcription of Nrf2-driven genes GCLM, HO-1, NQ01, and TrxR1 was significantly increased as was transcription of vascular endothelial growth factor (VEGF), an endothelial cell mitogen that is significantly decreased in BPD. Our novel preliminary data indicate that a single ATG injection at birth attenuates O2-induced alterations in alveolar development in newborn mice. Furthermore, ATG treatment was well tolerated as evidenced by normal lung growth in RA-exposed controls and attenuation of O2-induced decreases body weight in saline-treated mice. Induction of Nrf2 target genes by AFN treatment in MLE-12 cells support a working model in which the protective effects of TrxR1 inhibitors are Nrf2-dependent. Future studies will determine the safety and efficacy of TrxR1 inhibition as a novel approach to attenuate O2-mediated neonatal lung injury and arrested lung development, a significant and costly cause of morbidity in preterm infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71276724
TI  - Hyperoxia interacts with circadian rhythm to worsen neonatal lung injury
AU  - Sengupta S.
AU  - Yang G.
AU  - Sadreameli A.
AU  - Go H.
AU  - Dennery P.A.
Y1  - 2013//
KW  - *hyperoxia
KW  - *circadian rhythm
KW  - *lung injury
KW  - *society
KW  - lung
KW  - gene
KW  - gene expression
KW  - newborn
KW  - mouse
KW  - density
KW  - regulator gene
KW  - human
KW  - in vitro study
KW  - lung function
KW  - lung development
KW  - lung dysplasia
KW  - architecture
KW  - thickness
KW  - histology
KW  - prematurity
KW  - exposure
KW  - ambient air
KW  - lung blood vessel
KW  - injury
KW  - light dark cycle
KW  - *free radical
KW  - oxygen
KW  - antioxidant
KW  - cigarette smoke
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 65
IS  - SUPPL. 2
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - S. Sengupta, Children's Hospital of Philadelphia, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2013.10.543
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71276724
AB  - Background: Bronchopulmonary dysplasia is a disease of lung development seen in premature neonates exposed to high concentration of oxygen. It is characterized by alveolar oversimplification and vascular dysgenesis. Others have shown that cigarette smoke alters lung circadian rhythm and affects lung function. Previously, we have shown that hyperoxia regulates circadian gene expression in vitro. However, the role of circadian genes in the developing lung in response to stressors such as hyperoxia is not clear. Objective(s): Given its roles in integrating various antioxidant and cell homoestasis, we hypothesized that the expression of the key circadian genes, Rev-erbalpha, Bmal and Per1, is regulated by hyperoxia in neonatal mice and that disrupted circadian rhythm may exacerbate hyperoxic lung injury. Design/Methods: Newborn (<12 hours old) C57Bl/6 mice pups were exposed to any of the following groups: >95% oxygen (O2) + CL (constant light); >95% O2 + 12hr light-dark (LD) cycles; RA (Room Air) + CL; RA + 12h LD cycle for 0-72 hrs. The lungs were removed at the end of exposure (day 3) or after recovery in RA/12h LD on day14. Gene expression of circadian genes as well as other downstream targets (p21, cmyc, PGC1alpha, OGG1) and lung histology was studied. Result(s): Expression of circadian genes especially Rev-erba and BMAL as well as downstream targets such as p21 and PGC1alpha were significantly altered by the combined effect of hyperoxia and constant light on day 3. Radial alveolar count and vessel density were reduced and medial wall thickness was increased in this group, most pronounced by day 14 (p<0.05). Conclusion(s): in the neonatal lung, hyperoxia disrupts circadian gene expression and interacts with circadian dysregulation to distort alveolar architecture and reduce pulmonary vessel density. Circadian regulation may be an avenue for modulating hyperoxic injury and repair in neonates.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71198624
TI  - Amniocentesis in preterm labor between 24-29 weeks' gestation and neonatal/infant outcomes
AU  - Meints L.
AU  - Harrison R.
AU  - Albayrak S.
AU  - Chelliah A.
AU  - Kruger M.
AU  - Bahado-Singh R.
Y1  - 2013//
KW  - *amniocentesis
KW  - *premature labor
KW  - *pregnancy
KW  - *society
KW  - *gynecological examination
KW  - maternal age
KW  - female
KW  - newborn morbidity
KW  - risk
KW  - death
KW  - child death
KW  - newborn death
KW  - birth weight
KW  - population
KW  - diseases
KW  - prevention
KW  - mortality
KW  - diabetes mellitus
KW  - disease control
KW  - anemia
KW  - newborn
KW  - air conditioning
KW  - hyaline membrane disease
KW  - congenital malformation
KW  - fever
KW  - national health organization
KW  - patient
KW  - human
KW  - study design
T2  - Reproductive Sciences
LA  - English
VL  - 20
IS  - 3 SUPPL. 1
PB  - SAGE Publications Inc.
SN  - 1933-7191
AD  - L. Meints, Obstetrics and Gynecology, Wayne State University, Detroit, MI, United States
DO  - https://dx.doi.org/10.1177/1933719113482088
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71198624
AB  - Objective: To ascertain the rate of utilization of amniocentesis (AC) in preterm labor (PTL) in the US and the association with pediatric outcomes including mortality rates. Study Design: Data from the National Center for Health Statistics at the Centers for Disease Control and Prevention were analyzed from the years 2004 to 2006. Nineteen states, representing 49% of the population, reported data. There were a total of 8,405,654 births. Analysis was limited to singleton cases between 24-29 weeks with documented preterm labor. Maternal age >= 35 years and congenital anomaly cases were excluded to minimize the chances that AC was performed for genetic reasons. Only cases reporting whether or not AC was performed were included. The frequency of AC overall and in different GA groups was determined, as was the correlation between AC and different maternal and newborn outcomes. Odds Ratios (OR) were calculated and then adjusted for GA at delivery, maternal race and age, diabetes and hypertensive disorders; the non-AC served as the reference group. Result(s): There were 19,909 eligible PTL cases of which 273 (1.4%) underwent AC. There was no difference in mean birth weight (p=0.20), mean maternal age (p=0.06), or race (0.83) in cases with and without AC. The rate of AC utilization did not vary with GA. No differences were found in early onset neonatal morbidities such as hyaline membrane disease, ventilation, anemia, fever. AC was associated with a higher adjusted OR for death at less than 7 days of life (2.16, 95% CI 1.60, 2.90), neonatal death (2.07, 95% CI 1.54, 2.77), and infant death (2.24, 95% CI 1.71, 2.94). Conclusion(s): These data suggest low rates of AC utilization in potentially eligible patients with PTL. There were no significant differences in maternal age or race for rates of AC utilization or in neonatal morbidities. However, death at less than 7 days of life, neonatal death, and infant death were positively associated with AC, possibly suggesting increased utilization of AC in pregnancies at the highest risk.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71156904
TI  - The role of the type III transforming growth factor-beta receptor Tgfbr3 in the regulation of pulmonary vascular development
AU  - Niess G.
AU  - Wygowski J.
AU  - Seeger W.
AU  - Morty R.E.
Y1  - 2013//
KW  - smooth muscle fiber
KW  - vascular smooth muscle
KW  - lung blood vessel
KW  - mouse
KW  - lung
KW  - lung dysplasia
KW  - lung hypoplasia
KW  - hyperoxia
KW  - smooth muscle
KW  - artery muscle
KW  - laser microdissection
KW  - patient
KW  - model
KW  - muscle tissue
KW  - pulmonary artery
KW  - human
KW  - assay
KW  - apoptosis
KW  - cell function
KW  - growth, development and aging
KW  - *transforming growth factor
KW  - *receptor
KW  - messenger RNA
KW  - protein
KW  - 4 [4 (1,3 benzodioxol 5 yl) 5 (2 pyridinyl) 1h imidazol 2 yl]benzamide
T2  - FASEB Journal
LA  - English
VL  - 27
IS  - Meeting Abstracts
SP  -
PB  - FASEB
SN  - 1530-6860
AD  - G. Niess, Lung Development and Remodelling, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany
UR  - http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1141.2?sid=bad8356c-dbca-4580-be1d-65c179857d46
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71156904
AB  - Bronchopulmonary dysplasia (BPD) is associated with poor alveolar and vascular development. The molecular basis of this is not well understood. Expression studies in the lung of hyperoxia (85% O2) treated mice, a model of BPD, have revealed that the protein level of the type III TGF-beta receptor (Tgfbr3) is reduced by 4-fold. Laser microdissection confirmed downregulated expression (mRNA level) of tgfbr3 in the pulmonary vasculature of the developing mouse lung. Immunohistochemical studies suggested that the changes in TGF-beta receptor expression were largely confined to the pulmonary vascular smooth muscle, suggesting a possible role for these receptors in the smooth muscle tissue in the development of BPD. Knockdown of TGFBR3 in primary pulmonary artery smooth muscle cells (PASMC) increased proliferation by 2-fold, in a TGF-beta-independent manner (observed in the presence of the TGF-beta pathway inhibitor SB431542). Migration of PASMC assessed by Boyden Assay was increased 4-fold. However, apoptosis of PASMC was not affected by the knockdown of TGFBR3. Taken together, these data suggest a role for TGFBR3 in vascular smooth muscle cell function which could lead to a dysregulation of TGF-beta signalling in the pulmonary vasculature which in turn could contribute to the impaired pulmonary vascular growth and development associated with the lung hypoplasia observed in patients with BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71121188
TI  - Antenatal glucocorticoids counteract LPS-induced changes in TGF-beta signalling pathway in fetal lung
AU  - Kunzmann S.
AU  - Collins J.
AU  - Kuypers E.
AU  - Newnham J.
AU  - Kallapur S.
AU  - Jobe A.
AU  - Speer C.
AU  - Kramer B.
Y1  - 2013//
KW  - *fetus lung
KW  - exposure
KW  - inflammation
KW  - phosphorylation
KW  - fetus
KW  - lung dysplasia
KW  - injection
KW  - lung development
KW  - Western blotting
KW  - immunohistochemistry
KW  - down regulation
KW  - etiology
KW  - uterus
KW  - enzyme linked immunosorbent assay
KW  - *glucocorticoid
KW  - lipopolysaccharide
KW  - protein
KW  - connective tissue growth factor
KW  - messenger RNA
KW  - transforming growth factor
KW  - betamethasone
KW  - sodium chloride
KW  - caveolin 1
T2  - Monatsschrift fur Kinderheilkunde
LA  - English
VL  - 161
IS  - SUPPL. 1
PB  - Springer Verlag
SN  - 0026-9298
AD  - S. Kunzmann, Universitats-Kinderklinik, Neonatologie, Wurzburg, Germany
DO  - https://dx.doi.org/10.1007/ s00112-013-2932-5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71121188
AB  - Background. Inflammation and antenatal glucocorticoids affect lung development and may contribute to the development of bronchopulmonary dysplasia (BPD). Transforming growth factor-beta (TGF-beta), its activated Smad signalling pathway and its downstream mediators, like connective tissue growth factor (CTGF) and Caveolin-1 (Cav-1), are implicated in the etiology of BPD. The effects of the combined exposures on inflammation and antenatal glucocorticoids on these members of TGF-beta family are unknown. Therefore we asked whether glucocorticoids altered intra-amniotic lipopolysaccharide (LPS) effects on TGF-beta expression, its signaling molecule pSmad2, and CTGF and Cav-1 expression. Methods. Ovine singleton fetuses were randomized to receive either an intra-amniotic injection of LPS and/or maternal betamethasone (BTM) intra-muscularly 7 and/or 14 days prior to delivery at 120 days GA (term = 150 days GA). Saline was used for controls. Protein levels of TGF-beta1 and 2 were measured by ELISA. Smad2 phosphorylation was assessed by immuno-histochemistry. CTGF and Cav-1 mRNA and protein levels were determined by RT-PCR and Western blot. Results. Free TGF-beta1 and -2 and total TGF-beta1 levels were unchanged after LPS and/or BTM exposure, although total TGF-beta2 increased in animals exposed to BTM 7 days before LPS. Smad2 phosphorylation increased 7 days after LPS exposure. Similarly, CTGF mRNA and protein levels increased 7 days after LPS exposure as Cav-1 mRNA and protein levels decreased. BTM exposure prior to LPS prevented Smad2 phosphorylation, CTGF induction and Cav-1 down-regulation. Conclusion. This study demonstrated that the intra-uterine inflammation induced TGF-beta signaling can be inhibited by antenatal glucocorticoids in fetal lungs, which may influence the development of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71121187
TI  - Bronchopulmonary dysplasia (BPD) in a double-hit mouse model induced by intrauterine hypoxia and postnatal hyperoxia: Are human cord blood mononuclear cells (UCB-MNCs) a therapeutic option?
AU  - Tutdibi E.
AU  - Monz D.
AU  - Mildau C.
AU  - Shen J.
AU  - Kasoha M.
AU  - Laschke M.
AU  - Roolfs T.
AU  - Schmiedl A.
AU  - Meier C.
AU  - Tschernig T.
AU  - Gortner L.
Y1  - 2013//
KW  - *human
KW  - *lung dysplasia
KW  - *mouse
KW  - *animal model
KW  - *fetus hypoxia
KW  - *hyperoxia
KW  - *umbilical cord blood
KW  - *mononuclear cell
KW  - lung
KW  - therapy
KW  - brain weight
KW  - newborn
KW  - experimental model
KW  - prematurity
KW  - prevention
KW  - stem cell
KW  - prenatal growth
KW  - fetus lung maturity
KW  - thickness
KW  - down regulation
KW  - fetus lung maturation
KW  - neonatology
KW  - gene
KW  - mortality
KW  - lung parenchyma
KW  - single drug dose
KW  - hypoxia
KW  - control group
KW  - Germany
KW  - cell count
KW  - river
KW  - allotransplantation
KW  - clinical feature
KW  - model
KW  - inflammation
KW  - transplantation
KW  - body weight
KW  - architecture
KW  - gene expression
KW  - pathogenesis
KW  - diseases
KW  - adverse drug reaction
KW  - safety
KW  - marker
T2  - Monatsschrift fur Kinderheilkunde
LA  - English
VL  - 161
IS  - SUPPL. 1
PB  - Springer Verlag
SN  - 0026-9298
AD  - E. Tutdibi, Unversitatskliniken fur Kinder und Jugendmedizin, Klinik fur Neonatologie und Allg. Padiatrie, Homburg, Germany
DO  - https://dx.doi.org/10.1007/ s00112-013-2932-5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71121187
AB  - Background. BPD remains a major threat of very preterm neonates especially with intrauterine growth restriction and treatment options still are limited. Stem cell-based regenerative therapy offers an innovative option in the prevention and treatment of BPD but is controversial in neonatology. Aim. As an adequate experimental model of BPD in small animals for evaluation of novel therapies is still lacking, the goal of the present study was to develop a perinatal double-hit model of BPD in neonatal mice, which is close to clinical features in humans. It was aimed to test whether allogenic transplantation of human UCB-MNCs improves experimental BPD in mice. Methods. In the experimental setting date-mated pregnant mice (C57BL/6, Charles River, Sulzfeld, Germany) were randomly assigned to a control group (normoxia) or to a double-hit group: prenatal hypoxia (FiO2 0.1) from gestational day E14 until spontaneous delivery and postnatal hyperoxia (FiO2 0.75) from postnatal day P1 to P14. At day P7 double-hit pups were randomly allocated to receive intraperitoneally a single dose of UCB-MNCs with median cell numbers of 2x105. At day P14 pups were sacrificed and lung tissues were immediately excised for further histological and molecular analyses. Results. In double-hit exposed neonatal mice the development of body, lung and brain weight was retarded and pups showed a less morphological lung maturity by day P14 compared with normoxic controls. Histomormphometric analysis revealed reduced alveolarization and increased septal thickness without pronounced inflammatory lesions. A down-regulation of transcriptional markers of lung maturation Sftpb, Sftpc and Mtor genes was observed in double-hit animals compared with controls. Transplantation of human UCB-MNCs did not lead to adverse events; mortality was in the same range as for untreated animals. Furthermore there was tendency to increased body weight, lung and brain weight in the treated animals in comparison to the controls. Pulmonary architecture was slightly improved in treated animals and showed increased Mtor gene expression. Conclusion. We established a new experimental model of BPD mimicking closely the pathogenesis in human preterm neonates using pre- and postnatal hits as a basis for research on restoration of normal lung growth. Our study results demonstrate that UCB-MNC therapy of BPD in a double-hit rodent model was efficient by reducing the severity of the disorder without adverse effects. It thus might be considered as a translational option, given further studies will improve efficacy without loss in safety.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71115371
TI  - The relation between vitamin D binding protein single nucleotid polymorphisms and bronchopulmonary dysplasia or related diseases
AU  - Serce O.
AU  - Karatekin G.
AU  - Koksal V.
AU  - Benzer D.
AU  - Gursoy T.
AU  - Ovali F.
Y1  - 2013//
KW  - *lung dysplasia
KW  - *perinatal care
KW  - *diseases
KW  - *single nucleotide polymorphism
KW  - sepsis
KW  - risk factor
KW  - tissue injury
KW  - antiangiogenic activity
KW  - human
KW  - patient
KW  - genetic susceptibility
KW  - DNA sequence
KW  - patent ductus arteriosus
KW  - classification
KW  - angiogenesis
KW  - newborn
KW  - very low birth weight
KW  - infection
KW  - inflammation
KW  - respiratory distress syndrome
KW  - gene
KW  - tumor cell
KW  - pathology
KW  - *vitamin D binding protein
KW  - oxygen
KW  - sobetirome
KW  - fatty acid
KW  - actin
KW  - vitamin D
KW  - DNA
T2  - Journal of Perinatal Medicine
LA  - English
VL  - 41
IS  - SUPPL. 1
SP  -
PB  - Walter de Gruyter GmbH and Co. KG
SN  - 0300-5577
AD  - O. Serce, Zeynep Kamil Maternity and Child Health Education and Training Hospital, Neonatology Unit, Istanbul, Turkey
DO  - https://dx.doi.org/10.1515/jpm-2013-2003
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71115371
AB  - Introduction/Background: Vitamin D binding protein (VDBP) has anti-inflammatory, immunmodulatory functions, actin cleavage at tissue damage, binding to mono/polyunsaturied fatty acids and anti-angiogenesis on tumor cells together with vitamin D or alone. The main pathophysiologies of the bronchopulmonary dysplasia (BPD) are inflammation, infection, tissue damage, defects on angiogenesis, and genetic susceptibility. Since VDBP may affect these factors, we aimed to investigate the relationship between VDBP polymorphisms and BPD or BPD related diseases. Patients, Methods: PCR DNA sequence analysis were used for GC gene p.T436K (T420K, rs4588) and p.D432E (D416E, rs7041) single nucleotide polymorphisms (SNP) in 160 very low birth weight neonates (= 32 GWs, = 1500 g) who were hospitalised between July 2010 - 2011. Bancalari classification was used to define BPD. Result(s): Although oxygen dependent ?28 days group had less Gc 2 (35%-54%, p:0.020) and Gc1s-2 (19.2%-35.6%, p:0.021), and more Gc1s-1s (42.5%-25.3%, p:0.021); oxygen dependent group at 36 weeks PMA had less Gc1s-2 (13.5%-32.5%, p:0.024) than oxygen free group. Gc1S were more common in patent ductus arteriosus (PDA) group compared with non-PDA group (83.3%-67%, p:0.035). These SNP's had no relationship with respiratory distress syndrome and early onset culture proven sepsis. Gc 1S (88%-68.9%, p: 0.051) were more common in the late onset culture proven sepsis. Conclusion(s): Gc 2 allel was protective against oxygen dependency at 28th postnatal day. Although Gc1s-1s diplotype was risk factor for BPD, Gc1s-2 was protective against oxygen dependency at 28th postnatal day and 36 weeks PMA. Gc 1S was risk factor for PDA. Gc 1F was not releated with all these pathologies.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71115217
TI  - Protective effect of enteral lipid and protein intake against bronchopulmonary dysplasia in the very low birth weight preterm infant
AU  - Uberos J.
AU  - Molina-Oya M.
AU  - Lardon M.
AU  - Rodriguez-Belmonte R.
AU  - Sevilla-Perez B.
AU  - Jerez-Calero A.
AU  - Molina-Carballo A.
AU  - Munoz-Hoyos A.
Y1  - 2013//
KW  - *protein intake
KW  - *lung dysplasia
KW  - *very low birth weight
KW  - *infant
KW  - *human
KW  - *prematurity
KW  - *perinatal care
KW  - calorie
KW  - caloric intake
KW  - oxygen therapy
KW  - infection
KW  - concurrent infection
KW  - immaturity
KW  - gestational age
KW  - nutrition
KW  - inflammation
KW  - growth curve
KW  - malnutrition
KW  - lung
KW  - cohort analysis
KW  - survival
KW  - fat intake
KW  - caloric restriction
KW  - nutritional parameters
KW  - liquid
KW  - weight
KW  - logistic regression analysis
KW  - artificial ventilation
KW  - animal model
KW  - positive end expiratory pressure
KW  - experimental animal
KW  - *lipid
KW  - protein
KW  - carbohydrate
KW  - ferrous gluconate
T2  - Journal of Perinatal Medicine
LA  - English
VL  - 41
IS  - SUPPL. 1
SP  -
PB  - Walter de Gruyter GmbH and Co. KG
SN  - 0300-5577
AD  - J. Uberos, NICU. Departamento de Pediatria, Hospital Clinico San Cecilio, Universidad de Granada, Spain
DO  - https://dx.doi.org/10.1515/jpm-2013-2003
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71115217
AB  - INTRODUCTION The increased survival of extreme preterm infants has shifted the framework of bronchopulmonary dysplasia (BPD), typically related to oxygen therapy, toward another condition that has been termed 'new BPD', which in these infants is more closely related to lung immaturity and impaired alveolarization. Other factors such as nutrition or concomitant infections play an important role in the development of new BPD. Besides the prenatal inflammation that is facilitated by some infections, some authors consider malnutrition to be a factor favouring BDP. In an experimental animal model, caloric restriction has been shown to reduce the number of alveoli and the effective alveolar surface area {12055}. The aim of this study is to analyse the contribution of enteral and parenteral protein and lipid intake during the first 14 days of life to the development of BPD. MATERIAL AND METHOD A retrospective cohort study was conducted between 1 January 2007 and 31 December 2012 in infants weighing less than 1500 g and/or born before 32 weeks' gestational age. The nutritional parameters examined included the cumulative consumption of liquids, proteins, calories and carbohydrates in the first 14 days of life. The infants' weights were recorded at birth and on days 7 and 14 of postnatal life. The Z score was calculated at each time, in accordance with the Fenton growth charts. Also recorded were the days of oxygen therapy, mechanical ventilation and continuous positive airway pressure. BPD was defined according to the criteria of Jobe and Bancalari. RESULTS The total protein intake did not differ significantly between the groups; the average contribution in this respect was 36.5+/-9.2 g/Kg, lower than the recommended value. During the first 14 days of life, the infants with BPD received a lower intake of enteral protein than did those without BPD. Multinomial logistic regression analysis indicated that the amount of protein administered parenterally in the first 14 days of life was not associated with BPD (2 = 4.02, df = 3, p = 0.25). However, the proteins and fats supplied enterally were associated with a protective effect against the development of severe BPD (OR=0.65, 95%CI: 0.43-0.98 and OR=0.73, 95%CI: 0.58-0.91 respectively). CONCLUSIONS We observed a protective effect of enteral protein and caloric intake against the onset of BPD. There was no association between parenteral protein and caloric intake and BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71115216
TI  - Protective effect of enteral caloric intake against bronchopulmonary dysplasia in the very low birth weight preterm infant
AU  - Molina-Oya M.
AU  - Uberos J.
AU  - Lardon M.
AU  - Romero-Garcia R.
AU  - Machado-Casas I.
AU  - Ruiz-Lopez A.
AU  - Molina-Carballo A.
AU  - Narbona-Lopez E.
Y1  - 2013//
KW  - *caloric intake
KW  - *lung dysplasia
KW  - *very low birth weight
KW  - *infant
KW  - *human
KW  - *prematurity
KW  - *perinatal care
KW  - calorie
KW  - oxygen therapy
KW  - cohort analysis
KW  - newborn intensive care
KW  - concurrent infection
KW  - nutrition
KW  - positive end expiratory pressure
KW  - intensive care unit
KW  - hospital
KW  - capillary
KW  - artificial ventilation
KW  - growth curve
KW  - immaturity
KW  - weight
KW  - lung
KW  - liquid
KW  - nutritional parameters
KW  - gestational age
KW  - logistic regression analysis
KW  - death
KW  - prevalence
KW  - fluid intake
KW  - patient
KW  - survival
KW  - protein
KW  - ferrous gluconate
KW  - carbohydrate
T2  - Journal of Perinatal Medicine
LA  - English
VL  - 41
IS  - SUPPL. 1
SP  -
PB  - Walter de Gruyter GmbH and Co. KG
SN  - 0300-5577
AD  - M. Molina-Oya, UCIN. Departamento de Pediatria, Hospital Clinico San Cecilio, Universidad de Granada, Spain
DO  - https://dx.doi.org/10.1515/jpm-2013-2003
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71115216
AB  - INTRODUCTION The increased survival of extreme preterm infants has shifted the framework of bronchopulmonary dysplasia (BPD), typically related to oxygen therapy, toward another condition that has been termed 'new BPD', which in these infants is more closely related to lung immaturity, impaired alveolarization, dysmorphic capillary configuration and/or variable interstitial cellularity and fibroproliferation, and other factors such as nutrition or concomitant infections play an important role in its development. The aim of this study is to analyse the contribution of enteral and parenteral protein-caloric intake during the first 14 days of life to the development of BPD among very low birth weight preterm infants. MATERIAL AND METHOD A retrospective cohort study was conducted between 1 January 2007 and 31 December 2012 in infants weighing less than 1500 g and/or born before 32 weeks' gestational age. The nutritional parameters examined included the cumulative consumption of liquids, proteins, calories and carbohydrates in the first 14 days of life. The infants' weights were recorded at birth and on days 7 and 14 of postnatal life. The Z score was calculated at each time, in accordance with the Fenton growth charts. Also recorded were the days of oxygen therapy, mechanical ventilation and continuous positive airway pressure. BPD was defined according to the criteria of Jobe and Bancalari. RESULTS Our neonatal intensive care unit treated 185 very low birth weight infants, of whom 20 were excluded from analysis due to death or transfer to other hospitals. The prevalence of BPD in the period analysed was 38.4%. Total caloric intake was significantly lower in the infants with subsequent BPD. According to our results, the energy intake of the latter infants, during the first two weeks of life, was below recommended levels. Taken overall, parenteral caloric intake was not associated with BPD. Multinomial logistic regression indicates that for every increase of one KCal/Kg enteral intake in the first 14 days of life, the chance of developing mild, moderate or severe BPD is multiplied by an OR of 0.99, 0.99 and 0.98, respectively. In all, this reflects a slight protective effect against BPD. We observed no difference in total fluid intake between patients with and without subsequent BPD. CONCLUSIONS We observed a slight protective effect of enteral cacaloric intake against theonset of BPD, but no such effect concerning parenteral caloric intake.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2023 to 2024>
TI  - High-mobility group box-1 peptide ameliorates bronchopulmonary dysplasia by suppressing inflammation and fibrosis in a mouse model.
DO  - https://dx.doi.org/10.1016/j.bbrc.2023.06.032
AU  - Hara, Takeya
AU  - Shimbo, Takashi
AU  - Masuda, Tatsuo
AU  - Kitayama, Tomomi
AU  - Fujii, Makoto
AU  - Hanawa, Morifumi
AU  - Yokota, Kazuha
AU  - Endo, Masayuki
AU  - Tomimatsu, Takuji
AU  - Kimura, Tadashi
AU  - Tamai, Katsuto
Y1  - 2023//
Y2  - 20230609//
KW  - Animals
KW  - Humans
KW  - Mice
KW  - Infant, Newborn
KW  - Bronchopulmonary Dysplasia/dt [Drug Therapy]
KW  - Bronchopulmonary Dysplasia/ge [Genetics]
KW  - *Bronchopulmonary Dysplasia
KW  - Lung Injury/pa [Pathology]
KW  - *Lung Injury
KW  - HMGB1 Protein/me [Metabolism]
KW  - *HMGB1 Protein
KW  - Animals, Newborn
KW  - Lung/pa [Pathology]
KW  - Hyperoxia/pa [Pathology]
KW  - *Hyperoxia
KW  - Cytokines/ae [Adverse Effects]
KW  - Inflammation/dt [Drug Therapy]
KW  - Inflammation/pa [Pathology]
KW  - Disease Models, Animal
KW  - Fibrosis
T2  - Biochemical and biophysical research communications
VL  - 671
SN  - 0006-291X
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med24&NEWS=N&AN=37329659
AD  - United States
AB  - BACKGROUND: This study aimed to examine the effect of the HMGB1 peptide on Bronchopulmonary dysplasia (BPD)-related lung injury in a mouse model., RESULTS: HMGB1 peptide ameliorates lung injury by suppressing the release of inflammatory cytokines and decreasing soluble collagen levels in the lungs. Single-cell RNA sequencing showed that the peptide suppressed the hyperoxia-induced inflammatory signature in macrophages and the fibrotic signature in fibroblasts. These changes in the transcriptome were confirmed using protein assays., CONCLUSION: Systemic administration of HMGB1 peptide exerts anti-inflammatory and anti-fibrotic effects in a mouse model of BPD. This study provides a foundation for the development of new and effective therapies for BPD. Copyright Â© 2023 Elsevier Inc. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - rIL-10 enhances IL-10 signalling proteins in foetal alveolar type II cells exposed to hyperoxia.
DO  - https://dx.doi.org/10.1111/jcmm.12596
AU  - Lee, Hyeon-Soo
AU  - Lee, Dong Gun
Y1  - 2015//
Y2  - 20150608//
KW  - Alveolar Epithelial Cells/de [Drug Effects]
KW  - *Alveolar Epithelial Cells/me [Metabolism]
KW  - Animals
KW  - *Fetus/cy [Cytology]
KW  - Gene Expression Regulation/de [Drug Effects]
KW  - *Hyperoxia/me [Metabolism]
KW  - Interleukin-10/bi [Biosynthesis]
KW  - *Interleukin-10/me [Metabolism]
KW  - Interleukin-8/me [Metabolism]
KW  - Oxygen/pd [Pharmacology]
KW  - Rats, Sprague-Dawley
KW  - Receptors, Interleukin-10/ge [Genetics]
KW  - Receptors, Interleukin-10/me [Metabolism]
KW  - Recombinant Proteins/pd [Pharmacology]
KW  - Signal Transduction/de [Drug Effects]
KW  - *Signal Transduction
T2  - Journal of cellular and molecular medicine
VL  - 19
IS  - 7
SN  - 1582-1838
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26059905
AD  - England
AB  - Although the mechanisms by which hyperoxia promotes bronchopulmonary dysplasia are not fully defined, the inability to maintain optimal interleukin (IL)-10 levels in response to injury secondary to hyperoxia seems to play an important role. We previously defined that hyperoxia decreased IL-10 production and pre-treatment with recombinant IL-10 (rIL-10) protected these cells from injury. The objectives of these studies were to investigate the responses of IL-10 receptors (IL-10Rs) and IL-10 signalling proteins (IL-10SPs) in hyperoxic foetal alveolar type II cells (FATIICs) with and without rIL-10. FATIICs were isolated on embryonic day 19 and exposed to 65%-oxygen for 24 hrs. Cells in room air were used as controls. IL-10Rs protein and mRNA were analysed by ELISA and qRT-PCR, respectively. IL-10SPs were assessed by Western blot using phospho-specific antibodies. IL-10Rs protein and mRNA increased significantly in FATIICs during hyperoxia, but JAK1 and TYK2 phosphorylation showed the opposite pattern. To evaluate the impact of IL-8 (shown previously to be increased) and the role of IL-10Rs, IL-10SPs were reanalysed in IL-8-added normoxic cells and in the IL-10Rs' siRNA-treated hyperoxic cells. The IL-10Rs' siRNA-treated hyperoxic cells and IL-8-added normoxic cells showed the same pattern in IL10SPs with the hyproxic cells. And pre-treatment with rIL-10 prior to hyperoxia exposure increased phosphorylated IL-10SPs, compared to the rIL-10-untreated hyperoxic cells. These studies suggest that JAK1 and TYK2 were significantly suppressed during hyperoxia, where IL-8 may play a role, and rIL-10 may have an effect on reverting the suppressed JAK1 and TYK2 in FATIICs exposed to hyperoxia. Copyright Â© 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71111518
TI  - Gene encoding kit ligand is associated with bronchopulmonary dysplasia
AU  - Huusko J.M.
AU  - Mahlman M.
AU  - Karjalainen M.K.
AU  - Toldi G.
AU  - Szabo M.
AU  - Ramet M.
AU  - Lavoie P.M.
AU  - Hallman M.
Y1  - 2013//
KW  - *lung dysplasia
KW  - *workshop
KW  - *gene
KW  - population
KW  - infant
KW  - Finland
KW  - prematurity
KW  - human
KW  - lung
KW  - mast cell
KW  - risk factor
KW  - Hungary
KW  - genetic predisposition
KW  - Canada
KW  - family study
KW  - single nucleotide polymorphism
KW  - inflammation
KW  - haplotype
KW  - pneumonia
KW  - lung disease
KW  - respiratory failure
KW  - chronic inflammation
KW  - *stem cell factor
KW  - *surfactant
KW  - receptor
T2  - Neonatology
LA  - English
VL  - 103
IS  - 4
PB  - S. Karger AG
SN  - 1661-7800
AD  - J.M. Huusko, Department of Pediatrics and Biocenter, University of Oulu, Oulu, Finland
DO  - https://dx.doi.org/10.1159/000349955
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71111518
AB  - Background: Bronchopulmonary dysplasia (BPD) is characterized by chronic inflammation, inadequate lung growth and respiratory insufficiency. Family studies indicate that BPD has a significant genetic component. We assessed the gene encoding Kit ligand (KITLG) as a candidate for genetic predisposition to BPD due to its role in augmentation of inflammation. Method(s): Eight KITLG -tagging single nucleotide polymorphisms (SNPs) were analyzed in cohorts of very preterm infants originating from northern Finland (56 cases of moderate or severe BPD and 197 controls), southern Finland (n = 59 + 52 controls) and Canada (n = 58 + 68 controls). Additional replication populations included infants born in Finland (n = 41 + 241 controls) and Hungary (n = 29 + 40 controls). The results were controlled for the degree of prematurity and for other known risk factors of BPD. Result(s): Six SNPs of KITLG and a haplotype including all eight genotyped SNPs were associated with moderate-to-severe BPD. When the Finnish and Hungarian replication populations were combined with the original Finnish and Canadian populations, SNP rs11104948 was significantly associated with BPD. Conclusion(s): Polymorphisms of the KITLG gene are associated with susceptibility to BPD. Kit ligand and its receptor have proposed roles in lung inflammation and pulmonary growth. In addition, Kit ligand promotes the differentiation of mast cells that accumulate in the lungs of infants with severe BPD. This supports the possibility that KITLG polymorphisms predispose to reactive lung disease associated with mast cells.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71111517
TI  - Caffeine and rolipram down-regulate smad signalling and TGF-beta-stimulated ctgf and transgelin expression in lung epithelial cells
AU  - Kunzmann S.
AU  - Fehrholz M.
AU  - Bersani I.
AU  - Speer C.P.
Y1  - 2013//
KW  - *lung
KW  - *epithelium cell
KW  - *workshop
KW  - lung fibrosis
KW  - respiratory tract inflammation
KW  - airway remodeling
KW  - promoter region
KW  - lung dysplasia
KW  - upregulation
KW  - Western blotting
KW  - lung development
KW  - real time polymerase chain reaction
KW  - phosphorylation
KW  - second messenger
KW  - newborn
KW  - pathogenesis
KW  - genetic transfection
KW  - actin filament
KW  - assay
KW  - plasmid
KW  - prematurity
KW  - human
KW  - *caffeine
KW  - *rolipram
KW  - *transgelin
KW  - *surfactant
KW  - connective tissue growth factor
KW  - protein
KW  - messenger RNA
KW  - transforming growth factor beta
KW  - luciferase
KW  - phosphodiesterase IV inhibitor
KW  - phosphodiesterase inhibitor
KW  - factor A
T2  - Neonatology
LA  - English
VL  - 103
IS  - 4
PB  - S. Karger AG
SN  - 1661-7800
AD  - S. Kunzmann, Children's Hospital, University of Wurzburg, Wurzburg, Germany
DO  - https://dx.doi.org/10.1159/000349955
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71111517
AB  - Background: Caffeine reduces the incidence of bronchopulmonary dysplasia (BPD). However, the effects of caffeine on airway remodelling in preterm neonates are still undefined. The transforming growth factor-beta (TGF-beta)/Smad signalling pathway is one of the key regulators of lung development, airway inflammation, airway remodelling and lung fibrosis. All contribute to development of BPD. Connective tissue growth factor (CTGF), a downstream mediator of TGF-beta, and transgelin, a binding and stabilising protein of the actin cytoskeleton, are both regulated by TGF-beta and play an important role in airway/vascular remodelling. Objective(s): To clarify whether caffeine, an unspecific phosphodiesterase (PDE) inhibitor, and Rolipram, a specific PDE IV inhibitor, affect TGF-beta-induced Smad signalling and CTGF/ transgelin expression in lung epithelial cells. Method(s): The effects of caffeine and Rolipram on Smad signalling were investigated using a luciferase- assay via transfection of a TGF-beta-inducible reporter-plasmid in A549 cells. The regulation of CTGF and transgelin expression by caffeine and Rolipram were studied by promoter analysis, real-time PCR and Western-blotting. Result(s): Caffeine and Rolipram inhibited TGF-beta induced Smad3 phosphorylation in a dosedependent manner, with an 84 +/- 3.5% inhibition by caffeine (10 m M ; p < 0.05) and a 75 +/- 4% inhibition by Rolipram (1 m M ; p < 0.05). They also antagonized the TGF-beta-induced up-regulation of CTGF and transgelin on promoter-, mRNA-, and protein-level (p < 0.05 for all methods). Both effects of caffeine and Rolipram on inhibition on Smad signalling and CTGF/transgelin expression were mediated by the second messenger cAMP. Conclusion(s): The findings support possible new molecular mechanisms of caffeine and Rolipram in pathogenesis of BPD. We speculate that caffeine and Rolipram which essentially inhibit the TGF-beta signalling pathway including various downstream mediators, may reduce airway inflammation, remodelling and pulmonary fibrosis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71064891
TI  - Interventional closure of secundum type atrial septal defect in children with a bodyweight less than 10 kg: Indications, feasibility and outcome
AU  - Quandt D.
AU  - Knirsch W.
AU  - Kretschmar O.
Y1  - 2013//
KW  - *society
KW  - *heart atrium septum defect
KW  - *cardiology
KW  - *child
KW  - *human
KW  - *Japanese
KW  - *pediatric cardiology
KW  - *heart surgery
KW  - *Asia
KW  - devices
KW  - echocardiography
KW  - procedures
KW  - patient
KW  - failure to thrive
KW  - vein thrombosis
KW  - bleeding
KW  - prematurity
KW  - fluoroscopy
KW  - pulmonary hypertension
KW  - infant
KW  - trisomy 21
KW  - morbidity
KW  - genetic disorder
KW  - lung dysplasia
KW  - follow up
KW  - risk
KW  - male
KW  - sildenafil
T2  - Cardiology in the Young
LA  - English
VL  - 23
IS  - SUPPL. 1
PB  - Cambridge University Press
SN  - 1047-9511
AD  - D. Quandt, Division of Paediatric Cardiology, University Children's Hospital, Zurich, Switzerland
DO  - https://dx.doi.org/10.1017/S104795111300036X
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71064891
AB  - Background/Objectives: Interventional device closure of secundum type atrial septal defect (ASD) in children can be performed safely at the age of 2-4years. Aim of our study was to evaluate indications, feasibility, periprocedural complications, and outcome of interventional ASD closures in very small children with a bodyweight less than 10 kg. Method(s): Retrospective analysis (2005-2012) of ASD closures in children less than 10 kg bodyweight. Result(s): In 25 children (13 male) 24 successful interventional ASD device closures were performed at a median age of 1.2 years (0.2-2.8) and a bodyweight of median 7.5 kg (4.6-9.9). RV volume overload was present on echocardiography in 24 patients, resulting in a Qp/Qs of mean 1.7 (61). Clinically 9 (36%) pts presented with failure to thrive. 8 (32%) were past preterm infants with bronchopulmonary dysplasia (BPD). In 12 pts a genetic syndrome (Trisomy 21 in 9pts, 36%) was present. In more than 2/3 of the pts (n=18, 72%) pulmonary hypertension (PAH) was suspected on echocardiography. Haemodynamic evaluation revealed baseline PVR of mean 3.8WU/m2 (+/-6.7) and mean PAP 25mmHg (+/-10). ASD size was mean 8.1mm (62.7) with a ratio of bodyweight/defect-size of median 0.87. Mean femoral sheath size used was 7Fr (61.5) and ASD closure devices of 10mm (+/-3 mm), procedure time 84 min(+/-34), fluoroscopy time 13 min (67). There were no periprocedural complications, postinterventionally prolonged femoral bleeding (n=1) and femoral venous thrombosis (n=1) occurred. Median follow-up was 0.5 years (0.1-6) showing complete closure of ASD with no residual shunt in all 24 pts. All pts showed regression of PAH measured by echocardiography, one pt still being treated with sildenafil. Conclusion(s): Interventional ASD closure in children weighing less than 10 kg can be performed without any additional risks and shows a favorable outcome with a slight device oversizing in defect sizes up to 8 mm. Defect sizes in these small children, which comply with the bodyweight of the patient in kg, mostly can be addressed successfully with a percutaneous device closure. Indications for early closure are co-morbidities as BPD, failure to thrive or suspected PAH on echocardiography. As these pts do benefit significantly from the procedure, there are no restrictions to withhold timely procedures from this specific group.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71033753
TI  - Lipid peroxidation products and anti-oxidant enzymes in sick preterm neonates and their relation with bronchopulmonary dysplasia
AU  - Kanya M.
AU  - Mohammad A.
AU  - Shalmoli B.
AU  - Praveen K.
Y1  - 2013//
KW  - *lipid peroxidation
KW  - *newborn
KW  - *human
KW  - *prematurity
KW  - *lung dysplasia
KW  - *society
KW  - *Australia and New Zealand
KW  - baby
KW  - blood
KW  - pregnancy
KW  - birth weight
KW  - blood level
KW  - urine level
KW  - death
KW  - urine
KW  - disease predisposition
KW  - gestational age
KW  - *oxidizing agent
KW  - *enzyme
KW  - catalase
KW  - oxide
KW  - malonaldehyde
KW  - antioxidant
KW  - protein
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 49
IS  - SUPPL. 2
PB  - Blackwell Publishing
SN  - 1034-4810
AD  - M. Kanya, Neonatal unit, Dept of Pediatrics, Chandigarh, India. E-mail: kanyapupul@yahoo.com
DO  - https://dx.doi.org/10.1111/jpc.12133
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71033753
AB  - Background: Preterm neonates have inadequate antioxidant defense system which may be one of the predisposing factors to develop bronchopulmonary dysplasia (BPD). Method(s): This was an exploratory study in a Level III neonatal unit over 1 year period. Fifty consecutive sick neonates of <=34 weeks gestation were enrolled and followed till discharge or death. Their baseline blood and urine levels of Malondialdehyde (MDA) and blood levels of anti-oxidant enzymes super oxide dismutase (SOD) and Catalase were compared in the babies who developed BPD vs those who did not. Result(s): The mean birth weight and gestational age were 1416 +/- 219 grams and 29.9 +/- 2.5 weeks respectively. Base line blood MDA (4.6 +/- 1.2 vs 3.9 +/- 1.2 nMol/ml) was higher (p = 0.032) and SOD (p = 0.02) (26.6 +/- 28.2 vs 46 +/- 21.6 U/ml) and Catalase (p = 0.00) were significantly lower (0.8 +/- 0.8 vs 1.8 +/- 1.2 nMol/g protein) in babies with gestation <30 wks (n = 24) as compared to >=30 wks babies (n = 26) respectively. In babies who developed BPD (n = 17), blood (5 +/- 0.5 vs 3.8 +/- 1.2) and urine MDA levels (9.4 +/- 5.1 vs 5.6 +/- 1.8) were significantly higher (p = 0.00) and SOD (19.1 +/- 14.4 vs 43.9 +/- 26.4) and Catalase levels (0.6 +/- 0.3 vs 2 +/- 1.1) were significantly (p = 0.00) lower than those who did not develop BPD (n = 21). Conclusion(s): Baseline oxidant levels are higher and anti-oxidant enzymes are lower in <30 weeks gestation babies and in those who developed BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71033489
TI  - Prophylactic erythropoietin exacerbates ventilation-induced lung inflammation in preterm lambs
AU  - Polglase G.
AU  - Zahra V.
AU  - Tolcos M.
AU  - Wallace M.
AU  - Siew M.
AU  - Barton S.
AU  - Melville J.
AU  - Hooper S.
AU  - Moss T.
Y1  - 2013//
KW  - *air conditioning
KW  - *pneumonia
KW  - *lamb
KW  - *society
KW  - *Australia and New Zealand
KW  - human
KW  - lung injury
KW  - female
KW  - prematurity
KW  - analysis of variance
KW  - pregnancy
KW  - infant
KW  - lung dysplasia
KW  - tidal volume
KW  - inflammation
KW  - pathogenesis
KW  - oxygenation
KW  - ultraviolet C radiation
KW  - newborn period
KW  - lung parenchyma
KW  - gene expression
KW  - early response gene
KW  - hypothesis
KW  - respiratory tract disease
KW  - newborn
KW  - *erythropoietin
KW  - cytokine
KW  - sodium chloride
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 49
IS  - SUPPL. 2
PB  - Blackwell Publishing
SN  - 1034-4810
AD  - G. Polglase, Ritchie Centre, Department of Obstetrics and Gynaecology, Monash University, Clayton, Australia. E-mail: graeme.polglase@monash.edu
DO  - https://dx.doi.org/10.1111/jpc.12132
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71033489
AB  - Background: Lung inflammation resulting from inadvertent ventilationinduced lung injury (VILI) of preterm neonates during the immediate neonatal period likely contributes to the pathogenesis of bronchopulmonary dysplasia (BPD). Erythropoietin (EPO) has been suggested to reduce BPD in preterm infants. We hypothesised that prophylactic administration of EPO would reduce the initial lung inflammation caused by VILI. Method(s): Lambs delivered at 126 days of gestation were ventilated with a high tidal volume, lung injury strategy for 15 minutes then gently ventilated for 105 minutes. At 5 minutes lambs received either saline (Ventilated: 3mL i.v. n = 6) or recombinant human (rh)EPO (Ventilated+rhEPO: 5000 IU/kg; n = 5). Pro-inflammatory cytokine and early response gene expression in lung tissue was measured using qRTPCR, and compared to unventilated controls (UVC; n = 5). Repeated measures ANOVA, one-way ANOVA or Kruskal-Wallis ANOVA determined significance. Result(s): Ventilation pressures and volumes were not different between groups. Ventilated+rhEPO lambs had higher FiO2, SaO2 and oxygenation during the first 10 minutes than Ventilated lambs (p < 0.001 for all). There were no differences in indices beyond this time. Conclusion(s): Contrary to our hypothesis, prophylactic rhEPO exacerbates the pulmonary inflammatory response to VILI, which may increase the incidence and severity of long-term respiratory disease. (Table Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70993578
TI  - Nebulized nano-curcumin: A novel approach against hyperoxia-induced lung injury
AU  - Husain S.M.
AU  - Sakurai R.
AU  - Siddiqui M.
AU  - Torday J.S.
AU  - Rehan V.K.
Y1  - 2013//
KW  - *hyperoxia
KW  - *lung injury
KW  - *medical research
KW  - fetus lung maturation
KW  - lung
KW  - bioavailability
KW  - nebulization
KW  - in vitro study
KW  - Sprague Dawley rat
KW  - lung fibroblast
KW  - lung dysplasia
KW  - rat
KW  - apoptosis
KW  - pathology
KW  - *curcumin
KW  - nanoparticle
KW  - peroxisome proliferator activated receptor
KW  - apotransferrin
KW  - marker
KW  - vimentin
KW  - fibronectin
KW  - triolein
KW  - molecular marker
KW  - parathyroid hormone related protein receptor
KW  - sodium chloride
KW  - antioxidant
T2  - Journal of Investigative Medicine
LA  - English
VL  - 61
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - S.M. Husain, LA BioMed, Harbor-UCLA Medical Center, Torrance, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e31827d3ac9
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=70993578
AB  - Purpose of Study: Curcumin (diferuloylmethane) has potent antioxidant and anti-inflammatory properties, and it is known to modulates PPARgamma signaling, a key molecule in the pathobiology of Bronchopulmonary Dysplasia (BPD). We have shown that curcumin accelerates lung maturation by stimulating key alveolar epithelial-mesenchymal interactions and it blocks hyperoxia-induced neonatal lung injury, suggesting it as a potential intervention against BPD. However, its useful as a therapeutic modality has remained limited due to its low bioavailability. We hypothesized that curcumin delivered directly to lungs via nebulization in nanoparticle form would be an effective alternate strategy to overcome the issue of its low bioavailability. Methods Used: Curcumin-loaded apotransferrin nanoparticles (nanocurcumin) were prepared by sol-oil chemistry according to previously described methods. To determine the effect of nanocurcumin on lung maturation, embryonic day 19 rat lung fibroblasts or 1-day old neonatal Sprague-Dawley rat pups were exposed to graded doses of nanocurcumin, in vitro (0-10 muM), or in vivo (0-25 mg/kg administered via nebulization in 2 ml saline), respectively, for 24h. Furthermore, nebulized (10 mg/kg once daily) nanocurcumin's effect on hyperoxia (95% O2 for 72h)-induced lung injury was determined by analyzing for functional biomarkers of lung injury/repair. Summary of Results: Both in vitro and in vivo, nanocurcumin administration increased functional biomarkers of lung maturation dose-and timedependently (increased parathyroid hormone-related protein receptor, PPARgamma, C/EBPalpha, CCT-alpha, and triolein uptake). Concomitant treatment with nebulized nanocurcumin blocked both the hyperoxia-induced decrease (C/EBPalpha and PPARgamma) and increase (fibronectin and vimentin) in markers of lung injury/ repair. Similarly, in vivo hyperoxia-induced changes in molecular markers of lung apoptosis (decreased BCL2/Bax ratio) were effectively blocked in the nanocurcumin-treated group. Conclusion(s): Nanocurcumin, which has significantly increased bioavailability over curcumin itself, accelerates lung maturation by stimulating key alveolar epithelial-mesenchymal interactions, and blocks hyperoxia-induced neonatal lung injury, suggesting it as a potential intervention against BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70993577
TI  - Curcumin protects the developing lung against hyperoxic injury long-term
AU  - Sakurai R.
AU  - Husain S.M.
AU  - Saraswat A.
AU  - Villarreal P.G.
AU  - Siddiqui M.
AU  - Torday J.S.
AU  - Rehan V.K.
Y1  - 2013//
KW  - *lung
KW  - *injury
KW  - *medical research
KW  - lung injury
KW  - hyperoxia
KW  - lung fibroblast
KW  - mother
KW  - apoptosis
KW  - female
KW  - rat
KW  - human
KW  - lung function
KW  - lung dysplasia
KW  - mare
KW  - pathology
KW  - breast
KW  - lung development
KW  - Sprague Dawley rat
KW  - cell division
KW  - morphology
KW  - exposure
KW  - in vitro study
KW  - prevention
KW  - phosphorylation
KW  - *curcumin
KW  - marker
KW  - antioxidant
KW  - tropoelastin
KW  - elastin
KW  - matrix protein
KW  - peroxisome proliferator activated receptor
KW  - collagen type 3
T2  - Journal of Investigative Medicine
LA  - English
VL  - 61
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - R. Sakurai, LA BioMed, Harbor-UCLA Medical Center, Torrance, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e31827d3ac9
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=70993577
AB  - Purpose of Study: There is no effective intervention to prevent or treat Bronchopulmonary Dysplasia (BPD). Curcumin has potent antioxidant and anti-inflammatory properties, and it modulates signaling of PPARgamma, an important molecule in the pathobiology of BPD. Curcumin protects against hyperoxia-induced lung injury in the short-term; however, its role in longerterm prevention of BPD is not known. Therefore, we determined if curcumin has a protective effect against hyperoxic neonatal rat lung injury for 5 days at 21 days of age. Methods Used: 1-day old Sprague Dawley rat pups were exposed to either 21% or 95% O2 for 5 days with or without curcumin (5 mg/kg) administered i.p. once daily in 100 Kl volumes. During this time period, the pups were allowed to breast feed ad libitum. To prevent hyperoxic lung injury to the mother, the dams were interchanged every 24h between the 21% and 95 % O2 groups. After 5 days, the pups were allowed to grow with their mothers. At postnatal day (PND)21, pup lung development was studied, including the determination of pulmonary function, gross and cellular structural and functional effects, and molecular mediators of inflammatory injury. To gain mechanistic insights to curcumin's protective effect against hyperoxia-induced lung injury, embryonic day 19 rat lung fibroblasts were cultured and examined for markers of apoptosis and MAPK activation following in vitro exposure to hyperoxia for 24h in the presence or absence of curcumin (5KM). Summary of Results: Systematic analysis for markers of lung injury [apoptosis, Bcl-2/Bax, collagen III, alphaSMA] and lung morphology (radial alveolar count, matrix proteins elastin, tropoelastin, FGFR3, 4, Fibrillin2, 5 and Lox) demonstrated that curcumin effectively blocks hyperoxia-induced lung injury. Exposing e19 lung fibroblasts to 95%O2 for 24 h inhibited cell division, an effect that was dose-dependently reversed by curcumin; mechanistically, curcumin prevented the hyperoxia-induced increases in cleaved caspace-3 and phosphorylation of MapKinase mediators (Erk 1/2, p42 and p44). Conclusion(s): Structural and cytoprotective molecular effects of curcumin suggest that its effects against hyperoxia-induced lung injury are mediated via Erk 1/2 activation and that it is a potential intervention against BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70993499
TI  - The unique role of the nf-kappab inhibitory protein IkappaBbeta in mediating the response to inflammation in the developing lung
AU  - Michaelis K.A.
AU  - Luna J.
AU  - Han K.
AU  - Liu T.
AU  - Tang J.
AU  - Balasubramaniam V.
AU  - Abman S.H.
AU  - Wright C.J.
Y1  - 2013//
KW  - *inflammation
KW  - *lung
KW  - *medical research
KW  - gene
KW  - DNA binding
KW  - endothelium
KW  - kinetics
KW  - exposure
KW  - immunofluorescence
KW  - chorioamnionitis
KW  - staining
KW  - lung dysplasia
KW  - risk
KW  - prematurity
KW  - lung blood vessel
KW  - lung injury
KW  - mouse
KW  - endothelium cell
KW  - human
KW  - gene expression
KW  - infant
KW  - epithelium cell
KW  - wild type
KW  - fibroblast
KW  - apoptosis
KW  - lung development
KW  - therapy
KW  - *synapsin I
KW  - lipopolysaccharide
KW  - DNA
KW  - protein
KW  - transcription factor
KW  - caspase 3
KW  - interleukin 11
KW  - RANTES
T2  - Journal of Investigative Medicine
LA  - English
VL  - 61
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - K.A. Michaelis, Univ of Colorado, School of Medicine, Aurora, CO, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e31827d3ac9
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=70993499
AB  - Purpose of Study: Whether chorioamnionitis increases or decreases the risk of bronchopulmonary dysplasia in premature infants is widely debated. The transcription factor NFkappaB regulates expression of both cytoprotective and pro-inflammatory genes, providing a potential mechanistic link for both findings. We hypothesized that the NF-kappaB inhibitory proteins IkappaBalpha and IkappaBbeta serve separate and specialized roles in mediating the transcriptional response to inflammation in the developing pulmonary endothelium. Methods Used: Presence of IkappaBalpha and IkappaBbeta in the developing lung was assessed by immunofluorescence staining on lung sections obtained from P1 mice and by Western analysis of fetal pulmonary arterial endothelial cells (PAEC) and alveolar type-2 epithelial cells (AT2). The kinetics of IkappaB degradation, NF-kappaB nuclear translocation and DNA binding, and downstream gene expression (QPCR) in response to lipopolysaccharide (LPS) was assessed in wild-type (WT) and IkappaBbeta overexpressing (AKBI) murine embryonic fibroblasts (MEF). Summary of Results: Though IkappaBalpha stained diffusely through the lung, IkappaBbeta was expressed primarily in the microvascular endothelium. Supporting this finding, a higher ratio of IkappaBbeta to IkappaBalpha was found in PAEC compared to AT2 (p<0.05). In WT and AKBI MEF, LPS (1h) induced IkappaBalpha and IkappaBbeta degradation, with return to baseline by 2h of exposure. WT MEF demonstrated peak NF-kappaB nuclear translocation and DNA binding at 1h exposure. AKBI MEF demonstrated prolonged NF-kappaB nuclear translocation and DNA binding compared to WT MEF. Apoptosis, measured by Caspase-3 activity and expression of anti-apoptotic genes, was unaltered in AKBI MEF. However, AKBI MEF demonstrated a muted transcriptional response of multiple pro-inflammatory genes (IP-10, MCP-1, RANTES, IL-11). Conclusion(s): Differential expression of IkappaBalpha and IkappaBbeta can alter the kinetics and gene targets of NF-kappaB activation. The developing pulmonary microvascular endothelium predominately expresses IkappaBbeta, suggesting a unique role for IkappaBbeta in lung development and response to inflammatory insults. A better understanding of the roles played by IkappaBalpha and IkappaBbeta in mediating cytoprotective and pro-inflammatory responses in the developing pulmonary vasculature may lead to novel therapies aimed to prevent neonatal lung injury.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70993419
TI  - The incidence and impact of CMV infection in preterm infants
AU  - Turner K.M.
AU  - Lee H.C.
AU  - Boppana S.B.
AU  - Carlo W.A.
AU  - Randolph D.A.
Y1  - 2013//
KW  - *infant
KW  - *human
KW  - *prematurity
KW  - *medical research
KW  - *cytomegalovirus infection
KW  - very low birth weight
KW  - hearing impairment
KW  - nursery
KW  - death
KW  - adverse outcome
KW  - data base
KW  - patient
KW  - screening
KW  - risk
KW  - necrotizing enterocolitis
KW  - sepsis
KW  - multivariate analysis
KW  - hospital
KW  - medical record
KW  - controlled study
KW  - premature labor
KW  - lung dysplasia
KW  - United States
KW  - encephalomalacia
KW  - brain hemorrhage
KW  - perception deafness
KW  - retrolental fibroplasia
KW  - neuroimaging
KW  - digestive system perforation
KW  - child
KW  - Cytomegalovirus
T2  - Journal of Investigative Medicine
LA  - English
VL  - 61
IS  - 2
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - K.M. Turner, University of Alabama, Birmingham, AL, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e3182820c55
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=70993419
AB  - Purpose of Study: Congenital cytomegalovirus (CMV) is the leading cause of non-genetic deafness in children in the U.S. and can cause of neurodevelopmental impairment (NDI) in term infants. Limited data exist regarding whether congenital CMV is associated with preterm delivery. The extent to which CMV infection increases the risk of adverse outcomes in very low birth weight (VLBW) preterm infants is also unknown. We aimed to determine the incidence of congenital CMV in VLBW infants, and to describe and role of congenital and acquired CMV in modifying outcomes of VLBW preterm infants. Methods Used: This was a retrospective case controlled study of infants admitted to the UAB nursery where CMV screening is part of routine admission orders. All infants admitted between the years 1993-2008 and weighing G1500 grams were included. CMV status and clinical outcomes were queried using two internal patient databases and hospital-based medical records. For clinical outcomes analysis, the 5 consecutive VLBW infants born before and after each CMV-positive case were used as controls. The primary outcome was death or NDI. Secondary outcomes included sensorineural hearing loss, intraventricular hemorrhage, periventricular leukomalacia, bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of prematurity, and culture proven late-onset sepsis. Multivariate analysis was performed. Summary of Results: Seventeen of 4,594 VLBW infants queried had congenital CMV (0.37%), a lower rate than that published for term infants. An additional 16 infants (0.35%) acquired CMV in the nursery. Compared to controls, congenitally infected VLBW infants were more likely to have hearing loss (64% vs. 10%, p<0.0001) and abnormal neuroimaging (71% vs. 28%, p<0.0001). Developmental motor outcomes were also significantly worse for CMV infected infants (50% vs. 12%, p=0.03), although this information was available for only 6 congenital CMV infants and 33 controls. Congenital CMV was not associated with death. Acquired CMV was only associated with gastrointestinal perforation (p=0.008). Conclusion(s): CMV infection is not positively associated with prematurity. Congenital but not acquired CMV in VLBW infants is associated with hearing loss and neurologic deficits.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71223497
TI  - Role of flow cytometry in diagnosis and management of neonatal sepsis
AU  - Jain P.
AU  - Pradhan R.
AU  - Warner N.
AU  - Singh A.K.
AU  - Chatterjee M.
Y1  - 2013//
KW  - *flow cytometry
KW  - *diagnosis
KW  - *newborn sepsis
KW  - *Indian
KW  - *society
KW  - *hematology
KW  - *blood transfusion
KW  - sepsis
KW  - human
KW  - patient
KW  - monocyte
KW  - neutrophil
KW  - monitoring
KW  - infant
KW  - infection
KW  - newborn
KW  - predictive value
KW  - risk
KW  - laboratory
KW  - innate immunity
KW  - pathogenesis
KW  - thrombocyte count
KW  - exposure
KW  - bloodstream infection
KW  - lung dysplasia
KW  - prematurity
KW  - leukocyte count
KW  - control group
KW  - blood sampling
KW  - parameters
KW  - treatment response
KW  - blood
KW  - fluorescence
KW  - antibiotic resistance
KW  - newborn apnea
KW  - hospitalization
KW  - T lymphocyte
KW  - hospital infection
KW  - body temperature
KW  - antigen presentation
KW  - major histocompatibility complex
KW  - prospective study
KW  - publication
KW  - bacterial infection
KW  - upregulation
KW  - transient tachypnea of the newborn
KW  - antibiotic therapy
KW  - algorithm
KW  - antimicrobial therapy
KW  - physical disease by body function
KW  - economic aspect
KW  - health care
KW  - antibiotic agent
KW  - marker
KW  - acute phase protein
KW  - C reactive protein
KW  - biochemical marker
KW  - antiinfective agent
KW  - interleukin 6
KW  - cell surface receptor
KW  - alpha integrin
KW  - Fc receptor
KW  - procalcitonin
KW  - cell surface marker
T2  - Indian Journal of Hematology and Blood Transfusion
LA  - English
VL  - 29
IS  - 4
PB  - Springer India
SN  - 0971-4502
AD  - P. Jain, BD Biosciences, India
DO  - https://dx.doi.org/10.1007/s12288-013-0303-y
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed14&NEWS=N&AN=71223497
AB  - Every year, more than a million newborns are treated for infection worldwide at a very significant cost to the health care economy. In both term and preterm infants, early warning signs and symptoms are often minimal, subtle, non-specific, and can easily be misinterpreted as being due to non-infective causes such as transient tachypnea of the newborn, environmentally induced fluctuation of body temperature, apnea of prematurity, and acute exacerbations of bronchopulmonary dysplasia [1]. In particular, blood stream infections (sepsis) develop very rapidly, and are often fatal within hours of neonatal exposure to pathogens. It is classified into early-onset form (EONS) within the first 72 h of life and late-onset form (LONS) afterwards. Infected infants must be promptly identified and differentiated from non-infected patients, and antibiotics started without delay. Consequently, treatment is often initiated empirically based on clinical algorithms and it is estimated that an average of 17 infants is treated for each one who is truly infected [2]. Continuation of antibiotics for presumptive bacterial infection often leads to unnecessary and prolonged treatment adding to cost of care, risk of developing nosocomial infections during hospital stay and may lead to emergence of antibiotic resistance. An 'ideal' marker for neonatal sepsis should have a sensitivity and negative predictive value approaching 100 % along with specificity and positive predictive value of 85 % or better [1]. A wide variety of surrogate hematological and biochemical markers have been investigated for the evaluation of clinical sepsis. Most notable of these include total WBC count, Immature to Total neutrophil ratio (I/T ratio), Platelet counts, micro-ESR, IL-6 and acute phase reactants such as Creactive protein and procalcitonin. None of these tests are however, sensitive and specific enough to influence the clinical decision for withholding antibiotic treatment at the onset or within 24 h of suspected infection [1]. Over the last decade various flow cytometry based methods have been explored to identify activation of cells of innate immunity as markers of sepsis that detect infection earlier than the acute phase reactants, with the rationale that it is the activation of these cells that leads to the generation of acute phase reactants [3]. Up-regulated expression of CD64, the Fc-gamma receptor [1], and CD11b (Integrin alpha M) on neutrophils and down-regulated expression of HLA-DR (MHC class II cell surface receptor involved in antigen presentation to T cells) on monocytes have shown promise in various studies for diagnosis, prognostication or monitoring response to antibiotics in neonatal sepsis [1-7] In a prospective study (manuscript under preparation) we have investigated the utility of flow cytometric evaluation of five markers pertaining to innate immunity (CD64, CD11b, HLA-DR, CD282 and CD88) in 100 patients with suspected neonatal sepsis. We also derived and evaluated a novel composite parameter "Sepsis Index (SI)", based on ratio of median fluorescence intensity (MFI) of CD64 on neutrophils (nCD64) to MFI of HLA-DR on monocytes (mHLA-DR). Peripheral blood samples were collected at diagnosis based on clinical suspicion (sample 1), after 24 h of initiation of antibiotics (sample 2), and after 4-6 days from diagnosis (sample 3). Twenty-nine control samples from healthy neonates were also studied to define the cut-offs for upregulation or downregulation of these markers. Of the 100 cases, 63 patients were eventually classified to have sepsis based on culture positivity (21 cases) and European Medical Agency (EMA) clinical sepsis criteria [8] (42 cases). These 63 patients were grouped as 'Final Sepsis' (FS) cases. The remaining 47 patients were grouped as 'Final No Sepsis' (FNS) cases. Expectedly, the expression of nCD64 on sample 1 was significantly upregulated in the FS group when compared to the FNS and healthy controls (p<0.001). Expression of nCD88 was significantly downregulated in FS and FNS groups in comparison to the control group (p<0.001). However, in terms of expression of nCD11b, nCD282 and nHLA-DR, there were no significant differences between the groups. With regard to monocytes, mHLA-DR was significantly down-regulated in the FS group as compared to FNS and healthy controls (p<0.001) and mCD88 showed a consistent but non-significant decrease in the FS and FNS groups (p = 0.064). There was no clear cut trend observed with mCD64 expression as also mCD11b and mCD282 showed no significant differences across the groups. Amongst the laboratory parameters studied, nCD64 and Sepsis Index had the highest sensitivity to detect sepsis on day 1 sample (73 %each) followed by '=2 EMA laboratory signs for sepsis' (63 %), CRP (38 %) and mHLA-DR (19 %). Sensitivity improved with information from sample 2 in case of nCD64 (86.53 %) and SI (82.69 %). It further improved to 92.3 %, when either nCD64 or SI values were considered from both Samples 1 and 2. Specificity to detect sepsis at day 1 for nCD64 and SI was 89 and 72 % respectively. Overall as a stand-alone parameter nCD64 had the best diagnostic efficacy. We also explored the role of nCD64 and SI in monitoring the response to antibiotics and predicting the need to add/ change the antimicrobial therapy. We found SI to perform better than nCD64 in these aspects. In sepsis cases, where sample 3 was > cut-off, the odds ratio (OR) for change of antimicrobials on/beyond day 4 was 5.92 (p = 0.021, 95 %CI 1.22-32.22) for nCD64 and 6.33 (p = 0.007, 95 % CI 1.52-26.34) for SI. Taken together, this study and the experience of others as evident in published literature, endorse that flow cytometric testing of cell surface markers should be incorporated as a part of the 'septic screen' to diagnose/rule-out sepsis. It would also be worthwhile to undertake further studies to validate the role of nCD64 and Sepsis Index in monitoring therapeutic responses in comparison with more established tools like CRP.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Exome Sequencing of Neonatal Blood Spots and the Identification of Genes Implicated in Bronchopulmonary Dysplasia.
DO  - https://dx.doi.org/10.1164/rccm.201501-0168OC
AU  - Li, Jingjing
AU  - Yu, Kun-Hsing
AU  - Oehlert, John
AU  - Jeliffe-Pawlowski, Laura L
AU  - Gould, Jeffrey B
AU  - Stevenson, David K
AU  - Snyder, Michael
AU  - Shaw, Gary M
AU  - O'Brodovich, Hugh M
Y1  - 2015//
KW  - Animals
KW  - Blood Specimen Collection
KW  - *Bronchopulmonary Dysplasia/ge [Genetics]
KW  - Case-Control Studies
KW  - *Exome/ge [Genetics]
KW  - Female
KW  - Genetic Predisposition to Disease
KW  - Genome-Wide Association Study
KW  - Haploinsufficiency
KW  - Humans
KW  - Infant
KW  - Infant, Extremely Premature
KW  - Infant, Newborn
KW  - Infant, Premature
KW  - *Lung/em [Embryology]
KW  - Male
KW  - Mice
KW  - *Morphogenesis/ge [Genetics]
KW  - Neonatal Screening
KW  - Sequence Analysis, DNA
KW  - *Twins, Dizygotic/ge [Genetics]
KW  - *Twins, Monozygotic/ge [Genetics]
KW  - *Wnt Signaling Pathway/ge [Genetics]
T2  - American journal of respiratory and critical care medicine
VL  - 192
IS  - 5
SN  - 1073-449X
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=26030808
AD  - United States
AB  - RATIONALE: Bronchopulmonary dysplasia (BPD), a prevalent severe lung disease of premature infants, has a strong genetic component. Large-scale genome-wide association studies for common variants have not revealed its genetic basis., OBJECTIVES: Given the historical high mortality rate of extremely preterm infants who now survive and develop BPD, we hypothesized that risk loci underlying this disease are under severe purifying selection during evolution; thus, rare variants likely explain greater risk of the disease., METHODS: We performed exome sequencing on 50 BPD-affected and unaffected twin pairs using DNA isolated from neonatal blood spots and identified genes affected by extremely rare nonsynonymous mutations. Functional genomic approaches were then used to systematically compare these affected genes., MEASUREMENTS AND MAIN RESULTS: We identified 258 genes with rare nonsynonymous mutations in patients with BPD. These genes were highly enriched for processes involved in pulmonary structure and function including collagen fibril organization, morphogenesis of embryonic epithelium, and regulation of Wnt signaling pathway; displayed significantly elevated expression in fetal and adult lungs; and were substantially up-regulated in a murine model of BPD. Analyses of mouse mutants revealed their phenotypic enrichment for embryonic development and the cyanosis phenotype, a clinical manifestation of BPD., CONCLUSIONS: Our study supports the role of rare variants in BPD, in contrast with the role of common variants targeted by genome-wide association studies. Overall, our study is the first to sequence BPD exomes from newborn blood spot samples and identify with high confidence genes implicated in BPD, thereby providing important insights into its biology and molecular etiology.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365366847
TI  - Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growth
AU  - Hilgendorff A.
AU  - Parai K.
AU  - Ertsey R.
AU  - Juliana Rey-Parra G.
AU  - Thebaud B.
AU  - Tamosiuniene R.
AU  - Jain N.
AU  - Navarro E.F.
AU  - Starcher B.C.
AU  - Nicolls M.R.
AU  - Rabinovitch M.
AU  - Bland R.D.
Y1  - 2012//
KW  - airway remodeling
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - apoptosis
KW  - article
KW  - *artificial ventilation
KW  - controlled study
KW  - *DNA modification
KW  - emphysema
KW  - enzyme activity
KW  - enzyme inhibition
KW  - *lung development
KW  - mouse
KW  - newborn
KW  - nonhuman
KW  - priority journal
KW  - protein degradation
KW  - protein expression
KW  - signal transduction
KW  - vascular endothelium
KW  - *ventilator induced lung injury/et [Etiology]
KW  - caspase 3/ec [Endogenous Compound]
KW  - *elafin/ec [Endogenous Compound]
KW  - elastase/ec [Endogenous Compound]
KW  - gelatinase B/ec [Endogenous Compound]
KW  - immunoglobulin enhancer binding protein/ec [Endogenous Compound]
KW  - oxygen
KW  - transforming growth factor beta/ec [Endogenous Compound]
KW  - vasculotropin/ec [Endogenous Compound]
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 303
IS  - 3
PB  - American Physiological Society (9650 Rockville Pike, Bethesda MD 20814-3991, United States)
SN  - 1522-1504
AD  - R. D. Bland, Stanford Univ. School of Medicine, CCSR Bldg., 269 Campus Dr, Stanford, CA 94305-5162, United States. E-mail: rbland@stanford.edu
UR  - http://ajplung.physiology.org/content/303/3/L215.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=365366847
DO  - https://dx.doi.org/10.1152/ajplung.00405.2011
AB  - Mechanical ventilation (MV) with O2-rich gas (MV-O2) offers life-saving treatment for newborn infants with respiratory failure, but it also can promote lung injury, which in neonates translates to defective alveolar formation and disordered lung elastin, a key determinant of lung growth and repair. Prior studies in preterm sheep and neonatal mice showed that MV-O2 stimulated lung elastase activity, causing degradation and remodeling of matrix elastin. These changes yielded an inflammatory response, with TGF-beta activation, scattered elastic fibers, and increased apoptosis, culminating in defective alveolar septation and arrested lung growth. To see whether sustained inhibition of elastase activity would prevent these adverse pulmonary effects of MV-O2, we did studies comparing wild-type (WT) and mutant neonatal mice genetically modified to express in their vascular endothelium the human serine elastase inhibitor elafin (Eexp). Five-day-old WT and Eexp mice received MV with 40% O2 (MV-O2) for 24-36 h. WT and Eexp controls breathed 40% O2 without MV. MV-O2 increased lung elastase and MMP-9 activity, resulting in elastin degradation (urine desmosine doubled), TGF-beta activation (pSmad-2 increased 6-fold), apoptosis (cleaved-caspase-3 increased 10-fold), and inflammation (NF-kappaB activation, influx of neutrophils and monocytes) in lungs of WT vs. unventilated controls. These changes were blocked or blunted during MV-O2 of Eexp mice. Scattered lung elastin and emphysematous alveoli observed in WT mice after 36 h of MV-O2 were attenuated in Eexp mice. Both WT and Eexp mice showed defective VEGF signaling (decreased lung VEGF-R2 protein) and loss of pulmonary microves-sels after lengthy MV-O2, suggesting that elafin's beneficial effects during MV-O2 derived primarily from preserving matrix elastin and suppressing lung inflammation, thereby enabling alveolar formation during MV-O2. These results suggest that degradation and remodeling of lung elastin can contribute to defective lung growth in response to MV-O2 and might be targeted therapeutically to prevent ventilator-induced neonatal lung injury. Â© 2012 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365664346
TI  - Thrombotic thrombocytopenic purpura
AU  - Kaiser C.
AU  - Gembruch U.
AU  - Janzen V.
AU  - Gast A.-S.
Y1  - 2012//
KW  - abdominal bleeding/th [Therapy]
KW  - adult
KW  - article
KW  - blurred vision/co [Complication]
KW  - brain hemorrhage
KW  - brain ventricle peritoneum shunt
KW  - case report
KW  - cesarean section
KW  - Coombs test
KW  - erythrocyte transfusion
KW  - eye examination
KW  - facial nerve paralysis
KW  - female
KW  - fetus lung maturity
KW  - gestational age
KW  - HELLP syndrome
KW  - hospital admission
KW  - human
KW  - hydrocephalus/co [Complication]
KW  - hydrocephalus/su [Surgery]
KW  - intracytoplasmic sperm injection
KW  - laboratory test
KW  - laparotomy
KW  - lung dysplasia
KW  - male
KW  - newborn
KW  - newborn mortality
KW  - plasmapheresis
KW  - pneumothorax
KW  - positive end expiratory pressure
KW  - prematurity
KW  - primipara
KW  - priority journal
KW  - reoperation
KW  - reticulocyte count
KW  - sepsis
KW  - survival rate
KW  - thrombocyte count
KW  - thrombocyte transfusion
KW  - *thrombotic thrombocytopenic purpura/di [Diagnosis]
KW  - *thrombotic thrombocytopenic purpura/th [Therapy]
KW  - treatment response
KW  - twins
KW  - betamethasone
KW  - D dimer/ec [Endogenous Compound]
KW  - haptoglobin/ec [Endogenous Compound]
KW  - hemoglobin/ec [Endogenous Compound]
KW  - lactate dehydrogenase/ec [Endogenous Compound]
KW  - von Willebrand factor cleaving proteinase/ec [Endogenous Compound]
KW  - dichorionic diamniotic twins
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 25
IS  - 10
PB  - Informa Healthcare (69-77 Paul Street, London EC2A 4LQ, United Kingdom)
SN  - 1476-4954
AD  - A.-S. Gast, Universitats-Frauenklinik Bonn, Abteilung fur Geburtshilfe und Pranatalmedizin, Sigmund-Freud-Str. 25, 53117 Bonn, Germany. E-mail: anne-sybil.gast@ukb.uni-bonn.de
DO  - https://dx.doi.org/10.3109/14767058.2012.666586
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=365664346
AB  - A 34-year old primipara was admitted to hospital with dichorionicdiamniotic twins in 263 weeks of gestation. In suspicion of HELLP-syndrome, caesarean section was performed at 274 weeks of gestation, because of platelet count was reduced to 44000/l. A re-laparotomy had to be performed because of intra-abdominal bleedings. The patient was given seven packed thrombocytes and five packed erythrocytes. The patient complained about blurred vision. The right corner of the mouth was slightly depressed in terms of a facial nerve paresis. Further platelet counts were about 50000/l. Haemoglobin: 7.8 mg/l. D-Dimer: 1066 mg/l. LDH was elevated to 1610 U/l, reticulocytes were elevated to 13.19% and haptoglobin was reduced to <0.08 g/l. The Coombs' test was negative. The ADAMTS-13 test showed a reduced activity. Hereby, the diagnoses of thrombotic thrombocytopenic purpura was confirmed. Plasma exchange is the most effective option; application of platelet concentrate should be avoided, because of worsening microangiopathy and subsequent neurological situation. After the patient has received plasma exchange, platelet count normalized. An ophthalmic examination showed a dysfunction in choroid perfusion as a cause for the blurred vision. After discharge regular lab tests were planned, but no further treatment was necessary at that point of time. The premature twins survived after ventricular haemorrhage, severe sepsis, bronchopulmonary dysplasia and other complications of neonates. Â© 2012 Informa UK, Ltd.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365169639
TI  - Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-alpha
AU  - Sewing A.C.P.
AU  - Kantores C.
AU  - Ivanovska J.
AU  - Lee A.H.
AU  - Masood A.
AU  - Jain A.
AU  - McNamara P.J.
AU  - Keith Tanswell A.
AU  - Jankov R.P.
Y1  - 2012//
KW  - animal experiment
KW  - animal tissue
KW  - apoptosis
KW  - arterial gas
KW  - article
KW  - body weight
KW  - brain cortex
KW  - brain weight
KW  - controlled study
KW  - cytokine production
KW  - heart right ventricle function
KW  - heart right ventricle hypertrophy
KW  - kidney mass
KW  - liver weight
KW  - lung alveolus macrophage
KW  - lung hypoplasia
KW  - lung vascular resistance
KW  - lung weight
KW  - neutrophil
KW  - newborn
KW  - nonhuman
KW  - nucleotide sequence
KW  - pH
KW  - priority journal
KW  - protein localization
KW  - *pulmonary hypertension/pc [Prevention]
KW  - *pulmonary hypertension/th [Therapy]
KW  - rat
KW  - signal transduction
KW  - *therapy
KW  - bleomycin/to [Drug Toxicity]
KW  - bleomycin/ip [Intraperitoneal Drug Administration]
KW  - carbon dioxide
KW  - CXCL1 chemokine/ec [Endogenous Compound]
KW  - etanercept/ip [Intraperitoneal Drug Administration]
KW  - *tumor necrosis factor alpha/ec [Endogenous Compound]
KW  - *therapeutic hypercapnia
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 303
IS  - 1
PB  - American Physiological Society (9650 Rockville Pike, Bethesda MD 20814-3991, United States)
SN  - 1522-1504
AD  - R. P. Jankov, Physiology and Experimental Medicine Program, Hospital for Sick Children Research Institute, 555 Univ. Ave, Toronto, ON, M5G 1X8, Canada. E-mail: robert.jankov@sickkids.ca
UR  - http://ajplung.physiology.org/content/303/1/L75.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=365169639
DO  - https://dx.doi.org/10.1152/ajplung.00072.2012
AB  - Bleomycin- induced lung injury is characterized in the neonatal rat by inflammation, arrested lung growth, and pulmonary hypertension (PHT), as observed in human infants with severe bronchopulmonary dysplasia. Inhalation of CO2 (therapeutic hypercapnia) has been described to limit cytokine production and to have anti-inflammatory effects on the injured lung; we therefore hypothesized that therapeutic hypercapnia would prevent bleomycin-induced lung injury. Spontaneously breathing rat pups were treated with bleomycin (1 mg/kg/d ip) or saline vehicle from postnatal days 1-14 while being continuously exposed to 5% CO2 (PaCO2 elevated by 15-20 mmHg), 7% CO2 (PaCO2 elevated by 35 mmHg), or normocapnia. Bleomycin-treated animals exposed to 7%, but not 5%, CO2, had significantly attenuated lung tissue macrophage influx and PHT, as evidenced by normalized pulmonary vascular resistance and right ventricular systolic function, decreased right ventricular hypertrophy, and attenuated remodeling of pulmonary resistance arteries. The level of CO2 neither prevented increased tissue neutrophil influx nor led to improvements in decreased lung weight, septal thinning, impaired alveolarization, or decreased numbers of peripheral arteries. Bleomycin led to increased expression and content of lung tumor necrosis factor (TNF)-alpha, which was found to colocalize with tissue macrophages and to be attenuated by exposure to 7% CO2. Inhibition of TNF-alpha signaling with the soluble TNF-2 receptor etanercept (0.4 mg/kg ip from days 1-14 on alternate days) prevented bleomycin-induced PHT without decreasing tissue macrophages and, similar to CO2, had no effect on arrested alveolar development. Our findings are consistent with a preventive effect of therapeutic hypercapnia with 7% CO2 on bleomycin-induced PHT via attenuation of macrophage-derived TNF-alpha. Neither tissue macrophages nor TNF-alpha appeared to contribute to arrested lung development induced by bleomycin. That 7% CO2 normalized pulmonary vascular resistance and right ventricular function without improving inhibited airway and vascular development suggests that vascular hypoplasia does not contribute significantly to functional changes of PHT in this model. Â© 2012 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52085412
TI  - Spectrum of chronic lung disease in a population of newborns with extremely low gestational age
AU  - Hjalmarson O.
AU  - Brynjarsson H.
AU  - Nilsson S.
AU  - Sandberg K.L.
Y1  - 2012//
KW  - Apgar score
KW  - article
KW  - artificial ventilation
KW  - *blood oxygenation
KW  - clinical article
KW  - cohort analysis
KW  - disease severity
KW  - female
KW  - gestational age
KW  - hospital discharge
KW  - human
KW  - infant
KW  - lung alveolus oxygen tension
KW  - *lung dysplasia
KW  - lung function
KW  - male
KW  - *newborn disease
KW  - oxygen therapy
KW  - pathogenesis
KW  - population research
KW  - predictor variable
KW  - priority journal
KW  - prospective study
KW  - risk factor
KW  - sensitivity and specificity
KW  - tertiary health care
KW  - *extremely low gestational age
T2  - Acta Paediatrica, International Journal of Paediatrics
LA  - English
VL  - 101
IS  - 9
PB  - Blackwell Publishing Ltd (9600 Garsington Road, Oxford OX4 2XG, United Kingdom)
SN  - 1651-2227
AD  - O. Hjalmarson, Department of Paediatrics, Queen Silvia Children's Hospital, Sahlgrenska Academy at University of Gothenburg, SE-41685 Gothenburg, Sweden. E-mail: ola.hjalmarson@pediat.gu.se
DO  - https://dx.doi.org/10.1111/j.1651-2227.2012.02753.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=52085412
AB  - Aims: To determine how the ability to oxygenate the blood develops after birth in infants of extremely low gestational age (ELGANs) and to find risk factors for chronic lung disease. Method(s): A prospective, population-based, cohort study was undertaken in one tertiary-care centre. The alveolar-arterial oxygen pressure difference (AaDO2) was monitored. Result(s): Of 41 survivors, 21 had a period of normal lung function in the first week of life, after which oxygenation deteriorated. Low gestational age and low Apgar score at 5 min were found to be strong and independent predictors of AaDO2 in the first month of life. Mechanical ventilation did not appear as a risk factor. Lung function at 36 weeks of gestation and duration of oxygen treatment could be better predicted by the severity of lung disease in the first month than by gestational age at birth. Conclusion(s): Difficulty in oxygenation was a general observation in ELGANs and not only a particular subset. Gestational age and Apgar score were independent predictors of the degree of difficulty over the first month of life. As oxygenation failure often developed after a few days, the process may be possible to treat or prevent once the pathogenesis is known. Â© 2012 The Author(s)/Acta Paediatrica Â© 2012 Foundation Acta Paediatrica.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52030011
TI  - Uncoordinated sucking patterns in preterm infants are associated with abnormal general movements
AU  - Nieuwenhuis T.
AU  - Da Costa S.P.
AU  - Bilderbeek E.
AU  - Geven W.B.
AU  - Van Der Schans C.P.
AU  - Bos A.F.
Y1  - 2012//
KW  - article
KW  - clinical article
KW  - clinical trial
KW  - female
KW  - gestational age
KW  - human
KW  - infant
KW  - male
KW  - *motor dysfunction
KW  - *prematurity
KW  - priority journal
KW  - rating scale
KW  - *sucking
KW  - *fidgety movement
T2  - Journal of Pediatrics
LA  - English
VL  - 161
IS  - 5
PB  - Mosby Inc. (11830 Westline Industrial Drive, St. Louis MO 63146, United States)
SN  - 1097-6833
AD  - T. Nieuwenhuis, University Medical Center Groningen, PO Box 30001, 9700 RB Groningen, Netherlands. E-mail: t.nieuwenhuis@umcg.nl
DO  - https://dx.doi.org/10.1016/j.jpeds.2012.04.032
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=52030011
AB  - Objective: To examine the association between sucking patterns and the quality of fidgety movements in preterm infants. Study design: We studied the sucking patterns and fidgety movements of 44 preterm infants (gestational age <35 weeks) longitudinally from 34 weeks' postmenstrual age up to 14 weeks postterm. We used the Neonatal Oral-Motor Assessment Scale during feeding and scored the sucking patterns as normal or abnormal. Abnormal sucking patterns were categorized into arrhythmic sucking and uncoordinated sucking. At 14 weeks postterm, we scored the quality of fidgety movements from videotapes as normal, abnormal, or absent. Result(s): The postmenstrual age at which sucking patterns became normal (median, 48 weeks; range, 34 to >50 weeks) was correlated with the quality of fidgety movements (Spearman rho = -0.33; P =.035). The percentage per infant of normal and uncoordinated sucking patterns was also correlated with the quality of fidgety movements (rho = 0.31; P =.048 and rho = -0.33; P =.032, respectively). Infants with uncoordinated sucking patterns had a higher rate of abnormal fidgety movements (OR, 7.5; 95% CI, 1.4-40; P =.019). Conclusion(s): The development of sucking patterns in preterm infants was related to the quality of fidgety movements. Uncoordinated sucking patterns were associated with abnormal fidgety movements, indicating that uncoordinated sucking, swallowing, and breathing may represent neurologic dysfunction. Copyright Â© 2012 Mosby Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 51876122
TI  - Bronchopulmonary dysplasia: Then and now
AU  - Philip A.G.S.
Y1  - 2012//
KW  - article
KW  - assisted ventilation
KW  - bronchiolitis
KW  - chorioamnionitis
KW  - clinical feature
KW  - fluid intake
KW  - genetic predisposition
KW  - gestational age
KW  - histopathology
KW  - human
KW  - *lung dysplasia/dt [Drug Therapy]
KW  - *lung dysplasia/et [Etiology]
KW  - *lung dysplasia/pc [Prevention]
KW  - *lung dysplasia/th [Therapy]
KW  - lung dysplasia/dt [Drug Therapy]
KW  - lung fibrosis
KW  - malnutrition
KW  - newborn
KW  - oxygen therapy
KW  - pneumonia
KW  - prematurity
KW  - priority journal
KW  - sepsis
KW  - betamethasone/ct [Clinical Trial]
KW  - betamethasone/dt [Drug Therapy]
KW  - bosentan/dt [Drug Therapy]
KW  - bosentan/po [Oral Drug Administration]
KW  - caffeine/ct [Clinical Trial]
KW  - caffeine/dt [Drug Therapy]
KW  - nitric oxide/dt [Drug Therapy]
KW  - nitric oxide/ih [Inhalational Drug Administration]
KW  - oxygen/ec [Endogenous Compound]
KW  - oxygen radical/ec [Endogenous Compound]
KW  - prostacyclin/dt [Drug Therapy]
KW  - prostacyclin/po [Oral Drug Administration]
KW  - retinol/ct [Clinical Trial]
KW  - retinol/dt [Drug Therapy]
KW  - sildenafil/dt [Drug Therapy]
KW  - sildenafil/po [Oral Drug Administration]
KW  - surfactant/dt [Drug Therapy]
T2  - Neonatology
LA  - English
VL  - 102
IS  - 1
PB  - S. Karger AG (Allschwilerstrasse 10, P.O. Box, Basel CH-4009, Switzerland)
SN  - 1661-7819
AD  - A.G.S. Philip, Division of Neonatal and Developmental Medicine, Stanford University, School of Medicine, 750 Welch Road, Palo Alto, CA 94304, United States. E-mail: aphilip@stanford.edu
DO  - https://dx.doi.org/10.1159/000336030
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=51876122
AB  - When bronchopulmonary dysplasia (BPD) was first described in 1967, the use of assisted ventilation in neonates was in its infancy. High concentrations of oxygen were implicated, and BPD was equated with 'pulmonary oxygen toxicity'. The etiologic role of not only oxygen but also peak inspiratory pressures and the duration of exposure to both was emphasized in the 1970s, but BPD remained a dreaded complication of managing respiratory distress syndrome in the 1980s. It was only after exogenous surfactant became commercially available for endotracheal administration that 'classical' BPD began to disappear and was replaced by the 'new' BPD. 'Classical' BPD was seen in more mature preterm infants (>28 weeks' gestational age) and in its severe form was characterized radiographically by micro- and macrocysts of the lung, lung hyperinflation and flattening of the diaphragms. In contrast, 'new' BPD is seen in less mature infants (<28 weeks' gestational age), has comparatively mild radiographic abnormalities and has been defined as continued oxygen requirement at 36 weeks' postmenstrual age. Pathologically, 'classical' BPD frequently revealed obstructive bronchiolitis and fibrosis of lung parenchyma, whereas 'new' BPD demonstrates minimal fibrosis but uniform arrest of development. Herein, factors which may contribute to the etiology of BPD are described, as well as possible preventative and therapeutic strategies. Copyright Â© 2012 S. Karger AG, Basel..
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 368172003
TI  - Expression and activity of epithelial sodium channel in hyperoxia-induced bronchopulmonary dysplasia in neonatal rats
AU  - Ji W.
AU  - Fu J.
AU  - Nie H.
AU  - Xue X.
Y1  - 2012//
KW  - animal cell
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - cell culture
KW  - cell isolation
KW  - controlled study
KW  - female
KW  - hyperoxia
KW  - *lung dysplasia
KW  - lung edema
KW  - lung fluid
KW  - lung parenchyma
KW  - male
KW  - newborn
KW  - nonhuman
KW  - patch clamp
KW  - priority journal
KW  - *protein expression
KW  - rat
KW  - sodium current
KW  - Western blotting
KW  - amiloride
KW  - *epithelial sodium channel/ec [Endogenous Compound]
KW  - unclassified drug
KW  - alpha epithelial sodium channel/ec [Endogenous Compound]
KW  - beta epithelial sodium channel/ec [Endogenous Compound]
KW  - gamma epithelial sodium channel/ec [Endogenous Compound]
T2  - Pediatrics International
LA  - English
VL  - 54
IS  - 6
PB  - Blackwell Publishing (550 Swanston Street, Carlton South VIC 3053, Australia)
SN  - 1442-200X
AD  - X. Xue, Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China. E-mail: xdxue@163.com
DO  - https://dx.doi.org/10.1111/j.1442-200X.2012.03662.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=368172003
AB  - Background: The aim of the present study was to investigate the expression and activity of epithelial sodium channel (ENaC) in hyperoxia-induced bronchopulmonary dysplasia (BPD) in neonatal rats. Method(s): Neonatal rats were exposed to hyperoxia to establish BPD models (control group was exposed to air), lung water was measured and Western blot was applied to detect the expression of three homologous subunits: alpha-, beta- and gamma-ENaC in the lung tissues. Furthermore, ATII cells were isolated from neonatal rats, and primarily cultured under normoxic or hyperoxic conditions. The ENaC expression was also examined in these cells. In addition, the amiloride-sensitive Na+ currents induced by hyperoxia were recorded using the whole-cell patch clamp technique. Result(s): The alpha-ENaC expression was increased after 5 days of hyperoxia in rat lung tissues, whereas not after 1, 3 and 7 days. ATII cells showed alpha-ENaC expression was reduced after 1 and 2 days' hyperoxia, but no change after 3 days. In contrast, beta- and gamma-ENaC expression was increased after hyperoxia in both in vivo and in vitro experiments. The amiloride-sensitive Na+ currents in hyperoxia-exposed ATII cells were also increased, which was consistent with the upregulated expression of beta- and gamma-ENaC. Conclusion(s): Hyperoxia upregulates the expression of ENaC, especially beta- and gamma-ENaC subunits, in both neonatal rat lung tissues and ATII cells. Hyperoxia also enhanced the activity of ENaC in neonatal rat ATII cells. Dysfunctional transport of Na+ may not be a key factor involving pulmonary edema at the early stage of BPD. Â© 2012 The Authors.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365251104
TI  - Value of serum and bronchoalveolar fluid lavage pro- and anti-inflammatory cytokine levels for predicting bronchopulmonary dysplasia in premature infants
AU  - Koksal N.
AU  - Kayik B.
AU  - Cetinkaya M.
AU  - Ozkan H.
AU  - Budak F.
AU  - Kilic S.
AU  - Canitez Y.
AU  - Oral B.
Y1  - 2012//
KW  - article
KW  - controlled study
KW  - diagnostic accuracy
KW  - disease severity
KW  - enzyme linked immunosorbent assay
KW  - female
KW  - follow up
KW  - gestational age
KW  - human
KW  - *lung dysplasia/di [Diagnosis]
KW  - *lung lavage
KW  - major clinical study
KW  - male
KW  - neonatal respiratory distress syndrome
KW  - newborn
KW  - predictive value
KW  - *prematurity
KW  - protein blood level
KW  - tracheal aspiration procedure
KW  - interleukin 10/ec [Endogenous Compound]
KW  - interleukin 1beta/ec [Endogenous Compound]
KW  - interleukin 6/ec [Endogenous Compound]
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
T2  - European Cytokine Network
LA  - English
VL  - 23
IS  - 2
PB  - John Libbey Eurotext (127, avenue de la Republique, Montrouge 92120, France)
SN  - 1148-5493
AD  - M. Cetinkaya, Division of Neonatology, Department of Pediatrics, Uludag University School of Medicine, 16059, Gorukle, Bursa, Turkey. E-mail: drmerih@yahoo.com
UR  - http://www.jle.com/e-docs/00/04/79/3C/vers_alt/VersionPDF.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=365251104
DO  - https://dx.doi.org/10.1684/ecn.2012.0304
AB  - Objective: The aim of this study was to determine the value of pro- and anti-inflammatory cytokine levels in both blood and tracheal aspirate (TA) samples that were obtained within 24 h after birth for predicting bronchopulmonary dysplasia (BPD) development in premature infants. Material(s) and Method(s): Premature infants, who were born before 32 weeks of gestation, weighing less than 1,500 g, and admitted with respiratory distress between September 2009 and December 2010, were enrolled. Tracheal aspirate samples and serum were obtained from all infants on the first day of admittance for evaluation of pro- and anti-inflammatory cytokine levels using ELISA. Result(s): The study included 102 premature babies of whom 31 (30%) had BPD diagnosed in the follow-up. Mild, moderate and severe BPD was diagnosed in 10 (32%), 14 (45%) and seven (23%) infants, respectively. Both serum and TA sample pro-inflammatory cytokine (TNF-alpha, IL-1beta, IL-6) levels were significantly higher, and antiinflammatory cytokine (IL-10) levels were significantly lower in infants who developed BPD compared with those who had no BPD. No significant differences were detected in either serum or TA sample pro- and anti-inflammatory cytokine concentrations in preterm infants with BPD in terms of BPD severity. Cut-off values of both serum and TA sample pro- and anti-inflammatory cytokine concentrations for predicting BPD were also determined. Conclusion(s): It is suggested that higher serum and TA pro-inflammatory cytokine (TNF-alpha, IL-1beta, IL-6) concentrations, along with lower anti-inflammatory cytokine (IL-10) concentrations, might be used for predicting the development of BPD in premature infants with respiratory distress at birth.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 368367701
TI  - Genetic susceptibility to neonatal lung diseases
AU  - Somaschini M.
AU  - Castiglioni E.
AU  - Presi S.
AU  - Volonteri C.
AU  - Ferrari M.
AU  - Carrera P.
Y1  - 2012//
KW  - article
KW  - disease association
KW  - DNA polymorphism
KW  - environmental factor
KW  - gene mutation
KW  - *genetic susceptibility
KW  - genetic variability
KW  - human
KW  - interstitial lung disease/co [Complication]
KW  - lung biopsy
KW  - *lung disease/di [Diagnosis]
KW  - *lung disease/et [Etiology]
KW  - lung dysplasia/di [Diagnosis]
KW  - lung dysplasia/et [Etiology]
KW  - molecular genetics
KW  - newborn
KW  - *newborn disease/di [Diagnosis]
KW  - *newborn disease/et [Etiology]
KW  - pathogenesis
KW  - respiratory distress syndrome/di [Diagnosis]
KW  - respiratory distress syndrome/et [Etiology]
KW  - respiratory failure
KW  - carrier protein/ec [Endogenous Compound]
KW  - cytokine/ec [Endogenous Compound]
KW  - dipeptidyl carboxypeptidase/ec [Endogenous Compound]
KW  - glutathione transferase P1/ec [Endogenous Compound]
KW  - lung surfactant/ec [Endogenous Compound]
KW  - matrix metalloproteinase 16/ec [Endogenous Compound]
KW  - surfactant protein B/ec [Endogenous Compound]
KW  - surfactant protein C/ec [Endogenous Compound]
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
KW  - unclassified drug
KW  - vasculotropin/ec [Endogenous Compound]
KW  - abca3 gene
KW  - angiotensin converting enzyme gene
KW  - congenital surfactant deficiency/cn [Congenital Disorder]
KW  - congenital surfactant deficiency/et [Etiology]
KW  - glutathione transferase P1 gene
KW  - MMP16 gene
KW  - *neonatal lung disease/di [Diagnosis]
KW  - *neonatal lung disease/et [Etiology]
KW  - sftpb gene
KW  - Spock2 gene
KW  - TLR 5 gene
KW  - tumor necrosis factor alpha gene
KW  - VEGF gene
KW  - adenosine triphosphate binding cassette transporter a3/ec [Endogenous Compound]
T2  - Acta Biomedica
LA  - English
VL  - 83
IS  - SUPPL.1
PB  - L'Ateneo Parmense (Via Gramsci 14, Parma 43100, Italy)
SN  - 0392-4203
AD  - M. Somaschini, Unita di Genomica per la Diagnostica delle Patologie Umane, Centro di Genomica Traslazionale e Bioinformatica, Istituto Scientifico San Raffaele -Dibit 2, Via Olgettina 60, 20132 Milano, Italy. E-mail: masomaschini@gmail.com
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=368367701
AB  - Advances in molecular genetics have enabled improvement of knowledge in pathogenesis and diagnosis of either monogenic or multifactorial neonatal lung diseases. Variants in genes regulating surfactant function and metabolism are implicated in some rare and common respiratory diseases. Congenital surfactant deficiencies are rare diseases due to mutations in genes encoding surfactant proteins and cause significant and often lethal respiratory failure in newborns and interstitial lung disease in older children. Diagnosis is made by molecular analysis and eventually confirmed by histological analysis of lung tissue. A multi-factorial contribution, resulting from interaction between multiple genes and environmental factors, has been supposed for respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD). Several potential candidate genes, especially regarding surfactant proteins and cytokines, have been shown in association with these diseases. Genetic variants predisposing to RDS or BPD are usually polymorphisms which are not causative, but can increase susceptibility to the disease. Identification of infants at risk of disease can be useful to provide them individualized therapies. Â© Mattioli 1885.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52145870
TI  - Inflammatory markers in induced sputum of school children born before 32 completed weeks of gestation
AU  - Teig N.
AU  - Allali M.
AU  - Rieger C.
AU  - Hamelmann E.
Y1  - 2012//
KW  - article
KW  - *bronchitis
KW  - child
KW  - clinical article
KW  - controlled study
KW  - disease marker
KW  - gestational age
KW  - human
KW  - lung function test
KW  - lymphocyte
KW  - macrophage
KW  - neutrophil
KW  - *prematurity
KW  - priority journal
KW  - protein blood level
KW  - school child
KW  - sputum analysis
KW  - interleukin 8/ec [Endogenous Compound]
T2  - Journal of Pediatrics
LA  - English
VL  - 161
IS  - 6
PB  - Mosby Inc. (11830 Westline Industrial Drive, St. Louis MO 63146, United States)
SN  - 1097-6833
AD  - N. Teig, Department of Neonatology and Pediatric Intensive Care, University Children's Hospital, Ruhr-University, Alexandrinenstr. 5, D-44791 Bochum, Germany. E-mail: norbert.teig@rub.de
DO  - https://dx.doi.org/10.1016/j.jpeds.2012.06.007
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=52145870
AB  - Objective: To test whether chronic bronchial inflammation may be a contributing risk factor for persistent airflow limitation in children born before 32 weeks of gestation in later life. Study design: Thirty-six of 160 children born before 32 completed weeks of gestation who were born between 1988 and 1992 were recruited at a median age of 11 years. Eighteen age-matched children born at term were controls; 47% of the premature infants and 61% of the term born children produced sputum of sufficient quality for interleukin (IL)-8, cell numbers, and differential counts. Result(s): Compared with term born children, sputum from the premature group had a higher proportion of neutrophils (62% vs 3.8%; P <.001) and higher IL-8/protein values (1.93 mug/g vs 0.64 mug/g; P =.008). Forced expiratory flow 25%-75% and forced expiratory volume in 1 second/vital capacitywere significantly lower (73.4 % vs 116% predicted, P =.002 and 97% vs 101%, P =.012, respectively). Lung function values and sputum indices did not correlate. IL-8/protein and neutrophil percentages correlated significantly with decreasing gestational age (Spearman rank coefficient = -0.58, P =.020 and -.70, P =.03 respectively). Conclusion(s): A significant proportion of school children born very preterm demonstrate persistent peripheral airway obstruction that is accompanied by neutrophilic lower airway inflammation. Copyright Â© 2012 Mosby Inc. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Aryl hydrocarbon receptor is necessary to protect fetal human pulmonary microvascular endothelial cells against hyperoxic injury: Mechanistic roles of antioxidant enzymes and RelB.
DO  - https://dx.doi.org/10.1016/j.taap.2015.03.023
AU  - Zhang, Shaojie
AU  - Patel, Ananddeep
AU  - Chu, Chun
AU  - Jiang, Weiwu
AU  - Wang, Lihua
AU  - Welty, Stephen E
AU  - Moorthy, Bhagavatula
AU  - Shivanna, Binoy
Y1  - 2015//
Y2  - 20150329//
KW  - Adult
KW  - *Antioxidants/me [Metabolism]
KW  - Apoptosis/de [Drug Effects]
KW  - *Basic Helix-Loop-Helix Transcription Factors/de [Drug Effects]
KW  - Basic Helix-Loop-Helix Transcription Factors/ge [Genetics]
KW  - Capillaries/de [Drug Effects]
KW  - *Capillaries/pa [Pathology]
KW  - Cell Proliferation/de [Drug Effects]
KW  - Cell Survival/de [Drug Effects]
KW  - Endothelial Cells/de [Drug Effects]
KW  - *Endothelial Cells/pa [Pathology]
KW  - Female
KW  - Humans
KW  - *Hyperoxia/pa [Pathology]
KW  - Inflammation/pa [Pathology]
KW  - Necrosis
KW  - Oxidative Stress/de [Drug Effects]
KW  - Pregnancy
KW  - *Pulmonary Circulation/de [Drug Effects]
KW  - RNA, Small Interfering/pd [Pharmacology]
KW  - Reactive Oxygen Species/me [Metabolism]
KW  - *Receptors, Aryl Hydrocarbon/de [Drug Effects]
KW  - Receptors, Aryl Hydrocarbon/ge [Genetics]
KW  - *Transcription Factor RelB/me [Metabolism]
T2  - Toxicology and applied pharmacology
VL  - 286
IS  - 2
SN  - 0041-008X
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25831079
AD  - United States
AB  - Hyperoxia contributes to the development of bronchopulmonary dysplasia (BPD) in premature infants. Activation of the aryl hydrocarbon receptor (AhR) protects adult and newborn mice against hyperoxic lung injury by mediating increases in the expression of phase I (cytochrome P450 (CYP) 1A) and phase II (NADP(H) quinone oxidoreductase (NQO1)) antioxidant enzymes (AOE). AhR positively regulates the expression of RelB, a component of the nuclear factor-kappaB (NF-kappaB) protein that contributes to anti-inflammatory processes in adult animals. Whether AhR regulates the expression of AOE and RelB, and protects fetal primary human lung cells against hyperoxic injury is unknown. Therefore, we tested the hypothesis that AhR-deficient fetal human pulmonary microvascular endothelial cells (HPMEC) will have decreased RelB activation and AOE, which will in turn predispose them to increased oxidative stress, inflammation, and cell death compared to AhR-sufficient HPMEC upon exposure to hyperoxia. AhR-deficient HPMEC showed increased hyperoxia-induced reactive oxygen species (ROS) generation, cleavage of poly(ADP-ribose) polymerase (PARP), and cell death compared to AhR-sufficient HPMEC. Additionally, AhR-deficient cell culture supernatants displayed increased macrophage inflammatory protein 1alpha and 1beta, indicating a heightened inflammatory state. Interestingly, loss of AhR was associated with a significantly attenuated CYP1A1, NQO1, superoxide dismutase 1(SOD1), and nuclear RelB protein expression. These findings support the hypothesis that decreased RelB activation and AOE in AhR-deficient cells is associated with increased hyperoxic injury compared to AhR-sufficient cells. Copyright Â© 2015 Elsevier Inc. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52032809
TI  - Effects of maternal captopril treatment during late pregnancy on neonatal lung development in rats
AU  - Capelari D.N.
AU  - Sanchez S.I.
AU  - Ortega H.H.
AU  - Ciuffo G.M.
AU  - Fuentes L.B.
Y1  - 2012//
KW  - animal cell
KW  - animal experiment
KW  - animal tissue
KW  - article
KW  - cell differentiation
KW  - cell proliferation
KW  - controlled study
KW  - down regulation
KW  - drug effect
KW  - enzyme activity
KW  - enzyme inhibition
KW  - female
KW  - gene sequence
KW  - histopathology
KW  - lung alveolus cell
KW  - *lung development
KW  - lung dysplasia
KW  - lung fibroblast
KW  - lung injury
KW  - lung volume
KW  - myofibroblast
KW  - newborn
KW  - nonhuman
KW  - nucleotide sequence
KW  - postnatal development
KW  - prenatal drug exposure
KW  - priority journal
KW  - protein expression
KW  - protein localization
KW  - rat
KW  - renin angiotensin aldosterone system
KW  - reverse transcription polymerase chain reaction
KW  - *third trimester pregnancy
KW  - upregulation
KW  - Western blotting
KW  - alpha smooth muscle actin/ec [Endogenous Compound]
KW  - *captopril
KW  - cycline/ec [Endogenous Compound]
KW  - dipeptidyl carboxypeptidase/ec [Endogenous Compound]
KW  - glyceraldehyde 3 phosphate dehydrogenase (NADP)/ec [Endogenous Compound]
T2  - Regulatory Peptides
LA  - English
VL  - 177
IS  - 1-3
PB  - Elsevier (P.O. Box 211, Amsterdam 1000 AE, Netherlands)
SN  - 1873-1686
AD  - L.B. Fuentes, Facultad de Quimica Bioquimica y Farmacia, Universidad Nacional de San Luis (UNSL), Ejercito de los Andes 950, D5700HHW San Luis, Argentina. E-mail: lfuen@unsl.edu.ar
DO  - https://dx.doi.org/10.1016/j.regpep.2012.05.092
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=52032809
AB  - The renin-angiotensin system (RAS) has been implicated in pulmonary hypertension and pulmonary fibrosis. In the present study, we examined the effects of maternal exposure to captopril (2.85. mg/kg/day) during late pregnancy (G13-G21) on postnatal rat lung development. Treatment with captopril during late pregnancy caused a significant decrease in ACE activity in P0 rats. Body weight decreased at P0 (p < 0.001), P8 and P15 (p < 0.01) in captopril-treated rats. Lung weight of P0 and P8 pups was lower in treated-animals (p.< 0.05). Lungs from captopril-treated animals showed impaired alveolar formation, with enlarged distal airway spaces at P8, P15 and P30. Interalveolar wall distance measured by mean linear intercept increased in treated vs. age-matched animals at P8, P15 (p < 0.001) and P30 (p < 0.05) resembling new bronchopulmonary dysplasia. In control animals, the proliferating cell nuclear antigen (PCNA) marker was higher at P0 and then drops gradually, while in captopril-treated animals PCNA marker remains higher at all stages studied. alpha-Smooth muscle actin (alpha-SMA), a marker of fibroblast differentiation into myofibroblasts, was higher at the tips of developing secondary septa in captopril-treated lungs at P8 and P15. The increased expression of PCNA and alpha-SMA in treated pups suggest that beyond the effect caused by captopril, the developing lungs have the capacity to recover once the treatment was stopped. Taking together the low weight, histomorphological changes and increased expression of cellular markers caused by ACE inhibition during late pregnancy, it appears that the RAS could be an intrinsic factor involved in secondary septa formation during lung development. Â© 2012 Elsevier B.V.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 368721018
TI  - Randomized controlled trial of two methods of nasal continuous positive airway pressure (N-CPAP) in preterm infants with respiratory distress syndrome: Underwater bubbly CPAP vs. Medijet system device
AU  - Hosseini M.-B.
AU  - Heidarzadeh M.
AU  - Balila M.
AU  - Ghojazadeh M.
AU  - Janani R.
AU  - Safavi-Nia S.
AU  - Naghavi-Behzad M.
AU  - Alikhah H.
Y1  - 2012//
KW  - abdominal distension/co [Complication]
KW  - article
KW  - brain hemorrhage/co [Complication]
KW  - cause of death
KW  - comparative study
KW  - controlled study
KW  - extremely low birth weight
KW  - female
KW  - general medical device
KW  - gestational age
KW  - human
KW  - hyperemia/co [Complication]
KW  - infant
KW  - Iran
KW  - length of stay
KW  - lung dysplasia/co [Complication]
KW  - lung hemorrhage/co [Complication]
KW  - major clinical study
KW  - male
KW  - nasal prong
KW  - necrotizing enterocolitis/co [Complication]
KW  - *neonatal respiratory distress syndrome/th [Therapy]
KW  - newborn
KW  - newborn apnea/co [Complication]
KW  - newborn intensive care
KW  - outcome assessment
KW  - oxygen consumption
KW  - pneumothorax/co [Complication]
KW  - *positive end expiratory pressure
KW  - *prematurity
KW  - randomized controlled trial
KW  - respiratory gas humidifier
KW  - respiratory tract parameters
KW  - retrolental fibroplasia/co [Complication]
KW  - small for date infant
KW  - treatment duration
KW  - treatment failure
KW  - betamethasone
KW  - bubble continuous positive airway pressure device
KW  - fraction of inspired oxygen
KW  - *nasal positive end expiratory pressure
KW  - nose hyperemia/co [Complication]
T2  - Turkish Journal of Pediatrics
LA  - English
VL  - 54
IS  - 6
PB  - Turkish Journal of Pediatrics (Samanpazan, P.O. Box 66, Ankara 06240, Turkey)
SN  - 0041-4301
AD  - Departments of Neonatology and Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Islamic Republic of
C1  - BC161: Fischer and Paykel [United Kingdom], Medijet: Medin [Germany]
C2  - Fischer and Paykel [New Zealand], Fischer and Paykel [United Kingdom], Medin [Germany]
UR  - https://www.turkishjournalpediatrics.org/pediatrics/pdf/pdf_TJP_1131.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=368721018
AB  - There has been an increasing interest in the application of non-invasive respiratory support in preterm infants, and different types of nasal continuous positive airway pressure (N-CPAP) devices are being used in Neonatal Intensive Care Units (NICUs). The objective of the present study was to compare the duration of CPAP need and possible complications of two methods of (N-CPAP) delivery: Bubble CPAP (B-CPAP) and Medijet (MJ) system device in preterm infants with respiratory distress syndrome (RDS). This prospective randomized clinical trial was performed on 161 preterm infants (28-37 weeks of gestational age) with RDS and eligible for CPAP therapy. The infants were inborn and admitted in a level III NICU of Al-Zahra Teaching Hospital (Tabriz, Iran) from April 2010 to September 2011. All infants were randomized in the first hour of life to B-CPAP or MJ system. Short binasal prongs were used in both groups and CPAP was set at the level of 5-6 cm H2O. The primary outcome of this study was duration of CPAP need (hour). Other outcomes, such as complications of the two methods of N-CPAP, were evaluated using a checklist. Ninety infants were randomized to the MJ system, and 71 were randomized to B-CPAP. The mean gestational age and birth weight were similar in the two groups, as was the duration of CPAP need (44.3+/-20.64 vs. 49.2+/-21.2 hours, respectively; p=0.66). Moreover, the probability of complications, such as CPAP failure rate, pulmonary hemorrhage, pneumothorax, intraventricular hemorrhage, abdominal distention, necrotizing enterocolitis, and bronchopulmonary dysplasia, was the same between the two study groups (p>0.05). There was a trend of more hyperemia of the nose in the B-CPAP group in comparison to the MJ system group (10% versus 3.3%, respectively), but the difference was not significant (p=0.08). In conclusion, the MJ system is as effective as B-CPAP in the management of infants with RDS.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365543347
TI  - Effects of intrauterine infection or inflammation on fetal lung development
AU  - Westover A.J.
AU  - Moss T.J.
Y1  - 2012//
KW  - arachidonic acid metabolism
KW  - article
KW  - autocrine effect
KW  - *fetus lung maturation
KW  - human
KW  - hypothalamus hypophysis adrenal system
KW  - *intrauterine infection
KW  - lung function
KW  - lung parenchyma
KW  - meta analysis (topic)
KW  - *neonatal respiratory distress syndrome/dt [Drug Therapy]
KW  - *neonatal respiratory distress syndrome/pc [Prevention]
KW  - neonatal respiratory distress syndrome/dt [Drug Therapy]
KW  - nonhuman
KW  - paracrine signaling
KW  - premature labor
KW  - protein expression
KW  - risk
KW  - sheep
KW  - stimulation
KW  - urogenital tract inflammation
KW  - 11beta hydroxysteroid dehydrogenase 1/ec [Endogenous Compound]
KW  - arachidonic acid/ec [Endogenous Compound]
KW  - corticosteroid/dt [Drug Therapy]
KW  - glucocorticoid receptor/ec [Endogenous Compound]
KW  - hydrocortisone/ec [Endogenous Compound]
KW  - lung surfactant
KW  - prostaglandin E2/ec [Endogenous Compound]
KW  - prostaglandin synthase/ec [Endogenous Compound]
T2  - Clinical and Experimental Pharmacology and Physiology
LA  - English
VL  - 39
IS  - 9
PB  - Blackwell Publishing (550 Swanston Street, Carlton South VIC 3053, Australia)
SN  - 1440-1681
AD  - T.J. Moss, Ritchie Centre, Monash Institute of Medical Research, Po Box 5418, Clayton, Vic. 3168, Australia. E-mail: tim.moss@monash.edu
DO  - https://dx.doi.org/10.1111/j.1440-1681.2012.05742.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=365543347
AB  - Intrauterine infection or inflammation is common in cases of preterm birth. Preterm infants are at risk of acute respiratory distress as a result of lung immaturity; evidence of exposure to infection and/or inflammation before birth is associated with a reduced risk of neonatal respiratory distress syndrome (RDS). Experimentally induced intrauterine inflammation or infection in sheep causes a precocious increase in pulmonary surfactant in the preterm lungs that improves preterm lung function, consistent with the reduced risk of RDS in human infants exposed to infection and/or inflammation before birth. The effects of intrauterine inflammation on fetal lung development appear to result from direct action of proinflammatory stimuli within the lungs rather than by systemic signals, such as the classical glucocorticoid-mediated lung maturation pathway. However, paracrine and/or autocrine production and/or metabolism of glucocorticoids in fetal lung tissue may occur as a result of inflammation-induced changes in the expression of 11beta-hydroxysteroid dehydrogenase (types 1 and 2). Likely candidates that mediate inflammation-induced surfactant production by the preterm lung include prostaglandin E2 and/or other arachidonic acid metabolites. Intrauterine inflammation induces the expression of enzymes responsible for prostaglandin production in fetal lung tissue. Inhibition of prostaglandin production prevents, at least in part, the effects of inflammation on fetal lungs. Our experiments are identifying mechanisms of surfactant production by the preterm lungs that may be exploited as novel therapies for preventing respiratory distress in preterm infants. Elucidation of the effects of inflammation on the fetal lungs and other organs will allow more refined approaches to the care of preterm infants exposed to inflammation in utero. Clinical and Experimental Pharmacology and Physiology Â© 2012 Blackwell Publishing Asia Pty Ltd.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365238607
TI  - Transpulmonary flux of S-nitrosothiols and pulmonary vasodilation during nitric oxide inhalation role of transport
AU  - Torok J.A.
AU  - Brahmajothi M.V.
AU  - Zhu H.
AU  - Tinch B.T.
AU  - Auten R.L.
AU  - McMahon T.J.
Y1  - 2012//
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - effluent
KW  - female
KW  - lung alveolus
KW  - lung vascular resistance
KW  - male
KW  - mouse
KW  - nonhuman
KW  - protein expression
KW  - pulmonary hypertension
KW  - *vasodilatation
KW  - 15 hydroxy 11alpha,9alpha epoxymethanoprosta 5,13 dienoic acid
KW  - *amino acid transporter
KW  - carboxylic acid
KW  - *cysteine
KW  - leucine
KW  - *nitric oxide
KW  - *s nitrosothiol
KW  - unclassified drug
KW  - *lung vasodilatation
KW  - 2 amino 2 norborane carboxylic acid
T2  - American Journal of Respiratory Cell and Molecular Biology
LA  - English
VL  - 47
IS  - 1
PB  - American Thoracic Society (61 Broadway 4th Floor, New York NY 10006 - 2755, United States)
SN  - 1044-1549
AD  - T.J. McMahon, Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, NC, United States. E-mail: tim.mcmahon@duke.edu
UR  - http://ajrcmb.atsjournals.org/content/47/1/37.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=365238607
DO  - https://dx.doi.org/10.1165/rcmb.2011-0439OC
AB  - Inhaled nitric oxide (iNO) is used to treat pulmonary hypertension and is being investigated for prevention of bronchopulmonary dysplasia in neonates. Extrapulmonary effects of iNO are widely recognized, but the underlying chemistry and pharmacology are poorly understood. Growing evidence suggests that, in addition to acting via diffusion, NO can be converted into nitrosants capable of reacting with endogenous L-cysteine (L-Cys) in the alveolar lining fluid, forming S-nitrosothiol (SNO)-L-cysteine (CSNO). CSNO can then enter cells via the type L amino acid transporter (LAT). To determine the influence of LAT and supplemental L-Cys on the functional activity of iNO and transpulmonary movement of SNOs or other related species, we exposed C57Bl6 mice to nebulized L-Cys or D-cysteine (D-Cys) and/or LAT competitors. Isolated lungs were then perfused with physiologic buffer while effluent was collected to assay perfusate SNOs. Nebulized L-Cys, but not D-Cys, augmented the iNO-induced increase in circulating SNOs in the effluent without altering iNO-induced pulmonary vasodilation. Addition to the perfusate of either L-leucine (L-Leu) or 2-amino-2-norborane carboxylic acid, two distinct LAT competitors, inhibited appearance in the perfusate of SNOs in L-Cys-exposed lungs; a higher concentration of L-Leu significantly inhibited the iNO-induced pulmonary vasodilation as well as SNO accumulation. We conclude that iNO-induced pulmonary vasodilation and the transpulmonary movement of iNO-derived SNOs are mediated in part by formation of extracellular CSNO, uptake by alveolar epithelial LAT, and/or export by LAT from the pulmonary endothelium into the circulation. Therapies that exploit and optimize LAT-dependent SNO transport might improve the efficacy of and clinical outcomes with NO-based therapy by improving systemic SNO delivery. Copyright Â© 2012 by the American Thoracic Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 52090977
TI  - Bone marrow mesenchymal stem cells attenuate lung inflammation of hyperoxic newborn rats
AU  - Zhang H.
AU  - Fang J.
AU  - Su H.
AU  - Yang M.
AU  - Lai W.
AU  - Mai Y.
AU  - Wu Y.
Y1  - 2012//
KW  - adipocyte
KW  - animal cell
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - bone marrow cell
KW  - cartilage cell
KW  - cell differentiation
KW  - cell isolation
KW  - controlled study
KW  - gene expression
KW  - histology
KW  - *hyperoxia
KW  - in vitro gene transfer
KW  - *lung dysplasia/th [Therapy]
KW  - mesenchymal stem cell
KW  - newborn
KW  - nonhuman
KW  - osteoblast
KW  - pneumonia
KW  - randomized controlled trial
KW  - rat
KW  - tissue level
KW  - weight gain
KW  - beta1 integrin/ec [Endogenous Compound]
KW  - green fluorescent protein
KW  - Hermes antigen/ec [Endogenous Compound]
KW  - lentivirus vector
KW  - oxygen
KW  - Thy 1 antigen/ec [Endogenous Compound]
T2  - Pediatric Transplantation
LA  - English
VL  - 16
IS  - 6
PB  - Blackwell Publishing Ltd (9600 Garsington Road, Oxford OX4 2XG, United Kingdom)
SN  - 1399-3046
AD  - H. Zhang, Department of Pediatric, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Yanjiang Road 107, Guangzhou, Guangdong 510120, China. E-mail: zhhosh@126.com
DO  - https://dx.doi.org/10.1111/j.1399-3046.2012.01709.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=52090977
AB  - BPD is a significant global health problem and currently lacks effective therapy. We established a neonatal rat model of BPD to investigate therapeutic potential of BMSCs in neonatal lung disease. BMSCs were isolated, identified, and transfected by lentiviral vector carrying GFP gene in vitro. Neonatal rats were injected intravenously with either BMSCs or PBS after they had been already exposed to high oxygen for seven days, and assessed on post-injection day 3, day 7, and day 14 for weight gaining, lung histology, radical alveolar counts, and lung cytokine level. BMSCs were positive for CD29, CD44, and CD90 whereas negative for CD34, CD45, CD11b and with differentiation potential into osteoblasts, adipocytes, and chondrocytes. BMSCs expressed GFP after transfected by lentivirus. After injection, BMSCs exert their therapeutic benefit of improving weight gaining, preventing alveolar growth arrest, and suppressing lung inflammation of neonatal rats. Intravenous delivery of BMSCs in newborn rats conferred protection from hyperoxia-induced lung injury, and one of the effects of BMSCs treatment is suppressing lung inflammation. Â© 2012 John Wiley & Sons A/S.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 364237706
TI  - Intra-amniotic LPS and antenatal betamethasone: Inflammation and maturation in preterm lamb lungs
AU  - Kuypers E.
AU  - Collins J.J.P.
AU  - Kramer B.W.
AU  - Ofman G.
AU  - Nitsos I.
AU  - Jane Pillow J.
AU  - Polglase G.R.
AU  - Kemp M.W.
AU  - Newnham J.P.
AU  - Gavilanes A.W.D.
AU  - Nowacki R.
AU  - Ikegami M.
AU  - Jobe A.H.
AU  - Kallapur S.G.
Y1  - 2012//
KW  - animal cell
KW  - animal experiment
KW  - animal model
KW  - article
KW  - cell activation
KW  - controlled study
KW  - drug effect
KW  - female
KW  - *fetus lung maturity
KW  - fetus wastage
KW  - gestational age
KW  - inflammatory cell
KW  - leukocyte differential count
KW  - lung compliance
KW  - lung gas exchange
KW  - lung lavage
KW  - lung volume
KW  - male
KW  - nonhuman
KW  - pneumonia/dt [Drug Therapy]
KW  - *pneumonia/dt [Drug Therapy]
KW  - *prematurity
KW  - prenatal care
KW  - priority journal
KW  - protein expression
KW  - amyloid A protein/ec [Endogenous Compound]
KW  - *betamethasone/dt [Drug Therapy]
KW  - *betamethasone/im [Intramuscular Drug Administration]
KW  - CD3 antigen/ec [Endogenous Compound]
KW  - interleukin 1beta/ec [Endogenous Compound]
KW  - interleukin 6/ec [Endogenous Compound]
KW  - interleukin 8/ec [Endogenous Compound]
KW  - lipopolysaccharide
KW  - monocyte chemotactic protein 1/ec [Endogenous Compound]
KW  - myeloperoxidase/ec [Endogenous Compound]
KW  - surfactant/ec [Endogenous Compound]
KW  - toll like receptor 2/ec [Endogenous Compound]
KW  - toll like receptor 4/ec [Endogenous Compound]
KW  - toll like receptor 9/ec [Endogenous Compound]
KW  - transcription factor FOXP3/ec [Endogenous Compound]
KW  - transcription factor PU 1/ec [Endogenous Compound]
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 302
IS  - 4
PB  - American Physiological Society (9650 Rockville Pike, Bethesda MD 20814-3991, United States)
SN  - 1522-1504
AD  - S. G. Kallapur, Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 3333 Burnet Ave., Cincinnati, OH 45229-3039, United States. E-mail: suhas.kallapur@cchmc.org
UR  - http://ajplung.physiology.org/content/302/4/L380.full.pdf#page=1&view=FitH
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=364237706
DO  - https://dx.doi.org/10.1152/ajplung.00338.2011
AB  - The proinflammatory stimulus of chorioamnionitis is commonly associated with preterm delivery. Women at risk of preterm delivery receive antenatal glucocorticoids to functionally mature the fetal lung. However, the effects of the combined exposures of chorioamnionitis and antenatal glucocorticoids on the fetus are poorly understood. Time-mated ewes with singleton fetuses received an intra-amniotic injection of lipopolysaccharide (LPS) either preceding or following maternal intramuscular betamethasone 7 or 14 days before delivery, and the fetuses were delivered at 120 days gestational age (GA) (term = 150 days GA). Gestation matched controls received intra-amniotic and maternal intramuscular saline. Compared with saline controls, intra-amniotic LPS increased inflammatory cells in the bronchoalveolar lavage and myeloperoxidase, Toll-like receptor 2 and 4 mRNA, PU.1, CD3, and Foxp3-positive cells in the fetal lung. LPS-induced lung maturation measured as increased airway surfactant and improved lung gas volumes. Intra-amniotic LPS-induced inflammation persisted until 14 days after exposure. Betamethasone treatment alone induced modest lung maturation but, when administered before intra-amniotic LPS, suppressed lung inflammation. Interestingly, betamethasone treatment after LPS did not counteract inflammation but enhanced lung maturation. We conclude that the order of exposures of intra-amniotic LPS or maternal betamethasone had large effects on fetal lung inflammation and maturation. Â© 2012 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365988232
TI  - LPS-induced chorioamnionitis and antenatal corticosteroids modulate Shh signaling in the ovine fetal lung
AU  - Collins J.J.P.
AU  - Kuypers E.
AU  - Nitsos I.
AU  - Jane Pillow J.
AU  - Polglase G.R.
AU  - Kemp M.W.
AU  - Newnham J.P.
AU  - Cleutjens J.P.
AU  - Frints S.G.M.
AU  - Kallapur S.G.
AU  - Jobe A.H.
AU  - Kramer B.W.
Y1  - 2012//
KW  - animal experiment
KW  - article
KW  - *chorioamnionitis
KW  - controlled study
KW  - delivery
KW  - drug efficacy
KW  - drug exposure
KW  - ewe
KW  - female
KW  - fetus
KW  - *fetus lung maturity
KW  - gestational age
KW  - lung alveolus
KW  - *lung development
KW  - lung structure
KW  - nonhuman
KW  - nucleotide sequence
KW  - premature labor/dt [Drug Therapy]
KW  - premature labor/pc [Prevention]
KW  - prenatal period
KW  - priority journal
KW  - protein blood level
KW  - protein expression
KW  - protein folding
KW  - protein function
KW  - signal transduction
KW  - single drug dose
KW  - betamethasone/im [Intramuscular Drug Administration]
KW  - betamethasone/pd [Pharmacology]
KW  - betamethasone acetate plus betamethasone sodium phosphate
KW  - bone morphogenetic protein 4/ec [Endogenous Compound]
KW  - collagen/ec [Endogenous Compound]
KW  - collagen type 1/ec [Endogenous Compound]
KW  - *corticosteroid/pd [Pharmacology]
KW  - elastin/ec [Endogenous Compound]
KW  - *Escherichia coli lipopolysaccharide/ad [Drug Administration]
KW  - fibroblast growth factor 10/ec [Endogenous Compound]
KW  - medroxyprogesterone acetate/do [Drug Dose]
KW  - medroxyprogesterone acetate/dt [Drug Therapy]
KW  - medroxyprogesterone acetate/im [Intramuscular Drug Administration]
KW  - messenger RNA/ec [Endogenous Compound]
KW  - *sonic hedgehog protein/ec [Endogenous Compound]
KW  - transcription factor Gli1/ec [Endogenous Compound]
KW  - unclassified drug
KW  - collagen type 1 alpha 1/ec [Endogenous Compound]
KW  - collagen type 1 alpha 2/ec [Endogenous Compound]
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 303
IS  - 9
PB  - American Physiological Society (9650 Rockville Pike, Bethesda MD 20814-3991, United States)
SN  - 1522-1504
AD  - B. W. Kramer, Dept. of Pediatrics, Maastricht Univ., Medical Center, Postbus 5800, Maastricht, 6202 AZ Maastricht, Netherlands. E-mail: b.kramer@mumc.nl
C3  - celestone soluspan: Schering Plough [Australia], depo provera: Kenral [Australia]
C4  - Sigma [United States], Schering Plough [Australia], Kenral [Australia]
UR  - http://ajplung.physiology.org/content/303/9/L778.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=365988232
DO  - https://dx.doi.org/10.1152/ajplung.00280.2011
AB  - Chorioamnionitis and antenatal corticosteroids mature the fetal lung functionally but disrupt late-gestation lung development. Because Sonic Hedgehog (Shh) signaling is a major pathway directing lung development, we hypothesized that chorioamnionitis and antenatal corticosteroids modulated Shh signaling, resulting in an altered fetal lung structure. Time-mated ewes with singleton ovine fetuses received an intra-amniotic injection of lipopolysaccharide (LPS) and/or maternal intramuscular betamethasone 7 and/or 14 days before delivery at 120 days gestational age (GA) (term = 150 days GA). Intra-amniotic LPS exposure decreased Shh mRNA levels and Gli1 protein expression, which was counteracted by both betamethasone pre- or posttreatment. mRNA and protein levels of fibroblast growth factor 10 and bone morphogenetic protein 4, which are important mediators of lung development, increased 2-fold and 3.5-fold, respectively, 14 days after LPS exposure. Both 7-day and 14-day exposure to LPS changed the mRNA levels of elastin (ELN) and collagen type I alpha 1 (Col1A1) and 2 (Col1A2), which resulted in fewer elastin foci and increased collagen type I deposition in the alveolar septa. Corticosteroid posttreatment prevented the decrease in ELN mRNA and increased elastin foci and decreased collagen type I deposition in the fetal lung. In conclusion, fetal lung exposure to LPS was accompanied by changes in key modulators of lung development resulting in abnormal lung structure. Betamethasone treatment partially prevented the changes in developmental processes and lung structure. This study provides new insights into clinically relevant prenatal exposures and fetal lung development. Â© 2012 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 612983583
TI  - Nutrition and pediatric lung disease
AU  - Lands L.C.
Y1  - 2012//
KW  - adaptive immunity
KW  - air pollution
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - apple
KW  - artificial ventilation
KW  - asthma
KW  - atopy
KW  - blood level
KW  - blood oxygenation
KW  - bone
KW  - breast feeding
KW  - caloric intake
KW  - commensal
KW  - controlled study
KW  - cross-sectional study
KW  - cytosol
KW  - dendritic cell
KW  - Dermatophagoides
KW  - disease exacerbation
KW  - drug combination
KW  - drug solubility
KW  - eosinophil
KW  - exposure
KW  - extracellular space
KW  - family study
KW  - fat intake
KW  - female
KW  - forced expiratory volume
KW  - gene activation
KW  - gestational age
KW  - glutathione metabolism
KW  - grape
KW  - hydroxylation
KW  - immunocompetent cell
KW  - infant
KW  - inflammatory cell
KW  - innate immunity
KW  - Japan
KW  - kidney
KW  - lipid solubility
KW  - liver
KW  - *lung dysplasia
KW  - lung fluid
KW  - lung function
KW  - *Mediterranean diet
KW  - membrane
KW  - metabolite
KW  - microflora
KW  - mitochondrion
KW  - multicenter study
KW  - murine model
KW  - neutrophil
KW  - nonhuman
KW  - odds ratio
KW  - oxidation reduction potential
KW  - oxidative stress
KW  - peroxisome
KW  - photostimulation
KW  - precursor
KW  - preschool child
KW  - prevention
KW  - promoter region
KW  - Pseudomonas aeruginosa
KW  - pulmonology
KW  - recall
KW  - regulatory T lymphocyte
KW  - respiratory tract allergy
KW  - risk factor
KW  - smoking
KW  - thorax
KW  - total parenteral nutrition
KW  - transcription regulation
KW  - vegetable
KW  - wheezing
KW  - allergen
KW  - alpha tocopherol
KW  - amino acid
KW  - antioxidant
KW  - arachidonic acid
KW  - ascorbic acid
KW  - beta carotene
KW  - calcifediol
KW  - calcium
KW  - caspase recruitment domain protein 4
KW  - catalase
KW  - colecalciferol
KW  - endogenous compound
KW  - fish oil
KW  - gamma linolenic acid
KW  - glutathione
KW  - glutathione disulfide
KW  - glutathione peroxidase
KW  - glutathione reductase
KW  - irritant agent
KW  - leukotriene
KW  - linoleic acid
KW  - magnesium
KW  - manganese
KW  - omega 3 fatty acid
KW  - oxygen
KW  - parathyroid hormone
KW  - peroxide
KW  - pigment
KW  - polyphenol
KW  - prebiotic agent
KW  - primrose oil
KW  - reactive nitrogen species
KW  - reduced nicotinamide adenine dinucleotide phosphate oxidase
KW  - resveratrol
KW  - retinol
KW  - scavenger
KW  - selenium
KW  - superoxide dismutase
KW  - toll like receptor
KW  - transcription factor Nrf2
KW  - water
KW  - zinc
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 13
IS  - Supplement 1
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - L.C. Lands, McGill University, Pediatric Respiratory Medicine, Montreal Children's Hospital, Montreal, Canada
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=612983583
AB  - In this presentation, I will address irritants and antioxidant defences, nutritional aspects of asthma, nutrition and chronic lung disease of prematurity, and developing concepts related to vitamin D. Irritants and antioxidant defences: There a variety of irritating and pro-inflammatory environmental stimuli, including air pollution and smoking. Further, there are allergic agents, such as house dust mite that include oxidant-producing NADPH oxidases and infectious agents, such as Pseudomonas aeruginosa, with pigments that can stimulate the production of oxidants, such as pyocianin. Inflammatory cells will also lead to the production of reactive oxidative species and reactive nitrogen species. Nutrition will affect the microflora. The microflora has multiple effects on both innate immunity, eg by competing with pathogens, signalling through Toll Like Receptors (TLR's), peptadoglycan affecting neutrophil function through NOD1, and effects on adaptive immunity. Changes in the adaptive immunity may largely work through dendritic cell promotion of regulatory T cells (Tregs). This can lead to tolerance. Prebiotic oligosaccharides can promote the growth of beneficial commensal organisms and can also act directly on cellular receptors on immune cells such as Tregs (van 't Land B et al, Eur J Pharmacol 2011; 668: S101-S107). The antioxidant network really functions as a network, involving dietary elements, such as vitamins E and C and beta-carotene, the glutathione system which requires dietary precursors for glutathione synthesis, and enzymes, including SOD, catalase, Glutathione Peroxidase and Glutathione Reductase. Further, there is compartmentalization of antioxidant defenses. Vitamin E is lipid soluble and resides in membranes to protect the lipid fraction. Vitamin C is water soluble, and so works in the cytoplasm and extracellular fluid space. In fact, up to 30% of plasma antioxidant capacity can be attributed to Vitamin C. There are a variety of superoxide dismutases that require metals such as manganese and copper. Catalase exists in peroxisomes. Glutathione, which is the major scavenger of peroxides, is also responsible for restoring the antioxidant potential of vitamin E and vitamin C. Glutathione exists primarily intracellularly, mostly in the cytoplasm, but also in the mitochondria where oxidants are produced. It also is found in high abundance in the lung lining fluid, which is not surprising given the number of oxidants our lungs are exposed to daily. NrF2 is a transcription factor that is activated when there is oxidative stress in the cytosol. It binds to the promoter regions of many genes representing Phase II enzymes. This leads to a coordinated activation of many proteins active in the control of antioxidant defenses, such as the production of glutathione. Nutritional aspects related to asthma: Asthma is associated with oxidative stress. The inflammatory cells involved in asthma include both eosinophils and neutrophils, and both of these cells types produce oxidants. While airway total glutathione may be elevated in patients with asthma, potentially as a defense against oxidative stress, the amount of oxidized glutathione is elevated (Kelly FJ et al, Lancet, 1999; 354: 482-483). Further, patients with asthma have decreased amounts of several dietary-derived antioxidants, e.g. vitamins E and C, in their lung lining fluid (Kelly FJ et al, Lancet, 1999; 354: 482-483). Total antioxidant capacity of serum is reduced during an acute exacerbation. Of note, upon recovery, the degree of improvement in lung function correlated with the degree of increase in antioxidant capacity and the recovery level of antioxidant capacity (Katsoulis K et al, J Asthma 2003; 40: 847-853). As an example of derangement of antioxidant defences, the activity of Superoxide Dismutase is also suppressed during an asthma exacerbation (Katsoulis K et al, Monaldi Arch Chest Dis 2010; 73: 99-104). So can asthma be prevented? In a recent systematic review, it was noted that there are no randomized controlled trials. However, serum vitamin A is lower in asthmatic children, and maternal intakes of vitamin D and E during pregnancy were protective from developing wheezing and asthma outcomes (for example, Martindale et al, AJRCCM, 2005; Devereux G et al, AJRCCM, 2006; 174: 499-507). A Mediterranean diet seems to help in persistent wheeze, and fruit and vegetable intake appear beneficial for asthma (Nurmatov U et al, JACI 2011; 127: 724-733). In a cross-sectional study of three European countries, higher intakes of fruits and vegetables was associated with better lung function, as determined by the Forced Expiratory Volume in 1 second or FEV1. So, in other words, your mother was right (Tabak C et al, Thorax, 1999; 54: 1021-1026)! An apple a day does keep the doctor away; more than five apples per week is associated with a lowered incidence of asthma (Shaheen et al, Am J Resp Crit Care Med, 2001; 164: 1823-1828). Low intake of selenium, a co-factor in glutathione peroxidase activity, is also associated with asthma. However, it is easy to have too much selenium in your diet (Shaheen et al, Am J Resp Crit Care Med, 2001; 164: 1823-1828). Dietary intake of n-6 PUFAs has increased with the rise in the use of vegetable oils, such as margarines, containing lots of linoleic acid. This has resulted in an alteration in the intake of essential fatty acids skewed towards the n-6 PUFAs. n-6-PUFAs give rise to arachidonic acid and its metabolites, including leukotrienes, known contributors to asthma. Supplementing young children with fish oils, rich in omega-3 fatty acids will increase blood concentrations of these fatty acids (Marks GB et al, JACI 2006; 118: 53-61). However their effect on asthma symptoms at age 5years was not demonstrable. Further arachadonic acid levels may be low in atopy so simply focusing on omega-3 which targets arachadonic acid metabolism may not be adequate. Some n-6 fatty acids, such as gamma-linolenic acid (GLA), found in plant oils such as evening primrose oil, have been found to reduce inflammation. GLA in supplements is largely converted to DGLA, known to be anti-inflammatory; this conversion being promoted by adequate intakes of magnesium, zinc, vitamins C, B3, and B6 (Marks GB et al, JACI 2006; 118: 53-61; Sala-Vila A et al, Clin Exp All 2008; 38: 1432-1450 ). In looking at fatty acid intake during pregnancy, a UK study found that the ratio of linoleic: a-linolenic acid (n-6:n-3 PUFA) was slightly. associated with late-onset wheeze (Odds Ratio 1.30). However, the associations seen were no longer significant after adjusting for multiple comparisons (Newson RB et al, JACI 2004; 114: 531-537). In a more recent study from Japan, intake of linolenic (n-3) and DHA (n-3 product) was associated with decreased risk of wheeze (Odds Ratio 0.52). Intake of n-6 PUFAs and linoleic acid was not associated with increased risk of wheeze. Further, there was no exposure-response relationships to intake of meat and fish and n-3:n-6 PUFA consumption (Miyake Y et al, Thorax 2009; 64: 815- 821). As for breastfeeding as a preventative measure for asthma, the potential protective effect of breastfeeding is strongest in those with a positive family history for atopy (Gdalevich M et al, J Pediatr 2001; 139: 261-266). There is a move to study functional or medicinal foods. For example, resveratrol, a natural nonflavenoid polyphenol found in fruits and vegetables especially grapes, reduces airway hyper-reactivity in a murine model of asthma (Lee M et al, Int Pharmacol 2009; 9: 418- 424). Nutrition and chronic lung disease of prematurity or bronchopulmonary dysplasia (BPD): Nutritional and antioxidant interventions for the prevention of BPD have had limited success to date. However, there is data on risk factors for the development of BPD. In a single center study, while total caloric intake did not differ, those with BPD received less enteral calories during the first two weeks of life (Wemhoner A et al BMC Pulmonary Medicine 2011; 11:7). These enteral caloric differences were true for carbohydrate, protein, and total calories in the first two weeks of life. Of note those receiving excess fluid developed BPD (Wemhoner A et al BMC Pulmonary Medicine 2011; 11:7). In a large multi-center study, where the degree of illness was defined by needing mechanical ventilation for less than the first seven days or seven or more days, increased total caloric intake was associated with eventually having less severe BPD (Ehrenkranz RA et al Ped Res 2011; 69: 522-529). Of note, again all those receiving excess fluid developed BPD. Another study looked at infants born at less than 28 weeks and weighing less than 1000 gm who required total parenteral nutrition. The combination of high supplemental oxygen with vitamins being added to the amino acid portion of total parental nutrition rather than being added to the lipid portion increased oxidative stress (whole blood glutathione redox potential) in infants. Recall that vitamin E serves to stabilize lipids. The severity of eventual BPD at 36 weeks corrected gestational age was associated with the degree of oxidative stress at Day 7 or 10 (Chessex P et al, Free Rad Med Biol 2010; 49: 1380-1386). Vitamin D and lung disease: Vitamin D3 comes from two sources: the skin through photostimulation, and our diet. Vitamin D3 is first hydroxylated in the liver to 25-OH vitamin D3. Typically vitamin D is monitored through serum levels of 25-OH vitamin D3. For bone protection, levels of 30 ng/ml or 75 nmol/L are sought. 25-OH Vitamin D3 then undergoes a second hydroxylation step to its active form, 1,25-di-hydroxy vitamin D3. The best known second hydroxylation occurs in the kidney and is under regulation from parathyroid hormone, and is largely responsible for regulating serum calcium.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 612983415
TI  - Non invasive ventilation strategy in newborns
AU  - Kugelman A.
Y1  - 2012//
KW  - apnea monitoring
KW  - arterial carbon dioxide tension
KW  - catheter
KW  - cerebral palsy
KW  - clinical effectiveness
KW  - controlled study
KW  - death
KW  - endotracheal intubation
KW  - extremely low birth weight
KW  - extubation
KW  - follow up
KW  - general condition
KW  - gestational age
KW  - human
KW  - hypercapnia
KW  - infant
KW  - intermittent mandatory ventilation
KW  - intermittent positive pressure ventilation
KW  - learning curve
KW  - lung dysplasia
KW  - lung mechanics
KW  - maturation
KW  - meta analysis
KW  - morbidity
KW  - nasal prong
KW  - nervous system malformation
KW  - newborn
KW  - newborn apnea
KW  - *noninvasive ventilation
KW  - oxygenation
KW  - prematurity
KW  - prevention
KW  - respiratory distress syndrome
KW  - respiratory drive
KW  - retrospective study
KW  - thorax wall
KW  - upper respiratory tract
KW  - ventilator
KW  - work of breathing
KW  - steroid
KW  - surfactant
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 13
IS  - Supplement 1
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - A. Kugelman, Department of Neonatology and Pediatric Pulmonary Unit, Bnai Zion Medical Center, B and R Rappaport Faculty of Medicine, Technion, Haifa, Israel
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=612983415
AB  - The comprehensive strategy to prevent bronchopulmonary dysplasia (BPD) is based on ventilatory and non-ventilatory measures [1]. The ventilatory route allows an individualized endotracheal intubation approach. Two recent studies concluded that early nasal continuous positive airway pressure (NCPAP) is a safe alternative to immediate intubation in extremely low birth weight (ELBW) infants [2,3]. Endotracheal intubation and ventilation can result in significant damage to premature lungs [4] and are independently associated with cerebral palsy [5]. Furthermore, despite new modes of ventilation and surfactant, BPD remains a significant morbidity and its incidence was correlated with the use and length of endotracheal mechanical ventilation [6]. BPD in itself is associated with adverse neurodevelopmental outcome [7]. Thus, we need to avoid endotracheal ventilation, if possible. Recent trends show an increased use of NCPAP and decreased use of endotracheal ventilation even in ELBW infants [8]. The use of NCPAP requires experience, and learning curves show improved outcomes in rates of BPD [9]. When the infant requires nasal respiratory support (NRS), we should aim for adequate oxygenation (SpO2 of 88-92%), permissive hypercapnia (PaCO2 of 45-55mm Hg, pH> 7.2) and gentle ventilation, similarly as on endotracheal ventilation [1]. NCPAP can be used as the early primary treatment of active respiratory distress syndrome (RDS) (to avoid intubation or as part of the INSURE [INtubation SURfactant Extubation] approach), or later, post extubation at RDS resolution, in order to allow shortening of the duration of endotracheal ventilation and to treat apnea of prematurity. However, the common use of NCPAP raises several questions. Does it really prevent BPD? Can we enhance NCPAP? What is the role of surfactant in the era of NRS? While previous studies have shown that the lowest incidence of BPD [10,11] or pulmonary morbidity in ELBW infants [12] occurred in NICUs practicing early NCPAP instead of initial mechanical ventilation, new studies [2,3] do not support that conclusion, and report comparable rates of BPD in ELBW infants treated initially with NCPAP as compared to endotracheal ventilation with surfactant administration. Can we enhance NCPAP and get better outcome for NRS by using nasal intermittent positive pressure ventilation (NIPPV)? NIPPV was defined as a method of augmenting NCPAP by delivering ventilator breaths via nasal prongs [13]. The rationale behind the use of NIPPV is the administration of "sigh" to the infant, thus opening microatelectasis and recruiting more ventilation units. It was shown that synchronized NIPPV (SNIPPV) compared with NCPAP may improve the patency of the upper airway, could activate the respiratory drive, improves thoraco-abdominal synchrony, stabilizes the chest wall, improves lung mechanics and decreases the work of breathing in premature infants. When NIPPV was compared to NCPAP for the different indications of NRS, it was shown to enhance the potential of NRS. NIPPV for the initial treatment of RDS was shown to significantly decrease the rate of endotracheal ventilation and subsequently the rate of BPD when compared to NCPAP [14]. The results of this study in regards to BPD needs to be taken with caution as the number of ELBW infants in this study was relatively small. Two additional studies [15,16] reported shorter duration of respiratory support [15] and reduced need for endotracheal ventilation with NIPPV [16] compared to NCPAP but no difference in the rate of BPD. A recent study [17] reported no significant difference in rates of endotracheal intubation at 72 hours or in rates of BPD. However, in posthoc analysis, from 24 to 72 hours of life, significantly more infants in the NIPPV group remained extubated compared with those in the NCPAP group. The authors concluded that their results suggest that early use of NIPPV is feasible and safe and may have beneficial effects when compared with NCPAP, especially for infants with a birth weight >1000 g. SNIPPV vs. NCPAP for later use, post extubation at RDS resolution, as a "bridge" to spontaneous unsupported breathing was shown to be more effective than NCPAP [18,19]. A pooled meta-analysis showed that SNIPPV was more effective than NCPAP in preventing failure of extubation [RR 0.21 (0.10, 0.45)] and the number needed to treat was only 3 infants to prevent one extubation failure [18,19]. SNIPPV vs. NCPAP, post extubation, also tended to decrease the rate of BPD [18,19]. Two retrospective studies [20,21] showed a significantly decreased rate of BPD with NIPPV compared to NCPAP. The larger one showed that early or later use of SNIPPV vs. NCPAP, in infants at greatest risk of BPD or death (500-750 g) was associated with decreased rate of BPD and/or death and decreased rate of neurodevelopmental impairment and/or death [21]. SNIPPV may be more effective than NCPAP also for apnea of prematurity [22]. A meta-analysis, regarding apnea of prematurity, suggests that SNIPPV is more efficacious with apnea that is frequent or severe. However, the studies performed addressed short-term outcomes and as such could not address properly the incidence of requirement for reintubation. Thus, more studies are needed before recommending SNIPPV as standard of care for apnea of prematurity [22]. While non-invasive ventilation is probably safe, its success depends on gestational age [2,3,8]. The data indicate that surfactant may still have a significant role in the treatment of RDS, especially in ELBW infants. Recently, Morley et al. [2] and the SUPPORT study [3] reported on an intubation rate of ~50% in their NCPAP group in ELBW infants. This leads us to the INSURE approach. This approach may allow the infant to benefit from both, surfactant and NRS. A Cochrane review [23] concluded that the INSURE approach with NCPAP compared with later selective surfactant administration, continued mechanical ventilation, and extubation from low respiratory support was associated with less need for mechanical ventilation, lower incidence of BPD and fewer air leak syndromes. Bhandari et al. [24] showed that the INSURE approach with SNIPPV had a significantly lower incidence of BPD/death compared with continued mechanical ventilation. Ramanathan et al. [25] also reported a significant reduction in "physiologic" and clinical BPD in the NIPPV group after the INSURE approach compared to synchronized intermittent mandatory ventilation and early extubation to NCPAP. Results of these studies suggest that NCPAP and NIPPV seem to be feasible and effective and result in a lower incidence of BPD when compared with endotracheal ventilation. Another option for surfactant application to the trachea without endotracheal intubation was described by using a thin catheter in spontaneously breathing preterm infants receiving NCPAP. This technique was reported to reduce the need for mechanical ventilation [26]. To summarize, the available evidence supports the preference of early or later use of NIPPV/SNIPPV compared to NCPAP because of minimizing the use and the length of endotracheal ventilation [27]. There are data to suggest that this approach may also reduce the rate of BPD, however this was not shown yet [27]. Whether NIPPV/SNIPPV is more beneficial than NCPAP within the INSURE approach needs to be shown. This non invasive ventilator strategy needs to be confirmed by large prospective randomized controlled trials (with long-term follow up) in order to assure it is applicable to most ELBWinfants. Furthermore, the strategy needs to be tailored to individualized infants according to the infant's maturation; antenatal steroid treatment and severity of RDS; general condition; and to certain practical NICU conditions such as experience, personnel and timing during the day.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 612983375
TI  - Childhood interstitial lung disease
AU  - Bush A.
Y1  - 2012//
KW  - adulthood
KW  - airway cell
KW  - airway obstruction
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - autosomal dominant inheritance
KW  - biopsy
KW  - brain
KW  - bronchiolitis obliterans
KW  - capillaritis
KW  - case study
KW  - cell hyperplasia
KW  - chromosome 14
KW  - chromosome 16
KW  - chromosome 2
KW  - chromosome 8
KW  - classification
KW  - clearance
KW  - codon
KW  - complication
KW  - controlled study
KW  - coughing
KW  - crackle
KW  - death
KW  - developmental disorder
KW  - developmental stage
KW  - diagnosis
KW  - DNA structure
KW  - DNA transcription
KW  - exon
KW  - family study
KW  - fetus
KW  - follow up
KW  - frameshift mutation
KW  - gain of function mutation
KW  - gene frequency
KW  - gene locus
KW  - genetic predisposition
KW  - genetic susceptibility
KW  - glycogen metabolism
KW  - glycogen storage disease
KW  - heart
KW  - Human respiratory syncytial virus
KW  - hyaline membrane disease
KW  - hyperinflation
KW  - *infancy
KW  - infant
KW  - *interstitial lung disease
KW  - interstitium
KW  - intron
KW  - intubation
KW  - kidney
KW  - lamellar body
KW  - live birth
KW  - loss of function mutation
KW  - lung alveolus macrophage
KW  - lung alveolus proteinosis
KW  - lung development
KW  - lung dysplasia
KW  - lung function test
KW  - lung hemorrhage
KW  - lung hypoplasia
KW  - lung transplantation
KW  - male
KW  - mesenchyme cell
KW  - middle aged
KW  - multigene family
KW  - neonatal respiratory distress syndrome
KW  - neuroendocrine system
KW  - neurosecretory cell
KW  - newborn
KW  - newborn period
KW  - nonhuman
KW  - phenotype
KW  - physical disease by body function
KW  - pig
KW  - prematurity
KW  - preschool child
KW  - prevalence
KW  - protein C deficiency
KW  - protein family
KW  - protein processing
KW  - pulmonary hypertension
KW  - pulmonary vein
KW  - respiratory failure
KW  - staining
KW  - systemic disease
KW  - tachypnea
KW  - thinking
KW  - thorax radiography
KW  - thrombocyte
KW  - thyroid disease
KW  - transcription regulation
KW  - treatment response
KW  - virus infection
KW  - wheezing
KW  - acid protein
KW  - biological marker
KW  - bombesin
KW  - corticosteroid
KW  - endogenous compound
KW  - eosin
KW  - glass
KW  - glycogen
KW  - granulocyte macrophage colony stimulating factor receptor
KW  - hematoxylin
KW  - hydroxychloroquine
KW  - messenger RNA
KW  - oxygen
KW  - protein precursor
KW  - surfactant
KW  - surfactant protein B
KW  - surfactant protein C
KW  - thyroid transcription factor 1
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 13
IS  - Supplement 1
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - A. Bush, Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, Sydney Street, London SW3 6NP, United Kingdom. E-mail: a.bush@rbh.nthames.nhs.uk
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=612983375
AB  - Introduction: The ramifications of childhood interstitial lung disease (chILD) extend into adulthood. The total prevalence of chILD is estimated at 0.36/100,000 and there are numerous diverse conditions of great rarity which contribute to the spectrum of disease (see detailed review [ref 1]). The same genetic disorder may manifest very differently at different developmental stages. These factors combine to make chILD difficult to study, and unsurprisingly there are no evidence based treatments. Most statements about diagnostic pathways and prognosis are based on very small case series, and great caution should be exercised in discussions with parents. Classification of chILD: In most cases, separate classifications are used in the age groups 0-2 and 2-18 years. There is some overlap between the age groups, however. chILD age 0-2: The North American classification is most used [2], although as knowledge increases, modification is inevitably required. Eight broad categories are described. There is some overlap between categories pathologically, and some (for example, obliterative bronchiolitis) may better be considered as airway diseases, or diffuse distal lung diseases. Category One: Diffuse developmental disorders: These are largely fatal in early life. They are believed to be due to defects in one of the primary molecular mechanisms of lung development; they include acinar dysplasia, congenital alveolar dysplasia, and alveolar capillary dysplasia with misalignment of pulmonary veins. Category Two: Growth abnormalities reflecting deficient alveolarisation Abnormal alveolar development which is largely secondary is the hallmark of this group, leading to pulmonary hypoplasia. Chronic lung disease of prematurity is in this group, although it is arguable whether this should truly be considered part of the chILD spectrum. Category Three: Specific conditions of undefined aetiology: These two conditions (Neuroendocrine cell hyperplasia of infancy or NEHI, and Pulmonary I interstitial glycogenosis, or PIG) appear to be found purely in infancy; whether they are specific conditions, or related non-specifically to disordered lung development is unclear. Neuro-endocrine cell hyperplasia of infancy: Characteristically, NEHI presents in the first year of life (mean age 3.8 months in the largest published series) with tachypnoea and respiratory distress, in a relatively well infant [3]. Cough and wheeze are not prominent [3]. Presentation requiring intubation at birth has not been described [1]. Crackles are often heard. The chest radiograph (CXR) typically mimics post-viral infection airway changes. HRCT shows patchy ground glass opacification, typically centrally and in the right middle lobe and lingula, with air trapping elsewhere [4]. Infant pulmonary function tests show a mixed pattern with air trapping [5]. The pathology is of apparently almost normal lung tissue on haematoxylin and eosin staining, but with increased numbers of bombesin-positive airway cells, which intriguingly are seen in the normal developing lung, as well as other postnatal conditions. These are also seen in healthy controls, but the upper limit of normal is 5% of the epithelial area [3]. KL-6 has been proposed to be a useful biomarker distinguishing NEHI from surfactant protein disorders [6]. There is no treatment other than oxygen if the child is hypoxic, and the long term outlook is relatively good, with no deaths recorded, and long term pulmonary function at worst showing mild airflow obstruction. However, up to two thirds of the children remained symptomatic at follow up. Thus parents of infants diagnosed with NEHI can probably be reassured as to the prognosis. Pulmonary Interstitial Glycogenosis (PIG): Glycogen containing foetal Type 2 cells are seen in normal lung development, regressing towards term [7,8]. However, the pathological hallmark of PIG is the expansion of the interstitium by primitive mesenchymal cells rich in glycogen. This is specific to the lungs, there is no generalised disorder of glycogen metabolism or storage. Presentation is with non-specific respiratory symptoms, and onset is usually early, with biopsies in the first case series being performed at 2-4 weeks of age; four of the seven described cases were pre-term [9]. There is a male preponderance in the very small numbers of cases reported to date. Radiology is non-specific, with interstitial infiltrates, a fine reticular pattern, hyperinflation and ground glass shadowing. Six of seven infants did well, one died of the complications of extreme prematurity. Treatment was with corticosteroids and sometimes hydroxychloroquine. Category Four: Surfactant dysfunction disorders: There are five groups of genetic disorders currently placed in this category. These are mutations of surfactant protein (Sp)-B and -C (the two surface active members of the Sp family); ABCA-3, a protein important in the post-translational processing of surfactant; thyroid transcription factor (TTF) 1, a transcription factor relevant to Sp-B, Sp-C and ABCA-3; and GM-CSF-receptor mutations, preventing the clearance of surfactane from alveoli. SpB gene mutations: Sp-B deficiency is an autosomal recessive, loss of function mutation. It is a rare condition, with estimated prevalence being one in a million live births [10]. The gene is located on chromosome 2, comprises approximately 10,000 base pairs in 11 exons (of which only the first 10 are translated), and encodes a 381 amino-acid pre-protein. 23 amino acids are removed co-translationally to produce pro-Sp-B, which then undergoes complex processing to produce the mature protein. Production is primarily by the Type 2 cells [11]. The most common mutation is a net two base pair insertion in codon 121 (121ins2), which accounts for about two thirds of mutant alleles; more than 30 others have been described [11,12]. The classical presentation is with relentlessly progressive respiratory distress, mimicking hyaline membrane disease in the preterm, with no response to treatment and death within months, unless lung transplantation can be offered. The pathology is often but not invariably a PAP-like picture, but there may be more of a Type 2 cell hyperplasia. These infants may also have secondary abnormalities in Sp-C processing, (pro- Sp-C to Sp-C), with poorly organised lamellar bodies [13-15]. Although the classical disease is lethal in infancy, rare partial deficiencies have been described, with prolonged survival [16,17]. SpC gene mutations: Sp-C deficiency is an autosomal dominant condition caused by a gain of function mutation [18]. Sporadic disease has also been reported, about equally frequently with the inherited condition. The SpC gene is located on the short arm of chromosome 8, and is transcribed to a 900 base pair mRNA, which after post-translational processing yields one of either a 191 or 197 amino acid protein. At least 35 mutations have been described [19]. The clinical phenotype is extremely variable, and many present after RSV bronchiolitis [20], related to SpC gene mutation cells being more vulnerable to the cytotxic effects of the virus [21]. and studies of several generations in families detect presentation with the same Sp-C mutation in the newborn period with relentlessly progressive respiratory distress, and as onset of UIP in late middle age [22]. There is no known treatment. ABCA3 gene mutations: ABCA3 deficiency is an autosomal recessive condition of unknown prevalence. This very large gene is located on chromosome 16, and contains 60,000 base pairs in 33 exons (the first 3 of which are not translated) which encode a 1704 amino acid protein [23,24]. The disease is thought to be due to loss of function mutations. More than 100 mutations have been described [25]; the huge size of the gene means that many more mutations are likely so far undetected. The gene is most highly expressed in lung tissue, but also in heart, brain, platelets and kidney; however, ABCA3 deficiency has no known clinical phenotype in these tissues. The commonest mutation E292V, was found in 5% of older chILD patients [26,27]. However, as might be expected in such a complex gene, many different mutations have been described [25]. Typically presentation mimics Sp-B deficiency, with onset in infancy, and indeed ABCA3 deficiency may be the commonest genetic cause of neonatal respiratory failure. Rarely, ABCA3 deficiency may mimic primary pulmonary hypertension of the newborn [28]. Initially the disease was thought to be uniformly fatal [29]. However, it is becoming clear that late-presenting disease with a better prognosis can also be due to ABCA3 deficiency. Lung function may remain stable over a period of years, but poor growth is common [29]. As with Sp-C deficiency, a wide variety of lung pathology is found. TTF-1 gene mutations: These are autosomal dominant mutations, on chromosome 14, and around 20 mutations have been described. TTF-1 is a homeodomain-containing nuclear transcription protein of the Nkx2 gene family encoded by a single gene locus spanning approximately 3.3 kilobases and consisted of two exons and a single intron. The full-blown brain-lung-thyroid syndrome is characterized by severe dysfunction in all three organs, but it is becoming clear that lung disease can occur with only minor abnormalities in brain and thyroid. The commonest presentation is with neonatal respiratory distress [30,31]. GM-CSFR gene mutations: Clearance of surfactant by alveolar macrophages requires a functional GM-CSF receptor. Mutations in the b-, and more latterly the a-chain of the GM-CSF receptor have been shown to be a rare cause of pulmonary alveolar proteinosis (PAP) [32,33]. The condition must be distinguished from other causes of this condition (Table 1). Category Five: Disorders related to systemic disease processes: This includes pulmonary capillaritis, presenting with a suspected pulmonary hemorrhage syndrome.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - SOD2 activity is not impacted by hyperoxia in murine neonatal pulmonary artery smooth muscle cells and mice.
DO  - https://dx.doi.org/10.3390/ijms16036373
AU  - Gupta, Anita
AU  - Perez, Marta
AU  - Lee, Keng Jin
AU  - Taylor, Joann M
AU  - Farrow, Kathryn N
Y1  - 2015//
Y2  - 20150319//
KW  - Animals
KW  - Cell Hypoxia/ph [Physiology]
KW  - Disease Models, Animal
KW  - Hypertension, Pulmonary/me [Metabolism]
KW  - Hypertension, Pulmonary/pp [Physiopathology]
KW  - Hypertrophy, Right Ventricular/me [Metabolism]
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - *Myocytes, Smooth Muscle/me [Metabolism]
KW  - Oxidation-Reduction
KW  - *Pulmonary Artery/cy [Cytology]
KW  - *Pulmonary Artery/me [Metabolism]
KW  - *Superoxide Dismutase/me [Metabolism]
T2  - International journal of molecular sciences
VL  - 16
IS  - 3
SN  - 1422-0067
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25809610
AD  - Switzerland
AB  - Pulmonary hypertension (PH) complicates bronchopulmonary dysplasia (BPD) in 25% of infants. Superoxide dismutase 2 (SOD2) is an endogenous mitochondrial antioxidant, and overexpression protects against acute lung injury in adult mice. Little is known about SOD2 in neonatal lung disease and PH. C57Bl/6 mice and isogenic SOD2+/+ and SOD2-/+ mice were placed in room air (control) or 75% O2 (chronic hyperoxia, CH) for 14 days. Right ventricular hypertrophy (RVH) was assessed by Fulton's index. Medial wall thickness (MWT) and alveolar area were assessed on formalin fixed lung sections. Pulmonary artery smooth muscle cells (PASMC) were placed in 21% or 95% O2 for 24 h. Lung and PASMC protein were analyzed for SOD2 expression and activity. Oxidative stress was measured with a mitochondrially-targeted sensor, mitoRoGFP. CH lungs have increased SOD2 expression, but unchanged activity. SOD2-/+ PASMC have decreased expression and activity at baseline, but increased SOD2 expression in hyperoxia. Hyperoxia increased mitochondrial ROS in SOD2+/+ and SOD2-/+ PASMC. SOD2+/+ and SOD2-/+ CH pups induced SOD2 expression, but not activity, and developed equivalent increases in RVH, MWT, and alveolar area. Since SOD2-/+ mice develop equivalent disease, this suggests other antioxidant systems may compensate for partial SOD2 expression and activity in the neonatal period during hyperoxia-induced oxidative stress.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71993689
TI  - Induced pluripotent stem cells (iPSC) differentiate into alveolar epithelial cells in vitro and improve lung function following hyperoxia-induced lung injury
AU  - Ionescu L.
AU  - Vadivel A.
AU  - Ellis J.
AU  - Thebaud B.
Y1  - 2012//
KW  - *lung alveolus epithelium cell
KW  - *in vitro study
KW  - *lung function
KW  - *hyperoxia
KW  - *lung injury
KW  - *American
KW  - *society
KW  - *pluripotent stem cell
KW  - mouse
KW  - injury
KW  - lung dysplasia
KW  - somatic cell
KW  - lung
KW  - lung alveolus cell type 2
KW  - embryonic stem cell
KW  - immunofluorescence
KW  - lung alveolus cell
KW  - adult
KW  - lung resistance
KW  - heart
KW  - liver
KW  - airway
KW  - respiratory failure
KW  - lung development
KW  - embryoid body
KW  - prematurity
KW  - culture medium
KW  - staining
KW  - mouse model
KW  - lung fibroblast
KW  - fibroblast
KW  - compliance (physical)
KW  - wound closure
KW  - MTT assay
KW  - wound healing
KW  - hypothesis
KW  - chronic lung disease
KW  - cell therapy
KW  - prevention
KW  - protein C
KW  - activin A
KW  - marker
KW  - aquaporin 5
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - L. Ionescu, University of Alberta, Edmonton, AB, Canada
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A6535
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71993689
AB  - Background. Bronchopulmonary dysplasia (BPD), the chronic lung disease of prematurity, leads to arrested lung development and can be associated with permanent respiratory dysfunction. Recent evidence indicates that administration of embryonic stem cell (ESC)-derived alveolar type 2 cells (AT2) may benefit lung repair; however, ethical and immunological concerns limit the clinical relevance of ESC. Induced pluripotent stem cells (iPSC), ESC-like cells engineered from adult somatic cells, may alleviate some of ESC-associated concerns and there is increasing evidence that iPSC may differentiate in vivo and restore the functionality of damaged organs such as heart and liver. Hypothesis. iPSC differentiate into AT2 cells in vitro and attenuate hyperoxia-induced lung damage in vivo. Methods and results. For differentiation, mouse ESC and fibroblast-derived iPSC were cultured as embryoid bodies with activin A (4 days) and small airway growth medium (14 days). Immunofluorescence staining and FACS revealed that ESC and iPSC acquired lung cell-specific markers: prosurfactant protein C (AT2) and aquaporin 5 (AT1). Newborn mice were exposed to 95% O2 from postnatal day (P) 4 to P14. Cells (ESC, iPSC or lung fibroblasts - LF) were injected intratracheally at P4 (prevention) or P14 (rescue), followed by lung function testing and histological analysis at P28. ESC and iPSC could prevent, but not rescue, hyperoxia-induced decreases in lung resistance and elastance. ESC and, to a lesser extent, iPSC, prevented, but did not rescue, arrested alveolar growth, while LF had no effect. In vitro evaluation of potential paracrine actions revealed that ESC and iPSC conditioned medium (CdM) significantly accelerated wound closure rate in confluent AT2 compared to LF CdM. iPSC and ESC CdM also protected against AT2 hyperoxic injury while LF CdM had no effect (MTT assay). Conclusions. Mouse iPSC differentiate into alveolar epithelial cells, accelerate wound healing and prevent hyperoxic injury in vitro, while improving lung function in a mouse model of BPD. The possibility of using readily available iPSC to generate AT2 for cell-based therapy for lung injury warrants further study.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71993684
TI  - Endothelial progenitor cells repair experimental lung damage through a paracrine activity
AU  - Fung M.E.
AU  - Alphonse R.S.
AU  - Vadivel A.
AU  - Eaton F.
AU  - Yoder M.C.
AU  - Thebaud B.
Y1  - 2012//
KW  - *lung injury
KW  - *American
KW  - *society
KW  - *endothelial progenitor cell
KW  - human
KW  - lung
KW  - umbilical cord blood
KW  - chronic lung disease
KW  - pulmonary hypertension
KW  - rat
KW  - hyperoxia
KW  - therapy
KW  - stem cell
KW  - angiogenesis
KW  - lung dysplasia
KW  - colony forming cell
KW  - wound closure
KW  - cell culture
KW  - body weight
KW  - prematurity
KW  - newborn
KW  - model
KW  - serum
KW  - in vitro study
KW  - regeneration
KW  - cells by body anatomy
KW  - intraperitoneal drug administration
KW  - injection
KW  - Sprague Dawley rat
KW  - morphometrics
KW  - echocardiography
KW  - acceleration
KW  - pulmonary artery
KW  - heart right ventricle hypertrophy
KW  - angiogenic factor
KW  - matrigel
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.E. Fung, University of Alberta, Edmonton, AB, Canada. E-mail: mefung@ualberta.ca
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A6530
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71993684
AB  - INTRODUCTION: Bronchopulmonary dysplasia (BPD), the chronic lung disease of prematurity, currently lacks an effective treatment. Arrested alveolar growth and disrupted vasculogenesis are the histological hallmarks of BPD. Evidence suggests that pro-angiogenic factors promote alveolar growth and regeneration. Accordingly, we showed that endothelial colony forming cells (ECFCs), a recently identified vascular progenitor cell type with self-renewal and clonogenic potential, exist in the developing lung and promotes lung repair. Increasing evidence suggests that stem cells exert their therapeutic potential through a paracrine effect. We hypothesized that cell-free conditioned media from human cord blood derived ECFCs prevents lung injury in an experimental O2-induced BPD model in newborn rats. METHOD(S): To test the therapeutic potential of ECFCs, we generated ECFC conditioned media (CdM) by treating confluent human-umbilical cord blood ECFC cultures with serum free DMEM for 24 hrs. RESULT(S): In vitro, ECFC CdM significantly restored the endothelial network forming ability of hyperoxia exposed fetal human lung ECFCs on matrigel and improved wound closure of fetal rat alveolar type II cells cultured as a monolayer. In vivo, daily 1 muL/g body weight intraperitoneal ECFC CdM injections in Sprague Dawley rats exposed to hyperoxia from postnatal day (P) 1 to P14 significantly preserved alveolar development as assessed by lung morphometry at P21. Furthermore, ECFC CdM therapy significantly attenuated pulmonary hypertension, a major complication of severe BPD, as assessed by improved pulmonary artery acceleration time on echocardiograms and decreased right ventricular hypertrophy. CONCLUSION(S): Our findings suggest that ECFCs prevent lung injury and pulmonary hypertension through a paracrine effect. This may lead to novel therapies for chronic lung diseases characterized by impaired alveolar growth.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71993429
TI  - Hyperoxia regulates the degradation of the circadian protein rev-ERBalpha: Implications for cytoprotection
AU  - Biswas C.
AU  - Hinson M.
AU  - La P.
AU  - Yang G.
AU  - Dennery P.A.
Y1  - 2012//
KW  - *hyperoxia
KW  - *cell protection
KW  - *American
KW  - *society
KW  - myofibroblast
KW  - phosphorylation
KW  - injury
KW  - secretion (process)
KW  - lung
KW  - mutant
KW  - effluent
KW  - lung dysplasia
KW  - immunofluorescence
KW  - phenotype
KW  - microenvironment
KW  - cell differentiation
KW  - mouse
KW  - apoptosis
KW  - cell proliferation
KW  - Western blotting
KW  - adipocyte
KW  - steady state
KW  - pathogenesis
KW  - mesenchymal stem cell
KW  - enzyme linked immunosorbent assay
KW  - *Rev protein
KW  - protein
KW  - interleukin 1
KW  - broxuridine
KW  - interleukin 6
KW  - caspase 3
KW  - 2 (2,4 dichlorophenyl) 3 (1 methyl 3 indolyl)maleimide
KW  - messenger RNA
KW  - receptor protein
KW  - cell nucleus receptor
KW  - serine
KW  - cytokine
KW  - protein kinase B
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C. Biswas, Children's Hospital of Philadelphia, Philadelphia, PA, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A6262
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71993429
AB  - RATIONALE: Dysregulation of myofibroblast differentiation in the alveolar microenvironment contributes to the pathogenesis of bronchopulmonary dysplasia (Dickie R et al, Anat Rec. 2008). The precise signaling mechanisms dictating myofibroblast differentiation have not been clearly elucidated. The nuclear receptor protein Rev-ERBI+/- is an important regulator of adipocyte differentiation. Its degradation is regulated through phosphorylation of specific serine residues (55/59) via GSK3I2. The role of Rev-ERBI+/- in myofibroblast differentiation has not been elucidated. OBJECTIVE(S): To evaluate whether Rev-ERBI+/- inhibits myofibroblast differentiation in mouse neonatal lung-mesenchymal (MLg)-progenitor cells and protects against hyperoxic injury. METHOD(S): Rev-ERBI+/- WT and phosphorylation defective mutant (SD: 55/59 Ser to Asp) MLg cells were exposed to 95%O2/5%CO2 (hyperoxia) or air/5%CO2 (normoxia) for 0-24 hours. In other experiments, cells were pre-incubated with SB216763, an inhibitor of GSK3I2 to prevent Rev-ERBI+/- degradation. Cell proliferation was assessed by BrdU incorportation and p21 mRNA levels. Cell differentiation to a myofibroblast phenotype was asssessed by measuring I+/-SMA immunofluorescence. Apoptosis was evaluated with caspase-3 activity, and pro-inflammatory cytokine levels (IL-1I2 and IL-6) were evaluated in the effluent media using ELISA. Cellular steady-state lmRNA and protein levels of Rev-ERBI+/- and p-GSK3I2, were assessed by qRT-PCR and Western blot respectively. RESULT(S): MLg-WT cells exposed to hyperoxia had increased Akt/kinase activity, increased levels of pGSK3I2 protein and significantly decreased Rev-ERBI+/- protein levels,. This was associated with decreased BrdU incorporation and increased p21 mRNA levels. Immunoreactive I+/-SMA and caspase-3 activity were also increased, as was IL-1I2 and IL-6 secretion. In contrast, Rev-ERBI+/- levels remained stable in the SD mutants and in the cells pre-incubated with SB216763 and exposed to hyperoxia. This was associated with increased BrdU incorporation, decreased p21 as well as decreased immunoreactive I+/-SMA, caspase-3 activity and IL-1I2 and IL-6 secretion. CONCLUSION(S): We conclude that hyperoxia mediates the degradation of Rev-ERBI+/-. Preventing this degradation protects reduces myofibroblast differentiation and protects the cells against hyperoxic injury. SPECULATION: Activation of AKT kinase and subsequent phosphorylation of pGSK3I2 may mediate the degradation of lung Rev-ERB in hyperoxia, thereby reducing levels of this cytoprotective protein, promoting myofibroblast differentiation and enhancing susceptibility to hyperoxia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71989481
TI  - The role of the type III transforming growth factor-beta receptors in the regulation of pulmonary vascular development
AU  - Nieb G.
AU  - Seeger W.
AU  - Morty R.E.
Y1  - 2012//
KW  - *American
KW  - *society
KW  - mouse
KW  - human
KW  - vascular smooth muscle
KW  - model
KW  - apoptosis
KW  - hyperoxia
KW  - lung blood vessel
KW  - lung
KW  - immunohistochemistry
KW  - protein expression
KW  - in vitro study
KW  - lung injury
KW  - smooth muscle
KW  - lung development
KW  - exposure
KW  - lung dysplasia
KW  - lung hypoplasia
KW  - muscle tissue
KW  - pulmonary artery smooth muscle cell
KW  - machine
KW  - animal model
KW  - laser microdissection
KW  - vascular smooth muscle cell
KW  - immunoblotting
KW  - cell function
KW  - growth, development and aging
KW  - patient
KW  - *transforming growth factor
KW  - *receptor
KW  - messenger RNA
KW  - 4 [4 (1,3 benzodioxol 5 yl) 5 (2 pyridinyl) 1h imidazol 2 yl]benzamide
KW  - nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
KW  - transforming growth factor beta receptor 3
KW  - endoglin
KW  - broxuridine
KW  - small interfering RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - G. Nieb, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany. E-mail: gero.niess@mpi-bn.mpg.de
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A4846
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71989481
AB  - RATIONALE: Disturbed pulmonary vascular development is increasingly recognised as a key player in the perturbed alveolar development associated with bronchopulmonary dysplasia (BPD). The molecular basis of the peturbed pulmonary vascular development is not understood. Our preliminary studies in mice, employing a hyperoxia-based model of BPD, have revealed dysregulated expression of components of the transforming growth factor (TGF)-beta signalling machinery. In this study, we particularly address the type I and type III TGF-beta receptors, in pulmonary vascular smooth muscle behaviour. These receptors include two type I (Acvrl1 and Tgbfr1) and two type III [endoglin (Eng) and betaglycan (Tgfbr3)] receptors. METHOD(S): Exposure of C57BL/6N mice to 85% O2 for the first 28 days after birth was employed as a model or arrested late lung development. TGF-beta receptor localisation, and mRNA and protein expression were assessed by immunohistochemistry, real-time RT-PCR and immunoblot, respectively. Human pulmonary artery smooth muscle cells (PASMC) were transfected with siRNA with LipofectamineTM , and were assessed for proliferation by 5-bromodeoxyuridine incorporation, and for apoptosis by cleavage of poly (ADP-ribose) polymerase. RESULT(S): Preliminary immunohistochemical studies suggested that the changes in TGF-beta receptor expression were largely confined to the pulmonary vascular smooth muscle, suggesting a possible role for these receptors in the smooth muscle tissue in the development of BPD. Knockdown of TGFBR3 in PASMCs increased PASMC proliferation two-fold in vitro, in a TGF-beta-independent manner (revealed by parallel trends in proliferation observed in the presence of the TGF-beta pathway inhibitor SB431542). However, apoptosis of PASMCs was not affected by the knockdown of TGFBR3. Furthermore, Tgfbr3 expression is markedly perturbed in the lungs of neonatal mice with hyperoxia (85% O2)-induced lung injury, a popular animal model of BPD. The mRNA expression of tgfbr3 was downregulated (4.4-fold, respectively) while eng mRNA levels were upregulated (2.7-fold). Laser microdissection confirmed dysregulated expression of TGFBR3 in the pulmonary vasculature of the developing mouse lung. CONCLUSION(S): Taken together, these data suggest a role for TGFBR3 in vascular smooth muscle cell function which could lead to a dysregulation of TGF-beta signalling in the pulmonary vasculature which in turn could contribute to the impaired pulmonary vascular growth and development associated with the lung hypoplasia observed in patients with BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71989475
TI  - Endothelial-monocyte activating polypeptide II (EMAP II) is produced by epithelial cells and macrophages in bronchopulmonary dysplasia (BPD)
AU  - Persad E.A.
AU  - Xu H.
AU  - Savani R.C.
AU  - Schwarz M.A.
Y1  - 2012//
KW  - *epithelium cell
KW  - *macrophage
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - hyperoxia
KW  - mouse
KW  - lung
KW  - model
KW  - dysplasia
KW  - emphysema
KW  - capillary
KW  - cell proliferation
KW  - angiogenesis
KW  - Student t test
KW  - Western blotting
KW  - lung development
KW  - fetus lung
KW  - monocyte
KW  - protein analysis
KW  - immunohistochemistry
KW  - pathogenesis
KW  - harvesting
KW  - analysis of variance
KW  - *endothelial monocyte activating polypeptide II
KW  - fibronectin
KW  - oxygen
KW  - CD1 antigen
KW  - nonoxinol 9
KW  - chemoattractant
KW  - paraformaldehyde
KW  - peptide
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - E.A. Persad, UT Southwestern Dallas, Dallas, TX, United States. E-mail: elizabeth.persad@utsouthwestern.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A4840
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71989475
AB  - Rationale: EMAP II is a potent anti-angiogenic peptide and macrophage chemoattractant. Previous work regarding fetal lung development has illustrated that the expression of EMAP II decreases during periods of vasculogenesis, exogenous EMAP II profoundly disrupts alveolar-capillary growth, and is elevated in lung dysplasias such as BPD and emphysema. The cellular contributors of EMAP II in lung dysplasia have not been elucidated to date. We hypothesize that EMAP II overexpression by epithelial cells and macrophage are associated with vascular inhibition and lung dysplasia of BPD. Method(s): Lungs were harvested from neonatal CD1 mice exposed to 85% oxygen from day of life (DOL) 3 to 15 as well as normoxic controls. Harvesting was done on DOL 3, 10, 15, 20 and 30. Lung specimens were either inflation fixed at 25mmHg with 4% paraformaldehyde or harvested for protein analysis. EMAP II and monocyte (F480) expression were determined via Western Blot while EMAP II distribution in macrophages, fibronectin deposition and cell proliferation were examined using immunohistochemistry (IHC). Result(s): The murine hyperoxia model of BPD demonstrated distal alveolar dysplasia (mean linear intercept p<0.001, ANOVA), and increased macrophage infiltrate, fibronectin deposition and alveolar proliferation consistent with that seen in BPD. EMAP II expression was significantly increased on days 10, 15, and 20 (p=0.01, p=0.005, and p=0.07 respectively, Student T-test, figure) as compared to normoxia control. IHC identified increased EMAP II expression in the bronchial and alveolar regions. Co-localization with F480 determined that macrophages expressed EMAP II in hyperoxia mice. Conclusion(s): The murine hyperoxia model of BPD demonstrates increased fibronectin deposition, macrophage infiltrate, alveolar proliferation and alveolar dysplasia. Pulmonary EMAP II expression is markedly elevated at DOL 10 and 15 of mice exposed to hyperoxia and also at DOL 20 in mice post-hyperoxia as compared to controls. Macrophages contribute to EMAP II expression. These findings indicate that in BPD elevated EMAP II expression is in part due to macrophage recruitment and subsequent macrophage expression of EMAP II. We speculate that EMAP II expression in epithelial and macrophage cells may play an important role in the pathogenesis of BPD. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71988539
TI  - CHRM2 is a candidate susceptibility gene for hyperoxic lung injury in a murine model of bronchopulmonary dysplasia
AU  - Nichols J.
AU  - Gladwell W.
AU  - Cho H.-Y.
AU  - Wiltshire T.
AU  - Kleeberger S.
Y1  - 2012//
KW  - *lung injury
KW  - *murine model
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - *gene
KW  - exposure
KW  - newborn
KW  - phenotype
KW  - lung
KW  - mare
KW  - mouse
KW  - hyperoxia
KW  - allele
KW  - infant
KW  - wild type
KW  - haplotype
KW  - genetic polymorphism
KW  - prematurity
KW  - lymphocyte
KW  - lung development
KW  - histopathology
KW  - quantitative trait locus
KW  - blood vessel injury
KW  - neutrophil
KW  - lung disease
KW  - side effect
KW  - lung lavage
KW  - oxidative stress
KW  - food
KW  - genetic model
KW  - pathogenesis
KW  - permeability
KW  - heritability
KW  - genetic analysis
KW  - outbred mouse strain
KW  - chromosome
KW  - pneumonia
KW  - inbred mouse strain
KW  - assisted ventilation
KW  - amino acid substitution
KW  - physiology
KW  - mutant
KW  - edema
KW  - injury
KW  - human
KW  - oxidizing agent
KW  - protein
KW  - oxygen
KW  - muscarinic receptor
KW  - reactive oxygen metabolite
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J. Nichols, NIEHS, Research Triangle Park, NC, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A3903
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71988539
AB  - Background: Reactive oxygen species contribute to the pathogenesis of many pulmonary disorders, including bronchopulmonary dysplasia (BPD), a respiratory condition affecting preterm infants. In BPD, treatment involves respiratory support with high oxygen levels, and oxidative stress is an adverse side effect that has been associated with vascular damage and impaired lung development and function in a subset of infants. Genetic polymorphisms in a few candidate genes have been associated with BPD susceptibility, however the genetic basis of differential susceptibility remains poorly understood. In this study, we used haplotype association mapping (HAM) to identify the role of genetic background in differential susceptibility to oxidant injury in developing lungs. Method(s): Time-mated pregnant inbred mice were allowed to deliver spontaneously. Time-mated pregnant outbred mice were used as foster dams during exposure. At post-natal day 1 (P1), neonates were pooled and randomly reassigned to litters exposed to 100% O2 or air for 72hr. Dams were provided with food ad libitum. Following exposure, neonates were necropsied at P4, and bronchoalveolar lavage fluid analysis (protein concentration, total cells, neutrophils, and lymphocytes) and histopathology were measured as disease phenotypes. All exposures were conducted at NIEHS and approved by IACUC. HAM of response phenotypes was done using SNPster. Results and Conclusion(s): Significant inter-strain variation was found for all phenotypes and heritability estimates ranged from 33.6% to 55.7%. Further genetic analysis by SNPster identified significant quantitative trait loci on chromosomes 1, 2, 4, 6, 7, and 9, and candidate susceptibility genes were identified (Cntnap5a, Cntnap5b, Cyp2j5, Cyp2j6, Cyp2j9, Cyp2j11, Mgmt, Fat3, and Chrm2). Chrm2 (cholinergic receptor, muscarinic 2, cardiac) is known to have a role in lung physiology and disease. A SNP (rs30378838) in Chrm2 causes an amino acid substitution (P265L) in exon1 and, relative to neonate strains homozygous for the wild-type allele, significantly reduced hyperoxia-induced lung inflammation was found in strains with the mutant allele (p<0.0001). Further, targeted deletion of Chrm2 caused significantly (p<0.001) reduced lung permeability and edema following neonatal hyperoxia exposure compared to wild-type controls. Thus, we developed a genetic model of lung injury with similarities to BPD. We also found a novel susceptibility gene that may significantly improve the current understanding of neonatal lung injury.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71987486
TI  - Educating fellows in practice-based learning and improvement and systems-based practice: The value of quality improvement in clinical practice
AU  - Carey W.A.
AU  - Colby C.E.
Y1  - 2012//
KW  - *total quality management
KW  - *clinical practice
KW  - *American
KW  - *society
KW  - *learning
KW  - curriculum
KW  - competence
KW  - pediatrics
KW  - academic achievement
KW  - lung dysplasia
KW  - experiential learning
KW  - catheter infection
KW  - safety
KW  - teaching
KW  - accreditation
KW  - medical education
KW  - documentation
KW  - morbidity
KW  - certification
KW  - graduate
KW  - newborn morbidity
KW  - evidence based practice
KW  - feedback system
KW  - mortality
KW  - model
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - W.A. Carey, Mayo Clinic, Rochester, MN, United States. E-mail: carey.william@mayo.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A2897
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71987486
AB  - Rationale: In 1999, the Accreditation Council for Graduate Medical Education identified six general competencies in which residents must be trained. Among these are two relatively abstract and complex competencies: Practice-Based Learning & Improvement (PBLI) and Systems-Based Practice (SBP). Many program directors find that PBLI and SBP are difficult concepts to grasp, perhaps limiting their ability to develop effective means of teaching and evaluating these competencies. Because PBLI and SBP are related conceptually to Quality Improvement (QI), a QI-based curriculum may be an effective means by which to teach these competencies. However, there are few examples of QI curricula that have improved resident knowledge in PBLI and SBP while providing program directors the means by which to document resident competence. Method(s): We engaged our fellows in experiential learning by requiring them to participate in our division-level program of continuous quality improvement. Using the Plan-Do-Study-Act change model, fellows partnered with faculty to develop and implement QI projects designed to reduce common neonatal morbidities. To assess fellow competence in PBLI and SBP, program directors maintained portfolios for each fellow, including written self-reflections, evaluations and documentation of all resulting academic achievement. Result(s): As members of our unit's multidisciplinary Quality & Safety Committee (Q&S), our fellows identified two outcomes meriting improvement - bronchopulmonary dysplasia (BPD) and catheter-associated blood stream infection (CABSI). They then developed and implemented evidence-based plans to reduce the incidence of each disease, then collected and analyzed outcomes data with guidance from division faculty. To complete the QI cycle, fellows communicated outcomes and future plans for QI to all NICU staff. Our fellows' QI projects led to significant and sustained reductions in the rates of BPD and CABSI. We assessed fellow performance by reviewing goal- and strategy-based self-reflections with each fellow semi-annually. In addition, all division faculty provided competency-based feedback in response to fellow presentations of Q&S outcomes at our quarterly Morbidity & Mortality conferences. Our fellows' active engagement in QI also resulted in meaningful academic achievement as well. For example, our fellows have presented the clinical outcomes of their BPD initiative at two national academic meetings (American Academy of Pediatrics National Conference and Exhibition, 2010 and 2011). Also, one of our fellows earned Performance in Practice credit toward her maintenance of certification by the American Board of Pediatrics. Conclusion(s): By integrating clinical and educational systems, a QI-based curriculum may be an effective means by which to teach and assess PBLI and SBP.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71986357
TI  - Respiratory symptoms and health-related quality of life in adult survivors of bronchopulmonary dysplasia
AU  - Gough A.
Y1  - 2012//
KW  - *adult
KW  - *survivor
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - *quality of life
KW  - human
KW  - asthma
KW  - diagnosis
KW  - adulthood
KW  - infant
KW  - hospital
KW  - physician
KW  - very low birth weight
KW  - general practitioner
KW  - weight
KW  - drug therapy
KW  - childhood
KW  - dyspnea
KW  - wheezing
KW  - control group
KW  - lung function
KW  - chi square test
KW  - sample size
KW  - screening
KW  - health survey
KW  - European Union
KW  - adolescence
KW  - gender
KW  - artificial ventilation
KW  - birth weight
KW  - newborn care
KW  - risk
KW  - newborn period
KW  - statistical significance
KW  - analysis of variance
KW  - surfactant
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - A. Gough, Queen's University, Belfast, United Kingdom. E-mail: agough06@qub.ac.uk
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1830
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71986357
AB  - RATIONALE: With improved neonatal care, increasing numbers of infants with bronchopulmonary dysplasia (BPD) survive to adulthood. Studies suggest increasing respiratory symptoms and reduced lung function persist through childhood and into early adolescence but little is known about those reaching adulthood. The few studies to date have been limited by small sample size. We report respiratory symptoms and quality of life in adult survivors of BPD from the largest study to date with comparison groups comprising very low birth weight (VLBW) and term controls. METHOD(S): One hundred and fifty-three infants cared for in the Regional Neonatal Unit, Royal Maternity Hospital, Belfast, between January 1978 and April 1993, who developed BPD were prospectively traced from hospital birth records and contacted through their General Practitioner. Of those, 72 (47.1%) responded and participated and were compared with age, sex and birth weight matched individuals born prematurely with VLBW (<1500g) not requiring mechanical ventilation (n=56) and age and gender matched term infants (n=55). See Table 1 for demographics. Respiratory symptoms were assessed using the European Community Respiratory Health Survey (ECRHS) screening tool. Health-related quality of life was measured using the EuroQol 5D (EQ-5D). Differences between dichotomous and continuous variable were tested using chi-square analyses, and one-way ANOVA with contrasts. RESULT(S): No significant differences in baseline characteristics were observed between BPD participants (n=72) and BPD non-responders (n=81). ECRHS and EQ5D scores for BPD participants and control groups are shown in Table 2. BPD participants were significantly more likely to report respiratory symptoms (wheeze, shortness of breath) and use asthma medication. Compared to term controls, BPD subjects were twice as likely to be defined as 'symptomatic' on the ECRHS scoring tool (30.6% vs 14.5% p=0.035) and more likely to have a physician diagnosis of asthma (40.3% vs 16.4%, p=0.004). BPD subjects with a physician diagnosis of asthma were younger (mean GA; 26.6 weeks vs 27.5 weeks), and lighter (mean weight; 927g vs 974g) than those without an asthma diagnosis; however these did not reach statistical significance. BPD participants who had not been treated with surfactant were much more likely to have a diagnosis of asthma compared to those given surfactant (79.3% vs 20.7%, p=0.210). CONCLUSION(S): Although health-related quality of life is not significantly impaired, BPD survivors have increased respiratory symptoms and a greater likelihood of asthma which persists into adulthood. Whether surfactant treatment in the neonatal period reduces the risk of asthma in adulthood needs confirmation in further studies. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71986355
TI  - The role of 8-oxoguanine glycosylase (OGG1) in the development of bronchopulmonary dysplasia (BPD) and other neonatal ailments
AU  - Hurley E.
AU  - Telliard J.
AU  - Calo J.M.
AU  - Parton L.A.
Y1  - 2012//
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - oxidative stress
KW  - allele
KW  - enzyme activity
KW  - human
KW  - genotype
KW  - newborn
KW  - prematurity
KW  - Student t test
KW  - mutant
KW  - DNA damage
KW  - necrotizing enterocolitis
KW  - patient
KW  - chi square test
KW  - lung cancer
KW  - supplementation
KW  - real time polymerase chain reaction
KW  - chromosome aberration
KW  - infant
KW  - brain hemorrhage
KW  - statistical significance
KW  - tracheal aspiration procedure
KW  - gene
KW  - pathogenesis
KW  - *8 hydroxyguanine
KW  - oxygen
KW  - reactive oxygen metabolite
KW  - DNA
KW  - guanine
KW  - enzyme
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - E. Hurley, New York Medical College, Valhalla, NY, United States. E-mail: edward_hurley@nymc.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1828
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71986355
AB  - Rationale: The pathogenesis of bronchopulmonary dysplasia is multi-factorial. Oxidative stress is one factor. 8-Oxoguanine glycosylase (OGG1) is an enzyme that repairs DNA damaged by reactive oxygen species. Reactive oxygen species convert guanine to 8-oxoguanine. The Ser326Cys polymorphism (rs1052133) in the OGG1 gene results in decreased enzymatic activity and has been associated with lung cancer and other conditions. We hypothesize that the Ser326Cys polymorphism in OGG1 affects the enzyme activity thus leading to increased oxidative stress-mediated damage that renders patients more susceptible to ailments common to premature neonates such as BPD, necrotizing enterocolitis (NEC), and intraventricular hemorrhage (IVH). Method(s): DNA was isolated from buccal mucosal swabs (N=164). Infants were enrolled who weighed <1 kg at birth and had no congenital or chromosomal abnormalities. Allelic discrimination was performed using a specific probe for the Ser326Cys with Real-time PCR. BPD is graded by the need for oxygen at 36 weeks PMA. Mild BPD is need for supplemental oxygen at 28 DOL but no supplementation needed at 36 weeks PMA. Moderate BPD means FiO2 of <0.3 at 36 weeks PMA while severe means FiO2 is >0.3 at 36 week PMA. Chi square analyses and t-test for independent samples were performed with P<0.05 denoting statistical significance. Result(s): The Ser326Cys SNP was not associated with BPD (p=0.293). On the other hand, being homozygous for the mutant allele (GG) was associated with NEC (p=0.049). The G-allele was also associated with NEC (p=0.042). We found that the GG-genotype is associated with IVH (p=0.016). The G-allele is also significant (p=0.027) for IVH. Genotype tables for OGG1 polymorphism (rs1052133) Conclusion(s): The Ser326Cys SNP is associated with IVH and NEC but not BPD. This relationship points to a common mechanism such as increased DNA damage secondary to oxidative stress. Further work such as testing tracheal aspirates for presence or activity of OGG1 would be fruitful. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71986352
TI  - Aspirin reduces MCP-1 expression in bronchoalveolar lavage from newborn mice exposed to hyperoxia
AU  - Britt R.D.
AU  - Velten M.
AU  - Nelin L.D.
AU  - Rogers L.K.
Y1  - 2012//
KW  - *mouse
KW  - *hyperoxia
KW  - *American
KW  - *society
KW  - *lung lavage
KW  - human
KW  - lung dysplasia
KW  - infant
KW  - risk
KW  - prematurity
KW  - inflammation
KW  - newborn
KW  - ambient air
KW  - leukocyte
KW  - chronic lung disease
KW  - therapy
KW  - assay
KW  - enzyme linked immunosorbent assay
KW  - *acetylsalicylic acid
KW  - protein
KW  - chemokine
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - L.K. Rogers, Research Institute, Nationwide Children's Hospital, Columbus, OH, United States. E-mail: Lynette.Rogers@nationwidechildrens.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1825
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71986352
AB  - Rationale: Preterm infants are at risk of developing bronchopulmonary dysplasia (BPD), a chronic lung disease characterized by impaired alveolar development. Pro-inflammatory responses, including leukocyte infiltration, contribute to the development of bronchopulmonary dysplasia. We hypothesized that treatment with 10 mg/kg aspirin (ASA) would reduce expression of chemokines in newborn mice exposed to hyperoxia (85% O2). Method(s): Newborn pups were injected daily with vehicle or 10 mg/kg ASA, while exposed to room air (RA) or 85% O2 for 14 days. On day 14, mice were sacrificed and bronchoalveolar lavage (BAL) was collected. Protein concentrations were assessed by bradford assay and KC, MIP-2, and MCP-1 expressions were measured in BAL by ELISA. Result(s): Protein concentrations, KC, and MCP-1 expressions in BAL were significantly increased in vehicle injected and 85% O2 exposed mice compared to RA controls. Treatment with 10 mg/kg ASA while exposed to 85% O2 significantly reduced BAL protein concentrations and MCP-1 expression. Conclusion(s): Our data suggest that treatment with 10 mg/kg ASA reduced inflammation in pups exposed to hyperoxia. Aspirin may be a useful therapy for preterm infants at risk of developing BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Activin A contributes to the development of hyperoxia-induced lung injury in neonatal mice.
DO  - https://dx.doi.org/10.1038/pr.2015.46
AU  - Lim, Rebecca
AU  - Muljadi, Ruth
AU  - Koulaeva, Eugenia
AU  - Vosdoganes, Patricia
AU  - Chan, Siow Teng
AU  - Acharya, Rutu
AU  - Gurusinghe, Seshini
AU  - Ritvos, Olli
AU  - Pasternack, Arja
AU  - Wallace, Euan M
Y1  - 2015//
Y2  - 20150311//
KW  - *Activin Receptors, Type II/ai [Antagonists & Inhibitors]
KW  - *Activins/me [Metabolism]
KW  - Animals
KW  - Animals, Newborn
KW  - *Bronchopulmonary Dysplasia/pc [Prevention & Control]
KW  - Follistatin/pd [Pharmacology]
KW  - Growth Disorders/pc [Prevention & Control]
KW  - *Hyperoxia/pa [Pathology]
KW  - *Immunoglobulin Fc Fragments/pd [Pharmacology]
KW  - Immunoglobulin Fc Fragments/tu [Therapeutic Use]
KW  - *Lung/pa [Pathology]
KW  - Matrix Metalloproteinase 9/me [Metabolism]
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Neutrophil Infiltration/de [Drug Effects]
KW  - Phosphorylation/de [Drug Effects]
KW  - Recombinant Fusion Proteins/pd [Pharmacology]
KW  - Recombinant Fusion Proteins/tu [Therapeutic Use]
KW  - Smad3 Protein/me [Metabolism]
T2  - Pediatric research
VL  - 77
IS  - 6
SN  - 0031-3998
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25760549
AD  - United States
AB  - BACKGROUND: Bronchopulmonary dysplasia (BPD) is one of the leading causes of morbidity and mortality in babies born prematurely, yet there is no curative treatment. In recent years, a number of inhibitors against TGFbeta signaling have been tested for their potential to prevent neonatal injury associated with hyperoxia, which is a contributing factor of BPD. In this study, we assessed the contribution of activin A-a member of the TGFbeta superfamily-to the development of hyperoxia-induced lung injury in neonatal mice., METHODS: We placed newborn C57Bl6 mouse pups in continuous hyperoxia (85% O2) to mimic many aspects of BPD including alveolar simplification and pulmonary inflammation. The pups were administered activin A receptor type IIB-Fc antagonist (ActRIIB-Fc) at 5 mg/kg or follistatin at 0.1 mg/kg on postnatal days 4, 7, 10, and 13., RESULTS: Treatment with ActRIIB-Fc and follistatin protected against hyperoxia-induced growth retardation. ActRIIB-Fc also reduced pulmonary leukocyte infiltration, normalized tissue: airspace ratio and increased septal crest density. These findings were associated with reduced phosphorylation of Smad3 and decreased matrix metalloproteinase (MMP)-9 activity., CONCLUSION: This study suggests that activin A signaling may contribute to the pathology of bronchopulmonary dysplasia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71986350
TI  - BMP2 and eNOS expression is upregulated in human pulmonary artery endothelial cells (HPAECs) exposed to hyperoxia
AU  - Calo J.M.
AU  - Parton L.
AU  - Olson S.
Y1  - 2012//
KW  - *human
KW  - *endothelium cell
KW  - *hyperoxia
KW  - *American
KW  - *society
KW  - *pulmonary artery
KW  - oxidative stress
KW  - phosphorylation
KW  - vascular endothelium
KW  - morbidity
KW  - hypothesis
KW  - lung dysplasia
KW  - infection
KW  - culture medium
KW  - cell culture
KW  - primary culture
KW  - artificial ventilation
KW  - tissues
KW  - homeostasis
KW  - barotrauma
KW  - infant
KW  - vasodilatation
KW  - vascular remodeling
KW  - long term exposure
KW  - protein expression
KW  - incubator
KW  - gas
KW  - Western blotting
KW  - assay
KW  - prematurity
KW  - statistical significance
KW  - upregulation
KW  - bone morphogenetic protein
KW  - growth factor
KW  - transforming growth factor
KW  - nitric oxide
KW  - trypsin
KW  - antibody
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J.M. Calo, Maria Fareri Children's Hospital, Westchester Medical Center, Valhalla, NY, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1823
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71986350
AB  - Background: Bronchopulmonary dysplasia (BPD) is a common morbidity in premature infants. Multiple factors contribute to the development of BPD including barotrauma and volutrauma from mechanical ventilation, infection and oxidative stress among others. Bone morphogenetic proteins (BMPs) are multi-factorial growth factors that belong to the transforming growth factor beta (TGFbeta) superfamily, which has pleiotropic functions in regulating development, homeostasis and repair of various tissues including vascular endothelium. Endogenous nitric oxide is an important mediator of pulmonary vasodilation and reactivity and has a role in vascular remodeling during oxidative stress. Previous studies have shown that BMP2 and BMP4 may have a role in the phosphorylation and activity of eNOS in bPAECs. Objective(s): We tested the hypothesis that BMP2 and eNOS expression is attenuated in HPAECs exposed to hyperoxia. Method(s): HPAECs were cultured in endothelial cell culture medium and maintained in a sterile humidified cell culture incubator at 37oC with 5% CO2. Cells were passaged at 70-80% confluence with trypsin. Primary cultures of passage 5-6 were used in the experiments. HPAECs were plated in 60 mm plates and exposed to hyperoxic gas with 95% O2 and 5% CO2 for up to 48 hours and collected at 12, 24 and 48 hours. Antibodies to BMP2, phosphorylated eNOS and eNOS were used in Western blot assays to determine protein expression. Result(s): eNOS expression increased by up to 25% in cells exposed to hyperoxia at 24 hours compared to control although did not achieve statistical significance. BMP2 expression, was also upregulated with prolonged exposure to hyperoxia. Discussion/Conclusion: Contrary to our expected findings, our preliminary data demonstrated that BMP2 and eNOS expression was upregulated in hyperoxia. Based on previous published literature, BMP2 may have a role in eNOS phosphorylation. Thus, we speculate that upregulation of both BMP2 and eNOS may reflect a protective response of the vascular endothelium to oxidative stress. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71986348
TI  - Tracheal aspirate connective tissue mast cell (MCCT) peptidases are increased in infants at risk for bronchopulmonary dysplasia
AU  - Go D.
AU  - Bhattacharya S.
AU  - Krenitsky D.
AU  - Huyck H.
AU  - Gascon J.
AU  - Ren C.L.
AU  - Mariani T.
AU  - Pryhuber G.
Y1  - 2012//
KW  - *connective tissue
KW  - *mast cell
KW  - *infant
KW  - *risk
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - *tracheal aspiration procedure
KW  - lung
KW  - human
KW  - prematurity
KW  - Western blotting
KW  - lung disease
KW  - airway
KW  - barotrauma
KW  - inflammatory cell
KW  - chronic lung disease
KW  - gene
KW  - perinatal period
KW  - bodily secretions
KW  - lung parenchyma
KW  - pilot study
KW  - injury
KW  - inflammation
KW  - hyperoxia
KW  - immunohistochemistry
KW  - lung fibrosis
KW  - mortality
KW  - mouse
KW  - interstitial lung disease
KW  - asthma
KW  - mucosa
KW  - lung function
KW  - morbidity
KW  - respiratory distress syndrome
KW  - *peptidase
KW  - tryptase
KW  - chymase
KW  - protein
KW  - antibody
KW  - marker
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - D. Go, University of Rochester, Rochester, NY, United States. E-mail: diana_go@urmc.rochester.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1821
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71986348
AB  - Rationale. Bronchopulmonary dysplasia (BPD) is a chronic lung disease of premature infants, that causes significant morbidity and mortality. Hyperoxia, volutrauma and barotrauma directly injure the immature lung, however injury is partly mediated by recruitment and activation of inflammatory cells and release of inflammatory mediators. Marked inflammation and secondary inhibition of alveolarization occur with the destruction and abnormal repair that pathologically marks BPD. Our microarray expression analysis identified differential expression of mast cell (MC) specific genes in autopsied BPD and normal infant lungs. Two human mast cell subtypes have been described based on the production of peptidases. MC that produce tryptase without chymase are predominant in mucosa of normal lung while dual tryptase and chymase MC, generally submucosal and connective tissue (MCCT) in location, are infrequent in non-diseased lung. MCCT are noted to be increased in severe asthma, interstitial lung disease and lung fibrosis. Our previously reported immunohistochemistry confirmed numerous tryptase and chymase producing MCCT in BPD lungs. This study determines that MC peptidases can be detected in tracheal aspirates samples (TAs) of premature infants at risk for BPD in comparison to term infants without lung disease. Methods. TAs were collected at routine suctioning, centrifuged and supernatants frozen at -80degreeC until assayed for MC products. Peptidases were detected by Western blot using mouse monoclonal anti-human tryptase and chymase antibodies (Dako, Carpinteria, CA and AbD Serotec, Raleigh, NC, respectively). Results. In this pilot study, six subjects were evaluated, three preterm (age at birth <35 wks) with RDS or BPD, and three full term, intubated for reasons other than lung disease. On Western blot analysis, both 32 and 37 kDa bands consistent with tryptase and chymase, respectively, were observed in two of the preterm TAs. Light bands in a 4-day old infant, GA 35 wks and very intense bands in a 27-day old, ex-28 wk infant. The third PT infant was an ex-24 wk infant, 7 mo. old on testing, in which specific peptidases were not detected. No peptidase bands were detected in the term infant samples. Conclusions. MCCT are increased in distal lung tissue of infants with BPD. Products of those MC can be detected in airway secretions of premature babies during the postnatal period when BPD develops but not in healthy infant lungs. MC secretory products may be markers of BPD risk and suggest novel therapeutic targets. Studies to correlate airway MC signature proteins with pulmonary function and outcomes are underway.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71986232
TI  - Simulation of BPD and treatment of auto-PEEP-induced asynchrony
AU  - Demers R.
AU  - Swezea W.
AU  - Ngo C.
AU  - Angelico P.R.
Y1  - 2012//
KW  - *society
KW  - *simulation
KW  - *American
KW  - *positive end expiratory pressure
KW  - human
KW  - lung model
KW  - patient
KW  - chronic obstructive lung disease
KW  - population
KW  - neonatal ventilator
KW  - ventilator
KW  - lung dysplasia
KW  - artificial ventilation
KW  - breathing rate
KW  - airway obstruction
KW  - endotracheal tube
KW  - breathing
KW  - respiratory therapist
KW  - pulmonologist
KW  - exercise
KW  - caregiver
KW  - adult
KW  - obstructive airway disease
KW  - water
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - R. Demers, Kaiser Permanente of Southern California, Pasadena, CA, United States. E-mail: Robert.X.Demers@KP.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1705
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71986232
AB  - Rationale: Obstructive airway disease is commonly encountered in adult patients suffering from chronic obstructive pulmonary disease (COPD) and in neonatal/pediatric patients suffering from bronchopulmonary dysplasia (BPD). In both populations, intrinsic positive end-expiratory pressure (Auto-PEEP) can occur secondary to expiratory airflow obstruction. Asynchrony is often observed during mechanical ventilation of such patients, whereby inspiratory efforts sporadically fail to elicit triggering of the ventilator into the inspiratory phase. We wished to simulate BPD- and Auto-PEEP-induced asynchrony by means of a neonatal lung model, and to demonstrate how that asynchrony could be corrected. Method(s): We employed a neonatal lung model described elsewhere1. This apparatus was connected to a source of a pulsatile subatmospheric pressure, generated at a rate of 60 per minute, to simulate rhythmic and regular inspiratory efforts. A neonatal ventilator (Avea, CareFusion, San Diego, CA) in the pressure-controlled/assist-control mode was interfaced to the neonatal lung model, and its sensitivity was adjusted to deliver an assisted breath in response to each inspiratory effort. We then extrinsically compressed the endotracheal tube leading to each chamber of the lung model, until an Auto-PEEP level between four and five centimeters of water was observed. At that point, an external PEEP level of five centimeters of water was imposed. Result(s): The baseline respiratory rate (RR) was observed to be 60/min. The creation of an Auto-PEEP level between four and five centimeters of water resulted in asynchrony, with a resultant RR of 40/min. The subsequent imposition of an external PEEP level of five centimeters of water was observed to abolish asynchrony, with a return to the displayed RR of 60/min. Conclusion(s): Neurally-adjusted ventilatory assist (NAVA) can sometimes effectively deal with asynchrony2. However, one is not obliged to resort to such a sophisticated solution. The imposition of an external PEEP level equal to, or marginally higher than, the prevailing Auto-PEEP level also succeeds in dealing with asynchrony, and at far lower cost and complexity. Some respiratory care practitioners (RCPs) and pulmonologists are familiar with the imposition of external PEEP as a method of counteracting the effects of Auto-PEEP-induced asynchrony3, but many are not. This simulation exercise can increase caregivers awareness of this simple and straightforward method of dealing with asynchrony whenever that dysfunction is observed clinically.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71986229
TI  - Using the asynchrony index (AI) to quantify asynchrony events during simulated bronchopulmonary dysplasia (BPD)
AU  - Angelico P.R.
AU  - Demers R.R.
AU  - Swezea W.
AU  - Ngo C.
Y1  - 2012//
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - positive end expiratory pressure
KW  - human
KW  - simulation
KW  - ventilator
KW  - patient
KW  - model
KW  - breathing rate
KW  - mortality
KW  - lung
KW  - sedation
KW  - lung model
KW  - airway obstruction
KW  - mechanical ventilator
KW  - chronic obstructive lung disease
KW  - caregiver
KW  - exercise
KW  - clinical competence
KW  - water
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - P.R. Angelico, Kaiser Permanente of Southern California, Pasadena, CA, United States. E-mail: phyllis.angelico@covidien.com
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1702
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71986229
AB  - Rationale: Educating clinicians to recognize and respond to asynchrony events is key to their clinical competence. Clinicians often have difficulty identifying and responding to asynchrony appropriately, whether it is physiologically or mechanically induced. Regrettably, the first line of action is often sedation, not ventilatory optimization. This can lead to more time on the ventilator.1-3 Therefore; using simulation to teach clinicians to recognize and respond to asynchrony will benefit the patient. In obstructive disease states such as chronic obstructive pulmonary disease and bronchopulmonary dysplasia, physiologic asynchrony attributable to intrinsic positive end-expiratory pressure ("Auto-PEEP") can occur secondary to expiratory airflow obstruction, making the ventilator refractory to some inspiratory efforts. Using a mechanical lung model4 we simulated BPD- and Auto-PEEP-induced asynchrony4 and quantified it by calculation of the asynchrony index (AI). An AI of >=10% is an indicator of substantial asynchrony and is relatively common.5 Mortality can be higher in patients with an AI of >30%.1 Simulations can teach how asynchrony can be corrected.4 Methods: We employed a neonatal lung model to simulate BPD, elicit Auto-PEEP, and induce asynchrony.4 When an Auto-PEEP level of about five centimeters of water was observed, an external PEEP level of five centimeters of water was imposed. We calculated AI as [(# of wasted efforts/total respiratory rate (RR) x100], where "total RR" includes wasted efforts.3, 5 Results: The baseline RR was observed to be 60/min. The creation of the Auto-PEEP resulted in wasted efforts, with a resultant RR of 40/min and a worrisome AI of 33%. Subsequent imposition of an external PEEP level of five centimeters of water was observed to abolish asynchrony with a return to the displayed RR of 60/min. Conclusion(s): We employed a simple mechanical model to simulate asynchrony. We subsequently calculated AI, and implemented a solution to optimize patient-ventilator interaction. Some clinicians are familiar with the consequences of asynchrony, the AI, and the imposition of external PEEP as a method of counteracting the effects of Auto-PEEP-induced asynchrony, but many are not. A simulation exercise using a simple and inexpensive model can increase caregivers' awareness of: 1) asynchrony events; 2) quantification of asynchrony by means of the AI; and 3) the appropriate response to asynchrony events. Many more asynchrony simulations can be generated by means of various mechanical ventilator adjustments (e.g. sensitivity, inspiratory time, flow) and the AI index employed to quantify the degree of asynchrony. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985806
TI  - Extracellular superoxide dismutase (SOD3) deficiency contributes to durable effects of neonatal hyperoxic lung injury
AU  - Poonyagariyagorn H.K.
AU  - Metzger S.
AU  - Dikeman D.
AU  - Lopez-Mercado A.
AU  - Malinina A.
AU  - McGrath-Morrow S.
AU  - Neptune E.R.
Y1  - 2012//
KW  - *lung injury
KW  - *American
KW  - *society
KW  - hyperoxia
KW  - injury
KW  - gene
KW  - mouse
KW  - lung
KW  - lung parenchyma
KW  - inflammation
KW  - pathogenesis
KW  - immunohistochemistry
KW  - lung dysplasia
KW  - Western blotting
KW  - extracellular matrix
KW  - exposure
KW  - protein expression
KW  - liquid
KW  - prematurity
KW  - Student t test
KW  - ambient air
KW  - statistical significance
KW  - chronic respiratory tract disease
KW  - assay
KW  - immunofluorescence
KW  - murine model
KW  - model
KW  - *extracellular superoxide dismutase
KW  - antioxidant
KW  - messenger RNA
KW  - protein
KW  - transcription factor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - H.K. Poonyagariyagorn, Johns Hopkins University, Baltimore, MD, United States. E-mail: hpoonya1@jhmi.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1278
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985806
AB  - RATIONALE: Bronchopulmonary dysplasia (BPD) is a common chronic respiratory disease following premature birth. The pathogenesis of BPD is believed to be secondary to oxidative damage from hyperoxia and inflammation that leads to impaired alveolar formation and often chronic lung dysfunction. A murine model of BPD utilizing acute postnatal hyperoxia followed by short-term recovery in room air (RA) mimics the durable effects after injury during alveolar development. Although several antioxidant genes are induced during hyperoxic exposure, we hypothesize that extracellular superoxide dismutase (SOD3), an antioxidant uniquely targeted to the extracellular matrix and alveolar fluid, might have a different response (downregulation) and thereby contribute to the persistent airspace injury and inflammation after recovery. METHOD(S): C57Bl/6 pups (24h old) were placed in an 85 to 90% FIO2 chamber or RA for 4 days with recovery in RA for 14 days. Measures of alveolar injury were obtained. Western blot analysis and RT-PCR measured protein and mRNA expression in lung tissue lysates, respectively. SOD3 was localized in lung parenchyma using immunohistochemistry-immunofluorescence (IHC-IF), and assays were used to measure SOD activity. Values for measurements were expressed as means+/-SEM, and P-values for significance were designated at <0.05. Student's t-tests were used to determine differences between groups. RESULT(S): Interestingly, mRNA expression for antioxidant genes mediated by Nrf-2, a major antioxidant transcription factor, was significantly increased for Ho-1, Gclc, and Nqo-1 in the hyperoxia (n = 4) versus RA group (n = 5) (Table 1). Similar results were found for SOD1 and SOD2 mRNA expression. SOD3, an Nrf-2-independent antioxidant, was significantly reduced in the hyperoxia-exposed mice compared to RA (Table 1). IHC-IF revealed decreased and disrupted SOD3 deposition in the alveolar ECM of hyperoxia-exposed mice (Figure 1). SOD3 protein expression and SOD activity were not different between the two groups. CONCLUSION(S): Newborn mice exposed to acute hyperoxia followed by RA recovery demonstrated (1) increased mRNA expression of certain antioxidant genes mediated by Nrf-2 and (2) a significant decrease in SOD3 mRNA expression and fragmented deposition in the alveolar ECM. Importantly, this reduced SOD3 expression uniquely correlated with alveolar injury measures in the recovered neonatal hyperoxic lung. Such findings provide insight into a possible mechanism for the pathogenesis of BPD. Future studies are needed to determine if increased SOD3 levels in the lung or a mimetic can attenuate or reverse the airspace damage found in this particular model. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985754
TI  - Trail is upregulated during recovery from hyperoxia in a murine model of bronchopulmonary dysplasia
AU  - Morrow D.K.
AU  - Davies M.H.
AU  - Powers M.R.
Y1  - 2012//
KW  - *hyperoxia
KW  - *murine model
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - lung
KW  - apoptosis
KW  - macrophage
KW  - exposure
KW  - model
KW  - mouse
KW  - retrolental fibroplasia
KW  - epithelium cell
KW  - ambient air
KW  - injury
KW  - protein expression
KW  - eye
KW  - morbidity
KW  - neovascularization (pathology)
KW  - real time polymerase chain reaction
KW  - risk
KW  - lung parenchyma
KW  - immunohistochemistry
KW  - phenotype
KW  - tissues
KW  - laboratory
KW  - therapy
KW  - pregnancy
KW  - infant
KW  - tumor necrosis factor related apoptosis inducing ligand
KW  - caspase 3
KW  - oxygen
KW  - marker
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - D.K. Morrow, Oregon Health and Science University, Portland, OR, United States. E-mail: morrowd@ohsu.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1226
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985754
AB  - Rationale: Infants born prior to 30 weeks gestation are at risk for a number of morbidities, including but not limited to retinopathy of prematurity (ROP) and bronchopulmonary dysplasia (BPD).Previously our laboratory has demonstrated that TNF-Related Apoptosis Inducing Ligand (TRAIL) is involved in controlling pathologic neovascularization of the eye, via apoptosis, in a murine model of ROP during recovery in room air (RA). BPD is characterized in part by arrested development of the lung, and apoptosis is known to contribute to the hyperoxic response of the lung in models of BPD. TRAIL is known to target both endothelial and epithelial cells, therefore we hypothesize that TRAIL mediated apoptosis will play a role during recovery from hyperoxia. Method(s): C57BL/B6 (B6) mice were exposed to 75% oxygen from postnatal day (P) 2 to P14, a period of alveolarization of the developing murine lung, in order to generate a BPD phenotype. TRAIL expression in the lung was evaluated in RA and hyperoxia-exposed neonatal mice using Western analysis. Additionally, immunohistochemistry (IHC) was used to analyze and quantify TRAIL expression in lung tissue from RA and hyperoxia-exposed animals on P14 (end of hyperoxia exposure) and P17 (RA recovery for 3 days). Lung sections were also immunolabeled with F4/80, a macrophage specific marker. Quantitative real time PCR (qRT-PCR) was used to analyze caspase-3 expression. Result(s): Decreased TRAIL protein expression was shown by Western analysis during hyperoxia exposure, followed by an increase during the recovery phase. Interestingly, there was no significant difference in TRAIL expression by IHC between the hyperoxia-exposed tissue and RA controls on P14, the final day of oxygen exposure. However, TRAIL expression was increased approximately 3-fold (p=0.009, n=4) at P17 (3 days after hyperoxia) in the exposed animals compared to the RA controls. When lungs from P17 hyperoxia-exposed animals were compared to those from P14, TRAIL expression was increased >2.5-fold (p=0.01, n=4). Additionally, TRAIL expression was co-localized exclusively to F4/80 labeled macrophages. Increased apoptosis was demonstrated in hyperoxia-exposed animals at P17 assessed by caspase-3 expression using qRT-PCR. Conclusion(s): Increased TRAIL expression is associated with apoptosis during recovery from hyperoxia-induced injury in the developing lung. TRAIL expression was exclusively localized to macrophages in the parenchymal airspace wall. These results suggest that TRAIL expression contributes to lung recovery in a model of BPD. In order to better target therapies for BPD, an understanding of apoptosis during different phases of the disease is essential.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985753
TI  - Microrna-based regulation of angiogenic gene expression in a murine model of bronchopulmonary dysplasia
AU  - Collura C.A.
AU  - Carey W.A.
AU  - Dong J.
AU  - Sutor S.L.
AU  - Prakash Y.S.
AU  - Wigle D.A.
Y1  - 2012//
KW  - *gene expression
KW  - *murine model
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - gene
KW  - human
KW  - angiogenesis
KW  - lung
KW  - mouse
KW  - endothelium cell
KW  - hyperoxia
KW  - immunohistochemistry
KW  - cell proliferation
KW  - book
KW  - model
KW  - statistical analysis
KW  - regulatory mechanism
KW  - newborn
KW  - lung parenchyma
KW  - animal model
KW  - histology
KW  - ambient air
KW  - upregulation
KW  - Institute for Cancer Research mouse
KW  - protein expression
KW  - tube
KW  - cell migration
KW  - data base
KW  - maturity
KW  - cell growth
KW  - gene ontology
KW  - immunoblotting
KW  - analysis of variance
KW  - *microRNA
KW  - messenger RNA
KW  - angiogenin
KW  - vascular endothelial cadherin
KW  - protein
KW  - brain derived neurotrophic factor receptor
KW  - receptor
KW  - microRNA 210
KW  - catenin
KW  - CD31 antigen
KW  - oxygen
KW  - beta catenin
KW  - microRNA 29a
KW  - microRNA 29
KW  - locked nucleic acid
KW  - vasculotropin
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C.A. Collura, Mayo Clinic, Rochester, MN, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1225
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985753
AB  - Introduction: Abnormal angiogenesis is a prominent feature of bronchopulmonary dysplasia (BPD) and may underlie the arrest of alveolar development that characterizes this condition. Reduced expression of pro-angiogenic genes has been implicated in human cases and animal models of BPD, but the underlying regulatory mechanisms are poorly understood. The objective of this study was to determine whether miRNA up-regulation might correlate with the reduced pro-angiogenic gene expression in a model of BPD. Method(s): Neonatal ICR mice were exposed to 80% oxygen (O2) or room air for 29 days. Lung microanatomy was assessed using standard histological techniques. Comprehensive mRNA and miRNA profiling was performed using lung tissue from both groups. The effect of hyperoxia on mRNA and miRNA levels was determined using ANOVA statistical analysis of CT values and fold-change. Potential direct mRNA targets of miRNAs within angiogenic pathways were predicted through miRNA-mRNA endogenous correlation and computational mapping in miRBase. Individual genes involved in angiogenesis were assessed by Gene Ontology term enrichment analysis for miRNA regulatory networks using the DAVID database and manual reviews of known pro-angiogenic genes. Protein expression was evaluated by immunoblot and immunohistochemistry techniques. Result(s): After 29 days, the lungs of O2-exposed mice displayed histological changes consistent with BPD. We found decreased expression of several pro-angiogenic genes, including Angiogenin-1, Angiogenin-3, b-catenin, PECAM-1, VE-cadherin and VEGF-A. Many of these genes are predicted targets of simultaneously up-regulated miRNAs, including mir-135b, mir-210, mir-699, mir-690, let-7i, mir-322, mir-497 and mir-27a. Most of the observed down-regulated genes are required for normal alveolar and pulmonary vascular development, and many are diminished in the lungs of human neonates with BPD. Immunodensitometry demonstrated decreased expression of PECAM-1, VE-cadherin, beta-catenin and angiogenin proteins in the P29 O2-exposed mice. In our manual review, we discovered markedly decreased expression of Ntrk2 which encodes a neurotrophic receptor (TrkB) involved in a known signaling pathway that stimulates angiogenesis. In addition, Ntrk2 expression was a predicted target of up-regulated mir-29a and mir-29c. Immunohistochemistry clearly demonstrated decreased expression of the TrkB receptor. Conclusion(s): Using an established model of BPD, we found evidence that miRNAs may impair angiogenesis by targeting mRNA transcripts whose encoded proteins promote endothelial cell growth and functional maturity. Future directions include demonstrating the effect of hyperoxia on human endothelial cell proliferation, cell migration, and endothelial tube formation and attempting to recover impaired cellular processes by over-expression of mRNA and/or silencing miRNA via locked nucleic acids.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985750
TI  - Nuclear factor kappa B activation in the neonatal lung protects against lipopolysaccharide induced alveolar disruption by repressing macrophage inflammatory-2 expression
AU  - Hou Y.
AU  - Iosef C.
AU  - Chen C.
AU  - Cornfield D.N.
AU  - Alvira C.M.
Y1  - 2012//
KW  - *lung
KW  - *macrophage
KW  - *American
KW  - *society
KW  - mouse
KW  - inflammation
KW  - exposure
KW  - lung dysplasia
KW  - infection
KW  - lethal dose
KW  - gene expression
KW  - hypothesis
KW  - lung capillary
KW  - immunoblotting
KW  - risk
KW  - newborn period
KW  - density
KW  - capillary density
KW  - injury
KW  - lung development
KW  - immunohistochemistry
KW  - enzyme linked immunosorbent assay
KW  - *immunoglobulin enhancer binding protein
KW  - *lipopolysaccharide
KW  - cytokine
KW  - messenger RNA
KW  - transcription factor
KW  - fibroblast growth factor
KW  - vasculotropin receptor 2
KW  - protein
KW  - neutralizing antibody
KW  - macrophage inflammatory protein 2
KW  - immunoglobulin G
KW  - vasculotropin A
KW  - growth factor
KW  - vasculotropin
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C.M. Alvira, Stanford University, Stanford, CA, United States. E-mail: calvira@stanford.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1222
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985750
AB  - Rationale: Bronchopulmonary dysplasia (BPD) is characterized by arrested alveolar development. While systemic infections during the neonatal period increase the risk of BPD, the molecular mechanisms that impair alveolarization in response to inflammation are incompletely understood. Our previous work demonstrated a unique protective role for the transcription factor, nuclear factor kappa B (NF kappaB) in the neonatal lung. Therefore, we hypothesized that: i) postnatal exposure to systemic lipopolysaccharide (LPS) disrupts alveolarization; and ii) NFkappaB activity in the neonatal lung protects against this alveolar disruption. Method(s): To test this hypothesis, neonatal (6 day old) mice were treated with vehicle (PBS), a sub-lethal dose of systemic (LPS), or the combination of LPS and the NFkappaB inhibitor, 2 (LPS+BAY). At 8h, mRNA and protein was extracted for qPCR, western immunoblot and ELISA. At 24h, the lungs were inflation fixed at 25 cm H2O pressure for morphometric analysis, and determination of pulmonary vascular density by CD31 immunostaining. In separate experiments, LPS and LPS + BAY treated mice were pretreated with either macrophage inflammatory protein-2 (MIP-2) neutralizing antibody, or isotype control IgG. Result(s): Postnatal LPS impaired alveolarization, increasing airspace size (p<0.01), and decreasing radial alveolar counts (RAC) (p<0.001). Blocking NFkappaB with BAY markedly worsened this effect, increasing airspace size by 83% (p<0.001) and decreasing RAC by 38% (p<0.001). Either treatment with LPS alone, or LPS + BAY reduced the gene expression of fibroblast growth factors (FGF) -7 and -10, and vascular endothelial growth factor receptor-2 (VEGFR2) to a similar degree. While LPS + BAY treatment also decreased the expression of VEGF-A, pulmonary capillary density was unchanged. However, treatment with LPS + BAY also caused significant elevations in the expression of cytokines known to disrupt lung development, including a 300-fold increase in MIP-2 (p<0.01). Furthermore, neutralization of MIP-2 reduced alveolar size (p<0.01) and increased RAC (p<0.05) to levels that were similar to mice treated with LPS alone. Conclusion(s): Exposure to systemic LPS at the onset of alveolarization disrupts alveolar development, and decreases the expression of key epithelial growth factors. NFkappaB activity protects the developing lung against more severe injury by repressing the inflammatory cytokine, MIP-2. Taken together, our data demonstrate that NFkappaB plays a novel, developmentally regulated, protective role in alveolar development even in the presence of systemic inflammation. We speculate that diminished NFkappaB activity may play a pathogenic role in BPD, and that strategies to enhance NFkappaB signaling may be effective in promoting alveolar development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985747
TI  - Pulmonary neuroendocrine bodies (NEBS) form at stereotyped positions within the epithelium of developing airways
AU  - Kuo C.S.
AU  - Krasnow M.A.
Y1  - 2012//
KW  - *airway
KW  - *American
KW  - *society
KW  - *epithelium
KW  - lung
KW  - adult
KW  - infancy
KW  - mouse
KW  - staining
KW  - neurosecretory cell
KW  - precursor
KW  - lung dysplasia
KW  - optics
KW  - confocal microscopy
KW  - respiratory tract disease
KW  - fetus lung
KW  - diseases
KW  - dissection
KW  - cell hyperplasia
KW  - normal distribution
KW  - fluorescent antibody technique
KW  - tomography
KW  - model
KW  - cell labeling
KW  - vascularization
KW  - cell structure
KW  - pulmonary artery
KW  - cre recombinase
KW  - antibody
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C.S. Kuo, Stanford University, Palo Alto, CA, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1219
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985747
AB  - RATIONALE: Abnormalities in the number and distribution of pulmonary neuroendocrine (NE) cells are detected in pediatric and adult respiratory diseases. NE cells exist as solitary cells and as clusters in the developing and adult lung, but their relationship to each other is unknown. Increases in NEBs are specific to a pediatric condition known as neuroendocrine cell hyperplasia of infancy (NEHI), whereas other conditions such as bronchopulmonary dysplasia of infancy (BPD) are associated with increases in NE cells without the characteristic increase in NEBs seen in NEHI. One of the challenges to characterizing and experimentally modeling NE cell abnormalities is a lack in understanding of the normal distribution and placement of NE cells. We asked whether NEBs localization is stereotyped during embryonic lung growth as a first step towards the cellular and molecular dissection of NEB development. METHOD(S): Using whole mount staining techniques developed in our lab combined with immunohistochemical detection techniques, we have mapped the location of NEBs within embryonic mouse lungs. We used both confocal microscopy and optical projection tomography (OPT) to image the fluorescently labeled samples. Analysis of the precise location of each NEB at airway bifurcations was performed using the branching lineage of the mouse lung developed in our lab (Metzger, 2008). We also label individual NE precursors using genetic Cre-recombinase mediated to mark single NE cells. RESULT(S): Larger NEBs are biased towards airway branchpoints (such as branch Left 1 (L1), Anterior 2 (A2)), where we always see a cluster at the same location (Figure 1). All 20 samples examined at late embryonic stages had a cluster present at this characteristic location and a similar analysis was carried out within other branchpoints within the left lobe. Single cell-labeling techniques show reveal distinct NE cell morphology within a cluster. Representative images of E18 left upper lobe showing three-dimensional structure of proximal airway branches with accompanying vasculature along with NEBs (panel b and c). (a) Stereoscopic view of L1 and first two anterior (A1,A2) and ventral branches (V1, V2) demonstrated by whole mount fluorescent antibody staining with anti-alpha SMA antibody. The pulmonary artery (PA) accompanying each branch is also well-visualized. (b and c) Maximum projection images through a stack of confocal images of whole mount immunofluorescent samples double stained for alpha-SMA (green) and CGRP(red). CONCLUSION(S): Larger NEBs are biased towards airway bifurcations and development appears to be highly regulated at certain branchpoints. Understanding the signals regulating NEB placement is key for understanding diseases where NEB size or location is altered. (Figure Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985744
TI  - Transcriptional programs controlling perinatal lung maturation
AU  - Xu Y.
AU  - Wang Y.
AU  - Besnard V.
AU  - Ikegami M.
AU  - Wert S.E.
AU  - Heffner C.
AU  - Murray S.A.
AU  - Donahue L.
AU  - Whitsett J.A.
Y1  - 2012//
KW  - *fetus lung maturation
KW  - *American
KW  - *society
KW  - A J mouse
KW  - lung
KW  - chromatin assembly and disassembly
KW  - prematurity
KW  - gene
KW  - cell cycle
KW  - innate immunity
KW  - lung dysplasia
KW  - bioinformatics
KW  - histone modification
KW  - chromatin structure
KW  - functional genomics
KW  - genome
KW  - human
KW  - infant
KW  - respiratory distress syndrome
KW  - morbidity
KW  - gestational age
KW  - vascularization
KW  - cell adhesion
KW  - gene expression
KW  - mortality
KW  - breathing
KW  - mouse
KW  - mouse strain
KW  - premature labor
KW  - messenger RNA
KW  - surfactant
KW  - STAT1 protein
KW  - transcription factor
KW  - lipid
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - Y. Xu, Perinatal Institutution, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. E-mail: Yan.Xu@cchmc.org
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1216
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985744
AB  - Rationale: The timing of lung maturation is precisely regulated and likely controlled by complex genetic and cellular programs. Lung prematurity associated with preterm birth frequently results in respiratory distress syndrome and bronchopulmonary dysplasia, which remain the leading causes of mortality and morbidity in preterm infants. The mechanisms synchronizing gestational length and lung maturation remain to be elucidated. Method(s): A genome-wide mRNA expression time-course study (E15 to Postnatal Day 0) was designed using lung RNAs from C57BL/6J (B6) and A/J mice that differ in gestational length by ~30hr. Comprehensive bioinformatics and functional genomics analyses were used to identify key regulators, bioprocesses and transcriptional networks controlling lung maturation. Result(s): Both temporal and strain dependent gene expression patterns were identified during lung maturation. For time dependent changes, cell adhesion, vasculature development, and lipid metabolism/transport were major bioprocesses induced at E16-E17. CEBPA, PPARG, VEGFA, CAV1 and CDH were found to be key regulators of these processes. Innate defense/immune responses were induced at later gestational ages (E19-20), STAT1, AP1, and EGFR being key regulators of these responses. Cell cycle and chromatin assembly were repressed during lung maturation and were regulated by FOXM1, PLK1, chromobox, and high mobility group families of transcription factors. Strain dependent mRNA expression differences peaked at E18.5. At this time, mRNAs regulating surfactant and innate immunity were more abundantly expressed in lungs of B6 than in A/J mice, while genes involved in chromatin assembly and histone modification were expressed at lower levels in B6 than in A/J mice. Prior to birth, innate immune responses and surfactant production were critical and connected processes that contributed to lung maturation necessary for air breathing after birth. Epigenetic regulators played a repressive role by altering chromatin structure and controlling the cell cycle. The precise balance of these positive and negative gene networks is likely a critical determinant of the timing of lung maturation that differs in the B6 and A/J mouse strains. Conclusion(s): The present study systemically mapped key regulators, bioprocesses, and transcriptional networks controlling lung maturation, revealing insights into the molecular and cellular mechanisms underlying lung maturation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Genetic polymorphisms of heme-oxygenase 1 (HO-1) may impact on acute kidney injury, bronchopulmonary dysplasia, and mortality in premature infants.
DO  - https://dx.doi.org/10.1038/pr.2015.44
AU  - Askenazi, David J
AU  - Halloran, Brian
AU  - Patil, Neha
AU  - Keeling, Susan
AU  - Saeidi, Behtash
AU  - Koralkar, Rajesh
AU  - Ambalavanan, Namasivayam
Y1  - 2015//
Y2  - 20150309//
KW  - *Acute Kidney Injury/ge [Genetics]
KW  - *Bronchopulmonary Dysplasia/ge [Genetics]
KW  - DNA Primers/ge [Genetics]
KW  - *Heme Oxygenase-1/ge [Genetics]
KW  - Humans
KW  - Infant
KW  - Infant Mortality
KW  - Infant, Newborn
KW  - Infant, Premature
KW  - *Polymorphism, Single Nucleotide/ge [Genetics]
KW  - Prospective Studies
KW  - Ureohydrolases/bl [Blood]
T2  - Pediatric research
VL  - 77
IS  - 6
SN  - 0031-3998
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25751573
AD  - United States
AB  - BACKGROUND: Heme oxygenase 1 (HO1) catalyzes heme degradation, and offers protection for several organs, including the kidney. Genetic polymorphisms of HO-1 are associated with poor clinical outcomes in several populations., METHODS:, POPULATION: We prospectively enrolled 117 premature infants (birth weight <=1,200 g or postgestational age <=31 wk) and evaluated two DNA genetic variants proximal to the promoter region of HO-1 (GT(n) repeats, and -413T>A SNP). We evaluated how these polymorphisms affect two clinical outcomes: (i) Acute Kidney Injury (AKI)-rise in serum creatinine (SCr) >= 0.3 mg/dl or >= 150-200% from lowest previous value, (ii) the composite of mortality and bronchopulmonary dysplasia (BPD) defined as receipt of oxygen at 36 wk postmenstrual age., RESULTS: AKI occurred in 34/117 (29%) of neonates; 12/117 (10%) died; 29/105 (28%) survivors had BPD. Neonates with TT genotype at 413T>A before the HO-1 promoter had higher rates of AKI (P < 0.05). There was no difference in number of GT(n) repeats and clinical outcomes., CONCLUSION: We did not find an association between the GT(n) tandem repeat of HO-1 and AKI nor BPD/mortality. However, infants with TT genotype of the 413T>A genetic alteration had lower incidence of AKI. Further studies using larger cohorts are needed to better understand these relationships.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985742
TI  - Role of sphingolipids in murine lung development: Relevance to bronchopulmonary dysplasia
AU  - Harijith A.
AU  - Machireddy N.
AU  - Pendyala S.
AU  - Mohan V.
AU  - Raj U.
AU  - Reddy S.P.
AU  - Natarajan V.
Y1  - 2012//
KW  - *lung development
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - hyperoxia
KW  - mouse
KW  - wild type
KW  - lung injury
KW  - newborn
KW  - knockout mouse
KW  - pneumonia
KW  - histology
KW  - lung function
KW  - lung
KW  - lung parenchyma
KW  - Western blotting
KW  - human
KW  - inflammation
KW  - biochemical analysis
KW  - pathology
KW  - prematurity
KW  - cell infiltration
KW  - inflammatory cell
KW  - murine model
KW  - lung lavage
KW  - histopathology
KW  - adult
KW  - macrophage
KW  - exposure
KW  - injury
KW  - *sphingolipid
KW  - lyase
KW  - sphingosine 1 phosphate
KW  - protein
KW  - sphingosine kinase 1
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - A. Harijith, University of Illinois at Chicago, Chicago, IL, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1214
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985742
AB  - Rationale: Bronchopulmonary Dysplasia (BPD) of the premature newborn is characterized by lung injury resulting in alveolar simplification and reduced pulmonary function. We have earlier shown that genetic disruption of sphingosine kinase 1 (sphK1) protects hyperoxia-induced lung injury in an adult murine model. However, the role of sphingosine-1-phosphate (S1P) generation and signaling in the pathobiology of BPD has not been investigated. We hypothesized that altered S1P signaling axis in BPD in part is responsible for the lung injury and inflammation. Method(s): Newborn C57Bl6/J and SphK1-/- null mice were exposed to hyperoxia (95%) from postnatal day1 to 7. Mice pups were sacrificed on postnatal day 7, and lungs were perfused and used for histology and biochemical analysis. Result(s): Newborn SphK1-/- null mice showed significant lung inflammation and injury compared to wild type littermate controls upon exposure to hyperoxia. Histopathology revealed considerable alveolar damage accompanied by elevation of proteins in bronchoalveolar lavage (BAL) fluids in the SphK1-/- null newborn mice. Increased inflammatory cell infiltrate (predominantly macrophages) was noted in SphK1-/- null animals compared to the wild type exposed to hyperoxia. Analysis of total cell lysates by Western blotting showed increased expression of Sphingosine-1- Phosphate lyase (S1P lyase), but not SphK1 or SphK2, in lung tissue of wild type and SphK-/- mice exposed to hyperoxia. Conclusion(s): These results show an important role for the sphingolipid signaling axis regulated by S1P lyase in the development of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985741
TI  - Periostin is required for pro-fibrotic gene expression in hyperoxia-exposed neonatal mice
AU  - Bentley J.K.
AU  - Popova A.P.
AU  - Anyanwu A.C.
AU  - Linn M.J.
AU  - Lei J.
AU  - Hershenson M.B.
Y1  - 2012//
KW  - *gene expression
KW  - *hyperoxia
KW  - *mouse
KW  - *American
KW  - *society
KW  - lung
KW  - mesenchyme cell
KW  - knockout mouse
KW  - infant
KW  - gene
KW  - fibrosing alveolitis
KW  - extracellular matrix
KW  - animal model
KW  - lung dysplasia
KW  - wild type mouse
KW  - lung alveolus cell
KW  - pathogenesis
KW  - lung injury
KW  - fiber
KW  - cell isolation
KW  - protein analysis
KW  - survival
KW  - myofibroblast
KW  - fibrosis
KW  - adhesion
KW  - staining
KW  - analysis of variance
KW  - *transcription factor RUNX2
KW  - messenger RNA
KW  - protein
KW  - cysteine rich protein 61
KW  - smooth muscle actin
KW  - scleroprotein
KW  - collagenase
KW  - oxygen
KW  - collagen
KW  - elastin
KW  - connective tissue growth factor
KW  - smoothelin
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J.K. Bentley, University of Michigan, Ann Arbor, MI, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1213
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985741
AB  - Introduction: Matricellular proteins, including periostin (POSTN) and cysteine-rich protein 61 (CYR61), are non-structural extracellular matrix proteins that regulate cell-matrix interactions, thereby influencing fiber deposition, adhesion, migration, proliferation and survival. We recently found that expression of POSTN is increased in the lungs of infants with bronchopulmonary dysplasia (BPD) and hyperoxia-exposed neonatal mice, an animal model of BPD. POSTN knockout (KO) mice are protected against hyperoxia-induced hypoalveolarization and interstitial fibrosis, findings typical of BPD. We hypothesized that POSTN regulates pro-fibrotic gene expression in hyperoxia-exposed neonatal mouse lungs. Method(s): Postnatal day 2 mice were exposed to air or 75% oxygen for 14 days. Lungs were processed for sectioning, mRNA or protein analysis, or collagenase-digested for mesenchymal cell isolation. Mesenchymal cells were cultured for 5 days and treated with TGF-b1. Expression of genes involved in myofibroblast differentiation and fibrosis was examined by qPCR. Result(s): Hyperoxia increased the mean chord length of airspaces and expression of a-smooth muscle actin (ACTA2), collagen (COL1A1), and elastin (ELN) in the alveolar interstitia. These changes were not observed in the lungs of hyperoxia-treated POSTN KO mice. Hyperoxia also significantly increased lung mRNA expression of ELN, COL1A1, CTGF, POSTN, TGF-b1, and CXCL1 (p<0.05). ACTA2, CYR61, and CXCL2 were also increased. In contrast, hyperoxia failed to increase expression of these genes in POSTN KO mice. Compared to cells from normoxic mice, lung mesenchymal cells from hyperoxic wild-type mice showed increased ELN, SFRP (for secreted frizzled-related protein) and CYR61 transcripts (p<=0.05, ANOVA). Mesenchymal cells from POSTN KO mice did not show increased gene expression. In addition, TGF-b1 treatment of mesenchymal cells from hyperoxia-exposed mice increased mRNA expression of SMTN (smoothelin), SFRP and CYR61 (each p<=0.05) but had no effect in cells from hyperoxic POSTN KO mice. Finally, immunohistochemical staining showed that CYR61 expression was increased in the lungs of infants with BPD and hyperoxia-exposed neonatal mice. Conclusion(s): POSTN is required for hyperoxia- and TGF-b-induced pro-fibrotic gene expression in lung cells. Further studies examining the protective effect of POSTN KO may provide insight into the pathogenesis of neonatal lung injury.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985739
TI  - Differential expression of BPD genes
AU  - Chhabra D.
AU  - Kho A.
AU  - Sharma S.
AU  - Gaedigk R.
AU  - Leeder S.
AU  - Weiss S.T.
AU  - Tantisira K.
Y1  - 2012//
KW  - *American
KW  - *society
KW  - *gene
KW  - human
KW  - lung development
KW  - genetic variability
KW  - lung function
KW  - etiology
KW  - statistical significance
KW  - morbidity
KW  - low birth weight
KW  - newborn
KW  - lung dysplasia
KW  - hyperoxia
KW  - air conditioning
KW  - forced vital capacity
KW  - genome
KW  - gene expression
KW  - fetus lung
KW  - lung
KW  - statistical model
KW  - gestational age
KW  - parent
KW  - child
KW  - asthma
KW  - genetic association
KW  - gender
KW  - height
KW  - lung parenchyma
KW  - blood clotting factor 7
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - D. Chhabra, Channing Laboratory, Boston, MA, United States. E-mail: redic@channing.harvard.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1211
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985739
AB  - Introduction/Rationale: Bronchopulmonary dysplasia (BPD) is associated with significant morbidity in low birth weight neonates. Genetic variation in a number of genes has been suggested as one of the etiological factors. An underlying aberration in lung developmental pathways may result in the development of BPD when exposed to insults like hyperoxia and prolonged ventilation. We hypothesized that BPD genes are significantly differentially expressed over the course of normal lung development, consistent with BPD resulting from an aberration in development. We also wanted to assess the effect of variation in these genes on lung function later in life. Method(s): Eighteen human genes previously associated with BPD were selected after a comprehensive literature search. These genes were then tested for differential expression during human lung development. We used genome-wide gene expression profiles from 114 human fetal lung tissue samples with an estimated gestational age of 54 days-196 days on the Illumina HumanHT-12 v4 Expression BeadChip. The analysis was carried out under the assumption of a linear model of expression over time. A gene was considered to be differentially expressed if any of its probes had a significant p value (nominal p<0.0016, the Bonferroni correction for 31 probes). As a preliminary assessment of the impact of these genes on postnatal pulmonary function, 496 genetic variants, within 50 KB of the BPD genes, from 403 parent-child trios from the Childhood Asthma Management Program (CAMP), were assessed for genetic association with lung function (FEV1, FVC, and FEV1/FVC) using family-based association tests adjusted for age, gender and height. A p value <0.0001 was considered significant. Result(s): Of the 18 genes analyzed, 12(67%) were found to be differentially expressed during early human lung development. Of note, one genetic variant in the factor VII gene (rs9324220) was also found to be significantly associated with forced vital capacity (FVC) (p=5.08E-05) in the CAMP cohort. Conclusion(s): Our results demonstrate that genes previously associated with BPD are differentially expressed during early human lung development. These results highlight both the importance of the genetic etiology of BPD and suggest that perturbations in lung development caused may predispose individuals to develop BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985738
TI  - Misexpression of asporin, a unique IGF1-regulated extracellular matrix proteoglycan, in bronchopulmonary dysplasia
AU  - Bhattacharya S.
AU  - Srisuma S.
AU  - Solleti S.
AU  - Gonzalez L.
AU  - Guttentag S.H.
AU  - Pryhuber G.
AU  - Mariani T.
Y1  - 2012//
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - *extracellular matrix
KW  - human
KW  - mouse
KW  - lung fibroblast
KW  - lung parenchyma
KW  - mouse model
KW  - genome
KW  - in vitro study
KW  - isolated lung
KW  - primary culture
KW  - chronic lung disease
KW  - maturity
KW  - gene
KW  - perinatal period
KW  - lung
KW  - cell differentiation
KW  - receptor blocking
KW  - lung development
KW  - premature labor
KW  - *proteoglycan
KW  - somatomedin C
KW  - blocking antibody
KW  - growth factor
KW  - fibroblast growth factor receptor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Bhattacharya, University of Rochester Medical Center, Rochester, NY, United States. E-mail: Soumyaroop_Bhattacharya@URMC.rochester.edu
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1210
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985738
AB  - Introduction: Bronchopulmonary dysplasia (BPD) is a major complication of preterm birth and is associated with persistent pulmonary dysfunction and disease. Our understanding of the pathogenic mechanisms of this disease is incomplete and therapeutic interventions are severely limited. Method(s): We analyzed Insulin-like Growth Factor 1 (IGF1) and Asporin (ASPN) expression in lung tissues from human BPD subjects. We analyzed IGF1 and ASPN expression in a mouse model of BPD-like neonatal chronic lung disease resulting from Fibroblast Growth Factor (FGF) receptor deficiency. We studied the IGF1-ASPN regulatory axis in primary cultures of isolated lung fibroblasts in vitro. Result(s): Genome-wide expression profiling of BPD lung tissues identified a cluster of IGF1-related genes with abnormal expression in BPD, including increased expression of ASPN, a growth factor-binding extracellular matrix proteoglycan involved in cellular differentiation. In the normal mouse lung, ASPN expression initiates at birth, increases during the early postnatal period and returns to low levels at maturity. In a mouse model of BPD, characterized by increased IGF1 production, we observed excessive and persistent expression of ASPN. In early passage normal fetal human lung fibroblasts, baseline expression of ASPN was strongly induced by IGF1 treatment . In early passage, mouse lung fibroblasts, we find that IGF1 is both necessary and sufficient for maximal APSN expression. Treatment of mouse lung fibroblasts with 50 ng/ml IGF1 leads to a 10-fold increase in ASPN expression, while treatment of these cells with 10 ug/ml IGF1 receptor-blocking antibody leads to a 10-fold decrease in ASPN expression. In contrast, mouse lung fibroblasts treated with 25 ng/ml of FGF1 and FGF2 show reduced expression of both IGF1 and ASPN. Conclusion(s): Our data suggest that alterations in IGF1 and FGF signaling may contribute to aberrant expression of ASPN in BPD. The role of this novel extracellular matrix proteoglycan in lung development and disease is a focus of current studies.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985737
TI  - Reduced expression of platelet-derived growth factor receptor-alpha in neonatal lung mesenchymal stromal cells from infants developing bronchopulmonary dysplasia
AU  - Popova A.P.
AU  - Bentley J.K.
AU  - Bozyk P.
AU  - Linn M.J.
AU  - Lei J.
AU  - Goldsmith A.M.
AU  - Pryhuber G.S.
AU  - Hershenson M.B.
Y1  - 2012//
KW  - *lung
KW  - *mesenchymal stroma cell
KW  - *infant
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - human
KW  - mouse
KW  - prematurity
KW  - angiogenesis
KW  - DNA synthesis
KW  - hyperoxia
KW  - gene expression
KW  - tracheal aspiration procedure
KW  - gene
KW  - vascular smooth muscle cell
KW  - newborn
KW  - model
KW  - gene probe
KW  - immunohistochemistry
KW  - immunoblotting
KW  - university
KW  - risk
KW  - lung parenchyma
KW  - respiratory distress
KW  - artificial ventilation
KW  - phenotype
KW  - baby
KW  - protein expression
KW  - cell proliferation
KW  - *platelet derived growth factor alpha receptor
KW  - platelet derived growth factor
KW  - platelet derived growth factor D
KW  - oxygen
KW  - thymidine
KW  - DNA
KW  - platelet derived growth factor AA
KW  - actin
KW  - catenin
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - A.P. Popova, University of Michigan, Ann Arbor, MI, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1209
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985737
AB  - Background: Tracheal aspirates from premature infants undergoing mechanical ventilation for respiratory distress contain mesenchymal stromal cells (MSCs), the isolation of which is associated with increased risk of developing bronchopulmonary dysplasia (BPD). Objective(s): We hypothesized that, compared to infants not developing BPD, MSCs from infants developing BPD would show stable differences in the expression of genes regulating alveolar development and myofibroblastic differentiation. We also hypothesized that differences, if present, would be reflected in the lungs of infants with BPD and hyperoxia-exposed newborn mice, a model of BPD. Design/Methods: MSCs were isolated from tracheal aspirates of premature neonates. Low passage MSCs were studied. DNA synthesis in response to platelet-derived growth factor (PDGF)-AA was assessed by [3H]-thymidine uptake. Two day-old mice were exposed to air or 75% oxygen for 14 days. Lung tissue from human infants with BPD was obtained from University of Rochester Neonatal Lung Biorepository. Gene expression was analyzed by gene array, qPCR, immunoblot and immunohistochemistry. Result(s): Compared with cells from infants not developing BPD, 199 gene probe transcripts were differentially expressed by neonatal lung MSCs from infants developing BPD. MSCs from infants developing BPD showed significantly lower expression of mRNAs encoding PDGF-R a, PDGF-Rb and PDGF-D, which are important for lung alveolarization, vascular smooth muscle cell proliferation and angiogenesis. Results were confirmed by qPCR, and immunoblots showed reduced protein expression of PDGF-Ra and PDGF-Rb. MSCs from infants developing BPD showed reduced PDGF-AA-induced DNA synthesis. Lungs from hyperoxia-exposed neonatal mice and human infants with BPD showed hypoalveolarization and lower PDGF-Ra expression. Finally, a subset of MSCs from babies developing BPD showed a myofibroblastic phenotype characterized by increased a-actin, b-catenin and phospho-GSK-3b content. Conclusion(s): MSCs from infants developing BPD demonstrate stable alterations in gene expression which favor reduced proliferation and angiogenesis, as well as myofibroblastic differentiation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71985736
TI  - Neurotrophin overexpression in lower airways of neonates as a biomarker of bronchopulmonary dysplasia
AU  - Grayson S.
AU  - Samsell L.J.
AU  - Walton C.
AU  - Piedimonte G.
Y1  - 2012//
KW  - *lower respiratory tract
KW  - *newborn
KW  - *lung dysplasia
KW  - *American
KW  - *society
KW  - infant
KW  - human
KW  - prematurity
KW  - female
KW  - lung
KW  - cell fractionation
KW  - lavage
KW  - patient
KW  - liquid
KW  - morbidity
KW  - disease course
KW  - pregnancy
KW  - intensive care unit
KW  - respiratory tract inflammation
KW  - newborn intensive care
KW  - exposure
KW  - oxygen consumption
KW  - serum
KW  - immunoassay
KW  - artificial ventilation
KW  - hypothesis
KW  - virus infection
KW  - etiology
KW  - mortality
KW  - intubation
KW  - synthesis
KW  - fiber
KW  - blood level
KW  - disease severity
KW  - *neurotrophin
KW  - *biological marker
KW  - nerve growth factor
KW  - cytokine
KW  - protein
KW  - marker
KW  - oxygen
KW  - neurotransmitter
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 185
IS  - MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Grayson, West Virginia University, Morgantown, WV, United States
UR  - http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A1208
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71985736
AB  - Background: Bronchopulmonary dysplasia (BPD), defined as an oxygen requirement at 36 weeks gestation, is a common cause of morbidity and mortality in neonates. Previous studies have shown a multi-factorial etiology including prematurity, need for mechanical ventilation, and oxygen exposure. More recently, an imbalance between pro-inflammatory and anti-inflammatory cytokines has been shown to predict the development and disease course of BPD. Neurotrophins like the nerve growth factor (NGF) control the development of afferent and efferent fibers innervating the lower respiratory tract and modulate the synthesis and release of sensory and motor neurotransmitters. Our previous studies have shown significantly increased NGF levels in the lungs of term infants during acute viral infections, but neurotrophins expression in the lungs of premature infants has never been investigated. Objective(s): We tested the hypothesis that NGF levels are elevated in premature infants who develop BPD compared to premature infants who do not develop BPD and term infants. Method(s): We used a highly sensitive immunoassay to measure the nerve growth factor concentrations in serum samples and in the cell fractions of tracheal lavage fluid on day 1 and 2 post-intubation of 33 infants to our neonatal intensive care unit. Our patients included: 5 term patients intubated for cardiac conditions, 18 premature infants who did not develop BPD, and 10 premature infants who developed BPD. Result(s): Data show significantly higher NGF concentrations in the cell fraction of tracheal lavage fluid obtained from infants with BPD (26.6 +/- 10.9 pg/mg protein) compared to control term infants (2.3 +/- 10.9 pg/mL) and a smaller increase compared to premature infants without development of BPD (19.6 +/- 7.8 pg/mL). Serum levels of NGF from infants with BPD (1077.3 +/- 580.8 pg/mg) were significantly higher compared to control term infants (320 +/- 70.5 pg/mL) and similar to premature infants without development of BPD (1545.7 +/- 827 pg/mL). Conclusion(s): We conclude that NGF is markedly over-expressed in the lungs of infants born prematurely and may contribute to the development of airway inflammation and hyperreactivity. Additional studies are ongoing to determine whether this factor could be used as a prognostic marker for disease severity.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71925527
TI  - Pregnancy complications and respiratory outcomes in very preterm infants
AU  - Gagliardi L.
AU  - Rusconi F.
AU  - Da Fre M.
AU  - Mello G.
AU  - Carnielli V.
AU  - Di Lallo D.
AU  - Macagno F.
AU  - Miniaci S.
AU  - Corchia C.
AU  - Cuttini M.
Y1  - 2012//
KW  - *prematurity
KW  - *infant
KW  - *human
KW  - *European
KW  - *society
KW  - *pregnancy complication
KW  - mortality
KW  - risk
KW  - diseases
KW  - Italian (citizen)
KW  - premature labor
KW  - hypothesis
KW  - pathology
KW  - membrane
KW  - immaturity
KW  - rupture
KW  - lung dysplasia
KW  - newborn
KW  - maternal age
KW  - citizenship
KW  - infection
KW  - maternal hypertension
KW  - morbidity
KW  - mother
KW  - gestational age
KW  - population
KW  - intrauterine infection
KW  - death
KW  - respiratory distress syndrome
KW  - confidence interval
KW  - prenatal growth
KW  - education
KW  - female
KW  - steroid
T2  - European Respiratory Journal
LA  - English
VL  - 40
IS  - SUPPL. 56
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - L. Gagliardi
UR  - http://erj.ersjournals.com/content/40/Suppl_56/P4652.abstract?sid=c4d50af2-4f1b-42b2-8e67-33476cb2e6ba
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71925527
AB  - Very preterm infants have a high mortality and morbidity, due to a combination of immaturity per se, and of the underlying pathology causing preterm birth. The role of prenatal infection on increasing the risk of bronchopulmonary dysplasia (BPD) is still unsettled. Aim(s): To test the hypothesis that infection/inflammation disorders (I) (prelabor premature rupture of membranes, spontaneous preterm labor, infection and hemorrage) and hypertensive disorders (H) (maternal hypertension and intrauterine growth restriction) are differently associated to in-hospital mortality and BPD. Method(s): A population-based prospective cohort of 2085 singleton infants 23 to 31 weeks gestational age (GA) born in 6 Italian regions in 2003-2005 (ACTION study), was analyzed. Infants born of mothers with H (31%) were contrasted with those born after I (63%) with respect to mortality and BPD. Multivariable logistic analyses (generalized estimating equations) were used. Result(s): Mortality was 14.3%, with 48.7 % of deaths occurring in the first 5 days of life, largely due to respiratory causes. Infants born after H had more respiratory distress syndrome than the I group (odds ratio (OR)= 1.41, 95% confidence interval (CI): 1.1-1.8, adjusted for GA, sex and antenatal steroids). 12.8 % of neonates had BPD. After adjustment for GA, H disorders had a higher risk of mortality (OR=1.4; 95% CI:1.0, 2.0) and of BPD (OR=2.5; CI: 1.8, 3.6). Further adjustment for maternal age, education, citizenship, and antenatal steroids did not change results. Conclusion(s): Our results support the hypothesis that pathogenetic mechanisms involving the regulation of lung/airways size and vessels are more important than I in the development of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71925519
TI  - The association of NQO1 C609T polymorphism and the susceptibility of bronchopulmonary dysplasia in preterm neonates
AU  - Daraki A.
AU  - Zachaki S.
AU  - Polycarpou E.
AU  - Costalos C.
AU  - Gavrili S.
Y1  - 2012//
KW  - *lung dysplasia
KW  - *prematurity
KW  - *newborn
KW  - *human
KW  - *European
KW  - *society
KW  - genotype
KW  - heterozygote
KW  - Greek (citizen)
KW  - gender
KW  - mutant
KW  - gene
KW  - allele
KW  - case control study
KW  - lung alveolus epithelium
KW  - Greece
KW  - population
KW  - homozygote
KW  - real time polymerase chain reaction
KW  - detoxification
KW  - blood
KW  - environmental factor
KW  - control group
KW  - gestational age
KW  - enzyme activity
KW  - reactive oxygen metabolite
KW  - oxygen
KW  - biological marker
KW  - enzyme
KW  - genomic DNA
KW  - DNA
KW  - nicotinamide adenine dinucleotide
KW  - reduced nicotinamide adenine dinucleotide (phosphate) dehydrogenase (quinone)
T2  - European Respiratory Journal
LA  - English
VL  - 40
IS  - SUPPL. 56
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - A. Daraki
UR  - http://erj.ersjournals.com/content/40/Suppl_56/P4126.abstract?sid=49d0d27e-d355-4050-b9fe-e5a9149ce86a
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71925519
AB  - Introduction: The development of bronchopulmonary dysplasia (BPD) involves genetic and environmental factors. Supplemental oxygen can damage the pulmonary epithelium through the generation of reactive oxygen species (ROS). The NAD(P)H: quinone oxidoreductase (NQO1) enzyme is involved in ROS detoxification. The encoding gene is subjected to the inactivating sense polymorphism (C609T). Individuals homozygous for the mutant allele (T/T) completely lack NQO1 activity, whereas heterozygotes (C/T) have low enzyme activity. We conducted a case-control study to investigate the potential role of NQO1 inborn polymorphism in BPD susceptibility. Patients/Methods: The study enrolled 119 Greek premature neonates with gestational age <=32 weeks; 42 developed BPD (case group) and 77 did not develop BPD (control group). Genomic DNA was extracted from peripheral blood of all neonates. NQO1 genotyping was performed by real-time PCR. The NQO1 gene status was also evaluated in respect to gender. Result(s): A different distribution of NQO1 genotypes was found between BPD neonates and controls, with a higher frequency of variant genotypes (heterozygotes C/T and homozygotes T/T) in BPD population (50% in BPD vs 28.6% in no BPD neonates, p=0.046). Thus, a significantly higher frequency of the mutant T allele was observed in BPD neonates as compared to controls (0.27 vs 0.17, p=0.058). According to gender, we observed no genotypic differences. Conclusion(s): The higher incidence of the C/T and T/T variant genotypes among neonates who developed BPD suggests that the NQO1 C609T inborn polymorphism probably constitutes an early biomarker of BPD development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71925508
TI  - Development of a quality of life instrument for children with bronchopulmonary dysplasia
AU  - Schaap L.
AU  - Flokstra-De Blok B.M.J.
AU  - Van Der Hulst J.
AU  - Dubois A.E.J.
AU  - Vrijlandt E.J.L.E.
Y1  - 2012//
KW  - *child
KW  - *human
KW  - *lung dysplasia
KW  - *European
KW  - *society
KW  - *quality of life
KW  - questionnaire
KW  - parent
KW  - morbidity
KW  - risk
KW  - validity
KW  - hospitalization
KW  - social behavior
KW  - academic achievement
KW  - exercise
KW  - coughing
KW  - premature labor
T2  - European Respiratory Journal
LA  - English
VL  - 40
IS  - SUPPL. 56
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - L. Schaap
UR  - http://erj.ersjournals.com/content/40/Suppl_56/P4129.abstract?sid=49d0d27e-d355-4050-b9fe-e5a9149ce86a
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71925508
AB  - Background. Bronchopulmonary dysplasia (BPD) is a common complication of preterm birth. It is associated with prolonged hospitalization, long-term pulmonary morbidity and an increased risk for adverse neurodevelopmental outcome. The impact of these complications on health-related quality of life (HRQL) is not known because there is no disease-specific instrument to measure HRQL available. Aim. To develop a disease-specific questionnaire to measure HRQL in children with BPD aged 4 to 8 years old. Methods. Participant(s): children aged 4 to 8 years old with BPD. The first steps in the development of a HRQL instrument are item generation and item reduction. Sources for item generation were literature, expert opinion and parents of participants. For item reduction, parents indicated how much the items affected the HRQL of their child. The clinical impact method and item analysis were used to reduce items. Results. 51 children participated in the study; 20 in item generation and 31 in item reduction. 130 items were identified. With the clinical impact method 53 items with an overall importance (OI) >1.00 were selected. Three items with highest OI were 'easily distracted' (2.52), 'having a cold for longer period of time' (2.42) and 'coughing' (2.39). After item analysis, 47 items remained in the questionnaire. Items were linked to a variety of subjects such as pulmonary problems, growth/nutrition, exercise, school, behavior, social and emotional functioning. Conclusion. This is the first time the development of a disease-specific instrument to measure HRQL in BPD has been undertaken. The items in the developed questionnaire have clinical impact. The next step will be to determine validity of these items.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71923231
TI  - LSC 2012 abstract Repair of the very immature lung following brief, injurious mechanical ventilation commences within 24 hours
AU  - Brew N.
AU  - Hooper S.
AU  - Wallace M.
AU  - Harding R.
Y1  - 2012//
KW  - *artificial ventilation
KW  - *European
KW  - *society
KW  - *lung
KW  - injury
KW  - gene
KW  - lung injury
KW  - sheep
KW  - fetus
KW  - human
KW  - lung dysplasia
KW  - fetus lung
KW  - infant
KW  - trachea
KW  - surgery
KW  - gestational age
KW  - ewe
KW  - autopsy
KW  - early response gene
KW  - model
KW  - prematurity
KW  - gene expression
KW  - messenger RNA
KW  - interleukin 6
KW  - interleukin 8
KW  - metallothionein
KW  - urokinase receptor
KW  - interleukin 1
T2  - European Respiratory Journal
LA  - English
VL  - 40
IS  - SUPPL. 56
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - N. Brew
UR  - http://erj.ersjournals.com/content/40/Suppl_56/P823.abstract?sid=cb3dc326-1583-44f9-ba40-b4310b103482
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71923231
AB  - Background: Very preterm infants often require mechanical ventilation (MV). This intervention can cause lung injury that contributes to bronchopulmonary dysplasia. To investigate mechanisms of injury and repair in we have developed a novel method of ventilating the lungs of fetal sheep. Using this model MV-induced injury resolves within 15d, but it is not known when repair starts. Method(s): Pregnant sheep at 110d and 125d gestational age (GA; term=147dGA) underwent aseptic surgery in which the fetal trachea was intubated and fetal lungs ventilated for 2h with an injurious MV protocol. Ewes and fetuses remained healthy until necropsy, performed 1d later. Unventilated fetuses were controls, n=6. Result(s): Following MV, severe lung injury was present at 1d. At 1d potential repair genes (metallothionein and urokinase receptor) mRNA levels were increased in MV lungs at both stages of development. There was no difference in the mRNA levels of early response genes (CTGF, CYR-61, and EGR-1) and inflammatory genes (IL- 1beta, IL-6, IL-8 and TNFalpha). Conclusion(s): Following MV injury, repair processes, commencing with normalisation of early response and inflammatory gene expression and the activation of repair genes, occurs within 24h.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Combined iNO and endothelial progenitor cells improve lung alveolar and vascular structure in neonatal rats exposed to prolonged hyperoxia.
DO  - https://dx.doi.org/10.1038/pr.2015.39
AU  - Lu, Aizhen
AU  - Sun, Bo
AU  - Qian, Liling
Y1  - 2015//
Y2  - 20150305//
KW  - Analysis of Variance
KW  - Animals
KW  - Animals, Newborn
KW  - Blood Vessels/cy [Cytology]
KW  - *Blood Vessels/de [Drug Effects]
KW  - Blotting, Western
KW  - Bromodeoxyuridine
KW  - DNA Primers/ge [Genetics]
KW  - *Endothelial Progenitor Cells/ph [Physiology]
KW  - Endothelial Progenitor Cells/tr [Transplantation]
KW  - Enzyme-Linked Immunosorbent Assay
KW  - *Hyperoxia/pa [Pathology]
KW  - Immunohistochemistry
KW  - NG-Nitroarginine Methyl Ester/ad [Administration & Dosage]
KW  - Nitric Oxide/ad [Administration & Dosage]
KW  - *Nitric Oxide/pd [Pharmacology]
KW  - Nitric Oxide Synthase Type III/me [Metabolism]
KW  - Pulmonary Alveoli/bs [Blood Supply]
KW  - *Pulmonary Alveoli/de [Drug Effects]
KW  - Rats
KW  - Rats, Sprague-Dawley
KW  - Real-Time Polymerase Chain Reaction
KW  - Vascular Endothelial Growth Factor A/bl [Blood]
KW  - Vascular Endothelial Growth Factor A/me [Metabolism]
KW  - Vascular Endothelial Growth Factor Receptor-2/me [Metabolism]
T2  - Pediatric research
VL  - 77
IS  - 6
SN  - 0031-3998
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25742118
AD  - United States
AB  - BACKGROUND: Stem cells or inhaled nitric oxide (iNO) are reported to improve lung structures in bronchopulmonary dysplasia (BPD) models. We hypothesized that combined iNO and transplanted endothelial progenitor cells (EPCs) might restore lung structure in rats after neonatal hyperoxia., METHODS: Litters were separated into eight groups: room air, hyperoxia, hyperoxia + iNO, hyperoxia + iNO + L-NAME, hyperoxia + EPCs, hyperoxia + EPCs + L-NAME, hyperoxia + EPCs + iNO, and hyperoxia + EPCs + iNO + L-NAME. Litters were exposed to hyperoxia from the 21st day, then, sacrificed. EPCs were injected on the 21st day. L-NAME was injected daily for 7 d from the 21st day. Serum vascular endothelial growth factor (VEGF), radial alveolar count (RAC), VIII factor, EPCs engraftment, lung VEGF, VEGFR2, endothelial nitric oxide (eNOS) and SDF-1 expression, and NO production were examined., RESULTS: Hyperoxia exposure led to air space enlargement, loss of lung capillaries, and low expression of VEGF and eNOS. Transplanted EPCs, when combined with iNO, had significantly increased engraftment in lungs, compared to EPCs alone, upon hyperoxia exposure. There was improvement in alveolarization, microvessel density, and upregulation of VEGF and eNOS proteins in the hyperoxia-exposed EPCs with iNO group, compared to hyperoxia alone., CONCLUSION: Combined EPCs and iNO improved lung structures after neonatal hyperoxia. This was associated with the upregulation of VEGF and eNOS expression.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71923045
TI  - Regulation of microRNA-mRNA target pairs in a model of bronchopulmonary dysplasia
AU  - Collura C.
AU  - Carey W.
AU  - Dong J.
AU  - Prakash Y.S.
AU  - Wigle D.
Y1  - 2012//
KW  - *model
KW  - *lung dysplasia
KW  - *European
KW  - *society
KW  - lung
KW  - mouse
KW  - gene ontology
KW  - human
KW  - data analysis software
KW  - data base
KW  - hyperoxia
KW  - newborn
KW  - prematurity
KW  - ambient air
KW  - histology
KW  - lung parenchyma
KW  - murine model
KW  - angiogenesis
KW  - exposure
KW  - experimental model
KW  - inflammation
KW  - cell adhesion
KW  - cell cycle
KW  - gene
KW  - organogenesis
KW  - chronic lung disease
KW  - *messenger RNA
KW  - *microRNA
KW  - oxygen
T2  - European Respiratory Journal
LA  - English
VL  - 40
IS  - SUPPL. 56
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - C. Collura
UR  - http://erj.ersjournals.com/content/40/Suppl_56/1400.abstract?sid=a7142a05-370e-47de-b800-524855ec6315
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71923045
AB  - Background: Bronchopulmonary dysplasia (BPD) is a chronic lung disease of premature neonates characterized by arrested pulmonary alveolar development. Objective(s): Because microRNAs (miRNAs) may regulate the translation of messenger RNAs (mRNAs) during normal lung organogenesis, we hypothesized that an experimental model of BPD would be characterized by the altered expression of miRNAs and their mRNA targets. Method(s): Neonatal mice were exposed to 80% oxygen (O2) or room air (RA) for either 14 or 29 days. Lung histology was assessed using standard techniques. Comprehensive miRNA and mRNA profiling was performed using lung tissue from each group. Potential direct mRNA targets of miRNAs were systematically predicted through miRNA-mRNA correlations and computational mapping in miRBase. Functional significance was investigated using Gene Ontology (GO) term enrichment analysis for miRNA regulatory networks using the DAVID and MetaCore databases. Result(s): At both 14 and 29 days, the lungs of O2 mice displayed histological changes consistent with BPD. Between the two time points we identified 2,714 mRNAs and 66 miRNAs that were dynamically regulated by O2 exposure. All but one of the miRNAs were up-regulated. We identified 581 dynamically regulated, direct mRNA targets of these miRNAs by computational mapping in miRBase. Gene ontology enrichment and pathway analysis revealed that hyperoxia modulated genes involved in a variety of lung developmental processes, including cell cycle, cell adhesion, inflammation and angiogenesis. Conclusion(s): A murine model of BPD is characterized by dynamic regulation of miRNAs and their computationally predicted, developmentally relevant mRNA targets./.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71414713
TI  - The p66Shc adapter protein regulates the morphogenesis and epithelial maturation of fetal mouse lungs
AU  - Lee M.K.
AU  - Smith S.M.
AU  - Volpe M.V.
AU  - Nielsen H.C.
Y1  - 2012//
KW  - *morphogenesis
KW  - *maturation
KW  - *mouse
KW  - *lung
KW  - *society
KW  - *cytology
KW  - explant
KW  - lung development
KW  - apoptosis
KW  - stress
KW  - suspension
KW  - prematurity
KW  - mitochondrion
KW  - oxidative stress
KW  - lung dysplasia
KW  - cell proliferation
KW  - chronic lung disease
KW  - phenotype
KW  - gene
KW  - knockout mouse
KW  - serum
KW  - trachea
KW  - infant
KW  - organ culture
KW  - airway
KW  - Clara cell
KW  - *protein
KW  - small interfering RNA
KW  - growth factor
KW  - differentiation antigen
KW  - smooth muscle actin
KW  - cycline
KW  - thyroid transcription factor 1
KW  - lung surfactant
T2  - Molecular Biology of the Cell
LA  - English
VL  - 23
IS  - 24
SP  -
PB  - American Society for Cell Biology
SN  - 1059-1524
AD  - M.K. Lee, Ctr for Craniofacial Molec Biology, University of Southern California, Los Angeles, CA, United States
UR  - http://www.molbiolcell.org/content/suppl/2012/12/07/23.24.4663.DC1/2012_Abstracts.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71414713
DO  - https://dx.doi.org/10.1091/mbc.E12-10-0757
AB  - Multiple growth factor signaling pathways are mediated by Shc adapter proteins that, in turn, are expressed as three transcriptional and translational variants with distinct and opposing functions. The p66Shc isoform has anti-mitogenic properties, regulates oxidative stress responses, and participates in mitochondria-mediated apoptosis. It is also highly expressed in the canalicular but not the saccular or alveolar stages of mouse lung development, suggesting an important morphogenetic function. Moreover, p66Shc expression persists in the lungs of infants with bronchopulmonary dysplasia, a chronic lung disease that is induced by premature birth. However, constitutive p66Shc deletion yields no morphologic phenotype and the structure of the Shc gene precludes the development of an inducible isoform-specific knockout mouse. To elucidate its role in lung development, we microinjected Oligofectamine (Invitrogen) suspensions containing 6.6 nM isoform-specific p66Shc or nonsilencing siRNA into the tracheae of E12 mouse lungs. The lung explants were maintained in serum-free organ culture for three days, then subjected to morphometric analysis. To assess cellular proliferation and differentiation, sections were also immunostained for p66Shc; smooth muscle actin (SMA); proliferating cell nuclear antigen (PCNA); the proximal airway differentiation antigens Clara cell 10-kDa protein (CC10) and thyroid transcription factor (TTF)-1; and the alveolar surfactant proteins (SP) -A, B, and C. Explants injected with nonsilencing siRNA demonstrated specific epithelial uptake and normal morphological development relative to uninjected control explants. In contrast, explants injected with p66Shc siRNA had significantly increased lumenal crosssection areas, decreased branching, and increased epithelial proliferation (p<0.05 for all) as well as decreased epithelial p66Shc expression. Relative to controls, the expression of SP-B, SP-C, CC10, and TTF-1 were decreased by p66Shc knockdown. SP-A was not expressed in lungs transfected with either p66Shc or control siRNA, and SMA expression was not altered by p66Shc silencing. These data suggest that p66Shc attenuates epithelial proliferation while promoting both distal and proximal epithelial maturation during normal and pathological lung development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71386185
TI  - Impact of perinatal nutrition on kidney function at five years in very low birth-weight children
AU  - Rachel V.
AU  - Sorana G.
AU  - Aissata S.
AU  - Francis G.
AU  - Jean-Michel H.
Y1  - 2012//
KW  - *kidney function
KW  - *very low birth weight
KW  - *child
KW  - *human
KW  - *society
KW  - *nephrology
KW  - *nutrition
KW  - protein intake
KW  - newborn period
KW  - low birth weight
KW  - childhood
KW  - adulthood
KW  - kidney failure
KW  - multiple linear regression analysis
KW  - hypertension
KW  - model
KW  - monitoring
KW  - longitudinal study
KW  - control group
KW  - blood pressure
KW  - multivariate analysis
KW  - risk factor
KW  - albuminuria
KW  - glomerulus filtration rate
KW  - pregnancy
KW  - birth weight
KW  - lung dysplasia
KW  - gender
KW  - height
KW  - hyaline membrane disease
KW  - enterocolitis
KW  - urine
KW  - albumin
T2  - Pediatric Nephrology
LA  - English
VL  - 27
IS  - 9
PB  - Springer Verlag
SN  - 0931-041X
AD  - V. Rachel, Maternite Regionale, Universitaire Nancy, France
DO  - https://dx.doi.org/10.1007/s00467-012-2232-7
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71386185
AB  - Introduction: Low birth-weight is a risk factor of hypertension and renal failure in adulthood. Some symptoms may be diagnosed in childhood allowing a better monitoring. We aimed to determine the impact of perinatal factors on renal function in five year-old preterm-born children. Material(s) and Method(s): Prospective longitudinal study of preterm-born children followed-up from birth to five years. Neonatal renal function was evaluated weekly for one month. Then it was measured at four and five years. Five year-old full-term children (EDEN study) composed the control group. The primary outcome was renal function at five years: blood pressure (BP), estimated glomerular filtration rate (eGFR), albuminuria. Multivariate analysis was performed with multiple linear regression models. Result(s): 168 children were included aged 5.1+/-0.1 years. 133 preterm-born children, born at (mean+/-SD): 29.2+/- 1.4 weeks gestation, birth-weight: 1216+/-336 grams; 35 full-term children aged five. Systolic BP (sBP) was 97.5+/- 7.1 mmHg in preterm-born children versus 92.2+/-8.1 mmHg in full-term controls, p=0.0001. In preterm-born children, sBP increased by (beta+/-sigma): 2.2+/-1.0 mmHg for each gram/kg increase in proteins/day on day 28, and decreased by -3.0+/- 1.4 in case of bronchopulmonary dysplasia, after adjustment on gender and height at five years. eGFR was 176.3+/- 37.1 mL/min/1.73 m2 at five in preterm-born children. It was significantly decreased when children had presented hyaline membrane disease or necrotising enterocolitis, respectively (beta+/-sigma): -17.6+/-6.7 and -25.7+/-10.4 mL/min/ 1.73 m2. eGFR at five was not associated with neonatal nutrition. Urine albumin/creatinine ratio was: 1.3+/-2.8 mg/ mmol in preterm-born children vs. 1.1+/-0.8 mg/mmol in full-terms. 14.4 % preterm-born children had an albumin ratio >2 mg/mmol vs. 11.1 % full-terms, p=0.7. Renal volume, absolute or relative, at five years was negatively correlated to protein intakes from day 14 onwards in the neonatal period: R=-0.69, p=0.006. Conclusion(s): Protein intakes in the neonatal period are associated to an increased BP and decreased renal volume in five year-old preterm-born children.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71199865
TI  - Human amnion epithelial cells modulate hyperoxia-induced neonatal lung injury in mice
AU  - Vosdoganes P.
AU  - Lim R.
AU  - Koulaeva E.
AU  - Chan S.T.
AU  - Acharya R.Y.
AU  - Moss T.J.M.
AU  - Wallace E.M.
Y1  - 2012//
KW  - *human
KW  - *hyperoxia
KW  - *lung injury
KW  - *epithelium cell
KW  - *mouse
KW  - *society
KW  - *gynecological examination
KW  - *amnion
KW  - body weight
KW  - pneumonia
KW  - intraperitoneal drug administration
KW  - tissues
KW  - lung structure
KW  - lung disease
KW  - exposure
KW  - lung dysplasia
KW  - risk
KW  - infant
KW  - climate
KW  - therapy
KW  - leukocyte
KW  - adult
KW  - tissue repair
KW  - gene expression
KW  - density
KW  - inflammation
KW  - morbidity
KW  - lung
KW  - oxygen
KW  - sodium chloride
KW  - collagen
KW  - nonoxinol 9
KW  - platelet derived growth factor
T2  - Reproductive Sciences
LA  - English
VL  - 19
IS  - 3 SUPPL. 1
PB  - SAGE Publications Inc.
SN  - 1933-7191
AD  - P. Vosdoganes, Ritchie Centre, Monash Institute of Medical Research, Clayton, VIC, Australia
DO  - https://dx.doi.org/10.1177/1933719112442493
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71199865
AB  - Background: Postnatal exposure to supplemental oxygen increases an infant's risk of developing bronchopulmonary dysplasia among other morbidities. Human amnion epithelial cells (hAECs) can mitigate inflammation and aid tissue repair in fetal and adult lung disease. We hypothesised that hAECs would attenuate hyperoxia-induced changes to neonatal lung structure. Method(s): From birth, neonatal mice were exposed to hyperoxia (FiO2 = 85%) for 14 days. Mice were kept in climate-controlled chambers on a 12hour day/night cycle. Human AECs were administered to mice via intraperitoneal injection on days 5, 6 and 7. Controls were exposed to normoxia (FiO2 = 21%) and received IP saline replacement. Body weight was monitored every second day and lungs were collected on day 14 for assessment. Result(s): Hyperoxia exposure resulted in reduced neonatal growth, pulmonary inflammation and altered lung structure. Human AECs significantly improved neonatal body weight, and significantly attenuated hyperoxia-induced changes to mean linear intercept, septal crest density, and associated altered gene expression of TGF-beta and PDGF-beta (all, p<0.05). However, mitigation of hyperoxia-induced changes to alveolar airspace volume, septal tissue volume, tissue-to-airspace ratio, collagen content and leukocyte infiltration was nonsignificant (all, p>=0.05). Conclusion(s): Intraperitoneal administration of hAECs to neonatal mice partially reduced hyperoxia-induced lung inflammation and structural lung damage. These observations suggest that hAECs may be a potential therapy for neonatal lung disease.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71199603
TI  - Molecular characterization of in utero fetal lung injury: The birth of bronchopulmonary dysplasia
AU  - McAdams R.
AU  - Vanderhoeven J.
AU  - Beyer R.
AU  - Bammler T.
AU  - Farin F.
AU  - Gravett M.
AU  - Rubens C.
AU  - Waldorf K.A.
Y1  - 2012//
KW  - *fetus lung
KW  - *lung injury
KW  - *lung dysplasia
KW  - *society
KW  - *gynecological examination
KW  - gene
KW  - chorioamnionitis
KW  - morphogenesis
KW  - premature labor
KW  - angiogenesis
KW  - infection
KW  - statistical analysis
KW  - tissues
KW  - infusion
KW  - adaptive immunity
KW  - autopsy
KW  - lung development
KW  - cesarean section
KW  - colony forming unit
KW  - amnion fluid
KW  - neutrophil
KW  - uterus
KW  - Streptococcus agalactiae
KW  - exposure
KW  - upregulation
KW  - inoculation
KW  - chemotaxis
KW  - dendritic cell
KW  - antigen presentation
KW  - T lymphocyte activation
KW  - pregnancy
KW  - Haplorhini
KW  - cell survival
KW  - Macaca nemestrina
KW  - fetus membrane
KW  - interleukin 8
KW  - interleukin 1
KW  - sodium chloride
KW  - cytokine
KW  - cell antigen
KW  - interleukin 6
KW  - oxidoreductase
KW  - vasculotropin
KW  - RNA
T2  - Reproductive Sciences
LA  - English
VL  - 19
IS  - 3 SUPPL. 1
PB  - SAGE Publications Inc.
SN  - 1933-7191
AD  - R. McAdams, Pediatrics, University of Washington, Seattle, WA, United States
DO  - https://dx.doi.org/10.1177/1933719112442493
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71199603
AB  - Background: Intrauterine exposure to amniotic fluid (AF) cytokines is thought to play a role in development of bronchopulmonary dysplasia (BPD). Our objective was to determine for the first time early molecular pathways associated with fetal lung injury in the saccular stage of lung development, which is when BPD is thought to originate. Method(s): Ten chronically catheterized pregnant monkeys (Macaca nemestrina) at 118-125 days gestation (term=172 days) received choriodecidual inoculation of either: 1) Group B Streptococcus 1 x 106 colony forming units (n=5) or 2) saline (n=5). Cesarean section and fetal necropsy was performed 4 days after GBS or 7 days after saline infusion to collect tissues. RNA was extracted from fetal lungs and profiled by microarray. Statistical analysis focused on single genes and gene set analysis. Results were validated by RT-PCR (chorioamnion) and Luminex (AF). Result(s): Only two GBS animals developed early labor and chorioamnionitis with no cervical change in remaining animals. Despite uterine quiescence in most cases, fetal lung injury occurred in four GBS animals (intra-alveolar neutrophils, interstitial thickening) and was absent in controls. Significant elevations of AF cytokines (TNF-alpha, IL-8, IL-1beta, IL-6) were detected in GBS versus controls (p<0.05). Lung injury was not directly caused by GBS, because GBS was undetectable (AF, fetal lungs) by culture and PCR. A total of 187 genes were differentially expressed in fetal lungs (p <0.05; fold change >2.0) with a striking upregulation of innate and adaptive immunity (e.g. IL-1beta, IL- 8, chemotaxis, dendritic cell antigen processing, T cell activation). Pathways critical for angiogenesis (ANGPT1, VEGF regulation), morphogenesis (WNT3), and cell survival (aldo-keto reductase family 1 member B10) were downregulated. Conclusion(s): A transient choriodecidual infection may induce fetal lung injury without AF infection, chorioamnionitis or preterm labor. Our results provide a window for the first time into early molecular pathways disrupting fetal lung angiogenesis and morphogenesis before preterm labor occurs.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71194437
TI  - Primary ciliary dyskinesia (PCD) causing idiopathic tachypnoea in newborn
AU  - Allgood C.
AU  - Edwards M.
AU  - Chin R.
AU  - Dunstan R.
AU  - Freelander M.
AU  - Morgan L.
AU  - Whitehall J.
Y1  - 2012//
KW  - *ciliary dyskinesia
KW  - *tachypnea
KW  - *newborn
KW  - *human genetics
KW  - *human
KW  - *society
KW  - *Australia and New Zealand
KW  - female
KW  - dextrocardia
KW  - pregnancy
KW  - periostitis
KW  - hyperbilirubinemia
KW  - eukaryotic flagellum
KW  - resuscitation
KW  - male
KW  - pathogenesis
KW  - hyaline membrane disease
KW  - mother
KW  - patent ductus arteriosus
KW  - retrolental fibroplasia
KW  - mucus
KW  - Apgar score
KW  - arm
KW  - boy
KW  - gene
KW  - patent foramen ovale
KW  - microscopy
KW  - air conditioning
KW  - echocardiography
KW  - rubella
KW  - stenosis
KW  - mutation
KW  - situs inversus
KW  - plasma
KW  - phototherapy
KW  - blood
KW  - bodily secretions
KW  - patient
KW  - autosomal recessive disorder
KW  - urine
KW  - syphilis
KW  - cholestasis
KW  - positive end expiratory pressure
KW  - heart atrium septum defect
KW  - Human immunodeficiency virus
KW  - dynein adenosine triphosphatase
KW  - oxygen
KW  - galactose 1 phosphate uridylyltransferase
T2  - Twin Research and Human Genetics
LA  - English
VL  - 15
IS  - 4
PB  - Cambridge University Press
SN  - 1832-4274
AD  - C. Allgood, Department of Paediatrics, Campbelltown Hospital, P O Box 149, Campbelltown, NSW, Australia
DO  - https://dx.doi.org/10.1017/thg.2012.45
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71194437
AB  - PCD is an uncommon autosomal recessive disease, caused by mutations in various genes involving structure or function of cilia, causing impaired clearance of mucus and pathogens and chronic sinopulmonary disease. The ciliary abnormality causes random determination of situs, so 50% of patients have situs inversus/dextrocardia. A fullterm boy weighing 3725 gm after an uncomplicated pregnancy had Apgar scores of 9/1 and 9/5. His P6 G9 mother had a cousin with dextrocardia, her family is consanguineous. No resuscitation was required, but from age 31 hours, 7 days of supplemental oxygen was needed for tachypnoea of newborn, with mucopurulent upper respiratory secretions. ChestXray showed dextrocardia and situs inversus. Echocardiography showed ASD and a small patent foramen ovale. Cilia on nasal mucosal brushings were completely immotile on light microscopy and the number of inner and outer dynein arms was markedly deficient on EM. A younger brother was born at 24 weeks gestation weighing 596 gm and required ventilation for a month followed by CPAP for hyaline membrane disease. He had pulmonic stenosis, patent ductus arteriosus, retinopathy of prematurity and hyperbilirubinaemia treated by phototherapy, followed by chronic conjugated hyperbilirubinaemia. A skeletal survey showed marked periostitis attributed to CMV, detected by blood PCR analysis. Plasma VLCFA pattern, urine metabolic screen, DSIDA scan and galactose-1-phosphate uridyl transferase level were normal, CGH pending. Antenatal screens for rubella, syphilis and HIV were negative. Although it is unknown whether ciliopathies cause periostitis or cholestasis, these could be two more conditions associated with ciliary dysfunction.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71063316
TI  - Impact of perinatal nutrition on kidney function at five years in very low bieth-weight children
AU  - Vieux R.
AU  - Galu S.
AU  - Guillemin F.
AU  - Hascoet J.M.
Y1  - 2012//
KW  - *kidney function
KW  - *weight
KW  - *child
KW  - *human
KW  - *organization
KW  - *nutrition
KW  - newborn period
KW  - protein intake
KW  - glomerulus filtration rate
KW  - multiple linear regression analysis
KW  - blood pressure
KW  - hyaline membrane disease
KW  - multivariate analysis
KW  - enterocolitis
KW  - model
KW  - pregnancy
KW  - lung dysplasia
KW  - gender
KW  - height
KW  - albuminuria
KW  - longitudinal study
KW  - albumin
T2  - Archives of Disease in Childhood
LA  - English
VL  - 97
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - R. Vieux, Department of Neonatology, Maternite Regionale Universitaire, Nancy Cedex, Nancy, France
UR  - http://adc.bmj.com/cgi/reprint/97/Suppl_2/A389-a?sid=e5712d66-8f51-428e-97cf-98c51ffefa29
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71063316
DO  - https://dx.doi.org/10.1136/archdischild-2012-302724.1387
AB  - Aim To determine the impact of perinatal factors on renal function in five year-old preterm-born children. Material and Methods Prospective longitudinal study of pretermborn children from birth to five years of age, and five year-old fullterm controls. Renal function measured in the neonatal period and at five years. Primary outcome was renal function at five years: blood pressure (BP), estimated glomerular filtration rate (eGFR), albuminuria. Multivariate analysis was performed with multiple linear regression models. Results 168 children included aged 5.1+/-0.1 years. 133 pretermborn children, born: 29.2+/-1.4 weeks gestation; 35 full-term children aged five. Systolic BP (sBP) was 97.5+/-7.1 mmHg in preterm-born children versus 92.2+/-8.1 mmHg in full-term controls, p=0.0001. In pretermborn children, sBP increased by (beta+/-sigma): 2.2+/-1.0 mmHg for each gram/kg increase in proteins/day on day 28, and decreased by -3.0+/-1.4 in case of bronchopulmonary dysplasia, after adjustment on gender and height at five years. eGFR was 176.3+/-37.1 mL/min/1.73m2 at five in preterm-born children. It was significantly decreased when children had presented hyaline membrane disease or necrotising enterocolitis, respectively (beta+/-sigma): -17.6+/-6.7 and -25.7+/-10.4 mL/min/1.73m2. eGFR at five was not associated with neonatal nutrition. 14.4% preterm-born children had an albumin ratio >2 mg/mmol vs. 11.1% full-terms, p=0.7. Renal volume, absolute or relative, at five years was negatively correlated to protein intakes from day 14 onwards in the neonatal period: R= -0.69, p=0.006. Conclusion Protein intakes in the neonatal period are associated to an increased BP and decreased renal volume in five year-old pretermborn children.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71063185
TI  - Quality of general movements after treatment with low-dose dexamethasone in preterm infants at risk for bronchopulmonary dysplasia
AU  - Hitzert M.M.
AU  - Van Der Laan M.E.
AU  - Roescher A.M.
AU  - Bos A.F.
Y1  - 2012//
KW  - *human
KW  - *low drug dose
KW  - *infant
KW  - *prematurity
KW  - *risk
KW  - *lung dysplasia
KW  - *organization
KW  - treatment duration
KW  - videorecording
KW  - drug megadose
KW  - *dexamethasone
T2  - Archives of Disease in Childhood
LA  - English
VL  - 97
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - M.M. Hitzert, Division of Neonatology, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands
UR  - http://adc.bmj.com/cgi/reprint/97/Suppl_2/A355-c?sid=8eba6652-d706-4fe2-9af0-a51df8db0c9b
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71063185
DO  - https://dx.doi.org/10.1136/archdischild-2012-302724.1256
AB  - Background Postnatal dexamethasone (DXM) is widely used to treat preterm infants at risk for bronchopulmonary dysplasia. Previously, it was reported that high-dose DXM leads to deteriorated quality of general movements (GMs). We determined neurological functioning in infants after low-dose DXM treatment, assessed by the GM-quality until three months post term. Methods We included preterm infants, admitted to our NICU between 2010-2012 and treated with DXM (starting dose 0.25 mg/ kg/d). GM-quality was assessed before (day 0), during and after treatment until three months post term. We determined the change in GM-quality by comparing the GM-quality of day 0 with the GMquality of the last video recording. Additionally, we calculated a motor optimality score (MOS), ranging from 8 (low optimality) to 18 (high optimality). Results Sixteen infants were included [median GA 26.9 wks (25.0-29.7); BW 800 g (620-1665)]. Before treatment, 4 infants had normal GMs which remained normal after starting treatment. GM-quality improved in 8 of 12 initially abnormal infants (Mc Nemar; P=0.008), whilst MOS slightly increased: median 10.5, 12.0 and 12.5 on days 0, 1 and 7, respectively (NS). Cumulative DXM doses, treatment duration and postnatal ages at starting DXM were not associated with change in GM-quality. Infants whose GMs improved were ventilated for a shorter period than infants whose GMs remained the same quality (P=0.065). Conclusions GM-quality did not deteriorate after DXM treatment but rather improved in infants with initial abnormal GMs. Our findings suggest that neurological functioning until three months post term is not adversely affected after low-dose DXM.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71062533
TI  - Oxygen dependence is associated with supply protein offers at first 35 days of life for preterm infants with bronchopulmonary dysplasia
AU  - Moraes-Barbosa A.
AU  - Pacheco H.
Y1  - 2012//
KW  - *infant
KW  - *human
KW  - *prematurity
KW  - *lung dysplasia
KW  - *organization
KW  - newborn
KW  - weight
KW  - baby
KW  - Brazil
KW  - nutritional status
KW  - *protein
KW  - *oxygen
KW  - amino acid
T2  - Archives of Disease in Childhood
LA  - English
VL  - 97
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - A. Moraes-Barbosa, Pediatrics, Federal Fluminense University, Niteroi, Brazil
UR  - http://adc.bmj.com/cgi/reprint/97/Suppl_2/A179-c?sid=d52222da-49a5-4978-8482-5dcfdaff5885
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71062533
DO  - https://dx.doi.org/10.1136/archdischild-2012-302724.0603
AB  - Background and Aims The aims of this study was to determine if the time of introduction and diary quantity of amino acid offered at first 35 days of life for newborns with BPD, weight < 1500g at birth, may influence the oxygen dependence at final period. Methods Newborns with BPD, consecutively observed in the NICU (UFF - RJ - Brazil), from April 2006 to March 2008, were divided in Early Start (ES) and Late Start (LE) Groups when they began to received amino acids (AA) up (n=56) or after (n=48) 72 hours of life. It was also divided according to the quantity of AA administered in the first week of life (1.11+/- 0.04g/kg/day): Larger Supply (LAS) (n=42) and Lower Supply (LOS) (n=58) received a quantity of AA 2 SD above or below this mean. Results A total of 104 newborns were evaluated. At 35th of life the babies of ES and LE were weighing 34.1% and 21.9% more than his weight at birth, respectively, and from LOS and LAS, 39% and 23.7% regarding his birth (p>0.05). At the end of the studied period, 8.9% of the babies of the ES and 16.7% of the LE still stayed receiving some oxygen. In LAS 4.7% and 21% in LOS were receiving some oxygen support (p = 0.004). Conclusion Nutritional state is decisive in the oxygen necessity at neonatal final period, and the major offers of protein is a priority way.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71062528
TI  - Effects of catalytic antioxidant mntbap on pulmonary angiogenic and oxidative gene expression to hyperoxia in newborn mice
AU  - Paturi B.
AU  - Ryan R.M.
AU  - Nielson L.
AU  - Wang H.
AU  - Kumar V.
Y1  - 2012//
KW  - *gene expression
KW  - *hyperoxia
KW  - *mouse
KW  - *organization
KW  - gene
KW  - ambient air
KW  - exposure
KW  - lung
KW  - model
KW  - lung dysplasia
KW  - gene expression profiling
KW  - injection
KW  - data analysis
KW  - newborn
KW  - reverse transcription
KW  - lung injury
KW  - *antioxidant
KW  - angiopoietin 1
KW  - sodium chloride
KW  - myeloperoxidase
KW  - peroxiredoxin 6
T2  - Archives of Disease in Childhood
LA  - English
VL  - 97
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - B. Paturi, Neonatology, Rotunda Hospital, Dublin, Ireland
UR  - http://adc.bmj.com/cgi/reprint/97/Suppl_2/A178-a?sid=98252766-1eb3-47f3-9d40-913a658d9ec3
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71062528
DO  - https://dx.doi.org/10.1136/archdischild-2012-302724.0598
AB  - Background Development of lung injury during prolonged O2 exposure is a complex process, associated with changes in expression of a number of genes important in the adaptive response to hyperoxia. MnTBAP is a compound with strong antioxidant properties. Objective To study the effects of MnTBAP on angiogenic and oxidative gene expression in C57BL6 neonatal mice following hyperoxia. Design and methods: Newborn mice litters were randomized on postnatal day 4 to hyperoxia (> 95% O2)(OX) or room air (RA) for 72 hrs during which they received MnTBAP (MN) 10mg/kg or saline (SL) daily by IP injection for 3 days and then were sacrificed. Whole lung angiogenic and oxidative gene expression profiling (84 related genes for each) was done by real-time, reverse transcription, quantitative PCR (n=4). Data was processed and analyzed using SA Biosciences PCR array data analysis web portal. Results Hyperoxia significantly upregulated peroxiredoxin 6 expression compared to room air exposed newborn mice. Treatment with MnTBAP downregulated the expression of myeloperoxidase and Prdx6-rs1. Hyperoxia downregulated the expression of angiogenic genes such as angiopoietin 1 & 2, TGF 1, TGF 3 and HGF; MnTBAP treatment during the hyperoxia exposure reversed this effect and these genes were upregulated. Conclusions The catalytic antioxidant MnTBAP reversed the effects of hyperoxia on angiogenic gene expression in newborn mice. The protective effects of antioxidants in newborn hyperoxia models need to be studied further to provide additional understanding of the management of bronchopulmonary dysplasia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Tobacco smoke in infants with bronchopulmonary dysplasia.
DO  - https://dx.doi.org/10.1007/s00431-015-2491-y
AU  - Martinez, Stephanie
AU  - Garcia-Meric, Patricia
AU  - Millet, Veronique
AU  - Aymeric-Ponsonnet, Mellie
AU  - Alagha, Khuder
AU  - Dubus, Jean-Christophe
Y1  - 2015//
Y2  - 20150130//
KW  - Asthma/di [Diagnosis]
KW  - Asthma/ep [Epidemiology]
KW  - *Bronchopulmonary Dysplasia/ep [Epidemiology]
KW  - Bronchopulmonary Dysplasia/th [Therapy]
KW  - Case-Control Studies
KW  - Child, Preschool
KW  - Female
KW  - France/ep [Epidemiology]
KW  - Humans
KW  - Infant
KW  - Infant, Newborn
KW  - Infant, Premature
KW  - Male
KW  - Oxygen Inhalation Therapy
KW  - Pregnancy
KW  - *Prenatal Exposure Delayed Effects
KW  - Prospective Studies
KW  - Smoking/ae [Adverse Effects]
KW  - *Smoking/ep [Epidemiology]
KW  - *Tobacco Smoke Pollution/sn [Statistics & Numerical Data]
T2  - European journal of pediatrics
VL  - 174
IS  - 7
SN  - 0340-6199
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25633581
AD  - Germany
AB  - UNLABELLED: Exposure to tobacco smoke has been not evaluated in children with bronchopulmonary dysplasia (BPD). We evaluate the association of in utero smoking (IUS) and environmental tobacco smoke (ETS) with the respiratory events of BPD and non-BPD children. Two hundred sixty-two children born before 35 weeks of gestational age (GA) and regularly followed up in our regional network for preterms were enrolled. They were paired according to their BPD status, their gestational age and birth weight (131 children with BPD and 131 without BPD, 28 mean weeks GA; mean weight 1000 g). Respiratory data were obtained prospectively during their first 2 years of life. A complementary questionnaire was completed by the parents about their child's respiratory health at the age of 2, their home environment, and tobacco status. IUS concerned 12.6 %; ETS, 48.8 % (67 % in BPD children treated with oxygen at home). No further influence on respiratory outcome could be found by exposure to intrauterine smoke or extrauterine tobacco smoke in this patient sample., CONCLUSION: IUS and ETS exposures are as high in preterm children as in a general pediatric population. The highest exposure occurs among BPD infants treated with oxygen at home., WHAT IS KNOWN: * Environmental tobacco smoke (ETS) and in utero smoking (IUS) are responsible for many morphological, functional, and clinical changes in children. * Children with bronchopulmonary dysplasia (BPD) have more respiratory events in their first years of life than preterm children without BPB, maybe triggered by ETS and IUS. What is New: * The exposition to ETS and IUS is high in preterm children with and without BDP, as high as in a general. * Pedaitric population, particularly in children with BPD and treated with oxygen at home. * No further influence on respiratory outcome could be found by exposure to ETS or IUS in our studied population.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71062315
TI  - A double blind, randomized controlled trial on the resuscitation of preterm infants with 30% versus 65% oxygen at birth
AU  - Rook D.
AU  - Vlaardingerbroek H.
AU  - Schierbeek H.
AU  - Van Der Eijk A.C.
AU  - Escobar J.
AU  - Longini M.
AU  - Buonocore G.
AU  - Vento M.
AU  - Van Goudoever J.B.
AU  - Vermeulen M.J.
Y1  - 2012//
KW  - *human
KW  - *resuscitation
KW  - *randomized controlled trial
KW  - *infant
KW  - *prematurity
KW  - *organization
KW  - oxidative stress
KW  - survival
KW  - plasma
KW  - oxidation
KW  - lung dysplasia
KW  - heart rate
KW  - oxygen saturation
KW  - birth weight
KW  - *oxygen
KW  - protein
KW  - marker
KW  - iron
KW  - DNA
T2  - Archives of Disease in Childhood
LA  - English
VL  - 97
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - D. Rook, Pediatrics, Division of Neonatology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands
UR  - http://adc.bmj.com/cgi/reprint/97/Suppl_2/A113-a?sid=deac35d4-49c9-4a6a-bc60-fc03cb7ba2a7
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71062315
DO  - https://dx.doi.org/10.1136/archdischild-2012-302724.0385
AB  - Background Resuscitation of term infants at birth with 100% oxygen increases oxidative stress with concomitant deleterious effects. Optimal levels for preterm infants are unknown. We hypothesized that resuscitation of preterms with initial FiO2 of 30% is safe, decreases oxidative stress and improves outcome compared to an initial FiO2 of 65%. Design Preterm infants (GA<32 weeks) were randomized to start resuscitation after birth with 30% or 65% oxygen. FiO2 was adjusted based on oxygen saturation and heart rate. Primary outcome was survival without bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age. Oxidative stress was determined by urinary DNA and protein oxidation markers, and plasma non protein bound iron. Results We included 194 infants, mean GA (284/7+/-21/7 weeks) and birth weight (1076+/-347 gram) were not different between groups. FiO2 was significantly different during the first 5 minutes following birth. Clinical outcomes (table) and oxidative stress markers were not statistically different between groups. (Table presented) Conclusion Resuscitation of preterm infants at birth with 30% oxygen is as safe as resuscitation with 65%, but does not offer benefits with regard to survival without BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71062156
TI  - Nutrition in the critically ILL: Enteral and parenteral nutrition in the newborn
AU  - Agostoni C.
AU  - Francescato G.
AU  - Agosti M.
Y1  - 2012//
KW  - *parenteral nutrition
KW  - *nutrition
KW  - *newborn
KW  - *organization
KW  - *human
KW  - *critically ill patient
KW  - infant
KW  - adverse outcome
KW  - feeding
KW  - nutritional support
KW  - diseases
KW  - breast milk
KW  - sepsis
KW  - lung dysplasia
KW  - growth retardation
KW  - prematurity
KW  - nerve cell differentiation
KW  - risk
KW  - critical illness
KW  - organogenesis
KW  - gastrointestinal tract
KW  - caloric intake
KW  - enteric feeding
KW  - liquid
KW  - glucose blood level
KW  - supplementation
KW  - postnatal growth
KW  - protein
KW  - polyunsaturated fatty acid
KW  - glutamine
KW  - zinc
KW  - oleic acid
KW  - medium chain triacylglycerol
T2  - Archives of Disease in Childhood
LA  - English
VL  - 97
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - C. Agostoni, Pediatric Department 2, Fondazione IRCCS Policlinico, University of Milan, Milan, Italy
UR  - http://adc.bmj.com/cgi/reprint/97/Suppl_2/A65-c?sid=04bc7128-d2f0-4a0e-a8af-d1e4b2af6c55
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71062156
DO  - https://dx.doi.org/10.1136/archdischild-2012-302724.0226
AB  - Initiating both parenteral nutrition with adequate protein:energy ratios and early enteral feedings strategies (within the first hours of life, whenever possible) seem to offer preventive advantage towards developing complicating illnesses and favour neurodevelopment. Human milk as early enteral feeding has trophic effects on the gastrointestinal tract and shows anti-infectious properties. The requirements of growth and organ development create a challenge in nutritional management of newborn infants, especially preterms and those with additional disorders, such as intestinalfailure, bronchopulmonary dysplasia, and sepsis. Nutritional support improves outcome in critically ill infants but is affected by fluid restriction, metabolic derangements, gastric intolerance and feeding interruptions. Few studies compare more critically ill infants with less critically ill infants as far as nutritional support during the initial weeks of life looking at growth and rates of adverse outcomes. Accordingly, the influence of critical illness on the risk of adverse outcomes seems to be mediated by energy intakes during the first week of life (Pediatr Res 2011; 69:522). Changes in amounts and ratios of protein and energy, fat quality (medium chain triglycerides, oleic acid and n-3 long-chain polyunsaturated fatty acids through parenteral nutrition), maintaining normoglycemia during full or partial parenteral nutrition, shortand medium term effects of either parenteral or enteral glutamine supplementations, daily supplemental zinc, rate of feeding advancements and avoidance of postnatal growth retardation represent the main items whose roles in critically ill preterm infants have been considered so far. Available data are still limited and do not allow for firm conclusions in most cases.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71062106
TI  - The role of FGF10 for alveogenesis in bronchopulmonary dysplasia
AU  - Chao C.M.
AU  - Al Alam D.
AU  - Tiozzo C.
AU  - Virender R.
AU  - Bellusci S.
Y1  - 2012//
KW  - *lung dysplasia
KW  - *organization
KW  - hyperoxia
KW  - control group
KW  - real time polymerase chain reaction
KW  - mouse
KW  - histology
KW  - lung
KW  - model
KW  - gestational age
KW  - transgenic mouse
KW  - prematurity
KW  - chronic lung disease
KW  - animal model
KW  - cell damage
KW  - epithelium cell
KW  - transgene
KW  - morphogenesis
KW  - human
KW  - morphology
KW  - gene expression
KW  - infant
KW  - lung injury
KW  - vascularization
KW  - oxygen
KW  - fibroblast growth factor 10
KW  - nonoxinol 9
KW  - doxycycline
T2  - Archives of Disease in Childhood
LA  - English
VL  - 97
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - C.M. Chao, Department of Pediatrics, Excellence Cluster in Cardio-Pulmonary Systems (ECCPS), University of Giesen, Giessen, Germany
UR  - http://adc.bmj.com/cgi/reprint/97/Suppl_2/A51-c?sid=04bc7128-d2f0-4a0e-a8af-d1e4b2af6c55
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71062106
DO  - https://dx.doi.org/10.1136/archdischild-2012-302724.0176
AB  - Background and aim Bronchopulmonary dysplasia (BPD) is associated with impaired alveolar growth and pathologic vascularization. As a chronic lung disease it remains an important complication for preterm infants, especially born before 28th week of gestational age. Fibroblast-growth-factor 10 (Fgf10) is known to play an important role in lung morphogenesis. We aim to investigate the role of Fgf10 for alveogenesis in a mouse model of BPD. Methods Using an inducible double transgenic mouse line (SPC-rtTA; tet(O)Fgf10) we established a BPD model by exposing the pups to 85% oxygen (experimental and control group) and normoxia (control group) for 28 days. Activation of the transgene Fgf10 was done after birth (P0) by doxycycline treatment. Gene expressions for Fgfr2b and Fgf10 were analyzed by quantitative real-time PCR. To study lung morphology histology, mean linear intercept (MLI) and radial alveolar count (RAC) were performed. Results Real-time PCR results showed a significant decrease of Fgfr2b and Fgf10 expression in the hyperoxia group at day 21 and day 28 indicating epithelial cell damages. The histology showed a simplification of alveoli in the hyperoxia group (85% oxygen) but not in the normoxia group after 14 days. In contrast, the hyperoxia group with overexpression of Fgf10 showed less simplification of alveoli. These findings were confirmed by MLI and RAC. Conclusion We conclude that Fgf10 may have a protective/regenerative effect on lung injury by increasing secondary septa formation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71062103
TI  - Clues for the neurodevelopmental prognosis of the high risk preterm and term newborns
AU  - Gucuyener K.
Y1  - 2012//
KW  - *prognosis
KW  - *risk
KW  - *newborn
KW  - *organization
KW  - survivor
KW  - birth weight
KW  - childhood
KW  - seizure
KW  - necrotizing enterocolitis
KW  - neurologic disease
KW  - visual impairment
KW  - cerebral palsy
KW  - brain hemorrhage
KW  - gestational age
KW  - lung dysplasia
KW  - infant
KW  - retrolental fibroplasia
KW  - hyperactivity
KW  - hearing impairment
KW  - anxiety
KW  - attention deficit disorder
KW  - pregnancy
KW  - feeding
KW  - academic achievement
KW  - cognition
KW  - school
KW  - congenital malformation
KW  - brain injury
KW  - home environment
KW  - early intervention
KW  - extremely low birth weight
KW  - nuclear magnetic resonance imaging
T2  - Archives of Disease in Childhood
LA  - English
VL  - 97
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - K. Gucuyener, Pediatric Neurology, Gazi University, Faculty of Medicine, Ankara, Turkey
UR  - http://adc.bmj.com/cgi/reprint/97/Suppl_2/A50-c?sid=04bc7128-d2f0-4a0e-a8af-d1e4b2af6c55
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71062103
DO  - https://dx.doi.org/10.1136/archdischild-2012-302724.0173
AB  - Premature survivors are at increased risk for impaired neurodevelopmental outcome compared to full terms. These sequelae include cognitive abnormalities, mild fine or gross motor delay, cerebral palsy, vision and hearing losses, impairment increases with decreasing gestational age. Persistence of multiple abnormal neurologic signs in the first 12 to 18 months is ominous. Emergence of other findings (vision impairments, seizures, feeding issues delay of head growth) is associated with poor outcome. MRI is useful in predicting neurodevelopmental outcome at the equivalent of term gestation. Other neonatal complications as; bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of prematurity, intraventricular hemorrhage, poor growth, presence of congenital anomalies are associated with an increased risk of poor neurodevelopmental outcome. Premature survivors are more likely to have specific psychological and behavioral problems including attention deficit hyperactivity syndrome, general anxiety, and depression. Individuals with birth weights below 1500 g are at greater risk for poor academic performance than those born with normal birthweight because of their impaired cognition, neurosensory defects, and behavioral and psychological problems. Neurodevelopmental outcome is assessed more accurately at school age than in early childhood due to the cognitive recovery over time and lack of accurate predictive assessment tools in early childhood. Survivors of prematures need to be assessed for neurodevelopmental impairment and, if impairment is present, be referred to educational programs and subspecialty care in order to provide the best possible outcome. ELBW infants without evidence of significant neonatal brain injury can recover when exposed to a nurturing home environment and comprehensive early intervention services.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71062058
TI  - Intraperitoneal administration of cytidine 5'-diphosphocholine (CDP-choline) reduces hyperoxic lung injury in a neonatal rat model of bronchopulmonary dysplasia
AU  - Cetinkaya M.
AU  - Cansev M.
AU  - Tayman C.
AU  - Cekmez F.
AU  - Canpolat F.E.
AU  - Kafa I.M.
AU  - Uysal S.
AU  - Sarici S.U.
Y1  - 2012//
KW  - *lung dysplasia
KW  - *lung injury
KW  - *animal model
KW  - *rat
KW  - *organization
KW  - *intraperitoneal drug administration
KW  - hyperoxia
KW  - protein expression
KW  - injection
KW  - tissues
KW  - apoptosis
KW  - fibrosis
KW  - lamellar body
KW  - ambient air
KW  - human
KW  - prevention
KW  - control group
KW  - newborn
KW  - edema
KW  - cell infiltration
KW  - lung
KW  - enzyme activity
KW  - inflammation
KW  - nick end labeling
KW  - *citicoline
KW  - cytidine diphosphate
KW  - sodium chloride
KW  - cytokine
KW  - interleukin 6
KW  - interleukin 1
KW  - caspase 3
KW  - malonaldehyde
KW  - glutathione
T2  - Archives of Disease in Childhood
LA  - English
VL  - 97
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - M. Cetinkaya, GATA Teaching Hospital, Ankara, Turkey
UR  - http://adc.bmj.com/cgi/reprint/97/Suppl_2/A35-b?sid=d714481c-b673-4928-9586-5f0937d2a5a8
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71062058
DO  - https://dx.doi.org/10.1136/archdischild-2012-302724.0128
AB  - Purpose The purpose of this study was to evaluate the preventive effect of CDP-choline treatment on hyperoxic lung injury, inflammation and apoptosis in a neonatal rat model of bronchopulmonary dysplasia BPD. Methods A total of 30 newborn pups were arranged in control, hyperoxia, and hyperoxia+CDP-choline groups. Immediately after birth, pups in the control group were kept in room air containing 21% O2 and received daily saline injections, while those in hyperoxia and hyperoxia+CDP-choline groups were exposed to 95% O2 and received daily injections of saline and CDP-choline (300 mg/kg), respectively, throughout postnatal day 10 (P10). Histopathological scoring, radial alveolar count, lamellar body protein expression, fibrosis, proinflammatory cytokine levels, oxidant/antioxidant enzyme activities, malondialdehyde content and apoptosis were evaluated on lung samples obtained at P10. Results Hyperoxia induced severe lung damage as evidenced by cell infiltration, edema and fibrosis which were reduced significantly by CDP-choline treatment. Radial alveolar count and lamellar body protein expression were significantly recovered, while number of TUNEL-positive cells and active Caspase-3 expression were decreased by CDP-choline administration. Tissue proinflammatory cytokine (IL-1b, IL-6 and TNF-alpha) levels as well as tissue MDA content and MPO activities were reduced, whereas GSH-Px and SOD activities were preserved in hyperoxia+CDP-choline group. Conclusions Our data show for the first time that parenteral CDPcholine administration prevents hyperoxic lung injury in a neonatal rat model of BPD. It may therefore be suggested that CDP-choline can be used as an effective therapeutic agent for prevention of BPD in case it exhibits similar effects in humans.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71061991
TI  - Association of vitamin D receptor gene polymorphisms and bronchopulmonary dysplasia
AU  - Altun Koroglu O.
AU  - Onay H.
AU  - Cakmak B.
AU  - Bilgin B.
AU  - Yalaz M.
AU  - Tunc S.
AU  - Ozkinay F.
AU  - Kultursay N.
Y1  - 2012//
KW  - *receptor gene
KW  - *DNA polymorphism
KW  - *lung dysplasia
KW  - *organization
KW  - genotype
KW  - risk
KW  - infant
KW  - human
KW  - prematurity
KW  - model
KW  - innate immunity
KW  - restriction fragment length polymorphism
KW  - lung development
KW  - fetus lung
KW  - sepsis
KW  - prediction
KW  - gestational age
KW  - university hospital
KW  - multivariate logistic regression analysis
KW  - univariate analysis
KW  - lung disease
KW  - artificial ventilation
KW  - infection
KW  - *vitamin D receptor
KW  - vitamin D
KW  - surfactant
T2  - Archives of Disease in Childhood
LA  - English
VL  - 97
IS  - SUPPL. 2
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - O. Altun Koroglu, Neonatology, Izmir, Turkey
UR  - http://adc.bmj.com/cgi/reprint/97/Suppl_2/A17-c?sid=d714481c-b673-4928-9586-5f0937d2a5a8
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=71061991
DO  - https://dx.doi.org/10.1136/archdischild-2012-302724.0061
AB  - Background and aims Vitamin D is considered as an important regulator of fetal lung development and innate immune system. Its functions involved in susceptibility and resistance to infections and pulmonary diseases may be important for the occurrence of bronchopulmonary dysplasia (BPD). The aim of the study was to investigate the relationship between Vitamin D receptor gene polymorphism and BPD in preterm infants. Methods Fok I, Bsm I, Apa I, and Taq I polymorphisms in the Vitamin D Receptor (VDR) gene were genotyped using restriction fragment length polymorphism in109 preterm infants (47 with BPD, 62 without BPD) born at gestational age <= 32 weeks and admitted to NICU at Ege University Hospital. Results The univariate analysis showed Ff (OR=3.937, p=0.022, 95% CI= 1.22-12.69) and ff (OR=5.238, p=0.004, 95% CI= 1.69- 16.23) genotypes of Fok I polymorphism were associated with increased risk of BPD; whereas tt genotype of Taq 1 polymorphism; was associated with a protective effect against BPD (OR=0.30, p=0.04, 95% CI= 0.098-0.094). In a multivariate logistic regression analysis of the model including variant Fok1 genotype with significant PDA, clinical and culture proven sepsis, mechanical ventilation and surfactant treatment; variant Fok 1 genotype increased the risk of BPD (OR=4.115, CI=1.080-15.686, p=0.038) independent from these factors. Taq 1, Bsm 1 and Apa 1 polymorphisms did not have any effect in the same model. Conclusion Fok1 polymorphism was associated with increased frequency of BPD after adjusting for multiple confounders. VDR gene polymorphisms may be suitable for prediction of infants at high risk for BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70983060
TI  - Iugr decreases stearoyl-coa desaturase MRNA and palmitoleic acid levels in newborn rat lung
AU  - Riederer A.B.
AU  - Baack M.L.
AU  - Wang Y.
AU  - Jiang C.
AU  - Yu X.
AU  - Callaway C.W.
AU  - Norris A.W.
AU  - Lane R.H.
AU  - Joss-Moore L.A.
Y1  - 2012//
KW  - *rat
KW  - *lung
KW  - *medical research
KW  - *newborn
KW  - lung parenchyma
KW  - synthesis
KW  - lipid composition
KW  - lung dysplasia
KW  - artery ligation
KW  - human
KW  - uterine artery
KW  - risk
KW  - prenatal growth
KW  - gas chromatography
KW  - down regulation
KW  - *acyl coenzyme A desaturase
KW  - *palmitoleic acid
KW  - messenger RNA
KW  - peroxisome proliferator activated receptor
KW  - surfactant
KW  - lipid
T2  - Journal of Investigative Medicine
LA  - English
VL  - 60
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - A.B. Riederer, University of Utah, Salt Lake City, UT, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e318240c940
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70983060
AB  - Purpose of Study: Intrauterine growth restriction (IUGR) increases the risk of bronchopulmonary dysplasia (BPD), which is characterized by impaired alveolar formation. In humans and rats, alveolar formation depends on the transcriptional regulator, PPARgamma. We demonstrated that IUGR decreases PPARF expression in the newborn rat lung. Stearoyl-CoA desaturase (SCD) is an important downstream target of PPARgamma in the lung. SCD catalyzes the rate-limiting step in synthesis of palmitoleic acid (C16:1). Palmitoleic acid contributes to surfactant synthesis and alveolar formation. However, the effect of IUGR on SCD and palmitoleic acid levels in the rat lung is unknown. We hypothesize that IUGR will decrease SCD and palmitoleic acid levels in newborn rat lung compared to control lung. Methods Used: IUGR was induced by bilateral uterine artery ligation in the rat. SCD mRNA levels were measured in lung tissue harvested at birth (d0) from IUGR and control rat pups. Lung fatty acid composition of both IUGR and control rat pups was determined by gas chromatography. Summary of Results: IUGR decreased mRNA transcript levels of SCD (58.0 +/- 0.4*) in d0 rat lung compared to controls. IUGR also decreased palmitoleic acid levels in d0 rat lung when compared to controls (78.3 +/- 1.1%*). P<0.01 Conclusion(s): We conclude that IUGR reduces both SCD mRNA levels as well as levels of a key SCD product, palmitoleic acid, in lung tissue of newborn rat pups. Interestingly, the observed change in mRNA and lipid levels parallels the observed change in PPARgamma expression in IUGR. We speculate that the down regulation of SCD and palmitoleic acid levels in IUGR is a result of direct action by PPARgamma on SCD transcription.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70983054
TI  - Curcumin blocks hyperoxia-induced pulmonary alveolar type II cell and lipofibroblast apoptosis
AU  - Villarreal P.
AU  - Sakurai R.
AU  - Li Y.
AU  - Torday J.
AU  - Rehan V.K.
Y1  - 2012//
KW  - *hyperoxia
KW  - *apoptosis
KW  - *medical research
KW  - exposure
KW  - protection
KW  - lung
KW  - Western blotting
KW  - DNA synthesis
KW  - immunofluorescence
KW  - cell proliferation
KW  - staining
KW  - in vitro study
KW  - lung injury
KW  - spice
KW  - lung dysplasia
KW  - fetus lung maturation
KW  - Sprague Dawley rat
KW  - in vivo study
KW  - cell type
KW  - Indian
KW  - rat
KW  - *curcumin
KW  - caspase 3
KW  - protein p53
KW  - turmeric
KW  - marker
T2  - Journal of Investigative Medicine
LA  - English
VL  - 60
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - P. Villarreal, Harbor UCLA Medical Center, Torrance, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e318240c940
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70983054
AB  - Purpose of Study: To determine the effect of curcumin on hyperoxiainduced lung cellular apoptosis in neonatal rat lungs under in vitro and in vivo conditions. We have recently shown that curcumin, the Indian spice in turmeric, blocks hyperoxia-induced neonatal lung injury. However, the underlying mechanism (s) and the cell-types involved in this protection are not fully known. Since curcumin has potent anti-apoptotic properties, we hypothesized that it blocks the hyperoxia-induced cellular apoptosis of both alveolar type II (ATII) cells and lipofibroblasts (LIF). Methods Used: Embyronic day 19 ATII cells and LIF were exposed to 21% or 95% O2 for 1-24h following 1h pretreatment with curcumin. Cell proliferation (thymidine incorporation) and apoptosis (Western blot analysis for p53, BcL-2, Bax, and cleaved caspase-3, and confocal immunofluorescence staining for caspase-3), were performed. For in vivo studies, 1-day old Sprague Dawley rat pups were exposed to: normoxia (21%O2), normoxia + curcumin (5 mg/kg BW), hyperoxia (7d exposure to 95%O2), or hyperoxia (7d exposure to 95%O2) + curcumin (5 mg/kg BW). Curcumin was administered i.p. once daily. At the end of the experimental period, the pups were sacrificed and the lungs analyzed for apoptosis markers by Western blotting and immunofluorescence staining. Summary of Results: Initially, we established and in vitro hyperoxia exposure results in time-dependent decreases ATII cell and LIF proliferation, accompanied by an increase apoptosis. 1h curcumin (5 KM) pretreatment blocked the hyperoxia-induced decrease in cell proliferation (decrease in thymidine incorporation) and increase in cellular apoptosis (decrease in BcL-2/Bax ratio, and increases in cleaved caspase-3 and p53) in both ATII cells and LIFs. Similarly, parenteral curcumin administration blocked the in vivo hyperoxia-induced increase in ATII cell and LIF apoptosis. Further studies on the mechanistic basis for this curcumin-mediated protection against cellular apoptosis are in progress. Conclusion(s): Curcumin, in addition to its previously documented role of accelerating neonatal lung maturation, blocks the hyperoxia-induced increase in cellular apoptosis in both ATII cells and LIF, offering a potential mechanism for protection against Bronchopulmonary Dysplasia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70983050
TI  - Macrophage polarization & bronchopulmonary dysplasia
AU  - Chan B.
AU  - Li A.
AU  - Lombardi V.
AU  - Geroge R.
AU  - Ramanathan R.
AU  - Akbari O.
AU  - Minoo P.
Y1  - 2012//
KW  - *macrophage
KW  - *polarization
KW  - *lung dysplasia
KW  - *medical research
KW  - human
KW  - mouse
KW  - newborn
KW  - lung alveolus macrophage
KW  - gene expression
KW  - female
KW  - Western blotting
KW  - bone marrow cell
KW  - tissue repair
KW  - lung
KW  - pregnancy
KW  - lung injury
KW  - prematurity
KW  - mating
KW  - inflammation
KW  - microenvironment
KW  - gestational age
KW  - tracheal aspiration procedure
KW  - phenotypic plasticity
KW  - flow cytometry
KW  - gene
KW  - genotype
KW  - transgenic mouse
KW  - tissues
KW  - animal model
KW  - receptor
KW  - transforming growth factor beta
KW  - protein
KW  - antibody
KW  - RNA
T2  - Journal of Investigative Medicine
LA  - English
VL  - 60
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - B. Chan, USC, Los Angeles, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e318240c940
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70983050
AB  - Purpose of Study: In previous studies we showed elevated TGF-beta (TGFb) is a predictor for BPD and the ability of lung macrophages to express IL10 is protective. Macrophages exhibit significant phenotypic plasticity. Depending on the microenvironment, they undergo "polarization" that either propagates inflammation (M1 polarized), or promotes tissue repair (M2 polarized). Little is known about lung macrophages in neonates and how TGFb impacts them. In this study we characterized polarization of macrophages obtained from the lungs of human premature neonates and determine their response to TGFb. To examine the mechanism, we generated & characterized transgenic mice that carry macrophage-specific homozygous inactivation of the gene for TGFb receptor II (TBRII). Methods Used: Tracheal aspirates (TA) was obtained from neonates born at various gestational ages. Macrophages were isolated and sorted by flow cytometry using antibodies specific for M1 or M2 polarization. Macrophages were treated with IL10 and gene expression was analyzed by Realtime-PCR. Macrophage-specific inactivation of TBRII was accomplished by mating between the Lyz22-cre driver line & TBRII flox/flox mice. TBRII inactivation was confirmed by genotyping and western blot. Macrophages from double-transgenic Lyz22-cre; TBRII flox/flox bone marrow cells were isolated and treated with M1 or M2 inducers. RNA and protein were quantified using Realtime-PCR & western blot analyses. Summary of Results: Macrophages from neonates born at <28 weeks gestation exhibited distinct dysregulation of IL10-induced M2 polarization. TGFb inhibited M2 polarization in human neonatal macrophages. IL4, an M2 inducer, activated M2 gene expression in WT mouse macrophages. Addition of TGFb inhibited IL4 induced polarization. TGFb upregulated M1 gene expression in WT mouse macrophages. Inactivation of TGFb receptor appeared to enhance M2 polarization of macrophages in response to IL4. Conclusion(s): To our knowledge, this is the first study to characterize lung macrophage polarization in human neonates. Our studies in genetically altered mice suggest that macrophage-specific inactivation of TBRII leads to M2-skewed polarization. Since M2 polarization is critical for tissue remodeling, further studies are underway to elucidate if TBRII deletion is protective against lung injury in BPD mouse models.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70982238
TI  - Sex differences in hyperoxic lung injury: Role of cytochrome p450 (CYP) 1a and inflammation
AU  - Lingappan K.
AU  - Jiang W.
AU  - Wang L.
AU  - Couroucli X.I.
AU  - Moorthy B.
Y1  - 2012//
KW  - *lung injury
KW  - *inflammation
KW  - *medical research
KW  - *sex difference
KW  - female
KW  - mouse
KW  - hyperoxia
KW  - male
KW  - human
KW  - lung
KW  - exposure
KW  - infant
KW  - prematurity
KW  - injury
KW  - wild type
KW  - modulation
KW  - gene
KW  - neutrophil
KW  - liver
KW  - newborn
KW  - hypothesis
KW  - lung dysplasia
KW  - respiration control
KW  - morbidity
KW  - assay
KW  - breathing
KW  - immunohistochemistry
KW  - experimental animal
KW  - histopathology
KW  - gender
KW  - weight
KW  - *cytochrome
KW  - *cytochrome P450
KW  - messenger RNA
KW  - enzyme
KW  - protein
KW  - apoprotein
KW  - ethoxyresorufin deethylase
T2  - Journal of Investigative Medicine
LA  - English
VL  - 60
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - K. Lingappan, Baylor College of Medicine, Houston, TX, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e3182820c55
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70982238
AB  - Purpose of Study: Sex differences in pulmonary morbidity in preterm infants are well documented. Hyperoxia contributes to lung injury in experimental animals and bronchopulmonary dysplasia (BPD) in preterm infants. CYP1A enzymes attenuate hyperoxic lung injury. Whether CYP1A enzymes play a role in gender differences is unknown. We tested the hypothesis that mice will display sex-specific differences in hyperoxic lung injury, and that this phenomenon will be altered in mice lacking the genes for CYP1A1 or 1A2. Methods Used: 8 week-old male and female (C57BL/6J) mice; wild type (WT), Cyp1a1-null, and Cyp1a2-null mice were exposed to 72 hours of hyperoxia (FiO2>0.95). Lung injury was estimated by lung weight/body weight (LW/BW) ratios, lung histopathology and immunohistochemistry. Pulmonary and hepatic CYP1A1 and CYP1A2 activities were determined by ethoxyresorufin O-deethylase (EROD) and methoxyresorufin O-deethylase (MROD) assays, respectively. Apoprotein levels were determined byWestern blotting, and mRNA levels by RT-PCR. TNF-alpha mRNA expression was quantified by RT-PCR. Summary of Results: Upon exposure to hyperoxia, WT males showed a greater increase in LW/BWratios, compared to air-breathing controls, and more pulmonary perivascular and alveolar injury, neutrophil infiltrates and TNF-alpha mRNA expression than females. Analysis of liver microsomal proteins showed higher CYP1A2 level and activity in WT females compared to WT males and a greater induction in CYP1A2 mRNA levels in WT females after hyperoxia exposure. These findings were reversed in Cyp1a1- and Cyp1a2- null mice. Conclusion(s): The increased susceptibility to hyperoxic lung injury of WT males compared to females and the reversal of effects in Cyp1a1- and 1a2- null mice indicates an important role for CYP1A in the sex-specific effects. Further studies to elucidate the role of CYP1A in the gender specific modulation of hyperoxic injury could explain the mechanisms underlying the better outcomes in female neonates.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Conditional overexpression of TGFbeta1 promotes pulmonary inflammation, apoptosis and mortality via TGFbetaR2 in the developing mouse lung.
DO  - https://dx.doi.org/10.1186/s12931-014-0162-6
AU  - Sureshbabu, Angara
AU  - Syed, Mansoor A
AU  - Boddupalli, Chandra Sekhar
AU  - Dhodapkar, Madhav V
AU  - Homer, Robert J
AU  - Minoo, Parviz
AU  - Bhandari, Vineet
Y1  - 2015//
Y2  - 20150116//
KW  - Acute Lung Injury/ge [Genetics]
KW  - *Acute Lung Injury/me [Metabolism]
KW  - Acute Lung Injury/pa [Pathology]
KW  - Acute Lung Injury/pp [Physiopathology]
KW  - Alveolar Epithelial Cells/me [Metabolism]
KW  - Alveolar Epithelial Cells/pa [Pathology]
KW  - Animals
KW  - Animals, Newborn
KW  - *Apoptosis
KW  - Disease Models, Animal
KW  - Genotype
KW  - Humans
KW  - Hyperoxia/co [Complications]
KW  - *Lung/me [Metabolism]
KW  - Lung/pa [Pathology]
KW  - Lung/pp [Physiopathology]
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - Mice, Transgenic
KW  - Phenotype
KW  - Pneumonia/ge [Genetics]
KW  - *Pneumonia/me [Metabolism]
KW  - Pneumonia/pa [Pathology]
KW  - Pneumonia/pp [Physiopathology]
KW  - Protein Serine-Threonine Kinases/df [Deficiency]
KW  - Protein Serine-Threonine Kinases/ge [Genetics]
KW  - *Protein Serine-Threonine Kinases/me [Metabolism]
KW  - Receptor, Transforming Growth Factor-beta Type II
KW  - Receptors, Transforming Growth Factor beta/df [Deficiency]
KW  - Receptors, Transforming Growth Factor beta/ge [Genetics]
KW  - *Receptors, Transforming Growth Factor beta/me [Metabolism]
KW  - Signal Transduction
KW  - Time Factors
KW  - *Transforming Growth Factor beta1/bi [Biosynthesis]
KW  - Transforming Growth Factor beta1/ge [Genetics]
KW  - Up-Regulation
T2  - Respiratory research
VL  - 16
SN  - 1465-9921
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25591994
AD  - England
AB  - BACKGROUND: Earlier studies have reported that transforming growth factor beta 1(TGFbeta1) is a critical mediator of hyperoxia-induced acute lung injury (HALI) in developing lungs, leading to impaired alveolarization and a pulmonary phenotype of bronchopulmonary dysplasia (BPD). However, the mechanisms responsible for the TGFbeta1-induced inflammatory signals that lead to cell death and abnormal alveolarization are poorly understood. We hypothesized that TGFbeta1 signaling via TGFbetaR2 is necessary for the pathogenesis of the BPD pulmonary phenotype resulting from HALI., METHODS: We utilized lung epithelial cell-specific TGFbeta1 overexpressing transgenic and TGFbetaR2 null mutant mice to evaluate the effects on neonatal mortality as well as pulmonary inflammation and apoptosis in developing lungs. Lung morphometry was performed to determine the impaired alveolarization and multicolor flow cytometry studies were performed to detect inflammatory macrophages and monocytes in lungs. Apoptotic cell death was measured with TUNEL assay, immunohistochemistry and western blotting and protein expression of angiogenic mediators were also analyzed., RESULTS: Our data reveals that increased TGFbeta1 expression in newborn mice lungs leads to increased mortality, macrophage and immature monocyte infiltration, apoptotic cell death specifically in Type II alveolar epithelial cells (AECs), impaired alveolarization, and dysregulated angiogenic molecular markers., CONCLUSIONS: Our study has demonstrated the potential role of inhibition of TGFbeta1 signaling via TGFbetaR2 for improved survival, reduced inflammation and apoptosis that may provide insights for the development of potential therapeutic strategies targeted against HALI and BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70936192
TI  - Comparison of the general movement assessment and the test of infant motor performance with cerebral magnetic resonance imaging in very low birthweight infants
AU  - Peyton C.
AU  - Adde L.
AU  - Yang E.
AU  - Schreiber M.D.
AU  - Fjortoft T.
AU  - Msall M.E.
Y1  - 2012//
KW  - *infant
KW  - *nuclear magnetic resonance imaging
KW  - *very low birth weight
KW  - *cerebral palsy
KW  - *motor performance
KW  - human
KW  - child
KW  - gestational age
KW  - neuroimaging
KW  - birth weight
KW  - brain hemorrhage
KW  - prematurity
KW  - gray matter
KW  - risk
KW  - newborn morbidity
KW  - videorecording
KW  - laser surgery
KW  - cohort analysis
KW  - necrotizing enterocolitis
KW  - lung dysplasia
KW  - motoneuron
KW  - pathology
KW  - intensive care unit
KW  - newborn intensive care
KW  - motor development
KW  - brain
KW  - white matter
KW  - high risk infant
KW  - motor dysfunction
KW  - early intervention
KW  - retrolental fibroplasia
KW  - study design
KW  - classification
KW  - tissue inhibitor of metalloproteinase
KW  - oxygen
T2  - Developmental Medicine and Child Neurology
LA  - English
VL  - 54
IS  - SUPPL. 6
PB  - Blackwell Publishing Ltd
SN  - 0012-1622
AD  - C. Peyton, Comer Children's Hospital, University of Chicago, Chicago, IL, United States
DO  - https://dx.doi.org/10.1111/j.1469-8749.2012.04387.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70936192
AB  - Background /Objectives: Early identification of neuromotor impairments, including cerebral palsy, in high-risk infants is notoriously difficult but essential for supporting families and accessing supports. The analysis of general movements (GMs), and fidgety movements (FMs) in particular, in the infant under 5 months post-term age has been reported to predict the development of cerebral palsy with a high degree of certainty. Cerebral Magnetic Resonance Imaging (MRI) scans at near term have improved our understanding of the preterm brain and have been found to predict neurodevelopmental outcomes at 2 years of age. Our objective was to describe early motor development of high risk preterm infants using GMs and the Test of Infant Motor Profile (TIMP) at 10 to 15 weeks post term after neuroimaging at term. Design(s): Prospective cohort study design of very preterm infants. Participants and Setting: Ten infants who were born at <=31 weeks gestational age, with a birthweight <1500 g, and required oxygen at birth were recruited from a regional neonatal intensive care unit. Materials/Methods: The infants received a cerebralMRI scan on a 3T Phillips Achievea MRI using a SENSE MRI coil array at term age equivalent.MRIs were scored using a standardized system by an experienced pediatric neuroradiologist masked to neonatal morbidities. Scores were given for white and gray matter pathology as well as cerebellar volume. Video recordings at 10 to 15 weeks post term age were classified based on absent or present FMs and the Assessment of Motor Repertoire (AMR) using Prechtl's approach. The TIMP Version 5 was administered at the same session as the video recordings by an experienced, credentialed testermasked to neonatal and neuroimaging status. Result(s): Of the 10 infants only one had an unscathed neonatal profile characterized as birthweight (BW) >1000 g, Gestational age (GA) >28 weeks, and absence of intraventricular hemorrhage (IVH), bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), or severe retinopathy of prematurity (ROP) requiring laser surgery. Overall four children had BPD, one child had NEC and IVH grade 3, and 1 child had severe ROP requiring laser surgery. Only one child had an abnormal performance on the TIMP and 50% had absent fidgety movements. Further results are shown in Table 1. No child was receiving early intervention services. Conclusions/Significance: Motor impairments in the first 5 months of life are not reliably predicted by birthweight, gestational age, neonatal morbidities, or neuroimaging metrics at term. The classification of FMs and AMR total optimality score, not TIMP, detected more motor risk in these vulnerable children. Further studies are required to determine the relationship between neuroimaging, early motor assessments and long term neurodevelopmental outcomes. Legend: GA, Gestational age in weeks-days; IVH, grade of intraventricular hemorrhage; WM, MRI Total White Matter Score; GM, MRI Grey Matter Total Score; Cerebellar, MRI Cerebellar Volume; Timp, Test of Infant Motor Profile Standard Score; AMR, optimality score (5-28); FM, fidgety movements. (Table Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70935129
TI  - Ginsenoside-Rg1 improves cell survival and VEGF production in vascular endothelial cells under hyperoxia
AU  - Yu-Hsueh C.
AU  - Ren-Huei F.
AU  - Hen-Hong C.
Y1  - 2012//
KW  - *cell survival
KW  - *endothelium cell
KW  - *hyperoxia
KW  - *integrative medicine
KW  - diseases
KW  - injury
KW  - prematurity
KW  - angiogenesis
KW  - cell function
KW  - infant
KW  - oxygenation
KW  - human
KW  - apoptosis
KW  - respiratory distress
KW  - retrolental fibroplasia
KW  - supplementation
KW  - lung dysplasia
KW  - cell culture
KW  - ginseng
KW  - *ginsenoside Rg 1
KW  - *vasculotropin
KW  - oxygen
KW  - phosphorus
KW  - receptor protein
KW  - protein
KW  - endothelial nitric oxide synthase
T2  - European Journal of Integrative Medicine
LA  - English
VL  - 4
IS  - SUPPL. 1
PB  - Elsevier GmbH
SN  - 1876-3820
AD  - C. Yu-Hsueh, Graduate Institute of Traditional Chinese Medicine, Chang Gung University, Taoyuan county, Taiwan (Republic of China)
DO  - https://dx.doi.org/10.1016/j.eujim.2012.07.911
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70935129
AB  - Background: Oxygen supplementation is necessary in the treatment of many diseases, especially in preterm infants with respiratory distress. However, oxygen overload may induce injury or other diseases. For the past decades, several diseases in preterm infants, such as bronchopulmonary dysplasia and retinopathy of prematurity, have been correlated with hyperoxia. Vascular endothelial cells are one of the major targets of hyperoxic injury. Hyperoxia increases cell apoptosis and suppresses cell functions, such as angiogenesis and vascular endothelial growth factor production. Rg1, the key component in Ginseng, has been demonstrated to promote the function of cultured vascular endothelial cell in proliferation, angiogenesis and protein production in previous research. Aim(s): To study the effect of Ginsenoside-Rg1 on cell survival and VEGF production in vascular endothelial cells under hyperoxia. Method(s): In this study, various concentrations of Rg1 were administrated to the medium of vascular endothelial cells cultured under 60% oxygenation. Cell functions were evaluated in 72 h duration. Result(s): The results showed that 60% oxygenation will suppress cell survival and function, but the Rg1 receptor protein was not decreased. Rg1 was able to increase vascular endothelial growth factor production in the first 24 h under hyperoxia. However, no obvious effect was found in the production of endothelial nitric oxide (NO) synthase or phosphor-Akt. Rg1 could improve cell survival and increase vascular endothelial growth factor production of cells under hyperoxic condition. However, some effects of Rg1 were suppressed, which appeared to be mediated through the Akt pathway. Conclusion(s): Rg1 may be useful in preventing some of the hyperoxic injury. However, further study on its mechanism should be performed.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70923793
TI  - Inhibition of Cox-2 decreases macrophage infiltration in newborn hyperoxic lung injury
AU  - Rogers L.K.
AU  - Velten M.
AU  - Tipple T.E.
AU  - Britt R.D.
Y1  - 2012//
KW  - *macrophage
KW  - *newborn
KW  - *lung injury
KW  - *society
KW  - hyperoxia
KW  - mouse
KW  - human
KW  - lung parenchyma
KW  - prematurity
KW  - infant
KW  - risk
KW  - lung dysplasia
KW  - mass spectrometry
KW  - leukocyte
KW  - tissue section
KW  - lung lavage
KW  - ambient air
KW  - chronic lung disease
KW  - metabolite
KW  - lung
KW  - *free radical
KW  - protein
KW  - celecoxib
KW  - acetylsalicylic acid
KW  - prostaglandin E2
KW  - antibody
KW  - prostaglandin
KW  - cyclooxygenase 2 inhibitor
KW  - chemokine
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 53
IS  - SUPPL. 2
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - L.K. Rogers, Research Institute at Nationwide Children's Hospital, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2012.10.158
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70923793
AB  - Rationale: Preterm infants are at risk of developing bronchopulmonary dysplasia (BPD), a chronic lung disease characterized by impaired alveolar development. Proinflammatory responses, including leukocyte infiltration, contribute to the development of BPD. We hypothesized that inhibition of Cox-2 activity using aspirin (ASA) or celecoxib would reduce chemokine expression and macrophage numbers in the lungs of newborn mice exposed to hyperoxia (85% O2). Method(s): Newborn pups were injected daily with vehicle, 10 mg/kg ASA or 5 mg/kg celecoxib while exposed to room air (RA) or hyperoxia for 14 days. On day 14, mice were sacrificed and bronchoalveolar lavage (BAL) and lung tissues were collected. Protein concentrations, and KC and MCP-1 protein levels were assessed in BAL. Macrophage numbers were determined in a blinded fashion in tissue sections immunohistochemically stained with F4/80 antibodies. Prostaglandin (PG) products of Cox-2 were measured by mass spectrometry. Result(s): Protein concentrations, and KC and MCP-1 protein levels in BAL were significantly increased in hyperoxia-exposed control mice when compared to RA controls. ASA treatment (10 mg/kg) significantly reduced protein concentrations and MCP-1 levels in the BAL. Both ASA and celecoxib treatment decreased macrophage numbers in lung tissues and the levels of PGE2, PGD2, and PGD2 metabolites PGJ2, 15-deoxyPGJ2, and 13,14- dihydro-15-keto PGD2 in BAL. Conclusion(s): Our data indicate that treatment with Cox-2 inhibitors decreases macrophage infiltration in newborn hyperoxic lung injury, likely by modulating MCP-1 and PGD2 levels. These results suggest that Cox-2 inhibition might be therapeutically beneficial in preterm infants at risk of developing BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70923781
TI  - Monocyte chemottractant protein-1 (MCP-1) deficient mice enhance survival and restores alveolar growth in a hyperoxia-induced neonatal murine lung injury model of bronchopulmonary dysplasia
AU  - Anyanwu A.C.
AU  - Bentley K.
AU  - Sheikh H.A.
AU  - Kaskar S.
AU  - Hershenson M.
AU  - Pinsky D.
Y1  - 2012//
KW  - *monocyte
KW  - *mouse
KW  - *survival
KW  - *hyperoxia
KW  - *lung injury
KW  - *model
KW  - *lung dysplasia
KW  - *society
KW  - lung
KW  - inflammation
KW  - angiogenesis
KW  - injury
KW  - capillary density
KW  - macrophage
KW  - flow cytometry
KW  - histopathology
KW  - body weight
KW  - architecture
KW  - mare
KW  - female
KW  - protection
KW  - vascularization
KW  - *synapsin I
KW  - *monocyte chemotactic protein 1
KW  - *free radical
KW  - oxygen
KW  - interleukin 1
KW  - beta chemokine
KW  - marker
KW  - cytokine
KW  - interleukin 6
KW  - nonoxinol 9
KW  - vasculotropin
KW  - chemokine receptor
KW  - messenger RNA
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 53
IS  - SUPPL. 2
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - A.C. Anyanwu, University of Michigan, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2012.10.146
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70923781
AB  - Rationale: BPD is a multifactorial disease resulting from the impact of injury on the immature lung. Inflammation is one of the primary processes underlying BPD. Recruitment and subsequent activation of macrophages in the lung is mainly controlled by MCP-1/CC chemokine receptor 2 signaling pathway. The role of CC chemokines and angiogenesis has not been extensively studied in the course of BPD. We hypothesized that hyperoxiainduced lung injured CCL-2deficient mice show increased alverolarization thereby promoting alveolar growth and pulmonary protection during hyperoxic injury. Method(s): Time-dated pregnant C57BL/6J (WT) and CCL-2-/- female dams were allowed to deliver spontaneously. On postnatal (PN) day 3, neonatal mice were divided into four groups: 1) WT- 21% oxygen (n=5); 2) CCL-2-/- 21% oxygen (n=5) 3) WT-75% oxygen (n=5); 2) CCL-2-/- 75% oxygen (n=5). Body weight, survival and lung architecture, capillary density, histopathology and inflammation were studied at PN 14 days. Lung angiogenesis and inflammation markers were assessed by flow cytometry, qRT-PCR and immunohistochemical analysis. Result(s): Hyperoxia adversely affected the survival and growth of neonatal mice (both p<0.01). CCL-2-/- show an increase in survival and growth compared with WT hyperoxic exposed animals (p<0.02) Morphometric analysis revealed significant decrease in mean linear intercept, an index of airspace size, indicating hyperalveolarization (p<0.01) in CCL-2-/- compared to age-matched WT hyperoxic control at 14days. Expressions of pro-inflammatory cytokines (IL-1beta, IL-6 and TNF-alpha) were upregulated under hyperoxic conditions. However, CCL-2-/- exposed to hyperoxia showed a significant decrease in TNF-alpha and IL-1beta mRNA levels. Hyperoxia decreased the VEGF-A/B expression in WT- hyperoxic mice compared to age-matched control. Conversely, absence of CCL-2 augments not only the production of VEGF-A/B under hyperoxic insult but also increases capillary density compared to oxygen-exposed group. Conclusion(s): We show that CCL-2deficiency may attenuate vascularization by decreasing the production of antiangiogenic mediators in vivo. We speculate that MCP-1/CCL2 signaling maybe protective against hyperoxia-indced lung injury by inducing angiogenic markers and consequently inhibiting the production of activated proinflammatory mediators.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70890842
TI  - Hyperoxia regulates the degradation of the circadian protein Rev-Erba: Implications for cytoprotection
AU  - Hinson M.D.
AU  - Biswas C.
AU  - La P.
AU  - Yang G.
AU  - Dennery P.A.
Y1  - 2012//
KW  - *hyperoxia
KW  - *cell protection
KW  - *society
KW  - *lung
KW  - myofibroblast
KW  - mutant
KW  - injury
KW  - secretion (process)
KW  - cell proliferation
KW  - effluent
KW  - adipocyte
KW  - lung dysplasia
KW  - phosphorylation
KW  - apoptosis
KW  - immunofluorescence
KW  - phenotype
KW  - cell differentiation
KW  - microenvironment
KW  - pathogenesis
KW  - mouse
KW  - Western blotting
KW  - steady state
KW  - mesenchymal stem cell
KW  - enzyme linked immunosorbent assay
KW  - *free radical
KW  - *Rev protein
KW  - interleukin 1
KW  - broxuridine
KW  - caspase 3
KW  - interleukin 6
KW  - protein
KW  - 2 (2,4 dichlorophenyl) 3 (1 methyl 3 indolyl)maleimide
KW  - messenger RNA
KW  - cytokine
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 53
IS  - SUPPL. 1
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - P.A. Dennery, University of Pennsylvania, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2012.08.496
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70890842
AB  - Introduction: Dysregulation of myofibroblast differentiation in the lung microenvironment contributes to the pathogenesis of bronchopulmonary dysplasia (Dickie R et al, Anat Rec. 2008), a devastating condition with longterm consequences. The precise signaling mechanisms dictating myofibroblast differentiation have not been elucidated. The circadian protein Rev-ERBa is an important regulator of adipocyte differentiation. The role of Rev-ERBa in myofibroblast differentiation is not known. Our objective was to evaluate whether Rev- ERBa inhibits myofibroblast differentiation in mouse neonatal lung-mesenchymal (MLg)-progenitor cells and protects against hyperoxic injury. Method(s): Rev-ERBa WT and phosphorylation defective mutant degradation resistant (SD: 55/59 Ser to Asp) MLg cells were exposed to 95%O2/5%CO2 (hyperoxia) or air/5%CO2 (normoxia) for 0-24 hours. In other experiments, cells were pre-incubated with SB216763, an inhibitor of GSK3b to prevent Rev-ERBa degradation. Cell proliferation was assessed by BrdU incorporation and p21 mRNA levels. Cell differentiation to a myofibroblast phenotype was assessed by measuring aSMA immunofluorescence. Apoptosis was evaluated with caspase-3 activity, and pro-inflammatory cytokine levels (IL-1b and IL-6) were evaluated in the effluent media using ELISA. Cellular steady-state lmRNA and protein levels of Rev-ERBa and p-GSK3b, were assessed by qRT-PCR and Western blot respectively. Result(s): MLg-WT cells exposed to hyperoxia had increased Akt/kinase activity, increased levels of pGSK3b protein and significantly decreased Rev-ERBa protein levels,. This was associated with decreased BrdU incorporation and increased p21 mRNA levels. Immunoreactive aSMA and caspase-3 activity were also increased, as was IL-1b and IL-6 secretion. In contrast, Rev-ERBa levels remained stable in the SD mutants and in the cells pre-incubated with SB216763. This was associated with increased BrdU incorporation, decreased p21 as well as decreased immunoreactive aSMA, caspase-3 activity and IL-1b and IL-6 secretion in hyperoxia. Conclusion(s): Hyperoxia mediates the degradation of Rev-ERBa. Preventing this degradation protects reduces myofibroblast differentiation and protects the cells against hyperoxic injury.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70877691
TI  - Lung fibroblast dysfunction associated with the development of severe BPD
AU  - Ehrhardt H.
AU  - Reicherzer T.
AU  - Schulze A.
Y1  - 2012//
KW  - *lung fibroblast
KW  - *workshop
KW  - *pediatrics
KW  - fibroblast
KW  - lung dysplasia
KW  - artificial ventilation
KW  - prematurity
KW  - pneumonia
KW  - lung
KW  - RNA interference
KW  - growth rate
KW  - stimulus
KW  - phenotype
KW  - in vitro study
KW  - transcription factor
KW  - marker
KW  - RNA
T2  - European Journal of Pediatrics
LA  - English
VL  - 171
IS  - 9
PB  - Springer Verlag
SN  - 0340-6199
AD  - H. Ehrhardt, Department of General Pediatrics and Neonatology, Justus-Liebig-University, Feulgenstr.12, Giesen 35392, Germany
DO  - https://dx.doi.org/10.1007/s00431-012-1789-2
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70877691
AB  - Bronchopulmonary dysplasia (BPD) is characterized by disturbed lungdevelopment caused by a bundle of noxious stimuli. The phenotypiccharacteristics of lung fibroblasts associated with the developmentof severe BPD were determined in preterm infants<29 weeks of gestational age.The increased proliferative capacity of these cells was highly predictivefor the duration of mechanical ventilation and the higherseverity score of BPD. The fibroblasts with an augmented spontaneousgrowth in vitro displayed an increased nuclear accumulationof the pro-proliferative transcription factor NFkappaB and a less differentiatedphenotype determined by the reduced expression of alpha-SMA, while classical fibroblast surface markers and intracellular proteinswere not predictive. Using RNA interference, the molecular proofwas provided to assign the constitutive activation of NFkappaB to thespontaneous growth rate and the undifferentiated status. Mimickingthe situation of pulmonary inflammation, the pro-inflammatory cytokineTNF-alpha induced the identical phenotype mediated by NFkappaBaccumulation.These data clearly indicate that distorted function of lung fibroblastsis predictive for the development of severe CLD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70866796
TI  - ABC drug transporter and nuclear receptor expression in human cytotrophoblasts: Influence of cell differentiation and induction by glucocorticoids
AU  - Manceau S.
AU  - Giraud C.
AU  - Decleves X.
AU  - Scherrmann J.M.
AU  - Chissey A.
AU  - Evain-Brion D.
AU  - Treluyer J.M.
Y1  - 2012//
KW  - *human
KW  - *society
KW  - *cell differentiation
KW  - *physiology
KW  - *pharmacology
KW  - *therapy
KW  - *cytotrophoblast
KW  - *drug surveillance program
KW  - female
KW  - fetus
KW  - placenta
KW  - pregnancy
KW  - gene expression
KW  - mother
KW  - blood placenta barrier
KW  - exposure
KW  - hyaline membrane disease
KW  - liver cell
KW  - risk
KW  - intestine cell
KW  - premature labor
KW  - cell culture
KW  - receptor gene
KW  - effusion
KW  - drug exposure
KW  - modulation
KW  - prevention
KW  - Human immunodeficiency virus
KW  - *glucocorticoid
KW  - *cell nucleus receptor
KW  - ABC transporter
KW  - messenger RNA
KW  - prednisone
KW  - betamethasone
KW  - antineoplastic agent
KW  - dexamethasone
KW  - receptor
T2  - Fundamental and Clinical Pharmacology
LA  - English
VL  - 26
IS  - SUPPL.1
PB  - Blackwell Publishing Ltd
SN  - 0767-3981
AD  - S. Manceau, Hopital Cochin, Service de Pharmacologie, EA 3620, Universite Paris Descartes, Paris, France
DO  - https://dx.doi.org/10.1111/j.1472-8206.2012.01032.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70866796
AB  - ABC transporters on the human placenta play a major role in protecting the fetus against potential toxic drugs. Dexamethasone (DEXA), a glucocorticoid (GC), has been shown to induce ABCB1 expression in enterocytes and hepatocytes. However, no data exists in placental cells neither for DEXA nor for betamethasone (BETA) and prednisone (PRED), while these GCs are used during pregnancy. We investigated the modulation of placental ABC transporter and nuclear receptor expression by these drugs. Placentas from normal full-term pregnancies were obtained and cytotrophoblasts isolated. We first assessed the influence of cell differentiation on transporter and nuclear receptor gene expression by taking samples of cytotrophoblasts after 24, 48 and 72 h of cell culture (n = 7 placentas). Then, incubations were conducted with DEXA, BETA and PRED vs. no drug for 24 h (n = 6). mRNA expression was quantified by qRT-PCR. No influence of syncytialisation was observed, except for ABCB1, ABCC2 and ABCC5 expression between t = 24 and 48 h (P < 0.05). DEXA (50, 200 nM, 1 muM) and BETA (20, 100, 400 nM) significantly induced ABCB1 gene expression by around 4-fold (3.54 +/- 1.79, 3.96 +/- 2.49 and 3.82 +/- 1.82, P < 10-2 for DEXA and 3.42 +/- 1.59, 3.97 +/- 2.83, 4.16 +/- 2.64, P < 10-3 for BETA, respectively). However, BETA decreased GR mRNA amount by 4-22% (0.96 +/- 0.20, 0.78 +/- 0.13 and 0.84 +/- 0.06, respectively; P < 10-2). Conversely, PRED showed no effect on transporter or receptor expression. As a conclusion, we showed that DEXA and BETA, which are in particular administered to women at risk of preterm birth to prevent hyaline membrane disease, can induce ABCB1 expression in the human placental barrier. Given ABCB1 apical localization, its induction may potentiate the efflux of its substrates when co-administered with GCs, entailing variable drug exposure for the fetus. This altered transfer may be protective for the fetus, notably when the mother needs to receive anticancer drugs. However, it may conversely be deleterious in particular cases in which fetal exposure is wanted, like in the prevention of HIV mother-tochild transmission.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70866283
TI  - Design of a neonatal intervention based on joint evaluation of efficacy and toxicity
AU  - Watterberg K.
AU  - Higgins R.
AU  - Das A.
Y1  - 2012//
KW  - *society
KW  - *clinical trial (topic)
KW  - *toxicity
KW  - safety
KW  - risk
KW  - human
KW  - death
KW  - sample size
KW  - hypothesis
KW  - morbidity
KW  - nerve cell differentiation
KW  - lung dysplasia
KW  - side effect
KW  - extubation
KW  - procedures
KW  - artificial ventilation
KW  - risk factor
KW  - model
KW  - prematurity
KW  - confidence interval
KW  - dose calculation
KW  - hydrocortisone
KW  - dexamethasone
T2  - Clinical Trials
LA  - English
VL  - 9
IS  - 4
PB  - SAGE Publications Ltd
SN  - 1740-7745
AD  - K. Watterberg, National Institute of Child Health and Human Development, Neonatal Research Network, University of New Mexico, Albuquerque, NM, United States
DO  - https://dx.doi.org/10.1177/1740774512453224
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70866283
AB  - While many Phase III clinical trials have efficacy and safety endpoints, sample size calculations are generally based on efficacy, with safety addressed separately as a secondary endpoint. However, the overall clinical effect often involves efficacy and adverse safety or side effect trade-offs. While joint efficacy and safety endpoints have often been used for Phase II dose finding studies, such approaches have found limited application in Phase III trials. Bronchopulmonary dysplasia (BPD) is a leading morbidity in extremely preterm infants, and prolonged mechanical ventilation increases BPD risk. Dexamethasone can facilitate extubation and decrease BPD incidence, but risk of neurodevelopment impairment (NDI) has led to decreased use. Because preliminary evidence suggests a better long-term safety profile for hydrocortisone than for dexamethasone, we designed a Phase III trial to sequentially evaluate the composite hypothesis that hydrocortisone (a) reduces the risk of death or BDP at 36 weeks; and (b) has an acceptable safety profile for death or NDI at 18 to 22 months. For the two- stage evaluation using robust Poisson models, we will first estimate relative risk and test the hypothesis that hydrocortisone lowers risk of death or BPD. If this test shows benefit, we will evaluate safety descriptively with safety considered achieved if either (1) the point estimate of risk of death/NDI is lower for hydrocortisone, or (2) death/NDI risk for hydrocortisone is increased, but the lower limit of a one-sided 95% confidence interval for the ratio of death/BPD benefit to death/NDI risk is greater than 4. We describe procedures used for power and sample size calculations for this two- stage testing approach, present results from those calculations, and compare operating characteristics of this approach to one previously reported that involves joint testing of the bivariate death/BPD and death/NDI outcomes using extensions of methods described by Tournoux.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70857539
TI  - The hyperoxia-mediated decrease in tenascin-C in fetal lung fibroblasts inhibits cell migration
AU  - DeCoux A.
AU  - Chaplin J.
AU  - Wilson G.
AU  - Benjamin J.
AU  - Gebb S.
Y1  - 2012//
KW  - *hyperoxia
KW  - *fetus lung
KW  - *lung fibroblast
KW  - *cell migration
KW  - fibroblast
KW  - exposure
KW  - lung
KW  - myofibroblast
KW  - lung dysplasia
KW  - protein expression
KW  - hypothesis
KW  - cell adhesion
KW  - *tenascin
KW  - protein C
KW  - protein
KW  - fibronectin
KW  - adhesive agent
KW  - scleroprotein
T2  - FASEB Journal
LA  - English
VL  - 26
IS  - Meeting Abstracts
SP  -
PB  - FASEB
SN  - 0892-6638
AD  - A. DeCoux, Department of Cell Biology and Neuroscience, University of South Alabama, Mobile, AL, United States
UR  - http://www.fasebj.org/cgi/content/meeting_abstract/26/1_MeetingAbstracts/1062.4?sid=b19e1576-1938-435f-b4c2-a9a29d2f883d
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70857539
AB  - Hyperoxic exposure is associated with the arrested alveolarization characteristic of bronchopulmonary dysplasia (BPD). The myofibroblast is required for normal alveolarization and synthesizes important extracellular matrix (ECM) proteins. In a reciprocal manner, this ECM modulates fibroblast function. To investigate the link between ECM and lung myofibroblast migration, we tested the hypothesis that hyperoxia inhibits fetal lung fibroblast TN-C expression, leading to a reduction in cell migration. Primary fetal lung fibroblasts were maintained at fetal O2 tension (3% O2) and transitioned to hyperoxia (21%, 40%, and 65% O2) for 48 hours. Hyperoxia exposure reduced TN-C protein expression in a dose-dependent manner, with a >10-fold decrease in TN-C protein in fibroblasts grown in 65% O2. In contrast, the ECM protein fibronectin (FN) was unchanged by hyperoxia exposure. Functionally, the hyperoxia-mediated decrease in TN-C was accompanied by a 40% reduction in cell migration. We speculate that the anti-adhesive properties of TN-C promote fibroblast migration in the developing lung, and hyperoxia-induced loss of TN-C inhibits this migration by promoting cell adhesion.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70834763
TI  - Intraperitoneal cytidine 5'-diphosphocholine (CDP-choline) reduces hyperoxic lung injury in a neonatal rat model of bronchopulmonary dysplasia
AU  - Cetinkaya M.
AU  - Tayman C.
AU  - Cekmez F.
AU  - Canpolat F.E.
AU  - Kafa I.M.
AU  - Uysal S.
AU  - Sarici S.U.
AU  - Cansev M.
Y1  - 2012//
KW  - *lung dysplasia
KW  - *lung injury
KW  - *model
KW  - *rat
KW  - *neonatology
KW  - *intraperitoneal drug administration
KW  - hyperoxia
KW  - apoptosis
KW  - prevention
KW  - fibrosis
KW  - injection
KW  - tissues
KW  - newborn
KW  - lung
KW  - ambient air
KW  - control group
KW  - morbidity
KW  - lipid peroxidation
KW  - edema
KW  - cell infiltration
KW  - lung parenchyma
KW  - biosynthesis
KW  - nick end labeling
KW  - *citicoline
KW  - cytidine diphosphate
KW  - protein
KW  - sodium chloride
KW  - antioxidant
KW  - oxidizing agent
KW  - surfactant
KW  - myeloperoxidase
KW  - glutathione peroxidase
KW  - superoxide dismutase
KW  - glutathione
T2  - Early Human Development
LA  - English
VL  - 88
IS  - SUPPL. 2
PB  - Elsevier Ireland Ltd
SN  - 0378-3782
AD  - M. Cetinkaya, Gulhane Military Medical Academy, Department of Pediatrics, Division of Neonatology, Ankara, Turkey
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70834763
AB  - Background: Bronchopulmonary dysplasia (BPD) is an important cause of short and long term morbidity in preterm neonates. Although various strategies have been reported, prevention of BPD still remains elusive. CDP-choline is an endogenous intermediate in the biosynthesis of phospatidylcholine, a major constituent of surfactant. The aim of this study was to evaluate the preventive effect of CDP-choline treatment on hyperoxic lung injury and apoptosis in a neonatal rat model of BPD. Method(s): A total of 30 newborn pups were arranged in 3 groups: control, hyperoxia, and hyperoxia+CDP-choline. Ten hours after birth, pups in the control group were kept in room air containing 21% O2 and received daily saline injections, while those in hyperoxia and hyperoxia+CDPcholine groups were exposed to 95% O2 and received daily injections of saline and CDP-choline (300 mg/kg) throughout postnatal day 10, respectively. Histopathological scoring, radial alveolar count, lamellar protein count, fibrosis and apoptosis (TUNEL) evaluation was performed on the lung samples obtained on the 10th day. In addition, activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and myeloperoxidase (MPO), and malonedialdehyde (MDA) content in lung tissues were determined. Result(s): Hyperoxia induced severe lung damage which was reduced significantly by CDP-choline treatment as indicated by histological grading. Masson's trichrome stained sections showed cell infiltration, oedema and fibrosis in the hyperoxia group, but not in the control or hyperoxia+CDP-choline group. Radial alveolar count and lamellar protein count were significantly recovered, while number of TUNEL positive cells was significantly decreased by CDP-choline treatment. Moreover, activities of tissue GSH-Px and SOD were preserved, whereas tissue MDA content and MPO activities were significantly reduced in hyperoxia+CDPcholine group compared to those in hyperoxia group. Conclusion(s): This is the first study that reported prevention by CDPcholine treatment of hyperoxic lung injury in a neonatal rat model of BPD. Intraperitoneal CDP-choline administration significantly improved histopathological lung injury, preserved alveolarisation, and decreased both fibrosis and apoptosis. Furthermore, CDP-choline decreased lipid peroxidation and oxidant status, while increasing antioxidant status. These data suggest that, CDP-choline may be used as an effective therapeutic agent for prevention of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants.
DO  - https://dx.doi.org/10.1038/pr.2014.200
AU  - Sampath, Venkatesh
AU  - Garland, Jeffery S
AU  - Helbling, Daniel
AU  - Dimmock, David
AU  - Mulrooney, Neil P
AU  - Simpson, Pippa M
AU  - Murray, Jeffrey C
AU  - Dagle, John M
Y1  - 2015//
Y2  - 20141217//
KW  - *Antioxidant Response Elements/ge [Genetics]
KW  - *Bronchopulmonary Dysplasia/ge [Genetics]
KW  - Enzyme Induction/ge [Genetics]
KW  - *Genetic Predisposition to Disease/ge [Genetics]
KW  - *Genetic Variation/ge [Genetics]
KW  - Genotype
KW  - Humans
KW  - Infant, Newborn
KW  - *Infant, Very Low Birth Weight
KW  - Models, Genetic
KW  - NF-E2-Related Factor 2/me [Metabolism]
T2  - Pediatric research
VL  - 77
IS  - 3
SN  - 0031-3998
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25518008
AD  - United States
AB  - BACKGROUND: Lung injury resulting from oxidative stress contributes to bronchopulmonary dysplasia (BPD) pathogenesis. Nuclear factor erythroid-2 related factor-2 (NFE2L2) regulates cytoprotective responses to oxidative stress by inducing enzymes containing antioxidant response elements (ARE). We hypothesized that ARE genetic variants will modulate susceptibility or severity of BPD in very-low-birth-weight (VLBW) infants., METHODS: Blood samples obtained from VLBW infants were used for genotyping variants in the SOD2, NFE2L2, GCLC, GSTP1, HMOX1, and NQO1 genes. SNPs were genotyped utilizing TaqMan probes (Applied Biosystems (ABI), Grand Island, NY), and data were analyzed using the ABI HT7900. Genetic dominance and recessive models were tested to determine associations between SNPs and BPD., RESULTS: In our cohort (n = 659), 284 infants had BPD; 135 of whom developed severe BPD. Presence of the hypomorphic NQO1 SNP (rs1800566) in a homozygous state was associated with increased BPD, while presence of the NFE2L2 SNP (rs6721961) was associated with decreased severe BPD in the entire cohort and in Caucasian infants. In regression models that adjusted for epidemiological confounders, the NQO1 and the NFE2L2 SNPs were associated with BPD and severe BPD, respectively., CONCLUSION: Genetic variants in NFE2L2-ARE axis may contribute to the variance in liability to BPD observed in preterm infants. These results require confirmation in independent cohorts.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70821411
TI  - Top ten lesions of the pediatric lung
AU  - Le Pointe H.D.
Y1  - 2012//
KW  - *postgraduate student
KW  - *human
KW  - *society
KW  - *radiology
KW  - *lung
KW  - child
KW  - congenital malformation
KW  - classification
KW  - lung sequestration
KW  - lung abscess
KW  - pneumonia
KW  - thorax
KW  - infant
KW  - cystic fibrosis
KW  - thorax radiography
KW  - female
KW  - tuberculosis
KW  - X ray
KW  - newborn period
KW  - newborn
KW  - lung disease
KW  - airway
KW  - patient
KW  - hyaline membrane disease
KW  - genetic disorder
KW  - bronchiolitis
KW  - lung parenchyma
KW  - pathology
KW  - imaging
KW  - diseases
KW  - interstitial lung disease
KW  - diagnosis
KW  - respiratory distress
KW  - emphysema
KW  - vascular lesion
KW  - lung infection
KW  - X ray film
KW  - artificial ventilation
KW  - prognosis
KW  - infectious complication
KW  - prenatal diagnosis
KW  - childhood
KW  - atelectasis
KW  - obstruction
KW  - Respiratory syncytial pneumovirus
KW  - morbidity
KW  - pathologist
KW  - cyanosis
KW  - respiratory distress syndrome
KW  - radiologist
KW  - tachypnea
KW  - lymph node
KW  - World Health Organization
KW  - adult
KW  - infection
KW  - arterial circulation
KW  - recurrent infection
KW  - adenomatoid tumor
KW  - gas exchange
KW  - prematurity
KW  - hyperinflation
KW  - death
KW  - cystic adenomatoid malformation
KW  - follow up
KW  - lung dysplasia
KW  - radiation dose
KW  - gold standard
KW  - lung lesion
KW  - computer assisted tomography
KW  - mycosis
KW  - low drug dose
KW  - lung insufficiency
KW  - gene
KW  - mutation
KW  - airway obstruction
KW  - abscess
KW  - virus infection
KW  - bleeding
KW  - therapy
KW  - nuclear magnetic resonance
KW  - scoring system
KW  - pregnancy
KW  - nuclear magnetic resonance imaging
KW  - surfactant
KW  - surfactant protein C
KW  - surfactant protein B
KW  - thyroid transcription factor 1
KW  - adenosine triphosphate
KW  - glass
T2  - Pediatric Radiology
LA  - English
VL  - 42
IS  - SUPPL. 3
PB  - Springer Verlag
SN  - 0301-0449
AD  - H.D. Le Pointe, Department of Pediatric Radiology, Hopital d'Enfants Armand-Trousseau, Paris, France
DO  - https://dx.doi.org/10.1007/s00247-012-2383-5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70821411
AB  - Selecting 10 pediatric lung lesions is a hard challenge! Our choice was based on some of the lesions most commonly found in children, or lesions concerned by a new classification. Respiratory distress in newborn infants can be related to numerous causes. Hyaline membrane disease, also called respiratory distress syndrome, remains one of the major causes of death in live-born infants. Hyaline membrane disease affects premature infants. It is the clinical expression of surfactant deficiency in neonates. Infants are usually symptomatic within minutes following birth. Neonates present with non-specific tachypnea, grunting and cyanosis. Classic radiologic findings are observed in untreated patients and reflect generalized acinar collapse. Chest radiograph demonstrates underaeration of the lungs and diffuse consolidation (fine granular appearance) with air bronchograms. Mechanical ventilation and exogenous surfactant therapy have modified the radiological appearance of the disease. Bronchopulmonary dysplasia remains a long-term consequence of this disease. The incidence has not changed significantly, but the severity in infants born before 28 weeks of gestation is less important due to improved management and treatment. Pediatric diffuse lung disease, also called interstitial lung disease (ILD), encompasses a heterogeneous group of uncommon disorders characterized by impaired gas exchange and widespread pulmonary parenchymal pathology. It is now widely accepted that the idiopathic interstitial lung disease described in adults is not applicable to children. A new and specific pediatric classification was proposed in 2007 by the Child Research Cooperative group. This new classification is largely based on clinicopathologic findings. Radiologists must be aware of this classification so as to work with clinicians and pathologists and define characteristic imaging patterns. Genetic disorders of surfactant should be highlighted. They currently represent a well known cause of chronic diffuse lung disease in the neonatal period and childhood. Most frequent genetic defects involve adenosine triphosphate binding cassette A3 (ABCA3), surfactant protein B (SP-B), surfactant protein C (SP-C) and thyroid transcription factor 1 (TTF-1). Congenital pulmonary malformations also represent a challenging topic. Their classification depends on investigators' specialties. Some investigators classify congenital pulmonary malformations according to embryological considerations (the lesions are defined as lesions of defective budding, differentiation and separation of the primitive foregut). Other investigators consider that congenital pulmonary malformations result from airway obstruction with secondary pulmonary dysplastic changes. Vascular theory has also been supported. Some authors have developed a very practical approach based on morphological findings in radiology and pathology. Three groups have been defined: parenchymal lesions, vascular lesions and a combination of both. Three malformations need highlighting: congenital lobar emphysema, congenital pulmonary airway malformations and pulmonary sequestrations. Congenital lobar emphysema may cause respiratory distress in the neonatal period. Classification of congenital pulmonary airway malformations, previously known as congenital cystic adenomatoid malformations, has been updated to include 5 types by Stocker 2002. This new classification highlights two points: the term "adenomatoid" should not be used any longer, as it refers to one of the 5 types only. Moreover, the term "cystic" refers to 3 types only (1, 2 and 4). Pulmonary sequestrations combine parenchymal and vascular lesions. They are classified into two types (intralobar and extralobar). They are mostly located in lower lobes. Children with intralobar sequestration usually present with recurrent infections in the lower lobes. Extralobar pulmonary sequestration is diagnosed during the neonatal period and presents as a lung mass. This malformation is characterized by a systemic arterial supply. The pulmonary tissue of intralobar pulmonary sequestration has roughly the same appearance as that of CPAM and up to 50% of extralobar pulmonary sequestrations are associated with type 2 CPAM. Pneumonia is a very frequent infection in children (more than 150 million pediatric cases reported each year, according to the estimation of the World Health Organization). Numerous types of infectious agents are responsible for pneumonia in children. The radiological findings are rarely specific. Frontal chest radiographs are frequently the only required imaging modality. The lateral view is useful for visualizing hilar lymph nodes. CT is useful in pulmonary complications, in case of tuberculosis or in immunocompromised children. Bronchiolitis is a major cause of morbidity in children younger than 2 years of age. Respiratory syncytial virus is the most common cause of bronchiolitis. X-ray findings are related to a small airways obstruction (hyperinflation, peribronchial thickening, subsegmental atelectasis). Performing chest Xrays rarely impacts on the treatment and X-ray is recommended only for severe cases. Lung abscess is a complication of pneumonia. Lung abscesses used to be related to congenital pulmonary malformations with primitive lung abscesses being less frequent. Due to prenatal diagnosis, these malformations are now commonly treated before infectious complications occur. Recognizing the primitive nature of lung abscesses at diagnosis is challenging even when a chest CT is performed. In our experience, the CTshould be performed much later, after the acute episode, so as to detect an underlying pulmonary malformation. The prognosis of lung abscesses in children is usually good without sequelae. Pediatric tuberculosis remains a worldwide challenge. About 1 million annual cases occur in children younger than 15 years of age. The great majority (95%) of infected children will not develop the disease, and a disseminated form of the disease is more frequent in children younger than 2 years of age. The association between chronic pneumonia and hilar lymphadenopathies should raise suspicion for tuberculosis. Chests radiographs remain very effective for detecting parenchymal lesions and lymphadenopathies. CT is useful in case of equivocal chest X-ray, complicated presentation or disseminated disease. In immunocompromised children, chest CT is helpful for the evaluation of lung infection, particularly when X-ray does not contribute. CT findings in keeping with pulmonary fungal infection are characterized by nodules with poorly defined margins. Cavitation of the nodules and ground-glass opacity surrounding the nodules strongly suggest this diagnosis. Cavitation occurs in half of all cases and is characterized by the air-crescent sign. The halo sign is related to haemorrhage around a nodule or to inflammatory infiltration within the lung parenchyma. This sign may also be observed in other diseases such as viral infections and bacterial abscesses. Cystic fibrosis is caused by mutation in the CFTR gene and remains the most common cause of pulmonary insufficiency in children. Low-dose high-resolution technique computed tomography is the technique of choice (the gold standard) for the evaluation of lung disease in cystic fibrosis. However, there are concerns about the cumulative radiation dose in these patients. MRI seems to be a valuable technique to replace CT in the near future for the evaluation of cystic fibrosis. Recently, an MR-scoring system based on morphological and functional data was suggested for annual follow up.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70821410
TI  - Neonatal chest: What the neonatologist needs to know from the pediatric radiologist
AU  - Enriquez G.
Y1  - 2012//
KW  - *human
KW  - *radiologist
KW  - *radiology
KW  - *postgraduate student
KW  - *society
KW  - *thorax
KW  - lung
KW  - congenital malformation
KW  - patient
KW  - tube
KW  - diagnosis
KW  - newborn
KW  - respiratory distress
KW  - surgery
KW  - perforation
KW  - prematurity
KW  - esophagus atresia
KW  - adenomatoid tumor
KW  - pneumomediastinum
KW  - pneumothorax
KW  - feeding apparatus
KW  - emphysema
KW  - lymphangiectasis
KW  - rib
KW  - respiratory distress syndrome
KW  - nuclear magnetic resonance imaging
KW  - reading
KW  - patient positioning
KW  - trachea stenosis
KW  - thorax radiography
KW  - examination
KW  - atelectasis
KW  - lung disease
KW  - density
KW  - tissues
KW  - pharynx
KW  - muscle spasm
KW  - endotracheal tube
KW  - X ray tube
KW  - thymus
KW  - granuloma
KW  - stomach
KW  - agenesis
KW  - cystic adenomatoid malformation
KW  - conservative treatment
KW  - iatrogenic disease
KW  - esophagus
KW  - cardiomegaly
KW  - hypoplastic left heart syndrome
KW  - clavicle
KW  - heart injury
KW  - screening
KW  - infant
KW  - ultrasound
KW  - pneumonia
KW  - heart right ventricle hypertrophy
KW  - meconium aspiration
KW  - lymphangiomatosis
KW  - venous return
KW  - pulmonary vein
KW  - atresia
KW  - lymph vessel
KW  - positive end expiratory pressure
KW  - tachypnea
KW  - diaphragm hernia
KW  - nasogastric tube
KW  - hyaline membrane disease
KW  - supine position
KW  - X ray film
KW  - forelimb
KW  - lung malformation
KW  - vascularization
KW  - lung sequestration
KW  - aeration
KW  - solid
KW  - infection
KW  - lung hypoplasia
KW  - emergency surgery
KW  - congenital diaphragm hernia
KW  - differential diagnosis
KW  - newborn period
KW  - radiodiagnosis
KW  - surfactant
T2  - Pediatric Radiology
LA  - English
VL  - 42
IS  - SUPPL. 3
PB  - Springer Verlag
SN  - 0301-0449
AD  - G. Enriquez, Pediatric Radiology Department, Hospital Infantil Vall d'Hebron, Barcelona, Spain
DO  - https://dx.doi.org/10.1007/s00247-012-2383-5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70821410
AB  - Chest X-ray continues to be the first radiologic examination performed to assess chest lesions in neonates and it requires a meticulous technique. Proper positioning of the patient and X-ray tube is extremely important to avoid a distorted chest image. Upward angulation of the tube can result in a bizarre configuration of the ribs, whereas lordotic patient positioning produces an abnormally prominent cardiac apex, simulating right ventricular hypertrophy. If the infant is rotated to one side the upper lung may appear hyperlucent and be misinterpreted as a pathologic finding. To ensure that the chest is not rotated, the operator should verify that the ribs and the medial borders of the clavicles are symmetrical. It is also essential to know that the features of films obtained in expiration often simulate cardiomegaly or increased lung density, mimicking pulmonary disease. Hence, the chest examination must be performed in appropriate inspiration, which can only be determined with the experience of reading numerous radiographs. The nasogastric tube is the chosen nutritional technique in premature infants. It is essential to check the position of feeding tubes because it can provide important diagnostic information regarding esophageal atresia and traumatic esophageal pseudodiverticulae. Inability to properly advance an oral tube may indicate esophageal atresia. Traumatic pharyngeal perforation should be suspected when the feeding tube is seen outside the esophagus in unexpected locations. These iatrogenic lesions can occur when the tube comes into contact with the fragile pharyngeal wall tissue, causing cricopharyngeal spasm and perforation. The endotracheal tube position should also be checked. Improperly positioned tubes can cause lobar or lung atelectasis or hyperaeration, or lead to long-term complications of tracheal stenosis or granuloma formation. Furthermore, visualization of the tracheobronchial tube in the stomach while the lungs are well aerated in a newborn is the key to establishing the diagnosis of tracheal agenesis. Clinical conditions leading to respiratory distress in the first days of life can be divided into two groups: those that can be treated medically and those requiring surgery. The radiologic patterns of several medical conditions, such as hyaline membrane disease, also known as respiratory distress syndrome (RDS), transient tachypnea (TRDN), meconium aspiration and neonatal pneumonia, have been extensively reported. Ultrasound is particularly useful in the diagnosis of RDS and some authors speculate that it may serve as a screening method for early administration of surfactant in preterm infants with this condition. A huge increase in lung echogenicity ("white lung") is the US diagnostic hallmark. Pulmonary lymphangiectasis is a less common condition that also produces severe respiratory distress. It can occur as an isolated abnormality, as a part of generalized lymphangiectasis or associated with heart lesions (hypoplastic left heart syndrome, anomalous venous return or pulmonary vein atresia). The lymphatic vessels are dilated in this condition and appear as nodular or somewhat reticular images on plain films. Positive-pressure ventilation is often a part of the treatment for these conditions and related complications such as interstitial emphysema, pneumothorax, and pneumomediastinum can be recognized on plain films. The variety of air-leak patterns produced should not be interpreted as pulmonary malformations. Interstitial blebs can simulate lung adenomatoid malformation and air in the anterior portion of the chest seen in patients in supine position ("anterior pneumothorax") may simulate lobar emphysema. In patients with pneumomediastinum, air sometimes elevates the thymus, producing the so-called "angel wings" or "spinnaker sail" sign, simulating a mediastinal mass. Congenital lung malformations are usually detected prenatally, and most newborns are asymptomatic at birth and show normal chest plain films. To postnatally confirm the malformation, US, CT, or MRI should be performed. On US, an echogenic mass with systemic vascularization is seen in cases of pulmonary sequestration, whereas abnormal aeration with increased and heterogeneous parenchymal echogenicity is common in cystic adenomatoid malformation. In asymptomatic patients, contrast-enhanced CT or MRI can be performed later on (6-8 months) for complete characterization of the malformation. There is considerable debate in the literature on the management of patients with these congenital malformations. Most authors agree that solid sequestrations can regress spontaneously, and conservative management is recommended. However, cystic or hybrid lesions usually persist and may increase in size or develop infection; therefore surgical management may be more appropriate. Last, conditions causing respiratory distress in the neonatal period requiring surgery usually manifest on plain films as mediastinal displacement to the contralateral side. Congenital diaphragmatic hernia is a major surgical emergency in the newborn. The prenatal assessment, which mainly focuses on the degree of pulmonary hypoplasia and determines the postnatal management, is based on US and MRI study. In more severe cases, prenatal tracheal plug placement can be applied to increase the volume of the affected lung. The differential diagnosis of diaphragmatic hernia should be established, particularly with congenital adenomatoid malformation and pulmonary lymphangiomatosis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70804197
TI  - Transforming Growth Factor Beta (TGFB) signaling is required for distal lung development
AU  - Ahlfeld S.K.
AU  - Poindexter E.
AU  - Gao Y.
AU  - Wang J.
AU  - Conway S.J.
Y1  - 2012//
KW  - *lung development
KW  - transgene
KW  - lung structure
KW  - lung alveolus cell
KW  - pathogenesis
KW  - lung
KW  - lung dysplasia
KW  - chronic lung disease
KW  - prematurity
KW  - hyperoxia
KW  - lung alveolus epithelium
KW  - hypothesis
KW  - nursing
KW  - mare
KW  - model
KW  - oncogene c myc
KW  - density
KW  - morphogenesis
KW  - mouse
KW  - therapy
KW  - *transforming growth factor beta
KW  - doxycycline
KW  - transcription factor RUNX2
KW  - nonoxinol 9
T2  - Clinical and Translational Science
LA  - English
VL  - 5
IS  - 2
PB  - Blackwell Publishing
SN  - 1752-8054
AD  - S.K. Ahlfeld, Indiana University, School of Medicine, Indianapolis, IN, United States
DO  - https://dx.doi.org/10.1111/j.1752-8062.2012.00398.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70804197
AB  - OBJECTIVES/SPECIFIC AIMS: Bronchopulmonary Dysplasia (BPD), a chronic lung disease of preterm infants, is characterized by interrupted saccular lung development. Using a hyperoxia model of BPD, we have observed decreased TGFB signaling coincident with the earliest evidence of BPD. Therefore, we genetically inhibited TGFB superfamily signaling in the lung epithelium during alveolar development to test the hypothesis that loss of TGFB signaling simplifies distal lung structure. METHODS/STUDY POPULATION: Neonatal mice carrying a Tet-On myc-tagged Smad7 transgene as well as a doxycycline-inducible SPC-rtTA were generated. At birth, nursing dams were given dox-feed continuously to activate the transgene and overexpress Smad 7 in Type II alveolar cells to inhibit TGFB signaling. At P14, distal lung structure was analyzed and compared to single transgenic (TetO-Smad7-/SPC-rtTA+) control pups. RESULTS/ ANTICIPATED RESULTS: Double transgenic pups had marked elevation of c-myc, indicating activation of the myc-tagged Smad7 transgene, and reduced expression of periostin, a downstream product of TGFB signaling. Distal lung structure was simplified with reduced septal development, as evidenced by a nearly 10% increase in mean linear intercept, 15% increase in airspace-to-septal ratio, and 15% decrease in nodal density. DISCUSSION/SIGNIFICANCE OF IMPACT: Inhibition of TGFB signaling in Type II alveolar cells alone during postnatal distal lung morphogenesis sufficiently phenocopies the lung structural changes in BPD. These results indicate that loss of TGFB signaling during a critical window of saccular lung development may contribute to BPD pathogenesis. Understanding BPD pathogenesis will aid in designing appropriate therapies to treat and prevent BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70796609
TI  - Pulmonary angiogenesis: Genetic association with bronchopulmonary dysplasia
AU  - Mahlman M.
AU  - Huusko J.
AU  - Hallman M.
Y1  - 2012//
KW  - *angiogenesis
KW  - *genetic association
KW  - *lung dysplasia
KW  - *workshop
KW  - infant
KW  - human
KW  - female
KW  - allele
KW  - pregnancy
KW  - population
KW  - hypothesis
KW  - gene
KW  - single nucleotide polymorphism
KW  - pathogenesis
KW  - biogenesis
KW  - patient
KW  - heredity
KW  - disease predisposition
KW  - twins
KW  - safety
KW  - risk
KW  - clinical trial
KW  - haplotype
KW  - *surfactant
KW  - vasculotropin A
KW  - vasculotropin receptor 2
KW  - vasculotropin
KW  - receptor
T2  - Neonatology
LA  - English
VL  - 101
IS  - 4
PB  - S. Karger AG
SN  - 1661-7800
AD  - M. Mahlman, Department of Pediatrics, Oulu University Hospital, Oulu, Finland
DO  - https://dx.doi.org/10.1159/000337360
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70796609
AB  - Background and Objective: According to twin studies genetic effects account for about 80% of the variance in susceptibility to bronchopulmonary dysplasia (BPD). The vascular hypothesis states that the deficiency in biogenesis of alveoli is a prominent feature in pathogenesis. Formation of alveoli depends on normal pulmonary angiogenesis that is critically dependent on genes encoding vascular endothelial growth factor A (VEGF-A) and its receptor, VEGFR-2. Our aim was to investigate whether the allelic variants of VEGF-A and VEGFR-2 associate with predisposition to BPD. Patients and Methods: The study population consisted of 259 infants (61 cases with moderate or severe BPD) born in Oulu during 1997-2010. All infants were of the Finnish origin and were born before 31 weeks' gestation. An additional study population consisted of 110 infants (63 BPD cases) born in Helsinki during 1997-2003. Six VEGF-A and 25 VEGFR-2 tagging single nucleotide polymorphisms (SNPs) were genotyped. Results were corrected for length of gestation and for multiple comparisons. Result(s): VEGF-A SNP rs3025000 associated with BPD with the minor allele T being overrepresented in BPD infants compared to their controls (32.8 vs. 22.8%, p < 0.05). VEGFR-2 SNP rs4576072 minor allele C was overrepresented in infants with BPD compared to controls (22.5 vs. 13.1%, p < 0.05) and a low-frequency VEGFR-2 6-SNP haplotype was overrepresented in BPD infants (4.2 vs. 0.2%). Significant associations between the alleles and BPD were also detected in infants born in Helsinki. Conclusion(s): We show evidence for the first time that the polymorphisms of VEGF-A and VEGFR-2 influence susceptibility to BPD. This strengthens the vascular hypothesis of BPD. A clinical trial of VEGF in infants with very high-risk of BPD is not indicated until safety and efficacy are further proven.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70791939
TI  - Impact of perinatal nutrition on kidney function at five years in very low birth-weight children
AU  - Vieux R.
AU  - Galu S.
AU  - Guillemin F.
AU  - Hascoet J.M.
Y1  - 2012//
KW  - *kidney function
KW  - *very low birth weight
KW  - *child
KW  - *human
KW  - *workshop
KW  - *neonatology
KW  - *nutrition
KW  - newborn period
KW  - protein intake
KW  - longitudinal study
KW  - hyaline membrane disease
KW  - pregnancy
KW  - height
KW  - lung dysplasia
KW  - gender
KW  - enterocolitis
KW  - urine
T2  - Journal of Neonatal-Perinatal Medicine
LA  - English
VL  - 5
IS  - 2
PB  - IOS Press
SN  - 1934-5798
AD  - R. Vieux, Neonatal Department, Maternite Regionale Universitaire Nancy, Nancy, France
DO  - https://dx.doi.org/10.3233/NPM-2012-65000
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70791939
AB  - Introduction: To determine the impact of perinatal factors on renal function in five year-old preterm-born children. Method(s): Prospective longitudinal study of preterm-born children until five years, and five year-old full-term controls. Renal function measured in the neonatal period and at four and five years. Result(s): 168 children included aged 5.1 +/- 0.1 years. 133 preterm-born children (born 29.2 +/- 1.4 weeks gestation), 35 full-terms aged five. Systolic BP (sBP) was 97.5 +/- 7.1 mmHg in preterm-born children versus 92.2 +/- 8.1 mmHg in full-term controls, p = 0.0001. In preterm-born children, sBP increased by (beta +/- sigma): 2.2 +/- 1.0 mmHg for each gram/kg increase in proteins/day on day 28, and decreased by -3.0 +/- 1.4 in case of bronchopulmonary dysplasia, after adjustment on gender and height at five years. eGFR was 176.3 +/- 37.1 mL/ min/1.73m2 at five in preterm-born children, and decreased when children had presented hyaline membrane disease or necrotising enterocolitis, (beta +/- sigma): -17.6 +/- 6.7, -25.7 +/- 10.4 mL/min/1.73m2. 14.4% preterm-born children had a urine albumin/creatinine ratio >2 mg/mmol vs. 11.1% full-terms, p = 0.7. Renal volume, absolute or relative, at five years was negatively correlated to protein intakes from day 14 onwards in the neonatal period: R = -0.69, p = 0.006. Conclusion(s): Protein intakes in the neonatal period are associated with increased BP and decreased renal volume in five year-old preterm-born children.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70781462
TI  - NQO1 gene polymorphism and the risk of bronchopulmonary dysplasia in preterm neonates
AU  - Zachaki S.
AU  - Polycarpou E.
AU  - Daraki A.
AU  - Karalexi M.
AU  - Baroutis G.
AU  - Kostalos C.
AU  - Gavrili S.
Y1  - 2012//
KW  - *DNA polymorphism
KW  - *risk
KW  - *lung dysplasia
KW  - *newborn
KW  - *perinatal care
KW  - genotype
KW  - human
KW  - mutant
KW  - allele
KW  - gender
KW  - gene
KW  - heterozygote
KW  - risk factor
KW  - amino acid sequence
KW  - blood sampling
KW  - therapy
KW  - real time polymerase chain reaction
KW  - homozygote
KW  - population
KW  - genetic polymorphism
KW  - detoxification
KW  - prematurity
KW  - defense mechanism
KW  - environmental factor
KW  - gestational age
KW  - control group
KW  - Greece
KW  - blood
KW  - case report
KW  - wild type
KW  - lung alveolus epithelium
KW  - enzyme activity
KW  - exposure
KW  - oxygen
KW  - enzyme
KW  - genomic DNA
KW  - reactive oxygen metabolite
KW  - nicotinamide adenine dinucleotide
KW  - DNA
KW  - reduced nicotinamide adenine dinucleotide (phosphate) dehydrogenase (quinone)
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 25
IS  - SUPPL. 2
PB  - Informa Healthcare
SN  - 1476-7058
AD  - S. Zachaki, NCSR Demokritos, Greece
DO  - https://dx.doi.org/10.3109/14767058.2012.679162
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70781462
AB  - Introduction/background: The development of bronchopulmonary dysplasia (BPD) is complex and involves genetic and environmental factors. Although supplemental oxygen is the most commonly used therapy, direct exposure to oxygen can damage the pulmonary epithelium through the generation of reactive oxygen species (ROS). To protect against ROS there are powerful defence mechanisms. The detoxification enzyme NAD(P)H:quinone oxidoreductase (NQO1) is involved in the cellular response to oxidative damage. The encoding NQO1 gene is subject to an inactivating polymorphism, namely C609T, leading to a change in its aminoacid sequence. Individuals homozygous for the mutant allele (T/T) completely lack NQO1 activity, whereas heterozygotes (C/T) have low enzyme activity as compared to the wild type (C/C). Therefore, the mutant T allele may predispose neonates to BPD. The aim was to investigate the potential role of NQO1 inborn polymorphism in BPD susceptibility. Patients/methods: This case-report study enrolled 119 Greek premature neonates with gestational age U32 weeks. Of these 42 developed BPD (case group) and 77 did not developed BPD (control group). Genomic DNA was extracted from peripheral blood samples of all neonates. The NQO1 genotype was examined by real-time polymerase chain reaction. The NQO1 gene status was also evaluated in respect to gender. Result(s): A different distribution of NQO1 genotypes was found between BPD neonates and controls, with a higher frequency of variant genotypes (heterozygotes C/T and homozygotes T/T) in BPD population (50% in BPD vs. 28.6% in no BPD neonates, chi2 = 6.14; d.f. = 2; p = 0.046). Thus, a significantly higher frequency of the mutant T allele was observed in BPD neonates as compared to controls (0.27 vs. 0.17, chi2 = 3, 59; d.f. = 1; p = 0.058). According to gender, we observed no differences in the genotype frequencies. Discussion/conclusion: Our results provide evidence for a pathogenetic role of the NQO1 polymorphism on BPD occurrence. The higher incidence of the C/T and T/T variant genotypes among neonates who developed BPD suggests that the NQO1 C609T inborn polymorphism constitutes a risk factor in BPD susceptibility. Identification of involved genetic polymorphisms would permit early identification of neonates at increased risk of BPD development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70781423
TI  - Caffeine affects smad signalling and TGF-beta stimulated transgelin expression in the lung epithelial cells A549
AU  - Kunzmann K.
AU  - Fehrholz F.
AU  - Bersani B.
AU  - Speer S.
Y1  - 2012//
KW  - *lung
KW  - *epithelium cell
KW  - *perinatal care
KW  - airway remodeling
KW  - prematurity
KW  - cytoskeleton
KW  - phosphorylation
KW  - actin filament
KW  - genetic transfection
KW  - assay
KW  - lung injury
KW  - gene expression
KW  - lung dysplasia
KW  - Western blotting
KW  - real time polymerase chain reaction
KW  - plasmid
KW  - second messenger
KW  - upregulation
KW  - *caffeine
KW  - *transgelin
KW  - protein
KW  - luciferase
KW  - transforming growth factor
KW  - messenger RNA
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 25
IS  - SUPPL. 2
PB  - Informa Healthcare
SN  - 1476-7058
AD  - K. Kunzmann, Children's Hospital, University of Wurzburg, Germany
DO  - https://dx.doi.org/10.3109/14767058.2012.679162
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70781423
AB  - Caffeinization is an inherent part of bronchopulmonary dysplasia therapeutic treatment among preterm infants. However, caffeine effects on airway remodelling in the lung of premature neonates are still undefined. Transgelin, a binding and stabilising protein of actin cytoskeleton, is a novel immediate target of transforming growth factor (TGF)-beta/ Smad3-dependent gene expression in lung epithelial cells. It was hypothesized that transgelin may contribute to the TGF-beta- dependent airway remodelling after lung injury by altering and rearranging the epithelial cytoskeleton. Aim(s): The present study had the aim to clarify whether caffeine was able to affect TGF-beta-induced Smad signalling and transgelin expression in lung epithelial cells. Method(s): The pharmacological effect of caffeine on Smad signalling was investigated by means of a luciferase-assay through the transfection of the TGF-beta-inducible CAGA-plasmid in A549 cells by lipofectamin. The regulation of transgelin expression was studied by real-time polymerase chain reaction and western-blotting. Result(s): Caffeine inhibited Smad2/3 phosphorylation in a dose-dependent manner in A549 lung epithelial cells. The highest inhibition was found with a caffeine concentration of 10 mM. The effect of caffeine on Smad2/3 phosphorylation was mediated by the caffeineinduced second messenger cAMP. In addition, caffeine leads to a downregulation of both transgelin mRNA and protein in A549 cells. Caffeine also antagonized the TGF-beta-induced upregulation of transgelin. This effect of caffeine on transgelin expression was also mediated by cAMP. Conclusion(s): The present study highlighted a new molecular mechanism of caffeine, inhibiting Smad signalling and modifying transgelin expression in the lung. Since destabilisation of the actin cytoskeleton might result in a suppression of the TGF-beta/Smad signalling, transgelin, linking molecule between cytoskeleton and TGF-beta/ Smad signalling, may be a new regulator involved in the airway remodelling process, and its activity was found to be affected by caffeine.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70781414
TI  - Acute or expectant management of premature labour with pprom before 30th week of gestation
AU  - Hajek Z.
AU  - Koucky M.
AU  - Dokoupilova M.
AU  - Germanova A.
Y1  - 2012//
KW  - *pregnancy
KW  - *perinatal care
KW  - *premature labor
KW  - latent period
KW  - newborn mortality
KW  - morbidity
KW  - female
KW  - infection
KW  - newborn
KW  - human
KW  - mother
KW  - chorioamnionitis
KW  - infant
KW  - funisitis
KW  - Apgar score
KW  - umbilical cord
KW  - monitoring
KW  - placenta
KW  - infantile spasm
KW  - hypoxia
KW  - gestational age
KW  - lung dysplasia
KW  - examination
KW  - bleeding
KW  - newborn morbidity
KW  - membrane
KW  - fetus distress
KW  - leukomalacia
KW  - brain hemorrhage
KW  - rupture
KW  - retrolental fibroplasia
KW  - mortality
KW  - fetus
KW  - profit
KW  - methodology
KW  - marker
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 25
IS  - SUPPL. 2
PB  - Informa Healthcare
SN  - 1476-7058
AD  - Z. Hajek, Department of Obstetrics and Gynecology, Czechia
DO  - https://dx.doi.org/10.3109/14767058.2012.679162
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70781414
AB  - Methodology: The aim of study was to evaluate the impact of preterm premature ruptures of the membrane (PPROM) on the neonatal mortality and morbidity of infants before 30th week of gestation and demonstrate that close monitoring of mother and fetus enable to prolong pregnancy. We evaluated 191 newborns with PPROM between 23 + 0 and 29 + 6 weeks of gestation in years 2006-2009. As an acute labour we presented a labour <48 h after PPROM and an expectant one after 48 h of latency, with maximum 542 +/- 412.3 h, it is approximately 3 weeks. The pregnancy with PPROM was terminated at the beginning of fetal distress, increasing infection markers, severe infection and bleeding of mother. After birth, histological examination of placenta and umbilical cord have been done. We evaluated Apgar score, severe morbidity of the newborn (bronchopulmonary dysplasia [BPD], retinopathy of prematurity, intraventricular hemorrhage III and IV groups, periventricular leucomalacia), the incidence of chorioamnionitis, funisitis and neonatal mortality. Results and discussion: The incidence of chorioamnionitis and funisitis was rising with latency period, but was not statistically different in comparison with acute management. The newborn morbidity, especially BPD was higher (neonatal seizures [NS]), but the mortality rate was the same (5.8% vs. 5.3% NS). The infection was the general cause of delivery, the fetal apposition with hypoxia was statistically significant in category with latency of labour than in category of acute labour. (46%, 42% vs. 12%, p < 0.001). Conclusion(s): The prolongation of latency period in the group of mothers with PPROM before 30th week of gestation does not deteriorate neonatal mortality and morbidity of infants and the newborns can profit from increased gestational age.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70760857
TI  - Attenuation of hyperoxic lung injury in newborn mice by-napthoflavone
AU  - Couroucli X.
AU  - Liang Y.
AU  - Wang L.
AU  - Jiang W.
AU  - Moorthy B.
Y1  - 2012//
KW  - *lung injury
KW  - *mouse
KW  - *health care organization
KW  - *toxicology
KW  - *attenuation
KW  - hyperoxia
KW  - newborn
KW  - hypothesis
KW  - prematurity
KW  - lung
KW  - lung dysplasia
KW  - lung insufficiency
KW  - infant
KW  - detoxification
KW  - mass fragmentography
KW  - exposure
KW  - ambient air
KW  - wild type
KW  - Western blotting
KW  - histology
KW  - weight
KW  - liver
KW  - oxygen therapy
KW  - isoprostane derivative
KW  - isoprostane
KW  - corn oil
KW  - protein
KW  - messenger RNA
T2  - Toxicology Letters
LA  - English
VL  - 211
IS  - SUPPL. 1
PB  - Elsevier Ireland Ltd
SN  - 0378-4274
AD  - X. Couroucli, Baylor College of Medicine, United States
DO  - https://dx.doi.org/10.1016/j.toxlet.2012.03.593
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70760857
AB  - Purpose: Supplemental oxygen administration is frequently administered to infants having pulmonary insufficiency. However, prolonged hyperoxia contributes to bronchopulmonary dysplasia (BPD) in premature infants. In this study, we tested the hypothesis that postnatal treatment of newborn wild type (WT) or Cyp1a2-null mice with BNF, followed by exposure to hyperoxia, would alleviate lung injury by mechanisms involving CYP1A-mediated detoxification of F2-isoprostanes. Method(s): Newborn WT or Cyp1a2-null mice were treated, i.p., once daily with the vehicle corn oil (CO) or BNF (25Mol/kg), for 4 days, and were maintained in room air or exposed to hyperoxia (>95% O2) for 3 days. The mice were sacrificed on day 7 of life. Lung injury was assessed by measuring lung weight/body weight (LW/BW) ratios and histology. CYP1A1 and 1A2 expression was studied at the enzymatic (flourimetry), protein (western blotting) and mRNA levels (real time RT-PCR), respectively. F2-isoprostane levels in lung and liver were determined by gas chromatography-mass spectrometry (GC/MS). Result(s) and Conclusion(s): Newborn WT and Cyp1a2-null mice showed lung damage in response to hyperoxia, with Cyp1a2-null mice displaying increased susceptibility to lung injury compared to WT mice. The extent of lung injury positively correlated with levels of F2- isoprostanes. BNF, which induced CYP1A expression, attenuated lung injury inWTas well as Cyp1a2-null mice. These results support the hypothesis that BNF protects against hyperoxic lung injury by inducing CYP1A1, which may act via detoxifying F2-isoprostanes. Future studies could lead to the development of rational strategies in the prevention/treatment of BPD in premature infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70702689
TI  - Human amnion epithelial cells modulate hyperoxia-induced neonatal lung injury in mice
AU  - Vosdoganes P.
AU  - Lim R.
AU  - Koulaeva E.
AU  - Chan S.T.
AU  - Acharya R.Y.
AU  - Moss T.J.M.
AU  - Wallace E.M.
Y1  - 2012//
KW  - *lung injury
KW  - *hyperoxia
KW  - *human
KW  - *Pacific islands
KW  - *mouse
KW  - *epithelium cell
KW  - *health care organization
KW  - *amnion
KW  - *Asian
KW  - *Australia and New Zealand
KW  - *society
KW  - exposure
KW  - lung disease
KW  - pneumonia
KW  - intraperitoneal drug administration
KW  - body weight
KW  - lung structure
KW  - tissues
KW  - density
KW  - gene expression
KW  - leukocyte
KW  - therapy
KW  - infant
KW  - risk
KW  - lung dysplasia
KW  - morbidity
KW  - inflammation
KW  - tissue repair
KW  - adult
KW  - lung
KW  - collagen
KW  - oxygen
KW  - sodium chloride
KW  - nonoxinol 9
KW  - platelet derived growth factor
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 48
IS  - SUPPL. 1
PB  - Wiley Blackwell
SN  - 1034-4810
AD  - P. Vosdoganes, Ritchie Centre, Monash Institute of Medical Research, Clayton, Australia. E-mail: Patricia.Vosdoganes@monash.edu
DO  - https://dx.doi.org/10.1111/j.1440-1754.2012.02412.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70702689
AB  - Background: Postnatal exposure to supplemental oxygen increases an infant's risk of developing bronchopulmonary dysplasia among other morbidities. Human amnion epithelial cells (hAECs) can mitigate inflammation and aid tissue repair in fetal and adult lung disease. We hypothesised that hAECs would attenuate hyperoxia-induced changes to neonatal lung structure. Method(s): From birth, neonatal mice were exposed to hyperoxia (FiO2 = 85%) for 14 days. Human AECs were administered to mice via intraperitoneal injection on days 5, 6 and 7. Controls were exposed to normoxia (FiO2 = 21%) and received IP saline replacement. Body weight was monitored every second day and lungs were collected on day 14 for assessment. Result(s): Hyperoxia exposure resulted in reduced neonatal growth, pulmonary inflammation and altered lung structure. Human AECs signifi- cantly improved neonatal body weight, and significantly attenuated hyperoxia-induced changes to mean linear intercept, septal crest density, and associated altered gene expression of TGF-beta and PDGF-beta (all, P < 0.05). However, mitigation of hyperoxia-induced changes to alveolar airspace volume, septal tissue volume, tissue-to-airspace ratio, collagen content and leukocyte infiltration was non-significant (all, P >= 0.05). Conclusion(s): Intraperitoneal administration of hAECs to neonatal mice partially reduced hyperoxia-induced lung inflammation and structural lung damage. These observations suggest that hAECs may be a potential therapy for neonatal lung disease.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2023 to 2024>
TI  - The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism.
DO  - https://dx.doi.org/10.1186/s12890-023-02498-1
AU  - Qu, Sehua
AU  - Shan, Lianqiang
AU  - Chen, Xin
AU  - Zhang, Zhen
AU  - Wu, Yumeng
AU  - Chen, Yun
AU  - Zhuo, Feixiang
AU  - Wang, Yitong
AU  - Dong, Huaifu
Y1  - 2023//
Y2  - 20230615//
KW  - Infant, Newborn
KW  - Pregnancy
KW  - Female
KW  - Rats
KW  - Animals
KW  - Humans
KW  - Mice
KW  - Bronchopulmonary Dysplasia/me [Metabolism]
KW  - *Bronchopulmonary Dysplasia
KW  - Hypertension, Pulmonary/dt [Drug Therapy]
KW  - Hypertension, Pulmonary/pc [Prevention & Control]
KW  - Hypertension, Pulmonary/me [Metabolism]
KW  - *Hypertension, Pulmonary
KW  - Lung Injury/me [Metabolism]
KW  - *Lung Injury
KW  - Hyperoxia/me [Metabolism]
KW  - *Hyperoxia
KW  - Lipopolysaccharides/pd [Pharmacology]
KW  - Pulmonary Fibrosis/pa [Pathology]
KW  - *Pulmonary Fibrosis
KW  - Animals, Newborn
KW  - Insulin-Like Growth Factor I/me [Metabolism]
KW  - Rats, Sprague-Dawley
KW  - Lung/pa [Pathology]
KW  - Hypertrophy, Right Ventricular/et [Etiology]
KW  - Hypertrophy, Right Ventricular/pc [Prevention & Control]
KW  - Hypertrophy, Right Ventricular/me [Metabolism]
KW  - Disease Models, Animal
T2  - BMC pulmonary medicine
VL  - 23
IS  - 1
SN  - 1471-2466
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med24&NEWS=N&AN=37322452
AD  - England
AB  - BACKGROUND: This study aimed to determine whether postnatal treatment with recombinant human IGF-1 (rhIGF-1)/binding peptide 3 (BP3) ameliorates lung injury and prevents pulmonary hypertension (PH) in bronchopulmonary dysplasia (BPD) models., METHODS: We used two models of BPD in this study: one model that was associated with chorioamnionitis (CA), stimulated by intra-amniotic fluid and exposure to lipopolysaccharide (LPS), whereas the other was exposed to postnatal hyperoxia. Newborn rats were treated with rhIGF-1/BP3 (0.2 mg/Kg/d) or saline via intraperitoneal injection. The study endpoints included the wet/dry weight (W/D) ratio of lung tissues, radial alveolar counts (RACs), vessel density, right ventricular hypertrophy (RVH), lung resistance, and lung compliance. Hematoxylin and eosin (H&E) and Masson staining were used to evaluate the degree of lung injury and pulmonary fibrosis. IGF-1 and eNOS expression were detected using western blotting or quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). The levels of SP-C, E-cadherin, N-cadherin, FSP1, and Vimentin in the lung tissues were detected by immunofluorescence., RESULTS: LPS and hyperoxia treatment increased lung injury and pulmonary fibrosis, enhanced RVH and total respiratory resistance, and decreased RAC, pulmonary vascular density and pulmonary compliance in young mice (all p < 0.01). Simultaneously, LPS and hyperoxia induced an increase in epithelial-mesenchymal transition (EMT) in airway epithelial cells. However, rhIGF-1/BP3 treatment reduced lung injury and pulmonary fibrosis, decreased RVH and total respiratory resistance, and enhanced RAC, pulmonary vascular density and pulmonary compliance, as well as inhibited EMT in airway epithelial cells in LPS and hyperoxia treated mice., CONCLUSION: Postnatal rhIGF-1/BP3 treatment relieved the effects of LPS or hyperoxia on lung injury and prevented RVH, providing a promising strategy for the treatment of BPD. Copyright Â© 2023. The Author(s).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Evaluation of a nasal cannula in noninvasive ventilation using a lung simulator.
DO  - https://dx.doi.org/10.4187/respcare.03560
AU  - Iyer, Narayan P
AU  - Chatburn, Robert
Y1  - 2015//
Y2  - 20141209//
KW  - *Catheters
KW  - Computer Simulation
KW  - Equipment Design
KW  - *Equipment Failure Analysis/mt [Methods]
KW  - Humans
KW  - Infant, Newborn
KW  - Lung
KW  - Models, Biological
KW  - Nasal Cavity
KW  - *Noninvasive Ventilation/is [Instrumentation]
KW  - *Positive-Pressure Respiration/is [Instrumentation]
KW  - *Respiratory Mechanics/ph [Physiology]
KW  - Ventilators, Mechanical
T2  - Respiratory care
VL  - 60
IS  - 4
SN  - 0020-1324
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25492958
AD  - United States
AB  - BACKGROUND: Nasal noninvasive ventilation (NIV) is a common form of noninvasive respiratory mode used in newborn infants. A next-generation nasal cannula (Neotech RAM cannula) has recently been used to provide nasal NIV. The impact of the Neotech RAM cannula on the delivery of pressure needs to be studied., METHODS: In this ex vivo experimental design, a lung simulator (IngMar ASL 5000, version 3.4) was programmed to model a neonate (~1-3 kg of body weight) with normal-to-moderately affected lungs. We used a Covidien PB840 ventilator with NIV software activated to compensate for leaks. Nasal NIV was set at peak airway pressures of 15, 20, and 25 cm H2O and PEEP of 5, 6, and 7 cm H2O. Three sizes of the Neotech RAM cannula were used (prong outer diameters of 3.0, 3.5, and 4.0 mm). The nose was designed to keep the leak of the nares by the prongs to 30%. We also created a worst case leak (58% leak) by using the largest simulated nostril diameter with the smallest diameter Neotech RAM cannula prong. The outcome measure was the difference in pressures, referred to as leak effect, measured by the lung simulator relative to the set peak airway pressure and PEEP on the ventilator., RESULTS: For the interface with 30% leak, leak effects of peak airway pressure during simulated nasal NIV were similar with all Neotech RAM cannula sizes, with 63-75% of peak airway pressure and 70-90% of PEEP being transmitted across the nasal interface. The worst case scenario produced a 92% leak effect in peak airway pressure and PEEP., CONCLUSIONS: When used with <= 30% leak, the Neotech RAM cannula interface results in clinically acceptable transmission of pressures. With > 50% leak, a clinically negligible amount of pressure is transmitted to the artificial lungs. Copyright Â© 2015 by Daedalus Enterprises.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70702332
TI  - Characteristics of neoplasms in children admitted to neonatal intensive care units (NICUs)
AU  - Somanathan A.
AU  - Bajuk B.
AU  - Abdel-Latif M.E.
AU  - Lui K.
AU  - Oei J.
Y1  - 2012//
KW  - *neoplasm
KW  - *human
KW  - *health care organization
KW  - *intensive care unit
KW  - *child
KW  - *newborn intensive care
KW  - *society
KW  - *Pacific islands
KW  - *Australia and New Zealand
KW  - *Asian
KW  - infant
KW  - population
KW  - irradiation
KW  - drug therapy
KW  - prevalence
KW  - information processing
KW  - health
KW  - data base
KW  - diagnosis
KW  - delivery room
KW  - resuscitation
KW  - hyaline membrane disease
KW  - birth weight
KW  - surgery
KW  - air conditioning
KW  - linkage analysis
KW  - oxygen
KW  - carcinogen
KW  - corticosteroid
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 48
IS  - SUPPL. 1
PB  - Wiley Blackwell
SN  - 1034-4810
AD  - A. Somanathan, School of Women's and Children's Health, UNSW, NSW, Australia
DO  - https://dx.doi.org/10.1111/j.1440-1754.2012.02411.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70702332
AB  - Background: Infants in NICU may be exposed to potential carcinogens such as irradiation and certain medications. We aimed to determine the prevalence and outcomes of neoplasms in children to 5 years of age who were admitted to one of the 10 NICUs in NSW and the ACT between January 1998 and December 2006. Method(s): Probabilistic linkage analysis between the Neonatal Intensive Care Units' (NICUS) Data Collection (18,845 infants) and NSW Department Ministry of Health Databases (99,187 records). Neoplasms were coded with the ICD 9 and 10 AM codes. Result(s): There were 120 (0.64%) neoplasms (59 (49.2%) malignant, 61 (50.8%) benign) in NICUS infants up to 5 years of age. Most common were haematological (20%), followed by dermatological (19.2%), skeletal (14.2%), and neurological (10.8%) neoplasms. Median (IQR) age of diagnosis was 12.0 (0.13, 33.8) months. Children with neoplasms were less likely to be exposed to antenatal corticosteroids (OR, 95% CI: 0.62, 0.43-0.89*), be part of a multiple birth (0.59, 0.35-1.00*), have required delivery room resuscitation (0.52, 0.35-0.74*) or be diagnosed with hyaline membrane disease (0.60, 0.41-0.87*). They were born larger (mean birthweight percentile 55.3 +/- 32.8 vs. 47.5 +/- 29.6*) and were more likely to have undergone surgery (4.72, 3.28-6.78*). There was no difference in the need for ventilation and supplemental oxygen. Conclusion(s): Children admitted to NICUs have a higher rate of neoplasms than the general population, with most diagnosed after discharge.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70702327
TI  - Outcomes of preterm infants receiving positive pressure ventilation at term corrected gestation
AU  - McMorrow A.
AU  - Smirk C.
AU  - Davis P.G.
AU  - Kuschel C.
AU  - Fox L.M.
Y1  - 2012//
KW  - *Australia and New Zealand
KW  - *Pacific islands
KW  - *positive end expiratory pressure
KW  - *pregnancy
KW  - *prematurity
KW  - *Asian
KW  - *society
KW  - *health care organization
KW  - human
KW  - infant
KW  - death
KW  - area under the curve
KW  - counseling
KW  - prognosis
KW  - hospital discharge
KW  - oxygen consumption
KW  - survivor
KW  - risk
KW  - infection
KW  - high frequency oscillation
KW  - artificial ventilation
KW  - gestational age
KW  - data base
KW  - medical record
KW  - receiver operating characteristic
KW  - newborn care
KW  - mortality
KW  - endotracheal tube
KW  - population
KW  - lung dysplasia
KW  - pneumothorax
KW  - parent
KW  - steroid
KW  - oxygen
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 48
IS  - SUPPL. 1
PB  - Wiley Blackwell
SN  - 1034-4810
AD  - A. McMorrow, Royal Women's Hospital, Melbourne, Australia
DO  - https://dx.doi.org/10.1111/j.1440-1754.2012.02411.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70702327
AB  - Background: With advances in neonatal care, there is an emerging population of surviving infants with severe bronchopulmonary dysplasia who continue to receive positive pressure ventilation (PPV) at term corrected gestation. There is little information currently available to assist clinicians in counselling parents of these infants regarding prognosis. Method(s): Infants born <30 weeks gestation between 1 January 2000 and 31 December 2009 who were receiving CPAP or mechanical ventilation at 40 weeks corrected gestational age (CGA) were identified from our database and their medical records reviewed. Fraction of inspired oxygen (FiO2) and PaCO2 at 40 weeks were recorded and ROC curves for death were generated. Result(s): 1359 of 1572 infants survived to term. For those not receiving PPV, the post-term mortality rate to hospital discharge was 0.5%. 49 infants were receiving PPV at 40 weeks CGA. Of these, 15 (31%) infants died before hospital discharge. All three infants ventilated via an endotracheal tube died. Increased oxygen requirement at term was predictive of death before discharge (area under curve (AUC) 0.79). An FiO2 > 0.50 was associated with an 80% risk of death. PaCO2 was less predictive of death (AUC 0.58). There were no significant differences between survivors and non-survivors in rates of pneumothorax, infection, post-natal steroid use or high frequency oscillation. Conclusion(s): Two thirds of very preterm infants who remain on positive pressure ventilation at 40 weeks CGA survive. Risk of death rises with increasing oxygen requirements. This information can assist clinicians in counselling families regarding prognosis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70698184
TI  - Educating fellows in practice-based learning & improvement and systemsbased practice: The value of quality improvement in clinical practice
AU  - Carey W.
AU  - Collura C.
AU  - Matthews G.
AU  - Picasso J.
AU  - Colby C.
Y1  - 2012//
KW  - *hospital
KW  - *learning
KW  - *total quality management
KW  - *society
KW  - *clinical practice
KW  - human
KW  - curriculum
KW  - competence
KW  - academic achievement
KW  - pediatrics
KW  - feedback system
KW  - morbidity
KW  - mortality
KW  - accreditation
KW  - medical education
KW  - teaching
KW  - certification
KW  - experiential learning
KW  - model
KW  - newborn morbidity
KW  - documentation
KW  - safety
KW  - lung dysplasia
KW  - catheter infection
KW  - graduate
T2  - Journal of Hospital Medicine
LA  - English
VL  - 7
IS  - SUPPL. 2
PB  - Wiley Blackwell
SN  - 1553-5592
AD  - W. Carey, Mayo Clinic, Rochester, MN, United States
DO  - https://dx.doi.org/10.1002/jhm.1927
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=70698184
AB  - Background: In 1999, the Accreditation Council for Graduate Medical Education identified six general competencies in which residents must be trained. Among these are two relatively abstract and complex competencies: Practice- Based Learning & Improvement (PBLI) and Systems-Based Practice (SBP). Many program directors find that PBLI and SBP are difficult concepts to grasp, perhaps limiting their ability to develop effective means of teaching and evaluating these competencies. Because PBLI and SBP are related conceptually to Quality Improvement (QI), a QI-based curriculum may be an effective means by which to teach these competencies. However, there are few examples of QI curricula that have improved resident knowledge in PBLI and SBP while providing program directors the means by which to document resident competence. Purpose(s): We engaged our fellows in experiential learning by requiring them to participate in our division-level program of continuous quality improvement. Using the Plan-Do-Study-Act change model, fellows partnered with faculty to develop and implement QI projects designed to reduce common neonatal morbidities. To assess fellow competence in PBLI and SBP, program directors maintained portfolios for each fellow, including written self-reflections, evaluations and documentation of all resulting academic achievement. Description: As members of our unit's unit's multidisciplinary Quality & Safety Committee (Q&S), our fellows identified two outcomes meriting improvement- bronchopulmonary dysplasia (BPD) and catheter-associated blood stream infection (CABSI). They then developed and implemented evidencebased plans to reduce the incidence of each disease, then collected and analyzed outcomes data with guidance from division faculty. To complete the QI cycle, fellows communicated outcomes and future plans for QI to all NICU staff. Our fellows' QI projects led to significant and sustained reductions in the rates of BPD and CABSI. We assessed fellow performance by reviewing goal- and strategy-based self-reflections with each fellow semi-annually. In addition, all division faculty provided competency-based feedback in response to fellow presentations of Q&S outcomes at our quarterly Morbidity & Mortality conferences. Our fellows' active engagement in QI also resulted in meaningful academic achievement as well. For example, our fellows have presented the clinical outcomes of their BPD initiative at two national academic meetings (American Academy of Pediatrics National Conference and Exhibition, 2010 and 2011). Also, one of our fellows earned Performance in Practice credit toward her maintenance of certification by the American Board of Pediatrics. Conclusion(s): By integrating clinical and educational systems, a QI-based curriculum may be an effective means by which to teach and assess PBLI and SBP.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365763181
TI  - Dynamic regulation of platelet-derived growth factor receptor alpha expression in alveolar fibroblasts during realveolarization
AU  - Chen L.
AU  - Acciani T.
AU  - Le Cras T.
AU  - Lutzko C.
AU  - Perl A.-K.T.
Y1  - 2012//
KW  - animal cell
KW  - animal experiment
KW  - animal tissue
KW  - article
KW  - cell differentiation
KW  - controlled study
KW  - epithelial mesenchymal transition
KW  - flow cytometry
KW  - gene expression
KW  - immunohistochemistry
KW  - inhibition kinetics
KW  - lung resection
KW  - mouse
KW  - *myofibroblast
KW  - nonhuman
KW  - precursor
KW  - protein expression
KW  - real time polymerase chain reaction
KW  - regeneration
KW  - signal transduction
KW  - transgene
KW  - alpha smooth muscle actin/ec [Endogenous Compound]
KW  - bone morphogenetic protein 4/ec [Endogenous Compound]
KW  - fibroblast growth factor/ec [Endogenous Compound]
KW  - fibroblast growth factor receptor/ec [Endogenous Compound]
KW  - fibroblast growth factor receptor 2/ec [Endogenous Compound]
KW  - green fluorescent protein/ec [Endogenous Compound]
KW  - peroxisome proliferator activated receptor gamma/ec [Endogenous Compound]
KW  - *platelet derived growth factor alpha receptor/ec [Endogenous Compound]
KW  - rosiglitazone
KW  - sonic hedgehog protein/ec [Endogenous Compound]
KW  - Wnt protein/ec [Endogenous Compound]
T2  - American Journal of Respiratory Cell and Molecular Biology
LA  - English
VL  - 47
IS  - 4
PB  - American Thoracic Society (61 Broadway 4th Floor, New York NY 10006 - 2755, United States)
SN  - 1044-1549
AD  - A.-K.T. Perl, Children's Hospital Medical Center, Divisions of Neonatology and Pulmonary Biology, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, United States. E-mail: Anne.Perl@cchmc.org
UR  - http://ajrcmb.atsjournals.org/content/47/4/517.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=365763181
DO  - https://dx.doi.org/10.1165/rcmb.2012-0030OC
AB  - Although the importance of platelet-derived growth factor receptor (PDGFR)-alpha signaling during normal alveogenesis is known, it is unclear whether this signaling pathway can regulate realveolarization in the adult lung. During alveolar development, PDGFR-alpha-expressing cells induce alpha smooth muscle actin (alpha-SMA) and differentiate to interstitial myofibroblasts. Fibroblast growth factor (FGF) signaling regulates myofibroblast differentiation during alveolarization, whereas peroxisome proliferator- activated receptor (PPAR)-gamma activation antagonizes myofibroblast differentiation in lung fibrosis. Using left lung pneumonectomy, the roles of FGF and PPAR-gamma signaling in differentiation of myofibroblasts from PDGFR-alpha-positive precursors during compensatory lung growth were assessed. FGF receptor (FGFR) signaling was inhibited by conditionally activating a soluble dominant-negative FGFR2 transgene. PPAR-gamma signaling was activated by administration of rosiglitazone. Changes in alpha-SMA and PDGFR-alpha protein expression were assessed in PDGFR-alpha-green fluorescent protein (GFP) reporter mice using immunohistochemistry, flow cytometry, and real-time PCR. Immunohistochemistry and flow cytometry demonstrated that the cell ratio and expression levels of PDGFR-alpha-GFP changed dynamically during alveolar regeneration and that alpha-SMA expression was induced in a subset of PDGFR-alpha-GFP cells. Expression of a dominant-negative FGFR2 and administration of rosiglitazone inhibited induction of alpha-SMA in PDGFR-alpha-positive fibroblasts and formation of new septae. Changes in gene expression of epithelial and mesenchymal signaling molecules were assessed after left lobe pneumonectomy, and results demonstrated that inhibition of FGFR2 signaling and increase in PPAR-gamma signaling altered the expression of Shh, FGF, Wnt, and Bmp4, genes that are also important for epithelial- mesenchymal crosstalk during early lung development. Our data demonstrate for the first time that a comparable epithelial- mesenchymal crosstalk regulates fibroblast phenotypes during alveolar septation. Copyright Â© 2012 by the American Thoracic Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 364699791
TI  - Quantitative assessment of chronic lung disease of infancy using computed tomography
AU  - Sarria E.E.
AU  - Mattiello R.
AU  - Rao L.
AU  - Tiller C.J.
AU  - Poindexter B.
AU  - Applegate K.E.
AU  - Granroth-Cook J.
AU  - Denski C.
AU  - Nguyen J.
AU  - Yu Z.
AU  - Hoffman E.
AU  - Tepper R.S.
Y1  - 2012//
KW  - article
KW  - artificial ventilation
KW  - body height
KW  - Caucasian
KW  - child
KW  - *chronic lung disease/di [Diagnosis]
KW  - clinical article
KW  - controlled study
KW  - disease severity
KW  - female
KW  - gestational age
KW  - growth disorder
KW  - human
KW  - infant
KW  - lung volume
KW  - male
KW  - maternal smoking
KW  - *multidetector computed tomography
KW  - oxygen therapy
KW  - prematurity
KW  - preschool child
KW  - priority journal
KW  - quantitative analysis
KW  - respiratory tract parameters
KW  - sex difference
KW  - treatment duration
KW  - contrast medium/iv [Intravenous Drug Administration]
KW  - *chronic lung disease of infancy/di [Diagnosis]
KW  - lung airway generation
KW  - lung airway size
KW  - lung tissue density
T2  - European Respiratory Journal
LA  - English
VL  - 39
IS  - 4
PB  - European Respiratory Society (4 Ave Sainte-Luce, Lausanne CH-1003, Switzerland)
SN  - 1399-3003
AD  - R.S. Tepper, Dept. of Pediatrics, Indiana University Medical Center, James Whitcomb Riley Hospital for Children, 702 Barnhill Drive, Indianapolis, IN 46202-5225, United States. E-mail: rtepper@iupui.edu
UR  - http://erj.ersjournals.com/content/39/4/992.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=364699791
DO  - https://dx.doi.org/10.1183/09031936.00064811
AB  - The aims of this study were to determine whether infants and toddlers with chronic lung disease of infancy (CLDI) have smaller airways and lower lung density compared with full-term healthy controls. Multi-slice computed tomography (CT) chest scans were obtained at elevated lung volumes during a brief respiratory pause in sedated infants and toddlers; 38 CLDI were compared with 39 full-term controls. For CLDI subjects, gestational age at birth ranged from 25 to 29 weeks. Airway size was measured for the trachea and the next three to four generations into the right lower lobe; lung volumes and tissue density were also measured. The relationship between airway size and airway generation differed between the CLDI and full-term groups; the sizes of the first and second airway generations were larger in the shorter CLDI than in the shorter full-term subjects. The increased size in the airways in the CLDI subjects was associated with increasing mechanical ventilation time in the neonatal period. CLDI subjects had a greater heterogeneity of lung density compared with full-term subjects. Our results indicate that quantitative analysis of multi-slice CT scans at elevated volumes provides important insights into the pulmonary pathology of infants and toddlers with CLDI. CopyrightÂ©ERS 2012.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365426936
TI  - Parathyroid Hormone-Related Protein in the Healthy and Injured Lung
AU  - Montgrain P.R.
AU  - Hastings R.H.
Y1  - 2012//
KW  - article
KW  - biosynthesis
KW  - cell activity
KW  - cell growth
KW  - cell proliferation
KW  - chronic thromboembolic pulmonary hypertension/su [Surgery]
KW  - endarterectomy
KW  - fetus lung maturation
KW  - hormone action
KW  - hormone structure
KW  - human
KW  - inflammation
KW  - lung alveolus cell type 2
KW  - lung alveolus epithelium
KW  - *lung development
KW  - *lung injury/co [Complication]
KW  - *lung injury/et [Etiology]
KW  - molecular mechanics
KW  - nonhuman
KW  - pathophysiology
KW  - priority journal
KW  - protein localization
KW  - risk factor
KW  - vasodilatation
KW  - lung surfactant/ec [Endogenous Compound]
KW  - *parathyroid hormone related protein/ec [Endogenous Compound]
T2  - ICU Director
LA  - English
VL  - 3
IS  - 3
PB  - SAGE Publications Inc. (2455 Teller Road, Thousand Oaks CA 91320, United States)
SN  - 1944-4524
AD  - R. H. Hastings, Anesthesiology Service, VA San Diego Healthcare System, 3350 La Jolla Village Drive (125), San Diego, CA 92161, United States. E-mail: rhhastings@ucsd.edu
DO  - https://dx.doi.org/10.1177/1944451612443067
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=365426936
AB  - Parathyroid hormone-related protein (PTHrP) is an oncofetal protein with functional effects in normal and diseased lung. In the respiratory system, the hormone has implications for a variety of processes, including lung development, alveolar type II cell function and differentiation, cell proliferation, apoptosis, motility, and matrix interactions. PTHrP regulates branching morphogenesis and type II cell maturation in fetal lung through bidirectional interactions with lung fibroblasts. Consequently, it appears to have a role in the pathophysiology of respiratory distress syndrome and bronchopulmonary dysplasia. In adult lung, the molecule has autocrine actions on type II pneumocytes that stimulate phosphatidylcholine production, inhibit cell proliferation, and sensitize to apoptotic stimuli. Type II cell PTHrP levels fall after lung injury, inversely coordinated in time with their proliferation, suggesting that reduction in its growth inhibitory effect may contribute to the increase in type II cell numbers after injury. Air space levels of the protein are inversely related to the risk of lung injury or injury severity in neonatal and adult lung, consistent with its production by pneumocytes. Thus, PTHrP has clinical significance as a biomarker for injury and as a potential target for treatment. Â© 2012 The Author(s).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 363112886
TI  - Hyperoxia-induced activation of the integrated stress response in the newborn rat lung
AU  - Konsavage W.M.
AU  - Zhang L.
AU  - Wu Y.
AU  - Shenberger J.S.
Y1  - 2012//
KW  - animal experiment
KW  - article
KW  - cell structure
KW  - endoplasmic reticulum
KW  - endothelium cell
KW  - epithelium cell
KW  - *hyperoxia
KW  - immunoreactivity
KW  - *lung
KW  - lung alveolus cell type 2
KW  - newborn
KW  - nonhuman
KW  - priority journal
KW  - protein expression
KW  - protein phosphorylation
KW  - protein synthesis
KW  - rat
KW  - RNA splicing
KW  - *stress
KW  - *unfolded protein response
KW  - activating transcription factor 3/ec [Endogenous Compound]
KW  - activating transcription factor 4/ec [Endogenous Compound]
KW  - activating transcription factor 6/ec [Endogenous Compound]
KW  - glutamate cysteine ligase/ec [Endogenous Compound]
KW  - initiation factor 2alpha/ec [Endogenous Compound]
KW  - mitogen activated protein kinase 1/ec [Endogenous Compound]
KW  - mitogen activated protein kinase 3/ec [Endogenous Compound]
KW  - mitogen activated protein kinase p38/ec [Endogenous Compound]
KW  - nuclear protein/ec [Endogenous Compound]
KW  - protein kinase R/ec [Endogenous Compound]
KW  - stress activated protein kinase/ec [Endogenous Compound]
KW  - X box binding protein 1/ec [Endogenous Compound]
KW  - *integrated stress response
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 302
IS  - 1
PB  - American Physiological Society (9650 Rockville Pike, Bethesda MD 20814-3991, United States)
SN  - 1522-1504
AD  - J. S. Shenberger, Departments of Pediatrics, H085, The Milton S. Hershey Medical Center, 500 Univ. Drive, PO Box 850, Hershey, PA 17033-0850, United States. E-mail: jshenberger@hmc.psu.edu
UR  - http://ajplung.physiology.org/content/302/1/L27.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=363112886
DO  - https://dx.doi.org/10.1152/ajplung.00174.2011
AB  - Diverse environmental stresses stimulate eukaryotic translation initiation factor 2alpha (eIF2alpha) phosphorylation, leading to a stress-resistant state characterized by global attenuation of protein synthesis and induction of cytoprotective genes. The signal transduction network culminating in these effects is referred to as the integrated stress response (ISR) or, when initiated by misfolded proteins within the endoplasmic reticulum (ER), the unfolded protein response (UPR). Given that we previously reported that exposure of 4-day-old Sprague-Dawley rats to 95% O2 (Ox) diminishes global pulmonary protein synthesis and increases eIF2alpha phosphorylation, we conducted the current study to determine whether Ox activates the ISR or UPR. We found that Ox-induced alterations in ER morphology of alveolar type II cells and interstitial fibroblasts were not associated with activation of the UPR sensors PERK or activating transcription factor (ATF) 6 or with X-box binding protein-1 mRNA splicing in whole lung extracts. Exposure to Ox enhanced ATF4 immunoreactivity and nuclear protein content, followed by a 2- and 5-fold increase in ATF3 protein and mRNA expression, respectively. The accumulation of nuclear ATF4 protein coincided with induction of glutamate-cysteine ligase catalytic subunit, an ISR-responsive gene. Immunohistochemistry revealed that changes in ATF3/4 expression were prominent in the alveolus, whereas primary cell culture implicated epithelial and endothelial cells as targets. Finally, induction of ISR intermediates in the intact lung occurred in the absence of the phosphorylation of PKR, JNK, ERK1/2, and p38 MAPK. These findings demonstrate that Ox activates the ISR within the newborn lung and highlight regional and cell-specific alterations in the expression ISR transcription factors that regulate redox balance. Â© 2012 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365175752
TI  - Role of lung epithelial-mesenchymal transformation mechanism in bronchopulmonary dysplasia of mice
AU  - Liu F.-J.
AU  - Deng C.
AU  - Guo C.-B.
AU  - Fu Z.
Y1  - 2012//
KW  - animal cell
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - breathing rate
KW  - controlled study
KW  - *epithelial mesenchymal transition
KW  - immunohistochemistry
KW  - inhibition kinetics
KW  - lung alveolus
KW  - *lung dysplasia/et [Etiology]
KW  - lung fibroblast
KW  - lung fibrosis
KW  - lung function test
KW  - lung parenchyma
KW  - mouse
KW  - nonhuman
KW  - oxygen concentration
KW  - plethysmography
KW  - polymerase chain reaction
KW  - protein expression
KW  - quantitative analysis
KW  - tidal volume
KW  - calvasculin/ec [Endogenous Compound]
KW  - collagen/ec [Endogenous Compound]
KW  - messenger RNA/ec [Endogenous Compound]
KW  - surfactant protein B/ec [Endogenous Compound]
T2  - Chinese Journal of Biologicals
LA  - Chinese
VL  - 25
IS  - 5
PB  - Changchun Institute of Biological Products (No. 137, Xi'an Road, Chnagchun, Jilin 130062, China)
SN  - 1004-5503
AD  - F.-J. Liu, Key Laboratory of Developmental Diseases in Childhood of Chongqing City, Children's Hospital, Chongqing Medical University, Chongqing 400014, China
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed13&NEWS=N&AN=365175752
AB  - Objective: To observe the expressions of lung surfactant protein B (SP-B) and fibroblast-specific protein 1 (FSP1) in mouse model of bronchopulmonary dysplasia (BPD) and investigate the role of lung epithelial-mesenchymal transformation (EMT) mechanism in BPD. Method(s): Mouse model of BPD was established. The mice in various groups were observed for pathological changes of lung tissues by immunohistochemial assay, then analyzed for collagen contents by Masson staining and for expression levels of SP-B and FSP1 mRNAs by double-labeled immunofluorescence assay and fluorescent quantitative PCR method, and observed for changes of lung functions by plethysmography. Result(s): As compared with those in control group, significant developmental inhibition of pulmonary alveoli, pulmonary septal thickening and collagen deposition were observed in lung tissues of mice of BPD group after exposure to high oxygen concentration. Co-expression of SP-B and FSPl was observed in lung tissues of mice in BPD group 14 and 21 d after exposure, while were not observed in those in control group. The expression level of SP-B mRNA in BPD group 21 d after exposure decreased significantly, while that of FSP1 increased significantly, as compared with those in control group (both P < 0.05). Both the respiratory frequency(F) and tidal volume(TV) of mice in BPD group were significantly lower than those in control group (P < 0.05). Conclusion(s): The fibroblasts generated by EMT mechanism was an important source of pulmonary fibrosis in BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 364237192
TI  - Intratracheal transplantation of human umbilical cordblood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats
AU  - Chang Y.S.
AU  - Choi S.J.
AU  - Sung D.K.
AU  - Kim S.Y.
AU  - Oh W.
AU  - Yang Y.S.
AU  - Park W.S.
Y1  - 2011//
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - cell structure
KW  - controlled study
KW  - enzyme activity
KW  - human
KW  - human cell
KW  - hyperoxia
KW  - inflammation
KW  - lung alveolus
KW  - *lung injury/th [Therapy]
KW  - lung parenchyma
KW  - *mesenchymal stem cell
KW  - *mesenchymal stem cell transplantation
KW  - newborn
KW  - nick end labeling
KW  - nonhuman
KW  - oxidative stress
KW  - priority journal
KW  - protein expression
KW  - rat
KW  - treatment response
KW  - *umbilical cord blood
KW  - collagen/ec [Endogenous Compound]
KW  - interleukin 1beta/ec [Endogenous Compound]
KW  - interleukin 6/ec [Endogenous Compound]
KW  - messenger RNA/ec [Endogenous Compound]
KW  - myeloperoxidase/ec [Endogenous Compound]
KW  - protein p47/ec [Endogenous Compound]
KW  - transforming growth factor beta/ec [Endogenous Compound]
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
KW  - unclassified drug
KW  - glyceradehyde 3 phosphate dehydrogenase/ec [Endogenous Compound]
T2  - Cell Transplantation
LA  - English
VL  - 20
IS  - 11-12
PB  - Cognizant Communication Corporation
SN  - 0963-6897
AD  - W. S. Park, Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, South Korea. E-mail: wonspark@skku.edu
UR  - http://docserver.ingentaconnect.com/deliver/connect/cog/09636897/v20n11/s14.pdf?expires=1328840905&id=67126887&titleid=5476&accname=Elsevier&checksum=D3434F7EAE6072B0825848C2BF8B5B5D
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=364237192
DO  - https://dx.doi.org/10.3727/096368911x565038a
AB  - Intratracheal transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) attenuates the hyperoxia-induced neonatal lung injury. The aim of this preclinical translation study was to optimize the dose of human UCB-derived MSCs in attenuating hyperoxia-induced lung injury in newborn rats. Newborn Sprague-Dawley rats were randomly exposed to hyperoxia (95% oxygen) or normoxia after birth for 14 days. Three different doses of human UCB-derived MSCs, 5 x 103 (HT1), 5 x 104 (HT2), and 5 x 105 (HT3), were delivered intratracheally at postnatal day (P) 5. At P14, lungs were harvested for analyses including morphometry for alveolarization, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) staining, myeoloperoxidase activity, mRNA level of tumor necross factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), IL-6, and transforming growth factor-beta (TGF-beta), human glycera-dehyde-3-phosphate dehydrogenase (GAPDH), and p47phox, and collagen levels. Increases in TUNEL-positive cells were attenuated in all transplantation groups. However, hyperoxia-induced lung injuries, such as reduced alveolarization, as evidenced by increased mean linear intercept and mean alveolar volume, and increased collagen levels were significantly attenuated in both HT2 and HT3, but not in HT1, with better attenuation in HT3 than in HT2. Dose-dependent human GAPDH expression, indicative of the presence of human RNA in lung tissue, was observed only in the transplantation groups, with higher expression in HT3 than in HT2, and higher expression in HT2 than in HT1. Hyperoxia-induced inflammatory responses such as increased myeloperoxidase acitivity, mRNA levels of TNF-alpha, IL-1beta, IL-6, and TGF-beta of the lung tissue, and upregulation of both cytosolic and membrane p47phox, indicative of oxidative stress, were significantly attenuated in both HT2 and HT3 but not in HT1. These results demonstrate that intratracheal transplantation of human UCB-derived MSCs with appropriate doses may attenuate hyperoxia-induced lung injury through active involvement of these cells in modulating host inflammatory responses and oxidative stress in neonatal rats. Â© 2011 Cognizant Comm. Corp.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 51412889
TI  - Glucocorticoid receptor stimulation and the regulation of neonatal cerebellar neural progenitor cell apoptosis
AU  - Noguchi K.K.
AU  - Lau K.
AU  - Smith D.J.
AU  - Swiney B.S.
AU  - Farber N.B.
Y1  - 2011//
KW  - animal cell
KW  - animal tissue
KW  - *apoptosis
KW  - article
KW  - *brain development
KW  - cell granule
KW  - cell population
KW  - controlled study
KW  - drug exposure
KW  - enzyme inhibition
KW  - female
KW  - male
KW  - mouse
KW  - *neural stem cell
KW  - newborn
KW  - nonhuman
KW  - perinatal period
KW  - priority journal
KW  - *11beta hydroxysteroid dehydrogenase 2/ec [Endogenous Compound]
KW  - betamethasone/cm [Drug Comparison]
KW  - carbenoxolone/cb [Drug Combination]
KW  - carbenoxolone/cm [Drug Comparison]
KW  - corticosterone/cb [Drug Combination]
KW  - corticosterone/cm [Drug Comparison]
KW  - cytarabine/cb [Drug Combination]
KW  - dexamethasone/cb [Drug Combination]
KW  - dexamethasone/cm [Drug Comparison]
KW  - *glucocorticoid receptor/ec [Endogenous Compound]
KW  - mifepristone
T2  - Neurobiology of Disease
LA  - English
VL  - 43
IS  - 2
PB  - Academic Press Inc. (1250 Sixth Avenue, San Diego, California CA 92101, United States)
SN  - 1095-953X
AD  - K.K. Noguchi, Washington University in Saint Louis, School of Medicine, Department of Psychiatry, 660 South Euclid, Box #8134, Saint Louis, MO 63110, United States. E-mail: noguchik@psychiatry.wustl.edu
DO  - https://dx.doi.org/10.1016/j.nbd.2011.04.004
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=51412889
AB  - Glucocorticoids are used to treat respiratory dysfunction associated with premature birth but have been shown to cause neurodevelopmental deficits when used therapeutically. Recently, we established that acute glucocorticoid exposure at clinically relevant doses produces neural progenitor cell apoptosis in the external granule layer of the developing mouse cerebellum and permanent decreases in the number of cerebellar neurons. As the cerebellum naturally matures and neurogenesis is no longer needed, the external granule layer decreases proliferation and permanently disappears during the second week of life. At this same time, corticosterone (the endogenous rodent glucocorticoid) release increases and a glucocorticoid-metabolizing enzyme that protects the external granule layer against glucocorticoid receptor stimulation (11beta-Hydroxysteroid-Dehydrogenase-Type 2; HSD2) naturally disappears. Here we show that HSD2 inhibition and raising corticosterone to adult physiological levels both can independently increase neural progenitor cell apoptosis in the neonatal mouse. Conversely, glucocorticoid receptor antagonism decreases natural physiological apoptosis in this same progenitor cell population suggesting that endogenous glucocorticoid stimulation may regulate apoptosis in the external granule layer. We also found that glucocorticoids which HSD2 can effectively metabolize generate less external granule layer apoptosis than glucocorticoids this enzyme is ineffective at breaking down. This finding may explain why glucocorticoids that this enzyme can metabolize are clinically effective at treating respiratory dysfunction yet seem to produce no neurodevelopmental deficits. Finally, we demonstrate that both acute and chronic glucocorticoid exposures produce external granule layer apoptosis but without appropriate control groups this effect becomes masked. These results are discussed in terms of their implications for glucocorticoid therapy and neurodevelopment during the perinatal period. Â© 2011 Elsevier Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Aberrant elastin remodeling in the lungs of O2-exposed newborn mice; primarily results from perturbed interaction between integrins and elastin.
DO  - https://dx.doi.org/10.1007/s00441-014-2035-1
AU  - Han, Wenli
AU  - Guo, Chunbao
AU  - Liu, Qiutong
AU  - Yu, Benli
AU  - Liu, Zhaoyun
AU  - Yang, Junqing
AU  - Deng, Chun
Y1  - 2015//
Y2  - 20141127//
KW  - Animals
KW  - Animals, Newborn
KW  - *Elastin/me [Metabolism]
KW  - Extracellular Matrix Proteins/me [Metabolism]
KW  - Gene Expression Profiling
KW  - Hyperoxia/pa [Pathology]
KW  - *Integrin alphaV/me [Metabolism]
KW  - Lung/de [Drug Effects]
KW  - *Lung/me [Metabolism]
KW  - Mice, Inbred C57BL
KW  - *Oxygen/pd [Pharmacology]
KW  - Pulmonary Alveoli/de [Drug Effects]
KW  - Pulmonary Alveoli/pa [Pathology]
KW  - Recombinant Proteins/me [Metabolism]
KW  - Time Factors
KW  - Transforming Growth Factor beta1/me [Metabolism]
KW  - Tropoelastin/me [Metabolism]
T2  - Cell and tissue research
VL  - 359
IS  - 2
SN  - 0302-766X
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25428696
AD  - Germany
AB  - Excessive localization of elastin from septal tips to alveolar walls is a key feature of bronchopulmonary dysplasia (BPD). The abnormal accumulation of lung elastin, involving the structural and functional interaction of a series of proteins, remains poorly understood. To further investigate the mechanisms accounting for the abnormal accumulation of elastin in the lungs of newborn mice with BPD, we evaluate elastin distribution and its interaction with proteins involved in its aberrant localization, such as integrin alphav, fibulin-5 and transforming growth factor beta1 (TGF-beta1), in lungs of newborn mice exposed to 60% O2 for 21 days. Lung histology revealed aberrant elastin production and impaired lung septation in O2-exposed lungs, while tropoelastin, integrin alphav, fibulin-1, fibulin-2 and fibulin-4 gene expression were elevated. Dual staining image analysis of lung sections revealed that co-localization of integrin alphav and elastin increased following O2 exposure with elastin distributed throughout the walls of air spaces rather than at septal tips. Furthermore, integrin alphav appeared to be induced initially. Concurrently, increased fibulin-5 and TGF-beta1 (which may regulate elastic fiber assembly) expression was detected, which may explain the altered lung elastin deposition and defective septation that are observed during BPD. These data support the hypothesis that excessive and aberrant alphav integrin expression was initially induced by hyperoxia; alphav integrin then interacted with and recruited elastin. These alterations were accompanied by fibulin-5 deposition and TGF-beta1 activation, which may impede normal matrix remodeling, thereby contributing to the pathological pulmonary features of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 362235799
TI  - Phosphodiesterases: Emerging therapeutic targets for neonatal pulmonary hypertension
T2  - Handbook of Experimental Pharmacology
AU  - Farrow K.N.
AU  - Steinhorn R.H.
Y1  - 2011//
KW  - article
KW  - artificial ventilation
KW  - cause of death
KW  - combination chemotherapy
KW  - congenital diaphragm hernia/cn [Congenital Disorder]
KW  - congenital diaphragm hernia/et [Etiology]
KW  - congenital heart disease/cn [Congenital Disorder]
KW  - congenital heart disease/dt [Drug Therapy]
KW  - congenital heart disease/et [Etiology]
KW  - cor pulmonale/cn [Congenital Disorder]
KW  - cor pulmonale/et [Etiology]
KW  - disease association
KW  - drug blood level
KW  - drug clearance
KW  - drug cost
KW  - drug efficacy
KW  - drug fatality/si [Side Effect]
KW  - drug safety
KW  - drug withdrawal
KW  - enzyme activity
KW  - enzyme phosphorylation
KW  - heart output
KW  - heart right ventricle hypertrophy/dt [Drug Therapy]
KW  - hospitalization
KW  - human
KW  - hypotension/si [Side Effect]
KW  - infant mortality
KW  - length of stay
KW  - loading drug dose
KW  - lung artery pressure
KW  - lung disease/dt [Drug Therapy]
KW  - lung dysplasia/cn [Congenital Disorder]
KW  - lung dysplasia/dt [Drug Therapy]
KW  - lung dysplasia/et [Etiology]
KW  - lung dysplasia/pc [Prevention]
KW  - lung hypertrophy/dt [Drug Therapy]
KW  - lung vascular resistance
KW  - meconium aspiration/cn [Congenital Disorder]
KW  - meconium aspiration/et [Etiology]
KW  - monotherapy
KW  - neonatal pulmonary hypertension/dt [Drug Therapy]
KW  - newborn disease/dt [Drug Therapy]
KW  - *newborn disease/cn [Congenital Disorder]
KW  - *newborn disease/dm [Disease Management]
KW  - *newborn disease/dt [Drug Therapy]
KW  - *newborn disease/et [Etiology]
KW  - *newborn disease/pc [Prevention]
KW  - *newborn disease/th [Therapy]
KW  - nonhuman
KW  - oxidative stress
KW  - oxygenation
KW  - pathogenesis
KW  - persistent pulmonary hypertension of the newborn/dt [Drug Therapy]
KW  - pharmacodynamics
KW  - pneumothorax
KW  - priority journal
KW  - protein expression
KW  - *pulmonary hypertension/cn [Congenital Disorder]
KW  - *pulmonary hypertension/dm [Disease Management]
KW  - *pulmonary hypertension/dt [Drug Therapy]
KW  - *pulmonary hypertension/et [Etiology]
KW  - *pulmonary hypertension/pc [Prevention]
KW  - *pulmonary hypertension/th [Therapy]
KW  - pulmonary hypertension/dt [Drug Therapy]
KW  - single drug dose
KW  - cimetidine/cb [Drug Combination]
KW  - cimetidine/cr [Drug Concentration]
KW  - cyclic AMP/ec [Endogenous Compound]
KW  - cyclic AMP derivative/dt [Drug Therapy]
KW  - cyclic AMP derivative/pd [Pharmacology]
KW  - cyclic GMP/ec [Endogenous Compound]
KW  - dipyridamole/pd [Pharmacology]
KW  - endothelial nitric oxide synthase/ec [Endogenous Compound]
KW  - erythromycin/cb [Drug Combination]
KW  - erythromycin/cr [Drug Concentration]
KW  - guanylate cyclase/ec [Endogenous Compound]
KW  - inducible nitric oxide synthase/ec [Endogenous Compound]
KW  - milrinone/cb [Drug Combination]
KW  - milrinone/pd [Pharmacology]
KW  - nitric oxide/ct [Clinical Trial]
KW  - nitric oxide/cb [Drug Combination]
KW  - nitric oxide/dt [Drug Therapy]
KW  - nitric oxide/ec [Endogenous Compound]
KW  - nitric oxide/ih [Inhalational Drug Administration]
KW  - nitric oxide/pe [Pharmacoeconomics]
KW  - nitric oxide/pd [Pharmacology]
KW  - *phosphodiesterase/ec [Endogenous Compound]
KW  - phosphodiesterase III/ec [Endogenous Compound]
KW  - *phosphodiesterase inhibitor/pd [Pharmacology]
KW  - phosphodiesterase IV/ec [Endogenous Compound]
KW  - phosphodiesterase IV inhibitor/ct [Clinical Trial]
KW  - phosphodiesterase IV inhibitor/dt [Drug Therapy]
KW  - phosphodiesterase IV inhibitor/pd [Pharmacology]
KW  - phosphodiesterase V/ec [Endogenous Compound]
KW  - phosphodiesterase V inhibitor/dt [Drug Therapy]
KW  - piclamilast/dt [Drug Therapy]
KW  - piclamilast/pd [Pharmacology]
KW  - placebo
KW  - prostacyclin receptor/ec [Endogenous Compound]
KW  - prostacyclin synthase/ec [Endogenous Compound]
KW  - prostaglandin synthase/ec [Endogenous Compound]
KW  - reactive oxygen metabolite/ec [Endogenous Compound]
KW  - rolipram/dt [Drug Therapy]
KW  - rolipram/pd [Pharmacology]
KW  - sildenafil/ae [Adverse Drug Reaction]
KW  - sildenafil/ct [Clinical Trial]
KW  - sildenafil/cb [Drug Combination]
KW  - sildenafil/do [Drug Dose]
KW  - sildenafil/dt [Drug Therapy]
KW  - sildenafil/iv [Intravenous Drug Administration]
KW  - sildenafil/po [Oral Drug Administration]
KW  - sildenafil/pk [Pharmacokinetics]
KW  - sildenafil/pd [Pharmacology]
KW  - unclassified drug
KW  - unindexed drug
KW  - zaprinast/pd [Pharmacology]
KW  - idiopathic persistent pulmonary hypertension of the newborn/cn [Congenital Disorder]
KW  - idiopathic persistent pulmonary hypertension of the newborn/et [Etiology]
KW  - lung hypertrophy/dt [Drug Therapy]
KW  - *neonatal pulmonary hypertension/cn [Congenital Disorder]
KW  - *neonatal pulmonary hypertension/dm [Disease Management]
KW  - *neonatal pulmonary hypertension/dt [Drug Therapy]
KW  - *neonatal pulmonary hypertension/et [Etiology]
KW  - *neonatal pulmonary hypertension/pc [Prevention]
KW  - *neonatal pulmonary hypertension/th [Therapy]
KW  - persistent pulmonary hypertension of the newborn/cn [Congenital Disorder]
KW  - persistent pulmonary hypertension of the newborn/dm [Disease Management]
KW  - persistent pulmonary hypertension of the newborn/dt [Drug Therapy]
KW  - persistent pulmonary hypertension of the newborn/et [Etiology]
KW  - phosphodiesterase 1a/ec [Endogenous Compound]
KW  - phosphodiesterase 1B/ec [Endogenous Compound]
LA  - English
VL  - 204
PB  - Springer New York (233 Spring Street, New York NY 10013-1578, United States)
SN  - 9783642179686
AD  - K.N. Farrow, Department of Pediatrics, Feinberg School of Medicine, Northwestern University, 310 E. Superior St., Chicago, IL 60611, United States. E-mail: k-farrow@northwestern.edu
DO  - https://dx.doi.org/10.1007/978-3-642-17969-3_11
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=362235799
AB  - Pulmonary hypertension in the neonate is associated with multiple underlying problems such as respiratory distress syndrome, meconium aspiration syndrome, congenital diaphragmatic hernia, bronchopulmonary dysplasia, sepsis, or congenital heart disease. Because of the heterogeneous group of disorders, the therapeutic approach and response often depends on the underlying disease. In many of these conditions, there is evidence that cyclic nucleotide signaling and specifically phosphodiesterases (PDEs) are disrupted. PDE inhibitors represent an emerging class of pulmonary vasodilators in adults. Studies are now under way to evaluate the utility, efficacy, and safety of such therapies in infants with pulmonary hypertension. Â© 2011 Springer-Verlag Berlin Heidelberg.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 613016859
TI  - Histological analysis of lung biopsies and airway smooth muscle cell culture
AU  - Fayon M.
Y1  - 2011//
KW  - adult
KW  - airway remodeling
KW  - *airway smooth muscle cell
KW  - angiogenesis
KW  - asthma
KW  - basement membrane
KW  - bronchus hyperreactivity
KW  - calcium homeostasis
KW  - cell nucleus
KW  - cell proliferation
KW  - cell volume
KW  - child
KW  - chronic obstructive lung disease
KW  - clinical article
KW  - clinical outcome
KW  - controlled study
KW  - cystic fibrosis
KW  - disease model
KW  - DNA synthesis
KW  - drug therapy
KW  - early diagnosis
KW  - edema
KW  - effector cell
KW  - endoplasmic reticulum
KW  - family
KW  - fetal calf serum
KW  - fetus
KW  - France
KW  - gene activation
KW  - gene expression regulation
KW  - human
KW  - human cell
KW  - human tissue
KW  - hyperplasia
KW  - immunohistochemistry
KW  - infant
KW  - inflammatory cell
KW  - *lung biopsy
KW  - lung dysplasia
KW  - mast cell
KW  - mediator
KW  - microscopy
KW  - mitochondrial biogenesis
KW  - mucus gland
KW  - muscle contractility
KW  - muscle hypertrophy
KW  - muscle mass
KW  - normal distribution
KW  - normal human
KW  - optical density
KW  - phenotype
KW  - prevention
KW  - quantitative study
KW  - recognition
KW  - respiratory epithelium
KW  - respiratory tract inflammation
KW  - software
KW  - staining
KW  - *stem cell culture
KW  - stroma
KW  - structure activity relation
KW  - thickness
KW  - tissue section
KW  - tissue structure
KW  - transcription regulation
KW  - adenosine triphosphatase (calcium)
KW  - antibody
KW  - calcium
KW  - calmodulin
KW  - chemokine
KW  - collagen
KW  - endogenous compound
KW  - eosin
KW  - hematoxylin
KW  - interleukin 6
KW  - leukemia inhibitory factor
KW  - messenger RNA
KW  - paraffin
KW  - periodic acid
KW  - peroxisome proliferator activated receptor gamma coactivator 1alpha
KW  - phosphotransferase
KW  - platelet derived growth factor AA
KW  - protein
KW  - tumor necrosis factor
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 12
IS  - Supplement 1
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - M. Fayon, Universite de Bordeaux, Centre de recherche Cardio- Thoracique de Bordeaux, INSERM U1045, Place Ame lie Raba Leon, Bordeaux F-33076, France. E-mail: michael.fayon@chu-bordeaux.fr
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=613016859
AB  - Introduction: Airway remodeling is observed in a variety of pediatric conditions such as asthma [1-7], bronchopulmonary dysplasia [7], cystic fibrosis [2,8] and COPD [2,7]. It includes a number of structural changes, such as epithelial detachment, basement membrane (BM) thickening, smooth muscle hypertrophy, and new vessel formation. These changes contribute to thickening of airway walls and, consequently, to irreversible airway narrowing, bronchial hyper-responsiveness, airway edema and mucous hypersecretion. Airway remodeling is associated with poor clinical outcomes among asthmatic patients [9]. Early diagnosis and prevention of airway remodeling has the potential to decrease disease severity, improve control and prevent disease expression [9]. We hereby summarize means currently used for the assessment of airway remodeling, which may further our understanding of the relationship between structural changes and clinical and functional abnormalities. Techniques for the assessment of remodeling in tissue: The usual assessment of remodeling is by histological examination of bronchial tissues. Tissue processing, visualisation and quantification have been well described [10]. Airway remodeling is evaluated after histochemical and immunohistochemical staining. In general, the assessment of tissue structure is performed with haematoxylin and eosin staining on paraffin tissues. Sirius red, van Gieson or Masson- Trichrome stain the total collagen. Periodic-acid shiff staining is used to visualise the mucus glands. Immunohistochemistry allows detection of specific proteins such as ECM proteins. Specific primary antibodies directed against a variety of cytokines are available. After staining, the slides are analyzed under light microscopy [2]. Reticular basement membrane thickness (RBM): Increased bronchial epithelial RBM thickness has been proposed as one of the main features of airway remodeling [1,3-6]. Measurements of RBM thickness in individuals follows a log-normal distribution. For a precision of approximately +/-15%, 31-45 measurements are required in adults. It is recommended that RBM be measured at 20mm intervals over a 1mm reticular basement membrane length [11]. This methodology has been successfully applied in preschool and school-age children [12]. Inflammatory and structural cells counts: It is recommended that a zone beneath the RBM of at least 5 mm of RBM should be included for counts of inflammatory cells [12]. The results are usually expressed as the number of cells per area [2]. Increased airway smooth muscle mass is present in fatal and nonfatal asthma. The study of the cellular mechanism (i.e., hyperplasia vs. hypertrophy) may add useful information regarding the functional consequences of airway smooth muscle remodeling [13]. For measurement of myocyte number and mean volume, cell nuclei are counted to enumerate myocytes under the assumption that these cells have only one nucleus. The volume of ASM may be measured using point and line intersection counts as previously described [8,10]. Epithelial integrity: Epithelial integrity is expressed as a percentage of length of the RBM with intact epithelium on 2 biopsies, if possible [14]. Tissue density quantification: - Surface area. A simple stereologic technique of point counting may be used to determine surface area and structural composition (ie, the percentage of the biopsy specimen composed of epithelium, RBM, subepithelial stroma, smooth muscle, submucosal glands, and other features) [10,15]. A grid with points is superimposed on the tissue section, and the number of points overlying the tissue of interest and other subepithelial tissue (for normalization) is recorded. The results are usually expressed as the area occupied by the tissu of interest on the area of the chosen subepithelial tissu within the same biopsy specimen. As an example, in one study, the areas of the structures of interest were determined at a magnification of x200 with the aid of an eyepiece graticule containing 100 points, and the data were expressed as a percentage of the whole biopsy specimen area. The biopsy specimen area was calculated as follows: area (in square millimeters) = number of points counted x0.0016 [15]. Surface area may also be determined by an automated cell recognition system based on colour analysis. Quancoul# software (Quant'Image, 1997; Bordeaux, France) is a tool which calculates three independent criteria, i.e., optic density (OD), hue density (HD), hue (H) from the three primary colours i.e., red, green and blue [16] for its colour recognition. - RBM-Smooth muscle distance. As airway smooth muscle (ASM) increases in size and ASM cells migrate, the distance between an area stained by ASM bundles and the RBM is reduced. This distance can be determined by at least 10 measurements at 50 mm regular intervals for each section [14]. Overall remodeling scores: Most of the structural changes are not characteristic of one specific airway disease, but are shared by all airway diseases (Table 1 [2]). It may be tempting to adopt an overall semi-quantitative score summarizing the entire remodelling process. However, a specific weight should be atributed to each individual component. (Table Presented) Smooth muscle cell cultures: In asthmatic airways, recent reports indicate that the increased mass of ASM plays a critical role. ASM is the critical effector cell modulating airway tone - its contraction induces airway narrowing. Increased ASM mass is due to a simultaneous increase in size (hypertrophy) and number (hyperplasia) of ASM cells. Primary ASM cells can successfully be isolated from human airways for cell culture [17-19], thereby providing in vitro remodeling models. It has been shown that adult ASM cells are not only structural cells. They also contribute to bronchial inflammation by secreting a range of inflammatory mediators (secretory phenotype), recruiting and activating inflammatory cells, such as mast cells or T-lymphocytes. Such an increase has been related to a deposition of extracellular matrix proteins [20]. Chemokines have the ability to induce human ASM cells migration to the subepithelial area of the asthmatic airways and to increase their contractility in vitro [21]. ASM cell proliferation (proliferative phenotype) in severe asthma implicates a gallopamil-sensitive calcium influx and the activation of calcium-calmodulin kinase IV leading to enhanced mitochondrial biogenesis through the activation of various transcription factors (PGC-1a, NRF-1 and mt-TFA). The altered expression and function of sarco/endoplasmic reticulum Ca(2+) pump could play a role in ASM remodeling in moderate to severe asthma. Additionally, aberrant communication between an injured airway epithelium and ASM could also contribute to disease severity [22,23]. Studies of ASM cells in children remain extremely scarce. We have shown that stimulated non-asthmatic infant ASM cells may contribute to airway remodeling to a greater extent than adult ASM cells [24]. DNA synthesis in 10% fetal calf serum of infant ASMC was significantly enhanced (>5-fold increase vs. ITS control medium) compared to adults (2-fold increase). PDGF-AA induced a response of lesser magnitude: 2.6-fold increase in infants vs. 1.5- fold in adults (p < 0.05). Newer data suggests that a mitochondrial biogenesis related mechanisms may be involved, similar to adult asthmatics. All the above suggests that ASM cells may be prone to non-specific remodeling. Paediatric ASM cells also have the ability to synthetize inflammatory mediators and cytokines. TNFalpha-stimulated immature ASMC produce more LIF (leukemia inhibitory factor (LIF) (an IL-6 family neurotrophic cytokine)) mRNA and protein than adult ASMC [19]. The secretion of LIF by stimulated immature human ASM cells potentially contributes to neuroimmune airway inflammation and subsequent remodeling. Thus, ASM culture may help us to further understand the mechanisms of airway remodeling, the effect of current asthma treatments on airway remodeling, potential pharmacological targets for the treatment of airway remodeling in asthma, the mechanisms of airway remodeling, the effect of current asthma treatments on airway remodeling and the potential pharmacological targets for the treatment of airway remodeling in asthma [25]. Perspective(s): Further studies involving ASMC cultures from asthmatic children are warranted. The interaction between ASM cells and other structural (e.g. epithelial) and inflammatory cells should also be explored.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 613016806
TI  - Intermediate respiratory care units (IRCU) in pediatric tertiary care hospitals
AU  - Braz M.
AU  - Nunes T.
AU  - Saianda A.
AU  - Ferreira R.
AU  - Pereira L.
AU  - Bandeira T.
Y1  - 2011//
KW  - adult
KW  - cerebral palsy
KW  - child
KW  - chronic patient
KW  - clinical trial
KW  - cystic fibrosis
KW  - genetic disorder
KW  - human
KW  - information processing
KW  - *intensive care unit
KW  - lung dysplasia
KW  - major clinical study
KW  - neuromuscular disease
KW  - noninvasive ventilation
KW  - oxygen therapy
KW  - pediatric ward
KW  - *tertiary care center
KW  - tracheostomy
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 12
IS  - Supplement 1
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - M. Braz, Hospital Santa Maria, Lisbon, Portugal
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=613016806
AB  - Introduction: IRCU provide specific care to adult respiratory chronic patients with an intermediate level of disease severity between conventional wards and Intensive Care Units (ICU). IRCU, endowed with appropriate human and technical resources, reduced the burden on ICU, being cost-effectiveness. IRCU are not described in pediatrics, but technological developments and increased survival, determined the referral of a growing number of pediatric patients dependent on respiratory technology. Objective(s): Description and characterization of chronic respiratory patients with technological dependence admitted in a Pediatric Respiratory Unit (PRU) from a tertiary care hospital in order to evaluate the organization and levels of service needed in respiratory units which treat or monitor these patients. Method(s): Retrospective descriptive study of patient's clinical records admitted to the PRU between October 2009 and September 2010 dependent on respiratory technology: invasive ventilation with tracheostomy (VIt), chronic noninvasive ventilation (NIV) and longterm oxygen therapy (LTOT). Result(s): From the 438 admissions (A), 176 (40%) occurred in 93 chronic patients (P): cystic fibrosis (CF) 49(28%)A in 19(20%)P, neuromuscular diseases 31(18%)A in 17(18%)P, cerebral palsy 14(8%)A in 10(11%)P and other neuropathic diseases 32(18%)A in 14(15%)P, genetic syndromes 20(11%)A in 11(12%)P, polymalformative syndromes 6(3%)A in 5(5,5%)P, craniofacial syndromes 3(2%)A in 2(2%)P, bronchopulmonary dysplasia (BPD) 15(9%)A in 9(10%)P and others 6(3%)A in 6(6,5%)P. Sixty-five percent of admissions in chronic respiratory patients required some type of respiratory technological dependence: 71 (40%) ventilation [bilevel NIV 50 (70%), CPAP 12 (17%) and VIt 9 (13%)] and 63 (36%) LTOT. Respiratory technology care was distributed as shown in the table. Discussion and Conclusion(s): This study supports the burden of care needed in a respiratory pediatric unit of a tertiary care hospital. NIV (70%) was the most frequently used type of ventilation in consonance with the criteria defined for IRCU. Distinctly from adults, we included children on LTOT, being one third of the admissions. These are patients mainly with BPD, CF and neurological or syndromatic diseases, who are particularly demanding and unstable in pediatric ages. These results strongly support the creation of IRCU adapted to the particular socio-psycho-behavioral needs of these pediatric patients. (Table Presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 613015907
TI  - Chronic lung disease of prematurity: Long-term respiratory outcome
AU  - Baraldi E.
Y1  - 2011//
KW  - adolescence
KW  - adult
KW  - adulthood
KW  - adverse drug reaction
KW  - aging
KW  - assisted ventilation
KW  - asthma
KW  - birth weight
KW  - case report
KW  - child
KW  - chronic cough
KW  - chronic obstructive lung disease
KW  - developmental disorder
KW  - diagnosis
KW  - exposure
KW  - follow up
KW  - forced expiratory volume
KW  - general practitioner
KW  - gestational age
KW  - human
KW  - longitudinal study
KW  - *lung dysplasia
KW  - lung function
KW  - lung injury
KW  - middle aged
KW  - newborn
KW  - phenotype
KW  - prematurity
KW  - respiratory tract inflammation
KW  - side effect
KW  - survivor
KW  - thorax
KW  - wheezing
KW  - oxygen
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 12
IS  - Supplement 1
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - E. Baraldi, Department of Pediatrics, University of Padova, Italy
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=613015907
AB  - Bronchopulmonary dysplasia (BPD) is a chronic respiratory disease that develops as a consequence of perinatal/neonatal lung injury, and it is one of the most important sequelae of premature birth. The diagnosis of BPD is currently based on the need for supplemental oxygen for at least 28 days after birth, and its severity is graded according to the respiratory support required at 36 postmenstrual weeks. BPD almost always occurs in neonates who are delivered at a gestational age of less than 30 weeks and who have a birth weight of less than 1500 g. These are about 1.5% of all newborns and BPD develops in about 20% of them. Today BPD is mainly a developmental disorder in which the immature lung fails to reach its full structural complexity. Longitudinal studies on children with BPD identified, at all ages, increased rates of chronic coughing and wheezing, a greater need to use inhaled asthma medications and a significant airflow obstruction. Children who have survived BPD and children with asthma share some clinical and functional characteristics, but available evidence suggests that the two obstructive lung diseases do not have the same underlying airway inflammation. Spirometric values reflecting airflow, such as FEV1, are consistently lower in survivors of BPD into adolescence and young adulthood than in controls born at term rising the concern that the chronic lung disease after premature birth may predispose to the development of a chronic obstructive pulmonary disease (COPD)-like phenotype with aging. This is an open question that only follow-up and lung function studies extended to middle-age and beyond will answer. Unfortunately, no pathologic data are available elucidating which structural and pathophysiological alterations underlie the clinical and functional pulmonary abnormalities seen at long-term in some subjects delivered prematurely. A relevant question is whether the long-term pulmonary consequences of prematurity and BPD essentially depend on a non-progressive reduction of the airway caliber, due to a stabilized, non-progressive structural damage of the airways, or instead also reflect an active airway disease. Chronic lung disease of prematurity can no longer be considered only a pediatric disease and also family doctors and chest physicians should be aware of this "new" Chronic Obstructive Pulmonary Disease.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 613016270
TI  - Role of human coronavirus in Brazilian hospitalized children with respiratory lower infection
AU  - Costa P.F.B.M.
AU  - Lima C.H.A.
AU  - Telles J.-N.
AU  - Vernet G.
AU  - Baccala G.P.
AU  - Siqueira M.A.M.T.
Y1  - 2011//
KW  - adult
KW  - adult respiratory distress syndrome
KW  - artificial ventilation
KW  - Brazil
KW  - bronchiolitis
KW  - child
KW  - clinical examination
KW  - controlled study
KW  - diagnosis
KW  - emergency ward
KW  - exposure
KW  - extraction
KW  - France
KW  - hospitalization
KW  - *hospitalized child
KW  - human
KW  - *Human coronavirus NL63
KW  - Human respiratory syncytial virus
KW  - human tissue
KW  - hypoxemia
KW  - infant
KW  - institutional review
KW  - intensive care unit
KW  - lung dysplasia
KW  - lysis
KW  - major clinical study
KW  - nasopharyngeal aspiration
KW  - *nonhuman
KW  - physical examination
KW  - pneumonia
KW  - prematurity
KW  - preschool child
KW  - prevalence
KW  - public health
KW  - respiratory failure
KW  - *respiratory tract infection
KW  - reverse transcription polymerase chain reaction
KW  - symptom
KW  - wheezing
KW  - buffer
KW  - corticosteroid
KW  - nucleic acid
KW  - oxygen
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 12
IS  - Supplement 1
PB  - W.B. Saunders Ltd
SN  - 1526-0550
AD  - P.F.B.M. Costa, Hospital Federal de Bonsucesso, Pedatric Pulmonology, Rio de Janeiro, Brazil
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=613016270
AB  - Acute lower respiratory infections (ALRI) are a major cause of morbidity and mortality worldwide, particularly in children under 5 year of age. These respiratory infections are mainly caused by bacteria and viruses. With the expansion of molecular diagnostics assays, human bocavirus (HBoV),human metapneumovirus (hMPV), Rhinovirus, human coronaviruses, and others viruses were discovered and easily detected in respiratory specimens compared with conventional methods such as viruses culture. Bronchiolitis(BVA) and Pneumonia(PNM) are frequent and constitute an important cause of hospitalization in Brazil and others countries in Latin America. An understanding of the Brazil epidemiology is crucial for identifying target groups and appropriate timing of public health preventive measures such as therapies. In this study, we aimed to investigate epidemiological of a Human coronavirus associated to a well defined clinical patients with lower respiratory infection. Materials, Patients and Methods: Patients: This is a substudy of an ongoing prospective brazilian investigation of respiratory tract infections in children and adults in the city of Rio de Janeiro, Brazil. This study was approved by all participating institutional review boards. Samples: The specimens were collected from infants within the first 48 hours after admission and up to five days of clinical manifestation before admission. All the patients included were submitted to a clinical examination, case history and nasopharyngeal aspirate (NPA). Respiratory Virus Nucleic Acids detection: Nasopharyngeal aspirates were submitted to nucleic acid extraction using the NucliSENS EasyMAG platform (bioMe rieux, France), in combination with the NucliSENS magnetic extraction reagents (bioMe rieux, France) and NucliSENS lysis buffer (bioMe rieux, France). Result(s): A total of 217 children with well documented diagnosis of pneumonia (n = 53/217, 24.4%), bronchiolitis (n = 160/217, 73.3%) or ARDS (n = 4/217, 1.8%) admitted in the emergency room (n = 174, 80.2%) or ICU (n = 43, 19.8%). Only one agent was detected in 49% and more than one was detected in 31%. The negative samples represented 13, 8% of all NPA submitted. The most common virus detected were RSV. The Human Coronavirus was detected in 15/217 samples (7%). Of these, five were presented alone and in 10/15 codetection with other agents. Five children had diagnosis of BVA and two of these required admission to the intensive care unit. The median age was 31 months, ranging from 1 month to 144 months. The BVA cases occurred in children under 1 year. The average days of symptoms before admission was 4 days, all cases had wheezing on physical examination and respiratory insufficiency occurred in 3 children (all with BVA). Respiratory symptoms, hypoxemia and need for mechanical ventilation was not different in group Coronavirus positive in relation to other agents found. All 15 cases had used inhaled oxygen, systemic corticosteroids in six and in 2 cases needed mechanical ventilation. Prematurity was present in 3 cases and 2 children had bronchopulmonary dysplasia. Discussion(s): In this study, we applied multiplex RT-PCR of nasopharyngeal aspirate samples for prospective evaluation of respiratory viruses associated with hospitalized with ALRI. HCoVNL63 was usually identified in younger children, primarily those less than 2 years of age, which could reflect greater susceptibility because of immunologic immaturity of young children.We analyzed the clinical characteristics of those with HCoV-NL63 infection with and without co-detection by another virus and there were no differences. Conclusion(s): Despite these limitations, this study compared prevalence, epidemiology, and clinical manifestations of Human coronavirus in ALRI. There are few reports with this results.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72120979
TI  - The role of the accessory type III transforming growth factor-beta receptors in the regulation of pulmonary vascular development
AU  - Niess G.
AU  - Michiels-Corsten M.
AU  - Seeger W.
AU  - Morty R.
Y1  - 2011//
KW  - *European
KW  - *society
KW  - apoptosis
KW  - human
KW  - lung
KW  - cell function
KW  - lung blood vessel
KW  - pulmonary artery smooth muscle cell
KW  - mouse
KW  - patient
KW  - lung hypoplasia
KW  - in vitro study
KW  - growth, development and aging
KW  - vascular smooth muscle cell
KW  - hyperoxia
KW  - laser capture microdissection
KW  - lung dysplasia
KW  - lung injury
KW  - electronystagmography
KW  - *transforming growth factor
KW  - *receptor
KW  - small interfering RNA
KW  - endoglin
KW  - broxuridine
KW  - protein
KW  - messenger RNA
KW  - transforming growth factor beta receptor 3
T2  - European Respiratory Journal
LA  - English
VL  - 38
IS  - SUPPL. 55
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - G. Niess
UR  - http://erj.ersjournals.com/content/38/Suppl_55/p3346
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=72120979
AB  - Pulmonary artery smooth muscle cell behaviour, including proliferation, apoptosis, and matrix production, is controlled by transforming growth factor (TGF)-beta, acting via two type I (Acvrl1 and Tgbfr1) and two type III [endoglin (Eng) and betaglycan (Tgfbr3)] TGF-beta receptors. Knockdown of TGFBR3 by siRNA in primary human pulmonary artery smooth muscle cells (PASMC) increased PASMC proliferation (3fold; assessed by BrdU incorporation) in vitro, in a TGF-beta-independent manner. However, apoptosis rates of the PASMC were not affected by siRNA knockdown of TGFBR3. The siRNA knockdown of other TGF-beta receptors, ACVRL1, TGFBR1, TGFBR2 and ENG, did not impact TGF-beta-independent proliferation or apoptosis of PASMC. These data point to a novel, TGF-beta-independent role for TGFBR3 in regulating PASMC growth. This idea assumes importance considering that we have also observed perturbed expression of TGFBR3 in the lungs of neonatal mice with hyperoxia (85% O2)-induced lung injury, which results in bronchopulmonary dysplasia (BPD). The mRNA levels (assessed by quantitative real-time RTPCR) for tgfbr3 were downregulated (4.4-fold, p=0.003), while TGFBR3 protein levels were downregulated by 70%. Laser capture microdissection confirmed dysregulated expression of TGFBR3 in the pulmonary vasculature of the developing mouse lung. Taken together, these data suggest a role for TGFBR3 in vascular smooth muscle cell function which could lead to a dysregulation of TGF-beta signalling in the pulmonary vasculature, which in turn could contribute to the impaired pulmonary vascular growth and development associated with the lung hypoplasia observed in patients with BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72117304
TI  - Home mechanical ventilation in chronic respiratory diseases: An experience from a pediatric semiintensive respiratory care unit
AU  - Rossi F.P.
AU  - Pavone M.
AU  - Verrillo E.
AU  - Schiavino A.
AU  - Testa M.B.C.
AU  - Paglietti M.G.
AU  - Soldini S.
AU  - Cutrera R.
Y1  - 2011//
KW  - *artificial ventilation
KW  - *chronic respiratory tract disease
KW  - *intensive care unit
KW  - *European
KW  - *society
KW  - human
KW  - patient
KW  - child
KW  - follow up
KW  - spinal muscular atrophy
KW  - diseases
KW  - brain disease
KW  - noninvasive ventilation
KW  - cerebral palsy
KW  - home care
KW  - diagnosis
KW  - myopathy
KW  - lung dysplasia
KW  - sleep disordered breathing
KW  - girl
KW  - cystic fibrosis
KW  - congenital central hypoventilation syndrome
KW  - Prader Willi syndrome
KW  - brain tumor
KW  - female
KW  - congenital heart disease
KW  - genetic disorder
KW  - muscular dystrophy
KW  - respiratory tract disease
KW  - nursing
KW  - childhood
T2  - European Respiratory Journal
LA  - English
VL  - 38
IS  - SUPPL. 55
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - F.P. Rossi
UR  - http://erj.ersjournals.com/content/38/Suppl_55/p2095
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=72117304
AB  - Mechanical, invasive and non invasive ventilation represents an important therapeutic tool for many acute and chronic respiratory diseases in childhood. We retrospectively analyzed clinical history of children receiving home mechanical ventilation (HMV) in our Pediatric Semi-Intensive Respiratory Care Unit from 2003 to 2010. From 2003 to 2010 we treated with HMV 153 children (M/F 80/73 girls, mean age 10.5years). Most of the patients (138) were treated with non-invasive ventilation (C-PAP or BiPAP). In this group, the most frequent diagnosis were Spinal Muscular Atrophy, followed by Prader Willi syndrome, obstructive sleep apnoea, myopathies, Cystic Fibrosis, encephalopathy, cerebral palsy, muscular dystrophy, metabolic or genetic diseases and others diseases such as congenital heart disease, brain tumors and othorinolaryngohiatric diseases. Fifteen patients were treated with invasive HMV through trachestomy. In this group the most frequent diagnoses were Cerebral Palsy, followed by Spinal Muscular Atrophy, Encephalopathies and others chronic respiratory disorders (Congenital central hypoventilation syndrome, bronchopulmonary dysplasia, etc). Sixtyone percent of the patients are still in follow-up in our Unit, 17% stopped mechanical ventilation, 14% were lost to follow-up, while 8% is died. Of the 95 patients followed at our unit, only 53 (56%) has an adequate home care. Home mechanical ventilation, invasive or non-invasive, is a valid tool for the management of children with chronic respiratory diseases. In our experience home care of these patients must be improved in terms of family support (nursing, technical support, psychological support).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72116646
TI  - Evolution of lung function in preterm infants with or without bronchopulmonary dysplasia
AU  - Sanchez-Solis M.
AU  - Garcia-Marcos L.
AU  - Perez V.
AU  - Pastor M.D.
AU  - Mondejar P.
Y1  - 2011//
KW  - *prematurity
KW  - *infant
KW  - *human
KW  - *lung dysplasia
KW  - *European
KW  - *society
KW  - *lung function
KW  - male
KW  - female
KW  - forced expiratory flow
KW  - girl
KW  - boy
KW  - body mass
KW  - forced vital capacity
KW  - gestational age
KW  - moth
KW  - compression
T2  - European Respiratory Journal
LA  - English
VL  - 38
IS  - SUPPL. 55
SP  -
PB  - European Respiratory Society
SN  - 0903-1936
AD  - M. Sanchez-Solis
UR  - http://erj.ersjournals.com/content/38/Suppl_55/p1112
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=72116646
AB  - Introduction: Healthy preterm infants do no catch-up lung function (LF) during the first two years of life. The aim of study is to compare the evolution of LF in infants born preterm, with and without BPD. Method(s): Forced vital capacity (FVC), forced expiratory flows at 50%, 75%, 25-75% of FVC (FEF50 , FEF75 , FEF25-75 ) and forced expiratory flow at 0.5 sec (FEV0.5 ), was obtained by raised volume rapid torachoabdominal compression technique (RVRTC) in 14 (7 males) BDP+ and in 12 (6 males) infants born preterm BPD-. Measurements were repeated at 6 and 12 moths after baseline. A generalized estimating ecuations (GEE) adjusted for gestational age, length, corrected age and body mass index z-score (according OMS tables) was built for boys and girls separately. Result(s): Conclusion(s): FVC, FEF25-75 and FEV0.5 decrease among male infants with BPD as compared to those without BPD; however in female infants they tend to be similar, and FEF50 , FEF25-75 and FEV0.5/FVC even improve.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71827564
TI  - Poster: TGF-beta signaling reduces FGF-10 in hypoxic newborn mouse lung during the critical period of lung development
AU  - Nicola T.
AU  - Zhang W.
AU  - Bulger A.
AU  - Ambalavanan N.
Y1  - 2011//
KW  - *mouse
KW  - *lung
KW  - *lung development
KW  - *society
KW  - *developmental biology
KW  - hypoxia
KW  - newborn
KW  - in vitro study
KW  - phenotype
KW  - human
KW  - capillary endothelial cell
KW  - air quality control
KW  - imaging software
KW  - infant
KW  - prematurity
KW  - lung fibroblast
KW  - lung dysplasia
KW  - mutation
KW  - wild type mouse
KW  - DNA responsive element
KW  - staining
KW  - promoter region
KW  - *transforming growth factor beta
KW  - *fibroblast growth factor 10
KW  - messenger RNA
KW  - neutralizing antibody
KW  - protein
KW  - receptor
T2  - Developmental Biology
LA  - English
VL  - 356
IS  - 1
PB  - Academic Press Inc.
SN  - 0012-1606
AD  - T. Nicola, UAB Pediatrics Neonatology, Birmingham, AL, United States
DO  - https://dx.doi.org/10.1016/j.ydbio.2011.05.370
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=71827564
AB  - Introduction: We have recently shown that excessive transforming grow factor (TGF-beta) signaling mediates hypoxia-induces inhibition of alveolar development and abnormal pulmonary arterial remodeling in the newborn lung, producing a phenotype that mimics bronchopulmonary dysplasia (BPD) in preterm infants. The mechanisms by which excessive TGF-beta signaling inhibits alveolar septation are not known. Fibroblast growth factor (FGF)-10 is a critical modulator of early lung development and in the saccular stage but its role in alveolar septation has not been defined. It has been shown that the FGF-10 promoter contains a TGF-beta response element. Objective(s): We hypothesized that excessive TGF-beta signaling in the newborn hypoxiainduced mouse lung inhibits alveolar septation via reduction of FGF- 10. Method(s): In vivo: Wilde type C57BL/6 were exposed to air or hypoxia (12% O2) from birth to two weeks (the critical period of lung development) and evaluated for FGF-10 and TGF-beta mRNA and protein. Inhibition of TGF-beta signaling was achieved by administration of TGF-beta neutralizing antibody (ID11) to WT mice or 20 ug/g ZnSO4 given intraperitoneally daily to DNIIR pups (an inducible dominantnegative mutation of the TGF-beta type II receptor) and exposed to hypoxia or air from birth to 14 days of age. In vitro: Newborn Lung Fibroblasts and Pulmonary Microvascular Endothelial Cells (PMVEC) were exposed to air or hypoxia for 24 h. FGF-10 mRNA and protein were evaluated in cell lysates. Result(s): Hypoxia reduces FGF-10 mRNA in both in vivo (Fig. 1) and in vitro studies (Fig. 3). Pups receiving the TGF-beta neutralizing antibody (ID11) had increased FGF-10 and better lung development (Fig. 1). FGF-10 staining was not significantly decreased in DNIIR hypoxic mice compared to air control (Fig. 2). Conclusion(s): These results suggest that hypoxia-induced increased TGF-beta signaling may reduce FGF-10, which may contribute to impairment of lung development. Future experiments: Additional studies are in progress to inhibit FGF-10 signaling in vivo, to determine if FGF-10 is necessary for alveolar septation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71124585
TI  - Oxidative stress and BPD
AU  - Saugstad O.D.
Y1  - 2011//
KW  - *oxidative stress
KW  - *perinatal care
KW  - human
KW  - pathogenesis
KW  - inflammation
KW  - newborn
KW  - oxygen toxicity
KW  - gene
KW  - hemolysis
KW  - diseases
KW  - newborn disease
KW  - adult
KW  - lung dysplasia
KW  - coworker
KW  - enzyme activity
KW  - prematurity
KW  - physiology
KW  - newborn period
KW  - retrolental fibroplasia
KW  - erythrocyte membrane
KW  - brain hemorrhage
KW  - artificial ventilation
KW  - leukomalacia
KW  - patent ductus arteriosus
KW  - perinatal period
KW  - necrotizing enterocolitis
KW  - lung
KW  - infant
KW  - respiratory burst
KW  - leukocyte
KW  - apoptosis
KW  - signal transduction
KW  - second messenger
KW  - gene expression
KW  - exposure
KW  - child
KW  - developmental stage
KW  - fibrosis
KW  - atelectasis
KW  - positive end expiratory pressure
KW  - oxygen radical
KW  - free radical
KW  - antioxidant
KW  - oxygen
KW  - hydrogen peroxide
KW  - alpha tocopherol
KW  - transcription factor
KW  - antiinfective agent
KW  - reactive oxygen metabolite
KW  - protein
KW  - steroid
KW  - surfactant
T2  - Journal of Perinatal Medicine
LA  - English
VL  - 39
IS  - SUPPL. 1
SP  -
PB  - Walter de Gruyter GmbH and Co. KG
SN  - 0300-5577
AD  - O.D. Saugstad, Norway
DO  - https://dx.doi.org/10.1515/jpm-2012-1009
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=71124585
AB  - The association between retinopathy of prematurity (ROP) and oxygen has been known since the 1950s. Immediately after the first description of bronchopulmonary dysplasia by Norwood et al in 1967 these authors linked the condition to oxygen toxicity. A decade earlier Rebecca Gerschman and her colleagues had introduced the free radical theory explaining oxygen toxicity and at the end of the 1960s oxidative stress per se was linked to neonatal disease, primarily hemolysis. The newborn erythrocyte membrane was shown to be less resistant to H2O2 than the adult one. Vitamin E was tested against a number of neonatal conditions, however, without good results. Around 1980 we started to speculate that oxidative stress and oxygen radicals may trigger a number of diseases in the newborn period. Free radical production theoretically could explain the pathogenesis of a wide variety of conditions in medicine. During the 1980s I coined the term "oxygen radical disease of the newborn" which implicated that ROP, BPD and some other conditions as necrotizing enterocolitis, and intraventricular hemorrhage, have a common pathogenesis via free radicals but different manifestations due to which organ is mostly affected. Since then a large body of studies and literature has accumulated and it has been shown that oxidative stress is associated with these conditions as well as others such as periventricular leucomalacia and patent ductus arteriosus. A new momentum in the understanding of oxidative stress in the perinatal period was added when Frank and his coworkers from the midst of the 1980's showed that antioxidant enzyme activity in the lungs are low in fetal life indicating a lowered antioxidant defense in premature infants. 25 years ago it was also understood oxygen radicals affect the circulation in several organs, as well as the perinatal circulation, and therefore exerts physiological functions. It has been known since 1973 that oxygen radicals are important in antibacterial defense through oxidative burst of leukocytes. A further insight was gained when oxidative stress and inflammation were linked and it was understood that these two phenomena could be two sides of the same coin. The last years it has been better understood that oxidative stress may activate transcription factors which may transcribe genes that are related to inflammation, apoptosis, as well as oxidative stress. It is by now also clear that oxidative stress and reactive oxygen species (ROS) regulate signal transduction pathways, are implicated as second messengers activating protein cascades, and also control gene expression. Which genes are regulated by oxidative stress for instance in BPD has been studied and more such data will come. Clinically several studies indicate that BPD is reduced if SaO2 is controlled and kept relatively low. However antioxidants seem not to prevent BPD development. Some authors report a reduction in BPD. A less use of mechanical ventilation with more CPAP together with a more aggressive nutritional regime, and lowered oxygen exposure may all have contributed to such a reduction. It is clear that BPD changed character after introduction of antenatal steroids and postnatal exogenous surfactant. In addition, more immature children with a more primitive pulmonary developmental stage survived. These factors contribute to a change away from the "old" BPD characterized by fibrosis and atelectasis to the "new" BPD where arrest of alveolar growth is more prominent.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Alterations in gene expression and DNA methylation during murine and human lung alveolar septation.
DO  - https://dx.doi.org/10.1165/rcmb.2014-0160OC
AU  - Cuna, Alain
AU  - Halloran, Brian
AU  - Faye-Petersen, Ona
AU  - Kelly, David
AU  - Crossman, David K
AU  - Cui, Xiangqin
AU  - Pandit, Kusum
AU  - Kaminski, Naftali
AU  - Bhattacharya, Soumyaroop
AU  - Ahmad, Ausaf
AU  - Mariani, Thomas J
AU  - Ambalavanan, Namasivayam
Y1  - 2015//
KW  - Adult
KW  - Animals
KW  - *Bronchopulmonary Dysplasia/em [Embryology]
KW  - *Bronchopulmonary Dysplasia/me [Metabolism]
KW  - Bronchopulmonary Dysplasia/pa [Pathology]
KW  - *DNA Methylation
KW  - Epigenesis, Genetic
KW  - Female
KW  - *Gene Expression Regulation, Developmental
KW  - Humans
KW  - Male
KW  - Mice
KW  - *Pulmonary Alveoli/em [Embryology]
KW  - *Pulmonary Alveoli/me [Metabolism]
KW  - Pulmonary Alveoli/pa [Pathology]
T2  - American journal of respiratory cell and molecular biology
VL  - 53
IS  - 1
SN  - 1044-1549
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25387348
AD  - United States
AB  - DNA methylation, a major epigenetic mechanism, may regulate coordinated expression of multiple genes at specific time points during alveolar septation in lung development. The objective of this study was to identify genes regulated by methylation during normal septation in mice and during disordered septation in bronchopulmonary dysplasia. In mice, newborn lungs (preseptation) and adult lungs (postseptation) were evaluated by microarray analysis of gene expression and immunoprecipitation of methylated DNA followed by sequencing (MeDIP-Seq). In humans, microarray gene expression data were integrated with genome-wide DNA methylation data from bronchopulmonary dysplasia versus preterm and term lung. Genes with reciprocal changes in expression and methylation, suggesting regulation by DNA methylation, were identified. In mice, 95 genes with inverse correlation between expression and methylation during normal septation were identified. In addition to genes known to be important in lung development (Wnt signaling, Angpt2, Sox9, etc.) and its extracellular matrix (Tnc, Eln, etc.), genes involved with immune and antioxidant defense (Stat4, Sod3, Prdx6, etc.) were also observed. In humans, 23 genes were differentially methylated with reciprocal changes in expression in bronchopulmonary dysplasia compared with preterm or term lung. Genes of interest included those involved with detoxifying enzymes (Gstm3) and transforming growth factor-beta signaling (bone morphogenetic protein 7 [Bmp7]). In terms of overlap, 20 genes and three pathways methylated during mouse lung development also demonstrated changes in methylation between preterm and term human lung. Changes in methylation correspond to altered expression of a number of genes associated with lung development, suggesting that DNA methylation of these genes may regulate normal and abnormal alveolar septation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71124568
TI  - New modalities of respiratory support in the preterm infant
AU  - Bancalari E.
Y1  - 2011//
KW  - *infant
KW  - *human
KW  - *prematurity
KW  - *perinatal care
KW  - *assisted ventilation
KW  - ventilator
KW  - patient
KW  - tidal volume
KW  - airway pressure
KW  - air conditioning
KW  - artificial ventilation
KW  - breathing rate
KW  - weaning
KW  - breathing
KW  - pressure support ventilation
KW  - gas
KW  - respiratory system
KW  - apnea
KW  - risk
KW  - endotracheal tube
KW  - hyperventilation
KW  - lung dysplasia
KW  - hypercapnia
KW  - lower respiratory tract
KW  - newborn
KW  - breathing pattern
KW  - sensor
KW  - oxygen therapy
KW  - runaway behavior
KW  - positive end expiratory pressure
KW  - cardiovascular effect
KW  - injury
KW  - intubation
KW  - extubation
KW  - nose breathing
KW  - therapy
KW  - respiratory distress syndrome
KW  - oxygen
KW  - water
T2  - Journal of Perinatal Medicine
LA  - English
VL  - 39
IS  - SUPPL. 1
SP  -
PB  - Walter de Gruyter GmbH and Co. KG
SN  - 0300-5577
AD  - E. Bancalari, United States
DO  - https://dx.doi.org/10.1515/jpm-2012-1009
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=71124568
AB  - Several new modalities of mechanical ventilation have been introduced in recent years in an attempt to reduce complications associated with this therapy such as acute volutrauma and bronchopulmonary dysplasia. PATIENT TRIGGERED VENTILATION (PTV) The aim of PTV is that each mechanical breath be triggered by the infant's own inspiratory effort achieving synchronization between the patient and the ventilator. Different signals have been used for triggering the ventilator but currently the most common sensors are those detecting flow. During PTV the infant determines his/her own respiratory rate and tidal volumes are generated with lower airway pressures than during non-synchronized ventilation. By eliminating asynchrony between patient and ventilator, PTV may reduce the risk of mechanical trauma and minimize the cardiovascular effects of positive pressure ventilation. PTV facilitates weaning and can shorten the duration of oxygen therapy and IPPV in preterm infants. Types of Patient Triggered Ventilation Synchronized IMV (S-IMV): During S-IMV the patient can trigger a preset number of mechanical breaths each minute and maintains spontaneous breathing during the intervals. The ventilator provides a back up rate if apnea occurs. The airway pressure and duration of inspiration are determined by the operator. Assist - Control (AC): During AC each inspiratory effort triggers the ventilator and is mechanically supported. The ventilator also provides a preset back up rate when apnea occurs. The airway pressure is determined by the operator while the inspiratory time can be set by the operator or in some ventilators it can be terminated when inspiratory flow falls to a predetermined level. Pressure Support Ventilation (PSV): This mode is similar to assist-control and the ventilator is triggered by each inspiratory effort but the inspiration is terminated when the flow delivered to the infant decreases to a predetermined level. This strategy can be used to unload the respiratory system with minimal interference with the spontaneous timing of the respiratory cycle. This method has been shown to facilitate weaning and reduce the duration of mechanical ventilation in preterm neonates. Possible drawbacks of PTV The high mechanical respiratory rate generated during assist control or pressure support ventilation can result in gas trapping and higher mean airway pressure increasing the risk for baro or volutrauma. Irregular respiratory rate from the infant can result in larger fluctuations in PaO2 and PaCO2. The pneumotachographs used to trigger the ventilator add dead space and this may produce CO2 retention in the smaller infants. Low sensitivity may result in lack or delayed triggering while excessive sensitivity may cause autotriggering resulting in runaway mechanical rate, hyperventilation, and gas trapping. This occurs when there are large leaks around the endotracheal tube or there is water condensation in the ventilator circuit. OTHER MODALITIES: Volume Targeted Ventilation (VTV): Newer ventilators measure the volume delivered to the patient as well as the expired tidal volume and continuously adjust the peak inspiratory pressure to maintain a preset expired tidal volume constant. This mode allows a significant reduction in PIP when the infant is able to generate a preset tidal volume by his own. On the other hand, it increases airway pressure to maintain a constant tidal volume when the infant does not make enough effort or when the mechanical characteristics of the respiratory system change. Nasal Ventilation: Noninvasive SIMV (N-SIMV) has been used as means of improving weaning success and avoiding mechanical ventilation. Randomized trials have shown lower extubation failure and better respiratory evolution with N-SIMV in comparison to NCPAP alone. Some studies comparing initial use of non-invasive IMV with NCPAP in infants with RDS showed a lower intubation rate and reduced oxygen dependency with noninvasive IMV.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70850997
TI  - Clinical impact of infant lung function tests
AU  - Peterson-Carmichael S.L.
AU  - Rosenfeld M.
AU  - Ascher S.B.
AU  - Arets H.
AU  - Davis S.D.
AU  - Hall G.
Y1  - 2011//
KW  - *lung function test
KW  - *society
KW  - *infant
KW  - human
KW  - population
KW  - laboratory
KW  - sedation
KW  - questionnaire
KW  - patient
KW  - clinical study
KW  - lung function
KW  - wheezing
KW  - lung dysplasia
KW  - administrative personnel
KW  - cystic fibrosis
KW  - reference value
KW  - devices
KW  - language
KW  - interstitial lung disease
KW  - lung
KW  - clinical practice
KW  - United States
KW  - procedures
KW  - therapy
KW  - geography
KW  - Europe
KW  - growth, development and aging
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S.L. Peterson-Carmichael, Duke University Medical Center, Durham, NC, United States
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A6309?sid=9396f866-fea8-488d-8226-9501e79ae056
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70850997
AB  - Rationale: Data are limited on the clinical utility of Infant Lung Function (ILF) tests and the frequency of testing at sites across the world. We lack standardized reference data from a large normative population making applicability of research and clinical data difficult. Our objective was to evaluate the actual use of ILF testing worldwide and to query users regarding the indications, limitations and perceived clinical benefit of testing. Method(s): We created an English language 27-item questionnaire linked to the American Thoracic Society (ATS) and European Respiratory Society (ERS) websites to be completed by medical directors of ILF laboratories. The questionnaire collected demographic information, ILF testing indications, patient populations, equipment, reference data and perceived limitations. We contacted pediatric respirologists worldwide to complete the survey using distribution lists from the ATS/ERS Infant Preschool Lung Function Working Group and the ATS Pediatric Assembly. Result(s): 148 respondents completed the survey representing 117 individual institutions. Most respondents were from Europe and the United States (76%). 118 (80%) had the capability to perform ILF testing, which was performed for research only in 20%, clinical studies only in 23%, and both in 57% of labs. Sites performing research studies only did not respond to questions regarding clinical ILF testing. Most centers use commercially available ILF devices (67%) with 18 different reference data sets. The most common patient populations to undergo ILF testing were: cystic fibrosis, bronchopulmonary dysplasia, recurrent wheezing, and interstitial lung disease. The majority of labs (45%) reported performing 10-50 clinical studies/year. Starting a new therapy was the most common clinical intervention based on ILF results. There were many factors limiting referral for clinical ILF testing including: need for sedation, uncertainty regarding clinical impact of study results, time intensive nature of the procedure and lack of formal guidelines for interpreting the data. Conclusion(s): Clinical practice and laboratory standards vary significantly regardless of geographic location or equipment. Though most centers stated that there is clinical benefit in acquiring ILF data, sedation, effort and lack of formal guidelines limit the number of studies performed. Prospective collection of all internationally available ILF data in healthy infants would significantly advance our understanding of lung growth and development in early life and facilitate the generation of technique specific reference values.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70849326
TI  - Notch signaling in cord blood derived Endothelial Progenitor Cells (EPC)
AU  - Balasubramaniam V.
AU  - Ryan S.L.
AU  - Nuanez B.
AU  - Baker C.D.
AU  - Abman S.H.
Y1  - 2011//
KW  - *umbilical cord blood
KW  - *endothelial progenitor cell
KW  - *society
KW  - hyperoxia
KW  - prematurity
KW  - exposure
KW  - lung dysplasia
KW  - flow cytometry
KW  - tissue repair
KW  - lung
KW  - phenotype
KW  - endothelium cell
KW  - chronic lung disease
KW  - population
KW  - ambient air
KW  - cell growth
KW  - Western blotting
KW  - injury
KW  - drug megadose
KW  - messenger RNA
KW  - protein
KW  - marker
KW  - oxygen
KW  - gamma secretase inhibitor
KW  - Jagged1
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - V. Balasubramaniam, University of Colorado Denver, Aurora, CO, United States. E-mail: Vivek.Balasubramaniam@UCDenver.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A5019?sid=de36803f-01dc-4fe8-b1d9-312506d196ad
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70849326
AB  - Rationale: Bronchopulmonary dysplasia (BPD), the chronic lung disease after premature birth, is characterized by decreased lung vascular growth. EPCs play a role in tissue repair after injury and can be cultured from peripheral umbilical cord blood. Late outgrowth EPCs (ECFCs) are a heterogeneous population capable of self-renewal and exhibit an endothelial cell phenotype. We have shown that ECFCs from preterm infants exposed to hyperoxia have impaired growth. ECFC organization suggests involvement of intercellular signaling or lateral fate inhibition that is mediated by the Notch pathway. We hypothesize that Notch signaling is necessary in EPC growth and function. Method(s): ECFCs were isolated from the umbilical cord blood of term and preterm infants. Cells were characterized for endothelial markers by flow cytometry. Term and preterm ECFCs were plated at 50 % confluence and growth was assessed over 7 days in room air and 50% oxygen. Cell lysates were collected for protein and mRNA. Western blot analysis was performed for Notch1 & 2, Jag1 and Dll4. qPCR was performed on mRNA. Cell growth was measured in the presence and absence of gamma-secretase inhibitor (DAPT; 0.5 uM & 0.75 uM) to block Notch signaling. Result(s): Preterm ECFCs growth increased by 25% as compared to term ECFCs (p<0.01). Hyperoxia decreased preterm ECFCs number by 40% and had no effect on term ECFCs (p<0.05). Notch1, Jag1 and Dll4 protein was increased by 50%, 65% and 70%, respectively (p<0.01) in preterm ECFCs compared to term. Notch 2 was increased by 55% in term ECFCs as compared to preterm (p<0.01). Hyperoxia exposure decreased Notch1, Jag1 & Dll4 protein in preterm ECFCs. Hyperoxia increased Notch1 and Jag1 protein in term ECFCs. There was a 2.5-fold increase in Hes1 expression in preterm vs. term ECFCs. (p<0.01) Hyperoxia decreased Hes1 and Hey1 mRNA by 2.8 and 3.4-fold (p<0.01). In a dose dependent manner, high dose DAPT treatment decreased term ECFC growth by 76% and preterm ECFC growth by 50% (p<0.01) Conclusion(s): Notch signaling is increased in preterm ECFCs as compared to term ECFCs. Hyperoxia exposure decreases Notch signaling in preterm ECFCs, but increases Notch in term ECFCs. Inhibition of Notch signaling impaired growth of both term and preterm ECFCs. We conclude that Notch signaling is important in ECFC growth and that impaired Notch signaling may be involved in the impaired growth of preterm ECFCs with exposure to hyperoxia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70848511
TI  - Transcriptional profiling of bronchopulmonary dysplasia (BPD) tissue reveals changes in the IGF1 pathway and mast cell accumulation are associated with disease pathogenesis
AU  - Bhattacharya S.
AU  - Srisuma S.
AU  - Solleti S.K.
AU  - Krenitsky D.
AU  - Huyck H.L.
AU  - Gascon J.L.
AU  - Parnell V.
AU  - Metlay L.
AU  - Mariani T.J.
AU  - Pryhuber G.S.
Y1  - 2011//
KW  - *lung dysplasia
KW  - *tissues
KW  - *mast cell
KW  - *pathogenesis
KW  - *society
KW  - gene
KW  - lung parenchyma
KW  - genome
KW  - human
KW  - airway
KW  - Student t test
KW  - disease marker
KW  - immunohistochemistry
KW  - diagnosis
KW  - morbidity
KW  - tissue structure
KW  - premature labor
KW  - death
KW  - DNA damage
KW  - blood
KW  - cell cycle regulation
KW  - meconium aspiration
KW  - lung disease
KW  - respiratory distress syndrome
KW  - DNA
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Bhattacharya, University of Rochester, Rochester, NY, United States. E-mail: soumyaroop_bhattacharya@URMC.Rochester.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A4204?sid=0e355b8d-d419-41a1-8e89-62ca18d439a0
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70848511
AB  - Rationale: Bronchopulmonary Dysplasia (BPD) is a major complication of preterm birth associated with both acute and chronic morbidity. Although recent progress has been made in the identification of diagnostic and potentially mechanistic disease markers, particularly from airway washings or peripheral blood, we currently lack a thorough understanding of the cellular and molecular defects that underly disease processes. This lack of understanding restricts attempts to reduce its incidence and impact. Method(s): Lung tissue samples from 28 subjects (including 11 BPD and 17 non-BPD) were harvested within 6 hours of death, following a standardized protocol to retain tissue structure and molecular integrity. Whole lung tissue RNA from each sample was interrogated for genome-wide expression using the Affymetrix U133 Plus 2.0 array. Ingenuity Pathway Analysis (IPA) was used for pathway and network analyses of differentially expressed genes. Gene Set Enrichment Analysis (GSEA) was performed to identify pre-defined gene sets that were statistically significant between BPD samples and controls. Global validation of array-based differential expression was carried out using quantitative RT-PCR (qPCR) and immunohistochemistry (IHC). Result(s): A total of 159 genes met test criteria for differential expression (T-Test p <0.05 and Fold Change >= 2) between 11 BPD cases and 9 non-BPD controls (5 no lung disease, 3 mild RDS, 1 meconium aspiration), and were considered for pathways analysis. The top dysregulated canonical pathways in BPD involved cell cycle control associated with DNA damage, and immune-related signaling, consistent with prior knowledge of disease-related processes. Thirty-one of these 159 genes (~20%) could be linked through a single network with IGF1 as the central node. GSEA also identified multiple IGF1-related gene sets significantly associated (p<0.05) with BPD. We confirmed significant increases in IGF1 expression in our BPD tissue, similar to previous reports. When ranked for magnitude of effect, 3 of the 5 top genes (and 9 of the top 26 probe sets) were mast cell-specific. IHC confirmed increased accumulation of mast cell in BPD tissues, particularly within the lung parenchyma. Summary: We have generated a unique set of genome-wide expression profiling data from human BPD and age matched control lung tissue. Using standard pathways analysis approaches, we were able to identify previously known, as well as novel processes associated with disease pathogenesis. Further analysis of these data should significantly expand our knowledge of BPD, and may be useful for the development of new therapeutic strategies.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70848507
TI  - Prenatal administration of rosiglitazone to rat pups does not alter the adult metabolic phenotype
AU  - Rehan V.K.
AU  - Sierra H.
AU  - Liu J.
AU  - Sakurai R.
AU  - Truong N.
AU  - Lee R.
AU  - Lee W.P.
AU  - Torday J.S.
Y1  - 2011//
KW  - *rat
KW  - *adult
KW  - *phenotype
KW  - *society
KW  - fetus lung maturity
KW  - plasma
KW  - lung
KW  - fatty acid synthesis
KW  - hybridization
KW  - agonist
KW  - insulin tolerance test
KW  - Sprague Dawley rat
KW  - skeletal muscle
KW  - liver
KW  - safety
KW  - mass spectrometry
KW  - body weight
KW  - lung dysplasia
KW  - fetus lung maturation
KW  - therapy
KW  - statistical significance
KW  - assay
KW  - glucose tolerance test
KW  - infant
KW  - mare
KW  - *rosiglitazone
KW  - insulin
KW  - deuterium oxide
KW  - glucagon
KW  - glucose
KW  - cholesterol
KW  - dexamethasone
KW  - deuterium
KW  - triacylglycerol
KW  - peroxisome proliferator activated receptor
KW  - peroxisome proliferator activated receptor gamma
KW  - marker
KW  - adipophilin
KW  - drinking water
KW  - troponin I
KW  - troponin
KW  - diluent
KW  - protein A
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - V.K. Rehan, Harbor-UCLA Medical Center, Torrance, CA, United States. E-mail: vrehan@labiomed.org
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A4200?sid=0e355b8d-d419-41a1-8e89-62ca18d439a0
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70848507
AB  - Background: Research has shown that rosiglitazone (RGZ) is effective in enhancing lung maturity, and it is a pulmonary protectant when administered prenatally to rat pups. However, its long-term safety has not been documented. Objective(s): To study the metabolic profiles of adult rats exposed prenatally to RGZ. Method(s): Pregnant Sprague-Dawley rat dams were administered either diluent, RGZ (0.3mg/kg), RGZ (3mg/kg), or dexamethasone (0.25mg/kg), intraperitoneally once daily x 2 doses, 24h apart, starting at embryonic day 18. At 11-12 wks of age, glucose and insulin tolerance tests were performed after a 12h fast (glucose administered at 1g/kg intraperitoneally, and insulin administered at 1U/kg subcutaneously). De novo fatty acid synthesis was analyzed by deuterium incorporation [99.9% deuterated water (D2O)]. D2O was injected intraperitoneally once at a dose equivalent to 4% of body weight, followed by free access to drinking water containing 6% D2O for 7 days] and mass spectrometry analysis of plasma samples at 14 wks. At 15 wks, the animals were sacrificed and lungs, liver, skeletal muscle and fat were collected for Western hybridization for peroxisome proliferator-activated receptor gamma (PPARgamma), a marker of lung maturity, and adipose differentiation-related protein (ADRP), a key down-stream functional target of PPARgamma. Plasma was assayed for triglycerides, cholesterol, insulin, glucagon and troponin-I. Result(s): Insulin and glucose tolerance tests were not different between the control and experimental groups. Deuterium incorporation studies showed no significant differences in de novo fatty acid synthesis, and Western hybridization showed equal expression of PPARgamma and ADRP. Similarly, triglyceride, cholesterol, insulin, glucagon and troponin-I assays revealed no significant differences among all 4 groups, (all p values > 0.05) Conclusion(s): Treatment with the PPARgamma agonist RGZ in early neonatal life does not alter developmental metabolic programming, and does not lead to an altered metabolic phenotype in the adult, further re-enforcing the safe use of PPARgamma agonists as a novel lung-protective strategy. We speculate that RGZ therapy is a safe, effective alternative to dexamethasone for accelerating lung maturation and in preventing bronchopulmonary dysplasia in the permature infant.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70848266
TI  - A polymorphism in manganese superoxide dismutase is associated with the presence and severity of lung disease in neonates
AU  - Hurley E.
AU  - Aland K.
AU  - Calo J.M.
AU  - Chhabra D.
AU  - Mendoza E.
AU  - Strassberg S.
AU  - Parton L.A.
Y1  - 2011//
KW  - *lung disease
KW  - *newborn
KW  - *society
KW  - allele
KW  - mitochondrion
KW  - lung dysplasia
KW  - asthma
KW  - lung cancer
KW  - risk factor
KW  - single nucleotide polymorphism
KW  - cardiomyopathy
KW  - wild type
KW  - neoplasm
KW  - diseases
KW  - necrotizing enterocolitis
KW  - prematurity
KW  - real time polymerase chain reaction
KW  - chromosome aberration
KW  - infant
KW  - supplementation
KW  - Caucasian
KW  - lung
KW  - health
KW  - baby
KW  - genotype
KW  - intestine necrosis
KW  - risk
KW  - *manganese superoxide dismutase
KW  - oxygen
KW  - enzyme
KW  - surfactant
KW  - antioxidant
KW  - genomic DNA
KW  - reactive oxygen metabolite
KW  - DNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - E. Hurley, New York Medical College, Valhalla, NY, United States. E-mail: Edward_Hurley@nymc.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A3953?sid=6b52f8e5-101f-4cef-bc29-ae7d0336f36b
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70848266
AB  - Rationale: Reactive oxygen species are a risk factor for the development of bronchopulmonary dysplasia (BPD) in neonates. Manganese superoxide dismutase (MnSOD) is an important antioxidant enzyme, which is encoded by genomic DNA but functions in the mitochondria. Some have hypothesized having the T-allele for the rs4880 single nucleotide polymorphism (SNP) in the targeting sequence of the enzyme affects the efficiency of transport into the mitochondria. The T-allele has been linked to cardiomyopathy. The wild-type, C-allele has been linked to various cancers, neuronal disorders and asthma. Both alleles have been found to be associated with lung cancer. We hypothesize that having at least one copy of the C-allele of the rs4880 SNP increases the likelihood and severity of BPD. Method(s): DNA was isolated from buccal mucosal swabs (N=193). Infants were enrolled who weighed <1 kg at birth and had no congenital or chromosomal abnormalities. Real-time PCR discriminated alleles for the rs4880 SNP. BPD is graded by the need for oxygen at 36 weeks PMA. Mild BPD is need for supplemental oxygen at 28 DOL but no supplementation needed at 36 weeks PMA. Moderate BPD means FiO2 of <0.3 at 36 weeks PMA while severe means FiO2 is >0.3 at 36 week PMA. Result(s): We found near significant correlation for the presence and severity of BPD for subjects with the CC/CT allele compared to the TT-allele: (Table Presented) Caucasian subjects with at least one C-allele were more likely to have BPD (P=0.018) and if they do have BPD then it tended to be more severe (P=0.001). There was no similar correlation for nonwhite subjects. We also found significance for subjects requiring surfactant: CC vs. CT/TT (P=0.05). This is an indirect measurement of lung health in babies. Subjects with at least one copy of the C-allele received significantly more doses of surfactant: 1.34 vs. 1.05 (P=0.038). For secondary findings, we found subjects with CC genotype were more likely to have necrotizing enterocolitis, a condition in premature infants that results in intestinal necrosis (P=0.02). Conclusion(s): Subjects with at least one C-allele for the rs4880 SNP seem more susceptible to BPD. Moreover, if they have BPD, it is likely more severe. The rs4880 SNP is a candidate for inclusion in a potential genetic panel to screen neonates at risk for BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70848255
TI  - Sildenafil blocks myofibroblastic differentiation of neonatal lung mesenchymal cells in vitro and in vivo
AU  - Bentley J.K.
AU  - Popova A.P.
AU  - Linn M.J.
AU  - Lei J.
AU  - Goldsmith A.M.
AU  - Hershenson M.B.
Y1  - 2011//
KW  - *lung
KW  - *mesenchyme cell
KW  - *in vitro study
KW  - *society
KW  - myofibroblast
KW  - human
KW  - hyperoxia
KW  - mouse
KW  - model
KW  - membrane
KW  - agonist
KW  - lung disease
KW  - lung dysplasia
KW  - extracellular matrix
KW  - mesenchymal stroma cell
KW  - cell type
KW  - rat
KW  - fibrosing alveolitis
KW  - heart right ventricle hypertrophy
KW  - pulmonary hypertension
KW  - fibrin deposition
KW  - pneumonia
KW  - mortality
KW  - prematurity
KW  - immunofluorescence
KW  - immunocytochemistry
KW  - Western blotting
KW  - chronic lung disease
KW  - gene
KW  - gene expression
KW  - phosphorylation
KW  - *sildenafil
KW  - cyclic GMP
KW  - guanylate cyclase
KW  - actin
KW  - marker
KW  - lificiguat
KW  - 8 (4 chlorophenylthio) cyclic GMP
KW  - phosphodiesterase inhibitor
KW  - smooth muscle actin
KW  - messenger RNA
KW  - elastin
KW  - natriuretic peptide type C
KW  - glycogen synthase kinase 3
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.B. Hershenson, University of Michigan, Ann Arbor, MI, United States. E-mail: mhershen@umich.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A3942?sid=6b52f8e5-101f-4cef-bc29-ae7d0336f36b
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70848255
AB  - Background: Bronchopulmonary dysplasia (BPD) is a chronic lung disease of premature infants which is characterized by impaired alveolar formation and interstitial fibrosis. BPD lungs show greater numbers of alpha-actin-expressing myofibroblasts. Myofibroblasts localize to fibrotic foci and are the main cell type responsible for extracellular matrix deposition and structural remodeling in fibrotic lung diseases. The cyclic guanosine 3',5' monophosphate (cGMP)-specific phosphodiesterase inhibitor sildenafil attenuates hyperoxia-induced pulmonary inflammation, fibrin deposition, pulmonary hypertension, right ventricular hypertrophy, hypoalveolarization and mortality in hyperoxia-exposed neonatal rats, a model of BPD. Activation of soluble guanylate cyclase has also been noted to inhibit myofibroblastic differentiation in vitro. Objective(s): We hypothesized that sildenafil inhibits TGF-beta-induced myofibroblastic differentiation of human neonatal lung mesenchymal stromal cells (MSCs). We also hypothesized that agents that activate membrane-bound or cytosolic guanylate cyclase potentiate the action of sildenafil. Design/Methods: MSCs were differentiated to myofibroblasts by the addition of TGF-beta or LiCl, an inhibitor of glycogen synthase kinase (GSK)-3beta. In addition, we developed a mouse model of BPD by exposing 2 day-old mice to 75% O2 for 14 days. Gene expression was monitored by Illumina gene chip analysis, qPCR, Western blotting, immunocytochemistry and immunofluorescence. Result(s): TGF-beta treatment increased neonatal lung MSC mRNA expression of myofibroblast markers such as alpha-smooth muscle actin (ACTA2) and elastin (ELN), whereas sildenafil lowered expression of these markers. Incorporation of alpha-actin into contractile filaments was also inhibited by sildenafil, particularly in the presence of a cGMP analog, 8- (4-chlorophenylthio)guanosine- 3', 5'-cyclic monophosphate (8-CPT-cGMP), the membrane-bound guanlyate cyclase agonist C-type natriuretic peptide (CNP), or the soluble guanylate cyclase agonist YC-1. The combination of sildenafil and 8-CPT-cGMP also blocked both TGF-beta- and LiCl-stimulated GSK-3beta phosphorylation. Finally, sildenafil treatment attenuated hyperoxia-induced myofibroblast differentiation in vivo. Conclusion(s): Sildenafil blocks human neonatal lung myofibroblastic differentiation in vitro and mouse lung myofibroblastic differentiation in vivo. The effect of sildenafil is potentiated by agents which increase cGMP. Sildenafil also appears to maintain GSK-3beta in a dephosphorylated state. Use of sildenafil and agents that raise cGMP may attenuate myofibroblastic differentiation in BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70848254
TI  - Ambrisentan prolongs survival by attenuating pulmonary hypertension, fibrin deposition and right ventricular hypertrophy in neonatal hyperoxic lung injury
AU  - Wagenaar G.T.
AU  - De Visser Y.P.
AU  - Laghmani E.
AU  - Walther F.J.
Y1  - 2011//
KW  - *survival
KW  - *pulmonary hypertension
KW  - *fibrin deposition
KW  - *heart right ventricle hypertrophy
KW  - *lung injury
KW  - *society
KW  - model
KW  - hyperoxia
KW  - lung
KW  - vascularization
KW  - rat
KW  - injury
KW  - inflammation
KW  - lung dysplasia
KW  - macrophage
KW  - neutrophil
KW  - blood vessel
KW  - prematurity
KW  - chronic lung disease
KW  - arteriole
KW  - thickness
KW  - gene
KW  - histopathology
KW  - heart
KW  - newborn period
KW  - parameters
KW  - exposure
KW  - ambient air
KW  - adverse drug reaction
KW  - *ambrisentan
KW  - messenger RNA
KW  - amphiregulin
KW  - nonoxinol 9
KW  - endothelin 1
KW  - marker
KW  - plasminogen activator inhibitor 1
KW  - oxygen
KW  - chemoattractant
KW  - chemokine
KW  - interleukin 6
KW  - sodium chloride
KW  - vasoconstrictor agent
KW  - thromboplastin
KW  - endothelin receptor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - G.T. Wagenaar, Leiden University Medical Center, Leiden, Netherlands. E-mail: g.t.m.wagenaar@lumc.nl
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A3941?sid=6b52f8e5-101f-4cef-bc29-ae7d0336f36b
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70848254
AB  - Rationale: Ambrisentan, a selective endothelin receptor type A antagonist, may be a novel therapeutic agent in neonatal chronic lung disease by blocking the adverse effects of the potent vasoconstrictor endothelin-1, including pulmonary arterial hypertension (PAH)-induced right ventricular hypertrophy (RVH). Method(s): We determined the cardiopulmonary effects of ambrisentan in neonatal rats with hyperoxia-induced lung injury, a valuable model for premature infants with bronchopulmonary dysplasia (BPD). Ambrisentan treatment was investigated in 2 models of experimental BPD: a prophylactic model, in which pups were continuously exposed to hyperoxia and treated daily with either saline or ambrisentan (20 mg/kg body weight/day; injected subcutaneously), and an injury-recovery model, in which pups were exposed to hyperoxia for 9 days, followed by 9 days of recovery in room-air and treatment with ambrisentan was started on day 6 of oxygen exposure and continued during the recovery period. Parameters investigated include survival, lung and heart histopathology, fibrin deposition, and differential mRNA expression in the lungs of key genes involved in inflammation, coagulation and alveolar enlargement. Result(s): In the prophylactic model treatment with ambrisentan improved survival (p <0.01) by reducing lung fibrin deposition (3-fold, p <0.001) and medial wall thickness of small arterioles as a marker for PAH (1.7-fold, p <0.001), and preventing associated RVH (p <0.001). Treatment with ambrisentan did not have beneficial effects on alveolar enlargement (mean linear intercept and number of alveolar crests), vascularisation (blood vessel counts) and the pulmonary influx of macrophages and neutrophils. Ambrisentan decreased mRNA expression of amphiregulin, but did not have an effect on the differential expression of interleukin-6, chemokine-induced neutrophilic chemoattractant-1, plasminogen activator inhibitor-1 and tissue factor. In the injury-recovery model treatment with ambrisentan attenuated PAH and RVH (p <0.001), demonstrating that established PAH-induced RVH is still reversible in the neonatal period. Beneficial effects on reduced vascularisation and alveolarization were absent. Conclusion(s): Ambrisentan prolongs survival by reversing PAH and RVH, and reducing pulmonary fibrin deposition, but does not have beneficial effects on inflammation, alveolar enlargement and vascularisation in neonatal rats with experimental BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70848252
TI  - The peroxisome proliferator-activated receptor (PPARgamma) agonist prostaglandin J2 blocks the hyperoxia-induced decrease in pulmonary FGF-10 signaling
AU  - Rehan V.K.
AU  - Sakurai R.
AU  - Alam D.A.
AU  - Torday J.S.
AU  - Bellusci S.
Y1  - 2011//
KW  - *society
KW  - *hyperoxia
KW  - fibroblast
KW  - lung
KW  - lung fibroblast
KW  - human
KW  - rat
KW  - agonist
KW  - lung dysplasia
KW  - apoptosis
KW  - down regulation
KW  - model
KW  - Western blotting
KW  - laboratory
KW  - exposure
KW  - Sprague Dawley rat
KW  - *prostaglandin
KW  - *fibroblast growth factor 10
KW  - *peroxisome proliferator activated receptor agonist
KW  - marker
KW  - leptin
KW  - peroxisome proliferator activated receptor
KW  - fibroblast growth factor receptor 2
KW  - caspase 3
KW  - fibronectin
KW  - protein
KW  - growth factor
KW  - triolein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - V.K. Rehan, Harbor-UCLA Medical Center, Torrance, CA, United States. E-mail: vrehan@labiomed.org
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A3939?sid=6b52f8e5-101f-4cef-bc29-ae7d0336f36b
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70848252
AB  - Background: Bronchopulmonary dysplasia (BPD) is characterized by fewer and larger alveoli, and abnormal branching of the affected lungs. Fibroblast growth factor 10 (FGF-10), an important growth factor that regulates lung branching and alveolarization, is decreased in BPD. Since our laboratory has recently shown that, in a rat model, BPD can be prevented by PPARgamma agonists such as prostaglandin J2 (PGJ2 ), we hypothesized that PGJ2 up-regulates FGF-10 signaling. Objective(s): To determine the effects of FGF-10 on alveolar fibroblast differentiation and determine if PGJ2 blocks hyperoxia-induced changes in FGF-10 signaling. Method Used: To determine the effects of FGF-10 on alveolar fibroblast differentiation, both day 19 fetal rat lung fibroblasts and embryonic human lung fibroblasts (WI38 cells) were treated with FGF-10 (1, 10, 50, 100 ng/ml) for 24h. Following which, markers of fibroblast differentiation (PPARgamma, ADRP, SREBP1c, aP2, leptin and triolein uptake) were analyzed. In a separate set of experiments, neonatal Sprague Dawley rat pups were categorized in the following groups: normoxia (control, 21%O2), normoxia + PGJ2 (0.3mg/kg), hyperoxia (exposure to 95%O2 for 7d), hyperoxia + PGJ2 (0.3mg/kg). PGJ2 was administered intraperitoneally once daily. At the end of the experimental period, the pups were killed and protein extracted from whole lung samples. Using Western blotting, we probed for FGF-10, FGF receptor 2, PPARgamma, ADRP, leptin, fibronectin, Bax, Bcl-2 and cleaved caspase-3. Result(s): FGF10-treated fibroblasts showed dose-dependent increases in markers of fibroblast differentiation. Under in vivo conditions, PGJ 2 blocked hyperoxia-induced decreases in FGF-10, PPARgamma, leptin and increases in FGF-receptor 2 and fibronectin levels. Furthermore, hyperoxia-induced changes in apoptotic markers (increases in Bax and cleaved caspase 3 and a decrease in Bcl-2) were also blocked by PGJ2 treatment. Conclusion(s): Our data demonstrate that hyperoxia-induced down-regulation of FGF-10 signaling and an increased apoptosis were blocked by PGJ2. We speculate a direct interaction between the FGF-10 and PPARgamma signaling pathways in the maintenance of alveolar growth and differentiation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70848251
TI  - Hyperoxia decreases junctional proteins and promotes extracellular matrix in alveolar epithelial cells
AU  - Vyas-Read S.
AU  - Colvocoresses-Dodds J.
AU  - Gauthier T.W.
AU  - Brown L.
Y1  - 2011//
KW  - *hyperoxia
KW  - *extracellular matrix
KW  - *lung alveolus epithelium
KW  - *society
KW  - lung
KW  - exposure
KW  - lung dysplasia
KW  - prematurity
KW  - protein expression
KW  - ambient air
KW  - immunofluorescence
KW  - mouse
KW  - cell junction
KW  - immunoblotting
KW  - pathogenesis
KW  - phenotype
KW  - oxidative stress
KW  - lung injury
KW  - risk
KW  - down regulation
KW  - *protein
KW  - uvomorulin
KW  - messenger RNA
KW  - occludin
KW  - claudin 18
KW  - vimentin
KW  - smooth muscle actin
KW  - alpha smooth muscle actin
KW  - oxygen
KW  - fibronectin
KW  - collagen type 5
KW  - collagen type 1
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Vyas-Read, Emory University, Atlanta, GA, United States. E-mail: svyasre@emory.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A3938?sid=6b52f8e5-101f-4cef-bc29-ae7d0336f36b
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70848251
AB  - Rationale: Exposure to hyperoxia is often unavoidable in the treatment of preterm infants and is implicated in the pathogenesis of bronchopulmonary dysplasia. The down-regulation of junctional contacts between alveolar epithelial cells (AEC) is associated with a fibroproliferative response to lung injury. We examined how chronic hyperoxia exposure affects expression of junctional epithelial proteins and contributes to extracellular matrix expression. Method(s): To assess changes in the lungs of animals exposed to oxygen in vivo, C57Bl/6 mice were exposed to room air or hyperoxic conditions (85%) for 5 days and the harvested lung was analyzed by immunofluorescence and RT-PCR. To specifically evaluate the effects of hyperoxia on type II AEC, RLE-6TN were cultured under control or hyperoxia conditions (85%) for 5 days and epithelial and mesenchymal proteins were evaluated by immunofluorescence and immunoblot. Result(s): The lungs of hyperoxia-exposed animals had 20% less E-cadherin and 40% less occludin mRNA when compared with controls (p=0.03). Whereas type II AEC cultured in room air expressed E-cadherin at cellular junctions, hyperoxia-exposed type II cells had minimal detectable E-cadherin protein and had 70% less claudin 18 protein expression. The lungs of hyperoxia-exposed animals had 1.8 times as much collagen Ialpha2, 2.1times as much collagen 5alpha2 (p=0.03), and 3.1 times as much fibronectin mRNA (p=0.01) as control animals. Alpha-smooth muscle actin, which was not detectable in the alveolar space of control animal lung, was expressed in the alveoli of hyperoxia-exposed animals. In culture, hyperoxia-exposed type II AEC expressed 3 times as much alpha-smooth muscle actin (p=0.002) and 1.9 times as much vimentin as controls (p=0.04). Conclusion(s): Hyperoxia exposure decreases normal alveolar junctional integrity and promotes extracellular matrix deposition in the type II AEC and in the mouse lung. A better understanding of the mechanistic relationship between oxidative stress, junctional protein expression and mesenchymal phenotype may have significant implications for preterm infants at risk for bronchopulmonary dysplasia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Foxm1 regulates resolution of hyperoxic lung injury in newborns.
DO  - https://dx.doi.org/10.1165/rcmb.2014-0091OC
AU  - Xia, Hongping
AU  - Ren, Xiaomeng
AU  - Bolte, Craig S
AU  - Ustiyan, Vladimir
AU  - Zhang, Yufang
AU  - Shah, Tushar A
AU  - Kalin, Tanya V
AU  - Whitsett, Jeffrey A
AU  - Kalinichenko, Vladimir V
Y1  - 2015//
KW  - Airway Remodeling
KW  - Alveolar Epithelial Cells/me [Metabolism]
KW  - Animals
KW  - Bronchopulmonary Dysplasia/me [Metabolism]
KW  - Case-Control Studies
KW  - Cathepsin G/me [Metabolism]
KW  - Disease Models, Animal
KW  - Forkhead Box Protein M1
KW  - Forkhead Transcription Factors/ge [Genetics]
KW  - *Forkhead Transcription Factors/me [Metabolism]
KW  - Humans
KW  - *Hyperoxia/co [Complications]
KW  - Hyperoxia/me [Metabolism]
KW  - Hyperoxia/pp [Physiopathology]
KW  - Infant, Newborn
KW  - *Lung/me [Metabolism]
KW  - Lung/pa [Pathology]
KW  - Lung/pp [Physiopathology]
KW  - Lung Injury/et [Etiology]
KW  - *Lung Injury/me [Metabolism]
KW  - Lung Injury/pa [Pathology]
KW  - Lung Injury/pp [Physiopathology]
KW  - Macrophages/me [Metabolism]
KW  - Mice, Knockout
KW  - Myeloblastin/me [Metabolism]
KW  - Neutrophils/me [Metabolism]
KW  - Peroxidase/me [Metabolism]
KW  - Pneumonia/et [Etiology]
KW  - *Pneumonia/me [Metabolism]
KW  - Pneumonia/pa [Pathology]
KW  - Pneumonia/pp [Physiopathology]
T2  - American journal of respiratory cell and molecular biology
VL  - 52
IS  - 5
SN  - 1044-1549
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25275225
AD  - United States
AB  - Current treatments for inflammation associated with bronchopulmonary dysplasia (BPD) fail to show clinical efficacy. Foxm1, a transcription factor of the Forkhead box family, is a critical mediator of lung development and carcinogenesis, but its role in BPD-associated pulmonary inflammation is unknown. Immunohistochemistry and RNA analysis were used to assess Foxm1 in lung tissue from hyperoxia-treated mice and patients with BPD. LysM-Cre/Foxm1(-/-) mice, in which Foxm1 was deleted from myeloid-derived inflammatory cells, including macrophages, monocytes, and neutrophils, were exposed to neonatal hyperoxia, causing lung injury and remodeling. Measurements of lung function and flow cytometry were used to evaluate the effects of Foxm1 deletion on pulmonary inflammation and repair. Increased Foxm1 expression was observed in pulmonary macrophages of hyperoxia-exposed mice and in lung tissue from patients with BPD. After hyperoxia, deletion of Foxm1 from the myeloid cell lineage decreased numbers of interstitial macrophages (CD45(+)CD11b(+)Ly6C(-)Ly6G(-)F4/80(+)CD68(-)) and impaired alveologenesis and lung function. The exaggerated BPD-like phenotype observed in hyperoxia-exposed LysM-Cre/Foxm1(-/-) mice was associated with increased expression of neutrophil-derived myeloperoxidase, proteinase 3, and cathepsin g, all of which are critical for lung remodeling and inflammation. Our data demonstrate that Foxm1 influences pulmonary inflammatory responses to hyperoxia, inhibiting neutrophil-derived enzymes and enhancing monocytic responses that limit alveolar injury and remodeling in neonatal lungs.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70848249
TI  - Hypoxia Inducible Factor (HIF) promotes alveolar growth and repair
AU  - Vadivel A.
AU  - Alphonse R.
AU  - Etches N.
AU  - Van Haaften T.
AU  - Eaton F.
AU  - Thebaud B.
Y1  - 2011//
KW  - *society
KW  - rat
KW  - angiogenesis
KW  - lung
KW  - newborn
KW  - gene
KW  - emphysema
KW  - intratracheal drug administration
KW  - lung development
KW  - therapy
KW  - diseases
KW  - lung dysplasia
KW  - adult
KW  - case study
KW  - model
KW  - prematurity
KW  - gene transfer
KW  - lung capillary
KW  - Adenovirus
KW  - chronic lung disease
KW  - *hypoxia inducible factor
KW  - vasculotropin
KW  - angiopoietin 1
KW  - transcription factor
KW  - angiogenic factor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - A. Vadivel, University of Alberta, Edmonton, AB, Canada. E-mail: vadivel@ualberta.ca
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A3936?sid=6b52f8e5-101f-4cef-bc29-ae7d0336f36b
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70848249
AB  - INTRODUCTION: Bronchopulmonary dysplasia (BPD), the chronic lung disease of prematurity, and emphysema are characterized by arrested alveolar growth and alveolar destruction. Case series describe early onset emphysema in young adults with BPD. Both diseases remain without effective therapy. Recent evidence suggest that lung angiogenesis promotes normal lung development and repair: we showed that VEGF preserves lung angiogenesis and alveolarization in experimental O2-induced BPD in newborn rats, a model of arrested alveolar growth. Combined VEGF+Angiopoietin 1 gene transfer corrects VEGF-induced vessel leakiness, highlighting the tightly orchestrated process of angiogenesis. The transcription factor HIF activates O2-sensitive genes, including angiogenic genes. By inducing the expression of not just a single, but a range of angiogenic factors in a coordinated fashion, HIF may orchestrate efficient and safe angiogenesis superior to VEGF. We hypothesized that disruption of HIF impairs alveolarization and HIF prevents irreversible alveolar destruction in O2-induced BPD. METHOD(S): HIF was blocked by using intratracheal dominant negative adenovirus (AdHif(dn)) at P4 during normal rat lung development. Experimental BPD was induced by exposing newborn rat pups from birth to 95% O2. In vivo intratracheal administration of AdHif was used to test HIF's therapeutic potential. RESULT(S): In vivo AdHif(dn) led to air space enlargement and arrested lung vascular growth, mimicking BPD. In experimental O2-induced BPD in newborn rats, the characteristic features of air space enlargement and loss of lung capillaries were associated with decreased lung HIF expression. Intratracheal administration of AdHif restored HIF, eNOS, VEGF, VEGFR2 and Tie2 expression and preserved alveolar and vascular growth in hyperoxic rats. CONCLUSION(S): HIF promotes normal alveolar development and may be a useful target to prevent arrested alveolar growth.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70848007
TI  - Characterization of human fetal airway smooth muscle cells: An in vitro model system for the developing airway
AU  - Hartman W.R.
AU  - Thompson M.A.
AU  - Prakash Y.
AU  - Pandya H.
AU  - Amrani Y.
AU  - Pabelick C.M.
Y1  - 2011//
KW  - *airway
KW  - *human
KW  - *model
KW  - *in vitro study
KW  - *society
KW  - *smooth muscle fiber
KW  - serum
KW  - cell proliferation
KW  - respiratory tract disease
KW  - assay
KW  - gestational age
KW  - diseases
KW  - lung dysplasia
KW  - trachea
KW  - hyperoxia
KW  - lung development
KW  - health care facility
KW  - medical research
KW  - ethics
KW  - lipid raft
KW  - agonist
KW  - fibroblast
KW  - examination
KW  - inflammation
KW  - newborn
KW  - prematurity
KW  - myosin heavy chain
KW  - histamine
KW  - vimentin
KW  - smooth muscle actin
KW  - ryanodine receptor
KW  - calcium
KW  - cyclodextrin
KW  - caffeine
KW  - protein
KW  - uvomorulin
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - W.R. Hartman, Mayo Clinic, Rochester, MN, United States. E-mail: hartman.william@mayo.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A3653?sid=92a7f5e5-132f-4080-b357-f7590407ba51
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70848007
AB  - Introduction: Study of airway diseases in the newborn requires an appropriate model system that allows for examination of signaling systems. We examined the suitability of human fetal airway smooth muscle (fASM) cells for use in studies relating to regulation of intracellular Ca2+ ([Ca2+] ) and cellular proliferation, relevant to diseases such as bronchopulmonary dysplasia. i Methods and Results: Under appropriate ethics approval of The Medical Research Council Tissue Bank (UK), anonymous fetal human tracheae (gestational age 15-18 weeks) were obtained and fASM cells enzymatically dissociated and grown (DMEM/F12) under standard conditions. Calcium regulation was examined in cells in 96 well plates that were serum deprivation for 24h, 48 or 72h and loaded with fluo-4/AM. Serum-deprived fASM cells showed robust [Ca2+]i responses to 1 muM ACh and 10 muM histamine, that were only partially blunted by removal of extracellular Ca2+. Smaller, yet robust transient responses to 5 mM caffeine persisted in zero extracellular Ca2+. Depletion of lipid rafts with 10 mM methyl-beta-cyclodextrin substantially blunted [Ca2+]i responses to agonist. Immunoblots of fASM lysates showed substantial expression of smooth muscle actin and myosin heavy chain, vimentin and IP3 and ryanodine receptors (RyR), but absence of fibroblast specific protein and E-cadherin. Cellular proliferation, measured using CyQuant assay, was robust in serum (enhanced PCNA expression), but was minimal in serum-deprived cells, with sustained viability until 96h. Conclusion(s): These results suggest that human fetal ASM may serve as a suitable model for the study of fetal airway development and the effect of factors such as hyperoxia or inflammation that contribute to disease early in lung development, especially the premature infant.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70847902
TI  - Fibroblasts expressing platelet-derived growth factor receptor-alpha (PDGF-RA) diminish during alveolar septal thinning in mice
AU  - McGowan S.E.
AU  - McCoy D.
Y1  - 2011//
KW  - *mouse
KW  - *society
KW  - *fibroblast
KW  - gene expression
KW  - apoptosis
KW  - population
KW  - maturation
KW  - lung fibroblast
KW  - myofibroblast
KW  - positive end expiratory pressure
KW  - lung gas exchange
KW  - lung dysplasia
KW  - survival
KW  - thickness
KW  - lung alveolus wall
KW  - perinatal period
KW  - arithmetic
KW  - phosphorylation
KW  - lung
KW  - stereology
KW  - optics
KW  - fluorescence activated cell sorting
KW  - capillary
KW  - atrophy
KW  - lung emphysema
KW  - promoter region
KW  - confocal microscopy
KW  - *platelet derived growth factor alpha receptor
KW  - imatinib
KW  - platelet derived growth factor
KW  - platelet derived growth factor A
KW  - platelet derived growth factor receptor
KW  - green fluorescent protein
KW  - Abelson kinase
KW  - alpha smooth muscle actin
KW  - protein tyrosine kinase inhibitor
KW  - receptor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S.E. McGowan, University of Iowa, College of Medicine, Iowa City, IA, United States
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A3548?sid=d5ab852c-4540-447a-825e-1b6940cc3c0b
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70847902
AB  - RATIONALE: In mice, secondary alveolar septal formation primarily occurs during a brief postnatal period and is accompanied by transient expansion of the interstitial lung fibroblast (LF) population. Platelet derived growth factor-A (PDGF-A), which solely signals through PDGF-receptor-alpha (PDGF-Ralpha) is required, although the relevant downstream targets of the receptor remain incompletely defined. We have evaluated the differential response to the protein tyrosine kinase inhibitor imatinib, which is selective for PDGF-receptors and Abelson kinase (Abl, which are present) and ckit (which is absent) in LF. HYPOTHESIS: Diminished signaling through PDGF-Ralpha-mediated pathways regulates the decline in myofibroblasts, which accompanies alveolar septal thinning, and ensures more efficient alveolar gas-exchange. METHOD(S): Mice, which express green fluorescent protein (GFP) regulated by the endogenous PDGR-Ralpha-promoter enabled spatial and temporal identification of PDGF-Ralpha gene expression using confocal microscopy and fluorescence activated cell sorting (FACS). We compared PDGFRalpha-LF (GFP present, GFP+) to their non-expressing LF counterparts (GFP-) in these mice. Lung fibroblast sub-populations were quantified using FACS, and PDGF-Ralpha-expressing (GFP+) LF were enumerated using the optical fractionator. RESULT(S): Using FACS we observed that administering imatinib for 4 days reduced proliferation to 44 +/- 17 and 98 +/- 16 % (mean +/- SEM, p<0.05) in GFP+ and GFP- LF, respectively, compared to control mice that received no imatinib. Apoptotic LF comprised 17.7 +/- 1.2 and 7.7 +/- 0.2 % (p<0.01) of GFP- and GFP+ sub-populations, respectively and imatinib treatment rendered GFP+ LF as susceptible to apoptosis as GFP- LF. Using quantitative stereology we observed 5.2 +/- 0.2 and 3.9 +/- 0.3 x 107 GFP+ cells per lung in untreated and imatinib-treated mice, repectively (P<0.01). Imatinib significantly reduced the number of alpha smooth muscle actin (alphaSMA) producing, GFP+ LF, but it did not directly reduce alphaSMA-gene expression. Imatinib did not suppress PDGF-Ralpha gene expression in cultured LF but it reduced PDGF-A mediated Akt phosphorylation by 75%, potentially explaining the increase in apoptosis. Imatinib significantly diminished arithmetic mean alveolar wall thickness at posnatal day 14. CONCLUSION(S): Imatinib negated the survival advantage, diminished proliferation in GFP+ LF, and accelerated wall thinning implicating signaling through PDGF-receptors and/or Abl. This suggests that a reduction in PDGF-Ralpha signaling may facilitate septal thinning during alveolar maturation. CLINICAL APPLICATION: Our findings are relevant to bronchopulmonary dysplasia (BPD), in which positive pressure ventilation interferes with myofibroblast depletion, septal thinning, and capillary maturation. They are also relevant to alveolar septal atrophy and apoptosis in pulmonary emphysema.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70847846
TI  - Pulmonary fibroblast Thy-1 expression modulates elastin expression during alveolarization - In part via rhoa activation of JNK
AU  - Varisco B.M.
AU  - Hagood J.S.
AU  - Kaminski N.
AU  - Whitsett J.
Y1  - 2011//
KW  - *society
KW  - *fibroblast
KW  - homeostasis
KW  - lung alveolus wall
KW  - lung dysplasia
KW  - computer program
KW  - mouse
KW  - microarray analysis
KW  - phenotype
KW  - gene
KW  - culture medium
KW  - assay
KW  - hypothesis
KW  - immunoprecipitation
KW  - *elastin
KW  - messenger RNA
KW  - glycoprotein
KW  - glycosylphosphatidylinositol
KW  - phentermine
KW  - protein
KW  - metalloproteinase
KW  - protein lysine 6 oxidase
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - B.M. Varisco, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States. E-mail: brian.varisco@cchmc.org
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A3492?sid=380d4c8a-5b04-4aa2-b301-b40c9640ec58
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70847846
AB  - Rationale: Elastin localization to the tip of the developing alveolar septum is critical to secondary alveolar septation. The mechanisms that regulate this localization are unknown. Thy-1 is a glycophosphatidylinositol-linked glycoprotein critical to pulmonary fibroblast phenotype. Similar to pulmonary histological patterns seen in bronchopulmonary dysplasia, the Thy-1 -/- mouse exhibits diffuse subepithelial deposition of elastin and impaired alveolar development. We have shown that pulmonary fibroblast Thy-1 expression increases at the onset of alveolarization and that the Thy-1 (+) fibroblast localizes to the alveolar septal base. Hypothesis: We hypothesize that the Thy-1 (+) fibroblast plays a key role in the localization of the elastin band to the tip of the developing alveolar septum and that the genes that regulate this localization are targets of Thy-1 signaling pathways. Method(s): (a) Microarray analysis using an Agilent platform and Ingenuity Pathways Analysis software was performed in triplicate on murine pulmonary fibroblasts sorted for Thy-1 expression. Conditioned serum free media of sorted fibroblasts was analyzed for elastin content using the Fastin assay kit (BioColor). (b) Pathway analysis of likely mechanisms by which Thy-1 influences elastin homeostasis was undertaken, and JNK activation by RhoA was deemed a likely pathway. Thus, immunoprecipitation and analysis of phospho-c-Jun (Cell Signaling) was performed to determine JNK activity. Result(s): (a) Thy-1 (-) fibroblasts expressed 83.8 fold more elastin mRNA and 2.83 fold more elastin protein (p=0.001) than Thy-1 (+) fibroblasts. Thy-1 (+) fibroblasts expressed 6.1 fold more matrix metalloprotease-9 and 2.2 fold less lysyl oxidase mRNA than Thy-1 (-) fibroblasts. (b) Pathway analysis revealed that activation of JNK was a likely mechanism by which Thy-1 was modulating elastin homeostasis. As Thy-1 signaling is known to activate RhoA, and RhoA is a well described activator of JNK, we hypothesized that Thy-1 was acting through JNK to alter elastin homeostasis. Phospho-c-Jun could be detected only in Thy-1 (+) fibroblasts. Conclusion(s): During alveolarization, pulmonary fibroblast Thy-1 expression is key to elastin localization. Thy-1 activation of RhoA and JNK appears important in this process. Further studies involving inhibition and activation of these pathways are needed to confirm their critical role in alveolar elastin homeostasis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70847051
TI  - Periostin secretion from lung-derived mesenchymal cells participates in fibrotic lung disease
AU  - Bozyk P.D.
AU  - Popova A.P.
AU  - Bentley J.K.
AU  - Linn M.J.
AU  - Hershenson M.B.
AU  - Moore B.B.
Y1  - 2011//
KW  - *secretion
KW  - *lung
KW  - *mesenchyme cell
KW  - *lung disease
KW  - *society
KW  - human
KW  - patient
KW  - immunohistochemistry
KW  - lung fibroblast
KW  - protein expression
KW  - lung fibrosis
KW  - DNA synthesis
KW  - hyperoxia
KW  - exposure
KW  - mouse
KW  - university
KW  - model
KW  - gene expression
KW  - lung dysplasia
KW  - open lung biopsy
KW  - adult
KW  - extracellular matrix
KW  - respiratory distress syndrome
KW  - United States
KW  - newborn
KW  - tracheal aspiration procedure
KW  - mesenchymal stroma cell
KW  - cell proliferation
KW  - fibroblast
KW  - animal model
KW  - tissues
KW  - *transcription factor RUNX2
KW  - messenger RNA
KW  - bleomycin
KW  - protein
KW  - elastin
KW  - broxuridine
KW  - receptor
KW  - ligand
KW  - DNA
KW  - fibronectin
KW  - alpha smooth muscle actin
KW  - collagen
KW  - scleroprotein
KW  - matrix protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - P.D. Bozyk, University of Michigan, Ann Arbor, MI, United States. E-mail: paulbozy@med.umich.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A2696?sid=fc34f564-9b89-4631-99a2-c85616333bba
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70847051
AB  - RATIONALE: The hallmark of fibrotic lung disease is abnormalextracellular matrix accumulation. The matricellular protein periostin bindsand stabilizes the extracellular matrix while acting as a ligand for cellsurface receptors. We hypothesizea role for mesenchymal cell-derived periostin in fibrotic lung disease. To test this, we analyzed periostin expression in two murine models of lung fibrosis(bleomycin, neonatal hyperoxic exposure) and tissue from patients with eitheridiopathic pulmonary fibrosis (IPF) or bronchopulmonary dysplasia (BPD). We also examined effects of periostin treatment on mesenchymal cell gene expression and proliferation. METHOD(S): Bleomycin was intratracheally administered to C57BL/6 mice. Two day-old C57BL/6 mice were exposed to hyperoxia for up to 21 days. Lung matrix protein expression was assessed by quantitative PCR, immunohistochemistry and immunoflourescence. Lung mesenchymal stromal cells (MSCs) were collected from tracheal aspirates of neonates intubated for respiratory distress syndrome. Adult lung fibroblasts from normal and IPF lungs were obtained by open lung biopsy at the University of Michigan. Perostin mRNA expression in mesenchymal cells from IPF and BPD patients was compared to normal controls. Murine lung fibroblasts were exposed to recombinant periostin and mRNA expression assessed. The effect of recombinant periostin on MSC DNA synthesis was measured by BrdU incorporation. Lung periostin protein expression from patients with IPF or BPD was compared tonormal lung by immunohistochemistry. BPD lung samples were provided by GSPryhuber, University of Rochester. RESULT(S): Following bleomycin or hyperoxia exposure, qPCRshowed a significant increase in murine periostin mRNA. Immunohistochemistry demonstrated increased deposition of periostin protein in fibrotic foci of both models. Bleomycin lungs demonstrated increase of periostin, and co-localization with type I collagen, elastin and alpha-smooth muscle actin by immunoflourescence. Recombinant periostin caused significant and dose-dependent increases in murine lung fibroblast Col1A, elastin, and fibronectin mRNA expression. Recombinant periostin also increased DNA synthesis in neonatal MSCs. Compared to control cells, periostin mRNA expression was over 3-fold higher in IPF fibroblasts (p<0.005) and over 6-fold greater in neonatal lung MSCs (p<0.005). Finally, IPF and BPD lungs showed more periostin protein accumulation than normal controls by immunohistochemistry. CONCLUSION(S): We show in two animal models that periostin expression is increased in fibrotic lung disease. Recombinant periostin increases mesenchymal cell proliferation and expression of extracellular matrix proteins. Finally, human patients with IPF and BPD showevidence of increased lung periostin transcript and protein expression. Together, these data suggest that periostin plays a role in human lung fibrosis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70846868
TI  - Glycogen synthase kinase-3beta/beta-catenin signaling in neonatal lung mesenchymal stromal cell myofibroblastic differentiation
AU  - Popova A.P.
AU  - Bentley J.K.
AU  - Bozyk P.D.
AU  - Goldsmith A.M.
AU  - Linn M.J.
AU  - Lei J.
AU  - Pryhuber G.S.
AU  - Hershenson M.B.
Y1  - 2011//
KW  - *lung
KW  - *mesenchymal stroma cell
KW  - *society
KW  - myofibroblast
KW  - mouse
KW  - hyperoxia
KW  - phosphorylation
KW  - lung alveolus wall
KW  - tracheal aspiration procedure
KW  - human
KW  - cat
KW  - infant
KW  - gene expression
KW  - flow cytometry
KW  - stroma cell
KW  - lung parenchyma
KW  - pathogenesis
KW  - immunocytochemistry
KW  - risk factor
KW  - immunoblotting
KW  - university
KW  - artificial ventilation
KW  - prematurity
KW  - Lentivirinae
KW  - lung dysplasia
KW  - model
KW  - Leydig cell
KW  - immunohistochemistry
KW  - adherent cell
KW  - genetic transfection
KW  - baby
KW  - gene
KW  - *catenin
KW  - *glycogen synthase kinase 3
KW  - actin
KW  - 2 (2,4 dichlorophenyl) 3 (1 methyl 3 indolyl)maleimide
KW  - collagen type 1
KW  - collagen
KW  - transforming growth factor
KW  - oxygen
KW  - fibronectin
KW  - plastic
KW  - elastin
KW  - phosphotransferase
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.B. Hershenson, University of Michigan, Ann Arbor, MI, United States. E-mail: mhershen@umich.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A2509?sid=560dd110-755f-4ec5-b03f-1b297895008e
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70846868
AB  - Background: Bronchopulmonary dysplasia (BPD) is characterized in part by alveolar septa thickened with collagen, alpha-actin- and transforming growth factor (TGF)-beta-expressing myofibroblasts. We have isolated mesenchymal stromal cells from tracheal aspirates of premature infants undergoing mechanical ventilation. These cells differentiate to myofibroblasts under the influence of autocrine TGF-beta. Isolation of stromal cells from tracheal aspirates increases the relative risk of developing BPD over 20-fold, suggesting that these cells play a role in BPD pathogenesis. Glycogen synthase kinase (GSK)-3beta is a constitutively-active kinase which phosphorylates beta-catenin, targets it for degradation, thereby preventing beta-catenin-mediated expression of myofibroblast genes including alpha-actin, collagen type I, Cyr61 and fibronectin. GSK-3beta phosphorylation inactivates it, allowing beta-catenin to accumulate in the cell, translocate to the nucleus, and activate gene expression. Objective(s): We hypothesized that myofibroblastic differentiation of mesenchymal stromal cells is accompanied by GSK-3beta phosphorylation and beta-catenin accumulation, and that similar events occur in the lungs of infants with BPD and hyperoxia-exposed newborn mice, a model of BPD. Method(s): Mesenchymal stromal cells were isolated from neonatal tracheal aspirates and treated with TGF-beta1, SB216763 or LiCl (GSK-3beta inhibitors). Selected cultures were transfected with a lentivirus encoding non-degradable beta-catenin (DELTAN beta-cat). Two day-old mice were exposed to air or 75% oxygen for 14 days. Lung tissue from hyperoxic mice and human infants with BPD (University of Rochester Neonatal Lung Biorepository) were examined. Gene expression was analyzed by qPCR, immunoblot, immunocytochemistry, immunohistochemistry or flow cytometry. Result(s): TGF-beta1 treatment increased neonatal lung mesenchymal stromal cell expression of a-actin, elastin and collagen I, consistent with myofibroblastic differentiation. TGF-beta1, LiCl and SB216763 increased phospho-GSK3beta content and beta-catenin nuclear localization. Transfection with DELTAN beta-cat was associated with increased nuclear accumulation of beta-catenin and alpha-actin expression. Lungs of hyperoxia-exposed mice showed hypoalveolarization and alveolar wall thickening comprised of a-actin-, phospho-GSK-3beta-and beta-catenin-positive myofibroblasts. Flow cytometry of plastic-adherent cells from lungs of hyperoxia-exposed mice showed an increase in cells co-expressing high levels of alpha-actin, phospho-GSK-3beta and beta-catenin. Finally, lung tissue from babies with BPD showed thickened alveolar walls with clusters of alpha-actin-, phospho-GSK-3beta- and beta-catenin-positive myofibroblast-like cells. Conclusion(s): TGF-beta1 stimulates myofibroblastic differentiation, GSK-3beta phosphorylation and beta-catenin accumulation in cultured neonatal lung mesenchymal stromal cells. GSK-3beta inhibition and beta-catenin overexpression are sufficient for stromal cell myofibroblastic differentiation. Hyperoxia is associated with GSK-3beta phosphorylation, accumulation of beta-catenin and myofibroblastic differentiation of alveolar interstitial cells. GSK-3beta and beta-catenin represent molecular targets for therapeutic intervention in BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70845622
TI  - Existence, functional impairment and therapeutic potential of endothelial colony forming cells (ECFCs) in oxygen-induced arrested alveolar growth
AU  - Alphonse R.
AU  - Vadivel A.
AU  - Waszak P.
AU  - Fung M.
AU  - Coltan L.
AU  - Eaton F.
AU  - Yoder M.C.
AU  - Thebaud B.
Y1  - 2011//
KW  - *colony forming cell
KW  - *society
KW  - *functional disease
KW  - lung
KW  - hyperoxia
KW  - rat
KW  - lung disease
KW  - angiogenesis
KW  - in vitro study
KW  - human
KW  - therapy
KW  - mouse
KW  - umbilical cord blood
KW  - lung function
KW  - pulmonary hypertension
KW  - injury
KW  - emphysema
KW  - lung dysplasia
KW  - supplementation
KW  - lung development
KW  - newborn
KW  - model
KW  - ambient air
KW  - endothelial progenitor cell
KW  - stem cell
KW  - morbidity
KW  - pulmonary artery
KW  - acceleration
KW  - heart right ventricle hypertrophy
KW  - *oxygen
KW  - matrigel
KW  - growth factor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 183
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - R. Alphonse, University of Alberta, Edmonton, AB, Canada. E-mail: anthuvan@ualberta.ca
UR  - http://ajrccm.atsjournals.org/cgi/reprint/183/1_MeetingAbstracts/A1237?sid=9c90cf80-27f3-4d44-a283-cd373113b9f5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70845622
AB  - INTRODUCTION: Bronchopulmonary dysplasia (BPD) and emphysema are life-threatening lung diseases characterized by alveolar simplification resulting either from impaired alveolar development or alveolar destruction. Both conditions currently lack effective therapy. There is growing evidence that angiogenic growth factors, via promoting lung vasculogenesis, actively support alveolar growth and contribute to alveolar maintenance throughout postnatal life. However, the likely role of vascular progenitor cells (endothelial progenitor cells, EPCs) in lung growth and maintenance is unknown. OBJECTIVE(S): In this study, we examine the role of ECFCs, an EPC subtype capable of self-renewal and de novo vessel formation, during lung development and repair. We hypothesize that ECFC-driven angiogenesis contributes to normal lung alveolar growth and ECFC supplementation restores disrupted alveolar development in hyperoxia-induced BPD. METHOD(S): In vitro, we assessed the proliferative, clonogenic and vessel forming potentials of lung ECFCs isolated from newborn rats housed in 95% O2 (rat BPD model) vs. normoxic (room air) controls. In vivo, the therapeutic potential of human umbilical cord blood (hUCB) ECFCs was assessed in immunocompromised rag-/- mice exposed to 85% O2 from Postnatal day- (P) 5 to 14 and sacrificed at P28. RESULT(S): ECFCs isolated from hyperoxic lungs proliferated less rapidly when cultured in vitro for 3 weeks. More strikingly, ECFCs from the hyperoxic group showed decreased clonogenic capacity (percentage of single ECFC capable of generating colonies after 14 days) and formed fewer endothelial networks in matrigel. Intra-jugular administration of hUCB-ECFCs on P14 improved lung function and preserved alveolar development in hyperoxia-exposed mouse pups. ECFC therapy also attenuated pulmonary hypertension, a co-morbidity commonly associated with severe BPD, assessed by improved pulmonary artery acceleration times and decreased right ventricular hypertrophy. CONCLUSION(S): Impaired ECFC function in hyperoxia-exposed rat pups could in part contribute to arrested alveolar growth in BPD. hUCB-derived ECFC may offer a new therapeutic avenue for lung diseases characterized by alveolar injury.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70784016
TI  - The caffeine for apnea of prematurity (CAP) trial: Outcomes at 5 years
AU  - Schmidt B.
AU  - Anderson P.J.
AU  - Doyle L.W.
AU  - Dewey D.
AU  - Grunau R.
AU  - Asztalos E.
AU  - Davis P.G.
AU  - Tin W.
AU  - Moddemann D.
AU  - Solimano A.
AU  - Ohlsson A.
AU  - Barrington K.
AU  - Roberts R.S.
AU  - Investigator C.A.P.
Y1  - 2011//
KW  - *newborn apnea
KW  - *society
KW  - therapy
KW  - human
KW  - infant
KW  - child
KW  - disability
KW  - survival
KW  - death
KW  - risk
KW  - motoneuron
KW  - cognition
KW  - safety
KW  - school
KW  - motor development
KW  - data base
KW  - follow up
KW  - birth weight
KW  - lung dysplasia
KW  - hearing
KW  - parent
KW  - Child Behavior Checklist
KW  - Wechsler intelligence scale
KW  - Gross Motor Function Classification System
KW  - health
KW  - *caffeine
KW  - placebo
T2  - Paediatrics and Child Health
LA  - English
VL  - 16
IS  - SA
PB  - Churchill Livingstone
SN  - 1751-7222
AD  - B. Schmidt, McMaster University, Hamilton, ON, Canada
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70784016
AB  - Background: The Caffeine for Apnea of Prematurity (CAP) trial enrolled 2006 infants with birth weights less than 1250 grams who were randomly assigned to receive caffeine therapy or placebo for apnea of prematurity (ClinicalTrials.gov NCT00182312). Caffeine-treated infants had a significantly decreased risk of bronchopulmonary dysplasia (N Engl J Med 2006;354:2112), as well as an improved rate of survival without neurodevel- opmental impairment at 18 to 21 months corrected age (N Engl J Med 2007;357:1893). Objective(s): To reassess the CAP trial participants at a corrected age of 5 years in order to estimate more accurately the long-term effects of neonatal caffeine therapy, with particular emphasis on cognitive, behavioural and motor development. Design/Methods: The main outcome at age 5 years is a composite of death or survival with disability in at least one of 6 domains: cognition, neuromotor function, behavior, vision, hearing, and general health. Standardized tests included a thorough history and physical exam, application of the Gross Motor Function Classification System, the Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III), and the Child Behavior Checklist Parent Form. Result(s): All but 4 of the original study centers participated in this extended follow up. These 4 centers enrolled a total of 74 infants, leaving 1932 children eligible for inclusion in the present study. As of November 23, 2010, vital status has been ascertained for 1800 children or 93% of the eligible cohort and adequate data for the composite outcome of death or disability have been received at the data center for 1636 children (85%). The last two assessments are booked for early December 2010 and the database will be declared closed in early 2011. The final analyses will be completed by the end of April 2011. Conclusion(s): To date, the CAP trial has shown that the benefits of caffeine therapy for apnea of prematurity outweigh any potential risks up to a corrected age of 18 to 21 months. However, several important potential long-term consequences of caffeine therapy may not become apparent until the study cohort reaches pre-school age. The present analysis will confirm or refute the longer-term safety of caffeine therapy for apnea of prematurity.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70757488
TI  - VEGF family growth factor ratio is abnormal in bronchopulmonary dysplasia
AU  - Bilko S.J.
AU  - Xiang L.
AU  - Liu L.
AU  - Lloyd P.G.
Y1  - 2011//
KW  - *lung dysplasia
KW  - pathogenesis
KW  - lung
KW  - prematurity
KW  - gene expression
KW  - Western blotting
KW  - rat
KW  - oxygen therapy
KW  - chronic lung disease
KW  - *growth factor
KW  - *vasculotropin
KW  - vasculotropin A
KW  - protein
KW  - messenger RNA
T2  - FASEB Journal
LA  - English
VL  - 25
IS  - Meeting Astracts
SP  -
PB  - FASEB
SN  - 0892-6638
AD  - S.J. Bilko, Physiological Sciences, Oklahoma State University, Stillwater, OK, United States
UR  - http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/660.3?sid=20d60365-6754-4199-a066-4f3ef02f73a7
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70757488
AB  - Reduced VEGF-A signaling has been implicated in the pathogenesis of bronchopulmonary dysplasia (BPD), a chronic lung disease affecting premature infants following O2 therapy. PLGF is a VEGF-family growth factor which can heterodimerize with VEGF-A and modulate VEGF-A signaling. Thus, changes in relative expression of VEGF-A and PLGF may be physiologically relevant. It is unknown if PLGF levels are altered in BPD. Thus, our goal was to determine whether the PLGF:VEGF ratio is altered in experimental BPD. We hypothesized that PLGF would increase, leading to a higher PLGF:VEGF ratio. To induce BPD, 3 d old neonatal rats were exposed to 95% O2 for 10 d. PLGF mRNA increased to 3.38 +/- 0.58 fold of control in BPD lungs (p<0.01), whereas VEGF-A mRNA decreased to 0.48 +/- 0.03 fold of control (p<0.01, N=3/group). Western blot confirmed reduced VEGF-A protein in BPD lungs (50% of control; p<0.05, N=5 control, 3 BPD). Surprisingly, PLGF protein was also slightly reduced, to 72% of control (p<0.05). However, the PLGF:VEGF ratio was mildly elevated in BPD (to 136% of control), due to the proportionally larger decrease in VEGF. Further studies are needed to determine whether this change in the PLGF:VEGF ratio contributes to the pathogenesis of BPD, and to characterize potential post-transcriptional mechanisms that regulate PLGF protein levels independently of gene expression.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70753764
TI  - Maternal DHA supplementation attenuates newborn hyperoxia-induced lung developmental deficits into early adulthood
AU  - Rogers L.K.
AU  - Dingess K.
AU  - Velten M.
AU  - Heyob K.
AU  - Valentine C.J.
Y1  - 2011//
KW  - *newborn
KW  - *hyperoxia
KW  - *lung
KW  - *adulthood
KW  - *supplementation
KW  - diet
KW  - lung function
KW  - mouse
KW  - tissues
KW  - mare
KW  - prematurity
KW  - exposure
KW  - lung dysplasia
KW  - newborn period
KW  - Western blotting
KW  - lung development
KW  - ambient air
KW  - inflammation
KW  - compliance (physical)
KW  - hypothesis
KW  - nursing
KW  - lung disease
KW  - protein
KW  - acid
T2  - FASEB Journal
LA  - English
VL  - 25
IS  - Meeting Astracts
SP  -
PB  - FASEB
SN  - 0892-6638
AD  - L.K. Rogers, Center for Perinatal Research, Research Institute at Nationwide Chlidrens Hospital, Columbus, OH, United States
UR  - http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/990.17?sid=59560fa8-3402-4d94-b99b-03af1f5ad339
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70753764
AB  - Newborn mice exposed to hyperoxia demonstrate decreased alveolarization similar to preterm infants with bronchopulmonary dysplasia. We tested the hypothesis that docosahexanoic acid (DHA) administration to pregnant and nursing dams would decrease inflammatory responses and improve lung function. Dams were fed purified control or DHA-supplemented diets beginning at E16. After birth, the pups were exposed to >85%O2 or room air (RA) for 14 days, then returned to standard diets and RA until 28 days. Lung development was assessed by morphometric analyses and pulmonary function. Protein levels of COX-2 and sRAGE were analyzed by western blot. Mice receiving DHA and hyperoxia exposure during the newborn period demonstrated increased alveolarization (alveolar number, 103 vs 65; alveolar area, 1516 vs 2058 microns2) and improved lung function (tissue elastance, 24.9 vs 32.0 ml/cmH2O; tissue compliance, 0.042 vs 0.035 ml/cmH2O) compared to control diet, hyperoxia exposed mice. Levels of COX-2 and sRAGE were higher in pups exposed to hyperoxia but were attenuated by DHA supplementation. Neonatal hyperoxia exposure caused sustained lung deficits in adulthood that were lessened by DHA supplementation and may be mediated through RAGE or COX-2 signaling pathways. We speculate that maternal DHA supplementation will be beneficial in preventing lung disease in premature infants. Supported by ATS unrestricted grant.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Hypoxia-inducible factor-1 stimulates postnatal lung development but does not prevent O2-induced alveolar injury.
DO  - https://dx.doi.org/10.1165/rcmb.2014-0037OC
AU  - Tibboel, Jeroen
AU  - Groenman, Freek A
AU  - Selvaratnam, Johanna
AU  - Wang, Jinxia
AU  - Tseu, Irene
AU  - Huang, Zhen
AU  - Caniggia, Isabella
AU  - Luo, Daochun
AU  - van Tuyl, Minke
AU  - Ackerley, Cameron
AU  - de Jongste, Johan C
AU  - Tibboel, Dick
AU  - Post, Martin
Y1  - 2015//
N1  - Erratum in (EIN)
KW  - Animals
KW  - HEK293 Cells
KW  - Humans
KW  - *Hyperoxia/me [Metabolism]
KW  - Hyperoxia/pa [Pathology]
KW  - *Hypoxia-Inducible Factor 1, alpha Subunit/ph [Physiology]
KW  - *Lung/me [Metabolism]
KW  - Lung/pa [Pathology]
KW  - Mice, Inbred C57BL
KW  - Mice, Transgenic
KW  - Pulmonary Alveoli/me [Metabolism]
KW  - *Pulmonary Alveoli/pa [Pathology]
KW  - Vascular Endothelial Growth Factor A/me [Metabolism]
T2  - American journal of respiratory cell and molecular biology
VL  - 52
IS  - 4
SN  - 1044-1549
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25180700
AD  - United States
AB  - This study investigated whether hypoxia-inducible factor (HIF)-1 influences postnatal vascularization and alveologenesis in mice and whether stable (constitutive-active) HIF could prevent hyperoxia-induced lung injury. We assessed postnatal vessel and alveolar formation in transgenic mice, expressing a stable, constitutive-active, HIF1alpha-subunit (HIF-1alphaDELTAODD) in the distal lung epithelium. In addition, we compared lung function, histology, and morphometry of neonatal transgenic and wild-type mice subjected to hyperoxia. We found that postnatal lungs of HIF-1alphaDELTAODD mice had a greater peripheral vessel density and displayed advanced alveolarization compared with control lungs. Stable HIF-1alpha expression was associated with increased postnatal expression of angiogenic factors, including vascular endothelial growth factor, angiopoietins 1 and 2, Tie2, and Ephrin B2 and B4. Hyperoxia-exposed neonatal HIF-1alphaDELTAODD mice exhibited worse lung function but had similar histological and surfactant abnormalities compared with hyperoxia-exposed wild-type controls. In conclusion, expression of constitutive-active HIF-1alpha in the lung epithelium was associated with increased postnatal vessel growth via up-regulation of angiogenic factors. The increase in postnatal vasculature was accompanied by enhanced alveolar formation. However, stable HIF-1alpha expression in the distal lung did not prevent hyperoxia-induced lung injury in neonates but instead worsened lung function.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70677239
TI  - Postnatal growth and growth factors in diseases of prematurity: Implications for affected angiogenesis in lung and retinal development
AU  - Lofqvist C.A.
AU  - Niklasson A.
AU  - Hansen-Pupp I.
AU  - Engstrom E.
AU  - Smith L.E.H.
AU  - Hard A.-L.
AU  - Ley D.
AU  - Hellstrom A.
Y1  - 2011//
KW  - *angiogenesis
KW  - *prematurity
KW  - *postnatal growth
KW  - *diseases
KW  - *society
KW  - *lung
KW  - human
KW  - infant
KW  - morbidity
KW  - weight
KW  - model
KW  - premature labor
KW  - gestational age
KW  - blood sampling
KW  - birth weight
KW  - multiple regression
KW  - male
KW  - perinatal period
KW  - lung dysplasia
KW  - retrolental fibroplasia
KW  - retrospective study
KW  - gender
KW  - *growth factor
KW  - protein
T2  - Endocrine Reviews
LA  - English
VL  - 32
IS  - 3 Meeting Abstracts
SP  -
PB  - Endocrine Society
SN  - 0163-769X
AD  - C.A. Lofqvist, Department of Ophthalmology, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
UR  - http://edrv.endojournals.org/cgi/content/meeting_abstract/32/03_MeetingAbstracts/P2-748?sid=d04ee2c6-6106-41a6-a56f-e1d2ed668a88
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70677239
AB  - Attaining appropriate growth in very preterm infants continues to be a challenge during the postnatal period. Preterm birth is followed by a decrease in circulatory levels of IGF-I a protein with important growth-promoting and angiogenic properties.We investigated the relationship between poor postnatal growth, the IGF system and the development of preterm morbidities i.e. bronchopulmonary dysplasia [BPD] and retinopathy of prematurity [ROP].A retrospective study was performed in 108 very preterm infants [mean (SD) gestational age (GA) 27 (2.2) wks] with weekly weight measurements and blood samples from birth to a postmenstrual age [PMA] of 36 weeks. Infants who developed preterm morbidity had significantly lower GA and BW but not birth weight (BW) SDS compared to infants with no morbidity. The mean (SD) weight SDS at PMA 36 weeks were significantly lower in infants with preterm morbidity compared to infants with no morbidity, -2.1 (1.1) SDS and -1.6 (0.9) ug/L, respectively, p=0.042.The number of infants with an weight SD score below -2 SDS increased from birth to PMA 36 weeks in infants with morbidity, from 18 to 31 infants (28% to 48%) and in infants with no morbidity from 8 to 13 infants (18% to 30%), respectively.All growth factors was analyzed longitudinally both with mean (SD) and median (min-max). No significant differences between infants with preterm morbidity compared to infants with no morbidity was found for IGF-II or IGFBP-1 and IGFBP-3 or ALS levels.Serum IGF-I at PMA 30-33 weeks were significantly lower in infants with preterm morbidity compared to infants with no morbidity, 23 (0.9) ug/L and 32 (1.5) ug/L, respectively, p=0.000 also after adjusting for GA at birth p=0.001. The mean IGF-I:IGFBP-3 ratio at PMA 30-33 was significantly lower in infants with preterm morbidity 2.6% compared to 3.3% for infants with no morbidity, respectively p=0.000 also after adjusting for GA at birth p=0.002.The best fitted binomial multiple regression model for development of preterm morbidity associated with poor postnatal growth included GA, male gender, BWSDS, and IGF-1:IGFBP-3 ratio at postmenstrual age at 30-33 weeks (r2=0.731, p=0.000). This regression model correctly identified 84% of the infants with no morbidity and 91% of the infants with preterm morbidity.In minimizing the adverse consequences of early preterm birth, in-depth understandings of the mechanisms involved in the regulation of postnatal growth in very preterm infants seem essential.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70657510
TI  - Increased energy intake directly following birth does not increase gsh synthesis rates in preterm infants
AU  - Rook D.
AU  - Schierbeek H.
AU  - Vlaardingerbroek H.
AU  - Dorst K.
AU  - Vermeulen M.J.
AU  - Van Goudoever J.B.
Y1  - 2011//
KW  - *synthesis
KW  - *prematurity
KW  - *gastroenterology
KW  - *society
KW  - *caloric intake
KW  - *nutrition
KW  - infant
KW  - human
KW  - gestational age
KW  - birth weight
KW  - oxidative stress
KW  - leukomalacia
KW  - defense mechanism
KW  - continuous infusion
KW  - precursor
KW  - mass spectrometry
KW  - erythrocyte
KW  - protein intake
KW  - newborn
KW  - newborn morbidity
KW  - lung dysplasia
KW  - necrotizing enterocolitis
KW  - retrolental fibroplasia
KW  - upregulation
KW  - glutathione
KW  - lipid
KW  - antioxidant
KW  - amino acid
KW  - oxidizing agent
KW  - glycine
KW  - protein
KW  - reactive oxygen metabolite
T2  - Journal of Pediatric Gastroenterology and Nutrition
LA  - English
VL  - 52
IS  - SUPPL. 1
PB  - Lippincott Williams and Wilkins
SN  - 0277-2116
AD  - D. Rook, Pediatrics- Neonatology, Erasmus MC, Sophia Children's Hospital, Rotterdam, Netherlands
DO  - https://dx.doi.org/10.1097/MPG.0b013e318224e326
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70657510
AB  - Objectives and Study: Preterm neonates are subjected to increased oxidative stress due to excessive formation of reactive oxygen species and reduced antioxidant defenses following birth. Oxidative stress is strongly related to major neonatal morbidities such as bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of prematurity and periventricular leucomalacia. Early amino acid administration (AA) is known to increase glutathione (GSH) concentration, the main intracellular antioxidant, in preterm infants.1 We hypothesized that additional energy (provided via intravenous lipids), results in a further upregulation of anti-oxidant defense mechanism via increased GSH synthesis rates. Method(s): Preterm infants (gestational age < 32 weeks) were randomly assigned to receiving AAs (2.4 g/kg/d) or AAs and lipids (2 g/kg/d) from birth onwards. On day 2, infants received a primed, continuous infusion of [U-1C]glycine, a precursor for GSH synthesis, to determine fractional synthesis rate (FSR) using mass spectrometry. Absolute synthesis rate was calculated from the FSR and erythrocyte GSH concentration. Data of this ongoing trial are presented as median (min-max). Result(s): Birth weight (800 (585-1140) g) and birth weight- SD (-2.0 (-4.3-0.2)) were not significantly different between groups. Gestational age was lower in infants receiving AA+lipids (252/7 (242/7-296/7) weeks) compared to infants receiving only AAs (285/7 (26-315/7) weeks), p <0.05. Protein intake was not different between the groups; 2.5 (1.9-2.8) on day 1 and 2.5 (1.9-3.1) g/kg/d on day 2. Per protocol was the non-protein energy significantly higher in the infants receiving lipids; 50 (35-62) vs 30 (26-36) kcal/ kg/d on day 1 (P=0.001) and 53 (45-74) vs 33 (27-37) kcal/kg/d on day 2 (p <0.001). GSH concentration and synthesis rate were not different between the groups (Table). (Table presented) Conclusion(s): Increased energy intake in preterm infants does not result in increased GSH synthesis rates.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70656263
TI  - Repair commences within 24 hours of brief ventilation-induced injury of the immature lung
AU  - Brew N.
AU  - Zahra V.
AU  - Hooper S.B.
AU  - Wallace M.
AU  - Harding R.
Y1  - 2011//
KW  - *lung
KW  - *air conditioning
KW  - *society
KW  - *injury
KW  - *Australia and New Zealand
KW  - gene
KW  - lung injury
KW  - sheep
KW  - gene expression
KW  - fetus
KW  - prematurity
KW  - artificial ventilation
KW  - morphology
KW  - gestational age
KW  - surgery
KW  - thorax
KW  - trachea
KW  - ewe
KW  - autopsy
KW  - early response gene
KW  - lung dysplasia
KW  - messenger RNA
KW  - interleukin 6
KW  - interleukin 8
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 47
IS  - SUPPL. 1
PB  - Blackwell Publishing
SN  - 1034-4810
AD  - N. Brew, Department of Anatomy and Developmental Biology, Monash University, VIC, Australia. E-mail: nadine.brew@monash.edu
DO  - https://dx.doi.org/10.1111/j.1440-1754.2011.02047.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70656263
AB  - Background: Very preterm infants often require mechanical ventilation (MV), but this can cause lung injury that contributes to bronchopulmonary dysplasia. Even brief periods of MV can injure the very immature lung and early response and inflammatory genes are thought to play an important role in lung injury manifestation. To investigate mechanisms of MV development and repair we have developed a novel method of ventilating fetal sheep to induce injury in the very immature lung. Brief MV (2 h) alters lung morphology within 24 h of MV but resolves without further treatment within 15 days. Our aim was to identify the mechanisms underlying repair of the immature lung following MV. Method(s): Pregnant sheep at 110 d and 125 d gestational age (DGA; term is ~147DGA) underwent aseptic, recovery surgery to exteriorise the fetal head and chest. The fetal trachea was intubated and the lungs ventilated for 2 h with an injurious ventilation protocol (PEEP = 0 cmH2O, PIP = 40 cmH2O, Vt = ~5 mL/kg, n = 6). Ewes and foetuses remained healthy until necropsy, performed 24 h later. Unventilated sham-operated foetuses were controls (n = 6). Gene expression was measured by qRT-PCR. Result(s): There was no difference in the relative mRNA levels of early response genes (CTGF, CYR-61, and EGR-1) and inflammatory genes (IL-1beta, IL-6, IL-8 and TNFalpha) between control and ventilated lungs at both the saccular and early alveolar stages of development. Conclusion(s): We conclude that repair processes, commencing with normalisation of early response and inflammatory gene expression, occur in the very immature lung within 24 h of brief, injurious, MV.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70646789
TI  - Alveolar growth abnormalities: Not just BPD
AU  - Metwalli Z.
AU  - Guillerman R.
Y1  - 2011//
KW  - *radiology
KW  - human
KW  - patient
KW  - infant
KW  - trisomy 21
KW  - pulmonary hypertension
KW  - child
KW  - respiratory failure
KW  - gene mutation
KW  - lung transplantation
KW  - Tertiary (period)
KW  - lung dysplasia
KW  - radiologist
KW  - pathologist
KW  - emphysema
KW  - pathology
KW  - data base
KW  - morbidity
KW  - idiopathic disease
KW  - pediatric hospital
KW  - thorax
KW  - imaging
KW  - lung biopsy
KW  - lung
KW  - transplantation
KW  - glycogen storage disease
KW  - hyperinflation
KW  - cyst
KW  - pulmonary artery
KW  - follow up
KW  - prematurity
KW  - congenital heart disease
KW  - filamin A
KW  - glass
T2  - Pediatric Radiology
LA  - English
VL  - 41
IS  - SUPPL. 1
PB  - Springer Verlag
SN  - 0301-0449
AD  - Z. Metwalli, Claire Langston Texas Children's Hospital, Houston, United States
DO  - https://dx.doi.org/10.1007/s00247-011-2024-4
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70646789
AB  - Purpose: Alveolar growth abnormalities are characterized by lobular simplification with enlarged alveoli with deficient septation, and are most commonly observed in premature infants with bronchopulmonary dysplasia (BPD). In infants and children without BPD, radiologists and pathologists can misdiagnose alveolar growth abnormalities as emphysema. To promote appropriate recognition, we present the imaging findings of the largest known series of alveolar growth abnormalities in infants and children without a history of BPD. Material(s) and Method(s): All patients with alveolar growth abnormalities over a 9-year period (2000-2009) at a tertiary children's hospital were identified from a pathology database. The chest CT exams and clinical charts were retrospectively reviewed. Preterm patients with BPD were excluded from analysis. Result(s): Alveolar growth abnormalities were diagnosed in 12 near- or full-term patients (age 6 days-4 years) by lung biopsy or following lung transplant. Associated abnormalities included trisomy 21 in 2 (17%), pulmonary interstitial glycogenosis in 2 (17%) and filamin A gene mutations in 2 (17%). All but one patient (92%) had structural cardiac abnormalities. CT findings included lobular architectural distortion in 7 (58%), intralobular hyperlucency in 6 (50%), ground glass opacities in 6 (50%), and coarse perilobular interstitial thickening in 4 (33%). Additional findings of multilobar hyperinflation were noted in 2 patients with filamin A gene mutations and subpleural cysts in 2 patients with trisomy 21. Pulmonary hypertension was present in 10 patients (83%), but not always associated with pulmonary artery enlargement on CT. Three patients were lost to follow-up, and 7 of the remaining 9 developed refractory respiratory insufficiency (2 requiring lung transplantation). Conclusion(s): Alveolar growth abnormalities can occur in near- and full-term patients as a primary idiopathic disorder or in association with congenital heart disease and certain genetic conditions. Appropriate recognition is important due to the high morbidity including pulmonary hypertension and refractory respiratory insufficiency that may require lung transplantation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70641674
TI  - The role of eosinophil in preterm infants with bronchopulmonary dysplasia
AU  - Rha Y.
AU  - Kim S.
AU  - Kim M.
AU  - Choi S.
Y1  - 2011//
KW  - *eosinophil
KW  - *clinical immunology
KW  - *allergy
KW  - *lung dysplasia
KW  - *prematurity
KW  - respiratory distress syndrome
KW  - serum
KW  - urine
KW  - patient
KW  - blood
KW  - human
KW  - eosinophil count
KW  - pH
KW  - arterial gas
KW  - blood gas analysis
KW  - statistical significance
KW  - wheezing
KW  - immunity
KW  - inflammation
KW  - neutrophil
KW  - macrophage
KW  - pathogenesis
KW  - artificial ventilation
KW  - eosinophil cationic protein
KW  - eosinophil protein X
KW  - lung surfactant
KW  - marker
T2  - Allergy: European Journal of Allergy and Clinical Immunology
LA  - English
VL  - 66
IS  - SUPPL. 94
PB  - Blackwell Publishing Ltd
SN  - 0105-4538
AD  - Y. Rha, Kyunghee University Hospital, Department of Pediatrics, Seoul, South Korea
DO  - https://dx.doi.org/10.1111/j.1398-9995.2011.02608.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70641674
AB  - Background: Bronchopulmonary dysplasia (BPD) results in bronchial hyper-responsiveness and recurrent wheezing. Recent studies suggested that eosinophil has relevance to innate immune defense and inflammatory process in early life. While the activation of neutrophil and macrophage in pathogenesis of BPD are rather well studied, very few studies have addressed the possible participation of eosinophil. We hypothesized that eosinophil may be involved in early phase of BPD. Method(s): Preterm infants were recruited consecutively and grouped to respiratory distress syndrome (RDS) or non-RDS. RDS group was divided to BPD or non- BPD group then. We investigated blood eosinophil, serum eosinophil cationic protein (ECP), eosinophil protein X (EPX), and urine EPX to determine the relationship between eosinophil activation and BPD in premature infants prospectively. The eosinophil count, serum ECP/ EPX and urine ECP/ EPX were compared. Spearman rank test was used to analyze the correlation between serum, tracheal and urine ECP. Result(s): Among total 43 patients recruited, 13 patients were treated with pulmonary surfactant and mechanical ventilation for RDS. Six out of 13 patients were diagnosed with BPD. There were no difference of blood eosinophil, serum ECP, EPX, or urine EPX between RDS and non-RDS groups. Blood eosinophil, serum ECP, EPX, and urine EPX were higher in BPD group than non-BPD group which was not statistically significant. Interestingly serum EPX was significantly correlated with pH of arterial blood gas analysis which was done at discharge. (r = 0.441, P = 0.012). Conclusion(s): Eosinophil activation markers were higher in BPD group which suggests the possible role of eosinophil in BPD although there was no statistical significance.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70632385
TI  - Mice deficient in the cytochrome p450 (CYP)1A2 gene show enhanced levels of F2-isoprostanes, oxidative DNA adducts, and augmented susceptibility to oxygen-mediated lung injury in vivo: Novel biomarkers for bronchopulmonary dysplasia (BPD) in preterm infants
AU  - Moorthy B.
AU  - Wang L.
AU  - Couroucli X.
AU  - Jiang W.
Y1  - 2011//
KW  - *DNA adduct
KW  - *mouse
KW  - *lung dysplasia
KW  - *gene
KW  - *prematurity
KW  - *lung injury
KW  - *toxicology
KW  - *health care organization
KW  - tracheal aspiration procedure
KW  - DNA damage
KW  - hyperoxia
KW  - human
KW  - lung
KW  - ambient air
KW  - infant
KW  - hypothesis
KW  - assay
KW  - air quality control
KW  - liver
KW  - oxygen therapy
KW  - wild type
KW  - male
KW  - pilot study
KW  - *DNA
KW  - *isoprostane derivative
KW  - *oxygen
KW  - *cytochrome P450
KW  - *cytochrome
KW  - phosphorus 32
T2  - Toxicology Letters
LA  - English
VL  - 205
IS  - SUPPL. 1
PB  - Elsevier Ireland Ltd
SN  - 0378-4274
AD  - B. Moorthy, Pediatrics, Baylor College of Medicine, Houston, United States
DO  - https://dx.doi.org/10.1016/j.toxlet.2011.05.640
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70632385
AB  - Purpose: Supplemental oxygen therapy contributes to BPD in infants. In this investigation, we tested the hypothesis that mice lacking the gene for CYP1A2 would display increased susceptibility to oxidative DNA damage in vivo in response to hyperoxia, compared to wild type (WT) mice. We also tested the hypothesis that tracheal aspirates of premature infants who develop BPD will display higher levels of oxidative DNA adducts. Method(s): Twelve week-old male WT (C57BL/6J) mice or Cyp1a2-null mice were exposed to hyperoxia (greater than 95%O2) or room air for 24-72 h. In another experiment, tracheal aspirates from premature infants who received supplemental oxygen (6 BPD group and 5 non-BPD group) were used to measure oxidative DNA adducts 5 days after birth. Oxidative DNA lesions in lung or liver tissues of mice or human tracheal aspirates were determined by the 32P-postlabeling assay. Result(s): The Cyp1a2-null mice were more susceptible to lung damagethan similarly exposedWTanimals. OxidativeDNAadducts were augmented in the lungs of WT and Cyp1a2-null mice exposed to 72 h of hyperoxia, compared to room air controls, with Cyp1a2- null mice showing a greater degree of enhancement. In a pilot study using tracheal aspirates, the oxidative DNA lesions were significantly higher in the BPD group than the non-BPD group. The positive correlation between oxidative DNA adducts, and extent of lung injury suggests that oxidative DNA damage contributes to lung injury. Further studies could lead to the development of novel strategies for the prevention/treatment of BPD in infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70582739
TI  - Hyperoxic regulation of mitochondrial cell death via Trx2
AU  - Titus B.K.
AU  - Forred B.J.
AU  - Floen M.J.
AU  - Vitiello P.F.
Y1  - 2011//
KW  - *cell death
KW  - *society
KW  - hyperoxia
KW  - injury
KW  - protein expression
KW  - pathogenesis
KW  - mitochondrion
KW  - exposure
KW  - homeostasis
KW  - human
KW  - epithelium cell
KW  - cell line
KW  - lung dysplasia
KW  - chronic lung disease
KW  - newborn
KW  - pathology
KW  - respiratory epithelium
KW  - cell damage
KW  - death
KW  - oxidation reduction potential
KW  - *free radical
KW  - protein
KW  - thiol
KW  - oxygen
KW  - oxidoreductase
KW  - thioredoxin 2
KW  - protein bcl 2
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 51
IS  - SUPPL. 1
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - B.K. Titus, Sanford Research, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2011.10.038
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70582739
AB  - Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in newborns and its pathology has been associated with exposure to excess oxygen levels (hyperoxia). It is clear that oxidative injury to the developing respiratory epithelium is involved in BPD pathogenesis; however, not much is known about redox-dependent pathways that regulate respiratory cell injury and death. It has been previously shown that mitochondria are a critical target of oxidative injury and exhibit altered redox potentials resulting in activation of cell death pathways. the thiol oxidoreductase protein, thioredoxin-2 (Trx2), is regulates mitochondrial redox homeostasis and has been shown to regulate mitochondrial-dependent cell death through inhibition of antiapoptotic members of the Bcl-2 family. Previous studies demonstrate that hyperoxic cell death is dictated by interactions between anti-apoptotic (Bcl-XL, Mcl-1) and pro-apoptotic (Bax, Bak) Bcl-2 family proteins. Therefore, these studies were aimed at understanding the role of Trx2 in mitochondrial cell death during hyperoxia. Human immortalized pulmonary epithelial cells (A549, H1299) were treated with 95% oxygen and analyzed for expression of Trx2 pathway and Bcl-2 family proteins. Hyperoxic exposure resulted in alterations in Bcl-2 family protein expression marked by increased Bcl-XL, Bax, and Bak and decreased Mcl-1 levels. Hyperoxic treatment induced expression of Trx2 and its respective thiol reductase, TrxR2. To test for functional associations between Trx2 and Bcl-2 proteins during hyperoxia, we generated a cell line with inducible expression of Trx2 and this is a major focus of ongoing investigations. Taken together, these studies show that mitochondria are a critical target of hyperoxic injury due to altered Trx2 and Bcl-2 family protein expression which may contribute to BPD pathogenesis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70575123
TI  - Respiratory syncytial virus hospitalizations in the Canadian registry for synagis (CARESS)
AU  - Paes B.A.
AU  - Li A.
AU  - Lanctot K.L.
AU  - Mitchell I.
Y1  - 2011//
KW  - *register
KW  - *hospitalization
KW  - *Respiratory syncytial pneumovirus
KW  - human
KW  - infant
KW  - general aspects of disease
KW  - respiratory tract disease
KW  - length of stay
KW  - prophylaxis
KW  - season
KW  - congenital heart disease
KW  - Down syndrome
KW  - airway
KW  - immunocompromised patient
KW  - congenital malformation
KW  - cystic fibrosis
KW  - prematurity
KW  - hospital
KW  - infection
KW  - advisory committee
KW  - population
KW  - risk
KW  - data base
KW  - gestational age
KW  - morbidity
KW  - intubation
KW  - assisted ventilation
KW  - dysplasia
KW  - lung
KW  - respiratory syncytial virus infection
KW  - *palivizumab
T2  - Value in Health
LA  - English
VL  - 14
IS  - 7
PB  - Elsevier Ltd
SN  - 1098-3015
AD  - B.A. Paes, McMaster University, Hamilton, ON, Canada
DO  - https://dx.doi.org/10.1016/j.jval.2011.08.908
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70575123
AB  - OBJECTIVES: Paediatric advisory committee guidelines recommend palivizumab prophylaxis for specific sub-populations of infants at high risk for respiratory syncytial virus (RSV) infection. However, effectiveness of palivizumab may vary across indications and countries. The objective of our study was to determine hospitalization rates for respiratory illness (RIH) and RSV-positive infections (RSVH) following prophylaxis and compare rates found in this study with other world-wide data from published registries. METHOD(S): Neonatal and demographic data were collected prospectively across 29 national sites as part of an established CAnadian REgistry for SynagiS (CARESS) database from infants who received >=1 dose of palivizumab during the 2005-2010 RSV seasons. Respiratory illness (RI) events were documented monthly. RESULT(S): The 7699 infants enrolled were premature (<=35 completed weeks gestational age, without any underlying medical illnesses; n=5237), had chronic lung disease/bronchopulmonary dysplasia (n=646), hemodynamically significant congenital heart disease (n=766), or had other pre-existing conditions such as neuromuscular impairments, Down syndrome, pulmonary or airway malformations, immunocompromise or cystic fibrosis (n=1050). The overall RIH rate was 6.0%. Premature infants had a significantly lower rate (4.1%) than the other groups (range 8.7% -11.5%; B=-0.912, df=1, p=0.005). The overall RSVH rate was 1.47% with significant differences between groups (range 1.22% - 2.46%; chi2=22.606, df=3, p < 0.0005). Apart from hospital length of stay, morbidities differed significantly across the sub-groups during RSVH including number of ICU admissions and length of stay, number ventilated and duration of intubation, number requiring respiratory support and duration (all p<0.05). CONCLUSION(S): Hospitalization rates for RI events and RSV illness were different across the groups. Comparisons with other registries indicate that RSVH rates are in the lower range overall (range 1.3 -8.1%); however, comparisons are difficult to establish as most studies do not account for the varying lengths of observation that arise because infants are enrolled at different times during the RSV season.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70573153
TI  - Role of oxidative stress biomarkers in prematurity related diseases
AU  - Tataranno M.L.
AU  - Perrone S.
AU  - Negro S.
AU  - Bellieni C.V.
AU  - Longini M.
AU  - Marzocchi B.
AU  - Proietti F.
AU  - Napoliello L.
AU  - Buonocore G.
Y1  - 2011//
KW  - *neonatology
KW  - *oxidative stress
KW  - *workshop
KW  - *prematurity
KW  - umbilical cord blood
KW  - newborn
KW  - blood level
KW  - risk
KW  - cell damage
KW  - perinatal period
KW  - promoter region
KW  - necrotizing enterocolitis
KW  - brain damage
KW  - patent ductus arteriosus
KW  - hypothesis
KW  - lung dysplasia
KW  - antioxidant
KW  - free radical
KW  - protein
KW  - iron
KW  - hydroperoxide
T2  - Journal of Neonatal-Perinatal Medicine
LA  - English
VL  - 4
IS  - 3
PB  - IOS Press
SN  - 1934-5798
AD  - M.L. Tataranno, Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Sienna, Italy
DO  - https://dx.doi.org/10.3233/NPM-2011-2800
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70573153
AB  - Background: Imbalance between free radicals (FR) generation and antioxidant systems induce oxidative stress (OS) that negatively impact on newborns development. Consequently OS emerged as a promoter of several prematurityrelated disorders (PRD): bronchopulmonary dysplasia, necrotizing enterocolitis, brain damage, patent ductus arteriosus. The aim was to test the hypothesis that OS biomarkers in cord blood may early identify the onset of PRD. Method(s): Non protein bound iron (NPBI) and total hydroperoxide (TH) were measured in cord blood of 909 preterm newborns recruited in four European centers. The associations between PRD onset and OS biomarkers was checked through inferential analysis. Result(s): The onset of PRD was significantly associated with highest cord blood levels of TH (p = 0.01, OR = 1.003, 95% CI = 1.001-1.004) and NPBI (p = 0.003, OR = 1.098, 95% CI = 1.033-1.166). Conclusion(s): High levels of cord NPBI and TH were associated with increased risk for PRD in newborns. We hypothesize an impairment of the antioxidant defense systems and enhancement of FR generation which alters cellular signaling and/or damage cells during pre-perinatal period.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70528945
TI  - Pulmonary hyaline membrane aspects in the forensic practice
AU  - Koumpanaki M.-M.
AU  - Enache A.
AU  - Chatzinikolaou F.
AU  - Zegelidou E.
AU  - Kalyva E.
Y1  - 2011//
KW  - *pathology
KW  - *membrane
KW  - *diagnosis
KW  - sudden death
KW  - bronchopneumonia
KW  - perinatal period
KW  - adult
KW  - death
KW  - injury
KW  - respiratory distress syndrome
KW  - human
KW  - membrane formation
KW  - newborn
KW  - mother
KW  - female
KW  - HELLP syndrome
KW  - inflammation
KW  - hyaline membrane disease
KW  - brain damage
KW  - skull fracture
KW  - pneumonia
KW  - pregnancy toxemia
KW  - *hyalin
T2  - Virchows Archiv
LA  - English
VL  - 459
IS  - SUPPL. 1
PB  - Springer Verlag
SN  - 0945-6317
AD  - M.-M. Koumpanaki, Theageneion Cancer Hospital, Dept. of Pathology, Thessaloniki, Greece
DO  - https://dx.doi.org/10.1007/s00428-011-1113-y
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70528945
AB  - Objective: We studied the preconditions and the traumatic and pathological history in 1,090 cases of sudden death at IMLTimisoara in which the microscopic exam made by the usual HE coloration highlighted hyaline membrane formation at the pulmonary level. Method(s): We present three characteristic cases: a newborn whose mother had gestational toxemia complicated with HELLP syndrome, a 33-year-old who died from acute bronchopneumonic inflammatory process complicated with hyaline membrane disease and a 46-year-old who presented a cranio-cerebral lesion with cranial fractures, meningial lesion, bronchopneumonia and formation of alveolar hyaline membrane. Result(s): The analysis of the microscopic investigations revealed an association between the infectious processes with a silent evolution (pneumonias, bronchopneumonias, leptomeningitis) and the formation of HM on the alveoli. Considering the characteristical lack of severe symptoms we can classify the situations in which we encountered pulmonary hyaline into three groups: perinatal period associated death, sudden death in an adult with silent infectious pathology and deaths in which trauma is associated with secondary infectious processes. Conclusion(s): In sudden death cases in which infectious type changes appear, the main life-threatening condition is the pulmonary hyaline membrane deposits with an important role in the genesis of the respiratory distress syndrome.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Role of microRNA-150 and glycoprotein nonmetastatic melanoma protein B in angiogenesis during hyperoxia-induced neonatal lung injury.
DO  - https://dx.doi.org/10.1165/rcmb.2013-0021OC
AU  - Narasaraju, Telugu
AU  - Shukla, Dhananjay
AU  - More, Sunil
AU  - Huang, Chaoqun
AU  - Zhang, Li
AU  - Xiao, Xiao
AU  - Liu, Lin
Y1  - 2015//
KW  - Animals
KW  - Animals, Newborn
KW  - *Eye Proteins/me [Metabolism]
KW  - Humans
KW  - *Hyperoxia/me [Metabolism]
KW  - Lung/bs [Blood Supply]
KW  - Lung/me [Metabolism]
KW  - Lung Injury/ge [Genetics]
KW  - *Lung Injury/me [Metabolism]
KW  - Lung Injury/pa [Pathology]
KW  - *Membrane Glycoproteins/me [Metabolism]
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - *MicroRNAs/ge [Genetics]
KW  - *MicroRNAs/me [Metabolism]
KW  - Neovascularization, Pathologic
KW  - Rats
T2  - American journal of respiratory cell and molecular biology
VL  - 52
IS  - 2
SN  - 1044-1549
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25054912
AD  - United States
AB  - Glycoprotein nonmetastatic melanoma protein B (GPNMB), a transmembrane protein, has been reported to have an important role in tissue repair and angiogenesis. Recently, we have demonstrated that hyperoxia exposure down-regulates microRNA (miR)-150 expression and concurrent induction of its target gene, GPNMB, in neonatal rat lungs. This study aimed to test the hypothesis that soluble GPNMB (sGPNMB) promotes angiogenesis in the hyperoxic neonatal lungs. Wild-type (WT) or miR-150 knockout (KO) neonates, exposed to 95% O2 for 3, 6, and 10 days, were evaluated for lung phenotypes, GPNMB protein expression in the lungs, and sGPNMB levels in the bronchoalveolar lavage. Angiogenic effects of sGPNMB were examined both in vitro and in vivo. After a 6-day exposure, similar analyses were performed in WT and miR-150 KO neonates during recovery at 7, 14, and 21 days. miR-150 KO neonates displayed an increased capillary network, decreased inflammation, and less alveolar damage compared with WT neonates after hyperoxia exposure. The early induction of GPNMB and sGPNMB were found in miR-150 KO neonates. The recombinant GPNMB, which contained a soluble portion of GPNMB, promoted endothelial tube formation in vitro and enhanced angiogenesis in vivo. The increased capillaries in the hyperoxic lungs of miR-150 KO neonates appeared dysmorphic. They were abnormally enlarged in size and occasionally laid at subepithelial regions in the alveoli. However, the lung architecture returned to normal during recovery, suggesting that abnormal vascularity during hyperoxia does not affect postnatal lung development. GPNMB plays an important role in angiogenesis during hyperoxia injury. Treatment with GPNMB may offer a novel therapeutic approach in reducing pathologic complications in bronchopulmonary dysplasia.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70524687
TI  - Analysis of alveolar macrophage polarization following lung injury in premature neonates
AU  - Chan B.
AU  - Li A.
AU  - George R.
AU  - Groffen J.
AU  - Heisterkamp N.
AU  - Kwong K.
AU  - Ramanathan R.
AU  - Minoo P.
Y1  - 2011//
KW  - *polarization
KW  - *medical research
KW  - *prematurity
KW  - *lung alveolus macrophage
KW  - *lung injury
KW  - risk
KW  - newborn
KW  - human
KW  - female
KW  - pregnancy
KW  - fluorescence activated cell sorting
KW  - inflammation
KW  - infant
KW  - patient
KW  - clinical study
KW  - high risk population
KW  - death
KW  - lung
KW  - phenotypic plasticity
KW  - microenvironment
KW  - tissue repair
KW  - gene
KW  - tissue
KW  - lung dysplasia
KW  - tracheal aspiration procedure
KW  - inflammatory cell
KW  - marker
KW  - antibody
T2  - Journal of Investigative Medicine
LA  - English
VL  - 59
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - B. Chan, University of Southern California, Los Angeles, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e31820501bd
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70524687
AB  - Purpose of Study: Alveolar Macrophages (AM) exhibit significant phenotypic plasticity. Depending on the microenvironment, they undergo distinct polarization that either propagate inflammation, or alternatively promote tissue repair. Inflammation related genes are increased in M1-polarized cells; whereas, M2 polarized cells are important for tissue remodeling. No information is currently available onAM polarization in premature neonates at risk of Bronchopulmonary Dysplasia (BPD). The imbalance of pro-inflammatory and anti-inflammatory factors leads to BPDin premature neonates;we speculate AM polarization may be perturbed in this paradigm.We examined polarization state of AM obtained from the tracheal aspirates (TA) of preterm neonates at risk for BPD. Methods Used: We obtained serial TA samples from a cohort of intubated premature infants. The neonates were in two groups: Group 1, infants born between 22 and 30 weeks gestation (High BPD risk). Group 2 included infants born between 31 and 36 weeks gestation (Low BPD Risk). The inflammatory cells were isolated and subjected to Fluorescence Activated Cell Sorting (FACS) using antibodies against specific surface markers. Anti-CD14 and Anti-CD163 were used to identify M1- and M2- polarized AM respectively. The patients' clinical data were also analyzed. Summary of Results: TA samples from 12 premature neonates were collected and analyzed. Among the subjects, only 5 neonates survived without BPD. FACS analysis was performed on 47 samples. The percentile of CD14- positive AM was highly variable in both High and Low BPD Risk groups. No differences were found between the two groups. The abundance of M1-polarized AM did not correlate with the risk for BPD or death. Interestingly in a small number of Group 2 neonates M2-polarized AM increased as a function of postnatal age. Conclusion(s): To our knowledge, this is the first study to analyze polarization of AM in the lungs of neonates at risk for BPD. The relationship between AM polarization and BPD appears complex. In the neonates examined, M1 polarization did not correlate with BPD risk. Additional studies are underway to elucidate the role of AM polarization in BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70524422
TI  - Late surfactant increases surfactant protein (SP) levels in ventilated extremely low birthweight (ELBW) newborns
AU  - Keller R.L.
AU  - Merrill J.
AU  - Palermo L.
AU  - Truog W.
AU  - Steinhorn R.
AU  - Ryan R.
AU  - Eichenwald E.
AU  - Durand D.
AU  - Courtney S.
AU  - Black D.
AU  - Ballard P.
AU  - Ballard R.
Y1  - 2011//
KW  - *medical research
KW  - *newborn
KW  - *low birth weight
KW  - human
KW  - infant
KW  - prematurity
KW  - extremely low birth weight
KW  - survival
KW  - safety
KW  - immunoblotting
KW  - assay
KW  - tracheal aspiration procedure
KW  - male
KW  - ligation
KW  - bradycardia
KW  - morbidity
KW  - artificial ventilation
KW  - lung dysplasia
KW  - *surfactant
KW  - *protein
KW  - nitric oxide
KW  - calfactant
T2  - Journal of Investigative Medicine
LA  - English
VL  - 59
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - R.L. Keller, UCSF, San Francisco, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e31820501bd
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70524422
AB  - Purpose of Study: ELBW newborns requiring mechanical ventilation after 7 d of age have > 70% incidence of bronchopulmonary dysplasia (BPD), and most infants experience episodes of surfactant dysfunction secondary to SP-B deficiency (Merrill, Peds Res 2004). Treatment with inhaled nitric oxide (INO) increases survival without BPD (Ballard R, NEJM 2006,2007) but does not abolish surfactant dysfunction. We investigated the safety and efficacy of late doses of surfactant (calfactant) plus INO to improve surfactant composition in ventilated preterm infants. Methods Used: Randomized, blinded trial of ELBW (<= 1000g and 30 0/7 wk GA) ventilated at 73-14 d. Infants received INO plus 5 dose procedures of surfactant (SURF) or sham (CTRL). SP-B content (% of total protein) was quantified by immunoblot assay in large aggregate surfactant isolated from tracheal tracheal aspirate samples. 85 infants were enrolled; 48 were treated every 3-4 d (SURF n=28 and CTRL n=20) and the remainder were treated weekly after the first 2 doses. Summary of Results: Infants treated every 3-4 d that received SURF (vs. CTRL) were less mature (25.0 vs. 25.7 wks, P=0.05), and more likely male (68 vs. 40%, P=0.06). SP-B content at study entry was lower in SURF (1.06%) vs. CTRL (2.34%, P=0.05). Compared to baseline levels, SP-B content increased 0.69% (P=0.0003) and 0.05% (P=0.11) on days 1 and 2 after SURF; content decreased slightly in CTRL. The change in SP-B content on d 1 for treated infants was correlated with the mean levels of SP-B content (r=0.60, p=0.004), perhaps indicating enhanced SP-B degradation in deficient infants. There was no difference (SURF vs. CTRL) in PDA ligation (41 vs. 28%, P=0.37), NEC (11 vs. 15%) or IVH 3/4 (4 vs. 5%) after enrollment. 201 doses of surfactant were administered with adverse event frequency <= 2% (reintubation, or significant bradycardia or respiratory decompensation). Conclusion(s): Late surfactant increased SP-B content. Administration of late surfactant is well-tolerated and appears safe with regard to co-morbidities of prematurity.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70524419
TI  - Peroxisome proliferator-activated receptor (PPARGAMMA) agonist prostaglandin J2 blocks hyperoxia-induced decrease in pulmonary FGF-10 signaling
AU  - Sakurai R.
AU  - Chen A.
AU  - Torday J.
AU  - Rehan V.
Y1  - 2011//
KW  - *medical research
KW  - *hyperoxia
KW  - *agonist
KW  - fibroblast
KW  - lung
KW  - rat
KW  - exposure
KW  - lung dysplasia
KW  - human
KW  - model
KW  - lung fibroblast
KW  - down regulation
KW  - apoptosis
KW  - Sprague Dawley rat
KW  - *fibroblast growth factor 10
KW  - *peroxisome proliferator activated receptor
KW  - *prostaglandin
KW  - marker
KW  - leptin
KW  - fibronectin
KW  - caspase 3
KW  - fibroblast growth factor receptor 2
KW  - protein
KW  - receptor
KW  - growth factor
KW  - triolein
T2  - Journal of Investigative Medicine
LA  - English
VL  - 59
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - R. Sakurai, Los Angeles Biomedical Institute, Torrance, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e31820501bd
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70524419
AB  - Purpose of Study: Bronchopulmonary dysplasia (BPD) is characterized by fewer and larger alveoli, and abnormal branching of the affected lungs. Fibroblast growth factor 10 (FGF-10), an important growth factor that regulates lung branching and alveolarization, is decreased in BPD. On the other hand, our lab has recently shown in a rat model that BPD can be prevented by PPARGAMMA agonists such as prostaglandin J2 (PGJ2). How PGJ2 affects FGF-10 signaling is not known. The purpose of the study is to determine the effects of FGF-10 on alveolar fibroblast differentiation and determine if PGJ2 blocks hyperoxia-induced changes in FGF-10 signaling. Methods Used: To determine the effects of FGF-10 on alveolar fibroblast differentiation, both e19 (primary) fetal rat lung fibroblasts and human embryonic (WI38 cells) were treated with FGF-10 (1-100 ng/ml) for 24h. Following which, markers of fibroblast differentiation (PPARGAMMA, ADRP, SREBP1c, aP2, leptin and triolein uptake) were analyzed. In separate experiments, neonatal Sprague Dawley rat pups were categorized in the following groups: normoxia (control, 21%O2), normoxia + PGJ2 (0.3mg/kg), hyperoxia (exposure to 95%O2 for 7d), hyperoxia + PGJ2 (0.3mg/kg). PGJ2 was administered i.p. once daily. At the end of experimental period, the rat pups were sacrificed and protein was extracted from whole lung samples. UsingWestern blotting, we probed for FGF-10, and its receptor FGF receptor 2, PPARGAMMA, ADRP, leptin, fibronectin, Bax, Bcl-2 and cleaved caspase-3. Summary of Results: FGF10-treated fibroblasts showed dose-dependent increases in markers of differentiation. Under in vivo conditions, PGJ2 blocked hyperoxia-induced decreases in FGF-10, PPARGAMMA, leptin and increases in FGF-receptor 2 and fibronectin levels. Furthermore, hyperoxiainduced changes in apoptotic markers (increases in Bax and cleaved caspase 3 and decrease in Bcl-2) were also blocked in the PGJ2-treated group. Conclusion(s): Our data demonstrate the down-regulation of FGF-10 signaling and increase in apoptosis on exposure to hyperoxia, both of which were blocked by PGJ2. We speculate a direct interaction between FGF-10 and PPARGAMMA signaling pathways in the maintenance of alveolar growth and differentiation (Grant support: NIH-HL55268, HL075405, HD058948, HD051857) and TRDRP (15IT-0250, 17RT-0170).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70524418
TI  - Lung lipofibroblasts (LIFS) actively recruit, store and release retinoic acid in response to PGE2
AU  - Truong N.
AU  - Sakurai R.
AU  - Rehan V.
AU  - Torday J.
Y1  - 2011//
KW  - *medical research
KW  - *lung
KW  - secretion
KW  - lung fibroblast
KW  - kinetics
KW  - agonist
KW  - human
KW  - phospholipid synthesis
KW  - protein expression
KW  - atelectasis
KW  - storage
KW  - fibroblast
KW  - fetus lung
KW  - rat
KW  - adult
KW  - sensitivity and specificity
KW  - dose response
KW  - homeostasis
KW  - pathophysiology
KW  - respiratory distress syndrome
KW  - lung dysplasia
KW  - fibrosing alveolitis
KW  - emphysema
KW  - *prostaglandin E2
KW  - *retinoic acid
KW  - surfactant
KW  - lipid
KW  - fat droplet
KW  - phospholipid
KW  - protein
KW  - butaprost
KW  - prostaglandin
KW  - receptor
KW  - phloretin
T2  - Journal of Investigative Medicine
LA  - English
VL  - 59
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - N. Truong, Harbor-UCLA, Torrance, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e31820501bd
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70524418
AB  - Purpose of Study: Retinoic Acid (RA) is necessary for epithelial phenotypic expression and alveolar barrier function, yet treatment with exogenous RA has not been found to consistently promote and protect the alveolar epithelial barrier, either experimentally or clinically. We have previously shown that the alveolar type II (ATII) cell increases PGE2 secretion when stretched, stimulating Lipid Droplet (LD) secretion from neighboring lipofibroblasts (LIFs) at PGE2 concentrations comparable to those produced by ATIIs in culture. Since RA is also stored in LIF LDs, we hypothesized that PGE2 would concomitantly stimulate RA and lipid secretion by LIFs, coordinating the release of ATII surfactant lipid substrate with RA, the latter being an agonist for both surfactant phospholipid synthesis and surfactant protein expression. Such a pleiotropic mechanism of RA action would coordinate surfactant phospholipid and protein production with alveolar distension, preventing atelectasis. Methods Used: Uptake, storage and release of RA by cultured fibroblasts was determined based on the kinetics of 3H-RA in cultured WI38 human embryonic lung fibroblasts, primary fetal rat lung fibroblasts and adult lung fibroblasts. Cells were treated with Prostaglandin E2 (5 x 10-7M), an agonist for the uptake and release of RA from LIFs. The sensitivity and specificity of the PGE2 effects on LIF RA kinetics were determined using time-course and dose-response curves in combination with the use of specific molecular inhibitors (phloretin) and stimulators (butaprost) of the PGE2 receptor. Summary of Results: LIFs actively recruit RA over a 1-2 hour period, and store it in lipid droplets. PGE2 (5 x 10-7M) caused release of RA, whereas baseline secretion was minimal. Conclusion(s): LIF uptake and release of RA is coordinately regulated by PGE2 signaling from ATII cells. This effect has novel implications for understanding the basis for alveolar homeostasis and pathophysiology, providing new molecular targets for the treatment of Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Interstitial Pulmonary Fibrosis and Emphysema.(Partially supported by grants from the NIH (HL-55268, HL-075405, HD058948, and HD-051857) and the TRDRP (14RT-0073, 15IT-0250, 17RT-0170).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70524417
TI  - Prenatal administration of rosiglitazone to rat pups does not alter the adult metabolic phenotype
AU  - Sierra H.
AU  - Liu J.
AU  - Sakurai R.
AU  - Truong N.
AU  - Lee R.J.
AU  - Zhang G.
AU  - Lee P.W.
AU  - Torday J.
AU  - Rehan V.
Y1  - 2011//
KW  - *medical research
KW  - *phenotype
KW  - *adult
KW  - *rat
KW  - fatty acid synthesis
KW  - infant
KW  - human
KW  - Sprague Dawley rat
KW  - mare
KW  - insulin tolerance test
KW  - body weight
KW  - mass spectrometry
KW  - lung
KW  - liver
KW  - skeletal muscle
KW  - fetus lung maturity
KW  - plasma
KW  - glucose tolerance test
KW  - assay
KW  - statistical significance
KW  - therapy
KW  - fetus lung maturation
KW  - lung dysplasia
KW  - hybridization
KW  - *rosiglitazone
KW  - insulin
KW  - deuterium oxide
KW  - peroxisome proliferator activated receptor
KW  - dexamethasone
KW  - glucose
KW  - cholesterol
KW  - glucagon
KW  - triacylglycerol
KW  - diluent
KW  - drinking water
KW  - peroxisome proliferator activated receptor gamma
KW  - marker
KW  - deuterium
KW  - adipophilin
KW  - troponin
KW  - troponin I
T2  - Journal of Investigative Medicine
LA  - English
VL  - 59
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - H. Sierra, Harbor UCLA, Torrance, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e31820501bd
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70524417
AB  - Purpose of Study: To study the metabolic profiles of adult rats exposed prenatally to RGZ. Methods Used: Pregnant Sprague-Dawley rat dams were administered either diluent, RGZ (0.3mg/kg), RGZ (3mg/kg), or Dexamethasone (0.25mg/kg), intraperitoneally (IP) once daily x 2 doses, 24h apart, starting at embryonic day 18. At 11-12 wks of age glucose and insulin tolerance tests were performed after a 12h fast (glucose administered at 1g/kg IP, and insulin administered at 1U/kg subcutaneously). de novo fatty acid synthesis was analyzed by deuterium incorporation (DI) [99.9% deuterated water (D2O)]. D2O was injected IP once at a dose equivalent to 4% of body weight, followed by free access to drinking water containing 6% D2O for 7 days] and mass spectrometry analysis at 14 wks. At 15 wks, the animals were sacrificed and lungs, liver, skeletal muscle and fat were collected for Western hybridization (WH) for PPARGAMMA (peroxisome proliferator-activated receptor gamma) a marker of lung maturity, and ADRP (adipose differentiation-related protein) a key down-stream functional target of PPARGAMMA. Plasma was assayed for triglycerides, cholesterol, insulin, glucagon and troponin-I. Summary of Results: Insulin and glucose tolerance tests were not different between any groups. DI showed no significant differences in de novo fatty acid synthesis, and WH showed equal expression of PPARGAMMA and ADRP. Similarly, triglyceride, cholesterol, insulin, glucagon and troponin-I assays revealed no significant differences among all 4 groups, (all p values > 0.05). Conclusion(s): Prenatal administration of RGZ does not alter the adult metabolic phenotype. We speculate that RGZ therapy is a safe alternative to dexamethasone for accelerating lung maturation and in preventing bronchopulmonary dysplasia in the permature infant.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70521934
TI  - Novel role of omeprazole beyond an antacid action: Omeprazole decreases hyperoxic lung injury in vivo and in vitro via arylhydrocarbon receptor
AU  - Shivanna B.
AU  - Jiang W.
AU  - Couroucli X.I.
AU  - Moorthy B.
Y1  - 2011//
KW  - *medical research
KW  - *lung injury
KW  - *in vitro study
KW  - mouse
KW  - hyperoxia
KW  - human
KW  - assay
KW  - oxidative stress
KW  - prematurity
KW  - ambient air
KW  - inflammation
KW  - lung
KW  - epithelium cell
KW  - flow cytometry
KW  - lung dysplasia
KW  - stomach acid
KW  - wild type
KW  - cell viability
KW  - Western blotting
KW  - histopathology
KW  - immunohistochemistry
KW  - neutrophil
KW  - macrophage
KW  - cell damage
KW  - prevention
KW  - *omeprazole
KW  - *aromatic hydrocarbon
KW  - *receptor
KW  - *antacid agent
KW  - small interfering RNA
KW  - enzyme
KW  - acetoacetic acid
KW  - cytochrome
KW  - cytochrome P450
KW  - reactive oxygen metabolite
KW  - proton pump inhibitor
KW  - corn oil
KW  - ethoxyresorufin
KW  - protein
KW  - monocyte chemotactic protein 1
KW  - deoxyguanosine
KW  - dimethyl sulfoxide
KW  - lipid
T2  - Journal of Investigative Medicine
LA  - English
VL  - 59
IS  - 2
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - B. Shivanna, Texas Children's Hospital, Houston, TX, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e31820bab4c
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70521934
AB  - Purpose of Study: Hyperoxia causes bronchopulmonary dysplasia (BPD) in preterm infants. We showed that arylhydrocarbon receptor (AHR) deficient mice are more susceptible to hyperoxic lung injury due to lack of expression of cytochrome P450 (CYP)1A enzymes, which detoxify lipid hydroperoxides generated by reactive oxygen species (ROS). Omeprazole (OM), a proton pump inhibitor, used in humans with gastric acid related disorders is known to act via the AHR. Whether OM protects against hyperoxic lung injury is unknown. So, we hypothesized that OM protects against hyperoxic lung injury in vivo and in vitro via AHR. Methods Used: 1. In Vivo: Eight-week old wild type C57BL/6J (WT) and arylhydrocarbon receptor dysfunctional (AHRd) mice were treated i.p. with either OM (50 mg/kg) or corn oil (control) once daily for 5 days and exposed to room air or hyperoxia for 72 hours. AHR activation was assessed by pulmonary CYP 1A1 expression at the enzyme (ethoxyresorufin-O-deethylase assay) and protein (Western blot assay) levels. Lung injury, inflammation and oxidative stress were determined by histopathology and immunohistochemistry for neutrophils, macrophages, monocyte chemoattractant protein-1, and 8-hydroxy-2'-deoxyguanosine, respectively. 2. In Vitro: H441(Human lung epithelial cells) cells were treated with either OM (10 or 50 HM) or dimethylsulfoxide (control) and exposed to room air or hyperoxia for upto 72 hours. ROS were detected using 2'-7'- dichorodihyrofluorecein diacetate and flow cytometry. Cell viability was measured by XTT assay. The experiments were repeated after transfecting the cells with siRNA to knockdown the AHR. Summary of Results: OM increased AHR activation and decreased hyperoxic lung injury, inflammation and oxidative stress in WT mice. In contrast, OM failed to protect against hyperoxic lung damage in AHRd mice. Likewise, in human lung epithelial cells; OM attenuated hyperoxia induced ROS and cell injury in the presence of AHR, and siRNA mediated knockdown of AHR decreased the protective effects of OM. Conclusion(s): OM protects against hyperoxic lung injury in vivo and in vitro by detoxifying ROS via AHR. Our data suggests that OM may be effective in the prevention and treatment of BPD in preterm infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70521751
TI  - 10 year update of growth in extremely low birthweight infants with bronchopulmonary dysplasia
AU  - Theile A.R.
AU  - Radmacher P.
AU  - Anschutz T.
AU  - Adamkin D.H.
Y1  - 2011//
KW  - *infant
KW  - *human
KW  - *medical research
KW  - *lung dysplasia
KW  - *low birth weight
KW  - extremely low birth weight
KW  - postnatal growth
KW  - weight gain
KW  - weight reduction
KW  - birth weight
KW  - weight
KW  - diagnosis
KW  - risk
KW  - feeding
KW  - head circumference
KW  - growth disorder
KW  - nutritional support
KW  - medical record review
KW  - steroid
KW  - amino acid
KW  - protein
T2  - Journal of Investigative Medicine
LA  - English
VL  - 59
IS  - 2
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - A.R. Theile, University of Louisville, Louisville, KY, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e31820bab4c
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70521751
AB  - Purpose of Study: Changes in nutritional strategies over the past decade have been shown to improve postnatal growth. We previously showed 10 years ago that the majority of these infants suffer postnatal growth failure. We theorized that recent changes in nutritional support strategies would positively affect growth outcomes in ELBW infants with BPD. Methods Used: A retrospective chart review of 88 ELBW infants with BPD. Nutritional data, postnatal growth, and BPD severity were compared across 3 weight cohorts: 1) weight gain <=14 g/kg/day; 2) 14.1-16 g/kg/day; and 3) >=16.1 g/kg/day) as well as to our previous study. Summary of Results: Seventy-three percent of subjects grew at or above fetal rates. No differences were seen in postnatal steroid use, percent postnatal weight loss or days to return to birth weight across cohorts. The first 20-day amino acid intake (g/k/d) was higher with increasing weight gain and head circumference (HC) growth. There were less EUGR (extrauterine growth restriction) by Wt and HC for those ELBW infants with BPD receiving higher amounts of protein that grew at or above fetal rate. There were less postnatal weight loss and earlier return to birth weight for ELBW infants with BPD over the past 10 years. Conclusion(s): Despite a diagnosis of BPD, improved nutritional strategies have contributed to better postnatal growth in infants at high risk for EUGR. We speculate that caloric dense feeding strategies (>24 cal/oz) have also led to improve growth of ELBW infants with BPD over the past 10 years.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70412154
TI  - Sedated percutaneous endoscopic gastrostomy (PEG) placement in the neonate
AU  - Green A.
AU  - Shepherd E.G.
AU  - Erdman S.H.
Y1  - 2011//
KW  - *newborn
KW  - *gastrointestinal disease
KW  - *percutaneous endoscopic gastrostomy
KW  - patient
KW  - sedation
KW  - infant
KW  - population
KW  - patient assessment
KW  - nutrition
KW  - airway
KW  - weight gain
KW  - nasogastric tube
KW  - pneumoperitoneum
KW  - respiratory distress
KW  - mortality
KW  - chronic patient
KW  - stomach tube
KW  - general anesthesia
KW  - therapy
KW  - risk
KW  - respiration control
KW  - medical history
KW  - intensive care unit
KW  - nutritional status
KW  - drug therapy
KW  - gestational age
KW  - weight
KW  - lung dysplasia
KW  - genetic disorder
KW  - brain hemorrhage
KW  - newborn intensive care
KW  - fentanyl
KW  - midazolam
KW  - oxygen
T2  - Gastroenterology
LA  - English
VL  - 140
IS  - 5 SUPPL. 1
PB  - W.B. Saunders
SN  - 0016-5085
AD  - A. Green
DO  - https://dx.doi.org/10.1016/S0016-5085%2811%2962851-5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70412154
AB  - Background: Nutrition support is a cornerstone therapy for premature and sick neonates. Long-term nutrition support is best achieved by gastrostomy tube (GT) which can be placed endoscopically (PEG) using bedside sedation or operatively under general anesthesia (GA). Controversy exists regarding the safest method of PEG placement in ill neonates who may be at particular risk of respiratory or airway complications relating to GA. To avoid such complications, bedside PEG placement with IV sedation has been utilized in our neonatal intensive care units (NICUs). This multidisciplinary approach emphasizes individualized patient assessment and the presence of a neonatologist for sedation and airway management. Patients/Methods: Charts of all infants who underwent bedside PEG in our NICUs from August 2006 to March 2010 were reviewed. Available demographic information, past medical history, nutritional status at time of procedure and up to one year after, procedure information (ASA scores, medications, respiratory status), and short- and long-term outcomes were collected and analyzed. Result(s): A total of 93 patients underwent bedside PEG placement during the review period. The mean age at placement was 17.4 weeks (2-60 weeks) with an adjusted gestational age of 48.4 weeks (17-84 weeks). The average weight at the time of the procedure was 4298 gm (2175-8040 gm). The patients had a number of underlying conditions including bronchopulmonary dysplasia (45%), genetic disease (26%), intraventricular hemorrhage (22%), and poor weight gain (20%). There were 18 ASA II, 52 ASA III, and 4 ASA IV patients. Mean total sedation dosing was fentanyl 3mcg/kg (2-10 mcg/kg) and midazolam 0.15 mg/kg (0.1-0.5 mg/kg). Per protocol, all patients received supplemental oxygen during the procedure with a majority of patients only requiring nasal cannula (63%). Five of the infants (6%) were electively intubated for PEG placement due to airway or other concerns. One procedure was aborted due to medical instability and was completed in the OR under GA. Feedings had returned to pre-PEG rates/volumes by a mean of 2.1 days (1- 15 days). There were 2 significant complications; one case resulted in a perforated viscus, and a second patient had pneumoperitoneum with respiratory distress. There was no mortality due to the PEG placement. Conclusion(s): Sedated bedside PEG placement in chronically ill neonates can be an effective and safe method of providing permanent enteral access. There were few serious complications, especially given the chronic medical acuity of this population, and the outcomes data appears comparable with other reported series. We believe that careful patient assessment and selection along with utilization of a multidisciplinary team are keys to successful utilization of sedated PEG placement in this special and fragile population of infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70383168
TI  - Area under the reactance curve: Reference values and disease detection in children born preterm
AU  - Simpson S.J.
AU  - Sly P.D.
AU  - Franklin P.
AU  - Lombardi E.
AU  - Calogero C.
AU  - Palumbo M.
AU  - Hall G.L.
Y1  - 2011//
KW  - *child
KW  - *reference value
KW  - height
KW  - population
KW  - male
KW  - device
KW  - lung dysplasia
KW  - respiratory tract disease
KW  - linear regression analysis
KW  - diagnosis
KW  - oscillation
KW  - impedance
KW  - Belgium
T2  - Respirology
LA  - English
VL  - 16
IS  - SUPPL. 1
PB  - Blackwell Publishing
SN  - 1323-7799
AD  - S.J. Simpson, Telethon Institute for Child Health Research, Perth, WA, Australia
DO  - https://dx.doi.org/10.1111/j.1440-1843.2011.01937.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70383168
AB  - Introduction The forced oscillation technique (FOT) is effort independent and thus ideal for young children. The area under the reactance curve (AX) has been proposed to amplify clinically relevant signal by taking advantage of any shape change in the reactance (Xrs) curve below the resonant frequency. This study aimed to develop reference values for resistance (Rrs), Xrs and AX in a large healthy population of children, and determine if AX conferred any additional clinical benefit when examining disease in children born preterm. Methods Impedance spectra were obtained in 760 healthy children (335 male), aged less than 13 years and with height less than 160 cm using a commercial device (I2M, Chess Medical, Belgium). AX was calculated in 647 of these children between 6 Hz and the resonant frequency. Backwards stepwise linear regressions identified the best predictors of AX, and Xrs and Rrs at 8 Hz (Xrs8, Rrs8), and Z scores were generated. Z scores were calculated for 156 children born preterm, of which 87 received a neonatal diagnosis of bronchopulmonary dysplasia (BPD). Chi squared tests examined the difference in proportion of children born preterm (with and without BPD) with abnormal Z scores for each FOT variable. Results All FOT variables were predicted by height (p < 0.001) and sex. Mean (SD) Z scores for preterm children with and without BPD for Rrs8 (0.59 (0.88); 0.58 (1.03)), Xrs8 (1.05 (0.68); 0.61 (0.82)) and AX (0.84 (0.70); 0.51 (0.98)) were all significantly different (p < 0.001) from the healthy population. The number of children born preterm with abnormal Z scores was not signifi- cantly different when comparing AX, Rrs8 and Xrs8. Conclusions While AX is able to detect respiratory disease in preterm children with and without BPD, it is no more sensitive than Xrs or Rrs.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70370649
TI  - Latin American Society for Paediatric Research (LASPR) Selected Abstracts from the 48th Annual Meeting
AU  - Anonymous.
Y1  - 2011//
KW  - *society
KW  - embryo
KW  - white matter
KW  - injury
KW  - protection
KW  - oxidative stress
KW  - neonatal stress
KW  - bone mineral
KW  - density
KW  - gene expression
KW  - Rett syndrome
KW  - gene
KW  - childhood
KW  - immunoglobulin A nephropathy
KW  - sarcoplasmic reticulum
KW  - mouse
KW  - developmental stage
KW  - lung injury
KW  - heart
KW  - model
KW  - lung dysplasia
KW  - positive end expiratory pressure
KW  - high frequency ventilation
KW  - oxygenation
KW  - lamb
KW  - newborn
KW  - air conditioning
KW  - necdin
KW  - neurotrophin receptor
KW  - morphine
KW  - receptor
KW  - adenosine
T2  - Pediatric Research
LA  - English
VL  - 69
IS  - 4
SP  -
PB  - Lippincott Williams and Wilkins
SN  - 0031-3998
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70370649
AB  - The proceedings contain 16 papers. The topics discussed include: adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection; necdin and neurotrophin receptors: interactors of relevance for neuronal resistance to oxidant stress; effects of neonatal stress and morphine on murine hippocampal gene expression; bone mineral content and density in Rett syndrome and their contributing factors; linkage and association study of neurotrophins and their receptors as novel susceptibility genes for childhood IgA nephropathy; contribution of sarcoplasmic reticulum Ca2+ release and Ca2+ transporters on sarcolemmal channels to Ca2+ transient in fetal mouse heart; developmental stage is a major determinant of lung injury in a murine model of bronchopulmonary dysplasia; and high positive end-expiratory pressure during high-frequency jet ventilation improves oxygenation and ventilation in preterm lambs.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2015>
TI  - Pigment epithelium-derived factor mediates impaired lung vascular development in neonatal hyperoxia.
DO  - https://dx.doi.org/10.1165/rcmb.2013-0229OC
AU  - Chetty, Anne
AU  - Bennett, Michelle
AU  - Dang, Linh
AU  - Nakamura, Daisy
AU  - Cao, Gong-Jie
AU  - Mujahid, Sana
AU  - Volpe, MaryAnn
AU  - Herman, Ira
AU  - Becerra, S Patricia
AU  - Nielsen, Heber C
Y1  - 2015//
KW  - Angiostatins/me [Metabolism]
KW  - Animals
KW  - *Animals, Newborn/me [Metabolism]
KW  - Bronchopulmonary Dysplasia/me [Metabolism]
KW  - Cell Line
KW  - Cell Movement/ph [Physiology]
KW  - Cell Proliferation/ph [Physiology]
KW  - *Endothelium, Vascular/me [Metabolism]
KW  - *Eye Proteins/me [Metabolism]
KW  - *Hyperoxia/me [Metabolism]
KW  - *Lung/me [Metabolism]
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - *Nerve Growth Factors/me [Metabolism]
KW  - Oxygen/me [Metabolism]
KW  - Platelet Endothelial Cell Adhesion Molecule-1/me [Metabolism]
KW  - *Serpins/me [Metabolism]
KW  - Vascular Endothelial Growth Factors/me [Metabolism]
T2  - American journal of respiratory cell and molecular biology
VL  - 52
IS  - 3
SN  - 1044-1549
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med12&NEWS=N&AN=25054647
AD  - United States
AB  - Bronchopulmonary dysplasia is a chronic lung disease of preterm infants characterized by arrested microvascularization and alveolarization. Studies show the importance of proangiogenic factors for alveolarization, but the importance of antiangiogenic factors is unknown. We proposed that hyperoxia increases the potent angiostatin, pigment epithelium-derived factor (PEDF), in neonatal lungs, inhibiting alveolarization and microvascularization. Wild-type (WT) and PEDF(-/-) mice were exposed to room air (RA) or 0.9 fraction of inspired oxygen from Postnatal Day 5 to 13. PEDF protein was increased in hyperoxic lungs compared with RA-exposed lungs (P < 0.05). In situ hybridization and immunofluorescence identified PEDF production primarily in alveolar epithelium. Hyperoxia reduced alveolarization in WT mice (P < 0.05) but not in PEDF(-/-) mice. WT hyperoxic mice had fewer platelet endothelial cell adhesion molecule (PECAM)-positive cells per alveolus (1.4 +/- 0.4) than RA-exposed mice (4.3 +/- 0.3; P < 0.05); this reduction was absent in hyperoxic PEDF(-/-) mice. The interactive regulation of lung microvascularization by vascular endothelial growth factor and PEDF was studied in vitro using MFLM-91U cells, a fetal mouse lung endothelial cell line. Vascular endothelial growth factor stimulation of proliferation, migration, and capillary tube formation was inhibited by PEDF. MFLM-91U cells exposed to conditioned medium (CM) from E17 fetal mouse lung type II (T2) cells cultured in 0.9 fraction of inspired oxygen formed fewer capillary tubes than CM from T2 cells cultured in RA (hyperoxia CM, 51 +/- 10% of RA CM, P < 0.05), an effect abolished by PEDF antibody. We conclude that PEDF mediates reduced vasculogenesis and alveolarization in neonatal hyperoxia. Bronchopulmonary dysplasia likely results from an altered balance between pro- and antiangiogenic factors.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70359528
TI  - The role of eosinophil activation in preterm infants with bronchopulmonary dysplasia
AU  - Choi S.
AU  - Rha Y.
Y1  - 2011//
KW  - *eosinophil
KW  - *immunology
KW  - *prematurity
KW  - *allergic asthma
KW  - *lung dysplasia
KW  - respiratory distress syndrome
KW  - serum
KW  - urine
KW  - patient
KW  - blood
KW  - macrophage
KW  - pathogenesis
KW  - artificial ventilation
KW  - pH
KW  - arterial gas
KW  - blood gas analysis
KW  - statistical significance
KW  - wheezing
KW  - immunity
KW  - inflammation
KW  - neutrophil
KW  - eosinophil count
KW  - eosinophil cationic protein
KW  - eosinophil protein X
KW  - lung surfactant
KW  - marker
T2  - Journal of Allergy and Clinical Immunology
LA  - English
VL  - 127
IS  - 2 SUPPL. 1
PB  - Mosby Inc.
SN  - 0091-6749
AD  - S. Choi, Kyunghee University, School of Medicine, Seoul, South Korea
DO  - https://dx.doi.org/10.1016/j.jaci.2010.12.822
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70359528
AB  - RATIONALE: Bronchopulmonary dysplasia (BPD) results in bronchial hyperresponsiveness and recurrent wheezing. Recent studies suggested that eosinophil has relevance to innate immune defense and inflammatory process in early life. While the activation of neutrophil and macrophage in pathogenesis of BPD are rather well studied, very few studies have addressed the possible participation of eosinophil. We hypothesized that eosinophil may be involved in early phase of BPD. METHOD(S): Preterm infants were recruited consecutively and grouped to respiratory distress syndrome (RDS) or non-RDS. RDS group was divided to BPD or non-BPD group then. We investigated blood eosinophil, serum eosinophil cationic protein (ECP), eosinophil protein X (EPX), and urine EPX to determine the relationship between eosinophil activation and BPD in premature infants prospectively. The eosinophil count, serum ECP/EPX and urine ECP/EPX were compared. Spearman rank test was used to analyze the correlation between serum, tracheal and urine ECP. RESULT(S): Among total 43 patients recruited, 13 patients were treated with pulmonary surfactant and mechanical ventilation for RDS. Six out of 13 patients were diagnosed with BPD. There were no difference of blood eosinophil, serum ECP, EPX, or urine EPX between RDS and non-RDS groups. Blood eosinophil, serum ECP, EPX, and urine EPX were higher in BPD group than non-BPD group which was not statistically significant. Interestingly serum EPX was significantly correlated with pH of arterial blood gas analysis which was done at discharge. (r=0.441, p=0.012) CONCLUSION(S): Eosinophil activation markers were higher in BPD group which suggests the possible role of eosinophil in BPD although there was no statistical significance.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70328197
TI  - Impact of acute and chronic inflammatory events on the matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of MMP (TIMP-1) homeostasis in preterm infants with adverse neonatal outcomes
AU  - Werner E.
AU  - Buhimschi I.
AU  - Han C.
AU  - Dulay A.
AU  - Ali U.
AU  - Thung S.
AU  - Bahtiyar M.
AU  - Zhao G.
AU  - Funai E.
AU  - Bhandari V.
AU  - Buhimschi C.
Y1  - 2011//
KW  - *society
KW  - *prematurity
KW  - *tissue
KW  - *homeostasis
KW  - *pregnancy
KW  - adverse outcome
KW  - newborn
KW  - inflammation
KW  - longitudinal study
KW  - amniocentesis
KW  - umbilical cord blood
KW  - necrotizing enterocolitis
KW  - retrolental fibroplasia
KW  - lung dysplasia
KW  - brain hemorrhage
KW  - encephalomalacia
KW  - death
KW  - infant
KW  - dissociation
KW  - cell damage
KW  - tissue injury
KW  - enzyme linked immunosorbent assay
KW  - *gelatinase B
KW  - tissue inhibitor of metalloproteinase
KW  - interleukin 6
KW  - cytokine
KW  - nuclear protein
T2  - American Journal of Obstetrics and Gynecology
LA  - English
VL  - 204
IS  - 1 SUPPL.
PB  - Mosby Inc.
SN  - 0002-9378
AD  - E. Werner, Yale University, New Haven, CT, United States
DO  - https://dx.doi.org/10.1016/j.ajog.2010.10.201
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=70328197
AB  - OBJECTIVE: MMPs, discovered to mediate cellular injury processes, also play beneficial roles in tissue remodeling and repair. TIMPs reduce and modulate the activity of MMPs. High-mobility group box 1 (HMGB1), an endogenous nuclear protein released during chronic tissue damage, is a known inducer of MMP-9. We propose that adverse outcomes of premature infants are the consequence of intrauterine acute and chronic inflammatory processes involving MMP-9 and TIMP-1. This study was conducted to investigate the interaction between systemic acute (IL-6) and chronic (HMGB1) cytokines, MMP-9 and TIMP-1 in neonates with prematurity-related adverse outcomes. STUDY DESIGN: We conducted a prospective longitudinal study in 226 consecutive preterm singleton neonates delivered in the presence (n=107, GA: median [IQR]: 27 [25-29] wks) or absence (n=119, GA: 31 [28-33] wks) of intra-amniotic inflammation (IAI). Amniocentesis was used to confirm or exclude IAI. Cord blood was obtained at birth for all cases. A composite end-organ damage indicator was computed based on the presence of either intraventricular hemorrhage (gr.3-4), necrotizing enterocolitis (gr.2-4), retinopathy of prematurity (gr.2- 4), bronchopulmonary dysplasia, periventricular leukomalacia and/or death. IL-6, HMGB1, MMP-9 and TIMP-1 were evaluated by ELISA. Data were corrected for GA at birth and other variables as appropriate. RESULT(S): (1) In the absence of IAI,GAimpacted on MMP-9 (R=0.52, P< 0.001), TIMP-1 (R=0.17, P=0.02), IL-6 (R=-0.39, P< 0.001) and HMGB1 (R=-0.19, P< 0.02) levels; (2) IAI did not impact on the levels of the sought analytes; (3) IL-6 correlated with TIMP-1 (R=0.27, P< 0.001) while HMGB1 correlated with MMP-9 only (R=0.31, P< 0.001); (4) Newborns with at least one adverse outcome (n=75) had lower MMP-9 concentrations compared to unaffected infants (105 [56-201] vs. 129 [81-247] ng/mL, P=0.016). CONCLUSION(S): Our results point to a dissociation between the effect of acute and chronic inflammatory events on MMP-9 and TIMP-1 homeostasis. Targeting MMP-9 may reduce the incidence of adverse prematurity-related outcomes.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 361885962
TI  - Role of pulmonary infection in the development of chronic lung disease of prematurity
AU  - Beeton M.L.
AU  - Maxwell N.C.
AU  - Davies P.L.
AU  - Nuttall D.
AU  - McGreal E.
AU  - Chakraborty M.
AU  - Spiller O.B.
AU  - Kotecha S.
Y1  - 2011//
KW  - article
KW  - bacterium culture
KW  - *chronic lung disease/et [Etiology]
KW  - controlled study
KW  - DNA isolation
KW  - female
KW  - gene identification
KW  - human
KW  - infant
KW  - lung fluid
KW  - *lung infection
KW  - major clinical study
KW  - male
KW  - newborn
KW  - nonhuman
KW  - pathogenesis
KW  - polymerase chain reaction
KW  - priority journal
KW  - respiratory distress syndrome
KW  - stomach juice
KW  - Ureaplasma
KW  - interleukin 6/ec [Endogenous Compound]
KW  - interleukin 8/ec [Endogenous Compound]
KW  - RNA 16S/ec [Endogenous Compound]
KW  - *chronic lung disease of prematurity/et [Etiology]
T2  - European Respiratory Journal
LA  - English
VL  - 37
IS  - 6
PB  - European Respiratory Society (4 Ave Sainte-Luce, Lausanne CH-1003, Switzerland)
SN  - 1399-3003
AD  - S. Kotecha, Dept. of Child Health, School of Medicine, Cardiff University, Cardiff CF14 4XN, United Kingdom. E-mail: kotechas@cardiff.ac.uk
UR  - http://erj.ersjournals.com/content/37/6/1424.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=361885962
DO  - https://dx.doi.org/10.1183/09031936.00037810
AB  - We studied the role of ante- and post-natal infection in the development of chronic lung disease (CLD) of prematurity. 192 newborn infants (61 term and 131 pre-term of <34 weeks gestation: 88 with respiratory distress syndrome, 35 developed CLD and eight died) were recruited. 16S ribosomal RNA (rRNA) genes were identified by PCR of DNA isolated from 840 gastric and lung fluid samples. Ureaplasma spp. were also cultured. Presence of 16S rRNA genes (OR 1.6, 95% CI 1.2-2.2) and Ureaplasma spp. (OR 3.6, 95% CI 1.7-7.7) was significantly associated with the development of CLD. This association remained if the 16S rRNA genes and Ureaplasma spp. were first identified within the first 3 days of life (OR 2.4 (95% CI 1.4-4.1) and 3.8 (95% CI 1.4-10.0), respectively) or if first identified after 3 days of age (OR 1.7 (95% CI 1.1-2.8) and OR 5.1 (95% CI 1.3-19.8), respectively). Peak lung fluid interleukin (IL)-6 and IL-8 were significantly associated with presence of microbes (p<0.0001 and p=0.0001, respectively) and development of CLD (p=0.003 and 0.001, respectively). Both early and late microbial presence in neonatal lung fluid samples was significantly associated with the development of CLD suggesting that both ante- and post-natal infection play a role in the development of CLD. CopyrightÂ©ERS 2011.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 51652564
TI  - Early end-tidal carbon monoxide levels and neurodevelopmental outcome at 3years 6months of age in preterm infants
AU  - Blok C.A.
AU  - Krediet T.G.
AU  - Kavelaars A.
AU  - Koopman-Esseboom C.
AU  - Vreman H.J.
AU  - Van Bel F.
Y1  - 2011//
KW  - adverse outcome
KW  - article
KW  - birth weight
KW  - *brain hemorrhage
KW  - carbon monoxide blood level
KW  - child
KW  - female
KW  - follow up
KW  - gestational age
KW  - human
KW  - *lung dysplasia
KW  - major clinical study
KW  - male
KW  - newborn intensive care
KW  - outcome assessment
KW  - predictive value
KW  - prematurity
KW  - preschool child
KW  - priority journal
KW  - protein blood level
KW  - *respiratory distress syndrome
KW  - sensitivity and specificity
KW  - *carbon monoxide/ec [Endogenous Compound]
KW  - interleukin 6/ec [Endogenous Compound]
KW  - interleukin 8/ec [Endogenous Compound]
KW  - malonaldehyde/ec [Endogenous Compound]
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
KW  - unclassified drug
KW  - *end tidal carbon monoxide/ec [Endogenous Compound]
T2  - Developmental Medicine and Child Neurology
LA  - English
VL  - 53
IS  - 12
PB  - Blackwell Publishing Ltd (9600 Garsington Road, Oxford OX4 2XG, United Kingdom)
SN  - 1469-8749
AD  - F. Van Bel, Department of Neonatology, Wilhelmina Children's Hospital, Room KE.04.123.1, PO Box 85090, 3508 AB Utrecht, Netherlands. E-mail: f.vanbel@umcutrecht.nl
DO  - https://dx.doi.org/10.1111/j.1469-8749.2011.04110.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=51652564
AB  - Aim Increased end-tidal carbon monoxide (ETCOc) and cytokines in preterm infants are related to bronchopulmonary dysplasia and intraventricular haemorrhages. The aim was to study the predictive value of ETCOc and cytokine levels for long-term outcome. Methods This study comprised 105 very preterm infants (57 males, 48 females; gestational age range 25wks 5d-31wks 4d; birthweight 610-2100g) who were admitted to a neonatal intensive care unit between 1 February and 31 December 2002. ETCOc, plasma tumour necrosis factor alpha (TNF-alpha) and interleukins (IL) 6 and 8, and malondialdehyde (MDA, a marker of lipid peroxidation), were measured at days 1, 3, and 5 of life and related to outcome at 3years 6months of age (Griffiths Mental Developmental Scales). Results Of the 105 infants, 69 were eligible for follow-up (37 males; 32 females; bronchopulmonary dysplasia, n=12). ETCOc at 0 to 24hours was higher in infants with adverse outcome (Griffiths developmental quotient <85, n=15) compared with favourable outcome (2.7SD 0.7 vs 2.0SD 0.5; p<0.05). MDA and cytokines did not differ between groups. Regression analysis with bootstrapping of independent variables (gestational age, birthweight, ETCOc, TNF-alpha, IL-6, IL-8, and bronchopulmonary dysplasia) showed that ETCOc was the only parameter that correlated with outcome. The sensitivity and negative predictive value of ETCOc for adverse outcome were 93% and 85% respectively. Interpretation Adverse neurodevelopmental outcome is associated with increased endogenous carbon monoxide. ETCOc less than 2.0ppm during the first day indicates a favourable outcome. Â© The Authors. Developmental Medicine & Child Neurology Â© 2011 Mac Keith Press.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 361635864
TI  - Inhibition of apoptosis by 60% oxygen: A novel pathway contributing to lung injury in neonatal rats
AU  - Yi M.
AU  - Masood A.
AU  - Ziino A.
AU  - Johnson B.-H.
AU  - Belcastro R.
AU  - Li J.
AU  - Shek S.
AU  - Kantores C.
AU  - Jankov R.P.
AU  - Keith Tanswell A.
Y1  - 2011//
KW  - animal cell
KW  - animal experiment
KW  - animal tissue
KW  - apoptosis
KW  - article
KW  - cell cycle arrest
KW  - cell growth
KW  - cell proliferation
KW  - DNA fragmentation
KW  - enzyme activity
KW  - female
KW  - hyperoxia
KW  - immunohistochemistry
KW  - lung alveolus cell
KW  - lung development
KW  - *lung injury
KW  - newborn
KW  - nonhuman
KW  - parenchyma
KW  - priority journal
KW  - protein expression
KW  - rat
KW  - caspase 3/ec [Endogenous Compound]
KW  - caspase 7/ec [Endogenous Compound]
KW  - cytochrome c/ec [Endogenous Compound]
KW  - *oxygen
KW  - protein Bax/ec [Endogenous Compound]
KW  - protein bcl xl/ec [Endogenous Compound]
KW  - survivin/ec [Endogenous Compound]
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 300
IS  - 3
PB  - American Physiological Society (9650 Rockville Pike, Bethesda MD 20814-3991, United States)
SN  - 1522-1504
AD  - A. Keith Tanswell, Division of Neonatology, Hospital for Sick Children, 55 Univ. Ave., Toronto, ON M5G 1X8, Canada. E-mail: keith.tanswell@sickkids.ca
UR  - http://ajplung.physiology.org/content/300/3/L319.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=361635864
DO  - https://dx.doi.org/10.1152/ajplung.00126.2010
AB  - During early postnatal alveolar formation, the lung tissue of rat pups undergoes a physiological remodeling involving apoptosis of distal lung cells. Exposure of neonatal rats to severe hyperoxia (>95% O2) both arrests lung growth and results in increased lung cell apoptosis. In contrast, exposure to moderate hyperoxia (60% O2) for 14 days does not completely arrest lung cell proliferation and is associated with parenchymal thickening. On the basis of similarities in lung architecture observed following either exposure to 60% O2, or pharmacological inhibition of physiological apoptosis, we hypothesized that exposure to 60% O2 would result in an inhibition of physiological lung cell apoptosis. Consistent with this hypothesis, we observed that the parenchymal thickening induced by exposure to 60% O2 was associated with decreased numbers of apoptotic cells, increased expressions of the antiapoptotic regulator Bcl-xL, and the putative antiapoptotic protein survivin, and decreased expressions of the proapoptotic cleaved caspases-3 and -7. In summary, exposure of the neonatal rat lung to moderate hyperoxia results in an inhibition of physiological apoptosis, which contributes to the parenchymal thickening observed in the resultant lung injury. Â© 2011 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 361584762
TI  - Adenosine deaminase levels in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia
AU  - Canpolat F.E.
AU  - Yurdakok M.
AU  - Korkmaz A.
AU  - Yigit S.
AU  - Tekinalp G.
Y1  - 2011//
KW  - article
KW  - artificial ventilation
KW  - birth weight
KW  - clinical feature
KW  - controlled study
KW  - demography
KW  - disease association
KW  - disease severity
KW  - enzyme activity
KW  - enzyme blood level
KW  - female
KW  - gestational age
KW  - human
KW  - infant
KW  - *lung dysplasia/di [Diagnosis]
KW  - *lung dysplasia/et [Etiology]
KW  - major clinical study
KW  - male
KW  - *neonatal respiratory distress syndrome/di [Diagnosis]
KW  - *neonatal respiratory distress syndrome/et [Etiology]
KW  - newborn intensive care
KW  - outcome assessment
KW  - positive end expiratory pressure
KW  - prematurity
KW  - priority journal
KW  - protein function
KW  - *adenosine deaminase/ec [Endogenous Compound]
KW  - indometacin
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 24
IS  - 5
PB  - Informa Healthcare (69-77 Paul Street, London EC2A 4LQ, United Kingdom)
SN  - 1476-4954
AD  - F. E. Canpolat, Harbiye Mahallesi, Salkim Sogut Sokak 18-9, 06460 Dikmen Cankaya, Ankara, Turkey. E-mail: femrecan@gmail.com
DO  - https://dx.doi.org/10.3109/14767058.2010.516286
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=361584762
AB  - Adenosine is produced in the inflammed and damaged lung where it plays roles in the regulation of inflammation and tissue remodeling. Adenosine deaminase (ADA) is an enzyme responsible for the degradation of adenosine. Our aim was to compare the levels of ADA between infants with and without respiratory distress syndrome (RDS) and to determine the relationship between plasma ADA levels and bronchopulmonary dysplasia (BPD). One-hundred and twenty-five premature infants who were admitted to our neonatal intensive care unit were included in the study. Eighty-one of these infants with RDS were study group and the other 44 infants without RDS served as controls. Blood collection was made in the first day of life at the end of 24th-h and was used for laboratory testing. In the RDS group, mean ADA level was 25.5 (+/- 4.5) U/l, and in controls it was 26.3 (+/- 5.7) U/l. There was no statistically significant difference (p=0.326) in these groups although there was a statistically difference of ADA levels between BPD (34.5+/-5.2 U/l) and non-BPD (24.6 +/- 4.1) patients (p=0.001). There was also a positive relationship between ADA levels and severity of BPD (r=+0.845, p=0.01). Perinatal inflammation is the key mechanism of BPD. ADA level in early postnatal life is elevated in infants with BPD and may be related with perinatal inflammation. Â© 2011 Informa UK, Ltd.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 51456766
TI  - Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep
AU  - Vosdoganes P.
AU  - Hodges R.J.
AU  - Lim R.
AU  - Westover A.J.
AU  - Acharya R.Y.
AU  - Wallace E.M.
AU  - Moss T.J.M.
Y1  - 2011//
KW  - *amnion cell
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - cell therapy
KW  - controlled study
KW  - female
KW  - fetus
KW  - gestational age
KW  - human
KW  - human cell
KW  - jugular vein
KW  - leukocyte
KW  - lung function
KW  - lung infiltrate
KW  - *lung injury/th [Therapy]
KW  - lung structure
KW  - lung volume
KW  - nonhuman
KW  - *pneumonia/th [Therapy]
KW  - priority journal
KW  - sheep
KW  - trachea
KW  - Escherichia coli lipopolysaccharide
KW  - interleukin 1beta/ec [Endogenous Compound]
KW  - interleukin 6/ec [Endogenous Compound]
KW  - messenger RNA/ec [Endogenous Compound]
KW  - sodium chloride
KW  - surfactant protein A/ec [Endogenous Compound]
KW  - surfactant protein C/ec [Endogenous Compound]
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
T2  - American Journal of Obstetrics and Gynecology
LA  - English
VL  - 205
IS  - 2
PB  - Mosby Inc. (11830 Westline Industrial Drive, St. Louis MO 63146, United States)
SN  - 1097-6868
AD  - P. Vosdoganes, Ritchie Centre, Monash Institute of Medical Research, Monash University, Clayton, VIC, Australia
DO  - https://dx.doi.org/10.1016/j.ajog.2011.03.054
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=51456766
AB  - Objective: The purpose of this study was to determine whether human amnion epithelial cells (hAECs) can modulate the pulmonary developmental consequences of intrauterine inflammation in fetal sheep that are exposed to intraamniotic lipopolysaccharide (LPS) injection. Study Design: At 117 days' gestation, fetal sheep (n = 16) received intraamniotic LPS (20 mg). hAECs were delivered at 0, 6, and 12 hours into the fetal jugular vein (n = 4), trachea (n = 4), or both (n = 4). Controls (n = 6) received equivalent administration of saline solution. Lungs were collected at 124 days. Result(s): Intraamniotic LPS caused pulmonary inflammation and altered lung structure and function. hAECs attenuated changes in lung function and structure that had been induced by LPS: lung volume, 40 cm H2O (P <.05, intravenous + intratracheal hAECs vs LPS), tissue-to-airspace ratio (P <.05, intravenous + intratracheal hAECs vs LPS), and septal crest density (P <.001, all hAEC groups vs LPS). Leukocyte infiltration of the lungs was not reduced by hAECs; however, inflammatory cytokines were reduced (tumor necrosis factoralpha, P <.01, vs LPS; interleukin-1b, P <.01, vs LPS; interleukin-6, P <.01 vs LPS). Surfactant protein A and C messenger RNA was increased by LPS, although this was not statistically significant (P >.05 vs control); there were significant increases in all hAEC-treated animals (surfactant proteinA, P <.05 vs LPS; surfactant proteinC, P <.01 vs LPS). Conclusion(s): Human amnion epithelial cells attenuate the fetal pulmonary inflammatory response to experimental intrauterine inflammation and reduce, but (as administered in our study) do not prevent, consequent alterations in lung development. Â© 2011 Mosby, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 51307575
TI  - Dynamic expression of IL-6 trans-signalling molecules in the lungs of preterm baboons undergoing mechanical ventilation
AU  - McGreal E.P.
AU  - Chakraborty M.
AU  - Winter V.T.
AU  - Jones S.A.
AU  - Coalson J.J.
AU  - Kotecha S.
Y1  - 2011//
KW  - animal experiment
KW  - animal model
KW  - article
KW  - artificial ventilation
KW  - baboon
KW  - cell count
KW  - inflammatory cell
KW  - *lung
KW  - lung aspiration
KW  - mononuclear cell
KW  - neutrophil
KW  - newborn
KW  - nonhuman
KW  - *prematurity
KW  - priority journal
KW  - *protein expression
KW  - signal transduction
KW  - chemokine/ec [Endogenous Compound]
KW  - glycoprotein gp 130/ec [Endogenous Compound]
KW  - *interleukin 6/ec [Endogenous Compound]
KW  - interleukin 6 receptor/ec [Endogenous Compound]
KW  - interleukin 8/ec [Endogenous Compound]
KW  - monocyte chemotactic protein 1/ec [Endogenous Compound]
T2  - Neonatology
LA  - English
VL  - 100
IS  - 2
PB  - S. Karger AG (Allschwilerstrasse 10, P.O. Box, Basel CH-4009, Switzerland)
SN  - 1661-7819
AD  - E.P. McGreal, Departments of Child Health, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, United Kingdom. E-mail: mcgrealep@cf.ac.uk
DO  - https://dx.doi.org/10.1159/000322148
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=51307575
AB  - Background: Interleukin (IL)-6, when complexed with soluble IL-6 receptor (sIL-6R), has emerged as an important modulator of chemokine expression and leukocyte recruitment during inflammation and in this state can be specifically antagonised by soluble gp130 (sgp130). The expression of these modifiers of IL-6 activity during ventilator-induced inflammation remains poorly understood. Objective(s): To ascertain the expression pattern of IL-6, sIL-6R and sgp130 in response to mechanical ventilation in the preterm neonatal lung and define its relationship to associated markers of inflammation. Method(s): Inflammatory cell recruitment and expression of IL-6, sIL-6R, sgp130, IL-8 and monocyte chemotactic protein-1 (MCP-1) were quantified in tracheal aspirate fluid collected over a 14-day period from preterm (125 days) baboons undergoing mechanical ventilation. Result(s): Over the period of ventilation, the ratio of agonistic IL-6/sIL-6R increased 4.3-fold between days 3 and 10-11 (p < 0.01) while the ratio of antagonistic sgp130/IL-6 decreased 2.6-fold over the same period (p < 0.05). Over the same period, the relative numbers of neutrophils compared to mononuclear cells shifted from an excess of 1.8 on day 1 to 0.6 on day 14 (p < 0.01). Both IL-8 and MCP-1 were elevated between days 1 and 10-11 of ventilation (p < 0.01). Conclusion(s): In the ventilated preterm baboon lung, expression of sIL-6R and dynamic modulation of sgp130 expression appear to modulate the activity and inflammatory potential of IL-6. Copyright Â© 2011 S. Karger AG, Basel.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 51263046
TI  - Endothelin-1 and L -arginine in preterm infants with respiratory distress
AU  - El Sayed M.
AU  - Sherif L.
AU  - Said R.N.
AU  - El-Wakkad A.S.E.
AU  - El-Refay A.
AU  - Aly H.
Y1  - 2011//
KW  - amino acid blood level
KW  - arterial blood
KW  - article
KW  - child death
KW  - controlled study
KW  - disease association
KW  - disease course
KW  - disease severity
KW  - enzyme linked immunosorbent assay
KW  - female
KW  - gestational age
KW  - human
KW  - infant
KW  - lung blood vessel
KW  - lung dysplasia/di [Diagnosis]
KW  - major clinical study
KW  - male
KW  - *neonatal respiratory distress syndrome/cn [Congenital Disorder]
KW  - *neonatal respiratory distress syndrome/et [Etiology]
KW  - newborn
KW  - oxygen therapy
KW  - *prematurity/cn [Congenital Disorder]
KW  - *prematurity/et [Etiology]
KW  - prenatal stress
KW  - priority journal
KW  - prospective study
KW  - protein blood level
KW  - *respiratory distress/cn [Congenital Disorder]
KW  - *respiratory distress/et [Etiology]
KW  - spectrophotometry
KW  - *arginine/ec [Endogenous Compound]
KW  - *endothelin 1/ec [Endogenous Compound]
T2  - American Journal of Perinatology
LA  - English
VL  - 28
IS  - 2
PB  - Thieme Medical Publishers, Inc. (333 7th Avenue, New York NY 10001-5004, United States)
SN  - 1098-8785
AD  - H. Aly, 900 23rd Street, NW, Washington, DC 20037, United States. E-mail: haly@mfa.gwu.edu
DO  - https://dx.doi.org/10.1055/s-0030-1263295
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=51263046
AB  - In addition to the immaturity of air sacs and surfactant deficiency, preterm infants with respiratory distress syndrome (RDS) have abnormalities in the pulmonary vascular bed. We aimed to study two known modulators of pulmonary vessels: endothelin-1 (ET-1) and L-arginine. We hypothesized that plasma concentrations of ET-1 and L-arginine could correlate with the severity of RDS. We prospectively studied 71 preterm infants (gestational age = 29 to 35 weeks) with and without RDS. We measured plasma ET-1 by enzyme-linked immunosorbent assay and L-arginine by spectrophotometry. Infants who continued to require oxygen support or died by day of life 28 were considered to have bronchopulmonary dysplasia (BPD). ET-1 concentrations were significantly higher in RDS infants (p = 0.039) than controls. Among infants with RDS, it was significantly higher in those who later developed BPD (p = 0.026). L-arginine was significantly lower in RDS infants (p = 0.001), but did not differ between BPD and non-BPD infants (p = 0.19). There was no correlation between L-arginine and ET-1 (r = 0.1, p = 0.41). The acute phase of RDS is associated with increased plasma concentrations of ET-1 and decreased L-arginine. Infants who later developed BPD had higher plasma ET-1 at birth. Concentrations of ET-1 and L-arginine did not correlate. Copyright Â© 2011 by Thieme Medical Publishers, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 362481719
TI  - Pulmonary and systemic inflammatory responses to intra-amniotic IL-1alpha in fetal sheep
AU  - Kallapur S.G.
AU  - Kramer B.W.
AU  - Nitsos I.
AU  - Jane Pillow J.
AU  - Collins J.J.P.
AU  - Polglase G.R.
AU  - Newnham J.P.
AU  - Jobe A.H.
Y1  - 2011//
KW  - amnion
KW  - animal cell
KW  - animal experiment
KW  - animal tissue
KW  - article
KW  - cell isolation
KW  - controlled study
KW  - female
KW  - fetus
KW  - gastrointestinal tract
KW  - gestational age
KW  - in vitro study
KW  - inflammatory cell
KW  - lamb
KW  - leukocyte count
KW  - lung lavage
KW  - lung volume
KW  - lymphocyte count
KW  - mediastinum lymph node
KW  - monocyte
KW  - neutrophil count
KW  - nonhuman
KW  - *pneumonia
KW  - priority journal
KW  - protein expression
KW  - regulatory T lymphocyte
KW  - sheep
KW  - *systemic inflammatory response syndrome
KW  - T lymphocyte
KW  - cyclooxygenase 1/ec [Endogenous Compound]
KW  - cyclooxygenase 2/ec [Endogenous Compound]
KW  - haptoglobin/ec [Endogenous Compound]
KW  - hydrogen peroxide/ec [Endogenous Compound]
KW  - inducible nitric oxide synthase/ec [Endogenous Compound]
KW  - interleukin 1beta/ec [Endogenous Compound]
KW  - interleukin 8/ec [Endogenous Compound]
KW  - lipopolysaccharide
KW  - messenger RNA/ec [Endogenous Compound]
KW  - *recombinant interleukin 1alpha
KW  - transcription factor FOXP3/ec [Endogenous Compound]
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 301
IS  - 3
PB  - American Physiological Society (9650 Rockville Pike, Bethesda MD 20814-3991, United States)
SN  - 1522-1504
AD  - S. G. Kallapur, Cincinnati Children's Hospital Medical Center, Univ. of Cincinnati, Division of Pulmonary Biology, 3333 Burnet Ave, Cincinnati, OH 45229-3039, United States. E-mail: suhas.kallapur@cchmc.org
UR  - http://ajplung.physiology.org/content/301/3/L285.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=362481719
DO  - https://dx.doi.org/10.1152/ajplung.00446.2010
AB  - Clinical and epidemiological studies implicate IL-1 as an important mediator of perinatal inflammation. We tested the hypothesis that intra-amniotic IL-1alpha would induce pulmonary and systemic fetal inflammatory responses. Sheep with singleton fetuses were given an intra-amniotic injection of recombinant sheep IL-1alpha (100 mug) and were delivered 1, 3, or 7 days later, at 124 +/- 1 days gestation (n 5-8/group). A separate group of sheep were given two intra-amniotic IL-1alpha injections (100 mug dose each): 7 days and again 1 day prior to delivery. IL-1alpha induced a robust increase in monocytes, neutrophils, lymphocytes, and IL-8 protein in bronchoalveolar lavage fluid. H2O2 secretion was increased in inflammatory cells isolated from lungs of IL-1alpha -exposed lambs upon LPS challenge in vitro compared with control monocytes. T lymphocytes were recruited to the lung. IL-1beta, cyclooxygenase-1, and cyclooxygenase-2 mRNA expression increased in the lung 1 day after intra-amniotic IL-1alpha exposure. Lung volumes increased 7 days after intra-amniotic IL-1alpha exposure, with minimal anatomic changes in air space morphology. The weight of the posterior mediastinal lymph node draining the lung and the gastrointestinal tract doubled, inducible nitric oxide synthase (NOSII)-positive cells increased, and Foxp3-positive T-regulatory lymphocytes decreased in the lymph node after IL-1alpha exposure. In the blood, neutrophil counts and plasma haptoglobin increased after IL-1alpha exposure. Compared with a single exposure, exposure to intra-amniotic IL-1alpha 7 days and again 1 day before delivery had a variable effect (increases in some inflammatory markers, but not pulmonary cytokines). IL-1alpha is a potent mediator of the fetal inflammatory response syndrome. Â© 2011 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2014>
TI  - Disrupted pulmonary artery cyclic guanosine monophosphate signaling in mice with hyperoxia-induced pulmonary hypertension.
DO  - https://dx.doi.org/10.1165/rcmb.2013-0118OC
AU  - Lee, Keng Jin
AU  - Berkelhamer, Sara K
AU  - Kim, Gina A
AU  - Taylor, Joann M
AU  - O'Shea, Kelly M
AU  - Steinhorn, Robin H
AU  - Farrow, Kathryn N
Y1  - 2014//
KW  - Animals
KW  - Cyclic GMP/me [Metabolism]
KW  - *Guanosine Monophosphate/me [Metabolism]
KW  - Hyperoxia/co [Complications]
KW  - *Hyperoxia/me [Metabolism]
KW  - *Hypertension, Pulmonary/dt [Drug Therapy]
KW  - Hypertension, Pulmonary/et [Etiology]
KW  - Hypertension, Pulmonary/me [Metabolism]
KW  - Lung/me [Metabolism]
KW  - Lung Injury/dt [Drug Therapy]
KW  - Lung Injury/me [Metabolism]
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - *Piperazines/pd [Pharmacology]
KW  - *Pulmonary Artery/me [Metabolism]
KW  - Pulmonary Artery/pa [Pathology]
KW  - Purines/pd [Pharmacology]
KW  - Signal Transduction/de [Drug Effects]
KW  - Signal Transduction/ph [Physiology]
KW  - *Signal Transduction
KW  - Sildenafil Citrate
KW  - *Sulfones/pd [Pharmacology]
T2  - American journal of respiratory cell and molecular biology
VL  - 50
IS  - 2
SN  - 1044-1549
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med11&NEWS=N&AN=24032519
AD  - United States
AB  - Pulmonary hypertension (PH) occurs in 25 to 35% of premature infants with significant bronchopulmonary dysplasia (BPD). Neonatal mice exposed to 14 days of hyperoxia develop BPD-like lung injury and PH. To determinne the impact of hyperoxia on pulmonary artery (PA) cyclic guanosine monophosphate (cGMP) signaling in a murine model of lung injury and PH, neonatal C57BL/6 mice were placed in room air, 75% O2 for 14 days (chronic hyperoxia [CH]) or 75% O2 for 24 hours, followed by 13 days of room air (acute hyperoxia with recovery [AHR]) with or without sildenafil. At 14 days, mean alveolar area, PA medial wall thickness (MWT), right ventricular hypertrophy (RVH), and vessel density were assessed. PA protein was analyzed for cGMP, soluble guanylate cyclase, and PDE5 activity. CH and AHR mice had RVH, but only CH mice had increased alveolar area and MWT and decreased vessel density. In CH and AHR PAs, soluble guanylate cyclase activity was decreased, and PDE5 activity was increased. In CH mice, sildenafil attenuated MWT and RVH but did not improve mean alveolar area or vessel density. In CH and AHR PAs, sildenafil decreased PDE5 activity and increased cGMP. Our results indicate that prolonged hyperoxia leads to lung injury, PH, RVH, and disrupted PA cGMP signaling. Furthermore, 24 hours of hyperoxia causes RVH and disrupted PA cGMP signaling that persists for 13 days. Sildenafil reduced RVH and restored vascular cGMP signaling but did not attenuate lung injury. Thus, hyperoxia can rapidly disrupt PA cGMP signaling in vivo with sustained effects, and concurrent sildenafil therapy can be protective.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 362480625
TI  - Urinary N-terminal B-type natriuretic peptide predicts severe retinopathy of prematurity
AU  - Czernik C.
AU  - Metze B.
AU  - Muller C.
AU  - Muller B.
AU  - Buhrer C.
Y1  - 2011//
KW  - article
KW  - controlled study
KW  - creatinine urine level
KW  - diagnostic accuracy
KW  - disease association
KW  - disease severity
KW  - eye examination
KW  - female
KW  - gestational age
KW  - high risk infant
KW  - hospital discharge
KW  - human
KW  - infant
KW  - longitudinal study
KW  - lung dysplasia/dt [Drug Therapy]
KW  - lung dysplasia/th [Therapy]
KW  - major clinical study
KW  - male
KW  - morbidity
KW  - newborn
KW  - oxygen therapy
KW  - prediction
KW  - predictive value
KW  - prematurity
KW  - priority journal
KW  - prospective study
KW  - *protein analysis
KW  - *protein urine level
KW  - receiver operating characteristic
KW  - retina surgery
KW  - *retrolental fibroplasia/di [Diagnosis]
KW  - *retrolental fibroplasia/su [Surgery]
KW  - sensitivity and specificity
KW  - very low birth weight
KW  - *amino terminal pro brain natriuretic peptide/ec [Endogenous Compound]
KW  - creatinine/ec [Endogenous Compound]
KW  - oxygen/dt [Drug Therapy]
T2  - Pediatrics
LA  - English
VL  - 128
IS  - 3
PB  - American Academy of Pediatrics (141 Northwest Point Blvd, P.O. Box 927, Elk Grove Village IL 60007-1098, United States)
SN  - 1098-4275
AD  - C. Czernik, Klinik fur Neonatologie, Charite Universitatsmedizin Berlin, D-13344 Berlin, Germany. E-mail: christoph.czernik@charite.de
UR  - http://pediatrics.aappublications.org/content/128/3/e545.full.pdf+html
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=362480625
DO  - https://dx.doi.org/10.1542/peds.2011-0603
AB  - OBJECTIVE: The goal of this study was to evaluate urinary N-terminal fragment of B-type natriuretic peptide concentrations, normalized to creatinine (UNBCR), to predict morbidities at discharge in preterm infants. METHOD(S): UNBCR were determined in urine collected on day of life (DOL) 2, 7, 14, and 28 in 136 preterm infants < 1500 g birth weight, 22 of whom developed bronchopulmonary dysplasia (BPD), defined as oxygen supplementation at 36 weeks' gestational age) and 11 infants developed severe retinopathy (ROP), defined as stage 3 or stage >=2 requiring surgery). RESULT(S): UNBCR on DOL 7, 14, and 28 was elevated in infants who developed BPD or ROP compared with controls (P <= .001). On multiple regression analysis including birth weight and gestational age, ROP but not BPD remained independently associated with UNBCR on DOL 14 and 28. Areas under receiver operating characteristic curves for UNBCR on DOL 14 and 28 to predict ROP were 0.938 (0.027) and 0.954 (0.021), respectively. UNBCR DOL 14 and 28 thresholds exceeded by all infants with severe ROP (100% sensitivity, 100% negative predictive value) had a specificity of 66% and 85%, respectively. CONCLUSION(S): UNBCR might hold promise to reduce unnecessary eye examinations by timely and accurate identification of infants at risk of severe ROP. Copyright Â© 2011 by the American Academy of Pediatrics.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 362047193
TI  - Chronic obstructive pulmonary disease and bronchopulmonary dysplasia: Common mechanisms but distinct manifestations?
AU  - Neptune E.R.
Y1  - 2011//
KW  - age
KW  - article
KW  - cell death
KW  - *chronic obstructive lung disease/et [Etiology]
KW  - cigarette smoking
KW  - clinical feature
KW  - disease association
KW  - genetic analysis
KW  - human
KW  - inflammation
KW  - *lung dysplasia/et [Etiology]
KW  - lung injury
KW  - nonhuman
KW  - oxidative stress
KW  - pathogenesis
KW  - priority journal
KW  - risk factor
KW  - tissue repair
KW  - elastase/ec [Endogenous Compound]
KW  - epidermal growth factor/ec [Endogenous Compound]
KW  - metalloproteinase/ec [Endogenous Compound]
KW  - scatter factor/ec [Endogenous Compound]
T2  - Pediatric, Allergy, Immunology, and Pulmonology
LA  - English
VL  - 24
IS  - 2
PB  - Mary Ann Liebert Inc. (140 Huguenot Street, New Rochelle NY 10801-5215, United States)
SN  - 2151-3228
AD  - E.R. Neptune, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, 1830 East Monument St., Baltimore, MD 21205, United States. E-mail: eneptune@jhmi.edu
DO  - https://dx.doi.org/10.1089/ped.2011.0072
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=362047193
AB  - The complex disorders of chronic obstructive pulmonary disease (COPD) and bronchopulmonary dysplasia (BPD) are common, costly, and clinically burdensome. Both lung disorders develop after complex injurious triggers and can result in significant lung disease and disability. Similarities in their lung pathology and injury measures suggest common pathogenetic mechanisms. Evidence exists for both common molecular triggers and for injury-by-age interactions that may confer distinct end pathology. An emerging concept is that BPD may be a predisposing pathology for COPD development in late life. Future studies focusing on this provocative connection between BPD and COPD may translate into novel ameliorative and regenerative therapies for both disorders. Â© Copyright 2011, Mary Ann Liebert, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 361925988
TI  - Endothelial progenitor cells, bronchopulmonary dysplasia and other short-term outcomes of extremely preterm birth
AU  - Paviotti G.
AU  - Fadini G.P.
AU  - Boscaro E.
AU  - Agostini C.
AU  - Avogaro A.
AU  - Chiandetti L.
AU  - Baraldi E.
AU  - Filippone M.
Y1  - 2011//
KW  - antibiotic therapy
KW  - antigen expression
KW  - article
KW  - artificial ventilation
KW  - birth
KW  - birth weight
KW  - brain hemorrhage/et [Etiology]
KW  - clinical article
KW  - controlled clinical trial
KW  - controlled study
KW  - delivery
KW  - disease association
KW  - endothelial progenitor cell
KW  - erythrocyte count
KW  - female
KW  - flow cytometry
KW  - gestational age
KW  - human
KW  - human cell
KW  - infant
KW  - leukocyte count
KW  - lung dysplasia/dt [Drug Therapy]
KW  - *lung dysplasia/dt [Drug Therapy]
KW  - *lung dysplasia/et [Etiology]
KW  - *lung dysplasia/th [Therapy]
KW  - male
KW  - menstruation
KW  - mortality
KW  - necrotizing enterocolitis/et [Etiology]
KW  - newborn
KW  - outcome assessment
KW  - oxygen therapy
KW  - *patent ductus arteriosus/et [Etiology]
KW  - phenotype
KW  - positive end expiratory pressure
KW  - prematurity
KW  - prospective study
KW  - protein expression
KW  - respiratory tract intubation
KW  - retrolental fibroplasia/et [Etiology]
KW  - sepsis/dt [Drug Therapy]
KW  - sepsis/et [Etiology]
KW  - thrombocyte count
KW  - antibiotic agent/dt [Drug Therapy]
KW  - CD133 antigen/ec [Endogenous Compound]
KW  - CD34 antigen/ec [Endogenous Compound]
KW  - corticosteroid/dt [Drug Therapy]
KW  - oxygen
KW  - surfactant/dt [Drug Therapy]
KW  - vasculotropin receptor 2/ec [Endogenous Compound]
KW  - extremely premature newborn
T2  - Early Human Development
LA  - English
VL  - 87
IS  - 7
PB  - Elsevier Ireland Ltd (P.O. Box 85, Limerick, Ireland)
SN  - 1872-6232
AD  - G. Paviotti, Neonatal Intensive Care Unit, Dept. of Pediatrics, University of Padova, Via Giustiniani 3, 35128 Padova, Italy. E-mail: giupav@hotmail.com
DO  - https://dx.doi.org/10.1016/j.earlhumdev.2011.03.011
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=361925988
AB  - Aim: To evaluate the impact of endothelial progenitor cells (EPCs), a subset of committed circulatory stem cells, on the development of bronchopulmonary dysplasia (BPD) and other short term outcomes in a cohort of extremely premature newborns. Method(s): Progenitor cells were quantified by flow cytometry at birth in 36 neonates born <=28. weeks of gestation and at 36 postmenstrual weeks in 18 of them. Cells expressing the stemness markers CD34, CD133, or both were defined as circulating progenitor cells (CPCs). EPCs were defined as CPCs co-expressing the endothelial marker KDR. Result(s): Mean (SD) gestational age and birth weight of the infants studied were 26.2(1.5) weeks and 761.6(171.8) grams, respectively. EPC levels at birth did not differ between infants who subsequently developed BPD (n=9) and those who did not (n=24) [CD34+KDR+ EPCs: 81(34-41) vs 80(56-110), p=0.7] and were not correlated with the duration of mechanical ventilation or O2-dependence, nor with the need of surfactant replacement. Infants with a hemodynamically significant patent ductus arteriosus (PDA) (n=22) had significantly lower EPC levels at birth than those with no PDA (n=11) [CD34+KDR+ cells: 47(34-92) vs 142(84.5-221), p=0.008]. Data from the 18 infants studied both at birth and at 36 postmenstrual weeks showed that, while CPCs sharply decline over time, levels of all EPCs phenotypes are preserved after delivery. Conclusion(s): Levels of EPCs at birth did not affect the risk of developing BPD in our group of extremely premature neonates. However, the association between low EPC counts at birth and PDA may be clinically relevant, and deserves further studies. Â© 2011 Elsevier Ltd.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 361740409
TI  - "New" bronchopulmonary dysplasia: A clinical review
AU  - Bhandari A.
AU  - Bhandari V.
Y1  - 2011//
KW  - article
KW  - chronic obstructive lung disease
KW  - computer assisted tomography
KW  - disease severity
KW  - environmental factor
KW  - exercise
KW  - fluid therapy
KW  - heredity
KW  - human
KW  - immunization
KW  - influenza/dt [Drug Therapy]
KW  - *lung dysplasia/di [Diagnosis]
KW  - *lung dysplasia/dt [Drug Therapy]
KW  - *lung dysplasia/et [Etiology]
KW  - *lung dysplasia/pc [Prevention]
KW  - *lung dysplasia/th [Therapy]
KW  - lung dysplasia/dt [Drug Therapy]
KW  - lung function
KW  - nutritional support
KW  - oxygen therapy
KW  - pathogenesis
KW  - prematurity
KW  - pulmonary hypertension/dt [Drug Therapy]
KW  - respiratory syncytial virus infection/dt [Drug Therapy]
KW  - survival
KW  - thorax radiography
KW  - beta adrenergic receptor stimulating agent/dt [Drug Therapy]
KW  - bosentan/dt [Drug Therapy]
KW  - bosentan/po [Oral Drug Administration]
KW  - caffeine/dt [Drug Therapy]
KW  - chlorothiazide/dt [Drug Therapy]
KW  - cholinergic receptor blocking agent/dt [Drug Therapy]
KW  - dexamethasone/dt [Drug Therapy]
KW  - furosemide/dt [Drug Therapy]
KW  - influenza vaccine/dt [Drug Therapy]
KW  - prednisolone/dt [Drug Therapy]
KW  - respiratory syncytial virus vaccine/dt [Drug Therapy]
KW  - retinol/dt [Drug Therapy]
KW  - retinol/im [Intramuscular Drug Administration]
KW  - salbutamol/dt [Drug Therapy]
KW  - salbutamol/ih [Inhalational Drug Administration]
KW  - sildenafil/dt [Drug Therapy]
KW  - sildenafil/po [Oral Drug Administration]
KW  - spironolactone/dt [Drug Therapy]
KW  - steroid/dt [Drug Therapy]
KW  - steroid/ih [Inhalational Drug Administration]
KW  - steroid/po [Oral Drug Administration]
T2  - Clinical Pulmonary Medicine
LA  - English
VL  - 18
IS  - 3
PB  - Lippincott Williams and Wilkins (530 Walnut Street,P O Box 327, Philadelphia PA 19106-3621, United States)
SN  - 1068-0640
AD  - V. Bhandari, Department of Pediatrics, Yale University, School of Medicine, LCI 401B, New Haven, CT 06520-8064, United States. E-mail: vineet.bhandari@yale.edu
DO  - https://dx.doi.org/10.1097/CPM.0b013e318218a071
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=361740409
AB  - New bronchopulmonary dysplasia (BPD), the most common chronic lung disease in infancy, is mostly seen in infants of <30 weeks gestational age and/or <1000 g birthweight. The lungs are characterized by fewer and larger simplified alveoli that are associated with dysmorphic vasculature. Genetic and environmental factors are involved in the pathogenesis of new BPD. Strategies are presented to manage the early, evolving, and established phases of new BPD. Long-term pulmonary outcomes suggest the persistence of structural and functional deficits in childhood survivors of new BPD. Ongoing research in various aspects of new BPD has not only the potential to decrease new BPD, but also to impact on adult chronic obstructive pulmonary disease. Â© 2011 by Lippincott Williams & Wilkins.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 362837687
TI  - Positive end-expiratory pressure and surfactant decrease lung injury during initiation of ventilation in fetal sheep
AU  - Hillman N.H.
AU  - Nitsos I.
AU  - Berry C.
AU  - Pillow J.J.
AU  - Kallapur S.G.
AU  - Jobe A.H.
Y1  - 2011//
KW  - animal experiment
KW  - animal tissue
KW  - article
KW  - *artificial ventilation
KW  - cytokine release
KW  - fetus
KW  - gestational age
KW  - humidity
KW  - hysterotomy
KW  - lung compliance
KW  - lung fluid
KW  - *lung injury/dt [Drug Therapy]
KW  - *lung injury/th [Therapy]
KW  - lung injury/dt [Drug Therapy]
KW  - lung lavage
KW  - lung parenchyma
KW  - nonhuman
KW  - obstetric anesthesia
KW  - peak inspiratory flow
KW  - placenta circulation
KW  - *positive end expiratory pressure
KW  - priority journal
KW  - sheep
KW  - tidal volume
KW  - treatment outcome
KW  - early growth response factor 1/ec [Endogenous Compound]
KW  - heat shock protein 60/ec [Endogenous Compound]
KW  - heat shock protein 70/ec [Endogenous Compound]
KW  - messenger RNA/ec [Endogenous Compound]
KW  - monocyte chemotactic protein 1/ec [Endogenous Compound]
KW  - *nitrogen
KW  - *poractant/dt [Drug Therapy]
T2  - American Journal of Physiology - Lung Cellular and Molecular Physiology
LA  - English
VL  - 301
IS  - 5
PB  - American Physiological Society (9650 Rockville Pike, Bethesda MD 20814-3991, United States)
SN  - 1522-1504
AD  - N. H. Hillman, Cincinnati Children's Hospital Medical Center, University of Cincinnati, 3333 Burnet Ave, Cincinnati, OH 45229-3039, United States. E-mail: Noah.Hillman@cchmc.org
C3  - curosurf: Chiesi
C4  - Chiesi
UR  - http://ajplung.physiology.org/content/301/5/L712.full.pdf#page=1&view=FitH
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=362837687
DO  - https://dx.doi.org/10.1152/ajplung.00157.2011
AB  - The initiation of ventilation in preterm, surfactant-deficient sheep without positive endexpiratory pressure (PEEP) causes airway injury and lung inflammation. We hypothesized that PEEP and surfactant treatment would decrease the lung injury from initiation of ventilation with high tidal volumes. Fetal sheep at 128-day gestational age were randomized to ventilation with: 1) no PEEP, no surfactant; 2) 8-cmH2O PEEP, no surfactant; 3) no PEEP + surfactant; 4) 8-cmH2O PEEP + surfactant; or 5) control (2-cmH2O continuous positive airway pressure) (n = 6-7/group). After maternal anesthesia and hysterotomy, the head and chest were exteriorized, and the fetus was intubated. While maintaining placental circulation, the fetus was ventilated for 15 min with a tidal volume escalating to 15 ml/kg using heated, humidified, 100% nitrogen. The fetus then was returned to the uterus, and tissue was collected after 30 min for evaluation of early markers of lung injury. Lambs receiving both surfactant and PEEP had increased dynamic compliance, increased static lung volumes, and decreased total protein and heat shock proteins 70 and 60 in bronchoalveolar lavage fluid compared with other groups. Ventilation, independent of PEEP or surfactant, increased mRNA expression of acute phase response genes and proinflammatory cytokine mRNA in the lung tissue compared with controls. PEEP decreased mRNA for cytokines (2-fold) compared with groups receiving no PEEP. Surfactant administration further decreased some cytokine mRNAs and changed the distribution of early growth response protein-1 expression. The use of PEEP during initiation of ventilation at birth decreased early mediators of lung injury. Surfactant administration changed the distribution of injury and had a moderate additive protective effect. Â© 2011 the American Physiological Society.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 51177818
TI  - Urinary beta-2-microglobulin as an alternative marker for fetal inflammatory response and development of bronchopulmonary dysplasia in premature infants
AU  - Shima Y.
AU  - Nishimaki S.
AU  - Nakajima M.
AU  - Kumasaka S.
AU  - Migita M.
Y1  - 2011//
KW  - article
KW  - chorioamnionitis
KW  - controlled study
KW  - disease marker
KW  - gestational age
KW  - human
KW  - infant
KW  - *inflammation
KW  - *lung dysplasia/et [Etiology]
KW  - major clinical study
KW  - newborn
KW  - prediction
KW  - *prematurity
KW  - protein urine level
KW  - receiver operating characteristic
KW  - risk factor
KW  - *beta 2 microglobulin/ec [Endogenous Compound]
T2  - Journal of Perinatology
LA  - English
VL  - 31
IS  - 5
PB  - Nature Publishing Group (Houndmills, Basingstoke, Hampshire RG21 6XS, United Kingdom)
SN  - 1476-5543
AD  - Y. Shima, Department of Pediatrics, Nippon Medical School, Japanese Red Cross Maternity Hospital, 5-11-12 Tateishi, Katsushika-ku, Tokyo 124-0012, Japan. E-mail: shima-p@nms.ac.jp
DO  - https://dx.doi.org/10.1038/jp.2010.129
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=51177818
AB  - Objective:To evaluate the clinical utility of urinary B-2- microglobulin (B2M) at birth, an alternative to proinflammatory cytokines, as an indicative marker of fetal inflammatory response and subsequent higher risk of bronchopulmonary dysplasia (BPD) in premature infants. Study Design:The relationship between urinary B2M at birth and the occurrence of BPD was examined in 96 premature infants with a description of perinatal backgrounds. Constructing a receiver-operating characteristic curve to determine the cutoff value of urinary B2M at birth for the development of BPD, a multivariate logistic regression analysis was performed to evaluate whether elevated urinary B2M at birth can be used as a predictor of BPD. Result(s):BPD was diagnosed in 34% (33/96) of the infants. Neonates with BPD had a significantly higher occurrence rate of chorioamnionitis and greater levels of median urinary B2M at birth than did those without BPD. The selected cutoff value of urinary B2M at birth correlated with the development of BPD, even after adjusting for gestational age and other confounding factors. Conclusion(s):Elevated urinary B2M levels at birth can be used as an alternative marker of fetal inflammatory response and subsequent higher risk of BPD in premature infants. Â© 2011 Nature America, Inc. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 362519137
TI  - Elastase inhibitory activity of airway alpha1-antitrypsin is protected by treatment with a catalytic antioxidant in a baboon model of severe bronchopulmonary dysplasia
AU  - Karaaslan C.
AU  - Hirakawa H.
AU  - Yasumatsu R.
AU  - Chang L.-Y.L.
AU  - Pierce R.A.
AU  - Crapo J.D.
AU  - Cataltepe S.
Y1  - 2011//
KW  - airway
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - article
KW  - baboon
KW  - disease severity
KW  - *enzyme inhibition
KW  - liver
KW  - *lung dysplasia
KW  - lung parenchyma
KW  - nonhuman
KW  - priority journal
KW  - protein function
KW  - protein synthesis
KW  - *alpha 1 antitrypsin
KW  - antioxidant
KW  - *elastase
KW  - unclassified drug
KW  - manganese 3 meso tetrakis (n ethylpyridinium 2 yl) porphyrin
T2  - Pediatric Research
LA  - English
VL  - 70
IS  - 4
PB  - Nature Publishing Group (Houndmills, Basingstoke, Hampshire RG21 6XS, United Kingdom)
SN  - 1530-0447
AD  - S. Cataltepe, Division of Newborn Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, United States. E-mail: scataltepe@partners.org
DO  - https://dx.doi.org/10.1203/PDR.0b013e31822a357e
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=362519137
AB  - Recent studies in animal models of bronchopulmonary dysplasia (BPD) suggest that antioxidant treatments may be beneficial for the disease. However, the mechanisms by which these drugs improve the course of BPD are not completely known. Alpha1-antitrypsin (alpha1-AT) is one of the major serine protease inhibitors in human plasma that has antielastase and antiapoptotic activities. Both activities of alpha1-AT are dependent on its reactive site loop (RSL), which is highly susceptible to oxidative inactivation. In this study, we investigated the elastase inhibitory activity of alpha1-AT in two different baboon models of BPD, the "new BPD" and the "severe BPD" models, and determined the effect of treatment with a catalytic antioxidant, Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin (MnTE-2-PyP), on the elastase inhibitory activity of alpha1-AT in the severe BPD model. Our results demonstrate the presence of sufficient elastase inhibitory activity of the airway alpha1-AT in the new but not in the severe BPD model. Treatment of severe BPD group baboons with the catalytic antioxidant MnTE-2-PyP resulted in augmentation of the elastase inhibitory activity of alpha1-AT. These findings suggest that prevention of the oxidative inactivation of alpha1-AT may be one of the mechanisms by which antioxidant therapy improves the pulmonary outcomes in animal models of severe BPD. Copyright Â© 2011 International Pediatric Research Foundation, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 362501681
TI  - Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice
AU  - Hilgendorff A.
AU  - Parai K.
AU  - Ertsey R.
AU  - Jain N.
AU  - Navarro E.F.
AU  - Peterson J.L.
AU  - Tamosiuniene R.
AU  - Nicolls M.R.
AU  - Starcher B.C.
AU  - Rabinovitch M.
AU  - Bland R.D.
Y1  - 2011//
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - apoptosis
KW  - article
KW  - *artificial ventilation
KW  - chronic lung disease
KW  - controlled study
KW  - drug effect
KW  - drug mechanism
KW  - enzyme activity
KW  - enzyme inhibition
KW  - histology
KW  - *lung injury/dt [Drug Therapy]
KW  - *lung injury/pc [Prevention]
KW  - lung injury/dt [Drug Therapy]
KW  - mouse
KW  - newborn
KW  - nonhuman
KW  - *organ growth
KW  - priority journal
KW  - protein degradation
KW  - caspase 3/ec [Endogenous Compound]
KW  - desmosine/ec [Endogenous Compound]
KW  - *elafin/dt [Drug Therapy]
KW  - *elafin/tr [Intratracheal Drug Administration]
KW  - *elafin/pd [Pharmacology]
KW  - *elastase/ec [Endogenous Compound]
KW  - elastase inhibitor
KW  - elastin/ec [Endogenous Compound]
KW  - gelatinase B/ec [Endogenous Compound]
KW  - Smad2 protein/ec [Endogenous Compound]
KW  - transforming growth factor beta/ec [Endogenous Compound]
KW  - *lung growth
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 184
IS  - 5
PB  - American Thoracic Society (61 Broadway 4th Floor, New York NY 10006 - 2755, United States)
SN  - 1535-4970
AD  - R.D. Bland, Stanford University School of Medicine, CCSR 1225, 269 Campus Drive, Stanford, CA 94305-5162, United States. E-mail: rbland@stanford.edu
C4  - Proteo [Germany]
UR  - http://ajrccm.atsjournals.org/cgi/reprint/184/5/537
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=362501681
DO  - https://dx.doi.org/10.1164/rccm.201012-2010OC
AB  - Rationale: Mechanical ventilation with O2-rich gas (MV-O 2) offers life-saving treatment for respiratory failure, but also promotes lung injury. We previously reported that MV-O2 of newborn mice increased lung elastase activity, causing elastin degradation and redistribution of elastic fibers from septal tips to alveolar walls. These changes were associated with transforming growth factor (TGF)-beta activation and increased apoptosis leading to defective alveolarizationandlung growtharrest, as seen in neonatal chronic lung disease. Objective(s): To determine if intratracheal treatment of newborn mice with the serine elastase inhibitor elafin would prevent MV-O2-induced lung elastin degradation and the ensuing cascade of events causing lung growth arrest. Method(s): Five-day-old mice were treated via tracheotomy with recombinant human elafin or vehicle (lactated-Ringer solution), followed by MV with 40% O2 for 8-24 hours; control animals breathed 40% O2 without MV. At study's end, lungs were harvested to assess key variables noted below. Measurements and Main Results: MV-O2 of vehicle-treated pups increased lung elastase and matrix metalloproteinase-9 activity when compared with unventilated control animals, causing elastin degradation (urine desmosine doubled), TGF-beta activation (pSmad-2 tripled), andapoptosis (cleaved-caspase-3 increased 10-fold).Quantitative lung histology showed larger and fewer alveoli, greater inflammation, and scattered elastic fibers. Elafin blocked these MV-O 2-induced changes. Conclusion(s): Intratracheal elafin, by blocking lung protease activity, prevented MV-O2-induced elastin degradation, TGF-beta activation, apoptosis, and dispersion of matrix elastin, and attenuated lung structural abnormalities noted in vehicle-treated mice after 24 hours of MV-O2. These findings suggest that elastin breakdown contributes to defective lung growth in response to MV-O2 and might be targeted therapeutically to prevent MV-O2-induced lung injury.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 362354748
TI  - Stem cells and cell therapies in lung biology and lung diseases
AU  - Weiss D.J.
AU  - Bertoncello I.
AU  - Borok Z.
AU  - Kim C.
AU  - Panoskaltsis-Mortari A.
AU  - Reynolds S.
AU  - Rojas M.
AU  - Stripp B.
AU  - Warburton D.
AU  - Prockop D.J.
Y1  - 2011//
KW  - acute lung injury/th [Therapy]
KW  - adult respiratory distress syndrome/th [Therapy]
KW  - adult stem cell
KW  - asthma
KW  - bioengineering
KW  - cancer stem cell
KW  - cell adhesion
KW  - cell homing
KW  - cell proliferation
KW  - cell transdifferentiation
KW  - chronic obstructive lung disease/th [Therapy]
KW  - clinical trial (topic)
KW  - conference paper
KW  - embryonic stem cell
KW  - endothelial progenitor cell
KW  - engraftment
KW  - hematopoietic stem cell
KW  - human
KW  - immune response
KW  - immunomodulation
KW  - inflammation
KW  - lung alveolus epithelium
KW  - *lung disease/th [Therapy]
KW  - lung dysplasia
KW  - *lung function
KW  - mesenchymal stem cell
KW  - multicenter study (topic)
KW  - multipotent stem cell
KW  - nonhuman
KW  - pathogenesis
KW  - phagocytosis
KW  - phase 1 clinical trial (topic)
KW  - phase 2 clinical trial (topic)
KW  - phenotype
KW  - pluripotent stem cell
KW  - pulmonary hypertension/th [Therapy]
KW  - randomized controlled trial (topic)
KW  - sepsis
KW  - *stem cell
KW  - *stem cell transplantation
KW  - tissue regeneration
KW  - tissue repair
KW  - totipotent stem cell
KW  - amniotic fluid stem cell
KW  - bronchioalveolar stem cell
KW  - bronchiolar stem cell
KW  - facultative progenitor cell
KW  - fibrocyte
KW  - obligate progenitor cell
KW  - transit amplifying cell
KW  - unipotent stem cell
T2  - Proceedings of the American Thoracic Society
LA  - English
VL  - 8
IS  - 3
PB  - American Thoracic Society (61 Broadway 4th Floor, New York NY 10006 - 2755, United States)
SN  - 1943-5665
AD  - D.J. Weiss, Department of Medicine Pulmonary and Critical Care, Vermont Lung Center, University of Vermont College of Medicine, Burlington, VT 05405, United States. E-mail: dweiss@uvm.edu
UR  - http://pats.atsjournals.org/cgi/reprint/8/3/223
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=362354748
DO  - https://dx.doi.org/10.1513/pats.201012-071DW
AB  - The University of Vermont College of Medicine and the Vermont Lung Center, with support of the National Heart, Lung, and Blood Institute (NHLBI), the Alpha-1 Foundation, the American Thoracic Society, the Emory Center for Respiratory Health, the Lymphangioleiomyomatosis (LAM) Treatment Alliance, and the Pulmonary Fibrosis Foundation, convened a workshop, "Stem Cells and Cell Therapies in Lung Biology and Lung Diseases," held July 26-29, 2009 at the University of Vermont, to review the current understanding of the role of stem and progenitor cells in lung repair after injury and to review the current status of cell therapy approaches for lung diseases. These are rapidly expanding areas of study that provide further insight into and challenge traditional views of the mechanisms of lung repair after injury and pathogenesis of several lung diseases. The goals of the conference were to summarize the current state of the field, discuss and debate current controversies, and identify future research directions and opportunities for both basic and translational research in cell-based therapies for lung diseases. This conference was a follow-up to two previous conferences held at the University of Vermont, "Adult Stem Cells, Lung Biology, and Lung Disease" sponsored by the NHLBI, the Cystic Fibrosis Foundation, the University of Vermont College of Medicine, and the Vermont Lung Center in 2005 and "Stem Cells and Cell Therapies in Lung Biology and Diseases sponsored by the NHLBI, Alpha-1 Foundation, American Thoracic Society, Pulmonary Fibrosis Foundation, University of Vermont College of Medicine, and the Vermont Lung Center in 2007. Those conferences have been instrumental in helping to guide research and funding priorities (1, 2). Since the 2007 conference, investigations of stem cells and cell therapies in lung biology and diseases have continued to expand rapidly. However, there continue to be changes in focus and direction, particularly with respect to cell-based therapy approaches. Recent studies of immunomodulation and paracrine effects of adult stem and progenitor cells, notably adult mesenchymal stromal (stem) cells (MSCs) derived from bone marrow, adipose, and other tissues, have increasingly provided evidence of efficacy in animal models of acute and fibrotic lung injuries as well as in asthma, bronchopulmonary dysplasia, chronic obstructive pulmonary disease (COPD), sepsis, and other lung diseases. Although the mechanisms of MSC effects in these models are not yet fully understood, growing evidence implicates both soluble mediators released by the MSCs as well as cell to cell contact of MSCs with different inflammatory and immune effector cells. These studies have recently been extended to human lung explant models, and it is anticipated that clinical investigations of initial safety and efficacy of MSCs in acute lung injury will occur in the near future. In parallel, a 6-month interim analysis of a current clinical trial in the United States assessing systemic administration of MSCs in patients with moderate to severeCOPDhas demonstrated safety and has yielded promising results with respect to efficacy. This trial has completed its 2-year observation period, and data is expected to be released in late 2010 or early 2011.Circulating endothelial progenitor cells (EPCs) can contribute to regeneration of diseased pulmonary vasculature, and two recent clinical investigations in China have suggested the efficacy of autologous bone marrow-derived EPC administration in both adult and pediatric patients with pulmonary hypertension. A comparable trial of autologous EPC administration in pulmonary hypertension, the Pulmonary Hypertension: Assessment of Cell Therapy (PHaCET) trial, is ongoing in Canada. Circulating endothelial progenitor cells may also play roles in both acute lung injury and in fibrotic lung diseases. Engraftment of systemically or intratracheally administered cells remains a controversial issue. Although most available evidence argues against significant engraftment, publications and abstracts presented at the conference suggest that several newly investigated cell types, including those derived from placental tissues or novel cell populations derived from adult bone marrow, may demonstrate a more robust ability to engraft and participate in lung repair. Further, significant advances continue to be made in novel areas of investigation including increasing exploration of 3-dimensional culture systems and bioengineering approaches to generate functional lung tissue ex vivo and in vivo. This has culminated in the first successful clinical use of a bioengineered trachea. In parallel, several recent reports demonstrate the potential feasibility of using decellularized whole lungs as scaffolds for recellularization and subsequent implantation. These areas are predicted to be of intense investigation over the next several years. Comparably, progress continues in studies of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPS). Several groups have presented protocols for deriving definitive endoderm from either ESCs or iPS cultured in vitro and some have further demonstrated the ability to generate cellswith phenotypicmarkers of type 2 alveolar cells from either mouse or human ESCs. In addition, a recent study demonstrated the potential ability of type 2 alveolar epithelial cells, derived in culture from human embryonic stem cells, to engraft in lung and ameliorate experimentally induced lung injury in a rodent model. Nonetheless, many challenges remain to generating functional lung cells fromeither ESCs or iPS. One potentially fruitful area of investigation derives from the recently demonstrated generation of disease-specific iPS from tissue samples obtained from patients with cystic fibrosis, a-1 antitrypsin deficiency, and other genetic or acquired lung diseases. Significant progress continues to be made in investigations of local (endogenous) stem and progenitor cells residing in the lungs. Advances in lineage-tracing approaches and other techniques have provided important insights into understanding the identity and lineage expansion properties of previously identified putative endogenous progenitor populations and suggest an increasingly complex network of cellular repair after injury. However, the study of endogenous lung stem and progenitor cells remains complicated by the role of the specific microenvironmental niches in which these cells reside. Alteration of the niches with experimental protocols or removal of cells from the niches can change their identifying characteristics and biologic activities. One of the challenges continuing to face the field is to continue to devise more refined lineage tracing and other study mechanisms to define, characterize, and explore potential therapeutic and/or pathologic properties of endogenous lung progenitor cells. This includes studies of lung cancer stem cells, an area of increasing focus and high interest that remains incompletely understood. Another challenge is that most studies of endogenous progenitor cells continue to use mouse models. Correlative information in human lungs remains poorly defined. Acontinuing issue of confusion is that of terminology. Despite suggested guidelines from previous conferences and from other sources, precise definitions and characterizations of specific cell populations, notably the putative endogenous cell populations in the lung as well as mesenchymal stromal cells and endothelial progenitor cells, are not agreed upon. The terms "stem cell" and "progenitor cell" are still used with varying degrees of clarity and precision by different investigators and in recent publications. This continues to complicate the comparison of different investigative approaches. A glossary of relevant working definitions applicable to the lung, originally presented in the report of the 2007 conference, is depicted in Table 1. This glossary does not necessarily reflect a consensus for the definition of each term and will undergo continuing revision as an overall understanding of the cell types and mechanisms involved in lung repair continue to be elucidated. Nonetheless, it is a useful framework. The first session, "Endogenous Lung Progenitor Cells/Lung Cancer Stem Cells," following an overview of the field by Paul Simmons (University of Texas) and respective presentations by Susan Reynolds (National Jewish), Ed Morrisey (University of Pennsylvania), Barry Stripp (Duke), Majd Mouded (University of Pittsburgh), and Kerstin Sinkevicius (Boston Children's Hospital), reviewed the current state of knowledge of endogenous progenitor cell populations, mechanisms regulating their behavior, and their potential to initiate or augment repair. This included lessons learned from lung development, the role of the local microenvironmental niches, and consideration of lung cancer progenitor cells. Key points emphasized during this session were that stem cells are operationally defined not solely by their intrinsic developmental potential but by their interaction with the microenvironments in which they reside. Further, the stem cell niche is a dynamic "temporal" niche with the capacity to modify stem cell behavior/readout in different contexts. Moreover, stem cell-associated markers are not uniquely expressed by stem cells and are unreliable predictors of the "stem" or "progenitor" cell potential of isolated cells. Validation by functional assays and lineage-tracing studies, particularly when interrogating isolated cells where histomorphometric spatial and positional cues are lost, are increasingly valid and necessary.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 360224819
TI  - Granulocyte colony stimulating factor attenuates hyperoxia-induced lung injury by down-modulating inflammatory responses in neonatal rats
AU  - Jeon G.W.
AU  - Sung D.K.
AU  - Jung Y.J.
AU  - Koo S.H.
AU  - Choi S.H.
AU  - Chang Y.S.
AU  - Sin J.B.
AU  - Park W.S.
Y1  - 2011//
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - antiinflammatory activity
KW  - article
KW  - attenuation
KW  - controlled study
KW  - drug effect
KW  - experimental model
KW  - histopathology
KW  - *hyperoxia
KW  - *inflammation/dt [Drug Therapy]
KW  - inflammation/dt [Drug Therapy]
KW  - Korea
KW  - lung alveolus wall
KW  - *lung injury/dt [Drug Therapy]
KW  - lung injury/dt [Drug Therapy]
KW  - newborn
KW  - nick end labeling
KW  - nonhuman
KW  - perinatal period
KW  - rat
KW  - Sprague Dawley rat
KW  - upregulation
KW  - weight gain
KW  - interleukin 6/ec [Endogenous Compound]
KW  - messenger RNA/ec [Endogenous Compound]
KW  - myeloperoxidase/ec [Endogenous Compound]
KW  - protein p67/ec [Endogenous Compound]
KW  - *recombinant granulocyte colony stimulating factor/dt [Drug Therapy]
KW  - *recombinant granulocyte colony stimulating factor/ip [Intraperitoneal Drug Administration]
KW  - *recombinant granulocyte colony stimulating factor/pd [Pharmacology]
KW  - reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound]
KW  - superoxide/ec [Endogenous Compound]
KW  - transforming growth factor beta/ec [Endogenous Compound]
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
T2  - Yonsei Medical Journal
LA  - English
VL  - 52
IS  - 1
PB  - Yonsei University College of Medicine (Shinchon dong 134, Seodaemoon ku, Seoul 120-752, South Korea)
SN  - 0513-5796
AD  - W. S. Park, Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, South Korea. E-mail: wonspark@skku.edu
C4  - Dong A [South Korea]
UR  - http://www.eymj.org/Synapse/Data/PDFData/0069YMJ/ymj-52-65.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed12&NEWS=N&AN=360224819
DO  - https://dx.doi.org/10.3349/ymj.2011.52.1.65
AB  - Purpose: Granulocyte colony stimulating factor (G-CSF) has been known to increase neutrophil production and have anti-inflammatory properties, but the effect of G-CSF on pulmonary system is in controversy. We investigated whether G-CSF treatment could attenuate hyperoxia-induced lung injury, and whether this protective effect is mediated by the down-modulation of inflammatory responses in a neonatal rat model. Material(s) and Method(s): Newborn Sprague-Dawley rats (Orient Co., Seoul, Korea) were subjected to 14 days of hyperoxia (90% oxygen) beginning within 10 h after birth. G-CSF (20 mug/kg) was administered intraperitoneally on the fourth, fifth, and sixth postnatal days. Result(s): This treatment significantly improved hyperoxia-induced reduction in body weight gain and lung pathology such as increased mean linear intercept, mean alveolar volume, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling positive cells. Hyperoxia-induced activation of nicotinamide adenine dinucleotide phosphate oxidase, which is responsible for superoxide anion production, as evidenced by upregulation and membrane translocation of p67phox was significantly attenuated after G-CSF treatment, as were inflammatory responses such as increased myeloperoxidase activity and mRNA expression of transforming growth factor-beta. However, the attenuation of other proinflammatory cytokines such as tumor necrosis factor-alpha and interleukin-6 was not significant. Conclusion(s): In sum, G-CSF treatment significantly attenuated hyperoxia-induced lung injury by down-modulating the inflammatory responses in neonatal rats. Â© Yonsei University College of Medicine 2011.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2014>
TI  - Epithelial-mesenchymal co-culture model for studying alveolar morphogenesis.
DO  - https://dx.doi.org/10.4161/org.29198
AU  - Greer, Rachel M
AU  - Miller, J Davin
AU  - Okoh, Victor O
AU  - Halloran, Brian A
AU  - Prince, Lawrence S
Y1  - 2014//
Y2  - 20141031//
KW  - Animals
KW  - Cell Communication/ph [Physiology]
KW  - Cell Movement
KW  - Cell Size
KW  - Cells, Cultured
KW  - Coculture Techniques/mt [Methods]
KW  - Epithelial Cells/cy [Cytology]
KW  - *Epithelial Cells/ph [Physiology]
KW  - *Epithelial-Mesenchymal Transition/ph [Physiology]
KW  - *Mesoderm/cy [Cytology]
KW  - *Mesoderm/ph [Physiology]
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Models, Animal
KW  - *Morphogenesis/ph [Physiology]
KW  - *Pulmonary Alveoli/cy [Cytology]
KW  - *Pulmonary Alveoli/gd [Growth & Development]
T2  - Organogenesis
VL  - 10
IS  - 4
SN  - 1547-6278
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med11&NEWS=N&AN=25482312
AD  - United States
AB  - Division of large, immature alveolar structures into smaller, more numerous alveoli increases the surface area available for gas exchange. Alveolar division requires precise epithelial-mesenchymal interactions. However, few experimental models exist for studying how these cell-cell interactions produce changes in 3-dimensional structure. Here we report an epithelial-mesenchymal cell co-culture model where 3-dimensional peaks form with similar cellular orientation as alveolar structures in vivo. Co-culturing fetal mouse lung mesenchyme with A549 epithelial cells produced tall peaks of cells covered by epithelia with cores of mesenchymal cells. These structures did not form when using adult lung fibroblasts. Peak formation did not require localized areas of cell proliferation or apoptosis. Mesenchymal cells co-cultured with epithelia adopted an elongated cell morphology closely resembling myofibroblasts within alveolar septa in vivo. Because inflammation inhibits alveolar formation, we tested the effects of E. coli lipopolysaccharide on 3-dimensional peak formation. Confocal and time-lapse imaging demonstrated that lipopolysaccharide reduced mesenchymal cell migration, resulting in fewer, shorter peaks with mesenchymal cells present predominantly at the base. This epithelial-mesenchymal co-culture model may therefore prove useful in future studies of mechanisms regulating alveolar morphogenesis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 359945773
TI  - Intra and interobserver reliability of the interpretation of high-resolution computed tomography on the lungs of premature infants
AU  - Boechat M.C.B.
AU  - de Mello R.R.
AU  - Dutra M.V.P.
AU  - da Silva K.S.
AU  - Daltro P.
AU  - Marchiori E.
Y1  - 2010//
KW  - article
KW  - atelectasis/di [Diagnosis]
KW  - clinical evaluation
KW  - clinical practice
KW  - clinical research
KW  - controlled study
KW  - cross-sectional study
KW  - *fetus lung maturity
KW  - gestational age
KW  - *high resolution computer tomography
KW  - hospital discharge
KW  - human
KW  - image analysis
KW  - infant
KW  - interrater reliability
KW  - intrarater reliability
KW  - kappa statistics
KW  - length of stay
KW  - low birth weight
KW  - major clinical study
KW  - *prematurity
T2  - Sao Paulo Medical Journal
LA  - Portuguese
VL  - 128
IS  - 3
PB  - Associacao Paulista de Medicina (E-mail: revistas@apm.org.br)
SN  - 1516-3180
AD  - M. C. B. Boechat, Instituto Fernandes Figueira, Servico de Radiologia, Avenida Rui Barbosa, 716, Flamengo - Rio de Janeiro (RJ), CEP 22250-020, Brazil. E-mail: marciaboechat@iff.fiocruz.br
C1  - ProSpeed S: General Electric [United States]
C2  - General Electric [United States]
UR  - http://www.scielo.br/pdf/spmj/v128n3/v128n3a05.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=359945773
DO  - https://dx.doi.org/10.1590/s1516-31802010000300005
AB  - Context and objective: High-resolution computed tomography (HRCT) of the lungs is more sensitive than radiographs for evaluating pulmonary disease, but little has been described about HRCT interpretation during the neonatal period or shortly afterwards. The aim here was to evaluate the reliability of the interpretation of HRCT among very low birth weight premature infants (VLBWPI; < 1500 g). Design and setting: Cross-sectional study on intra and interobserver reliability of HRCT on VLBWPI. Method(s): 86 VLBWPI underwent HRCT. Two pediatric radiologists analyzed the HRCT images. The reliability was measured by the proportion of agreement, kappa coefficient (KC) and positive and negative agreement indices. RESULT(S): For radiologist A, the intraobserver reliability KC was 0.79 (confidence interval, CI: 0.54-1.00) for normal/abnormal examinations; for each abnormality on CT, KC ranged from 0.05 to 1.00. For radiologist B, the intraobserver reliability KC was 0.79 (CI: 0.54-1.00) for normal/abnormal examinations; for each abnormality on CT, KC ranged from 0.37 to 0.83. The interobserver agreement was 88% for normal/abnormal examinations and KC was 0.71 (CI: 0.5- 0.93); for most abnormal fndings, KC ranged from 0.51-0.67. CONCLUSION(S): For normal/abnormal examinations, the intra and interobserver agreements were substantial. For most of the imaging findings, the intraobserver agreement ranged from moderate to substantial. Our data demonstrate that in clinical practice, there is no reason for more than one tomographic image evaluator, provided that this person is well trained in VLBWPI HRCT interpretation. Analysis by different observers should be reserved for research and for difficult cases in clinical contexts.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 359960960
TI  - Adrenomedullin promotes lung angiogenesis, alveolar development, and repair
AU  - Vadivel A.
AU  - Abozaid S.
AU  - Van Haaften T.
AU  - Sawicka M.
AU  - Eaton F.
AU  - Chen M.
AU  - Thebaud B.
Y1  - 2010//
KW  - *angiogenesis
KW  - animal cell
KW  - animal experiment
KW  - animal model
KW  - apoptosis
KW  - arterial wall thickness
KW  - article
KW  - competitive inhibition
KW  - controlled study
KW  - density
KW  - heart right ventricle hypertrophy
KW  - in vivo study
KW  - *lung alveolus
KW  - lung blood vessel
KW  - lung capillary
KW  - *lung development
KW  - lung dysplasia/dt [Drug Therapy]
KW  - newborn
KW  - nonhuman
KW  - protection
KW  - protein expression
KW  - pulmonary artery
KW  - pulmonary hypertension/dt [Drug Therapy]
KW  - pulmonary hypertension/pc [Prevention]
KW  - rat
KW  - real time polymerase chain reaction
KW  - reverse transcription polymerase chain reaction
KW  - *adrenomedullin/dv [Drug Development]
KW  - *adrenomedullin/dt [Drug Therapy]
KW  - *adrenomedullin/na [Intranasal Drug Administration]
KW  - *adrenomedullin/pd [Pharmacology]
KW  - *adrenomedullin/sc [Subcutaneous Drug Administration]
KW  - adrenomedullin receptor/ec [Endogenous Compound]
KW  - endothelial nitric oxide synthase/ec [Endogenous Compound]
KW  - hypertensive agent
KW  - messenger RNA/ec [Endogenous Compound]
KW  - unclassified drug
KW  - vasculotropin A/ec [Endogenous Compound]
KW  - *lung angiogenesis
KW  - adrenomedullin 22-25
T2  - American Journal of Respiratory Cell and Molecular Biology
LA  - English
VL  - 43
IS  - 2
PB  - American Thoracic Society (61 Broadway 4th Floor, New York NY 10006 - 2755, United States)
SN  - 1044-1549
AD  - B. Thebaud, University of Alberta, HMRC 407, Edmonton, AB T6G 2S2, Canada. E-mail: bthebaud@ualberta.ca
UR  - http://ajrcmb.atsjournals.org/cgi/reprint/43/2/152
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=359960960
DO  - https://dx.doi.org/10.1165/rcmb.2009-0004OC
AB  - Bronchopulmonary dysplasia (BPD) and emphysema are significant global health problems at the extreme stages of life. Both are characterized by alveolar simplification andabnormal distal airspace enlargement due to arrested development or loss of alveoli, respectively. Both lack effective treatments. Mechanisms that inhibit distal lung growth are poorly understood. Adrenomedullin (AM), a recently discovered potent vasodilator, promotes angiogenesis and has protective effects on the cardiovascular and respiratory system. Its role in the developing lung is unknown. We hypothesized that AM promotes lung angiogenesis and alveolar development. Accordingly, we report that lung mRNA expression of AM increases during normal alveolar development. In vivo, intranasal administration of the AM antagonist, AM22-52 decreases lung capillary density (12.4 +/- 1.5 versus 18 +/- 1.5 in control animals; P < 0.05) and impairs alveolar development (mean linear intercept, 52.3 +/- 1.5 versus 43.8 +/- 1.8 [P < 0.05] and septal counts 62.0 +/- 2.7 versus 90.4 +/- 3.5 [P < 0.05]) in neonatal rats, resulting in larger and fewer alveoli, reminiscent of BPD. This was associated with decreased lung endothelial nitric oxide synthase and vascular endothelial growth factor-A mRNA expression. In experimental oxygen-induced BPD, a model of arrested lung vascular and alveolar growth, AM attenuates arrested lung angiogenesis (vessel density, 6.9 +/- 1.1 versus 16.2 +/- 1.3, P < 0.05) and alveolar development (mean linear intercept, 51.9 +/- 3.2 versus 44.4 +/- 0.7, septal counts 47.6 +/- 3.4 versus 67.7 +/- 4.0, P < 0.05), an effect in part mediated by inhibition of apoptosis. AM also prevents pulmonary hypertension in this model, as assessed by decreased right ventricular hypertrophy and pulmonary artery medial wall thickness. Our findings suggest a role for AM during normal alveolar development. AM may have therapeutic potential in diseases associated with alveolar injury.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 358910601
TI  - N-terminal pro-B-type natriuretic peptide as a marker of bronchopulmonary dysplasia in premature infants
AU  - Joseph L.
AU  - Nir A.
AU  - Hammerman C.
AU  - Goldberg S.
AU  - Ben Shalom E.
AU  - Picard E.
Y1  - 2010//
KW  - article
KW  - clinical article
KW  - controlled study
KW  - correlation function
KW  - disease severity
KW  - female
KW  - gestational age
KW  - human
KW  - *lung dysplasia/cn [Congenital Disorder]
KW  - *lung dysplasia/dt [Drug Therapy]
KW  - lung dysplasia/dt [Drug Therapy]
KW  - male
KW  - newborn
KW  - *prematurity
KW  - priority journal
KW  - protein analysis
KW  - protein blood level
KW  - respiratory distress
KW  - *amino terminal pro brain natriuretic peptide/ec [Endogenous Compound]
KW  - biological marker/ec [Endogenous Compound]
KW  - diuretic agent/dt [Drug Therapy]
T2  - American Journal of Perinatology
LA  - English
VL  - 27
IS  - 5
PB  - Thieme Medical Publishers, Inc.
SN  - 1098-8785
AD  - E. Picard, Department of Pediatric Pulmonology, Shaare Zedek Medical Center, POB 3235, Jerusalem 91031, Israel. E-mail: picard@szmc.org.il
UR  - http://www.thieme-connect.com/ejournals/toc/ajp
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=358910601
DO  - https://dx.doi.org/10.1055/s-0029-1243312
AB  - We performed an observational pilot study of plasma concentrations of N-terminal pro-B-type natriuretic peptide (BNP) in premature infants with a diagnosis of bronchopulmonary dysplasia (BPD) at 4 weeks of age and after 1 month of conventional therapy. Thirty-four premature infants born before 34 weeks' gestational age without cardiac or infectious diseases were included. Serum NT-pro-BNP was measured in all neonates at 4 weeks of age. In infants with the diagnosis of BPD (n=11), measurements were repeated at 6 and 8 weeks of age under conventional treatment. Specific clinical characteristics were collected prospectively. Baseline NT-pro-BNP concentrations were high in healthy premature infants compared with previously reported healthy neonates, and significantly higher in those who developed BPD. There was a significant correlation between concentrations of NT-pro-BNP and severity of respiratory distress as assessed by several methods. The concentrations of NT-pro-BNP decreased significantly over time in BPD infants. Premature infants have high concentrations of NT-pro-BNP at 1 month of age. NT-pro-BNP concentrations are significantly higher in BPD infants and decline over time. NT-pro-BNP concentrations correlate with clinical severity of respiratory disease. Copyright Â© 2010 by Thieme Medical Publishers, Inc.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 365386863
TI  - Nutritional strategies to prevent bronchopulmonary dysplasia (BPD)
AU  - Luna M.S.
Y1  - 2009//
KW  - birth weight
KW  - clinical trial (topic)
KW  - controlled study
KW  - death
KW  - drug megadose
KW  - feeding
KW  - human
KW  - infant
KW  - liquid
KW  - lung
KW  - lung development
KW  - *lung dysplasia
KW  - lung injury
KW  - morbidity
KW  - newborn
KW  - nutrient
KW  - nutrition
KW  - premature labor
KW  - prematurity
KW  - risk factor
KW  - survival
KW  - *lipid
KW  - protein
KW  - *retinol
T2  - Revista Espanola de Pediatria
LA  - Spanish
VL  - 65
IS  - 3
PB  - Ediciones Ergon SA (C/Arboleda 1, Majadahonda (Madrid) 28220, Spain)
SN  - 0034-947X
AD  - M.S. Luna, Departamento de Pediatria, Universidad Complutense de Madrid, Hospital General Universitario Gregorio Maranon, Madrid, Spain. E-mail: msanchezl.hgugm@vehd.madrid.org
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=365386863
AB  - The important role of nutrition in survival of preterm newborn is a well-studied and recognized issue, but its direct implication in all morbidities related to preterm birth is something to be defined. One of these morbidities is Bronchopulmonary Dysplasia (BPD). It is clear that nutrition plays a roll in lung development of premature infant, but don't know exactly how nutrition can benefit this growth or how it can interference if it is wrong. Excessive amounts of fluids during the first days of life has been proposed as a promoting factor of BPD, but controlled trials have a high variability of designs and do not demonstrated this relation. Early and aggressive feeding has been proposed to prevent metabolic shock and induce better growth but again there are no data to support any effect decreasing BPD rate. Recent studies do not support this higher growth with earlier and higher protein administration. Intravenous lipids given very early after birth was proposed as a risk factor for death and morbidity, recent data support a beneficial effect of early-administrated intravenous are well tolerated. But high doses of Vitamin A given intramuscularly during the first weeks of life has demonstrated a benefit decreasing BPD in newborns with a birth weight of less than 1.000 grams. Other nutrients have demonstrated no effect in preventing the development of BPD. So even a close relation between nutrition and lung growth is proven, there are no well clinical trials in human designated to show how nutrition acts, being necessary more trials to better define how we can decrease chronic lung injuries in preterm newborns improving nutrition.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 354982836
TI  - alpha-Phenyl-n-tert-butylnitrone attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats
AU  - Chang Y.S.
AU  - Kim Y.J.
AU  - Yoo H.S.
AU  - Sung D.K.
AU  - Kim S.Y.
AU  - Kang S.
AU  - Park W.S.
Y1  - 2009//
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - *antiinflammatory activity
KW  - article
KW  - controlled study
KW  - down regulation
KW  - enzyme activation
KW  - female
KW  - *hyperoxia
KW  - inflammation
KW  - lung alveolus
KW  - lung injury/dt [Drug Therapy]
KW  - *lung injury/dt [Drug Therapy]
KW  - newborn
KW  - nick end labeling
KW  - nonhuman
KW  - priority journal
KW  - rat
KW  - Sprague Dawley rat
KW  - upregulation
KW  - interleukin 6/ec [Endogenous Compound]
KW  - messenger RNA/ec [Endogenous Compound]
KW  - *n tert butyl alpha phenylnitrone/dt [Drug Therapy]
KW  - *n tert butyl alpha phenylnitrone/ip [Intraperitoneal Drug Administration]
KW  - *n tert butyl alpha phenylnitrone/pd [Pharmacology]
KW  - oxygen/ec [Endogenous Compound]
KW  - protein p67/ec [Endogenous Compound]
KW  - reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound]
KW  - superoxide/ec [Endogenous Compound]
KW  - transforming growth factor beta/ec [Endogenous Compound]
KW  - tumor necrosis factor alpha/ec [Endogenous Compound]
T2  - Experimental Lung Research
LA  - English
VL  - 35
IS  - 3
PB  - Informa Healthcare (69-77 Paul Street, London EC2A 4LQ, United Kingdom)
SN  - 1521-0499
AD  - W. S. Park, Department of Pediatrics, Samsung Seoul Hospital, 50 Irwon-dong, Kangnam-gu, Seoul, 135-710, South Korea. E-mail: wonspark@skku.edu
C4  - Sigma [United States]
DO  - https://dx.doi.org/10.1080/01902140802573007
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=354982836
AB  - This study was done to determine whether -phenyl-N-tert-butylnitrone (PBN), a spin-trapping agent possessing significant anti-inflammatory capabilities, could attenuate hyperoxia-induced lung injury, and if so, whether this protective effect is mediated by the down-modulation of inflammation in neonatal rats. Newborn Sprague-Dawley rat pups were subjected to 14 days of hyperoxia ( 90% oxygen) within 10 hours after birth. PBN treatment, given 100 mg/kg intraperitoneally daily throughout the experiment, significantly attenuated hyperoxia-induced lung pathology, such as decreased radial alveolar count, increased mean linear intercept, and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling-positive cells. Hyperoxia-indcued activation of nicotinamide adenine dinucleotide phosphate oxidase that is responsible for superoxide anion production, as evidenced by up-regulation and membrane translocation of p67phox, and the inflammatory responses, such as increased mRNA expression of tumor necrosis factor-, interleukin-6, and transforming growth factor-, were also significantly attenuated with PBN treatment. In summary, a spin-trapping agent PBN significantly attenuated hyperoxia-induced lung injury by down-regulating the inflammatory responses in neonatal rats.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 362010839
TI  - Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease
T2  - Advances in Experimental Medicine and Biology
AU  - Abman S.H.
Y1  - 2010//
KW  - conference paper
KW  - gene therapy
KW  - human
KW  - hyperoxia
KW  - lung circulation
KW  - lung development
KW  - lung dysplasia/dt [Drug Therapy]
KW  - lung hypoplasia/dt [Drug Therapy]
KW  - lung injury/th [Therapy]
KW  - lung vascular resistance
KW  - newborn
KW  - nonhuman
KW  - pathogenesis
KW  - *persistent pulmonary hypertension/dt [Drug Therapy]
KW  - *persistent pulmonary hypertension/et [Etiology]
KW  - persistent pulmonary hypertension/dt [Drug Therapy]
KW  - priority journal
KW  - protein expression
KW  - protein interaction
KW  - signal transduction
KW  - acetylcholine
KW  - angiogenesis inhibitor/cm [Drug Comparison]
KW  - angiogenesis inhibitor/dt [Drug Therapy]
KW  - fumagillin/cm [Drug Comparison]
KW  - nitric oxide/dt [Drug Therapy]
KW  - nitric oxide/ih [Inhalational Drug Administration]
KW  - nitrofen/dt [Drug Therapy]
KW  - semaxanib
KW  - thalidomide/cm [Drug Comparison]
KW  - *vasculotropin/ec [Endogenous Compound]
KW  - vasculotropin 165
KW  - vasculotropin receptor/ec [Endogenous Compound]
LA  - English
VL  - 661
PB  - Springer New York (233 Spring Street, New York NY 10013-1578, United States)
SN  - 9781607614999
AD  - S. H. Abman, Pediatric Heart Lung Center, Box B395, Children's Hospital, 13123 E. 16th Avenue, Aurora, CO 80045, United States. E-mail: steven.abman@uchsc.edu
DO  - https://dx.doi.org/10.1007/978-1-60761-500-2_21
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=362010839
AB  - Of diverse growth factors that contribute to normal lung development, vascular endothelial growth factor (VEGF) plays an especially prominent role in the normal growth and development of the pulmonary circulation in the fetus and newborn. Strong experimental and clinical data support the role of impaired VEGF signaling in the pathogenesis of two major clinical disorders of the developing lung circulation: persistent pulmonary hypertension of the newborn (PPHN) and bronchopulmonary dysplasia (BPD). These disorders are each characterized by impaired vascular growth, structure and reactivity, which are at least partly due to endothelial cell dysfunction. This chapter will briefly discuss VEGF signaling during normal lung development and how disruption of VEGF signaling contribute to the pathogenesis of neonatal pulmonary vascular disease in these settings. Â© Humana Press, a part of Springer Science+ Business Media, LLC 2010.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72092998
TI  - Effectiveness and side-effects of 2 different doses of caffeine citrate in preventing apnea in VLBW pre-mature infants
AU  - Shah V.A.
AU  - Wong C.W.
Y1  - 2010//
KW  - *apnea
KW  - *prematurity
KW  - *side effect
KW  - *very low birth weight
KW  - recommended drug dose
KW  - breathing
KW  - bradycardia
KW  - infant
KW  - fatty acid desaturation
KW  - maturity
KW  - cyanosis
KW  - general hospital
KW  - brain hemorrhage
KW  - Singapore
KW  - risk
KW  - newborn apnea
KW  - intensive care unit
KW  - newborn intensive care
KW  - lung dysplasia
KW  - retinopathy
KW  - morbidity
KW  - cohort analysis
KW  - tachycardia
KW  - toxicity
KW  - therapy
KW  - nervousness
KW  - birth weight
KW  - safety
KW  - *caffeine citrate
KW  - caffeine
T2  - Proceedings of Singapore Healthcare
LA  - English
VL  - 19
IS  - SUPPL. 2
PB  - SAGE Publications Inc.
SN  - 2010-1058
AD  - V.A. Shah, Department of Neonatal and Developmental Medicine, Singapore General Hospital, Singapore, Singapore
DO  - https://dx.doi.org/10.1177/20101058100190S201
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=72092998
AB  - Aims: To compare the effectiveness and safety of recommended dose vs half dose of caffeine citrate in Very Low Birth Weight (VLBW) infants. Method(s): A case-control cohort study was conducted at the Neonatal Intensive Care Unit of Singapore General Hospital on 221 VLBW infants born <34 weeks with birth weight <1,500g and received caffeine citrate for 2 weeks for treatment of apnea of pre-maturity. The demographic and clinical characteristics among study infants in the two groups were similar. The primary outcome measure is the total number of episodes of apnea, shallow breathing, bradycardia and desaturation over the first 2 weeks of caffeine therapy. Secondary outcome measures include i) frequency of shallow breathing, apnea, bradycardia and desaturation episodes, caffeine levels and reintubation rates; ii) evaluation of toxicity i.e. tachycardia, jitteriness and feed intolerance, and iii) evaluation of associated morbidity such as retinopathy of pre-maturity requiring treatment, bronchopulmonary dysplasia and grade 1 or 2 intraventricular haemorrhage. Result(s): The total number of episodes of shallow breathing, apnea, bradycardia and cyanosis (SABC) within the first week was significantly higher at 42.5 in half-dose vs 27 in recommended-dose caffeine (p<0.001). The difference is not significant in second week, when total shallow breathing, apnea, bradycardia and cyanosis (SABC) were 23.5 and 21 in half-and recommended-dose caffeine respectively (p=0.155). The total number of SBAC in 2 weeks was 73.5 vs 49 in half-dose and recommended-dose respectively (p=0.011). There was no difference in the incidence of side-effects, reintubation rate, or duration of caffeine in the two groups. There was no difference in rate of BPD or ROP in the two groups. Contrary to belief, there was a decrease in the incidence of feed intolerance in the recommended dose of caffeine p=0.006, odds ratio (95% CI) at 0.451(0.261-0.780). Conclusion(s): There is a clinically significant difference in apnea control in recommended Caffeine Citrate dose in the first week of life without significant increase in side-effects. There was a decrease in incidence of feed intolerance in recommended dose of caffeine. It is beneficial to use the recommended dose of caffeine in the treatment of apnea of prematurity and it reduces rate of feed intolerance as well.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 72023564
TI  - Effectiveness and safety of surfacen in the present circumstances in Cuba
AU  - Fernandez-Limia O.
AU  - Diaz E.
AU  - Yera I.
AU  - Morilla A.
Y1  - 2010//
KW  - *Cuba
KW  - *pharmacology
KW  - *therapy
KW  - *safety
KW  - infant mortality
KW  - mortality
KW  - arterial blood
KW  - human
KW  - blood oxygenation
KW  - death
KW  - hyaline membrane disease
KW  - patient
KW  - neonatal respiratory distress syndrome
KW  - lung dysplasia
KW  - Mexico
KW  - drug surveillance program
KW  - newborn
KW  - live birth
KW  - pneumothorax
KW  - ductus arteriosus
KW  - pneumonia
KW  - intensive care unit
KW  - newborn intensive care
KW  - artificial ventilation
KW  - clinical trial
KW  - survival
KW  - oxygenation
KW  - surfactant
KW  - beractant
T2  - VacciMonitor
LA  - English
VL  - 19
IS  - SUPPL. 2
PB  - Finlay Ediciones
SN  - 1025-028X
AD  - O. Fernandez-Limia, Centro Nacional De Sanidad Agropecuaria (CENSA), Carretera De Jamaica y Autopista Nacional, San Jose De Las Lajas, La Habana, Cuba. E-mail: octavio@censa.edu.cu
UR  - http://www.finlay.sld.cu/publicaciones/vaccimonitor/Vm2010/ABSTRACTS-PHARMACOLOGY-2010.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=72023564
AB  - Introduction: SURFACEN is a porcine natural surfactant used to treat the Newborn Respiratory Distress Syndrome, (NRDS) known formerly as Hyaline Membrane disease. Since its approval for use in 1995 has been used increasingly and has helped with Neonatal Intensive Care Units (ICU) facilities the decline in infant mortality from this cause from 0.8 in 1994 to 0.1 per thousand live births in 2008. However, since the first clinical trial (CT) conducted in 1994 and a further comparative CT with Beractant made in Mexico, after more than 10 years of use is not aware of the effectiveness and frequency of adverse events associated with the use of the drug today. Material(s) and Method(s): As we set out to make a CT of pharmacovigilance (Phase IV) prospectively in 13 provinces and 17 neonatal ICU in the country. We included 259 newborns with SDRN to whom SURFACEN was applied at 100 mg / kg dose by tracheal instillation in one or more applications depending on the patient requirements. Results and discussion: The results show a rapid and sustained increase in arterial blood oxygenation index measured by PaO2/FiO2 almost immediately after applying the surfactant, the number of applications were 2.0 +/- 1 and the output indicators as ICU stay was 11.9 +/- 11.4 days, mechanical ventilation 7.1 +/- 8.9 days and mortality 19.7%. Most striking was the reduction of mortality to almost half compared with the previous EC and that was the cause SDRN only 13.7% of deaths. The observed complications were: late pneumonia 22.8%, ductus arteriosus reopening 13.9%, pneumothorax 12.4%, bronchopulmonary dysplasia 11.4%, other complications were below 7%. We conclude that survival is higher than in previous studies and tends to increase, most deaths are not caused by SDRN, oxygenation after treatment was comparable to that reported and is considered adequate and the complication rate is very similar the previous EC, other adverse events were related with the rapid increase in arterial blood oxygenation. Conclusion(s): In general SURFACEN has high effectiveness and safety and has contributed to the decline in infant mortality by SDRN in Cuba.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 71766566
TI  - Activated protein C protects the developing lung from hyperoxia-induced lung injury
AU  - Nold-Petry C.A.
AU  - Veldman A.
AU  - Nold M.F.
AU  - Sands S.A.
AU  - Silas R.
AU  - Skuza E.M.
AU  - Stockx E.M.
AU  - Cohen G.
AU  - Joshi M.S.
AU  - Dinarello C.A.
AU  - Berger P.J.
Y1  - 2010//
KW  - *society
KW  - *hyperoxia
KW  - *lung injury
KW  - *lung
KW  - *infection
KW  - *autoimmune disease
KW  - *neoplasm
KW  - inflammation
KW  - mortality
KW  - ambient air
KW  - mouse
KW  - inhalation
KW  - lung dysplasia
KW  - subcutaneous drug administration
KW  - pneumonia
KW  - death
KW  - long term survival
KW  - lung development
KW  - fibrosis
KW  - infant
KW  - morbidity
KW  - side effect
KW  - baby
KW  - lung disease
KW  - cerebrospinal fluid
KW  - *cytokine
KW  - *activated protein C
KW  - *interferon
KW  - interleukin 6
KW  - interleukin 1
KW  - interleukin 5
KW  - colony stimulating factor 1
KW  - chemokine
KW  - protein C
KW  - oxygen
KW  - placebo
KW  - interleukin 10
T2  - Cytokine
LA  - English
VL  - 52
IS  - 1-2
PB  - Academic Press
SN  - 1043-4666
AD  - C.A. Nold-Petry, Ritchie Centre, Monash Institute of Medical Research, Melbourne, Australia
DO  - https://dx.doi.org/10.1016/j.cyto.2010.07.213
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=71766566
AB  - Protein C inhibits inflammation, one of the main pathogenetic factors in bronchopulmonary dysplasia (BPD). BPD is a severe lung disease that affects babies born preterm. Apart from side-effect-prone glucocorticosteroids, no anti-inflammatory strategy is available, and considerable morbidity and mortality in affected infants cannot be prevented. Therefore, we set out to investigate the benefits of protein C in BPD. Newborn mice were exposed to room air or to 85% oxygen (hyperoxia). 10 control and 10 hyperoxia animals received daily subcutaneous injections with placebo, whereas 10 additional hyperoxia animals received 2 mg/kg activated protein C (aPC) daily. Compared to room air, inhalation of 85% oxygen resulted in up to over 30-fold increases in the levels of several cytokines, including IL-1alpha/beta, IL-6, TNFalpha, IL-5, IL-17, and M-CSF as well as chemokines in the neonatal lung on day 2 of life. Treatment with aPC nearly completely abolished this inflammatory response, reducing the production of pro-inflammatory cytokines to near baseline/room air (e.g., IL-1alpha/beta, IL-6, TNFalpha, M-CSF, and chemokines 40 to 80% lower). IL-5 and IL-17 were also reduced (64%, 54%), whereas anti-inflammatory IL-10 was 2-fold increased. At day 28, IL-1alpha/beta, IL-6, MIP-1alpha, and TNFalpha were still 33 to 70% decreased. At this time point, we furthermore observed the histological changes characteristic of severe BPD, namely reduced alveolarization and increased fibrosis, in vehicle-injected animals after hyperoxia. aPC administration markedly improved lung development in hyperoxia, as assessed by a decrease in alveolar area by 55% and an increase in the number of alveoli by 35%. In a long-term survival study, mortality in the hyperoxia-placebo group was 75% after 2 months, whereas only 10% of the hyperoxia- aPC mice had died. These data suggest that aPC protects the developing lung from the detrimental effects of hyperoxia, including early death, by reducing lung inflammation; aPC may thus become a treatment option in BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70981844
TI  - Epithelial-specific deletion of APC alters cell fate determination during lung development
AU  - Chan B.
AU  - Li A.
AU  - Li C.
AU  - Xing Y.
AU  - Li M.
AU  - Minoo P.
Y1  - 2010//
KW  - *cell fate
KW  - *lung development
KW  - *medical research
KW  - lung
KW  - epithelium cell
KW  - Western blotting
KW  - mutant
KW  - identity
KW  - polyp
KW  - prematurity
KW  - LoxP site
KW  - human
KW  - staining
KW  - cell proliferation
KW  - infant
KW  - airway
KW  - cell lineage
KW  - basal cell
KW  - lung dysplasia
KW  - Wnt signaling pathway
KW  - angiogenesis
KW  - neurosecretory cell
KW  - smooth muscle
KW  - attenuation
KW  - immunohistochemistry
KW  - morphogenesis
KW  - embryo
KW  - mouse
KW  - bronchiole
KW  - lung alveolus cell
KW  - tumor suppressor gene
KW  - catenin
KW  - marker
T2  - Journal of Investigative Medicine
LA  - English
VL  - 58
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - B. Chan, University of Southern California, Los Angeles, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e3181c87db3
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70981844
AB  - Purpose of Study: Bronchopulmonary dysplasia (BPD) is a debilitating disease among premature infants. Normal lung morphogenesis is interrupted, as evidenced by the attenuation of alveogenesis and vasculogenesis. The Wnt signaling pathway, mediated via beta-catenin, plays a key role in cell proliferation and cell fate determination during development. In the absence of Wnt signal, Adenomatous Polyosis Coli (APC) forms a destruction complex and inhibits beta-catenin activity. The role of APC in lung development is unknown. The current study was designed to address this knowledge gap by examining the consequences of inactivating the APC gene via a Cre-LoxP approach, specifically in lung epithelial cells. Methods Used: Nkx2.1 is a marker of lung epithelial cell identity. We used the Nkx2.1-cre to drive recombination in Apc flox/flox mice. Double-transgenic Nkx2.1-cre; Apc flox/flox embryos were sacrificed at different stages of development. The lungs were analyzed by western blot and immunohistochemistry. Summary of Results: APC is expressed in normal developing lungs. APC is co-localized with markers for smooth muscle, ciliated and neuroendocrine cells, but not Clara and basal cells. In mutant lung epithelial cells, immunoflourescent staining and western blot confirmed a significant decrease in APC and a commensurate accumulation of beta-catenin. Phenotypically, the Apc mutant lungs showed abnormal dilation of the distal airways and formation of polyps within the bronchioles. The polyps lacked both A-TUBULIN and NKX2.1 expression, which indicate the loss of lung epithelial cell lineage. Conclusion(s): Epithelial-specific deletion of APC leads to accumulation of beta-catenin and distinct phenotypic changes in developing lungs with loss of pulmonary cell identity. Further studies are underway to delineate the mechanism in which Apc controls lung development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2014>
TI  - A study of genes encoding cytokines (IL6, IL10, TNF), cytokine receptors (IL6R, IL6ST), and glucocorticoid receptor (NR3C1) and susceptibility to bronchopulmonary dysplasia.
DO  - https://dx.doi.org/10.1186/s12881-014-0120-7
AU  - Huusko, Johanna M
AU  - Karjalainen, Minna K
AU  - Mahlman, Mari
AU  - Haataja, Ritva
AU  - Kari, M Anneli
AU  - Andersson, Sture
AU  - Toldi, Gergely
AU  - Tammela, Outi
AU  - Ramet, Mika
AU  - Lavoie, Pascal M
AU  - Hallman, Mikko
AU  - Andersson S
AU  - Janer C
AU  - Kari MA
AU  - Ketola I
AU  - Sankilampi U
AU  - Hallman M
AU  - Huusko JM
AU  - Karjalainen MK
AU  - Mahlman M
AU  - Marttila R
AU  - Ramet M
AU  - Tammela O
AU  - Lehtonen L
AU  - Lacaze-Masmonteil T
AU  - Gen-BPD Study Group
Y1  - 2014//
Y2  - 20141101//
KW  - *Bronchopulmonary Dysplasia/ge [Genetics]
KW  - Bronchopulmonary Dysplasia/pa [Pathology]
KW  - Case-Control Studies
KW  - Cytokine Receptor gp130/ge [Genetics]
KW  - *Cytokines/ge [Genetics]
KW  - Disease Susceptibility
KW  - Epistasis, Genetic
KW  - Genotype
KW  - Gestational Age
KW  - Humans
KW  - Infant, Newborn
KW  - Interleukin-10/ge [Genetics]
KW  - Interleukin-6/ge [Genetics]
KW  - Linkage Disequilibrium
KW  - Polymorphism, Single Nucleotide
KW  - *Receptors, Cytokine/ge [Genetics]
KW  - *Receptors, Glucocorticoid/ge [Genetics]
KW  - Receptors, Interleukin-6/ge [Genetics]
KW  - Tumor Necrosis Factor-alpha/ge [Genetics]
T2  - BMC medical genetics
VL  - 15
SN  - 1471-2350
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med11&NEWS=N&AN=25409741
AD  - England
AB  - BACKGROUND: Bronchopulmonary dysplasia (BPD) is a common chronic lung disease associated with very preterm birth. The major risk factors include lung inflammation and lung immaturity. In addition, genetic factors play an important role in susceptibility to moderate-to-severe BPD. In this study, the aim was to investigate whether common polymorphisms of specific genes that are involved in inflammation or differentiation of the lung have influence on BPD susceptibility., METHODS: Genes encoding interleukin-6 (IL6) and its receptors (IL6R and IL6ST), IL-10 (IL10), tumor necrosis factor (TNF), and glucocorticoid receptor (NR3C1) were assessed for associations with moderate-to-severe BPD susceptibility. Five IL6, nine IL6R, four IL6ST, one IL10, two TNF, and 23 NR3C1 single nucleotide polymorphisms (SNPs) were analyzed in very preterm infants born in northern Finland (56 cases and 197 controls) and Canada (58 cases and 68 controls). IL-6, TNF and gp130 contents in umbilical cord blood, collected from very preterm infants, were studied for associations with the polymorphisms. Epistasis (i.e., interactions between SNPs in BPD susceptibility) was also examined. SNPs showing suggestive associations were analyzed in additional replication populations from Finland (39 cases and 188 controls) and Hungary (29 cases and 40 controls)., RESULTS: None of the studied SNPs were associated with BPD nor were the IL6, TNF or IL6ST SNPs associated with cord blood IL-6, TNF and gp130, respectively. However, epistasis analysis suggested that SNPs in IL6ST and IL10 were associated interactively with risk of BPD in the northern Finnish population; however, this finding did not remain significant after correction for multiple testing and the finding was not replicated in the other populations., CONCLUSIONS: We conclude that the analyzed SNPs within IL6, IL6R, IL6ST, IL10, TNF, and NR3C1 were not associated with BPD. Furthermore, there was no evidence that the studied SNPs directly contribute to the cord blood protein contents.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70981839
TI  - Late doses of surfactant in ventilated premature infants: A pilot study
AU  - Ballard R.
AU  - Keller R.
AU  - Merrill J.
AU  - Palermo L.
AU  - Truog W.
AU  - Steinhorn R.
AU  - Ryan R.
AU  - Eichenwald E.
AU  - Durand D.
AU  - Courtney S.
AU  - Black D.
AU  - Ballard P.
Y1  - 2010//
KW  - *infant
KW  - *human
KW  - *prematurity
KW  - *pilot study
KW  - *medical research
KW  - artificial ventilation
KW  - lung dysplasia
KW  - intubation
KW  - bradycardia
KW  - resuscitation
KW  - hospital
KW  - survival
KW  - newborn
KW  - gestational age
KW  - male
KW  - lung hemorrhage
KW  - procedures
KW  - pneumothorax
KW  - tracheal aspiration procedure
KW  - multicenter study
KW  - *surfactant
KW  - nitric oxide
KW  - calfactant
KW  - surfactant protein B
T2  - Journal of Investigative Medicine
LA  - English
VL  - 58
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - R. Ballard, UCSF, San Francisco, CA, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e3181c87db3
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70981839
AB  - Purpose of Study: Extremely low gestational age newborns requiring mechanical ventilation after 7 days of age have > 70% incidence of bronchopulmonary dysplasia (BPD), and 2/3rds of these infants experience episodes of surfactant dysfunction secondary to deficiency of surfactant protein (SP)-B (Merrill, Peds Res. 2004). Treatment with inhaled Nitric Oxide (iNO) increases survival without BPD (Ballard R, New Engl J Med 2006, 2007) but does not abolish surfactant dysfunction. We hypothesized that late doses of surfactant plus iNO would improve surfactant function and decrease occurrence of BPD. Methods Used: We enrolled infants <30 wk GA who required mechanical ventilation and were receiving iNO at 7-14 d in a multicenter, randomized, blinded pilot Trial Of Late SURFactant (TOLSURF) and treated with up to five additional doses of surfactant (Infasurf) or sham administration over 3 wk. Summary of Results: Between 2/08 and 6/09, 60 infants at 9 hospitals were enrolled with mean BWof 693 +/-114 g, GA of 25.4 +/- 1.3 wk, and 58% male. 7 infants (12%) died before 36 wk. 70% of the infants remained intubated and received all 5 doses per protocol. During 259 doses of study drug (or sham) only 4 (1.5%) infants had significant bradycardia, 4 required re-intubation and 1 infant required resuscitation. The mean respiratory severity score (RSS=MAP X FiO2) was 3.1 at study entry and decreased or was unchanged 2 h after each of 5 dosing procedures. There were no episodes of pneumothorax, pulmonary hemorrhage or worsening of a PDA. Conclusion(s): We conclude that late administration of surfactant is safe and tolerated well by intubated premature infants. Tracheal aspirate samples are being evaluated for the interaction of iNO with surfactant. A large multicenter study (TOLSURF) to evaluate clinical outcome is underway.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70981831
TI  - Intrauterine growth restriction decreases retinoic acid receptor gene expression in the developing rat lung
AU  - Carroll T.R.
AU  - Oman J.
AU  - Hale M.
AU  - Yu X.
AU  - Lane R.
Y1  - 2010//
KW  - *prenatal growth
KW  - *receptor gene
KW  - *gene expression
KW  - *rat
KW  - *lung
KW  - *medical research
KW  - lung development
KW  - serum
KW  - architecture
KW  - male
KW  - lung dysplasia
KW  - mouse mutant
KW  - knockout mouse
KW  - mouse
KW  - gender
KW  - hypothesis
KW  - genetic transcription
KW  - diseases
KW  - high performance liquid chromatography
KW  - immunohistochemistry
KW  - model
KW  - retinol deficiency
KW  - infant
KW  - blood level
KW  - newborn
KW  - *retinoic acid receptor
KW  - retinoic acid
KW  - messenger RNA
KW  - protein
KW  - retinol
T2  - Journal of Investigative Medicine
LA  - English
VL  - 58
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - T.R. Carroll, University of Utah, Salt Lake City, UT, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e3181c87db3
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70981831
AB  - Purpose of Study: Intrauterine growth restriction (IUGR), one of the most common disease states of newborns, predisposes infants to a variety of diseases including bronchopulmonary dysplasia (BPD) and vitamin A deficiency (VAD). Vitamin A, or retinoic acid (RA), acts via retinoic acid receptors alpha, A, and F (RARalpha, RARbeta and RARF, respectively) to effect gene transcription. The role of the RARs is vital for normal lung development as demonstrated by knockout mice. However, the effect of IUGR on RAR gene expression and retinoic acid levels has not been well elucidated.We therefore hypothesized IUGR would decrease RAR gene expression and serum retinoic acid levels, and would adversely affect lung architecture at critical stages of rat lung development. Methods Used: We used a vascular model of IUGR in the rat and measured mRNA and protein levels of RARalpha, RARbeta and RARF using standard methods. Measurements were performed at 3 ages - day 0 (D0), day 6 (D6) and day 21 (D21) of life. We used immunohistochemistry (IHC) to evaluate localization of RARs. High performance liquid chromatography was used to measure serum RA levels, and morphometric analysis was incorporated to assess quantitative architecture changes in the rat lung. Summary of Results: IUGR significantly decreased gene expression of RARalpha in both sexes and RARbeta in males only at D0, the saccular stage of rat lung development. At D6, the alveolar stage of rat lung development, IUGR significantly decreased mRNA levels of RARF without changing protein abundance. Contrary to our hypothesis IUGR actually increased gene expression of RARF at D21, a time of waning lung development. The noted changes in gene expression caused by IUGR occurred in the absence of any changes in serum levels of retinoic acid or RAR localization at D6 or D21, or quantifiable changes in lung architecture at D6. Conclusion(s): We conclude that IUGR decreases expression of RARalpha, RARbeta and RARF at critical stages of rat lung development and does so in the presence of normal serum retinoic acid levels. As hypothesized, affects of IUGR showed gender specificity, and males appear to be more adversely affected. We speculate that IUGR results in prenatal reprogramming, the effects of which alter retinoic acid signaling pathways.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70981539
TI  - Intrauterine growth restriction decreases pulmonary TRPV4 expression
AU  - Zinkhan E.
AU  - Wang Y.
AU  - Brown A.
AU  - Fung C.
AU  - Joss-Moore L.
AU  - Lane R.
Y1  - 2010//
KW  - *prenatal growth
KW  - *medical research
KW  - female
KW  - mouse
KW  - lung edema
KW  - male
KW  - endothelium cell
KW  - pregnancy
KW  - lung dysplasia
KW  - lung
KW  - pump
KW  - human
KW  - hypothesis
KW  - risk
KW  - adult
KW  - uterus
KW  - retroperitoneum
KW  - placenta insufficiency
KW  - postnatal development
KW  - Western blotting
KW  - gender
KW  - prenatal exposure
KW  - cell function
KW  - lung development
KW  - messenger RNA
KW  - protein
KW  - thromboxane
KW  - vanilloid receptor 4
T2  - Journal of Investigative Medicine
LA  - English
VL  - 58
IS  - 1
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - E. Zinkhan, University of Utah, Salt Lake City, UT, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e3181c87db3
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70981539
AB  - Purpose of Study: Intrauterine growth restriction (IUGR) increases the risk for bronchopulmonary dysplasia (BPD) in neonatal humans and mice. BPD is characterized by pulmonary edema with subsequent arrest of alveolar development. Activation of pulmonary endothelial cell transient receptor potential vanilloid 4 (TRPV4) channels leads to pulmonary edema in adult mice. Despite the potential importance of TRPV4 in the development of pulmonary edema, little is known about how TRPV4 and expression changes during normal postnatal lung development. Further, whether IUGR affects the normal ontological pattern of TRPV4 remains unknown. We hypothesized that IUGR increases TRPV4 mRNA and protein levels. Methods Used: To test this hypothesis, murine IUGR was induced by implanting pumps to deliver 0.5% EtOH (control) or thromboxane in 0.5% EtOH at 2000ng/h into the retroperitoneum of female mice at day 13 of pregnancy to create placental insufficiency. Pups allowed to deliver at term and lungs harvested at day 0 (DOL 0), day 21 (DOL 21), or day 90 (DOL 90). Real time RT PCR used to determine the quantity of TRPV4 mRNA at each time point. Western blotting was used to quantify TRPV4 protein. Summary of Results: Results are presented as either DOL 0 relative to DOL 90 or IUGR relative to control, +/- standard error of the mean. Control TRPV4 mRNA and protein increased significantly from DOL 0 to DOL 90 in both males (400% +/- 100% mRNA and 285% +/- 59% protein) and females (420% +/- 100% mRNA and 417% +/- 52% protein). IUGR significantly decreased TRPV4 mRNA relative to control at DOL 0 in males (40% +/- 20%) and females (40% +/- 3%), and at DOL 21 in females (61% +/- 6%). At DOL 90 no statistically significant differences were seen in TRPV4 mRNA levels in IUGR mice. TRPV4 protein levels trended toward significant decrease in IUGR DOL 0 males (57% +/- 4%) with significant decrease in DOL 21 female IUGR mice (54% +/- 4%), and no change at DOL 90. Conclusion(s): TRPV4 mRNA and protein levels increase during normal postnatal development. IUGR decreases TRPV4 mRNA and protein levels in an age and gender specific manner. These findings are intriguing because they demonstrate that the prenatal environment alters TRPV4 expression. We speculate that by decreasing TRPV4 expression, IGUR alters endothelial cell function throughout development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70981306
TI  - Ureaplasma increases matrix metallopeptidase 9 in the fetal mouse lung
AU  - Fierro-Perez G.A.
AU  - Benjamin J.T.
AU  - Chaplin J.
AU  - Gebb S.A.
Y1  - 2010//
KW  - *mouse
KW  - *lung
KW  - *medical research
KW  - *Ureaplasma
KW  - explant
KW  - fetus lung
KW  - lung fibroblast
KW  - Ureaplasma infection
KW  - zymography
KW  - lung alveolus epithelium
KW  - extracellular matrix
KW  - prematurity
KW  - macrophage
KW  - infant
KW  - fibroblast
KW  - Ureaplasma parvum
KW  - lung dysplasia
KW  - phenotype
KW  - mesenchyme
KW  - real time polymerase chain reaction
KW  - branching morphogenesis
KW  - gene expression
KW  - cell line
KW  - airway
KW  - upregulation
KW  - risk factor
KW  - lung development
KW  - human
KW  - *matrix metalloproteinase
KW  - messenger RNA
KW  - collagenase
KW  - lipopeptide
KW  - gelatin
KW  - peptide
T2  - Journal of Investigative Medicine
LA  - English
VL  - 58
IS  - 2
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - G.A. Fierro-Perez, University of South Alabama, Mobile, AL, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e3182820c55
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70981306
AB  - Purpose of Study: Antenatal Ureaplasma infections is a risk factor for Bronchopulmonary Dysplasia (BPD) in the preterm infant. BPD is characterized by abnormalities in terminal airway branching and alveolarization. In the developing lung, collagenases Matrix Metallopeptidase's (MMP) 9 & 2 remodel the extracellular matrix scaffold thus allowing normal branching morphogenesis. We speculate that Ureaplasma alters collagenase expression in fetal lungs contributing to the BPD phenotype. To test this we hypothesized that Ureaplasma alters expression and activity of MMP9 and MMP2 in the fetal mouse lung. Methods Used: Lung explants were isolated from E15 mice and cultured with or without Ureaplasma parvum or Pam2CSK4, a synthetic diacylated lipopeptide with activity similar to the macrophage stimulatory activity of Ureaplasma. Primary fetal lung fibroblasts and a murine lung alveolar epithelial cell line (MLE-12) were cultured and treated with either Ureaplasma or the peptide. Gene expression was quantified using real time PCR. Activity of secreted MMP9 and MMP2 was measured using gelatin zymography. Summary of Results: Ureaplasma treatment resulted in a 6.7 fold increase in MMP9 mRNA expression in fetal mouse lung explants (P < 0.05). Pam2CSK4 also increased explant MMP9 mRNA expression compared to control (100ng/ml- 6 fold increase, 200ng/ml - 9 fold increase; P < 0.05). MMP2 mRNA expression was unaffected by either treatment. To test if both the fetal lung mesenchyme and the alveolar epithelium were involved in the up-regulation of explant MMP9, we cultured primary fetal lung fibroblasts and MLE-12 cells. Ureaplasma and Pam2CSK4 increased MMP9 mRNA expression in primary lung fibroblasts (50.2 fold increase, P < 0.05) but not in MLE-12 cells. In preliminary zymography experiments we have found MMP9 but not MMP2 secreted activity to be increased in explants and in fetal lung fibroblasts treated with Pam2CSK4 or Ureaplasma. This awaits confirmation in future experiments. Conclusion(s): In fetal mouse lung explants and cultured fibroblasts, Ureaplasma and Pam2CSK4 increase MMP9 mRNA expression. We speculate that increased MMP9 by altering extracellular matrix deposition and degradation may contribute to the altered lung development seen with antenatal Ureaplasma infections.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70981304
TI  - Retinoids attenuate hyperoxia effects on newborn mouse lung
AU  - James M.L.
AU  - Ross A.C.
AU  - Bulger A.
AU  - Ambalavanan N.
Y1  - 2010//
KW  - *hyperoxia
KW  - *mouse
KW  - *lung
KW  - *medical research
KW  - lung development
KW  - newborn
KW  - lung function
KW  - prematurity
KW  - morphometrics
KW  - human
KW  - lung dysplasia
KW  - ambient air
KW  - supplementation
KW  - lung homogenate
KW  - infant
KW  - clinical trial (topic)
KW  - death
KW  - enzyme linked immunosorbent assay
KW  - high performance liquid chromatography
KW  - *retinoid
KW  - cytokine
KW  - retinol
KW  - interferon
KW  - retinoic acid
KW  - messenger RNA
KW  - macrophage inflammatory protein 2
KW  - gamma interferon
KW  - protein
T2  - Journal of Investigative Medicine
LA  - English
VL  - 58
IS  - 2
PB  - Lippincott Williams and Wilkins
SN  - 1081-5589
AD  - M.L. James, Univ of Ala at Birmingham, Birmingham, AL, United States
DO  - https://dx.doi.org/10.231/JIM.0b013e3182820c55
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70981304
AB  - Purpose of Study: Bronchopulmonary dysplasia in preterm infants is characterized by inhibition of lung alveolar development associated with increased pro-inflammatory cytokines. Clinical trials indicate Vitamin A (VA) supplementation decreases BPD and/or death. VA is metabolized into retinoic acid (RA). We have previously shown that a 10:1 molar combination of VA and RA (VARA) synergistically increases lung retinol content in newborn mice. We hypothesized that this biochemical synergistic effect translates into functional benefits in attenuating hyperoxia-induced effects on the newborn lung. (Figure presented) Methods Used: Newborn C57BL/6 mice were exposed to hyperoxia (85% O2) or room air for 7 or 14 days and given vehicle or VARA. Lung retinol content was measured by HPLC, lung function was assessed by flexiVent, and lung development was evaluated by morphometry. A panel of cytokines were evaluated by a qPCR array and by ELISA in lung homogenates. Summary of Results: VARA attenuated the hyperoxia-induced inhibition of alveolarization and improved lung function, with higher compliance and lower resistance (Figure). VARA also attenuated the hyperoxia-induced increases in macrophage inflammatory protein -2alpha (MIP-2alpha; Cxcl2) and interferon-gamma (IFN-gamma) mRNA and protein. Conclusion(s): VARA improved lung development and function, and reduced pro-inflammatory cytokines in newborn mice exposed to hyperoxia. Studies are in progress to determine how retinoids regulate MIP-2alpha and IFN-gamma.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70871298
TI  - Neonatal Marfan sydrome with pulmonary artery cystic degeneration
AU  - Segura M.E.
AU  - Margotto P.R.
AU  - Falcao S.R.
AU  - Rosa M.T.
AU  - Falcao C.
AU  - Ribeiro A.
Y1  - 2010//
KW  - *degeneration
KW  - *pathology
KW  - *pulmonary artery
KW  - human
KW  - aorta
KW  - female
KW  - Marfan syndrome
KW  - mutation
KW  - cardiomegaly
KW  - pneumonia
KW  - tricuspid valve
KW  - pregnancy
KW  - gene
KW  - arachnodactyly
KW  - heart right ventricle
KW  - patient
KW  - mitral valve
KW  - micrognathia
KW  - heart injury
KW  - cardiovascular system
KW  - eye
KW  - skeleton
KW  - pulmonary hypertension
KW  - examination
KW  - autopsy
KW  - spleen
KW  - resuscitation
KW  - connective tissue disease
KW  - fiber
KW  - liver
KW  - heart atrium
KW  - hyaline membrane disease
KW  - child
KW  - artery media
KW  - histopathology
KW  - dilatation
KW  - infant
KW  - diagnosis
KW  - adult
KW  - case report
KW  - autosomal dominant disorder
KW  - elastin
KW  - fibrillin 1
KW  - fibrillin
T2  - Histopathology
LA  - English
VL  - 57
IS  - SUPPL.1
PB  - Blackwell Publishing Ltd
SN  - 0309-0167
AD  - M.E. Segura, Hospital Regional da Asa Sul, Brasilia, Brazil
DO  - https://dx.doi.org/10.1111/j.1365-2559.2010.03637.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70871298
AB  - Introduction: Marfan syndrome is an autosomal dominant disorder characterized by an inherited genetic mutation at 15q21, the fibrillin- 1 gene. This gene expresses fibrillin, the major component of elastin associated microfibrils. As a result of this mutation a connective tissue disorder is manifested principally by changes in the skeleton, eyes and cardiovascular system. The two most common cardiac lesions are mitral valve myxomatous degeneration and media cystic degenetation of the aorta. Patient(s): The infant was a female at the 31st week of gestation referred because of cardiomegaly associated with tricuspid and mitral dysmorphogenesis, leading to severe insufficiency detected on ultrasonogram. The child was born at 32nd week of gestation, needed resuscitation, persisted with respiratory discomfort and died on 2nd day of life. Autopsy examination revealed micrognathia and arachnodactyly. Cardiomegaly with concordant cardiac connections, soft and billowy mitral and tricuspid valves were observed. Right ventricle and atrium were dilated. In addition, ascending pulmonary artery showed a sacular dilatation. Histopathology revealed elastin fragmentation (cystic degeneration) of pulmonary artery media but not in aorta. Mitral and tricuspid valves showed myxomatous stromal degeneration. Other relevant findings were bilateral pneumonia, hyaline membrane disease and passive congestion of liver and spleen. A post-mortem diagnosis of Marfan syndrome was made. Conclusion(s): Marfan syndrome frequently affects aorta causing cystic media degeneration in adults. In this case report, authors suggest pulmonary artery hypertension caused by peculiar neonatal circulation, associated with bilateral pneumonia resulted in media lesions on pulmonary artery but not on aorta.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70844588
TI  - Neonatal hyperoxia exposure augments respiratory syncytial virus disease in nrf2 deficient mice
AU  - Cho H.
AU  - Miller-DeGraff L.
AU  - Perrow L.
AU  - Yamamoto M.
AU  - Polack F.
AU  - Kleeberger S.
Y1  - 2010//
KW  - *hyperoxia
KW  - *exposure
KW  - *Respiratory syncytial pneumovirus
KW  - *virus infection
KW  - *mouse
KW  - *society
KW  - infection
KW  - genotype
KW  - epithelium cell
KW  - cell damage
KW  - adult
KW  - lymphocytic infiltration
KW  - antioxidant responsive element
KW  - lung lavage
KW  - pneumonia
KW  - lung dysplasia
KW  - rodent
KW  - adulthood
KW  - model
KW  - mucus
KW  - injury
KW  - wild type
KW  - inflammation
KW  - mucous cell
KW  - lipid peroxidation
KW  - acute lung injury
KW  - edema
KW  - lung
KW  - lung parenchyma
KW  - airway
KW  - metaplasia
KW  - cell vacuole
KW  - protein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - H. Cho, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States. E-mail: cho2@niehs.nih.gov
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A6347?sid=fb8d5ca9-e039-45c7-935f-b18485d1bd34
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70844588
AB  - Rationale: Hyperoxia exposure of neonatal rodents has been examined as a model for bronchopulmonary dysplasia (BPD). NF-E2, related factor 2 (Nrf2) activates antioxidant response element (ARE)-mediated induction of antioxidant/defense proteins, and protects murine airways from acute lung injury, respiratory syncytial virus (RSV) disease, and BPD in mice. The present study was designed to determine if (1) neonatal hyperoxia exposure enhances RSV responses in adult mice, and (2) Nrf2 contributes to the exacerbation of RSV. Method(s): Adult Nrf2-deficient (Nrf2-/-) and wild-type (Nrf2+/+) mice exposed to hyperoxia (100% O2) or air at birth (P1-P3) were infected intranasally with RSV19 (1x106 PFU). Mice were sacrificed at 1 and 5 days post-RSV infection, and lung inflammation and injury was determined by bronchoalveolar lavage (BAL) and histopathologic analysis. Result(s): Relative to air-exposed controls, pulmonary neutrophilic and eosinophilic inflammation induced by RSV infection (1 day) was heightened in Nrf2-/- mice exposed to O2, but not in Nrf2+/+ mice. Neonatal hyperoxia exposure resulted in early epithelial cell injury and lymphocytic infiltration after RSV infection (1 day), relative to air exposure, in both genotypes. However, Nrf2-/- mice displayed greater and extended epithelial and lymphocytic responses by 5 days post-RSV. Lung protein edema was not affected by either pre-exposure to hyperoxia or RSV infection in both genotypes. Neonatal hyperoxia exposure enhanced lipid peroxidation levels slightly in BAL cells from both genotypes, while RSV infection potentiated it only in Nrf2-/- mice at 5 days. Histopathologic analysis of lung tissues demonstrated that RSV caused marked mucous cell metaplasia only in Nrf2-/- mice, while neonatal hyperoxia suppressed this pathologic change in Nrf2-/- mice, probably due to epithelial cell injury and mucus hypersecretion. Nrf2-/- mice neonatally exposed to hyperoxia displayed more severe lymphocytic accumulation, alveolar vacuolization, and fibroproliferation at 5 days post-RSV, compared to similarly-exposed Nrf2+/+ mice. Conclusion(s): Results suggests that neonatal hyperoxia exposure enhances sensitivity to RSV disease in adulthood and Nrf2 deficiency boosts this response in mice.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70842813
TI  - Changes in thoracic cage and lung mechanics secondary to hypophosphatasia and human recombinant enzyme replacement therapy
AU  - Rodriguez M.E.
AU  - Bober M.B.
AU  - Heinle R.
AU  - Zamora A.
AU  - Rogers K.
AU  - Davey L.
AU  - Li Puma A.
AU  - Locke R.
AU  - Shaffer T.
AU  - Chidekel A.
Y1  - 2010//
KW  - *human
KW  - *hypophosphatasia
KW  - *enzyme replacement
KW  - *society
KW  - *lung mechanics
KW  - ventilator
KW  - thorax wall
KW  - breathing mechanics
KW  - thorax
KW  - compliance (physical)
KW  - normal value
KW  - pneumonia
KW  - patient
KW  - deformity
KW  - lung function
KW  - bronchoscopy
KW  - mouse
KW  - tissues
KW  - model
KW  - clinical trial (topic)
KW  - infant
KW  - survival
KW  - lung dysplasia
KW  - mineralization
KW  - autosomal recessive disorder
KW  - oscillometry
KW  - bone
KW  - lung
KW  - tidal volume
KW  - therapy
KW  - tracheostomy
KW  - bone mineralization
KW  - muscle hypotonia
KW  - tracheomalacia
KW  - mechanics
KW  - dynamics
KW  - solid
KW  - septic shock
KW  - respiratory failure
KW  - ambient air
KW  - hospital
KW  - male
KW  - *recombinant enzyme
KW  - alkaline phosphatase
KW  - hybrid protein
KW  - antibiotic agent
KW  - mucolytic agent
KW  - oxygen
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.E. Rodriguez, DuPont Hospital for Children, Wilmington, United States. E-mail: merodrig@nemours.org
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A5366?sid=f453499d-f41b-4f9c-90b1-bdbe194bc929
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70842813
AB  - Introduction: Hypophosphatasia (HPP) is a rare autosomal recessive disorder caused by deficient activity of tissue nonspecific alkaline phosphatase (TNSALP) and characterized by defective bone mineralization. In the perinatal lethal form, respiratory complications due to hypoplastic lungs and rachitic deformities of the thoracic cage are present. ENB-0040 is a bone-targeted, human recombinant TNSALP fusion protein that restored skeletal mineralization and survival in a mouse model of lethal HPP and is now undergoing clinical trials in infants with severe HPP. Description: A 2 week (w) old, 33w premature male was transferred to the NICU with the perinatal lethal form of HHP. He remained in ventilator dependent respiratory failure since birth due to chest wall insufficiency and hypotonia. A baseline chest film is shown (Figure 1A) and tracheostomy was performed at 7w of age; averaged respiratory mechanics measurements for the pt along with predicted normal values are given in figure 2: Compliance was reduced (25%) and resistance was greater (>400%) than predicted. Baseline noninvasive pulmonary function testing (NIPFT) showed that impulse oscillometry (IOS) measurements (resistance and reactance) were possible and systematic % of changes were seen at 4, 12 and 27w. Thoracoabdominal motion analysis (TAM) showed asynchrony with a phase angle of 163degree and 5% of rib cage contribution to tidal volume excursions was observed. ENB-0040 therapy was started in the third w of life. After 4 w, despite maximum care, the pt developed bronchopulmonary dysplasia, pneumonia and a bronchoscopy revealed tracheomalacia; changes were also seen in NIPFT. Antibiotics, bronchodilators, anti-inflammatory and mucolytic agents were utilized with good response. At 12 w on treatment, a consistent decrease in ventilator requirements (VR), improvement in lung function (Figure 2) and chest wall mechanics were observed and correlated with thoracic cage radiologic (Figure 1B) and metabolic findings. The pt was slowly weaned from VR and inspired oxygen and discharged from the hospital with a home ventilator on w 28 on room air. We were informed that the pt died in w 31 from bilateral pneumonia and septic shock. (Figure presented) Respiratory-Mechanics measurements at baseline (BL), 4 weeks (4w), 10 weeks (10w), 12 weeks (12w) and 27 weeks (27w) after ENB-0040. Solid line indicates averaged patient measurements. Dashed line indicates predicted normal values. Discussion(s): Measurable NIPFT changes in chest wall dynamics and respiratory mechanics using TAM and IOS were feasible and useful for therapeutic guidance of ENB-0040 treatment in this patient with rachitic deformities of the thoracic cage secondary to HPP. Based on preclinical results and the other limited clinical results, we speculate that ENB- 0040 may be a promising treatment for this perinatal form of HPP.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70842386
TI  - Hyperoxia induced ROS generation and assessment of DNA damage and cell death in human bronchial epithelial cells
AU  - Panduri V.
Y1  - 2010//
KW  - *human
KW  - *DNA damage
KW  - *hyperoxia
KW  - *epithelium cell
KW  - *society
KW  - *cell death
KW  - exposure
KW  - electron microscopy
KW  - mitochondrion
KW  - gene
KW  - necrosis
KW  - autophagy
KW  - macromolecule
KW  - long term exposure
KW  - therapy
KW  - mitochondrial membrane potential
KW  - S phase cell cycle checkpoint
KW  - acute lung injury
KW  - confocal microscopy
KW  - lung dysplasia
KW  - imaging
KW  - assay
KW  - apoptosis
KW  - cell cycle
KW  - infant
KW  - lung disease
KW  - electron spin resonance
KW  - *DNA
KW  - superoxide
KW  - lipocortin 5
KW  - reactive oxygen metabolite
KW  - oxygen
KW  - cell nucleus DNA
KW  - cell DNA
KW  - hydrogen peroxide
KW  - lipid
KW  - caspase 3
KW  - nucleic acid
KW  - protein
KW  - adenosine triphosphate
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - V. Panduri, NIEHS, RTP, NC, United States
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A4937?sid=a01dc2ef-0f54-491e-8e23-396b1e4d3ee5
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70842386
AB  - Rationale: Inspired oxygen, an essential therapy for cardiac and pulmonary diseases, has the potential to generate reactive oxygen species that can damage cellular DNA. Prolonged exposure to high levels of oxygen >50% causes hyperoxic acute lung injury and in infants with bronchopulmonary dysplasia, however the mechanism is still unclear. ROS generated by hyperoxia include superoxide radical and H2O2 which can damage cellular macromolecules like lipids, proteins and nucleic acids. DNA damage activates signaling pathways that can halt the cell cycle for subsequent repair or induce cells to undergo programmed cell death. The current study was designed to understand how cells respond to ROS induced DNA damage in response to hyperoxia and subsequent cell death in human bronchial epithelial cells. Method(s): Bronchial epithelial cells were exposed to 95% O2(1-48h) .ROS was measured by EPR, MitoSOXTM Red confocal imaging. A gene specific DNA damage was assessed by QPCR method. Annexin V and electron microscopy used to measure cell death. Result(s): Our results show that Beas2B cells exposed to hyperoxia for 1h released significant amounts of superoxide radical (O2 as -) measured by EPR. We measured the superoxide production in the mitochondria of the living cells with MitoSOXTM Red using confocal microscopy. Using a gene specific DNA damage assay based on quantitave PCR of large fragments, hyperoxia caused significantly increase in nuclear DNA damage by 2 hrs of exposure,(0.3/10kb).This lesion frequency increased to a maximum at 12 hrs to (1.5/10kb) and is consistent with a direct effect of reactive oxygen species attack upon DNA. Surprisingly, mitochondria suffered less DNA damage than the nucleus and showed (0.7 /10kb) at 12 hr. Exposure to hyperoxia led to S-phase arrest. Apoptotic features including Annexin V incorporation, and elevated caspase-3 activity, PARP cleavage were not readily observed in hyperoxia treated Bea2B cells in contrast to control cells. We further found that hyperoxia after 12h exposure decreased mitochondrial membrane potential (DELTAPSIm) that leads to decrease in ATP production which causes necrosis in bronchial epithelial cells. These trends were also repeated in primary human bronchial epithelial cells (NHBE) but showing some evidence of autophagy occurrence in response to hyperoxia using electron microscopy. Conclusion(s): The results of this study support an association of nuclear DNA lesions with necrosis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841607
TI  - Thioredoxin interacting protein overexpression decreases hypoxia response element promoter activity in murine alveolar epithelial cells
AU  - Tipple T.E.
AU  - Rogers L.K.
AU  - Liu Y.
AU  - Nelin L.D.
AU  - Welty S.E.
Y1  - 2010//
KW  - *hypoxia
KW  - *DNA responsive element
KW  - *promoter region
KW  - *lung alveolus epithelium
KW  - *society
KW  - lung
KW  - mouse
KW  - ambient air
KW  - human
KW  - plasmid
KW  - epithelium cell
KW  - protein expression
KW  - hypothesis
KW  - lung development
KW  - lung dysplasia
KW  - Western blotting
KW  - cell culture
KW  - model
KW  - regression analysis
KW  - infant
KW  - analysis of variance
KW  - *thioredoxin interacting protein
KW  - luciferase
KW  - vasculotropin
KW  - hypoxia inducible factor
KW  - plasmid DNA
KW  - Renilla luciferin 2 monooxygenase
KW  - protein
KW  - DNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - T.E. Tipple, Research Institute, Nationwide Children's Hospital, Columbus, OH, United States. E-mail: trent.tipple@nationwidechildrens.org
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A4155?sid=786d5205-5340-413a-8518-7c37e8e927ee
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841607
AB  - RATIONALE: Vascular endothelial growth factor (VEGF) expression, required for proper lung development, is transcriptionally regulated in alveolar epithelial cells by hypoxia inducible factor (HIF) via a hypoxia response element (HRE). Previous data indicate that lung thioredoxin interacting protein (Txnip) and VEGF protein levels are inversely correlated in a newborn mouse model of bronchopulmonary dysplasia (BPD). The present studies tested the hypothesis that a similar correlation exists between in utero and postnatal lung VEGF and Txnip protein expression and that Txnip overexpression decreases HRE promoter activity in mouse lung epithelial cells. METHOD(S): Lung Txnip and VEGF contents in E19 and 1 day-old mice were determined by western blot and a regression analysis was performed. MLE-12 cells were co-transfected with HRE-luciferase reporter, renilla-luciferase, and Txnip plasmid DNA and were cultured in 1% hypoxia or room air for 24 h. HRE-luciferase activities in cell lysates were determined. Data represent the results of 2-4 separate experiments and were analyzed by ANOVA. RESULT(S): VEGF contents were lower and Txnip protein levels greater in the lungs of 1 day-old newborn mice than in E19 mice and an inverse correlation between lung VEGF and Txnip protein levels was detected (n=18, R=-0.85, p<0.0001). HRE-luciferase activity was 9.7 times greater in MLE-12 cells exposed to hypoxia than in cells cultured in room air (n=22, p<0.001). In room air-exposed cells, HRE-luciferase activity was decreased by 17%, 23%, and 51% in cells transfected with 0.5, 1, and 2 mug Txnip plasmid DNA/well, respectively, compared to control-transfected cells (n=10-22, p<0.001). In hypoxia-exposed cells, HRE-luciferase activity was decreased by 9%,12%, and 35% in cells transfected with 0.5, 1, and 2 mug Txnip plasmid DNA/well, respectively, compared to similarly exposed control-transfected cells (n=16-22, p<0.01). CONCLUSION(S): Our data are consistent with Txnip-dependent regulation of VEGF production in the murine lung and Txnip-dependent regulation of HRE promoter activity in murine alveolar epithelial cells. Studies designed to elucidate the direct mechanism by which Txnip regulates HIF-dependent VEGF production are currently ongoing. Similar alterations of Txnip expression could alter lung VEGF expression in prematurely born human infants contributing to the development of BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2023 to 2024>
TI  - Bone Marrow Stromal Cell-Secreted Extracellular Vesicles Containing miR-34c-5p Alleviate Lung Injury and Inflammation in Bronchopulmonary Dysplasia Through Promotion of PTEN Degradation by Targeting OTUD3.
DO  - https://dx.doi.org/10.1080/08820139.2023.2217854
AU  - He, Xiao
AU  - Kuang, Juan
AU  - Wang, Yijing
AU  - Lan, Guofeng
AU  - Shi, Xuekai
Y1  - 2023//
Y2  - 20230613//
KW  - Infant, Newborn
KW  - Humans
KW  - Animals
KW  - Mice
KW  - Bronchopulmonary Dysplasia/th [Therapy]
KW  - Bronchopulmonary Dysplasia/me [Metabolism]
KW  - *Bronchopulmonary Dysplasia
KW  - Lung Injury/th [Therapy]
KW  - Lung Injury/me [Metabolism]
KW  - *Lung Injury
KW  - MicroRNAs/ge [Genetics]
KW  - MicroRNAs/me [Metabolism]
KW  - *MicroRNAs
KW  - Interleukin-13/me [Metabolism]
KW  - PTEN Phosphohydrolase/ge [Genetics]
KW  - PTEN Phosphohydrolase/me [Metabolism]
KW  - Hyperoxia/me [Metabolism]
KW  - *Hyperoxia
KW  - Interleukin-4
KW  - Interleukin-6/me [Metabolism]
KW  - Extracellular Vesicles/me [Metabolism]
KW  - *Extracellular Vesicles
KW  - Mesenchymal Stem Cells/me [Metabolism]
KW  - *Mesenchymal Stem Cells
KW  - Inflammation/me [Metabolism]
KW  - Ubiquitin-Specific Proteases/me [Metabolism]
T2  - Immunological investigations
VL  - 52
IS  - 6
SN  - 0882-0139
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med24&NEWS=N&AN=37310728
AD  - England
AB  - BACKGROUND: Bronchopulmonary dysplasia (BPD) is the predominant chronic disorder in preterm neonates. This study explored impacts of miR-34c-5p carried by bone marrow stromal cells-secreted extracellular vesicles (BMSC-EVs) on BPD progression., METHODS: A BPD mouse model was established, followed by measurement of miR-34c-5p, OTUD3, and PTEN expression. EVs were isolated from BMSCs transfected with miR-34c-5p mimic or mimic NC and intratracheally injected into mice. CD31 and Ki67 expression was detected and the pathological changes of lung tissues and lung function indexes were observed for mice. A neonatal human pulmonary microvascular endothelial cell (HPMEC) model was developed with hyperoxia, followed by co-culture with extracted EVs and ectopic experiments for measurement of cell viability, migration, and angiogenesis. IL-4, IL-13, IL-1beta, and IL-6 levels were measured in cell supernatants and lung tissues. Dual-luciferase reporter, ubiquitination, Co-IP, and RIP assays were adopted to determine the relationship among miR-34c-5p, OTUD3, and PTEN., RESULTS: Lung tissues of BPD mice had downregulated miR-34c-5p expression and upregulated OTUD3 and PTEN expression. BMSC-EVs and BMSC-EVs-miR-34c-5p treatment improved lung injury and alveolar structure, decreased lung resistance and IL-4, IL-13, IL-1beta, and IL-6 levels, and elevated dynamic lung compliance in BPD mice, as well as enhanced proliferation, angiogenesis, and migration and restrained inflammation in HPMECs. Mechanistically, miR-34c-5p negatively targeted OTUD3 which restrained ubiquitination to promote PTEN protein stabilization. Upregulation of OTUD3 or PTEN negated the changes in the proliferation, angiogenesis, migration, and inflammation of hyperoxia-treated HPMECs induced by BMSC-EVs-miR-34c-5p., CONCLUSION: BMSC-EVs-miR-34c-5p alleviated lung injury and inflammation in hyperoxia-induced BPD by blocking the OTUD3/PTEN axis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2014>
TI  - [Yellow nail syndrome: two pediatric case reports].
T2  - Annales de dermatologie et de venereologie
DO  - https://dx.doi.org/10.1016/j.annder.2014.06.026
AU  - Dessart, P
AU  - Deries, X
AU  - Guerin-Moreau, M
AU  - Troussier, F
AU  - Martin, L
Y1  - 2014//
Y2  - 20140820//
KW  - Adolescent
KW  - Bronchopulmonary Dysplasia/di [Diagnosis]
KW  - Child
KW  - Humans
KW  - Hydrops Fetalis/di [Diagnosis]
KW  - Infant, Premature, Diseases/di [Diagnosis]
KW  - Lymphatic Abnormalities/di [Diagnosis]
KW  - Lymphoscintigraphy
KW  - Male
KW  - *Yellow Nail Syndrome/di [Diagnosis]
KW  - Yellow Nail Syndrome/et [Etiology]
VL  - 141
IS  - 10
SN  - 0151-9638
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med11&NEWS=N&AN=25288066
AD  - France
AB  - BACKGROUND: Yellow nail syndrome (YNS) is a combination of specific nail dystrophy (yellowish or green nails, transverse ridging, increased curvature with "a hump" and distal onycholysis), lymphoedema and respiratory tract involvement (mainly bronchial hyper-responsiveness, recurrent pneumonia, bronchiectasis and pleural effusion), with or without sinusitis. This rare condition is most often seen in middle age. We report two pediatric cases., PATIENTS: A 9-year-old boy had 20 yellow nails and lymphedema of the lower and upper left limbs. He was born at 32 weeks of gestation. At birth, he had fetal hydrops with bilateral chylothorax. Since then, he presented bronchopulmonary dysplasia. In his first year of life, he had recurrent nasopharyngitis and serosal otitis. Lymphoscintigraphy was not performed. A 14-year-old boy had 10 yellow toenails and 2 yellow fingernails. He was born at 36 weeks of gestation with fetal hydrops. He had recurrent serosal otitis and asthma attacks. Lymphoscintigraphy showed lymphatic hypoplasia, especially of the left limbs., DISCUSSION: These two children have the classic triad of YNS, including yellow nails, lymphedema and respiratory tract involvement. Thirteen cases have been reported in children from birth to 10 years of age, three of whom were siblings, thus suggesting genetic predisposition. In most cases lymphoscintigraphy showed hypoplasia and/or ectasia of lymphatic vessels. These lymphatic abnormalities may be responsible for nail changes as seen in Turner's syndrome. The prognosis of YNS in adults may be serious because of the pulmonary tract involvement. However, it is not known in children., CONCLUSION: Yellow dystrophic nails in children may be associated with lymphedema and respiratory tract involvement, as in adults, and this condition should therefore be investigated in cases of YNS. Copyright Â© 2014 Elsevier Masson SAS. All rights reserved.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841605
TI  - MMP12 deficient newborn mouse pups are protected from hyperoxia-induced impaired alveolar development
AU  - Brass D.M.
AU  - Fattman C.L.
AU  - Auten R.L.
Y1  - 2010//
KW  - *hyperoxia
KW  - *society
KW  - *mouse
KW  - density
KW  - macrophage
KW  - hypothesis
KW  - ambient air
KW  - human
KW  - immunohistochemistry
KW  - newborn
KW  - respiratory failure
KW  - lung dysplasia
KW  - risk factor
KW  - nursing assistant
KW  - prematurity
KW  - elastin
KW  - oxygen
KW  - proteinase
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - D.M. Brass, Duke University Medical Center, Durham, NC, United States. E-mail: david.brass@duke.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A4153?sid=786d5205-5340-413a-8518-7c37e8e927ee
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841605
AB  - Extremely premature babies frequently require supplemental oxygen support at birth. Supplemental oxygen (hyperoxia) is also a risk factor for development of bronchopulmonary dysplasia, characterized by airspace enlargement and respiratory insufficiency. How hyperoxia contributes to airspace enlargement in newborns is unknown. Alveoli form at secondary septal crests beginning at postnatal day 4 (P4) in mice. Orderly elastin deposition at these sites is essential for this process. We hypothesize that hyperoxia-induced macrophage protease expression impedes elastin deposition and impairs alveolar development. To address this hypothesis we exposed litters of C57BL/6 mouse pups (n = at least 5/group) to 95% oxygen (hyperoxia) or to room air for 11 days beginning at birth. We measured alveolar volume density and secondary septal crest density at P3, P7, P14 and P21. Hyperoxia significantly (p<0.05) decreased alveolar volume density from day 7 onward, and elastin-positive septal crest density at P14 and P21. Hyperoxia prominently induced MMP9 in airspace wall associated macrophages, and induced MMP12 expression in airspace macrophages as detected by immunohistochemistry. To address the role of MMP12 in hyperoxia-induced impaired alveolar development we exposed MMP12 deficient mice to hyperoxia or to room air for 11 days beginning at birth. We measured alveolar volume density and secondary septal crest density at P21. Both alveolar volume density and secondary septal crest density were protected at P21 in hyperoxia-exposed MMP12 deficient mouse pups compared to hyperoxia-exposed hyperoxia-exposed pups (p<0.05). These observations taken together support the hypothesis that MMP12 contributes to hyperoxia-induced airspace enlargement.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841604
TI  - CD44 is required for TGFbeta signaling during hypoxia-induced pulmonary hypertension and inhibition of alveolar development
AU  - Williams O.W.
AU  - Wang L.
AU  - Savani R.C.
Y1  - 2010//
KW  - *hypoxia
KW  - *pulmonary hypertension
KW  - *society
KW  - mouse
KW  - phosphorylation
KW  - lung
KW  - ambient air
KW  - gene expression
KW  - exposure
KW  - protection
KW  - lung dysplasia
KW  - lung homogenate
KW  - pulmonary artery
KW  - thickness
KW  - heart right ventricle hypertrophy
KW  - prevention
KW  - alpha smooth muscle actin
KW  - receptor
KW  - hyaluronic acid
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - O.W. Williams, Ut Southwestern, Dallas, TX, United States. E-mail: olatunji.williams@utsouthwestern.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A4152?sid=786d5205-5340-413a-8518-7c37e8e927ee
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841604
AB  - Impaired vascular and alveolar development are key components of pulmonary arterial hypertension (PAH) and Bronchopulmonary Dysplasia (BPD), and elevated TGFs promotes both disease processes. Since the hyaluronan receptor CD44 has been implicated in TGFs signaling, we examined the effects of hypoxia (12% vs. 21% O2 from birth to PN14) in neonatal CD44 (WT) and CD44 mice, as well as +/+ -/- the effects of CD44 deletion on potential TGFs signaling pathways. At PN14, hypoxia exposure of WT mice resulted in right ventricular hypertrophy, increased medial thickness of pulmonary arteries and decreased alveolarization. CD44-/- mice exposed to hypoxia were completely protected from these changes. Lung homogenates of hypoxia-exposed WT mice had a two-fold increase in active TGFs as compared to mice kept in room air. Surprisingly, CD44-/- mice kept in room air had elevated active TGFs at baseline and hypoxia exposure did not change this. In support of these results, hypoxia-exposed WT mice had a 2-fold increase in lung Smad2 phosphorylation, whereas CD44-/- mice kept in room air had elevated phospho-Smad2, with no further change after hypoxia. The lungs of hypoxia-exposed WT mice also had increased phosphorylation of ERK1/2. In contrast, ERK1/2 phosphorylation was impaired in the lungs of hypoxia-exposed CD44-/- mice, indicating a block in MAPK signaling. TGFs target gene expression (alpha-smooth muscle actin, alphaSMA) was increased in WT mice after hypoxia, but this increase was not seen in hypoxia-exposed CD44-/- mice. We conclude that hypoxia-stimulated changes in pulmonary hypertension and alveolarization require CD44. The defect in CD44-/- mice affording this protection from the effects of hypoxia is at the level of ERK phosphorylation. We speculate that Smad signaling is necessary but insufficient, whereas ERK1/2 signaling, which is regulated by CD44, is required for TGFs target gene expression. These data are potentially important for novel therapeutic approaches for the prevention and/or treatment of PAH and BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841598
TI  - Maternal high fat diet upregulates transforming growth factor beta 2 (TGF-beta2) in the rodent lung
AU  - Hilvers P.
AU  - Piedimonte G.
AU  - Samsell L.
AU  - Walton C.
AU  - Scuri M.
Y1  - 2010//
KW  - *rodent
KW  - *lung
KW  - *society
KW  - *lipid diet
KW  - progeny
KW  - female
KW  - calorie
KW  - human
KW  - body weight
KW  - mother
KW  - pregnancy
KW  - body fat
KW  - maternal obesity
KW  - lactation
KW  - preeclampsia
KW  - blood
KW  - inflammation
KW  - premature labor
KW  - obesity
KW  - risk factor
KW  - stillbirth
KW  - resuscitation
KW  - lung fibrosis
KW  - mortality
KW  - asthma
KW  - adult
KW  - rat
KW  - diet
KW  - lung dysplasia
KW  - lung homogenate
KW  - cholesterol blood level
KW  - perinatal morbidity
KW  - respiratory tract disease
KW  - metabolic parameters
KW  - baby
KW  - serum
KW  - congenital disorder
KW  - upregulation
KW  - triacylglycerol blood level
KW  - lung disease
KW  - enzyme linked immunosorbent assay
KW  - Apgar score
KW  - *transforming growth factor beta2
KW  - growth factor
KW  - high density lipoprotein cholesterol
KW  - protein
KW  - cytokine
KW  - glucose
KW  - virus protein V
KW  - fatty acid
KW  - high density lipoprotein
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - P. Hilvers, West Virginia University, Morgantown, WV, United States. E-mail: philvers@hsc.wvu.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A4146?sid=786d5205-5340-413a-8518-7c37e8e927ee
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841598
AB  - Maternal obesity is recognized as a risk factor for premature delivery, preeclampsia, congenital defects and perinatal morbidity and mortality, including need for resuscitation, low APGAR scores, and stillbirth. Obesity is associated with low grade systemic inflammation as shown by increased levels of inflammatory cytokines and growth factors, including TGF-beta. Increased expression of TGF-beta, especially in preterm babies is considered a key factor in the development of respiratory diseases including bronchopulmonary dysplasia (BPD), asthma and pulmonary fibrosis. In this study, we investigated whether high fat diet (HFD) during gestation and lactation affects the expression of TGF-beta in the lungs of 2 week-old rodent offspring. Upon confirmation of pregnancy, adult (12-week-old) female rats were started on a diet consisting of 60% calories from fat, while age-matched controls were fed a standard chow (16% calories from fat). Offspring (n=?) were nursed by their mothers until 14 days of age, at which time they were sacrificed and lungs were harvested. Protein concentrations of TGF-beta1 and TGF-beta2 in lung homogenates were determined by ELISA. In addition, glucose, total cholesterol, HDL cholesterol, and tryglycerides were measured in peripheral blood. TGF-beta2 was significantly increased in the lungs of offspring from HFD mothers compared to their age-matched controls (4.02+/-1.55 pg/mg protein vs 2.17+/-1.00 pg/mg protein respectively; n=7 for both groups; p<0.05) whereas TGF-beta1 was unaffected. Serum tryglycerides in HFD offspring were dramatically elevated compared to their age-matched controls (534.3+/-73.2 mg/100ml vs 266.2+/-48.4 mg/100ml respectively; p<0.05, n=6 and 4 respectively), while the other metabolic parameters were unchanged. Interestingly, weanlings from HFD mothers also showed lower body weight (27.8+/-0.2 grams vs 29.9+/-0.3 grams respectively; p<0.001, n=7 for both groups) but increased body fat expressed as a percentage of total body weight (0.55+/-0.04% vs 0.43+/-0.03 respectively; p<0.05, n=7 for both groups) compared to controls. In conclusion, HFD during gestation and lactation resulted in up-regulation of TGF-beta2 in the lungs of offspring. This effect was associated with a significant elevation of serum triglycerides and body fat whereas total body weight was decreased. Although still preliminary, these novel findings may indicate an association between maternal obesity, fatty acid abnormalities and increased expression of growth factors leading to the development of pulmonary disease early in life.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841597
TI  - Gastrin-releasing peptide (GRP) blockade modulates alveolarization in hyperoxic newborn mice
AU  - Degan S.
AU  - Subramaniam M.
AU  - Auten R.L.
AU  - Sunday M.E.
Y1  - 2010//
KW  - *mouse
KW  - *society
KW  - ambient air
KW  - low drug dose
KW  - drug megadose
KW  - lung
KW  - lung injury
KW  - baboon
KW  - prematurity
KW  - infant
KW  - hyperoxia
KW  - hypothesis
KW  - barotrauma
KW  - fibrosing alveolitis
KW  - model
KW  - host resistance
KW  - newborn
KW  - chronic lung disease
KW  - lung dysplasia
KW  - neurosecretory cell
KW  - histopathology
KW  - gene expression
KW  - injection
KW  - hedgehog
KW  - oxygen therapy
KW  - *gastrin releasing peptide
KW  - protein
KW  - defensin
KW  - PADGEM protein
KW  - antibody
KW  - nonoxinol 9
KW  - dectin 2
KW  - thrombospondin 1
KW  - sodium chloride
KW  - immunoglobulin G
KW  - loricrin
KW  - granzyme
KW  - thrombospondin 2
KW  - tenascin
KW  - chitinase
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.E. Sunday, Duke University Medical Center, Durham, NC, United States. E-mail: mary.sunday@duke.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A4145?sid=786d5205-5340-413a-8518-7c37e8e927ee
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841597
AB  - Bronchopulmonary dysplasia (BPD) is a chronic lung disease of premature infants associated with barotrauma, oxygen therapy, and prematurity, and characterized by arrested alveolarization. Infants with BPD have increased numbers of pulmonary neuroendocrine cells containing gastrin-releasing peptide (GRP). We identified 2-fold higher GRP levels in preterm baboons and infants that later developed BPD. GRP blockade with antibody 2A11 abrogates lung injury and arrested alveolarization in 2 different baboon models of BPD. Conversely, newborn mice treated with exogenous GRP have diminished alveolar development. Our objective was to test the hypothesis that GRP blockade can modulate lung injury and development in mice. Newborn C57BL/6 pups were at room air or exposed to continuous 75% hyperoxia (HO) from postnatal day 1 (P1)-P18, given IP injections of 2A11 (5 or 0.2mug/kg), or MOPC21, negative control IgG (5 or 0.2mug/kg), or saline (PBS). At P18, lungs were harvested for histopathology and expression analysis using Affymetrix microarrays. Compared to pups at room air, HO-exposed pups given MOPC or PBS had higher mean linear intercepts (MLI) (P=0.001), indicating decreased septation. HO-exposed lungs given high-dose 2A11 had even larger alveoli than HO controls. However, with HO low-dose 2A11 (0.2mug/kg) improved alveolarization and reduced interstitial fibrosis. Room air pups given any dose 2A11 had more alveolar septation than control room air pups (P=0.03). Lung expression analysis (3-7 microarrays/group) compared room air vs. HO, high-dose vs. low-dose 2A11 or MOPC. High-dose 2A11+HO vs. HO+MOPC increased gene expression (FC>2, P<0.05) for host defense (IL-18, defensin-beta4), epithelial barrier function (repetin, loricrin, MUC5B), pro-inflammatory (CD68, granzyme-1, and P-selectin), but decreased tenascin-C and thrombospondin-2. Low-dose 2A11 increased expression (FC>2, P<0.05) of SP-A, PDGFR-alpha, Hedgehog-interacting protein and MMP3, and decreased expression (FC<0.5, P<0.05) of thrombospondin-1, chitinase 3-like-3, dectin-2beta, FcRgamma, TNFalpha-induced protein-2). In conclusion, low-dose 2A11+HO promotes alveolarization, with increased pro-developmental and decreased pro-inflammatory mRNAs. In contrast, high-dose 2A11+HO impairs alveolarization, with increased pro-inflammatory and few decreased developmental mRNAs. These observations suggest that some GRP is necessary for normal septation but blockade of excessive GRP in hyperoxic animals may promote alveolar formation.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841594
TI  - Nuclear factor kappa B is an essential regulator of postnatal alveolarization by promoting angiogenesis
AU  - Alvira C.M.
AU  - Alastalo T.
AU  - Chen C.
AU  - Lyu S.C.
AU  - Cornfield D.N.
Y1  - 2010//
KW  - *angiogenesis
KW  - *society
KW  - in vitro study
KW  - lung development
KW  - gene
KW  - mouse
KW  - survival
KW  - endothelium cell
KW  - tube
KW  - assay
KW  - protein expression
KW  - homeostasis
KW  - prematurity
KW  - lung parenchyma
KW  - lung dysplasia
KW  - capillary tube
KW  - hypothesis
KW  - capillary density
KW  - lung capillary
KW  - chronic lung disease
KW  - cell survival
KW  - inflammation
KW  - lung
KW  - RNA interference
KW  - pathogenesis
KW  - *immunoglobulin enhancer binding protein
KW  - vasculotropin
KW  - protein
KW  - transcription factor
KW  - phosphotransferase
KW  - messenger RNA
KW  - gelatinase A
KW  - angiogenic factor
KW  - vasculotropin receptor 2
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - C.M. Alvira, Stanford University, Stanford, CA, United States. E-mail: calvira@stanford.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A4142?sid=786d5205-5340-413a-8518-7c37e8e927ee
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841594
AB  - Bronchopulmonary dysplasia (BPD), a chronic lung disease affecting premature infants, is characterized by an arrest in normal lung development due to disrupted alveolar and vascular development. However, the transcriptional regulators that determine alveolarization are unknown. While the transcription factor, nuclear factor kappa B (NFkappaB) plays a key role in regulating inflammation and cell survival, to this point, no role for NFkappaB has been demonstrated in lung development. We have previously shown that in vivo inhibition of NFkappaB signaling in neonatal mice results in larger and fewer alveoli, consistent with the alveolar simplification pathognomonic of BPD. This effect was associated with a reduction in pulmonary capillary density, therefore, we hypothesized that NFkappaB is an essential regulator of alveolarization by promoting angiogenesis. To test this hypothesis, neonatal mice were treated systemically with the NFkappaB inhibitor, BAY 11-7082 (BAY), or vehicle (PBS), and lung tissue was harvested at 8 and 24h for gene and protein expression analysis. Pulmonary endothelial cells (PEC) were isolated from neonatal mice using CD31 coated beads for determination of vascular endothelial growth factor receptor-2 (VEGFR2) expression and used in assays to assess vascular endothelial growth factor (VEGF)-mediated survival, proliferation, and in vitro tube formation. Inhibiting NFkappaB with BAY decreased VEGFR2 mRNA (p=0.005) and protein (p=0.007) expression in whole lung at 8h, and suppressed the activity of matrix metalloproteinase-2 (p=0.006), both key angiogenic factors. Furthermore, NFkappaB blockade with BAY (2.5 and 5 muM) caused a dose dependent reduction of VEGFR2 gene (p<0.01) and protein (p<0.01) expression in PEC, impaired PEC survival at 24h (p<0.05) and blocked VEGF-mediated proliferation at 48h (p<0.001). Pretreatment of PEC with BAY (2.5 muM) for 4h prior to in vitro angiogenesis assays attenuated capillary tube and network formation at baseline, and prevented VEGF-mediated enhancement of tube formation (p<0.001). Finally, decreasing the expression of either of the principle activators of NFkappaB, inhibitory kappaB-kinase-alpha or -beta (IKK-alpha or IKK-beta) by RNA interference impaired in vitro angiogenesis (p<0.05). In summary, inhibition of NFkappaB disrupts postnatal alveolarization by decreasing genes critical for endothelial cell homeostasis. Taken together, our data demonstrate an entirely novel role for NFkappaB in promoting postnatal lung development by enhancing angiogenesis. We speculate that: (i) disruption of NFkappaB signaling may contribute to the pathogenesis of BPD; and (ii) that therapeutic strategies to enhance NFkappaB activity could enhance postnatal alveolarization.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841584
TI  - Modulation of CC10 mrna expression in the immature lung
AU  - Hubert T.L.
AU  - Wu J.
AU  - Kimura K.
AU  - Higuchi S.
AU  - Eguchi S.
AU  - Shaffer T.H.
AU  - Wolfson M.R.
Y1  - 2010//
KW  - *lung
KW  - *society
KW  - *modulation
KW  - low drug dose
KW  - inflammation
KW  - human
KW  - lung parenchyma
KW  - lamb
KW  - Clara cell
KW  - respiratory distress syndrome
KW  - lung dysplasia
KW  - monitoring
KW  - therapy
KW  - airway
KW  - extracellular fluid
KW  - protection
KW  - negative feedback
KW  - antiinflammatory activity
KW  - *messenger RNA
KW  - complementary DNA
KW  - surfactant
KW  - secretory protein
KW  - beractant
KW  - protein
KW  - beta actin
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - T.L. Hubert, Temple Univ, Sch of Med, Phila., PA, United States
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A4132?sid=786d5205-5340-413a-8518-7c37e8e927ee
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841584
AB  - Rationale: CC10, is a pleiotrophic protein produced by airway clara cells, secreted into the extracellular fluids, known to have anti-inflammatory effects, but is deficient in the immature lung. Progression from respiratory distress syndrome (RDS) to bronchopulmonary dysplasia (BPD) has been linked to acute, iatrogenic, inflammation. Recombinant human clara cell secretory protein 10 (rhCC10) administration, in conjunction with surfactant therapy (SFT), reduces inflammation in the immature ventilated lung compared to SFT alone. The effect of rhCC10 on endogenous CC10 expression in early development is unknown. Our objective was to evaluate the effect of rhCC10 (Clarassance, Inc.) administration on endogenous CC10 expression in the preterm lamb with RDS. Design(s): 24 premature lambs (126 +/- 3 SE days) were instrumented for cardiopulmonary monitoring, delivered, paralyzed, and ventilated. Following baseline measurement, animals received SFT (Survanta, Ross Labs.; 100mg/kg) and then randomized to one of four groups (n=6/group): none; 0.5 mg/kg (low); 1.5 mg/kg (medium); or 5 mg/kg (highest) intratracheal rhCC10. After 4 hrs, the animals were deeply anesthetized, lung tissues were harvested and snap frozen. Ovine cc10 cDNA was cloned and sequenced (Genebank #FJ959385). RNA was extracted from lung tissue, and qPCR with the specific primers was used to measure cc10 expression normalized to beta-actin expression. Mean +/- SEM ; * p < 0.05 vs untreated ; degree p < 0.05 vs low dose. Result(s): No and low dose rhCC10 treatment had comparable levels of CC10 mRNA expression. CC10 mRNA expression in non-treated and low dose groups were greater (p < 0.05) than higher dose treated groups. There was no significant difference between the medium and highest dosed groups. (Table Presented) Conclusion(s): These data demonstrate a dose dependent effect of rhCC10 administration on CC10 mRNA expression during early development. While the mechanism of how rhCC10 lowers CC10 mRNA expression is unknown, we speculate that the higher doses of rhCC10 cause negative feedback either directly or indirectly by lowering inflammation. Further study is needed to determine optimal rhCC10 dosing, with respect to lung protection and endogenous CC10 production, and to quantify the effect of the SFT alone on CC10 mRNA expression during early development.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841583
TI  - Tracheal aspirate wnt-related proteins lef-1 and beta-catenin, novel biomarkers of bronchopulmonary dysplasia
AU  - Rehan V.K.
AU  - Sakurai R.
AU  - Dhar V.
AU  - Torday J.S.
Y1  - 2010//
KW  - *lung dysplasia
KW  - *society
KW  - *tracheal aspiration procedure
KW  - infant
KW  - Western blotting
KW  - cell transdifferentiation
KW  - extubation
KW  - down regulation
KW  - very low birth weight
KW  - pathogenesis
KW  - enzyme linked immunosorbent assay
KW  - artificial ventilation
KW  - myofibroblast
KW  - Wnt signaling pathway
KW  - upregulation
KW  - respiratory distress syndrome
KW  - protein content
KW  - fibroblast
KW  - interpersonal communication
KW  - *protein
KW  - *catenin
KW  - marker
KW  - lymphoid enhancer factor 1
KW  - parathyroid hormone
KW  - Wnt protein
KW  - receptor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - V.K. Rehan, Harbor UCLA Medical Center, Torrance, CA, United States. E-mail: vrehan@labiomed.org
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A4131?sid=786d5205-5340-413a-8518-7c37e8e927ee
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841583
AB  - Rationale: Disruption of normal homeostatic epithelial-mesenchymal communications, resulting in alveolar interstitial fibroblast-to-myofibroblast transdifferentiation, is a key event in the pathogenesis of Bronchopulmonary Dysplasia (BPD). This AIF-to-MYF transdifferentiation is characterized by down-regulation of the Parathyroid Hormone-related Protein/Peroxisome Proliferator Activated Receptor gamma (PTHrP/PPARgamma) signaling pathway and up-regulation of the Wnt signaling pathway. We have previously reported decreased tracheal aspirate (TA) PTHrP levels in ventilated Very-Low-Birth-Weight Infants (VLBWIs) during the first week of life who later go on to develop BPD. However, there is no information on the levels of Wnt-related proteins in the TA of these infants. We hypothesized that Wnt protein content in the TA of ventilated VLBWI would correlate with the development of BPD. Material(s) and Method(s): Twenty VLBWIs (BW 943 +/- 302 grams (mean +/- SD); GA 27 +/- 2 weeks; 10M:10F) ventilated for Respiratory Distress Syndrome were studied. The TAs were collected once daily during the first 3 days of life, or until extubation, whichever was earlier, and immediately frozen for subsequent analysis by ELISA and Western blot analysis for LEF-1 and beta-catenin, two key markers of Wnt activation. Levels of LEF-1 and beta-catenin were correlated with the probability of extubation at 1 wk of age, and with the later development of BPD, as defined by 02 requirement at 36 wk GA. Result(s): LEF-1 and beta-catenin levels, as determined by both ELISA and Western blot analysis, were significantly higher in infants who continued to be ventilated at 1 wk of age, and who later went on to develop BPD, compared to infants who were extubated by 1 wk of age and did not develop BPD. Conclusion(s): During the first 3 days of life, the TA levels of LEF-1 and beta-catenin, two key markers of Wnt activation, correlated with the duration of mechanical ventilation needed and the later development of BPD in VLBWI infants. We conclude that in combination with the lower TA PTHrP content, higher Wnt-related proteins can be developed into sensitive and specific biomarkers to predict, diagnose, and monitor BPD in ventilated VLBWIs.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841582
TI  - Identification of candidate susceptibility genes for a murine model of bronchopulmonary dysplasia
AU  - Nichols J.
AU  - Gladwell W.
AU  - Cho H.
AU  - Wiltshire T.
AU  - Kleeberger S.R.
Y1  - 2010//
KW  - *model
KW  - *lung dysplasia
KW  - *society
KW  - *gene
KW  - phenotype
KW  - newborn
KW  - lung injury
KW  - haplotype
KW  - mouse
KW  - hyperoxia
KW  - exposure
KW  - inbred strain
KW  - mare
KW  - blood vessel injury
KW  - computer model
KW  - genetic model
KW  - heritability
KW  - assisted ventilation
KW  - prematurity
KW  - lung
KW  - injury
KW  - cell count
KW  - lung disease
KW  - liquid
KW  - genetics
KW  - neutrophil
KW  - epithelium cell
KW  - lavage
KW  - food
KW  - infant
KW  - quantitative trait locus
KW  - adult
KW  - lung development
KW  - pathogenesis
KW  - oxygen
KW  - oxidizing agent
KW  - protein
KW  - reactive oxygen metabolite
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J. Nichols, NIEHS, Durham, NC, United States
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A4130?sid=786d5205-5340-413a-8518-7c37e8e927ee
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841582
AB  - Introduction: Reactive oxygen species (ROS) contribute to the pathogenesis of many acute and chronic pulmonary disorders, including bronchopulmonary dysplasia (BPD), a respiratory condition affecting preterm infants. In BPD, treatment often involves respiratory support with high oxygen levels and generation of ROS is an adverse consequence that has been associated with vascular damage and impaired lung development and function in a subset of infants. Polymorphisms in a few candidate genes have been associated with BPD susceptibility, however the genetic basis of differential susceptibility remains poorly understood. Understanding the role of genetics is critical to improving treatment strategies and reducing oxidant injury in developing lungs. Herein, we report a genetic model of hyperoxic lung injury including 30 neonate inbred strains of mice. The objective was to utilize haplotype association mapping of quantitative phenotypes to identify genes important to susceptibility of neonatal hyperoxic lung injury. Method(s): Time-mated pregnant inbred mice were allowed to deliver spontaneously. During exposures, CFW dams we used for cross-fostering every 24hr. At postnatal day 1 (P1), neonates were pooled and reassigned to litters exposed to 100% O2 or air for 72hr. Dams were provided with food ad libitum. Following exposure, neonates were necropsied at P4 and bronchealveolar lavage fluid analysis (protein concentration, total cell counts, neutrophils, and epithelial cells) and histophathology were measured as disease phenotypes. All exposures were carried out at the NIEHS and approved by IACUC. Haplotype mapping of response phenotypes was done using SNPster. Result(s): The neonate inbred strains demonstrate lung injury following hyperoxia exposure. Significant inter-strain variation in hyperoxia response phenotypes was found, with broad-sense heritability estimates ranging from 47.2 to 58.6%. The most resistant strains to hyperoxic lung injury include 129S1/SvImJ and BALB/cByJ while C3H/HeJ and PWD/Ph mice are among the most susceptible. Haplotype association mapping studies identified quantitative trait loci (QTLs)with genes of interest for the disease phenotypes. Conclusion(s): Significant inter-strain variation in hyperoxia-induced disease phenotypes is consistent with a strong genetic contribution to disease. Interestingly, hyperoxia responses in neonate mice do not predict responses in adults of the same strain. Furthermore, through in silico haplotype mapping we have identified novel QTLs and candidate genes underlying susceptibility to hyperoxic lung injury in this model of BPD that will provide important mechanistic insight.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841362
TI  - Single nucleotide polymorphisms of superoxide dismutase in the pathogenesis of bronchopulmonary dysplasia
AU  - Calo J.M.
AU  - Maramreddy H.
AU  - Fisher J.
AU  - Chhabra D.
AU  - Dwarakanath K.
AU  - Strassberg S.
AU  - Ali N.
AU  - Parton L.A.
Y1  - 2010//
KW  - *single nucleotide polymorphism
KW  - *pathogenesis
KW  - *lung dysplasia
KW  - *society
KW  - sepsis
KW  - parental consent
KW  - real time polymerase chain reaction
KW  - lung alveolus epithelium
KW  - aerobic metabolism
KW  - Student t test
KW  - genetics
KW  - hypothesis
KW  - infant
KW  - chi square test
KW  - statistical significance
KW  - gestational age
KW  - birth weight
KW  - exposure
KW  - extremely low birth weight
KW  - *superoxide dismutase
KW  - enzyme
KW  - superoxide
KW  - antioxidant
KW  - steroid
KW  - DNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J.M. Calo, Maria Fareri Children's Hospital, Westchester Medical Center, Valhalla, NY, United States. E-mail: joycalo@yahoo.com
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A3910?sid=3c75b30f-6331-40cc-9640-185bc457df50
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841362
AB  - Background: CuZnSOD (extracellular SOD, EC SOD) is a cytoplasmic enzyme found in lung epithelium responsible for scavenging superoxide radicals that are produced as by-products of oxidative metabolism. We investigated the genetics of this putative antioxidant enzyme pathway for BPD. Objective(s): We tested the hypothesis that SNPs of CuZnSOD are associated with the development of BPD in ELBW infants. Design/Methods: DNA was isolated from buccal mucosal swabs (N=96) following informed parental consent. Allelic discrimination was performed using specific probes for CuZnSOD (+809, +5982, +5321, and -631) with Real-time PCR. Chi square analyses and t-test for independent samples were performed with P<0.05 denoting statistical significance. Result(s): We found statistically significant differences between the No BPD and BPD cohorts for Gestational Age, Birth Weights and exposure to antenatal steroids. There was also a statistically significant association between SNP +5982 and BPD (P=0.03), PDA (P=0.01), and culture positive sepsis (P=0.04). (Figure presented) Conclusion(s): The SOD SNP +5982 was significantly associated with BPD, PDA treatment and culture positive sepsis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841348
TI  - Chronic hyperoxia results in neonatal lung disease associated with up-regulation of transforming growth factor beta-2 ligand MRNA expression
AU  - Ahlfeld S.K.
AU  - Michels G.E.
AU  - Ingram D.A.
AU  - Conway S.J.
AU  - Clapp D.W.
Y1  - 2010//
KW  - *hyperoxia
KW  - *upregulation
KW  - *lung disease
KW  - *society
KW  - exposure
KW  - mouse
KW  - lung
KW  - prematurity
KW  - phosphorylation
KW  - lung dysplasia
KW  - attenuation
KW  - animal model
KW  - lung development
KW  - wild type
KW  - protein electrophoresis
KW  - in situ hybridization
KW  - examination
KW  - gas exchange
KW  - lung alveolus epithelium
KW  - lung homogenate
KW  - ambient air
KW  - chronic lung disease
KW  - *transforming growth factor beta2
KW  - *ligand
KW  - messenger RNA
KW  - oxygen
KW  - protein
KW  - transforming growth factor beta
KW  - paraformaldehyde
KW  - transcription factor RUNX2
KW  - protein A
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S.K. Ahlfeld, Indiana University, Indianapolis, IN, United States. E-mail: skahlfel@iupui.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A3896?sid=3c75b30f-6331-40cc-9640-185bc457df50
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841348
AB  - Rationale: Bronchopulmonary Dysplasia (BPD) is a chronic lung disease that affects preterm infants, characterized by fewer, larger, simpler alveoli due to an absence of secondary alveolar septation resulting in a reduced surface area for gas exchange. Up-regulation of the Transforming Growth Factor Beta (TGFbeta) superfamily signaling pathway has been associated with the development of BPD in multiple animal models and premature infants. Although it is known that TGFbeta signaling is mediated via three ligands, TGFbeta-1, 2, and 3, that serve overlapping yet specific functions in normal lung development, there is a lack of data describing how these ligands are affected by neonatal exposure to hyperoxia. We hypothesized that exposure to chronic hyperoxia would have differential effects on the expression of these ligands in the neonatal mouse lung. Method(s): Within 12hr of birth, C57/B6 wild-type mice were subjected to 21 consecutive days of continuous exposure to 85% oxygen (O2) or room-air (RA) as controls. At 21 days, lungs were either inflation-fixed with 4% Paraformaldehyde at 30cm of H20 (for histological examination of distal airspace size and TGFbeta-isoform mRNA in-situ hybridization) or frozen and homogenized for protein electrophoresis (to quantify TGFbeta signaling via relative phospho-Smad 2/3 expression and BMP signaling via relative phospho-Smad 1/5/8 expression). Result(s): Exposure to 21 days of chronic hyperoxia resulted in an arrest of alveolar development with enlarged, simplified distal airspaces. TGFbeta-2 mRNA expression was increased in 85% oxygen-exposed mice compared to RA controls, with a punctuate pattern noted within the alveolar epithelium. TGFbeta-1 mRNA appeared to be equivalent between the two groups, and TGFbeta-3 mRNA was not present in either group. Whole lung homogenates revealed potentiation of TGFbeta signaling levels as evidenced by increased phosphorylation of Smad2/3 protein (O2:RA increased 41%, p<0.001) and attenuation of BMP signaling levels as evidenced by decreased phosphorylation of Smad 1/5/8 protein (O2:RA decreased 43%, p<0.05). Significantly, Periostin protein, a known down-stream effector of phospho-Smad 2/3 signaling, was increased in 85% oxygen-exposed mice compared to RA control lungs. Conclusion(s): Hyperoxia-induced arrested alveolar development is associated with long-lasting enhancement of TGFbeta signaling and a gradual loss of BMP signaling. Further, the potentiation of TGFbeta signaling is mediated via increased TGFbeta-2 ligand expression. Future studies to delineate the spatio-temporal expression of TGFbeta-2 mRNA as well as the cell-specific targets of TGFbeta-signaling are needed, as this will be paramount to understanding the possible role of TGFbeta in the development of neonatal lung diseases. (Figure presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2014>
TI  - A comparison of KL-6 and Clara cell protein as markers for predicting bronchopulmonary dysplasia in preterm infants.
DO  - https://dx.doi.org/10.1155/2014/736536
AU  - Wang, Keyi
AU  - Huang, Xianmei
AU  - Lu, Hui
AU  - Zhang, Zhiqun
Y1  - 2014//
Y2  - 20140827//
KW  - Biomarkers/bl [Blood]
KW  - *Bronchopulmonary Dysplasia/bl [Blood]
KW  - Female
KW  - Humans
KW  - Infant, Newborn
KW  - Infant, Premature/bl [Blood]
KW  - Male
KW  - *Mucin-1/bl [Blood]
KW  - *Uteroglobin/bl [Blood]
T2  - Disease markers
VL  - 2014
SN  - 0278-0240
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med11&NEWS=N&AN=25242856
AD  - United States
AB  - OBJECTIVES: To evaluate the predictive characteristics of KL-6 and CC16 for bronchopulmonary dysplasia (BPD) in preterm infants, either independently or in combination., STUDY DESIGN: This prospective cohort study was performed from 2011 to 2013 with preterm neonates of gestational age <=32 weeks and birth weight <=1500 g. Serum KL-6 and CC16 levels were determined 7 and 14 days after birth., RESULTS: Seventy-three preterm infants were studied. BPD was identified in 24 of these infants. After adjusting for potential confounders, serum KL-6 concentrations were found to be elevated in BPD infants at both time points relative to non-BPD infants, while serum CC16 concentrations were lower at 14 days. At both 7 d and 14 d of life the predictive power of KL-6 levels exceeded that of CC16 (area under receiver operating characteristic curve: at 7 d, 0.91 cf. 0.73, P = 0.02; at 14 d, 0.95 cf. 0.85, P = 0.05). The combination of these markers enhanced the sensitivity further., CONCLUSIONS: Serum KL-6 levels higher than 79.26 ng/mL at 14 days postpartum in preterm infants predict the occurrence of BPD. CC16 was less predictive than KL-6 at this time point, but KL-6 and CC16 together enhanced the prediction.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70841206
TI  - Retinoids attenuate hyperoxia-induced impaired alveolarization and abnormal lung function in the newborn mouse lung
AU  - James M.L.
AU  - Ross A.C.
AU  - Nicola T.
AU  - Bulger A.
AU  - Zhang W.
AU  - Halloran B.
AU  - Olave N.
AU  - Ambalavanan N.
Y1  - 2010//
KW  - *hyperoxia
KW  - *lung function
KW  - *mouse
KW  - *lung
KW  - *society
KW  - lung development
KW  - exposure
KW  - prematurity
KW  - model
KW  - death
KW  - supplementation
KW  - randomized controlled trial (topic)
KW  - newborn
KW  - lung dysplasia
KW  - human
KW  - lung homogenate
KW  - lung injury
KW  - tissues
KW  - density
KW  - plasma
KW  - ambient air
KW  - enzyme linked immunosorbent assay
KW  - high performance liquid chromatography
KW  - *retinoid
KW  - retinol
KW  - cytokine
KW  - interleukin 1
KW  - interferon
KW  - protein
KW  - messenger RNA
KW  - gelatinase B
KW  - retinoic acid
KW  - tumor necrosis factor
KW  - macrophage inflammatory protein 2
KW  - retinol ester
KW  - gamma interferon
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.L. James, Pennsylvania State University, University Park, PA, United States
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A3754?sid=103924e3-062d-4283-9979-aa0144e4afc8
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70841206
AB  - Rationale: Bronchopulmonary dysplasia (BPD) in preterm infants is characterized by inhibition of lung alveolar development associated with an increase in pro-inflammatory cytokines and low plasma and tissue concentrations of vitamin A (VA). Randomized controlled trials indicate VA supplementation decreases BPD and/or death. Vitamin A is metabolized into retinoic acid (RA), and we have previously demonstrated that a 10:1 molar combination of VA and RA (VARA) synergistically increases lung retinol content in newborn mice. Objective(s): To determine whether the biochemical synergistic effect of VARA translates into functional benefits in attenuating abnormal lung development and lung function in newborn mice exposed to hyperoxia. Method(s): Newborn C57BL/6 mice were exposed to hyperoxia (85% O2) or room air for 7 or 14 days and given vehicle or VARA every other day. Lung retinol content was measured by HPLC, lung function was assessed by flexiVent, and lung development was evaluated by radial alveolar counts and secondary septal crest density. Additionally, cytokines known to be involved in hyperoxic lung injury were evaluated by a qPCR array and by ELISA in lung homogenates. Result(s): VARA attenuated the hyperoxia-induced inhibition of alveolarization and improved lung function, with higher compliance and lower resistance (Figure), associated with increased lung retinyl ester stores. qPCR array analysis indicated hyperoxia increased mRNA expression of macrophage inflammatory protein -2 (MIP-2alpha; Cxcl2), interferon-gamma (IFN-gamma), interleukin-1beta (IL-1beta), matrix metalloproteinase-9, and tumor necrosis factor-alpha (TNF-alpha). VARA completely abrogated these changes in mRNA expression. VARA attenuated the hyperoxia-induced increases in MIP-2alpha and IFN-gamma protein, but did not change IL-1beta, MMP-9, and TNF-alpha protein amounts. Conclusion(s): The VARA combination improves lung development and function, and reduces pro-inflammatory cytokines in the newborn mouse model of hyperoxia exposure. Further studies are in progress to determine if reductions in MIP-2alpha and IFN-gamma mediate the beneficial effects of retinoids during hyperoxia exposure. (Figure presented) .
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70840733
TI  - Inflammation in fetal sheep from intra amniotic injection of ureaplasma
AU  - Collins J.J.P.
AU  - Kallapur S.G.
AU  - Knox C.L.
AU  - Nitsos I.
AU  - Polglase G.P.
AU  - Pillow J.J.
AU  - Kuypers E.
AU  - Newnham J.P.
AU  - Jobe A.H.
AU  - Kramer B.W.
Y1  - 2010//
KW  - *sheep
KW  - *injection
KW  - *Ureaplasma
KW  - *society
KW  - *inflammation
KW  - exposure
KW  - lung
KW  - amnion fluid
KW  - fetus
KW  - fetus lung
KW  - lung parenchyma
KW  - prematurity
KW  - bacterium
KW  - inflammatory cell
KW  - umbilical cord blood
KW  - lung dysplasia
KW  - chorioamnionitis
KW  - aspiration
KW  - immunohistochemistry
KW  - pneumonia
KW  - cell count
KW  - cesarean section
KW  - premature labor
KW  - pregnancy
KW  - subspecies
KW  - mediastinum lymph node
KW  - lung structure
KW  - lung lavage
KW  - serotype
KW  - T lymphocyte
KW  - placenta
KW  - lung development
KW  - neutrophil
KW  - macrophage
KW  - fetus lung maturation
KW  - monocyte
KW  - hypothesis
KW  - elastin
KW  - CD3 antigen
KW  - interleukin 6
KW  - interleukin 1
KW  - protein
KW  - lymphocyte surface marker
KW  - messenger RNA
KW  - marker
KW  - myeloperoxidase
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - J.J.P. Collins, Maastricht University Medical Centre, Maastricht, Netherlands. E-mail: j.collins@kg.unimaas.nl
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A3280?sid=023ac2dc-cd5b-4043-a6f8-1083d3171495
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70840733
AB  - Rationale: Chorioamnionitis can lead to preterm birth and may be associated with the development of bronchopulmonary dysplasia (BPD). Ureaplasma are the most frequently isolated bacteria from the amniotic fluid (AF), placentas and cord blood of preterm infants. It is known that the developing fetus aspirates amniotic fluid, but it is not clear what effect exposure to AF contaminated with Ureaplasma has on the structural development of the lung, besides low grade lung inflammation and lung maturation after long term Ureaplasma exposure. Therefore, we hypothesized that Ureaplasma elicited an inflammatory response in the fetal lung shortly after Ureaplasma exposure, which may affect lung development. Method(s): Ovine singleton fetuses received an intra-amniotic injection of Ureaplasma parvum serovar 3, the most commonly isolated subspecies of Ureaplasma bacteria in preterm infants, or control media at 110, 117, or 121 days of gestation (GA), and were delivered by caesarian section at 124 days GA (term=150 days GA). Inflammation was assessed by cell counts in bronchoalveolar lavage (BAL) and cord blood, total protein and IL-1beta and IL-6 mRNA levels, immunohistochemistry and FACS for inflammatory cells, and elastin deposition for future alveolar growth in lung tissue. Result(s): There was a 3-fold increase in inflammatory cells in the lungs of fetuses that had been exposed to Ureaplasma. Neutrophils and monocytes were increased in the BAL after 3 and 7 days of exposure (p=0.02 and p=0.02 respectively). In lung tissue significant increases in myeloperoxidase positive cells after 3 days (p=0.03) and MHCII positive cells after 14 days of exposure (p=0.001) were observed. Interestingly, there was no increase in PU.1 (macrophage specific marker) or CD3 (T-lymphocyte marker) positive cells. In the posterior mediastinal lymph nodes, which drain the lung, CD3 positive cells increased in all Ureaplasma exposed animals (UP 3d p=0.02; UP 7d p=0.01; UP 14d p=0.03). With regard to lung structure, concentrated elastin depositions decreased on alveolar septae after 14 days of Ureaplasma exposure (p=0.001) in combination with a more diffuse, dysmorphic elastin expression throughout the alveoli. Conclusion(s): These results support the hypothesis that UP induced an acute inflammatory response in the fetal lung, being one of the sites of first contact with the contaminated amniotic fluid. Our findings show that a short term exposure to UP was sufficient to induce structural changes in elastin deposition, which may affect further alveolarization of the lung.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70839745
TI  - Isolation of mesenchymal stem cells from tracheal aspirates of premature infants with respiratory distress is associated with an increased risk of bronchopulmonary dysplasia
AU  - Popova A.P.
AU  - Bozyk P.D.
AU  - Linn M.J.
AU  - Goldsmith A.M.
AU  - Schumacher R.
AU  - Bentley J.K.
AU  - Filbrun A.
AU  - Hershenson M.B.
Y1  - 2010//
KW  - *mesenchymal stem cell
KW  - *tracheal aspiration procedure
KW  - *prematurity
KW  - *respiratory distress
KW  - *risk
KW  - *lung dysplasia
KW  - *society
KW  - infant
KW  - birth weight
KW  - gestational age
KW  - artificial ventilation
KW  - myofibroblast
KW  - risk factor
KW  - human
KW  - pathogenesis
KW  - monocyte
KW  - chronic lung disease
KW  - patient
KW  - oxygen therapy
KW  - lung
KW  - gender
KW  - adherent cell
KW  - culture medium
KW  - aspiration
KW  - ex vivo study
KW  - scatter factor
KW  - vasculotropin
KW  - smooth muscle actin
KW  - transforming growth factor
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - M.B. Hershenson, University of Michigan, Ann Arbor, MI, United States. E-mail: mhershen@umich.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A2280?sid=31a33c6d-bd31-464a-885c-f34f4d5e926f
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70839745
AB  - Rationale: We have isolated mesenchymal stem cells (MSCs) from tracheal aspirates of premature infants with respiratory distress. Under the influence of transforming growth factor-beta, MSCs differentiate into alpha-smooth muscle actin-expressing myofibroblasts. Myofibroblasts are increased in the lungs of patients with bronchopulmonary dysplasia (BPD), a chronic lung disease of prematurely-born infants. Objective(s): We tested whether isolation of MSCs from tracheal aspirates of premature infants with respiratory distress during the first week of life would correlate with development of BPD. Method(s): Eighty-four infants born at gestational age less than 32 weeks requiring mechanical ventilation were studied. Aspirates were collected during routine suctioning and centrifuged. The cell pellet was resuspended in cell culture medium and plated. Adherent cells were grown to confluence. Cells of passage three were used for further analysis. Measurements and Main Results: Tracheal aspirates were obtained from 84 infants. MSCs were isolated from the tracheal aspirates of 56 infants; 28 infants showed no MSCs. There was no statistical difference in gestational age or birth weight between the 'MSC' and 'no MSC' groups. In the MSC group, 11 died and 25 developed BPD, as defined by a requirement for supplemental O2 at 36 wks post-conceptual age. In the 'no MSC' group, 6 infants died and 1 developed BPD. Accounting for the potential influences of gender, birth weight and gestational age, isolation of MSCs increased the adjusted relative risk of BPD over 31-fold (P=0.004). Birth weight was also a predictor of BPD (adjusted relative risk, 0.995, P=0.031). The MSC group showed significantly greater days of mechanical ventilation (MSC, 32+/-12; no MSC, 8+/-2; mean+/-SD, P<0.001) and supplemental O2 administration (MSC, 106+/-19; no MSC, 31+/-8; P<0.001). Finally, cultured MSCs produced significant levels (>5 ng/ml conditioned medium/day) of vascular endothelial growth factor, hepatocyte growth factor and monocyte chemotactic protein/CCL2 ex vivo. Conclusion(s): Isolation of tracheal aspirate MSCs predicts the development of BPD, suggesting that MSCs play an important role in the pathogenesis of this disease.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70839325
TI  - Genome-wide expression analysis of human bronchopulmonary dysplasia
AU  - Bhattacharya S.
AU  - Gascon J.L.
AU  - Huyck H.L.
AU  - Srisuma S.
AU  - Metlay L.A.
AU  - Solleti S.
AU  - Mariani T.J.
AU  - Pryhuber G.S.
Y1  - 2010//
KW  - *human
KW  - *lung dysplasia
KW  - *society
KW  - *genome
KW  - female
KW  - prematurity
KW  - lung
KW  - gene
KW  - health care cost
KW  - sepsis
KW  - risk
KW  - gestational age
KW  - tissue structure
KW  - baby
KW  - tissues
KW  - autopsy
KW  - risk factor
KW  - gene expression
KW  - death
KW  - cluster analysis
KW  - patient
KW  - pregnancy
KW  - laboratory
KW  - RNA
T2  - American Journal of Respiratory and Critical Care Medicine
LA  - English
VL  - 181
IS  - 1 MeetingAbstracts
SP  -
PB  - American Thoracic Society
SN  - 1073-449X
AD  - S. Bhattacharya, University of Rochester Medical Center, Rochester, NY, United States. E-mail: soumyaroop_bhattacharya@urmc.rochester.edu
UR  - http://ajrccm.atsjournals.org/cgi/reprint/181/1_MeetingAbstracts/A1859?sid=8557ffc7-623e-4bd5-9e00-26296af05589
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70839325
AB  - Bronchopulmonary Dysplasia (BPD) is a major complication in premature infants, particularly those born at less than 32 weeks of gestation or weighing less than 1500 g. More than 55,000 babies with increased risk of developing BPD are born each year, and an estimated annual health care cost of $26 billion. Due to the complexity of risk factors and limited availability of clinical samples, an understanding of this disease, its potential biomarkers and causal mechanisms are limited. Over the past decade, under an IRB-approved protocol, this laboratory has established a unique biorepository of autopsy tissue samples from human premature babies diagnosed with BPD and non-BPD controls. These lung samples are harvested within 6 hours, following a standardized protocol to retain tissue structure and molecular integrity. Data from this sample collection have been previously published. In order to discover novel BPD biomarkers, 28 of these samples were selected for genome-wide expression profiling, including 11 BPD and 9 control cases, matched for gestational age at birth and at death, as well as 4 cases with culture-positive, acute overwhelming sepsis. Each total lung RNA was demonstrated to meet quality standards and was then subjected to the Affymetrix U133 Plus 2.0 array. Normalized and background corrected data was extracted and non-informative probe sets were excluded. Cluster analysis of samples identified subgroups of patients, consistent with known clinical complications of prematurity. Preliminary analysis using Significance Analysis of Microarrays (SAM) identified novel genes with differential expression between BPD cases and non-BPD controls. Global validation of array-based expression data, demonstrated a significant correlation (p<0.05) with qPCR-based expression data for 16 of 20 genes analyzed. Also, consistent with previous reports, we were able to demonstrate a significant increase in IGF1 expression in BPD samples by qPCR. Additional ongoing analyses are aimed at identifying and validating novel disease biomarkers. These data will significantly expand our knowledge of gene expression patterns in BPD lungs, and may be useful for the development of new therapeutic strategies.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70668202
TI  - Inflammation through NFkappaB inhibits Sp1-mediated FGF-10 expression in developing lung
AU  - Carver B.
AU  - Plosa E.
AU  - Van Der Meer R.
AU  - Liu J.
AU  - Han W.
AU  - Blackwell T.
AU  - Prince L.S.
Y1  - 2010//
KW  - *lung
KW  - *society
KW  - *cytology
KW  - *inflammation
KW  - promoter region
KW  - CHO cell
KW  - fetus lung
KW  - plasmid
KW  - binding site
KW  - airway
KW  - patient
KW  - human
KW  - mutant
KW  - mesenchyme cell
KW  - DNA binding
KW  - consensus
KW  - mesenchyme
KW  - lung dysplasia
KW  - lung development
KW  - prematurity
KW  - morphogenesis
KW  - mouse
KW  - *fibroblast growth factor 10
KW  - carisoprodol
KW  - luciferase
KW  - DNA
KW  - interleukin 1
KW  - transcription factor Sp3
KW  - lipopolysaccharide
KW  - growth factor
T2  - Molecular Biology of the Cell
LA  - English
VL  - 21
IS  - 24
SP  -
PB  - American Society for Cell Biology
SN  - 1059-1524
AD  - B. Carver, Vanderbilt University, Nashville, TN, United States
UR  - http://www.molbiolcell.org/content/suppl/2010/12/11/21.24.4299.DC1/2010_Regular_Abstracts.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70668202
DO  - https://dx.doi.org/10.1091/mbc.E10-10-0839
AB  - Bronchopulmonary dysplasia (BPD) results from arrested fetal lung development in preterm infants. Inflammation and NF-kB activation in the fetal lung inhibits airway morphogenesis and contributes to BPD. The mesenchymal growth factor FGF-10 is crucial for normal airway branching and is decreased in lungs of patients with BPD. We therefore hypothesized that NF-kB activation disrupts normal FGF-10 expression. We measured FGF-10 promoter activity using an FGF-10-luciferase reporter plasmid expressed in CHO cells. Plasmids expressing Sp1, Sp3, the NF-kappaB subunit RelA, and a constitutively active IKKbeta mutant (cIKKbeta) were co-transfected to measure effects on FGF-10 promoter activity. ChIP was performed on primary fetal mouse lung mesenchymal cells. Sp1, and RelA were co-immunoprecipitated from CHO cells. Transfecting CHO cells with cIKKbeta inhibited FGF-10 promoter activity. The effects of NF-kappaB on the FGF-10 promoter did not appear to involve direct RelA:DNA binding, as deletion of a predicted NF-kappaB binding site in the FGF-10 promoter did not affect the ability of NF-kappaB to suppress FGF-10 expression. These data suggest that NF-kappaB may indirectly interfere with FGF-10 transcription. The FGF-10 promoter contains multiple consensus Sp1-binding sites, and overexpression of Sp1 strongly stimulated FGF-10 promoter activity. NF-kappaB activation by IL-1beta treatment or cIKKbeta co-expression inhibited Sp1-mediated FGF-10 expression. Co-expression with the related transcription factor Sp3 also inhibited Sp1-mediated FGF-10 expression. Expression of Sp3 alone did not affect FGF-10 promoter activity. ChIP experiments showed that Sp1 constitutively occupies the FGF-10 promoter, while lipopolysaccharide treatment recruited RelA and Sp3 to the FGF-10 promoter. RelA co-immunoprecipitates with Sp1, suggesting a potential Sp1-RelA interaction. These data suggest that inflammatory signaling through NF-kappaB inhibits FGF-10 expression by disrupting normal Sp1-mediated FGF-10 promoter activity. NF-kappaB activation may therefore use a novel mechanism to disrupt a normal developmental expression program in the fetal lung mesenchyme.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70666201
TI  - Effect of hyperoxia on lung epithelial cell growth and epithelial-mesenchymal transition
AU  - Nguyen M.
AU  - Shapiro J.B.
AU  - King J.M.
Y1  - 2010//
KW  - *hyperoxia
KW  - *epithelial mesenchymal transition
KW  - *epithelium cell
KW  - *cell growth
KW  - *lung
KW  - *cytology
KW  - *society
KW  - lung injury
KW  - tight junction
KW  - wound healing
KW  - exposure
KW  - mouse
KW  - lung dysplasia
KW  - pathogenesis
KW  - extracellular matrix
KW  - turnover time
KW  - apoptosis
KW  - cell junction
KW  - model
KW  - cell motility
KW  - upregulation
KW  - prematurity
KW  - artificial ventilation
KW  - gelatinase B
KW  - ilomastat
KW  - proteinase
KW  - caspase 3
KW  - oxygen
T2  - Molecular Biology of the Cell
LA  - English
VL  - 21
IS  - 24
SP  -
PB  - American Society for Cell Biology
SN  - 1059-1524
AD  - M. Nguyen, Biology, Trinity University, San Antonio, TX, United States
UR  - http://www.molbiolcell.org/content/suppl/2010/12/11/21.24.4299.DC1/2010_Regular_Abstracts.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70666201
DO  - https://dx.doi.org/10.1091/mbc.E10-10-0839
AB  - Preterm infants subjected to high levels of oxygen through mechanical ventilation often develop bronchopulmonary dysplasia (BPD). Although the mechanisms underlying the pathogenesis of BPD remain unclear, it is known that disturbances in extracellular matrix (ECM) turnover play a key role. Matrix metalloproteinase-9 (MMP-9), a proteinase that plays an important role in ECM destruction and remodeling, is increased in lung injury following hyperoxia exposure in neonatal mice. The aim of this study was to investigate the effects of hyperoxia on proliferation, apoptosis, motility, and cell-cell junctions in a mouse lung epithelial (MLE-12) model. We determined that in MLE-12 cells continuously exposed to hyperoxia, there was a decrease in proliferation and motility, and weakened tight junctions. In an effort to understand functional contributions to epithelial wound repair altered by hyperoxia, we showed that acute exposure to hyperoxia increases activity of MMP-9. Furthermore, inhibition of MMP-9 with GM6001 in hyperoxia-treated cells improved cell motility and strengthened tight junctions. We propose that the upregulation of MMP-9 by lung epithelial cells contributes to hyperoxic lung injury by restricting proper wound repair. However, inhibition of MMP-9 in hyperoxia-treated cells also significantly increased caspase-3 activity. This finding suggests that blocking MMP-9 activity using GM6001 may not be a valuable therapeutic approach in preventing BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70543600
TI  - Elevated Wnt-related tracheal aspirate proteins LEF-1 and -betacatenin predicts the development of bronchopulmonary dysplasia in very-low-birth-weight infants
AU  - Rehan V.K.
AU  - Sakurai R.
AU  - Dhar V.
AU  - Torday J.
Y1  - 2010//
KW  - *lung dysplasia
KW  - *tracheal aspiration procedure
KW  - *very low birth weight
KW  - human
KW  - infant
KW  - Western blotting
KW  - enzyme linked immunosorbent assay
KW  - fibroblast
KW  - myofibroblast
KW  - cell transdifferentiation
KW  - down regulation
KW  - upregulation
KW  - pathogenesis
KW  - birth weight
KW  - extubation
KW  - model
KW  - *catenin
KW  - *lymphoid enhancer factor 1
KW  - *protein
KW  - parathyroid hormone related protein
KW  - marker
T2  - FASEB Journal
LA  - English
VL  - 24
IS  - Meeting Abstracts
SP  -
PB  - FASEB
SN  - 0892-6638
AD  - V.K. Rehan, Pediatrics, L.A. Biomed, Torrance, CA, United States
UR  - http://www.fasebj.org/cgi/content/meeting_abstract/24/1_MeetingAbstracts/798.3?sid=1eb85923-c787-4b49-979e-601fc887ee2c
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70543600
AB  - Taking a basic biologic approach, and using a wide range of models, we have demonstrated alveolar interstitial fibroblast-to-myofibroblast transdifferentiation, characterized by the down-regulation of Parathyroid Hormone-related Protein (PTHrP) signaling, and up-regulation of Wnt signaling as a key event in the pathogenesis of Bronchopulmonary Dysplasia (BPD). Though decreased tracheal aspirate (TA) PTHrP levels in ventilated Very-Low-Birth-Weight Infants (VLBWIs) during the first wk of life predict the later development of BPD, there is no information on the levels of Wnt-related proteins in the TA of these infants. Twenty ventilated VLBWIs (birth weight 943 +/- 302 g (mean +/- SD); GA 27 +/- 2weeks; 10M:10F) were studied. The TAs were collected once daily during the first 3 days of life, or until extubation, whichever was earlier, and immediately frozen for subsequent analysis by ELISA and Western blot for LEF-1 and beta-catenin, two key markers of Wnt activation. LEF-1 and beta-catenin levels, as determined by both ELISA and Western blotting, were significantly higher in infants who continued to be ventilated at 1 wk of age, and who later went on to develop BPD, compared to infants who were extubated by 1 wk of age and did not develop BPD. We conclude that in combination with the lower TA PTHrP content, higher Wnt-related proteins can be developed into sensitive and specific biomarkers to predict, diagnose, and monitor BPD in ventilated VLBWIs.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70539947
TI  - Neonatal CD44 null mice are protected from hypoxia-induced pulmonary hypertension and decreased alveolarization, and have defects in TGFbeta and ERK signaling
AU  - Savani R.C.
AU  - Wang L.
AU  - Williams O.W.
Y1  - 2010//
KW  - *hypoxia
KW  - *mouse
KW  - *pulmonary hypertension
KW  - lung
KW  - phosphorylation
KW  - pH
KW  - air quality control
KW  - heart right ventricle hypertrophy
KW  - lung dysplasia
KW  - gene
KW  - ambient air
KW  - hyaluronic acid
KW  - receptor
KW  - alpha smooth muscle actin
T2  - FASEB Journal
LA  - English
VL  - 24
IS  - Meeting Abstracts
SP  -
PB  - FASEB
SN  - 0892-6638
AD  - R.C. Savani, Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, United States
UR  - http://www.fasebj.org/cgi/content/meeting_abstract/24/1_MeetingAbstracts/31.10?sid=c7778126-1d0c-4b01-a3ad-de3349730902
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70539947
AB  - Impaired neonatal vascular and alveolar development, and elevated TGFbeta contribute to pulmonary hypertension (PH) and bronchopulmonary dysplasia (BPD). Since the hyaluronan receptor CD44 regulates TGFbeta signaling, we examined the effects of hypoxia (12% vs. 21% O2) from birth to postnatal day (PN) 14 in neonatal CD44+/+ (WT) and CD44-/- mice. At PN14, hypoxia-exposed WT mice had right ventricular hypertrophy and decreased alveolarization. CD44-/- mice exposed to hypoxia were completely protected from these changes. Hypoxia-exposed WT lungs had increased active TGFbeta and phospho-Smad2 as compared to room air (RA) controls. Surprisingly, lungs from RA CD44-/- mice had elevated active TGFbeta and phospho-Smad2 at baseline and these were not altered by hypoxia. Compared to lungs from hypoxia WT mice, lungs from hypoxia CD44-/- mice had impaired ERK1/2 phosphorylation. After hypoxia, the TGFbeta target gene alpha-smooth muscle actin, was increased in WT, but not CD44-/- mice. We conclude that hypoxia-induced PH and decreased alveolarization require CD44 and ERK phosphorylation, and that Smad2 phosphorylation is necessary but not sufficient for TGFbeta signaling in this context. We speculate that CD44 may be a novel therapeutic target for PH and BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70179169
TI  - Peculiarities of bronchial asthma treatment in pediatric patients with remote sequelae of bronchopulmonary dysplasia
AU  - Besh L.
AU  - Matsyura O.
AU  - Akdis C.
AU  - Bohle B.
AU  - Bonadonna P.
AU  - Bonini S.
AU  - Calderon M.
AU  - Cecchi L.
AU  - Corrigan C.
AU  - Custovic A.
AU  - del Giacco S.
AU  - Durham S.
AU  - Eigenmann P.
AU  - Eng P.
AU  - Frew A.
AU  - Gevaert P.
AU  - Grattan C.
AU  - Hellings P.
AU  - Hoffmann-Sommergruber K.
AU  - Kalayci O.
AU  - Knol E.
AU  - Mari A.
AU  - Moreira A.
AU  - Moscato G.
AU  - Ollert M.
AU  - Pagani M.
AU  - Passalacqua G.
AU  - Powell R.
AU  - Raulf-Heimsoth M.
AU  - Roberts G.
AU  - Rueff F.
AU  - Scadding G.
AU  - Scharf C.
AU  - Schmid-Grendelmeier P.
AU  - Schwarze J.
AU  - Smith H.
AU  - Virchow J.C.
AU  - Wardlaw A.
AU  - Werfel T.
Y1  - 2010//
KW  - *asthma
KW  - *patient
KW  - *lung dysplasia
KW  - *clinical immunology
KW  - *allergy
KW  - newborn period
KW  - child
KW  - therapy
KW  - pediatrics
KW  - artificial ventilation
KW  - thorax radiography
KW  - radiodiagnosis
KW  - control group
KW  - drug megadose
KW  - inhalation
KW  - antibiotic therapy
KW  - lung
KW  - respiratory system
KW  - medical technology
KW  - intensive care
KW  - survival
KW  - body weight
KW  - dysplasia
KW  - prematurity
KW  - anamnesis
KW  - physical examination
KW  - serum
KW  - follow up
KW  - glucocorticoid
KW  - chlordiazepoxide
KW  - immunoglobulin A
KW  - immunoglobulin M
KW  - immunoglobulin G
KW  - immunoglobulin E
KW  - bronchodilating agent
T2  - Allergy: European Journal of Allergy and Clinical Immunology
LA  - English
VL  - 65
IS  - SUPPL. 92
PB  - Blackwell Publishing Ltd
SN  - 0105-4538
AD  - L. Besh, Allergy Department, Lviv City Children's Clinical Hospital, Lviv, Ukraine
DO  - https://dx.doi.org/10.1111/j.1398-9995.2010.02393.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70179169
AB  - Due to implementation of update medical technologies and improved methods of intensive therapy into pediatric practice, rate of survival of the premature newborns with low body weight has been considerably increasing. There has been noticed higher incidence of complications resulting from a long-term assisted mechanical ventilation (MV) in the neonatal period. One of the most severe complications is broncho-pulmonary dysplasia (BPD). Thus, delivery of adequate bronchial asthma (BA) treatment and organization of appropriate follow-up for pediatric patients with remote sequelae of BPD are urgent problems of contemporary medicine. The purpose of the work was to analyze the efficacy of BA treatment in children with remote sequelae of BPD. Study group: 64 children with bronchial asthma, aged 6 months to 9 years, who were provided MV in the neonatal period. Investigation was conducted in two groups of patients, consisting of 32 individuals each. Group I (study) included children with BPD development vs group II (control) that included ones without BPD. Selection was case-contol. Duration of BA treatment lasted 6 months, medical supervision - for 3 years. Method(s): Assessment of the patients included the following data: history-taking; family anamneses; full physical examination; routine clinical methods; immunological investigation (serum IgA, IgM, IgG, IgE); modified test with bronchial spasmolytic; chest X-ray examination. Efficacy of therapy was estimated before the treatment and on the 6th, 12th and 24th weeks of therapy. Result(s): During the treatment period incidence of BA exacerbations was higher in study group vs in control group. Patients of group I required administration of repeated courses of high doses of systemic and inhalation glucocorticoid drugs, antibiotic therapy and administration of cholinolithics. Control of the disease was achieved in 46.9% (15) group I and 65.6% (21) group II. Conclusion(s): (1) Bronchopulmonary dysplasia is not only neonatal but a general pediatric problem. (2) Causative-consequential relationship has been proved to exist between mechanical ventilation of lungs in the neonatal period and succeeding development of hyperreactivity of the respiratory tracts often clinically manifested by bronchial asthma. (3) Therapeutic protocol of bronchial asthma treatment in patients with and remote sequelae of bronchopulmonary dysplasia can be recommended for wide application in the clinical pediatric practice.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70159906
TI  - Association between HLA and susceptibility to bronchopulmonary dysplasia
AU  - Rocha G.
AU  - Proenca E.
AU  - Areias A.
AU  - Freitas F.
AU  - Lima B.A.
AU  - Alves H.
AU  - Guimaraes H.
Y1  - 2010//
KW  - *immunogenetics
KW  - *transplantation
KW  - *histocompatibility
KW  - *society
KW  - *lung dysplasia
KW  - gestational age
KW  - birth weight
KW  - allele
KW  - newborn
KW  - gene frequency
KW  - child
KW  - haplotype
KW  - gene
KW  - inflammation
KW  - HLA typing
KW  - lung injury
KW  - vascularization
KW  - lung
KW  - clinical study
KW  - Student t test
KW  - logistic regression analysis
KW  - risk factor
KW  - confidence interval
KW  - chronic lung disease
KW  - oxygen
T2  - Tissue Antigens
LA  - English
VL  - 75
IS  - 5
PB  - Blackwell Publishing Ltd
SN  - 0001-2815
AD  - G. Rocha, Hospital de Sao Joao, Porto, Poland
DO  - https://dx.doi.org/10.1111/j.1399-0039.2010.01488.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70159906
AB  - Little is known about the immunologic involvement of HLA in the development of chronic lung disease of the preterm newborn, also known as bronchopulmonary dysplasia (BPD). BPD is the final result of a pulmonary inflammatory process and lung repair with impaired alveolarization and vascularization in response to a multi-factorial lung injury. To assess whether HLA alleles play a role in BPD susceptibility, we studied 156 preterm neonates (82 M/ 74 F) 'U 30 weeks gestational age and/ or 'U 1250 g birth weight, alive at 36 weeks gestational age. Detailed perinatal and clinical data were collected. HLA typing was performed by PCR-SSO. HLA allele frequencies where determined by direct counting for BPD (oxygen dependency at 36 weeks) and non- BPD groups. Comparison between BPD and no BDP groups was performed using t-test, IO2 test or Fisher's exact test and logistic regression as appropriate. Relative risks (RR) and their 95% confidence intervals (95% CI) were also calculated as association measures. We diagnosed 27 (17%) children with BPD and 129 (83%) without BPD. Mean birth weight and gestational age were statistically different between BPD and no BPD groups (890.2g vs. 1077.6g; p < 0.01) and (26.8 wks vs. 28.6 wks; p < 0.01), respectively. We found increased frequencies in BPD group for the alleles: HLA-A*68 (RR = 2.3, 95%CI 1.2-4.6, P = 0.04), B*51 (RR = 1.9, 95%CI 1.1-3.3, P = 0.05), Cw*14 (RR = 2.8, 95%CI 1.4-5.6, P = 0.03), Cw*15 (RR = 2.8, 95%CI 1.5-5.1), DRB1*01(RR = 2.3, 95%CI 1.2-4.2). When we adjusted the allele frequencies for birth weight and gestational age, HLAA* 68, B*51 and Cw*14 remained statistically significant. Considering 2 loci haplotypes, B*51 -Cw*15 has a higher frequency in the BPD group (11.1% vs. 2.7% in non-BPD, RR = 2.88, 95%CI 1.5-5.5, P = 0.004). Our findings suggest an association between some HLA alleles or genes inside the MHC region and BPD susceptibility.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2014>
TI  - The role of nutrition in promoting growth in pre-term infants with bronchopulmonary dysplasia: a prospective non-randomised interventional cohort study.
DO  - https://dx.doi.org/10.1186/1471-2431-14-235
AU  - Gianni, Maria Lorella
AU  - Roggero, Paola
AU  - Colnaghi, Maria Rosa
AU  - Piemontese, Pasqua
AU  - Amato, Orsola
AU  - Orsi, Anna
AU  - Morlacchi, Laura
AU  - Mosca, Fabio
Y1  - 2014//
Y2  - 20140922//
KW  - *Bronchopulmonary Dysplasia/dh [Diet Therapy]
KW  - *Energy Intake
KW  - *Enteral Nutrition/mt [Methods]
KW  - Female
KW  - *Food, Fortified
KW  - Humans
KW  - *Infant Formula
KW  - Infant Nutritional Physiological Phenomena
KW  - Infant, Newborn
KW  - *Infant, Premature/gd [Growth & Development]
KW  - Linear Models
KW  - Male
KW  - *Milk, Human
KW  - Prospective Studies
KW  - Treatment Outcome
KW  - Weight Gain
T2  - BMC pediatrics
VL  - 14
SN  - 1471-2431
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med11&NEWS=N&AN=25241811
AD  - England
AB  - BACKGROUND: Pre-term infants who develop bronchopulmonary dysplasia (BPD) are at risk of postnatal growth failure. It has been reported that energy expenditure is higher in infants with BPD than in those without BPD. The aim of the study was to evaluate whether increasing the enteral energy intake of pre-term infants with BPD can improve post-natal growth., METHODS: This prospective, non-randomised interventional cohort study was designed to assess growth in 57 preterm infants with BPD (gestational age <32 weeks, birth weight <1500 g, and persistent oxygen dependency for up to 28 days of life) fed individually tailored fortified breast milk and/or preterm formula, and a historical control group of 73 pre-term infants with BPD fed breast milk fortified in accordance with the instructions of the manufacturer and/or pre-term formula. Between-group differences in the continuous variables were analysed using Student's t test or the Mann-Whitney test; the discrete variables were compared using the chi-squared test. Linear regression analysis was used to investigate the independent contribution of enteral energy intake to weight gain velocity., RESULTS: The duration of parenteral nutrition was similar in the historical and intervention groups (43.7 +/- 30.9 vs 39.6 +/- 17.4 days). After the withdrawal of parenteral nutrition, enteral energy intake was higher in the infants in the intervention group with mild or moderate BPD (131 +/- 6.3 vs 111 +/- 4.6 kcal/kg/day; p < 0.0001) and in those with severe BPD (126 +/- 5.3 vs 105 +/- 5.1 kcal/kg/day; p < 0.0001), whereas enteral protein intake was similar (3.2 +/- 0.27 vs 3.1 +/- 0.23 g/kg/day). Weight gain velocity was greater in the infants in the intervention group with mild or moderate BPD (14.7 +/- 1.38 vs 11.5 +/- 2 g/kg/day, p < 0.0001) and in those with severe BPD (11.9 +/- 2.9 vs 8.9 +/- 2.3 g/kg/day; p < 0.007). The percentage of infants with post-natal growth retardation at 36 weeks of gestational age was higher in the historical group (75.3 vs 47.4; p = 0.02)., CONCLUSIONS: On the basis of the above findings, it seems that improved nutritional management promotes post-natal ponderal growth in pre-term infants with BPD.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70127180
TI  - Postnatal growth as a predictor of retinopathy of prematurity: A multivariate model
AU  - Nieto R.
AU  - Benitez A.
AU  - Dinerstein A.
AU  - Perez G.
AU  - Solana C.
Y1  - 2010//
KW  - *postnatal growth
KW  - *society
KW  - *retrolental fibroplasia
KW  - *model
KW  - patient
KW  - infant
KW  - lung dysplasia
KW  - multivariate analysis
KW  - prevalence
KW  - screening
KW  - cohort analysis
KW  - gestational age
KW  - birth weight
KW  - statistical analysis
KW  - sepsis
KW  - artificial ventilation
KW  - growth disorder
KW  - protein
KW  - oxygen
T2  - Pediatric Research
LA  - English
VL  - 67
IS  - 4
PB  - Lippincott Williams and Wilkins
SN  - 0031-3998
AD  - R. Nieto, Maternidad Ramon Sarda, Argentina
DO  - https://dx.doi.org/10.1203/01.pdr.0000369791.32606.21
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70127180
AB  - Recent studies suggest that postnatal growth and related factors such as IGF levels can play an important role in the development of retinopathy of prematurity (ROP). Objective(s): To evaluate clinical and nutritional factors associated with the development of ROP. Method(s): Cohort study. Inclusion criteria: infants born between 08/2003 and 11/2005 with gestational age (GA) <32 weeks and birth weight (BW) <1500 g at birth. Daily growth in grams was recorded from day of BW recovery up to day 28. Statistical analysis: A predictive logistical regression model was constructed. Result(s): 152 patients met the inclusion criteria, 8 were transferred and 3 died before day 28 .Data from the remaining 141 patients were analyzed. The fifty five patients who developed ROP (39%) had lower GA: 28.3w vs. 29.6w (p<0.001), lower BW: 1090 g vs.1190 g (p=0.007) and higher prevalence of late onset sepsis: 44% vs. 22% (p=0.012), more oxygen days: 55 vs. 28 (p< 0.001), more days in mechanical ventilation: 21 vs. 10 (p=0.02), and higher incidence of bronchopulmonary dysplasia: 51% vs. 31% (p=0.02), higher caloric and protein deficit: -695 cal/k and -22 g/k vs. -466 g/k and -15 g/k (p= 0.003 and 0.004 respectively), and had lower daily growth: 6 g/k/d vs. 22g/k/d (p=0.038). Multivariate analysis showed that for each week of GA the chance of ROP decreased 40% (95%CI 19-45). When postnatal growth was analyzed, patients whose growth was in the 3rd and 4th quartile had 68% (95%CI 2-89) and 86% (95%CI 15-94) less chance of ROP when compared with the infants of the lower quartile. Conclusion(s): GA and postnatal growth failure can be associated independently with ROP development. The impact of new nutritional interventions for decreasing postnatal growth restriction should be evaluated. This paper confirms the relevance of GA as a major guide for ROP screening in our clinical setting.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70126212
TI  - Airway and vessel development in preterm lambs chronically colonised with ureaplasma parvum
AU  - Dalton R.G.B.
AU  - Kallapur S.G.
AU  - Nitsos I.
AU  - Knox C.L.
AU  - Pillow J.J.
AU  - Jobe A.H.
AU  - Moss T.J.M.
AU  - Newnham J.P.
AU  - Polglase G.R.
Y1  - 2010//
KW  - *Australia and New Zealand
KW  - *society
KW  - *airway
KW  - *lamb
KW  - *Ureaplasma
KW  - exposure
KW  - lung
KW  - fetus
KW  - serotype
KW  - lung dysplasia
KW  - chorioamnionitis
KW  - lung resistance
KW  - thickness
KW  - funding
KW  - species
KW  - microorganism
KW  - female
KW  - premature labor
KW  - risk
KW  - persistent pulmonary hypertension
KW  - newborn
KW  - inflammation
KW  - pathogenesis
KW  - chronic inflammation
KW  - infection
KW  - pregnancy
KW  - ewe
KW  - injection
KW  - drug megadose
KW  - neutrophil
KW  - monocyte
KW  - gas
KW  - fetus lung maturation
KW  - pneumonia
KW  - maturation
KW  - long term exposure
KW  - elastin
KW  - collagen
KW  - protein
KW  - acivicin
KW  - messenger RNA
KW  - interleukin 1
KW  - interleukin 8
KW  - interleukin 6
KW  - surfactant
T2  - Journal of Paediatrics and Child Health
LA  - English
VL  - 46
IS  - SUPPL. 1
PB  - Blackwell Publishing
SN  - 1034-4810
AD  - R.G.B. Dalton, University of Western Australia, Subiaco, Australia
DO  - https://dx.doi.org/10.1111/j.1440-1754.2010.01707.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70126212
AB  - Background: Ureaplasma species, the most commonly isolated microorganisms in women with chorioamnionitis, are associated with preterm delivery. Chorioamnionitis increases the risk and severity of bronchopulmonary dysplasia and persistent pulmonary hypertension in newborns. It is not known whether the timing of exposure to inflammation in utero is an important contributor to the pathogenesis of bronchopulmonary dysplasia. We hypothesized that chronic inflammation would augment the airway and vascular disruption that occur after exposure to infection at 55 days of gestation. Method(s): Pregnant ewes were given intra-amniotic injection of U.parvum serovar 3 or 6 at low (2 x 104 cfu) or high doses (2 x 107 cfu), or media (controls). Fetuses were delivered at 125 days (term = 150 days). Result(s): U.parvum was grown from the lungs of all exposed fetuses, and neutrophils and monocytes were increased in the airspaces. Lung mRNA expression of IL-1beta and IL-8, but not IL-6 were modestly increased in U.parvum exposed fetuses. U.parvum exposure increased surfactant and improved lung gas volumes indicating lung maturation. The changes in lung inflammation and maturation were independent of serovar or dose. Exposure to U.parvum did not change multiple indices of airspace or vascular development. Parenchymal elastin and collagen content were similar between groups. Expression of several endothelial proteins, and pulmonary resistance arteriolar media thickness were also not different between groups. Conclusion(s): We conclude that chronic exposure to U.parvum does not cause sustained effects on airspace or vascular development in premature lambs. Funding(s): NH&MRC (458576), NIH HD57869 & HL97064 (SGK, AHJ), WIRF, NHFA/NH&MRC 458503 (GP).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70089653
TI  - Serotonin transporter (SERT) of lung endothelium promotes perinatal pulmonary vascular adaptation and its defective expression characterizes alveolar capillary dysplasia/misalignment of pulmonary veins (ACD/MPV)
AU  - Castrol E.C.
AU  - Scn P.
AU  - Parks W.T.
AU  - Potoka D.A.
AU  - Langston C.
AU  - Galambos C.
Y1  - 2010//
KW  - *pulmonary vein
KW  - *capillary
KW  - *pathology
KW  - *adaptation
KW  - *lung endothelium
KW  - *society
KW  - lung
KW  - allele
KW  - promoter region
KW  - patient
KW  - pulmonary hypertension
KW  - gene activity
KW  - endothelium cell
KW  - tissue
KW  - autopsy
KW  - etiology
KW  - DNA sequence
KW  - immunohistochemistry
KW  - gestational age
KW  - congenital diaphragm hernia
KW  - dysplasia
KW  - lung dysplasia
KW  - amplicon
KW  - homozygosity
KW  - adult
KW  - lung blood vessel
KW  - diagnosis
KW  - mutational analysis
KW  - gene
KW  - vasodilatation
KW  - bioavailability
KW  - *serotonin transporter
KW  - serotonin
KW  - marker
KW  - vasoconstrictor agent
KW  - antibody
KW  - DNA
T2  - Laboratory Investigation
LA  - English
VL  - 90
IS  - 2
PB  - Nature Publishing Group
SN  - 0023-6837
AD  - E.C. Castrol, Children's and Magee Women's Hospitals of Pittsburgh, UPMC, Pittsburgh, PA, United States
DO  - https://dx.doi.org/10.1038/labinvest.2009.151
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70089653
AB  - Background: SERT promotes pulmonary vasodilatation by controlling bioavailability of serotonin, a potent vasoconstrictor. The SERT promoter has a length polymorphic region (SERT-LPR) with a long (L) and a short (S) allele. The S allele is said to lower the transcription rate of SERT, thus reducing gene activity, while the L allele provides high SERT gene activity. We hypothesize that 1) SERT function is unique to intact pulmonary endothelial cells (EC); 2) SERT plays a role in pulmonary vascular remodeling, ensuring proper adaptation to extrauterine life 3) SERT expression is defective in ACD/MPV lungs resulting in maladaptative vascular changes leading to lethal pulmonary hypertension. 4) Defective SERT expression is due to SERT promoter length polymorphism. Design(s): We studied 1) SERT EC specificity/sensitivity in tissue arrays of 4 autopsy lungs (4 days and 1, 5, and 11 years of age); 2) tcmporo-spatial expression of SERT in normal antenatal (all trimesters, n=17) and postnatal lungs (1 &10 years); 3) SERT expression in ACD/MPV lungs (n=12) and in lungs of patients with pulmonary hypertension of varied etiology (n=14) by immunohistochemistry. 4) SERT-LPR of ACD/MPV patients was assessed by PCR and confirmed by DNA sequencing. Result(s): SERT expression was observed only in pulmonary EC; no other organs showed EC positivity. Expression of EC SERT began at about 30 weeks gestational age, gradually increased to become strongly diffuse near term and continued at high level postnatally. ACD/MPV lungs showed no or very minimal EC SERT reactivity; SERT antibody diffusely marked pulmonary ECs in congenital diaphragmatic hernia (n=5), congenital alveolar dysplasia (1), bronchopulmonary dysplasia (3). and primary pulmonary hypertension (5). Amplicon of SERT-LRP of all ACD/MVP lungs showed homozygosity for the L allele. Conclusion(s): SERT is a highly specific and sensitive EC marker of perinatal and adult lung. The late gestational expression peaking at birth implies that SERT plays a role in pulmonary vessel remodeling near term by lowering scrum serotonin level. Because of its defective expression, SERT may be a diagnostic marker for ACD/MPV and thus can be utilized in pediatric pathology practice. We tested SERT promoter length polymorphism as a possible explanation for the lack of SERT expression. All ACD/MPV patients had the L allele, excluding this possibility. Further studies of upstream regulators of SERT promoter region and mutational analysis of SERT gene may unravel key aspects of the pathomechanism that leads to ACD/MVP.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70494442
TI  - Human amnion epithelial cells reduce ventilation-induced preterm lung injury
AU  - Hodges R.
AU  - Jenkin G.
AU  - Hooper S.
AU  - Miller S.L.
AU  - Allison B.
AU  - Lim R.
AU  - Wallace E.M.
Y1  - 2010//
KW  - *lung injury
KW  - *air conditioning
KW  - *epithelium cell
KW  - *amnion
KW  - *human
KW  - *gynecological examination
KW  - *society
KW  - fetus
KW  - female
KW  - lung alveolus cell
KW  - ewe
KW  - pregnancy
KW  - morphology
KW  - tissue
KW  - lung
KW  - model
KW  - cell therapy
KW  - prematurity
KW  - lung dysplasia
KW  - chronic lung disease
KW  - baby
KW  - adult
KW  - sheep
KW  - surgery
KW  - catheter
KW  - endotracheal tube
KW  - immunohistochemistry
KW  - fetus lung
KW  - collagen
KW  - elastin
KW  - surfactant protein C
T2  - Reproductive Sciences
LA  - English
VL  - 17
IS  - 3 SUPPL. 1
PB  - SAGE Publications Inc.
SN  - 1933-7191
AD  - R. Hodges, Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia
DO  - https://dx.doi.org/10.1177/193371912010173s067
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70494442
AB  - Background Bronchopulmonary dysplasia (BPD), or neonatal chronic lung disease, affects about 30% of babies born very preterm. Currently, there are no effective treatments. We have recently shown that amnion epithelial cells (hAECs) can repair adult lung injury. In this study we explored whether hAECs were able to reduce lung injury in a fetal sheep model of BPD. Method(s): Ewes with a singleton pregnancy underwent surgery at 105 days gestation for insertion of fetal catheters and a modified endotracheal tube. On 110 days the fetus was either ventilated in utero for 12 hours alone (IUV alone; n=4) or with administration of 30 million hAECs iv and ETT at both 3 and 6 hours (120 million cells total) (IUV+hAECs; n=5) or was not ventilated (control; n=4). Both ewe and fetus were killed 7 days later. Result(s): Compared to controls, IUV caused lung injury resembling BPD - increased mean+/-SEM tissue:airspace ratio (1.56+/-0.47 vs 0.23+/-0.03, P<0.001), increased collagen (22.9+/-2.5% vs 10.9+/-1%, P=0.009) and elastin (15.9+/-2.4% vs 4.5+/-1.2%, P=0.02) and reduced secondary septal crest (developing alveoli) number (2.6% vs 18.5%, P<0.001). In those fetuses receiving IUV+hAECs, dual label immunohistochemistry (CFSE and surfactant protein C) localised CFSE/SP-C positive cells in the lungs with morphology consistent with both type I and type II alveolar cells. Lung injury was reduced compared to IUV alone: tissue:airspace ratio (0.73+/-0.24, P<0.001), collagen (9.9+/-0.7%, P<0.01), elastin (7.8+/-1.2%, P=0.02) and normalised secondary septal crest number (9.6%, P<0.001) Figure 1. Lung morphology in control, ventilation alone and ventilation+hAEC ovine fetuses. Summary and (Figure presented) conclusion: The administration of hAECs mitigated ventilationinduced fetal lung injury, partly through in vivo differentiation into alveolar cells. These observations suggest that hAECs may be a novel cell-based therapy for BPD able to improve the outcomes for very preterm infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70453177
TI  - ABCA3+/- mice have significantly decreased amounts of phosphatidylcholine and phosphatidylglycerol in lung tissue
AU  - Mittal R.
AU  - Jin L.
AU  - Hammel M.
AU  - Liebisch G.
AU  - Schmitz G.
AU  - Holzinger A.
Y1  - 2010//
KW  - *mouse
KW  - *lung parenchyma
KW  - adult
KW  - lung
KW  - respiratory distress
KW  - mutation
KW  - prematurity
KW  - mass spectrometry
KW  - newborn
KW  - female
KW  - lamellar body
KW  - lung alveolus cell
KW  - haplotype
KW  - gene
KW  - lung dysplasia
KW  - heterozygosity
KW  - lung disease
KW  - death
KW  - null allele
KW  - newborn period
KW  - leukocyte count
KW  - lung lavage
KW  - allele
KW  - weight
KW  - human
KW  - male
KW  - lung injury
KW  - stimulus
KW  - membrane
KW  - *phosphatidylglycerol
KW  - *phosphatidylcholine
KW  - phospholipid
KW  - surfactant
KW  - protein
KW  - adenosine triphosphate
KW  - chloroform
KW  - phosphatidylinositol
KW  - lipid
T2  - Klinische Padiatrie
LA  - English
VL  - 222
IS  - SUPPL. 1
SP  -
PB  - Georg Thieme Verlag
SN  - 0300-8630
AD  - R. Mittal, Klinikum der Universitat Munchen, Munchen, Germany
DO  - https://dx.doi.org/10.1055/s-0030-1261416
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70453177
AB  - Introduction: ABCA3 (ATP-binding cassette A3 transporter) is found predominantly in the membrane of lamellar bodies in lung type II alveolar cells, where it mediates ATP-dependent import of surfactant phospholipids. Haplotype analysis of the ABCA3 gene has identified a polymorphism which is significantly associated with respiratory distress and bronchopulmonary dysplasia in premature infants. Heterozygosity of ABCA3 mutations is also known to affect the severity of lung disease associated with other surfactant protein mutations. ABCA3 deficiency in humans and mice results in decreased phospholipid content, absence of surfactant and irreversible respiratory distress leading to death. ABCA3+/- (heterozygous for null allele) mice survive the neonatal period but have increased leukocyte count in their bronchoalveolar lavage fluid. As it is possible that loss of one functioning allele of ABCA3 translates into a change in lung phospholipid content, we investigated the phospholipid content of surfactant in ABCA3+/- mice. Method(s): The lung tissues of wildtype (WT) and ABCA3+/- adult as well as neonatal mice were investigated for phopsholipid content (nmol/mg wet weight) by mass spectrometry. In each group, lung tissues from mice were dissected and total lipids extracted. These were then resuspended in chloroform, and an aliquot taken for mass spectrometry analysis. Result(s): Total phospholipids were significantly lower in ABCA3+/- adult mice as compared to WT mice (36.5 vs. 38.1, p=0.03). As the predominant phospholipids in the surfactant are phosphatidylcholine (PC), phosphatidylglycerol (PG) and phosphatidylinositol (PI), these were further investigated. Dipalmitoylated PC (DPPC) was significantly lower in the BCA3+/- mice as compared to WT in both newborns (2.1+/-0.4 vs. 2.8+/-0.3, p=0.04) and adults (4.2+/-0.4 vs. 4.5+/-0.5; p=0.01). In adults, this difference was seen only in the female mice (females 4.1 vs. 4.7, p=0.01; males 4.2 vs. 4.2). Similarly, levels of PC 32:1 and PC 34:2 were significantly lower. A corresponding increase in PCs with long acyl chains was observed. Total PG was significantly decreased in the ABCA3+/- mice, both newborns and adults, with no difference observed between the sexes (p=0.01). Conclusion(s): ABCA3+/- status results in a decrease in total phospholipids, PC and PG in the lungs. In addition, a significant reduction in DPPC and PC 32:1 is observed. As DPPC is the major surface-active component in surfactant, we speculate that a significant decrease of DPPC might translate into a greater susceptibility to lung injury either due to external stimuli or due to prematurity. However, this needs to be investigated in further studies.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70448559
TI  - Glutathione reductase deficiency alters lung development in newborn mice
AU  - Luchsinger J.
AU  - Rogers L.K.
AU  - Locy M.L.
AU  - Hill C.L.
AU  - Velten M.
AU  - Nelin L.D.
AU  - Tipple T.E.
Y1  - 2010//
KW  - *mouse
KW  - *lung development
KW  - *society
KW  - lung
KW  - wild type
KW  - hyperoxia
KW  - phenotype
KW  - exposure
KW  - growth disorder
KW  - compensation
KW  - mouse mutant
KW  - knockout mouse
KW  - infant
KW  - adult
KW  - lung injury
KW  - lung dysplasia
KW  - hypothesis
KW  - ambient air
KW  - homogenate
KW  - Western blotting
KW  - human
KW  - analysis of variance
KW  - *free radical
KW  - *glutathione reductase
KW  - protein
KW  - thioredoxin
KW  - oxidoreductase
KW  - glutathione
T2  - Free Radical Biology and Medicine
LA  - English
VL  - 49
IS  - SUPPL. 1
PB  - Elsevier Inc.
SN  - 0891-5849
AD  - J. Luchsinger, Nationwide Children's Hospital, United States
DO  - https://dx.doi.org/10.1016/j.freeradbiomed.2010.10.113
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70448559
AB  - Adult glutathione reductase (GR)-knockout (KO) mice are more resistant to hyperoxic lung injury through mechanisms that likely involve compensation by the thioredoxin (Trx) system. Exposure of neonatal wild-type mice to 85% O2 results in a phenotype similar to that seen in infants with bronchopulmonary dysplasia (BPD) with lung growth arrest manifested by fewer and larger alveoli. However, the roles of the GSH and Trx systems in this pathologic phenotype are not well defined. The present studies tested the hypothesis that neonatal GR-KO mice exposed to 85% O2 would not exhibit the BPD phenotype following hyperoxia exposure. Within 24 h of birth, wild-type C3H/HeN and GR-KO mice were exposed to 85% O2 or were kept in room air (RA). Morphometric analyses were performed on lung sections from 14 d mice. Homogenates prepared from the lungs of 7 d mice were analyzed for Trx1 and Trx reductase-1 (TrxR1) contents by western blotting. Data (in arbitrary units) were analyzed by 2-way ANOVA with differences noted at p<0.05. Lung morphometric analyses of RA-raised animals indicated that 14 d GR-KO mice had statistically fewer and smaller alveoli than wild-type C3H/HeN mice. GR-KO mice exposed to 85% O2 exhibited much less severe growth arrest than did hyperoxia-exposed wild-type controls. Lung Trx1 protein levels were greater in GR-knockout mice than in wild-type mice (31.0+/-2.8 vs 7.0+/-2.6) raised in RA but no differences in TrxR1 protein levels between strains were detected (6.3+/-0.4 vs 5.3+/-0.7). In contrast to wild-type animals, exposure of GR-KO mice to hyperoxia increased both Trx1 (49.5+/-5.5) and TrxR1 (12.0+/-0.7) lung protein levels. Our data indicate that GR is necessary for normal lung development. Interestingly, GR deficient mice exhibit less severe hyperoxia-induced lung phenotypic alterations. Increases in Trx1 and TrxR1 protein levels in the lungs of GR-KO mice suggest compensation for GR deficiency by the Trx system. We speculate that the Trx system may protect against the effects of hyperoxia on lung development in prematurely born human infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70388773
TI  - Pregnancy in women with portal vein thrombosis (PVT): Results of a multicentric european study on maternal and foetal management and outcome
AU  - Hoekstra J.
AU  - Seijo S.
AU  - Rautou P.-E.
AU  - Ducarme G.
AU  - Luton D.
AU  - Alijotas-Reig J.
AU  - Condat B.
AU  - Garcia-Pagan J.C.
AU  - Janssen H.L.
AU  - Valla D.
AU  - Casellas-Caro M.
Y1  - 2010//
KW  - *pregnancy
KW  - *female
KW  - *liver
KW  - *liver disease
KW  - *portal vein thrombosis
KW  - anticoagulation
KW  - patient
KW  - bleeding
KW  - prophylaxis
KW  - premature labor
KW  - HELLP syndrome
KW  - infant
KW  - diagnosis
KW  - portal vein obstruction
KW  - fetus outcome
KW  - France
KW  - Netherlands
KW  - Spain
KW  - mesenteric vein
KW  - varicosis
KW  - antiphospholipid syndrome
KW  - ascites
KW  - spleen infarction
KW  - univariate analysis
KW  - prognosis
KW  - thrombocyte
KW  - spontaneous abortion
KW  - deep vein thrombosis
KW  - contraception
KW  - death
KW  - portal hypertension
KW  - vein occlusion
KW  - obstruction
KW  - gene mutation
KW  - term birth
KW  - emergency surgery
KW  - congenital malformation
KW  - hyaline membrane disease
KW  - necrotizing colitis
KW  - fetus
KW  - mother
KW  - cesarean section
KW  - genital bleeding
KW  - vaginal delivery
KW  - myeloproliferative disorder
KW  - nitrogen 13
KW  - blood clotting factor 5 Leiden
KW  - estrogen
KW  - prothrombin
KW  - low molecular weight heparin
KW  - protein S
T2  - Hepatology
LA  - English
VL  - 52
IS  - SUPPL. 1
PB  - John Wiley and Sons Ltd
SN  - 0270-9139
AD  - J. Hoekstra, Gastroenterology and hepatology, Erasmus Medical Center, Rotterdam, Netherlands
UR  - http://onlinelibrary.wiley.com/doi/10.1002/hep.23993/pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70388773
DO  - https://dx.doi.org/10.1002/hep.23993
AB  - Background: Although many patients with primary PVT are females of childbearing age, data on pregnancy in this context are scarce. Aim(s): To assess maternal and fetal outcome of pregnancies in women with known PVT. Method(s): Retrospective European multicenter analysis of pregnancy in women with chronic PVT seen between 1986 and 2010. Pregnancies occurred 6 months or more after PVT diagnosis. Result(s): 23 women, median age 32 years (20-45) had 42 pregnancies (France n=16, Netherlands n=13, Spain n=13). Median duration between PVT diagnosis and pregnancy was 54 months (7 to 370 months). Twenty-one women had portal vein obstruction, including 8 with mesenteric vein (MV) obstruction; 2 left or right portal vein obstruction, including 1 with MV obstruction. Fifteen had oesophageal varices, which had ruptured in 9.Four had myeloproliferative disorder, 7protein S or C deficiency, 3 antiphospholipid syndrome, 1 factor V Leiden and 1 prothrombine gene mutation. Low molecular weight heparin (LWMH) was started before gestation-week 5 in 14 pregnancies; and after week 6 in 13. No LMWH was given during 15 pregnancies. Median duration of gestation was 36 weeks (range 6-39 weeks). Eight fetuses were lost before week 20. There were 2 very preterm birth at week 24-25; 19 moderately preterm birth (at 32-36 weeks); and 13 term birth (after week 37). One infant underwent emergency surgery for a cardiac malformation; another infant had hyaline membrane disease, and necrotic colitis, both with favourable outcome. Two mothers had HELLP syndrome at week 24 and 33 respectively. There were 3/17 parietal bleeding after caesarean sections, and 1/17 genital bleeding after vaginal deliveries. Two oesophageal variceal bleedings occurred, in the absence of primary prophylaxis, at week 18 and 38 respectively. Three had ascites during pregnancy. Post-partum splenic infarction occurred once without anticoagulation. In univariate analysis, significant prognosis factors for unfavourable outcome of pregnancy were high platelets (253 +/- 140 vs 220+/-78 (p=0.017), past history of spontaneous abortion or deep vein thrombosis (p=0,042) and past oestrogen contraception (p=0,008). There were no deaths. Conclusion(s): In chronic PVT patients, who become pregnant, foetal outcome is generally favourable and maternal outcome is good. Variceal bleeding is rare. HELLP syndrome seems more common than expected. Thrombotic events can occur postpartum in the absence of anticoagulation. Therefore, intensified prophylaxis for portal hypertension, close surveillance for HELLP, and brief anticoagulation interruption around delivery may reduce the rate of bleeding and thrombotic complications in these patients.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70367624
TI  - Healthcare utilisation and cost of care at school age related to home oxygen status during infancy
AU  - Greenough A.
AU  - Alexander J.
AU  - Chetcuti P.
AU  - Lenney W.
AU  - Shaw N.
AU  - Boorman J.
AU  - Turner J.
Y1  - 2010//
KW  - *health care utilization
KW  - *school
KW  - *infancy
KW  - *college
KW  - *child health
KW  - *pediatrics
KW  - child
KW  - lung function
KW  - newborn intensive care
KW  - drug therapy
KW  - intensive care unit
KW  - general practitioner
KW  - outpatient
KW  - hospital admission
KW  - publication
KW  - coughing
KW  - wheezing
KW  - cold air
KW  - prescription
KW  - follow up
KW  - lung dysplasia
KW  - morbidity
KW  - gestational age
KW  - parent
KW  - questionnaire
KW  - hospital
KW  - *oxygen
T2  - Archives of Disease in Childhood
LA  - English
VL  - 95
IS  - SUPPL. 1
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - A. Greenough, Division of Asthma, Allergy and Lung Biology, King's College Hospital, London, United Kingdom
UR  - http://adc.bmj.com/cgi/content/meeting_abstract/95/1_MeetingAbstracts/A58?sid=8d9669ab-017f-41f9-aef6-1240c441c414
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70367624
DO  - https://dx.doi.org/10.1136/adc.2010.186338.129
AB  - Aims: To determine in prematurely born children who had bronchopulmonary dysplasia (BPD), if respiratory morbidity, lung function, healthcare utilisation and cost of care at school age were influenced by a requirement for supplementary oxygen at home after discharge from the neonatal intensive care unit (NICU). Method(s): One hundred and sixty children, median gestational age 27 (range 22-31) weeks, cared for on four tertiary neonatal intensive care units were examined. Sixty five of them had received supplementary oxygen when discharged home from the NICU (home oxygen group). A parent completed respiratory questionnaire was administered and lung function measurements (including assessment of bronchial hyper-responsiveness) were undertaken when the children were eight years old. Healthcare utilisation during years five to seven was assessed by examining hospital and general practitioner records to identify all hospital admissions, out-patient and general practitioner attendances and medication prescribed; whether the healthcare utilisation was related to respiratory problems was noted. The cost of care was calculated using the National Scheme of Reference Costs (2003) and medication costs calculated using the British National Formulary prices. Result(s): No child was oxygen dependent at school age. There were no significant differences in cough or wheeze or in the baseline lung function results between the two groups, but there was tendency for more of the home oxygen group to respond to a cold air challenge (p=0.0596). The home oxygen group had more out-patient attendances (p=0.0168), particularly for respiratory related problems (p=0.0032), with greater associated costs of care (p=0.0186, p=0.0030 respectively). In addition, their cost of care for prescriptions (p=0.0409) and total respiratory related cost of care (p=0.0354) were significantly greater that that of the non-home oxygen group. Conclusion(s): Children with BPD who required supplementary oxygen at home after discharge from the NICU have increased healthcare utilisation and associated cost of care at school age. These results emphasise such prematurely born children need ongoing follow up beyond when they cease to require home oxygen.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70367555
TI  - Deaths in preterm infants less than 32 weeks gestation: clinico-pathological diagnoses and trends over 2 decades
AU  - Hearns R.
AU  - Berrington J.
AU  - Bythell M.
AU  - Wright C.
AU  - Embleton N.
Y1  - 2010//
KW  - *death
KW  - *prematurity
KW  - *pregnancy
KW  - *college
KW  - *diagnosis
KW  - *child health
KW  - *pediatrics
KW  - population
KW  - infection
KW  - infant
KW  - data base
KW  - immaturity
KW  - hyaline membrane disease
KW  - congenital malformation
KW  - enterocolitis
KW  - morbidity
KW  - birth weight
KW  - case study
KW  - mortality
KW  - survival
KW  - prevalence
KW  - newborn morbidity
KW  - perinatal mortality
KW  - child death
T2  - Archives of Disease in Childhood
LA  - English
VL  - 95
IS  - SUPPL. 1
PB  - BMJ Publishing Group
SN  - 0003-9888
AD  - R. Hearns, Newcastle Neonatal Service, Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom
UR  - http://adc.bmj.com/cgi/content/meeting_abstract/95/1_MeetingAbstracts/A88-a?sid=0d21a81b-f313-4967-b295-eb731fe5afa0
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70367555
DO  - https://dx.doi.org/10.1136/adc.2010.186338.195
AB  - Background: There have been dramatic improvements in survival for preterm infants over the last two decades that is likely to result in a changing prevalence of the major neonatal morbidities. It is important to accurately document these changes, and identify current patterns, in order to inform research and development priorities. Objective(s): To ascertain the major causes of death in preterm infants using a population based database, and to determine any changes over the last two decades. Design/Methods: The authors used the Perinatal Mortality Survey-a large population based database to obtain information on all infant deaths among those live born between 24 and 31 weeks gestation between 1988 and 2008. Clinico-pathological diagnoses for the major morbidities were hyaline membrane disease, pulmonary immaturity (immaturity making sustained ventilatory support impossible), malformations (genetic or structural), infection (including ante-, intra-, and postpartum) and necrotising enterocolitis (NEC). Infants were subdivided into those born extremely (24-27 weeks) and very (28-31 weeks) preterm, and into three 7-year cohorts 1988-1994, 1995-2001 and 2002-2008. Result(s): There were 1504 deaths in live born preterm infants <32 weeks gestation with median gestation 26 weeks (IQR 3w), median birth weight 880 g (IQR 469g) and median age at death 3 days (IQR 14 days). There was a major decrease in respiratory deaths especially in those born at 28-31 weeks, and a significant increase in the relative importance of deaths from NEC and infection especially in those born at 24-27 weeks. Conclusion(s): This is one of the largest published population based case series of mortality in preterm infants. This shows a large overall decrease in deaths in infants born preterm, differential trends between extremely and very preterm infants, and the increasing importance of deaths due to NEC and infection. (Figure presented).
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70325933
TI  - General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: A systematic review
AU  - Gough A.
AU  - Spence D.
AU  - Linden M.A.
AU  - McGarvey L.
AU  - Halliday H.
Y1  - 2010//
KW  - *systematic review
KW  - *survivor
KW  - *adult
KW  - *lung dysplasia
KW  - *health
KW  - *winter
KW  - *society
KW  - checklist
KW  - lung function
KW  - cohort analysis
KW  - control group
KW  - controlled study
KW  - airway obstruction
KW  - classification
KW  - adaptation
KW  - chronic lung disease
KW  - infancy
KW  - asthma
KW  - child
KW  - prematurity
KW  - adulthood
KW  - empirical research
KW  - data base
KW  - Medline
KW  - PsycINFO
KW  - nursing
KW  - medical literature
KW  - skill
KW  - survival
T2  - Thorax
LA  - English
VL  - 65
IS  - SUPPL. 4
PB  - BMJ Publishing Group
SN  - 0040-6376
AD  - A. Gough, Queen's University Belfast, United Kingdom
UR  - http://thorax.bmj.com/content/65/Suppl_4/A109.2.full.pdf
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70325933
DO  - https://dx.doi.org/10.1136/thx.2010.150979.27
AB  - Introduction and Objectives:Bronchopulmonary dysplasia (BPD) is the most common form of chronic lung disease in infancy and the second most common after asthma in children. With the improved survival of extremely preterm infants the incidence of BPD has increased. Currently there is only limited information on the health of BPD survivors who have reached adulthood. The purpose of this systematic literature review was to examine current empirical research on adult survivors of BPD. Methods Six electronic databases were searched between 1950 and February 2010 (Medline, PubMed, Embase, PsycINFO, Cumulative Index of Nursing and Allied Health Literature (CINAHL Plus) and Web of Knowledge. Studies were independently screened and were only included if they related to the assessment of outcome measures in adult survivors of BPD. From a total of 1453 search results, 14 eligible studies were included in the review. Data on methodological design and findings were extracted from each included study; in addition the methodological quality of each study was assessed using the Critical Appraisal Skills Programme (CASP) checklist. Result(s): 14 cohort studies met the review criteria. 12 scored highly on the CASP checklist, with a score > 10 out of 12. No study scored less than 7. Nine studies included a control group and only four studies in total had a singular focus on BPD outcomes. Six controlled studies found differences between the groups on respiratory symptoms. 11 studies carried out lung function testing and found evidence of airflow obstruction. Of these, one study found no difference between preterm and controls. However, there were only seven adults who were born preterm with BPD in this study. Five studies in total examined radiographical outcomes, and all found evidence of abnormalities. Those with moderate-severe BPD were found to be most affected compared to mild BPD subjects. Conclusions The effects of BPD on pulmonary function do not diminish over time. This may reflect issues related to means of testing, differing definitions and classification of BPD, and the adaptation of individuals to their circumstances over time.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2014>
TI  - Cord blood fibroblast growth factor-10 as a possible predictor of bronchopulmonary dysplasia in preterm infants.
DO  - https://dx.doi.org/10.3233/NPM-1476613
AU  - Mohamed, Walid A
AU  - Aseeri, Mohamed A
Y1  - 2014//
KW  - Biomarkers/bl [Blood]
KW  - *Bronchopulmonary Dysplasia/bl [Blood]
KW  - Bronchopulmonary Dysplasia/di [Diagnosis]
KW  - Bronchopulmonary Dysplasia/mo [Mortality]
KW  - Early Diagnosis
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Female
KW  - *Fetal Blood/ch [Chemistry]
KW  - *Fibroblast Growth Factor 10/bl [Blood]
KW  - Humans
KW  - Infant, Newborn
KW  - Infant, Premature
KW  - *Infant, Premature, Diseases/bl [Blood]
KW  - Infant, Premature, Diseases/di [Diagnosis]
KW  - Infant, Premature, Diseases/mo [Mortality]
KW  - Male
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - Prospective Studies
KW  - Saudi Arabia
T2  - Journal of neonatal-perinatal medicine
VL  - 7
IS  - 2
SN  - 1878-4429
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med11&NEWS=N&AN=25104125
AD  - Netherlands
AB  - OBJECTIVE: To evaluate fibroblast growth factor-10 (FGF-10) levels in cord blood as a possible predictor of the subsequent development of bronchopulmonary dysplasia (BPD) in preterm infants., PATIENTS AND METHODS: A total of 269 preterm (<=32 weeks gestation) infants (76 infants developed BPD and 193 had no BPD) were enrolled. FGF-10 levels were measured by enzyme-linked immunosorbent assay., RESULTS: Preterm infants who subsequently developed BPD had significantly lower cord serum levels of FGF-10 than those who did not (p < 0.001). Cord blood levels of FGF-10 were significantly lower in infants with severe BPD than those with moderate or mild disease (p < 0.001). Logistic regression analysis demonstrated that low cord blood FGF-10 level was independently associated with the subsequent risk of BPD (OR = 0.978 [95 % CI: 0.959 - 0.997]; p = 0.02)., CONCLUSION: Low cord blood FGF-10 levels may predict the subsequent development of BPD in preterm infants.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70316877
TI  - Effect of hyperoxia on the pulmonary function of newborn rats
AU  - Sanchez Luna M.
AU  - Chimenti P.
AU  - Maderuelo E.
AU  - Sanz E.
AU  - Zurita M.
AU  - Zubeldia J.
Y1  - 2010//
KW  - *hyperoxia
KW  - *workshop
KW  - *rat
KW  - *newborn
KW  - *lung function
KW  - *neonatology
KW  - exposure
KW  - tidal volume
KW  - breathing rate
KW  - lung
KW  - lung function test
KW  - lung dysplasia
KW  - control group
KW  - ambient air
KW  - progeny
KW  - body plethysmography
KW  - oxidative stress
KW  - pathogenesis
KW  - breathing
KW  - protein
KW  - oxygen
T2  - Journal of Neonatal-Perinatal Medicine
LA  - English
VL  - 3
IS  - 3
PB  - IOS Press
SN  - 1934-5798
AD  - M. Sanchez Luna, Hospital General Universitario Gregorio Maranon, Madrid, Spain
DO  - https://dx.doi.org/10.3233/NPM-2010-0110
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70316877
AB  - Introduction: Hyperoxia and oxidative stress play an important role in the pathogenesis of bronchopulmonary dysplasia (BPD). Method(s): We studied two litters of Sprague Dawley newborn rats divided into a control Group (CG): exposure to room air and Hyperoxia Group (HG): exposure to 60% of Oxygen from birth and during 14 days. Pulmonary function tests were performed on day 15th in both groups by total body plethysmography. VEGFA, was measured and compared between groups. Result(s): 14 offspring in each group were studied. A significant decrease in tidal volume in the hyperoxia group compared to controls was found, HG: 0.0059 ml/g (SE: 0.000468 ml/g), CG: 0.0046 ml/g (SE: 0.000319 ml/g), p 0, 000) with a significant increase in the respiratory rate (HG: 310 rpm; CG: 266 rpm; p 0.03). VEGFA, was statistically significant lower in the hyperoxia group, (HG: 4.84 pg/mg lung protein, CG: 5.43 pg/mg lung protein). Conclusion(s): Prolong exposure of newborn rats to hyperoxia alters the spontaneously breathing pulmonary function test, by decreasing tidal volume with a compensatory increase in the respiratory rate.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70313202
TI  - Overlap syndrome of asthma and chronic obstructive pulmonary disease (COPD)
AU  - James A.
Y1  - 2010//
KW  - *asthma
KW  - *Asian
KW  - *chronic obstructive lung disease
KW  - *society
KW  - airway
KW  - lung function
KW  - patient
KW  - macrophage
KW  - neutrophil
KW  - inflammation
KW  - airway remodeling
KW  - smooth muscle
KW  - T lymphocyte
KW  - B lymphocyte
KW  - exposure
KW  - respiratory tract disease
KW  - emphysema
KW  - smoking
KW  - cigarette smoking
KW  - biomass
KW  - early intervention
KW  - lung dysplasia
KW  - disease severity
KW  - smoke
KW  - smoking cessation
KW  - prevention
KW  - eosinophil
KW  - adult
KW  - basement membrane
KW  - lung parenchyma
KW  - spirometer
KW  - thickness
KW  - tissue
KW  - virus infection
KW  - irritant agent
KW  - fuel
KW  - CD4 antigen
KW  - collagen
KW  - cigarette smoke
KW  - CD8 antigen
T2  - Respirology
LA  - English
VL  - 15
IS  - SUPPL. 2
PB  - Blackwell Publishing
SN  - 1323-7799
AD  - A. James, Department of Pulmonary Physiology, University of Western Australia, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA 6009, Australia
DO  - https://dx.doi.org/10.1111/j.1400-1843.2010.01863.x
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70313202
AB  - Asthma is a disease that is diagnosed largely on a history of variable symptoms and the demonstration of variable airway narrowing. It is associated with airway inflammation (CD4 T-lymphocytes, B-cell lymphoid aggregates, macrophages, eosinophils and, in adults, neutrophils) and airway wall remodelling (airway wall thickening, principally increased airway smooth muscle and deposition of collagen below the basement membrane, with minor encroachment on the airway lumen). It is not associated with a prominent effect on the lung parenchyma. The cause(s) of asthma remains unknown and the severity of disease remains largely constant. COPD is diagnosed with a spirometer and is defined as a fixed reduction in FEV1, relative to FVC. When caused by cigarette smoke it is associated with airway inflammation (CD8 T-lymphocytes, B-cell lymphoid aggregates, macrophages and neutrophils) and airway remodelling (mild increase in airway wall thickness including airway smooth muscle with encroachment on the airway lumen) and tissue destruction (emphysema and loss of small conducting airways). The severity of COPD increases with age and continued exposure to irritants. COPD has many causes including smoking cigarettes, burning of biomass fuels, asthma and early life respiratory illness and exposures (viral infections, bronchopulmonary dysplasia). As a group, patients with asthma have reduced lung function, in relation to disease severity, and may have a slightly increased rate of decline in lung function. Patients with asthma who smoke have reduced lung function and an accelerated decline in lung function. Apart from stopping smoking there is no current treatment that can improve the rate of decline in lung function in patients with asthma or COPD. Therefore prevention, early intervention and uncovering the unknown environmental and genetic contributions to airway diseases remain critical.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70309846
TI  - HLA and bronchopulmonary dysplasia susceptibility
AU  - Rochaa G.
AU  - Guimaraesa H.
AU  - Proencab E.
AU  - Areiasb A.
AU  - Freitasc F.
AU  - Limac B.
AU  - Rodriguesd T.
AU  - Alvesc H.
Y1  - 2010//
KW  - *lung dysplasia
KW  - *health care organization
KW  - newborn
KW  - allele
KW  - gestational age
KW  - logistic regression analysis
KW  - risk factor
KW  - confidence interval
KW  - gene frequency
KW  - human
KW  - clinical study
KW  - HLA typing
KW  - Student t test
KW  - Fisher exact test
KW  - birth weight
KW  - leukocyte antigen
T2  - Early Human Development
LA  - English
VL  - 86
IS  - SUPPL. 1
PB  - Elsevier Ireland Ltd
SN  - 0378-3782
AD  - G. Rochaa, Department of Pediatrics, Faculty of Medicine, Porto University, Portugal
DO  - https://dx.doi.org/10.1016/j.earlhumdev.2010.09.326
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70309846
AB  - Aim: Background - There is little data on the association between Human Leucocyte Antigen (HLA) alleles and Bronchopulmonary Dysplasia (BPD) of the preterm newborn. Aim - To assess associations between HLA alleles and BPD susceptibility. Material(s) and Method(s): We studied 156 preterm neonates (82 M/74 F) <32 weeks gestational age, alive at 36 weeks gestational age. Detailed clinical data were collected. HLA typing was performed by PCR-SSO. HLA allele frequencies where determined by direct counting for BPD and no-BPD groups. Comparison between BPD and no BPD groups was performed using t-test, X2 test or Fisher exact test and logistic regression as appropriate. Relative risks (RR) and their 95% confidence intervals (95% CI) were also calculated as association measures. Result(s): We diagnosed 56 (35.9%) neonates with mild BPD and 27 (17%) with moderate/severe BPD. We found a significant association between HLA-DRB1*01 and mild BPD (OR=3.48]1.23-10.2[).The alleles HLA-A*24, -A*68, -B*51,-Cw*07, -Cw*14, -Cw*15 and -DRB1*01 presented a significant association with moderate/ severe BPD. When adjusted to gestational age and birth weight HLA-A*68 (OR=5.41] 1.46; 20.05[), -B*51 (OR=3.09]1.11; 8.63[) and -Cw*14 (OR=4.94] 1.15; 21.25[) were significantly associated with moderate/severe BPD. Conclusions Our findings suggest an association between HLA-A*68, -B*51 and -C*14 and BPD susceptibility.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70309559
TI  - Predictive power of oxidative stress markers for the early identification of newborns at high risk for free radicals related diseases
AU  - Buonocore G.
AU  - Tataranno M.L.
AU  - Perrone S.
AU  - Negro S.
AU  - Proietti F.
AU  - Longini M.
AU  - Turrisi G.
AU  - Iantorno L.
Y1  - 2010//
KW  - *risk
KW  - *newborn
KW  - *oxidative stress
KW  - *health care organization
KW  - umbilical cord blood
KW  - pathogenesis
KW  - pathology
KW  - lung dysplasia
KW  - necrotizing enterocolitis
KW  - hypothesis
KW  - blood level
KW  - infant
KW  - exposure
KW  - retrolental fibroplasia
KW  - *free radical
KW  - *marker
KW  - antioxidant
KW  - protein
KW  - iron
KW  - advanced oxidation protein product
T2  - Early Human Development
LA  - English
VL  - 86
IS  - SUPPL. 1
PB  - Elsevier Ireland Ltd
SN  - 0378-3782
AD  - G. Buonocore, Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Italy
DO  - https://dx.doi.org/10.1016/j.earlhumdev.2010.09.034
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70309559
AB  - Aim: Newborns, particularly if preterm, are susceptible to oxidative stress (OS) due to the high exposure to free radicals (FRs) action and the lack of the antioxidant systems. OS plays a key role in pathogenesis of pathologies such as retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), intraventricular hemorrage (IVH), grouped as 'free radicals-related diseases' (FRD). This study tests the hypothesis that OS marker levels in cord blood may predict the onset of FRD. Material(s) and Method(s): 322 preterm newborns of GA: 24-32 weeks (27.75+/-1.82) and BW: 460-2370 g (1285.20+/-440.10) were consecutively recruited. Markers of potential OS risk (non-protein bound iron, NPBI) and markers of OS-related damage (total hydroperoxides, TH; advanced oxidation protein products, AOPP) were assessed in cord blood. Associations between FRD onset and OS markers were checked through inferential analysis. Result(s): The development of FRD was significantly associated with high cord blood levels of TH, AOPP and NPBI (respectively p=0.000, OR=1.014; p=0.04, OR=0.946; p=0.003, OR=1.149). Conclusions Elevated levels of TH, AOPP and NPBI in cord blood are associated with increased risk for FRD. OS markers can be considered useful tools for the early identification of infants at risk for FRs damage. These findings add to the evidence that antioxidant strategies could have beneficial effects to prevent or ameliorate perinatal outcome.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70309558
TI  - Cognitive outcome in pretermtwins conceived after in-vitro fertilization compared with a control group at 3 years of age
AU  - Kyriakidoua M.
AU  - Karagiannib P.
AU  - Mitsiakosb G.
AU  - Pratsioub P.
AU  - Tsakalidisb C.
AU  - Chatziioannidisa I.
AU  - Nikoalidesb N.
Y1  - 2010//
KW  - *control group
KW  - *fertilization in vitro
KW  - *health care organization
KW  - twins
KW  - child
KW  - cognitive development
KW  - fertilization
KW  - patent ductus arteriosus
KW  - necrotizing enterocolitis
KW  - sepsis
KW  - lung dysplasia
KW  - bleeding
KW  - encephalomalacia
KW  - artificial ventilation
KW  - hospitalization
KW  - Greece
KW  - genetics
KW  - statistical analysis
KW  - Student t test
KW  - chi square test
KW  - gestational age
KW  - birth weight
KW  - newborn period
KW  - respiratory distress syndrome
KW  - chromosome aberration
KW  - surfactant
T2  - Early Human Development
LA  - English
VL  - 86
IS  - SUPPL. 1
PB  - Elsevier Ireland Ltd
SN  - 0378-3782
AD  - M. Kyriakidoua, Department of Physiotherapy, General Papageorgiou Hospital, Greece
DO  - https://dx.doi.org/10.1016/j.earlhumdev.2010.09.033
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70309558
AB  - Aim: There are few studies on the cognitive development of twins born after in-vitro fertilization. The Aim of the present study was the assessment of cognitive development of preterm twins born after invitro fertilization (IVF) compared with a control group in Greece, when they had reached an age of at least 24 months of corrected age (CA). Material(s) and Method(s): The study comprised 26 twin IVF children and 17 preterm control twins. All the twins were dichorionic-diamniotic. Children with chromosomal anomalies or major genetics syndromes were excluded. The children were examined when they were 24-36 months of CA and the Bayley III developmental scale was used. All statistical analyses were performed using the SPSS 17.0. The t-test was used to compare means of continuous variables while the chi-square test was used for proportion comparisons. Result(s): The mean (+/-SD) gestational age was 31.9 (+/-3.1) and 33.0 (+/-2.1) (p=0.2) and the mean (+/-SD) birth weight was 1588.4 (+/-464.4) and 1933.5 (+/-404.8) (p=0.16) for IVF and control groups respectively. The mean (+/-SD) assessment age was 29.2 (+/-4.7) months CA for the IVF group and 30.6 (+/-3.9) for the controls (p=0.30). During the neonatal period, no differences were observed concerning the incidence of respiratory distress syndrome, need for surfactant administration, patent ductus arteriosus, necrotizing enterocolitis, sepsis bronchopulmonary dysplasia, intra-ventricular hemorrhage, periventricular leukomalacia, days on mechanical ventilation, supplemental O2 and duration of hospital stay between the two groups. There was no significant difference concerning the composite score in the cognitive scale of the Bayley III test for the twins born after IVF and the control group (94. 6 (+/-7.0) vs 90.5 (+/-7.6) respectively, (p=0.08). Conclusions The study showed that the cognitive development of the twins invitro fertilization children was within normal range and did not differ from the controls.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70309547
TI  - Whole genome expression in very low birth weight (VLBW) infants with and without bronchopulmonary dysplasia (BPD)-Preliminary results
AU  - Pietrzyk J.J.
AU  - Kwinta P.
AU  - Madetko-Talowska A.
AU  - Bik-Multanowski M.
AU  - Saugstad O.D.
Y1  - 2010//
KW  - *gene expression
KW  - *health care organization
KW  - *lung dysplasia
KW  - *very low birth weight
KW  - gene
KW  - infant
KW  - human
KW  - birth weight
KW  - gestational age
KW  - blood sampling
KW  - blood
KW  - newborn
KW  - messenger RNA
KW  - lipid
KW  - surfactant
T2  - Early Human Development
LA  - English
VL  - 86
IS  - SUPPL. 1
PB  - Elsevier Ireland Ltd
SN  - 0378-3782
AD  - J.J. Pietrzyk, Jagiellonian University, Cracow, Poland
DO  - https://dx.doi.org/10.1016/j.earlhumdev.2010.09.022
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70309547
AB  - Aim: BPD is one of the most serious complications observed in prematures. Owing to the microarray technique, expression of all potential human genes potentially involved in BPD development can be reliably evaluated. The Aim of the study was to compare whole genome expression in the first month of life in the groups of infants with and without BPD. Materials and methods 52 VLBW newborns (mean birthweight 1086 g, mean gestational age 28.2 weeks) were prospectively evaluated. Blood samples were drawn from all the study participants on the 5th, 14th and 28th days of life (DOL). AMBION RiboPure Blood kits were used to extract mRNA. The mRNA samples were evaluated for gene expression with the use of GeneChip Human Gene 1.0ST microarrays. The infants were divided into 2 groups: A) no BPD (n=25) and BPD (n=27). Result(s): 251 genes were significantly differentially expressed between the groups during the first month of life (249 genes on the 5th DOL, 2 genes on the 14th DOL and 0 genes on 28th DOL). Preliminary gene ontology analyses showthat someof the genes expressed differently are involved in lipid metabolismwhich could influence surfactant production. Conclusions Significant difference in 251 genes expression in the groups of infants with BPD was found. It should be emphasized that a different gene expression was observed practically only on the 5th DOL. This suggests that dysregulation of genes potentially involved in the BPD pathomechanism is present only during the first weeks of life. The impact of the over- and underexpressed genes needs further analysis.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70276274
TI  - Chronic hyperoxia results in neonatal lung disease associated with up-regulation of transforming growth factor beta-2 ligand mRNA expression
AU  - Ahlfeld S.K.
AU  - Ingram D.A.
AU  - Conway S.J.
AU  - Clapp D.W.
Y1  - 2010//
KW  - *hyperoxia
KW  - *pediatrics
KW  - *upregulation
KW  - *lung disease
KW  - *society
KW  - mouse
KW  - exposure
KW  - lung
KW  - prematurity
KW  - lung dysplasia
KW  - animal model
KW  - lung development
KW  - wild type
KW  - ambient air
KW  - examination
KW  - in situ hybridization
KW  - protein electrophoresis
KW  - lung alveolus epithelium
KW  - phosphorylation
KW  - chronic lung disease
KW  - *messenger RNA
KW  - *ligand
KW  - *transforming growth factor beta2
KW  - oxygen
KW  - transcription factor RUNX2
KW  - protein A
KW  - transforming growth factor beta
KW  - paraformaldehyde
KW  - protein
T2  - Pediatric Research
LA  - English
VL  - 68
IS  - 4
PB  - Lippincott Williams and Wilkins
SN  - 0031-3998
AD  - S.K. Ahlfeld, Indiana University School of Medicine, Indianapolis, IN, United States
DO  - https://dx.doi.org/10.1203/PDR.0b013e3181f528f1
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70276274
AB  - Background: Bronchopulmonary Dysplasia (BPD) is a chronic lung disease that affects preterm infants, characterized by fewer, larger, simpler alveoli due to an absence of secondary alveolar septation resulting in a reduced surface area for air exchange. Up-regulation of the Transforming Growth Factor Beta (TGFbeta) superfamily signaling pathway has been associated with the development of BPD in multiple animal models as well as premature infants. Although it is known that TGFbeta signaling is mediated via three ligands, TGFbeta-1, 2, and 3, that serve overlapping yet specific functions in normal lung development, there is a lack of data describing how these ligands are affected by neonatal exposure to hyperoxia. We hypothesized that exposure to chronic hyperoxia will have differential effects on the expression of these isoforms in the neonatal mouse lung. Method(s): Within 12 hr of birth, C57/B6 wild-type mice were subjected to 21 consecutive days of continuous exposure to 85% oxygen (O2) or room-air (RA) as controls. At the end of the study period, lungs were pressure-fixed with 4% Paraformaldehyde (for examination of distal airspace size and TGFbeta-isoform mRNA in-situ hybridization) or frozen and homogenized for protein electrophoresis (to quantify TGFbeta signaling via relative phospho-Smad 2/3 expression). Result(s): Exposure to chronic hyperoxia resulted in an arrest of alveolar development with enlarged, simplified distal airspaces. TGFbeta-2 mRNA expression was increased in 85% oxygen-exposed mice compared to RA controls, with a punctuate pattern noted within the alveolar epithelium. TGFbeta-1 mRNA appeared to be equivalent between the two groups, and TGFbeta-3 mRNA was not present in either group. There was potentiation of TGFbeta signaling levels as evidenced by increased phosphorylation of Smad2/3 protein (O2:RA increased 41%, p<0.001). Significantly, Periostin protein, a known down-stream effector of phospho-Smad 2/3 signaling, was increased in 85% oxygen-exposed mice compared to RA control lungs. Conclusion(s): Hyperoxia-induced arrested alveolar development is associated with long-lasting enhancement of TGFbeta signaling. Further, we show that the potentiation of TGFbeta signaling is mediated via specifically increased TGFbeta-2 ligand expression. Future studies to delineate the spatio-temporal expression of TGFbeta-2 mRNA as well as the cell-specific targets of TGFbeta-signaling are needed, as this will be paramount to understanding the possible role of TGFbeta in the development of neonatal lung diseases.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70236126
TI  - The Forgotten Majority - Late preterm infants and their vulnerability to lung disease
AU  - Colin A.A.
Y1  - 2010//
KW  - *prematurity
KW  - *airway
KW  - *morbidity
KW  - *pulmonology
KW  - *functional residual capacity
KW  - *lung disease
KW  - *lung dysplasia
KW  - *airway conductance
KW  - infant
KW  - gestational age
KW  - risk
KW  - lung function
KW  - lung
KW  - lung volume
KW  - thorax wall
KW  - hospitalization
KW  - lung development
KW  - gas exchange
KW  - child
KW  - infection
KW  - respiratory system
KW  - mortality
KW  - hospital
KW  - bronchiolitis
KW  - death
KW  - growth, development and aging
KW  - expiratory flow
KW  - hospital readmission
KW  - population
KW  - respiratory tract disease
KW  - follow up
KW  - lung alveolus wall
KW  - longitudinal study
KW  - adulthood
KW  - adult
KW  - lifespan
KW  - sacculus
KW  - chronic obstructive lung disease
KW  - live birth
KW  - hospital discharge
KW  - newborn morbidity
KW  - risk factor
KW  - infant mortality
KW  - pathogenesis
KW  - Respiratory syncytial pneumovirus
KW  - outpatient
KW  - newborn
KW  - United States
KW  - human
KW  - continuous process
KW  - maturation
KW  - gas
KW  - capillary
KW  - breathing
KW  - lung compliance
KW  - fatty acid desaturation
KW  - bronchus
KW  - airway resistance
KW  - total lung capacity
KW  - pregnancy
KW  - maturity
KW  - hyperoxia
KW  - uterus
KW  - environment
KW  - hypothesis
KW  - premature labor
KW  - adverse drug reaction
KW  - compression
KW  - forced vital capacity
KW  - muscle contraction
T2  - Paediatric Respiratory Reviews
LA  - English
VL  - 11
IS  - SUPPL. 1
PB  - W.B. Saunders Ltd
SN  - 1526-0542
AD  - A.A. Colin, Division of Pediatric Pulmonology, Miller School of Medicine, University of Miami, 1580 NW 10th Avenue, Miami, FL 33136, United States. E-mail: acolin@med.miami.edu
DO  - https://dx.doi.org/10.1016/S152605421070062-2
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70236126
AB  - The frequency of late preterm births has generally increased in the United States over the past 2 decades [1]. Infants 34-36 weeks gestational age (wGA) comprise approximately 71% of all preterm births (in 2007 approximately 390,000 live births) [1]. Infants of this gestational age termed "late preterm" are often considered to be as physiologically and metabolically mature as term infants, and therefore at low risk for morbidity and mortality. The resulting early discharge from hospital may be a factor in an increased overall risk of re-hospitalization [2]. A growing body of literature has documented the broad range of complications that late preterm infants may experience [3]. They have a higher risk of developing a large array of medical complications, and mortality rate for late preterm infants are 3-5 fold higher than that for term infants. Each weekly reduction in estimated gestational age at birth was found to be associated with increased morbidity before hospital discharge and higher rates of hospital readmission in the first months of life [2]. A study involving 377,638 term and 26,170 late preterm (34-36 wGA) infants showed that 22.2% of the late preterm vs. 3.0% of term infants had newborn morbidity during their birth hospitalization. Preterm infants born at 34 wGA had 20-fold (relative risk [RR]: 20.6) and at 35wGA had 10-fold (RR: 10.2) higher risk of morbidity compared with infants born at 40wGA. Relative morbidity increased approximately 2-fold with every week of decreasing gestational age earlier than 38wGA [4]. A recent review on the respiratory consequences of preterm birth suggests that many adverse respiratory consequences of preterm birth are likely the result of persistent pulmonary structural abnormalities [5]. Retrospective analyses of records of infants born to US residents showed higher infant mortality rates in 34-36wGA infants compared with term infants [6]. All forms of respiratory morbidity affect late preterm infants at a higher rate than infants of more advanced gestational age, but in particular preterm infants (33-36wGA) who are outside of the typical bronchopulmonary dysplasia (BPD) age range are highly susceptible to infection by such pathogens as respiratory syncytial virus (RSV). Boyce et al. [7] showed that infants born at 33-36wGA had similar rates of admission to the hospital for RSV infection as infants <33wGA, and that there were substantially higher rates of admission in these 2 populations compared with term infants. In other studies infants 33-35wGA had hospital outcomes that were similar to or worse than those of infants <=32wGA, whether RSV infection was confirmed or they were hospitalized for nonspecific bronchiolitis. After RSV-hospitalization infants 32-36wGA experienced rehospitalization rates twice as high, hospital stays 3 times as long, and outpatient visits twice as frequent as infants of similar gestational age who were not hospitalized for RSV [8]. Prematurity was also associated with an increased risk of bronchiolitis-associated death. The odds ratio for death related to RSV in 32-35wGA compared with full-term infants was approximately 5 [9]. The mechanisms explaining the morbidity in infants 34-36wGA are at least in part related to physiologic deficiencies related to their stage of lung development. Stages of lung development: Early growth and development of the human lung is a continuous process that is highly variable between individuals and has traditionally been divided into 5 stages. Premature infants are predominantly born in the saccular stage (28-36wGA) that precedes the final alveolar stage [10]. The saccular period, is a transitional phase before full maturation of alveoli occurs characterized by an increased number of primitive alveoli (saccules) that become gradually more effective as gas exchangers and may be sufficient in number and quality to sustain life in the preterm infant. The alveolar walls are more compact and thick than the final thin walls of alveoli and include an immature capillary system that is capable of carrying out the function of gas exchange and also fully matures in the alveolar phase. Mature alveoli are not uniformly present until 36wGA [10]. These structural changes not only affect gas exchange but have profound effects on the mechanical properties of the lung and hence the respiratory system as a whole. Impaired maintenance of FRC due to chest wall compliance, deficient airway tethering, and small lung volumes: The physiologic consequences of this early birth are that maintenance of a stable and adequate functional residual capacity (FRC) that secures stable gas exchange is impaired. FRC is determined by the balance between the opposing forces of the chest wall and lung and is thus a direct function of their respective mechanical properties. In early life, a compliant chest wall offers little outward recoil to the respiratory system and thus the elastic characteristics of the respiratory system approximate those of the lung with a tendency to decrease to lower lung volumes. Only within the first 2 years of life is this vulnerability corrected as the chest wall stiffens. To circumvent this limitation, infants actively elevate their FRC by modulating expiratory flow using laryngeal braking during tidal expiration and by maintaining inspiratory muscle activity into the expiratory phase. In addition they initiate inspiration early within the expiratory phase. Thus it is reasonable to assume that breathing with an overly compliant chest wall, high lung compliance, and reduced number of air-containing units is a challenge for infants delivered before term. The challenge of maintaining an FRC that permits stable gas exchange is likely compounded in the premature infant by apneic events, which have been shown to drive the system to critically low lung volumes and result in rapid desaturation. An additional crucial mechanism that secures airway patency and thus adequate maintenance of FRC is airway tethering. Tethering depends on a complex mesh-like elastic network within the alveolar walls that transmits tension from the pleural surface and exerts a circumferential pull on individual bronchi. Thus, tethering couples lung volume changes with airway caliber. Tethering of airways is less effective in infants born prematurely because alveolarization and the associated development of the parenchymal elastic network are still in the saccular stage of development at 32-36 wGA. The effect of reduced tethering is decreased airway stability, increased tendency to closure, increased airway resistance, and, ultimately, a tendency to collapse alveolar units in the lung periphery. Total lung volume undergoes rapid changes during the last trimester of gestation. At 30wGA, the lung volume is only 34% of the ultimate volume at mature birth, and at 34 weeks only reaches 47% of the final volume at maturity. This change parallels a marked thinning of air space walls associated with a dramatic increases in air space surface area from 1.0-2.0m2 at 30-32wGA, to 3.0-4.0m2 at term. These volume changes likely have direct mechanical implications in reducing the vulnerability caused by a low and unstable FRC. Altered lung development and function in association with preterm (30-36 wGA) birth: It is now recognized that postnatal hyperoxia plays a key role in the development of BPD. Premature birth interrupts normal in utero lung development and results in an early transition from the hypoxic intrauterine environment to a comparatively hyperoxic atmospheric environment. There is increasing evidence to support the hypothesis that preterm delivery, even in the absence of any neonatal respiratory disease, may have adverse effects on subsequent lung growth and development, and that these alterations may persist during the first 5 years of life and possibly beyond. Using pulmonary function testing a number of studies have shown a direct association between premature birth and altered pulmonary function. These studies demonstrated reduced expiratory flows in premature infants of varying gestational ages, but born without clinical lung disease. Most convincing was a recent study using the raised volume rapid thoracic compression technique [11]. In this study healthy preterm infants (mean, 33.4wGA) were studied at 8 weeks and had reduced airway flows in the presence of normal forced vital capacity compared with term infants. In a follow-up analysis, the reduced flows did not normalize in these children by 16 months of age, thus demonstrating a lack of "catch-up" growth in airway function [12]. The long-term significance of reduced airway function early in life has recently been emphasized in a longitudinal study involving a large group of non-selected infants who had participated in the Tucson Children's Respiratory study [13]. In this study Stern et al. showed that infants whose pulmonary function was in the lowest quartile also had pulmonary function in the lowest quartile through the years of follow-up until early adulthood. These findings in a normal unselected population, suggest that the level of pulmonary function in early life tracks and changes little with growth. Weiss and Ware [14] suggest that deficits in lung function during early life, especially if associated with lower respiratory illnesses, increase the risk of chronic obstructive pulmonary disease (COPD) in late adult life. Of particular importance in this context may be the role played by RSV, which affects most children during their first year of life. Conclusion(s): Long term prospective data are needed to elucidate the lifetime impact of birth in the late preterm stage and the consequences of the morbidities associated with such birth.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70201248
TI  - Complications of antiphospholipid syndrome. A report of a case
AU  - Cabrera Sevilla M.P.
AU  - Zuniga Gutierrez M.A.
AU  - Cabrera Sevilla J.E.
AU  - Fiol Ruiz G.
Y1  - 2010//
KW  - *antiphospholipid syndrome
KW  - *perinatal care
KW  - thrombocytopenia
KW  - cesarean section
KW  - respiratory distress
KW  - preeclampsia
KW  - twins
KW  - influenza
KW  - mixed connective tissue disease
KW  - autoimmunity
KW  - newborn
KW  - brain hemorrhage
KW  - retinopathy
KW  - sepsis
KW  - lung dysplasia
KW  - fever
KW  - laboratory
KW  - HELLP syndrome
KW  - infection
KW  - patient
KW  - pregnancy
KW  - emergency ward
KW  - headache
KW  - proteinuria
KW  - ultrasound
KW  - emergency
KW  - twin pregnancy
KW  - lung edema
KW  - thorax radiography
KW  - hypertransaminasemia
KW  - myositis
KW  - lactate dehydrogenase
KW  - steroid
KW  - magnesium sulfate
KW  - labetalol
KW  - alanine aminotransferase
KW  - corticosteroid
KW  - heparin
KW  - oseltamivir
KW  - aspartate aminotransferase
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 23
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - M.P. Cabrera Sevilla, Obstetricia, Hospital Torrecardenas, Spain
DO  - https://dx.doi.org/10.3109/14767051003802503
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70201248
AB  - Brief Introduction: To report a case of severe preeclampsia in monoamniotic twin gestation, carry- ing mixed connective tissue disease, which is complicated after cesarean section with a picture of respiratory distress due to infection with influenza A. Clinical Cases or Summary Results: Patient with a history of mixed connective tissue disease with twin pregnancy who come to the emergency room with headache of several days duration. TA 180/120, proteinuria, thrombocytopenia, GPT (83), GOT (115) and LDH (> 500) diagnosed with HELLP. She was treated with magnesium sulfate and labetalol, but worsen the thrombocytopenia. Obstetric ultrasound is performed by observing exitus of second twin, emergency cesarean section is performed. In postoperative has been suffering from pulmonary edema, respiratory distress, admitted to the ICU. Chest X-ray compatible with influenza A. she was treated corticosteroids, heparin and oseltamivir. Reappeared elevation of transaminases and LDH with thrombocytopenia and fever accompanied by myositis is suspected outbreak of autoimmunity and steroid boluses administered, obtaining excellent clinical response. Newborn weighing 600 g. Apgar 2/ 5/7. she presented intraventricular hemorrhage, severe retinopathy, sepsis and bronchopulmonary dysplasia. Conclusion(s): In the presence of severe preeclampsia presenting laboratory abnormalities suggestive of HELLP syndrome, we suspect the existence of autoimmune process, apply the appropriate test and consider the appropriate treatment.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70200798
TI  - Influence of antenatal dexamethasone therapy on systemic inflammatory response intensity in early-onset neonatal sepsis
AU  - Pankratyeva L.L.
AU  - Biryukova T.V.
AU  - Soldatova I.G.
AU  - Kafarskaya K.O.
AU  - Degtyareva M.V.
AU  - Volodin N.N.
Y1  - 2010//
KW  - *perinatal care
KW  - *therapy
KW  - *newborn sepsis
KW  - *inflammation
KW  - newborn
KW  - serum
KW  - bleeding
KW  - prematurity
KW  - infant
KW  - blood level
KW  - gestational age
KW  - mother
KW  - leukocyte
KW  - necrotizing enterocolitis
KW  - lung dysplasia
KW  - pregnancy
KW  - blood cell count
KW  - *dexamethasone
KW  - interleukin 8
KW  - C reactive protein
KW  - procalcitonin
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 23
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - L.L. Pankratyeva, Postgraduate Faculty, Department of Neonatology, Russian State Medical University, Russian Federation
DO  - https://dx.doi.org/10.3109/14767051003802503
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70200798
AB  - Objectives: To study the influence of antenatal therapy with dexamethasone on blood count, serum levels of SIR mediators (procalcitonin, PCT; interleukin 8, IL-8; C-reactive protein, CRP) and clinical signs of EONS in premature neonates. Material(s) and Method(s): Methods. We observed 58 neonates (gestation age 25-34 weeks, postnatal age <=3 days) with EONS. Infants were devided into 2 groups: (1) 22 neonates whose mothers were treated with dexamethasone before delivery; (2) 36 neonates without antenatal dexamethasone treatment. Levels of SIR mediators were measured at 48-72 h of life. Clinical Cases or Summary Results: Serum levels of PCT (4.8 +/-1.1 ng/ml vs. 16 +/- 4 ng/ml, respectively;p <0.05) and IL-8 (131.7 +/- 27.8 pg/ml vs. 586.7 +/- 94.3 pg/ml; p < 0.05) were lower in group 1 than in group 2. Serum CRP levels were similar in both groups. Levels of peripheral blood leukocytes were statistically higher in dexamethasone group compared with group 2. We revealed an increased incidence of necrotizing enterocolitis (NEC) in group 1 in comparison with group 2 (19/ 22(86%) versus 20/36(54%), respectively; p = 0.04). The incidence of bleeding and bronchopulmonary dysplasia (BPD) was higher in group 1 among infants of 32-34 weeks of gestation than in group 2. Conclusion(s): Antenatal dexamethasone therapy must be taken into account while interpreting the results of serum PCT and IL-8 testing and may promote an increased incidence of NEC, bleeding and BPD in premature infants with EONS.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Ovid MEDLINE(R) <2014>
TI  - Ascorbylperoxide from parenteral nutrition induces an increase of redox potential of glutathione and loss of alveoli in newborn guinea pig lungs.
DO  - https://dx.doi.org/10.1016/j.redox.2014.05.002
AU  - Elremaly, Wesam
AU  - Mohamed, Ibrahim
AU  - Mialet-Marty, Tiphaine
AU  - Rouleau, Therese
AU  - Lavoie, Jean-Claude
Y1  - 2014//
Y2  - 20140520//
KW  - Animals
KW  - Animals, Newborn
KW  - *Ascorbic Acid/aa [Analogs & Derivatives]
KW  - Ascorbic Acid/to [Toxicity]
KW  - Caspase 3/me [Metabolism]
KW  - *Glutathione/me [Metabolism]
KW  - Guinea Pigs
KW  - Hydrogen Peroxide/to [Toxicity]
KW  - Interleukin-6/me [Metabolism]
KW  - *Lung/de [Drug Effects]
KW  - Lung/me [Metabolism]
KW  - NF-E2-Related Factor 2/me [Metabolism]
KW  - NF-kappa B/me [Metabolism]
KW  - Oxidation-Reduction/de [Drug Effects]
KW  - Oxidative Stress/de [Drug Effects]
KW  - Parenteral Nutrition
KW  - *Peroxides/to [Toxicity]
KW  - Prostaglandin D2/aa [Analogs & Derivatives]
KW  - Prostaglandin D2/an [Analysis]
KW  - *Pulmonary Alveoli/pp [Physiopathology]
T2  - Redox biology
VL  - 2
SN  - 2213-2317
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=med11&NEWS=N&AN=25009773
AD  - Netherlands
AB  - BACKGROUND: Bronchopulmonary dysplasia is one of the main complications associated with extreme prematurity. Oxidative stress is suspected to be a trigger event of this lung disease, which is characterized by impaired alveolar development. Peroxides, mainly ascorbylperoxide and H2O2, are known contaminant of parenteral nutrition. We hypothesize that these oxidant molecules induce bronchopulmonary dysplasia development. The aim was to determine if the infusion of ascorbylperoxide, whether in presence or absence of H2O2, is associated with oxidative stress, apoptosis and loss of alveoli in the lungs of newborn guinea pigs., METHOD: Three-day-old guinea pigs received parenteral solutions containing 0, 20, 60 or 180 microM ascorbylperoxide in the presence or not of 350 microM H2O2 (concentrations similar to those measured in parenteral nutrition). After 4 days, the lungs were collected for determination of glutathione's redox potential, caspase-3 activation (an apoptosis marker), alveolarization index (by histology), activation of Nrf2 and NF?B (biological markers of oxidative stress), and IL-6 and PGJ2 levels (markers of NF?B activation). Groups were compared by ANOVA, p < 0.05., RESULTS: Loss of alveoli was associated with ascorbylperoxide in a dose-dependent manner, without an influence of H2O2. The dose-dependent activation of caspase-3 by ascorbylperoxide was lower in the presence of H2O2. Ascorbylperoxide induced an increase of redox potential in a dose-dependent manner, which reached a plateau in presence of H2O2. Nrf2 and NF?B were activated by H2O2 but not by ascorbylperoxide., CONCLUSION: Results suggest that ascorbylperoxide, generated in parenteral nutrition, is involved in the development of bronchopulmonary dysplasia, independently of the increase of the redox potential. This study underlines the importance of developing a safer formulation of parenteral nutrition.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70200584
TI  - Nutritional assessment of children with bronchopulmonary dysplasia until the fourth year of age
AU  - Moreno R.A.
AU  - Ceccon M.E.J.
AU  - Falcao M.C.
AU  - Redondo A.C.
Y1  - 2010//
KW  - *child
KW  - *lung dysplasia
KW  - *perinatal care
KW  - *nutritional assessment
KW  - prematurity
KW  - nutritional status
KW  - general aspects of disease
KW  - congenital infection
KW  - weight
KW  - nutritional deficiency
KW  - head circumference
KW  - World Health Organization
KW  - gestational age
KW  - respiratory function
KW  - follow up
KW  - growth, development and aging
KW  - dysplasia
KW  - congenital malformation
KW  - genetic disorder
KW  - questionnaire
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 23
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - R.A. Moreno, Department of Pediatria, Universidade de Sao Paulo, Sao Paulo, Brazil
DO  - https://dx.doi.org/10.3109/14767051003802503
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70200584
AB  - Brief Introduction: The bronchopulmonary dysplasia (BPD) can cause an important nutritional deficit during the first years of life. The aim of the study was to analyze the nutritional state until the 4th year of age in premature children with bronchopulmonary dysplasia. Material(s) and Method(s): The study encloses children born prematurely with BPD, who had regular medical visits until the 4th year. The children were excluded presented beyond the bronchopul-monary dysplasia congenital malformations, genetic syndromes, congenital infections or neurological illnesses. They had monthly medical visits in the 1st year of life, every 3 months during the 2nd, and every 6 months until complete 4 years. In each visit, they had the weight, length, and head circumference measurements, and alimentary questionnaire. For the anthropometric data, the correction of the prematurity was applied. Clinical Cases or Summary Results: Thirty children were studied who had filled the inclusion and exclusion criteria. Ten children (33%) born with gestational age lesser than 28 weeks. In relation to the growth, using the curves of the WHO (2006), only 20% of the sample placed below of the Z score 73 at the 4th year of age. Conclusion(s): The bronchopulmonary dysplasia causes innumerable alterations in respiratory function, nutritional status, and neurological development. It is extremely important that these children have a differentiated follow-up, in order to precociously detect the growth and development alterations, and to prevent and/or minimize the sequels of this sever illness.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70200246
TI  - Antenatal inflammation influences caveolin expression and associated cellular signalling pathways in preterm lungs
AU  - Kunzmann S.
AU  - Speer C.P.
AU  - Yang Y.
AU  - Jobe A.H.
AU  - Uhlig S.
AU  - Kramer B.W.
Y1  - 2010//
KW  - *lung
KW  - *inflammation
KW  - *perinatal care
KW  - protein expression
KW  - phosphorylation
KW  - down regulation
KW  - vascularization
KW  - modulation
KW  - upregulation
KW  - chorioamnionitis
KW  - airway
KW  - sheep
KW  - premature labor
KW  - pregnancy
KW  - lung dysplasia
KW  - *caveolin
KW  - endotoxin
KW  - messenger RNA
KW  - sphingomyelin
KW  - acivicin
KW  - STAT3 protein
KW  - sphingomyelin phosphodiesterase
KW  - heme oxygenase 1
KW  - sodium chloride
KW  - ceramide
KW  - carbon 14
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 23
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - S. Kunzmann, Department of Neonatology, University Childen's Hospital Wurzburg, Germany
DO  - https://dx.doi.org/10.3109/14767051003802503
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70200246
AB  - Brief Introduction: Chorioamnionitis (CA) is associated with bronchopulmonary dysplasia (BPD). In lungs, caveolins (Cav) have been implicated in airway-and vascular remodelling by modulating signalling pathway like the Stat- and Smad-signalling pathway and influencing activity of sphingomyelinase(aSMase) and heme oxygenase 1(HO-1). We asked whether CA-associated antenatal inflammation affects Cav-1 expression in preterm lungs and alters Smad- and Stat-signalling, and activity of aSMase and HO-1. Material(s) and Method(s): Fetal sheep were exposed to 4 mg of intra-amniotic (IA) endotoxin or saline for 2, 7, or 2 + 7 days before preterm delivery at 125 days gestation (full term= 150 days). Expression of Cav-1, HO-1, ceramide, and phosphorylation of Smad's and Stat's were evaluated by RT-PCR, WP, or IH. aSMase activity was measured by using 14C-labelled sphingomyelin. Clinical Cases or Summary Results: IA endotoxin decreased lung Cav-1 mRNA and protein expression in the LPS exposed groups, with a maximum decrease of Cav-1 mRNA of 60% and of Cav-1 protein expression of 75% in the 2 days exposed group. Decreased Cav-1 levels were associated with elevated phosphorylation of Smad2/3 and Stat3. Pulmonary aSMase activity (38-fold) and HO-1 expression (7.3-fold) were elevated in the 7 days LPS exposed group. Conclusion(s): The antenatal inflammation-induced down-regulation of pulmonary Cav-1 expression may contribute to impaired lung alveolarization and vascularization in BPD by modulation of the Smad-and Stat-signalling pathways, up-regulation of the HO-1, and increasing aSMase activity.
ER  -
TY  - JFULL
TY  - journalArticle
DB  - Embase
AN  - 70200167
TI  - Antenatal steroids and antioxidant enzyme activity in preterm infants
AU  - Vento M.
AU  - Escrig R.
AU  - Izquierdo I.
AU  - Escobar J.
AU  - Arduini A.
AU  - Sastre J.
AU  - Asensi M.A.
Y1  - 2010//
KW  - *perinatal care
KW  - *prematurity
KW  - *enzyme activity
KW  - oxidative stress
KW  - antioxidant activity
KW  - female
KW  - retrolental fibroplasia
KW  - supplementation
KW  - boy
KW  - gender
KW  - survival
KW  - newborn
KW  - umbilical cord blood
KW  - cohort analysis
KW  - oxidation
KW  - artificial ventilation
KW  - lung dysplasia
KW  - brain hemorrhage
KW  - *steroid
KW  - *antioxidant
KW  - enzyme
KW  - glutathione
KW  - DNA
KW  - protein
KW  - tyrosine
KW  - phenylalanine
KW  - oxygen
KW  - glutathione disulfide
T2  - Journal of Maternal-Fetal and Neonatal Medicine
LA  - English
VL  - 23
IS  - SUPPL. 1
PB  - Informa Healthcare
SN  - 1476-7058
AD  - M. Vento, Division of Neonatology, University Hospital La Fe, Valencia, Spain
DO  - https://dx.doi.org/10.3109/14767051003802495
UR  - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed11&NEWS=N&AN=70200167
AB  - Antenatal steroids have improved the survival of preterm infants; however, the mechanism of action is not fully understood. We aimed to establish an association between antenatal steroids and antioxidant activity and postnatal oxidative stress. In a prospective cohort study, extremely preterm neonates receiving antenatal steroids (CORT) or not (NOCORT) were enrolled. An association between antenatal steroids and activities of antioxidant enzymes and glutathione cycle enzymes in cord blood was found. In addition, reduced oxidative stress (GSH = GSSG ratio, CORT vs. NOCORT, 35.6812.20 vs. 28.389.92; p <0.01) and, decreased oxidation of proteins (ortho-tyrosine = phenylalanine ratio, CORT vs. NOCORT, 8.662.45 vs. 12.554.41; p <0.01) and DNA (8oxodG = 2dG ratio, CORT vs. NOCORT, 6.732.18 vs. 9.533.83; p <0.01) also was found. Antenatal steroids were associated with reduced oxygen supplementation, mechanical ventilation, and conditions such as bronchopulmonary dysplasia, intra-periventricular hemorrhage, or retinopathy of prematurity. The maximal effectiveness was when steroids were administered 2-4 days before delivery. Female preterm infants had less oxidative stress and increased antioxidant activity and better clinical outcomes than did male infants, independent of receiving or not antenatal steroids. Antenatal steroids are accompanied by a reduction in postnatal oxidative-stress-derived conditions and increased antioxidant enzyme activity. Both these effects seem to be influenced by specific timing and female gender.
ER  -
